data_3zg4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3zg4 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 358' ' ' LYS . 8.4 m . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 107.396 -1.335 . . . . 1.04 107.396 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' A' ' 344' ' ' TYR . 17.8 p90 -163.33 -170.84 2.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.76 0.791 . . . . 0.94999999999999996 111.04 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.591 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -103.85 156.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.603 -1.18 . . . . 1.02 107.938 166.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.472 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.7 tt0 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.171 0.896 . . . . 0.17000000000000001 110.595 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 465' ' ' VAL . 66.8 t -149.27 137.27 14.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.614 -1.176 . . . . 1.03 109.098 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -120.42 115.02 22.68 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.077 -1.083 . . . . 0.37 108.077 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.7 mm? -66.2 -48.37 70.85 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 123.099 1.428 . . . . 1.0600000000000001 110.195 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.32 -52.01 49.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 112.623 -2.081 . . . . 1.51 112.901 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -102.71 9.74 38.99 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.191 -1.368 . . . . 0.91000000000000003 108.664 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.825 ' NE2' HD13 ' A' ' 368' ' ' ILE . 15.1 mm100 36.09 72.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 125.154 1.534 . . . . 2.6299999999999999 111.8 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.6 t60 -150.11 126.41 10.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.641 -1.163 . . . . 0.17000000000000001 109.469 -176.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.573 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.1 ttp -112.99 128.34 56.47 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.659 0.783 . . . . 0.97999999999999998 110.618 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.674 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.75 173.61 6.34 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.513 -1.221 . . . . 0.11 111.889 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.631 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 1.2 t80 -125.1 115.92 21.26 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.336 -1.727 . . . . 1.02 106.336 165.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 357' ' ' TYR . 27.9 m-85 -101.24 127.29 47.89 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.153 0.978 . . . . 0.90000000000000002 112.021 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.592 ' HA ' HG22 ' A' ' 343' ' ' THR . 2.8 ttpt -148.26 137.19 21.81 Favored 'General case' 0 N--CA 1.399 -3.023 0 CA-C-N 113.376 -1.738 . . . . 1.21 108.628 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.45 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.9 OUTLIER 71.29 13.84 6.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 113.159 -1.837 . . . . 0.59999999999999998 108.992 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.89 74.97 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 112.783 -2.008 . . . . 0.23999999999999999 111.771 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.573 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.09 168.11 19.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 105.991 -1.855 . . . . 1.26 105.991 -171.037 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.573 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.6 m -101.05 139.02 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-O 124.164 1.935 . . . . 1.26 111.868 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 356' ' ' TYR . . . -92.67 -25.01 18.45 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 109.675 -3.421 . . . . 1.03 108.586 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.645 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.42 155.2 35.9 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 113.711 -1.586 . . . . 1.01 109.222 -171.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.674 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.79 122.63 1.41 Allowed 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.736 -0.665 . . . . 0.60999999999999999 109.498 -176.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.653 ' HB ' HG12 ' A' ' 449' ' ' VAL . 4.7 t -147.11 166.9 25.5 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.631 0.729 . . . . 0.98999999999999999 110.823 173.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 48.1 m-20 -84.23 148.76 26.54 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.984 -1.488 . . . . 1.8799999999999999 106.984 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.825 HD13 ' NE2' ' A' ' 352' ' ' GLN . 1.4 pp -144.37 -178.32 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.841 0.713 . . . . 1.04 111.535 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.681 ' HA ' ' NE2' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -149.85 118.5 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.449 -0.796 . . . . 1.04 109.56 173.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 443' ' ' ILE . 34.3 p -141.32 142.55 33.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.835 -1.075 . . . . 1.0 111.699 -165.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.785 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.04 44.62 29.25 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 116.678 1.431 . . . . 0.13 116.678 162.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.597 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.65 144.56 3.47 Favored Pre-proline 0 C--O 1.221 -0.439 0 CA-C-N 118.639 1.219 . . . . 1.2 110.187 -174.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.804 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.12 -28.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.553 1 C-N-CA 126.056 4.504 . . . . 0.26000000000000001 116.215 -172.518 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.597 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -85.45 -32.13 22.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.265 0.555 . . . . 1.0600000000000001 110.813 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.464 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 11.8 m -140.91 72.9 28.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 122.14 0.971 . . . . 1.0800000000000001 110.155 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.785 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.3 Cg_exo -70.85 161.28 46.63 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 125.269 3.979 . . . . 0.19 114.39 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.562 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.64 151.73 89.27 Favored Pre-proline 0 N--CA 1.435 -1.219 0 CA-C-N 113.375 -1.738 . . . . 1.04 110.835 175.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.539 ' CD ' HG21 ' A' ' 377' ' ' THR . 2.0 Cg_endo -81.04 -51.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 125.144 3.896 . . . . 0.10000000000000001 113.886 -171.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.645 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 69.35 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.301 0.852 . . . . 1.01 113.301 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.89 -124.97 1.29 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 114.302 -1.317 . . . . 0.11 111.417 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 381' ' ' VAL . 13.0 p -126.04 108.17 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 122.093 0.949 . . . . 1.54 109.222 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.623 ' CB ' HG23 ' A' ' 463' ' ' VAL . 91.8 m-85 -113.68 155.87 24.76 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.128 -0.942 . . . . 0.26000000000000001 109.633 -170.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 1.641 ' HE1' ' CE2' ' A' ' 383' ' ' TYR . 10.6 m-85 -147.06 139.83 25.01 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 117.872 0.306 . . . . 1.1799999999999999 110.447 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.604 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -74.66 124.3 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 119.88 -0.728 . . . . 1.05 110.895 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -107.5 1.96 23.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.314 -0.857 . . . . 0.20000000000000001 111.925 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.711 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.2 t30 -164.63 150.26 10.19 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.189 -0.914 . . . . 0.40999999999999998 110.276 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -111.28 119.41 38.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.783 0.802 . . . . 1.8200000000000001 110.138 171.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.576 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -118.54 122.1 41.84 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.589 -1.187 . . . . 0.38 111.076 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -120.43 136.96 54.57 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.416 -1.265 . . . . 1.96 109.95 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.6 t70 52.21 38.82 25.58 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 123.584 1.659 . . . . 0.40000000000000002 107.292 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.576 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -91.74 170.44 9.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 112.329 -2.214 . . . . 0.98999999999999999 111.907 -175.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 15.5 m -129.86 104.54 7.44 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.691 -1.595 . . . . 1.02 109.545 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.694 HD11 ' N ' ' A' ' 393' ' ' LEU . 10.1 mp -72.02 155.0 40.8 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.147 -1.842 . . . . 1.03 109.713 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' A' ' 393' ' ' LEU . 10.3 mtpt . . . . . 0 N--CA 1.4 -2.931 0 CA-C-N 114.704 -1.134 . . . . 1.26 108.415 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.7 mt-10 . . . . . 0 CA--C 1.508 -0.667 0 CA-C-O 122.604 1.192 . . . . 0.62 112.224 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.672 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -141.59 98.85 6.4 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.443 -2.162 . . . . 1.9099999999999999 107.562 172.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.72 103.38 0.84 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.496 2.131 . . . . 0.22 110.613 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.578 ' HB ' HD12 ' A' ' 393' ' ' LEU . 1.2 t -115.55 161.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-N 114.332 -1.304 . . . . 1.0900000000000001 110.242 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.555 ' N ' HG11 ' A' ' 407' ' ' VAL . 18.0 m-80 -113.4 -32.23 6.31 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.5 -1.682 . . . . 1.8400000000000001 107.501 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.622 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 67.1 m-85 -136.56 116.02 12.78 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.828 -1.987 . . . . 0.88 110.713 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.557 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.4 t-105 -125.01 135.21 52.56 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.656 -1.156 . . . . 0.14999999999999999 110.379 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.444 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.3 OUTLIER -136.07 86.3 26.26 Favored Pre-proline 0 C--N 1.3 -1.583 0 CA-C-N 114.941 -1.027 . . . . 1.03 111.205 174.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.694 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.9 Cg_endo -71.44 139.93 35.58 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 122.993 2.462 . . . . 0.23999999999999999 112.427 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -124.03 -15.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.751 -1.568 . . . . 1.03 110.941 -174.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -133.72 165.28 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.171 -0.922 . . . . 1.5900000000000001 109.582 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -98.47 15.22 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.215 0.45 . . . . 0.33000000000000002 112.215 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.8 p -95.04 -26.81 15.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.601 -1.259 . . . . 1.1499999999999999 107.601 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.75 31.72 1.01 Allowed Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 112.927 -1.942 . . . . 0.28000000000000003 111.971 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.593 HG11 ' O ' ' A' ' 441' ' ' GLY . 81.6 t -101.6 148.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.204 0.525 . . . . 0.96999999999999997 110.775 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 171.57 -167.49 40.56 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.735 -1.12 . . . . 0.13 111.191 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.74 139.53 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.875 -0.787 . . . . 1.03 108.875 175.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.618 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 30.9 p80 -149.2 163.31 37.99 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.823 0.821 . . . . 0.17000000000000001 111.792 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.749 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.92 138.27 31.72 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.091 -1.413 . . . . 0.41999999999999998 107.453 172.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.474 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.8 OUTLIER -131.36 101.07 5.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.48 1.133 . . . . 2.0 109.057 -174.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -95.18 -35.26 11.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.953 -1.931 . . . . 0.34999999999999998 111.562 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -63.53 -26.96 68.94 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.398 -1.274 . . . . 0.19 109.055 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.776 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.81 83.42 36.39 Favored Pre-proline 0 CA--C 1.498 -1.035 0 CA-C-N 113.404 -1.726 . . . . 1.3300000000000001 109.966 -172.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -80.93 5.53 6.15 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 124.901 3.734 . . . . 0.28000000000000003 114.649 -160.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.2 156.35 23.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.975 0.417 . . . . 1.1000000000000001 111.021 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.83 125.15 2.31 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.653 -1.158 . . . . 0.98999999999999999 109.312 -171.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.94 -166.3 28.87 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 119.659 -1.258 . . . . 0.13 111.769 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.632 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.02 155.67 0.0 OUTLIER Glycine 0 C--N 1.339 0.745 0 O-C-N 125.21 1.182 . . . . 0.23000000000000001 112.989 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.425 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.7 m-20 -56.36 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 123.97 1.843 . . . . 0.33000000000000002 112.134 -147.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 51.3 mt -96.49 -32.62 12.2 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 110.342 -3.117 . . . . 1.05 108.055 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.553 ' HA ' HG21 ' A' ' 369' ' ' VAL . 4.4 p-90 -46.24 -37.27 7.0 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 124.002 0.814 . . . . 0.22 111.15 -174.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.804 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 40.2 mttt -59.28 -27.19 65.61 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.695 -1.138 . . . . 1.29 112.762 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -112.3 -36.41 5.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.604 -0.726 . . . . 1.0700000000000001 109.908 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.541 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.7 mtp85 -84.53 -15.46 45.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.542 -1.208 . . . . 0.41999999999999998 113.038 -167.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.483 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.03 41.58 31.92 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 116.769 1.468 . . . . 0.20999999999999999 116.769 159.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.6 m -85.74 131.73 34.27 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 118.272 1.036 . . . . 0.81999999999999995 109.228 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -97.05 67.43 2.21 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.67 -0.643 . . . . 0.5 111.358 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.593 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 87.46 -13.6 59.93 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.213 -1.155 . . . . 0.19 110.213 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.0 p -86.15 140.92 29.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.708 -0.746 . . . . 1.22 110.164 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.562 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -94.98 115.33 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.549 0.69 . . . . 1.04 111.087 -176.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.776 ' OD1' ' HB3' ' A' ' 426' ' ' GLN . 0.1 OUTLIER -76.66 89.41 3.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.606 -1.179 . . . . 2.29 111.021 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 32.0 m -91.22 140.62 25.79 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.47 0.652 . . . . 1.02 109.335 174.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 49.7 Cg_exo -57.84 136.27 74.26 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.801 2.334 . . . . 0.12 111.836 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.749 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.6 Cg_exo -55.72 -32.49 84.22 Favored 'Trans proline' 0 CA--C 1.501 -1.133 0 C-N-CA 124.244 3.296 . . . . 0.16 113.069 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.5 p -82.02 -38.7 24.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.63 -1.168 . . . . 1.47 110.348 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.653 HG12 ' HB ' ' A' ' 366' ' ' THR . 59.0 t -80.64 -29.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.374 0.607 . . . . 1.0600000000000001 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.681 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.3 tpt -67.92 -19.18 64.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.945 0.878 . . . . 1.0 109.969 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.04 -22.54 42.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.442 -1.254 . . . . 1.4399999999999999 110.777 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.98 -46.85 14.47 Favored 'General case' 0 CA--C 1.476 -1.89 0 CA-C-N 112.991 -1.913 . . . . 0.38 107.438 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.623 HD21 ' SD ' ' A' ' 450' ' ' MET . 27.2 tp -64.76 -67.19 0.46 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 111.872 -2.422 . . . . 1.0 112.486 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.457 ' HB2' ' HE1' ' A' ' 450' ' ' MET . 19.3 t80 -50.47 -26.18 4.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.0 1.381 . . . . 0.40000000000000002 108.066 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.31 -30.24 67.37 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 112.517 -2.129 . . . . 0.13 112.296 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.645 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.05 -48.42 7.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.775 0.797 . . . . 1.02 111.444 171.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.591 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.8 OUTLIER -103.38 138.01 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 123.415 1.578 . . . . 1.04 114.103 -167.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -137.22 -178.18 5.09 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 110.754 -2.93 . . . . 0.82999999999999996 106.778 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.711 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.0 mtmt -51.48 161.28 0.49 Allowed 'General case' 0 N--CA 1.412 -2.354 0 CA-C-O 122.894 1.331 . . . . 1.04 112.534 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.55 -28.95 8.29 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-N 112.646 -2.07 . . . . 0.37 112.185 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 462' ' ' PRO . 10.0 m -84.96 140.9 37.39 Favored Pre-proline 0 N--CA 1.433 -1.292 0 N-CA-C 108.534 -0.913 . . . . 1.01 108.534 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.93 173.69 13.65 Favored 'Trans proline' 0 N--CA 1.416 -3.084 0 C-N-CA 121.097 1.198 . . . . 0.17000000000000001 111.738 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.623 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.31 159.54 35.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.642 -1.244 . . . . 1.75 107.642 167.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.472 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.8 tp -130.27 146.11 51.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 115.159 -0.928 . . . . 1.04 110.046 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.645 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 146.82 20.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.292 -1.373 . . . . 1.02 107.292 165.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.454 ' CE2' ' HG2' ' A' ' 346' ' ' GLU . 19.9 p90 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.533 -0.746 . . . . 1.1599999999999999 111.464 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 358' ' ' LYS . 97.2 m . . . . . 0 N--CA 1.426 -1.669 0 N-CA-C 108.539 -0.911 . . . . 1.04 108.539 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.654 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 8.5 p90 -162.44 -170.32 2.4 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.461 -1.245 . . . . 0.94999999999999996 110.489 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.605 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.9 mm -102.19 157.32 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.071 -1.085 . . . . 1.02 108.071 165.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.472 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.6 tt0 -139.06 154.39 48.19 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 118.617 0.644 . . . . 0.17000000000000001 110.543 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.544 HG23 ' HG3' ' A' ' 354' ' ' MET . 53.5 t -149.98 136.38 12.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.035 -0.984 . . . . 1.03 109.988 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -117.19 116.31 27.03 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.703 -1.135 . . . . 0.37 108.24 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.7 mm? -69.02 -49.03 61.29 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.53 1.157 . . . . 1.0600000000000001 110.452 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.69 -54.82 36.78 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.835 -1.984 . . . . 1.51 112.213 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -96.62 10.08 39.61 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.559 -1.201 . . . . 0.91000000000000003 108.601 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.752 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.1 mm-40 38.16 71.85 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 125.315 1.634 . . . . 2.6299999999999999 111.98 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.449 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -152.68 124.91 8.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.548 -0.751 . . . . 0.17000000000000001 109.634 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.544 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.7 ttp -111.87 128.61 56.18 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.667 -0.697 . . . . 0.97999999999999998 110.3 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.678 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.25 173.05 6.55 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 114.595 -1.184 . . . . 0.11 111.899 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.639 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 0.3 OUTLIER -125.38 112.78 16.71 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.621 -1.992 . . . . 1.02 105.621 163.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 357' ' ' TYR . 25.6 m-85 -94.97 125.09 39.4 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.499 -0.88 . . . . 0.90000000000000002 110.963 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.523 ' HA ' HG21 ' A' ' 343' ' ' THR . 37.3 ttmt -134.42 137.38 43.98 Favored 'General case' 0 N--CA 1.387 -3.583 0 CA-C-N 114.332 -1.304 . . . . 1.21 109.68 173.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.32 12.22 7.05 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 112.941 -1.936 . . . . 0.59999999999999998 109.092 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 358' ' ' LYS . . . 88.61 14.28 61.73 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 112.79 -2.005 . . . . 0.23999999999999999 112.301 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -128.36 172.65 10.89 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.383 -2.081 . . . . 1.26 105.383 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.621 ' CG2' ' HG2' ' A' ' 365' ' ' GLU . 3.5 m -104.86 136.01 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 CA-C-O 124.318 2.009 . . . . 1.26 112.316 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.538 ' HB1' ' CD1' ' A' ' 356' ' ' TYR . . . -89.49 -25.13 21.6 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.408 -3.542 . . . . 1.03 108.355 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.589 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.7 tp -154.71 154.18 32.48 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.051 -1.431 . . . . 1.01 108.927 -172.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.678 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.22 121.51 1.42 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 123.514 0.509 . . . . 0.60999999999999999 109.913 -175.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.612 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.3 t -148.62 167.41 25.52 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 122.225 1.012 . . . . 0.98999999999999999 112.12 175.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.567 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.2 p-10 -84.73 141.71 30.35 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 113.238 -1.801 . . . . 1.8799999999999999 107.893 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.631 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -142.32 -171.91 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 1.04 112.091 -176.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.752 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -158.31 114.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.035 -0.984 . . . . 1.04 109.283 177.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.508 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 15.0 t -141.93 145.46 34.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.908 -1.042 . . . . 1.0 112.802 -167.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.11 44.95 33.67 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 116.747 1.459 . . . . 0.13 116.747 162.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.577 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.75 143.42 6.04 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 118.601 1.2 . . . . 1.2 110.456 -174.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.803 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.13 -32.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.749 4.299 . . . . 0.26000000000000001 116.089 -171.29 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.577 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 2.0 p -80.23 -35.36 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.36 0.6 . . . . 1.0600000000000001 110.816 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.488 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.1 m -139.77 72.2 35.68 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 122.291 1.043 . . . . 1.0800000000000001 109.688 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.727 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.5 Cg_exo -70.21 162.92 40.52 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 125.253 3.969 . . . . 0.19 114.007 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.567 HG23 HD12 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.82 149.5 83.14 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 113.625 -1.625 . . . . 1.04 110.001 174.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.559 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.5 Cg_endo -76.89 -49.0 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 125.108 3.872 . . . . 0.10000000000000001 113.283 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.655 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.69 121.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.965 1.098 . . . . 1.01 113.965 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.45 -126.31 1.51 Allowed Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 113.995 -1.457 . . . . 0.11 110.613 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.431 HG11 ' O ' ' A' ' 381' ' ' VAL . 14.5 p -126.18 108.98 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.935 0.874 . . . . 1.54 108.96 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.609 ' CE2' HG23 ' A' ' 465' ' ' VAL . 53.0 m-85 -113.14 170.1 8.46 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.381 -0.827 . . . . 0.26000000000000001 109.16 -173.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 79.0 m-85 -150.8 139.81 21.02 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.239 -0.282 . . . . 1.1799999999999999 110.239 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.573 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.68 121.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.691 -0.804 . . . . 1.05 110.328 176.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . 0.422 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 46.6 p-90 -109.66 3.0 20.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.492 -0.777 . . . . 0.20000000000000001 112.422 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.701 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.0 t30 -161.13 144.72 13.07 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.579 -1.267 . . . . 0.40999999999999998 107.579 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 387' ' ' LYS . 0.3 OUTLIER -118.56 109.85 16.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.324 1.059 . . . . 1.8200000000000001 108.506 -177.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.562 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -116.73 130.6 56.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.41 -1.268 . . . . 0.38 110.829 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.79 135.12 48.06 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 113.738 -1.574 . . . . 1.96 109.601 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 23.2 t70 52.95 40.53 31.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 123.298 1.523 . . . . 0.40000000000000002 107.357 -173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.551 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.19 170.42 9.41 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 112.223 -2.262 . . . . 0.98999999999999999 111.807 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 5.2 m -127.84 105.53 8.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.942 -1.481 . . . . 1.02 110.157 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.72 HD11 ' N ' ' A' ' 393' ' ' LEU . 9.9 mp -74.41 158.35 34.04 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.061 -1.881 . . . . 1.03 110.767 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.4 mtpt . . . . . 0 N--CA 1.396 -3.17 0 CA-C-N 114.72 -1.127 . . . . 1.26 108.818 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.0 mt-10 . . . . . 0 CA--C 1.512 -0.489 0 CA-C-O 122.167 0.984 . . . . 0.62 112.028 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.693 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.95 99.97 9.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 113.268 -1.787 . . . . 1.9099999999999999 107.75 176.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.02 102.31 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.741 2.294 . . . . 0.22 110.493 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 393' ' ' LEU . 1.2 t -116.36 160.77 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-N 114.483 -1.235 . . . . 1.0900000000000001 110.563 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.541 ' N ' HG11 ' A' ' 407' ' ' VAL . 18.0 m-80 -113.3 -31.48 6.58 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.33 -1.759 . . . . 1.8400000000000001 107.564 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.606 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 68.2 m-85 -137.18 116.85 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.143 -1.844 . . . . 0.88 110.898 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.562 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 6.7 t-105 -125.27 134.04 52.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.813 -1.085 . . . . 0.14999999999999999 111.084 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.501 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.5 mtp -134.57 86.68 33.82 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 114.628 -1.169 . . . . 1.03 111.334 173.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.701 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 89.7 Cg_endo -72.96 139.08 29.51 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.846 2.364 . . . . 0.23999999999999999 111.445 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -125.7 -12.85 4.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 1.03 111.055 -172.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.434 ' CG ' ' HG1' ' A' ' 416' ' ' THR . 0.0 OUTLIER -133.95 168.85 18.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.845 . . . . 1.5900000000000001 109.448 173.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.5 14.78 28.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.45 0.907 . . . . 0.33000000000000002 113.45 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.434 ' HG1' ' CG ' ' A' ' 414' ' ' ASP . 37.9 p -99.73 -27.69 13.53 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.916 -1.142 . . . . 1.1499999999999999 107.916 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 134.73 29.72 0.41 Allowed Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 113.814 -1.539 . . . . 0.28000000000000003 112.711 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.666 HG11 ' O ' ' A' ' 441' ' ' GLY . 60.3 t -102.45 146.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.513 0.673 . . . . 0.96999999999999997 111.583 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.19 37.86 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.743 -1.117 . . . . 0.13 111.546 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.441 HG12 ' SD ' ' A' ' 354' ' ' MET . 0.9 OUTLIER -104.82 140.93 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.613 -0.884 . . . . 1.03 108.613 176.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.539 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 31.8 p80 -150.78 166.41 30.54 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.672 0.749 . . . . 0.17000000000000001 111.288 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.749 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.44 136.19 33.29 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.193 -1.367 . . . . 0.41999999999999998 107.482 171.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 6.2 t -130.86 102.72 6.19 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 122.879 1.324 . . . . 2.0 109.435 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.14 -30.57 14.56 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.387 -2.188 . . . . 0.34999999999999998 110.964 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 20.6 p90 -68.66 -27.36 65.92 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.436 -1.256 . . . . 0.19 109.35 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -120.69 80.16 31.59 Favored Pre-proline 0 CA--C 1.496 -1.114 0 CA-C-N 113.788 -1.551 . . . . 1.3300000000000001 109.615 -176.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -83.71 8.65 4.5 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 C-N-CA 125.248 3.965 . . . . 0.28000000000000003 113.991 -163.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -114.22 148.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.207 -0.664 . . . . 1.1000000000000001 109.207 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.567 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -159.47 131.38 6.37 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.841 1.338 . . . . 0.98999999999999999 107.497 -171.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 146.56 -166.76 28.18 Favored Glycine 0 C--N 1.296 -1.684 0 C-N-CA 119.19 -1.481 . . . . 0.13 111.036 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.573 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 152.11 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 O-C-N 125.201 1.177 . . . . 0.23000000000000001 112.834 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.77 101.13 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 123.864 1.792 . . . . 0.33000000000000002 111.766 -145.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.8 mt -96.62 -31.57 12.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 110.524 -3.034 . . . . 1.05 108.213 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.567 ' HA ' HG22 ' A' ' 369' ' ' VAL . 7.3 p-90 -46.34 -38.48 8.83 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.894 0.746 . . . . 0.22 111.425 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.803 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.5 mttt -62.01 -24.85 67.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.115 -0.948 . . . . 1.29 112.819 -175.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.4 p -112.53 -37.45 4.93 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.497 -0.774 . . . . 1.0700000000000001 110.074 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.6 mtp85 -82.44 -18.85 40.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.41999999999999998 112.016 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.02 42.45 24.65 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.709 -1.234 . . . . 0.20999999999999999 115.746 164.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.7 m -85.26 131.54 34.4 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 118.404 1.102 . . . . 0.81999999999999995 108.905 174.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -98.83 68.64 1.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.501 -0.749 . . . . 0.5 110.609 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.666 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 86.32 -7.76 77.21 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.833 -0.907 . . . . 0.19 110.833 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.539 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 13.8 p -94.16 128.56 40.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.657 0.742 . . . . 1.22 110.789 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.567 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -88.47 112.94 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.821 -1.081 . . . . 1.04 110.556 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.529 ' HB2' HG11 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -78.83 88.84 4.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.851 -1.068 . . . . 2.29 111.263 -177.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.582 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 28.5 m -86.69 136.58 34.55 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 108.988 -0.745 . . . . 1.02 108.988 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -54.21 135.41 64.65 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.583 2.188 . . . . 0.12 111.083 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.749 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 29.1 Cg_exo -54.6 -31.66 71.27 Favored 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 124.063 3.175 . . . . 0.16 112.816 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.7 -39.2 24.64 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.4 -1.273 . . . . 1.47 110.338 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 366' ' ' THR . 64.2 t -79.26 -30.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.464 0.65 . . . . 1.0600000000000001 111.355 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.694 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 8.1 tpt -67.31 -19.62 65.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.939 0.876 . . . . 1.0 110.103 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.34 -22.98 43.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.413 -1.267 . . . . 1.4399999999999999 110.572 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' A' ' 456' ' ' MET . 10.8 mm-40 -80.28 -47.86 13.91 Favored 'General case' 0 CA--C 1.474 -1.965 0 CA-C-N 112.803 -1.999 . . . . 0.38 107.293 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.591 HD21 ' SD ' ' A' ' 450' ' ' MET . 23.6 tp -64.68 -67.45 0.43 Allowed 'General case' 0 N--CA 1.401 -2.885 0 CA-C-N 111.85 -2.432 . . . . 1.0 112.631 176.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.649 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 27.8 t80 -51.11 -26.57 6.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.36 1.552 . . . . 0.40000000000000002 107.989 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.429 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.88 -31.37 72.72 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.04 -2.346 . . . . 0.13 111.948 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.668 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.42 -49.21 6.83 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 121.748 0.785 . . . . 1.02 111.116 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.605 ' CB ' HD13 ' A' ' 345' ' ' ILE . 1.2 p -106.71 133.37 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 CA-C-O 123.635 1.683 . . . . 1.04 114.151 -167.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.444 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 9.9 pt-20 -139.93 -177.01 4.79 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 110.379 -3.1 . . . . 0.82999999999999996 106.302 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.642 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.2 mtmt -47.09 155.08 0.31 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 122.854 1.311 . . . . 1.04 113.679 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.37 -34.23 5.27 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 112.169 -2.287 . . . . 0.37 112.71 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.507 ' HB ' HG21 ' A' ' 457' ' ' VAL . 10.5 m -79.88 142.26 56.15 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-O 120.968 0.414 . . . . 1.01 110.035 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.606 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.71 165.01 33.36 Favored 'Trans proline' 0 N--CA 1.433 -2.057 0 C-N-CA 122.353 2.035 . . . . 0.17000000000000001 111.254 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 81.6 t -135.2 134.8 52.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 113.816 -1.538 . . . . 1.75 108.474 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.472 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -113.94 143.44 44.7 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.126 -0.488 . . . . 1.04 110.369 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.655 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.45 149.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.383 -1.34 . . . . 1.02 107.383 165.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.511 ' HA ' ' CB ' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.565 -0.731 . . . . 1.1599999999999999 111.254 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.522 HG21 ' HA ' ' A' ' 358' ' ' LYS . 85.4 m . . . . . 0 N--CA 1.426 -1.665 0 N-CA-C 107.255 -1.387 . . . . 1.04 107.255 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 344' ' ' TYR . 9.7 p90 -156.66 -170.67 3.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.265 -0.88 . . . . 0.94999999999999996 110.625 -174.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.6 HD13 ' CB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.97 161.06 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.271 -1.011 . . . . 1.02 108.271 167.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.457 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.1 tt0 -142.24 155.67 45.26 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.691 0.678 . . . . 0.17000000000000001 111.229 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.613 HG23 ' HG3' ' A' ' 354' ' ' MET . 60.7 t -150.93 138.35 13.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.648 -1.16 . . . . 1.03 109.64 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -117.89 117.74 30.11 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.729 -1.123 . . . . 0.37 107.989 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.7 mm? -72.69 -45.12 60.45 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.589 0.709 . . . . 1.0600000000000001 110.045 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.12 -45.42 93.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.862 -1.517 . . . . 1.51 112.826 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.26 18.26 21.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.687 -1.142 . . . . 0.91000000000000003 108.928 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.649 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.7 mp0 34.3 68.96 0.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.994 -1.912 . . . . 2.6299999999999999 112.773 171.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.499 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.9 t60 -152.47 125.02 8.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.216 0.531 . . . . 0.17000000000000001 109.649 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.613 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.8 ttp -111.25 127.48 55.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.649 -0.705 . . . . 0.97999999999999998 110.28 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.649 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.06 173.37 6.39 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.536 -1.211 . . . . 0.11 111.746 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 0.2 OUTLIER -126.35 116.39 21.13 Favored 'General case' 0 C--O 1.201 -1.468 0 N-CA-C 105.622 -1.992 . . . . 1.02 105.622 163.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.668 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 20.7 m-85 -97.0 125.09 41.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.43 -0.908 . . . . 0.90000000000000002 111.613 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.522 ' HA ' HG21 ' A' ' 343' ' ' THR . 35.6 ttmt -138.23 140.31 39.65 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 113.818 -1.537 . . . . 1.21 109.0 173.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.9 t70 65.41 14.56 9.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.473 -1.694 . . . . 0.59999999999999998 109.036 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.29 16.09 72.52 Favored Glycine 0 N--CA 1.419 -2.44 0 CA-C-N 112.281 -2.236 . . . . 0.23999999999999999 111.968 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.629 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -130.84 172.91 11.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.177 -2.157 . . . . 1.26 105.177 -173.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.629 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 3.8 m -102.73 138.49 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 124.136 1.922 . . . . 1.26 111.604 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.59 ' HB1' ' CD1' ' A' ' 356' ' ' TYR . . . -92.99 -23.81 18.57 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.529 -3.487 . . . . 1.03 108.243 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.664 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -155.3 154.66 32.44 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.942 -1.481 . . . . 1.01 108.72 -172.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.649 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.12 121.87 1.48 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.103 -0.499 . . . . 0.60999999999999999 109.706 -175.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.579 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.7 t -148.1 167.09 25.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 122.473 1.13 . . . . 0.98999999999999999 112.429 174.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.763 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.3 p-10 -83.85 139.92 32.34 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.675 -2.057 . . . . 1.8799999999999999 107.791 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.649 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -143.06 -172.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.501 -0.772 . . . . 1.04 111.886 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.568 HG21 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.59 120.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.006 -0.997 . . . . 1.04 108.856 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.6 t -142.68 145.08 33.05 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.505 -0.77 . . . . 1.0 113.038 -167.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.16 46.6 49.75 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 116.959 1.544 . . . . 0.13 116.959 162.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.555 ' HE2' ' CA ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.71 143.21 4.31 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 118.982 1.391 . . . . 1.2 110.495 -174.283 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.792 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.17 -32.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 1 C-N-CA 125.866 4.377 . . . . 0.26000000000000001 116.22 -170.466 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.414 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 1.6 p -82.71 -32.81 27.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.181 0.515 . . . . 1.0600000000000001 111.081 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.508 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -139.06 72.51 39.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 122.237 1.018 . . . . 1.0800000000000001 110.059 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.706 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.8 Cg_exo -73.35 163.06 38.8 Favored 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.528 4.152 . . . . 0.19 114.18 -177.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.568 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.48 154.17 87.75 Favored Pre-proline 0 N--CA 1.435 -1.211 0 CA-C-N 113.347 -1.751 . . . . 1.04 110.992 175.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.547 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.0 OUTLIER -79.93 -51.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.995 3.797 . . . . 0.10000000000000001 113.641 -172.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.646 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 69.48 122.58 0.03 OUTLIER 'General case' 0 C--O 1.232 0.153 0 N-CA-C 113.474 0.916 . . . . 1.01 113.474 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.67 -124.64 1.25 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.243 -1.344 . . . . 0.11 111.384 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.448 ' O ' HG11 ' A' ' 381' ' ' VAL . 12.7 p -128.23 107.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.547 1.165 . . . . 1.54 109.296 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.648 ' CE2' HG23 ' A' ' 465' ' ' VAL . 96.4 m-85 -109.79 160.25 16.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.755 -1.111 . . . . 0.26000000000000001 109.831 -170.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 80.8 m-85 -148.23 135.73 20.6 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 119.592 -0.242 . . . . 1.1799999999999999 110.609 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.36 123.6 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.337 -0.945 . . . . 1.05 110.656 178.186 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -109.12 2.75 21.29 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.709 -0.678 . . . . 0.20000000000000001 112.284 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.649 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 5.6 t30 -161.52 148.07 14.31 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.198 -1.038 . . . . 0.40999999999999998 108.198 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -117.41 116.67 27.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.948 -1.13 . . . . 1.8200000000000001 107.948 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.573 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -121.49 129.79 53.15 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.689 -1.141 . . . . 0.38 111.045 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.6 mt-10 -128.29 136.1 50.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 113.781 -1.554 . . . . 1.96 109.887 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 38.7 t70 51.67 40.06 26.54 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 123.611 1.672 . . . . 0.40000000000000002 107.213 -172.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.573 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.82 168.19 11.35 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 112.131 -2.304 . . . . 0.98999999999999999 111.581 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 49.6 m -127.26 101.06 6.32 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.657 -1.61 . . . . 1.02 109.959 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.712 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -73.28 157.3 37.31 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 112.765 -2.016 . . . . 1.03 110.16 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 393' ' ' LEU . 9.4 mtpt . . . . . 0 N--CA 1.394 -3.269 0 CA-C-N 114.615 -1.175 . . . . 1.26 108.255 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.674 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 18.1 mt-10 . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 122.459 1.123 . . . . 0.62 112.678 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.712 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.47 99.05 9.74 Favored Pre-proline 0 N--CA 1.422 -1.859 0 CA-C-N 112.965 -1.925 . . . . 1.9099999999999999 108.525 174.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.9 103.67 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.787 2.324 . . . . 0.22 110.604 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.591 HG22 ' HB2' ' A' ' 421' ' ' HIS . 1.2 t -118.42 154.37 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 CA-C-N 114.555 -1.202 . . . . 1.0900000000000001 110.578 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.1 OUTLIER -95.91 -34.47 11.81 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.437 -0.801 . . . . 1.8400000000000001 108.881 174.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.604 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 60.2 m-85 -136.91 115.94 12.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.172 -1.376 . . . . 0.88 111.218 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.555 ' CE3' HD22 ' A' ' 393' ' ' LEU . 9.7 t-105 -123.63 134.54 53.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.002 -1.454 . . . . 0.14999999999999999 111.089 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.542 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.0 OUTLIER -133.97 87.23 35.48 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 114.639 -1.164 . . . . 1.03 111.372 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.2 Cg_endo -73.68 140.0 28.8 Favored 'Trans proline' 0 CA--C 1.505 -0.937 0 C-N-CA 123.164 2.576 . . . . 0.23999999999999999 111.545 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.4 pt -123.35 -17.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.329 -1.305 . . . . 1.03 111.425 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.812 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.0 p30 -136.31 173.75 11.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.5900000000000001 110.124 172.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -100.26 15.84 26.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.829 -0.623 . . . . 0.33000000000000002 111.832 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 16.8 p -97.57 -27.88 14.2 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.051 -1.092 . . . . 1.1499999999999999 108.051 174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.6 26.98 0.91 Allowed Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 113.874 -1.512 . . . . 0.28000000000000003 113.355 173.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.812 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.8 t -103.64 151.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.704 0.764 . . . . 0.96999999999999997 111.394 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.39 -166.06 36.82 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.562 -1.199 . . . . 0.13 110.841 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.73 136.83 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 108.672 -0.862 . . . . 1.03 108.672 175.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.591 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.2 p80 -151.1 168.12 25.61 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.142 0.972 . . . . 0.17000000000000001 110.937 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.728 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.09 150.65 22.64 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.359 -1.746 . . . . 0.41999999999999998 108.363 174.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -138.0 100.34 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.688 1.232 . . . . 2.0 109.989 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -94.61 -31.59 13.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 112.667 -2.061 . . . . 0.34999999999999998 110.189 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . 0.497 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 19.9 p90 -70.17 -27.64 64.69 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 114.52 -1.218 . . . . 0.19 109.296 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.515 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.1 OUTLIER -114.73 81.88 7.61 Favored Pre-proline 0 CA--C 1.492 -1.281 0 CA-C-N 113.821 -1.536 . . . . 1.3300000000000001 109.427 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 27.8 Cg_endo -80.18 5.2 6.19 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 124.788 3.659 . . . . 0.28000000000000003 113.944 -161.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 152.82 32.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 123.702 0.626 . . . . 1.1000000000000001 110.69 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 1.642 ' HE1' ' CE2' ' A' ' 429' ' ' TYR . 0.3 OUTLIER -164.2 125.4 2.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 114.293 -1.321 . . . . 0.98999999999999999 108.084 -172.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.522 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.32 -165.88 28.61 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.633 -1.27 . . . . 0.13 110.206 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.587 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.49 152.53 0.01 OUTLIER Glycine 0 C--N 1.34 0.752 0 O-C-N 125.093 1.114 . . . . 0.23000000000000001 113.178 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.08 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 124.244 1.973 . . . . 0.33000000000000002 112.42 -152.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.5 mt -97.71 -32.5 11.72 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.013 -3.267 . . . . 1.05 107.906 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.568 ' HA ' HG21 ' A' ' 369' ' ' VAL . 6.9 p-90 -47.8 -39.36 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.873 -0.603 . . . . 0.22 111.568 -173.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.792 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 22.7 mttt -60.33 -25.23 65.64 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.919 -1.037 . . . . 1.29 112.595 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 55.5 p -112.09 -36.27 5.41 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.494 -0.775 . . . . 1.0700000000000001 110.306 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.515 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.7 mtp85 -85.49 -16.18 40.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.905 -1.043 . . . . 0.41999999999999998 112.326 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.555 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.84 43.13 28.93 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 119.425 -1.369 . . . . 0.20999999999999999 116.198 162.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.4 m -82.31 130.92 35.21 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 118.185 0.992 . . . . 0.81999999999999995 108.996 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -98.28 67.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.838 -0.539 . . . . 0.5 110.539 -169.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.494 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 89.13 -14.7 60.03 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.392 -1.083 . . . . 0.19 110.392 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.525 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.9 p -86.75 148.19 25.52 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.344 -0.428 . . . . 1.22 110.55 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.568 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -102.47 119.46 50.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.093 -0.503 . . . . 1.04 110.191 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.513 ' HB3' ' OG ' ' A' ' 423' ' ' SER . 8.6 m120 -81.55 89.88 6.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.864 -0.607 . . . . 2.29 111.135 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.6 m -88.06 137.93 31.09 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.285 -0.635 . . . . 1.02 109.285 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.9 Cg_exo -58.6 132.3 47.41 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.905 2.403 . . . . 0.12 113.04 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.728 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.7 Cg_exo -51.07 -40.46 59.42 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.52 2.813 . . . . 0.16 112.052 -169.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.3 m -71.66 -40.83 69.4 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.496 -1.229 . . . . 1.47 109.724 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' A' ' 366' ' ' THR . 84.5 t -76.51 -31.09 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.626 -0.715 . . . . 1.0600000000000001 111.684 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.69 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.4 tpt -66.49 -21.43 66.18 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.966 0.888 . . . . 1.0 110.203 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -76.9 -25.52 53.1 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.18 -1.373 . . . . 1.4399999999999999 111.124 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.704 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -79.07 -47.01 16.93 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 113.41 -1.723 . . . . 0.38 107.392 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.549 HD21 ' SD ' ' A' ' 450' ' ' MET . 24.5 tp -63.75 -67.71 0.41 Allowed 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 111.444 -2.617 . . . . 1.0 112.395 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.632 ' HE1' ' CE2' ' A' ' 454' ' ' PHE . 33.8 t80 -51.77 -26.85 10.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 123.108 1.432 . . . . 0.40000000000000002 107.878 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.02 -29.04 72.46 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 112.404 -2.18 . . . . 0.13 112.079 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.704 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.9 ptp -90.78 -48.75 6.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.617 0.722 . . . . 1.02 111.056 170.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.6 ' CB ' HD13 ' A' ' 345' ' ' ILE . 1.1 p -106.87 134.18 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 123.403 1.573 . . . . 1.04 114.614 -167.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.485 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 7.8 pt-20 -140.15 -176.19 4.51 Favored 'General case' 0 N--CA 1.405 -2.679 0 CA-C-N 110.889 -2.869 . . . . 0.82999999999999996 107.018 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.649 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 49.0 mtmt -45.26 153.43 0.22 Allowed 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 122.88 1.324 . . . . 1.04 113.66 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.6 -30.91 8.44 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 112.191 -2.277 . . . . 0.37 112.312 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.488 ' HB ' HG21 ' A' ' 457' ' ' VAL . 5.0 m -86.76 142.42 34.5 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 109.578 -0.527 . . . . 1.01 109.578 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.644 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -75.62 170.29 20.53 Favored 'Trans proline' 0 N--CA 1.428 -2.349 0 C-N-CA 122.083 1.856 . . . . 0.17000000000000001 111.631 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.634 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.3 158.5 38.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.797 -1.186 . . . . 1.75 107.797 165.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 345' ' ' ILE . 2.3 tp -129.95 145.56 51.63 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.335 -0.848 . . . . 1.04 110.179 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.648 HG23 ' CE2' ' A' ' 382' ' ' PHE . 1.1 m -143.2 148.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.304 -1.369 . . . . 1.02 107.304 165.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.436 ' HE2' ' CG ' ' A' ' 346' ' ' GLU . 13.2 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.772 -0.632 . . . . 1.1599999999999999 111.785 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 358' ' ' LYS . 3.6 m . . . . . 0 N--CA 1.428 -1.54 0 N-CA-C 106.956 -1.498 . . . . 1.04 106.956 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.647 ' HD1' ' CD2' ' A' ' 344' ' ' TYR . 16.4 p90 -160.7 -172.04 3.35 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.643 0.735 . . . . 0.94999999999999996 110.951 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.619 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.8 mm -104.58 159.25 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.002 -1.11 . . . . 1.02 108.002 166.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.496 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -139.95 155.09 47.31 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 118.881 0.764 . . . . 0.17000000000000001 111.036 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.606 HG23 ' HG3' ' A' ' 354' ' ' MET . 65.4 t -150.79 137.09 12.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 114.425 -1.261 . . . . 1.03 109.476 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.481 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 30.2 t0 -118.03 116.32 26.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.737 -1.12 . . . . 0.37 108.219 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.9 mm? -71.96 -44.3 63.78 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.078 0.942 . . . . 1.0600000000000001 109.391 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.481 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 7.1 mm-40 -57.38 -49.48 76.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.876 -1.965 . . . . 1.51 112.515 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -106.29 14.07 27.93 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.352 -1.295 . . . . 0.91000000000000003 109.296 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.611 ' OE1' ' HA2' ' A' ' 431' ' ' GLY . 20.5 mp0 38.87 73.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 125.151 1.532 . . . . 2.6299999999999999 112.096 174.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.5 t60 -155.91 125.26 6.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.243 0.544 . . . . 0.17000000000000001 110.164 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.606 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.5 ttp -110.83 128.33 55.73 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.766 -0.652 . . . . 0.97999999999999998 110.563 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.674 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -114.31 173.95 6.19 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.635 -1.166 . . . . 0.11 112.027 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 1.7 t80 -126.29 119.79 28.28 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.963 -1.866 . . . . 1.02 105.963 164.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.648 ' HD2' ' CD1' ' A' ' 357' ' ' TYR . 22.6 m-85 -103.9 130.79 51.53 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.159 0.981 . . . . 0.90000000000000002 111.811 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.569 ' HA ' HG22 ' A' ' 343' ' ' THR . 4.4 ttpt -147.73 136.13 21.58 Favored 'General case' 0 N--CA 1.398 -3.028 0 CA-C-N 113.206 -1.815 . . . . 1.21 108.338 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.428 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.1 t70 71.63 13.15 6.34 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.375 -1.739 . . . . 0.59999999999999998 108.573 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.01 83.51 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 112.788 -2.005 . . . . 0.23999999999999999 112.02 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.632 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -124.9 169.58 11.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.668 -1.975 . . . . 1.26 105.668 -172.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.632 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 3.2 m -102.18 138.76 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.819 0 CA-C-O 124.258 1.98 . . . . 1.26 112.092 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.496 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -92.56 -24.67 18.66 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 109.322 -3.581 . . . . 1.03 108.656 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.665 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -152.93 154.72 35.61 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.927 -1.488 . . . . 1.01 109.168 -172.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.674 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.37 121.96 1.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.002 -0.545 . . . . 0.60999999999999999 110.196 -174.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.587 ' HB ' HG12 ' A' ' 449' ' ' VAL . 4.5 t -147.22 166.83 25.84 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.517 0.675 . . . . 0.98999999999999999 111.352 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 1.3 m-20 -85.73 149.52 25.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.646 -1.613 . . . . 1.8799999999999999 106.646 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -146.32 -171.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 124.052 0.845 . . . . 1.04 111.305 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.57 HG21 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.16 118.91 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.761 -1.109 . . . . 1.04 108.775 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.457 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.86 146.12 35.43 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.081 -0.963 . . . . 1.0 112.561 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.28 44.82 41.89 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 116.548 1.379 . . . . 0.13 116.548 163.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.511 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.93 144.21 3.94 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-N 118.335 1.068 . . . . 1.2 110.24 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.776 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.49 -31.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.787 1 C-N-CA 125.82 4.346 . . . . 0.26000000000000001 116.278 -170.749 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.511 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.87 -34.82 29.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.014 0.435 . . . . 1.0600000000000001 110.791 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.479 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.9 m -140.53 73.62 29.44 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-O 122.112 0.958 . . . . 1.0800000000000001 110.423 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.66 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -72.29 161.06 45.5 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 125.187 3.925 . . . . 0.19 113.898 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.562 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.3 152.42 88.0 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.518 -1.674 . . . . 1.04 111.395 178.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.537 ' CD ' HG21 ' A' ' 377' ' ' THR . 2.0 Cg_endo -80.93 -49.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 125.234 3.956 . . . . 0.10000000000000001 113.986 -171.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.656 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 69.36 123.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.616 0.969 . . . . 1.01 113.616 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.91 -126.57 1.46 Allowed Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.42 -1.264 . . . . 0.11 111.441 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.46 HG11 ' O ' ' A' ' 381' ' ' VAL . 10.1 p -127.19 98.9 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 122.475 1.131 . . . . 1.54 109.884 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.639 ' CE2' HG23 ' A' ' 465' ' ' VAL . 99.1 m-85 -101.71 162.02 13.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.67 -1.15 . . . . 0.26000000000000001 110.22 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.675 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -147.58 135.57 21.27 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 121.337 -0.145 . . . . 1.1799999999999999 110.878 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.82 124.2 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.741 -0.784 . . . . 1.05 110.612 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.89 2.76 20.03 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.399 -0.818 . . . . 0.20000000000000001 112.183 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.707 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.2 t30 -165.14 151.85 10.44 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.544 -0.753 . . . . 0.40999999999999998 110.3 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -112.25 128.37 56.24 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.802 0.811 . . . . 1.8200000000000001 109.725 170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.582 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.3 mt-10 -129.43 118.56 22.36 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.361 -1.29 . . . . 0.38 112.019 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -115.27 136.73 52.79 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.315 -1.311 . . . . 1.96 110.592 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.5 t70 49.83 37.74 14.14 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.585 1.66 . . . . 0.40000000000000002 107.565 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -89.76 169.7 11.05 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.161 -2.29 . . . . 0.98999999999999999 111.844 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 104.56 8.02 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.812 -1.54 . . . . 1.02 109.991 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.702 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -74.66 158.09 34.22 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.733 -2.031 . . . . 1.03 110.47 173.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.8 mtpt . . . . . 0 N--CA 1.395 -3.209 0 CA-C-N 114.962 -1.017 . . . . 1.26 108.685 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.9 mt-10 . . . . . 0 CA--C 1.506 -0.712 0 CA-C-O 122.162 0.982 . . . . 0.62 111.561 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.702 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.54 98.3 12.4 Favored Pre-proline 0 N--CA 1.419 -1.99 0 CA-C-N 113.168 -1.833 . . . . 1.9099999999999999 107.793 175.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.6 Cg_endo -67.46 102.68 0.73 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.328 2.019 . . . . 0.22 110.091 174.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.581 HG12 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -113.98 159.74 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 CA-C-N 114.4 -1.273 . . . . 1.0900000000000001 109.757 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.476 ' N ' HG11 ' A' ' 407' ' ' VAL . 21.2 m-80 -108.92 -34.23 6.7 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.585 -1.643 . . . . 1.8400000000000001 107.167 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.665 ' HD2' ' CD1' ' A' ' 409' ' ' TYR . 46.9 m-85 -136.43 116.17 13.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.923 -1.944 . . . . 0.88 110.684 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.582 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.3 t-105 -123.02 135.01 54.28 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.931 -1.031 . . . . 0.14999999999999999 110.025 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.466 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -136.36 86.33 24.49 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 114.875 -1.057 . . . . 1.03 110.82 173.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.701 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 78.0 Cg_endo -71.34 140.42 36.89 Favored 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 123.024 2.483 . . . . 0.23999999999999999 112.046 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 6.0 pt -123.65 -16.61 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.972 -1.467 . . . . 1.03 111.111 -172.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.499 ' CG ' ' HG1' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.83 169.37 17.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 1.5900000000000001 109.33 176.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -101.75 14.62 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.242 0.831 . . . . 0.33000000000000002 113.242 -176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.499 ' HG1' ' CG ' ' A' ' 414' ' ' ASP . 23.9 p -98.25 -28.08 13.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.968 -1.123 . . . . 1.1499999999999999 107.968 172.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.86 28.96 0.37 Allowed Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 113.967 -1.469 . . . . 0.28000000000000003 113.259 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 441' ' ' GLY . 97.7 t -102.76 148.23 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.548 0.69 . . . . 0.96999999999999997 111.717 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.75 -166.47 37.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.664 -1.153 . . . . 0.13 111.204 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.63 138.44 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.541 -0.911 . . . . 1.03 108.541 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.584 ' NE2' ' HB2' ' A' ' 442' ' ' CYS . 32.0 p80 -151.24 166.13 31.84 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.869 0.843 . . . . 0.17000000000000001 111.451 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.714 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.68 145.05 24.9 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 113.77 -1.559 . . . . 0.41999999999999998 107.742 173.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.56 102.22 5.23 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 123.32 1.533 . . . . 2.0 110.208 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.93 -30.63 15.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 110.09 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . 0.442 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 10.8 p90 -71.46 -27.28 63.15 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.023 -1.444 . . . . 0.19 109.146 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.44 HE22 ' HD3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.3 82.9 19.32 Favored Pre-proline 0 CA--C 1.49 -1.328 0 CA-C-N 113.762 -1.563 . . . . 1.3300000000000001 108.724 -172.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 35.8 Cg_endo -79.32 3.64 7.3 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 124.571 3.514 . . . . 0.28000000000000003 114.452 -159.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -114.78 156.56 24.63 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.169 0.509 . . . . 1.1000000000000001 111.916 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.488 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -164.08 124.01 2.06 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.115 -1.402 . . . . 0.98999999999999999 108.675 -172.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.541 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.42 -167.49 28.55 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.861 -1.161 . . . . 0.13 111.149 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.648 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.9 154.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 O-C-N 125.389 1.287 . . . . 0.23000000000000001 113.151 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.76 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 111.985 -152.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 53.1 mt -97.32 -32.05 12.08 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 109.962 -3.29 . . . . 1.05 108.086 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.57 ' HA ' HG21 ' A' ' 369' ' ' VAL . 5.5 p-90 -46.44 -37.47 7.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.65 -0.704 . . . . 0.22 111.584 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.776 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 24.4 mttt -60.86 -24.44 65.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.18 -0.918 . . . . 1.29 113.192 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 p -113.95 -35.19 5.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.691 0.758 . . . . 1.0700000000000001 110.256 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.481 ' HD2' HD23 ' A' ' 433' ' ' LEU . 5.8 mtp85 -85.62 -15.34 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.605 -1.18 . . . . 0.41999999999999998 112.481 -169.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.501 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.06 42.0 38.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.256 1.263 . . . . 0.20999999999999999 116.256 159.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.5 m -85.62 130.38 34.58 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 118.485 1.143 . . . . 0.81999999999999995 109.226 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . 0.483 ' NE2' ' HE3' ' A' ' 372' ' ' LYS . 62.2 m80 -101.21 68.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.547 -0.721 . . . . 0.5 110.75 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.567 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 90.92 -14.17 64.08 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.353 -1.099 . . . . 0.19 110.353 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.584 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 23.4 p -89.95 148.14 23.29 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.326 -0.437 . . . . 1.22 110.62 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.562 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -104.15 119.0 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 116.204 -0.453 . . . . 1.04 110.621 -176.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.479 HD21 ' CE1' ' A' ' 421' ' ' HIS . 6.9 m120 -79.28 88.99 4.92 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.609 -0.436 . . . . 2.29 111.186 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 41.3 m -86.97 135.65 35.01 Favored Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 109.17 -0.678 . . . . 1.02 109.17 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 53.0 Cg_exo -55.75 135.37 69.17 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.725 2.283 . . . . 0.12 111.398 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.714 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.0 Cg_exo -54.8 -33.89 82.84 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 C-N-CA 124.225 3.284 . . . . 0.16 112.99 -173.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 67.8 m -79.24 -39.02 34.19 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.783 -1.098 . . . . 1.47 110.06 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.587 HG12 ' HB ' ' A' ' 366' ' ' THR . 97.8 t -78.8 -30.48 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 1.0600000000000001 111.408 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.679 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.9 tpt -67.56 -19.0 65.21 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.788 0.804 . . . . 1.0 110.32 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -80.03 -22.88 41.88 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 114.528 -1.215 . . . . 1.4399999999999999 110.839 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.68 -46.78 15.01 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 112.921 -1.945 . . . . 0.38 107.329 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.651 HD21 ' SD ' ' A' ' 450' ' ' MET . 25.8 tp -64.64 -66.58 0.52 Allowed 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 111.906 -2.406 . . . . 1.0 112.423 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.632 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 32.6 t80 -50.34 -25.16 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 123.059 1.409 . . . . 0.40000000000000002 108.247 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.63 -28.66 66.94 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 112.486 -2.143 . . . . 0.13 112.507 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.665 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -92.2 -48.18 6.83 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.783 0.802 . . . . 1.02 111.614 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.619 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.8 OUTLIER -103.94 136.75 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 123.344 1.545 . . . . 1.04 113.953 -167.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -136.56 -178.49 5.2 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 110.916 -2.856 . . . . 0.82999999999999996 106.583 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.4 mtmt -51.71 160.85 0.6 Allowed 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 123.114 1.435 . . . . 1.04 112.958 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.75 7.91 Favored Glycine 0 N--CA 1.426 -2.033 0 CA-C-N 112.527 -2.124 . . . . 0.37 112.528 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 462' ' ' PRO . 6.1 m -82.01 142.95 48.69 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 109.308 -0.627 . . . . 1.01 109.308 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.643 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.36 168.75 23.92 Favored 'Trans proline' 0 N--CA 1.426 -2.48 0 C-N-CA 121.855 1.703 . . . . 0.17000000000000001 111.262 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.6 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.2 m -136.32 155.13 34.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.125 -1.435 . . . . 1.75 107.125 165.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.459 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.4 tp -126.06 145.68 50.22 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.254 -0.885 . . . . 1.04 110.158 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.656 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.0 146.3 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 N-CA-C 106.896 -1.52 . . . . 1.02 106.896 164.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.496 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 16.4 p90 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.229 -0.891 . . . . 1.1599999999999999 111.431 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.517 HG21 ' HA ' ' A' ' 358' ' ' LYS . 98.5 m . . . . . 0 N--CA 1.417 -2.089 0 CA-C-O 121.566 0.698 . . . . 1.04 109.189 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 4.7 p90 -159.12 -170.61 3.06 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.012 -1.449 . . . . 0.94999999999999996 110.637 -174.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.622 HD13 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -99.87 159.64 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 108.073 -1.084 . . . . 1.02 108.073 166.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.507 ' CG ' HD21 ' A' ' 464' ' ' LEU . 3.2 tt0 -138.68 154.1 48.58 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.074 -0.65 . . . . 0.17000000000000001 111.146 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.563 HG23 ' HG3' ' A' ' 354' ' ' MET . 64.1 t -149.98 134.33 9.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 114.263 -1.335 . . . . 1.03 109.436 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 15.4 t0 -115.57 124.5 51.15 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.714 -1.13 . . . . 0.37 108.377 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.4 ' O ' ' HG2' ' A' ' 352' ' ' GLN . 2.1 mm? -75.22 -43.81 49.73 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.811 1.291 . . . . 1.0600000000000001 110.525 -177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.439 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 5.4 mm-40 -57.38 -54.96 40.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.623 -2.08 . . . . 1.51 112.816 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 20.58 18.61 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.843 0.83 . . . . 0.91000000000000003 109.752 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.837 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.3 mm-40 35.94 71.25 0.13 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 112.104 -2.316 . . . . 2.6299999999999999 112.16 169.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.475 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -149.19 125.89 11.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.186 -0.916 . . . . 0.17000000000000001 109.174 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.563 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.8 ttp -111.81 127.5 55.83 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.488 0.661 . . . . 0.97999999999999998 110.481 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.666 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -111.55 173.39 6.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.552 -1.204 . . . . 0.11 111.753 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.655 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 1.5 t80 -125.3 111.79 15.61 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.242 -1.762 . . . . 1.02 106.242 165.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 21.9 m-85 -97.47 127.44 43.43 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.766 0.793 . . . . 0.90000000000000002 111.174 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.524 ' HB2' ' HE2' ' A' ' 356' ' ' TYR . 4.3 ttpt -142.86 135.35 27.62 Favored 'General case' 0 N--CA 1.398 -3.049 0 CA-C-N 113.964 -1.471 . . . . 1.21 108.297 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.8 t70 71.26 11.37 6.78 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 113.209 -1.814 . . . . 0.59999999999999998 108.806 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.84 68.81 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 112.763 -2.017 . . . . 0.23999999999999999 111.757 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -129.66 167.0 18.66 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.15 -1.796 . . . . 1.26 106.15 -172.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.583 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.1 m -101.91 138.68 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 CA-C-O 124.429 2.062 . . . . 1.26 112.21 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.423 ' CB ' ' CD1' ' A' ' 356' ' ' TYR . . . -93.61 -25.45 17.52 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 109.341 -3.572 . . . . 1.03 108.671 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.625 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.71 155.26 36.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 113.627 -1.624 . . . . 1.01 108.891 -172.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.666 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.38 122.12 1.45 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.691 -0.686 . . . . 0.60999999999999999 109.473 -175.087 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.597 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.3 t -148.95 166.68 27.89 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.326 1.06 . . . . 0.98999999999999999 112.224 173.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.721 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.6 p-10 -84.54 139.62 32.01 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.936 -1.938 . . . . 1.8799999999999999 107.737 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -141.46 -172.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.163 -0.926 . . . . 1.04 111.724 -175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.837 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.22 120.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.127 -0.942 . . . . 1.04 109.26 175.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.5 t -141.84 144.58 33.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.56 0.948 . . . . 1.0 113.56 -165.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.743 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.63 45.96 50.01 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 116.771 1.468 . . . . 0.13 116.771 161.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.537 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -48.09 144.04 6.2 Favored Pre-proline 0 CA--C 1.511 -0.535 0 CA-C-N 118.263 1.031 . . . . 1.2 111.342 -176.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.8 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.02 -31.91 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.564 1 C-N-CA 125.88 4.387 . . . . 0.26000000000000001 115.671 -172.88 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.537 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 0.9 OUTLIER -78.94 -36.89 41.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.263 -0.426 . . . . 1.0600000000000001 110.838 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.468 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -141.44 72.74 25.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-O 122.174 0.988 . . . . 1.0800000000000001 110.15 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.4 Cg_exo -69.33 162.38 42.07 Favored 'Trans proline' 0 C--N 1.322 -0.837 1 C-N-CA 125.357 4.038 . . . . 0.19 114.245 -176.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.572 HG21 ' CD ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -74.0 152.46 88.66 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 113.581 -1.645 . . . . 1.04 110.647 176.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.572 ' CD ' HG21 ' A' ' 377' ' ' THR . 0.9 OUTLIER -79.68 -49.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 125.076 3.851 . . . . 0.10000000000000001 113.461 -172.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.653 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.05 124.25 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.974 0.892 . . . . 1.01 113.267 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 162.63 -122.48 1.11 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.445 -1.252 . . . . 0.11 111.405 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 381' ' ' VAL . 10.2 p -130.77 106.62 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-O 121.979 0.895 . . . . 1.54 109.283 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.62 ' CE2' HG23 ' A' ' 465' ' ' VAL . 52.2 m-85 -111.48 167.53 10.25 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.223 -0.899 . . . . 0.26000000000000001 109.282 -172.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.694 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 82.2 m-85 -149.02 138.46 21.7 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 110.618 -0.141 . . . . 1.1799999999999999 110.618 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.586 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -72.82 122.77 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 119.67 -0.812 . . . . 1.05 110.476 175.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -109.79 3.87 21.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.46 -0.791 . . . . 0.20000000000000001 112.286 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.656 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 8.0 t30 -163.88 148.03 10.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.279 -1.008 . . . . 0.40999999999999998 108.279 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -118.98 114.9 23.27 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.196 0.998 . . . . 1.8200000000000001 108.43 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -118.84 132.54 56.12 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.28 -1.327 . . . . 0.38 110.298 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -131.68 134.51 46.03 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.026 -1.443 . . . . 1.96 109.622 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 52.69 40.45 30.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 123.435 1.588 . . . . 0.40000000000000002 107.479 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.568 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.76 169.53 9.95 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 112.35 -2.204 . . . . 0.98999999999999999 111.683 -172.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 7.7 m -126.57 106.49 9.47 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 113.956 -1.474 . . . . 1.02 109.926 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 8.3 mp -71.02 158.9 35.72 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.986 . . . . 1.03 110.626 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.442 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.3 mtpt . . . . . 0 N--CA 1.393 -3.3 0 O-C-N 124.39 1.056 . . . . 1.26 108.529 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 12.6 mt-10 . . . . . 0 CA--C 1.511 -0.53 0 CA-C-O 122.037 0.922 . . . . 0.62 112.038 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.5 m -144.12 99.18 5.05 Favored Pre-proline 0 N--CA 1.428 -1.536 0 CA-C-N 113.835 -1.529 . . . . 1.9099999999999999 110.418 -177.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 73.7 Cg_endo -67.18 109.01 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 125.236 3.957 . . . . 0.22 113.492 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -122.82 151.73 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-N 114.559 -1.201 . . . . 1.0900000000000001 111.405 -173.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.598 ' H ' HD21 ' A' ' 408' ' ' ASN . 0.1 OUTLIER -93.61 -28.83 15.79 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.457 -1.247 . . . . 1.8400000000000001 110.065 177.252 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.598 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 67.5 m-85 -142.77 119.66 11.27 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.296 . . . . 0.88 110.601 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.607 ' CE3' ' HB3' ' A' ' 421' ' ' HIS . 6.1 t-105 -125.56 135.15 51.92 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.606 -1.179 . . . . 0.14999999999999999 111.112 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.535 ' SD ' ' CD2' ' A' ' 454' ' ' PHE . 1.0 OUTLIER -134.9 86.38 32.79 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.804 -1.089 . . . . 1.03 111.279 174.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 94.7 Cg_endo -72.23 138.61 30.76 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 122.833 2.355 . . . . 0.23999999999999999 111.558 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.2 pt -124.66 -14.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.973 -1.467 . . . . 1.03 110.916 -173.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -133.7 162.81 30.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.449 -0.796 . . . . 1.5900000000000001 109.7 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -94.11 14.29 20.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.022 0.378 . . . . 0.33000000000000002 112.022 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.1 p -93.27 -25.6 17.7 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.565 -1.272 . . . . 1.1499999999999999 107.565 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 121.59 26.31 1.99 Allowed Glycine 0 N--CA 1.426 -2.031 0 CA-C-N 112.773 -2.012 . . . . 0.28000000000000003 111.63 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 441' ' ' GLY . 55.9 t -98.07 146.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.165 0.507 . . . . 0.96999999999999997 111.0 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.75 -165.0 36.06 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.923 -1.035 . . . . 0.13 111.464 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -105.53 137.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.693 -0.854 . . . . 1.03 108.693 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.614 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.7 p80 -154.16 170.58 20.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 122.011 0.91 . . . . 0.17000000000000001 111.582 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.719 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 153.52 20.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.523 -1.671 . . . . 0.41999999999999998 108.766 174.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.549 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 3.4 p -141.24 99.65 3.62 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 122.827 1.298 . . . . 2.0 109.833 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.35 -31.13 13.57 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 112.457 -2.156 . . . . 0.34999999999999998 109.992 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . 0.546 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 9.2 p90 -68.23 -26.88 65.92 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 114.354 -1.294 . . . . 0.19 108.923 173.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.571 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -119.38 82.42 24.26 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.613 -1.63 . . . . 1.3300000000000001 110.135 -175.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.76 5.02 6.2 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 C-N-CA 124.802 3.668 . . . . 0.28000000000000003 114.211 -161.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.33 153.25 30.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.406 0.441 . . . . 1.1000000000000001 110.07 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 429' ' ' TYR . 0.5 OUTLIER -163.15 127.98 3.04 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.99 1.316 . . . . 0.98999999999999999 107.86 -173.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.28 -167.72 29.02 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 119.689 -1.243 . . . . 0.13 111.05 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.601 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.15 156.64 0.0 OUTLIER Glycine 0 C--N 1.341 0.857 0 O-C-N 124.935 1.021 . . . . 0.23000000000000001 113.225 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.468 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -54.92 100.62 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 123.692 1.711 . . . . 0.33000000000000002 111.579 -148.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 32.8 mt -97.21 -31.16 12.58 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 110.611 -2.995 . . . . 1.05 109.453 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.48 ' HA ' HG21 ' A' ' 369' ' ' VAL . 14.8 p-90 -49.06 -32.32 9.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 112.881 -1.963 . . . . 0.22 111.729 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.8 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 53.4 mttt -64.06 -19.67 65.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.297 0.851 . . . . 1.29 113.297 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 72.5 p -120.72 -36.64 3.13 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.644 -0.707 . . . . 1.0700000000000001 110.628 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.571 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.2 mtp85 -82.05 -15.04 54.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.65 -1.159 . . . . 0.41999999999999998 112.773 -169.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.528 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.82 41.42 33.89 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 116.554 1.381 . . . . 0.20999999999999999 116.554 159.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 18.4 m -85.81 131.97 34.21 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 118.225 1.013 . . . . 0.81999999999999995 109.563 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -97.68 68.74 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.683 -0.635 . . . . 0.5 110.85 -170.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.579 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 85.4 -9.81 66.15 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.819 -0.913 . . . . 0.19 110.819 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 20.8 p -89.52 137.58 32.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.946 -0.627 . . . . 1.22 110.079 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -96.77 113.12 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.618 -0.719 . . . . 1.04 110.483 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.549 ' HB3' ' OG ' ' A' ' 423' ' ' SER . 2.2 m-20 -80.76 92.12 6.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.006 . . . . 2.29 111.678 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 98.0 m -89.44 140.85 28.48 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.542 -0.754 . . . . 1.02 109.572 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 53.3 Cg_exo -55.08 136.81 74.7 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.803 2.335 . . . . 0.12 111.202 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.719 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 58.4 Cg_exo -55.96 -32.94 87.65 Favored 'Trans proline' 0 CA--C 1.5 -1.199 0 C-N-CA 124.195 3.263 . . . . 0.16 112.634 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.7 p -79.64 -38.35 33.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.522 -1.217 . . . . 1.47 109.719 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.597 HG12 ' HB ' ' A' ' 366' ' ' THR . 84.3 t -78.54 -30.44 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.522 -0.763 . . . . 1.0600000000000001 111.439 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.671 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -64.47 -23.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.893 0.854 . . . . 1.0 110.426 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -75.42 -27.02 58.82 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.408 -1.269 . . . . 1.4399999999999999 111.916 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.9 mm-40 -77.6 -46.19 22.92 Favored 'General case' 0 CA--C 1.472 -2.045 0 CA-C-N 113.489 -1.687 . . . . 0.38 106.991 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 457' ' ' VAL . 24.6 tp -65.4 -67.78 0.41 Allowed 'General case' 0 N--CA 1.401 -2.903 0 CA-C-N 111.472 -2.604 . . . . 1.0 112.601 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 0.535 ' CD2' ' SD ' ' A' ' 411' ' ' MET . 31.4 t80 -51.31 -27.16 8.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.183 1.468 . . . . 0.40000000000000002 107.988 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.425 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.06 -31.02 74.33 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 112.116 -2.311 . . . . 0.13 112.064 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.644 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.26 -48.39 7.4 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.834 0.826 . . . . 1.02 111.189 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.622 ' CB ' HD13 ' A' ' 345' ' ' ILE . 1.1 p -107.19 134.36 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-O 123.344 1.545 . . . . 1.04 114.461 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.52 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 12.6 pt-20 -139.81 -176.55 4.61 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 110.948 -2.842 . . . . 0.82999999999999996 107.032 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.656 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.9 mtmt -46.21 154.42 0.27 Allowed 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 123.032 1.396 . . . . 1.04 113.578 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 95.22 -24.75 27.47 Favored Glycine 0 C--N 1.292 -1.913 0 CA-C-N 112.275 -2.239 . . . . 0.37 112.821 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.495 ' HB ' HG21 ' A' ' 457' ' ' VAL . 6.6 m -89.3 142.23 29.67 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 109.685 -0.487 . . . . 1.01 109.685 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.604 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.9 Cg_exo -74.64 168.3 25.13 Favored 'Trans proline' 0 N--CA 1.43 -2.209 0 C-N-CA 122.067 1.844 . . . . 0.17000000000000001 111.571 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 69.8 t -135.46 134.77 52.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 113.869 -1.514 . . . . 1.75 108.265 173.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.507 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.7 tp -112.93 143.43 44.23 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.157 0.503 . . . . 1.04 110.408 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.653 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.13 146.64 21.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.74 -1.578 . . . . 1.02 106.74 164.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 379' ' ' ALA . 21.0 p90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.523 -0.751 . . . . 1.1599999999999999 111.217 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 358' ' ' LYS . 6.9 m . . . . . 0 N--CA 1.423 -1.823 0 N-CA-C 108.518 -0.919 . . . . 1.04 108.518 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.662 ' HE1' ' CE2' ' A' ' 344' ' ' TYR . 14.0 p90 -164.66 -169.81 1.84 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.136 -0.938 . . . . 0.94999999999999996 110.443 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.622 HD13 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -103.57 158.07 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.178 -0.919 . . . . 1.02 108.6 166.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.476 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.6 tt0 -140.07 155.91 46.82 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 118.89 0.768 . . . . 0.17000000000000001 111.131 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.586 HG23 ' HG3' ' A' ' 354' ' ' MET . 56.3 t -151.07 138.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.721 -1.127 . . . . 1.03 109.432 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.45 115.35 23.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.723 -1.126 . . . . 0.37 108.076 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 349' ' ' LEU . 2.0 mm? -66.51 -47.83 71.71 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.789 1.281 . . . . 1.0600000000000001 110.319 -175.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -55.38 -53.87 50.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.49 -2.141 . . . . 1.51 112.384 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -98.03 10.34 40.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 114.093 -1.412 . . . . 0.91000000000000003 108.51 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.895 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.0 mm-40 38.01 69.48 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 125.316 1.635 . . . . 2.6299999999999999 111.841 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 365' ' ' GLU . 7.7 t60 -148.16 125.96 11.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.273 -0.876 . . . . 0.17000000000000001 109.729 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.586 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.0 ttp -113.0 127.96 56.37 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.57 0.7 . . . . 0.97999999999999998 110.428 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.679 ' CD1' HG12 ' A' ' 362' ' ' VAL . 32.0 m-90 -112.78 173.16 6.51 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 114.386 -1.279 . . . . 0.11 111.76 -176.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 0.2 OUTLIER -125.25 113.65 17.91 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.97 -1.863 . . . . 1.02 105.97 163.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.661 ' HE2' ' CE1' ' A' ' 357' ' ' TYR . 22.1 m-85 -95.35 126.0 40.36 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.90000000000000002 112.028 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 343' ' ' THR . 4.0 ttpt -148.19 139.02 23.07 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 113.293 -1.776 . . . . 1.21 108.305 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.63 14.89 6.1 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.677 -1.601 . . . . 0.59999999999999998 109.0 178.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.59 16.45 77.67 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.555 -2.111 . . . . 0.23999999999999999 111.653 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.662 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.5 OUTLIER -138.37 178.44 7.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.238 -2.134 . . . . 1.26 105.238 -170.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.679 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.0 m -107.0 135.67 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-O 124.093 1.901 . . . . 1.26 112.517 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.523 ' HB1' ' CD1' ' A' ' 356' ' ' TYR . . . -86.29 -26.0 25.19 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 109.412 -3.54 . . . . 1.03 108.009 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.657 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.25 154.68 36.23 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 113.953 -1.476 . . . . 1.01 109.785 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.482 ' HB2' ' HE2' ' A' ' 353' ' ' HIS . 2.0 pt-20 -162.41 121.99 2.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 110.533 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.612 ' HB ' HG12 ' A' ' 449' ' ' VAL . 6.0 t -149.35 167.28 26.55 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 122.352 1.072 . . . . 0.98999999999999999 112.662 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.579 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.0 p-10 -86.11 141.5 29.36 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 112.925 -1.943 . . . . 1.8799999999999999 107.64 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.659 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -141.79 -176.31 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.546 -0.752 . . . . 1.04 112.356 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.895 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -151.71 116.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.051 -0.977 . . . . 1.04 110.322 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 56.5 p -140.53 141.09 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.475 0.916 . . . . 1.0 113.475 -163.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.81 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.54 46.86 45.34 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 116.961 1.545 . . . . 0.13 116.961 162.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.534 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 6.1 pttt -46.05 145.71 2.4 Favored Pre-proline 0 C--O 1.216 -0.678 0 CA-C-N 119.318 1.559 . . . . 1.2 111.041 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.801 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.3 OUTLIER -37.95 -31.19 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 125.244 3.962 . . . . 0.26000000000000001 115.276 -175.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.3 p -81.88 -33.33 30.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 1.0600000000000001 111.096 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.491 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -140.47 71.61 31.8 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 122.134 0.969 . . . . 1.0800000000000001 110.066 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.81 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.1 Cg_exo -69.93 163.0 40.04 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 125.552 4.168 . . . . 0.19 115.451 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.554 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.64 154.5 87.44 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 113.285 -1.779 . . . . 1.04 111.127 172.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.536 ' CD ' HG21 ' A' ' 377' ' ' THR . 3.4 Cg_endo -83.81 -52.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 1 C-N-CA 125.378 4.052 . . . . 0.10000000000000001 114.334 -172.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.662 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 70.64 122.79 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.932 1.086 . . . . 1.01 113.932 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.66 -129.59 1.96 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 114.135 -1.393 . . . . 0.11 111.363 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.78 98.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.363 -0.977 . . . . 1.54 108.363 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.626 ' CE2' HG23 ' A' ' 465' ' ' VAL . 97.0 m-85 -102.69 166.76 10.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.392 -0.822 . . . . 0.26000000000000001 110.484 -169.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.701 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -150.09 139.23 21.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 119.753 -0.165 . . . . 1.1799999999999999 110.62 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.59 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -75.5 119.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 119.723 -0.791 . . . . 1.05 110.432 176.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -107.26 4.5 26.66 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.796 -0.638 . . . . 0.20000000000000001 112.616 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.641 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.6 t30 -162.98 146.3 10.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.766 -1.198 . . . . 0.40999999999999998 107.766 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 387' ' ' LYS . 0.2 OUTLIER -119.45 112.11 18.98 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.102 -1.073 . . . . 1.8200000000000001 108.102 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -118.33 128.21 54.44 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.399 -1.273 . . . . 0.38 111.052 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -128.2 134.21 49.0 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.849 -1.523 . . . . 1.96 109.827 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.5 t70 52.53 39.39 27.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 123.367 1.556 . . . . 0.40000000000000002 107.675 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -94.06 169.84 9.97 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 112.439 -2.164 . . . . 0.98999999999999999 111.546 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 19.9 m -127.12 105.25 8.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.094 -1.412 . . . . 1.02 110.033 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 8.5 mp -71.74 154.66 41.18 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.375 -1.739 . . . . 1.03 109.692 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.427 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 9.7 mtpt . . . . . 0 N--CA 1.402 -2.85 0 CA-C-N 114.583 -1.19 . . . . 1.26 108.26 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.4 mt-10 . . . . . 0 CA--C 1.503 -0.83 0 CA-C-O 122.337 1.065 . . . . 0.62 111.287 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.6 m -143.89 97.76 5.32 Favored Pre-proline 0 N--CA 1.419 -2.019 0 CA-C-N 113.067 -1.878 . . . . 1.9099999999999999 109.06 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.5 106.46 1.25 Allowed 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 124.269 3.313 . . . . 0.22 112.726 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.598 HG22 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -116.79 163.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.695 -1.138 . . . . 1.0900000000000001 111.206 -174.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.585 ' N ' HG11 ' A' ' 407' ' ' VAL . 17.9 m-80 -113.91 -31.51 6.38 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.083 -1.871 . . . . 1.8400000000000001 107.39 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.594 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 70.9 m-85 -136.98 116.16 12.53 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.063 -1.881 . . . . 0.88 110.905 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.566 ' HB2' HG12 ' A' ' 407' ' ' VAL . 5.7 t-105 -124.02 134.15 53.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.44 -1.255 . . . . 0.14999999999999999 110.974 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.85 ' SD ' HG23 ' A' ' 457' ' ' VAL . 5.8 mtm -134.32 88.05 31.38 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 114.728 -1.124 . . . . 1.03 112.28 171.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.641 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.03 137.87 29.94 Favored 'Trans proline' 0 CA--C 1.506 -0.897 0 C-N-CA 123.113 2.542 . . . . 0.23999999999999999 111.744 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.701 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.9 pt -123.51 -16.37 5.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 113.763 -1.562 . . . . 1.03 110.696 -173.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -135.15 158.51 44.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.748 -0.66 . . . . 1.5900000000000001 109.895 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -87.92 13.55 10.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.337 0.495 . . . . 0.33000000000000002 112.337 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 5.8 p -92.15 -25.85 18.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.444 -1.317 . . . . 1.1499999999999999 107.444 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 120.06 30.79 1.4 Allowed Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 112.933 -1.939 . . . . 0.28000000000000003 111.78 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.578 HG11 ' O ' ' A' ' 441' ' ' GLY . 53.4 t -100.94 147.5 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.384 -0.408 . . . . 0.96999999999999997 110.73 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.27 -168.5 41.27 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.191 -0.913 . . . . 0.13 112.058 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.06 139.55 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.56 -0.904 . . . . 1.03 108.56 175.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.598 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.7 p80 -151.84 164.88 36.13 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.641 0.734 . . . . 0.17000000000000001 112.079 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.73 141.4 28.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 113.931 -1.486 . . . . 0.41999999999999998 107.549 172.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.548 ' HG ' ' HB2' ' A' ' 426' ' ' GLN . 3.6 t -138.57 104.28 5.09 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 123.194 1.473 . . . . 2.0 110.731 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.37 -30.77 14.94 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.798 -2.456 . . . . 0.34999999999999998 110.852 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . 0.41 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 14.6 p90 -68.27 -27.32 66.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.541 -1.209 . . . . 0.19 109.475 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.548 ' HB2' ' HG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -120.1 81.59 28.53 Favored Pre-proline 0 CA--C 1.495 -1.144 0 CA-C-N 113.747 -1.57 . . . . 1.3300000000000001 109.798 -175.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -82.55 6.52 5.71 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 124.833 3.689 . . . . 0.28000000000000003 114.522 -161.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -114.72 151.09 34.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.508 -0.553 . . . . 1.1000000000000001 109.508 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.579 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -160.73 128.25 4.35 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.578 1.151 . . . . 0.98999999999999999 108.115 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.62 -166.53 28.72 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.31 -1.424 . . . . 0.13 111.254 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.593 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.32 152.47 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 O-C-N 125.159 1.152 . . . . 0.23000000000000001 113.006 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.441 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 4.1 m-20 -55.04 101.5 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 123.506 1.622 . . . . 0.33000000000000002 112.136 -146.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.9 mt -96.73 -31.31 12.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 110.856 -2.883 . . . . 1.05 109.364 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.575 ' HA ' HG22 ' A' ' 369' ' ' VAL . 12.8 p-90 -50.0 -31.99 14.13 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 112.84 -1.982 . . . . 0.22 111.871 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.801 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 38.5 mttt -65.27 -20.56 66.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.356 -0.838 . . . . 1.29 112.685 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.0 p -118.65 -37.92 3.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.29 -0.868 . . . . 1.0700000000000001 110.297 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.4 mtp85 -83.35 -16.24 46.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.868 -1.06 . . . . 0.41999999999999998 113.056 -169.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 77.72 40.74 21.31 Favored Glycine 0 C--N 1.31 -0.861 0 N-CA-C 116.895 1.518 . . . . 0.20999999999999999 116.895 159.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 19.8 m -80.72 136.52 36.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 118.26 1.03 . . . . 0.81999999999999995 109.763 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -98.03 65.77 1.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.943 -0.473 . . . . 0.5 110.932 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.578 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 87.29 -14.1 58.44 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.618 -0.993 . . . . 0.19 110.618 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.4 p -85.36 148.58 25.95 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.464 -0.368 . . . . 1.22 110.142 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.554 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -99.37 123.2 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 122.212 1.005 . . . . 1.04 110.934 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.738 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.7 OUTLIER -81.44 83.35 6.98 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.51 -1.677 . . . . 2.29 111.395 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 24.5 m -88.04 138.02 31.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-O 121.558 0.694 . . . . 1.02 109.581 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.7 Cg_exo -57.48 136.15 74.17 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.716 2.277 . . . . 0.12 111.827 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.742 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.5 Cg_exo -53.93 -32.77 69.26 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 124.547 3.498 . . . . 0.16 112.915 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.2 m -79.52 -41.94 26.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.383 -1.281 . . . . 1.47 109.881 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 366' ' ' THR . 65.4 t -78.58 -30.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.558 0.694 . . . . 1.0600000000000001 111.7 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.734 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.24 -19.44 65.52 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.851 0.834 . . . . 1.0 110.294 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -79.31 -23.23 43.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 114.494 -1.23 . . . . 1.4399999999999999 111.01 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.04 -46.98 15.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 113.075 -1.875 . . . . 0.38 107.193 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.642 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.0 tp -64.24 -66.7 0.51 Allowed 'General case' 0 N--CA 1.402 -2.844 0 CA-C-N 111.826 -2.443 . . . . 1.0 112.289 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.667 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 18.0 t80 -52.99 -24.7 10.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.97 1.367 . . . . 0.40000000000000002 108.387 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.52 -26.01 74.07 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 112.533 -2.121 . . . . 0.13 112.025 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.4 ptp -94.97 -49.92 5.34 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.876 0.846 . . . . 1.02 111.161 169.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.85 HG23 ' SD ' ' A' ' 411' ' ' MET . 2.1 p -108.61 132.08 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 CA-C-O 123.585 1.66 . . . . 1.04 114.447 -167.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.419 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 7.3 pt-20 -140.82 -176.85 4.81 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.335 -3.12 . . . . 0.82999999999999996 106.127 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.3 mtmt -45.32 154.24 0.18 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.971 1.367 . . . . 1.04 114.095 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 98.43 -32.75 6.62 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 112.013 -2.358 . . . . 0.37 112.54 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.543 ' HB ' HG21 ' A' ' 457' ' ' VAL . 6.2 m -83.6 143.12 43.56 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.304 -0.628 . . . . 1.01 109.304 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.615 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.36 169.8 21.67 Favored 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 121.789 1.659 . . . . 0.17000000000000001 111.503 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.615 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.29 158.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.891 -1.152 . . . . 1.75 107.891 167.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.476 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.4 tp -130.56 146.2 52.03 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.514 -0.766 . . . . 1.04 110.331 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.7 147.61 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.501 -1.296 . . . . 1.02 107.501 165.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.465 ' HE2' ' CG ' ' A' ' 346' ' ' GLU . 16.9 p90 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.499 -0.762 . . . . 1.1599999999999999 111.402 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 358' ' ' LYS . 3.9 m . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 106.94 -1.504 . . . . 1.04 106.94 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 11.8 p90 -160.16 -170.11 2.72 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.617 0.723 . . . . 0.94999999999999996 111.009 -173.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.536 ' O ' ' HD2' ' A' ' 344' ' ' TYR . 11.7 mm -103.91 160.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.781 -1.099 . . . . 1.02 108.216 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.0 tt0 -140.94 156.1 46.13 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 119.0 0.818 . . . . 0.17000000000000001 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.591 HG23 ' HG3' ' A' ' 354' ' ' MET . 68.3 t -150.62 137.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.663 -1.153 . . . . 1.03 109.625 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.07 106.36 9.54 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 122.153 0.978 . . . . 0.37 108.826 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.9 mm? -63.4 -38.97 93.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 112.89 -1.959 . . . . 1.0600000000000001 111.298 -168.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.88 -57.06 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 111.673 -2.512 . . . . 1.51 112.552 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -95.64 2.74 54.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 114.685 -1.143 . . . . 0.91000000000000003 110.066 -172.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.831 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.4 mm-40 49.54 66.01 1.24 Allowed 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 112.654 -2.066 . . . . 2.6299999999999999 111.406 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.525 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -145.5 127.4 15.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.344 0.592 . . . . 0.17000000000000001 109.725 -176.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.591 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.6 ttp -114.15 128.41 56.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.433 -0.803 . . . . 0.97999999999999998 110.613 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.635 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.54 173.29 6.48 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 114.608 -1.178 . . . . 0.11 112.084 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.617 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 1.1 t80 -124.79 113.43 17.92 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.666 -1.605 . . . . 1.02 106.666 165.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.642 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 19.2 m-85 -96.94 125.41 41.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.303 1.049 . . . . 0.90000000000000002 112.43 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 343' ' ' THR . 3.8 ttpt -149.34 139.46 22.14 Favored 'General case' 0 N--CA 1.398 -3.075 0 CA-C-N 112.827 -1.988 . . . . 1.21 108.091 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.443 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.1 17.62 7.24 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 113.61 -1.632 . . . . 0.59999999999999998 109.011 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.47 18.36 79.19 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 112.466 -2.152 . . . . 0.23999999999999999 111.824 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.654 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -138.82 177.61 7.76 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.798 -1.927 . . . . 1.26 105.798 -169.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.654 ' H ' ' HD3' ' A' ' 361' ' ' LYS . 3.2 m -106.96 138.09 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 CA-C-O 124.008 1.861 . . . . 1.26 112.15 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.437 ' HB1' ' HD2' ' A' ' 356' ' ' TYR . . . -93.03 -23.76 18.56 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 109.587 -3.46 . . . . 1.03 108.479 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.586 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.7 tp -154.4 154.69 33.69 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.712 -1.585 . . . . 1.01 108.977 -172.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.635 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.11 122.43 1.55 Allowed 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.576 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.628 ' HB ' HG12 ' A' ' 449' ' ' VAL . 3.6 t -146.88 166.24 27.31 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.688 0.756 . . . . 0.98999999999999999 111.215 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.462 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 42.1 m-20 -84.84 148.87 26.07 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.463 -1.681 . . . . 1.8799999999999999 106.463 174.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.66 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -144.02 -171.15 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.412 -0.813 . . . . 1.04 110.945 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.831 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -152.99 120.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.995 -1.002 . . . . 1.04 108.604 173.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.488 ' HB2' HG13 ' A' ' 443' ' ' ILE . 5.7 t -143.51 142.91 31.33 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.684 0.994 . . . . 1.0 113.684 -167.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.76 44.78 37.34 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 117.046 1.578 . . . . 0.13 117.046 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.551 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.66 145.02 3.21 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 119.255 1.528 . . . . 1.2 110.509 -174.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.776 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -35.11 -31.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.803 4.336 . . . . 0.26000000000000001 115.972 -173.283 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.551 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -81.17 -35.87 30.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.043 0.449 . . . . 1.0600000000000001 111.033 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.485 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -140.39 72.64 31.43 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 122.227 1.013 . . . . 1.0800000000000001 110.461 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.688 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 24.5 Cg_exo -71.02 163.21 40.05 Favored 'Trans proline' 0 C--N 1.322 -0.817 1 C-N-CA 125.526 4.151 . . . . 0.19 114.153 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.561 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.04 153.61 88.68 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.418 -1.719 . . . . 1.04 110.946 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.55 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.71 -49.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.038 3.825 . . . . 0.10000000000000001 113.673 -171.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.65 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.66 122.87 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.568 0.951 . . . . 1.01 113.568 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.41 -123.55 1.18 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.16 -1.382 . . . . 0.11 111.396 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 14.1 p -127.88 112.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 122.035 0.922 . . . . 1.54 108.915 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.634 ' CE2' HG23 ' A' ' 465' ' ' VAL . 94.3 m-85 -115.74 160.87 19.53 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.027 -0.988 . . . . 0.26000000000000001 109.706 -169.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.75 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 78.5 m-85 -147.63 137.19 22.61 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 119.703 -0.189 . . . . 1.1799999999999999 110.535 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.44 118.2 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 119.258 -0.977 . . . . 1.05 110.172 176.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -106.36 2.15 26.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.385 -0.825 . . . . 0.20000000000000001 112.451 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.675 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -160.24 148.75 16.91 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.815 -1.18 . . . . 0.40999999999999998 107.815 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.5 OUTLIER -119.73 117.88 29.4 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.915 -1.143 . . . . 1.8200000000000001 107.915 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.552 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.5 mt-10 -123.54 128.11 49.27 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.523 -1.217 . . . . 0.38 111.265 -173.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -125.75 135.52 52.14 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 113.559 -1.655 . . . . 1.96 109.393 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.89 38.67 29.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 123.338 1.542 . . . . 0.40000000000000002 107.731 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -93.1 170.14 9.87 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.213 -2.267 . . . . 0.98999999999999999 111.841 -175.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 11.6 m -128.39 104.91 7.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.998 -1.455 . . . . 1.02 110.413 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.696 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -76.57 158.43 31.17 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 112.74 -2.027 . . . . 1.03 110.628 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 8.6 mtpt . . . . . 0 N--CA 1.4 -2.934 0 CA-C-N 115.218 -0.901 . . . . 1.26 109.117 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.6 mt-10 . . . . . 0 CA--C 1.506 -0.738 0 CA-C-O 122.135 0.969 . . . . 0.62 111.52 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.696 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.15 99.25 12.31 Favored Pre-proline 0 N--CA 1.418 -2.072 0 CA-C-N 113.429 -1.714 . . . . 1.9099999999999999 107.726 175.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.42 102.3 0.69 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.348 2.032 . . . . 0.22 110.042 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 421' ' ' HIS . 1.2 t -116.2 160.46 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 114.547 -1.206 . . . . 1.0900000000000001 110.362 -173.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.545 ' N ' HG11 ' A' ' 407' ' ' VAL . 11.3 m-80 -113.59 -32.06 6.3 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.288 -1.778 . . . . 1.8400000000000001 107.377 -174.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.639 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 62.2 m-85 -137.77 115.92 11.73 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.894 -1.957 . . . . 0.88 110.46 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.552 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.1 t-105 -123.56 134.1 53.88 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.932 -1.031 . . . . 0.14999999999999999 110.823 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.519 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.6 mtp -134.06 86.18 37.89 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.705 -1.134 . . . . 1.03 111.297 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.675 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 97.7 Cg_endo -72.5 139.52 31.58 Favored 'Trans proline' 0 CA--C 1.507 -0.862 0 C-N-CA 123.063 2.509 . . . . 0.23999999999999999 111.828 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.97 -14.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 1.03 111.054 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -134.11 164.69 26.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.339 -0.846 . . . . 1.5900000000000001 109.4 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -96.78 14.41 25.25 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.135 0.42 . . . . 0.33000000000000002 112.135 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.2 p -94.41 -27.05 16.24 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.674 -1.232 . . . . 1.1499999999999999 107.674 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.27 31.64 0.83 Allowed Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 112.898 -1.955 . . . . 0.28000000000000003 112.166 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.612 HG11 ' O ' ' A' ' 441' ' ' GLY . 73.3 t -102.3 147.47 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.296 0.569 . . . . 0.96999999999999997 110.914 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.94 -166.18 37.73 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 114.637 -1.165 . . . . 0.13 111.325 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.35 140.3 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.504 -0.925 . . . . 1.03 108.504 175.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.58 ' HB2' HG22 ' A' ' 407' ' ' VAL . 29.4 p80 -151.42 164.26 37.14 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.55 0.69 . . . . 0.17000000000000001 111.428 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.727 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -87.15 146.6 25.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.143 -1.389 . . . . 0.41999999999999998 108.066 172.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.5 m -139.35 102.5 4.5 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.021 1.391 . . . . 2.0 111.003 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.76 -26.96 16.75 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 109.904 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -72.65 -26.6 61.71 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.148 -1.387 . . . . 0.19 109.817 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 80.56 25.17 Favored Pre-proline 0 CA--C 1.491 -1.296 0 CA-C-N 114.005 -1.452 . . . . 1.3300000000000001 108.953 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -81.94 5.54 6.26 Favored 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 125.083 3.855 . . . . 0.28000000000000003 114.121 -162.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -115.07 150.18 36.34 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.986 -0.552 . . . . 1.1000000000000001 109.516 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.462 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.43 125.02 4.23 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.626 1.203 . . . . 0.98999999999999999 108.08 -172.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 148.55 -166.77 29.18 Favored Glycine 0 C--N 1.294 -1.778 0 C-N-CA 119.199 -1.476 . . . . 0.13 111.083 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.631 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.26 153.16 0.0 OUTLIER Glycine 0 C--N 1.338 0.691 0 O-C-N 125.115 1.127 . . . . 0.23000000000000001 113.432 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.415 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.3 m-20 -55.56 100.73 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 123.832 1.777 . . . . 0.33000000000000002 112.063 -147.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.2 mt -96.82 -30.48 13.14 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 110.51 -3.041 . . . . 1.05 108.098 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.563 ' HA ' HG22 ' A' ' 369' ' ' VAL . 6.0 p-90 -47.34 -38.61 13.21 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.791 0.682 . . . . 0.22 111.496 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.776 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 23.8 mttt -60.92 -23.05 64.95 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.306 -0.861 . . . . 1.29 112.855 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 67.5 p -114.4 -37.06 4.44 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.799 0.809 . . . . 1.0700000000000001 110.248 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.0 mtp85 -85.44 -15.61 42.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.691 -1.14 . . . . 0.41999999999999998 112.761 -169.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.509 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.89 41.17 28.74 Favored Glycine 0 C--N 1.313 -0.695 0 N-CA-C 116.128 1.211 . . . . 0.20999999999999999 116.128 159.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' SER . . . . . 0.425 ' OG ' HG21 ' A' ' 369' ' ' VAL . 1.2 m -79.56 141.76 36.32 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 117.823 0.811 . . . . 0.81999999999999995 109.138 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -110.79 71.93 0.76 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.362 -0.836 . . . . 0.5 110.554 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.612 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 83.97 -12.61 52.93 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.377 -1.089 . . . . 0.19 110.377 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.486 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.0 p -90.26 145.05 25.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.213 -0.494 . . . . 1.22 110.595 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.561 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -104.26 115.45 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.717 -0.674 . . . . 1.04 110.416 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.522 ' HB2' HG11 ' A' ' 369' ' ' VAL . 18.7 m120 -79.69 91.96 5.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 2.29 111.217 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 38.3 m -88.45 137.82 30.45 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.29 -0.633 . . . . 1.02 109.29 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.6 Cg_exo -55.67 135.94 71.82 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.892 2.395 . . . . 0.12 111.528 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.727 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 40.2 Cg_exo -54.96 -33.99 84.88 Favored 'Trans proline' 0 CA--C 1.502 -1.08 0 C-N-CA 124.372 3.382 . . . . 0.16 112.864 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.8 m -79.32 -40.11 31.15 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.76 -1.109 . . . . 1.47 109.857 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.628 HG12 ' HB ' ' A' ' 366' ' ' THR . 72.4 t -78.76 -29.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.763 -0.653 . . . . 1.0600000000000001 111.518 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.688 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.2 tpt -68.08 -18.94 64.8 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.916 0.865 . . . . 1.0 110.089 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -79.97 -24.13 41.14 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.432 -1.258 . . . . 1.4399999999999999 110.887 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.1 mm-40 -79.77 -46.95 16.05 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 112.955 -1.929 . . . . 0.38 107.094 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 450' ' ' MET . 22.3 tp -64.88 -67.72 0.41 Allowed 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 111.857 -2.429 . . . . 1.0 112.576 175.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.645 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 30.0 t80 -50.68 -26.37 5.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.054 1.407 . . . . 0.40000000000000002 108.201 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.48 -30.72 68.71 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-N 112.316 -2.22 . . . . 0.13 112.052 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.676 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -88.57 -49.61 6.79 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.729 0.776 . . . . 1.02 110.714 170.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.587 ' HB ' ' HE1' ' A' ' 356' ' ' TYR . 1.3 p -106.91 132.84 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 123.575 1.655 . . . . 1.04 114.39 -167.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.457 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 9.3 pt-20 -139.65 -176.68 4.64 Favored 'General case' 0 N--CA 1.404 -2.738 0 CA-C-N 110.646 -2.979 . . . . 0.82999999999999996 106.469 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.655 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.1 mtmt -45.4 154.14 0.2 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.971 1.367 . . . . 1.04 113.789 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.51 -36.89 3.68 Favored Glycine 0 C--N 1.293 -1.823 0 CA-C-N 112.105 -2.316 . . . . 0.37 112.501 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.51 ' HB ' HG21 ' A' ' 457' ' ' VAL . 4.3 m -79.54 142.76 58.16 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 109.676 -0.491 . . . . 1.01 109.676 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.609 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 6.0 Cg_exo -75.9 169.9 21.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 121.931 1.754 . . . . 0.17000000000000001 111.677 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.91 157.59 38.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.718 -1.216 . . . . 1.75 107.718 165.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.444 HD21 ' HG3' ' A' ' 346' ' ' GLU . 3.0 tp -128.39 145.34 51.11 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.343 -0.844 . . . . 1.04 110.004 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.65 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.33 147.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.158 -1.423 . . . . 1.02 107.158 165.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.449 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 18.4 p90 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.4 -0.81 . . . . 1.1599999999999999 111.026 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.568 HG22 ' HA ' ' A' ' 358' ' ' LYS . 2.3 m . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 107.741 -1.207 . . . . 1.04 107.741 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.632 ' HD1' ' CD2' ' A' ' 344' ' ' TYR . 12.1 p90 -160.11 -171.21 3.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.407 -0.815 . . . . 0.94999999999999996 110.533 -175.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.596 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.5 mm -106.05 161.11 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.25 -1.018 . . . . 1.02 108.25 167.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.468 ' CG ' ' HE2' ' A' ' 466' ' ' PHE . 3.7 tt0 -141.57 155.45 45.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.877 0.762 . . . . 0.17000000000000001 111.12 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 354' ' ' MET . 60.0 t -151.05 137.07 12.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.519 -1.218 . . . . 1.03 109.763 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -116.61 117.7 30.57 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.04 -1.096 . . . . 0.37 108.04 171.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.49 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.9 mm? -72.5 -46.05 56.51 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.705 0.764 . . . . 1.0600000000000001 109.716 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -59.86 -46.46 89.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.542 -1.663 . . . . 1.51 112.601 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -107.62 19.49 20.1 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.91000000000000003 109.161 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.593 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 20.8 mp0 33.6 69.08 0.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 125.743 1.902 . . . . 2.6299999999999999 112.568 171.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.599 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 8.4 t60 -152.06 124.12 8.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.2 0.524 . . . . 0.17000000000000001 110.054 -176.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.6 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.6 ttp -109.82 127.76 54.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.521 0.677 . . . . 0.97999999999999998 110.616 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.644 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.5 m-90 -112.57 173.01 6.58 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.447 -1.251 . . . . 0.11 111.925 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.632 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 3.7 t80 -126.35 118.96 26.14 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.495 -1.668 . . . . 1.02 106.495 165.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 22.4 m-85 -101.12 127.21 47.77 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-O 122.335 1.064 . . . . 0.90000000000000002 112.467 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.568 ' HA ' HG22 ' A' ' 343' ' ' THR . 2.6 ttpt -149.38 139.82 22.42 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-N 112.73 -2.032 . . . . 1.21 107.326 174.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 72.74 15.9 4.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.08 -1.418 . . . . 0.59999999999999998 109.069 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.65 79.0 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 112.523 -2.126 . . . . 0.23999999999999999 111.533 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.648 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 2.2 tppt? -140.17 178.23 7.43 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.446 -1.877 . . . . 1.26 105.961 -167.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.648 ' H ' ' HD3' ' A' ' 361' ' ' LYS . 2.9 m -106.36 138.61 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-O 124.053 1.882 . . . . 1.26 112.328 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.542 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -94.71 -24.59 17.07 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 109.419 -3.537 . . . . 1.03 108.589 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.601 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.4 tp -153.05 154.91 35.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.701 -1.591 . . . . 1.01 108.808 -171.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.644 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.7 122.94 1.21 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.817 -0.629 . . . . 0.60999999999999999 109.475 -174.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.629 ' HB ' HG12 ' A' ' 449' ' ' VAL . 4.6 t -147.56 166.84 26.12 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.564 0.697 . . . . 0.98999999999999999 111.406 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 50.6 m-20 -83.92 147.56 27.42 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.08 -1.452 . . . . 1.8799999999999999 107.08 174.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.593 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.66 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.281 -0.872 . . . . 1.04 111.425 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.561 HG21 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.03 118.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.997 -1.002 . . . . 1.04 108.727 175.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.3 t -142.26 147.85 37.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.327 -0.851 . . . . 1.0 112.306 -168.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.44 45.31 55.01 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 116.736 1.454 . . . . 0.13 116.736 162.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.6 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.28 144.24 3.29 Favored Pre-proline 0 C--O 1.217 -0.611 0 CA-C-N 118.706 1.253 . . . . 1.2 110.309 -175.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.797 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.69 -29.15 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.593 1 C-N-CA 125.75 4.3 . . . . 0.26000000000000001 116.001 -171.977 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.6 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -84.14 -33.92 24.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.4 0.619 . . . . 1.0600000000000001 111.04 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.482 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -140.35 72.08 32.16 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 122.201 1.001 . . . . 1.0800000000000001 110.245 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.733 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.9 Cg_exo -70.78 165.55 31.77 Favored 'Trans proline' 0 C--N 1.324 -0.727 1 C-N-CA 125.368 4.046 . . . . 0.19 114.21 -176.568 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.565 HG23 HD12 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -78.69 152.82 78.08 Favored Pre-proline 0 N--CA 1.435 -1.202 0 CA-C-N 113.799 -1.546 . . . . 1.04 110.427 174.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.56 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.34 -49.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.983 3.788 . . . . 0.10000000000000001 113.311 -172.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.652 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 69.52 122.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.666 0.987 . . . . 1.01 113.666 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.95 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.282 -1.326 . . . . 0.11 111.577 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.441 HG11 ' O ' ' A' ' 381' ' ' VAL . 12.3 p -129.09 106.0 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.307 1.051 . . . . 1.54 109.323 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.649 ' CE2' HG23 ' A' ' 465' ' ' VAL . 96.5 m-85 -109.54 163.88 13.04 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.799 -1.091 . . . . 0.26000000000000001 110.071 -169.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 69.6 m-85 -147.93 137.88 22.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 121.261 -0.176 . . . . 1.1799999999999999 110.749 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.583 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.5 124.6 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.863 -0.735 . . . . 1.05 110.538 177.45 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -109.52 4.49 22.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.533 -0.758 . . . . 0.20000000000000001 112.163 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.702 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.2 t30 -166.52 150.97 7.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.40999999999999998 110.684 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.403 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 12.1 mtpt -109.53 118.68 37.23 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.583 0.706 . . . . 1.8200000000000001 109.86 169.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.6 mt-10 -119.4 112.96 20.07 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 123.034 1.397 . . . . 0.38 112.803 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -108.93 136.58 48.23 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 113.785 -1.552 . . . . 1.96 110.994 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 38.7 t70 51.36 34.74 12.38 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 123.466 1.603 . . . . 0.40000000000000002 107.9 -175.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.15 170.82 10.72 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.21 -2.268 . . . . 0.98999999999999999 111.991 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.0 m -129.32 104.41 7.49 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.742 -1.572 . . . . 1.02 109.64 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.678 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.12 155.06 40.69 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 112.889 -1.959 . . . . 1.03 109.972 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 393' ' ' LEU . 9.6 mtpt . . . . . 0 N--CA 1.404 -2.767 0 O-C-N 124.529 1.143 . . . . 1.26 108.543 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.7 mt-10 . . . . . 0 CA--C 1.507 -0.71 0 CA-C-O 122.764 1.269 . . . . 0.62 112.111 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.678 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -140.1 98.15 7.65 Favored Pre-proline 0 N--CA 1.421 -1.916 0 CA-C-N 112.356 -2.202 . . . . 1.9099999999999999 107.768 172.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 62.9 Cg_endo -68.17 102.66 0.82 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.325 2.017 . . . . 0.22 110.658 175.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.6 HG11 ' N ' ' A' ' 408' ' ' ASN . 1.2 t -115.06 163.84 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.684 -1.144 . . . . 1.0900000000000001 110.393 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.6 ' N ' HG11 ' A' ' 407' ' ' VAL . 19.5 m-80 -115.94 -31.38 5.77 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 113.517 -1.674 . . . . 1.8400000000000001 107.602 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 55.8 m-85 -138.61 115.65 10.92 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.142 -1.845 . . . . 0.88 110.107 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.569 ' HB2' HG12 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.09 135.65 54.48 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.075 -0.966 . . . . 0.14999999999999999 109.95 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.459 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -135.89 85.1 30.12 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.98 -1.009 . . . . 1.03 111.019 174.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.702 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.6 Cg_endo -71.41 140.67 37.15 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.98 2.453 . . . . 0.23999999999999999 112.236 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -124.25 -15.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.841 -1.527 . . . . 1.03 111.105 -173.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -134.36 166.01 23.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 1.5900000000000001 109.328 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.44 13.86 31.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.405 0.52 . . . . 0.33000000000000002 112.405 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.2 p -92.88 -27.1 17.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.342 -1.355 . . . . 1.1499999999999999 107.342 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 126.65 32.25 0.72 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 113.062 -1.881 . . . . 0.28000000000000003 112.36 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.643 HG11 ' O ' ' A' ' 441' ' ' GLY . 72.4 t -102.59 147.62 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 121.24 0.543 . . . . 0.96999999999999997 111.164 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.57 -166.0 38.16 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.979 -1.009 . . . . 0.13 111.621 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.33 140.35 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.846 -0.798 . . . . 1.03 108.846 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.545 ' HB2' HG23 ' A' ' 407' ' ' VAL . 33.4 p80 -150.83 165.42 33.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.763 0.792 . . . . 0.17000000000000001 111.556 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.737 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.53 139.64 30.33 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.936 -1.484 . . . . 0.41999999999999998 107.611 172.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.8 p -128.49 99.79 5.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.897 1.332 . . . . 2.0 109.957 -177.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.0 -34.41 11.78 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 112.497 -2.138 . . . . 0.34999999999999998 110.778 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -67.14 -26.91 66.9 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.566 -1.197 . . . . 0.19 109.213 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.559 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.98 81.91 20.41 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.586 -1.643 . . . . 1.3300000000000001 109.253 -174.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -79.91 5.9 5.63 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 C-N-CA 124.844 3.696 . . . . 0.28000000000000003 113.824 -161.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.76 153.53 30.16 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.945 -0.57 . . . . 1.1000000000000001 111.14 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -164.0 123.72 2.05 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 114.347 -1.297 . . . . 0.98999999999999999 108.341 -172.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.589 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.61 -166.66 28.71 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 119.394 -1.384 . . . . 0.13 110.535 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.621 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.94 151.7 0.0 OUTLIER Glycine 0 C--N 1.34 0.767 0 O-C-N 125.296 1.233 . . . . 0.23000000000000001 113.416 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 124.089 1.9 . . . . 0.33000000000000002 111.913 -152.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 46.5 mt -97.17 -33.47 11.48 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 109.964 -3.289 . . . . 1.05 107.752 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.561 ' HA ' HG21 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.82 -37.48 6.17 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.961 0.788 . . . . 0.22 111.61 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.797 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 35.3 mttt -60.51 -24.4 65.29 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.984 -1.007 . . . . 1.29 112.737 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -114.8 -36.43 4.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.753 0.787 . . . . 1.0700000000000001 110.044 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.559 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.4 mtp85 -83.72 -15.02 50.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.553 -1.203 . . . . 0.41999999999999998 112.724 -169.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.482 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.41 40.9 38.72 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.331 1.292 . . . . 0.20999999999999999 116.331 159.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.4 m -81.88 134.5 35.41 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 118.038 0.919 . . . . 0.81999999999999995 109.612 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -99.28 70.45 1.75 Allowed 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.771 -0.58 . . . . 0.5 110.466 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.643 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 80.72 -7.13 59.56 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.754 -0.938 . . . . 0.19 110.754 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 19.1 p -93.05 131.09 38.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.692 0.758 . . . . 1.22 110.548 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.565 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -91.61 113.74 27.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.978 -1.01 . . . . 1.04 110.494 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.545 HD21 ' N ' ' A' ' 444' ' ' ASN . 0.8 OUTLIER -76.89 89.73 3.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.992 -1.003 . . . . 2.29 110.982 -177.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.582 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 31.5 m -89.05 136.09 30.88 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 109.214 -0.661 . . . . 1.02 109.214 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.2 Cg_exo -57.46 131.93 47.6 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.39 . . . . 0.12 113.107 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.737 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.9 Cg_exo -50.79 -39.1 58.06 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 123.463 2.775 . . . . 0.16 112.398 -168.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 17.0 p -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.529 -1.214 . . . . 1.47 109.974 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.629 HG12 ' HB ' ' A' ' 366' ' ' THR . 68.7 t -78.37 -29.64 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.211 0.529 . . . . 1.0600000000000001 111.252 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.67 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.48 -20.28 65.45 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 122.009 0.909 . . . . 1.0 110.013 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 451' ' ' LYS . 0.1 OUTLIER -75.67 -29.71 59.15 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 114.059 -1.428 . . . . 1.4399999999999999 111.266 176.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -76.05 -47.28 25.29 Favored 'General case' 0 CA--C 1.473 -2.0 0 CA-C-N 112.645 -2.07 . . . . 0.38 107.297 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.604 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.9 tp -64.57 -66.49 0.54 Allowed 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 111.771 -2.468 . . . . 1.0 112.546 175.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 36.6 t80 -50.32 -24.93 3.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.041 1.4 . . . . 0.40000000000000002 108.342 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.8 -28.14 63.49 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 112.432 -2.167 . . . . 0.13 111.967 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.653 ' HB2' ' CE2' ' A' ' 356' ' ' TYR . 1.6 ptp -89.84 -48.4 7.26 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 121.769 0.795 . . . . 1.02 111.461 170.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.596 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.7 OUTLIER -103.21 137.45 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 CA-C-O 123.503 1.62 . . . . 1.04 114.297 -167.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.83 -178.6 5.26 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 110.592 -3.004 . . . . 0.82999999999999996 106.607 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.669 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.5 mtmt -52.1 162.19 0.51 Allowed 'General case' 0 N--CA 1.413 -2.324 0 CA-C-O 123.092 1.425 . . . . 1.04 113.009 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.92 4.55 Favored Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 112.576 -2.102 . . . . 0.37 112.535 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 384' ' ' VAL . 4.3 m -77.04 141.13 67.13 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.231 -0.655 . . . . 1.01 109.231 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.629 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.8 Cg_exo -73.62 167.42 27.3 Favored 'Trans proline' 0 N--CA 1.427 -2.438 0 C-N-CA 121.677 1.585 . . . . 0.17000000000000001 111.106 174.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.614 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.7 156.78 38.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.398 -1.334 . . . . 1.75 107.398 166.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.466 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.1 tp -128.06 145.33 51.03 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 115.552 -0.749 . . . . 1.04 110.17 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.652 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.32 147.72 20.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.962 -1.496 . . . . 1.02 106.962 165.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.504 ' HA ' ' HB2' ' A' ' 379' ' ' ALA . 14.8 p90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.079 -0.962 . . . . 1.1599999999999999 111.573 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.521 HG21 ' HA ' ' A' ' 358' ' ' LYS . 96.2 m . . . . . 0 N--CA 1.426 -1.663 0 N-CA-C 107.754 -1.202 . . . . 1.04 107.754 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.647 ' HE1' ' CE2' ' A' ' 344' ' ' TYR . 10.7 p90 -160.58 -170.73 2.87 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.031 -0.986 . . . . 0.94999999999999996 110.987 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.601 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -102.53 157.2 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 107.693 -1.225 . . . . 1.02 107.693 165.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.474 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.2 tt0 -137.91 154.08 49.46 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 118.59 0.632 . . . . 0.17000000000000001 110.659 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 465' ' ' VAL . 58.0 t -150.81 135.17 9.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.911 -1.04 . . . . 1.03 109.913 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -114.78 117.88 32.0 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.607 -1.179 . . . . 0.37 108.097 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 349' ' ' LEU . 2.0 mm? -72.07 -48.77 41.75 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.335 1.064 . . . . 1.0600000000000001 110.122 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -54.58 -51.68 64.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.026 -1.897 . . . . 1.51 112.374 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -104.4 16.62 25.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.38 -1.282 . . . . 0.91000000000000003 108.914 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.757 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.7 mm-40 34.09 69.27 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 112.94 -1.936 . . . . 2.6299999999999999 112.55 172.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.482 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.8 t60 -150.05 125.38 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.702 -0.681 . . . . 0.17000000000000001 109.561 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.553 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.1 ttp -111.78 128.44 56.1 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.495 0.664 . . . . 0.97999999999999998 110.356 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.604 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 30.9 m-90 -113.07 171.71 7.38 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.438 -1.255 . . . . 0.11 111.636 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.663 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 3.6 t80 -122.3 116.07 23.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.823 -1.918 . . . . 1.02 105.823 164.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 21.0 m-85 -100.82 131.35 46.75 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.739 0.78 . . . . 0.90000000000000002 110.962 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.546 ' HB2' ' HE2' ' A' ' 356' ' ' TYR . 4.6 ttpt -147.7 137.66 22.82 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 114.266 -1.334 . . . . 1.21 108.656 174.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.8 OUTLIER 69.72 18.31 7.54 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 113.104 -1.862 . . . . 0.59999999999999998 108.34 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.01 71.89 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 112.28 -2.236 . . . . 0.23999999999999999 111.834 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.592 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.84 165.39 27.42 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.91 -1.645 . . . . 1.26 106.729 -168.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.592 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 54.5 t -94.66 132.42 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 123.54 1.638 . . . . 1.26 111.632 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.517 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -98.87 -28.14 13.59 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 110.944 -2.844 . . . . 1.03 109.856 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.618 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.2 tp -152.64 148.61 27.52 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.408 -1.269 . . . . 1.01 109.625 -170.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.604 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -158.71 123.02 4.05 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.257 -0.428 . . . . 0.60999999999999999 110.099 -171.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.629 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.9 t -148.93 166.74 27.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 122.402 1.096 . . . . 0.98999999999999999 112.262 172.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.607 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.9 p-10 -86.01 141.27 29.6 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 112.827 -1.988 . . . . 1.8799999999999999 107.418 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.647 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.83 -171.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.477 -0.783 . . . . 1.04 112.155 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.757 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.26 119.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.998 -1.001 . . . . 1.04 109.529 175.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.481 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.8 t -142.35 144.56 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 1.0 112.642 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.02 45.37 26.56 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 116.784 1.474 . . . . 0.13 116.784 163.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.547 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.6 143.08 5.99 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-N 118.921 1.361 . . . . 1.2 110.007 -174.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.765 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -32.94 -31.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.7 1 C-N-CA 126.056 4.504 . . . . 0.26000000000000001 116.471 -170.041 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.449 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.9 p -81.94 -33.75 30.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.208 0.528 . . . . 1.0600000000000001 111.126 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.482 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.8 m -140.16 73.82 31.33 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-O 122.212 1.006 . . . . 1.0800000000000001 109.955 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.73 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.9 Cg_exo -71.21 161.73 44.86 Favored 'Trans proline' 0 C--N 1.319 -0.998 1 C-N-CA 125.308 4.006 . . . . 0.19 113.741 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.553 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.95 152.18 90.84 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-N 113.657 -1.611 . . . . 1.04 110.67 175.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.542 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.4 Cg_endo -80.18 -49.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 125.044 3.829 . . . . 0.10000000000000001 113.497 -171.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.661 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.23 123.04 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.143 0.973 . . . . 1.01 113.545 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.82 -126.31 1.48 Allowed Glycine 0 N--CA 1.436 -1.325 0 CA-C-N 113.895 -1.502 . . . . 0.11 110.671 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 381' ' ' VAL . 10.9 p -129.18 104.46 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.286 1.041 . . . . 1.54 109.346 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.635 ' CE2' HG23 ' A' ' 465' ' ' VAL . 51.1 m-85 -107.78 169.25 8.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.005 -0.998 . . . . 0.26000000000000001 109.173 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.704 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 74.1 m-85 -148.92 138.04 21.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 121.225 -0.19 . . . . 1.1799999999999999 110.579 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.526 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.17 123.66 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 119.833 -0.747 . . . . 1.05 110.123 176.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -111.63 6.48 20.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.412 -0.813 . . . . 0.20000000000000001 111.846 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.673 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.5 t30 -166.7 150.66 7.15 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.401 -0.818 . . . . 0.40999999999999998 110.93 175.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.403 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.7 mtpt -109.99 120.32 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.529 -0.76 . . . . 1.8200000000000001 109.466 169.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.583 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.9 mt-10 -122.58 112.88 18.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 123.29 1.519 . . . . 0.38 113.243 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 24.0 mp0 -108.93 135.38 50.22 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.509 -1.678 . . . . 1.96 111.022 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 24.6 t70 52.23 35.69 17.5 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.582 1.658 . . . . 0.40000000000000002 107.545 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.583 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.03 170.81 10.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.196 -2.275 . . . . 0.98999999999999999 112.225 -175.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 30.5 m -128.12 102.53 6.76 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.341 -1.754 . . . . 1.02 109.937 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.683 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.42 156.49 36.95 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.878 -1.965 . . . . 1.03 110.262 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.449 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 10.3 mtpt . . . . . 0 N--CA 1.401 -2.918 0 O-C-N 124.235 0.959 . . . . 1.26 108.701 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 5.4 mt-10 . . . . . 0 CA--C 1.507 -0.707 0 CA-C-O 122.448 1.118 . . . . 0.62 112.302 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.683 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.21 98.77 9.14 Favored Pre-proline 0 N--CA 1.422 -1.843 0 CA-C-N 113.012 -1.904 . . . . 1.9099999999999999 108.193 174.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.42 102.7 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.454 2.102 . . . . 0.22 110.336 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.56 HG11 ' N ' ' A' ' 408' ' ' ASN . 1.2 t -115.64 160.88 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.397 -1.274 . . . . 1.0900000000000001 110.134 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.56 ' N ' HG11 ' A' ' 407' ' ' VAL . 13.7 m-80 -111.82 -32.85 6.49 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.656 -1.611 . . . . 1.8400000000000001 107.19 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 49.8 m-85 -137.67 115.98 11.87 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.064 -1.88 . . . . 0.88 110.225 175.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.553 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 9.8 t-105 -122.87 135.57 54.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.957 -1.02 . . . . 0.14999999999999999 109.794 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.472 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.5 OUTLIER -136.34 86.07 25.19 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.882 -1.054 . . . . 1.03 110.851 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.6 Cg_endo -72.34 141.5 35.51 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.975 2.45 . . . . 0.23999999999999999 111.691 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.52 -15.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.393 -1.276 . . . . 1.03 111.809 -171.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.817 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 3.9 p30 -135.98 171.03 15.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.778 -0.646 . . . . 1.5900000000000001 110.074 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -98.23 16.43 21.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 0.33000000000000002 111.681 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.9 p -99.65 -27.91 13.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.583 -0.895 . . . . 1.1499999999999999 108.583 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 132.31 26.24 0.68 Allowed Glycine 0 N--CA 1.432 -1.622 0 CA-C-N 114.337 -1.302 . . . . 0.28000000000000003 113.902 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.817 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.1 t -105.12 152.4 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.523 0.678 . . . . 0.96999999999999997 112.083 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.76 -168.07 40.55 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 114.82 -1.082 . . . . 0.13 111.209 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.5 141.6 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 109.119 -0.697 . . . . 1.03 109.119 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.616 ' O ' ' HB ' ' A' ' 445' ' ' THR . 33.7 p80 -150.54 165.04 34.47 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.75 0.786 . . . . 0.17000000000000001 111.768 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.729 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -93.25 142.85 26.85 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.004 -1.453 . . . . 0.41999999999999998 107.16 171.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.93 104.94 5.89 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.925 1.345 . . . . 2.0 110.203 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.97 -27.62 15.56 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 112.34 -2.209 . . . . 0.34999999999999998 111.288 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -69.3 -24.61 63.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.481 -1.236 . . . . 0.19 108.877 174.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.405 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.1 OUTLIER -119.17 100.2 50.36 Favored Pre-proline 0 CA--C 1.488 -1.404 0 CA-C-N 112.985 -1.916 . . . . 1.3300000000000001 108.465 -176.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -88.52 2.2 6.21 Favored 'Trans proline' 0 C--N 1.283 -2.914 0 C-N-CA 123.04 2.493 . . . . 0.28000000000000003 114.863 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.97 151.86 30.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.986 -1.086 . . . . 1.1000000000000001 111.567 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.607 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.64 125.77 2.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.762 -1.563 . . . . 0.98999999999999999 108.472 -171.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.71 -169.01 28.6 Favored Glycine 0 C--N 1.299 -1.527 0 C-N-CA 119.416 -1.373 . . . . 0.13 111.203 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.66 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.06 0.01 OUTLIER Glycine 0 C--N 1.34 0.778 0 O-C-N 125.163 1.155 . . . . 0.23000000000000001 112.97 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.415 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.4 m-20 -54.55 100.96 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 123.988 1.852 . . . . 0.33000000000000002 111.799 -146.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.8 mt -97.14 -31.71 12.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 110.09 -3.232 . . . . 1.05 108.614 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.56 ' HA ' HG21 ' A' ' 369' ' ' VAL . 5.6 p-90 -45.95 -37.68 6.74 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.804 0.69 . . . . 0.22 111.515 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.765 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 56.4 mttt -61.34 -24.18 66.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.113 -0.949 . . . . 1.29 113.211 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.5 p -114.85 -37.38 4.21 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.684 0.754 . . . . 1.0700000000000001 110.162 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.486 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.5 mtp85 -82.36 -15.72 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.78 -1.1 . . . . 0.41999999999999998 112.137 -170.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 71.87 41.43 55.62 Favored Glycine 0 C--N 1.314 -0.66 0 N-CA-C 116.13 1.212 . . . . 0.20999999999999999 116.13 160.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 38.5 m -90.28 130.1 36.44 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.565 1.182 . . . . 0.81999999999999995 108.522 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -95.4 65.35 2.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.06 -0.4 . . . . 0.5 111.187 -166.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.598 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 93.76 -13.77 66.75 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.548 -1.021 . . . . 0.19 110.548 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.562 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 21.0 p -87.52 138.45 31.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.971 0.415 . . . . 1.22 110.455 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.553 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -91.72 116.15 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.78 0.8 . . . . 1.04 110.768 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.483 ' CB ' HG11 ' A' ' 369' ' ' VAL . 1.8 t-20 -76.73 84.3 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.236 -1.347 . . . . 2.29 111.405 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 51.3 m -89.64 137.96 28.41 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-O 121.659 0.743 . . . . 1.02 109.773 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 52.8 Cg_exo -57.55 135.84 72.13 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.909 2.406 . . . . 0.12 111.735 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.729 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.8 Cg_exo -55.27 -34.04 86.95 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.256 3.304 . . . . 0.16 112.96 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.7 p -78.54 -39.48 37.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.651 -1.159 . . . . 1.47 109.928 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.629 HG12 ' HB ' ' A' ' 366' ' ' THR . 86.2 t -79.58 -31.25 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.866 -0.606 . . . . 1.0600000000000001 111.384 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.686 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.6 tpt -66.76 -18.73 65.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.521 0.677 . . . . 1.0 110.448 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -81.04 -23.05 38.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.395 1.093 . . . . 1.4399999999999999 110.989 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 456' ' ' MET . 7.7 mm-40 -79.69 -46.95 16.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 112.841 -1.981 . . . . 0.38 107.106 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.636 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.2 tp -64.39 -66.99 0.47 Allowed 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 111.835 -2.439 . . . . 1.0 112.243 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.627 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 33.0 t80 -49.67 -27.04 4.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.018 1.39 . . . . 0.40000000000000002 108.328 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.57 -30.76 66.12 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 112.465 -2.152 . . . . 0.13 112.409 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.63 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -88.38 -48.34 7.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.929 0.871 . . . . 1.02 111.369 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.601 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -102.45 138.03 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 123.587 1.66 . . . . 1.04 113.992 -168.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.96 -178.44 5.2 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 110.52 -3.037 . . . . 0.82999999999999996 106.419 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.667 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.6 mtmt -50.87 162.96 0.22 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 123.06 1.41 . . . . 1.04 113.318 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.02 -35.29 3.95 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 112.577 -2.102 . . . . 0.37 112.47 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.469 ' O ' HG13 ' A' ' 384' ' ' VAL . 17.8 m -72.57 141.69 82.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 CA-C-N 115.252 -0.474 . . . . 1.01 109.837 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.629 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.4 164.97 33.73 Favored 'Trans proline' 0 N--CA 1.43 -2.241 0 C-N-CA 122.043 1.829 . . . . 0.17000000000000001 111.084 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.0 t -135.16 133.45 53.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 CA-C-N 113.702 -1.59 . . . . 1.75 107.872 173.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.43 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.9 tp -112.55 142.96 44.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.032 -0.531 . . . . 1.04 110.371 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.661 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.19 147.46 20.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.06 -1.459 . . . . 1.02 107.06 165.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.474 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 15.9 p90 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.657 -0.687 . . . . 1.1599999999999999 111.342 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 358' ' ' LYS . 4.1 m . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 106.95 -1.5 . . . . 1.04 106.95 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.643 ' HD2' ' CD1' ' A' ' 344' ' ' TYR . 12.2 p90 -158.65 -171.03 3.27 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.597 0.713 . . . . 0.94999999999999996 111.081 -174.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.613 HD13 ' CB ' ' A' ' 457' ' ' VAL . 8.9 mm -105.58 161.09 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.719 -1.128 . . . . 1.02 108.022 167.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.452 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.2 tt0 -142.42 155.39 45.1 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 118.843 0.747 . . . . 0.17000000000000001 111.046 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' A' ' 354' ' ' MET . 63.2 t -150.3 136.57 12.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.795 -1.093 . . . . 1.03 109.851 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -117.84 111.28 18.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.721 -1.127 . . . . 0.37 108.053 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.8 mm? -64.63 -49.41 71.16 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 122.704 1.24 . . . . 1.0600000000000001 110.197 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -53.31 -54.82 30.86 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 112.507 -2.133 . . . . 1.51 112.224 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -94.9 3.86 54.48 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.788 -1.097 . . . . 0.91000000000000003 109.994 -173.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.736 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.2 mm-40 47.01 64.96 1.36 Allowed 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 112.584 -2.098 . . . . 2.6299999999999999 112.27 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.551 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.5 t60 -145.86 124.62 12.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.107 0.48 . . . . 0.17000000000000001 110.021 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.59 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.4 ttp -110.83 127.61 55.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.438 0.637 . . . . 0.97999999999999998 110.515 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.617 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -111.55 173.26 6.43 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.538 -1.21 . . . . 0.11 111.889 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 2.5 t80 -127.14 117.48 22.46 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 106.251 -1.759 . . . . 1.02 106.251 164.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 357' ' ' TYR . 25.2 m-85 -100.48 128.6 46.49 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.188 0.994 . . . . 0.90000000000000002 111.898 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.58 ' HA ' HG22 ' A' ' 343' ' ' THR . 5.1 ttpt -148.35 137.37 21.81 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.218 -1.81 . . . . 1.21 108.225 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.7 OUTLIER 70.56 14.46 7.27 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 113.409 -1.723 . . . . 0.59999999999999998 108.92 178.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.62 15.65 75.3 Favored Glycine 0 N--CA 1.423 -2.203 0 CA-C-N 112.588 -2.096 . . . . 0.23999999999999999 111.847 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.63 171.75 13.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.954 -1.869 . . . . 1.26 105.954 -170.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.592 HG12 ' CD1' ' A' ' 355' ' ' TRP . 2.9 m -102.99 137.84 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.834 0 CA-C-O 124.421 2.058 . . . . 1.26 112.186 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -93.01 -24.76 18.24 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 109.291 -3.595 . . . . 1.03 108.574 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.671 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.4 154.81 36.33 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.854 -1.521 . . . . 1.01 109.018 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.617 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.56 122.05 1.41 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.763 -0.653 . . . . 0.60999999999999999 109.442 -175.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.569 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.2 t -148.34 167.55 24.91 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 122.34 1.066 . . . . 0.98999999999999999 112.133 174.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.665 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.0 OUTLIER -86.45 139.97 30.41 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 112.941 -1.936 . . . . 1.8799999999999999 107.41 176.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.28 -171.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.349 -0.841 . . . . 1.04 112.014 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.736 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.17 117.14 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.862 -1.063 . . . . 1.04 109.203 177.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.0 t -142.85 146.62 34.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.78 -1.1 . . . . 1.0 112.531 -168.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.6 45.93 50.36 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 116.824 1.489 . . . . 0.13 116.824 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.491 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.55 144.45 3.44 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 118.994 1.397 . . . . 1.2 110.616 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.795 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.74 -29.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 1 C-N-CA 125.848 4.365 . . . . 0.26000000000000001 116.45 -172.412 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.45 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.2 p -86.97 -31.99 20.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.465 0.65 . . . . 1.0600000000000001 110.809 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.523 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.7 m -138.47 70.55 45.91 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 122.187 0.994 . . . . 1.0800000000000001 109.892 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.7 Cg_exo -72.64 163.47 38.41 Favored 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.325 4.017 . . . . 0.19 114.36 -175.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.563 HG23 HD12 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.41 152.65 85.74 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 113.23 -1.804 . . . . 1.04 110.271 173.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.559 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.28 -49.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.326 -0.634 0 C-N-CA 124.909 3.74 . . . . 0.10000000000000001 113.634 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.653 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.71 123.03 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.586 0.958 . . . . 1.01 113.586 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.05 -122.76 1.1 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.225 -1.352 . . . . 0.11 111.575 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.439 HG11 ' O ' ' A' ' 381' ' ' VAL . 11.7 p -129.12 107.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.117 0.96 . . . . 1.54 109.301 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.618 ' CE2' HG23 ' A' ' 465' ' ' VAL . 98.9 m-85 -110.59 161.95 15.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.154 -0.93 . . . . 0.26000000000000001 109.945 -170.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.0 m-85 -148.21 135.68 20.59 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 121.234 -0.186 . . . . 1.1799999999999999 111.13 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.58 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.08 125.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.585 0.707 . . . . 1.05 110.891 177.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -109.68 2.4 20.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.21 -0.905 . . . . 0.20000000000000001 111.745 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.691 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.2 t30 -165.17 146.71 7.62 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.355 -0.839 . . . . 0.40999999999999998 110.805 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -107.24 109.8 21.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.179 -0.919 . . . . 1.8200000000000001 109.224 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.575 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -107.74 119.66 40.06 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 122.589 1.185 . . . . 0.38 111.447 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.769 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 19.2 mt-10 -115.96 142.15 47.17 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.966 -1.47 . . . . 1.96 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 35.2 t70 55.86 26.87 10.18 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 111.21 -2.723 . . . . 0.40000000000000002 107.656 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 169.64 15.37 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 112.753 -2.021 . . . . 0.98999999999999999 112.404 -166.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 60.8 m -125.07 102.96 7.75 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 112.866 -1.97 . . . . 1.02 109.532 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 9.0 mp -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-N 113.176 -1.829 . . . . 1.03 109.76 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 393' ' ' LEU . 9.9 mtpt . . . . . 0 N--CA 1.4 -2.928 0 N-CA-C 107.814 -1.18 . . . . 1.26 107.814 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.9 mt-10 . . . . . 0 CA--C 1.506 -0.735 0 CA-C-O 122.205 1.002 . . . . 0.62 111.388 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.613 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.3 m -142.72 98.05 5.86 Favored Pre-proline 0 N--CA 1.42 -1.959 0 CA-C-N 113.36 -1.745 . . . . 1.9099999999999999 109.478 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.2 Cg_endo -66.89 108.28 1.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 124.648 3.565 . . . . 0.22 113.22 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -118.62 161.11 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.495 -1.23 . . . . 1.0900000000000001 110.003 -175.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.769 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.2 OUTLIER -100.23 -40.3 7.62 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.394 -1.336 . . . . 1.8400000000000001 107.394 169.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.647 ' HD2' ' CD1' ' A' ' 409' ' ' TYR . 10.2 m-30 -125.94 113.47 17.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.395 -1.275 . . . . 0.88 110.439 -175.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.575 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 6.4 t-105 -123.28 135.92 54.46 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.747 -1.57 . . . . 0.14999999999999999 110.1 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.534 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.5 OUTLIER -135.96 85.02 29.85 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-N 114.859 -1.064 . . . . 1.03 111.092 174.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.679 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.8 Cg_endo -70.68 140.47 39.28 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.025 2.484 . . . . 0.23999999999999999 111.63 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.659 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.6 pt -123.53 -16.33 5.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.085 -1.416 . . . . 1.03 111.154 -172.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.425 ' CG ' ' HG1' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.58 169.75 16.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.093 -0.958 . . . . 1.5900000000000001 108.945 177.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.2 14.19 32.76 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.489 0.922 . . . . 0.33000000000000002 113.489 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' THR . . . . . 0.425 ' HG1' ' CG ' ' A' ' 414' ' ' ASP . 23.3 p -98.16 -28.36 13.76 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.906 -1.146 . . . . 1.1499999999999999 107.906 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.6 31.17 0.31 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 114.037 -1.438 . . . . 0.28000000000000003 113.148 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 441' ' ' GLY . 72.9 t -102.75 149.4 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.383 0.611 . . . . 0.96999999999999997 111.515 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.77 -166.04 37.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.911 -1.041 . . . . 0.13 111.57 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.7 138.45 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.936 -0.764 . . . . 1.03 108.936 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.599 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.4 p80 -151.86 171.46 17.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.093 0.949 . . . . 0.17000000000000001 111.712 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.726 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -92.44 149.56 21.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.122 -1.854 . . . . 0.41999999999999998 108.322 174.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 4.8 p -133.8 101.75 5.2 Favored 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 123.137 1.446 . . . . 2.0 110.376 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -95.8 -32.0 12.91 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 112.139 -2.3 . . . . 0.34999999999999998 110.846 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . 0.611 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 15.5 p90 -71.67 -26.76 62.66 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 114.73 -1.123 . . . . 0.19 108.972 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.503 ' HG2' ' HB3' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -111.05 95.5 25.11 Favored Pre-proline 0 CA--C 1.489 -1.365 0 CA-C-N 113.469 -1.696 . . . . 1.3300000000000001 108.923 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -85.12 2.4 7.92 Favored 'Trans proline' 0 N--CA 1.415 -3.122 0 C-N-CA 122.808 2.338 . . . . 0.28000000000000003 113.418 -176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.1 148.69 36.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.041 -1.064 . . . . 1.1000000000000001 110.162 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 1.608 ' HD2' ' CD1' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -162.93 124.78 2.56 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.733 1.271 . . . . 0.98999999999999999 108.225 -173.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.02 -166.04 28.47 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 119.389 -1.386 . . . . 0.13 111.241 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.608 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.52 149.58 0.01 OUTLIER Glycine 0 C--N 1.342 0.883 0 O-C-N 125.17 1.159 . . . . 0.23000000000000001 112.907 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.411 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 1.8 m-20 -54.97 101.6 0.05 Allowed 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 112.112 -145.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.4 mt -97.35 -32.14 12.03 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 110.498 -3.046 . . . . 1.05 108.302 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.574 ' HA ' HG22 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.32 -37.79 5.17 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.745 0.653 . . . . 0.22 111.465 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.795 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.9 mttt -60.47 -26.57 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 114.822 -1.081 . . . . 1.29 112.758 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.9 p -112.73 -37.89 4.74 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.717 0.77 . . . . 1.0700000000000001 110.083 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.444 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.3 mtp85 -82.74 -14.76 53.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.6 -1.182 . . . . 0.41999999999999998 112.616 -168.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.491 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.63 40.7 37.48 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 116.069 1.187 . . . . 0.20999999999999999 116.069 159.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.2 m -79.86 140.87 36.61 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 117.809 0.804 . . . . 0.81999999999999995 109.52 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -106.29 68.54 0.76 Allowed 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.881 -0.512 . . . . 0.5 110.392 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.669 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 84.63 -8.13 70.31 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.069 -0.813 . . . . 0.19 111.069 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.487 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 26.3 p -94.92 135.09 36.86 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.393 0.616 . . . . 1.22 110.715 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.563 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -96.42 113.74 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.254 -0.885 . . . . 1.04 110.343 -174.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.514 ' OD1' ' HE1' ' A' ' 421' ' ' HIS . 18.9 m-80 -83.45 93.04 7.71 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.835 -1.075 . . . . 2.29 111.881 -175.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 53.4 m -91.36 136.68 26.68 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.35 -0.841 . . . . 1.02 109.604 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.2 Cg_exo -52.99 135.55 58.91 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.524 2.15 . . . . 0.12 111.214 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.726 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 49.0 Cg_exo -55.28 -31.38 76.37 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.055 3.17 . . . . 0.16 112.547 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.3 m -79.75 -38.3 33.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.286 -1.324 . . . . 1.47 109.943 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.569 HG12 ' HB ' ' A' ' 366' ' ' THR . 86.5 t -78.55 -29.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.643 -0.708 . . . . 1.0600000000000001 111.539 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.611 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.3 tpt -66.34 -20.9 66.21 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.598 0.713 . . . . 1.0 110.179 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -76.27 -25.27 54.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.827 -1.079 . . . . 1.4399999999999999 111.628 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -79.21 -46.66 17.43 Favored 'General case' 0 CA--C 1.473 -2.003 0 CA-C-N 113.129 -1.85 . . . . 0.38 107.092 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.562 HD21 ' SD ' ' A' ' 450' ' ' MET . 24.3 tp -66.06 -67.42 0.45 Allowed 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 111.72 -2.491 . . . . 1.0 112.43 175.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.631 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 28.7 t80 -48.94 -26.88 2.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.806 1.289 . . . . 0.40000000000000002 108.344 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.54 -30.35 64.46 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.601 -2.09 . . . . 0.13 112.555 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.671 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -88.75 -48.5 7.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.65 0.738 . . . . 1.02 111.513 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.613 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.4 OUTLIER -101.03 138.3 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 123.105 1.431 . . . . 1.04 113.902 -168.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -136.5 -178.94 5.39 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 111.284 -2.689 . . . . 0.82999999999999996 107.397 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.691 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.1 mtmt -52.79 157.73 1.56 Allowed 'General case' 0 N--CA 1.413 -2.286 0 CA-C-O 122.82 1.295 . . . . 1.04 114.009 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.1 18.01 70.53 Favored Glycine 0 C--N 1.281 -2.492 0 CA-C-N 112.659 -2.064 . . . . 0.37 113.699 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 462' ' ' PRO . 9.5 m -103.85 141.68 23.02 Favored Pre-proline 0 N--CA 1.427 -1.585 0 N-CA-C 107.664 -1.235 . . . . 1.01 107.664 165.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.621 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.3 Cg_exo -74.74 164.62 33.27 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.648 1.565 . . . . 0.17000000000000001 110.73 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.61 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.1 m -134.73 154.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 107.271 -1.381 . . . . 1.75 107.271 166.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.452 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.3 tp -126.59 145.15 50.65 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 1.04 110.195 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.653 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.04 147.44 20.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.291 -1.374 . . . . 1.02 107.291 165.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 379' ' ' ALA . 17.3 p90 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.535 -0.745 . . . . 1.1599999999999999 110.846 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 358' ' ' LYS . 98.9 m . . . . . 0 N--CA 1.428 -1.565 0 N-CA-C 106.841 -1.54 . . . . 1.04 106.841 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.655 ' HE1' ' CE2' ' A' ' 344' ' ' TYR . 12.9 p90 -158.4 -171.05 3.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.388 -0.824 . . . . 0.94999999999999996 111.322 -170.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.595 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.1 mm -103.24 156.47 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.935 -1.135 . . . . 1.02 107.935 165.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.447 ' CG ' HD21 ' A' ' 464' ' ' LEU . 3.5 tt0 -137.22 155.02 50.02 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.596 0.634 . . . . 0.17000000000000001 110.633 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.551 HG23 ' HG3' ' A' ' 354' ' ' MET . 55.7 t -150.41 136.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.775 -1.102 . . . . 1.03 110.0 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.04 118.94 34.3 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.553 -1.203 . . . . 0.37 108.074 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.7 mm? -71.17 -49.3 45.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.419 1.104 . . . . 1.0600000000000001 110.511 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -54.85 -53.56 53.77 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 112.996 -1.911 . . . . 1.51 112.308 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -98.09 10.65 39.94 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.543 -1.208 . . . . 0.91000000000000003 108.738 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.837 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.2 mm-40 38.14 71.76 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 125.088 1.493 . . . . 2.6299999999999999 111.856 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.481 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -151.63 124.11 8.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.685 -0.689 . . . . 0.17000000000000001 109.872 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.551 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.0 ttp -110.87 128.01 55.64 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.379 0.609 . . . . 0.97999999999999998 110.484 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.662 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.9 m-90 -111.37 173.39 6.36 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.612 -1.176 . . . . 0.11 111.895 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 2.5 t80 -126.84 116.34 20.72 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.194 -1.78 . . . . 1.02 106.194 165.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.665 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 21.5 m-85 -100.07 129.63 46.13 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.927 0.87 . . . . 0.90000000000000002 111.534 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.538 ' HA ' HG21 ' A' ' 343' ' ' THR . 5.1 ttpt -149.12 139.2 22.14 Favored 'General case' 0 N--CA 1.398 -3.053 0 CA-C-N 113.633 -1.621 . . . . 1.21 107.66 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.447 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 72.64 11.68 5.5 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.064 -1.425 . . . . 0.59999999999999998 108.908 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.84 13.99 73.78 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 112.747 -2.024 . . . . 0.23999999999999999 111.753 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.612 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.75 172.75 12.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.705 -1.961 . . . . 1.26 105.705 -171.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.612 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 3.0 m -102.68 139.27 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.864 0 CA-C-O 124.364 2.031 . . . . 1.26 112.358 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -93.38 -25.32 17.74 Favored 'General case' 0 N--CA 1.396 -3.166 0 CA-C-N 109.206 -3.634 . . . . 1.03 108.498 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.681 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.32 155.18 37.16 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.695 -1.593 . . . . 1.01 109.102 -172.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.662 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.19 122.54 1.3 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.718 -0.673 . . . . 0.60999999999999999 109.543 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.648 ' HB ' HG12 ' A' ' 449' ' ' VAL . 4.6 t -147.35 166.81 26.01 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.866 0.841 . . . . 0.98999999999999999 111.744 173.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.469 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 1.6 m-20 -82.68 146.0 29.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.592 -1.633 . . . . 1.8799999999999999 106.592 174.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.17 -172.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.506 -0.77 . . . . 1.04 111.245 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.837 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -154.01 118.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.931 -1.031 . . . . 1.04 108.973 174.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.433 ' HB2' HG13 ' A' ' 443' ' ' ILE . 6.9 t -143.02 142.84 31.68 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.164 -0.925 . . . . 1.0 113.395 -166.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.751 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.86 47.56 24.98 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.941 1.536 . . . . 0.13 116.941 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 17.5 ptmt -44.56 148.1 0.95 Allowed Pre-proline 0 C--O 1.222 -0.39 0 CA-C-N 118.521 1.16 . . . . 1.2 111.372 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.793 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -37.2 -31.18 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.053 1 C-N-CA 125.522 4.148 . . . . 0.26000000000000001 115.268 -177.664 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.423 HG21 ' HE2' ' A' ' 372' ' ' LYS . 4.0 p -82.68 -36.28 26.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.327 0.584 . . . . 1.0600000000000001 110.776 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.456 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 8.9 m -140.74 73.94 27.72 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 122.067 0.937 . . . . 1.0800000000000001 110.238 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.751 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 36.9 Cg_exo -69.3 161.62 45.14 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 125.061 3.841 . . . . 0.19 114.073 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.567 HG21 ' CD ' ' A' ' 378' ' ' PRO . 0.1 OUTLIER -71.35 151.62 94.22 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 113.35 -1.75 . . . . 1.04 110.91 175.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.567 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.01 -49.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.997 3.798 . . . . 0.10000000000000001 113.443 -171.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.659 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.59 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.155 0.979 . . . . 1.01 113.552 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.02 -128.67 1.8 Allowed Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 113.997 -1.456 . . . . 0.11 111.13 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 97.7 t -128.19 99.89 5.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.424 -0.954 . . . . 1.54 108.424 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.607 ' CE2' HG23 ' A' ' 465' ' ' VAL . 50.4 m-85 -104.58 169.87 8.21 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.39 -0.823 . . . . 0.26000000000000001 109.124 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.74 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.6 m-85 -149.23 139.54 22.32 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 110.413 -0.217 . . . . 1.1799999999999999 110.413 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.576 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.55 120.69 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 119.903 -0.719 . . . . 1.05 110.397 176.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 40.8 p-90 -109.21 4.41 22.81 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.391 -0.822 . . . . 0.20000000000000001 112.159 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.689 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.1 t30 -165.11 148.16 8.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.227 -0.897 . . . . 0.40999999999999998 110.009 175.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.416 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 14.8 mtpt -109.62 110.69 21.82 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.423 -0.808 . . . . 1.8200000000000001 109.866 170.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.551 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -109.08 120.82 43.69 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.561 1.172 . . . . 0.38 110.763 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.04 142.97 46.28 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.225 -1.352 . . . . 1.96 109.784 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 36.3 t70 54.19 26.34 6.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 111.782 -2.463 . . . . 0.40000000000000002 108.63 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.29 170.74 14.3 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.079 -1.873 . . . . 0.98999999999999999 112.247 -167.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 22.4 m -128.5 102.88 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.568 -1.651 . . . . 1.02 109.733 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.698 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.76 157.84 36.73 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 112.865 -1.971 . . . . 1.03 110.459 176.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.441 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.8 mtpt . . . . . 0 N--CA 1.392 -3.369 0 CA-C-N 114.5 -1.227 . . . . 1.26 108.082 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 9.4 mt-10 . . . . . 0 CA--C 1.512 -0.516 0 CA-C-O 122.302 1.048 . . . . 0.62 111.706 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.698 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.47 98.66 12.25 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 113.199 -1.819 . . . . 1.9099999999999999 108.273 178.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.97 101.76 0.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.442 2.095 . . . . 0.22 110.28 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.584 HG11 ' N ' ' A' ' 408' ' ' ASN . 1.2 t -114.43 163.55 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.852 0 CA-C-N 114.239 -1.346 . . . . 1.0900000000000001 109.83 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.584 ' N ' HG11 ' A' ' 407' ' ' VAL . 15.2 m-80 -114.99 -33.82 5.28 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.474 -1.694 . . . . 1.8400000000000001 106.808 -176.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.639 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 54.8 m-85 -136.09 116.25 13.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.796 -2.002 . . . . 0.88 110.681 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.551 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.4 t-105 -123.33 134.72 54.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.665 -1.152 . . . . 0.14999999999999999 110.102 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.483 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.6 OUTLIER -136.28 86.24 25.17 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.905 -1.043 . . . . 1.03 110.937 174.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 79.9 Cg_endo -72.11 141.61 36.57 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.892 2.395 . . . . 0.23999999999999999 111.655 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.74 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.09 -16.2 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.537 -1.21 . . . . 1.03 111.936 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.76 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.7 p30 -136.1 171.12 14.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 1.5900000000000001 110.222 170.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -99.18 15.9 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.76 -0.655 . . . . 0.33000000000000002 111.467 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 1.8 p -97.03 -26.88 14.85 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.089 -1.078 . . . . 1.1499999999999999 108.089 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 130.15 27.62 0.76 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.904 -1.498 . . . . 0.28000000000000003 113.677 169.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.76 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 49.2 t -104.43 149.78 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.43 0.633 . . . . 0.96999999999999997 112.463 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -178.96 -164.32 31.5 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.966 -1.016 . . . . 0.13 111.942 174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.47 139.55 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.54 -0.911 . . . . 1.03 108.54 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.533 ' HB2' HG22 ' A' ' 407' ' ' VAL . 31.7 p80 -150.02 164.16 36.25 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.637 0.732 . . . . 0.17000000000000001 111.457 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.73 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.07 138.79 31.33 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.203 -1.362 . . . . 0.41999999999999998 107.474 172.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.604 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 4.8 t -133.13 104.67 6.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.326 1.536 . . . . 2.0 110.667 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.32 -28.83 15.97 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 111.43 -2.623 . . . . 0.34999999999999998 110.83 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . 0.421 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 18.7 p90 -72.01 -27.23 62.59 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.471 -1.24 . . . . 0.19 109.728 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.604 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -118.01 81.18 15.71 Favored Pre-proline 0 CA--C 1.496 -1.106 0 CA-C-N 114.276 -1.329 . . . . 1.3300000000000001 110.015 -176.067 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 14.9 Cg_endo -84.34 8.59 4.54 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 C-N-CA 125.122 3.881 . . . . 0.28000000000000003 114.313 -163.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -114.89 150.52 35.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.177 -0.675 . . . . 1.1000000000000001 109.177 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.469 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -159.61 125.52 4.28 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.629 1.172 . . . . 0.98999999999999999 108.285 -171.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 148.3 -166.97 29.05 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.353 -1.403 . . . . 0.13 111.305 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.591 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.85 154.44 0.0 OUTLIER Glycine 0 C--N 1.341 0.818 0 O-C-N 125.151 1.148 . . . . 0.23000000000000001 113.2 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.463 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 2.9 m-20 -55.28 101.42 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.806 1.765 . . . . 0.33000000000000002 112.17 -146.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.0 mt -97.03 -31.35 12.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 110.53 -3.032 . . . . 1.05 109.39 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.53 ' HA ' HG22 ' A' ' 369' ' ' VAL . 14.2 p-90 -50.13 -30.87 12.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.96 -1.927 . . . . 0.22 111.844 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.793 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 44.9 mttt -66.65 -22.12 66.1 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.919 -1.037 . . . . 1.29 112.872 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.8 p -117.43 -38.72 3.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.855 0.836 . . . . 1.0700000000000001 110.049 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 433' ' ' LEU . 10.0 mtp85 -80.3 -15.32 57.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.48 -1.236 . . . . 0.41999999999999998 111.952 -171.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 71.84 40.58 57.61 Favored Glycine 0 C--N 1.311 -0.821 0 N-CA-C 115.697 1.039 . . . . 0.20999999999999999 115.697 159.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' SER . . . . . 0.402 ' OG ' HG21 ' A' ' 369' ' ' VAL . 1.4 m -80.01 130.84 35.58 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 108.85 -0.796 . . . . 0.81999999999999995 108.85 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -99.97 65.64 1.3 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.314 -0.866 . . . . 0.5 111.562 -169.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.527 ' O ' HG22 ' A' ' 377' ' ' THR . . . 94.92 -18.77 56.65 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 111.09 -0.804 . . . . 0.19 111.09 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 421' ' ' HIS . 37.1 m -90.36 159.17 16.75 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.951 -0.7 . . . . 1.22 111.214 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.527 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -107.64 120.29 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.522 -0.763 . . . . 1.04 110.578 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.487 ' HB2' HG11 ' A' ' 369' ' ' VAL . 25.2 m-80 -83.74 91.93 7.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.686 -0.688 . . . . 2.29 111.588 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 37.3 m -90.0 136.86 28.51 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-O 121.393 0.615 . . . . 1.02 109.489 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -57.15 132.12 49.36 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.842 2.361 . . . . 0.12 112.862 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.73 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.5 Cg_exo -50.51 -40.47 54.36 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 123.489 2.793 . . . . 0.16 112.39 -169.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.1 p -73.44 -40.44 64.21 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.806 -1.088 . . . . 1.47 110.113 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' A' ' 366' ' ' THR . 67.3 t -77.05 -29.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.382 0.61 . . . . 1.0600000000000001 111.303 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.669 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.0 tpt -67.85 -19.67 65.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.748 0.785 . . . . 1.0 109.958 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -79.4 -22.66 44.0 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.63 -1.168 . . . . 1.4399999999999999 110.918 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.54 -47.73 13.8 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 112.922 -1.945 . . . . 0.38 107.329 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.626 HD21 ' SD ' ' A' ' 450' ' ' MET . 27.1 tp -63.66 -66.91 0.48 Allowed 'General case' 0 N--CA 1.403 -2.799 0 CA-C-N 111.83 -2.441 . . . . 1.0 112.241 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.64 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 35.5 t80 -50.15 -26.55 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.962 1.363 . . . . 0.40000000000000002 108.167 176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.01 -28.19 69.0 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 112.592 -2.095 . . . . 0.13 112.347 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -91.71 -47.96 7.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.666 0.746 . . . . 1.02 111.768 171.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.595 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -101.5 138.36 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 123.457 1.599 . . . . 1.04 113.892 -168.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.416 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.7 pt-20 -136.83 -178.69 5.3 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 110.813 -2.903 . . . . 0.82999999999999996 106.503 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.685 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.7 mtmt -51.69 162.48 0.4 Allowed 'General case' 0 N--CA 1.413 -2.321 0 CA-C-O 123.12 1.438 . . . . 1.04 113.179 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.38 -33.64 4.66 Favored Glycine 0 N--CA 1.424 -2.141 0 CA-C-N 112.441 -2.163 . . . . 0.37 112.284 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.471 ' O ' HG13 ' A' ' 384' ' ' VAL . 10.6 m -73.96 140.78 77.62 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-O 121.119 0.485 . . . . 1.01 109.822 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.639 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.44 162.96 38.9 Favored 'Trans proline' 0 N--CA 1.432 -2.132 0 C-N-CA 122.265 1.977 . . . . 0.17000000000000001 111.142 174.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.5 t -132.95 131.96 59.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 CA-C-N 113.757 -1.565 . . . . 1.75 108.169 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.447 HD21 ' CG ' ' A' ' 346' ' ' GLU . 2.9 tp -112.03 143.04 43.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.989 -0.551 . . . . 1.04 110.331 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.659 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.16 148.08 19.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.126 -1.435 . . . . 1.02 107.126 165.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.446 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 15.7 p90 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.301 -0.857 . . . . 1.1599999999999999 111.27 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 358' ' ' LYS . 88.9 m . . . . . 0 N--CA 1.428 -1.571 0 CA-C-O 121.595 0.712 . . . . 1.04 109.801 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.667 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 5.0 p90 -160.94 -169.31 2.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.119 -1.4 . . . . 0.94999999999999996 110.584 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.567 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.7 mm -101.39 162.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.204 -1.036 . . . . 1.02 108.204 165.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.455 ' CG ' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -143.67 156.31 44.5 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 119.063 0.847 . . . . 0.17000000000000001 111.729 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.583 HG23 ' HG3' ' A' ' 354' ' ' MET . 77.8 t -150.71 137.44 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.741 -1.118 . . . . 1.03 110.115 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -124.61 106.51 10.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.175 0.988 . . . . 0.37 108.52 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.73 -42.13 95.45 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 112.772 -2.013 . . . . 1.0600000000000001 111.602 -168.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.46 -57.58 11.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.412 -2.176 . . . . 1.51 112.892 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -92.79 1.44 57.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 114.838 -1.074 . . . . 0.91000000000000003 109.924 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.817 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.0 mm-40 48.73 63.75 1.98 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 112.624 -2.08 . . . . 2.6299999999999999 111.565 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.533 ' HE2' ' HB2' ' A' ' 365' ' ' GLU . 6.8 t60 -143.41 128.63 18.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.803 -0.635 . . . . 0.17000000000000001 109.716 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.583 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.7 ttp -115.28 128.6 56.23 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.438 0.695 . . . . 0.97999999999999998 110.444 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.624 ' CD1' HG12 ' A' ' 362' ' ' VAL . 32.5 m-90 -112.82 173.43 6.38 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.755 -1.111 . . . . 0.11 111.598 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 0.2 OUTLIER -125.08 112.9 17.05 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 105.577 -2.008 . . . . 1.02 105.577 163.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 18.1 m-85 -92.98 124.85 37.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.457 -0.897 . . . . 0.90000000000000002 111.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.527 ' HA ' HG21 ' A' ' 343' ' ' THR . 37.4 ttmt -140.17 142.52 35.93 Favored 'General case' 0 N--CA 1.386 -3.634 0 CA-C-N 114.031 -1.441 . . . . 1.21 108.771 173.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.0 16.35 10.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.742 -1.572 . . . . 0.59999999999999998 108.849 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.02 72.49 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 112.167 -2.288 . . . . 0.23999999999999999 111.968 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.618 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 4.9 tppt? -138.83 179.21 6.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.435 -2.061 . . . . 1.26 105.435 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.624 HG12 ' CD1' ' A' ' 355' ' ' TRP . 2.8 m -106.65 135.6 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.72 0 CA-C-O 124.197 1.951 . . . . 1.26 112.394 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.545 ' HB1' ' CD1' ' A' ' 356' ' ' TYR . . . -87.84 -26.06 23.0 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 109.351 -3.568 . . . . 1.03 107.985 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.705 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 4.0 tp -153.15 156.0 37.79 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.181 -1.372 . . . . 1.01 109.777 -173.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 2.2 pt-20 -162.6 121.99 2.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.84 -0.618 . . . . 0.60999999999999999 110.706 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.658 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.3 t -149.13 166.78 27.75 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 122.501 1.143 . . . . 0.98999999999999999 113.196 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.673 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.6 p-10 -84.36 140.02 31.87 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.712 -2.04 . . . . 1.8799999999999999 108.182 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.658 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.96 -171.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.161 -0.927 . . . . 1.04 111.843 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.817 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -153.74 121.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.794 -1.094 . . . . 1.04 108.849 174.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.49 ' HB2' HG13 ' A' ' 443' ' ' ILE . 7.0 t -144.57 143.01 30.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 -167.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.47 45.93 35.02 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 116.845 1.498 . . . . 0.13 116.845 162.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.543 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.46 144.1 4.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 118.636 1.218 . . . . 1.2 110.917 -174.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.798 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.34 -32.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -0.979 1 C-N-CA 125.709 4.273 . . . . 0.26000000000000001 116.183 -170.8 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.543 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.8 p -79.92 -35.42 37.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.095 0.474 . . . . 1.0600000000000001 111.161 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.472 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 m -140.31 74.63 29.21 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 122.431 1.11 . . . . 1.0800000000000001 110.003 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.5 Cg_exo -69.79 160.42 49.75 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.044 3.83 . . . . 0.19 113.365 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.549 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -69.79 150.36 96.56 Favored Pre-proline 0 N--CA 1.434 -1.255 0 CA-C-N 113.55 -1.659 . . . . 1.04 110.92 177.259 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.544 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.0 OUTLIER -77.14 -48.78 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.893 3.729 . . . . 0.10000000000000001 112.98 -170.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.626 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.13 122.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.626 0.973 . . . . 1.01 113.626 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.7 -126.62 1.5 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.457 -1.247 . . . . 0.11 111.382 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.466 HG11 ' O ' ' A' ' 381' ' ' VAL . 14.1 p -126.01 104.12 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 122.516 1.15 . . . . 1.54 109.328 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.646 ' CE2' HG23 ' A' ' 465' ' ' VAL . 96.2 m-85 -107.33 162.16 14.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.904 -1.044 . . . . 0.26000000000000001 110.014 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.683 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.8 m-85 -147.91 137.51 22.45 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 121.252 -0.179 . . . . 1.1799999999999999 110.789 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.592 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.63 124.97 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 119.993 -0.683 . . . . 1.05 110.296 177.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -109.55 3.99 21.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.491 -0.777 . . . . 0.20000000000000001 111.929 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.667 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.6 t30 -165.13 149.34 8.78 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.485 -0.779 . . . . 0.40999999999999998 111.083 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.452 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.8 mtpt -107.46 110.74 22.77 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.411 -0.813 . . . . 1.8200000000000001 109.685 169.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.564 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -112.08 123.17 49.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.654 1.216 . . . . 0.38 111.067 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.76 143.48 47.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.139 -1.391 . . . . 1.96 110.035 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 35.4 t70 54.24 25.99 6.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 111.894 -2.412 . . . . 0.40000000000000002 108.667 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 167.13 17.8 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.205 -1.816 . . . . 0.98999999999999999 112.163 -167.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 107.84 12.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.774 -1.557 . . . . 1.02 110.131 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 8.9 mp -75.85 156.7 34.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 112.834 -1.985 . . . . 1.03 110.448 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.454 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 11.8 mtpt . . . . . 0 N--CA 1.401 -2.916 0 CA-C-N 114.651 -1.159 . . . . 1.26 108.016 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 15.0 mt-10 . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 122.052 0.929 . . . . 0.62 111.058 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.0 m -142.28 98.3 6.08 Favored Pre-proline 0 N--CA 1.421 -1.879 0 CA-C-N 113.678 -1.601 . . . . 1.9099999999999999 109.222 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.9 Cg_endo -67.97 106.19 1.29 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 124.342 3.362 . . . . 0.22 112.644 -177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -114.61 163.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 114.534 -1.212 . . . . 1.0900000000000001 110.56 -175.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.47 ' N ' HG11 ' A' ' 407' ' ' VAL . 22.8 m-80 -111.76 -34.04 6.15 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.403 -1.726 . . . . 1.8400000000000001 106.943 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.638 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 54.4 m-85 -133.86 115.99 15.12 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.726 -2.034 . . . . 0.88 110.639 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.6 ' HB2' HG12 ' A' ' 407' ' ' VAL . 5.1 t-105 -123.86 135.29 53.65 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.4 -1.273 . . . . 0.14999999999999999 110.355 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.477 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -136.53 84.81 26.99 Favored Pre-proline 0 N--CA 1.427 -1.579 0 CA-C-N 115.007 -0.997 . . . . 1.03 110.943 172.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 72.2 Cg_endo -70.84 141.07 39.97 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.06 2.507 . . . . 0.23999999999999999 112.258 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.683 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -123.8 -16.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.009 -1.45 . . . . 1.03 111.063 -173.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -135.46 162.7 31.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.277 -0.874 . . . . 1.5900000000000001 109.312 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -93.78 13.32 22.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.236 0.458 . . . . 0.33000000000000002 112.236 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -91.36 -26.57 18.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.396 -1.335 . . . . 1.1499999999999999 107.396 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.93 29.55 1.13 Allowed Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 112.976 -1.92 . . . . 0.28000000000000003 112.326 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 441' ' ' GLY . 89.5 t -102.55 147.9 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.297 0.57 . . . . 0.96999999999999997 110.93 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.37 -166.11 37.91 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.734 -1.121 . . . . 0.13 111.306 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.54 138.42 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.698 -0.853 . . . . 1.03 108.698 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.63 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.1 p80 -151.24 164.9 35.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.725 0.774 . . . . 0.17000000000000001 112.076 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.715 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 146.05 24.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.074 -1.421 . . . . 0.41999999999999998 107.858 173.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.07 102.85 4.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 123.06 1.409 . . . . 2.0 110.998 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -93.16 -26.97 17.17 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 111.752 -2.476 . . . . 0.34999999999999998 109.742 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . 0.56 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 5.7 p90 -70.27 -26.14 63.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.312 -1.313 . . . . 0.19 109.714 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.8 80.7 25.09 Favored Pre-proline 0 CA--C 1.492 -1.286 0 CA-C-N 113.829 -1.532 . . . . 1.3300000000000001 109.315 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -81.08 5.53 6.17 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 125.089 3.86 . . . . 0.28000000000000003 114.015 -162.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -115.67 149.73 37.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.739 -0.664 . . . . 1.1000000000000001 109.411 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -160.99 125.57 3.57 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 124.587 1.18 . . . . 0.98999999999999999 108.179 -173.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.88 -166.92 28.83 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 119.484 -1.341 . . . . 0.13 110.899 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.585 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 154.1 0.0 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.931 1.018 . . . . 0.23000000000000001 113.159 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.415 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -55.72 101.33 0.05 Allowed 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 123.924 1.821 . . . . 0.33000000000000002 112.289 -146.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.7 mt -97.33 -32.03 12.1 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 110.228 -3.169 . . . . 1.05 108.222 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.559 ' HA ' HG22 ' A' ' 369' ' ' VAL . 6.4 p-90 -45.82 -38.84 7.67 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 124.067 0.854 . . . . 0.22 111.49 -174.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.798 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.5 mttt -60.05 -26.12 65.9 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.006 -0.997 . . . . 1.29 112.821 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.9 p -111.93 -36.11 5.49 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.701 0.762 . . . . 1.0700000000000001 110.033 -176.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 6.8 mtp85 -84.54 -15.94 44.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.689 -1.141 . . . . 0.41999999999999998 112.642 -169.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.52 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.05 40.39 30.03 Favored Glycine 0 C--N 1.313 -0.714 0 N-CA-C 116.089 1.196 . . . . 0.20999999999999999 116.089 159.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.63 131.6 36.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 117.782 0.791 . . . . 0.81999999999999995 109.545 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -100.7 68.3 1.31 Allowed 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.643 -0.661 . . . . 0.5 110.306 -172.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.617 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 88.7 -11.8 67.49 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.924 -0.87 . . . . 0.19 110.924 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.453 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 27.2 p -90.79 142.82 27.36 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.361 -0.42 . . . . 1.22 110.8 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.549 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -101.43 114.55 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.752 -0.658 . . . . 1.04 110.362 -176.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.529 ' HB2' HG11 ' A' ' 369' ' ' VAL . 18.7 m120 -78.81 90.38 4.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.842 -0.617 . . . . 2.29 111.098 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.9 m -86.63 137.34 34.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 109.132 -0.692 . . . . 1.02 109.132 174.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.5 Cg_exo -54.86 135.79 69.44 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.747 2.298 . . . . 0.12 111.337 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.715 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.4 Cg_exo -55.34 -32.16 80.17 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 C-N-CA 124.225 3.283 . . . . 0.16 112.825 -173.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.23 -38.79 26.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.441 -1.254 . . . . 1.47 110.09 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.658 HG12 ' HB ' ' A' ' 366' ' ' THR . 60.2 t -80.77 -29.41 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.096 -0.502 . . . . 1.0600000000000001 111.376 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.678 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.4 tpt -65.93 -19.91 66.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.781 0.8 . . . . 1.0 109.985 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -79.36 -24.97 42.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.522 -1.217 . . . . 1.4399999999999999 111.239 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.67 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -79.15 -46.3 18.24 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 113.127 -1.851 . . . . 0.38 107.111 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.587 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.7 tp -64.43 -67.17 0.45 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.663 -2.517 . . . . 1.0 112.169 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 36.2 t80 -49.62 -27.73 4.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 123.127 1.442 . . . . 0.40000000000000002 108.304 177.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.2 -31.3 69.08 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 112.37 -2.195 . . . . 0.13 112.237 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.705 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.5 ptp -88.17 -48.43 7.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.729 0.776 . . . . 1.02 111.501 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.567 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.7 OUTLIER -102.09 138.16 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 123.582 1.658 . . . . 1.04 114.005 -167.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.452 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.2 pt-20 -136.37 -178.28 5.09 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 110.705 -2.952 . . . . 0.82999999999999996 106.552 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.667 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.4 mtmt -52.71 162.56 0.57 Allowed 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.949 1.357 . . . . 1.04 112.405 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.23 -30.56 6.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 112.685 -2.052 . . . . 0.37 112.383 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 462' ' ' PRO . 15.0 m -80.89 141.96 51.7 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.134 -0.691 . . . . 1.01 109.134 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.608 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.5 Cg_exo -75.78 168.54 24.06 Favored 'Trans proline' 0 N--CA 1.425 -2.502 0 C-N-CA 121.681 1.587 . . . . 0.17000000000000001 111.098 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.628 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.81 154.49 34.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.299 -1.371 . . . . 1.75 107.299 166.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.455 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.0 tp -125.86 144.25 50.74 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.45 -0.796 . . . . 1.04 110.657 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.646 HG23 ' CE2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -143.14 146.04 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 105.937 -1.875 . . . . 1.02 105.937 163.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 379' ' ' ALA . 8.6 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.089 -0.958 . . . . 1.1599999999999999 111.824 -175.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 358' ' ' LYS . 9.1 m . . . . . 0 N--CA 1.425 -1.693 0 N-CA-C 106.688 -1.597 . . . . 1.04 106.688 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 8.2 p90 -156.15 -171.59 3.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.485 0.659 . . . . 0.94999999999999996 110.852 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.62 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.8 mm -102.52 161.5 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.97 -1.122 . . . . 1.02 107.97 167.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.496 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.4 tt0 -140.61 155.18 46.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 118.818 0.736 . . . . 0.17000000000000001 111.1 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.602 HG23 ' HG3' ' A' ' 354' ' ' MET . 64.4 t -150.81 135.8 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.539 -1.21 . . . . 1.03 110.027 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -116.89 117.78 30.64 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.797 -1.092 . . . . 0.37 108.176 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.8 mm? -70.26 -48.2 57.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.51 1.148 . . . . 1.0600000000000001 110.487 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -54.89 -54.13 46.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 112.851 -1.977 . . . . 1.51 112.454 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -98.27 11.31 38.36 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.572 -1.195 . . . . 0.91000000000000003 108.637 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.831 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.1 mm-40 37.6 70.38 0.19 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 125.269 1.606 . . . . 2.6299999999999999 111.829 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.497 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -150.22 125.12 9.86 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.773 -0.649 . . . . 0.17000000000000001 109.827 -175.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.602 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.9 ttp -111.93 127.61 55.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.471 0.653 . . . . 0.97999999999999998 110.451 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.671 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.84 173.72 6.24 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.528 -1.214 . . . . 0.11 111.841 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.611 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 2.4 t80 -126.79 117.07 21.9 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 106.795 -1.557 . . . . 1.02 106.795 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.632 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 18.8 m-85 -100.77 124.84 46.98 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.128 0.966 . . . . 0.90000000000000002 112.33 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.593 ' HA ' HG22 ' A' ' 343' ' ' THR . 3.0 ttpt -149.46 139.34 21.92 Favored 'General case' 0 N--CA 1.4 -2.939 0 CA-C-N 113.105 -1.861 . . . . 1.21 107.992 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 70.95 16.46 6.5 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 113.768 -1.56 . . . . 0.59999999999999998 108.608 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.56 17.47 78.99 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.377 -2.192 . . . . 0.23999999999999999 111.715 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.585 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.2 OUTLIER -136.9 170.86 15.39 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.91 -1.885 . . . . 1.26 105.91 -168.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.585 ' N ' ' HG3' ' A' ' 361' ' ' LYS . 3.7 m -101.35 137.56 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.853 0 CA-C-O 124.157 1.932 . . . . 1.26 111.72 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -23.84 19.0 Favored 'General case' 0 N--CA 1.399 -2.984 0 CA-C-N 109.392 -3.549 . . . . 1.03 108.529 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.665 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -154.07 154.82 34.33 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 113.511 -1.677 . . . . 1.01 108.856 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.671 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.98 121.78 1.29 Allowed 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.766 -0.652 . . . . 0.60999999999999999 109.395 -175.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.596 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.1 t -148.08 166.5 27.62 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.245 1.021 . . . . 0.98999999999999999 111.967 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.621 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.1 p-10 -85.37 140.36 30.83 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 113.025 -1.898 . . . . 1.8799999999999999 107.193 176.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.639 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -141.47 -171.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.154 -0.93 . . . . 1.04 111.888 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.831 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -157.73 119.38 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.136 -0.938 . . . . 1.04 109.792 175.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.6 t -143.15 145.98 33.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.977 -1.011 . . . . 1.0 112.839 -166.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.04 46.09 37.95 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 117.178 1.631 . . . . 0.13 117.178 161.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.448 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.2 pttt -46.75 145.83 2.9 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.6 1.7 . . . . 1.2 111.129 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.82 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -33.41 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.041 1 C-N-CA 125.543 4.162 . . . . 0.26000000000000001 115.609 -175.884 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.4 p -77.19 -39.27 49.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.267 0.555 . . . . 1.0600000000000001 110.917 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.488 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.9 m -140.56 72.92 30.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.245 1.021 . . . . 1.0800000000000001 110.434 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.709 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.7 Cg_exo -68.9 163.3 38.03 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 125.256 3.97 . . . . 0.19 114.118 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.575 HG21 ' CD ' ' A' ' 378' ' ' PRO . 0.1 OUTLIER -74.76 151.23 86.73 Favored Pre-proline 0 N--CA 1.437 -1.092 0 CA-C-N 113.512 -1.676 . . . . 1.04 110.714 175.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.575 ' CD ' HG21 ' A' ' 377' ' ' THR . 0.9 OUTLIER -78.28 -50.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.83 3.686 . . . . 0.10000000000000001 113.724 -171.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.653 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.0 121.91 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.443 0.905 . . . . 1.01 113.443 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.89 -124.48 1.26 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.268 -1.333 . . . . 0.11 111.46 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 381' ' ' VAL . 10.7 p -126.28 108.88 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 122.137 0.97 . . . . 1.54 109.372 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.626 ' CB ' HG23 ' A' ' 463' ' ' VAL . 94.0 m-85 -114.24 159.89 19.64 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.881 -1.054 . . . . 0.26000000000000001 109.661 -170.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.718 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 70.0 m-85 -146.01 135.63 23.22 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 117.661 0.209 . . . . 1.1799999999999999 111.113 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.589 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.57 122.26 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.872 -0.731 . . . . 1.05 110.46 176.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -108.93 3.16 21.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.43 -0.804 . . . . 0.20000000000000001 112.026 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.707 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.6 t30 -164.08 149.57 10.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.181 -0.918 . . . . 0.40999999999999998 110.704 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -109.24 114.65 28.54 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.377 -0.829 . . . . 1.8200000000000001 109.386 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -113.12 120.39 41.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.724 1.25 . . . . 0.38 111.478 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.794 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 25.9 mt-10 -116.11 143.71 45.12 Favored 'General case' 0 N--CA 1.409 -2.475 0 CA-C-N 113.802 -1.544 . . . . 1.96 110.562 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 37.8 t70 55.98 27.3 11.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 111.196 -2.729 . . . . 0.40000000000000002 107.758 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.499 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.14 169.58 15.69 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 112.692 -2.049 . . . . 0.98999999999999999 112.16 -167.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.411 ' CG2' ' HG2' ' A' ' 404' ' ' GLU . 16.1 m -128.72 102.45 6.58 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 113.12 -1.855 . . . . 1.02 109.382 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.707 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.0 mp -71.97 156.3 39.39 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 112.789 -2.005 . . . . 1.03 109.767 174.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.5 mtpt . . . . . 0 N--CA 1.395 -3.183 0 CA-C-N 114.647 -1.161 . . . . 1.26 108.089 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.4 mt-10 . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 122.387 1.089 . . . . 0.62 112.208 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.707 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.69 99.43 8.49 Favored Pre-proline 0 N--CA 1.426 -1.664 0 CA-C-N 112.857 -1.974 . . . . 1.9099999999999999 108.543 175.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.44 103.43 0.8 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.868 2.378 . . . . 0.22 110.912 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.577 HG22 ' HB2' ' A' ' 421' ' ' HIS . 1.2 t -118.12 158.78 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.27 -1.332 . . . . 1.0900000000000001 109.391 -174.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.794 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.2 OUTLIER -101.46 -38.93 7.78 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 107.762 -1.199 . . . . 1.8400000000000001 107.762 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' A' ' 409' ' ' TYR . 10.3 m-30 -125.53 113.46 17.47 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.726 -1.124 . . . . 0.88 110.51 -176.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.553 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 8.3 t-105 -123.59 136.39 54.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.692 -1.594 . . . . 0.14999999999999999 110.379 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.496 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -136.3 85.93 25.76 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 114.792 -1.094 . . . . 1.03 111.041 173.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 82.6 Cg_endo -71.64 141.75 38.54 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 123.163 2.575 . . . . 0.23999999999999999 112.091 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -122.94 -17.74 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.207 -1.36 . . . . 1.03 111.239 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.772 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 6.9 p30 -134.76 170.47 15.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.715 -0.675 . . . . 1.5900000000000001 109.695 171.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -96.88 16.08 20.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 0.33000000000000002 111.993 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 20.3 p -100.16 -28.31 13.08 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.258 -1.015 . . . . 1.1499999999999999 108.258 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 131.74 26.41 0.71 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.24 -1.346 . . . . 0.28000000000000003 113.546 173.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.772 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 68.8 t -102.46 148.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.492 0.663 . . . . 0.96999999999999997 111.165 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 175.59 -164.1 34.22 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.712 -1.131 . . . . 0.13 111.13 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.59 138.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.988 -0.745 . . . . 1.03 108.988 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.577 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.4 p80 -149.35 167.28 26.56 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.065 0.936 . . . . 0.17000000000000001 111.178 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.725 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -89.43 149.28 23.03 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 113.501 -1.682 . . . . 0.41999999999999998 107.806 172.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -136.42 100.0 4.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.675 1.226 . . . . 2.0 110.035 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -95.17 -33.37 12.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.606 -2.088 . . . . 0.34999999999999998 110.416 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -68.08 -27.08 66.18 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.589 -1.187 . . . . 0.19 109.255 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.556 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.95 82.0 20.45 Favored Pre-proline 0 CA--C 1.494 -1.208 0 CA-C-N 113.816 -1.538 . . . . 1.3300000000000001 110.201 -173.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -80.33 4.96 6.39 Favored 'Trans proline' 0 N--CA 1.432 -2.103 0 C-N-CA 124.821 3.681 . . . . 0.28000000000000003 114.464 -162.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.32 154.03 28.73 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 123.385 0.428 . . . . 1.1000000000000001 110.293 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.621 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -163.64 126.34 2.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.25 -1.341 . . . . 0.98999999999999999 108.364 -172.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.81 -167.85 28.74 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.051 -1.547 . . . . 0.13 111.556 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.625 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.52 153.36 0.0 OUTLIER Glycine 0 C--N 1.342 0.916 0 O-C-N 125.043 1.084 . . . . 0.23000000000000001 113.207 174.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.449 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.8 m-20 -54.9 100.99 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 123.999 1.857 . . . . 0.33000000000000002 112.156 -146.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.4 mt -97.16 -33.44 11.49 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 110.273 -3.149 . . . . 1.05 109.357 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.55 ' HA ' HG21 ' A' ' 369' ' ' VAL . 11.2 p-90 -47.36 -33.59 6.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 112.8 -2.0 . . . . 0.22 111.9 -174.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.82 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 43.4 mttt -63.5 -22.99 67.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 124.08 0.863 . . . . 1.29 113.055 -176.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.2 p -117.43 -38.41 3.33 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.525 -0.761 . . . . 1.0700000000000001 110.215 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.556 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 4.5 mtp85 -79.14 -15.22 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.609 -1.178 . . . . 0.41999999999999998 112.375 -169.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 75.72 40.48 31.46 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 116.216 1.246 . . . . 0.20999999999999999 116.216 159.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 442' ' ' CYS . 7.4 m -82.15 134.35 35.31 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 117.768 0.784 . . . . 0.81999999999999995 109.188 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -101.75 70.09 1.24 Allowed 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.477 -0.764 . . . . 0.5 110.447 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.651 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 83.63 -8.2 66.34 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.815 -0.914 . . . . 0.19 110.815 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 22.4 p -94.17 128.77 40.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.689 0.757 . . . . 1.22 110.561 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.559 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -89.74 113.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.813 -1.085 . . . . 1.04 110.527 -172.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.537 HD21 ' N ' ' A' ' 444' ' ' ASN . 0.8 OUTLIER -77.27 91.39 3.79 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.042 -0.981 . . . . 2.29 111.068 -177.467 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 79.3 m -89.88 137.54 28.26 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 109.2 -0.667 . . . . 1.02 109.2 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.1 Cg_exo -55.41 135.88 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.66 2.24 . . . . 0.12 111.248 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.725 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.8 Cg_exo -55.34 -32.87 83.22 Favored 'Trans proline' 0 CA--C 1.501 -1.148 0 C-N-CA 124.125 3.217 . . . . 0.16 112.849 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.2 m -79.75 -38.01 34.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.774 -1.103 . . . . 1.47 110.016 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.596 HG12 ' HB ' ' A' ' 366' ' ' THR . 88.7 t -78.8 -29.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 1.0600000000000001 111.454 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.629 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -66.23 -20.48 66.13 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.698 0.761 . . . . 1.0 109.925 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -76.3 -25.63 55.02 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.569 -1.196 . . . . 1.4399999999999999 111.69 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.7 mm-40 -80.33 -45.87 17.08 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-N 113.13 -1.85 . . . . 0.38 107.056 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.541 HD21 ' SD ' ' A' ' 450' ' ' MET . 23.7 tp -66.22 -66.59 0.53 Allowed 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 111.756 -2.474 . . . . 1.0 112.229 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' A' ' 454' ' ' PHE . 26.7 t80 -50.03 -25.77 3.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.89 1.329 . . . . 0.40000000000000002 108.28 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.41 -27.65 65.26 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 112.867 -1.969 . . . . 0.13 112.583 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.665 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -91.02 -49.02 6.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.776 0.798 . . . . 1.02 111.384 171.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.62 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.84 137.39 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 CA-C-O 123.478 1.608 . . . . 1.04 113.87 -167.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.64 -178.45 5.18 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 110.671 -2.968 . . . . 0.82999999999999996 106.567 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.0 mtmt -52.56 161.29 0.72 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-O 123.063 1.411 . . . . 1.04 113.361 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.51 -32.88 5.26 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 112.498 -2.137 . . . . 0.37 112.31 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.499 ' O ' HG13 ' A' ' 384' ' ' VAL . 3.4 m -78.25 141.07 61.56 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.412 -0.588 . . . . 1.01 109.412 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.616 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 5.8 Cg_exo -75.63 167.74 25.83 Favored 'Trans proline' 0 N--CA 1.425 -2.542 0 C-N-CA 122.084 1.856 . . . . 0.17000000000000001 111.244 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.626 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.1 m -133.55 150.51 32.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.602 -1.259 . . . . 1.75 107.602 165.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.432 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.8 tp -119.41 144.34 46.98 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.954 -1.021 . . . . 1.04 109.634 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.653 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -142.89 146.54 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.757 -1.571 . . . . 1.02 106.757 165.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.496 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 17.5 p90 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.258 -0.877 . . . . 1.1599999999999999 110.993 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 358' ' ' LYS . 2.7 m . . . . . 0 N--CA 1.422 -1.86 0 N-CA-C 108.096 -1.075 . . . . 1.04 108.096 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.661 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 11.9 p90 -161.12 -171.04 2.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.322 -0.854 . . . . 0.94999999999999996 110.533 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.612 HD13 ' CB ' ' A' ' 457' ' ' VAL . 12.2 mm -105.06 160.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.977 -1.119 . . . . 1.02 107.977 167.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.47 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -140.93 155.92 46.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.972 0.806 . . . . 0.17000000000000001 111.327 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.596 HG23 ' HG3' ' A' ' 354' ' ' MET . 65.5 t -151.16 136.65 11.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.747 -1.115 . . . . 1.03 109.923 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -116.97 119.11 34.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.615 -1.175 . . . . 0.37 108.078 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 352' ' ' GLN . 1.9 mm? -70.81 -47.83 57.36 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.202 1.001 . . . . 1.0600000000000001 110.492 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -57.97 -55.07 39.61 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.752 -2.022 . . . . 1.51 112.0 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -94.77 10.69 34.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.21 -1.359 . . . . 0.91000000000000003 108.657 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.68 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 3.6 mm-40 35.01 74.14 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.349 1.656 . . . . 2.6299999999999999 112.964 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.527 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.5 t60 -152.27 124.3 8.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.32 -0.855 . . . . 0.17000000000000001 109.744 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.596 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.3 ttp -111.88 126.94 55.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.586 -0.734 . . . . 0.97999999999999998 110.366 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.63 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.8 m-90 -111.95 172.9 6.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 114.528 -1.214 . . . . 0.11 111.911 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.629 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 1.3 t80 -125.93 115.73 20.39 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.577 -1.638 . . . . 1.02 106.577 165.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.67 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 23.8 m-85 -98.98 126.4 44.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.259 1.028 . . . . 0.90000000000000002 112.519 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.578 ' HA ' HG22 ' A' ' 343' ' ' THR . 3.2 ttpt -148.94 139.29 22.42 Favored 'General case' 0 N--CA 1.396 -3.135 0 CA-C-N 112.95 -1.932 . . . . 1.21 107.759 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 72.4 15.22 5.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 113.929 -1.487 . . . . 0.59999999999999998 108.871 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.79 78.58 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.603 -2.09 . . . . 0.23999999999999999 111.699 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.604 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -139.58 174.69 10.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 112.416 -1.892 . . . . 1.26 106.108 -168.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.617 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.0 m -104.89 138.86 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 CA-C-O 124.227 1.965 . . . . 1.26 112.397 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 356' ' ' TYR . . . -93.36 -24.83 17.96 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 109.37 -3.559 . . . . 1.03 108.707 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.653 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -152.65 154.31 35.08 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.578 -1.646 . . . . 1.01 108.67 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.63 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.11 120.49 1.16 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.708 -0.678 . . . . 0.60999999999999999 109.675 -174.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.622 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.0 t -147.79 167.33 25.0 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 122.199 0.999 . . . . 0.98999999999999999 111.981 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.3 p-10 -86.0 140.2 30.51 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 113.225 -1.807 . . . . 1.8799999999999999 107.867 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.68 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -140.88 -171.89 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.238 -0.892 . . . . 1.04 111.989 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.65 119.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.05 -0.977 . . . . 1.04 108.816 174.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.574 ' H ' HE22 ' A' ' 352' ' ' GLN . 7.6 t -142.23 144.2 33.24 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.415 -0.811 . . . . 1.0 112.397 -166.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.02 44.48 45.46 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 116.569 1.388 . . . . 0.13 116.569 163.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.563 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.58 143.64 5.53 Favored Pre-proline 0 CA--C 1.509 -0.598 0 CA-C-N 118.472 1.136 . . . . 1.2 110.49 -174.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.811 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.46 -33.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.966 1 C-N-CA 125.745 4.296 . . . . 0.26000000000000001 116.034 -170.925 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.563 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -79.74 -34.02 40.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.082 0.467 . . . . 1.0600000000000001 110.723 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.47 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.0 m -140.65 73.38 29.05 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 122.144 0.973 . . . . 1.0800000000000001 110.461 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.3 Cg_exo -70.62 161.51 45.78 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.201 3.934 . . . . 0.19 114.41 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.547 HG21 ' CD ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -74.77 154.02 87.17 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 113.551 -1.659 . . . . 1.04 110.936 176.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.547 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.3 Cg_endo -80.84 -49.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 125.062 3.841 . . . . 0.10000000000000001 113.752 -172.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.637 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.05 122.55 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.123 0.964 . . . . 1.01 113.449 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.35 -125.32 1.32 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.23 -1.35 . . . . 0.11 111.7 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.28 103.84 9.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.262 -1.014 . . . . 1.54 108.262 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.645 ' CE2' HG23 ' A' ' 465' ' ' VAL . 95.6 m-85 -110.23 158.5 18.32 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.478 -0.783 . . . . 0.26000000000000001 109.656 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 1.626 ' HD1' ' CD2' ' A' ' 383' ' ' TYR . 9.3 m-85 -146.59 139.63 25.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 118.194 0.452 . . . . 1.1799999999999999 110.699 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.582 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -75.63 125.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 119.92 -0.712 . . . . 1.05 110.626 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -111.03 4.03 19.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.181 -0.918 . . . . 0.20000000000000001 112.04 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.694 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.7 t30 -164.56 150.11 10.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.326 -0.852 . . . . 0.40999999999999998 110.51 175.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.417 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.3 mtpt -109.98 113.65 26.53 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.609 -0.723 . . . . 1.8200000000000001 110.025 170.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.543 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 1.9 mt-10 -112.79 125.1 53.97 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.647 -1.16 . . . . 0.38 110.931 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -123.5 135.05 53.85 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.14 -1.391 . . . . 1.96 110.196 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.8 t70 52.56 39.44 28.05 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 123.387 1.565 . . . . 0.40000000000000002 107.661 -172.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.9 167.47 12.41 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 112.474 -2.148 . . . . 0.98999999999999999 111.256 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 37.5 m -128.11 102.5 6.74 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.964 -1.471 . . . . 1.02 109.682 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 10.1 mp -74.28 157.34 35.97 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 112.984 -1.916 . . . . 1.03 110.406 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 8.5 mtpt . . . . . 0 N--CA 1.399 -3.024 0 CA-C-N 114.945 -1.025 . . . . 1.26 108.759 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.702 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 8.7 mt-10 . . . . . 0 CA--C 1.508 -0.645 0 CA-C-O 122.34 1.067 . . . . 0.62 111.831 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.695 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.56 98.62 12.17 Favored Pre-proline 0 N--CA 1.419 -1.982 0 CA-C-N 113.07 -1.877 . . . . 1.9099999999999999 107.747 175.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.04 101.59 0.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.308 2.006 . . . . 0.22 110.326 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.581 HG12 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -114.48 157.53 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.866 0 CA-C-N 114.242 -1.344 . . . . 1.0900000000000001 109.95 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.402 ' N ' HG11 ' A' ' 407' ' ' VAL . 22.5 m-80 -108.22 -33.8 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.39 -1.732 . . . . 1.8400000000000001 107.098 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.589 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 61.3 m-85 -134.55 116.18 14.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.86 -1.973 . . . . 0.88 111.134 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.581 ' HB2' HG12 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.71 134.24 53.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.223 -1.353 . . . . 0.14999999999999999 110.258 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.446 ' HG2' HG22 ' A' ' 384' ' ' VAL . 0.1 OUTLIER -134.91 86.54 32.31 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.124 -0.943 . . . . 1.03 111.054 174.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.668 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.06 140.22 34.17 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.81 2.34 . . . . 0.23999999999999999 112.154 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.79 -15.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.479 . . . . 1.03 111.214 -172.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -134.63 162.5 32.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.392 -0.822 . . . . 1.5900000000000001 109.447 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -93.47 13.8 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.358 0.503 . . . . 0.33000000000000002 112.358 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.1 p -94.24 -27.42 16.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.674 -1.232 . . . . 1.1499999999999999 107.674 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.48 34.36 0.76 Allowed Glycine 0 N--CA 1.427 -1.95 0 CA-C-N 113.112 -1.858 . . . . 0.28000000000000003 112.414 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.615 HG11 ' O ' ' A' ' 441' ' ' GLY . 76.8 t -103.79 151.49 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 120.987 0.422 . . . . 0.96999999999999997 110.762 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 170.92 -168.1 41.24 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.214 -0.903 . . . . 0.13 111.664 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.46 141.16 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.933 -0.766 . . . . 1.03 108.933 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.562 ' O ' ' HB ' ' A' ' 445' ' ' THR . 34.0 p80 -150.6 163.72 37.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.803 0.811 . . . . 0.17000000000000001 111.776 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.718 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.14 142.6 27.56 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.916 -1.493 . . . . 0.41999999999999998 107.323 172.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.445 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 3.5 t -136.92 103.51 5.19 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.877 1.323 . . . . 2.0 110.395 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.55 -28.7 15.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.125 -2.307 . . . . 0.34999999999999998 111.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -70.27 -26.56 63.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 114.432 -1.258 . . . . 0.19 109.342 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.551 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -120.58 82.18 33.0 Favored Pre-proline 0 CA--C 1.491 -1.31 0 CA-C-N 113.5 -1.682 . . . . 1.3300000000000001 109.465 -175.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -81.34 6.68 5.45 Favored 'Trans proline' 0 N--CA 1.43 -2.254 0 C-N-CA 124.693 3.596 . . . . 0.28000000000000003 113.907 -162.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 3.2 tp10 -114.47 154.54 28.01 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 1.1000000000000001 111.013 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.65 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -164.11 127.84 2.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.715 -1.584 . . . . 0.98999999999999999 108.076 -169.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.31 -167.24 28.51 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 119.232 -1.461 . . . . 0.13 111.124 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.634 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.43 153.95 0.01 OUTLIER Glycine 0 C--N 1.336 0.583 0 O-C-N 124.927 1.016 . . . . 0.23000000000000001 112.897 174.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.65 100.81 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 123.862 1.791 . . . . 0.33000000000000002 112.0 -146.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 54.1 mt -97.02 -30.32 13.13 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 110.562 -3.017 . . . . 1.05 108.205 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.582 ' HA ' HG21 ' A' ' 369' ' ' VAL . 7.6 p-90 -46.85 -38.01 9.66 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.876 0.735 . . . . 0.22 111.583 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.811 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.7 mttt -62.22 -23.01 66.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.274 -0.876 . . . . 1.29 112.9 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -114.95 -37.03 4.26 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.578 -0.737 . . . . 1.0700000000000001 110.361 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.551 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.8 mtp85 -85.18 -15.86 42.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.811 -1.086 . . . . 0.41999999999999998 112.691 -168.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.09 42.05 25.38 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 116.804 1.482 . . . . 0.20999999999999999 116.804 159.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.6 m -85.82 131.11 34.37 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 118.682 1.241 . . . . 0.81999999999999995 108.946 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -100.04 71.38 1.62 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.678 -0.639 . . . . 0.5 111.227 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.615 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 87.74 -14.12 59.15 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.422 -1.071 . . . . 0.19 110.422 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.516 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -88.29 148.53 24.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.36 -0.42 . . . . 1.22 110.192 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.545 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -100.01 119.54 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.776 0.798 . . . . 1.04 110.759 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.482 ' HB3' HG12 ' A' ' 369' ' ' VAL . 2.6 t30 -79.93 82.97 5.92 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.557 -1.201 . . . . 2.29 111.42 -175.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.562 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.2 m -87.42 140.25 31.99 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-O 121.605 0.716 . . . . 1.02 109.846 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.9 Cg_exo -58.85 136.14 71.64 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.814 2.342 . . . . 0.12 111.744 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.718 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.3 Cg_exo -55.01 -34.07 85.59 Favored 'Trans proline' 0 CA--C 1.504 -1.009 0 C-N-CA 124.415 3.41 . . . . 0.16 113.005 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.5 t -79.47 -38.33 34.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.893 -1.049 . . . . 1.47 109.418 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.622 HG12 ' HB ' ' A' ' 366' ' ' THR . 46.9 t -82.51 -28.42 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 1.0600000000000001 111.269 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.716 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.5 tpt -67.68 -18.74 65.03 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.882 0.849 . . . . 1.0 110.008 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -80.43 -23.24 40.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.442 -1.253 . . . . 1.4399999999999999 111.007 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.66 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.0 mm-40 -80.35 -46.99 15.15 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.957 -1.929 . . . . 0.38 107.215 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.594 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -64.68 -67.18 0.46 Allowed 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 111.798 -2.455 . . . . 1.0 112.321 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 24.1 t80 -50.47 -26.36 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.18 1.467 . . . . 0.40000000000000002 108.21 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.44 -32.77 67.96 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 112.182 -2.281 . . . . 0.13 112.22 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.66 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.8 ptp -87.5 -49.43 7.2 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 121.745 0.783 . . . . 1.02 111.509 172.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.612 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.7 OUTLIER -102.08 137.6 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 CA-C-O 123.518 1.627 . . . . 1.04 113.835 -167.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.417 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.58 -178.23 5.08 Favored 'General case' 0 N--CA 1.401 -2.881 0 CA-C-N 110.585 -3.007 . . . . 0.82999999999999996 106.89 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.694 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 48.2 mtmt -51.59 161.78 0.46 Allowed 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 122.888 1.328 . . . . 1.04 112.593 175.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.67 -31.52 5.8 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 112.623 -2.08 . . . . 0.37 112.368 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 462' ' ' PRO . 4.5 m -82.92 140.77 43.39 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.683 -0.858 . . . . 1.01 108.683 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.707 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.57 173.46 14.15 Favored 'Trans proline' 0 N--CA 1.415 -3.146 0 C-N-CA 121.093 1.196 . . . . 0.17000000000000001 111.71 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.616 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.1 m -137.09 160.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.768 -1.197 . . . . 1.75 107.768 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.449 HD21 ' CG ' ' A' ' 346' ' ' GLU . 2.8 tp -129.83 146.22 51.57 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.443 -0.799 . . . . 1.04 110.334 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.645 HG23 ' CE2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -143.1 147.26 20.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.073 -1.454 . . . . 1.02 107.073 165.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.47 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 14.1 p90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.855 -0.593 . . . . 1.1599999999999999 111.646 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.499 HG21 ' HA ' ' A' ' 358' ' ' LYS . 94.0 m . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 108.813 -0.81 . . . . 1.04 108.813 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.654 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 8.0 p90 -160.93 -170.31 2.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.217 -1.356 . . . . 0.94999999999999996 110.668 -173.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.589 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.3 mm -101.7 161.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.183 -1.043 . . . . 1.02 108.183 166.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.454 ' CG ' HD21 ' A' ' 464' ' ' LEU . 3.8 tt0 -142.24 155.6 45.25 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.407 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.572 HG23 ' HG3' ' A' ' 354' ' ' MET . 68.0 t -151.0 142.35 16.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.437 -1.256 . . . . 1.03 109.146 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.477 ' HA ' ' OXT' ' A' ' 466' ' ' PHE . 7.2 t70 -130.67 107.49 9.21 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.37 109.129 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.9 mm? -69.27 -30.08 68.11 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.814 -1.539 . . . . 1.0600000000000001 110.575 -170.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -57.09 -63.61 1.16 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.89 0.852 . . . . 1.51 111.096 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -89.42 -3.53 58.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.047 -1.433 . . . . 0.91000000000000003 110.774 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.698 ' OE1' HD13 ' A' ' 368' ' ' ILE . 85.1 mm-40 49.64 68.64 0.7 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 112.084 -2.325 . . . . 2.6299999999999999 111.368 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.5 t60 -143.82 128.43 18.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.991 -1.004 . . . . 0.17000000000000001 109.293 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.572 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.9 ttp -114.33 129.01 56.63 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 123.573 0.749 . . . . 0.97999999999999998 110.558 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.645 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.32 173.1 6.57 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.724 -1.126 . . . . 0.11 111.802 -176.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.603 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 2.5 t80 -125.88 113.96 17.91 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.008 -1.849 . . . . 1.02 106.008 164.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.662 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 22.1 m-85 -98.53 129.21 45.09 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.811 0.815 . . . . 0.90000000000000002 111.218 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.499 ' HA ' HG21 ' A' ' 343' ' ' THR . 5.7 ttpt -147.6 137.65 22.94 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 113.912 -1.494 . . . . 1.21 108.161 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.79 11.94 7.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 113.489 -1.687 . . . . 0.59999999999999998 108.629 178.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.06 12.25 71.38 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 112.785 -2.007 . . . . 0.23999999999999999 111.806 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.619 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -131.43 168.68 17.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.107 -1.812 . . . . 1.26 106.107 -172.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.619 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 3.2 m -100.96 136.9 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 124.442 2.067 . . . . 1.26 111.958 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -90.62 -25.92 19.9 Favored 'General case' 0 N--CA 1.397 -3.081 0 CA-C-N 109.085 -3.688 . . . . 1.03 108.57 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.624 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.6 tp -152.51 154.25 35.1 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.577 -1.647 . . . . 1.01 108.744 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.645 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -164.92 121.53 1.5 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.67 -0.696 . . . . 0.60999999999999999 109.489 -175.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.621 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.5 t -148.51 167.03 26.44 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.25 1.024 . . . . 0.98999999999999999 112.099 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.677 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.8 p-10 -85.9 139.79 30.93 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 113.173 -1.831 . . . . 1.8799999999999999 107.827 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.698 HD13 ' OE1' ' A' ' 352' ' ' GLN . 1.7 pp -140.63 -172.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.207 -0.906 . . . . 1.04 111.554 -175.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.64 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.8 119.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.399 -0.819 . . . . 1.04 109.05 174.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.2 t -141.27 145.11 35.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.747 -1.115 . . . . 1.0 112.562 -167.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.08 46.1 37.51 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 117.333 1.693 . . . . 0.13 117.333 162.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.461 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.1 pttt -45.86 145.55 2.31 Favored Pre-proline 0 C--N 1.347 0.462 0 CA-C-N 119.842 1.821 . . . . 1.2 110.779 -174.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.778 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.99 -36.46 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 1 C-N-CA 125.422 4.081 . . . . 0.26000000000000001 115.529 -173.58 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -35.89 57.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.076 0.465 . . . . 1.0600000000000001 110.903 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.484 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -139.88 72.56 34.67 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 122.111 0.958 . . . . 1.0800000000000001 110.522 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.724 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.4 Cg_exo -71.75 162.76 41.06 Favored 'Trans proline' 0 C--N 1.324 -0.741 1 C-N-CA 125.35 4.033 . . . . 0.19 113.978 -177.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.588 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.33 152.43 90.09 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 113.651 -1.613 . . . . 1.04 111.062 175.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.546 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.42 -49.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 125.116 3.877 . . . . 0.10000000000000001 113.712 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.649 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.89 120.95 0.03 OUTLIER 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.767 1.025 . . . . 1.01 113.767 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.77 -123.25 1.15 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.343 -1.299 . . . . 0.11 111.563 -176.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.407 ' O ' HG11 ' A' ' 381' ' ' VAL . 12.1 p -126.13 112.17 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.079 0.942 . . . . 1.54 108.933 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.632 ' CE2' HG23 ' A' ' 465' ' ' VAL . 90.4 m-85 -115.66 160.09 20.49 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.219 -0.9 . . . . 0.26000000000000001 109.83 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.717 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 77.2 m-85 -147.8 135.29 20.74 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 120.97 -0.292 . . . . 1.1799999999999999 111.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.594 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.49 121.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.63 -0.828 . . . . 1.05 110.234 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -108.44 2.21 22.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.247 -0.888 . . . . 0.20000000000000001 111.784 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.706 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.4 t30 -164.65 150.81 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.838 -1.074 . . . . 0.40999999999999998 110.217 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -112.8 126.98 56.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.616 -0.72 . . . . 1.8200000000000001 109.123 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.58 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -127.14 112.76 15.53 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 123.195 1.474 . . . . 0.38 113.249 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 3.1 mp0 -108.17 134.15 51.43 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.286 -1.779 . . . . 1.96 110.862 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 36.9 t70 52.17 37.11 20.94 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.394 1.568 . . . . 0.40000000000000002 107.744 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.58 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.79 170.31 10.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.225 -2.261 . . . . 0.98999999999999999 112.028 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 16.5 m -125.98 105.81 9.17 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.679 -1.601 . . . . 1.02 109.823 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 8.7 mp -72.05 156.11 39.56 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.243 -1.799 . . . . 1.03 109.79 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.417 ' HG2' ' HG3' ' A' ' 404' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.389 -3.482 0 CA-C-N 114.863 -1.062 . . . . 1.26 109.136 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.7 mt-10 . . . . . 0 CA--C 1.504 -0.827 0 CA-C-O 122.383 1.087 . . . . 0.62 112.027 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.621 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.8 m -143.64 97.86 5.42 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.254 -1.794 . . . . 1.9099999999999999 109.464 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.93 105.97 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.534 0 C-N-CA 124.359 3.373 . . . . 0.22 112.999 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.607 HG12 ' HB2' ' A' ' 410' ' ' TRP . 0.6 OUTLIER -115.89 162.6 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 114.58 -1.191 . . . . 1.0900000000000001 110.87 -174.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.491 ' N ' HG11 ' A' ' 407' ' ' VAL . 27.0 m-80 -111.25 -33.59 6.39 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.152 -1.84 . . . . 1.8400000000000001 107.008 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 50.1 m-85 -135.36 115.53 13.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.189 -1.823 . . . . 0.88 110.835 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.607 ' HB2' HG12 ' A' ' 407' ' ' VAL . 6.8 t-105 -122.59 136.26 54.84 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.558 -1.201 . . . . 0.14999999999999999 109.897 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.47 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -136.54 86.17 23.81 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.006 -0.997 . . . . 1.03 111.222 173.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.688 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.1 Cg_endo -70.85 140.11 37.88 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.889 2.393 . . . . 0.23999999999999999 112.053 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.717 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.46 -15.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.804 -1.544 . . . . 1.03 111.068 -173.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -135.37 163.76 29.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 1.5900000000000001 110.032 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -94.38 14.53 20.24 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.304 0.483 . . . . 0.33000000000000002 112.304 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.4 p -94.11 -26.98 16.49 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.613 -1.254 . . . . 1.1499999999999999 107.613 173.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.06 30.44 1.02 Allowed Glycine 0 N--CA 1.427 -1.93 0 CA-C-N 113.053 -1.885 . . . . 0.28000000000000003 112.274 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 441' ' ' GLY . 73.1 t -102.46 149.81 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 120.587 -0.445 . . . . 0.96999999999999997 111.112 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.18 -166.69 39.25 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.153 -0.93 . . . . 0.13 111.789 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.88 141.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.036 -0.727 . . . . 1.03 109.036 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.603 ' HB2' HG22 ' A' ' 407' ' ' VAL . 35.5 p80 -151.48 165.1 35.23 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.669 0.747 . . . . 0.17000000000000001 112.26 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.737 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.8 139.68 30.43 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.027 -1.442 . . . . 0.41999999999999998 107.449 171.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.626 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 1.6 t -135.6 104.25 5.73 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 123.212 1.482 . . . . 2.0 110.144 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -93.17 -25.85 17.66 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 111.855 -2.43 . . . . 0.34999999999999998 110.17 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . 0.476 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 6.9 p90 -70.8 -26.41 63.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.385 -1.279 . . . . 0.19 109.316 173.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.552 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.1 OUTLIER -118.93 83.08 22.27 Favored Pre-proline 0 CA--C 1.496 -1.121 0 CA-C-N 114.036 -1.438 . . . . 1.3300000000000001 110.6 -174.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -82.94 6.58 5.72 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 C-N-CA 124.515 3.477 . . . . 0.28000000000000003 114.554 -162.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.64 153.46 30.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 123.372 0.42 . . . . 1.1000000000000001 110.226 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 1.672 ' HE1' ' CE2' ' A' ' 429' ' ' TYR . 0.6 OUTLIER -162.74 125.62 2.8 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.327 1.051 . . . . 0.98999999999999999 109.203 -170.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.8 28.83 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.026 -1.559 . . . . 0.13 111.792 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.588 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.5 154.96 0.01 OUTLIER Glycine 0 C--N 1.339 0.748 0 O-C-N 124.985 1.05 . . . . 0.23000000000000001 112.762 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.41 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.039 1.876 . . . . 0.33000000000000002 112.284 -147.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 43.6 mt -96.68 -33.54 11.7 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 110.223 -3.171 . . . . 1.05 108.094 175.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.49 ' HA ' HG21 ' A' ' 369' ' ' VAL . 2.9 p-90 -45.37 -37.96 5.46 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.936 0.772 . . . . 0.22 111.327 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.778 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.4 mttt -58.27 -23.7 57.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.059 -0.973 . . . . 1.29 113.007 -176.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 49.0 p -116.63 -35.55 4.19 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.458 -0.792 . . . . 1.0700000000000001 110.0 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.552 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.6 mtp85 -84.65 -14.92 47.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.634 -1.167 . . . . 0.41999999999999998 112.714 -169.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 73.47 41.54 44.25 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 116.459 1.344 . . . . 0.20999999999999999 116.459 159.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.7 m -87.53 131.49 34.36 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 118.267 1.033 . . . . 0.81999999999999995 109.113 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -97.58 68.32 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.817 -0.552 . . . . 0.5 111.097 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.597 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 87.64 -12.28 63.8 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.582 -1.007 . . . . 0.19 110.582 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.515 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 26.3 p -87.34 143.66 27.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.271 -0.464 . . . . 1.22 109.923 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -99.26 115.97 41.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.23 0.538 . . . . 1.04 110.734 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' A' ' 423' ' ' SER . 8.2 t30 -78.39 93.74 4.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.132 -0.94 . . . . 2.29 111.356 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 25.0 m -91.49 136.07 27.22 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.621 -0.718 . . . . 1.02 109.284 173.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 50.1 Cg_exo -56.79 132.65 53.01 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.073 2.515 . . . . 0.12 112.696 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.737 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 16.2 Cg_exo -50.21 -39.24 52.24 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.625 2.883 . . . . 0.16 112.713 -168.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 61.6 m -74.99 -42.22 57.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.709 -1.132 . . . . 1.47 109.867 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.621 HG12 ' HB ' ' A' ' 366' ' ' THR . 62.0 t -75.88 -28.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.353 0.597 . . . . 1.0600000000000001 111.294 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.69 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.7 tpt -68.33 -20.13 64.71 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.583 0.706 . . . . 1.0 110.17 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -79.61 -22.27 43.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 122.496 1.141 . . . . 1.4399999999999999 110.974 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.25 -47.4 14.67 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 112.894 -1.957 . . . . 0.38 107.399 177.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.594 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.8 tp -63.93 -67.27 0.44 Allowed 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 111.81 -2.45 . . . . 1.0 112.302 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.629 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 39.7 t80 -49.82 -27.23 4.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 123.026 1.393 . . . . 0.40000000000000002 108.335 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.06 -31.16 66.89 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 112.388 -2.187 . . . . 0.13 112.266 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -87.97 -49.35 7.12 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 121.772 0.796 . . . . 1.02 111.383 172.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.589 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.07 138.02 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-O 123.455 1.598 . . . . 1.04 113.796 -167.27 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.25 -178.87 5.35 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 110.821 -2.9 . . . . 0.82999999999999996 106.662 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.706 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.3 mtmt -51.61 161.5 0.5 Allowed 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.966 1.365 . . . . 1.04 112.869 175.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.77 -33.69 4.89 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.688 -2.051 . . . . 0.37 112.535 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 462' ' ' PRO . 6.9 m -78.78 142.34 60.85 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.362 -0.607 . . . . 1.01 109.362 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.612 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 5.1 Cg_exo -76.09 169.2 22.55 Favored 'Trans proline' 0 N--CA 1.425 -2.527 0 C-N-CA 121.89 1.727 . . . . 0.17000000000000001 111.335 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.631 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.12 157.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 107.422 -1.325 . . . . 1.75 107.422 166.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.454 HD21 ' CG ' ' A' ' 346' ' ' GLU . 2.8 tp -127.25 146.05 50.56 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.197 -0.911 . . . . 1.04 109.935 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.649 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 147.08 20.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.276 -1.379 . . . . 1.02 107.276 165.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.477 ' OXT' ' HA ' ' A' ' 348' ' ' ASP . 20.4 p90 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.742 -0.647 . . . . 1.1599999999999999 111.103 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 358' ' ' LYS . 8.0 m . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 107.129 -1.434 . . . . 1.04 107.129 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' A' ' 344' ' ' TYR . 8.2 p90 -157.15 -171.38 3.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.451 0.643 . . . . 0.94999999999999996 111.636 -174.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.589 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.2 mm -104.31 160.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 107.839 -1.171 . . . . 1.02 107.839 166.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.497 ' CG ' HD21 ' A' ' 464' ' ' LEU . 2.1 tt0 -140.41 155.49 46.71 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 118.82 0.737 . . . . 0.17000000000000001 111.336 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 354' ' ' MET . 63.8 t -150.38 134.48 8.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.589 -1.187 . . . . 1.03 110.251 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -115.48 114.66 25.33 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.832 -1.076 . . . . 0.37 108.139 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.8 mm? -68.21 -51.93 39.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.803 1.287 . . . . 1.0600000000000001 110.586 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.57 -52.97 15.9 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.179 -1.828 . . . . 1.51 113.298 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -102.54 9.14 39.66 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.73 -1.123 . . . . 0.91000000000000003 109.06 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.737 ' OE1' HD13 ' A' ' 368' ' ' ILE . 85.0 mm-40 36.93 73.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.058 1.474 . . . . 2.6299999999999999 111.871 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.8 t60 -150.3 125.95 10.31 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.54 -1.209 . . . . 0.17000000000000001 109.434 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.532 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.1 ttp -112.46 128.43 56.32 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.234 0.614 . . . . 0.97999999999999998 110.743 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.659 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.0 m-90 -111.87 173.11 6.51 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.634 -1.167 . . . . 0.11 111.817 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 1.9 t80 -126.06 116.12 20.91 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 106.775 -1.565 . . . . 1.02 106.775 165.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 17.8 m-85 -98.86 126.33 44.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.142 0.973 . . . . 0.90000000000000002 112.165 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.601 ' HA ' HG22 ' A' ' 343' ' ' THR . 3.5 ttpt -149.64 139.76 22.11 Favored 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 113.196 -1.82 . . . . 1.21 107.846 174.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.43 15.44 6.21 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 114.008 -1.451 . . . . 0.59999999999999998 108.799 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.59 18.62 77.34 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 112.378 -2.192 . . . . 0.23999999999999999 111.783 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.619 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.07 173.65 11.34 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.86 -1.904 . . . . 1.26 105.86 -170.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.619 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 3.5 m -104.23 137.67 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 124.338 2.018 . . . . 1.26 112.246 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -92.37 -23.73 19.13 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-N 109.218 -3.628 . . . . 1.03 108.624 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.674 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -153.84 154.72 34.46 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 113.567 -1.651 . . . . 1.01 108.405 -172.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.659 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.26 122.39 1.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.73 -0.668 . . . . 0.60999999999999999 109.299 -174.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.564 ' HB ' HG12 ' A' ' 449' ' ' VAL . 6.3 t -149.05 166.87 27.42 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 122.105 0.955 . . . . 0.98999999999999999 111.84 173.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.637 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.7 p-10 -86.48 141.55 29.01 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 113.228 -1.805 . . . . 1.8799999999999999 107.444 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.737 HD13 ' OE1' ' A' ' 352' ' ' GLN . 1.6 pp -142.0 -171.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.21 -0.904 . . . . 1.04 111.525 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.628 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -155.66 119.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.466 -0.788 . . . . 1.04 108.92 175.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.409 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.8 143.89 33.66 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.792 -1.095 . . . . 1.0 112.748 -165.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.08 44.82 34.39 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 116.924 1.529 . . . . 0.13 116.924 162.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.484 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.69 142.36 6.71 Favored Pre-proline 0 CA--C 1.507 -0.676 0 CA-C-N 118.593 1.196 . . . . 1.2 110.081 -175.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.779 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.59 -31.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.967 1 C-N-CA 125.885 4.39 . . . . 0.26000000000000001 116.365 -170.07 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.441 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -82.89 -32.58 27.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.297 0.57 . . . . 1.0600000000000001 110.672 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.465 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 12.1 m -140.77 74.55 26.71 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 122.151 0.976 . . . . 1.0800000000000001 110.239 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.76 162.41 42.13 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 125.068 3.845 . . . . 0.19 113.419 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.561 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.05 152.47 90.7 Favored Pre-proline 0 N--CA 1.436 -1.15 0 CA-C-N 113.665 -1.607 . . . . 1.04 110.806 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.556 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.47 -48.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.885 3.723 . . . . 0.10000000000000001 113.548 -172.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.657 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 66.31 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.918 1.081 . . . . 1.01 113.918 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.79 -123.47 1.18 Allowed Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 114.301 -1.318 . . . . 0.11 111.414 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 381' ' ' VAL . 10.6 p -129.8 104.93 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 122.371 1.081 . . . . 1.54 109.538 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.612 ' CE2' HG23 ' A' ' 465' ' ' VAL . 55.3 m-85 -110.4 166.33 11.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.994 -1.003 . . . . 0.26000000000000001 108.862 -172.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.7 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -148.77 136.28 20.4 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 117.63 0.195 . . . . 1.1799999999999999 110.714 177.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.542 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -72.29 124.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.555 0.693 . . . . 1.05 110.573 176.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -113.04 4.49 16.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.275 -0.875 . . . . 0.20000000000000001 112.005 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.69 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 5.8 t30 -163.96 148.97 10.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.493 -0.776 . . . . 0.40999999999999998 110.583 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.401 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.7 mtpt -110.81 109.74 20.07 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.811 0.815 . . . . 1.8200000000000001 110.412 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -107.95 131.87 54.09 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.304 -1.316 . . . . 0.38 109.382 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.548 -1.205 . . . . 1.96 110.092 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 25.8 t70 50.43 40.42 22.99 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.597 1.665 . . . . 0.40000000000000002 107.516 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.32 170.2 9.98 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 111.927 -2.397 . . . . 0.98999999999999999 110.809 -173.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 23.9 m -129.91 102.92 6.5 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.1 -1.409 . . . . 1.02 110.136 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.724 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -75.17 158.16 33.46 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 112.717 -2.038 . . . . 1.03 110.298 174.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.445 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 6.8 mtpt . . . . . 0 N--CA 1.398 -3.048 0 CA-C-N 115.224 -0.898 . . . . 1.26 108.919 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.4 mt-10 . . . . . 0 CA--C 1.511 -0.541 0 CA-C-O 122.329 1.061 . . . . 0.62 112.182 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.724 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -134.16 99.21 13.62 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-N 113.236 -1.802 . . . . 1.9099999999999999 108.595 176.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.91 101.05 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.793 2.329 . . . . 0.22 110.182 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.594 HG22 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -120.28 133.91 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-N 114.004 -1.453 . . . . 1.0900000000000001 111.234 -171.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.485 ' N ' HD21 ' A' ' 408' ' ' ASN . 0.1 OUTLIER -78.08 -30.32 49.56 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.822 -1.081 . . . . 1.8400000000000001 110.599 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.611 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 64.1 m-85 -142.15 117.83 10.41 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.728 -1.124 . . . . 0.88 110.758 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.572 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.9 t-105 -122.94 135.65 54.57 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.24 -1.346 . . . . 0.14999999999999999 110.296 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.518 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.3 OUTLIER -136.33 87.18 22.89 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 115.25 -0.886 . . . . 1.03 110.962 174.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 90.8 Cg_endo -72.68 140.95 33.34 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.834 2.356 . . . . 0.23999999999999999 111.554 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -122.55 -15.81 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.38 -1.282 . . . . 1.03 111.656 -171.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.782 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.9 p30 -135.78 170.16 16.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.486 -0.779 . . . . 1.5900000000000001 109.58 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -96.08 15.31 21.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.206 -0.452 . . . . 0.33000000000000002 111.989 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 18.3 p -96.85 -27.52 14.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.072 -1.085 . . . . 1.1499999999999999 108.072 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.82 27.3 0.87 Allowed Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.958 -1.473 . . . . 0.28000000000000003 113.314 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.782 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 61.5 t -103.44 151.77 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.266 0.555 . . . . 0.96999999999999997 111.428 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.34 -163.99 35.62 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.149 -0.932 . . . . 0.13 111.41 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.98 137.81 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 109.251 -0.648 . . . . 1.03 109.251 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.594 ' HB2' HG22 ' A' ' 407' ' ' VAL . 33.3 p80 -152.65 169.84 21.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.725 0.774 . . . . 0.17000000000000001 111.422 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.713 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.87 154.5 19.44 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 113.827 -1.533 . . . . 0.41999999999999998 108.699 174.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.629 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 18.5 p -140.11 99.95 3.8 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.583 1.182 . . . . 2.0 109.936 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.93 -31.17 13.78 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.621 -2.081 . . . . 0.34999999999999998 110.411 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 426' ' ' GLN . 18.2 p90 -70.25 -26.99 64.09 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.369 -1.287 . . . . 0.19 108.765 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.443 ' HG3' ' ND2' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.27 82.83 24.02 Favored Pre-proline 0 CA--C 1.489 -1.375 0 CA-C-N 113.437 -1.711 . . . . 1.3300000000000001 109.037 -174.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.07 3.61 7.47 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 124.483 3.455 . . . . 0.28000000000000003 114.619 -159.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 2.9 tp10 -113.96 157.17 22.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.892 0.377 . . . . 1.1000000000000001 110.738 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.637 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.66 125.89 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.293 -1.321 . . . . 0.98999999999999999 108.68 -171.277 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -168.34 28.72 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.419 -1.372 . . . . 0.13 112.158 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.589 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.36 0.01 OUTLIER Glycine 0 C--N 1.341 0.843 0 O-C-N 124.983 1.049 . . . . 0.23000000000000001 112.783 173.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.414 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 2.4 m-20 -55.22 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.281 0 CA-C-O 124.025 1.869 . . . . 0.33000000000000002 112.249 -146.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 36.3 mt -97.84 -33.53 11.21 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 110.06 -3.246 . . . . 1.05 109.298 175.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.539 ' HA ' HG21 ' A' ' 369' ' ' VAL . 8.0 p-90 -46.88 -34.45 5.43 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.214 -1.812 . . . . 0.22 112.16 -174.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.779 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 47.9 mttt -61.93 -23.79 66.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.334 -0.848 . . . . 1.29 113.188 -177.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -115.8 -36.66 4.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.686 0.755 . . . . 1.0700000000000001 110.085 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.509 ' HD2' HD23 ' A' ' 433' ' ' LEU . 4.5 mtp85 -81.65 -15.48 54.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.489 -1.232 . . . . 0.41999999999999998 112.973 -169.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.484 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.48 42.85 26.23 Favored Glycine 0 C--N 1.314 -0.646 0 N-CA-C 116.344 1.298 . . . . 0.20999999999999999 116.344 158.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 13.7 m -85.73 131.37 34.34 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 118.282 1.041 . . . . 0.81999999999999995 109.117 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -101.8 71.73 1.32 Allowed 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.405 -0.809 . . . . 0.5 110.919 -169.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.505 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 85.8 -13.57 55.79 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.223 -1.151 . . . . 0.19 110.223 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.563 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.1 p -88.59 148.18 24.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.063 -0.568 . . . . 1.22 110.218 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.561 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -103.64 118.78 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.107 -0.497 . . . . 1.04 110.348 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.629 ' HB3' ' OG ' ' A' ' 423' ' ' SER . 2.1 m-20 -85.49 90.01 7.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.589 -0.732 . . . . 2.29 111.641 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 99.5 m -87.02 138.76 32.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 121.473 0.654 . . . . 1.02 109.726 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.0 Cg_exo -54.36 136.58 69.61 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.685 2.257 . . . . 0.12 111.043 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.713 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 44.5 Cg_exo -55.65 -31.98 81.71 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 C-N-CA 123.984 3.122 . . . . 0.16 112.638 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.7 p -80.63 -39.04 28.11 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.279 -1.328 . . . . 1.47 109.623 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.564 HG12 ' HB ' ' A' ' 366' ' ' THR . 92.3 t -77.32 -31.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.552 -0.749 . . . . 1.0600000000000001 111.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.638 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 3.6 tpt -63.03 -24.4 67.9 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.584 0.707 . . . . 1.0 110.523 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -72.28 -30.49 64.87 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.539 -1.209 . . . . 1.4399999999999999 112.628 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.7 mm-40 -75.68 -46.6 30.35 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-N 113.005 -1.907 . . . . 0.38 107.362 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.477 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 26.1 tp -64.97 -67.35 0.44 Allowed 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 111.491 -2.595 . . . . 1.0 112.379 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.639 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 26.8 t80 -50.37 -25.91 4.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 123.146 1.45 . . . . 0.40000000000000002 108.309 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.34 -30.89 64.13 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 112.475 -2.148 . . . . 0.13 112.156 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.674 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -87.63 -48.38 7.94 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-O 121.661 0.743 . . . . 1.02 111.324 172.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.589 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.19 137.89 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.351 1.548 . . . . 1.04 113.989 -168.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.401 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.3 pt-20 -136.25 -178.56 5.21 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 110.965 -2.834 . . . . 0.82999999999999996 106.739 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.69 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.8 mtmt -50.95 160.54 0.46 Allowed 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 123.102 1.43 . . . . 1.04 113.363 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.76 -36.21 3.78 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 112.433 -2.167 . . . . 0.37 112.475 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 384' ' ' VAL . 19.3 m -70.35 141.17 88.15 Favored Pre-proline 0 N--CA 1.438 -1.048 0 CA-C-O 121.196 0.522 . . . . 1.01 110.282 -175.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.619 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.58 161.56 41.86 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.215 1.943 . . . . 0.17000000000000001 110.884 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 71.8 t -132.26 131.42 60.84 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 113.466 -1.697 . . . . 1.75 107.833 173.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.497 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.1 tp -109.83 142.03 41.69 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.232 0.539 . . . . 1.04 110.308 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.657 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.01 145.49 22.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.088 -1.819 . . . . 1.02 106.088 164.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.547 ' HA ' ' HB2' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.135 -0.936 . . . . 1.1599999999999999 111.591 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 358' ' ' LYS . 22.6 m . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 108.627 -0.879 . . . . 1.04 108.627 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.661 ' HD2' ' CD1' ' A' ' 344' ' ' TYR . 6.1 p90 -156.88 -171.01 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.52 0.676 . . . . 0.94999999999999996 111.41 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.585 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.4 mm -102.26 162.14 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 108.221 -1.029 . . . . 1.02 108.221 167.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.48 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.4 tt0 -142.14 156.54 45.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 118.835 0.743 . . . . 0.17000000000000001 111.545 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.611 HG23 ' HG3' ' A' ' 354' ' ' MET . 62.7 t -151.3 136.91 11.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.491 -1.231 . . . . 1.03 110.077 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -117.67 115.34 24.87 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.68 -1.145 . . . . 0.37 108.104 172.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.8 mm? -67.83 -49.5 61.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.355 1.074 . . . . 1.0600000000000001 110.564 -176.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -52.89 -55.2 24.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.774 -2.012 . . . . 1.51 112.185 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -95.82 4.0 53.24 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.738 -1.119 . . . . 0.91000000000000003 109.964 -171.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.685 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.5 mm-40 47.08 66.14 1.07 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.448 -2.16 . . . . 2.6299999999999999 112.129 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.508 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -148.48 125.35 11.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.286 0.565 . . . . 0.17000000000000001 109.916 -175.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.611 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.0 ttp -112.35 127.42 56.0 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 123.606 0.763 . . . . 0.97999999999999998 110.359 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.67 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -113.62 173.7 6.28 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.609 -1.178 . . . . 0.11 112.062 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.595 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 2.5 t80 -126.49 115.83 20.17 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 106.529 -1.656 . . . . 1.02 106.529 165.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 22.9 m-85 -100.44 127.91 46.65 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.993 0.901 . . . . 0.90000000000000002 112.118 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.578 ' HA ' HG21 ' A' ' 343' ' ' THR . 6.0 ttpt -147.79 137.68 22.71 Favored 'General case' 0 N--CA 1.398 -3.034 0 CA-C-N 113.667 -1.606 . . . . 1.21 108.548 174.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.451 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 70.48 14.2 7.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.402 -1.726 . . . . 0.59999999999999998 108.601 178.439 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.49 71.01 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 112.701 -2.045 . . . . 0.23999999999999999 112.186 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.69 169.9 16.97 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.158 -1.793 . . . . 1.26 106.158 -170.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.579 ' N ' ' HG3' ' A' ' 361' ' ' LYS . 3.1 m -101.41 138.23 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 CA-C-O 124.207 1.956 . . . . 1.26 111.976 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.446 ' CB ' ' CD1' ' A' ' 356' ' ' TYR . . . -92.63 -25.01 18.48 Favored 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 109.361 -3.563 . . . . 1.03 108.688 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.698 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.87 155.18 36.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 113.74 -1.573 . . . . 1.01 109.301 -173.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.67 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.14 123.0 1.6 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.469 -0.787 . . . . 0.60999999999999999 109.339 -175.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.614 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.9 t -148.32 165.68 30.31 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 122.415 1.102 . . . . 0.98999999999999999 112.017 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.728 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.7 p-10 -83.46 140.85 32.09 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 112.881 -1.963 . . . . 1.8799999999999999 107.821 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.64 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.26 -171.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.264 -0.88 . . . . 1.04 112.064 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.685 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -157.94 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.936 -1.029 . . . . 1.04 109.352 176.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.5 t -140.94 145.54 36.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.28 -0.873 . . . . 1.0 112.892 -165.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.69 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 68.54 46.68 61.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 116.199 1.24 . . . . 0.13 116.199 162.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.525 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.38 145.42 2.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 118.267 1.033 . . . . 1.2 110.184 -175.252 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.773 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.47 -33.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 125.242 3.961 . . . . 0.26000000000000001 115.911 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -80.41 -34.4 36.24 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.738 -0.601 . . . . 1.0600000000000001 110.752 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.476 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.3 m -139.98 73.06 33.53 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 122.209 1.004 . . . . 1.0800000000000001 109.994 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.69 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 29.5 Cg_exo -69.71 161.62 45.24 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 C-N-CA 125.301 4.001 . . . . 0.19 113.967 -177.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.577 HG21 ' CD ' ' A' ' 378' ' ' PRO . 0.1 OUTLIER -72.99 154.03 90.85 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.562 -1.654 . . . . 1.04 110.358 175.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.577 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.1 Cg_endo -80.24 -50.32 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 125.029 3.82 . . . . 0.10000000000000001 113.564 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.635 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.8 123.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.996 0.903 . . . . 1.01 113.322 -176.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.29 -124.07 1.22 Allowed Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.271 -1.331 . . . . 0.11 111.491 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.438 ' O ' HG11 ' A' ' 381' ' ' VAL . 9.2 p -128.63 104.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.454 1.121 . . . . 1.54 109.831 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.649 ' CE2' HG23 ' A' ' 465' ' ' VAL . 93.8 m-85 -107.92 161.35 15.01 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.516 -1.22 . . . . 0.26000000000000001 110.03 -170.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.726 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.5 m-85 -147.3 136.99 22.92 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 122.974 0.171 . . . . 1.1799999999999999 110.694 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.596 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.2 120.36 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.937 -0.705 . . . . 1.05 110.16 176.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . 0.449 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 40.6 p-90 -106.31 3.62 27.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.404 -0.816 . . . . 0.20000000000000001 111.789 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.682 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.7 t30 -164.54 148.86 9.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.224 -0.898 . . . . 0.40999999999999998 110.813 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . 0.452 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.3 mtpt -107.4 111.16 23.36 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.478 -0.783 . . . . 1.8200000000000001 109.863 169.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.1 mt-10 -111.87 122.92 49.11 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.657 1.218 . . . . 0.38 110.912 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -118.1 145.0 45.18 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.079 -1.419 . . . . 1.96 109.253 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 34.6 t70 54.34 25.88 6.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 112.026 -2.352 . . . . 0.40000000000000002 108.582 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.09 170.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.09 -1.868 . . . . 0.98999999999999999 112.063 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 31.5 m -127.49 102.26 6.79 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.526 -1.67 . . . . 1.02 110.099 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 9.9 mp -72.9 158.46 35.46 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 113.03 -1.896 . . . . 1.03 110.502 175.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 6.4 mtpt . . . . . 0 N--CA 1.396 -3.148 0 N-CA-C 108.636 -0.876 . . . . 1.26 108.636 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.702 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.1 mt-10 . . . . . 0 CA--C 1.509 -0.603 0 CA-C-O 122.342 1.067 . . . . 0.62 111.692 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.697 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.2 98.95 12.39 Favored Pre-proline 0 N--CA 1.42 -1.951 0 CA-C-N 113.12 -1.855 . . . . 1.9099999999999999 107.568 176.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.29 102.02 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 122.318 2.012 . . . . 0.22 110.165 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.58 HG11 ' N ' ' A' ' 408' ' ' ASN . 1.2 t -114.39 163.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.853 0 CA-C-N 114.192 -1.367 . . . . 1.0900000000000001 109.914 -173.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.58 ' N ' HG11 ' A' ' 407' ' ' VAL . 18.6 m-80 -114.92 -33.8 5.32 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 113.417 -1.72 . . . . 1.8400000000000001 107.081 -176.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.638 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 59.8 m-85 -134.87 115.68 13.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.629 -2.078 . . . . 0.88 110.485 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.549 ' CD1' ' HD3' ' A' ' 412' ' ' PRO . 6.5 t-105 -123.81 134.27 53.66 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.14999999999999999 110.254 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.461 ' HG2' HG23 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -135.56 85.04 32.22 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.936 -1.029 . . . . 1.03 110.93 173.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 73.2 Cg_endo -70.52 140.65 40.3 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.929 2.42 . . . . 0.23999999999999999 112.102 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -124.39 -16.19 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.076 -1.42 . . . . 1.03 111.162 -173.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -134.88 161.0 36.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.536 -0.756 . . . . 1.5900000000000001 109.532 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -92.13 13.84 17.81 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.147 0.425 . . . . 0.33000000000000002 112.147 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -93.02 -25.66 17.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.745 -1.206 . . . . 1.1499999999999999 107.745 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.22 29.16 1.38 Allowed Glycine 0 N--CA 1.425 -2.054 0 CA-C-N 113.073 -1.876 . . . . 0.28000000000000003 112.179 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 441' ' ' GLY . 84.8 t -102.27 148.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.281 0.562 . . . . 0.96999999999999997 110.626 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.97 -166.04 38.01 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.731 -1.122 . . . . 0.13 111.186 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.4 HG21 ' SD ' ' A' ' 450' ' ' MET . 0.9 OUTLIER -103.67 138.99 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 108.795 -0.817 . . . . 1.03 108.795 176.074 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.531 ' HB2' HG22 ' A' ' 407' ' ' VAL . 31.3 p80 -149.98 163.63 37.59 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.652 0.739 . . . . 0.17000000000000001 111.969 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.745 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.33 137.35 32.43 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.293 -1.321 . . . . 0.41999999999999998 107.951 173.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.5 OUTLIER -130.73 101.46 5.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.421 1.105 . . . . 2.0 109.606 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -95.18 -30.54 13.96 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.082 -1.872 . . . . 0.34999999999999998 111.021 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -66.66 -26.54 67.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.414 -1.266 . . . . 0.19 109.151 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.474 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.95 82.65 28.84 Favored Pre-proline 0 CA--C 1.49 -1.347 0 CA-C-N 113.614 -1.63 . . . . 1.3300000000000001 109.451 -173.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -80.86 5.94 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 124.784 3.656 . . . . 0.28000000000000003 114.21 -160.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.67 153.7 29.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.336 -0.393 . . . . 1.1000000000000001 110.614 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.728 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.95 124.73 2.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.214 -1.357 . . . . 0.98999999999999999 108.097 -172.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.86 -168.12 28.75 Favored Glycine 0 C--N 1.297 -1.629 0 C-N-CA 119.283 -1.437 . . . . 0.13 111.123 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.663 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.6 152.33 0.0 OUTLIER Glycine 0 C--N 1.342 0.891 0 O-C-N 125.141 1.142 . . . . 0.23000000000000001 113.176 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.46 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.6 m-20 -54.59 101.06 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 123.86 1.79 . . . . 0.33000000000000002 111.797 -145.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 55.6 mt -96.53 -30.79 13.11 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 110.474 -3.057 . . . . 1.05 108.111 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.584 ' HA ' HG21 ' A' ' 369' ' ' VAL . 5.0 p-90 -46.46 -38.01 8.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.867 0.73 . . . . 0.22 111.398 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.773 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 36.4 mttt -62.3 -24.34 67.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.921 -1.036 . . . . 1.29 112.845 -175.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 31.1 p -113.23 -36.18 5.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.568 0.699 . . . . 1.0700000000000001 110.16 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.482 ' HB2' HG22 ' A' ' 369' ' ' VAL . 5.7 mtp85 -86.96 -16.83 34.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.783 -1.099 . . . . 0.41999999999999998 112.664 -168.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.493 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.47 43.79 29.34 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 116.506 1.362 . . . . 0.20999999999999999 116.506 162.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -86.21 130.74 34.42 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 118.701 1.251 . . . . 0.81999999999999995 108.179 172.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -99.72 64.34 1.27 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.47 -0.769 . . . . 0.5 110.96 -168.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.599 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 94.9 -12.75 68.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.577 -1.009 . . . . 0.19 110.577 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.517 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 10.7 p -90.49 142.77 27.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.238 -0.481 . . . . 1.22 110.66 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.55 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -95.91 120.74 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 122.579 1.18 . . . . 1.04 111.19 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.5 OUTLIER -78.92 82.48 5.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.784 -2.007 . . . . 2.29 111.936 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 16.5 m -87.05 137.75 32.99 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-O 121.383 0.611 . . . . 1.02 109.509 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.492 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 50.9 Cg_exo -57.42 136.14 74.21 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.723 2.282 . . . . 0.12 111.595 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.745 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.8 Cg_exo -55.14 -33.0 82.44 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 124.245 3.297 . . . . 0.16 113.138 -172.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 4.6 t -81.42 -38.51 26.38 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.883 -1.053 . . . . 1.47 109.304 -177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.614 HG12 ' HB ' ' A' ' 366' ' ' THR . 26.1 t -82.9 -26.85 8.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.652 . . . . 1.0600000000000001 111.11 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.689 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.7 tpt -68.58 -19.92 64.49 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.878 0.847 . . . . 1.0 110.073 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.48 -23.22 46.53 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.609 -1.178 . . . . 1.4399999999999999 111.075 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.84 -45.97 16.05 Favored 'General case' 0 CA--C 1.477 -1.838 0 CA-C-N 112.905 -1.952 . . . . 0.38 107.473 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.61 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -65.01 -66.85 0.49 Allowed 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 111.89 -2.414 . . . . 1.0 112.311 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.654 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 24.1 t80 -50.16 -27.86 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.94 1.352 . . . . 0.40000000000000002 107.965 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.58 -30.13 71.09 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 112.491 -2.14 . . . . 0.13 112.469 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.698 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.88 -48.26 7.35 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.597 0.713 . . . . 1.02 111.611 172.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.585 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.24 138.69 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 123.365 1.555 . . . . 1.04 114.182 -167.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . 0.452 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.4 -178.74 5.3 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 110.834 -2.894 . . . . 0.82999999999999996 106.845 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.672 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.9 mtmt -52.22 162.77 0.45 Allowed 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 123.114 1.435 . . . . 1.04 113.058 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.64 -34.63 4.27 Favored Glycine 0 N--CA 1.424 -2.149 0 CA-C-N 112.48 -2.145 . . . . 0.37 112.283 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 462' ' ' PRO . 7.6 m -76.04 141.33 71.01 Favored Pre-proline 0 N--CA 1.434 -1.261 0 N-CA-C 109.484 -0.562 . . . . 1.01 109.484 -176.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.613 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.6 166.47 28.4 Favored 'Trans proline' 0 N--CA 1.425 -2.53 0 C-N-CA 122.024 1.816 . . . . 0.17000000000000001 111.157 173.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.628 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.63 153.2 34.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 107.634 -1.247 . . . . 1.75 107.634 166.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.46 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.3 tp -123.4 145.25 48.93 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.096 -0.956 . . . . 1.04 110.155 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.649 HG23 ' CE2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -143.28 146.05 21.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.413 -1.699 . . . . 1.02 106.413 164.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.48 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 18.0 p90 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.62 -0.705 . . . . 1.1599999999999999 111.364 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.584 HG21 ' HB2' ' A' ' 358' ' ' LYS . 27.1 m . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.959 -1.126 . . . . 1.04 107.959 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 11.4 p90 -161.0 -170.75 2.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.153 -0.931 . . . . 0.94999999999999996 110.768 -175.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.608 HD13 ' CB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.45 161.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.097 -1.075 . . . . 1.02 108.097 167.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.7 tt0 -140.35 155.85 46.63 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.956 0.798 . . . . 0.17000000000000001 111.253 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.606 HG23 ' HG3' ' A' ' 354' ' ' MET . 67.0 t -150.84 133.4 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.413 -1.267 . . . . 1.03 109.721 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 50.9 t0 -115.05 111.78 21.61 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.336 -1.357 . . . . 0.37 107.336 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.6 mm? -60.61 -58.67 7.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.783 1.277 . . . . 1.0600000000000001 107.618 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.485 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 11.9 mm-40 -48.94 -46.85 43.92 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 111.353 -2.658 . . . . 1.51 112.943 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -111.13 20.73 17.13 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 125.206 1.567 . . . . 0.91000000000000003 109.203 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.713 ' NE2' ' HA2' ' A' ' 431' ' ' GLY . 1.2 mp0 36.24 68.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.27 -1.787 . . . . 2.6299999999999999 112.622 170.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.505 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -153.17 124.5 7.58 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.194 0.521 . . . . 0.17000000000000001 109.914 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.606 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.1 ttp -110.91 127.54 55.5 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.454 0.702 . . . . 0.97999999999999998 110.605 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.641 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.1 m-90 -112.25 173.76 6.21 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 114.459 -1.246 . . . . 0.11 112.05 -175.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.615 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 3.3 t80 -127.41 119.15 25.51 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 106.261 -1.755 . . . . 1.02 106.261 165.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 18.5 m-85 -102.49 129.52 49.03 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.941 0.877 . . . . 0.90000000000000002 111.524 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.584 ' HB2' HG21 ' A' ' 343' ' ' THR . 3.5 ttpt -148.46 137.43 21.7 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 113.722 -1.581 . . . . 1.21 108.116 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.38 15.1 6.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.456 -1.702 . . . . 0.59999999999999998 108.752 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 80.51 17.79 72.57 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 112.667 -2.06 . . . . 0.23999999999999999 111.899 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.543 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -137.12 168.07 20.31 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.098 -1.816 . . . . 1.26 106.098 -171.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.1 m -100.11 138.21 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.802 0 CA-C-O 124.25 1.976 . . . . 1.26 111.874 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.57 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -93.24 -25.18 17.9 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 109.305 -3.589 . . . . 1.03 108.564 177.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.663 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -152.46 155.36 37.36 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.868 -1.515 . . . . 1.01 109.227 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.641 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.93 122.51 1.36 Allowed 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 109.614 -174.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.647 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.6 t -148.3 167.16 25.9 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.177 0.989 . . . . 0.98999999999999999 112.136 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.597 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.5 p-10 -86.77 140.93 29.25 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.222 -1.808 . . . . 1.8799999999999999 107.916 177.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -143.15 -172.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.309 -0.859 . . . . 1.04 112.484 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -154.36 119.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.705 -1.134 . . . . 1.04 108.696 175.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 6.6 t -141.27 143.41 34.09 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.759 -0.655 . . . . 1.0 112.742 -168.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.53 45.1 24.59 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 117.716 -1.602 . . . . 0.13 117.001 163.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.428 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 0.3 OUTLIER -46.71 143.85 3.94 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-N 119.722 1.761 . . . . 1.2 110.363 -173.146 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.808 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.68 -33.67 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.948 4.432 . . . . 0.26000000000000001 115.912 -170.811 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 3.1 p -75.06 -37.97 61.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.3 0.571 . . . . 1.0600000000000001 111.076 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.483 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.1 m -140.55 74.31 28.32 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.106 0.955 . . . . 1.0800000000000001 110.606 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.4 Cg_exo -70.94 160.44 49.37 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 125.175 3.917 . . . . 0.19 113.853 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.558 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -71.1 153.09 94.65 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.269 -1.787 . . . . 1.04 111.357 177.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.552 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.5 Cg_endo -80.17 -49.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 125.09 3.86 . . . . 0.10000000000000001 113.734 -171.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.64 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.3 122.86 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.737 1.014 . . . . 1.01 113.737 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.08 -124.74 1.28 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.242 -1.345 . . . . 0.11 111.423 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.464 HG11 ' O ' ' A' ' 381' ' ' VAL . 12.6 p -128.72 105.65 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 122.296 1.046 . . . . 1.54 109.267 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.625 ' CB ' HG23 ' A' ' 463' ' ' VAL . 96.8 m-85 -108.97 164.16 12.65 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.138 -0.937 . . . . 0.26000000000000001 110.058 -169.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.7 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 68.9 m-85 -147.34 137.23 23.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 121.196 -0.202 . . . . 1.1799999999999999 110.954 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.576 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.63 121.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.491 0.662 . . . . 1.05 110.364 176.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -108.62 5.86 25.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.421 -0.809 . . . . 0.20000000000000001 111.88 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.676 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 4.2 t30 -164.6 146.82 8.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.874 . . . . 0.40999999999999998 110.251 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -108.89 115.63 30.45 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.958 -0.756 . . . . 1.8200000000000001 108.958 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.582 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -118.65 111.98 19.23 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.472 1.606 . . . . 0.38 113.065 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 2.6 mp0 -103.84 143.74 32.42 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 113.289 -1.778 . . . . 1.96 109.708 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.7 t70 57.08 22.23 7.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.259 -2.246 . . . . 0.40000000000000002 108.604 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.582 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -82.33 171.15 14.53 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.403 -1.726 . . . . 0.98999999999999999 112.56 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.416 ' CG2' ' HG2' ' A' ' 404' ' ' GLU . 15.7 m -127.5 104.23 7.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.051 -1.886 . . . . 1.02 110.004 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.716 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 10.0 mp -73.26 156.99 37.93 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 112.642 -2.072 . . . . 1.03 109.98 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.433 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.3 mtpt . . . . . 0 N--CA 1.398 -3.058 0 O-C-N 124.352 1.032 . . . . 1.26 108.789 -176.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.2 mt-10 . . . . . 0 CA--C 1.512 -0.487 0 CA-C-O 122.392 1.091 . . . . 0.62 112.112 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.692 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.91 99.22 10.24 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-N 112.948 -1.933 . . . . 1.9099999999999999 108.239 176.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.62 102.24 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.549 2.166 . . . . 0.22 110.669 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.614 HG11 ' N ' ' A' ' 408' ' ' ASN . 1.2 t -113.64 165.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 114.238 -1.346 . . . . 1.0900000000000001 109.84 -173.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.614 ' N ' HG11 ' A' ' 407' ' ' VAL . 18.0 m-80 -116.3 -33.5 4.95 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.551 -1.659 . . . . 1.8400000000000001 107.083 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.665 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 46.3 m-85 -136.2 115.47 12.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.062 -1.881 . . . . 0.88 110.474 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.558 ' CD1' ' HD3' ' A' ' 412' ' ' PRO . 7.7 t-105 -122.95 135.77 54.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.712 -1.131 . . . . 0.14999999999999999 110.065 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.473 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.8 OUTLIER -136.51 83.49 30.88 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.892 -1.049 . . . . 1.03 110.923 173.496 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.675 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 13.9 Cg_endo -70.31 139.5 38.44 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.141 2.561 . . . . 0.23999999999999999 112.659 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.93 -15.15 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 113.792 -1.549 . . . . 1.03 111.453 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -134.39 163.64 29.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 1.5900000000000001 109.483 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -96.96 13.55 28.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.801 0.334 . . . . 0.33000000000000002 111.735 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.4 p -92.45 -27.06 17.7 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.538 -1.282 . . . . 1.1499999999999999 107.538 173.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.68 29.36 1.07 Allowed Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 112.862 -1.972 . . . . 0.28000000000000003 112.353 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 441' ' ' GLY . 74.3 t -102.47 148.76 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.232 0.539 . . . . 0.96999999999999997 111.142 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.49 -167.46 39.78 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.831 -1.077 . . . . 0.13 111.336 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.61 141.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.858 -0.793 . . . . 1.03 108.858 175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.597 ' O ' ' HB ' ' A' ' 445' ' ' THR . 32.9 p80 -149.46 165.16 32.95 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.747 0.784 . . . . 0.17000000000000001 111.616 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.733 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -93.28 139.39 30.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.019 -1.475 . . . . 0.41999999999999998 107.019 171.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.403 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 1.8 t -134.06 103.2 5.69 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.97 1.367 . . . . 2.0 110.066 -176.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.49 -32.36 13.53 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 112.234 -2.257 . . . . 0.34999999999999998 111.162 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -65.67 -27.19 68.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.55 -1.205 . . . . 0.19 109.055 175.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.566 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -121.36 82.62 39.21 Favored Pre-proline 0 CA--C 1.493 -1.221 0 CA-C-N 113.406 -1.724 . . . . 1.3300000000000001 109.485 -174.239 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -81.24 7.33 5.03 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 C-N-CA 124.818 3.678 . . . . 0.28000000000000003 114.471 -160.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 0.9 OUTLIER -113.68 154.46 27.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.009 0.433 . . . . 1.1000000000000001 111.303 -177.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.597 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.97 126.0 2.39 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.178 -1.374 . . . . 0.98999999999999999 108.86 -171.165 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . 0.576 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 146.95 -166.63 28.38 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.68 -1.248 . . . . 0.13 110.65 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.713 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -29.14 151.89 0.0 OUTLIER Glycine 0 C--N 1.341 0.822 0 O-C-N 125.187 1.169 . . . . 0.23000000000000001 113.258 173.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.01 100.5 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 111.944 -152.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.3 mt -97.69 -32.12 11.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 110.403 -3.089 . . . . 1.05 107.941 174.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.556 ' HA ' HG21 ' A' ' 369' ' ' VAL . 3.8 p-90 -46.0 -38.54 7.89 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.987 0.804 . . . . 0.22 111.414 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.808 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 34.9 mttt -59.11 -26.63 64.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 114.781 -1.1 . . . . 1.29 113.021 -176.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.6 p -111.53 -35.35 5.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.898 0.856 . . . . 1.0700000000000001 109.859 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.566 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.0 mtp85 -86.77 -15.55 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.439 -1.255 . . . . 0.41999999999999998 112.647 -168.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 74.65 41.89 33.95 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 116.608 1.403 . . . . 0.20999999999999999 116.608 159.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.7 p -91.07 131.76 36.45 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 118.318 1.059 . . . . 0.81999999999999995 109.124 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -98.6 69.08 1.86 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.673 -0.642 . . . . 0.5 111.209 -167.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.579 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 88.41 -11.77 66.96 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 110.39 -1.084 . . . . 0.19 110.39 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.565 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 18.4 p -86.88 141.34 28.84 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.181 -0.51 . . . . 1.22 109.924 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.558 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -95.52 117.71 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.668 0.747 . . . . 1.04 110.781 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.505 ' HB3' HG12 ' A' ' 369' ' ' VAL . 2.1 t30 -76.86 82.59 3.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.498 -1.228 . . . . 2.29 111.354 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.4 m -86.94 138.85 32.75 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-O 121.549 0.69 . . . . 1.02 109.628 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.6 Cg_exo -58.13 135.26 67.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.654 2.236 . . . . 0.12 111.416 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.733 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 30.3 Cg_exo -54.44 -34.08 79.97 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 124.299 3.333 . . . . 0.16 112.783 -174.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 44.7 m -78.98 -41.37 29.29 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.458 -1.247 . . . . 1.47 110.07 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.647 HG12 ' HB ' ' A' ' 366' ' ' THR . 54.0 t -79.21 -28.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.252 0.549 . . . . 1.0600000000000001 111.487 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.682 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.8 tpt -68.29 -18.58 64.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.775 0.797 . . . . 1.0 110.096 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.09 -22.23 42.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.7 -1.136 . . . . 1.4399999999999999 110.875 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.664 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.3 mm-40 -81.0 -47.3 13.81 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 112.767 -2.015 . . . . 0.38 107.38 177.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.637 HD21 ' SD ' ' A' ' 450' ' ' MET . 25.5 tp -64.28 -67.01 0.47 Allowed 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 111.878 -2.419 . . . . 1.0 112.318 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 36.0 t80 -49.76 -26.8 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 123.181 1.467 . . . . 0.40000000000000002 108.285 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.7 -30.95 65.54 Favored Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 112.251 -2.25 . . . . 0.13 112.331 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.664 ' HB2' ' CE2' ' A' ' 356' ' ' TYR . 1.7 ptp -89.19 -48.88 7.08 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 121.688 0.756 . . . . 1.02 111.572 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.608 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -100.26 139.23 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 123.328 1.537 . . . . 1.04 113.764 -168.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -136.19 -178.78 5.31 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 110.816 -2.902 . . . . 0.82999999999999996 106.883 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.676 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.6 mtmt -52.98 162.73 0.59 Allowed 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 123.025 1.393 . . . . 1.04 112.694 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.4 -36.51 3.61 Favored Glycine 0 N--CA 1.423 -2.207 0 CA-C-N 112.577 -2.101 . . . . 0.37 112.514 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 384' ' ' VAL . 4.1 m -74.27 141.72 77.66 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.471 -0.566 . . . . 1.01 109.471 -175.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.627 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.7 Cg_exo -74.39 167.74 26.44 Favored 'Trans proline' 0 N--CA 1.424 -2.559 0 C-N-CA 121.765 1.644 . . . . 0.17000000000000001 111.041 173.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.625 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.57 156.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 107.504 -1.295 . . . . 1.75 107.504 166.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.438 HD21 ' CG ' ' A' ' 346' ' ' GLU . 2.8 tp -126.98 145.15 50.8 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.462 -0.79 . . . . 1.04 110.233 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.64 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.27 146.7 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 106.869 -1.53 . . . . 1.02 106.869 164.429 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.473 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 14.7 p90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.372 -0.823 . . . . 1.1599999999999999 111.477 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.569 HG21 ' HA ' ' A' ' 358' ' ' LYS . 33.1 m . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 108.524 -0.917 . . . . 1.04 108.524 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.667 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 7.9 p90 -162.33 -170.32 2.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.913 -1.039 . . . . 0.94999999999999996 110.585 -174.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.596 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.1 mm -101.71 160.98 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.078 -1.082 . . . . 1.02 108.078 166.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.455 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 3.6 tt0 -140.95 154.62 46.16 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 118.805 0.73 . . . . 0.17000000000000001 110.898 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.607 HG23 ' HG3' ' A' ' 354' ' ' MET . 61.4 t -150.24 134.69 9.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.31 -1.314 . . . . 1.03 109.296 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -117.51 110.42 17.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.202 -1.407 . . . . 0.37 107.202 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.8 mm? -58.52 -56.98 15.13 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.835 -1.172 . . . . 1.0600000000000001 107.835 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -46.27 -51.21 14.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 111.956 -2.384 . . . . 1.51 112.993 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -100.73 4.42 43.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.394 -1.73 . . . . 0.91000000000000003 110.082 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.684 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 1.7 mp0 47.42 67.01 0.88 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 112.428 -2.169 . . . . 2.6299999999999999 112.363 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.3 t60 -146.79 125.69 12.74 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.377 0.608 . . . . 0.17000000000000001 110.107 -177.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.607 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.0 ttp -112.6 128.38 56.35 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.54 0.736 . . . . 0.97999999999999998 110.658 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.66 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.76 173.27 6.46 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.44 -1.254 . . . . 0.11 111.869 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.625 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 3.0 t80 -126.93 116.67 21.16 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.33 -1.729 . . . . 1.02 106.33 165.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.668 ' HE2' ' CE1' ' A' ' 357' ' ' TYR . 24.4 m-85 -100.53 128.93 46.44 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.899 0.857 . . . . 0.90000000000000002 111.609 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.569 ' HA ' HG21 ' A' ' 343' ' ' THR . 4.5 ttpt -148.18 137.37 22.02 Favored 'General case' 0 N--CA 1.399 -3.013 0 CA-C-N 113.761 -1.563 . . . . 1.21 108.473 173.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.449 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.73 16.69 6.71 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 113.332 -1.758 . . . . 0.59999999999999998 108.803 178.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.9 72.06 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 112.652 -2.067 . . . . 0.23999999999999999 111.819 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.568 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.96 169.56 17.57 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.349 -1.723 . . . . 1.26 106.349 -170.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.573 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.1 m -102.36 138.36 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.865 0 CA-C-O 124.252 1.977 . . . . 1.26 111.839 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -93.18 -25.37 17.87 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 109.24 -3.618 . . . . 1.03 108.647 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.624 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -153.23 154.87 35.53 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.762 -1.563 . . . . 1.01 108.654 -171.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.66 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.59 122.07 1.17 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.738 -0.665 . . . . 0.60999999999999999 109.651 -174.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.641 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.8 t -148.74 167.09 26.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.98999999999999999 112.01 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.656 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.2 p-10 -85.13 142.01 29.81 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 113.061 -1.881 . . . . 1.8799999999999999 107.69 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.684 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -142.02 -174.34 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.257 -0.883 . . . . 1.04 112.122 -175.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.709 ' O ' ' HB2' ' A' ' 444' ' ' ASN . 0.2 OUTLIER -152.46 117.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.931 . . . . 1.04 109.318 175.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.544 ' OG ' HD13 ' A' ' 443' ' ' ILE . 30.2 t -141.54 148.25 39.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.963 0.727 . . . . 1.0 112.963 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.665 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.7 44.96 47.02 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 116.197 1.239 . . . . 0.13 116.197 162.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.559 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.9 143.76 4.2 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 118.317 1.058 . . . . 1.2 109.977 -174.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.776 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.19 -32.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.826 1 C-N-CA 125.705 4.27 . . . . 0.26000000000000001 116.08 -170.681 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' THR . . . . . 0.528 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.35 -34.56 31.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.359 0.599 . . . . 1.0600000000000001 110.755 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.487 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 m -140.04 73.04 33.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 122.125 0.964 . . . . 1.0800000000000001 110.302 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.665 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.81 161.47 44.97 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 125.22 3.947 . . . . 0.19 113.869 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.569 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.52 151.97 91.71 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 113.333 -1.758 . . . . 1.04 111.05 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.553 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.9 Cg_endo -80.0 -48.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 125.277 3.984 . . . . 0.10000000000000001 113.913 -170.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.648 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.32 122.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.992 1.108 . . . . 1.01 113.992 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.36 -125.88 1.43 Allowed Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.121 -1.4 . . . . 0.11 110.778 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 381' ' ' VAL . 12.7 p -125.77 112.57 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.921 0.867 . . . . 1.54 108.761 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.644 ' CE2' HG23 ' A' ' 465' ' ' VAL . 98.1 m-85 -114.17 163.35 15.34 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.296 -0.866 . . . . 0.26000000000000001 109.994 -169.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 71.8 m-85 -146.68 136.68 23.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 121.188 -0.205 . . . . 1.1799999999999999 110.974 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.571 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.89 123.13 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 C-N-CA 119.938 -0.705 . . . . 1.05 110.552 177.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -107.08 3.41 25.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.602 -0.727 . . . . 0.20000000000000001 112.035 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.694 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -165.4 148.44 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.461 -0.79 . . . . 0.40999999999999998 110.764 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -107.59 109.05 20.6 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.444 -0.798 . . . . 1.8200000000000001 109.714 168.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.3 mt-10 -106.41 121.21 43.8 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.44 1.114 . . . . 0.38 110.634 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -120.62 134.84 55.24 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.535 -1.211 . . . . 1.96 110.511 -174.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.58 38.72 23.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 123.636 1.684 . . . . 0.40000000000000002 107.141 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.29 169.4 11.14 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 112.1 -2.318 . . . . 0.98999999999999999 111.671 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' THR . . . . . 0.4 ' CG2' ' HG2' ' A' ' 404' ' ' GLU . 7.6 m -127.24 105.12 8.34 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 113.417 -1.719 . . . . 1.02 109.626 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.69 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.27 157.67 35.42 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 112.963 -1.926 . . . . 1.03 110.302 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.1 mtpt . . . . . 0 N--CA 1.397 -3.094 0 CA-C-N 114.793 -1.094 . . . . 1.26 108.454 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.4 mt-10 . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 122.034 0.921 . . . . 0.62 111.914 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.69 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.68 99.75 10.31 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-N 113.355 -1.748 . . . . 1.9099999999999999 108.046 176.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.41 102.83 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.577 2.185 . . . . 0.22 110.653 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.31 156.68 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.588 0 CA-C-N 114.146 -1.388 . . . . 1.0900000000000001 109.776 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.42 ' N ' HG11 ' A' ' 407' ' ' VAL . 22.8 m-80 -105.17 -34.67 7.85 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.529 -1.669 . . . . 1.8400000000000001 107.359 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.655 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 52.4 m-85 -137.85 119.43 14.97 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.306 -1.77 . . . . 0.88 111.217 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.573 ' HB2' HG12 ' A' ' 407' ' ' VAL . 8.1 t-105 -125.2 135.58 52.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 113.841 -1.527 . . . . 0.14999999999999999 110.185 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.474 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.3 OUTLIER -134.94 85.18 35.59 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 114.992 -1.004 . . . . 1.03 111.152 174.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.694 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 87.5 Cg_endo -72.29 141.23 35.18 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.161 2.574 . . . . 0.23999999999999999 112.469 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -124.97 -15.93 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 113.828 -1.533 . . . . 1.03 111.031 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.93 162.32 32.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.303 -0.862 . . . . 1.5900000000000001 109.393 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -95.03 13.78 23.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.355 0.502 . . . . 0.33000000000000002 112.355 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 13.1 p -94.0 -26.66 16.71 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.531 -1.285 . . . . 1.1499999999999999 107.531 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.67 33.25 0.77 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.108 -1.86 . . . . 0.28000000000000003 112.32 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.681 HG11 ' O ' ' A' ' 441' ' ' GLY . 79.8 t -103.16 148.48 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.184 0.516 . . . . 0.96999999999999997 110.963 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 169.97 -167.43 40.52 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.948 -1.024 . . . . 0.13 111.446 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . 0.401 HG23 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -101.97 140.08 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 109.141 -0.688 . . . . 1.03 109.141 174.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.537 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 32.2 p80 -146.52 160.54 41.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.956 0.884 . . . . 0.17000000000000001 111.712 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.754 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -85.72 136.9 33.16 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 113.817 -1.538 . . . . 0.41999999999999998 107.399 170.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.95 102.01 5.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 123.015 1.388 . . . . 2.0 110.999 -175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -94.82 -33.48 12.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 112.168 -2.287 . . . . 0.34999999999999998 111.484 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -66.48 -27.24 67.64 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.687 -1.142 . . . . 0.19 109.505 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.59 ' HB3' HD22 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -121.27 81.27 37.3 Favored Pre-proline 0 CA--C 1.494 -1.202 0 CA-C-N 113.664 -1.607 . . . . 1.3300000000000001 110.351 -174.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -82.2 7.84 4.86 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 125.062 3.841 . . . . 0.28000000000000003 114.162 -163.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -114.58 153.35 30.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 123.462 0.476 . . . . 1.1000000000000001 110.267 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.656 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.47 126.87 2.72 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.756 1.285 . . . . 0.98999999999999999 108.202 -169.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 146.55 -164.54 28.43 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 118.849 -1.643 . . . . 0.13 111.193 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.588 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -27.84 151.04 0.0 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 125.208 1.181 . . . . 0.23000000000000001 113.075 171.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 112.031 -149.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 40.4 mt -97.44 -33.87 11.23 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 110.583 -3.008 . . . . 1.05 107.95 174.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.584 ' HA ' HG22 ' A' ' 369' ' ' VAL . 5.1 p-90 -46.2 -37.45 7.12 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.638 0.586 . . . . 0.22 111.61 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.776 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 32.3 mttt -61.5 -23.74 66.11 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.223 -0.899 . . . . 1.29 112.923 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.5 p -113.58 -35.02 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.886 0.851 . . . . 1.0700000000000001 109.879 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.492 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 3.7 mtp180 -87.2 -16.49 35.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.612 -1.176 . . . . 0.41999999999999998 112.785 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.559 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.01 41.75 39.28 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.264 1.266 . . . . 0.20999999999999999 116.264 159.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.0 m -84.21 133.83 34.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 118.233 1.016 . . . . 0.81999999999999995 108.541 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -103.96 68.14 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.45 -0.781 . . . . 0.5 110.884 -166.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.681 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 89.46 -11.11 70.97 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.518 -1.033 . . . . 0.19 110.518 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.537 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.6 p -90.68 137.24 32.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.211 -0.494 . . . . 1.22 110.667 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 377' ' ' THR . 1.4 mp -92.01 120.6 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 CA-C-O 122.734 1.254 . . . . 1.04 111.164 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.709 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.8 OUTLIER -79.42 82.44 5.56 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.317 -2.22 . . . . 2.29 112.14 -177.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.46 ' HA ' HG23 ' A' ' 368' ' ' ILE . 19.6 m -86.75 137.72 33.63 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-O 121.499 0.666 . . . . 1.02 109.599 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 49.4 Cg_exo -58.67 134.12 58.68 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.562 2.174 . . . . 0.12 110.679 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.754 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.9 Cg_exo -56.43 -34.89 95.69 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 C-N-CA 123.881 3.054 . . . . 0.16 112.938 -171.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.8 m -77.21 -37.59 53.12 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.698 -1.137 . . . . 1.47 109.778 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.641 HG12 ' HB ' ' A' ' 366' ' ' THR . 59.2 t -80.77 -27.39 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.835 -0.62 . . . . 1.0600000000000001 111.063 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 409' ' ' TYR . 0.0 OUTLIER -63.62 -35.48 80.66 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-O 121.859 0.838 . . . . 1.0 109.281 177.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -64.54 -25.03 67.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.48 -1.236 . . . . 1.4399999999999999 111.985 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 456' ' ' MET . 16.1 mm-40 -79.1 -46.96 17.0 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 113.692 -1.595 . . . . 0.38 107.64 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.481 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 28.8 tp -64.48 -67.16 0.46 Allowed 'General case' 0 N--CA 1.404 -2.772 0 CA-C-N 111.644 -2.525 . . . . 1.0 112.55 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.636 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 39.8 t80 -49.31 -28.62 5.03 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.216 1.484 . . . . 0.40000000000000002 107.919 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.65 -32.43 74.57 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 112.143 -2.298 . . . . 0.13 112.058 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.648 ' HB2' ' CE2' ' A' ' 356' ' ' TYR . 1.6 ptp -87.83 -48.09 8.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.66 0.743 . . . . 1.02 111.677 172.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.596 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.3 138.39 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 123.604 1.669 . . . . 1.04 114.239 -167.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -136.88 -178.27 5.12 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 110.634 -2.985 . . . . 0.82999999999999996 106.504 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.678 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.0 mtmt -53.17 163.39 0.55 Allowed 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 123.129 1.442 . . . . 1.04 112.661 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.49 4.74 Favored Glycine 0 N--CA 1.423 -2.179 0 CA-C-N 112.496 -2.138 . . . . 0.37 112.26 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 462' ' ' PRO . 8.7 m -76.65 141.61 69.21 Favored Pre-proline 0 N--CA 1.433 -1.321 0 N-CA-C 109.335 -0.617 . . . . 1.01 109.335 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.609 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -75.26 166.34 29.08 Favored 'Trans proline' 0 N--CA 1.425 -2.525 0 C-N-CA 121.833 1.689 . . . . 0.17000000000000001 110.865 173.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.71 155.79 39.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 107.449 -1.315 . . . . 1.75 107.449 167.036 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.455 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -126.39 145.06 50.61 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.327 -0.851 . . . . 1.04 110.051 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.648 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.22 147.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 N-CA-C 107.189 -1.411 . . . . 1.02 107.189 164.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.471 ' HA ' ' CB ' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.274 -0.869 . . . . 1.1599999999999999 111.496 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 358' ' ' LYS . 8.5 m . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 107.761 -1.2 . . . . 1.04 107.761 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' A' ' 344' ' ' TYR . 8.0 p90 -157.11 -171.08 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.596 0.712 . . . . 0.94999999999999996 111.178 -174.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' ILE . . . . . 0.58 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.3 mm -103.05 161.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.055 -1.091 . . . . 1.02 108.055 167.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.479 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.1 tt0 -141.53 155.36 45.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.493 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.604 HG23 ' HG3' ' A' ' 354' ' ' MET . 76.2 t -150.98 137.4 12.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.701 -1.136 . . . . 1.03 110.355 -177.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -123.48 107.34 11.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.852 -1.166 . . . . 0.37 107.852 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 349' ' ' LEU . 2.3 mm? -68.26 -39.43 82.2 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 113.228 -1.805 . . . . 1.0600000000000001 111.24 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.4 -55.78 16.16 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.022 -2.354 . . . . 1.51 111.432 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -93.51 11.83 27.25 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.62 -1.173 . . . . 0.91000000000000003 108.654 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' GLN . . . . . 0.697 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 2.4 mm-40 35.36 73.28 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 125.537 1.773 . . . . 2.6299999999999999 113.079 177.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.0 t60 -151.15 125.59 9.48 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.333 -0.849 . . . . 0.17000000000000001 109.625 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' MET . . . . . 0.604 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.0 ttp -113.34 127.48 56.15 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.478 0.711 . . . . 0.97999999999999998 110.358 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' TRP . . . . . 0.669 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.5 m-90 -113.14 173.68 6.27 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.659 -1.155 . . . . 0.11 111.886 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' TYR . . . . . 1.607 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 2.5 t80 -127.12 117.44 22.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.625 -1.62 . . . . 1.02 106.625 165.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 26.5 m-85 -101.37 126.33 48.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.146 0.974 . . . . 0.90000000000000002 112.362 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 343' ' ' THR . 3.8 ttpt -148.96 137.5 21.11 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 113.099 -1.864 . . . . 1.21 108.458 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 70.52 15.98 7.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 113.334 -1.757 . . . . 0.59999999999999998 108.822 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.03 78.87 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 112.561 -2.109 . . . . 0.23999999999999999 111.551 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -133.86 169.75 16.62 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.344 -1.928 . . . . 1.26 106.255 -169.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' VAL . . . . . 0.586 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.2 m -101.03 137.5 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 CA-C-O 124.325 2.012 . . . . 1.26 111.824 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ALA . . . . . 0.575 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -24.31 18.85 Favored 'General case' 0 N--CA 1.398 -3.047 0 CA-C-N 109.211 -3.632 . . . . 1.03 108.573 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' LEU . . . . . 0.659 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.71 154.93 35.0 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.729 -1.578 . . . . 1.01 108.919 -172.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLU . . . . . 0.669 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.08 122.06 1.29 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.562 -175.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.641 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.7 t -148.7 167.58 25.16 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-O 122.22 1.009 . . . . 0.98999999999999999 112.3 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ASP . . . . . 0.514 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 6.3 p-10 -86.09 139.9 30.71 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.163 -1.835 . . . . 1.8799999999999999 107.913 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.697 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -140.8 -172.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.138 -0.937 . . . . 1.04 112.22 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.82 115.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.133 -0.939 . . . . 1.04 109.704 174.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' SER . . . . . 0.615 ' OG ' HD13 ' A' ' 443' ' ' ILE . 30.2 t -140.54 149.67 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 1.0 112.535 -169.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.715 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.35 44.17 52.57 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 116.854 1.502 . . . . 0.13 116.854 162.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' LYS . . . . . 0.515 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 1.6 pttt -47.61 146.1 3.86 Favored Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 119.153 1.477 . . . . 1.2 110.683 -174.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' PRO . . . . . 0.784 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -34.19 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 1 C-N-CA 125.985 4.457 . . . . 0.26000000000000001 115.71 -174.127 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.1 p -77.43 -39.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.171 0.51 . . . . 1.0600000000000001 110.975 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' THR . . . . . 0.491 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 4.1 m -140.21 72.83 32.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 122.263 1.03 . . . . 1.0800000000000001 110.197 -177.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 31.9 Cg_exo -69.13 164.46 33.84 Favored 'Trans proline' 0 C--N 1.322 -0.84 1 C-N-CA 125.64 4.227 . . . . 0.19 114.463 -176.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' THR . . . . . 0.556 HG23 HD12 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -76.4 152.01 83.45 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 113.565 -1.652 . . . . 1.04 110.45 174.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.552 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.55 -49.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.328 -0.516 0 C-N-CA 125.093 3.862 . . . . 0.10000000000000001 113.813 -170.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' ALA . . . . . 0.64 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.34 122.8 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.921 1.082 . . . . 1.01 113.921 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.21 -122.26 1.07 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.257 -1.338 . . . . 0.11 111.426 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.01 112.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.86 0.838 . . . . 1.54 108.812 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' PHE . . . . . 0.66 ' CE2' HG23 ' A' ' 465' ' ' VAL . 95.9 m-85 -115.79 161.21 19.07 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.42 -0.809 . . . . 0.26000000000000001 109.697 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' TYR . . . . . 0.671 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -147.78 136.31 21.68 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 121.132 -0.227 . . . . 1.1799999999999999 110.681 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' VAL . . . . . 0.596 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.6 125.31 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.855 -0.738 . . . . 1.05 110.653 177.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -110.71 0.7 17.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.436 -0.802 . . . . 0.20000000000000001 112.176 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' ASN . . . . . 0.703 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.2 t30 -162.56 149.25 13.08 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.155 -0.93 . . . . 0.40999999999999998 109.639 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -113.0 119.76 39.01 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.807 0.813 . . . . 1.8200000000000001 109.934 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -119.35 121.28 39.2 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.226 -1.352 . . . . 0.38 111.229 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.78 143.58 46.83 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.032 -1.44 . . . . 1.96 109.774 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 24.0 t70 54.1 26.12 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.835 -2.439 . . . . 0.40000000000000002 108.637 -175.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.26 171.16 13.88 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 112.769 -2.014 . . . . 0.98999999999999999 111.879 -167.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 8.9 m -129.89 102.95 6.52 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.628 -1.624 . . . . 1.02 110.159 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 10.1 mp -72.42 156.89 38.58 Favored 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 112.254 -2.248 . . . . 1.03 110.242 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 9.7 mtpt . . . . . 0 N--CA 1.396 -3.136 0 CA-C-N 114.436 -1.256 . . . . 1.26 108.419 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.8 mt-10 . . . . . 0 CA--C 1.51 -0.576 0 CA-C-O 122.535 1.16 . . . . 0.62 111.446 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' SER . . . . . 0.688 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.44 99.23 9.71 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 112.822 -1.99 . . . . 1.9099999999999999 107.791 174.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.7 Cg_endo -68.17 102.1 0.77 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.269 1.979 . . . . 0.22 110.362 174.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' VAL . . . . . 0.557 HG12 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.69 162.56 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.631 0 CA-C-N 114.446 -1.252 . . . . 1.0900000000000001 109.95 -173.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' ASN . . . . . 0.548 ' N ' HG11 ' A' ' 407' ' ' VAL . 23.4 m-80 -112.14 -34.99 5.77 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 113.597 -1.638 . . . . 1.8400000000000001 107.018 -177.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' TYR . . . . . 1.67 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 54.5 m-85 -134.56 115.89 14.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.966 -1.925 . . . . 0.88 110.879 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' TRP . . . . . 0.572 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.9 t-105 -123.41 134.78 53.93 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.237 -1.347 . . . . 0.14999999999999999 110.263 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' MET . . . . . 0.464 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.1 OUTLIER -135.83 86.18 27.92 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 114.808 -1.087 . . . . 1.03 111.293 174.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . 0.703 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 98.1 Cg_endo -71.84 140.03 34.52 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.961 2.441 . . . . 0.23999999999999999 112.175 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.2 pt -123.05 -15.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 113.883 -1.508 . . . . 1.03 110.869 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -134.86 163.55 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 1.5900000000000001 109.552 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -95.03 13.83 23.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.529 0.566 . . . . 0.33000000000000002 112.529 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.6 p -93.1 -27.22 17.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.412 -1.329 . . . . 1.1499999999999999 107.412 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.61 30.89 0.86 Allowed Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 112.919 -1.946 . . . . 0.28000000000000003 112.086 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' VAL . . . . . 0.679 HG11 ' O ' ' A' ' 441' ' ' GLY . 70.7 t -102.08 148.88 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 120.564 -0.455 . . . . 0.96999999999999997 110.976 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 171.49 -166.47 39.51 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.118 -0.946 . . . . 0.13 111.812 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.95 141.04 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.815 -0.809 . . . . 1.03 108.815 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' HIS . . . . . 0.554 ' HB2' HG22 ' A' ' 407' ' ' VAL . 33.5 p80 -150.22 165.55 32.6 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.721 0.772 . . . . 0.17000000000000001 111.215 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.72 147.98 22.59 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 113.9 -1.5 . . . . 0.41999999999999998 107.11 171.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 3.7 t -141.87 103.97 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.988 1.375 . . . . 2.0 110.589 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.63 -30.23 15.05 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 111.915 -2.402 . . . . 0.34999999999999998 111.13 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 17.1 p90 -68.95 -27.02 65.36 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 114.52 -1.218 . . . . 0.19 109.352 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' GLN . . . . . 0.486 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -119.44 81.18 22.76 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 113.581 -1.645 . . . . 1.3300000000000001 109.311 -176.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -82.32 8.13 4.7 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 124.95 3.767 . . . . 0.28000000000000003 113.694 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -114.08 147.64 38.41 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.925 0.765 . . . . 1.1000000000000001 109.572 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' TYR . . . . . 0.514 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.8 OUTLIER -158.84 128.43 5.65 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.993 1.317 . . . . 0.98999999999999999 107.67 -172.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.33 -165.16 28.67 Favored Glycine 0 N--CA 1.431 -1.68 0 C-N-CA 118.884 -1.627 . . . . 0.13 111.196 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' GLY . . . . . 0.594 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.36 154.02 0.0 OUTLIER Glycine 0 C--N 1.336 0.58 0 O-C-N 124.879 0.988 . . . . 0.23000000000000001 113.013 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' ASP . . . . . 0.409 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.0 m-20 -56.47 101.32 0.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 123.612 1.673 . . . . 0.33000000000000002 112.143 -147.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.8 mt -97.8 -31.94 11.97 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 110.654 -2.975 . . . . 1.05 108.178 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 434' ' ' TRP . . . . . 0.583 ' HA ' HG22 ' A' ' 369' ' ' VAL . 9.0 p-90 -44.78 -40.23 5.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.674 0.609 . . . . 0.22 111.737 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 435' ' ' LYS . . . . . 0.784 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 37.0 mttt -61.14 -23.68 65.71 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 113.009 0.744 . . . . 1.29 113.009 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.2 p -113.57 -35.92 5.08 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.455 -0.793 . . . . 1.0700000000000001 110.208 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' ARG . . . . . 0.477 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.4 mtp85 -88.91 -15.69 33.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.858 -1.064 . . . . 0.41999999999999998 113.204 -168.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' GLY . . . . . 0.515 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 76.46 41.45 25.17 Favored Glycine 0 C--N 1.31 -0.914 0 N-CA-C 116.59 1.396 . . . . 0.20999999999999999 116.59 158.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 21.6 m -83.51 141.8 31.37 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 118.136 0.968 . . . . 0.81999999999999995 108.752 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -109.31 73.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.726 -0.609 . . . . 0.5 110.836 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' GLY . . . . . 0.679 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 82.8 -8.54 62.35 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.914 -0.874 . . . . 0.19 110.914 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' CYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -96.06 131.96 41.92 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.322 0.582 . . . . 1.22 110.526 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' ILE . . . . . 0.615 HD13 ' OG ' ' A' ' 370' ' ' SER . 1.5 mp -88.77 117.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.283 -0.871 . . . . 1.04 111.109 -174.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 2.8 t30 -78.44 82.54 4.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.492 -1.685 . . . . 2.29 111.572 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.7 m -87.78 140.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.508 0.67 . . . . 1.02 110.048 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.4 Cg_exo -57.37 136.48 76.37 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.815 2.343 . . . . 0.12 111.714 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' PRO . . . . . 0.742 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 52.3 Cg_exo -56.03 -32.53 86.58 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.296 3.331 . . . . 0.16 112.888 -173.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.1 p -81.72 -38.22 26.09 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.717 -1.129 . . . . 1.47 110.115 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' VAL . . . . . 0.641 HG12 ' HB ' ' A' ' 366' ' ' THR . 88.2 t -80.29 -29.88 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.326 0.584 . . . . 1.0600000000000001 111.407 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' MET . . . . . 0.678 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.0 tpt -66.65 -19.62 65.81 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.842 0.83 . . . . 1.0 110.115 177.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.94 -23.6 41.59 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.511 -1.222 . . . . 1.4399999999999999 111.124 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 456' ' ' MET . 6.8 mm-40 -78.31 -47.36 17.94 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 113.192 -1.822 . . . . 0.38 107.103 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' LEU . . . . . 0.602 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.5 tp -63.92 -67.36 0.44 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.642 -2.526 . . . . 1.0 112.292 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 38.1 t80 -49.95 -26.93 4.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 123.193 1.473 . . . . 0.40000000000000002 108.303 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.86 -31.81 66.95 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 112.426 -2.17 . . . . 0.13 112.291 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' MET . . . . . 0.659 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -87.5 -48.0 8.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.637 0.732 . . . . 1.02 111.586 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' VAL . . . . . 0.58 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -102.84 139.05 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 123.407 1.575 . . . . 1.04 114.06 -168.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.46 -178.62 5.25 Favored 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 110.961 -2.836 . . . . 0.82999999999999996 107.108 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' LYS . . . . . 0.696 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -50.44 160.8 0.36 Allowed 'General case' 0 N--CA 1.411 -2.385 0 CA-C-O 123.043 1.401 . . . . 1.04 113.109 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.26 -35.93 3.78 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 112.565 -2.107 . . . . 0.37 112.354 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 384' ' ' VAL . 3.9 m -74.44 141.12 76.31 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 109.452 -0.573 . . . . 1.01 109.452 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' PRO . . . . . 0.604 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 5.1 Cg_exo -75.18 166.26 29.36 Favored 'Trans proline' 0 N--CA 1.422 -2.682 0 C-N-CA 121.98 1.787 . . . . 0.17000000000000001 111.07 174.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' VAL . . . . . 0.617 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.1 m -133.65 154.76 39.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 107.455 -1.313 . . . . 1.75 107.455 166.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.461 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.0 tp -124.36 144.82 49.81 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.317 -0.856 . . . . 1.04 110.087 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' VAL . . . . . 0.66 HG23 ' CE2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -143.17 146.67 21.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.843 -1.54 . . . . 1.02 106.843 165.1 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' PHE . . . . . 0.479 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 15.4 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.79 -0.624 . . . . 1.1599999999999999 111.486 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.094 -0.802 . . . . 4.3899999999999997 111.094 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.663 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.6 t-160 -174.61 94.4 0.08 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.913 -0.773 . . . . 2.1899999999999999 108.913 -172.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.663 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 33.7 mtm 77.53 179.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.776 1.298 . . . . 1.23 110.696 -171.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -118.33 -7.74 10.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.153 -0.93 . . . . 1.1000000000000001 111.231 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.66 166.16 1.0 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 123.04 1.4 . . . . 0.97999999999999998 113.629 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.592 HG22 ' HA ' ' A' ' 358' ' ' LYS . 8.4 m -94.15 123.16 37.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.749 -2.023 . . . . 1.04 107.396 168.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' A' ' 344' ' ' TYR . 17.8 p90 -163.33 -170.84 2.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.76 0.791 . . . . 0.94999999999999996 111.04 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.591 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -103.85 156.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.603 -1.18 . . . . 1.02 107.938 166.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.472 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.7 tt0 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.171 0.896 . . . . 0.17000000000000001 110.595 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 465' ' ' VAL . 66.8 t -149.27 137.27 14.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.614 -1.176 . . . . 1.03 109.098 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -120.42 115.02 22.68 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.077 -1.083 . . . . 0.37 108.077 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.7 mm? -66.2 -48.37 70.85 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 123.099 1.428 . . . . 1.0600000000000001 110.195 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.32 -52.01 49.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 112.623 -2.081 . . . . 1.51 112.901 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -102.71 9.74 38.99 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.191 -1.368 . . . . 0.91000000000000003 108.664 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.825 ' NE2' HD13 ' A' ' 368' ' ' ILE . 15.1 mm100 36.09 72.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 125.154 1.534 . . . . 2.6299999999999999 111.8 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.6 t60 -150.11 126.41 10.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.641 -1.163 . . . . 0.17000000000000001 109.469 -176.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.573 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.1 ttp -112.99 128.34 56.47 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.659 0.783 . . . . 0.97999999999999998 110.618 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.674 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.75 173.61 6.34 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.513 -1.221 . . . . 0.11 111.889 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.631 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 1.2 t80 -125.1 115.92 21.26 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.336 -1.727 . . . . 1.02 106.336 165.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 357' ' ' TYR . 27.9 m-85 -101.24 127.29 47.89 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.153 0.978 . . . . 0.90000000000000002 112.021 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.592 ' HA ' HG22 ' A' ' 343' ' ' THR . 2.8 ttpt -148.26 137.19 21.81 Favored 'General case' 0 N--CA 1.399 -3.023 0 CA-C-N 113.376 -1.738 . . . . 1.21 108.628 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.45 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.9 OUTLIER 71.29 13.84 6.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 113.159 -1.837 . . . . 0.59999999999999998 108.992 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.89 74.97 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 112.783 -2.008 . . . . 0.23999999999999999 111.771 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.573 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.09 168.11 19.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 105.991 -1.855 . . . . 1.26 105.991 -171.037 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.573 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.6 m -101.05 139.02 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-O 124.164 1.935 . . . . 1.26 111.868 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 356' ' ' TYR . . . -92.67 -25.01 18.45 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 109.675 -3.421 . . . . 1.03 108.586 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.645 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.42 155.2 35.9 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 113.711 -1.586 . . . . 1.01 109.222 -171.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.674 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.79 122.63 1.41 Allowed 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.736 -0.665 . . . . 0.60999999999999999 109.498 -176.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.653 ' HB ' HG12 ' A' ' 449' ' ' VAL . 4.7 t -147.11 166.9 25.5 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.631 0.729 . . . . 0.98999999999999999 110.823 173.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 48.1 m-20 -84.23 148.76 26.54 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.984 -1.488 . . . . 1.8799999999999999 106.984 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.825 HD13 ' NE2' ' A' ' 352' ' ' GLN . 1.4 pp -144.37 -178.32 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.841 0.713 . . . . 1.04 111.535 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.681 ' HA ' ' NE2' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -149.85 118.5 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.449 -0.796 . . . . 1.04 109.56 173.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 443' ' ' ILE . 34.3 p -141.32 142.55 33.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.835 -1.075 . . . . 1.0 111.699 -165.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.785 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.04 44.62 29.25 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 116.678 1.431 . . . . 0.13 116.678 162.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.597 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.65 144.56 3.47 Favored Pre-proline 0 C--O 1.221 -0.439 0 CA-C-N 118.639 1.219 . . . . 1.2 110.187 -174.725 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.804 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.12 -28.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.553 1 C-N-CA 126.056 4.504 . . . . 0.26000000000000001 116.215 -172.518 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.597 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -85.45 -32.13 22.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.265 0.555 . . . . 1.0600000000000001 110.813 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.464 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 11.8 m -140.91 72.9 28.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 122.14 0.971 . . . . 1.0800000000000001 110.155 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.785 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.3 Cg_exo -70.85 161.28 46.63 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 125.269 3.979 . . . . 0.19 114.39 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.562 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.64 151.73 89.27 Favored Pre-proline 0 N--CA 1.435 -1.219 0 CA-C-N 113.375 -1.738 . . . . 1.04 110.835 175.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.539 ' CD ' HG21 ' A' ' 377' ' ' THR . 2.0 Cg_endo -81.04 -51.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 125.144 3.896 . . . . 0.10000000000000001 113.886 -171.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.645 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 69.35 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.301 0.852 . . . . 1.01 113.301 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.89 -124.97 1.29 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 114.302 -1.317 . . . . 0.11 111.417 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 381' ' ' VAL . 13.0 p -126.04 108.17 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 122.093 0.949 . . . . 1.54 109.222 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.623 ' CB ' HG23 ' A' ' 463' ' ' VAL . 91.8 m-85 -113.68 155.87 24.76 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.128 -0.942 . . . . 0.26000000000000001 109.633 -170.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 1.641 ' HE1' ' CE2' ' A' ' 383' ' ' TYR . 10.6 m-85 -147.06 139.83 25.01 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 117.872 0.306 . . . . 1.1799999999999999 110.447 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.604 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -74.66 124.3 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 119.88 -0.728 . . . . 1.05 110.895 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -107.5 1.96 23.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.314 -0.857 . . . . 0.20000000000000001 111.925 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.711 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.2 t30 -164.63 150.26 10.19 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.189 -0.914 . . . . 0.40999999999999998 110.276 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -111.28 119.41 38.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.783 0.802 . . . . 1.8200000000000001 110.138 171.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.576 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -118.54 122.1 41.84 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.589 -1.187 . . . . 0.38 111.076 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -120.43 136.96 54.57 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.416 -1.265 . . . . 1.96 109.95 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.6 t70 52.21 38.82 25.58 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 123.584 1.659 . . . . 0.40000000000000002 107.292 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.576 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -91.74 170.44 9.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 112.329 -2.214 . . . . 0.98999999999999999 111.907 -175.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 15.5 m -129.86 104.54 7.44 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.691 -1.595 . . . . 1.02 109.545 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.694 HD11 ' N ' ' A' ' 393' ' ' LEU . 10.1 mp -72.02 155.0 40.8 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.147 -1.842 . . . . 1.03 109.713 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 10.3 mtpt -155.68 174.27 15.53 Favored 'General case' 0 N--CA 1.4 -2.931 0 CA-C-N 114.704 -1.134 . . . . 1.26 108.415 -175.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.889 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 170.0 164.89 26.49 Favored Glycine 0 CA--C 1.475 -2.46 0 C-N-CA 117.875 -2.107 . . . . 0.81000000000000005 113.285 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.86 118.4 32.43 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 122.493 1.139 . . . . 1.2 108.509 173.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.498 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.5 m-80 -51.85 179.05 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 111.868 -2.423 . . . . 1.1200000000000001 111.967 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -54.61 -24.35 20.95 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.436 0.636 . . . . 1.6499999999999999 110.397 167.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.433 ' HB3' HG21 ' A' ' 401' ' ' THR . 1.0 OUTLIER -88.0 -25.65 23.02 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.486 -0.779 . . . . 2.0 109.975 -174.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.85 32.95 6.27 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.343 -1.103 . . . . 0.70999999999999996 110.343 -170.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.498 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 57.8 p -114.79 126.81 27.45 Favored Pre-proline 0 N--CA 1.413 -2.278 0 N-CA-C 107.588 -1.264 . . . . 1.26 107.588 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.889 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 13.1 Cg_exo -72.21 141.35 35.68 Favored 'Trans proline' 0 N--CA 1.421 -2.755 0 C-N-CA 122.498 2.132 . . . . 1.1399999999999999 111.386 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.618 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 17.5 p90 -134.94 -177.95 4.87 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.491 -2.141 . . . . 0.84999999999999998 107.958 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.693 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.7 mt-10 -141.92 163.1 33.81 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.604 1.192 . . . . 0.62 112.224 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.672 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -141.59 98.85 6.4 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.443 -2.162 . . . . 1.9099999999999999 107.562 172.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.72 103.38 0.84 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.496 2.131 . . . . 0.22 110.613 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.578 ' HB ' HD12 ' A' ' 393' ' ' LEU . 1.2 t -115.55 161.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-N 114.332 -1.304 . . . . 1.0900000000000001 110.242 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.555 ' N ' HG11 ' A' ' 407' ' ' VAL . 18.0 m-80 -113.4 -32.23 6.31 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.5 -1.682 . . . . 1.8400000000000001 107.501 -176.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.622 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 67.1 m-85 -136.56 116.02 12.78 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.828 -1.987 . . . . 0.88 110.713 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.557 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.4 t-105 -125.01 135.21 52.56 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.656 -1.156 . . . . 0.14999999999999999 110.379 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.444 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.3 OUTLIER -136.07 86.3 26.26 Favored Pre-proline 0 C--N 1.3 -1.583 0 CA-C-N 114.941 -1.027 . . . . 1.03 111.205 174.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.694 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.9 Cg_endo -71.44 139.93 35.58 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 122.993 2.462 . . . . 0.23999999999999999 112.427 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -124.03 -15.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.751 -1.568 . . . . 1.03 110.941 -174.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -133.72 165.28 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.171 -0.922 . . . . 1.5900000000000001 109.582 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -98.47 15.22 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.215 0.45 . . . . 0.33000000000000002 112.215 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.8 p -95.04 -26.81 15.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.601 -1.259 . . . . 1.1499999999999999 107.601 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.75 31.72 1.01 Allowed Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 112.927 -1.942 . . . . 0.28000000000000003 111.971 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.593 HG11 ' O ' ' A' ' 441' ' ' GLY . 81.6 t -101.6 148.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.204 0.525 . . . . 0.96999999999999997 110.775 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 171.57 -167.49 40.56 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.735 -1.12 . . . . 0.13 111.191 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.74 139.53 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.875 -0.787 . . . . 1.03 108.875 175.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.618 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 30.9 p80 -149.2 163.31 37.99 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.823 0.821 . . . . 0.17000000000000001 111.792 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.749 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.92 138.27 31.72 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.091 -1.413 . . . . 0.41999999999999998 107.453 172.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.474 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.8 OUTLIER -131.36 101.07 5.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.48 1.133 . . . . 2.0 109.057 -174.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -95.18 -35.26 11.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.953 -1.931 . . . . 0.34999999999999998 111.562 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 21.1 p90 -63.53 -26.96 68.94 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.398 -1.274 . . . . 0.19 109.055 174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.776 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.81 83.42 36.39 Favored Pre-proline 0 CA--C 1.498 -1.035 0 CA-C-N 113.404 -1.726 . . . . 1.3300000000000001 109.966 -172.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -80.93 5.53 6.15 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 124.901 3.734 . . . . 0.28000000000000003 114.649 -160.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.2 156.35 23.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.975 0.417 . . . . 1.1000000000000001 111.021 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.452 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.83 125.15 2.31 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.653 -1.158 . . . . 0.98999999999999999 109.312 -171.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.94 -166.3 28.87 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 119.659 -1.258 . . . . 0.13 111.769 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.632 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.02 155.67 0.0 OUTLIER Glycine 0 C--N 1.339 0.745 0 O-C-N 125.21 1.182 . . . . 0.23000000000000001 112.989 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.425 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.7 m-20 -56.36 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 123.97 1.843 . . . . 0.33000000000000002 112.134 -147.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.632 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 51.3 mt -96.49 -32.62 12.2 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 110.342 -3.117 . . . . 1.05 108.055 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.553 ' HA ' HG21 ' A' ' 369' ' ' VAL . 4.4 p-90 -46.24 -37.27 7.0 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 124.002 0.814 . . . . 0.22 111.15 -174.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.804 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 40.2 mttt -59.28 -27.19 65.61 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.695 -1.138 . . . . 1.29 112.762 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -112.3 -36.41 5.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.604 -0.726 . . . . 1.0700000000000001 109.908 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.541 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.7 mtp85 -84.53 -15.46 45.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.542 -1.208 . . . . 0.41999999999999998 113.038 -167.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.483 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.03 41.58 31.92 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 116.769 1.468 . . . . 0.20999999999999999 116.769 159.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.6 m -85.74 131.73 34.27 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 118.272 1.036 . . . . 0.81999999999999995 109.228 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.444 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 80.5 m80 -97.05 67.43 2.21 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.67 -0.643 . . . . 0.5 111.358 -169.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.593 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 87.46 -13.6 59.93 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.213 -1.155 . . . . 0.19 110.213 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.618 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.0 p -86.15 140.92 29.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.708 -0.746 . . . . 1.22 110.164 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.562 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -94.98 115.33 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.549 0.69 . . . . 1.04 111.087 -176.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.776 ' OD1' ' HB3' ' A' ' 426' ' ' GLN . 0.1 OUTLIER -76.66 89.41 3.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.606 -1.179 . . . . 2.29 111.021 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.545 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 32.0 m -91.22 140.62 25.79 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.47 0.652 . . . . 1.02 109.335 174.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 49.7 Cg_exo -57.84 136.27 74.26 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.801 2.334 . . . . 0.12 111.836 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.749 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.6 Cg_exo -55.72 -32.49 84.22 Favored 'Trans proline' 0 CA--C 1.501 -1.133 0 C-N-CA 124.244 3.296 . . . . 0.16 113.069 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.5 p -82.02 -38.7 24.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.63 -1.168 . . . . 1.47 110.348 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.653 HG12 ' HB ' ' A' ' 366' ' ' THR . 59.0 t -80.64 -29.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.374 0.607 . . . . 1.0600000000000001 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.681 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.3 tpt -67.92 -19.18 64.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.945 0.878 . . . . 1.0 109.969 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.04 -22.54 42.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.442 -1.254 . . . . 1.4399999999999999 110.777 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.633 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.98 -46.85 14.47 Favored 'General case' 0 CA--C 1.476 -1.89 0 CA-C-N 112.991 -1.913 . . . . 0.38 107.438 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.623 HD21 ' SD ' ' A' ' 450' ' ' MET . 27.2 tp -64.76 -67.19 0.46 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 111.872 -2.422 . . . . 1.0 112.486 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.457 ' HB2' ' HE1' ' A' ' 450' ' ' MET . 19.3 t80 -50.47 -26.18 4.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.0 1.381 . . . . 0.40000000000000002 108.066 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.31 -30.24 67.37 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 112.517 -2.129 . . . . 0.13 112.296 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.645 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.05 -48.42 7.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.775 0.797 . . . . 1.02 111.444 171.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.591 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.8 OUTLIER -103.38 138.01 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 123.415 1.578 . . . . 1.04 114.103 -167.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -137.22 -178.18 5.09 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 110.754 -2.93 . . . . 0.82999999999999996 106.778 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.711 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.0 mtmt -51.48 161.28 0.49 Allowed 'General case' 0 N--CA 1.412 -2.354 0 CA-C-O 122.894 1.331 . . . . 1.04 112.534 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.55 -28.95 8.29 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-N 112.646 -2.07 . . . . 0.37 112.185 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 462' ' ' PRO . 10.0 m -84.96 140.9 37.39 Favored Pre-proline 0 N--CA 1.433 -1.292 0 N-CA-C 108.534 -0.913 . . . . 1.01 108.534 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.698 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.93 173.69 13.65 Favored 'Trans proline' 0 N--CA 1.416 -3.084 0 C-N-CA 121.097 1.198 . . . . 0.17000000000000001 111.738 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.623 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.31 159.54 35.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.642 -1.244 . . . . 1.75 107.642 167.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.472 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.8 tp -130.27 146.11 51.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 115.159 -0.928 . . . . 1.04 110.046 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.645 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 146.82 20.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.292 -1.373 . . . . 1.02 107.292 165.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.454 ' CE2' ' HG2' ' A' ' 346' ' ' GLU . 19.9 p90 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.533 -0.746 . . . . 1.1599999999999999 111.464 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 111.983 -0.447 . . . . 4.3899999999999997 111.983 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.4 t-160 -82.75 96.14 8.09 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.646 -0.501 . . . . 2.1899999999999999 109.646 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 11.9 mtp 71.71 -178.29 0.21 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.877 1.361 . . . . 1.23 111.051 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.63 -6.81 1.31 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.168 0.433 . . . . 1.1000000000000001 112.168 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.94 169.08 0.55 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.859 1.314 . . . . 0.97999999999999998 113.062 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 358' ' ' LYS . 97.2 m -91.99 123.7 35.55 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 113.274 -1.785 . . . . 1.04 108.539 167.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.654 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 8.5 p90 -162.44 -170.32 2.4 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.461 -1.245 . . . . 0.94999999999999996 110.489 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.605 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.9 mm -102.19 157.32 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.071 -1.085 . . . . 1.02 108.071 165.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.472 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.6 tt0 -139.06 154.39 48.19 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 118.617 0.644 . . . . 0.17000000000000001 110.543 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.544 HG23 ' HG3' ' A' ' 354' ' ' MET . 53.5 t -149.98 136.38 12.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.035 -0.984 . . . . 1.03 109.988 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -117.19 116.31 27.03 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.703 -1.135 . . . . 0.37 108.24 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.7 mm? -69.02 -49.03 61.29 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.53 1.157 . . . . 1.0600000000000001 110.452 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.69 -54.82 36.78 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.835 -1.984 . . . . 1.51 112.213 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -96.62 10.08 39.61 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.559 -1.201 . . . . 0.91000000000000003 108.601 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.752 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.1 mm-40 38.16 71.85 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 125.315 1.634 . . . . 2.6299999999999999 111.98 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.449 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -152.68 124.91 8.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.548 -0.751 . . . . 0.17000000000000001 109.634 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.544 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.7 ttp -111.87 128.61 56.18 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.667 -0.697 . . . . 0.97999999999999998 110.3 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.678 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.25 173.05 6.55 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 114.595 -1.184 . . . . 0.11 111.899 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.639 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 0.3 OUTLIER -125.38 112.78 16.71 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.621 -1.992 . . . . 1.02 105.621 163.449 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 357' ' ' TYR . 25.6 m-85 -94.97 125.09 39.4 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.499 -0.88 . . . . 0.90000000000000002 110.963 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.523 ' HA ' HG21 ' A' ' 343' ' ' THR . 37.3 ttmt -134.42 137.38 43.98 Favored 'General case' 0 N--CA 1.387 -3.583 0 CA-C-N 114.332 -1.304 . . . . 1.21 109.68 173.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.32 12.22 7.05 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 112.941 -1.936 . . . . 0.59999999999999998 109.092 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 358' ' ' LYS . . . 88.61 14.28 61.73 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 112.79 -2.005 . . . . 0.23999999999999999 112.301 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -128.36 172.65 10.89 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.383 -2.081 . . . . 1.26 105.383 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.621 ' CG2' ' HG2' ' A' ' 365' ' ' GLU . 3.5 m -104.86 136.01 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 CA-C-O 124.318 2.009 . . . . 1.26 112.316 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.538 ' HB1' ' CD1' ' A' ' 356' ' ' TYR . . . -89.49 -25.13 21.6 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.408 -3.542 . . . . 1.03 108.355 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.589 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.7 tp -154.71 154.18 32.48 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.051 -1.431 . . . . 1.01 108.927 -172.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.678 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.22 121.51 1.42 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 123.514 0.509 . . . . 0.60999999999999999 109.913 -175.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.612 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.3 t -148.62 167.41 25.52 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 122.225 1.012 . . . . 0.98999999999999999 112.12 175.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.567 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.2 p-10 -84.73 141.71 30.35 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 113.238 -1.801 . . . . 1.8799999999999999 107.893 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.631 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -142.32 -171.91 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 1.04 112.091 -176.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.752 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -158.31 114.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.035 -0.984 . . . . 1.04 109.283 177.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.508 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 15.0 t -141.93 145.46 34.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.908 -1.042 . . . . 1.0 112.802 -167.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.11 44.95 33.67 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 116.747 1.459 . . . . 0.13 116.747 162.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.577 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.75 143.42 6.04 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 118.601 1.2 . . . . 1.2 110.456 -174.689 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.803 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.13 -32.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.749 4.299 . . . . 0.26000000000000001 116.089 -171.29 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.577 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 2.0 p -80.23 -35.36 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.36 0.6 . . . . 1.0600000000000001 110.816 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.488 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.1 m -139.77 72.2 35.68 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 122.291 1.043 . . . . 1.0800000000000001 109.688 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.727 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.5 Cg_exo -70.21 162.92 40.52 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 125.253 3.969 . . . . 0.19 114.007 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.567 HG23 HD12 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.82 149.5 83.14 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 113.625 -1.625 . . . . 1.04 110.001 174.637 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.559 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.5 Cg_endo -76.89 -49.0 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 125.108 3.872 . . . . 0.10000000000000001 113.283 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.655 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.69 121.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.965 1.098 . . . . 1.01 113.965 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.45 -126.31 1.51 Allowed Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 113.995 -1.457 . . . . 0.11 110.613 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.431 ' O ' HG11 ' A' ' 381' ' ' VAL . 14.5 p -126.18 108.98 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.935 0.874 . . . . 1.54 108.96 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.609 ' CE2' HG23 ' A' ' 465' ' ' VAL . 53.0 m-85 -113.14 170.1 8.46 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.381 -0.827 . . . . 0.26000000000000001 109.16 -173.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.697 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 79.0 m-85 -150.8 139.81 21.02 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.239 -0.282 . . . . 1.1799999999999999 110.239 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.573 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.68 121.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.691 -0.804 . . . . 1.05 110.328 176.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . 0.422 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 46.6 p-90 -109.66 3.0 20.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.492 -0.777 . . . . 0.20000000000000001 112.422 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.701 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.0 t30 -161.13 144.72 13.07 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.579 -1.267 . . . . 0.40999999999999998 107.579 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 387' ' ' LYS . 0.3 OUTLIER -118.56 109.85 16.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.324 1.059 . . . . 1.8200000000000001 108.506 -177.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.562 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -116.73 130.6 56.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.41 -1.268 . . . . 0.38 110.829 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.79 135.12 48.06 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 113.738 -1.574 . . . . 1.96 109.601 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 23.2 t70 52.95 40.53 31.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 123.298 1.523 . . . . 0.40000000000000002 107.357 -173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.551 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.19 170.42 9.41 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 112.223 -2.262 . . . . 0.98999999999999999 111.807 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 5.2 m -127.84 105.53 8.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.942 -1.481 . . . . 1.02 110.157 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.72 HD11 ' N ' ' A' ' 393' ' ' LEU . 9.9 mp -74.41 158.35 34.04 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.061 -1.881 . . . . 1.03 110.767 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.4 mtpt -148.5 -175.44 4.92 Favored 'General case' 0 N--CA 1.396 -3.17 0 CA-C-N 114.72 -1.127 . . . . 1.26 108.818 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.697 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.72 -147.4 7.51 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 117.331 -2.366 . . . . 0.81000000000000005 114.67 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.47 117.94 10.87 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 113.541 -1.329 . . . . 1.2 108.658 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.579 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.7 m-80 -54.31 -179.45 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 112.271 -2.241 . . . . 1.1200000000000001 113.221 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.543 ' HB3' ' CB ' ' A' ' 374' ' ' THR . 0.2 OUTLIER -53.23 -22.51 6.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.169 0.509 . . . . 1.6499999999999999 110.853 167.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.61 -24.34 18.72 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 116.026 -0.534 . . . . 2.0 111.545 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.07 33.86 6.14 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 119.751 -1.214 . . . . 0.70999999999999996 110.066 -168.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.579 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 55.0 p -116.19 126.99 27.11 Favored Pre-proline 0 N--CA 1.413 -2.275 0 N-CA-C 106.997 -1.482 . . . . 1.26 106.997 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.697 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 20.2 Cg_exo -67.69 151.41 79.09 Favored 'Trans proline' 0 C--N 1.284 -2.866 0 C-N-CA 122.102 1.868 . . . . 1.1399999999999999 111.366 -175.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.623 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 19.1 p90 -140.11 -174.33 3.9 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 112.786 -2.006 . . . . 0.84999999999999998 107.103 -175.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.677 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.0 mt-10 -142.02 160.74 39.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.167 0.984 . . . . 0.62 112.028 176.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.693 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.95 99.97 9.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 113.268 -1.787 . . . . 1.9099999999999999 107.75 176.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.02 102.31 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.741 2.294 . . . . 0.22 110.493 175.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.582 ' HB ' HD12 ' A' ' 393' ' ' LEU . 1.2 t -116.36 160.77 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-N 114.483 -1.235 . . . . 1.0900000000000001 110.563 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.541 ' N ' HG11 ' A' ' 407' ' ' VAL . 18.0 m-80 -113.3 -31.48 6.58 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.33 -1.759 . . . . 1.8400000000000001 107.564 -176.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.606 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 68.2 m-85 -137.18 116.85 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.143 -1.844 . . . . 0.88 110.898 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.562 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 6.7 t-105 -125.27 134.04 52.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.813 -1.085 . . . . 0.14999999999999999 111.084 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.501 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.5 mtp -134.57 86.68 33.82 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 114.628 -1.169 . . . . 1.03 111.334 173.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.701 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 89.7 Cg_endo -72.96 139.08 29.51 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.846 2.364 . . . . 0.23999999999999999 111.445 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.697 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -125.7 -12.85 4.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 1.03 111.055 -172.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.434 ' CG ' ' HG1' ' A' ' 416' ' ' THR . 0.0 OUTLIER -133.95 168.85 18.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.845 . . . . 1.5900000000000001 109.448 173.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.5 14.78 28.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.45 0.907 . . . . 0.33000000000000002 113.45 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.434 ' HG1' ' CG ' ' A' ' 414' ' ' ASP . 37.9 p -99.73 -27.69 13.53 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.916 -1.142 . . . . 1.1499999999999999 107.916 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 134.73 29.72 0.41 Allowed Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 113.814 -1.539 . . . . 0.28000000000000003 112.711 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.666 HG11 ' O ' ' A' ' 441' ' ' GLY . 60.3 t -102.45 146.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.513 0.673 . . . . 0.96999999999999997 111.583 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.19 37.86 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.743 -1.117 . . . . 0.13 111.546 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.441 HG12 ' SD ' ' A' ' 354' ' ' MET . 0.9 OUTLIER -104.82 140.93 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.613 -0.884 . . . . 1.03 108.613 176.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.539 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 31.8 p80 -150.78 166.41 30.54 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.672 0.749 . . . . 0.17000000000000001 111.288 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.749 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.44 136.19 33.29 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.193 -1.367 . . . . 0.41999999999999998 107.482 171.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 6.2 t -130.86 102.72 6.19 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 122.879 1.324 . . . . 2.0 109.435 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.14 -30.57 14.56 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.387 -2.188 . . . . 0.34999999999999998 110.964 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 20.6 p90 -68.66 -27.36 65.92 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.436 -1.256 . . . . 0.19 109.35 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.475 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -120.69 80.16 31.59 Favored Pre-proline 0 CA--C 1.496 -1.114 0 CA-C-N 113.788 -1.551 . . . . 1.3300000000000001 109.615 -176.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -83.71 8.65 4.5 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 C-N-CA 125.248 3.965 . . . . 0.28000000000000003 113.991 -163.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -114.22 148.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.207 -0.664 . . . . 1.1000000000000001 109.207 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.567 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -159.47 131.38 6.37 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.841 1.338 . . . . 0.98999999999999999 107.497 -171.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 146.56 -166.76 28.18 Favored Glycine 0 C--N 1.296 -1.684 0 C-N-CA 119.19 -1.481 . . . . 0.13 111.036 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.573 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 152.11 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 O-C-N 125.201 1.177 . . . . 0.23000000000000001 112.834 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.77 101.13 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 123.864 1.792 . . . . 0.33000000000000002 111.766 -145.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.8 mt -96.62 -31.57 12.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 110.524 -3.034 . . . . 1.05 108.213 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.567 ' HA ' HG22 ' A' ' 369' ' ' VAL . 7.3 p-90 -46.34 -38.48 8.83 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.894 0.746 . . . . 0.22 111.425 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.803 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.5 mttt -62.01 -24.85 67.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.115 -0.948 . . . . 1.29 112.819 -175.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.4 p -112.53 -37.45 4.93 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.497 -0.774 . . . . 1.0700000000000001 110.074 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.6 mtp85 -82.44 -18.85 40.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.41999999999999998 112.016 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.02 42.45 24.65 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.709 -1.234 . . . . 0.20999999999999999 115.746 164.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.7 m -85.26 131.54 34.4 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 118.404 1.102 . . . . 0.81999999999999995 108.905 174.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.432 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 63.1 m80 -98.83 68.64 1.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.501 -0.749 . . . . 0.5 110.609 -169.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.666 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 86.32 -7.76 77.21 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.833 -0.907 . . . . 0.19 110.833 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.539 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 13.8 p -94.16 128.56 40.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.657 0.742 . . . . 1.22 110.789 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.567 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -88.47 112.94 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.821 -1.081 . . . . 1.04 110.556 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.529 ' HB2' HG11 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -78.83 88.84 4.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.851 -1.068 . . . . 2.29 111.263 -177.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.582 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 28.5 m -86.69 136.58 34.55 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 108.988 -0.745 . . . . 1.02 108.988 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -54.21 135.41 64.65 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.583 2.188 . . . . 0.12 111.083 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.749 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 29.1 Cg_exo -54.6 -31.66 71.27 Favored 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 124.063 3.175 . . . . 0.16 112.816 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.7 -39.2 24.64 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.4 -1.273 . . . . 1.47 110.338 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 366' ' ' THR . 64.2 t -79.26 -30.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.464 0.65 . . . . 1.0600000000000001 111.355 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.694 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 8.1 tpt -67.31 -19.62 65.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.939 0.876 . . . . 1.0 110.103 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.34 -22.98 43.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.413 -1.267 . . . . 1.4399999999999999 110.572 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' A' ' 456' ' ' MET . 10.8 mm-40 -80.28 -47.86 13.91 Favored 'General case' 0 CA--C 1.474 -1.965 0 CA-C-N 112.803 -1.999 . . . . 0.38 107.293 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.591 HD21 ' SD ' ' A' ' 450' ' ' MET . 23.6 tp -64.68 -67.45 0.43 Allowed 'General case' 0 N--CA 1.401 -2.885 0 CA-C-N 111.85 -2.432 . . . . 1.0 112.631 176.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.649 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 27.8 t80 -51.11 -26.57 6.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.36 1.552 . . . . 0.40000000000000002 107.989 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.429 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.88 -31.37 72.72 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.04 -2.346 . . . . 0.13 111.948 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.668 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.42 -49.21 6.83 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 121.748 0.785 . . . . 1.02 111.116 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.605 ' CB ' HD13 ' A' ' 345' ' ' ILE . 1.2 p -106.71 133.37 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 CA-C-O 123.635 1.683 . . . . 1.04 114.151 -167.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.444 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 9.9 pt-20 -139.93 -177.01 4.79 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 110.379 -3.1 . . . . 0.82999999999999996 106.302 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.642 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.2 mtmt -47.09 155.08 0.31 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 122.854 1.311 . . . . 1.04 113.679 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.37 -34.23 5.27 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 112.169 -2.287 . . . . 0.37 112.71 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.507 ' HB ' HG21 ' A' ' 457' ' ' VAL . 10.5 m -79.88 142.26 56.15 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-O 120.968 0.414 . . . . 1.01 110.035 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.606 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.71 165.01 33.36 Favored 'Trans proline' 0 N--CA 1.433 -2.057 0 C-N-CA 122.353 2.035 . . . . 0.17000000000000001 111.254 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 81.6 t -135.2 134.8 52.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 113.816 -1.538 . . . . 1.75 108.474 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.472 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -113.94 143.44 44.7 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.126 -0.488 . . . . 1.04 110.369 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.655 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.45 149.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.383 -1.34 . . . . 1.02 107.383 165.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.511 ' HA ' ' CB ' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.565 -0.731 . . . . 1.1599999999999999 111.254 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 111.508 -0.637 . . . . 4.3899999999999997 111.508 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.6 t-160 59.21 84.56 0.11 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.296 0.569 . . . . 2.1899999999999999 110.474 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 33.2 mtm 76.47 -175.43 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.806 -1.543 . . . . 1.23 110.847 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -138.35 -4.87 1.64 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.308 -0.86 . . . . 1.1000000000000001 110.907 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -55.64 167.37 0.54 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 123.041 1.401 . . . . 0.97999999999999998 112.949 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.522 HG21 ' HA ' ' A' ' 358' ' ' LYS . 85.4 m -92.73 122.03 34.72 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.119 -1.855 . . . . 1.04 107.255 166.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 344' ' ' TYR . 9.7 p90 -156.66 -170.67 3.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.265 -0.88 . . . . 0.94999999999999996 110.625 -174.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.6 HD13 ' CB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.97 161.06 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.271 -1.011 . . . . 1.02 108.271 167.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.457 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.1 tt0 -142.24 155.67 45.26 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.691 0.678 . . . . 0.17000000000000001 111.229 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.613 HG23 ' HG3' ' A' ' 354' ' ' MET . 60.7 t -150.93 138.35 13.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.648 -1.16 . . . . 1.03 109.64 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -117.89 117.74 30.11 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.729 -1.123 . . . . 0.37 107.989 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.482 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.7 mm? -72.69 -45.12 60.45 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.589 0.709 . . . . 1.0600000000000001 110.045 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.12 -45.42 93.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.862 -1.517 . . . . 1.51 112.826 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.26 18.26 21.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.687 -1.142 . . . . 0.91000000000000003 108.928 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.649 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.7 mp0 34.3 68.96 0.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.994 -1.912 . . . . 2.6299999999999999 112.773 171.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.499 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.9 t60 -152.47 125.02 8.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.216 0.531 . . . . 0.17000000000000001 109.649 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.613 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.8 ttp -111.25 127.48 55.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.649 -0.705 . . . . 0.97999999999999998 110.28 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.649 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.06 173.37 6.39 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.536 -1.211 . . . . 0.11 111.746 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 0.2 OUTLIER -126.35 116.39 21.13 Favored 'General case' 0 C--O 1.201 -1.468 0 N-CA-C 105.622 -1.992 . . . . 1.02 105.622 163.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.668 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 20.7 m-85 -97.0 125.09 41.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.43 -0.908 . . . . 0.90000000000000002 111.613 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.522 ' HA ' HG21 ' A' ' 343' ' ' THR . 35.6 ttmt -138.23 140.31 39.65 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 113.818 -1.537 . . . . 1.21 109.0 173.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.9 t70 65.41 14.56 9.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.473 -1.694 . . . . 0.59999999999999998 109.036 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.29 16.09 72.52 Favored Glycine 0 N--CA 1.419 -2.44 0 CA-C-N 112.281 -2.236 . . . . 0.23999999999999999 111.968 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.629 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -130.84 172.91 11.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.177 -2.157 . . . . 1.26 105.177 -173.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.629 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 3.8 m -102.73 138.49 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 124.136 1.922 . . . . 1.26 111.604 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.59 ' HB1' ' CD1' ' A' ' 356' ' ' TYR . . . -92.99 -23.81 18.57 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.529 -3.487 . . . . 1.03 108.243 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.664 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -155.3 154.66 32.44 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.942 -1.481 . . . . 1.01 108.72 -172.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.649 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.12 121.87 1.48 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.103 -0.499 . . . . 0.60999999999999999 109.706 -175.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.579 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.7 t -148.1 167.09 25.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 122.473 1.13 . . . . 0.98999999999999999 112.429 174.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.763 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.3 p-10 -83.85 139.92 32.34 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.675 -2.057 . . . . 1.8799999999999999 107.791 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.649 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -143.06 -172.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.501 -0.772 . . . . 1.04 111.886 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.568 HG21 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.59 120.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.006 -0.997 . . . . 1.04 108.856 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.455 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.6 t -142.68 145.08 33.05 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.505 -0.77 . . . . 1.0 113.038 -167.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.706 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.16 46.6 49.75 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 116.959 1.544 . . . . 0.13 116.959 162.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.555 ' HE2' ' CA ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.71 143.21 4.31 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 118.982 1.391 . . . . 1.2 110.495 -174.283 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.792 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.17 -32.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 1 C-N-CA 125.866 4.377 . . . . 0.26000000000000001 116.22 -170.466 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.414 ' C ' ' HD3' ' A' ' 376' ' ' PRO . 1.6 p -82.71 -32.81 27.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.181 0.515 . . . . 1.0600000000000001 111.081 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.508 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -139.06 72.51 39.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 122.237 1.018 . . . . 1.0800000000000001 110.059 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.706 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.8 Cg_exo -73.35 163.06 38.8 Favored 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.528 4.152 . . . . 0.19 114.18 -177.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.568 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.48 154.17 87.75 Favored Pre-proline 0 N--CA 1.435 -1.211 0 CA-C-N 113.347 -1.751 . . . . 1.04 110.992 175.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.547 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.0 OUTLIER -79.93 -51.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.995 3.797 . . . . 0.10000000000000001 113.641 -172.006 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.646 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 69.48 122.58 0.03 OUTLIER 'General case' 0 C--O 1.232 0.153 0 N-CA-C 113.474 0.916 . . . . 1.01 113.474 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.67 -124.64 1.25 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.243 -1.344 . . . . 0.11 111.384 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.448 ' O ' HG11 ' A' ' 381' ' ' VAL . 12.7 p -128.23 107.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.547 1.165 . . . . 1.54 109.296 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.648 ' CE2' HG23 ' A' ' 465' ' ' VAL . 96.4 m-85 -109.79 160.25 16.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.755 -1.111 . . . . 0.26000000000000001 109.831 -170.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.664 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 80.8 m-85 -148.23 135.73 20.6 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 119.592 -0.242 . . . . 1.1799999999999999 110.609 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.606 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.36 123.6 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.337 -0.945 . . . . 1.05 110.656 178.186 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -109.12 2.75 21.29 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.709 -0.678 . . . . 0.20000000000000001 112.284 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.649 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 5.6 t30 -161.52 148.07 14.31 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.198 -1.038 . . . . 0.40999999999999998 108.198 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -117.41 116.67 27.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.948 -1.13 . . . . 1.8200000000000001 107.948 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.573 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -121.49 129.79 53.15 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.689 -1.141 . . . . 0.38 111.045 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.6 mt-10 -128.29 136.1 50.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 113.781 -1.554 . . . . 1.96 109.887 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 38.7 t70 51.67 40.06 26.54 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 123.611 1.672 . . . . 0.40000000000000002 107.213 -172.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.573 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.82 168.19 11.35 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 112.131 -2.304 . . . . 0.98999999999999999 111.581 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 49.6 m -127.26 101.06 6.32 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.657 -1.61 . . . . 1.02 109.959 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.712 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -73.28 157.3 37.31 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 112.765 -2.016 . . . . 1.03 110.16 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.4 mtpt -152.13 168.0 26.7 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 114.615 -1.175 . . . . 1.26 108.255 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.871 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.3 163.38 30.82 Favored Glycine 0 CA--C 1.481 -2.077 0 C-N-CA 118.512 -1.804 . . . . 0.81000000000000005 113.339 -170.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.21 117.75 31.4 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-O 122.99 1.376 . . . . 1.2 110.48 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.556 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 4.0 m-80 -50.85 -179.65 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.263 -2.699 . . . . 1.1200000000000001 113.44 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.429 ' CG ' ' HZ3' ' A' ' 372' ' ' LYS . 0.6 OUTLIER -55.14 -22.36 16.62 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.607 -0.724 . . . . 1.6499999999999999 110.256 170.34 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -96.15 -25.91 15.67 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.435 0.636 . . . . 2.0 110.1 -174.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.14 33.89 4.75 Favored Glycine 0 N--CA 1.433 -1.536 0 N-CA-C 110.37 -1.092 . . . . 0.70999999999999996 110.37 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 42.0 p -115.77 128.22 26.14 Favored Pre-proline 0 N--CA 1.414 -2.226 0 N-CA-C 107.376 -1.342 . . . . 1.26 107.376 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.871 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.4 Cg_exo -70.06 144.45 52.46 Favored 'Trans proline' 0 N--CA 1.417 -2.987 0 C-N-CA 121.934 1.756 . . . . 1.1399999999999999 111.844 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' A' ' 403' ' ' TYR . 6.2 p90 -131.64 -177.16 4.3 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 112.196 -2.274 . . . . 0.84999999999999998 106.646 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.674 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 18.1 mt-10 -137.74 162.45 33.86 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.459 1.123 . . . . 0.62 112.678 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.712 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.47 99.05 9.74 Favored Pre-proline 0 N--CA 1.422 -1.859 0 CA-C-N 112.965 -1.925 . . . . 1.9099999999999999 108.525 174.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -67.9 103.67 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.787 2.324 . . . . 0.22 110.604 174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.591 HG22 ' HB2' ' A' ' 421' ' ' HIS . 1.2 t -118.42 154.37 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 CA-C-N 114.555 -1.202 . . . . 1.0900000000000001 110.578 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.1 OUTLIER -95.91 -34.47 11.81 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.437 -0.801 . . . . 1.8400000000000001 108.881 174.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.604 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 60.2 m-85 -136.91 115.94 12.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.172 -1.376 . . . . 0.88 111.218 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.555 ' CE3' HD22 ' A' ' 393' ' ' LEU . 9.7 t-105 -123.63 134.54 53.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.002 -1.454 . . . . 0.14999999999999999 111.089 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.542 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.0 OUTLIER -133.97 87.23 35.48 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 114.639 -1.164 . . . . 1.03 111.372 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.645 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.2 Cg_endo -73.68 140.0 28.8 Favored 'Trans proline' 0 CA--C 1.505 -0.937 0 C-N-CA 123.164 2.576 . . . . 0.23999999999999999 111.545 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.4 pt -123.35 -17.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.329 -1.305 . . . . 1.03 111.425 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.812 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.0 p30 -136.31 173.75 11.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.5900000000000001 110.124 172.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -100.26 15.84 26.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.829 -0.623 . . . . 0.33000000000000002 111.832 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 16.8 p -97.57 -27.88 14.2 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.051 -1.092 . . . . 1.1499999999999999 108.051 174.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.6 26.98 0.91 Allowed Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 113.874 -1.512 . . . . 0.28000000000000003 113.355 173.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.812 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.8 t -103.64 151.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.704 0.764 . . . . 0.96999999999999997 111.394 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.39 -166.06 36.82 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.562 -1.199 . . . . 0.13 110.841 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.73 136.83 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 108.672 -0.862 . . . . 1.03 108.672 175.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.591 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.2 p80 -151.1 168.12 25.61 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.142 0.972 . . . . 0.17000000000000001 110.937 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.728 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.09 150.65 22.64 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.359 -1.746 . . . . 0.41999999999999998 108.363 174.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -138.0 100.34 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.688 1.232 . . . . 2.0 109.989 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -94.61 -31.59 13.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 112.667 -2.061 . . . . 0.34999999999999998 110.189 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.497 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 19.9 p90 -70.17 -27.64 64.69 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 114.52 -1.218 . . . . 0.19 109.296 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.515 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.1 OUTLIER -114.73 81.88 7.61 Favored Pre-proline 0 CA--C 1.492 -1.281 0 CA-C-N 113.821 -1.536 . . . . 1.3300000000000001 109.427 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 27.8 Cg_endo -80.18 5.2 6.19 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 124.788 3.659 . . . . 0.28000000000000003 113.944 -161.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 152.82 32.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 123.702 0.626 . . . . 1.1000000000000001 110.69 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 1.642 ' HE1' ' CE2' ' A' ' 429' ' ' TYR . 0.3 OUTLIER -164.2 125.4 2.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 114.293 -1.321 . . . . 0.98999999999999999 108.084 -172.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.522 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.32 -165.88 28.61 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.633 -1.27 . . . . 0.13 110.206 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.587 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.49 152.53 0.01 OUTLIER Glycine 0 C--N 1.34 0.752 0 O-C-N 125.093 1.114 . . . . 0.23000000000000001 113.178 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.08 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 124.244 1.973 . . . . 0.33000000000000002 112.42 -152.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.5 mt -97.71 -32.5 11.72 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.013 -3.267 . . . . 1.05 107.906 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.568 ' HA ' HG21 ' A' ' 369' ' ' VAL . 6.9 p-90 -47.8 -39.36 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.873 -0.603 . . . . 0.22 111.568 -173.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.792 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 22.7 mttt -60.33 -25.23 65.64 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.919 -1.037 . . . . 1.29 112.595 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 55.5 p -112.09 -36.27 5.41 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.494 -0.775 . . . . 1.0700000000000001 110.306 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.515 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.7 mtp85 -85.49 -16.18 40.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.905 -1.043 . . . . 0.41999999999999998 112.326 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.555 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.84 43.13 28.93 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 119.425 -1.369 . . . . 0.20999999999999999 116.198 162.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.4 m -82.31 130.92 35.21 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 118.185 0.992 . . . . 0.81999999999999995 108.996 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -98.28 67.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.838 -0.539 . . . . 0.5 110.539 -169.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.494 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 89.13 -14.7 60.03 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.392 -1.083 . . . . 0.19 110.392 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.525 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.9 p -86.75 148.19 25.52 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.344 -0.428 . . . . 1.22 110.55 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.568 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -102.47 119.46 50.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.093 -0.503 . . . . 1.04 110.191 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.513 ' HB3' ' OG ' ' A' ' 423' ' ' SER . 8.6 m120 -81.55 89.88 6.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.864 -0.607 . . . . 2.29 111.135 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.6 m -88.06 137.93 31.09 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.285 -0.635 . . . . 1.02 109.285 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.9 Cg_exo -58.6 132.3 47.41 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.905 2.403 . . . . 0.12 113.04 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.728 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.7 Cg_exo -51.07 -40.46 59.42 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.52 2.813 . . . . 0.16 112.052 -169.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.3 m -71.66 -40.83 69.4 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.496 -1.229 . . . . 1.47 109.724 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' A' ' 366' ' ' THR . 84.5 t -76.51 -31.09 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.626 -0.715 . . . . 1.0600000000000001 111.684 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.69 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.4 tpt -66.49 -21.43 66.18 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.966 0.888 . . . . 1.0 110.203 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -76.9 -25.52 53.1 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.18 -1.373 . . . . 1.4399999999999999 111.124 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.704 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -79.07 -47.01 16.93 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 113.41 -1.723 . . . . 0.38 107.392 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.549 HD21 ' SD ' ' A' ' 450' ' ' MET . 24.5 tp -63.75 -67.71 0.41 Allowed 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 111.444 -2.617 . . . . 1.0 112.395 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.632 ' HE1' ' CE2' ' A' ' 454' ' ' PHE . 33.8 t80 -51.77 -26.85 10.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 123.108 1.432 . . . . 0.40000000000000002 107.878 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.02 -29.04 72.46 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 112.404 -2.18 . . . . 0.13 112.079 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.704 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.9 ptp -90.78 -48.75 6.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.617 0.722 . . . . 1.02 111.056 170.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.6 ' CB ' HD13 ' A' ' 345' ' ' ILE . 1.1 p -106.87 134.18 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 123.403 1.573 . . . . 1.04 114.614 -167.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.485 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 7.8 pt-20 -140.15 -176.19 4.51 Favored 'General case' 0 N--CA 1.405 -2.679 0 CA-C-N 110.889 -2.869 . . . . 0.82999999999999996 107.018 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.649 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 49.0 mtmt -45.26 153.43 0.22 Allowed 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 122.88 1.324 . . . . 1.04 113.66 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.6 -30.91 8.44 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 112.191 -2.277 . . . . 0.37 112.312 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.488 ' HB ' HG21 ' A' ' 457' ' ' VAL . 5.0 m -86.76 142.42 34.5 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 109.578 -0.527 . . . . 1.01 109.578 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.644 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -75.62 170.29 20.53 Favored 'Trans proline' 0 N--CA 1.428 -2.349 0 C-N-CA 122.083 1.856 . . . . 0.17000000000000001 111.631 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.634 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.3 158.5 38.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.797 -1.186 . . . . 1.75 107.797 165.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 345' ' ' ILE . 2.3 tp -129.95 145.56 51.63 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.335 -0.848 . . . . 1.04 110.179 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.648 HG23 ' CE2' ' A' ' 382' ' ' PHE . 1.1 m -143.2 148.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.304 -1.369 . . . . 1.02 107.304 165.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.436 ' HE2' ' CG ' ' A' ' 346' ' ' GLU . 13.2 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.772 -0.632 . . . . 1.1599999999999999 111.785 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 111.364 -0.694 . . . . 4.3899999999999997 111.364 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.642 ' O ' ' HB2' ' A' ' 340' ' ' MET . 2.9 t-160 -79.19 93.33 5.2 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.402 -0.962 . . . . 2.1899999999999999 108.402 171.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.642 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 32.7 mtm 79.48 172.98 0.15 Allowed 'General case' 0 C--N 1.328 -0.367 0 O-C-N 125.214 1.571 . . . . 1.23 110.12 -166.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -106.56 -9.45 16.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.178 -0.919 . . . . 1.1000000000000001 111.555 -172.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.5 166.93 1.13 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 123.195 1.474 . . . . 0.97999999999999998 113.931 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.569 HG22 ' HA ' ' A' ' 358' ' ' LYS . 3.6 m -93.08 122.63 35.64 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 112.649 -2.068 . . . . 1.04 106.956 165.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.647 ' HD1' ' CD2' ' A' ' 344' ' ' TYR . 16.4 p90 -160.7 -172.04 3.35 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.643 0.735 . . . . 0.94999999999999996 110.951 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.619 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.8 mm -104.58 159.25 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.002 -1.11 . . . . 1.02 108.002 166.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.496 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -139.95 155.09 47.31 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 118.881 0.764 . . . . 0.17000000000000001 111.036 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.606 HG23 ' HG3' ' A' ' 354' ' ' MET . 65.4 t -150.79 137.09 12.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 114.425 -1.261 . . . . 1.03 109.476 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.481 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 30.2 t0 -118.03 116.32 26.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.737 -1.12 . . . . 0.37 108.219 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.9 mm? -71.96 -44.3 63.78 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.078 0.942 . . . . 1.0600000000000001 109.391 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.481 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 7.1 mm-40 -57.38 -49.48 76.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.876 -1.965 . . . . 1.51 112.515 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -106.29 14.07 27.93 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.352 -1.295 . . . . 0.91000000000000003 109.296 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.611 ' OE1' ' HA2' ' A' ' 431' ' ' GLY . 20.5 mp0 38.87 73.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 125.151 1.532 . . . . 2.6299999999999999 112.096 174.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.5 t60 -155.91 125.26 6.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.243 0.544 . . . . 0.17000000000000001 110.164 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.606 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.5 ttp -110.83 128.33 55.73 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.766 -0.652 . . . . 0.97999999999999998 110.563 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.674 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -114.31 173.95 6.19 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.635 -1.166 . . . . 0.11 112.027 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 1.7 t80 -126.29 119.79 28.28 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.963 -1.866 . . . . 1.02 105.963 164.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.648 ' HD2' ' CD1' ' A' ' 357' ' ' TYR . 22.6 m-85 -103.9 130.79 51.53 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.159 0.981 . . . . 0.90000000000000002 111.811 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.569 ' HA ' HG22 ' A' ' 343' ' ' THR . 4.4 ttpt -147.73 136.13 21.58 Favored 'General case' 0 N--CA 1.398 -3.028 0 CA-C-N 113.206 -1.815 . . . . 1.21 108.338 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.428 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.1 t70 71.63 13.15 6.34 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.375 -1.739 . . . . 0.59999999999999998 108.573 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.01 83.51 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 112.788 -2.005 . . . . 0.23999999999999999 112.02 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.632 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -124.9 169.58 11.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.668 -1.975 . . . . 1.26 105.668 -172.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.632 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 3.2 m -102.18 138.76 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.819 0 CA-C-O 124.258 1.98 . . . . 1.26 112.092 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.496 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -92.56 -24.67 18.66 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 109.322 -3.581 . . . . 1.03 108.656 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.665 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -152.93 154.72 35.61 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.927 -1.488 . . . . 1.01 109.168 -172.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.674 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.37 121.96 1.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.002 -0.545 . . . . 0.60999999999999999 110.196 -174.656 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.587 ' HB ' HG12 ' A' ' 449' ' ' VAL . 4.5 t -147.22 166.83 25.84 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.517 0.675 . . . . 0.98999999999999999 111.352 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 1.3 m-20 -85.73 149.52 25.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.646 -1.613 . . . . 1.8799999999999999 106.646 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.601 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -146.32 -171.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 124.052 0.845 . . . . 1.04 111.305 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.57 HG21 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.16 118.91 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.761 -1.109 . . . . 1.04 108.775 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.457 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.86 146.12 35.43 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.081 -0.963 . . . . 1.0 112.561 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.28 44.82 41.89 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 116.548 1.379 . . . . 0.13 116.548 163.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.511 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.93 144.21 3.94 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-N 118.335 1.068 . . . . 1.2 110.24 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.776 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.49 -31.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.787 1 C-N-CA 125.82 4.346 . . . . 0.26000000000000001 116.278 -170.749 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.511 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.87 -34.82 29.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.014 0.435 . . . . 1.0600000000000001 110.791 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.479 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.9 m -140.53 73.62 29.44 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-O 122.112 0.958 . . . . 1.0800000000000001 110.423 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.66 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -72.29 161.06 45.5 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 125.187 3.925 . . . . 0.19 113.898 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.562 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.3 152.42 88.0 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.518 -1.674 . . . . 1.04 111.395 178.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.537 ' CD ' HG21 ' A' ' 377' ' ' THR . 2.0 Cg_endo -80.93 -49.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 125.234 3.956 . . . . 0.10000000000000001 113.986 -171.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.656 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 69.36 123.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.616 0.969 . . . . 1.01 113.616 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.91 -126.57 1.46 Allowed Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.42 -1.264 . . . . 0.11 111.441 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.46 ' O ' HG11 ' A' ' 381' ' ' VAL . 10.1 p -127.19 98.9 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 122.475 1.131 . . . . 1.54 109.884 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.639 ' CE2' HG23 ' A' ' 465' ' ' VAL . 99.1 m-85 -101.71 162.02 13.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.67 -1.15 . . . . 0.26000000000000001 110.22 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.675 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -147.58 135.57 21.27 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 121.337 -0.145 . . . . 1.1799999999999999 110.878 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.82 124.2 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.741 -0.784 . . . . 1.05 110.612 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.89 2.76 20.03 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.399 -0.818 . . . . 0.20000000000000001 112.183 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.707 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.2 t30 -165.14 151.85 10.44 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.544 -0.753 . . . . 0.40999999999999998 110.3 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -112.25 128.37 56.24 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.802 0.811 . . . . 1.8200000000000001 109.725 170.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.582 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.3 mt-10 -129.43 118.56 22.36 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.361 -1.29 . . . . 0.38 112.019 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -115.27 136.73 52.79 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.315 -1.311 . . . . 1.96 110.592 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . 0.446 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.5 t70 49.83 37.74 14.14 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.585 1.66 . . . . 0.40000000000000002 107.565 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -89.76 169.7 11.05 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.161 -2.29 . . . . 0.98999999999999999 111.844 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 104.56 8.02 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.812 -1.54 . . . . 1.02 109.991 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.702 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -74.66 158.09 34.22 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.733 -2.031 . . . . 1.03 110.47 173.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.8 mtpt -145.27 -176.37 5.08 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 114.962 -1.017 . . . . 1.26 108.685 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.92 -146.48 6.94 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 116.956 -2.545 . . . . 0.81000000000000005 115.322 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 401' ' ' THR . 0.6 OUTLIER -141.46 121.06 13.33 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 112.873 -1.663 . . . . 1.2 109.774 175.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.553 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -52.77 -178.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 111.831 -2.441 . . . . 1.1200000000000001 112.162 178.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -51.03 -27.31 7.63 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.737 -0.665 . . . . 1.6499999999999999 111.346 171.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.553 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.6 OUTLIER -98.16 -29.97 12.91 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.137 0.494 . . . . 2.0 111.292 -174.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 396' ' ' THR . . . 114.68 37.52 1.16 Allowed Glycine 0 C--N 1.295 -1.696 0 C-N-CA 119.548 -1.31 . . . . 0.70999999999999996 111.797 -173.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 396' ' ' THR . 77.7 p -119.17 151.61 51.07 Favored Pre-proline 0 N--CA 1.422 -1.857 0 N-CA-C 107.911 -1.144 . . . . 1.26 107.911 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.739 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 72.5 Cg_endo -65.39 163.15 30.66 Favored 'Trans proline' 0 C--N 1.279 -3.117 0 C-N-CA 122.842 2.361 . . . . 1.1399999999999999 113.449 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.643 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 13.1 p90 -152.86 -173.92 4.74 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 112.44 -2.164 . . . . 0.84999999999999998 107.252 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.666 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.9 mt-10 -143.08 159.25 42.62 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.162 0.982 . . . . 0.62 111.561 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.702 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.54 98.3 12.4 Favored Pre-proline 0 N--CA 1.419 -1.99 0 CA-C-N 113.168 -1.833 . . . . 1.9099999999999999 107.793 175.431 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.6 Cg_endo -67.46 102.68 0.73 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.328 2.019 . . . . 0.22 110.091 174.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.581 HG12 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -113.98 159.74 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 CA-C-N 114.4 -1.273 . . . . 1.0900000000000001 109.757 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.476 ' N ' HG11 ' A' ' 407' ' ' VAL . 21.2 m-80 -108.92 -34.23 6.7 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.585 -1.643 . . . . 1.8400000000000001 107.167 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.665 ' HD2' ' CD1' ' A' ' 409' ' ' TYR . 46.9 m-85 -136.43 116.17 13.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.923 -1.944 . . . . 0.88 110.684 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.582 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.3 t-105 -123.02 135.01 54.28 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.931 -1.031 . . . . 0.14999999999999999 110.025 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.466 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -136.36 86.33 24.49 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 114.875 -1.057 . . . . 1.03 110.82 173.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.701 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 78.0 Cg_endo -71.34 140.42 36.89 Favored 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 123.024 2.483 . . . . 0.23999999999999999 112.046 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 6.0 pt -123.65 -16.61 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.972 -1.467 . . . . 1.03 111.111 -172.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.499 ' CG ' ' HG1' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.83 169.37 17.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 1.5900000000000001 109.33 176.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -101.75 14.62 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.242 0.831 . . . . 0.33000000000000002 113.242 -176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.499 ' HG1' ' CG ' ' A' ' 414' ' ' ASP . 23.9 p -98.25 -28.08 13.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.968 -1.123 . . . . 1.1499999999999999 107.968 172.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.86 28.96 0.37 Allowed Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 113.967 -1.469 . . . . 0.28000000000000003 113.259 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.567 HG11 ' O ' ' A' ' 441' ' ' GLY . 97.7 t -102.76 148.23 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.548 0.69 . . . . 0.96999999999999997 111.717 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.75 -166.47 37.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.664 -1.153 . . . . 0.13 111.204 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.63 138.44 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.541 -0.911 . . . . 1.03 108.541 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.584 ' NE2' ' HB2' ' A' ' 442' ' ' CYS . 32.0 p80 -151.24 166.13 31.84 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.869 0.843 . . . . 0.17000000000000001 111.451 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.714 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.68 145.05 24.9 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 113.77 -1.559 . . . . 0.41999999999999998 107.742 173.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.56 102.22 5.23 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 123.32 1.533 . . . . 2.0 110.208 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.93 -30.63 15.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 110.09 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.442 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 10.8 p90 -71.46 -27.28 63.15 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.023 -1.444 . . . . 0.19 109.146 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.44 HE22 ' HD3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.3 82.9 19.32 Favored Pre-proline 0 CA--C 1.49 -1.328 0 CA-C-N 113.762 -1.563 . . . . 1.3300000000000001 108.724 -172.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 35.8 Cg_endo -79.32 3.64 7.3 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 124.571 3.514 . . . . 0.28000000000000003 114.452 -159.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -114.78 156.56 24.63 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.169 0.509 . . . . 1.1000000000000001 111.916 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.488 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -164.08 124.01 2.06 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.115 -1.402 . . . . 0.98999999999999999 108.675 -172.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.541 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.42 -167.49 28.55 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.861 -1.161 . . . . 0.13 111.149 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.648 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.9 154.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 O-C-N 125.389 1.287 . . . . 0.23000000000000001 113.151 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.76 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 111.985 -152.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.648 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 53.1 mt -97.32 -32.05 12.08 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 109.962 -3.29 . . . . 1.05 108.086 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.57 ' HA ' HG21 ' A' ' 369' ' ' VAL . 5.5 p-90 -46.44 -37.47 7.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.65 -0.704 . . . . 0.22 111.584 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.776 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 24.4 mttt -60.86 -24.44 65.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.18 -0.918 . . . . 1.29 113.192 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 p -113.95 -35.19 5.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.691 0.758 . . . . 1.0700000000000001 110.256 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.481 ' HD2' HD23 ' A' ' 433' ' ' LEU . 5.8 mtp85 -85.62 -15.34 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.605 -1.18 . . . . 0.41999999999999998 112.481 -169.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.501 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.06 42.0 38.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.256 1.263 . . . . 0.20999999999999999 116.256 159.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.5 m -85.62 130.38 34.58 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 118.485 1.143 . . . . 0.81999999999999995 109.226 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.483 ' NE2' ' HE3' ' A' ' 372' ' ' LYS . 62.2 m80 -101.21 68.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.547 -0.721 . . . . 0.5 110.75 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.567 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 90.92 -14.17 64.08 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.353 -1.099 . . . . 0.19 110.353 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.584 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 23.4 p -89.95 148.14 23.29 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.326 -0.437 . . . . 1.22 110.62 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.562 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -104.15 119.0 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 116.204 -0.453 . . . . 1.04 110.621 -176.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.479 HD21 ' CE1' ' A' ' 421' ' ' HIS . 6.9 m120 -79.28 88.99 4.92 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.609 -0.436 . . . . 2.29 111.186 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.6 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 41.3 m -86.97 135.65 35.01 Favored Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 109.17 -0.678 . . . . 1.02 109.17 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 53.0 Cg_exo -55.75 135.37 69.17 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.725 2.283 . . . . 0.12 111.398 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.714 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.0 Cg_exo -54.8 -33.89 82.84 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 C-N-CA 124.225 3.284 . . . . 0.16 112.99 -173.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 67.8 m -79.24 -39.02 34.19 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.783 -1.098 . . . . 1.47 110.06 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.587 HG12 ' HB ' ' A' ' 366' ' ' THR . 97.8 t -78.8 -30.48 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 1.0600000000000001 111.408 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.679 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.9 tpt -67.56 -19.0 65.21 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.788 0.804 . . . . 1.0 110.32 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -80.03 -22.88 41.88 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 114.528 -1.215 . . . . 1.4399999999999999 110.839 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.618 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.68 -46.78 15.01 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 112.921 -1.945 . . . . 0.38 107.329 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.651 HD21 ' SD ' ' A' ' 450' ' ' MET . 25.8 tp -64.64 -66.58 0.52 Allowed 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 111.906 -2.406 . . . . 1.0 112.423 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.632 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 32.6 t80 -50.34 -25.16 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 123.059 1.409 . . . . 0.40000000000000002 108.247 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.63 -28.66 66.94 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 112.486 -2.143 . . . . 0.13 112.507 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.665 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -92.2 -48.18 6.83 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.783 0.802 . . . . 1.02 111.614 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.619 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.8 OUTLIER -103.94 136.75 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 123.344 1.545 . . . . 1.04 113.953 -167.027 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -136.56 -178.49 5.2 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 110.916 -2.856 . . . . 0.82999999999999996 106.583 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.4 mtmt -51.71 160.85 0.6 Allowed 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 123.114 1.435 . . . . 1.04 112.958 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.75 7.91 Favored Glycine 0 N--CA 1.426 -2.033 0 CA-C-N 112.527 -2.124 . . . . 0.37 112.528 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 462' ' ' PRO . 6.1 m -82.01 142.95 48.69 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 109.308 -0.627 . . . . 1.01 109.308 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.643 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.36 168.75 23.92 Favored 'Trans proline' 0 N--CA 1.426 -2.48 0 C-N-CA 121.855 1.703 . . . . 0.17000000000000001 111.262 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.6 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.2 m -136.32 155.13 34.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.125 -1.435 . . . . 1.75 107.125 165.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.459 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.4 tp -126.06 145.68 50.22 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.254 -0.885 . . . . 1.04 110.158 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.656 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.0 146.3 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 N-CA-C 106.896 -1.52 . . . . 1.02 106.896 164.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.496 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 16.4 p90 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.229 -0.891 . . . . 1.1599999999999999 111.431 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 112.06 -0.416 . . . . 4.3899999999999997 112.06 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.67 -176.01 6.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.573 0.701 . . . . 2.1899999999999999 110.257 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 40.8 mtm -54.46 176.53 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.705 -1.589 . . . . 1.23 115.127 -169.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -134.02 -5.13 2.75 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.667 -1.606 . . . . 1.1000000000000001 110.181 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.24 169.2 0.19 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 123.038 1.399 . . . . 0.97999999999999998 112.404 172.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.517 HG21 ' HA ' ' A' ' 358' ' ' LYS . 98.5 m -91.16 124.01 35.05 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 113.077 -1.874 . . . . 1.04 109.189 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 4.7 p90 -159.12 -170.61 3.06 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.012 -1.449 . . . . 0.94999999999999996 110.637 -174.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.622 HD13 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -99.87 159.64 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 108.073 -1.084 . . . . 1.02 108.073 166.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.507 ' CG ' HD21 ' A' ' 464' ' ' LEU . 3.2 tt0 -138.68 154.1 48.58 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.074 -0.65 . . . . 0.17000000000000001 111.146 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.563 HG23 ' HG3' ' A' ' 354' ' ' MET . 64.1 t -149.98 134.33 9.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 114.263 -1.335 . . . . 1.03 109.436 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 15.4 t0 -115.57 124.5 51.15 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.714 -1.13 . . . . 0.37 108.377 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.4 ' O ' ' HG2' ' A' ' 352' ' ' GLN . 2.1 mm? -75.22 -43.81 49.73 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.811 1.291 . . . . 1.0600000000000001 110.525 -177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.439 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 5.4 mm-40 -57.38 -54.96 40.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.623 -2.08 . . . . 1.51 112.816 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 20.58 18.61 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.843 0.83 . . . . 0.91000000000000003 109.752 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.837 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.3 mm-40 35.94 71.25 0.13 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 112.104 -2.316 . . . . 2.6299999999999999 112.16 169.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.475 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -149.19 125.89 11.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.186 -0.916 . . . . 0.17000000000000001 109.174 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.563 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.8 ttp -111.81 127.5 55.83 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.488 0.661 . . . . 0.97999999999999998 110.481 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.666 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -111.55 173.39 6.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.552 -1.204 . . . . 0.11 111.753 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.655 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 1.5 t80 -125.3 111.79 15.61 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.242 -1.762 . . . . 1.02 106.242 165.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.649 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 21.9 m-85 -97.47 127.44 43.43 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.766 0.793 . . . . 0.90000000000000002 111.174 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.524 ' HB2' ' HE2' ' A' ' 356' ' ' TYR . 4.3 ttpt -142.86 135.35 27.62 Favored 'General case' 0 N--CA 1.398 -3.049 0 CA-C-N 113.964 -1.471 . . . . 1.21 108.297 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.8 t70 71.26 11.37 6.78 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 113.209 -1.814 . . . . 0.59999999999999998 108.806 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.84 68.81 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 112.763 -2.017 . . . . 0.23999999999999999 111.757 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.525 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -129.66 167.0 18.66 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.15 -1.796 . . . . 1.26 106.15 -172.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.583 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.1 m -101.91 138.68 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 CA-C-O 124.429 2.062 . . . . 1.26 112.21 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.423 ' CB ' ' CD1' ' A' ' 356' ' ' TYR . . . -93.61 -25.45 17.52 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 109.341 -3.572 . . . . 1.03 108.671 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.625 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.71 155.26 36.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 113.627 -1.624 . . . . 1.01 108.891 -172.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.666 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.38 122.12 1.45 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.691 -0.686 . . . . 0.60999999999999999 109.473 -175.087 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.597 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.3 t -148.95 166.68 27.89 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.326 1.06 . . . . 0.98999999999999999 112.224 173.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.721 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.6 p-10 -84.54 139.62 32.01 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.936 -1.938 . . . . 1.8799999999999999 107.737 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.629 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -141.46 -172.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.163 -0.926 . . . . 1.04 111.724 -175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.837 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.22 120.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.127 -0.942 . . . . 1.04 109.26 175.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.437 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.5 t -141.84 144.58 33.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.56 0.948 . . . . 1.0 113.56 -165.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.743 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.63 45.96 50.01 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 116.771 1.468 . . . . 0.13 116.771 161.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.537 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -48.09 144.04 6.2 Favored Pre-proline 0 CA--C 1.511 -0.535 0 CA-C-N 118.263 1.031 . . . . 1.2 111.342 -176.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.8 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.02 -31.91 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.564 1 C-N-CA 125.88 4.387 . . . . 0.26000000000000001 115.671 -172.88 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.603 ' HB ' ' OD1' ' A' ' 398' ' ' ASP . 0.9 OUTLIER -78.94 -36.89 41.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.263 -0.426 . . . . 1.0600000000000001 110.838 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.468 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -141.44 72.74 25.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-O 122.174 0.988 . . . . 1.0800000000000001 110.15 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.743 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.4 Cg_exo -69.33 162.38 42.07 Favored 'Trans proline' 0 C--N 1.322 -0.837 1 C-N-CA 125.357 4.038 . . . . 0.19 114.245 -176.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.572 HG21 ' CD ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -74.0 152.46 88.66 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 113.581 -1.645 . . . . 1.04 110.647 176.362 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.572 ' CD ' HG21 ' A' ' 377' ' ' THR . 0.9 OUTLIER -79.68 -49.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 125.076 3.851 . . . . 0.10000000000000001 113.461 -172.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.653 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.05 124.25 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.974 0.892 . . . . 1.01 113.267 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 162.63 -122.48 1.11 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.445 -1.252 . . . . 0.11 111.405 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.45 ' O ' HG11 ' A' ' 381' ' ' VAL . 10.2 p -130.77 106.62 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-O 121.979 0.895 . . . . 1.54 109.283 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.62 ' CE2' HG23 ' A' ' 465' ' ' VAL . 52.2 m-85 -111.48 167.53 10.25 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.223 -0.899 . . . . 0.26000000000000001 109.282 -172.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.694 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 82.2 m-85 -149.02 138.46 21.7 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 110.618 -0.141 . . . . 1.1799999999999999 110.618 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.586 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -72.82 122.77 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 119.67 -0.812 . . . . 1.05 110.476 175.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -109.79 3.87 21.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.46 -0.791 . . . . 0.20000000000000001 112.286 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.656 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 8.0 t30 -163.88 148.03 10.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.279 -1.008 . . . . 0.40999999999999998 108.279 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -118.98 114.9 23.27 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.196 0.998 . . . . 1.8200000000000001 108.43 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -118.84 132.54 56.12 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.28 -1.327 . . . . 0.38 110.298 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -131.68 134.51 46.03 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.026 -1.443 . . . . 1.96 109.622 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 52.69 40.45 30.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 123.435 1.588 . . . . 0.40000000000000002 107.479 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.568 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.76 169.53 9.95 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 112.35 -2.204 . . . . 0.98999999999999999 111.683 -172.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 7.7 m -126.57 106.49 9.47 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 113.956 -1.474 . . . . 1.02 109.926 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 8.3 mp -71.02 158.9 35.72 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.986 . . . . 1.03 110.626 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.3 mtpt -147.96 -175.44 4.88 Favored 'General case' 0 N--CA 1.393 -3.3 0 O-C-N 124.39 1.056 . . . . 1.26 108.529 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.666 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -176.88 -145.15 5.57 Favored Glycine 0 C--N 1.296 -1.654 0 C-N-CA 117.493 -2.289 . . . . 0.81000000000000005 114.863 177.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.87 123.05 13.73 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.393 -1.404 . . . . 1.2 108.85 171.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -55.4 -178.18 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 112.055 -2.339 . . . . 1.1200000000000001 111.824 177.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.603 ' OD1' ' HB ' ' A' ' 374' ' ' THR . 26.0 t70 -53.47 -21.01 5.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.502 -0.317 . . . . 1.6499999999999999 111.569 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.5 OUTLIER -106.14 -28.83 10.24 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 120.962 0.41 . . . . 2.0 111.394 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.95 37.54 1.13 Allowed Glycine 0 C--N 1.293 -1.807 0 C-N-CA 119.502 -1.332 . . . . 0.70999999999999996 111.549 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 61.4 p -117.48 127.74 26.47 Favored Pre-proline 0 N--CA 1.418 -2.044 0 N-CA-C 106.158 -1.793 . . . . 1.26 106.158 174.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.666 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 28.1 Cg_exo -64.57 164.07 25.01 Favored 'Trans proline' 0 C--N 1.284 -2.846 0 C-N-CA 121.901 1.734 . . . . 1.1399999999999999 112.746 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.624 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 17.4 p90 -142.46 -169.93 3.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.716 -1.587 . . . . 0.84999999999999998 106.716 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.721 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 12.6 mt-10 -148.26 154.8 40.54 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.037 0.922 . . . . 0.62 112.038 175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.649 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.5 m -144.12 99.18 5.05 Favored Pre-proline 0 N--CA 1.428 -1.536 0 CA-C-N 113.835 -1.529 . . . . 1.9099999999999999 110.418 -177.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 73.7 Cg_endo -67.18 109.01 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 125.236 3.957 . . . . 0.22 113.492 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -122.82 151.73 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-N 114.559 -1.201 . . . . 1.0900000000000001 111.405 -173.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.598 HD21 ' H ' ' A' ' 408' ' ' ASN . 0.1 OUTLIER -93.61 -28.83 15.79 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.457 -1.247 . . . . 1.8400000000000001 110.065 177.252 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.598 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 67.5 m-85 -142.77 119.66 11.27 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.296 . . . . 0.88 110.601 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.607 ' CE3' ' HB3' ' A' ' 421' ' ' HIS . 6.1 t-105 -125.56 135.15 51.92 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.606 -1.179 . . . . 0.14999999999999999 111.112 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.535 ' SD ' ' CD2' ' A' ' 454' ' ' PHE . 1.0 OUTLIER -134.9 86.38 32.79 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.804 -1.089 . . . . 1.03 111.279 174.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 94.7 Cg_endo -72.23 138.61 30.76 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 122.833 2.355 . . . . 0.23999999999999999 111.558 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.2 pt -124.66 -14.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.973 -1.467 . . . . 1.03 110.916 -173.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -133.7 162.81 30.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.449 -0.796 . . . . 1.5900000000000001 109.7 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -94.11 14.29 20.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.022 0.378 . . . . 0.33000000000000002 112.022 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.1 p -93.27 -25.6 17.7 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.565 -1.272 . . . . 1.1499999999999999 107.565 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 121.59 26.31 1.99 Allowed Glycine 0 N--CA 1.426 -2.031 0 CA-C-N 112.773 -2.012 . . . . 0.28000000000000003 111.63 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 441' ' ' GLY . 55.9 t -98.07 146.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.165 0.507 . . . . 0.96999999999999997 111.0 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.75 -165.0 36.06 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.923 -1.035 . . . . 0.13 111.464 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -105.53 137.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.693 -0.854 . . . . 1.03 108.693 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.614 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.7 p80 -154.16 170.58 20.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 122.011 0.91 . . . . 0.17000000000000001 111.582 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.719 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 153.52 20.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.523 -1.671 . . . . 0.41999999999999998 108.766 174.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.549 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 3.4 p -141.24 99.65 3.62 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 122.827 1.298 . . . . 2.0 109.833 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.35 -31.13 13.57 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 112.457 -2.156 . . . . 0.34999999999999998 109.992 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.546 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 9.2 p90 -68.23 -26.88 65.92 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 114.354 -1.294 . . . . 0.19 108.923 173.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.571 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -119.38 82.42 24.26 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.613 -1.63 . . . . 1.3300000000000001 110.135 -175.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.76 5.02 6.2 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 C-N-CA 124.802 3.668 . . . . 0.28000000000000003 114.211 -161.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.33 153.25 30.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.406 0.441 . . . . 1.1000000000000001 110.07 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 429' ' ' TYR . 0.5 OUTLIER -163.15 127.98 3.04 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.99 1.316 . . . . 0.98999999999999999 107.86 -173.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.28 -167.72 29.02 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 119.689 -1.243 . . . . 0.13 111.05 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.601 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.15 156.64 0.0 OUTLIER Glycine 0 C--N 1.341 0.857 0 O-C-N 124.935 1.021 . . . . 0.23000000000000001 113.225 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.468 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -54.92 100.62 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 123.692 1.711 . . . . 0.33000000000000002 111.579 -148.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 32.8 mt -97.21 -31.16 12.58 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 110.611 -2.995 . . . . 1.05 109.453 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.48 ' HA ' HG21 ' A' ' 369' ' ' VAL . 14.8 p-90 -49.06 -32.32 9.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 112.881 -1.963 . . . . 0.22 111.729 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.8 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 53.4 mttt -64.06 -19.67 65.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.297 0.851 . . . . 1.29 113.297 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 72.5 p -120.72 -36.64 3.13 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.644 -0.707 . . . . 1.0700000000000001 110.628 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.571 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.2 mtp85 -82.05 -15.04 54.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.65 -1.159 . . . . 0.41999999999999998 112.773 -169.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.528 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.82 41.42 33.89 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 116.554 1.381 . . . . 0.20999999999999999 116.554 159.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 18.4 m -85.81 131.97 34.21 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 118.225 1.013 . . . . 0.81999999999999995 109.563 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.435 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 67.9 m80 -97.68 68.74 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.683 -0.635 . . . . 0.5 110.85 -170.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.579 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 85.4 -9.81 66.15 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.819 -0.913 . . . . 0.19 110.819 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 20.8 p -89.52 137.58 32.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.946 -0.627 . . . . 1.22 110.079 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.532 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -96.77 113.12 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.618 -0.719 . . . . 1.04 110.483 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.549 ' HB3' ' OG ' ' A' ' 423' ' ' SER . 2.2 m-20 -80.76 92.12 6.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.006 . . . . 2.29 111.678 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 98.0 m -89.44 140.85 28.48 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.542 -0.754 . . . . 1.02 109.572 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 53.3 Cg_exo -55.08 136.81 74.7 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.803 2.335 . . . . 0.12 111.202 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.719 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 58.4 Cg_exo -55.96 -32.94 87.65 Favored 'Trans proline' 0 CA--C 1.5 -1.199 0 C-N-CA 124.195 3.263 . . . . 0.16 112.634 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.7 p -79.64 -38.35 33.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.522 -1.217 . . . . 1.47 109.719 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.597 HG12 ' HB ' ' A' ' 366' ' ' THR . 84.3 t -78.54 -30.44 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.522 -0.763 . . . . 1.0600000000000001 111.439 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.671 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -64.47 -23.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.893 0.854 . . . . 1.0 110.426 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -75.42 -27.02 58.82 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.408 -1.269 . . . . 1.4399999999999999 111.916 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.9 mm-40 -77.6 -46.19 22.92 Favored 'General case' 0 CA--C 1.472 -2.045 0 CA-C-N 113.489 -1.687 . . . . 0.38 106.991 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.478 ' O ' HG13 ' A' ' 457' ' ' VAL . 24.6 tp -65.4 -67.78 0.41 Allowed 'General case' 0 N--CA 1.401 -2.903 0 CA-C-N 111.472 -2.604 . . . . 1.0 112.601 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 0.535 ' CD2' ' SD ' ' A' ' 411' ' ' MET . 31.4 t80 -51.31 -27.16 8.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.183 1.468 . . . . 0.40000000000000002 107.988 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.425 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.06 -31.02 74.33 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 112.116 -2.311 . . . . 0.13 112.064 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.644 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.26 -48.39 7.4 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.834 0.826 . . . . 1.02 111.189 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.622 ' CB ' HD13 ' A' ' 345' ' ' ILE . 1.1 p -107.19 134.36 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-O 123.344 1.545 . . . . 1.04 114.461 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.52 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 12.6 pt-20 -139.81 -176.55 4.61 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 110.948 -2.842 . . . . 0.82999999999999996 107.032 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.656 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.9 mtmt -46.21 154.42 0.27 Allowed 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 123.032 1.396 . . . . 1.04 113.578 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 95.22 -24.75 27.47 Favored Glycine 0 C--N 1.292 -1.913 0 CA-C-N 112.275 -2.239 . . . . 0.37 112.821 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.495 ' HB ' HG21 ' A' ' 457' ' ' VAL . 6.6 m -89.3 142.23 29.67 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 109.685 -0.487 . . . . 1.01 109.685 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.604 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.9 Cg_exo -74.64 168.3 25.13 Favored 'Trans proline' 0 N--CA 1.43 -2.209 0 C-N-CA 122.067 1.844 . . . . 0.17000000000000001 111.571 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 69.8 t -135.46 134.77 52.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 113.869 -1.514 . . . . 1.75 108.265 173.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.507 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.7 tp -112.93 143.43 44.23 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.157 0.503 . . . . 1.04 110.408 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.653 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.13 146.64 21.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.74 -1.578 . . . . 1.02 106.74 164.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 379' ' ' ALA . 21.0 p90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.523 -0.751 . . . . 1.1599999999999999 111.217 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.821 -0.511 . . . . 4.3899999999999997 111.821 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -84.66 96.3 9.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.047 0.451 . . . . 2.1899999999999999 109.85 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 36.9 mtm 63.78 -173.58 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.545 -1.207 . . . . 1.23 111.427 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -144.37 -5.69 0.75 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.641 -0.709 . . . . 1.1000000000000001 111.329 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.95 167.08 0.64 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.77 1.272 . . . . 0.97999999999999998 113.018 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 358' ' ' LYS . 6.9 m -92.78 123.14 35.84 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.417 -1.72 . . . . 1.04 108.518 172.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.662 ' HE1' ' CE2' ' A' ' 344' ' ' TYR . 14.0 p90 -164.66 -169.81 1.84 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.136 -0.938 . . . . 0.94999999999999996 110.443 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.622 HD13 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -103.57 158.07 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.178 -0.919 . . . . 1.02 108.6 166.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.476 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.6 tt0 -140.07 155.91 46.82 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 118.89 0.768 . . . . 0.17000000000000001 111.131 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.586 HG23 ' HG3' ' A' ' 354' ' ' MET . 56.3 t -151.07 138.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.721 -1.127 . . . . 1.03 109.432 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.45 115.35 23.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.723 -1.126 . . . . 0.37 108.076 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 349' ' ' LEU . 2.0 mm? -66.51 -47.83 71.71 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.789 1.281 . . . . 1.0600000000000001 110.319 -175.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -55.38 -53.87 50.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.49 -2.141 . . . . 1.51 112.384 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -98.03 10.34 40.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 114.093 -1.412 . . . . 0.91000000000000003 108.51 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.895 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.0 mm-40 38.01 69.48 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 125.316 1.635 . . . . 2.6299999999999999 111.841 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 365' ' ' GLU . 7.7 t60 -148.16 125.96 11.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.273 -0.876 . . . . 0.17000000000000001 109.729 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.586 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.0 ttp -113.0 127.96 56.37 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.57 0.7 . . . . 0.97999999999999998 110.428 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.679 ' CD1' HG12 ' A' ' 362' ' ' VAL . 32.0 m-90 -112.78 173.16 6.51 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 114.386 -1.279 . . . . 0.11 111.76 -176.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 0.2 OUTLIER -125.25 113.65 17.91 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.97 -1.863 . . . . 1.02 105.97 163.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.661 ' HE2' ' CE1' ' A' ' 357' ' ' TYR . 22.1 m-85 -95.35 126.0 40.36 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.90000000000000002 112.028 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 343' ' ' THR . 4.0 ttpt -148.19 139.02 23.07 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 113.293 -1.776 . . . . 1.21 108.305 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.63 14.89 6.1 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.677 -1.601 . . . . 0.59999999999999998 109.0 178.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.59 16.45 77.67 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.555 -2.111 . . . . 0.23999999999999999 111.653 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.662 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.5 OUTLIER -138.37 178.44 7.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.238 -2.134 . . . . 1.26 105.238 -170.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.679 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.0 m -107.0 135.67 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-O 124.093 1.901 . . . . 1.26 112.517 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.523 ' HB1' ' CD1' ' A' ' 356' ' ' TYR . . . -86.29 -26.0 25.19 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 109.412 -3.54 . . . . 1.03 108.009 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.657 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.25 154.68 36.23 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 113.953 -1.476 . . . . 1.01 109.785 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.482 ' HB2' ' HE2' ' A' ' 353' ' ' HIS . 2.0 pt-20 -162.41 121.99 2.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 110.533 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.612 ' HB ' HG12 ' A' ' 449' ' ' VAL . 6.0 t -149.35 167.28 26.55 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 122.352 1.072 . . . . 0.98999999999999999 112.662 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.579 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.0 p-10 -86.11 141.5 29.36 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 112.925 -1.943 . . . . 1.8799999999999999 107.64 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.659 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -141.79 -176.31 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.546 -0.752 . . . . 1.04 112.356 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.895 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -151.71 116.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.051 -0.977 . . . . 1.04 110.322 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' SER . . . . . . . . . . . . . 56.5 p -140.53 141.09 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.475 0.916 . . . . 1.0 113.475 -163.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.81 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.54 46.86 45.34 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 116.961 1.545 . . . . 0.13 116.961 162.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.534 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 6.1 pttt -46.05 145.71 2.4 Favored Pre-proline 0 C--O 1.216 -0.678 0 CA-C-N 119.318 1.559 . . . . 1.2 111.041 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.801 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.3 OUTLIER -37.95 -31.19 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 125.244 3.962 . . . . 0.26000000000000001 115.276 -175.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.3 p -81.88 -33.33 30.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 1.0600000000000001 111.096 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.491 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -140.47 71.61 31.8 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 122.134 0.969 . . . . 1.0800000000000001 110.066 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.81 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.1 Cg_exo -69.93 163.0 40.04 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 125.552 4.168 . . . . 0.19 115.451 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.554 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.64 154.5 87.44 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 113.285 -1.779 . . . . 1.04 111.127 172.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.536 ' CD ' HG21 ' A' ' 377' ' ' THR . 3.4 Cg_endo -83.81 -52.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 1 C-N-CA 125.378 4.052 . . . . 0.10000000000000001 114.334 -172.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.662 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 70.64 122.79 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.932 1.086 . . . . 1.01 113.932 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.66 -129.59 1.96 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 114.135 -1.393 . . . . 0.11 111.363 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.78 98.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.363 -0.977 . . . . 1.54 108.363 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.626 ' CE2' HG23 ' A' ' 465' ' ' VAL . 97.0 m-85 -102.69 166.76 10.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.392 -0.822 . . . . 0.26000000000000001 110.484 -169.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.701 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -150.09 139.23 21.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 119.753 -0.165 . . . . 1.1799999999999999 110.62 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.59 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -75.5 119.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 119.723 -0.791 . . . . 1.05 110.432 176.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -107.26 4.5 26.66 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.796 -0.638 . . . . 0.20000000000000001 112.616 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.641 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.6 t30 -162.98 146.3 10.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.766 -1.198 . . . . 0.40999999999999998 107.766 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 387' ' ' LYS . 0.2 OUTLIER -119.45 112.11 18.98 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.102 -1.073 . . . . 1.8200000000000001 108.102 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -118.33 128.21 54.44 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.399 -1.273 . . . . 0.38 111.052 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -128.2 134.21 49.0 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.849 -1.523 . . . . 1.96 109.827 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.5 t70 52.53 39.39 27.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 123.367 1.556 . . . . 0.40000000000000002 107.675 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.542 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -94.06 169.84 9.97 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 112.439 -2.164 . . . . 0.98999999999999999 111.546 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 19.9 m -127.12 105.25 8.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.094 -1.412 . . . . 1.02 110.033 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.704 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 8.5 mp -71.74 154.66 41.18 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.375 -1.739 . . . . 1.03 109.692 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.7 mtpt -154.49 175.59 13.41 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 114.583 -1.19 . . . . 1.26 108.26 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.874 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 167.22 166.09 25.72 Favored Glycine 0 CA--C 1.476 -2.354 0 C-N-CA 117.565 -2.255 . . . . 0.81000000000000005 113.866 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.55 121.11 34.62 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-O 122.771 1.272 . . . . 1.2 109.179 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.441 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 1.1 m-80 -51.62 179.29 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 111.649 -2.523 . . . . 1.1200000000000001 111.017 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.56 -21.9 29.69 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.511 0.672 . . . . 1.6499999999999999 110.612 168.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.34 -25.51 21.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.372 -0.831 . . . . 2.0 111.775 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.04 33.41 5.77 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 119.902 -1.142 . . . . 0.70999999999999996 110.473 -169.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.517 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 73.0 p -116.4 127.4 26.78 Favored Pre-proline 0 N--CA 1.418 -2.066 0 N-CA-C 107.644 -1.243 . . . . 1.26 107.644 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.874 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.4 Cg_exo -70.26 149.28 63.46 Favored 'Trans proline' 0 C--N 1.29 -2.53 0 C-N-CA 122.414 2.076 . . . . 1.1399999999999999 111.678 -175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.631 ' HE1' ' CE2' ' A' ' 403' ' ' TYR . 20.4 p90 -138.79 -175.95 4.32 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 112.984 -1.916 . . . . 0.84999999999999998 108.249 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.4 mt-10 -146.17 156.81 43.68 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.337 1.065 . . . . 0.62 111.287 175.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.619 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.6 m -143.89 97.76 5.32 Favored Pre-proline 0 N--CA 1.419 -2.019 0 CA-C-N 113.067 -1.878 . . . . 1.9099999999999999 109.06 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.5 106.46 1.25 Allowed 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 124.269 3.313 . . . . 0.22 112.726 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.598 HG22 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -116.79 163.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.695 -1.138 . . . . 1.0900000000000001 111.206 -174.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.585 ' N ' HG11 ' A' ' 407' ' ' VAL . 17.9 m-80 -113.91 -31.51 6.38 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.083 -1.871 . . . . 1.8400000000000001 107.39 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.594 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 70.9 m-85 -136.98 116.16 12.53 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.063 -1.881 . . . . 0.88 110.905 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.566 ' HB2' HG12 ' A' ' 407' ' ' VAL . 5.7 t-105 -124.02 134.15 53.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.44 -1.255 . . . . 0.14999999999999999 110.974 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.85 ' SD ' HG23 ' A' ' 457' ' ' VAL . 5.8 mtm -134.32 88.05 31.38 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 114.728 -1.124 . . . . 1.03 112.28 171.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.641 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.03 137.87 29.94 Favored 'Trans proline' 0 CA--C 1.506 -0.897 0 C-N-CA 123.113 2.542 . . . . 0.23999999999999999 111.744 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.701 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.9 pt -123.51 -16.37 5.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 113.763 -1.562 . . . . 1.03 110.696 -173.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -135.15 158.51 44.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.748 -0.66 . . . . 1.5900000000000001 109.895 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -87.92 13.55 10.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.337 0.495 . . . . 0.33000000000000002 112.337 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 5.8 p -92.15 -25.85 18.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.444 -1.317 . . . . 1.1499999999999999 107.444 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 120.06 30.79 1.4 Allowed Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 112.933 -1.939 . . . . 0.28000000000000003 111.78 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.578 HG11 ' O ' ' A' ' 441' ' ' GLY . 53.4 t -100.94 147.5 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.384 -0.408 . . . . 0.96999999999999997 110.73 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.27 -168.5 41.27 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.191 -0.913 . . . . 0.13 112.058 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.06 139.55 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.56 -0.904 . . . . 1.03 108.56 175.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.598 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.7 p80 -151.84 164.88 36.13 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.641 0.734 . . . . 0.17000000000000001 112.079 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.73 141.4 28.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 113.931 -1.486 . . . . 0.41999999999999998 107.549 172.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.548 ' HG ' ' HB2' ' A' ' 426' ' ' GLN . 3.6 t -138.57 104.28 5.09 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 123.194 1.473 . . . . 2.0 110.731 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.37 -30.77 14.94 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.798 -2.456 . . . . 0.34999999999999998 110.852 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.41 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 14.6 p90 -68.27 -27.32 66.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.541 -1.209 . . . . 0.19 109.475 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.548 ' HB2' ' HG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -120.1 81.59 28.53 Favored Pre-proline 0 CA--C 1.495 -1.144 0 CA-C-N 113.747 -1.57 . . . . 1.3300000000000001 109.798 -175.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -82.55 6.52 5.71 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 124.833 3.689 . . . . 0.28000000000000003 114.522 -161.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -114.72 151.09 34.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.508 -0.553 . . . . 1.1000000000000001 109.508 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.579 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -160.73 128.25 4.35 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.578 1.151 . . . . 0.98999999999999999 108.115 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.62 -166.53 28.72 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.31 -1.424 . . . . 0.13 111.254 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.593 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.32 152.47 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 O-C-N 125.159 1.152 . . . . 0.23000000000000001 113.006 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.441 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 4.1 m-20 -55.04 101.5 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 123.506 1.622 . . . . 0.33000000000000002 112.136 -146.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.9 mt -96.73 -31.31 12.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 110.856 -2.883 . . . . 1.05 109.364 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.575 ' HA ' HG22 ' A' ' 369' ' ' VAL . 12.8 p-90 -50.0 -31.99 14.13 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 112.84 -1.982 . . . . 0.22 111.871 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.801 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 38.5 mttt -65.27 -20.56 66.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.356 -0.838 . . . . 1.29 112.685 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.0 p -118.65 -37.92 3.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.29 -0.868 . . . . 1.0700000000000001 110.297 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.4 mtp85 -83.35 -16.24 46.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.868 -1.06 . . . . 0.41999999999999998 113.056 -169.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 77.72 40.74 21.31 Favored Glycine 0 C--N 1.31 -0.861 0 N-CA-C 116.895 1.518 . . . . 0.20999999999999999 116.895 159.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 19.8 m -80.72 136.52 36.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 118.26 1.03 . . . . 0.81999999999999995 109.763 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -98.03 65.77 1.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.943 -0.473 . . . . 0.5 110.932 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.578 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 87.29 -14.1 58.44 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.618 -0.993 . . . . 0.19 110.618 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.4 p -85.36 148.58 25.95 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.464 -0.368 . . . . 1.22 110.142 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.554 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -99.37 123.2 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 122.212 1.005 . . . . 1.04 110.934 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.738 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.7 OUTLIER -81.44 83.35 6.98 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.51 -1.677 . . . . 2.29 111.395 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 24.5 m -88.04 138.02 31.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-O 121.558 0.694 . . . . 1.02 109.581 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.7 Cg_exo -57.48 136.15 74.17 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.716 2.277 . . . . 0.12 111.827 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.742 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.5 Cg_exo -53.93 -32.77 69.26 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 124.547 3.498 . . . . 0.16 112.915 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.2 m -79.52 -41.94 26.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.383 -1.281 . . . . 1.47 109.881 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 366' ' ' THR . 65.4 t -78.58 -30.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.558 0.694 . . . . 1.0600000000000001 111.7 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.734 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.24 -19.44 65.52 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.851 0.834 . . . . 1.0 110.294 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -79.31 -23.23 43.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 114.494 -1.23 . . . . 1.4399999999999999 111.01 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.683 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.04 -46.98 15.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 113.075 -1.875 . . . . 0.38 107.193 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.642 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.0 tp -64.24 -66.7 0.51 Allowed 'General case' 0 N--CA 1.402 -2.844 0 CA-C-N 111.826 -2.443 . . . . 1.0 112.289 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.667 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 18.0 t80 -52.99 -24.7 10.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.97 1.367 . . . . 0.40000000000000002 108.387 177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.52 -26.01 74.07 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 112.533 -2.121 . . . . 0.13 112.025 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.683 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.4 ptp -94.97 -49.92 5.34 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.876 0.846 . . . . 1.02 111.161 169.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.85 HG23 ' SD ' ' A' ' 411' ' ' MET . 2.1 p -108.61 132.08 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 CA-C-O 123.585 1.66 . . . . 1.04 114.447 -167.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.419 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 7.3 pt-20 -140.82 -176.85 4.81 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.335 -3.12 . . . . 0.82999999999999996 106.127 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.626 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.3 mtmt -45.32 154.24 0.18 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.971 1.367 . . . . 1.04 114.095 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 98.43 -32.75 6.62 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 112.013 -2.358 . . . . 0.37 112.54 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.543 ' HB ' HG21 ' A' ' 457' ' ' VAL . 6.2 m -83.6 143.12 43.56 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.304 -0.628 . . . . 1.01 109.304 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.615 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.36 169.8 21.67 Favored 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 121.789 1.659 . . . . 0.17000000000000001 111.503 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.615 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.29 158.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.891 -1.152 . . . . 1.75 107.891 167.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.476 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.4 tp -130.56 146.2 52.03 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.514 -0.766 . . . . 1.04 110.331 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.7 147.61 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.501 -1.296 . . . . 1.02 107.501 165.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.465 ' HE2' ' CG ' ' A' ' 346' ' ' GLU . 16.9 p90 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.499 -0.762 . . . . 1.1599999999999999 111.402 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.691 0 N-CA-C 112.21 -0.356 . . . . 4.3899999999999997 112.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -94.8 94.01 7.82 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.513 0.673 . . . . 2.1899999999999999 110.003 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.443 ' SD ' HD12 ' A' ' 464' ' ' LEU . 12.8 mtp 69.09 178.95 0.25 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.732 -1.576 . . . . 1.23 111.301 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -131.35 -7.01 3.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.135 -0.484 . . . . 1.1000000000000001 110.675 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.21 167.17 0.69 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.983 1.373 . . . . 0.97999999999999998 113.607 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 358' ' ' LYS . 3.9 m -93.28 122.63 35.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.039 -1.891 . . . . 1.04 106.94 165.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 11.8 p90 -160.16 -170.11 2.72 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.617 0.723 . . . . 0.94999999999999996 111.009 -173.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.536 ' O ' ' HD2' ' A' ' 344' ' ' TYR . 11.7 mm -103.91 160.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.781 -1.099 . . . . 1.02 108.216 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.449 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.0 tt0 -140.94 156.1 46.13 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 119.0 0.818 . . . . 0.17000000000000001 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.591 HG23 ' HG3' ' A' ' 354' ' ' MET . 68.3 t -150.62 137.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.663 -1.153 . . . . 1.03 109.625 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.07 106.36 9.54 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 122.153 0.978 . . . . 0.37 108.826 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.9 mm? -63.4 -38.97 93.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 112.89 -1.959 . . . . 1.0600000000000001 111.298 -168.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.88 -57.06 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 111.673 -2.512 . . . . 1.51 112.552 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -95.64 2.74 54.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 114.685 -1.143 . . . . 0.91000000000000003 110.066 -172.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.831 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.4 mm-40 49.54 66.01 1.24 Allowed 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 112.654 -2.066 . . . . 2.6299999999999999 111.406 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.525 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -145.5 127.4 15.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.344 0.592 . . . . 0.17000000000000001 109.725 -176.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.591 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.6 ttp -114.15 128.41 56.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.433 -0.803 . . . . 0.97999999999999998 110.613 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.635 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.54 173.29 6.48 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 114.608 -1.178 . . . . 0.11 112.084 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.617 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 1.1 t80 -124.79 113.43 17.92 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.666 -1.605 . . . . 1.02 106.666 165.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.642 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 19.2 m-85 -96.94 125.41 41.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.303 1.049 . . . . 0.90000000000000002 112.43 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 343' ' ' THR . 3.8 ttpt -149.34 139.46 22.14 Favored 'General case' 0 N--CA 1.398 -3.075 0 CA-C-N 112.827 -1.988 . . . . 1.21 108.091 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.443 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.1 17.62 7.24 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 113.61 -1.632 . . . . 0.59999999999999998 109.011 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.47 18.36 79.19 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 112.466 -2.152 . . . . 0.23999999999999999 111.824 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.654 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -138.82 177.61 7.76 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.798 -1.927 . . . . 1.26 105.798 -169.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.654 ' H ' ' HD3' ' A' ' 361' ' ' LYS . 3.2 m -106.96 138.09 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 CA-C-O 124.008 1.861 . . . . 1.26 112.15 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.437 ' HB1' ' HD2' ' A' ' 356' ' ' TYR . . . -93.03 -23.76 18.56 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 109.587 -3.46 . . . . 1.03 108.479 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.586 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.7 tp -154.4 154.69 33.69 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.712 -1.585 . . . . 1.01 108.977 -172.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.635 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.11 122.43 1.55 Allowed 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.576 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.628 ' HB ' HG12 ' A' ' 449' ' ' VAL . 3.6 t -146.88 166.24 27.31 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.688 0.756 . . . . 0.98999999999999999 111.215 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.462 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 42.1 m-20 -84.84 148.87 26.07 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.463 -1.681 . . . . 1.8799999999999999 106.463 174.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.66 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -144.02 -171.15 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.412 -0.813 . . . . 1.04 110.945 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.831 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -152.99 120.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.995 -1.002 . . . . 1.04 108.604 173.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.488 ' HB2' HG13 ' A' ' 443' ' ' ILE . 5.7 t -143.51 142.91 31.33 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.684 0.994 . . . . 1.0 113.684 -167.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.76 44.78 37.34 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 117.046 1.578 . . . . 0.13 117.046 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.551 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.66 145.02 3.21 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 119.255 1.528 . . . . 1.2 110.509 -174.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.776 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -35.11 -31.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.803 4.336 . . . . 0.26000000000000001 115.972 -173.283 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.551 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -81.17 -35.87 30.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.043 0.449 . . . . 1.0600000000000001 111.033 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.485 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -140.39 72.64 31.43 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 122.227 1.013 . . . . 1.0800000000000001 110.461 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.688 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 24.5 Cg_exo -71.02 163.21 40.05 Favored 'Trans proline' 0 C--N 1.322 -0.817 1 C-N-CA 125.526 4.151 . . . . 0.19 114.153 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.561 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.04 153.61 88.68 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.418 -1.719 . . . . 1.04 110.946 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.55 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.71 -49.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.038 3.825 . . . . 0.10000000000000001 113.673 -171.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.65 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.66 122.87 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.568 0.951 . . . . 1.01 113.568 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.41 -123.55 1.18 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.16 -1.382 . . . . 0.11 111.396 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 14.1 p -127.88 112.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 122.035 0.922 . . . . 1.54 108.915 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.634 ' CE2' HG23 ' A' ' 465' ' ' VAL . 94.3 m-85 -115.74 160.87 19.53 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.027 -0.988 . . . . 0.26000000000000001 109.706 -169.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.75 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 78.5 m-85 -147.63 137.19 22.61 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 119.703 -0.189 . . . . 1.1799999999999999 110.535 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.614 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.44 118.2 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 119.258 -0.977 . . . . 1.05 110.172 176.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -106.36 2.15 26.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.385 -0.825 . . . . 0.20000000000000001 112.451 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.675 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -160.24 148.75 16.91 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.815 -1.18 . . . . 0.40999999999999998 107.815 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.5 OUTLIER -119.73 117.88 29.4 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.915 -1.143 . . . . 1.8200000000000001 107.915 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.552 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.5 mt-10 -123.54 128.11 49.27 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.523 -1.217 . . . . 0.38 111.265 -173.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -125.75 135.52 52.14 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 113.559 -1.655 . . . . 1.96 109.393 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.89 38.67 29.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 123.338 1.542 . . . . 0.40000000000000002 107.731 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -93.1 170.14 9.87 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.213 -2.267 . . . . 0.98999999999999999 111.841 -175.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 11.6 m -128.39 104.91 7.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.998 -1.455 . . . . 1.02 110.413 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.696 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -76.57 158.43 31.17 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 112.74 -2.027 . . . . 1.03 110.628 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 8.6 mtpt -148.6 -176.07 5.18 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 115.218 -0.901 . . . . 1.26 109.117 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.649 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.34 -142.89 5.17 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 117.196 -2.431 . . . . 0.81000000000000005 115.09 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.65 122.95 13.86 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 112.697 -1.752 . . . . 1.2 108.291 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.458 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -54.29 179.97 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 112.587 -2.097 . . . . 1.1200000000000001 111.334 177.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.24 -24.25 26.83 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.21 0.529 . . . . 1.6499999999999999 110.586 168.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.23 -25.33 21.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.68 -0.691 . . . . 2.0 111.724 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.71 34.45 5.23 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.126 -1.035 . . . . 0.70999999999999996 110.694 -170.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 52.0 p -119.18 127.18 26.63 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 106.773 -1.565 . . . . 1.26 106.773 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.649 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 27.0 Cg_exo -64.16 159.24 44.02 Favored 'Trans proline' 0 C--N 1.285 -2.795 0 C-N-CA 122.037 1.824 . . . . 1.1399999999999999 112.468 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 24.2 p90 -143.47 -171.69 3.56 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.162 -1.835 . . . . 0.84999999999999998 106.953 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.6 mt-10 -143.83 160.46 40.73 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.135 0.969 . . . . 0.62 111.52 174.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.696 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.15 99.25 12.31 Favored Pre-proline 0 N--CA 1.418 -2.072 0 CA-C-N 113.429 -1.714 . . . . 1.9099999999999999 107.726 175.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.42 102.3 0.69 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.348 2.032 . . . . 0.22 110.042 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 421' ' ' HIS . 1.2 t -116.2 160.46 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 114.547 -1.206 . . . . 1.0900000000000001 110.362 -173.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.545 ' N ' HG11 ' A' ' 407' ' ' VAL . 11.3 m-80 -113.59 -32.06 6.3 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.288 -1.778 . . . . 1.8400000000000001 107.377 -174.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.639 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 62.2 m-85 -137.77 115.92 11.73 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.894 -1.957 . . . . 0.88 110.46 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.552 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.1 t-105 -123.56 134.1 53.88 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.932 -1.031 . . . . 0.14999999999999999 110.823 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.519 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.6 mtp -134.06 86.18 37.89 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.705 -1.134 . . . . 1.03 111.297 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.675 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 97.7 Cg_endo -72.5 139.52 31.58 Favored 'Trans proline' 0 CA--C 1.507 -0.862 0 C-N-CA 123.063 2.509 . . . . 0.23999999999999999 111.828 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.75 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.97 -14.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 1.03 111.054 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -134.11 164.69 26.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.339 -0.846 . . . . 1.5900000000000001 109.4 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -96.78 14.41 25.25 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.135 0.42 . . . . 0.33000000000000002 112.135 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.2 p -94.41 -27.05 16.24 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.674 -1.232 . . . . 1.1499999999999999 107.674 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.27 31.64 0.83 Allowed Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 112.898 -1.955 . . . . 0.28000000000000003 112.166 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.612 HG11 ' O ' ' A' ' 441' ' ' GLY . 73.3 t -102.3 147.47 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.296 0.569 . . . . 0.96999999999999997 110.914 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.94 -166.18 37.73 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 114.637 -1.165 . . . . 0.13 111.325 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -104.35 140.3 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.504 -0.925 . . . . 1.03 108.504 175.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.58 ' HB2' HG22 ' A' ' 407' ' ' VAL . 29.4 p80 -151.42 164.26 37.14 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.55 0.69 . . . . 0.17000000000000001 111.428 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.727 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -87.15 146.6 25.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.143 -1.389 . . . . 0.41999999999999998 108.066 172.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.5 m -139.35 102.5 4.5 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.021 1.391 . . . . 2.0 111.003 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.76 -26.96 16.75 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 109.904 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 12.2 p90 -72.65 -26.6 61.71 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.148 -1.387 . . . . 0.19 109.817 174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 80.56 25.17 Favored Pre-proline 0 CA--C 1.491 -1.296 0 CA-C-N 114.005 -1.452 . . . . 1.3300000000000001 108.953 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -81.94 5.54 6.26 Favored 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 125.083 3.855 . . . . 0.28000000000000003 114.121 -162.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -115.07 150.18 36.34 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.986 -0.552 . . . . 1.1000000000000001 109.516 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.462 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.43 125.02 4.23 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.626 1.203 . . . . 0.98999999999999999 108.08 -172.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 148.55 -166.77 29.18 Favored Glycine 0 C--N 1.294 -1.778 0 C-N-CA 119.199 -1.476 . . . . 0.13 111.083 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.631 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.26 153.16 0.0 OUTLIER Glycine 0 C--N 1.338 0.691 0 O-C-N 125.115 1.127 . . . . 0.23000000000000001 113.432 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.415 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.3 m-20 -55.56 100.73 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 123.832 1.777 . . . . 0.33000000000000002 112.063 -147.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.2 mt -96.82 -30.48 13.14 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 110.51 -3.041 . . . . 1.05 108.098 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.563 ' HA ' HG22 ' A' ' 369' ' ' VAL . 6.0 p-90 -47.34 -38.61 13.21 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.791 0.682 . . . . 0.22 111.496 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.776 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 23.8 mttt -60.92 -23.05 64.95 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.306 -0.861 . . . . 1.29 112.855 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 67.5 p -114.4 -37.06 4.44 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.799 0.809 . . . . 1.0700000000000001 110.248 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.487 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.0 mtp85 -85.44 -15.61 42.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.691 -1.14 . . . . 0.41999999999999998 112.761 -169.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.509 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.89 41.17 28.74 Favored Glycine 0 C--N 1.313 -0.695 0 N-CA-C 116.128 1.211 . . . . 0.20999999999999999 116.128 159.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' SER . . . . . 0.425 ' OG ' HG21 ' A' ' 369' ' ' VAL . 1.2 m -79.56 141.76 36.32 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 117.823 0.811 . . . . 0.81999999999999995 109.138 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.414 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 63.2 m80 -110.79 71.93 0.76 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.362 -0.836 . . . . 0.5 110.554 -171.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.612 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 83.97 -12.61 52.93 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.377 -1.089 . . . . 0.19 110.377 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.486 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.0 p -90.26 145.05 25.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.213 -0.494 . . . . 1.22 110.595 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.561 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -104.26 115.45 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.717 -0.674 . . . . 1.04 110.416 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.522 ' HB2' HG11 ' A' ' 369' ' ' VAL . 18.7 m120 -79.69 91.96 5.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 2.29 111.217 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.618 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 38.3 m -88.45 137.82 30.45 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.29 -0.633 . . . . 1.02 109.29 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.6 Cg_exo -55.67 135.94 71.82 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.892 2.395 . . . . 0.12 111.528 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.727 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 40.2 Cg_exo -54.96 -33.99 84.88 Favored 'Trans proline' 0 CA--C 1.502 -1.08 0 C-N-CA 124.372 3.382 . . . . 0.16 112.864 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.8 m -79.32 -40.11 31.15 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.76 -1.109 . . . . 1.47 109.857 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.628 HG12 ' HB ' ' A' ' 366' ' ' THR . 72.4 t -78.76 -29.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.763 -0.653 . . . . 1.0600000000000001 111.518 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.688 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.2 tpt -68.08 -18.94 64.8 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.916 0.865 . . . . 1.0 110.089 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -79.97 -24.13 41.14 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.432 -1.258 . . . . 1.4399999999999999 110.887 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.1 mm-40 -79.77 -46.95 16.05 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 112.955 -1.929 . . . . 0.38 107.094 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 450' ' ' MET . 22.3 tp -64.88 -67.72 0.41 Allowed 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 111.857 -2.429 . . . . 1.0 112.576 175.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.645 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 30.0 t80 -50.68 -26.37 5.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.054 1.407 . . . . 0.40000000000000002 108.201 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.48 -30.72 68.71 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-N 112.316 -2.22 . . . . 0.13 112.052 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.676 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -88.57 -49.61 6.79 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.729 0.776 . . . . 1.02 110.714 170.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.587 ' HB ' ' HE1' ' A' ' 356' ' ' TYR . 1.3 p -106.91 132.84 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 123.575 1.655 . . . . 1.04 114.39 -167.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.457 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 9.3 pt-20 -139.65 -176.68 4.64 Favored 'General case' 0 N--CA 1.404 -2.738 0 CA-C-N 110.646 -2.979 . . . . 0.82999999999999996 106.469 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.655 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.1 mtmt -45.4 154.14 0.2 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.971 1.367 . . . . 1.04 113.789 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.51 -36.89 3.68 Favored Glycine 0 C--N 1.293 -1.823 0 CA-C-N 112.105 -2.316 . . . . 0.37 112.501 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.51 ' HB ' HG21 ' A' ' 457' ' ' VAL . 4.3 m -79.54 142.76 58.16 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 109.676 -0.491 . . . . 1.01 109.676 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.609 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 6.0 Cg_exo -75.9 169.9 21.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 121.931 1.754 . . . . 0.17000000000000001 111.677 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.91 157.59 38.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.718 -1.216 . . . . 1.75 107.718 165.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.444 HD21 ' HG3' ' A' ' 346' ' ' GLU . 3.0 tp -128.39 145.34 51.11 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.343 -0.844 . . . . 1.04 110.004 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.65 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.33 147.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.158 -1.423 . . . . 1.02 107.158 165.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.449 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 18.4 p90 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.4 -0.81 . . . . 1.1599999999999999 111.026 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 112.299 -0.32 . . . . 4.3899999999999997 112.299 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.1 t-160 -88.72 91.99 9.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.691 -0.485 . . . . 2.1899999999999999 109.691 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.483 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 34.7 mtm 73.6 -175.42 0.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.218 -1.356 . . . . 1.23 111.774 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -145.09 -4.97 0.7 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.489 -0.778 . . . . 1.1000000000000001 112.102 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.14 169.41 0.25 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.763 1.268 . . . . 0.97999999999999998 112.411 171.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.568 HG22 ' HA ' ' A' ' 358' ' ' LYS . 2.3 m -91.52 121.52 33.29 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 113.61 -1.632 . . . . 1.04 107.741 169.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.632 ' HD1' ' CD2' ' A' ' 344' ' ' TYR . 12.1 p90 -160.11 -171.21 3.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.407 -0.815 . . . . 0.94999999999999996 110.533 -175.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.596 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.5 mm -106.05 161.11 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.25 -1.018 . . . . 1.02 108.25 167.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.468 ' CG ' ' HE2' ' A' ' 466' ' ' PHE . 3.7 tt0 -141.57 155.45 45.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.877 0.762 . . . . 0.17000000000000001 111.12 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.6 HG23 ' HG3' ' A' ' 354' ' ' MET . 60.0 t -151.05 137.07 12.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.519 -1.218 . . . . 1.03 109.763 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -116.61 117.7 30.57 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.04 -1.096 . . . . 0.37 108.04 171.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.49 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.9 mm? -72.5 -46.05 56.51 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.705 0.764 . . . . 1.0600000000000001 109.716 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -59.86 -46.46 89.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.542 -1.663 . . . . 1.51 112.601 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -107.62 19.49 20.1 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.91000000000000003 109.161 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.593 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 20.8 mp0 33.6 69.08 0.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 125.743 1.902 . . . . 2.6299999999999999 112.568 171.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.599 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 8.4 t60 -152.06 124.12 8.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.2 0.524 . . . . 0.17000000000000001 110.054 -176.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.6 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.6 ttp -109.82 127.76 54.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.521 0.677 . . . . 0.97999999999999998 110.616 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.644 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.5 m-90 -112.57 173.01 6.58 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.447 -1.251 . . . . 0.11 111.925 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.632 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 3.7 t80 -126.35 118.96 26.14 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.495 -1.668 . . . . 1.02 106.495 165.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 22.4 m-85 -101.12 127.21 47.77 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-O 122.335 1.064 . . . . 0.90000000000000002 112.467 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.568 ' HA ' HG22 ' A' ' 343' ' ' THR . 2.6 ttpt -149.38 139.82 22.42 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-N 112.73 -2.032 . . . . 1.21 107.326 174.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 72.74 15.9 4.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.08 -1.418 . . . . 0.59999999999999998 109.069 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.65 79.0 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 112.523 -2.126 . . . . 0.23999999999999999 111.533 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.648 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 2.2 tppt? -140.17 178.23 7.43 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.446 -1.877 . . . . 1.26 105.961 -167.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.648 ' H ' ' HD3' ' A' ' 361' ' ' LYS . 2.9 m -106.36 138.61 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-O 124.053 1.882 . . . . 1.26 112.328 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.542 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -94.71 -24.59 17.07 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 109.419 -3.537 . . . . 1.03 108.589 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.601 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.4 tp -153.05 154.91 35.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.701 -1.591 . . . . 1.01 108.808 -171.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.644 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.7 122.94 1.21 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.817 -0.629 . . . . 0.60999999999999999 109.475 -174.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.629 ' HB ' HG12 ' A' ' 449' ' ' VAL . 4.6 t -147.56 166.84 26.12 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.564 0.697 . . . . 0.98999999999999999 111.406 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 50.6 m-20 -83.92 147.56 27.42 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.08 -1.452 . . . . 1.8799999999999999 107.08 174.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.593 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.66 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.281 -0.872 . . . . 1.04 111.425 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.561 HG21 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.03 118.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.997 -1.002 . . . . 1.04 108.727 175.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.3 t -142.26 147.85 37.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.327 -0.851 . . . . 1.0 112.306 -168.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.733 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.44 45.31 55.01 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 116.736 1.454 . . . . 0.13 116.736 162.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.6 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.28 144.24 3.29 Favored Pre-proline 0 C--O 1.217 -0.611 0 CA-C-N 118.706 1.253 . . . . 1.2 110.309 -175.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.797 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.69 -29.15 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.593 1 C-N-CA 125.75 4.3 . . . . 0.26000000000000001 116.001 -171.977 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.6 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -84.14 -33.92 24.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.4 0.619 . . . . 1.0600000000000001 111.04 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.482 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -140.35 72.08 32.16 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 122.201 1.001 . . . . 1.0800000000000001 110.245 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.733 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.9 Cg_exo -70.78 165.55 31.77 Favored 'Trans proline' 0 C--N 1.324 -0.727 1 C-N-CA 125.368 4.046 . . . . 0.19 114.21 -176.568 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.565 HG23 HD12 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -78.69 152.82 78.08 Favored Pre-proline 0 N--CA 1.435 -1.202 0 CA-C-N 113.799 -1.546 . . . . 1.04 110.427 174.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.56 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.34 -49.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.983 3.788 . . . . 0.10000000000000001 113.311 -172.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.652 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 69.52 122.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.666 0.987 . . . . 1.01 113.666 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.95 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.282 -1.326 . . . . 0.11 111.577 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.441 ' O ' HG11 ' A' ' 381' ' ' VAL . 12.3 p -129.09 106.0 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.307 1.051 . . . . 1.54 109.323 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.649 ' CE2' HG23 ' A' ' 465' ' ' VAL . 96.5 m-85 -109.54 163.88 13.04 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.799 -1.091 . . . . 0.26000000000000001 110.071 -169.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.689 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 69.6 m-85 -147.93 137.88 22.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 121.261 -0.176 . . . . 1.1799999999999999 110.749 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.583 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.5 124.6 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.863 -0.735 . . . . 1.05 110.538 177.45 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -109.52 4.49 22.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.533 -0.758 . . . . 0.20000000000000001 112.163 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.702 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.2 t30 -166.52 150.97 7.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.40999999999999998 110.684 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.403 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 12.1 mtpt -109.53 118.68 37.23 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.583 0.706 . . . . 1.8200000000000001 109.86 169.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.6 mt-10 -119.4 112.96 20.07 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 123.034 1.397 . . . . 0.38 112.803 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -108.93 136.58 48.23 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 113.785 -1.552 . . . . 1.96 110.994 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 38.7 t70 51.36 34.74 12.38 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 123.466 1.603 . . . . 0.40000000000000002 107.9 -175.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.15 170.82 10.72 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.21 -2.268 . . . . 0.98999999999999999 111.991 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.0 m -129.32 104.41 7.49 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.742 -1.572 . . . . 1.02 109.64 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.678 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.12 155.06 40.69 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 112.889 -1.959 . . . . 1.03 109.972 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.6 mtpt -155.86 172.48 18.29 Favored 'General case' 0 N--CA 1.404 -2.767 0 O-C-N 124.529 1.143 . . . . 1.26 108.543 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.893 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 171.48 166.45 30.26 Favored Glycine 0 CA--C 1.48 -2.135 0 C-N-CA 117.518 -2.277 . . . . 0.81000000000000005 113.938 -175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 115.91 28.91 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 122.745 1.26 . . . . 1.2 109.448 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.552 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.2 m-80 -50.96 179.49 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 111.543 -2.571 . . . . 1.1200000000000001 113.261 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.38 -24.92 8.53 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.065 0.459 . . . . 1.6499999999999999 110.83 166.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.44 ' HB3' HG21 ' A' ' 401' ' ' THR . 0.2 OUTLIER -90.53 -24.7 20.55 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.304 0.573 . . . . 2.0 110.741 -175.62 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.49 34.24 5.88 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 110.126 -1.19 . . . . 0.70999999999999996 110.126 -169.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.552 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 42.2 p -117.01 128.9 25.71 Favored Pre-proline 0 N--CA 1.416 -2.148 0 N-CA-C 107.772 -1.196 . . . . 1.26 107.772 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.893 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.1 Cg_exo -70.55 146.99 56.8 Favored 'Trans proline' 0 N--CA 1.422 -2.714 0 C-N-CA 122.447 2.098 . . . . 1.1399999999999999 111.423 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.612 ' HD2' ' CD1' ' A' ' 403' ' ' TYR . 19.3 p90 -140.56 -177.77 5.2 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 112.692 -2.049 . . . . 0.84999999999999998 107.995 -175.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.675 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.7 mt-10 -141.47 162.8 34.61 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.764 1.269 . . . . 0.62 112.111 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.678 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -140.1 98.15 7.65 Favored Pre-proline 0 N--CA 1.421 -1.916 0 CA-C-N 112.356 -2.202 . . . . 1.9099999999999999 107.768 172.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 62.9 Cg_endo -68.17 102.66 0.82 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.325 2.017 . . . . 0.22 110.658 175.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.6 HG11 ' N ' ' A' ' 408' ' ' ASN . 1.2 t -115.06 163.84 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.684 -1.144 . . . . 1.0900000000000001 110.393 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.6 ' N ' HG11 ' A' ' 407' ' ' VAL . 19.5 m-80 -115.94 -31.38 5.77 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 113.517 -1.674 . . . . 1.8400000000000001 107.602 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 55.8 m-85 -138.61 115.65 10.92 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.142 -1.845 . . . . 0.88 110.107 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.569 ' HB2' HG12 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.09 135.65 54.48 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.075 -0.966 . . . . 0.14999999999999999 109.95 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.459 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -135.89 85.1 30.12 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.98 -1.009 . . . . 1.03 111.019 174.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.702 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.6 Cg_endo -71.41 140.67 37.15 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.98 2.453 . . . . 0.23999999999999999 112.236 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.689 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -124.25 -15.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.841 -1.527 . . . . 1.03 111.105 -173.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -134.36 166.01 23.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 1.5900000000000001 109.328 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.44 13.86 31.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.405 0.52 . . . . 0.33000000000000002 112.405 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.2 p -92.88 -27.1 17.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.342 -1.355 . . . . 1.1499999999999999 107.342 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 126.65 32.25 0.72 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 113.062 -1.881 . . . . 0.28000000000000003 112.36 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.643 HG11 ' O ' ' A' ' 441' ' ' GLY . 72.4 t -102.59 147.62 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 121.24 0.543 . . . . 0.96999999999999997 111.164 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.57 -166.0 38.16 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.979 -1.009 . . . . 0.13 111.621 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.33 140.35 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.846 -0.798 . . . . 1.03 108.846 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.545 ' HB2' HG23 ' A' ' 407' ' ' VAL . 33.4 p80 -150.83 165.42 33.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.763 0.792 . . . . 0.17000000000000001 111.556 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.737 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.53 139.64 30.33 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.936 -1.484 . . . . 0.41999999999999998 107.611 172.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.8 p -128.49 99.79 5.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.897 1.332 . . . . 2.0 109.957 -177.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.0 -34.41 11.78 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 112.497 -2.138 . . . . 0.34999999999999998 110.778 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 11.2 p90 -67.14 -26.91 66.9 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.566 -1.197 . . . . 0.19 109.213 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.559 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.98 81.91 20.41 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.586 -1.643 . . . . 1.3300000000000001 109.253 -174.223 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -79.91 5.9 5.63 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 C-N-CA 124.844 3.696 . . . . 0.28000000000000003 113.824 -161.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.76 153.53 30.16 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.945 -0.57 . . . . 1.1000000000000001 111.14 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -164.0 123.72 2.05 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 114.347 -1.297 . . . . 0.98999999999999999 108.341 -172.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.589 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.61 -166.66 28.71 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 119.394 -1.384 . . . . 0.13 110.535 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.621 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.94 151.7 0.0 OUTLIER Glycine 0 C--N 1.34 0.767 0 O-C-N 125.296 1.233 . . . . 0.23000000000000001 113.416 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 124.089 1.9 . . . . 0.33000000000000002 111.913 -152.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.621 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 46.5 mt -97.17 -33.47 11.48 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 109.964 -3.289 . . . . 1.05 107.752 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.561 ' HA ' HG21 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.82 -37.48 6.17 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.961 0.788 . . . . 0.22 111.61 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.797 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 35.3 mttt -60.51 -24.4 65.29 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.984 -1.007 . . . . 1.29 112.737 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -114.8 -36.43 4.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.753 0.787 . . . . 1.0700000000000001 110.044 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.559 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.4 mtp85 -83.72 -15.02 50.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.553 -1.203 . . . . 0.41999999999999998 112.724 -169.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.482 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.41 40.9 38.72 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.331 1.292 . . . . 0.20999999999999999 116.331 159.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.4 m -81.88 134.5 35.41 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 118.038 0.919 . . . . 0.81999999999999995 109.612 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -99.28 70.45 1.75 Allowed 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.771 -0.58 . . . . 0.5 110.466 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.643 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 80.72 -7.13 59.56 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.754 -0.938 . . . . 0.19 110.754 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 19.1 p -93.05 131.09 38.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.692 0.758 . . . . 1.22 110.548 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.565 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -91.61 113.74 27.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.978 -1.01 . . . . 1.04 110.494 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.545 HD21 ' N ' ' A' ' 444' ' ' ASN . 0.8 OUTLIER -76.89 89.73 3.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.992 -1.003 . . . . 2.29 110.982 -177.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.582 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 31.5 m -89.05 136.09 30.88 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 109.214 -0.661 . . . . 1.02 109.214 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.2 Cg_exo -57.46 131.93 47.6 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.39 . . . . 0.12 113.107 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.737 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.9 Cg_exo -50.79 -39.1 58.06 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 123.463 2.775 . . . . 0.16 112.398 -168.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 17.0 p -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.529 -1.214 . . . . 1.47 109.974 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.629 HG12 ' HB ' ' A' ' 366' ' ' THR . 68.7 t -78.37 -29.64 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.211 0.529 . . . . 1.0600000000000001 111.252 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.67 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.48 -20.28 65.45 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 122.009 0.909 . . . . 1.0 110.013 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 451' ' ' LYS . 0.1 OUTLIER -75.67 -29.71 59.15 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 114.059 -1.428 . . . . 1.4399999999999999 111.266 176.195 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -76.05 -47.28 25.29 Favored 'General case' 0 CA--C 1.473 -2.0 0 CA-C-N 112.645 -2.07 . . . . 0.38 107.297 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.604 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.9 tp -64.57 -66.49 0.54 Allowed 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 111.771 -2.468 . . . . 1.0 112.546 175.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 36.6 t80 -50.32 -24.93 3.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.041 1.4 . . . . 0.40000000000000002 108.342 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.8 -28.14 63.49 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 112.432 -2.167 . . . . 0.13 111.967 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.653 ' HB2' ' CE2' ' A' ' 356' ' ' TYR . 1.6 ptp -89.84 -48.4 7.26 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 121.769 0.795 . . . . 1.02 111.461 170.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.596 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.7 OUTLIER -103.21 137.45 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 CA-C-O 123.503 1.62 . . . . 1.04 114.297 -167.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.83 -178.6 5.26 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 110.592 -3.004 . . . . 0.82999999999999996 106.607 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.669 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.5 mtmt -52.1 162.19 0.51 Allowed 'General case' 0 N--CA 1.413 -2.324 0 CA-C-O 123.092 1.425 . . . . 1.04 113.009 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.92 4.55 Favored Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 112.576 -2.102 . . . . 0.37 112.535 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.491 ' O ' HG13 ' A' ' 384' ' ' VAL . 4.3 m -77.04 141.13 67.13 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.231 -0.655 . . . . 1.01 109.231 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.629 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.8 Cg_exo -73.62 167.42 27.3 Favored 'Trans proline' 0 N--CA 1.427 -2.438 0 C-N-CA 121.677 1.585 . . . . 0.17000000000000001 111.106 174.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.614 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.7 156.78 38.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.398 -1.334 . . . . 1.75 107.398 166.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.466 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.1 tp -128.06 145.33 51.03 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 115.552 -0.749 . . . . 1.04 110.17 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.652 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.32 147.72 20.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.962 -1.496 . . . . 1.02 106.962 165.04 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.504 ' HA ' ' HB2' ' A' ' 379' ' ' ALA . 14.8 p90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.079 -0.962 . . . . 1.1599999999999999 111.573 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.63 -0.588 . . . . 4.3899999999999997 111.63 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -75.36 100.55 4.46 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.028 0.442 . . . . 2.1899999999999999 110.278 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 17.8 mtp 63.87 -176.49 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.459 -1.246 . . . . 1.23 111.512 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -141.36 -6.6 1.04 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.126 -0.488 . . . . 1.1000000000000001 111.63 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -56.43 167.45 0.69 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 123.281 1.515 . . . . 0.97999999999999998 113.246 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.521 HG21 ' HA ' ' A' ' 358' ' ' LYS . 96.2 m -94.12 123.14 37.31 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 112.834 -1.985 . . . . 1.04 107.754 167.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.647 ' HE1' ' CE2' ' A' ' 344' ' ' TYR . 10.7 p90 -160.58 -170.73 2.87 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.031 -0.986 . . . . 0.94999999999999996 110.987 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.601 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -102.53 157.2 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 107.693 -1.225 . . . . 1.02 107.693 165.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.474 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.2 tt0 -137.91 154.08 49.46 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 118.59 0.632 . . . . 0.17000000000000001 110.659 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 465' ' ' VAL . 58.0 t -150.81 135.17 9.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.911 -1.04 . . . . 1.03 109.913 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -114.78 117.88 32.0 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.607 -1.179 . . . . 0.37 108.097 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 349' ' ' LEU . 2.0 mm? -72.07 -48.77 41.75 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.335 1.064 . . . . 1.0600000000000001 110.122 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -54.58 -51.68 64.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.026 -1.897 . . . . 1.51 112.374 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -104.4 16.62 25.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.38 -1.282 . . . . 0.91000000000000003 108.914 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.757 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.7 mm-40 34.09 69.27 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 112.94 -1.936 . . . . 2.6299999999999999 112.55 172.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.482 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.8 t60 -150.05 125.38 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.702 -0.681 . . . . 0.17000000000000001 109.561 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.553 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.1 ttp -111.78 128.44 56.1 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.495 0.664 . . . . 0.97999999999999998 110.356 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.604 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 30.9 m-90 -113.07 171.71 7.38 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.438 -1.255 . . . . 0.11 111.636 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.663 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 3.6 t80 -122.3 116.07 23.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.823 -1.918 . . . . 1.02 105.823 164.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.648 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 21.0 m-85 -100.82 131.35 46.75 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.739 0.78 . . . . 0.90000000000000002 110.962 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.546 ' HB2' ' HE2' ' A' ' 356' ' ' TYR . 4.6 ttpt -147.7 137.66 22.82 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 114.266 -1.334 . . . . 1.21 108.656 174.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.8 OUTLIER 69.72 18.31 7.54 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 113.104 -1.862 . . . . 0.59999999999999998 108.34 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.01 71.89 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 112.28 -2.236 . . . . 0.23999999999999999 111.834 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.592 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.84 165.39 27.42 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.91 -1.645 . . . . 1.26 106.729 -168.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.592 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 54.5 t -94.66 132.42 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 123.54 1.638 . . . . 1.26 111.632 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.517 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -98.87 -28.14 13.59 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 110.944 -2.844 . . . . 1.03 109.856 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.618 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.2 tp -152.64 148.61 27.52 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.408 -1.269 . . . . 1.01 109.625 -170.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.604 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -158.71 123.02 4.05 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.257 -0.428 . . . . 0.60999999999999999 110.099 -171.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.629 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.9 t -148.93 166.74 27.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 122.402 1.096 . . . . 0.98999999999999999 112.262 172.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.607 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.9 p-10 -86.01 141.27 29.6 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 112.827 -1.988 . . . . 1.8799999999999999 107.418 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.647 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.83 -171.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.477 -0.783 . . . . 1.04 112.155 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.757 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.26 119.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.998 -1.001 . . . . 1.04 109.529 175.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.481 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.8 t -142.35 144.56 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 1.0 112.642 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.02 45.37 26.56 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 116.784 1.474 . . . . 0.13 116.784 163.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.547 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.6 143.08 5.99 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-N 118.921 1.361 . . . . 1.2 110.007 -174.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.765 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -32.94 -31.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.7 1 C-N-CA 126.056 4.504 . . . . 0.26000000000000001 116.471 -170.041 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.494 ' HB ' ' HB3' ' A' ' 398' ' ' ASP . 1.9 p -81.94 -33.75 30.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.208 0.528 . . . . 1.0600000000000001 111.126 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.482 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.8 m -140.16 73.82 31.33 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-O 122.212 1.006 . . . . 1.0800000000000001 109.955 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.73 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.9 Cg_exo -71.21 161.73 44.86 Favored 'Trans proline' 0 C--N 1.319 -0.998 1 C-N-CA 125.308 4.006 . . . . 0.19 113.741 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.553 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.95 152.18 90.84 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-N 113.657 -1.611 . . . . 1.04 110.67 175.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.542 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.4 Cg_endo -80.18 -49.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 125.044 3.829 . . . . 0.10000000000000001 113.497 -171.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.661 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.23 123.04 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.143 0.973 . . . . 1.01 113.545 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.82 -126.31 1.48 Allowed Glycine 0 N--CA 1.436 -1.325 0 CA-C-N 113.895 -1.502 . . . . 0.11 110.671 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 381' ' ' VAL . 10.9 p -129.18 104.46 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.286 1.041 . . . . 1.54 109.346 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.635 ' CE2' HG23 ' A' ' 465' ' ' VAL . 51.1 m-85 -107.78 169.25 8.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.005 -0.998 . . . . 0.26000000000000001 109.173 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.704 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 74.1 m-85 -148.92 138.04 21.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 121.225 -0.19 . . . . 1.1799999999999999 110.579 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.526 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.17 123.66 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 119.833 -0.747 . . . . 1.05 110.123 176.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -111.63 6.48 20.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.412 -0.813 . . . . 0.20000000000000001 111.846 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.673 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.5 t30 -166.7 150.66 7.15 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.401 -0.818 . . . . 0.40999999999999998 110.93 175.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.403 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.7 mtpt -109.99 120.32 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.529 -0.76 . . . . 1.8200000000000001 109.466 169.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.583 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.9 mt-10 -122.58 112.88 18.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 123.29 1.519 . . . . 0.38 113.243 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 24.0 mp0 -108.93 135.38 50.22 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.509 -1.678 . . . . 1.96 111.022 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 24.6 t70 52.23 35.69 17.5 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.582 1.658 . . . . 0.40000000000000002 107.545 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.583 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.03 170.81 10.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.196 -2.275 . . . . 0.98999999999999999 112.225 -175.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 30.5 m -128.12 102.53 6.76 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.341 -1.754 . . . . 1.02 109.937 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.683 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.42 156.49 36.95 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.878 -1.965 . . . . 1.03 110.262 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 10.3 mtpt -154.08 169.34 23.76 Favored 'General case' 0 N--CA 1.401 -2.918 0 O-C-N 124.235 0.959 . . . . 1.26 108.701 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.857 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 177.73 164.58 31.36 Favored Glycine 0 CA--C 1.479 -2.177 0 C-N-CA 118.085 -2.007 . . . . 0.81000000000000005 113.302 -172.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.02 115.82 29.84 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 122.863 1.316 . . . . 1.2 110.082 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.58 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 4.8 m-80 -50.95 -179.72 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 111.376 -2.647 . . . . 1.1200000000000001 114.046 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . 0.494 ' HB3' ' HB ' ' A' ' 374' ' ' THR . 0.0 OUTLIER -51.15 -23.68 3.47 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.451 -0.795 . . . . 1.6499999999999999 110.697 168.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.418 ' HB3' HG21 ' A' ' 401' ' ' THR . 3.9 t70 -96.88 -25.83 15.3 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.586 0.707 . . . . 2.0 110.525 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.76 34.04 5.08 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 109.897 -1.281 . . . . 0.70999999999999996 109.897 -167.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.58 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 36.9 p -115.41 127.36 26.87 Favored Pre-proline 0 N--CA 1.413 -2.275 0 N-CA-C 107.154 -1.425 . . . . 1.26 107.154 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.857 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.5 Cg_exo -69.73 147.35 62.84 Favored 'Trans proline' 0 N--CA 1.42 -2.847 0 C-N-CA 122.299 1.999 . . . . 1.1399999999999999 111.462 -175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 11.5 p90 -135.43 -174.69 3.7 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 112.694 -2.048 . . . . 0.84999999999999998 107.13 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 5.4 mt-10 -143.53 163.09 34.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.448 1.118 . . . . 0.62 112.302 175.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.683 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.21 98.77 9.14 Favored Pre-proline 0 N--CA 1.422 -1.843 0 CA-C-N 113.012 -1.904 . . . . 1.9099999999999999 108.193 174.733 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.42 102.7 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.454 2.102 . . . . 0.22 110.336 174.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.56 HG11 ' N ' ' A' ' 408' ' ' ASN . 1.2 t -115.64 160.88 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.397 -1.274 . . . . 1.0900000000000001 110.134 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.56 ' N ' HG11 ' A' ' 407' ' ' VAL . 13.7 m-80 -111.82 -32.85 6.49 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.656 -1.611 . . . . 1.8400000000000001 107.19 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 49.8 m-85 -137.67 115.98 11.87 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.064 -1.88 . . . . 0.88 110.225 175.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.553 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 9.8 t-105 -122.87 135.57 54.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.957 -1.02 . . . . 0.14999999999999999 109.794 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.472 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.5 OUTLIER -136.34 86.07 25.19 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.882 -1.054 . . . . 1.03 110.851 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.6 Cg_endo -72.34 141.5 35.51 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.975 2.45 . . . . 0.23999999999999999 111.691 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.704 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.52 -15.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.393 -1.276 . . . . 1.03 111.809 -171.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.817 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 3.9 p30 -135.98 171.03 15.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.778 -0.646 . . . . 1.5900000000000001 110.074 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -98.23 16.43 21.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 0.33000000000000002 111.681 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.9 p -99.65 -27.91 13.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.583 -0.895 . . . . 1.1499999999999999 108.583 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 132.31 26.24 0.68 Allowed Glycine 0 N--CA 1.432 -1.622 0 CA-C-N 114.337 -1.302 . . . . 0.28000000000000003 113.902 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.817 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.1 t -105.12 152.4 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.523 0.678 . . . . 0.96999999999999997 112.083 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.76 -168.07 40.55 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 114.82 -1.082 . . . . 0.13 111.209 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.5 141.6 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 109.119 -0.697 . . . . 1.03 109.119 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.616 ' O ' ' HB ' ' A' ' 445' ' ' THR . 33.7 p80 -150.54 165.04 34.47 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.75 0.786 . . . . 0.17000000000000001 111.768 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.729 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -93.25 142.85 26.85 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.004 -1.453 . . . . 0.41999999999999998 107.16 171.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.93 104.94 5.89 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.925 1.345 . . . . 2.0 110.203 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.97 -27.62 15.56 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 112.34 -2.209 . . . . 0.34999999999999998 111.288 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -69.3 -24.61 63.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.481 -1.236 . . . . 0.19 108.877 174.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.405 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.1 OUTLIER -119.17 100.2 50.36 Favored Pre-proline 0 CA--C 1.488 -1.404 0 CA-C-N 112.985 -1.916 . . . . 1.3300000000000001 108.465 -176.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -88.52 2.2 6.21 Favored 'Trans proline' 0 C--N 1.283 -2.914 0 C-N-CA 123.04 2.493 . . . . 0.28000000000000003 114.863 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.97 151.86 30.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.986 -1.086 . . . . 1.1000000000000001 111.567 -177.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.607 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.64 125.77 2.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.762 -1.563 . . . . 0.98999999999999999 108.472 -171.423 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.71 -169.01 28.6 Favored Glycine 0 C--N 1.299 -1.527 0 C-N-CA 119.416 -1.373 . . . . 0.13 111.203 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.66 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.06 0.01 OUTLIER Glycine 0 C--N 1.34 0.778 0 O-C-N 125.163 1.155 . . . . 0.23000000000000001 112.97 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.415 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.4 m-20 -54.55 100.96 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 123.988 1.852 . . . . 0.33000000000000002 111.799 -146.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.8 mt -97.14 -31.71 12.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 110.09 -3.232 . . . . 1.05 108.614 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.56 ' HA ' HG21 ' A' ' 369' ' ' VAL . 5.6 p-90 -45.95 -37.68 6.74 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.804 0.69 . . . . 0.22 111.515 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.765 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 56.4 mttt -61.34 -24.18 66.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.113 -0.949 . . . . 1.29 113.211 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.5 p -114.85 -37.38 4.21 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.684 0.754 . . . . 1.0700000000000001 110.162 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.486 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.5 mtp85 -82.36 -15.72 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.78 -1.1 . . . . 0.41999999999999998 112.137 -170.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.547 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 71.87 41.43 55.62 Favored Glycine 0 C--N 1.314 -0.66 0 N-CA-C 116.13 1.212 . . . . 0.20999999999999999 116.13 160.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 38.5 m -90.28 130.1 36.44 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.565 1.182 . . . . 0.81999999999999995 108.522 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.504 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 73.2 m80 -95.4 65.35 2.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.06 -0.4 . . . . 0.5 111.187 -166.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.598 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 93.76 -13.77 66.75 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.548 -1.021 . . . . 0.19 110.548 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.562 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 21.0 p -87.52 138.45 31.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.971 0.415 . . . . 1.22 110.455 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.553 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -91.72 116.15 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.78 0.8 . . . . 1.04 110.768 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.483 ' CB ' HG11 ' A' ' 369' ' ' VAL . 1.8 t-20 -76.73 84.3 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.236 -1.347 . . . . 2.29 111.405 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.616 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 51.3 m -89.64 137.96 28.41 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-O 121.659 0.743 . . . . 1.02 109.773 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 52.8 Cg_exo -57.55 135.84 72.13 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.909 2.406 . . . . 0.12 111.735 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.729 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.8 Cg_exo -55.27 -34.04 86.95 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.256 3.304 . . . . 0.16 112.96 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.7 p -78.54 -39.48 37.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.651 -1.159 . . . . 1.47 109.928 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.629 HG12 ' HB ' ' A' ' 366' ' ' THR . 86.2 t -79.58 -31.25 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.866 -0.606 . . . . 1.0600000000000001 111.384 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.686 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.6 tpt -66.76 -18.73 65.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.521 0.677 . . . . 1.0 110.448 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -81.04 -23.05 38.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.395 1.093 . . . . 1.4399999999999999 110.989 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 456' ' ' MET . 7.7 mm-40 -79.69 -46.95 16.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 112.841 -1.981 . . . . 0.38 107.106 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.636 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.2 tp -64.39 -66.99 0.47 Allowed 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 111.835 -2.439 . . . . 1.0 112.243 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.627 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 33.0 t80 -49.67 -27.04 4.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.018 1.39 . . . . 0.40000000000000002 108.328 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.57 -30.76 66.12 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 112.465 -2.152 . . . . 0.13 112.409 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.63 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -88.38 -48.34 7.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.929 0.871 . . . . 1.02 111.369 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.601 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -102.45 138.03 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 123.587 1.66 . . . . 1.04 113.992 -168.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.96 -178.44 5.2 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 110.52 -3.037 . . . . 0.82999999999999996 106.419 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.667 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.6 mtmt -50.87 162.96 0.22 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 123.06 1.41 . . . . 1.04 113.318 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.02 -35.29 3.95 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 112.577 -2.102 . . . . 0.37 112.47 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.469 ' O ' HG13 ' A' ' 384' ' ' VAL . 17.8 m -72.57 141.69 82.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 CA-C-N 115.252 -0.474 . . . . 1.01 109.837 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.629 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.4 164.97 33.73 Favored 'Trans proline' 0 N--CA 1.43 -2.241 0 C-N-CA 122.043 1.829 . . . . 0.17000000000000001 111.084 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.0 t -135.16 133.45 53.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 CA-C-N 113.702 -1.59 . . . . 1.75 107.872 173.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.43 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.9 tp -112.55 142.96 44.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.032 -0.531 . . . . 1.04 110.371 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.661 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.19 147.46 20.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.06 -1.459 . . . . 1.02 107.06 165.291 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.474 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 15.9 p90 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.657 -0.687 . . . . 1.1599999999999999 111.342 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.834 -0.507 . . . . 4.3899999999999997 111.834 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -72.97 98.96 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.21 0.528 . . . . 2.1899999999999999 110.525 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 35.0 mtm 62.74 -176.15 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.466 -1.243 . . . . 1.23 111.921 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.4 -5.15 1.82 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.304 -0.862 . . . . 1.1000000000000001 110.602 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -55.22 167.06 0.48 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 123.026 1.393 . . . . 0.97999999999999998 113.508 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 358' ' ' LYS . 4.1 m -92.74 121.87 34.57 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 112.857 -1.974 . . . . 1.04 106.95 165.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.643 ' HD2' ' CD1' ' A' ' 344' ' ' TYR . 12.2 p90 -158.65 -171.03 3.27 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.597 0.713 . . . . 0.94999999999999996 111.081 -174.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.613 HD13 ' CB ' ' A' ' 457' ' ' VAL . 8.9 mm -105.58 161.09 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.719 -1.128 . . . . 1.02 108.022 167.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.452 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.2 tt0 -142.42 155.39 45.1 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 118.843 0.747 . . . . 0.17000000000000001 111.046 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' A' ' 354' ' ' MET . 63.2 t -150.3 136.57 12.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.795 -1.093 . . . . 1.03 109.851 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -117.84 111.28 18.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.721 -1.127 . . . . 0.37 108.053 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.8 mm? -64.63 -49.41 71.16 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 122.704 1.24 . . . . 1.0600000000000001 110.197 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -53.31 -54.82 30.86 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 112.507 -2.133 . . . . 1.51 112.224 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -94.9 3.86 54.48 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.788 -1.097 . . . . 0.91000000000000003 109.994 -173.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.736 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.2 mm-40 47.01 64.96 1.36 Allowed 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 112.584 -2.098 . . . . 2.6299999999999999 112.27 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.551 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.5 t60 -145.86 124.62 12.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.107 0.48 . . . . 0.17000000000000001 110.021 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.59 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.4 ttp -110.83 127.61 55.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.438 0.637 . . . . 0.97999999999999998 110.515 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.617 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -111.55 173.26 6.43 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.538 -1.21 . . . . 0.11 111.889 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 2.5 t80 -127.14 117.48 22.46 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 106.251 -1.759 . . . . 1.02 106.251 164.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 357' ' ' TYR . 25.2 m-85 -100.48 128.6 46.49 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.188 0.994 . . . . 0.90000000000000002 111.898 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.58 ' HA ' HG22 ' A' ' 343' ' ' THR . 5.1 ttpt -148.35 137.37 21.81 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.218 -1.81 . . . . 1.21 108.225 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.425 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.7 OUTLIER 70.56 14.46 7.27 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 113.409 -1.723 . . . . 0.59999999999999998 108.92 178.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.62 15.65 75.3 Favored Glycine 0 N--CA 1.423 -2.203 0 CA-C-N 112.588 -2.096 . . . . 0.23999999999999999 111.847 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.571 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.63 171.75 13.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.954 -1.869 . . . . 1.26 105.954 -170.646 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.592 HG12 ' CD1' ' A' ' 355' ' ' TRP . 2.9 m -102.99 137.84 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.834 0 CA-C-O 124.421 2.058 . . . . 1.26 112.186 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -93.01 -24.76 18.24 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 109.291 -3.595 . . . . 1.03 108.574 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.671 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.4 154.81 36.33 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.854 -1.521 . . . . 1.01 109.018 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.617 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.56 122.05 1.41 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.763 -0.653 . . . . 0.60999999999999999 109.442 -175.226 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.569 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.2 t -148.34 167.55 24.91 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 122.34 1.066 . . . . 0.98999999999999999 112.133 174.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.665 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.0 OUTLIER -86.45 139.97 30.41 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 112.941 -1.936 . . . . 1.8799999999999999 107.41 176.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.646 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.28 -171.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.349 -0.841 . . . . 1.04 112.014 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.736 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.17 117.14 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.862 -1.063 . . . . 1.04 109.203 177.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.0 t -142.85 146.62 34.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.78 -1.1 . . . . 1.0 112.531 -168.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.722 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.6 45.93 50.36 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 116.824 1.489 . . . . 0.13 116.824 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.491 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.55 144.45 3.44 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 118.994 1.397 . . . . 1.2 110.616 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.795 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.74 -29.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 1 C-N-CA 125.848 4.365 . . . . 0.26000000000000001 116.45 -172.412 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.45 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.2 p -86.97 -31.99 20.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.465 0.65 . . . . 1.0600000000000001 110.809 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.523 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.7 m -138.47 70.55 45.91 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 122.187 0.994 . . . . 1.0800000000000001 109.892 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.722 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.7 Cg_exo -72.64 163.47 38.41 Favored 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.325 4.017 . . . . 0.19 114.36 -175.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.563 HG23 HD12 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.41 152.65 85.74 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 113.23 -1.804 . . . . 1.04 110.271 173.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.559 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.28 -49.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.326 -0.634 0 C-N-CA 124.909 3.74 . . . . 0.10000000000000001 113.634 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.653 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.71 123.03 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.586 0.958 . . . . 1.01 113.586 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.05 -122.76 1.1 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.225 -1.352 . . . . 0.11 111.575 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.439 ' O ' HG11 ' A' ' 381' ' ' VAL . 11.7 p -129.12 107.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.117 0.96 . . . . 1.54 109.301 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.618 ' CE2' HG23 ' A' ' 465' ' ' VAL . 98.9 m-85 -110.59 161.95 15.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.154 -0.93 . . . . 0.26000000000000001 109.945 -170.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.659 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.0 m-85 -148.21 135.68 20.59 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 121.234 -0.186 . . . . 1.1799999999999999 111.13 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.58 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.08 125.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.585 0.707 . . . . 1.05 110.891 177.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -109.68 2.4 20.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.21 -0.905 . . . . 0.20000000000000001 111.745 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.691 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.2 t30 -165.17 146.71 7.62 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.355 -0.839 . . . . 0.40999999999999998 110.805 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -107.24 109.8 21.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.179 -0.919 . . . . 1.8200000000000001 109.224 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.575 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -107.74 119.66 40.06 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 122.589 1.185 . . . . 0.38 111.447 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.769 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 19.2 mt-10 -115.96 142.15 47.17 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.966 -1.47 . . . . 1.96 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 35.2 t70 55.86 26.87 10.18 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 111.21 -2.723 . . . . 0.40000000000000002 107.656 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 169.64 15.37 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 112.753 -2.021 . . . . 0.98999999999999999 112.404 -166.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 60.8 m -125.07 102.96 7.75 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 112.866 -1.97 . . . . 1.02 109.532 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 9.0 mp -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-N 113.176 -1.829 . . . . 1.03 109.76 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 393' ' ' LEU . 9.9 mtpt -154.09 172.38 17.62 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 107.814 -1.18 . . . . 1.26 107.814 -174.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.857 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 171.95 167.23 31.79 Favored Glycine 0 CA--C 1.481 -2.058 0 C-N-CA 118.052 -2.023 . . . . 0.81000000000000005 113.449 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.4 121.05 32.77 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 123.111 1.434 . . . . 1.2 110.842 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.465 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -50.21 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 110.935 -2.848 . . . . 1.1200000000000001 112.368 174.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.31 -24.02 10.71 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.88 -0.6 . . . . 1.6499999999999999 110.513 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.7 -28.83 13.72 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.372 0.606 . . . . 2.0 111.33 -172.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 106.73 32.52 3.57 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.064 -1.065 . . . . 0.70999999999999996 110.706 -167.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 40.0 p -118.4 130.53 24.71 Favored Pre-proline 0 N--CA 1.417 -2.095 0 N-CA-C 106.603 -1.629 . . . . 1.26 106.603 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.857 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 24.1 Cg_exo -66.19 156.15 66.28 Favored 'Trans proline' 0 N--CA 1.42 -2.809 0 C-N-CA 121.789 1.659 . . . . 1.1399999999999999 112.898 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.624 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 19.4 p90 -134.46 -169.69 2.39 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.396 -1.729 . . . . 0.84999999999999998 107.417 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.705 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.9 mt-10 -148.41 155.27 41.01 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 122.205 1.002 . . . . 0.62 111.388 172.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.613 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.3 m -142.72 98.05 5.86 Favored Pre-proline 0 N--CA 1.42 -1.959 0 CA-C-N 113.36 -1.745 . . . . 1.9099999999999999 109.478 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.2 Cg_endo -66.89 108.28 1.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 124.648 3.565 . . . . 0.22 113.22 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.599 HG22 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -118.62 161.11 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.495 -1.23 . . . . 1.0900000000000001 110.003 -175.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.769 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.2 OUTLIER -100.23 -40.3 7.62 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.394 -1.336 . . . . 1.8400000000000001 107.394 169.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.647 ' HD2' ' CD1' ' A' ' 409' ' ' TYR . 10.2 m-30 -125.94 113.47 17.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.395 -1.275 . . . . 0.88 110.439 -175.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.575 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 6.4 t-105 -123.28 135.92 54.46 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.747 -1.57 . . . . 0.14999999999999999 110.1 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.534 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.5 OUTLIER -135.96 85.02 29.85 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-N 114.859 -1.064 . . . . 1.03 111.092 174.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.679 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.8 Cg_endo -70.68 140.47 39.28 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.025 2.484 . . . . 0.23999999999999999 111.63 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.659 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.6 pt -123.53 -16.33 5.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.085 -1.416 . . . . 1.03 111.154 -172.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.425 ' CG ' ' HG1' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.58 169.75 16.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.093 -0.958 . . . . 1.5900000000000001 108.945 177.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.2 14.19 32.76 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.489 0.922 . . . . 0.33000000000000002 113.489 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' THR . . . . . 0.425 ' HG1' ' CG ' ' A' ' 414' ' ' ASP . 23.3 p -98.16 -28.36 13.76 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.906 -1.146 . . . . 1.1499999999999999 107.906 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.6 31.17 0.31 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 114.037 -1.438 . . . . 0.28000000000000003 113.148 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.669 HG11 ' O ' ' A' ' 441' ' ' GLY . 72.9 t -102.75 149.4 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.383 0.611 . . . . 0.96999999999999997 111.515 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.77 -166.04 37.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.911 -1.041 . . . . 0.13 111.57 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.7 138.45 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.936 -0.764 . . . . 1.03 108.936 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.599 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.4 p80 -151.86 171.46 17.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.093 0.949 . . . . 0.17000000000000001 111.712 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.726 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -92.44 149.56 21.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.122 -1.854 . . . . 0.41999999999999998 108.322 174.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 4.8 p -133.8 101.75 5.2 Favored 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 123.137 1.446 . . . . 2.0 110.376 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -95.8 -32.0 12.91 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 112.139 -2.3 . . . . 0.34999999999999998 110.846 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.611 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 15.5 p90 -71.67 -26.76 62.66 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 114.73 -1.123 . . . . 0.19 108.972 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.503 ' HG2' ' HB3' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -111.05 95.5 25.11 Favored Pre-proline 0 CA--C 1.489 -1.365 0 CA-C-N 113.469 -1.696 . . . . 1.3300000000000001 108.923 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -85.12 2.4 7.92 Favored 'Trans proline' 0 N--CA 1.415 -3.122 0 C-N-CA 122.808 2.338 . . . . 0.28000000000000003 113.418 -176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.1 148.69 36.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.041 -1.064 . . . . 1.1000000000000001 110.162 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 1.608 ' HD2' ' CD1' ' A' ' 429' ' ' TYR . 0.0 OUTLIER -162.93 124.78 2.56 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.733 1.271 . . . . 0.98999999999999999 108.225 -173.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.02 -166.04 28.47 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 119.389 -1.386 . . . . 0.13 111.241 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.608 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.52 149.58 0.01 OUTLIER Glycine 0 C--N 1.342 0.883 0 O-C-N 125.17 1.159 . . . . 0.23000000000000001 112.907 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.411 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 1.8 m-20 -54.97 101.6 0.05 Allowed 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 112.112 -145.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.4 mt -97.35 -32.14 12.03 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 110.498 -3.046 . . . . 1.05 108.302 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.574 ' HA ' HG22 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.32 -37.79 5.17 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.745 0.653 . . . . 0.22 111.465 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.795 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.9 mttt -60.47 -26.57 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 114.822 -1.081 . . . . 1.29 112.758 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.9 p -112.73 -37.89 4.74 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.717 0.77 . . . . 1.0700000000000001 110.083 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.444 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.3 mtp85 -82.74 -14.76 53.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.6 -1.182 . . . . 0.41999999999999998 112.616 -168.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.491 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.63 40.7 37.48 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 116.069 1.187 . . . . 0.20999999999999999 116.069 159.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.2 m -79.86 140.87 36.61 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 117.809 0.804 . . . . 0.81999999999999995 109.52 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -106.29 68.54 0.76 Allowed 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.881 -0.512 . . . . 0.5 110.392 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.669 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 84.63 -8.13 70.31 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.069 -0.813 . . . . 0.19 111.069 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.487 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 26.3 p -94.92 135.09 36.86 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.393 0.616 . . . . 1.22 110.715 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.563 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -96.42 113.74 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.254 -0.885 . . . . 1.04 110.343 -174.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.514 ' OD1' ' HE1' ' A' ' 421' ' ' HIS . 18.9 m-80 -83.45 93.04 7.71 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.835 -1.075 . . . . 2.29 111.881 -175.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.658 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 53.4 m -91.36 136.68 26.68 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.35 -0.841 . . . . 1.02 109.604 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.2 Cg_exo -52.99 135.55 58.91 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.524 2.15 . . . . 0.12 111.214 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.726 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 49.0 Cg_exo -55.28 -31.38 76.37 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.055 3.17 . . . . 0.16 112.547 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.3 m -79.75 -38.3 33.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.286 -1.324 . . . . 1.47 109.943 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.569 HG12 ' HB ' ' A' ' 366' ' ' THR . 86.5 t -78.55 -29.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.643 -0.708 . . . . 1.0600000000000001 111.539 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.611 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.3 tpt -66.34 -20.9 66.21 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.598 0.713 . . . . 1.0 110.179 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -76.27 -25.27 54.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.827 -1.079 . . . . 1.4399999999999999 111.628 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -79.21 -46.66 17.43 Favored 'General case' 0 CA--C 1.473 -2.003 0 CA-C-N 113.129 -1.85 . . . . 0.38 107.092 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.562 HD21 ' SD ' ' A' ' 450' ' ' MET . 24.3 tp -66.06 -67.42 0.45 Allowed 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 111.72 -2.491 . . . . 1.0 112.43 175.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.631 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 28.7 t80 -48.94 -26.88 2.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.806 1.289 . . . . 0.40000000000000002 108.344 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.54 -30.35 64.46 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.601 -2.09 . . . . 0.13 112.555 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.671 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -88.75 -48.5 7.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.65 0.738 . . . . 1.02 111.513 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.613 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.4 OUTLIER -101.03 138.3 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 123.105 1.431 . . . . 1.04 113.902 -168.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -136.5 -178.94 5.39 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 111.284 -2.689 . . . . 0.82999999999999996 107.397 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.691 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.1 mtmt -52.79 157.73 1.56 Allowed 'General case' 0 N--CA 1.413 -2.286 0 CA-C-O 122.82 1.295 . . . . 1.04 114.009 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.1 18.01 70.53 Favored Glycine 0 C--N 1.281 -2.492 0 CA-C-N 112.659 -2.064 . . . . 0.37 113.699 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.521 HG23 ' O ' ' A' ' 462' ' ' PRO . 9.5 m -103.85 141.68 23.02 Favored Pre-proline 0 N--CA 1.427 -1.585 0 N-CA-C 107.664 -1.235 . . . . 1.01 107.664 165.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.621 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.3 Cg_exo -74.74 164.62 33.27 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.648 1.565 . . . . 0.17000000000000001 110.73 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.61 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.1 m -134.73 154.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 107.271 -1.381 . . . . 1.75 107.271 166.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.452 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.3 tp -126.59 145.15 50.65 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 1.04 110.195 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.653 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.04 147.44 20.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.291 -1.374 . . . . 1.02 107.291 165.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.448 ' HA ' ' HB2' ' A' ' 379' ' ' ALA . 17.3 p90 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.535 -0.745 . . . . 1.1599999999999999 110.846 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.384 -0.686 . . . . 4.3899999999999997 111.384 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.576 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.5 t-160 -82.71 88.31 6.73 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.002 -0.74 . . . . 2.1899999999999999 109.002 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.576 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 36.9 mtm 73.85 -179.99 0.2 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.636 -1.62 . . . . 1.23 110.523 -170.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -116.64 -6.4 11.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.868 -1.06 . . . . 1.1000000000000001 111.133 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.03 166.14 3.73 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 123.248 1.499 . . . . 0.97999999999999998 114.253 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 358' ' ' LYS . 98.9 m -99.12 122.7 42.68 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.375 -2.193 . . . . 1.04 106.841 165.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.655 ' HE1' ' CE2' ' A' ' 344' ' ' TYR . 12.9 p90 -158.4 -171.05 3.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.388 -0.824 . . . . 0.94999999999999996 111.322 -170.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.595 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.1 mm -103.24 156.47 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.935 -1.135 . . . . 1.02 107.935 165.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.447 ' CG ' HD21 ' A' ' 464' ' ' LEU . 3.5 tt0 -137.22 155.02 50.02 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.596 0.634 . . . . 0.17000000000000001 110.633 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.551 HG23 ' HG3' ' A' ' 354' ' ' MET . 55.7 t -150.41 136.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.775 -1.102 . . . . 1.03 110.0 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.04 118.94 34.3 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.553 -1.203 . . . . 0.37 108.074 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.437 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.7 mm? -71.17 -49.3 45.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.419 1.104 . . . . 1.0600000000000001 110.511 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -54.85 -53.56 53.77 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 112.996 -1.911 . . . . 1.51 112.308 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -98.09 10.65 39.94 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.543 -1.208 . . . . 0.91000000000000003 108.738 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.837 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.2 mm-40 38.14 71.76 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 125.088 1.493 . . . . 2.6299999999999999 111.856 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.481 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -151.63 124.11 8.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.685 -0.689 . . . . 0.17000000000000001 109.872 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.551 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.0 ttp -110.87 128.01 55.64 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.379 0.609 . . . . 0.97999999999999998 110.484 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.662 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.9 m-90 -111.37 173.39 6.36 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.612 -1.176 . . . . 0.11 111.895 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 2.5 t80 -126.84 116.34 20.72 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.194 -1.78 . . . . 1.02 106.194 165.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.665 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 21.5 m-85 -100.07 129.63 46.13 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.927 0.87 . . . . 0.90000000000000002 111.534 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.538 ' HA ' HG21 ' A' ' 343' ' ' THR . 5.1 ttpt -149.12 139.2 22.14 Favored 'General case' 0 N--CA 1.398 -3.053 0 CA-C-N 113.633 -1.621 . . . . 1.21 107.66 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.447 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 72.64 11.68 5.5 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.064 -1.425 . . . . 0.59999999999999998 108.908 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.84 13.99 73.78 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 112.747 -2.024 . . . . 0.23999999999999999 111.753 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.612 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.75 172.75 12.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.705 -1.961 . . . . 1.26 105.705 -171.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.612 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 3.0 m -102.68 139.27 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.864 0 CA-C-O 124.364 2.031 . . . . 1.26 112.358 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.528 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -93.38 -25.32 17.74 Favored 'General case' 0 N--CA 1.396 -3.166 0 CA-C-N 109.206 -3.634 . . . . 1.03 108.498 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.681 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.32 155.18 37.16 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.695 -1.593 . . . . 1.01 109.102 -172.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.662 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.19 122.54 1.3 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.718 -0.673 . . . . 0.60999999999999999 109.543 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.648 ' HB ' HG12 ' A' ' 449' ' ' VAL . 4.6 t -147.35 166.81 26.01 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.866 0.841 . . . . 0.98999999999999999 111.744 173.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.469 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 1.6 m-20 -82.68 146.0 29.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.592 -1.633 . . . . 1.8799999999999999 106.592 174.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.17 -172.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.506 -0.77 . . . . 1.04 111.245 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.837 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -154.01 118.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.931 -1.031 . . . . 1.04 108.973 174.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.433 ' HB2' HG13 ' A' ' 443' ' ' ILE . 6.9 t -143.02 142.84 31.68 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.164 -0.925 . . . . 1.0 113.395 -166.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.751 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.86 47.56 24.98 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.941 1.536 . . . . 0.13 116.941 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.495 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 17.5 ptmt -44.56 148.1 0.95 Allowed Pre-proline 0 C--O 1.222 -0.39 0 CA-C-N 118.521 1.16 . . . . 1.2 111.372 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.793 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -37.2 -31.18 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.053 1 C-N-CA 125.522 4.148 . . . . 0.26000000000000001 115.268 -177.664 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.423 HG21 ' HE2' ' A' ' 372' ' ' LYS . 4.0 p -82.68 -36.28 26.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.327 0.584 . . . . 1.0600000000000001 110.776 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.456 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 8.9 m -140.74 73.94 27.72 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 122.067 0.937 . . . . 1.0800000000000001 110.238 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.751 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 36.9 Cg_exo -69.3 161.62 45.14 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 125.061 3.841 . . . . 0.19 114.073 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.567 HG21 ' CD ' ' A' ' 378' ' ' PRO . 0.1 OUTLIER -71.35 151.62 94.22 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 113.35 -1.75 . . . . 1.04 110.91 175.65 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.567 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.01 -49.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.997 3.798 . . . . 0.10000000000000001 113.443 -171.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.659 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.59 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.155 0.979 . . . . 1.01 113.552 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.02 -128.67 1.8 Allowed Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 113.997 -1.456 . . . . 0.11 111.13 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 97.7 t -128.19 99.89 5.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.424 -0.954 . . . . 1.54 108.424 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.607 ' CE2' HG23 ' A' ' 465' ' ' VAL . 50.4 m-85 -104.58 169.87 8.21 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.39 -0.823 . . . . 0.26000000000000001 109.124 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.74 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.6 m-85 -149.23 139.54 22.32 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 110.413 -0.217 . . . . 1.1799999999999999 110.413 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.576 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.55 120.69 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 119.903 -0.719 . . . . 1.05 110.397 176.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 40.8 p-90 -109.21 4.41 22.81 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.391 -0.822 . . . . 0.20000000000000001 112.159 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.689 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.1 t30 -165.11 148.16 8.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.227 -0.897 . . . . 0.40999999999999998 110.009 175.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.416 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 14.8 mtpt -109.62 110.69 21.82 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.423 -0.808 . . . . 1.8200000000000001 109.866 170.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.551 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -109.08 120.82 43.69 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.561 1.172 . . . . 0.38 110.763 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.04 142.97 46.28 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.225 -1.352 . . . . 1.96 109.784 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 36.3 t70 54.19 26.34 6.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 111.782 -2.463 . . . . 0.40000000000000002 108.63 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.459 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.29 170.74 14.3 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.079 -1.873 . . . . 0.98999999999999999 112.247 -167.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 22.4 m -128.5 102.88 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.568 -1.651 . . . . 1.02 109.733 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.698 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.76 157.84 36.73 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 112.865 -1.971 . . . . 1.03 110.459 176.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.8 mtpt -145.46 -177.46 5.58 Favored 'General case' 0 N--CA 1.392 -3.369 0 CA-C-N 114.5 -1.227 . . . . 1.26 108.082 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.673 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -172.42 -150.4 7.27 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 117.153 -2.451 . . . . 0.81000000000000005 114.92 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.54 121.24 12.61 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.312 -1.444 . . . . 1.2 108.449 170.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.494 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -55.62 -179.14 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 112.485 -2.143 . . . . 1.1200000000000001 111.133 177.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -56.26 -24.31 41.94 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.641 0.734 . . . . 1.6499999999999999 110.161 170.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.67 -26.45 21.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.006 -0.997 . . . . 2.0 111.828 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.46 31.57 5.78 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.804 -1.189 . . . . 0.70999999999999996 110.497 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.494 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 44.1 p -115.21 126.94 27.26 Favored Pre-proline 0 N--CA 1.417 -2.082 0 N-CA-C 106.825 -1.546 . . . . 1.26 106.825 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.673 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 24.1 Cg_exo -65.24 160.82 40.33 Favored 'Trans proline' 0 C--N 1.283 -2.874 0 C-N-CA 121.831 1.687 . . . . 1.1399999999999999 112.493 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' A' ' 403' ' ' TYR . 3.7 p90 -140.86 -169.55 2.84 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.429 -1.714 . . . . 0.84999999999999998 106.95 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.689 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 9.4 mt-10 -148.0 155.25 41.31 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.302 1.048 . . . . 0.62 111.706 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.698 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.47 98.66 12.25 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 113.199 -1.819 . . . . 1.9099999999999999 108.273 178.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.97 101.76 0.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.442 2.095 . . . . 0.22 110.28 174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.584 HG11 ' N ' ' A' ' 408' ' ' ASN . 1.2 t -114.43 163.55 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.852 0 CA-C-N 114.239 -1.346 . . . . 1.0900000000000001 109.83 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.584 ' N ' HG11 ' A' ' 407' ' ' VAL . 15.2 m-80 -114.99 -33.82 5.28 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.474 -1.694 . . . . 1.8400000000000001 106.808 -176.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.639 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 54.8 m-85 -136.09 116.25 13.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.796 -2.002 . . . . 0.88 110.681 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.551 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.4 t-105 -123.33 134.72 54.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.665 -1.152 . . . . 0.14999999999999999 110.102 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.483 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.6 OUTLIER -136.28 86.24 25.17 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.905 -1.043 . . . . 1.03 110.937 174.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.689 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 79.9 Cg_endo -72.11 141.61 36.57 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.892 2.395 . . . . 0.23999999999999999 111.655 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.74 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.09 -16.2 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.537 -1.21 . . . . 1.03 111.936 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.76 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.7 p30 -136.1 171.12 14.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 1.5900000000000001 110.222 170.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -99.18 15.9 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.76 -0.655 . . . . 0.33000000000000002 111.467 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 1.8 p -97.03 -26.88 14.85 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.089 -1.078 . . . . 1.1499999999999999 108.089 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 130.15 27.62 0.76 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.904 -1.498 . . . . 0.28000000000000003 113.677 169.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.76 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 49.2 t -104.43 149.78 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.43 0.633 . . . . 0.96999999999999997 112.463 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . -178.96 -164.32 31.5 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.966 -1.016 . . . . 0.13 111.942 174.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.47 139.55 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.54 -0.911 . . . . 1.03 108.54 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.533 ' HB2' HG22 ' A' ' 407' ' ' VAL . 31.7 p80 -150.02 164.16 36.25 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.637 0.732 . . . . 0.17000000000000001 111.457 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.73 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.07 138.79 31.33 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.203 -1.362 . . . . 0.41999999999999998 107.474 172.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.604 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 4.8 t -133.13 104.67 6.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.326 1.536 . . . . 2.0 110.667 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.32 -28.83 15.97 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 111.43 -2.623 . . . . 0.34999999999999998 110.83 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.421 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 18.7 p90 -72.01 -27.23 62.59 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.471 -1.24 . . . . 0.19 109.728 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.604 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -118.01 81.18 15.71 Favored Pre-proline 0 CA--C 1.496 -1.106 0 CA-C-N 114.276 -1.329 . . . . 1.3300000000000001 110.015 -176.067 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 14.9 Cg_endo -84.34 8.59 4.54 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 C-N-CA 125.122 3.881 . . . . 0.28000000000000003 114.313 -163.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -114.89 150.52 35.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.177 -0.675 . . . . 1.1000000000000001 109.177 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.469 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -159.61 125.52 4.28 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.629 1.172 . . . . 0.98999999999999999 108.285 -171.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 148.3 -166.97 29.05 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.353 -1.403 . . . . 0.13 111.305 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.591 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.85 154.44 0.0 OUTLIER Glycine 0 C--N 1.341 0.818 0 O-C-N 125.151 1.148 . . . . 0.23000000000000001 113.2 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.463 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 2.9 m-20 -55.28 101.42 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.806 1.765 . . . . 0.33000000000000002 112.17 -146.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.0 mt -97.03 -31.35 12.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 110.53 -3.032 . . . . 1.05 109.39 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.53 ' HA ' HG22 ' A' ' 369' ' ' VAL . 14.2 p-90 -50.13 -30.87 12.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.96 -1.927 . . . . 0.22 111.844 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.793 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 44.9 mttt -66.65 -22.12 66.1 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.919 -1.037 . . . . 1.29 112.872 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.8 p -117.43 -38.72 3.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.855 0.836 . . . . 1.0700000000000001 110.049 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 433' ' ' LEU . 10.0 mtp85 -80.3 -15.32 57.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.48 -1.236 . . . . 0.41999999999999998 111.952 -171.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 71.84 40.58 57.61 Favored Glycine 0 C--N 1.311 -0.821 0 N-CA-C 115.697 1.039 . . . . 0.20999999999999999 115.697 159.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' SER . . . . . 0.402 ' OG ' HG21 ' A' ' 369' ' ' VAL . 1.4 m -80.01 130.84 35.58 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 108.85 -0.796 . . . . 0.81999999999999995 108.85 176.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -99.97 65.64 1.3 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.314 -0.866 . . . . 0.5 111.562 -169.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.527 ' O ' HG22 ' A' ' 377' ' ' THR . . . 94.92 -18.77 56.65 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 111.09 -0.804 . . . . 0.19 111.09 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 421' ' ' HIS . 37.1 m -90.36 159.17 16.75 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.951 -0.7 . . . . 1.22 111.214 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.527 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -107.64 120.29 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.522 -0.763 . . . . 1.04 110.578 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.487 ' HB2' HG11 ' A' ' 369' ' ' VAL . 25.2 m-80 -83.74 91.93 7.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.686 -0.688 . . . . 2.29 111.588 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 37.3 m -90.0 136.86 28.51 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-O 121.393 0.615 . . . . 1.02 109.489 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -57.15 132.12 49.36 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.842 2.361 . . . . 0.12 112.862 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.73 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.5 Cg_exo -50.51 -40.47 54.36 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 123.489 2.793 . . . . 0.16 112.39 -169.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.1 p -73.44 -40.44 64.21 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.806 -1.088 . . . . 1.47 110.113 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.648 HG12 ' HB ' ' A' ' 366' ' ' THR . 67.3 t -77.05 -29.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.382 0.61 . . . . 1.0600000000000001 111.303 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.669 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.0 tpt -67.85 -19.67 65.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.748 0.785 . . . . 1.0 109.958 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -79.4 -22.66 44.0 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.63 -1.168 . . . . 1.4399999999999999 110.918 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.635 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.54 -47.73 13.8 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 112.922 -1.945 . . . . 0.38 107.329 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.626 HD21 ' SD ' ' A' ' 450' ' ' MET . 27.1 tp -63.66 -66.91 0.48 Allowed 'General case' 0 N--CA 1.403 -2.799 0 CA-C-N 111.83 -2.441 . . . . 1.0 112.241 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.64 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 35.5 t80 -50.15 -26.55 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.962 1.363 . . . . 0.40000000000000002 108.167 176.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.01 -28.19 69.0 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 112.592 -2.095 . . . . 0.13 112.347 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -91.71 -47.96 7.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.666 0.746 . . . . 1.02 111.768 171.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.595 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -101.5 138.36 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 123.457 1.599 . . . . 1.04 113.892 -168.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.416 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.7 pt-20 -136.83 -178.69 5.3 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 110.813 -2.903 . . . . 0.82999999999999996 106.503 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.685 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.7 mtmt -51.69 162.48 0.4 Allowed 'General case' 0 N--CA 1.413 -2.321 0 CA-C-O 123.12 1.438 . . . . 1.04 113.179 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.38 -33.64 4.66 Favored Glycine 0 N--CA 1.424 -2.141 0 CA-C-N 112.441 -2.163 . . . . 0.37 112.284 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.471 ' O ' HG13 ' A' ' 384' ' ' VAL . 10.6 m -73.96 140.78 77.62 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-O 121.119 0.485 . . . . 1.01 109.822 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.639 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.44 162.96 38.9 Favored 'Trans proline' 0 N--CA 1.432 -2.132 0 C-N-CA 122.265 1.977 . . . . 0.17000000000000001 111.142 174.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.51 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.5 t -132.95 131.96 59.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 CA-C-N 113.757 -1.565 . . . . 1.75 108.169 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.447 HD21 ' CG ' ' A' ' 346' ' ' GLU . 2.9 tp -112.03 143.04 43.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.989 -0.551 . . . . 1.04 110.331 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.659 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.16 148.08 19.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.126 -1.435 . . . . 1.02 107.126 165.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.446 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 15.7 p90 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.301 -0.857 . . . . 1.1599999999999999 111.27 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.954 0 N-CA-C 111.829 -0.509 . . . . 4.3899999999999997 111.829 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -162.55 97.74 0.98 Allowed 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.615 -0.513 . . . . 2.1899999999999999 109.615 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.439 ' HB3' ' OD1' ' A' ' 342' ' ' ASP . 34.4 mtm 67.99 -174.52 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 O-C-N 124.526 1.141 . . . . 1.23 111.148 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.41 -12.22 0.81 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.792 0.664 . . . . 1.1000000000000001 112.792 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . 0.439 ' OD1' ' HB3' ' A' ' 340' ' ' MET . 0.2 OUTLIER -59.8 167.87 1.98 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.427 1.108 . . . . 0.97999999999999998 113.702 175.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 358' ' ' LYS . 88.9 m -90.14 124.22 34.64 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.13 -1.396 . . . . 1.04 109.801 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.667 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 5.0 p90 -160.94 -169.31 2.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.119 -1.4 . . . . 0.94999999999999996 110.584 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.567 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.7 mm -101.39 162.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.204 -1.036 . . . . 1.02 108.204 165.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.455 ' CG ' HD21 ' A' ' 464' ' ' LEU . 3.8 tt0 -143.67 156.31 44.5 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 119.063 0.847 . . . . 0.17000000000000001 111.729 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.583 HG23 ' HG3' ' A' ' 354' ' ' MET . 77.8 t -150.71 137.44 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.741 -1.118 . . . . 1.03 110.115 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -124.61 106.51 10.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.175 0.988 . . . . 0.37 108.52 177.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.73 -42.13 95.45 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 112.772 -2.013 . . . . 1.0600000000000001 111.602 -168.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.46 -57.58 11.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.412 -2.176 . . . . 1.51 112.892 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -92.79 1.44 57.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 114.838 -1.074 . . . . 0.91000000000000003 109.924 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.817 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.0 mm-40 48.73 63.75 1.98 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 112.624 -2.08 . . . . 2.6299999999999999 111.565 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.533 ' HE2' ' HB2' ' A' ' 365' ' ' GLU . 6.8 t60 -143.41 128.63 18.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.803 -0.635 . . . . 0.17000000000000001 109.716 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.583 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.7 ttp -115.28 128.6 56.23 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.438 0.695 . . . . 0.97999999999999998 110.444 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.624 ' CD1' HG12 ' A' ' 362' ' ' VAL . 32.5 m-90 -112.82 173.43 6.38 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.755 -1.111 . . . . 0.11 111.598 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.656 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 0.2 OUTLIER -125.08 112.9 17.05 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 105.577 -2.008 . . . . 1.02 105.577 163.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 18.1 m-85 -92.98 124.85 37.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.457 -0.897 . . . . 0.90000000000000002 111.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.527 ' HA ' HG21 ' A' ' 343' ' ' THR . 37.4 ttmt -140.17 142.52 35.93 Favored 'General case' 0 N--CA 1.386 -3.634 0 CA-C-N 114.031 -1.441 . . . . 1.21 108.771 173.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.0 16.35 10.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.742 -1.572 . . . . 0.59999999999999998 108.849 175.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.02 72.49 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 112.167 -2.288 . . . . 0.23999999999999999 111.968 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.618 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 4.9 tppt? -138.83 179.21 6.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.435 -2.061 . . . . 1.26 105.435 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.624 HG12 ' CD1' ' A' ' 355' ' ' TRP . 2.8 m -106.65 135.6 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.72 0 CA-C-O 124.197 1.951 . . . . 1.26 112.394 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.545 ' HB1' ' CD1' ' A' ' 356' ' ' TYR . . . -87.84 -26.06 23.0 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 109.351 -3.568 . . . . 1.03 107.985 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.705 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 4.0 tp -153.15 156.0 37.79 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.181 -1.372 . . . . 1.01 109.777 -173.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.541 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 2.2 pt-20 -162.6 121.99 2.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.84 -0.618 . . . . 0.60999999999999999 110.706 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.658 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.3 t -149.13 166.78 27.75 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 122.501 1.143 . . . . 0.98999999999999999 113.196 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.673 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.6 p-10 -84.36 140.02 31.87 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.712 -2.04 . . . . 1.8799999999999999 108.182 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.658 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.96 -171.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.161 -0.927 . . . . 1.04 111.843 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.817 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -153.74 121.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.794 -1.094 . . . . 1.04 108.849 174.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.49 ' HB2' HG13 ' A' ' 443' ' ' ILE . 7.0 t -144.57 143.01 30.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.917 1.08 . . . . 1.0 113.917 -167.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.47 45.93 35.02 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 116.845 1.498 . . . . 0.13 116.845 162.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.543 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.46 144.1 4.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 118.636 1.218 . . . . 1.2 110.917 -174.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.798 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.34 -32.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -0.979 1 C-N-CA 125.709 4.273 . . . . 0.26000000000000001 116.183 -170.8 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.543 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.8 p -79.92 -35.42 37.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.095 0.474 . . . . 1.0600000000000001 111.161 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.472 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 m -140.31 74.63 29.21 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 122.431 1.11 . . . . 1.0800000000000001 110.003 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.731 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.5 Cg_exo -69.79 160.42 49.75 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.044 3.83 . . . . 0.19 113.365 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.549 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -69.79 150.36 96.56 Favored Pre-proline 0 N--CA 1.434 -1.255 0 CA-C-N 113.55 -1.659 . . . . 1.04 110.92 177.259 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.544 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.0 OUTLIER -77.14 -48.78 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.893 3.729 . . . . 0.10000000000000001 112.98 -170.632 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.626 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.13 122.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.626 0.973 . . . . 1.01 113.626 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.7 -126.62 1.5 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.457 -1.247 . . . . 0.11 111.382 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.466 ' O ' HG11 ' A' ' 381' ' ' VAL . 14.1 p -126.01 104.12 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 122.516 1.15 . . . . 1.54 109.328 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.646 ' CE2' HG23 ' A' ' 465' ' ' VAL . 96.2 m-85 -107.33 162.16 14.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.904 -1.044 . . . . 0.26000000000000001 110.014 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.683 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.8 m-85 -147.91 137.51 22.45 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 121.252 -0.179 . . . . 1.1799999999999999 110.789 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.592 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.63 124.97 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 119.993 -0.683 . . . . 1.05 110.296 177.055 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -109.55 3.99 21.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.491 -0.777 . . . . 0.20000000000000001 111.929 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.667 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.6 t30 -165.13 149.34 8.78 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.485 -0.779 . . . . 0.40999999999999998 111.083 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.452 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.8 mtpt -107.46 110.74 22.77 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.411 -0.813 . . . . 1.8200000000000001 109.685 169.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.564 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -112.08 123.17 49.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.654 1.216 . . . . 0.38 111.067 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.76 143.48 47.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.139 -1.391 . . . . 1.96 110.035 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 35.4 t70 54.24 25.99 6.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 111.894 -2.412 . . . . 0.40000000000000002 108.667 -174.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 167.13 17.8 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.205 -1.816 . . . . 0.98999999999999999 112.163 -167.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 107.84 12.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.774 -1.557 . . . . 1.02 110.131 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.68 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 8.9 mp -75.85 156.7 34.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 112.834 -1.985 . . . . 1.03 110.448 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 11.8 mtpt -151.7 167.76 27.15 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.651 -1.159 . . . . 1.26 108.016 -176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.877 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 178.94 165.47 33.37 Favored Glycine 0 CA--C 1.482 -1.993 0 C-N-CA 118.181 -1.961 . . . . 0.81000000000000005 113.33 -171.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.414 ' HB ' ' HA2' ' A' ' 400' ' ' GLY . 0.8 OUTLIER -94.94 122.19 37.33 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 123.036 1.398 . . . . 1.2 110.679 177.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -50.93 -178.71 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 110.939 -2.846 . . . . 1.1200000000000001 112.278 175.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -51.92 -21.87 3.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.365 -0.379 . . . . 1.6499999999999999 111.448 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.412 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.6 OUTLIER -108.88 -29.98 8.35 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.226 0.536 . . . . 2.0 111.729 -172.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . 0.414 ' HA2' ' HB ' ' A' ' 396' ' ' THR . . . 116.73 37.52 0.97 Allowed Glycine 0 C--N 1.295 -1.75 0 C-N-CA 119.529 -1.32 . . . . 0.70999999999999996 111.413 -171.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.443 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 62.4 p -116.93 128.47 26.0 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 106.652 -1.61 . . . . 1.26 106.652 173.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.877 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.9 Cg_exo -70.33 148.91 62.4 Favored 'Trans proline' 0 N--CA 1.419 -2.888 0 C-N-CA 122.024 1.816 . . . . 1.1399999999999999 112.588 -175.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 403' ' ' TYR . 10.4 p90 -128.99 -171.56 2.51 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 112.648 -2.069 . . . . 0.84999999999999998 107.051 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.68 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 15.0 mt-10 -144.81 157.3 44.22 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.052 0.929 . . . . 0.62 111.058 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.0 m -142.28 98.3 6.08 Favored Pre-proline 0 N--CA 1.421 -1.879 0 CA-C-N 113.678 -1.601 . . . . 1.9099999999999999 109.222 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.9 Cg_endo -67.97 106.19 1.29 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 124.342 3.362 . . . . 0.22 112.644 -177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.63 HG22 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -114.61 163.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 114.534 -1.212 . . . . 1.0900000000000001 110.56 -175.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.47 ' N ' HG11 ' A' ' 407' ' ' VAL . 22.8 m-80 -111.76 -34.04 6.15 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.403 -1.726 . . . . 1.8400000000000001 106.943 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.638 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 54.4 m-85 -133.86 115.99 15.12 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.726 -2.034 . . . . 0.88 110.639 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.6 ' HB2' HG12 ' A' ' 407' ' ' VAL . 5.1 t-105 -123.86 135.29 53.65 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.4 -1.273 . . . . 0.14999999999999999 110.355 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.477 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -136.53 84.81 26.99 Favored Pre-proline 0 N--CA 1.427 -1.579 0 CA-C-N 115.007 -0.997 . . . . 1.03 110.943 172.937 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 72.2 Cg_endo -70.84 141.07 39.97 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.06 2.507 . . . . 0.23999999999999999 112.258 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.683 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -123.8 -16.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.009 -1.45 . . . . 1.03 111.063 -173.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -135.46 162.7 31.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.277 -0.874 . . . . 1.5900000000000001 109.312 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -93.78 13.32 22.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.236 0.458 . . . . 0.33000000000000002 112.236 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -91.36 -26.57 18.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.396 -1.335 . . . . 1.1499999999999999 107.396 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.93 29.55 1.13 Allowed Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 112.976 -1.92 . . . . 0.28000000000000003 112.326 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 441' ' ' GLY . 89.5 t -102.55 147.9 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.297 0.57 . . . . 0.96999999999999997 110.93 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.37 -166.11 37.91 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.734 -1.121 . . . . 0.13 111.306 -179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.54 138.42 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.698 -0.853 . . . . 1.03 108.698 175.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.63 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.1 p80 -151.24 164.9 35.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.725 0.774 . . . . 0.17000000000000001 112.076 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.715 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 146.05 24.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.074 -1.421 . . . . 0.41999999999999998 107.858 173.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.07 102.85 4.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 123.06 1.409 . . . . 2.0 110.998 179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -93.16 -26.97 17.17 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 111.752 -2.476 . . . . 0.34999999999999998 109.742 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.56 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 5.7 p90 -70.27 -26.14 63.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.312 -1.313 . . . . 0.19 109.714 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.8 80.7 25.09 Favored Pre-proline 0 CA--C 1.492 -1.286 0 CA-C-N 113.829 -1.532 . . . . 1.3300000000000001 109.315 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -81.08 5.53 6.17 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 125.089 3.86 . . . . 0.28000000000000003 114.015 -162.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -115.67 149.73 37.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.739 -0.664 . . . . 1.1000000000000001 109.411 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 429' ' ' TYR . 0.2 OUTLIER -160.99 125.57 3.57 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 124.587 1.18 . . . . 0.98999999999999999 108.179 -173.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.88 -166.92 28.83 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 119.484 -1.341 . . . . 0.13 110.899 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.585 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 154.1 0.0 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.931 1.018 . . . . 0.23000000000000001 113.159 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.415 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -55.72 101.33 0.05 Allowed 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 123.924 1.821 . . . . 0.33000000000000002 112.289 -146.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.7 mt -97.33 -32.03 12.1 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 110.228 -3.169 . . . . 1.05 108.222 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.559 ' HA ' HG22 ' A' ' 369' ' ' VAL . 6.4 p-90 -45.82 -38.84 7.67 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 124.067 0.854 . . . . 0.22 111.49 -174.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.798 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.5 mttt -60.05 -26.12 65.9 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.006 -0.997 . . . . 1.29 112.821 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.9 p -111.93 -36.11 5.49 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.701 0.762 . . . . 1.0700000000000001 110.033 -176.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.462 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 6.8 mtp85 -84.54 -15.94 44.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.689 -1.141 . . . . 0.41999999999999998 112.642 -169.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.52 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.05 40.39 30.03 Favored Glycine 0 C--N 1.313 -0.714 0 N-CA-C 116.089 1.196 . . . . 0.20999999999999999 116.089 159.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.63 131.6 36.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 117.782 0.791 . . . . 0.81999999999999995 109.545 176.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.425 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 63.3 m80 -100.7 68.3 1.31 Allowed 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.643 -0.661 . . . . 0.5 110.306 -172.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.617 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 88.7 -11.8 67.49 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.924 -0.87 . . . . 0.19 110.924 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.453 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 27.2 p -90.79 142.82 27.36 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.361 -0.42 . . . . 1.22 110.8 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.549 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -101.43 114.55 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.752 -0.658 . . . . 1.04 110.362 -176.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.529 ' HB2' HG11 ' A' ' 369' ' ' VAL . 18.7 m120 -78.81 90.38 4.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.842 -0.617 . . . . 2.29 111.098 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.612 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.9 m -86.63 137.34 34.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 109.132 -0.692 . . . . 1.02 109.132 174.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.5 Cg_exo -54.86 135.79 69.44 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.747 2.298 . . . . 0.12 111.337 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.715 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.4 Cg_exo -55.34 -32.16 80.17 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 C-N-CA 124.225 3.283 . . . . 0.16 112.825 -173.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.23 -38.79 26.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.441 -1.254 . . . . 1.47 110.09 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.658 HG12 ' HB ' ' A' ' 366' ' ' THR . 60.2 t -80.77 -29.41 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.096 -0.502 . . . . 1.0600000000000001 111.376 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.678 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.4 tpt -65.93 -19.91 66.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.781 0.8 . . . . 1.0 109.985 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -79.36 -24.97 42.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.522 -1.217 . . . . 1.4399999999999999 111.239 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.67 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -79.15 -46.3 18.24 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 113.127 -1.851 . . . . 0.38 107.111 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.587 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.7 tp -64.43 -67.17 0.45 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.663 -2.517 . . . . 1.0 112.169 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 36.2 t80 -49.62 -27.73 4.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 123.127 1.442 . . . . 0.40000000000000002 108.304 177.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.2 -31.3 69.08 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 112.37 -2.195 . . . . 0.13 112.237 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.705 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.5 ptp -88.17 -48.43 7.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.729 0.776 . . . . 1.02 111.501 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.567 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.7 OUTLIER -102.09 138.16 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 123.582 1.658 . . . . 1.04 114.005 -167.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.452 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.2 pt-20 -136.37 -178.28 5.09 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 110.705 -2.952 . . . . 0.82999999999999996 106.552 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.667 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.4 mtmt -52.71 162.56 0.57 Allowed 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.949 1.357 . . . . 1.04 112.405 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.23 -30.56 6.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 112.685 -2.052 . . . . 0.37 112.383 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 462' ' ' PRO . 15.0 m -80.89 141.96 51.7 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.134 -0.691 . . . . 1.01 109.134 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.608 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.5 Cg_exo -75.78 168.54 24.06 Favored 'Trans proline' 0 N--CA 1.425 -2.502 0 C-N-CA 121.681 1.587 . . . . 0.17000000000000001 111.098 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.628 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.81 154.49 34.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.299 -1.371 . . . . 1.75 107.299 166.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.455 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.0 tp -125.86 144.25 50.74 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.45 -0.796 . . . . 1.04 110.657 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.646 HG23 ' CE2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -143.14 146.04 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 105.937 -1.875 . . . . 1.02 105.937 163.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.544 ' HA ' ' HB2' ' A' ' 379' ' ' ALA . 8.6 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.089 -0.958 . . . . 1.1599999999999999 111.824 -175.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 112.078 -0.409 . . . . 4.3899999999999997 112.078 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.497 ' CD2' ' H ' ' A' ' 340' ' ' MET . 1.8 t60 -76.45 -178.64 4.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.257 -0.645 . . . . 2.1899999999999999 109.257 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.497 ' H ' ' CD2' ' A' ' 339' ' ' HIS . 46.7 mtm -142.46 176.76 8.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.899 0.857 . . . . 1.23 112.553 -173.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.48 -4.45 8.28 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.733 -1.576 . . . . 1.1000000000000001 108.825 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.49 169.79 0.28 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.63 -1.623 . . . . 0.97999999999999998 113.262 172.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.593 HG22 ' HA ' ' A' ' 358' ' ' LYS . 9.1 m -90.79 121.68 32.87 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 112.473 -2.149 . . . . 1.04 106.688 167.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 8.2 p90 -156.15 -171.59 3.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.485 0.659 . . . . 0.94999999999999996 110.852 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.62 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.8 mm -102.52 161.5 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.97 -1.122 . . . . 1.02 107.97 167.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.496 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.4 tt0 -140.61 155.18 46.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 118.818 0.736 . . . . 0.17000000000000001 111.1 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.602 HG23 ' HG3' ' A' ' 354' ' ' MET . 64.4 t -150.81 135.8 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.539 -1.21 . . . . 1.03 110.027 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -116.89 117.78 30.64 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.797 -1.092 . . . . 0.37 108.176 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.8 mm? -70.26 -48.2 57.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.51 1.148 . . . . 1.0600000000000001 110.487 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -54.89 -54.13 46.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 112.851 -1.977 . . . . 1.51 112.454 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -98.27 11.31 38.36 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.572 -1.195 . . . . 0.91000000000000003 108.637 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.831 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.1 mm-40 37.6 70.38 0.19 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 125.269 1.606 . . . . 2.6299999999999999 111.829 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.497 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -150.22 125.12 9.86 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.773 -0.649 . . . . 0.17000000000000001 109.827 -175.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.602 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.9 ttp -111.93 127.61 55.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.471 0.653 . . . . 0.97999999999999998 110.451 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.671 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.84 173.72 6.24 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.528 -1.214 . . . . 0.11 111.841 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.611 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 2.4 t80 -126.79 117.07 21.9 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 106.795 -1.557 . . . . 1.02 106.795 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.632 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 18.8 m-85 -100.77 124.84 46.98 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.128 0.966 . . . . 0.90000000000000002 112.33 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.593 ' HA ' HG22 ' A' ' 343' ' ' THR . 3.0 ttpt -149.46 139.34 21.92 Favored 'General case' 0 N--CA 1.4 -2.939 0 CA-C-N 113.105 -1.861 . . . . 1.21 107.992 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 70.95 16.46 6.5 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 113.768 -1.56 . . . . 0.59999999999999998 108.608 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.56 17.47 78.99 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.377 -2.192 . . . . 0.23999999999999999 111.715 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.585 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.2 OUTLIER -136.9 170.86 15.39 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.91 -1.885 . . . . 1.26 105.91 -168.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.585 ' N ' ' HG3' ' A' ' 361' ' ' LYS . 3.7 m -101.35 137.56 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.853 0 CA-C-O 124.157 1.932 . . . . 1.26 111.72 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.472 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -23.84 19.0 Favored 'General case' 0 N--CA 1.399 -2.984 0 CA-C-N 109.392 -3.549 . . . . 1.03 108.529 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.665 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -154.07 154.82 34.33 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 113.511 -1.677 . . . . 1.01 108.856 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.671 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.98 121.78 1.29 Allowed 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.766 -0.652 . . . . 0.60999999999999999 109.395 -175.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.596 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.1 t -148.08 166.5 27.62 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.245 1.021 . . . . 0.98999999999999999 111.967 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.621 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.1 p-10 -85.37 140.36 30.83 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 113.025 -1.898 . . . . 1.8799999999999999 107.193 176.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.639 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -141.47 -171.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.154 -0.93 . . . . 1.04 111.888 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.831 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -157.73 119.38 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.136 -0.938 . . . . 1.04 109.792 175.656 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.6 t -143.15 145.98 33.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.977 -1.011 . . . . 1.0 112.839 -166.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.709 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.04 46.09 37.95 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 117.178 1.631 . . . . 0.13 117.178 161.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.448 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.2 pttt -46.75 145.83 2.9 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.6 1.7 . . . . 1.2 111.129 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.82 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -33.41 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.041 1 C-N-CA 125.543 4.162 . . . . 0.26000000000000001 115.609 -175.884 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.4 p -77.19 -39.27 49.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.267 0.555 . . . . 1.0600000000000001 110.917 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.488 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.9 m -140.56 72.92 30.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.245 1.021 . . . . 1.0800000000000001 110.434 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.709 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.7 Cg_exo -68.9 163.3 38.03 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 125.256 3.97 . . . . 0.19 114.118 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.575 HG21 ' CD ' ' A' ' 378' ' ' PRO . 0.1 OUTLIER -74.76 151.23 86.73 Favored Pre-proline 0 N--CA 1.437 -1.092 0 CA-C-N 113.512 -1.676 . . . . 1.04 110.714 175.702 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.575 ' CD ' HG21 ' A' ' 377' ' ' THR . 0.9 OUTLIER -78.28 -50.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.83 3.686 . . . . 0.10000000000000001 113.724 -171.248 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.653 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.0 121.91 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.443 0.905 . . . . 1.01 113.443 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.89 -124.48 1.26 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.268 -1.333 . . . . 0.11 111.46 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.425 ' O ' HG11 ' A' ' 381' ' ' VAL . 10.7 p -126.28 108.88 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 122.137 0.97 . . . . 1.54 109.372 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.626 ' CB ' HG23 ' A' ' 463' ' ' VAL . 94.0 m-85 -114.24 159.89 19.64 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.881 -1.054 . . . . 0.26000000000000001 109.661 -170.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.718 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 70.0 m-85 -146.01 135.63 23.22 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 117.661 0.209 . . . . 1.1799999999999999 111.113 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.589 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.57 122.26 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.872 -0.731 . . . . 1.05 110.46 176.493 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -108.93 3.16 21.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.43 -0.804 . . . . 0.20000000000000001 112.026 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.707 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.6 t30 -164.08 149.57 10.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.181 -0.918 . . . . 0.40999999999999998 110.704 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -109.24 114.65 28.54 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.377 -0.829 . . . . 1.8200000000000001 109.386 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.553 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -113.12 120.39 41.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.724 1.25 . . . . 0.38 111.478 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.794 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 25.9 mt-10 -116.11 143.71 45.12 Favored 'General case' 0 N--CA 1.409 -2.475 0 CA-C-N 113.802 -1.544 . . . . 1.96 110.562 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 37.8 t70 55.98 27.3 11.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 111.196 -2.729 . . . . 0.40000000000000002 107.758 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.499 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.14 169.58 15.69 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 112.692 -2.049 . . . . 0.98999999999999999 112.16 -167.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.411 ' CG2' ' HG2' ' A' ' 404' ' ' GLU . 16.1 m -128.72 102.45 6.58 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 113.12 -1.855 . . . . 1.02 109.382 -178.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.707 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.0 mp -71.97 156.3 39.39 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 112.789 -2.005 . . . . 1.03 109.767 174.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.5 mtpt -149.95 -176.58 5.49 Favored 'General case' 0 N--CA 1.395 -3.183 0 CA-C-N 114.647 -1.161 . . . . 1.26 108.089 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -178.8 -142.31 4.78 Favored Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 116.965 -2.541 . . . . 0.81000000000000005 115.062 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.79 124.24 14.79 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.791 -1.704 . . . . 1.2 108.449 171.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.513 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -54.7 -178.73 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 112.3 -2.227 . . . . 1.1200000000000001 111.856 177.016 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -51.79 -24.26 5.76 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.883 -0.598 . . . . 1.6499999999999999 111.665 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.513 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 1.1 p30 -102.72 -29.44 11.5 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.05 0.453 . . . . 2.0 111.957 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.9 37.52 1.14 Allowed Glycine 0 C--N 1.295 -1.724 0 C-N-CA 119.504 -1.331 . . . . 0.70999999999999996 111.545 -172.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 65.1 p -119.03 127.81 26.3 Favored Pre-proline 0 N--CA 1.422 -1.844 0 N-CA-C 106.722 -1.584 . . . . 1.26 106.722 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 26.1 Cg_exo -65.03 161.54 36.53 Favored 'Trans proline' 0 C--N 1.287 -2.694 0 C-N-CA 121.999 1.8 . . . . 1.1399999999999999 112.827 -173.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.651 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 17.8 p90 -141.7 -168.77 2.75 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 113.548 -1.66 . . . . 0.84999999999999998 107.066 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.4 mt-10 -147.56 159.93 43.19 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 122.387 1.089 . . . . 0.62 112.208 174.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.707 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.69 99.43 8.49 Favored Pre-proline 0 N--CA 1.426 -1.664 0 CA-C-N 112.857 -1.974 . . . . 1.9099999999999999 108.543 175.427 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -67.44 103.43 0.8 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.868 2.378 . . . . 0.22 110.912 174.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.577 HG22 ' HB2' ' A' ' 421' ' ' HIS . 1.2 t -118.12 158.78 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.27 -1.332 . . . . 1.0900000000000001 109.391 -174.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.794 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.2 OUTLIER -101.46 -38.93 7.78 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 107.762 -1.199 . . . . 1.8400000000000001 107.762 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.641 ' HD2' ' CD1' ' A' ' 409' ' ' TYR . 10.3 m-30 -125.53 113.46 17.47 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.726 -1.124 . . . . 0.88 110.51 -176.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.553 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 8.3 t-105 -123.59 136.39 54.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.692 -1.594 . . . . 0.14999999999999999 110.379 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.496 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -136.3 85.93 25.76 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 114.792 -1.094 . . . . 1.03 111.041 173.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 82.6 Cg_endo -71.64 141.75 38.54 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 123.163 2.575 . . . . 0.23999999999999999 112.091 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.718 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -122.94 -17.74 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.207 -1.36 . . . . 1.03 111.239 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.772 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 6.9 p30 -134.76 170.47 15.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.715 -0.675 . . . . 1.5900000000000001 109.695 171.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -96.88 16.08 20.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 0.33000000000000002 111.993 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 20.3 p -100.16 -28.31 13.08 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.258 -1.015 . . . . 1.1499999999999999 108.258 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 131.74 26.41 0.71 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.24 -1.346 . . . . 0.28000000000000003 113.546 173.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.772 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 68.8 t -102.46 148.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.492 0.663 . . . . 0.96999999999999997 111.165 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 175.59 -164.1 34.22 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.712 -1.131 . . . . 0.13 111.13 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.59 138.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.988 -0.745 . . . . 1.03 108.988 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.577 ' HB2' HG22 ' A' ' 407' ' ' VAL . 34.4 p80 -149.35 167.28 26.56 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.065 0.936 . . . . 0.17000000000000001 111.178 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.725 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -89.43 149.28 23.03 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 113.501 -1.682 . . . . 0.41999999999999998 107.806 172.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -136.42 100.0 4.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.675 1.226 . . . . 2.0 110.035 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -95.17 -33.37 12.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.606 -2.088 . . . . 0.34999999999999998 110.416 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -68.08 -27.08 66.18 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.589 -1.187 . . . . 0.19 109.255 174.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.556 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.95 82.0 20.45 Favored Pre-proline 0 CA--C 1.494 -1.208 0 CA-C-N 113.816 -1.538 . . . . 1.3300000000000001 110.201 -173.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -80.33 4.96 6.39 Favored 'Trans proline' 0 N--CA 1.432 -2.103 0 C-N-CA 124.821 3.681 . . . . 0.28000000000000003 114.464 -162.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.32 154.03 28.73 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 123.385 0.428 . . . . 1.1000000000000001 110.293 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.621 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -163.64 126.34 2.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.25 -1.341 . . . . 0.98999999999999999 108.364 -172.194 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.81 -167.85 28.74 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.051 -1.547 . . . . 0.13 111.556 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.625 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.52 153.36 0.0 OUTLIER Glycine 0 C--N 1.342 0.916 0 O-C-N 125.043 1.084 . . . . 0.23000000000000001 113.207 174.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.449 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.8 m-20 -54.9 100.99 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 123.999 1.857 . . . . 0.33000000000000002 112.156 -146.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.4 mt -97.16 -33.44 11.49 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 110.273 -3.149 . . . . 1.05 109.357 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.55 ' HA ' HG21 ' A' ' 369' ' ' VAL . 11.2 p-90 -47.36 -33.59 6.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 112.8 -2.0 . . . . 0.22 111.9 -174.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.82 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 43.4 mttt -63.5 -22.99 67.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 124.08 0.863 . . . . 1.29 113.055 -176.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.2 p -117.43 -38.41 3.33 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.525 -0.761 . . . . 1.0700000000000001 110.215 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.556 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 4.5 mtp85 -79.14 -15.22 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.609 -1.178 . . . . 0.41999999999999998 112.375 -169.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.448 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 75.72 40.48 31.46 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 116.216 1.246 . . . . 0.20999999999999999 116.216 159.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 442' ' ' CYS . 7.4 m -82.15 134.35 35.31 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 117.768 0.784 . . . . 0.81999999999999995 109.188 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.49 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 78.1 m80 -101.75 70.09 1.24 Allowed 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.477 -0.764 . . . . 0.5 110.447 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.651 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 83.63 -8.2 66.34 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.815 -0.914 . . . . 0.19 110.815 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 22.4 p -94.17 128.77 40.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.689 0.757 . . . . 1.22 110.561 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.559 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -89.74 113.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.813 -1.085 . . . . 1.04 110.527 -172.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.537 HD21 ' N ' ' A' ' 444' ' ' ASN . 0.8 OUTLIER -77.27 91.39 3.79 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.042 -0.981 . . . . 2.29 111.068 -177.467 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 79.3 m -89.88 137.54 28.26 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 109.2 -0.667 . . . . 1.02 109.2 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.1 Cg_exo -55.41 135.88 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.66 2.24 . . . . 0.12 111.248 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.725 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.8 Cg_exo -55.34 -32.87 83.22 Favored 'Trans proline' 0 CA--C 1.501 -1.148 0 C-N-CA 124.125 3.217 . . . . 0.16 112.849 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.2 m -79.75 -38.01 34.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.774 -1.103 . . . . 1.47 110.016 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.596 HG12 ' HB ' ' A' ' 366' ' ' THR . 88.7 t -78.8 -29.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 1.0600000000000001 111.454 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.629 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -66.23 -20.48 66.13 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.698 0.761 . . . . 1.0 109.925 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -76.3 -25.63 55.02 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.569 -1.196 . . . . 1.4399999999999999 111.69 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.63 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.7 mm-40 -80.33 -45.87 17.08 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-N 113.13 -1.85 . . . . 0.38 107.056 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.541 HD21 ' SD ' ' A' ' 450' ' ' MET . 23.7 tp -66.22 -66.59 0.53 Allowed 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 111.756 -2.474 . . . . 1.0 112.229 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' A' ' 454' ' ' PHE . 26.7 t80 -50.03 -25.77 3.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.89 1.329 . . . . 0.40000000000000002 108.28 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.41 -27.65 65.26 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 112.867 -1.969 . . . . 0.13 112.583 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.665 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -91.02 -49.02 6.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.776 0.798 . . . . 1.02 111.384 171.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.62 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.84 137.39 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 CA-C-O 123.478 1.608 . . . . 1.04 113.87 -167.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.64 -178.45 5.18 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 110.671 -2.968 . . . . 0.82999999999999996 106.567 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.707 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.0 mtmt -52.56 161.29 0.72 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-O 123.063 1.411 . . . . 1.04 113.361 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.51 -32.88 5.26 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 112.498 -2.137 . . . . 0.37 112.31 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.499 ' O ' HG13 ' A' ' 384' ' ' VAL . 3.4 m -78.25 141.07 61.56 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.412 -0.588 . . . . 1.01 109.412 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.616 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 5.8 Cg_exo -75.63 167.74 25.83 Favored 'Trans proline' 0 N--CA 1.425 -2.542 0 C-N-CA 122.084 1.856 . . . . 0.17000000000000001 111.244 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.626 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.1 m -133.55 150.51 32.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.602 -1.259 . . . . 1.75 107.602 165.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.432 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.8 tp -119.41 144.34 46.98 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.954 -1.021 . . . . 1.04 109.634 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.653 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -142.89 146.54 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.757 -1.571 . . . . 1.02 106.757 165.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.496 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 17.5 p90 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.258 -0.877 . . . . 1.1599999999999999 110.993 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.898 0 N-CA-C 112.104 -0.398 . . . . 4.3899999999999997 112.104 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.0 t-160 -92.03 93.52 8.79 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.368 -0.604 . . . . 2.1899999999999999 109.368 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.453 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 35.1 mtm 69.12 -175.69 0.2 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.379 -1.282 . . . . 1.23 110.654 -170.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.11 -4.38 0.91 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 111.166 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -55.21 167.84 0.4 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.669 1.223 . . . . 0.97999999999999998 112.403 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.578 HG22 ' HA ' ' A' ' 358' ' ' LYS . 2.7 m -91.64 122.34 34.12 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 113.7 -1.591 . . . . 1.04 108.096 169.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.661 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 11.9 p90 -161.12 -171.04 2.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.322 -0.854 . . . . 0.94999999999999996 110.533 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.612 HD13 ' CB ' ' A' ' 457' ' ' VAL . 12.2 mm -105.06 160.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.977 -1.119 . . . . 1.02 107.977 167.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.47 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -140.93 155.92 46.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.972 0.806 . . . . 0.17000000000000001 111.327 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.596 HG23 ' HG3' ' A' ' 354' ' ' MET . 65.5 t -151.16 136.65 11.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.747 -1.115 . . . . 1.03 109.923 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -116.97 119.11 34.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.615 -1.175 . . . . 0.37 108.078 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.579 ' O ' ' HG2' ' A' ' 352' ' ' GLN . 1.9 mm? -70.81 -47.83 57.36 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.202 1.001 . . . . 1.0600000000000001 110.492 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -57.97 -55.07 39.61 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.752 -2.022 . . . . 1.51 112.0 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -94.77 10.69 34.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.21 -1.359 . . . . 0.91000000000000003 108.657 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.68 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 3.6 mm-40 35.01 74.14 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.349 1.656 . . . . 2.6299999999999999 112.964 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.527 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.5 t60 -152.27 124.3 8.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.32 -0.855 . . . . 0.17000000000000001 109.744 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.596 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.3 ttp -111.88 126.94 55.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.586 -0.734 . . . . 0.97999999999999998 110.366 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.63 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.8 m-90 -111.95 172.9 6.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 114.528 -1.214 . . . . 0.11 111.911 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.629 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 1.3 t80 -125.93 115.73 20.39 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.577 -1.638 . . . . 1.02 106.577 165.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.67 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 23.8 m-85 -98.98 126.4 44.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.259 1.028 . . . . 0.90000000000000002 112.519 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.578 ' HA ' HG22 ' A' ' 343' ' ' THR . 3.2 ttpt -148.94 139.29 22.42 Favored 'General case' 0 N--CA 1.396 -3.135 0 CA-C-N 112.95 -1.932 . . . . 1.21 107.759 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.452 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 72.4 15.22 5.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 113.929 -1.487 . . . . 0.59999999999999998 108.871 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.79 78.58 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.603 -2.09 . . . . 0.23999999999999999 111.699 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.604 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -139.58 174.69 10.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 112.416 -1.892 . . . . 1.26 106.108 -168.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.617 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.0 m -104.89 138.86 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 CA-C-O 124.227 1.965 . . . . 1.26 112.397 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.409 ' CB ' ' CD1' ' A' ' 356' ' ' TYR . . . -93.36 -24.83 17.96 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 109.37 -3.559 . . . . 1.03 108.707 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.653 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -152.65 154.31 35.08 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.578 -1.646 . . . . 1.01 108.67 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.63 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.11 120.49 1.16 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.708 -0.678 . . . . 0.60999999999999999 109.675 -174.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.622 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.0 t -147.79 167.33 25.0 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 122.199 0.999 . . . . 0.98999999999999999 111.981 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.65 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.3 p-10 -86.0 140.2 30.51 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 113.225 -1.807 . . . . 1.8799999999999999 107.867 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.68 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -140.88 -171.89 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.238 -0.892 . . . . 1.04 111.989 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.65 119.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.05 -0.977 . . . . 1.04 108.816 174.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.574 ' H ' HE22 ' A' ' 352' ' ' GLN . 7.6 t -142.23 144.2 33.24 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.415 -0.811 . . . . 1.0 112.397 -166.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.737 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.02 44.48 45.46 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 116.569 1.388 . . . . 0.13 116.569 163.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.563 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.58 143.64 5.53 Favored Pre-proline 0 CA--C 1.509 -0.598 0 CA-C-N 118.472 1.136 . . . . 1.2 110.49 -174.211 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.811 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.46 -33.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.966 1 C-N-CA 125.745 4.296 . . . . 0.26000000000000001 116.034 -170.925 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.563 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -79.74 -34.02 40.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.082 0.467 . . . . 1.0600000000000001 110.723 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.47 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.0 m -140.65 73.38 29.05 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 122.144 0.973 . . . . 1.0800000000000001 110.461 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.737 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.3 Cg_exo -70.62 161.51 45.78 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.201 3.934 . . . . 0.19 114.41 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.547 HG21 ' CD ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -74.77 154.02 87.17 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 113.551 -1.659 . . . . 1.04 110.936 176.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.547 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.3 Cg_endo -80.84 -49.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 125.062 3.841 . . . . 0.10000000000000001 113.752 -172.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.637 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.05 122.55 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.123 0.964 . . . . 1.01 113.449 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.35 -125.32 1.32 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.23 -1.35 . . . . 0.11 111.7 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.28 103.84 9.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.262 -1.014 . . . . 1.54 108.262 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.645 ' CE2' HG23 ' A' ' 465' ' ' VAL . 95.6 m-85 -110.23 158.5 18.32 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.478 -0.783 . . . . 0.26000000000000001 109.656 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 1.626 ' HD1' ' CD2' ' A' ' 383' ' ' TYR . 9.3 m-85 -146.59 139.63 25.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 118.194 0.452 . . . . 1.1799999999999999 110.699 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.582 HG23 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -75.63 125.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 119.92 -0.712 . . . . 1.05 110.626 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -111.03 4.03 19.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.181 -0.918 . . . . 0.20000000000000001 112.04 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.694 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.7 t30 -164.56 150.11 10.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.326 -0.852 . . . . 0.40999999999999998 110.51 175.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.417 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.3 mtpt -109.98 113.65 26.53 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.609 -0.723 . . . . 1.8200000000000001 110.025 170.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.543 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 1.9 mt-10 -112.79 125.1 53.97 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.647 -1.16 . . . . 0.38 110.931 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -123.5 135.05 53.85 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.14 -1.391 . . . . 1.96 110.196 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . 0.424 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.8 t70 52.56 39.44 28.05 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 123.387 1.565 . . . . 0.40000000000000002 107.661 -172.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.9 167.47 12.41 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 112.474 -2.148 . . . . 0.98999999999999999 111.256 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 37.5 m -128.11 102.5 6.74 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.964 -1.471 . . . . 1.02 109.682 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 10.1 mp -74.28 157.34 35.97 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 112.984 -1.916 . . . . 1.03 110.406 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 8.5 mtpt -149.07 -176.6 5.42 Favored 'General case' 0 N--CA 1.399 -3.024 0 CA-C-N 114.945 -1.025 . . . . 1.26 108.759 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.667 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.96 -142.08 4.93 Favored Glycine 0 CA--C 1.489 -1.579 0 C-N-CA 117.269 -2.396 . . . . 0.81000000000000005 114.918 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.65 120.82 12.2 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.309 -1.445 . . . . 1.2 109.035 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.444 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -53.1 -179.14 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.183 -2.28 . . . . 1.1200000000000001 112.313 178.702 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -52.16 -26.67 11.99 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.624 -0.716 . . . . 1.6499999999999999 110.855 167.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -91.81 -27.2 18.13 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.871 -0.604 . . . . 2.0 111.19 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.91 30.06 5.29 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.201 -0.999 . . . . 0.70999999999999996 110.801 -169.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 43.4 p -115.78 128.56 25.87 Favored Pre-proline 0 N--CA 1.42 -1.961 0 N-CA-C 106.637 -1.616 . . . . 1.26 106.637 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.667 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 30.8 Cg_exo -63.79 160.75 35.46 Favored 'Trans proline' 0 C--N 1.284 -2.843 0 C-N-CA 121.898 1.732 . . . . 1.1399999999999999 112.647 -173.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 29.1 p90 -142.69 -171.36 3.41 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.352 -1.749 . . . . 0.84999999999999998 107.074 -177.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.702 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 8.7 mt-10 -145.21 158.76 43.74 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.34 1.067 . . . . 0.62 111.831 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.695 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.56 98.62 12.17 Favored Pre-proline 0 N--CA 1.419 -1.982 0 CA-C-N 113.07 -1.877 . . . . 1.9099999999999999 107.747 175.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.04 101.59 0.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.308 2.006 . . . . 0.22 110.326 173.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.581 HG12 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -114.48 157.53 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.866 0 CA-C-N 114.242 -1.344 . . . . 1.0900000000000001 109.95 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.402 ' N ' HG11 ' A' ' 407' ' ' VAL . 22.5 m-80 -108.22 -33.8 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.39 -1.732 . . . . 1.8400000000000001 107.098 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.589 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 61.3 m-85 -134.55 116.18 14.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.86 -1.973 . . . . 0.88 111.134 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.581 ' HB2' HG12 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.71 134.24 53.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.223 -1.353 . . . . 0.14999999999999999 110.258 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.446 ' HG2' HG22 ' A' ' 384' ' ' VAL . 0.1 OUTLIER -134.91 86.54 32.31 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.124 -0.943 . . . . 1.03 111.054 174.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.668 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.06 140.22 34.17 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.81 2.34 . . . . 0.23999999999999999 112.154 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.79 -15.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.479 . . . . 1.03 111.214 -172.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -134.63 162.5 32.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.392 -0.822 . . . . 1.5900000000000001 109.447 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -93.47 13.8 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.358 0.503 . . . . 0.33000000000000002 112.358 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.1 p -94.24 -27.42 16.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.674 -1.232 . . . . 1.1499999999999999 107.674 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.48 34.36 0.76 Allowed Glycine 0 N--CA 1.427 -1.95 0 CA-C-N 113.112 -1.858 . . . . 0.28000000000000003 112.414 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.615 HG11 ' O ' ' A' ' 441' ' ' GLY . 76.8 t -103.79 151.49 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 120.987 0.422 . . . . 0.96999999999999997 110.762 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 170.92 -168.1 41.24 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.214 -0.903 . . . . 0.13 111.664 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.46 141.16 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.933 -0.766 . . . . 1.03 108.933 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.562 ' O ' ' HB ' ' A' ' 445' ' ' THR . 34.0 p80 -150.6 163.72 37.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.803 0.811 . . . . 0.17000000000000001 111.776 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.718 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.14 142.6 27.56 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.916 -1.493 . . . . 0.41999999999999998 107.323 172.024 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.445 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 3.5 t -136.92 103.51 5.19 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.877 1.323 . . . . 2.0 110.395 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.55 -28.7 15.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.125 -2.307 . . . . 0.34999999999999998 111.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 18.4 p90 -70.27 -26.56 63.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 114.432 -1.258 . . . . 0.19 109.342 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.551 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -120.58 82.18 33.0 Favored Pre-proline 0 CA--C 1.491 -1.31 0 CA-C-N 113.5 -1.682 . . . . 1.3300000000000001 109.465 -175.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -81.34 6.68 5.45 Favored 'Trans proline' 0 N--CA 1.43 -2.254 0 C-N-CA 124.693 3.596 . . . . 0.28000000000000003 113.907 -162.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 3.2 tp10 -114.47 154.54 28.01 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 1.1000000000000001 111.013 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.65 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -164.11 127.84 2.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.715 -1.584 . . . . 0.98999999999999999 108.076 -169.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.31 -167.24 28.51 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 119.232 -1.461 . . . . 0.13 111.124 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.634 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.43 153.95 0.01 OUTLIER Glycine 0 C--N 1.336 0.583 0 O-C-N 124.927 1.016 . . . . 0.23000000000000001 112.897 174.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.65 100.81 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 123.862 1.791 . . . . 0.33000000000000002 112.0 -146.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 54.1 mt -97.02 -30.32 13.13 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 110.562 -3.017 . . . . 1.05 108.205 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.582 ' HA ' HG21 ' A' ' 369' ' ' VAL . 7.6 p-90 -46.85 -38.01 9.66 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.876 0.735 . . . . 0.22 111.583 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.811 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.7 mttt -62.22 -23.01 66.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.274 -0.876 . . . . 1.29 112.9 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -114.95 -37.03 4.26 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.578 -0.737 . . . . 1.0700000000000001 110.361 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.551 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.8 mtp85 -85.18 -15.86 42.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.811 -1.086 . . . . 0.41999999999999998 112.691 -168.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.09 42.05 25.38 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 116.804 1.482 . . . . 0.20999999999999999 116.804 159.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.6 m -85.82 131.11 34.37 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 118.682 1.241 . . . . 0.81999999999999995 108.946 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.483 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 68.3 m80 -100.04 71.38 1.62 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.678 -0.639 . . . . 0.5 111.227 -167.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.615 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 87.74 -14.12 59.15 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.422 -1.071 . . . . 0.19 110.422 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.516 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -88.29 148.53 24.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.36 -0.42 . . . . 1.22 110.192 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.545 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -100.01 119.54 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.776 0.798 . . . . 1.04 110.759 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.482 ' HB3' HG12 ' A' ' 369' ' ' VAL . 2.6 t30 -79.93 82.97 5.92 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.557 -1.201 . . . . 2.29 111.42 -175.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.562 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.2 m -87.42 140.25 31.99 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-O 121.605 0.716 . . . . 1.02 109.846 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.9 Cg_exo -58.85 136.14 71.64 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.814 2.342 . . . . 0.12 111.744 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.718 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.3 Cg_exo -55.01 -34.07 85.59 Favored 'Trans proline' 0 CA--C 1.504 -1.009 0 C-N-CA 124.415 3.41 . . . . 0.16 113.005 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.5 t -79.47 -38.33 34.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.893 -1.049 . . . . 1.47 109.418 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.622 HG12 ' HB ' ' A' ' 366' ' ' THR . 46.9 t -82.51 -28.42 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 1.0600000000000001 111.269 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.716 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.5 tpt -67.68 -18.74 65.03 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.882 0.849 . . . . 1.0 110.008 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -80.43 -23.24 40.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.442 -1.253 . . . . 1.4399999999999999 111.007 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.66 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.0 mm-40 -80.35 -46.99 15.15 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.957 -1.929 . . . . 0.38 107.215 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.594 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -64.68 -67.18 0.46 Allowed 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 111.798 -2.455 . . . . 1.0 112.321 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.661 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 24.1 t80 -50.47 -26.36 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.18 1.467 . . . . 0.40000000000000002 108.21 177.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.44 -32.77 67.96 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 112.182 -2.281 . . . . 0.13 112.22 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.66 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.8 ptp -87.5 -49.43 7.2 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 121.745 0.783 . . . . 1.02 111.509 172.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.612 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.7 OUTLIER -102.08 137.6 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 CA-C-O 123.518 1.627 . . . . 1.04 113.835 -167.136 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.417 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.58 -178.23 5.08 Favored 'General case' 0 N--CA 1.401 -2.881 0 CA-C-N 110.585 -3.007 . . . . 0.82999999999999996 106.89 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.694 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 48.2 mtmt -51.59 161.78 0.46 Allowed 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 122.888 1.328 . . . . 1.04 112.593 175.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.67 -31.52 5.8 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 112.623 -2.08 . . . . 0.37 112.368 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 462' ' ' PRO . 4.5 m -82.92 140.77 43.39 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.683 -0.858 . . . . 1.01 108.683 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.707 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.57 173.46 14.15 Favored 'Trans proline' 0 N--CA 1.415 -3.146 0 C-N-CA 121.093 1.196 . . . . 0.17000000000000001 111.71 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.616 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.1 m -137.09 160.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.768 -1.197 . . . . 1.75 107.768 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.449 HD21 ' CG ' ' A' ' 346' ' ' GLU . 2.8 tp -129.83 146.22 51.57 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.443 -0.799 . . . . 1.04 110.334 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.645 HG23 ' CE2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -143.1 147.26 20.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.073 -1.454 . . . . 1.02 107.073 165.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.47 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 14.1 p90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.855 -0.593 . . . . 1.1599999999999999 111.646 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 111.758 -0.537 . . . . 4.3899999999999997 111.758 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.473 ' CD2' HD22 ' A' ' 464' ' ' LEU . 0.1 OUTLIER -168.51 -172.92 1.79 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.309 0.576 . . . . 2.1899999999999999 111.349 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 33.3 mtm -69.75 -175.69 0.93 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.681 -1.145 . . . . 1.23 111.961 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.63 -3.95 2.06 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.813 -1.085 . . . . 1.1000000000000001 110.09 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -54.48 166.99 0.37 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.829 1.3 . . . . 0.97999999999999998 112.732 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.499 HG21 ' HA ' ' A' ' 358' ' ' LYS . 94.0 m -93.33 123.6 36.73 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 113.41 -1.723 . . . . 1.04 108.813 171.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.654 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 8.0 p90 -160.93 -170.31 2.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.217 -1.356 . . . . 0.94999999999999996 110.668 -173.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.589 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.3 mm -101.7 161.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.183 -1.043 . . . . 1.02 108.183 166.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.454 ' CG ' HD21 ' A' ' 464' ' ' LEU . 3.8 tt0 -142.24 155.6 45.25 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.407 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.572 HG23 ' HG3' ' A' ' 354' ' ' MET . 68.0 t -151.0 142.35 16.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.437 -1.256 . . . . 1.03 109.146 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.477 ' HA ' ' OXT' ' A' ' 466' ' ' PHE . 7.2 t70 -130.67 107.49 9.21 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.37 109.129 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.48 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.9 mm? -69.27 -30.08 68.11 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.814 -1.539 . . . . 1.0600000000000001 110.575 -170.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -57.09 -63.61 1.16 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.89 0.852 . . . . 1.51 111.096 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -89.42 -3.53 58.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.047 -1.433 . . . . 0.91000000000000003 110.774 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.698 ' OE1' HD13 ' A' ' 368' ' ' ILE . 85.1 mm-40 49.64 68.64 0.7 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 112.084 -2.325 . . . . 2.6299999999999999 111.368 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.5 t60 -143.82 128.43 18.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.991 -1.004 . . . . 0.17000000000000001 109.293 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.572 ' HG3' HG23 ' A' ' 347' ' ' VAL . 2.9 ttp -114.33 129.01 56.63 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 123.573 0.749 . . . . 0.97999999999999998 110.558 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.645 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.32 173.1 6.57 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.724 -1.126 . . . . 0.11 111.802 -176.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.603 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 2.5 t80 -125.88 113.96 17.91 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.008 -1.849 . . . . 1.02 106.008 164.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.662 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 22.1 m-85 -98.53 129.21 45.09 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.811 0.815 . . . . 0.90000000000000002 111.218 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.499 ' HA ' HG21 ' A' ' 343' ' ' THR . 5.7 ttpt -147.6 137.65 22.94 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 113.912 -1.494 . . . . 1.21 108.161 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.79 11.94 7.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 113.489 -1.687 . . . . 0.59999999999999998 108.629 178.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.06 12.25 71.38 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 112.785 -2.007 . . . . 0.23999999999999999 111.806 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.619 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -131.43 168.68 17.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.107 -1.812 . . . . 1.26 106.107 -172.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.619 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 3.2 m -100.96 136.9 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 124.442 2.067 . . . . 1.26 111.958 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.501 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -90.62 -25.92 19.9 Favored 'General case' 0 N--CA 1.397 -3.081 0 CA-C-N 109.085 -3.688 . . . . 1.03 108.57 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.624 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.6 tp -152.51 154.25 35.1 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.577 -1.647 . . . . 1.01 108.744 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.645 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -164.92 121.53 1.5 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.67 -0.696 . . . . 0.60999999999999999 109.489 -175.358 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.621 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.5 t -148.51 167.03 26.44 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.25 1.024 . . . . 0.98999999999999999 112.099 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.677 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.8 p-10 -85.9 139.79 30.93 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 113.173 -1.831 . . . . 1.8799999999999999 107.827 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.698 HD13 ' OE1' ' A' ' 352' ' ' GLN . 1.7 pp -140.63 -172.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.207 -0.906 . . . . 1.04 111.554 -175.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.64 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.8 119.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.399 -0.819 . . . . 1.04 109.05 174.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.2 t -141.27 145.11 35.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.747 -1.115 . . . . 1.0 112.562 -167.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.08 46.1 37.51 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 117.333 1.693 . . . . 0.13 117.333 162.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.461 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.1 pttt -45.86 145.55 2.31 Favored Pre-proline 0 C--N 1.347 0.462 0 CA-C-N 119.842 1.821 . . . . 1.2 110.779 -174.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.778 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.99 -36.46 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 1 C-N-CA 125.422 4.081 . . . . 0.26000000000000001 115.529 -173.58 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -35.89 57.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.076 0.465 . . . . 1.0600000000000001 110.903 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.484 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -139.88 72.56 34.67 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 122.111 0.958 . . . . 1.0800000000000001 110.522 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.724 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.4 Cg_exo -71.75 162.76 41.06 Favored 'Trans proline' 0 C--N 1.324 -0.741 1 C-N-CA 125.35 4.033 . . . . 0.19 113.978 -177.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.588 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.33 152.43 90.09 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 113.651 -1.613 . . . . 1.04 111.062 175.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.546 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.42 -49.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 125.116 3.877 . . . . 0.10000000000000001 113.712 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.649 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.89 120.95 0.03 OUTLIER 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.767 1.025 . . . . 1.01 113.767 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.77 -123.25 1.15 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.343 -1.299 . . . . 0.11 111.563 -176.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.407 ' O ' HG11 ' A' ' 381' ' ' VAL . 12.1 p -126.13 112.17 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.079 0.942 . . . . 1.54 108.933 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.632 ' CE2' HG23 ' A' ' 465' ' ' VAL . 90.4 m-85 -115.66 160.09 20.49 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.219 -0.9 . . . . 0.26000000000000001 109.83 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.717 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 77.2 m-85 -147.8 135.29 20.74 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 120.97 -0.292 . . . . 1.1799999999999999 111.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.594 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.49 121.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.63 -0.828 . . . . 1.05 110.234 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -108.44 2.21 22.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.247 -0.888 . . . . 0.20000000000000001 111.784 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.706 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.4 t30 -164.65 150.81 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.838 -1.074 . . . . 0.40999999999999998 110.217 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -112.8 126.98 56.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.616 -0.72 . . . . 1.8200000000000001 109.123 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.58 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -127.14 112.76 15.53 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 123.195 1.474 . . . . 0.38 113.249 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 3.1 mp0 -108.17 134.15 51.43 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.286 -1.779 . . . . 1.96 110.862 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 36.9 t70 52.17 37.11 20.94 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.394 1.568 . . . . 0.40000000000000002 107.744 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.58 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.79 170.31 10.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.225 -2.261 . . . . 0.98999999999999999 112.028 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 16.5 m -125.98 105.81 9.17 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.679 -1.601 . . . . 1.02 109.823 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 8.7 mp -72.05 156.11 39.56 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.243 -1.799 . . . . 1.03 109.79 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 0.0 OUTLIER -149.86 -177.04 5.67 Favored 'General case' 0 N--CA 1.389 -3.482 0 CA-C-N 114.863 -1.062 . . . . 1.26 109.136 -176.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.691 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 178.32 -143.47 5.98 Favored Glycine 0 CA--C 1.485 -1.811 0 C-N-CA 117.041 -2.504 . . . . 0.81000000000000005 115.104 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.26 122.12 13.56 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 112.814 -1.693 . . . . 1.2 108.353 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.427 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -52.21 -179.56 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 112.379 -2.191 . . . . 1.1200000000000001 112.079 178.564 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -22.36 7.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.282 -0.417 . . . . 1.6499999999999999 110.448 171.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.67 -27.02 13.6 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 116.383 -0.371 . . . . 2.0 111.504 -174.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.32 34.53 2.48 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.582 -1.294 . . . . 0.70999999999999996 111.444 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 64.9 p -117.56 127.05 26.91 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 106.582 -1.636 . . . . 1.26 106.582 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.691 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 24.2 Cg_exo -65.5 154.62 72.87 Favored 'Trans proline' 0 C--N 1.284 -2.827 0 C-N-CA 122.211 1.941 . . . . 1.1399999999999999 111.934 -173.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.631 ' HE1' ' CE2' ' A' ' 403' ' ' TYR . 29.1 p90 -141.95 -177.61 5.3 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.097 -1.865 . . . . 0.84999999999999998 107.203 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.7 mt-10 -142.09 159.13 42.84 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.383 1.087 . . . . 0.62 112.027 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.621 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.8 m -143.64 97.86 5.42 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.254 -1.794 . . . . 1.9099999999999999 109.464 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.93 105.97 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.534 0 C-N-CA 124.359 3.373 . . . . 0.22 112.999 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.607 HG12 ' HB2' ' A' ' 410' ' ' TRP . 0.6 OUTLIER -115.89 162.6 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 114.58 -1.191 . . . . 1.0900000000000001 110.87 -174.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.491 ' N ' HG11 ' A' ' 407' ' ' VAL . 27.0 m-80 -111.25 -33.59 6.39 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.152 -1.84 . . . . 1.8400000000000001 107.008 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.671 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 50.1 m-85 -135.36 115.53 13.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.189 -1.823 . . . . 0.88 110.835 175.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.607 ' HB2' HG12 ' A' ' 407' ' ' VAL . 6.8 t-105 -122.59 136.26 54.84 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.558 -1.201 . . . . 0.14999999999999999 109.897 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.47 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.4 OUTLIER -136.54 86.17 23.81 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.006 -0.997 . . . . 1.03 111.222 173.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.688 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.1 Cg_endo -70.85 140.11 37.88 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.889 2.393 . . . . 0.23999999999999999 112.053 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.717 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.46 -15.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.804 -1.544 . . . . 1.03 111.068 -173.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -135.37 163.76 29.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 1.5900000000000001 110.032 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -94.38 14.53 20.24 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.304 0.483 . . . . 0.33000000000000002 112.304 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.4 p -94.11 -26.98 16.49 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.613 -1.254 . . . . 1.1499999999999999 107.613 173.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.06 30.44 1.02 Allowed Glycine 0 N--CA 1.427 -1.93 0 CA-C-N 113.053 -1.885 . . . . 0.28000000000000003 112.274 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.597 HG11 ' O ' ' A' ' 441' ' ' GLY . 73.1 t -102.46 149.81 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 120.587 -0.445 . . . . 0.96999999999999997 111.112 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.18 -166.69 39.25 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.153 -0.93 . . . . 0.13 111.789 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -103.88 141.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.036 -0.727 . . . . 1.03 109.036 176.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.603 ' HB2' HG22 ' A' ' 407' ' ' VAL . 35.5 p80 -151.48 165.1 35.23 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.669 0.747 . . . . 0.17000000000000001 112.26 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.737 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.8 139.68 30.43 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.027 -1.442 . . . . 0.41999999999999998 107.449 171.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.626 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 1.6 t -135.6 104.25 5.73 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 123.212 1.482 . . . . 2.0 110.144 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -93.17 -25.85 17.66 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 111.855 -2.43 . . . . 0.34999999999999998 110.17 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.476 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 6.9 p90 -70.8 -26.41 63.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.385 -1.279 . . . . 0.19 109.316 173.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.552 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.1 OUTLIER -118.93 83.08 22.27 Favored Pre-proline 0 CA--C 1.496 -1.121 0 CA-C-N 114.036 -1.438 . . . . 1.3300000000000001 110.6 -174.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -82.94 6.58 5.72 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 C-N-CA 124.515 3.477 . . . . 0.28000000000000003 114.554 -162.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.64 153.46 30.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 123.372 0.42 . . . . 1.1000000000000001 110.226 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 1.672 ' HE1' ' CE2' ' A' ' 429' ' ' TYR . 0.6 OUTLIER -162.74 125.62 2.8 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.327 1.051 . . . . 0.98999999999999999 109.203 -170.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.8 28.83 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.026 -1.559 . . . . 0.13 111.792 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.588 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.5 154.96 0.01 OUTLIER Glycine 0 C--N 1.339 0.748 0 O-C-N 124.985 1.05 . . . . 0.23000000000000001 112.762 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.41 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.039 1.876 . . . . 0.33000000000000002 112.284 -147.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 43.6 mt -96.68 -33.54 11.7 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 110.223 -3.171 . . . . 1.05 108.094 175.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.49 ' HA ' HG21 ' A' ' 369' ' ' VAL . 2.9 p-90 -45.37 -37.96 5.46 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.936 0.772 . . . . 0.22 111.327 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.778 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.4 mttt -58.27 -23.7 57.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.059 -0.973 . . . . 1.29 113.007 -176.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 49.0 p -116.63 -35.55 4.19 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.458 -0.792 . . . . 1.0700000000000001 110.0 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.552 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.6 mtp85 -84.65 -14.92 47.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.634 -1.167 . . . . 0.41999999999999998 112.714 -169.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.461 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 73.47 41.54 44.25 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 116.459 1.344 . . . . 0.20999999999999999 116.459 159.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.7 m -87.53 131.49 34.36 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 118.267 1.033 . . . . 0.81999999999999995 109.113 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.471 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 72.1 m80 -97.58 68.32 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.817 -0.552 . . . . 0.5 111.097 -169.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.597 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 87.64 -12.28 63.8 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.582 -1.007 . . . . 0.19 110.582 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.515 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 26.3 p -87.34 143.66 27.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.271 -0.464 . . . . 1.22 109.923 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.588 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -99.26 115.97 41.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.23 0.538 . . . . 1.04 110.734 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.626 ' OD1' ' HB3' ' A' ' 423' ' ' SER . 8.2 t30 -78.39 93.74 4.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.132 -0.94 . . . . 2.29 111.356 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 25.0 m -91.49 136.07 27.22 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.621 -0.718 . . . . 1.02 109.284 173.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 50.1 Cg_exo -56.79 132.65 53.01 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.073 2.515 . . . . 0.12 112.696 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.737 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 16.2 Cg_exo -50.21 -39.24 52.24 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.625 2.883 . . . . 0.16 112.713 -168.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 61.6 m -74.99 -42.22 57.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.709 -1.132 . . . . 1.47 109.867 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.621 HG12 ' HB ' ' A' ' 366' ' ' THR . 62.0 t -75.88 -28.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.353 0.597 . . . . 1.0600000000000001 111.294 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.69 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.7 tpt -68.33 -20.13 64.71 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.583 0.706 . . . . 1.0 110.17 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -79.61 -22.27 43.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 122.496 1.141 . . . . 1.4399999999999999 110.974 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.25 -47.4 14.67 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 112.894 -1.957 . . . . 0.38 107.399 177.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.594 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.8 tp -63.93 -67.27 0.44 Allowed 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 111.81 -2.45 . . . . 1.0 112.302 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.629 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 39.7 t80 -49.82 -27.23 4.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 123.026 1.393 . . . . 0.40000000000000002 108.335 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.06 -31.16 66.89 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 112.388 -2.187 . . . . 0.13 112.266 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.652 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -87.97 -49.35 7.12 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 121.772 0.796 . . . . 1.02 111.383 172.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.589 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.07 138.02 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-O 123.455 1.598 . . . . 1.04 113.796 -167.27 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.25 -178.87 5.35 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 110.821 -2.9 . . . . 0.82999999999999996 106.662 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.706 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.3 mtmt -51.61 161.5 0.5 Allowed 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.966 1.365 . . . . 1.04 112.869 175.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.77 -33.69 4.89 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.688 -2.051 . . . . 0.37 112.535 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 462' ' ' PRO . 6.9 m -78.78 142.34 60.85 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.362 -0.607 . . . . 1.01 109.362 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.612 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 5.1 Cg_exo -76.09 169.2 22.55 Favored 'Trans proline' 0 N--CA 1.425 -2.527 0 C-N-CA 121.89 1.727 . . . . 0.17000000000000001 111.335 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.631 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.12 157.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 107.422 -1.325 . . . . 1.75 107.422 166.023 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.473 HD22 ' CD2' ' A' ' 339' ' ' HIS . 2.8 tp -127.25 146.05 50.56 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.197 -0.911 . . . . 1.04 109.935 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.649 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 147.08 20.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.276 -1.379 . . . . 1.02 107.276 165.705 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.477 ' OXT' ' HA ' ' A' ' 348' ' ' ASP . 20.4 p90 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.742 -0.647 . . . . 1.1599999999999999 111.103 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 CA-C-O 120.112 -0.271 . . . . 4.3899999999999997 112.596 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.624 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.5 p-80 -104.11 140.04 38.35 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 117.89 0.845 . . . . 2.1899999999999999 111.814 -176.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.624 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 35.6 mtm 83.69 172.2 0.08 Allowed 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 125.342 1.651 . . . . 1.23 110.959 -169.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -114.08 -9.15 12.98 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.667 -1.151 . . . . 1.1000000000000001 110.441 -175.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.23 167.07 1.41 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 123.024 1.392 . . . . 0.97999999999999998 113.756 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 358' ' ' LYS . 8.0 m -93.15 122.65 35.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 112.909 -1.951 . . . . 1.04 107.129 164.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.668 ' HD2' ' CD1' ' A' ' 344' ' ' TYR . 8.2 p90 -157.15 -171.38 3.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.451 0.643 . . . . 0.94999999999999996 111.636 -174.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.589 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.2 mm -104.31 160.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 107.839 -1.171 . . . . 1.02 107.839 166.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.497 ' CG ' HD21 ' A' ' 464' ' ' LEU . 2.1 tt0 -140.41 155.49 46.71 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 118.82 0.737 . . . . 0.17000000000000001 111.336 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.532 HG23 ' HG3' ' A' ' 354' ' ' MET . 63.8 t -150.38 134.48 8.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.589 -1.187 . . . . 1.03 110.251 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -115.48 114.66 25.33 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.832 -1.076 . . . . 0.37 108.139 174.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.439 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.8 mm? -68.21 -51.93 39.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.803 1.287 . . . . 1.0600000000000001 110.586 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.57 -52.97 15.9 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.179 -1.828 . . . . 1.51 113.298 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -102.54 9.14 39.66 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.73 -1.123 . . . . 0.91000000000000003 109.06 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.737 ' OE1' HD13 ' A' ' 368' ' ' ILE . 85.0 mm-40 36.93 73.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.058 1.474 . . . . 2.6299999999999999 111.871 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.424 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.8 t60 -150.3 125.95 10.31 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.54 -1.209 . . . . 0.17000000000000001 109.434 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.532 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.1 ttp -112.46 128.43 56.32 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.234 0.614 . . . . 0.97999999999999998 110.743 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.659 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.0 m-90 -111.87 173.11 6.51 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.634 -1.167 . . . . 0.11 111.817 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.659 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 1.9 t80 -126.06 116.12 20.91 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 106.775 -1.565 . . . . 1.02 106.775 165.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 17.8 m-85 -98.86 126.33 44.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.142 0.973 . . . . 0.90000000000000002 112.165 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.601 ' HA ' HG22 ' A' ' 343' ' ' THR . 3.5 ttpt -149.64 139.76 22.11 Favored 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 113.196 -1.82 . . . . 1.21 107.846 174.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.43 15.44 6.21 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 114.008 -1.451 . . . . 0.59999999999999998 108.799 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.59 18.62 77.34 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 112.378 -2.192 . . . . 0.23999999999999999 111.783 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.619 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.07 173.65 11.34 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.86 -1.904 . . . . 1.26 105.86 -170.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.619 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 3.5 m -104.23 137.67 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 124.338 2.018 . . . . 1.26 112.246 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -92.37 -23.73 19.13 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-N 109.218 -3.628 . . . . 1.03 108.624 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.674 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -153.84 154.72 34.46 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 113.567 -1.651 . . . . 1.01 108.405 -172.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.659 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.26 122.39 1.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.73 -0.668 . . . . 0.60999999999999999 109.299 -174.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.564 ' HB ' HG12 ' A' ' 449' ' ' VAL . 6.3 t -149.05 166.87 27.42 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 122.105 0.955 . . . . 0.98999999999999999 111.84 173.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.637 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.7 p-10 -86.48 141.55 29.01 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 113.228 -1.805 . . . . 1.8799999999999999 107.444 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.737 HD13 ' OE1' ' A' ' 352' ' ' GLN . 1.6 pp -142.0 -171.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.21 -0.904 . . . . 1.04 111.525 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.628 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -155.66 119.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.466 -0.788 . . . . 1.04 108.92 175.428 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.409 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.8 143.89 33.66 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.792 -1.095 . . . . 1.0 112.748 -165.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.08 44.82 34.39 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 116.924 1.529 . . . . 0.13 116.924 162.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.484 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.69 142.36 6.71 Favored Pre-proline 0 CA--C 1.507 -0.676 0 CA-C-N 118.593 1.196 . . . . 1.2 110.081 -175.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.779 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.59 -31.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.967 1 C-N-CA 125.885 4.39 . . . . 0.26000000000000001 116.365 -170.07 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.441 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -82.89 -32.58 27.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.297 0.57 . . . . 1.0600000000000001 110.672 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.465 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 12.1 m -140.77 74.55 26.71 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 122.151 0.976 . . . . 1.0800000000000001 110.239 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.76 162.41 42.13 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 125.068 3.845 . . . . 0.19 113.419 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.561 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.05 152.47 90.7 Favored Pre-proline 0 N--CA 1.436 -1.15 0 CA-C-N 113.665 -1.607 . . . . 1.04 110.806 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.556 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.47 -48.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.885 3.723 . . . . 0.10000000000000001 113.548 -172.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.657 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 66.31 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.918 1.081 . . . . 1.01 113.918 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.79 -123.47 1.18 Allowed Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 114.301 -1.318 . . . . 0.11 111.414 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 381' ' ' VAL . 10.6 p -129.8 104.93 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 122.371 1.081 . . . . 1.54 109.538 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.612 ' CE2' HG23 ' A' ' 465' ' ' VAL . 55.3 m-85 -110.4 166.33 11.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.994 -1.003 . . . . 0.26000000000000001 108.862 -172.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.7 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -148.77 136.28 20.4 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 117.63 0.195 . . . . 1.1799999999999999 110.714 177.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.542 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -72.29 124.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.555 0.693 . . . . 1.05 110.573 176.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -113.04 4.49 16.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.275 -0.875 . . . . 0.20000000000000001 112.005 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.69 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 5.8 t30 -163.96 148.97 10.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.493 -0.776 . . . . 0.40999999999999998 110.583 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.401 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.7 mtpt -110.81 109.74 20.07 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.811 0.815 . . . . 1.8200000000000001 110.412 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -107.95 131.87 54.09 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.304 -1.316 . . . . 0.38 109.382 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.548 -1.205 . . . . 1.96 110.092 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 25.8 t70 50.43 40.42 22.99 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.597 1.665 . . . . 0.40000000000000002 107.516 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.524 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.32 170.2 9.98 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 111.927 -2.397 . . . . 0.98999999999999999 110.809 -173.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 23.9 m -129.91 102.92 6.5 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.1 -1.409 . . . . 1.02 110.136 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.724 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -75.17 158.16 33.46 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 112.717 -2.038 . . . . 1.03 110.298 174.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 6.8 mtpt -148.55 -175.85 5.09 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 115.224 -0.898 . . . . 1.26 108.919 -177.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.683 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.33 -144.23 6.06 Favored Glycine 0 CA--C 1.489 -1.553 0 C-N-CA 117.338 -2.363 . . . . 0.81000000000000005 114.975 176.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.05 121.44 13.18 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 113.488 -1.356 . . . . 1.2 108.827 172.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -54.13 -179.38 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 112.113 -2.312 . . . . 1.1200000000000001 111.771 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -52.27 -27.23 14.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.889 -0.596 . . . . 1.6499999999999999 110.774 168.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.95 -26.99 18.16 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.312 0.577 . . . . 2.0 111.008 -174.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.61 35.54 3.77 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 110.469 -1.052 . . . . 0.70999999999999996 110.469 -170.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 41.6 p -118.83 127.88 26.28 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 106.504 -1.665 . . . . 1.26 106.504 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.683 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 26.7 Cg_exo -64.35 161.87 32.73 Favored 'Trans proline' 0 C--N 1.286 -2.745 0 C-N-CA 121.949 1.766 . . . . 1.1399999999999999 112.461 -173.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.653 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 25.0 p90 -143.23 -170.94 3.38 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.502 -1.681 . . . . 0.84999999999999998 107.119 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.712 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.4 mt-10 -147.76 157.35 43.5 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.329 1.061 . . . . 0.62 112.182 175.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.724 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -134.16 99.21 13.62 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-N 113.236 -1.802 . . . . 1.9099999999999999 108.595 176.49 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.91 101.05 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.793 2.329 . . . . 0.22 110.182 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.594 HG22 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -120.28 133.91 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-N 114.004 -1.453 . . . . 1.0900000000000001 111.234 -171.555 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.485 ' N ' HD21 ' A' ' 408' ' ' ASN . 0.1 OUTLIER -78.08 -30.32 49.56 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.822 -1.081 . . . . 1.8400000000000001 110.599 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.611 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 64.1 m-85 -142.15 117.83 10.41 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.728 -1.124 . . . . 0.88 110.758 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.572 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.9 t-105 -122.94 135.65 54.57 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.24 -1.346 . . . . 0.14999999999999999 110.296 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.518 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.3 OUTLIER -136.33 87.18 22.89 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 115.25 -0.886 . . . . 1.03 110.962 174.499 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.643 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 90.8 Cg_endo -72.68 140.95 33.34 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.834 2.356 . . . . 0.23999999999999999 111.554 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -122.55 -15.81 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.38 -1.282 . . . . 1.03 111.656 -171.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.782 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.9 p30 -135.78 170.16 16.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.486 -0.779 . . . . 1.5900000000000001 109.58 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -96.08 15.31 21.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.206 -0.452 . . . . 0.33000000000000002 111.989 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 18.3 p -96.85 -27.52 14.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.072 -1.085 . . . . 1.1499999999999999 108.072 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.82 27.3 0.87 Allowed Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.958 -1.473 . . . . 0.28000000000000003 113.314 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.782 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 61.5 t -103.44 151.77 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.266 0.555 . . . . 0.96999999999999997 111.428 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.34 -163.99 35.62 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.149 -0.932 . . . . 0.13 111.41 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.98 137.81 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 109.251 -0.648 . . . . 1.03 109.251 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.594 ' HB2' HG22 ' A' ' 407' ' ' VAL . 33.3 p80 -152.65 169.84 21.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.725 0.774 . . . . 0.17000000000000001 111.422 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.713 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.87 154.5 19.44 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 113.827 -1.533 . . . . 0.41999999999999998 108.699 174.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.629 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 18.5 p -140.11 99.95 3.8 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.583 1.182 . . . . 2.0 109.936 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.93 -31.17 13.78 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.621 -2.081 . . . . 0.34999999999999998 110.411 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 426' ' ' GLN . 18.2 p90 -70.25 -26.99 64.09 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.369 -1.287 . . . . 0.19 108.765 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.443 ' HG3' ' ND2' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.27 82.83 24.02 Favored Pre-proline 0 CA--C 1.489 -1.375 0 CA-C-N 113.437 -1.711 . . . . 1.3300000000000001 109.037 -174.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -80.07 3.61 7.47 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 124.483 3.455 . . . . 0.28000000000000003 114.619 -159.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 2.9 tp10 -113.96 157.17 22.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.892 0.377 . . . . 1.1000000000000001 110.738 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.637 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.66 125.89 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.293 -1.321 . . . . 0.98999999999999999 108.68 -171.277 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -168.34 28.72 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.419 -1.372 . . . . 0.13 112.158 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.589 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.36 0.01 OUTLIER Glycine 0 C--N 1.341 0.843 0 O-C-N 124.983 1.049 . . . . 0.23000000000000001 112.783 173.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.414 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 2.4 m-20 -55.22 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.281 0 CA-C-O 124.025 1.869 . . . . 0.33000000000000002 112.249 -146.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 36.3 mt -97.84 -33.53 11.21 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 110.06 -3.246 . . . . 1.05 109.298 175.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.539 ' HA ' HG21 ' A' ' 369' ' ' VAL . 8.0 p-90 -46.88 -34.45 5.43 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.214 -1.812 . . . . 0.22 112.16 -174.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.779 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 47.9 mttt -61.93 -23.79 66.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.334 -0.848 . . . . 1.29 113.188 -177.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -115.8 -36.66 4.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.686 0.755 . . . . 1.0700000000000001 110.085 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.509 ' HD2' HD23 ' A' ' 433' ' ' LEU . 4.5 mtp85 -81.65 -15.48 54.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.489 -1.232 . . . . 0.41999999999999998 112.973 -169.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.484 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.48 42.85 26.23 Favored Glycine 0 C--N 1.314 -0.646 0 N-CA-C 116.344 1.298 . . . . 0.20999999999999999 116.344 158.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 13.7 m -85.73 131.37 34.34 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 118.282 1.041 . . . . 0.81999999999999995 109.117 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.433 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 60.2 m80 -101.8 71.73 1.32 Allowed 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.405 -0.809 . . . . 0.5 110.919 -169.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.505 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 85.8 -13.57 55.79 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.223 -1.151 . . . . 0.19 110.223 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.563 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.1 p -88.59 148.18 24.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.063 -0.568 . . . . 1.22 110.218 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.561 HD12 HG23 ' A' ' 377' ' ' THR . 1.6 mp -103.64 118.78 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.107 -0.497 . . . . 1.04 110.348 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.629 ' HB3' ' OG ' ' A' ' 423' ' ' SER . 2.1 m-20 -85.49 90.01 7.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.589 -0.732 . . . . 2.29 111.641 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.666 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 99.5 m -87.02 138.76 32.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 121.473 0.654 . . . . 1.02 109.726 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.0 Cg_exo -54.36 136.58 69.61 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.685 2.257 . . . . 0.12 111.043 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.713 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 44.5 Cg_exo -55.65 -31.98 81.71 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 C-N-CA 123.984 3.122 . . . . 0.16 112.638 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.7 p -80.63 -39.04 28.11 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.279 -1.328 . . . . 1.47 109.623 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.564 HG12 ' HB ' ' A' ' 366' ' ' THR . 92.3 t -77.32 -31.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.552 -0.749 . . . . 1.0600000000000001 111.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.638 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 3.6 tpt -63.03 -24.4 67.9 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.584 0.707 . . . . 1.0 110.523 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -72.28 -30.49 64.87 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.539 -1.209 . . . . 1.4399999999999999 112.628 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.7 mm-40 -75.68 -46.6 30.35 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-N 113.005 -1.907 . . . . 0.38 107.362 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.477 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 26.1 tp -64.97 -67.35 0.44 Allowed 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 111.491 -2.595 . . . . 1.0 112.379 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.639 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 26.8 t80 -50.37 -25.91 4.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 123.146 1.45 . . . . 0.40000000000000002 108.309 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.34 -30.89 64.13 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 112.475 -2.148 . . . . 0.13 112.156 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.674 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -87.63 -48.38 7.94 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-O 121.661 0.743 . . . . 1.02 111.324 172.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.589 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.19 137.89 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.351 1.548 . . . . 1.04 113.989 -168.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.401 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.3 pt-20 -136.25 -178.56 5.21 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 110.965 -2.834 . . . . 0.82999999999999996 106.739 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.69 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.8 mtmt -50.95 160.54 0.46 Allowed 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 123.102 1.43 . . . . 1.04 113.363 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.76 -36.21 3.78 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 112.433 -2.167 . . . . 0.37 112.475 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 384' ' ' VAL . 19.3 m -70.35 141.17 88.15 Favored Pre-proline 0 N--CA 1.438 -1.048 0 CA-C-O 121.196 0.522 . . . . 1.01 110.282 -175.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.619 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.58 161.56 41.86 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.215 1.943 . . . . 0.17000000000000001 110.884 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 71.8 t -132.26 131.42 60.84 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 113.466 -1.697 . . . . 1.75 107.833 173.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.497 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.1 tp -109.83 142.03 41.69 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.232 0.539 . . . . 1.04 110.308 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.657 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.01 145.49 22.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.088 -1.819 . . . . 1.02 106.088 164.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.547 ' HA ' ' HB2' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.135 -0.936 . . . . 1.1599999999999999 111.591 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.238 -0.745 . . . . 4.3899999999999997 111.238 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.484 ' HD2' ' O ' ' A' ' 339' ' ' HIS . 1.0 OUTLIER -150.66 125.33 9.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.847 0.323 . . . . 2.1899999999999999 111.473 176.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 37.7 mtm 52.83 106.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.695 1.368 . . . . 1.23 114.695 164.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.58 -2.76 18.17 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.034 -1.894 . . . . 1.1000000000000001 110.45 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -57.24 166.5 1.12 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 123.175 1.464 . . . . 0.97999999999999998 114.266 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 358' ' ' LYS . 22.6 m -94.99 124.64 39.15 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 112.339 -2.21 . . . . 1.04 108.627 168.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.661 ' HD2' ' CD1' ' A' ' 344' ' ' TYR . 6.1 p90 -156.88 -171.01 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.52 0.676 . . . . 0.94999999999999996 111.41 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.585 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.4 mm -102.26 162.14 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 108.221 -1.029 . . . . 1.02 108.221 167.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.48 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.4 tt0 -142.14 156.54 45.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 118.835 0.743 . . . . 0.17000000000000001 111.545 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.611 HG23 ' HG3' ' A' ' 354' ' ' MET . 62.7 t -151.3 136.91 11.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.491 -1.231 . . . . 1.03 110.077 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -117.67 115.34 24.87 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.68 -1.145 . . . . 0.37 108.104 172.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.472 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.8 mm? -67.83 -49.5 61.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.355 1.074 . . . . 1.0600000000000001 110.564 -176.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -52.89 -55.2 24.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.774 -2.012 . . . . 1.51 112.185 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -95.82 4.0 53.24 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.738 -1.119 . . . . 0.91000000000000003 109.964 -171.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.685 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.5 mm-40 47.08 66.14 1.07 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.448 -2.16 . . . . 2.6299999999999999 112.129 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.508 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -148.48 125.35 11.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.286 0.565 . . . . 0.17000000000000001 109.916 -175.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.611 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.0 ttp -112.35 127.42 56.0 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 123.606 0.763 . . . . 0.97999999999999998 110.359 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.67 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -113.62 173.7 6.28 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.609 -1.178 . . . . 0.11 112.062 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.595 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 2.5 t80 -126.49 115.83 20.17 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 106.529 -1.656 . . . . 1.02 106.529 165.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 22.9 m-85 -100.44 127.91 46.65 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.993 0.901 . . . . 0.90000000000000002 112.118 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.578 ' HA ' HG21 ' A' ' 343' ' ' THR . 6.0 ttpt -147.79 137.68 22.71 Favored 'General case' 0 N--CA 1.398 -3.034 0 CA-C-N 113.667 -1.606 . . . . 1.21 108.548 174.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.451 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 70.48 14.2 7.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.402 -1.726 . . . . 0.59999999999999998 108.601 178.439 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.49 71.01 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 112.701 -2.045 . . . . 0.23999999999999999 112.186 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.69 169.9 16.97 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.158 -1.793 . . . . 1.26 106.158 -170.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.579 ' N ' ' HG3' ' A' ' 361' ' ' LYS . 3.1 m -101.41 138.23 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 CA-C-O 124.207 1.956 . . . . 1.26 111.976 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.446 ' CB ' ' CD1' ' A' ' 356' ' ' TYR . . . -92.63 -25.01 18.48 Favored 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 109.361 -3.563 . . . . 1.03 108.688 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.698 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.87 155.18 36.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 113.74 -1.573 . . . . 1.01 109.301 -173.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.67 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.14 123.0 1.6 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.469 -0.787 . . . . 0.60999999999999999 109.339 -175.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.614 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.9 t -148.32 165.68 30.31 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 122.415 1.102 . . . . 0.98999999999999999 112.017 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.728 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.7 p-10 -83.46 140.85 32.09 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 112.881 -1.963 . . . . 1.8799999999999999 107.821 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.64 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.26 -171.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.264 -0.88 . . . . 1.04 112.064 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.685 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -157.94 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.936 -1.029 . . . . 1.04 109.352 176.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.406 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.5 t -140.94 145.54 36.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.28 -0.873 . . . . 1.0 112.892 -165.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.69 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 68.54 46.68 61.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 116.199 1.24 . . . . 0.13 116.199 162.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.525 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.38 145.42 2.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 118.267 1.033 . . . . 1.2 110.184 -175.252 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.773 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.47 -33.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 125.242 3.961 . . . . 0.26000000000000001 115.911 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -80.41 -34.4 36.24 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.738 -0.601 . . . . 1.0600000000000001 110.752 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.476 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.3 m -139.98 73.06 33.53 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 122.209 1.004 . . . . 1.0800000000000001 109.994 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.69 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 29.5 Cg_exo -69.71 161.62 45.24 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 C-N-CA 125.301 4.001 . . . . 0.19 113.967 -177.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.577 HG21 ' CD ' ' A' ' 378' ' ' PRO . 0.1 OUTLIER -72.99 154.03 90.85 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.562 -1.654 . . . . 1.04 110.358 175.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.577 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.1 Cg_endo -80.24 -50.32 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 125.029 3.82 . . . . 0.10000000000000001 113.564 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.635 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 67.8 123.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.996 0.903 . . . . 1.01 113.322 -176.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.29 -124.07 1.22 Allowed Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.271 -1.331 . . . . 0.11 111.491 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.438 ' O ' HG11 ' A' ' 381' ' ' VAL . 9.2 p -128.63 104.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.454 1.121 . . . . 1.54 109.831 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.649 ' CE2' HG23 ' A' ' 465' ' ' VAL . 93.8 m-85 -107.92 161.35 15.01 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.516 -1.22 . . . . 0.26000000000000001 110.03 -170.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.726 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.5 m-85 -147.3 136.99 22.92 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 122.974 0.171 . . . . 1.1799999999999999 110.694 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.596 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.2 120.36 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.937 -0.705 . . . . 1.05 110.16 176.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . 0.449 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 40.6 p-90 -106.31 3.62 27.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.404 -0.816 . . . . 0.20000000000000001 111.789 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.682 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.7 t30 -164.54 148.86 9.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.224 -0.898 . . . . 0.40999999999999998 110.813 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . 0.452 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.3 mtpt -107.4 111.16 23.36 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.478 -0.783 . . . . 1.8200000000000001 109.863 169.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.1 mt-10 -111.87 122.92 49.11 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.657 1.218 . . . . 0.38 110.912 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -118.1 145.0 45.18 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.079 -1.419 . . . . 1.96 109.253 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 34.6 t70 54.34 25.88 6.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 112.026 -2.352 . . . . 0.40000000000000002 108.582 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.09 170.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.09 -1.868 . . . . 0.98999999999999999 112.063 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 31.5 m -127.49 102.26 6.79 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.526 -1.67 . . . . 1.02 110.099 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.702 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 9.9 mp -72.9 158.46 35.46 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 113.03 -1.896 . . . . 1.03 110.502 175.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 6.4 mtpt -146.09 -176.98 5.37 Favored 'General case' 0 N--CA 1.396 -3.148 0 N-CA-C 108.636 -0.876 . . . . 1.26 108.636 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.762 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -178.27 -149.8 8.29 Favored Glycine 0 C--N 1.296 -1.665 0 C-N-CA 117.1 -2.476 . . . . 0.81000000000000005 115.239 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 401' ' ' THR . 0.7 OUTLIER -139.44 119.8 13.87 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.522 -1.339 . . . . 1.2 110.077 174.222 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.418 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -52.72 -179.39 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 111.733 -2.485 . . . . 1.1200000000000001 112.192 175.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -52.42 -24.05 7.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.087 0.47 . . . . 1.6499999999999999 111.046 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -95.19 -27.78 15.37 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.317 -0.402 . . . . 2.0 111.909 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.45 31.68 4.21 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 119.314 -1.422 . . . . 0.70999999999999996 111.087 -170.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.674 ' O ' ' HA ' ' A' ' 396' ' ' THR . 44.9 p -113.84 153.32 46.06 Favored Pre-proline 0 N--CA 1.416 -2.166 0 N-CA-C 106.328 -1.73 . . . . 1.26 106.328 177.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.762 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 97.9 Cg_endo -69.6 172.31 12.72 Favored 'Trans proline' 0 C--N 1.274 -3.351 0 C-N-CA 121.777 1.652 . . . . 1.1399999999999999 112.88 -174.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.64 ' HD1' ' CD2' ' A' ' 403' ' ' TYR . 8.5 p90 -155.01 -170.45 3.5 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 112.518 -2.128 . . . . 0.84999999999999998 106.905 171.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.702 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.1 mt-10 -147.7 158.16 43.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.342 1.067 . . . . 0.62 111.692 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.697 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.2 98.95 12.39 Favored Pre-proline 0 N--CA 1.42 -1.951 0 CA-C-N 113.12 -1.855 . . . . 1.9099999999999999 107.568 176.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.29 102.02 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 122.318 2.012 . . . . 0.22 110.165 174.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.58 HG11 ' N ' ' A' ' 408' ' ' ASN . 1.2 t -114.39 163.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.853 0 CA-C-N 114.192 -1.367 . . . . 1.0900000000000001 109.914 -173.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.58 ' N ' HG11 ' A' ' 407' ' ' VAL . 18.6 m-80 -114.92 -33.8 5.32 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 113.417 -1.72 . . . . 1.8400000000000001 107.081 -176.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.638 ' HD1' ' CD2' ' A' ' 409' ' ' TYR . 59.8 m-85 -134.87 115.68 13.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.629 -2.078 . . . . 0.88 110.485 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.549 ' CD1' ' HD3' ' A' ' 412' ' ' PRO . 6.5 t-105 -123.81 134.27 53.66 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.14999999999999999 110.254 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.461 ' HG2' HG23 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -135.56 85.04 32.22 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.936 -1.029 . . . . 1.03 110.93 173.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 73.2 Cg_endo -70.52 140.65 40.3 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.929 2.42 . . . . 0.23999999999999999 112.102 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.726 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -124.39 -16.19 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.076 -1.42 . . . . 1.03 111.162 -173.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -134.88 161.0 36.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.536 -0.756 . . . . 1.5900000000000001 109.532 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -92.13 13.84 17.81 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.147 0.425 . . . . 0.33000000000000002 112.147 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -93.02 -25.66 17.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.745 -1.206 . . . . 1.1499999999999999 107.745 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.22 29.16 1.38 Allowed Glycine 0 N--CA 1.425 -2.054 0 CA-C-N 113.073 -1.876 . . . . 0.28000000000000003 112.179 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 441' ' ' GLY . 84.8 t -102.27 148.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.281 0.562 . . . . 0.96999999999999997 110.626 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.97 -166.04 38.01 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.731 -1.122 . . . . 0.13 111.186 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.4 HG21 ' SD ' ' A' ' 450' ' ' MET . 0.9 OUTLIER -103.67 138.99 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 108.795 -0.817 . . . . 1.03 108.795 176.074 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.531 ' HB2' HG22 ' A' ' 407' ' ' VAL . 31.3 p80 -149.98 163.63 37.59 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.652 0.739 . . . . 0.17000000000000001 111.969 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.745 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.33 137.35 32.43 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.293 -1.321 . . . . 0.41999999999999998 107.951 173.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.5 OUTLIER -130.73 101.46 5.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.421 1.105 . . . . 2.0 109.606 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -95.18 -30.54 13.96 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.082 -1.872 . . . . 0.34999999999999998 111.021 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 19.0 p90 -66.66 -26.54 67.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.414 -1.266 . . . . 0.19 109.151 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.474 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.95 82.65 28.84 Favored Pre-proline 0 CA--C 1.49 -1.347 0 CA-C-N 113.614 -1.63 . . . . 1.3300000000000001 109.451 -173.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -80.86 5.94 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 124.784 3.656 . . . . 0.28000000000000003 114.21 -160.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.67 153.7 29.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.336 -0.393 . . . . 1.1000000000000001 110.614 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.728 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.95 124.73 2.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.214 -1.357 . . . . 0.98999999999999999 108.097 -172.189 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.86 -168.12 28.75 Favored Glycine 0 C--N 1.297 -1.629 0 C-N-CA 119.283 -1.437 . . . . 0.13 111.123 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.663 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.6 152.33 0.0 OUTLIER Glycine 0 C--N 1.342 0.891 0 O-C-N 125.141 1.142 . . . . 0.23000000000000001 113.176 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.46 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.6 m-20 -54.59 101.06 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 123.86 1.79 . . . . 0.33000000000000002 111.797 -145.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 55.6 mt -96.53 -30.79 13.11 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 110.474 -3.057 . . . . 1.05 108.111 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.584 ' HA ' HG21 ' A' ' 369' ' ' VAL . 5.0 p-90 -46.46 -38.01 8.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.867 0.73 . . . . 0.22 111.398 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.773 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 36.4 mttt -62.3 -24.34 67.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.921 -1.036 . . . . 1.29 112.845 -175.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 31.1 p -113.23 -36.18 5.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.568 0.699 . . . . 1.0700000000000001 110.16 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.482 ' HB2' HG22 ' A' ' 369' ' ' VAL . 5.7 mtp85 -86.96 -16.83 34.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.783 -1.099 . . . . 0.41999999999999998 112.664 -168.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.493 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.47 43.79 29.34 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 116.506 1.362 . . . . 0.20999999999999999 116.506 162.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -86.21 130.74 34.42 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 118.701 1.251 . . . . 0.81999999999999995 108.179 172.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.47 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 61.7 m80 -99.72 64.34 1.27 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.47 -0.769 . . . . 0.5 110.96 -168.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.599 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 94.9 -12.75 68.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.577 -1.009 . . . . 0.19 110.577 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.517 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 10.7 p -90.49 142.77 27.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.238 -0.481 . . . . 1.22 110.66 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.55 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -95.91 120.74 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 122.579 1.18 . . . . 1.04 111.19 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.5 OUTLIER -78.92 82.48 5.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.784 -2.007 . . . . 2.29 111.936 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 16.5 m -87.05 137.75 32.99 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-O 121.383 0.611 . . . . 1.02 109.509 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.492 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 50.9 Cg_exo -57.42 136.14 74.21 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.723 2.282 . . . . 0.12 111.595 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.745 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.8 Cg_exo -55.14 -33.0 82.44 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 124.245 3.297 . . . . 0.16 113.138 -172.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 4.6 t -81.42 -38.51 26.38 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.883 -1.053 . . . . 1.47 109.304 -177.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.614 HG12 ' HB ' ' A' ' 366' ' ' THR . 26.1 t -82.9 -26.85 8.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.652 . . . . 1.0600000000000001 111.11 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.689 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.7 tpt -68.58 -19.92 64.49 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.878 0.847 . . . . 1.0 110.073 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.48 -23.22 46.53 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.609 -1.178 . . . . 1.4399999999999999 111.075 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.623 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.84 -45.97 16.05 Favored 'General case' 0 CA--C 1.477 -1.838 0 CA-C-N 112.905 -1.952 . . . . 0.38 107.473 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.61 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -65.01 -66.85 0.49 Allowed 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 111.89 -2.414 . . . . 1.0 112.311 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.654 ' HD2' ' CD1' ' A' ' 454' ' ' PHE . 24.1 t80 -50.16 -27.86 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.94 1.352 . . . . 0.40000000000000002 107.965 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.58 -30.13 71.09 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 112.491 -2.14 . . . . 0.13 112.469 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.698 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.88 -48.26 7.35 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.597 0.713 . . . . 1.02 111.611 172.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.585 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.24 138.69 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 123.365 1.555 . . . . 1.04 114.182 -167.073 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . 0.452 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.4 -178.74 5.3 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 110.834 -2.894 . . . . 0.82999999999999996 106.845 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.672 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.9 mtmt -52.22 162.77 0.45 Allowed 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 123.114 1.435 . . . . 1.04 113.058 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.64 -34.63 4.27 Favored Glycine 0 N--CA 1.424 -2.149 0 CA-C-N 112.48 -2.145 . . . . 0.37 112.283 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 462' ' ' PRO . 7.6 m -76.04 141.33 71.01 Favored Pre-proline 0 N--CA 1.434 -1.261 0 N-CA-C 109.484 -0.562 . . . . 1.01 109.484 -176.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.613 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.6 166.47 28.4 Favored 'Trans proline' 0 N--CA 1.425 -2.53 0 C-N-CA 122.024 1.816 . . . . 0.17000000000000001 111.157 173.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.628 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.63 153.2 34.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 107.634 -1.247 . . . . 1.75 107.634 166.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.46 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.3 tp -123.4 145.25 48.93 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.096 -0.956 . . . . 1.04 110.155 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.649 HG23 ' CE2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -143.28 146.05 21.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.413 -1.699 . . . . 1.02 106.413 164.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.48 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 18.0 p90 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.62 -0.705 . . . . 1.1599999999999999 111.364 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.961 -0.456 . . . . 4.3899999999999997 111.961 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -111.05 96.66 6.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.187 0.517 . . . . 2.1899999999999999 109.9 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 36.0 mtm 62.21 -173.53 0.15 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.411 -1.268 . . . . 1.23 111.597 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.83 -4.83 0.73 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.434 -0.803 . . . . 1.1000000000000001 111.029 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -54.88 168.04 0.33 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 123.193 1.473 . . . . 0.97999999999999998 113.008 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.584 HG21 ' HB2' ' A' ' 358' ' ' LYS . 27.1 m -91.82 123.28 35.08 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 112.803 -1.999 . . . . 1.04 107.959 169.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.652 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 11.4 p90 -161.0 -170.75 2.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.153 -0.931 . . . . 0.94999999999999996 110.768 -175.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.608 HD13 ' CB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.45 161.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.097 -1.075 . . . . 1.02 108.097 167.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.473 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.7 tt0 -140.35 155.85 46.63 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.956 0.798 . . . . 0.17000000000000001 111.253 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.606 HG23 ' HG3' ' A' ' 354' ' ' MET . 67.0 t -150.84 133.4 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.413 -1.267 . . . . 1.03 109.721 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 50.9 t0 -115.05 111.78 21.61 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.336 -1.357 . . . . 0.37 107.336 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.554 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.6 mm? -60.61 -58.67 7.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.783 1.277 . . . . 1.0600000000000001 107.618 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.485 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 11.9 mm-40 -48.94 -46.85 43.92 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 111.353 -2.658 . . . . 1.51 112.943 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -111.13 20.73 17.13 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 125.206 1.567 . . . . 0.91000000000000003 109.203 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.713 ' NE2' ' HA2' ' A' ' 431' ' ' GLY . 1.2 mp0 36.24 68.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.27 -1.787 . . . . 2.6299999999999999 112.622 170.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.505 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -153.17 124.5 7.58 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.194 0.521 . . . . 0.17000000000000001 109.914 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.606 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.1 ttp -110.91 127.54 55.5 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.454 0.702 . . . . 0.97999999999999998 110.605 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.641 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.1 m-90 -112.25 173.76 6.21 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 114.459 -1.246 . . . . 0.11 112.05 -175.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.615 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 3.3 t80 -127.41 119.15 25.51 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 106.261 -1.755 . . . . 1.02 106.261 165.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 18.5 m-85 -102.49 129.52 49.03 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.941 0.877 . . . . 0.90000000000000002 111.524 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.584 ' HB2' HG21 ' A' ' 343' ' ' THR . 3.5 ttpt -148.46 137.43 21.7 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 113.722 -1.581 . . . . 1.21 108.116 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.38 15.1 6.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.456 -1.702 . . . . 0.59999999999999998 108.752 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 80.51 17.79 72.57 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 112.667 -2.06 . . . . 0.23999999999999999 111.899 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.543 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -137.12 168.07 20.31 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.098 -1.816 . . . . 1.26 106.098 -171.67 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.548 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.1 m -100.11 138.21 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.802 0 CA-C-O 124.25 1.976 . . . . 1.26 111.874 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.57 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -93.24 -25.18 17.9 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 109.305 -3.589 . . . . 1.03 108.564 177.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.663 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -152.46 155.36 37.36 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.868 -1.515 . . . . 1.01 109.227 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.641 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -165.93 122.51 1.36 Allowed 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 109.614 -174.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.647 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.6 t -148.3 167.16 25.9 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.177 0.989 . . . . 0.98999999999999999 112.136 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.597 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.5 p-10 -86.77 140.93 29.25 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.222 -1.808 . . . . 1.8799999999999999 107.916 177.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -143.15 -172.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.309 -0.859 . . . . 1.04 112.484 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -154.36 119.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.705 -1.134 . . . . 1.04 108.696 175.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 6.6 t -141.27 143.41 34.09 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.759 -0.655 . . . . 1.0 112.742 -168.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.53 45.1 24.59 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 117.716 -1.602 . . . . 0.13 117.001 163.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.428 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 0.3 OUTLIER -46.71 143.85 3.94 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-N 119.722 1.761 . . . . 1.2 110.363 -173.146 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.808 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.68 -33.67 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.948 4.432 . . . . 0.26000000000000001 115.912 -170.811 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 3.1 p -75.06 -37.97 61.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.3 0.571 . . . . 1.0600000000000001 111.076 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.483 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.1 m -140.55 74.31 28.32 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.106 0.955 . . . . 1.0800000000000001 110.606 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.4 Cg_exo -70.94 160.44 49.37 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 125.175 3.917 . . . . 0.19 113.853 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.558 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -71.1 153.09 94.65 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.269 -1.787 . . . . 1.04 111.357 177.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.552 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.5 Cg_endo -80.17 -49.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 125.09 3.86 . . . . 0.10000000000000001 113.734 -171.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.64 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.3 122.86 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.737 1.014 . . . . 1.01 113.737 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.08 -124.74 1.28 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.242 -1.345 . . . . 0.11 111.423 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.464 ' O ' HG11 ' A' ' 381' ' ' VAL . 12.6 p -128.72 105.65 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 122.296 1.046 . . . . 1.54 109.267 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.625 ' CB ' HG23 ' A' ' 463' ' ' VAL . 96.8 m-85 -108.97 164.16 12.65 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.138 -0.937 . . . . 0.26000000000000001 110.058 -169.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.7 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 68.9 m-85 -147.34 137.23 23.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 121.196 -0.202 . . . . 1.1799999999999999 110.954 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.576 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.63 121.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.491 0.662 . . . . 1.05 110.364 176.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.7 p-90 -108.62 5.86 25.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.421 -0.809 . . . . 0.20000000000000001 111.88 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.676 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 4.2 t30 -164.6 146.82 8.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.874 . . . . 0.40999999999999998 110.251 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -108.89 115.63 30.45 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.958 -0.756 . . . . 1.8200000000000001 108.958 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.582 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -118.65 111.98 19.23 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.472 1.606 . . . . 0.38 113.065 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 2.6 mp0 -103.84 143.74 32.42 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 113.289 -1.778 . . . . 1.96 109.708 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.7 t70 57.08 22.23 7.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.259 -2.246 . . . . 0.40000000000000002 108.604 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.582 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -82.33 171.15 14.53 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.403 -1.726 . . . . 0.98999999999999999 112.56 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.416 ' CG2' ' HG2' ' A' ' 404' ' ' GLU . 15.7 m -127.5 104.23 7.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.051 -1.886 . . . . 1.02 110.004 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.716 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 10.0 mp -73.26 156.99 37.93 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 112.642 -2.072 . . . . 1.03 109.98 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.3 mtpt -150.83 -175.71 5.23 Favored 'General case' 0 N--CA 1.398 -3.058 0 O-C-N 124.352 1.032 . . . . 1.26 108.789 -176.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.665 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.44 -142.04 5.05 Favored Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 117.411 -2.328 . . . . 0.81000000000000005 114.922 176.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.401 ' HB ' ' HA2' ' A' ' 400' ' ' GLY . 0.6 OUTLIER -142.25 124.06 15.17 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 113.117 -1.542 . . . . 1.2 108.46 170.954 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.501 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -54.2 -178.75 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 112.222 -2.263 . . . . 1.1200000000000001 111.643 177.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -51.7 -25.34 7.1 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.838 -0.619 . . . . 1.6499999999999999 111.549 171.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.501 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.6 OUTLIER -101.43 -30.08 11.65 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.048 0.451 . . . . 2.0 111.554 -174.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . 0.401 ' HA2' ' HB ' ' A' ' 396' ' ' THR . . . 115.86 36.24 1.17 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.59 -1.291 . . . . 0.70999999999999996 111.736 -173.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 67.6 p -117.56 128.53 25.94 Favored Pre-proline 0 N--CA 1.421 -1.913 0 N-CA-C 106.035 -1.839 . . . . 1.26 106.035 174.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.665 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 27.4 Cg_exo -64.65 161.43 35.66 Favored 'Trans proline' 0 C--N 1.284 -2.858 0 C-N-CA 121.703 1.602 . . . . 1.1399999999999999 112.213 -174.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.647 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 26.9 p90 -140.88 -170.09 2.96 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 113.792 -1.549 . . . . 0.84999999999999998 106.998 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.716 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.2 mt-10 -148.79 158.01 43.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.392 1.091 . . . . 0.62 112.112 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.692 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.91 99.22 10.24 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-N 112.948 -1.933 . . . . 1.9099999999999999 108.239 176.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -67.62 102.24 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.549 2.166 . . . . 0.22 110.669 175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.614 HG11 ' N ' ' A' ' 408' ' ' ASN . 1.2 t -113.64 165.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 114.238 -1.346 . . . . 1.0900000000000001 109.84 -173.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.614 ' N ' HG11 ' A' ' 407' ' ' VAL . 18.0 m-80 -116.3 -33.5 4.95 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.551 -1.659 . . . . 1.8400000000000001 107.083 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.665 ' HE2' ' CE1' ' A' ' 409' ' ' TYR . 46.3 m-85 -136.2 115.47 12.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.062 -1.881 . . . . 0.88 110.474 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.558 ' CD1' ' HD3' ' A' ' 412' ' ' PRO . 7.7 t-105 -122.95 135.77 54.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.712 -1.131 . . . . 0.14999999999999999 110.065 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.473 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.8 OUTLIER -136.51 83.49 30.88 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.892 -1.049 . . . . 1.03 110.923 173.496 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.675 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 13.9 Cg_endo -70.31 139.5 38.44 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.141 2.561 . . . . 0.23999999999999999 112.659 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.7 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.93 -15.15 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 113.792 -1.549 . . . . 1.03 111.453 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -134.39 163.64 29.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 1.5900000000000001 109.483 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -96.96 13.55 28.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.801 0.334 . . . . 0.33000000000000002 111.735 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.4 p -92.45 -27.06 17.7 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.538 -1.282 . . . . 1.1499999999999999 107.538 173.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.68 29.36 1.07 Allowed Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 112.862 -1.972 . . . . 0.28000000000000003 112.353 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.579 HG11 ' O ' ' A' ' 441' ' ' GLY . 74.3 t -102.47 148.76 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.232 0.539 . . . . 0.96999999999999997 111.142 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.49 -167.46 39.78 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.831 -1.077 . . . . 0.13 111.336 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.61 141.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.858 -0.793 . . . . 1.03 108.858 175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.597 ' O ' ' HB ' ' A' ' 445' ' ' THR . 32.9 p80 -149.46 165.16 32.95 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.747 0.784 . . . . 0.17000000000000001 111.616 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.733 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -93.28 139.39 30.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.019 -1.475 . . . . 0.41999999999999998 107.019 171.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.403 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 1.8 t -134.06 103.2 5.69 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.97 1.367 . . . . 2.0 110.066 -176.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.49 -32.36 13.53 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 112.234 -2.257 . . . . 0.34999999999999998 111.162 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -65.67 -27.19 68.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.55 -1.205 . . . . 0.19 109.055 175.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.566 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -121.36 82.62 39.21 Favored Pre-proline 0 CA--C 1.493 -1.221 0 CA-C-N 113.406 -1.724 . . . . 1.3300000000000001 109.485 -174.239 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -81.24 7.33 5.03 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 C-N-CA 124.818 3.678 . . . . 0.28000000000000003 114.471 -160.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 0.9 OUTLIER -113.68 154.46 27.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.009 0.433 . . . . 1.1000000000000001 111.303 -177.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.597 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.97 126.0 2.39 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.178 -1.374 . . . . 0.98999999999999999 108.86 -171.165 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.576 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 146.95 -166.63 28.38 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.68 -1.248 . . . . 0.13 110.65 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.713 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -29.14 151.89 0.0 OUTLIER Glycine 0 C--N 1.341 0.822 0 O-C-N 125.187 1.169 . . . . 0.23000000000000001 113.258 173.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.01 100.5 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 111.944 -152.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.3 mt -97.69 -32.12 11.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 110.403 -3.089 . . . . 1.05 107.941 174.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.556 ' HA ' HG21 ' A' ' 369' ' ' VAL . 3.8 p-90 -46.0 -38.54 7.89 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.987 0.804 . . . . 0.22 111.414 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.808 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 34.9 mttt -59.11 -26.63 64.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 114.781 -1.1 . . . . 1.29 113.021 -176.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.6 p -111.53 -35.35 5.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.898 0.856 . . . . 1.0700000000000001 109.859 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.566 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.0 mtp85 -86.77 -15.55 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.439 -1.255 . . . . 0.41999999999999998 112.647 -168.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.428 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 74.65 41.89 33.95 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 116.608 1.403 . . . . 0.20999999999999999 116.608 159.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.7 p -91.07 131.76 36.45 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 118.318 1.059 . . . . 0.81999999999999995 109.124 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.51 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 71.3 m80 -98.6 69.08 1.86 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.673 -0.642 . . . . 0.5 111.209 -167.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.579 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 88.41 -11.77 66.96 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 110.39 -1.084 . . . . 0.19 110.39 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.565 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 18.4 p -86.88 141.34 28.84 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.181 -0.51 . . . . 1.22 109.924 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.558 HD12 HG23 ' A' ' 377' ' ' THR . 1.5 mp -95.52 117.71 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.668 0.747 . . . . 1.04 110.781 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.505 ' HB3' HG12 ' A' ' 369' ' ' VAL . 2.1 t30 -76.86 82.59 3.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.498 -1.228 . . . . 2.29 111.354 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.4 m -86.94 138.85 32.75 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-O 121.549 0.69 . . . . 1.02 109.628 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.6 Cg_exo -58.13 135.26 67.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.654 2.236 . . . . 0.12 111.416 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.733 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 30.3 Cg_exo -54.44 -34.08 79.97 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 124.299 3.333 . . . . 0.16 112.783 -174.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 44.7 m -78.98 -41.37 29.29 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.458 -1.247 . . . . 1.47 110.07 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.647 HG12 ' HB ' ' A' ' 366' ' ' THR . 54.0 t -79.21 -28.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.252 0.549 . . . . 1.0600000000000001 111.487 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.682 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.8 tpt -68.29 -18.58 64.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.775 0.797 . . . . 1.0 110.096 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.09 -22.23 42.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.7 -1.136 . . . . 1.4399999999999999 110.875 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.664 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.3 mm-40 -81.0 -47.3 13.81 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 112.767 -2.015 . . . . 0.38 107.38 177.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.637 HD21 ' SD ' ' A' ' 450' ' ' MET . 25.5 tp -64.28 -67.01 0.47 Allowed 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 111.878 -2.419 . . . . 1.0 112.318 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 36.0 t80 -49.76 -26.8 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 123.181 1.467 . . . . 0.40000000000000002 108.285 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.7 -30.95 65.54 Favored Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 112.251 -2.25 . . . . 0.13 112.331 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.664 ' HB2' ' CE2' ' A' ' 356' ' ' TYR . 1.7 ptp -89.19 -48.88 7.08 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 121.688 0.756 . . . . 1.02 111.572 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.608 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -100.26 139.23 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 123.328 1.537 . . . . 1.04 113.764 -168.719 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -136.19 -178.78 5.31 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 110.816 -2.902 . . . . 0.82999999999999996 106.883 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.676 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.6 mtmt -52.98 162.73 0.59 Allowed 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 123.025 1.393 . . . . 1.04 112.694 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.4 -36.51 3.61 Favored Glycine 0 N--CA 1.423 -2.207 0 CA-C-N 112.577 -2.101 . . . . 0.37 112.514 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.476 ' O ' HG13 ' A' ' 384' ' ' VAL . 4.1 m -74.27 141.72 77.66 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.471 -0.566 . . . . 1.01 109.471 -175.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.627 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.7 Cg_exo -74.39 167.74 26.44 Favored 'Trans proline' 0 N--CA 1.424 -2.559 0 C-N-CA 121.765 1.644 . . . . 0.17000000000000001 111.041 173.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.625 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.57 156.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 107.504 -1.295 . . . . 1.75 107.504 166.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.438 HD21 ' CG ' ' A' ' 346' ' ' GLU . 2.8 tp -126.98 145.15 50.8 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.462 -0.79 . . . . 1.04 110.233 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.64 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.27 146.7 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 106.869 -1.53 . . . . 1.02 106.869 164.429 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.473 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 14.7 p90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.372 -0.823 . . . . 1.1599999999999999 111.477 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.067 -0.413 . . . . 4.3899999999999997 112.067 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.502 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.5 t-160 -116.51 87.41 2.68 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.13 0.491 . . . . 2.1899999999999999 109.934 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' MET . . . . . 0.502 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 32.7 mtm 76.27 -175.97 0.12 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.82 -1.536 . . . . 1.23 111.53 -175.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.27 -8.91 1.3 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.408 -0.815 . . . . 1.1000000000000001 112.332 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.06 169.34 0.55 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 123.048 1.404 . . . . 0.97999999999999998 112.934 173.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.569 HG21 ' HA ' ' A' ' 358' ' ' LYS . 33.1 m -92.28 122.86 35.16 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 113.122 -1.854 . . . . 1.04 108.524 171.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.667 ' HE2' ' CE1' ' A' ' 344' ' ' TYR . 7.9 p90 -162.33 -170.32 2.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.913 -1.039 . . . . 0.94999999999999996 110.585 -174.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.596 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.1 mm -101.71 160.98 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.078 -1.082 . . . . 1.02 108.078 166.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.455 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 3.6 tt0 -140.95 154.62 46.16 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 118.805 0.73 . . . . 0.17000000000000001 110.898 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.607 HG23 ' HG3' ' A' ' 354' ' ' MET . 61.4 t -150.24 134.69 9.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.31 -1.314 . . . . 1.03 109.296 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -117.51 110.42 17.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.202 -1.407 . . . . 0.37 107.202 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 349' ' ' LEU . 1.8 mm? -58.52 -56.98 15.13 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.835 -1.172 . . . . 1.0600000000000001 107.835 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -46.27 -51.21 14.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 111.956 -2.384 . . . . 1.51 112.993 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -100.73 4.42 43.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.394 -1.73 . . . . 0.91000000000000003 110.082 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.684 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 1.7 mp0 47.42 67.01 0.88 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 112.428 -2.169 . . . . 2.6299999999999999 112.363 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.474 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.3 t60 -146.79 125.69 12.74 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.377 0.608 . . . . 0.17000000000000001 110.107 -177.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.607 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.0 ttp -112.6 128.38 56.35 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.54 0.736 . . . . 0.97999999999999998 110.658 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.66 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.76 173.27 6.46 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.44 -1.254 . . . . 0.11 111.869 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.625 ' HD2' ' CD1' ' A' ' 356' ' ' TYR . 3.0 t80 -126.93 116.67 21.16 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.33 -1.729 . . . . 1.02 106.33 165.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.668 ' HE2' ' CE1' ' A' ' 357' ' ' TYR . 24.4 m-85 -100.53 128.93 46.44 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.899 0.857 . . . . 0.90000000000000002 111.609 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.569 ' HA ' HG21 ' A' ' 343' ' ' THR . 4.5 ttpt -148.18 137.37 22.02 Favored 'General case' 0 N--CA 1.399 -3.013 0 CA-C-N 113.761 -1.563 . . . . 1.21 108.473 173.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.449 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.73 16.69 6.71 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 113.332 -1.758 . . . . 0.59999999999999998 108.803 178.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.9 72.06 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 112.652 -2.067 . . . . 0.23999999999999999 111.819 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.568 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.96 169.56 17.57 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.349 -1.723 . . . . 1.26 106.349 -170.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.573 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.1 m -102.36 138.36 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.865 0 CA-C-O 124.252 1.977 . . . . 1.26 111.839 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -93.18 -25.37 17.87 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 109.24 -3.618 . . . . 1.03 108.647 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.624 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -153.23 154.87 35.53 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.762 -1.563 . . . . 1.01 108.654 -171.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.66 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.59 122.07 1.17 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.738 -0.665 . . . . 0.60999999999999999 109.651 -174.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.641 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.8 t -148.74 167.09 26.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.98999999999999999 112.01 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.656 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.2 p-10 -85.13 142.01 29.81 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 113.061 -1.881 . . . . 1.8799999999999999 107.69 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.684 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -142.02 -174.34 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.257 -0.883 . . . . 1.04 112.122 -175.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.709 ' O ' ' HB2' ' A' ' 444' ' ' ASN . 0.2 OUTLIER -152.46 117.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.931 . . . . 1.04 109.318 175.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.544 ' OG ' HD13 ' A' ' 443' ' ' ILE . 30.2 t -141.54 148.25 39.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.963 0.727 . . . . 1.0 112.963 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.665 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.7 44.96 47.02 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 116.197 1.239 . . . . 0.13 116.197 162.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.559 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.9 143.76 4.2 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 118.317 1.058 . . . . 1.2 109.977 -174.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.776 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.19 -32.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.826 1 C-N-CA 125.705 4.27 . . . . 0.26000000000000001 116.08 -170.681 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' THR . . . . . 0.528 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.35 -34.56 31.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.359 0.599 . . . . 1.0600000000000001 110.755 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.487 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 m -140.04 73.04 33.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 122.125 0.964 . . . . 1.0800000000000001 110.302 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.665 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.81 161.47 44.97 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 125.22 3.947 . . . . 0.19 113.869 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.569 HG23 HD12 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.52 151.97 91.71 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 113.333 -1.758 . . . . 1.04 111.05 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.553 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.9 Cg_endo -80.0 -48.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 125.277 3.984 . . . . 0.10000000000000001 113.913 -170.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.648 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.32 122.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.992 1.108 . . . . 1.01 113.992 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.36 -125.88 1.43 Allowed Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.121 -1.4 . . . . 0.11 110.778 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . 0.401 HG11 ' O ' ' A' ' 381' ' ' VAL . 12.7 p -125.77 112.57 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.921 0.867 . . . . 1.54 108.761 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.644 ' CE2' HG23 ' A' ' 465' ' ' VAL . 98.1 m-85 -114.17 163.35 15.34 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.296 -0.866 . . . . 0.26000000000000001 109.994 -169.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.67 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 71.8 m-85 -146.68 136.68 23.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 121.188 -0.205 . . . . 1.1799999999999999 110.974 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.571 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.89 123.13 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 C-N-CA 119.938 -0.705 . . . . 1.05 110.552 177.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -107.08 3.41 25.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.602 -0.727 . . . . 0.20000000000000001 112.035 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.694 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -165.4 148.44 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.461 -0.79 . . . . 0.40999999999999998 110.764 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 13.5 mtpt -107.59 109.05 20.6 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.444 -0.798 . . . . 1.8200000000000001 109.714 168.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.3 mt-10 -106.41 121.21 43.8 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.44 1.114 . . . . 0.38 110.634 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -120.62 134.84 55.24 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.535 -1.211 . . . . 1.96 110.511 -174.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.58 38.72 23.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 123.636 1.684 . . . . 0.40000000000000002 107.141 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.537 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.29 169.4 11.14 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 112.1 -2.318 . . . . 0.98999999999999999 111.671 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' THR . . . . . 0.4 ' CG2' ' HG2' ' A' ' 404' ' ' GLU . 7.6 m -127.24 105.12 8.34 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 113.417 -1.719 . . . . 1.02 109.626 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.69 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.27 157.67 35.42 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 112.963 -1.926 . . . . 1.03 110.302 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.1 mtpt -148.03 -175.69 4.99 Favored 'General case' 0 N--CA 1.397 -3.094 0 CA-C-N 114.793 -1.094 . . . . 1.26 108.454 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.674 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.45 -141.69 4.89 Favored Glycine 0 CA--C 1.485 -1.816 0 C-N-CA 116.984 -2.531 . . . . 0.81000000000000005 115.13 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' THR . . . . . 0.406 ' HB ' ' HA2' ' A' ' 400' ' ' GLY . 0.6 OUTLIER -142.45 124.12 15.02 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 112.996 -1.602 . . . . 1.2 108.755 172.266 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.539 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -54.36 -178.35 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 112.093 -2.321 . . . . 1.1200000000000001 111.991 177.305 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -51.02 -25.18 4.45 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.834 -0.621 . . . . 1.6499999999999999 111.6 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 1.1 p30 -102.39 -29.53 11.58 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.193 0.52 . . . . 2.0 111.915 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 396' ' ' THR . . . 114.67 36.85 1.23 Allowed Glycine 0 C--N 1.296 -1.678 0 C-N-CA 119.53 -1.319 . . . . 0.70999999999999996 111.491 -172.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 70.9 p -118.22 128.46 25.97 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 106.31 -1.737 . . . . 1.26 106.31 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.674 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 32.3 Cg_exo -64.16 162.27 30.47 Favored 'Trans proline' 0 C--N 1.286 -2.759 0 C-N-CA 121.817 1.678 . . . . 1.1399999999999999 112.801 -174.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.645 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 26.6 p90 -143.88 -169.72 3.16 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.559 -1.655 . . . . 0.84999999999999998 106.959 -176.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.682 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.4 mt-10 -144.67 159.54 42.66 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.034 0.921 . . . . 0.62 111.914 173.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.69 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.68 99.75 10.31 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-N 113.355 -1.748 . . . . 1.9099999999999999 108.046 176.239 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.41 102.83 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.577 2.185 . . . . 0.22 110.653 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.573 HG12 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.31 156.68 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.588 0 CA-C-N 114.146 -1.388 . . . . 1.0900000000000001 109.776 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.42 ' N ' HG11 ' A' ' 407' ' ' VAL . 22.8 m-80 -105.17 -34.67 7.85 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.529 -1.669 . . . . 1.8400000000000001 107.359 -178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.655 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 52.4 m-85 -137.85 119.43 14.97 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.306 -1.77 . . . . 0.88 111.217 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.573 ' HB2' HG12 ' A' ' 407' ' ' VAL . 8.1 t-105 -125.2 135.58 52.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 113.841 -1.527 . . . . 0.14999999999999999 110.185 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.474 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.3 OUTLIER -134.94 85.18 35.59 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 114.992 -1.004 . . . . 1.03 111.152 174.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.694 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 87.5 Cg_endo -72.29 141.23 35.18 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.161 2.574 . . . . 0.23999999999999999 112.469 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -124.97 -15.93 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 113.828 -1.533 . . . . 1.03 111.031 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.93 162.32 32.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.303 -0.862 . . . . 1.5900000000000001 109.393 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -95.03 13.78 23.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.355 0.502 . . . . 0.33000000000000002 112.355 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 13.1 p -94.0 -26.66 16.71 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.531 -1.285 . . . . 1.1499999999999999 107.531 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.67 33.25 0.77 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.108 -1.86 . . . . 0.28000000000000003 112.32 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.681 HG11 ' O ' ' A' ' 441' ' ' GLY . 79.8 t -103.16 148.48 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.184 0.516 . . . . 0.96999999999999997 110.963 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 169.97 -167.43 40.52 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.948 -1.024 . . . . 0.13 111.446 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . 0.401 HG23 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -101.97 140.08 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 109.141 -0.688 . . . . 1.03 109.141 174.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.537 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 32.2 p80 -146.52 160.54 41.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.956 0.884 . . . . 0.17000000000000001 111.712 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.754 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -85.72 136.9 33.16 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 113.817 -1.538 . . . . 0.41999999999999998 107.399 170.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.95 102.01 5.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 123.015 1.388 . . . . 2.0 110.999 -175.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -94.82 -33.48 12.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 112.168 -2.287 . . . . 0.34999999999999998 111.484 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 21.5 p90 -66.48 -27.24 67.64 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.687 -1.142 . . . . 0.19 109.505 175.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.59 ' HB3' HD22 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -121.27 81.27 37.3 Favored Pre-proline 0 CA--C 1.494 -1.202 0 CA-C-N 113.664 -1.607 . . . . 1.3300000000000001 110.351 -174.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -82.2 7.84 4.86 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 125.062 3.841 . . . . 0.28000000000000003 114.162 -163.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -114.58 153.35 30.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 123.462 0.476 . . . . 1.1000000000000001 110.267 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.656 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.47 126.87 2.72 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.756 1.285 . . . . 0.98999999999999999 108.202 -169.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 146.55 -164.54 28.43 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 118.849 -1.643 . . . . 0.13 111.193 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.588 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -27.84 151.04 0.0 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 125.208 1.181 . . . . 0.23000000000000001 113.075 171.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 112.031 -149.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 40.4 mt -97.44 -33.87 11.23 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 110.583 -3.008 . . . . 1.05 107.95 174.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.584 ' HA ' HG22 ' A' ' 369' ' ' VAL . 5.1 p-90 -46.2 -37.45 7.12 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.638 0.586 . . . . 0.22 111.61 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.776 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 32.3 mttt -61.5 -23.74 66.11 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.223 -0.899 . . . . 1.29 112.923 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.5 p -113.58 -35.02 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.886 0.851 . . . . 1.0700000000000001 109.879 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.492 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 3.7 mtp180 -87.2 -16.49 35.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.612 -1.176 . . . . 0.41999999999999998 112.785 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.559 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.01 41.75 39.28 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.264 1.266 . . . . 0.20999999999999999 116.264 159.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.0 m -84.21 133.83 34.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 118.233 1.016 . . . . 0.81999999999999995 108.541 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.426 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 55.4 m80 -103.96 68.14 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.45 -0.781 . . . . 0.5 110.884 -166.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.681 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 89.46 -11.11 70.97 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.518 -1.033 . . . . 0.19 110.518 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.537 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.6 p -90.68 137.24 32.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.211 -0.494 . . . . 1.22 110.667 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.569 HD12 HG23 ' A' ' 377' ' ' THR . 1.4 mp -92.01 120.6 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 CA-C-O 122.734 1.254 . . . . 1.04 111.164 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.709 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.8 OUTLIER -79.42 82.44 5.56 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.317 -2.22 . . . . 2.29 112.14 -177.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.46 ' HA ' HG23 ' A' ' 368' ' ' ILE . 19.6 m -86.75 137.72 33.63 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-O 121.499 0.666 . . . . 1.02 109.599 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 49.4 Cg_exo -58.67 134.12 58.68 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.562 2.174 . . . . 0.12 110.679 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.754 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.9 Cg_exo -56.43 -34.89 95.69 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 C-N-CA 123.881 3.054 . . . . 0.16 112.938 -171.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.8 m -77.21 -37.59 53.12 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.698 -1.137 . . . . 1.47 109.778 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.641 HG12 ' HB ' ' A' ' 366' ' ' THR . 59.2 t -80.77 -27.39 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.835 -0.62 . . . . 1.0600000000000001 111.063 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 409' ' ' TYR . 0.0 OUTLIER -63.62 -35.48 80.66 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-O 121.859 0.838 . . . . 1.0 109.281 177.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -64.54 -25.03 67.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.48 -1.236 . . . . 1.4399999999999999 111.985 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 456' ' ' MET . 16.1 mm-40 -79.1 -46.96 17.0 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 113.692 -1.595 . . . . 0.38 107.64 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.481 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 28.8 tp -64.48 -67.16 0.46 Allowed 'General case' 0 N--CA 1.404 -2.772 0 CA-C-N 111.644 -2.525 . . . . 1.0 112.55 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.636 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 39.8 t80 -49.31 -28.62 5.03 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.216 1.484 . . . . 0.40000000000000002 107.919 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.65 -32.43 74.57 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 112.143 -2.298 . . . . 0.13 112.058 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.648 ' HB2' ' CE2' ' A' ' 356' ' ' TYR . 1.6 ptp -87.83 -48.09 8.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.66 0.743 . . . . 1.02 111.677 172.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.596 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.3 138.39 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 123.604 1.669 . . . . 1.04 114.239 -167.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -136.88 -178.27 5.12 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 110.634 -2.985 . . . . 0.82999999999999996 106.504 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.678 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.0 mtmt -53.17 163.39 0.55 Allowed 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 123.129 1.442 . . . . 1.04 112.661 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.49 4.74 Favored Glycine 0 N--CA 1.423 -2.179 0 CA-C-N 112.496 -2.138 . . . . 0.37 112.26 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 462' ' ' PRO . 8.7 m -76.65 141.61 69.21 Favored Pre-proline 0 N--CA 1.433 -1.321 0 N-CA-C 109.335 -0.617 . . . . 1.01 109.335 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.609 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -75.26 166.34 29.08 Favored 'Trans proline' 0 N--CA 1.425 -2.525 0 C-N-CA 121.833 1.689 . . . . 0.17000000000000001 110.865 173.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.627 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.71 155.79 39.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 107.449 -1.315 . . . . 1.75 107.449 167.036 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.455 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -126.39 145.06 50.61 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.327 -0.851 . . . . 1.04 110.051 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.648 ' CG2' ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.22 147.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 N-CA-C 107.189 -1.411 . . . . 1.02 107.189 164.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.471 ' HA ' ' CB ' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.274 -0.869 . . . . 1.1599999999999999 111.496 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.35 -0.7 . . . . 4.3899999999999997 111.35 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' HIS . . . . . 0.404 ' CD2' HD22 ' A' ' 464' ' ' LEU . 3.2 t-160 62.24 90.79 0.07 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.737 0.779 . . . . 2.1899999999999999 110.861 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 37.2 mtm 63.76 -171.81 0.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.699 -1.592 . . . . 1.23 111.744 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.83 -3.17 0.4 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.253 -0.885 . . . . 1.1000000000000001 111.392 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -55.67 167.71 0.51 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.954 1.359 . . . . 0.97999999999999998 113.117 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' THR . . . . . 0.586 HG22 ' HA ' ' A' ' 358' ' ' LYS . 8.5 m -92.26 121.92 34.24 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 113.376 -1.738 . . . . 1.04 107.761 168.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' TYR . . . . . 1.662 ' HD2' ' CD1' ' A' ' 344' ' ' TYR . 8.0 p90 -157.11 -171.08 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.596 0.712 . . . . 0.94999999999999996 111.178 -174.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ILE . . . . . 0.58 HD13 ' CB ' ' A' ' 457' ' ' VAL . 10.3 mm -103.05 161.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.055 -1.091 . . . . 1.02 108.055 167.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.479 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.1 tt0 -141.53 155.36 45.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.493 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.604 HG23 ' HG3' ' A' ' 354' ' ' MET . 76.2 t -150.98 137.4 12.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.701 -1.136 . . . . 1.03 110.355 -177.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -123.48 107.34 11.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.852 -1.166 . . . . 0.37 107.852 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.42 HD23 ' H ' ' A' ' 349' ' ' LEU . 2.3 mm? -68.26 -39.43 82.2 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 113.228 -1.805 . . . . 1.0600000000000001 111.24 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.4 -55.78 16.16 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.022 -2.354 . . . . 1.51 111.432 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -93.51 11.83 27.25 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.62 -1.173 . . . . 0.91000000000000003 108.654 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' GLN . . . . . 0.697 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 2.4 mm-40 35.36 73.28 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 125.537 1.773 . . . . 2.6299999999999999 113.079 177.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.0 t60 -151.15 125.59 9.48 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.333 -0.849 . . . . 0.17000000000000001 109.625 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' MET . . . . . 0.604 ' HG3' HG23 ' A' ' 347' ' ' VAL . 3.0 ttp -113.34 127.48 56.15 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.478 0.711 . . . . 0.97999999999999998 110.358 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' TRP . . . . . 0.669 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.5 m-90 -113.14 173.68 6.27 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.659 -1.155 . . . . 0.11 111.886 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' TYR . . . . . 1.607 ' HE1' ' CE2' ' A' ' 356' ' ' TYR . 2.5 t80 -127.12 117.44 22.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.625 -1.62 . . . . 1.02 106.625 165.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 357' ' ' TYR . 26.5 m-85 -101.37 126.33 48.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.146 0.974 . . . . 0.90000000000000002 112.362 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.586 ' HA ' HG22 ' A' ' 343' ' ' THR . 3.8 ttpt -148.96 137.5 21.11 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 113.099 -1.864 . . . . 1.21 108.458 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 70.52 15.98 7.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 113.334 -1.757 . . . . 0.59999999999999998 108.822 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.03 78.87 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 112.561 -2.109 . . . . 0.23999999999999999 111.551 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LYS . . . . . 0.575 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -133.86 169.75 16.62 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.344 -1.928 . . . . 1.26 106.255 -169.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . 0.586 HG12 ' CD1' ' A' ' 355' ' ' TRP . 3.2 m -101.03 137.5 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 CA-C-O 124.325 2.012 . . . . 1.26 111.824 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ALA . . . . . 0.575 ' HB2' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -24.31 18.85 Favored 'General case' 0 N--CA 1.398 -3.047 0 CA-C-N 109.211 -3.632 . . . . 1.03 108.573 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . 0.659 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.71 154.93 35.0 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.729 -1.578 . . . . 1.01 108.919 -172.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.669 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -166.08 122.06 1.29 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.562 -175.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.641 ' HB ' HG12 ' A' ' 449' ' ' VAL . 5.7 t -148.7 167.58 25.16 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-O 122.22 1.009 . . . . 0.98999999999999999 112.3 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ASP . . . . . 0.514 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 6.3 p-10 -86.09 139.9 30.71 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.163 -1.835 . . . . 1.8799999999999999 107.913 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.697 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -140.8 -172.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.138 -0.937 . . . . 1.04 112.22 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.82 115.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.133 -0.939 . . . . 1.04 109.704 174.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' SER . . . . . 0.615 ' OG ' HD13 ' A' ' 443' ' ' ILE . 30.2 t -140.54 149.67 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 1.0 112.535 -169.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.715 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.35 44.17 52.57 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 116.854 1.502 . . . . 0.13 116.854 162.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' LYS . . . . . 0.515 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 1.6 pttt -47.61 146.1 3.86 Favored Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 119.153 1.477 . . . . 1.2 110.683 -174.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' PRO . . . . . 0.784 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -34.19 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 1 C-N-CA 125.985 4.457 . . . . 0.26000000000000001 115.71 -174.127 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.1 p -77.43 -39.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.171 0.51 . . . . 1.0600000000000001 110.975 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' THR . . . . . 0.491 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 4.1 m -140.21 72.83 32.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 122.263 1.03 . . . . 1.0800000000000001 110.197 -177.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' PRO . . . . . 0.715 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 31.9 Cg_exo -69.13 164.46 33.84 Favored 'Trans proline' 0 C--N 1.322 -0.84 1 C-N-CA 125.64 4.227 . . . . 0.19 114.463 -176.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' THR . . . . . 0.556 HG23 HD12 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -76.4 152.01 83.45 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 113.565 -1.652 . . . . 1.04 110.45 174.506 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.552 ' CD ' HG21 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.55 -49.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.328 -0.516 0 C-N-CA 125.093 3.862 . . . . 0.10000000000000001 113.813 -170.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' ALA . . . . . 0.64 ' HA ' ' CG2' ' A' ' 465' ' ' VAL . . . 68.34 122.8 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.921 1.082 . . . . 1.01 113.921 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.21 -122.26 1.07 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.257 -1.338 . . . . 0.11 111.426 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.01 112.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.86 0.838 . . . . 1.54 108.812 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' PHE . . . . . 0.66 ' CE2' HG23 ' A' ' 465' ' ' VAL . 95.9 m-85 -115.79 161.21 19.07 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.42 -0.809 . . . . 0.26000000000000001 109.697 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' TYR . . . . . 0.671 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -147.78 136.31 21.68 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 121.132 -0.227 . . . . 1.1799999999999999 110.681 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' VAL . . . . . 0.596 HG21 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.6 125.31 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.855 -0.738 . . . . 1.05 110.653 177.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -110.71 0.7 17.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.436 -0.802 . . . . 0.20000000000000001 112.176 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' ASN . . . . . 0.703 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.2 t30 -162.56 149.25 13.08 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.155 -0.93 . . . . 0.40999999999999998 109.639 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -113.0 119.76 39.01 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.807 0.813 . . . . 1.8200000000000001 109.934 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -119.35 121.28 39.2 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.226 -1.352 . . . . 0.38 111.229 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.78 143.58 46.83 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.032 -1.44 . . . . 1.96 109.774 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 24.0 t70 54.1 26.12 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.835 -2.439 . . . . 0.40000000000000002 108.637 -175.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.26 171.16 13.88 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 112.769 -2.014 . . . . 0.98999999999999999 111.879 -167.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 8.9 m -129.89 102.95 6.52 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.628 -1.624 . . . . 1.02 110.159 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . 0.688 ' O ' ' HA ' ' A' ' 404' ' ' GLU . 10.1 mp -72.42 156.89 38.58 Favored 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 112.254 -2.248 . . . . 1.03 110.242 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.7 mtpt -149.14 -175.85 5.13 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 114.436 -1.256 . . . . 1.26 108.419 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' GLY . . . . . 0.549 ' HA3' ' CE2' ' A' ' 403' ' ' TYR . . . -179.08 -138.99 3.41 Favored Glycine 0 CA--C 1.482 -2.023 0 C-N-CA 117.12 -2.467 . . . . 0.81000000000000005 114.515 175.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.11 122.36 13.89 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 113.113 -1.543 . . . . 1.2 108.311 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ASN . . . . . 0.501 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -52.7 -179.69 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 112.652 -2.067 . . . . 1.1200000000000001 111.304 175.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -56.03 -23.95 36.36 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.482 0.658 . . . . 1.6499999999999999 109.954 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.72 -27.18 21.37 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.088 -0.96 . . . . 2.0 111.061 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.75 31.84 5.59 Favored Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 110.328 -1.109 . . . . 0.70999999999999996 110.328 -169.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' THR . . . . . 0.501 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 41.3 p -119.2 127.79 26.29 Favored Pre-proline 0 N--CA 1.42 -1.949 0 N-CA-C 106.746 -1.576 . . . . 1.26 106.746 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 1.0 OUTLIER -71.13 156.0 60.32 Favored 'Trans proline' 0 N--CA 1.407 -3.585 0 C-N-CA 121.124 1.216 . . . . 1.1399999999999999 112.836 -168.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 403' ' ' TYR . 38.9 p90 -131.88 -169.73 2.26 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.516 -1.674 . . . . 0.84999999999999998 107.491 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.8 mt-10 -144.59 159.6 42.53 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.535 1.16 . . . . 0.62 111.446 173.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' SER . . . . . 0.688 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.44 99.23 9.71 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 112.822 -1.99 . . . . 1.9099999999999999 107.791 174.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.7 Cg_endo -68.17 102.1 0.77 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.269 1.979 . . . . 0.22 110.362 174.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' VAL . . . . . 0.557 HG12 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.69 162.56 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.631 0 CA-C-N 114.446 -1.252 . . . . 1.0900000000000001 109.95 -173.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' ASN . . . . . 0.548 ' N ' HG11 ' A' ' 407' ' ' VAL . 23.4 m-80 -112.14 -34.99 5.77 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 113.597 -1.638 . . . . 1.8400000000000001 107.018 -177.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' TYR . . . . . 1.67 ' HE1' ' CE2' ' A' ' 409' ' ' TYR . 54.5 m-85 -134.56 115.89 14.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.966 -1.925 . . . . 0.88 110.879 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' TRP . . . . . 0.572 ' HB3' ' CB ' ' A' ' 388' ' ' GLU . 7.9 t-105 -123.41 134.78 53.93 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.237 -1.347 . . . . 0.14999999999999999 110.263 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' MET . . . . . 0.464 ' HE2' ' CG2' ' A' ' 457' ' ' VAL . 0.1 OUTLIER -135.83 86.18 27.92 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 114.808 -1.087 . . . . 1.03 111.293 174.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . 0.703 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 98.1 Cg_endo -71.84 140.03 34.52 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.961 2.441 . . . . 0.23999999999999999 112.175 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' ILE . . . . . 0.671 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.2 pt -123.05 -15.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 113.883 -1.508 . . . . 1.03 110.869 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -134.86 163.55 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 1.5900000000000001 109.552 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -95.03 13.83 23.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.529 0.566 . . . . 0.33000000000000002 112.529 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.6 p -93.1 -27.22 17.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.412 -1.329 . . . . 1.1499999999999999 107.412 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.61 30.89 0.86 Allowed Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 112.919 -1.946 . . . . 0.28000000000000003 112.086 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' VAL . . . . . 0.679 HG11 ' O ' ' A' ' 441' ' ' GLY . 70.7 t -102.08 148.88 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 120.564 -0.455 . . . . 0.96999999999999997 110.976 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 171.49 -166.47 39.51 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.118 -0.946 . . . . 0.13 111.812 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.95 141.04 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.815 -0.809 . . . . 1.03 108.815 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' HIS . . . . . 0.554 ' HB2' HG22 ' A' ' 407' ' ' VAL . 33.5 p80 -150.22 165.55 32.6 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.721 0.772 . . . . 0.17000000000000001 111.215 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.72 147.98 22.59 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 113.9 -1.5 . . . . 0.41999999999999998 107.11 171.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' SER . . . . . 0.486 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 3.7 t -141.87 103.97 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.988 1.375 . . . . 2.0 110.589 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.63 -30.23 15.05 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 111.915 -2.402 . . . . 0.34999999999999998 111.13 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 17.1 p90 -68.95 -27.02 65.36 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 114.52 -1.218 . . . . 0.19 109.352 176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLN . . . . . 0.486 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -119.44 81.18 22.76 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 113.581 -1.645 . . . . 1.3300000000000001 109.311 -176.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -82.32 8.13 4.7 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 124.95 3.767 . . . . 0.28000000000000003 113.694 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -114.08 147.64 38.41 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.925 0.765 . . . . 1.1000000000000001 109.572 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' TYR . . . . . 0.514 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.8 OUTLIER -158.84 128.43 5.65 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.993 1.317 . . . . 0.98999999999999999 107.67 -172.16 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.33 -165.16 28.67 Favored Glycine 0 N--CA 1.431 -1.68 0 C-N-CA 118.884 -1.627 . . . . 0.13 111.196 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' GLY . . . . . 0.594 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.36 154.02 0.0 OUTLIER Glycine 0 C--N 1.336 0.58 0 O-C-N 124.879 0.988 . . . . 0.23000000000000001 113.013 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.409 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.0 m-20 -56.47 101.32 0.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 123.612 1.673 . . . . 0.33000000000000002 112.143 -147.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.8 mt -97.8 -31.94 11.97 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 110.654 -2.975 . . . . 1.05 108.178 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' TRP . . . . . 0.583 ' HA ' HG22 ' A' ' 369' ' ' VAL . 9.0 p-90 -44.78 -40.23 5.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.674 0.609 . . . . 0.22 111.737 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' LYS . . . . . 0.784 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 37.0 mttt -61.14 -23.68 65.71 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 113.009 0.744 . . . . 1.29 113.009 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.2 p -113.57 -35.92 5.08 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.455 -0.793 . . . . 1.0700000000000001 110.208 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.477 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.4 mtp85 -88.91 -15.69 33.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.858 -1.064 . . . . 0.41999999999999998 113.204 -168.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' GLY . . . . . 0.515 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 76.46 41.45 25.17 Favored Glycine 0 C--N 1.31 -0.914 0 N-CA-C 116.59 1.396 . . . . 0.20999999999999999 116.59 158.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 21.6 m -83.51 141.8 31.37 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 118.136 0.968 . . . . 0.81999999999999995 108.752 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' HIS . . . . . 0.502 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 57.8 m80 -109.31 73.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.726 -0.609 . . . . 0.5 110.836 -170.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' GLY . . . . . 0.679 ' O ' HG11 ' A' ' 418' ' ' VAL . . . 82.8 -8.54 62.35 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.914 -0.874 . . . . 0.19 110.914 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' CYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -96.06 131.96 41.92 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.322 0.582 . . . . 1.22 110.526 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' ILE . . . . . 0.615 HD13 ' OG ' ' A' ' 370' ' ' SER . 1.5 mp -88.77 117.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.283 -0.871 . . . . 1.04 111.109 -174.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ASN . . . . . 0.533 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 2.8 t30 -78.44 82.54 4.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.492 -1.685 . . . . 2.29 111.572 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.7 m -87.78 140.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.508 0.67 . . . . 1.02 110.048 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.4 Cg_exo -57.37 136.48 76.37 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.815 2.343 . . . . 0.12 111.714 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' PRO . . . . . 0.742 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 52.3 Cg_exo -56.03 -32.53 86.58 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.296 3.331 . . . . 0.16 112.888 -173.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.1 p -81.72 -38.22 26.09 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.717 -1.129 . . . . 1.47 110.115 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' VAL . . . . . 0.641 HG12 ' HB ' ' A' ' 366' ' ' THR . 88.2 t -80.29 -29.88 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.326 0.584 . . . . 1.0600000000000001 111.407 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' MET . . . . . 0.678 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.0 tpt -66.65 -19.62 65.81 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.842 0.83 . . . . 1.0 110.115 177.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.94 -23.6 41.59 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.511 -1.222 . . . . 1.4399999999999999 111.124 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' GLU . . . . . 0.653 ' O ' ' HG2' ' A' ' 456' ' ' MET . 6.8 mm-40 -78.31 -47.36 17.94 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 113.192 -1.822 . . . . 0.38 107.103 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' LEU . . . . . 0.602 HD21 ' SD ' ' A' ' 450' ' ' MET . 26.5 tp -63.92 -67.36 0.44 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.642 -2.526 . . . . 1.0 112.292 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 454' ' ' PHE . 38.1 t80 -49.95 -26.93 4.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 123.193 1.473 . . . . 0.40000000000000002 108.303 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.86 -31.81 66.95 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 112.426 -2.17 . . . . 0.13 112.291 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' MET . . . . . 0.659 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -87.5 -48.0 8.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.637 0.732 . . . . 1.02 111.586 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' VAL . . . . . 0.58 ' CB ' HD13 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -102.84 139.05 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 123.407 1.575 . . . . 1.04 114.06 -168.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.46 -178.62 5.25 Favored 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 110.961 -2.836 . . . . 0.82999999999999996 107.108 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' LYS . . . . . 0.696 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -50.44 160.8 0.36 Allowed 'General case' 0 N--CA 1.411 -2.385 0 CA-C-O 123.043 1.401 . . . . 1.04 113.109 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.26 -35.93 3.78 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 112.565 -2.107 . . . . 0.37 112.354 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' THR . . . . . 0.481 ' O ' HG13 ' A' ' 384' ' ' VAL . 3.9 m -74.44 141.12 76.31 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 109.452 -0.573 . . . . 1.01 109.452 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' PRO . . . . . 0.604 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 5.1 Cg_exo -75.18 166.26 29.36 Favored 'Trans proline' 0 N--CA 1.422 -2.682 0 C-N-CA 121.98 1.787 . . . . 0.17000000000000001 111.07 174.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' VAL . . . . . 0.617 HG23 ' CB ' ' A' ' 382' ' ' PHE . 1.1 m -133.65 154.76 39.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 107.455 -1.313 . . . . 1.75 107.455 166.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.461 HD21 ' CG ' ' A' ' 346' ' ' GLU . 3.0 tp -124.36 144.82 49.81 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.317 -0.856 . . . . 1.04 110.087 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' VAL . . . . . 0.66 HG23 ' CE2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -143.17 146.67 21.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.843 -1.54 . . . . 1.02 106.843 165.1 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' PHE . . . . . 0.479 ' HE2' ' HG2' ' A' ' 346' ' ' GLU . 15.4 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.79 -0.624 . . . . 1.1599999999999999 111.486 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.647 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.4 m . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 107.396 -1.335 . . . . 0.45000000000000001 107.396 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.672 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 17.8 p90 -163.33 -170.84 2.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.76 0.791 . . . . 0.32000000000000001 111.04 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.553 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -103.85 156.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.603 -1.18 . . . . 0.080000000000000002 107.938 166.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.538 ' HG3' HD23 ' A' ' 464' ' ' LEU . 4.7 tt0 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.171 0.896 . . . . 0.17000000000000001 110.595 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.678 HG22 ' HG3' ' A' ' 354' ' ' MET . 66.8 t -149.27 137.27 14.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.614 -1.176 . . . . 0.080000000000000002 109.098 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 466' ' ' PHE . 7.8 t70 -120.42 115.02 22.68 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.077 -1.083 . . . . 0.37 108.077 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.523 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -66.2 -48.37 70.85 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 123.099 1.428 . . . . 0.32000000000000001 110.195 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.32 -52.01 49.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 112.623 -2.081 . . . . 1.51 112.901 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -102.71 9.74 38.99 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.191 -1.368 . . . . 0.91000000000000003 108.664 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.728 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 83.7 mm-40 36.09 72.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 125.154 1.534 . . . . 2.2200000000000002 111.8 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.6 t60 -150.11 126.41 10.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.641 -1.163 . . . . 0.13 109.469 -176.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.678 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -112.99 128.34 56.47 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.659 0.783 . . . . 0.059999999999999998 110.618 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.68 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.75 173.61 6.34 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.513 -1.221 . . . . 0.10000000000000001 111.889 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.615 ' CE2' ' HB2' ' A' ' 456' ' ' MET . 1.2 t80 -125.1 115.92 21.26 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.336 -1.727 . . . . 0.22 106.336 165.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.515 ' HB2' ' CE1' ' A' ' 344' ' ' TYR . 27.9 m-85 -101.24 127.29 47.89 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.153 0.978 . . . . 0.17999999999999999 112.021 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.647 ' HA ' HG23 ' A' ' 343' ' ' THR . 2.8 ttpt -148.26 137.19 21.81 Favored 'General case' 0 N--CA 1.399 -3.023 0 CA-C-N 113.376 -1.738 . . . . 0.46999999999999997 108.628 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.9 OUTLIER 71.29 13.84 6.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 113.159 -1.837 . . . . 0.59999999999999998 108.992 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.89 74.97 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 112.783 -2.008 . . . . 0.23000000000000001 111.771 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.573 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.09 168.11 19.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 105.991 -1.855 . . . . 0.68000000000000005 105.991 -171.037 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.851 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.6 m -101.05 139.02 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-O 124.164 1.935 . . . . 0.53000000000000003 111.868 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.614 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.67 -25.01 18.45 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 109.675 -3.421 . . . . 0.12 108.586 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.659 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.42 155.2 35.9 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 113.711 -1.586 . . . . 0.080000000000000002 109.222 -171.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.851 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.79 122.63 1.41 Allowed 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.736 -0.665 . . . . 0.60999999999999999 109.498 -176.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.69 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.7 t -147.11 166.9 25.5 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.631 0.729 . . . . 0.089999999999999997 110.823 173.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.474 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 48.1 m-20 -84.23 148.76 26.54 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.984 -1.488 . . . . 1.8799999999999999 106.984 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.728 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.4 pp -144.37 -178.32 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.841 0.713 . . . . 0.11 111.535 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -149.85 118.5 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.449 -0.796 . . . . 0.12 109.56 173.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 443' ' ' ILE . 34.3 p -141.32 142.55 33.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.835 -1.075 . . . . 0.69999999999999996 111.699 -165.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.04 44.62 29.25 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 116.678 1.431 . . . . 0.13 116.678 162.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.641 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.65 144.56 3.47 Favored Pre-proline 0 C--O 1.221 -0.439 0 CA-C-N 118.639 1.219 . . . . 0.47999999999999998 110.187 -174.725 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.808 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.12 -28.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.553 1 C-N-CA 126.056 4.504 . . . . 0.23000000000000001 116.215 -172.518 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.641 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -85.45 -32.13 22.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.265 0.555 . . . . 0.29999999999999999 110.813 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.448 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 11.8 m -140.91 72.9 28.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 122.14 0.971 . . . . 0.29999999999999999 110.155 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.739 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.3 Cg_exo -70.85 161.28 46.63 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 125.269 3.979 . . . . 0.16 114.39 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.691 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.64 151.73 89.27 Favored Pre-proline 0 N--CA 1.435 -1.219 0 CA-C-N 113.375 -1.738 . . . . 0.12 110.835 175.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.502 ' CD ' HG22 ' A' ' 377' ' ' THR . 2.0 Cg_endo -81.04 -51.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 125.144 3.896 . . . . 0.089999999999999997 113.886 -171.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.741 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.35 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.301 0.852 . . . . 0.089999999999999997 113.301 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.89 -124.97 1.29 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 114.302 -1.317 . . . . 0.11 111.417 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 381' ' ' VAL . 13.0 p -126.04 108.17 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 122.093 0.949 . . . . 0.89000000000000001 109.222 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.744 ' HB2' HG22 ' A' ' 463' ' ' VAL . 91.8 m-85 -113.68 155.87 24.76 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.128 -0.942 . . . . 0.16 109.633 -170.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.798 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 10.6 m-85 -147.06 139.83 25.01 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 117.872 0.306 . . . . 0.68999999999999995 110.447 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.648 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -74.66 124.3 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 119.88 -0.728 . . . . 0.14000000000000001 110.895 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -107.5 1.96 23.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.314 -0.857 . . . . 0.19 111.925 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.759 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 16.9 t-20 -164.63 150.26 10.19 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.189 -0.914 . . . . 0.40999999999999998 110.276 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 458' ' ' GLU . 15.0 mtpt -111.28 119.41 38.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.783 0.802 . . . . 1.0900000000000001 110.138 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.573 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -118.54 122.1 41.84 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.589 -1.187 . . . . 0.38 111.076 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -120.43 136.96 54.57 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.416 -1.265 . . . . 1.96 109.95 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.6 t70 52.21 38.82 25.58 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 123.584 1.659 . . . . 0.40000000000000002 107.292 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.573 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -91.74 170.44 9.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 112.329 -2.214 . . . . 0.16 111.907 -175.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 15.5 m -129.86 104.54 7.44 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.691 -1.595 . . . . 0.27000000000000002 109.545 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.72 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.02 155.0 40.8 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.147 -1.842 . . . . 0.23999999999999999 109.713 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.425 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 10.3 mtpt . . . . . 0 N--CA 1.4 -2.931 0 CA-C-N 114.704 -1.134 . . . . 0.67000000000000004 108.415 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.7 mt-10 . . . . . 0 CA--C 1.508 -0.667 0 CA-C-O 122.604 1.192 . . . . 0.62 112.224 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.72 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -141.59 98.85 6.4 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.443 -2.162 . . . . 1.3300000000000001 107.562 172.16 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.2 Cg_endo -67.72 103.38 0.84 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.496 2.131 . . . . 0.20000000000000001 110.613 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.55 161.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-N 114.332 -1.304 . . . . 0.29999999999999999 110.242 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -113.4 -32.23 6.31 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.5 -1.682 . . . . 1.8400000000000001 107.501 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.47 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 67.1 m-85 -136.56 116.02 12.78 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.828 -1.987 . . . . 0.44 110.713 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.757 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -125.01 135.21 52.56 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.656 -1.156 . . . . 0.13 110.379 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.483 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -136.07 86.3 26.26 Favored Pre-proline 0 C--N 1.3 -1.583 0 CA-C-N 114.941 -1.027 . . . . 0.40999999999999998 111.205 174.06 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.697 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.9 Cg_endo -71.44 139.93 35.58 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 122.993 2.462 . . . . 0.16 112.427 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -124.03 -15.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.751 -1.568 . . . . 0.17000000000000001 110.941 -174.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -133.72 165.28 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.171 -0.922 . . . . 1.5900000000000001 109.582 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -98.47 15.22 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.215 0.45 . . . . 0.31 112.215 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.8 p -95.04 -26.81 15.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.601 -1.259 . . . . 0.44 107.601 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.75 31.72 1.01 Allowed Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 112.927 -1.942 . . . . 0.23999999999999999 111.971 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 441' ' ' GLY . 81.6 t -101.6 148.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.204 0.525 . . . . 0.17000000000000001 110.775 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 171.57 -167.49 40.56 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.735 -1.12 . . . . 0.10000000000000001 111.191 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.74 139.53 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.875 -0.787 . . . . 0.12 108.875 175.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.626 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 30.9 p80 -149.2 163.31 37.99 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.823 0.821 . . . . 0.14999999999999999 111.792 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.782 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.92 138.27 31.72 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.091 -1.413 . . . . 0.41999999999999998 107.453 172.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.8 OUTLIER -131.36 101.07 5.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.48 1.133 . . . . 1.48 109.057 -174.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -95.18 -35.26 11.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.953 -1.931 . . . . 0.34999999999999998 111.562 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.438 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 21.1 p90 -63.53 -26.96 68.94 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.398 -1.274 . . . . 0.17999999999999999 109.055 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.809 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.81 83.42 36.39 Favored Pre-proline 0 CA--C 1.498 -1.035 0 CA-C-N 113.404 -1.726 . . . . 1.3300000000000001 109.966 -172.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -80.93 5.53 6.15 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 124.901 3.734 . . . . 0.23000000000000001 114.649 -160.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.2 156.35 23.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.975 0.417 . . . . 1.1000000000000001 111.021 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.474 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.83 125.15 2.31 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.653 -1.158 . . . . 0.38 109.312 -171.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.94 -166.3 28.87 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 119.659 -1.258 . . . . 0.13 111.769 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.641 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.02 155.67 0.0 OUTLIER Glycine 0 C--N 1.339 0.745 0 O-C-N 125.21 1.182 . . . . 0.20000000000000001 112.989 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.415 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.7 m-20 -56.36 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 123.97 1.843 . . . . 0.33000000000000002 112.134 -147.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 51.3 mt -96.49 -32.62 12.2 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 110.342 -3.117 . . . . 0.17999999999999999 108.055 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.572 ' HA ' HG23 ' A' ' 369' ' ' VAL . 4.4 p-90 -46.24 -37.27 7.0 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 124.002 0.814 . . . . 0.22 111.15 -174.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.808 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 40.2 mttt -59.28 -27.19 65.61 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.695 -1.138 . . . . 0.64000000000000001 112.762 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -112.3 -36.41 5.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.604 -0.726 . . . . 0.25 109.908 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.567 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.7 mtp85 -84.53 -15.46 45.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.542 -1.208 . . . . 0.35999999999999999 113.038 -167.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.03 41.58 31.92 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 116.769 1.468 . . . . 0.20999999999999999 116.769 159.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.6 m -85.74 131.73 34.27 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 118.272 1.036 . . . . 0.46999999999999997 109.228 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 75.1 m-70 -97.05 67.43 2.21 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.67 -0.643 . . . . 0.40999999999999998 111.358 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.46 -13.6 59.93 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.213 -1.155 . . . . 0.17999999999999999 110.213 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.626 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.0 p -86.15 140.92 29.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.708 -0.746 . . . . 0.82999999999999996 110.164 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.691 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -94.98 115.33 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.549 0.69 . . . . 0.14999999999999999 111.087 -176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.809 ' OD1' ' HB3' ' A' ' 426' ' ' GLN . 0.1 OUTLIER -76.66 89.41 3.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.606 -1.179 . . . . 1.77 111.021 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.564 HG23 HG21 ' A' ' 366' ' ' THR . 32.0 m -91.22 140.62 25.79 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.47 0.652 . . . . 0.17999999999999999 109.335 174.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 49.7 Cg_exo -57.84 136.27 74.26 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.801 2.334 . . . . 0.12 111.836 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.782 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.6 Cg_exo -55.72 -32.49 84.22 Favored 'Trans proline' 0 CA--C 1.501 -1.133 0 C-N-CA 124.244 3.296 . . . . 0.16 113.069 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.5 p -82.02 -38.7 24.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.63 -1.168 . . . . 1.1699999999999999 110.348 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.69 HG11 ' HB ' ' A' ' 366' ' ' THR . 59.0 t -80.64 -29.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.374 0.607 . . . . 0.17000000000000001 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.689 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.3 tpt -67.92 -19.18 64.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.945 0.878 . . . . 0.46000000000000002 109.969 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.04 -22.54 42.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.442 -1.254 . . . . 0.81000000000000005 110.777 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.98 -46.85 14.47 Favored 'General case' 0 CA--C 1.476 -1.89 0 CA-C-N 112.991 -1.913 . . . . 0.38 107.438 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.607 HD23 ' SD ' ' A' ' 450' ' ' MET . 27.2 tp -64.76 -67.19 0.46 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 111.872 -2.422 . . . . 0.059999999999999998 112.486 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.43 ' HB2' ' HE3' ' A' ' 450' ' ' MET . 19.3 t80 -50.47 -26.18 4.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.0 1.381 . . . . 0.31 108.066 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.31 -30.24 67.37 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 112.517 -2.129 . . . . 0.13 112.296 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.659 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.05 -48.42 7.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.775 0.797 . . . . 0.13 111.444 171.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.553 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.8 OUTLIER -103.38 138.01 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 123.415 1.578 . . . . 0.23000000000000001 114.103 -167.043 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 387' ' ' LYS . 6.8 pt-20 -137.22 -178.18 5.09 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 110.754 -2.93 . . . . 0.82999999999999996 106.778 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.759 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.0 mtmt -51.48 161.28 0.49 Allowed 'General case' 0 N--CA 1.412 -2.354 0 CA-C-O 122.894 1.331 . . . . 0.23999999999999999 112.534 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.55 -28.95 8.29 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-N 112.646 -2.07 . . . . 0.37 112.185 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 462' ' ' PRO . 10.0 m -84.96 140.9 37.39 Favored Pre-proline 0 N--CA 1.433 -1.292 0 N-CA-C 108.534 -0.913 . . . . 0.14999999999999999 108.534 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.93 173.69 13.65 Favored 'Trans proline' 0 N--CA 1.416 -3.084 0 C-N-CA 121.097 1.198 . . . . 0.12 111.738 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.31 159.54 35.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.642 -1.244 . . . . 1.0900000000000001 107.642 167.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.538 HD23 ' HG3' ' A' ' 346' ' ' GLU . 2.8 tp -130.27 146.11 51.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 115.159 -0.928 . . . . 0.13 110.046 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.741 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 146.82 20.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.292 -1.373 . . . . 0.089999999999999997 107.292 165.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.481 ' CE2' ' HG2' ' A' ' 346' ' ' GLU . 19.9 p90 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.533 -0.746 . . . . 1.1599999999999999 111.464 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 358' ' ' LYS . 97.2 m . . . . . 0 N--CA 1.426 -1.669 0 N-CA-C 108.539 -0.911 . . . . 0.45000000000000001 108.539 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.633 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.5 p90 -162.44 -170.32 2.4 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.461 -1.245 . . . . 0.32000000000000001 110.489 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.9 mm -102.19 157.32 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.071 -1.085 . . . . 0.080000000000000002 108.071 165.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.523 ' HG3' HD23 ' A' ' 464' ' ' LEU . 4.6 tt0 -139.06 154.39 48.19 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 118.617 0.644 . . . . 0.17000000000000001 110.543 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.655 HG22 ' HG3' ' A' ' 354' ' ' MET . 53.5 t -149.98 136.38 12.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.035 -0.984 . . . . 0.080000000000000002 109.988 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -117.19 116.31 27.03 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.703 -1.135 . . . . 0.37 108.24 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -69.02 -49.03 61.29 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.53 1.157 . . . . 0.32000000000000001 110.452 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.69 -54.82 36.78 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.835 -1.984 . . . . 1.51 112.213 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -96.62 10.08 39.61 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.559 -1.201 . . . . 0.91000000000000003 108.601 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.79 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.1 mm-40 38.16 71.85 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 125.315 1.634 . . . . 2.2200000000000002 111.98 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.442 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -152.68 124.91 8.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.548 -0.751 . . . . 0.13 109.634 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.655 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.7 ttp -111.87 128.61 56.18 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.667 -0.697 . . . . 0.059999999999999998 110.3 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.682 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.25 173.05 6.55 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 114.595 -1.184 . . . . 0.10000000000000001 111.899 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.559 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.3 OUTLIER -125.38 112.78 16.71 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.621 -1.992 . . . . 0.22 105.621 163.449 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 25.6 m-85 -94.97 125.09 39.4 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.499 -0.88 . . . . 0.17999999999999999 110.963 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.565 ' HA ' HG23 ' A' ' 343' ' ' THR . 37.3 ttmt -134.42 137.38 43.98 Favored 'General case' 0 N--CA 1.387 -3.583 0 CA-C-N 114.332 -1.304 . . . . 0.46999999999999997 109.68 173.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.32 12.22 7.05 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 112.941 -1.936 . . . . 0.59999999999999998 109.092 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 88.61 14.28 61.73 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 112.79 -2.005 . . . . 0.23000000000000001 112.301 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -128.36 172.65 10.89 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.383 -2.081 . . . . 0.68000000000000005 105.383 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.805 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.5 m -104.86 136.01 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 CA-C-O 124.318 2.009 . . . . 0.53000000000000003 112.316 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.5 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -89.49 -25.13 21.6 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.408 -3.542 . . . . 0.12 108.355 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.614 HD13 ' CE ' ' A' ' 456' ' ' MET . 2.7 tp -154.71 154.18 32.48 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.051 -1.431 . . . . 0.080000000000000002 108.927 -172.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.805 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.22 121.51 1.42 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 123.514 0.509 . . . . 0.60999999999999999 109.913 -175.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.636 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.3 t -148.62 167.41 25.52 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 122.225 1.012 . . . . 0.089999999999999997 112.12 175.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.2 p-10 -84.73 141.71 30.35 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 113.238 -1.801 . . . . 1.8799999999999999 107.893 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -142.32 -171.91 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 0.11 112.091 -176.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.79 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -158.31 114.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.035 -0.984 . . . . 0.12 109.283 177.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 15.0 t -141.93 145.46 34.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.908 -1.042 . . . . 0.69999999999999996 112.802 -167.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.696 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.11 44.95 33.67 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 116.747 1.459 . . . . 0.13 116.747 162.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.618 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.75 143.42 6.04 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 118.601 1.2 . . . . 0.47999999999999998 110.456 -174.689 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.822 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.13 -32.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.749 4.299 . . . . 0.23000000000000001 116.089 -171.29 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.618 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 2.0 p -80.23 -35.36 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.36 0.6 . . . . 0.29999999999999999 110.816 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.481 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.1 m -139.77 72.2 35.68 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 122.291 1.043 . . . . 0.29999999999999999 109.688 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.5 Cg_exo -70.21 162.92 40.52 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 125.253 3.969 . . . . 0.16 114.007 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.737 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.82 149.5 83.14 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 113.625 -1.625 . . . . 0.12 110.001 174.637 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.516 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.5 Cg_endo -76.89 -49.0 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 125.108 3.872 . . . . 0.089999999999999997 113.283 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.695 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.69 121.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.965 1.098 . . . . 0.089999999999999997 113.965 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.45 -126.31 1.51 Allowed Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 113.995 -1.457 . . . . 0.11 110.613 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.5 p -126.18 108.98 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.935 0.874 . . . . 0.89000000000000001 108.96 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.632 ' HB3' ' HB ' ' A' ' 413' ' ' ILE . 53.0 m-85 -113.14 170.1 8.46 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.381 -0.827 . . . . 0.16 109.16 -173.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.706 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 79.0 m-85 -150.8 139.81 21.02 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.239 -0.282 . . . . 0.68999999999999995 110.239 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.68 121.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.691 -0.804 . . . . 0.14000000000000001 110.328 176.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 385' ' ' TRP . . . . . 0.44 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 46.6 p-90 -109.66 3.0 20.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.492 -0.777 . . . . 0.19 112.422 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.709 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 12.5 t-20 -161.13 144.72 13.07 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.579 -1.267 . . . . 0.40999999999999998 107.579 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 387' ' ' LYS . 0.3 OUTLIER -118.56 109.85 16.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.324 1.059 . . . . 1.0900000000000001 108.506 -177.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -116.73 130.6 56.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.41 -1.268 . . . . 0.38 110.829 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.79 135.12 48.06 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 113.738 -1.574 . . . . 1.96 109.601 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 23.2 t70 52.95 40.53 31.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 123.298 1.523 . . . . 0.40000000000000002 107.357 -173.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.548 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.19 170.42 9.41 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 112.223 -2.262 . . . . 0.16 111.807 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 5.2 m -127.84 105.53 8.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.942 -1.481 . . . . 0.27000000000000002 110.157 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.74 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.9 mp -74.41 158.35 34.04 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.061 -1.881 . . . . 0.23999999999999999 110.767 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.474 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.4 mtpt . . . . . 0 N--CA 1.396 -3.17 0 CA-C-N 114.72 -1.127 . . . . 0.67000000000000004 108.818 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.0 mt-10 . . . . . 0 CA--C 1.512 -0.489 0 CA-C-O 122.167 0.984 . . . . 0.62 112.028 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.74 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.95 99.97 9.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 113.268 -1.787 . . . . 1.3300000000000001 107.75 176.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 68.3 Cg_endo -68.02 102.31 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.741 2.294 . . . . 0.20000000000000001 110.493 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.739 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.36 160.77 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-N 114.483 -1.235 . . . . 0.29999999999999999 110.563 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -113.3 -31.48 6.58 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.33 -1.759 . . . . 1.8400000000000001 107.564 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 68.2 m-85 -137.18 116.85 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.143 -1.844 . . . . 0.44 110.898 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.739 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.7 t-105 -125.27 134.04 52.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.813 -1.085 . . . . 0.13 111.084 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.501 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.5 mtp -134.57 86.68 33.82 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 114.628 -1.169 . . . . 0.40999999999999998 111.334 173.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 89.7 Cg_endo -72.96 139.08 29.51 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.846 2.364 . . . . 0.16 111.445 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -125.7 -12.85 4.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 0.17000000000000001 111.055 -172.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -133.95 168.85 18.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.845 . . . . 1.5900000000000001 109.448 173.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.5 14.78 28.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.45 0.907 . . . . 0.31 113.45 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.445 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 37.9 p -99.73 -27.69 13.53 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.916 -1.142 . . . . 0.44 107.916 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 134.73 29.72 0.41 Allowed Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 113.814 -1.539 . . . . 0.23999999999999999 112.711 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 441' ' ' GLY . 60.3 t -102.45 146.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.513 0.673 . . . . 0.17000000000000001 111.583 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.19 37.86 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.743 -1.117 . . . . 0.10000000000000001 111.546 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.458 HG12 ' SD ' ' A' ' 354' ' ' MET . 0.9 OUTLIER -104.82 140.93 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.613 -0.884 . . . . 0.12 108.613 176.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.548 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 31.8 p80 -150.78 166.41 30.54 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.672 0.749 . . . . 0.14999999999999999 111.288 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.786 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.44 136.19 33.29 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.193 -1.367 . . . . 0.41999999999999998 107.482 171.757 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 6.2 t -130.86 102.72 6.19 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 122.879 1.324 . . . . 1.48 109.435 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.14 -30.57 14.56 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.387 -2.188 . . . . 0.34999999999999998 110.964 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.455 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 20.6 p90 -68.66 -27.36 65.92 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.436 -1.256 . . . . 0.17999999999999999 109.35 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.604 ' HB3' HD21 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.69 80.16 31.59 Favored Pre-proline 0 CA--C 1.496 -1.114 0 CA-C-N 113.788 -1.551 . . . . 1.3300000000000001 109.615 -176.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -83.71 8.65 4.5 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 C-N-CA 125.248 3.965 . . . . 0.23000000000000001 113.991 -163.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -114.22 148.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.207 -0.664 . . . . 1.1000000000000001 109.207 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.575 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -159.47 131.38 6.37 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.841 1.338 . . . . 0.38 107.497 -171.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 146.56 -166.76 28.18 Favored Glycine 0 C--N 1.296 -1.684 0 C-N-CA 119.19 -1.481 . . . . 0.13 111.036 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.581 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 152.11 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 O-C-N 125.201 1.177 . . . . 0.20000000000000001 112.834 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.77 101.13 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 123.864 1.792 . . . . 0.33000000000000002 111.766 -145.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.8 mt -96.62 -31.57 12.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 110.524 -3.034 . . . . 0.17999999999999999 108.213 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.59 ' HA ' HG23 ' A' ' 369' ' ' VAL . 7.3 p-90 -46.34 -38.48 8.83 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.894 0.746 . . . . 0.22 111.425 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.822 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.5 mttt -62.01 -24.85 67.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.115 -0.948 . . . . 0.64000000000000001 112.819 -175.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.4 p -112.53 -37.45 4.93 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.497 -0.774 . . . . 0.25 110.074 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.506 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.6 mtp85 -82.44 -18.85 40.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.35999999999999999 112.016 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.546 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.02 42.45 24.65 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.709 -1.234 . . . . 0.20999999999999999 115.746 164.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.7 m -85.26 131.54 34.4 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 118.404 1.102 . . . . 0.46999999999999997 108.905 174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -98.83 68.64 1.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.501 -0.749 . . . . 0.40999999999999998 110.609 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.683 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 86.32 -7.76 77.21 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.833 -0.907 . . . . 0.17999999999999999 110.833 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 13.8 p -94.16 128.56 40.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.657 0.742 . . . . 0.82999999999999996 110.789 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.737 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -88.47 112.94 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.821 -1.081 . . . . 0.14999999999999999 110.556 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.604 HD21 ' HB3' ' A' ' 426' ' ' GLN . 2.8 m-20 -78.83 88.84 4.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.851 -1.068 . . . . 1.77 111.263 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.61 HG23 HG21 ' A' ' 366' ' ' THR . 28.5 m -86.69 136.58 34.55 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 108.988 -0.745 . . . . 0.17999999999999999 108.988 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -54.21 135.41 64.65 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.583 2.188 . . . . 0.12 111.083 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.786 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 29.1 Cg_exo -54.6 -31.66 71.27 Favored 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 124.063 3.175 . . . . 0.16 112.816 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.7 -39.2 24.64 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.4 -1.273 . . . . 1.1699999999999999 110.338 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.636 HG11 ' HB ' ' A' ' 366' ' ' THR . 64.2 t -79.26 -30.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.464 0.65 . . . . 0.17000000000000001 111.355 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.7 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 8.1 tpt -67.31 -19.62 65.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.939 0.876 . . . . 0.46000000000000002 110.103 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.34 -22.98 43.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.413 -1.267 . . . . 0.81000000000000005 110.572 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.693 ' O ' ' HG2' ' A' ' 456' ' ' MET . 10.8 mm-40 -80.28 -47.86 13.91 Favored 'General case' 0 CA--C 1.474 -1.965 0 CA-C-N 112.803 -1.999 . . . . 0.38 107.293 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.565 HD23 ' SD ' ' A' ' 450' ' ' MET . 23.6 tp -64.68 -67.45 0.43 Allowed 'General case' 0 N--CA 1.401 -2.885 0 CA-C-N 111.85 -2.432 . . . . 0.059999999999999998 112.631 176.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.501 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 27.8 t80 -51.11 -26.57 6.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.36 1.552 . . . . 0.31 107.989 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.429 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.88 -31.37 72.72 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.04 -2.346 . . . . 0.13 111.948 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.693 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.42 -49.21 6.83 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 121.748 0.785 . . . . 0.13 111.116 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.572 ' CB ' HD11 ' A' ' 345' ' ' ILE . 1.2 p -106.71 133.37 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 CA-C-O 123.635 1.683 . . . . 0.23000000000000001 114.151 -167.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.482 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 9.9 pt-20 -139.93 -177.01 4.79 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 110.379 -3.1 . . . . 0.82999999999999996 106.302 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.2 mtmt -47.09 155.08 0.31 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 122.854 1.311 . . . . 0.23999999999999999 113.679 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.37 -34.23 5.27 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 112.169 -2.287 . . . . 0.37 112.71 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.533 ' HB ' HG23 ' A' ' 457' ' ' VAL . 10.5 m -79.88 142.26 56.15 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-O 120.968 0.414 . . . . 0.14999999999999999 110.035 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.633 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.71 165.01 33.36 Favored 'Trans proline' 0 N--CA 1.433 -2.057 0 C-N-CA 122.353 2.035 . . . . 0.12 111.254 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 81.6 t -135.2 134.8 52.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 113.816 -1.538 . . . . 1.0900000000000001 108.474 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.523 HD23 ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -113.94 143.44 44.7 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.126 -0.488 . . . . 0.13 110.369 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.45 149.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.383 -1.34 . . . . 0.089999999999999997 107.383 165.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.683 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.565 -0.731 . . . . 1.1599999999999999 111.254 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 358' ' ' LYS . 85.4 m . . . . . 0 N--CA 1.426 -1.665 0 N-CA-C 107.255 -1.387 . . . . 0.45000000000000001 107.255 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.679 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 9.7 p90 -156.66 -170.67 3.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.265 -0.88 . . . . 0.32000000000000001 110.625 -174.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.585 HD11 ' CB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.97 161.06 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.271 -1.011 . . . . 0.080000000000000002 108.271 167.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.485 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.1 tt0 -142.24 155.67 45.26 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.691 0.678 . . . . 0.17000000000000001 111.229 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 354' ' ' MET . 60.7 t -150.93 138.35 13.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.648 -1.16 . . . . 0.080000000000000002 109.64 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -117.89 117.74 30.11 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.729 -1.123 . . . . 0.37 107.989 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.529 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -72.69 -45.12 60.45 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.589 0.709 . . . . 0.32000000000000001 110.045 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.12 -45.42 93.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.862 -1.517 . . . . 1.51 112.826 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.26 18.26 21.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.687 -1.142 . . . . 0.91000000000000003 108.928 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.641 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.7 mp0 34.3 68.96 0.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.994 -1.912 . . . . 2.2200000000000002 112.773 171.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.489 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.9 t60 -152.47 125.02 8.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.216 0.531 . . . . 0.13 109.649 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.708 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.8 ttp -111.25 127.48 55.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.649 -0.705 . . . . 0.059999999999999998 110.28 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.658 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.06 173.37 6.39 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.536 -1.211 . . . . 0.10000000000000001 111.746 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.573 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -126.35 116.39 21.13 Favored 'General case' 0 C--O 1.201 -1.468 0 N-CA-C 105.622 -1.992 . . . . 0.22 105.622 163.466 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 20.7 m-85 -97.0 125.09 41.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.43 -0.908 . . . . 0.17999999999999999 111.613 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 343' ' ' THR . 35.6 ttmt -138.23 140.31 39.65 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 113.818 -1.537 . . . . 0.46999999999999997 109.0 173.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.9 t70 65.41 14.56 9.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.473 -1.694 . . . . 0.59999999999999998 109.036 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.29 16.09 72.52 Favored Glycine 0 N--CA 1.419 -2.44 0 CA-C-N 112.281 -2.236 . . . . 0.23000000000000001 111.968 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.649 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -130.84 172.91 11.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.177 -2.157 . . . . 0.68000000000000005 105.177 -173.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.76 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.8 m -102.73 138.49 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 124.136 1.922 . . . . 0.53000000000000003 111.604 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.99 -23.81 18.57 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.529 -3.487 . . . . 0.12 108.243 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.676 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -155.3 154.66 32.44 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.942 -1.481 . . . . 0.080000000000000002 108.72 -172.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.76 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.12 121.87 1.48 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.103 -0.499 . . . . 0.60999999999999999 109.706 -175.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.6 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.7 t -148.1 167.09 25.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 122.473 1.13 . . . . 0.089999999999999997 112.429 174.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.774 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.3 p-10 -83.85 139.92 32.34 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.675 -2.057 . . . . 1.8799999999999999 107.791 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.641 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -143.06 -172.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.501 -0.772 . . . . 0.11 111.886 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.616 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.59 120.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.006 -0.997 . . . . 0.12 108.856 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.467 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.6 t -142.68 145.08 33.05 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.505 -0.77 . . . . 0.69999999999999996 113.038 -167.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.16 46.6 49.75 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 116.959 1.544 . . . . 0.13 116.959 162.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.562 ' HE2' ' CA ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.71 143.21 4.31 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 118.982 1.391 . . . . 0.47999999999999998 110.495 -174.283 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.795 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.17 -32.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 1 C-N-CA 125.866 4.377 . . . . 0.23000000000000001 116.22 -170.466 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.43 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -82.71 -32.81 27.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.181 0.515 . . . . 0.29999999999999999 111.081 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.5 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -139.06 72.51 39.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 122.237 1.018 . . . . 0.29999999999999999 110.059 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.66 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.8 Cg_exo -73.35 163.06 38.8 Favored 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.528 4.152 . . . . 0.16 114.18 -177.552 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.724 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.48 154.17 87.75 Favored Pre-proline 0 N--CA 1.435 -1.211 0 CA-C-N 113.347 -1.751 . . . . 0.12 110.992 175.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.523 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.0 OUTLIER -79.93 -51.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.995 3.797 . . . . 0.089999999999999997 113.641 -172.006 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.705 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.48 122.58 0.03 OUTLIER 'General case' 0 C--O 1.232 0.153 0 N-CA-C 113.474 0.916 . . . . 0.089999999999999997 113.474 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.67 -124.64 1.25 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.243 -1.344 . . . . 0.11 111.384 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.7 p -128.23 107.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.547 1.165 . . . . 0.89000000000000001 109.296 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.763 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.4 m-85 -109.79 160.25 16.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.755 -1.111 . . . . 0.16 109.831 -170.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.681 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 80.8 m-85 -148.23 135.73 20.6 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 119.592 -0.242 . . . . 0.68999999999999995 110.609 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.36 123.6 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.337 -0.945 . . . . 0.14000000000000001 110.656 178.186 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -109.12 2.75 21.29 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.709 -0.678 . . . . 0.19 112.284 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.653 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 20.9 t-20 -161.52 148.07 14.31 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.198 -1.038 . . . . 0.40999999999999998 108.198 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.546 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -117.41 116.67 27.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.948 -1.13 . . . . 1.0900000000000001 107.948 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.569 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -121.49 129.79 53.15 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.689 -1.141 . . . . 0.38 111.045 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.6 mt-10 -128.29 136.1 50.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 113.781 -1.554 . . . . 1.96 109.887 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 38.7 t70 51.67 40.06 26.54 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 123.611 1.672 . . . . 0.40000000000000002 107.213 -172.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.569 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.82 168.19 11.35 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 112.131 -2.304 . . . . 0.16 111.581 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 49.6 m -127.26 101.06 6.32 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.657 -1.61 . . . . 0.27000000000000002 109.959 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.76 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -73.28 157.3 37.31 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 112.765 -2.016 . . . . 0.23999999999999999 110.16 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 9.4 mtpt . . . . . 0 N--CA 1.394 -3.269 0 CA-C-N 114.615 -1.175 . . . . 0.67000000000000004 108.255 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 18.1 mt-10 . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 122.459 1.123 . . . . 0.62 112.678 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.76 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.47 99.05 9.74 Favored Pre-proline 0 N--CA 1.422 -1.859 0 CA-C-N 112.965 -1.925 . . . . 1.3300000000000001 108.525 174.413 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 63.3 Cg_endo -67.9 103.67 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.787 2.324 . . . . 0.20000000000000001 110.604 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 421' ' ' HIS . 1.2 t -118.42 154.37 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 CA-C-N 114.555 -1.202 . . . . 0.29999999999999999 110.578 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.1 OUTLIER -95.91 -34.47 11.81 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.437 -0.801 . . . . 1.8400000000000001 108.881 174.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.478 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 60.2 m-85 -136.91 115.94 12.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.172 -1.376 . . . . 0.44 111.218 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.663 ' HB2' HG11 ' A' ' 407' ' ' VAL . 9.7 t-105 -123.63 134.54 53.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.002 -1.454 . . . . 0.13 111.089 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.542 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.0 OUTLIER -133.97 87.23 35.48 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 114.639 -1.164 . . . . 0.40999999999999998 111.372 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.2 Cg_endo -73.68 140.0 28.8 Favored 'Trans proline' 0 CA--C 1.505 -0.937 0 C-N-CA 123.164 2.576 . . . . 0.16 111.545 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.4 pt -123.35 -17.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.329 -1.305 . . . . 0.17000000000000001 111.425 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.814 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.0 p30 -136.31 173.75 11.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.5900000000000001 110.124 172.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -100.26 15.84 26.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.829 -0.623 . . . . 0.31 111.832 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 16.8 p -97.57 -27.88 14.2 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.051 -1.092 . . . . 0.44 108.051 174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.6 26.98 0.91 Allowed Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 113.874 -1.512 . . . . 0.23999999999999999 113.355 173.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.814 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.8 t -103.64 151.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.704 0.764 . . . . 0.17000000000000001 111.394 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.39 -166.06 36.82 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.562 -1.199 . . . . 0.10000000000000001 110.841 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.439 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -102.73 136.83 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 108.672 -0.862 . . . . 0.12 108.672 175.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.2 p80 -151.1 168.12 25.61 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.142 0.972 . . . . 0.14999999999999999 110.937 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.762 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.09 150.65 22.64 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.359 -1.746 . . . . 0.41999999999999998 108.363 174.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.514 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -138.0 100.34 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.688 1.232 . . . . 1.48 109.989 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -94.61 -31.59 13.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 112.667 -2.061 . . . . 0.34999999999999998 110.189 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.53 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 19.9 p90 -70.17 -27.64 64.69 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 114.52 -1.218 . . . . 0.17999999999999999 109.296 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.542 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.1 OUTLIER -114.73 81.88 7.61 Favored Pre-proline 0 CA--C 1.492 -1.281 0 CA-C-N 113.821 -1.536 . . . . 1.3300000000000001 109.427 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 427' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 27.8 Cg_endo -80.18 5.2 6.19 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 124.788 3.659 . . . . 0.23000000000000001 113.944 -161.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 152.82 32.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 123.702 0.626 . . . . 1.1000000000000001 110.69 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.774 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -164.2 125.4 2.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 114.293 -1.321 . . . . 0.38 108.084 -172.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.32 -165.88 28.61 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.633 -1.27 . . . . 0.13 110.206 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.49 152.53 0.01 OUTLIER Glycine 0 C--N 1.34 0.752 0 O-C-N 125.093 1.114 . . . . 0.20000000000000001 113.178 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.08 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 124.244 1.973 . . . . 0.33000000000000002 112.42 -152.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.5 mt -97.71 -32.5 11.72 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.013 -3.267 . . . . 0.17999999999999999 107.906 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.616 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.9 p-90 -47.8 -39.36 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.873 -0.603 . . . . 0.22 111.568 -173.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.795 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 22.7 mttt -60.33 -25.23 65.64 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.919 -1.037 . . . . 0.64000000000000001 112.595 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 55.5 p -112.09 -36.27 5.41 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.494 -0.775 . . . . 0.25 110.306 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.542 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.7 mtp85 -85.49 -16.18 40.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.905 -1.043 . . . . 0.35999999999999999 112.326 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.562 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.84 43.13 28.93 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 119.425 -1.369 . . . . 0.20999999999999999 116.198 162.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 439' ' ' SER . . . . . 0.541 ' HG ' HG22 ' A' ' 369' ' ' VAL . 2.4 m -82.31 130.92 35.21 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 118.185 0.992 . . . . 0.46999999999999997 108.996 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -98.28 67.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.838 -0.539 . . . . 0.40999999999999998 110.539 -169.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 377' ' ' THR . . . 89.13 -14.7 60.03 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.392 -1.083 . . . . 0.17999999999999999 110.392 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.523 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.9 p -86.75 148.19 25.52 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.344 -0.428 . . . . 0.82999999999999996 110.55 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.724 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -102.47 119.46 50.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.093 -0.503 . . . . 0.14999999999999999 110.191 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.583 ' HB2' HG13 ' A' ' 369' ' ' VAL . 49.6 m-20 -81.55 89.88 6.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.864 -0.607 . . . . 1.77 111.135 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.6 m -88.06 137.93 31.09 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.285 -0.635 . . . . 0.17999999999999999 109.285 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 52.9 Cg_exo -58.6 132.3 47.41 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.905 2.403 . . . . 0.12 113.04 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.762 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.7 Cg_exo -51.07 -40.46 59.42 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.52 2.813 . . . . 0.16 112.052 -169.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.3 m -71.66 -40.83 69.4 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.496 -1.229 . . . . 1.1699999999999999 109.724 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.6 HG11 ' HB ' ' A' ' 366' ' ' THR . 84.5 t -76.51 -31.09 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.626 -0.715 . . . . 0.17000000000000001 111.684 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.702 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.4 tpt -66.49 -21.43 66.18 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.966 0.888 . . . . 0.46000000000000002 110.203 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -76.9 -25.52 53.1 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.18 -1.373 . . . . 0.81000000000000005 111.124 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.727 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -79.07 -47.01 16.93 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 113.41 -1.723 . . . . 0.38 107.392 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.534 HD23 ' SD ' ' A' ' 450' ' ' MET . 24.5 tp -63.75 -67.71 0.41 Allowed 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 111.444 -2.617 . . . . 0.059999999999999998 112.395 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.542 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 33.8 t80 -51.77 -26.85 10.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 123.108 1.432 . . . . 0.31 107.878 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.02 -29.04 72.46 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 112.404 -2.18 . . . . 0.13 112.079 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.727 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.9 ptp -90.78 -48.75 6.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.617 0.722 . . . . 0.13 111.056 170.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.585 ' CB ' HD11 ' A' ' 345' ' ' ILE . 1.1 p -106.87 134.18 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 123.403 1.573 . . . . 0.23000000000000001 114.614 -167.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.546 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 7.8 pt-20 -140.15 -176.19 4.51 Favored 'General case' 0 N--CA 1.405 -2.679 0 CA-C-N 110.889 -2.869 . . . . 0.82999999999999996 107.018 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.652 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 49.0 mtmt -45.26 153.43 0.22 Allowed 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 122.88 1.324 . . . . 0.23999999999999999 113.66 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.6 -30.91 8.44 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 112.191 -2.277 . . . . 0.37 112.312 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 462' ' ' PRO . 5.0 m -86.76 142.42 34.5 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 109.578 -0.527 . . . . 0.14999999999999999 109.578 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.681 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 3.8 Cg_exo -75.62 170.29 20.53 Favored 'Trans proline' 0 N--CA 1.428 -2.349 0 C-N-CA 122.083 1.856 . . . . 0.12 111.631 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.3 158.5 38.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.797 -1.186 . . . . 1.0900000000000001 107.797 165.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.485 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.3 tp -129.95 145.56 51.63 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.335 -0.848 . . . . 0.13 110.179 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.2 148.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.304 -1.369 . . . . 0.089999999999999997 107.304 165.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.534 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 13.2 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.772 -0.632 . . . . 1.1599999999999999 111.785 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.689 HG23 ' HA ' ' A' ' 358' ' ' LYS . 3.6 m . . . . . 0 N--CA 1.428 -1.54 0 N-CA-C 106.956 -1.498 . . . . 0.45000000000000001 106.956 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.671 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 16.4 p90 -160.7 -172.04 3.35 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.643 0.735 . . . . 0.32000000000000001 110.951 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.586 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.8 mm -104.58 159.25 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.002 -1.11 . . . . 0.080000000000000002 108.002 166.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.542 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -139.95 155.09 47.31 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 118.881 0.764 . . . . 0.17000000000000001 111.036 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.689 HG22 ' HG3' ' A' ' 354' ' ' MET . 65.4 t -150.79 137.09 12.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 114.425 -1.261 . . . . 0.080000000000000002 109.476 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 30.2 t0 -118.03 116.32 26.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.737 -1.12 . . . . 0.37 108.219 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.571 HD21 HG23 ' A' ' 465' ' ' VAL . 1.9 mm? -71.96 -44.3 63.78 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.078 0.942 . . . . 0.32000000000000001 109.391 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.484 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 7.1 mm-40 -57.38 -49.48 76.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.876 -1.965 . . . . 1.51 112.515 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -106.29 14.07 27.93 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.352 -1.295 . . . . 0.91000000000000003 109.296 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.616 ' OE1' ' HA2' ' A' ' 431' ' ' GLY . 20.5 mp0 38.87 73.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 125.151 1.532 . . . . 2.2200000000000002 112.096 174.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.5 t60 -155.91 125.26 6.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.243 0.544 . . . . 0.13 110.164 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.689 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.5 ttp -110.83 128.33 55.73 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.766 -0.652 . . . . 0.059999999999999998 110.563 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.684 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -114.31 173.95 6.19 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.635 -1.166 . . . . 0.10000000000000001 112.027 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.716 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.7 t80 -126.29 119.79 28.28 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.963 -1.866 . . . . 0.22 105.963 164.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.504 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.6 m-85 -103.9 130.79 51.53 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.159 0.981 . . . . 0.17999999999999999 111.811 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.689 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.4 ttpt -147.73 136.13 21.58 Favored 'General case' 0 N--CA 1.398 -3.028 0 CA-C-N 113.206 -1.815 . . . . 0.46999999999999997 108.338 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.1 t70 71.63 13.15 6.34 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.375 -1.739 . . . . 0.59999999999999998 108.573 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.01 83.51 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 112.788 -2.005 . . . . 0.23000000000000001 112.02 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.636 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -124.9 169.58 11.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.668 -1.975 . . . . 0.68000000000000005 105.668 -172.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.757 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -102.18 138.76 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.819 0 CA-C-O 124.258 1.98 . . . . 0.53000000000000003 112.092 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.716 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.56 -24.67 18.66 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 109.322 -3.581 . . . . 0.12 108.656 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.68 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -152.93 154.72 35.61 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.927 -1.488 . . . . 0.080000000000000002 109.168 -172.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.757 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.37 121.96 1.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.002 -0.545 . . . . 0.60999999999999999 110.196 -174.656 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.61 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.5 t -147.22 166.83 25.84 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.517 0.675 . . . . 0.089999999999999997 111.352 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 1.3 m-20 -85.73 149.52 25.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.646 -1.613 . . . . 1.8799999999999999 106.646 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -146.32 -171.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 124.052 0.845 . . . . 0.11 111.305 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.588 HG23 ' CA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.16 118.91 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.761 -1.109 . . . . 0.12 108.775 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.467 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.86 146.12 35.43 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.081 -0.963 . . . . 0.69999999999999996 112.561 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.635 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.28 44.82 41.89 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 116.548 1.379 . . . . 0.13 116.548 163.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.551 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.93 144.21 3.94 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-N 118.335 1.068 . . . . 0.47999999999999998 110.24 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.785 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.49 -31.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.787 1 C-N-CA 125.82 4.346 . . . . 0.23000000000000001 116.278 -170.749 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.551 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.87 -34.82 29.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.014 0.435 . . . . 0.29999999999999999 110.791 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.459 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.9 m -140.53 73.62 29.44 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-O 122.112 0.958 . . . . 0.29999999999999999 110.423 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.635 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -72.29 161.06 45.5 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 125.187 3.925 . . . . 0.16 113.898 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.696 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.3 152.42 88.0 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.518 -1.674 . . . . 0.12 111.395 178.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.508 ' CD ' HG22 ' A' ' 377' ' ' THR . 2.0 Cg_endo -80.93 -49.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 125.234 3.956 . . . . 0.089999999999999997 113.986 -171.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.727 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.36 123.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.616 0.969 . . . . 0.089999999999999997 113.616 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.91 -126.57 1.46 Allowed Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.42 -1.264 . . . . 0.11 111.441 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.1 p -127.19 98.9 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 122.475 1.131 . . . . 0.89000000000000001 109.884 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.754 ' HB2' HG22 ' A' ' 463' ' ' VAL . 99.1 m-85 -101.71 162.02 13.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.67 -1.15 . . . . 0.16 110.22 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -147.58 135.57 21.27 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 121.337 -0.145 . . . . 0.68999999999999995 110.878 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.632 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.82 124.2 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.741 -0.784 . . . . 0.14000000000000001 110.612 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.89 2.76 20.03 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.399 -0.818 . . . . 0.19 112.183 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.751 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 17.6 t-20 -165.14 151.85 10.44 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.544 -0.753 . . . . 0.40999999999999998 110.3 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -112.25 128.37 56.24 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.802 0.811 . . . . 1.0900000000000001 109.725 170.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.582 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.3 mt-10 -129.43 118.56 22.36 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.361 -1.29 . . . . 0.38 112.019 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 1.5 mp0 -115.27 136.73 52.79 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.315 -1.311 . . . . 1.96 110.592 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.5 t70 49.83 37.74 14.14 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.585 1.66 . . . . 0.40000000000000002 107.565 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -89.76 169.7 11.05 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.161 -2.29 . . . . 0.16 111.844 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 104.56 8.02 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.812 -1.54 . . . . 0.27000000000000002 109.991 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.749 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -74.66 158.09 34.22 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.733 -2.031 . . . . 0.23999999999999999 110.47 173.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.8 mtpt . . . . . 0 N--CA 1.395 -3.209 0 CA-C-N 114.962 -1.017 . . . . 0.67000000000000004 108.685 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.9 mt-10 . . . . . 0 CA--C 1.506 -0.712 0 CA-C-O 122.162 0.982 . . . . 0.62 111.561 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.749 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.54 98.3 12.4 Favored Pre-proline 0 N--CA 1.419 -1.99 0 CA-C-N 113.168 -1.833 . . . . 1.3300000000000001 107.793 175.431 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.6 Cg_endo -67.46 102.68 0.73 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.328 2.019 . . . . 0.20000000000000001 110.091 174.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.796 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -113.98 159.74 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 CA-C-N 114.4 -1.273 . . . . 0.29999999999999999 109.757 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 13.1 m120 -108.92 -34.23 6.7 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.585 -1.643 . . . . 1.8400000000000001 107.167 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.497 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 46.9 m-85 -136.43 116.17 13.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.923 -1.944 . . . . 0.44 110.684 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.796 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.3 t-105 -123.02 135.01 54.28 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.931 -1.031 . . . . 0.13 110.025 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.521 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.36 86.33 24.49 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 114.875 -1.057 . . . . 0.40999999999999998 110.82 173.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 78.0 Cg_endo -71.34 140.42 36.89 Favored 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 123.024 2.483 . . . . 0.16 112.046 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 6.0 pt -123.65 -16.61 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.972 -1.467 . . . . 0.17000000000000001 111.111 -172.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.83 169.37 17.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 1.5900000000000001 109.33 176.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -101.75 14.62 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.242 0.831 . . . . 0.31 113.242 -176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.513 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 23.9 p -98.25 -28.08 13.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.968 -1.123 . . . . 0.44 107.968 172.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.86 28.96 0.37 Allowed Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 113.967 -1.469 . . . . 0.23999999999999999 113.259 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 441' ' ' GLY . 97.7 t -102.76 148.23 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.548 0.69 . . . . 0.17000000000000001 111.717 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.75 -166.47 37.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.664 -1.153 . . . . 0.10000000000000001 111.204 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.63 138.44 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.541 -0.911 . . . . 0.12 108.541 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.779 ' CE1' ' HB2' ' A' ' 442' ' ' CYS . 10.4 p-80 -151.24 166.13 31.84 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.869 0.843 . . . . 0.14999999999999999 111.451 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.778 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.68 145.05 24.9 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 113.77 -1.559 . . . . 0.41999999999999998 107.742 173.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.56 102.22 5.23 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 123.32 1.533 . . . . 1.48 110.208 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.93 -30.63 15.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 110.09 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.471 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 10.8 p90 -71.46 -27.28 63.15 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.023 -1.444 . . . . 0.17999999999999999 109.146 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.426 HE22 ' HD3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.3 82.9 19.32 Favored Pre-proline 0 CA--C 1.49 -1.328 0 CA-C-N 113.762 -1.563 . . . . 1.3300000000000001 108.724 -172.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 427' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 35.8 Cg_endo -79.32 3.64 7.3 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 124.571 3.514 . . . . 0.23000000000000001 114.452 -159.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -114.78 156.56 24.63 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.169 0.509 . . . . 1.1000000000000001 111.916 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.515 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -164.08 124.01 2.06 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.115 -1.402 . . . . 0.38 108.675 -172.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.42 -167.49 28.55 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.861 -1.161 . . . . 0.13 111.149 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.655 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.9 154.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 O-C-N 125.389 1.287 . . . . 0.20000000000000001 113.151 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.76 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 111.985 -152.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 53.1 mt -97.32 -32.05 12.08 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 109.962 -3.29 . . . . 0.17999999999999999 108.086 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.588 ' CA ' HG23 ' A' ' 369' ' ' VAL . 5.5 p-90 -46.44 -37.47 7.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.65 -0.704 . . . . 0.22 111.584 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.785 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 24.4 mttt -60.86 -24.44 65.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.18 -0.918 . . . . 0.64000000000000001 113.192 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 p -113.95 -35.19 5.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.691 0.758 . . . . 0.25 110.256 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.541 ' HD2' HD22 ' A' ' 433' ' ' LEU . 5.8 mtp85 -85.62 -15.34 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.605 -1.18 . . . . 0.35999999999999999 112.481 -169.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.506 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.06 42.0 38.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.256 1.263 . . . . 0.20999999999999999 116.256 159.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.5 m -85.62 130.38 34.58 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 118.485 1.143 . . . . 0.46999999999999997 109.226 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.495 ' NE2' ' HE3' ' A' ' 372' ' ' LYS . 62.2 m80 -101.21 68.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.547 -0.721 . . . . 0.40999999999999998 110.75 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.541 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 90.92 -14.17 64.08 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.353 -1.099 . . . . 0.17999999999999999 110.353 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.779 ' HB2' ' CE1' ' A' ' 421' ' ' HIS . 23.4 p -89.95 148.14 23.29 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.326 -0.437 . . . . 0.82999999999999996 110.62 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -104.15 119.0 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 116.204 -0.453 . . . . 0.14999999999999999 110.621 -176.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.48 ' HB2' HG13 ' A' ' 369' ' ' VAL . 6.9 m120 -79.28 88.99 4.92 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.609 -0.436 . . . . 1.77 111.186 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 41.3 m -86.97 135.65 35.01 Favored Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 109.17 -0.678 . . . . 0.17999999999999999 109.17 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.418 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 53.0 Cg_exo -55.75 135.37 69.17 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.725 2.283 . . . . 0.12 111.398 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.778 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.0 Cg_exo -54.8 -33.89 82.84 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 C-N-CA 124.225 3.284 . . . . 0.16 112.99 -173.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 67.8 m -79.24 -39.02 34.19 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.783 -1.098 . . . . 1.1699999999999999 110.06 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.61 HG11 ' HB ' ' A' ' 366' ' ' THR . 97.8 t -78.8 -30.48 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 0.17000000000000001 111.408 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.685 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.9 tpt -67.56 -19.0 65.21 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.788 0.804 . . . . 0.46000000000000002 110.32 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -80.03 -22.88 41.88 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 114.528 -1.215 . . . . 0.81000000000000005 110.839 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.68 -46.78 15.01 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 112.921 -1.945 . . . . 0.38 107.329 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.635 HD23 ' SD ' ' A' ' 450' ' ' MET . 25.8 tp -64.64 -66.58 0.52 Allowed 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 111.906 -2.406 . . . . 0.059999999999999998 112.423 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.429 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 32.6 t80 -50.34 -25.16 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 123.059 1.409 . . . . 0.31 108.247 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.63 -28.66 66.94 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 112.486 -2.143 . . . . 0.13 112.507 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.68 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -92.2 -48.18 6.83 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.783 0.802 . . . . 0.13 111.614 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.632 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.8 OUTLIER -103.94 136.75 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 123.344 1.545 . . . . 0.23000000000000001 113.953 -167.027 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -136.56 -178.49 5.2 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 110.916 -2.856 . . . . 0.82999999999999996 106.583 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.751 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.4 mtmt -51.71 160.85 0.6 Allowed 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 123.114 1.435 . . . . 0.23999999999999999 112.958 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.75 7.91 Favored Glycine 0 N--CA 1.426 -2.033 0 CA-C-N 112.527 -2.124 . . . . 0.37 112.528 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 462' ' ' PRO . 6.1 m -82.01 142.95 48.69 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 109.308 -0.627 . . . . 0.14999999999999999 109.308 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.36 168.75 23.92 Favored 'Trans proline' 0 N--CA 1.426 -2.48 0 C-N-CA 121.855 1.703 . . . . 0.12 111.262 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.2 m -136.32 155.13 34.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.125 -1.435 . . . . 1.0900000000000001 107.125 165.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.436 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 3.4 tp -126.06 145.68 50.22 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.254 -0.885 . . . . 0.13 110.158 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.0 146.3 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 N-CA-C 106.896 -1.52 . . . . 0.089999999999999997 106.896 164.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.678 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 16.4 p90 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.229 -0.891 . . . . 1.1599999999999999 111.431 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 358' ' ' LYS . 98.5 m . . . . . 0 N--CA 1.417 -2.089 0 CA-C-O 121.566 0.698 . . . . 0.45000000000000001 109.189 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.636 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 4.7 p90 -159.12 -170.61 3.06 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.012 -1.449 . . . . 0.32000000000000001 110.637 -174.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.606 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -99.87 159.64 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 108.073 -1.084 . . . . 0.080000000000000002 108.073 166.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.2 tt0 -138.68 154.1 48.58 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.074 -0.65 . . . . 0.17000000000000001 111.146 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.682 HG22 ' HG3' ' A' ' 354' ' ' MET . 64.1 t -149.98 134.33 9.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 114.263 -1.335 . . . . 0.080000000000000002 109.436 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 15.4 t0 -115.57 124.5 51.15 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.714 -1.13 . . . . 0.37 108.377 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 465' ' ' VAL . 2.1 mm? -75.22 -43.81 49.73 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.811 1.291 . . . . 0.32000000000000001 110.525 -177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 5.4 mm-40 -57.38 -54.96 40.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.623 -2.08 . . . . 1.51 112.816 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 20.58 18.61 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.843 0.83 . . . . 0.91000000000000003 109.752 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.873 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.3 mm-40 35.94 71.25 0.13 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 112.104 -2.316 . . . . 2.2200000000000002 112.16 169.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -149.19 125.89 11.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.186 -0.916 . . . . 0.13 109.174 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.682 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.8 ttp -111.81 127.5 55.83 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.488 0.661 . . . . 0.059999999999999998 110.481 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.68 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -111.55 173.39 6.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.552 -1.204 . . . . 0.10000000000000001 111.753 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.697 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.5 t80 -125.3 111.79 15.61 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.242 -1.762 . . . . 0.22 106.242 165.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 362' ' ' VAL . 21.9 m-85 -97.47 127.44 43.43 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.766 0.793 . . . . 0.17999999999999999 111.174 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.621 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 4.3 ttpt -142.86 135.35 27.62 Favored 'General case' 0 N--CA 1.398 -3.049 0 CA-C-N 113.964 -1.471 . . . . 0.46999999999999997 108.297 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.8 t70 71.26 11.37 6.78 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 113.209 -1.814 . . . . 0.59999999999999998 108.806 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.84 68.81 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 112.763 -2.017 . . . . 0.23000000000000001 111.757 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -129.66 167.0 18.66 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.15 -1.796 . . . . 0.68000000000000005 106.15 -172.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.747 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -101.91 138.68 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 CA-C-O 124.429 2.062 . . . . 0.53000000000000003 112.21 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.61 -25.45 17.52 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 109.341 -3.572 . . . . 0.12 108.671 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.64 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.71 155.26 36.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 113.627 -1.624 . . . . 0.080000000000000002 108.891 -172.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.747 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.38 122.12 1.45 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.691 -0.686 . . . . 0.60999999999999999 109.473 -175.087 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.698 HG21 HG23 ' A' ' 445' ' ' THR . 5.3 t -148.95 166.68 27.89 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.326 1.06 . . . . 0.089999999999999997 112.224 173.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.732 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.6 p-10 -84.54 139.62 32.01 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.936 -1.938 . . . . 1.8799999999999999 107.737 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -141.46 -172.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.163 -0.926 . . . . 0.11 111.724 -175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.873 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.22 120.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.127 -0.942 . . . . 0.12 109.26 175.2 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.5 t -141.84 144.58 33.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.56 0.948 . . . . 0.69999999999999996 113.56 -165.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.63 45.96 50.01 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 116.771 1.468 . . . . 0.13 116.771 161.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.571 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -48.09 144.04 6.2 Favored Pre-proline 0 CA--C 1.511 -0.535 0 CA-C-N 118.263 1.031 . . . . 0.47999999999999998 111.342 -176.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.814 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.02 -31.91 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.564 1 C-N-CA 125.88 4.387 . . . . 0.23000000000000001 115.671 -172.88 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.571 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 0.9 OUTLIER -78.94 -36.89 41.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.263 -0.426 . . . . 0.29999999999999999 110.838 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.455 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -141.44 72.74 25.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-O 122.174 0.988 . . . . 0.29999999999999999 110.15 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.4 Cg_exo -69.33 162.38 42.07 Favored 'Trans proline' 0 C--N 1.322 -0.837 1 C-N-CA 125.357 4.038 . . . . 0.16 114.245 -176.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.67 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.0 152.46 88.66 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 113.581 -1.645 . . . . 0.12 110.647 176.362 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.536 ' CD ' HG22 ' A' ' 377' ' ' THR . 0.9 OUTLIER -79.68 -49.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 125.076 3.851 . . . . 0.089999999999999997 113.461 -172.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.729 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 67.05 124.25 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.974 0.892 . . . . 0.089999999999999997 113.267 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 162.63 -122.48 1.11 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.445 -1.252 . . . . 0.11 111.405 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.2 p -130.77 106.62 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-O 121.979 0.895 . . . . 0.89000000000000001 109.283 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 465' ' ' VAL . 52.2 m-85 -111.48 167.53 10.25 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.223 -0.899 . . . . 0.16 109.282 -172.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.688 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 82.2 m-85 -149.02 138.46 21.7 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 110.618 -0.141 . . . . 0.68999999999999995 110.618 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.626 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -72.82 122.77 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 119.67 -0.812 . . . . 0.14000000000000001 110.476 175.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -109.79 3.87 21.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.46 -0.791 . . . . 0.19 112.286 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.658 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 18.9 t-20 -163.88 148.03 10.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.279 -1.008 . . . . 0.40999999999999998 108.279 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.588 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -118.98 114.9 23.27 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.196 0.998 . . . . 1.0900000000000001 108.43 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -118.84 132.54 56.12 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.28 -1.327 . . . . 0.38 110.298 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -131.68 134.51 46.03 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.026 -1.443 . . . . 1.96 109.622 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 52.69 40.45 30.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 123.435 1.588 . . . . 0.40000000000000002 107.479 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.564 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.76 169.53 9.95 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 112.35 -2.204 . . . . 0.16 111.683 -172.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 7.7 m -126.57 106.49 9.47 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 113.956 -1.474 . . . . 0.27000000000000002 109.926 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.741 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.3 mp -71.02 158.9 35.72 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.986 . . . . 0.23999999999999999 110.626 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.498 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.3 mtpt . . . . . 0 N--CA 1.393 -3.3 0 O-C-N 124.39 1.056 . . . . 0.67000000000000004 108.529 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 12.6 mt-10 . . . . . 0 CA--C 1.511 -0.53 0 CA-C-O 122.037 0.922 . . . . 0.62 112.038 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.741 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.5 m -144.12 99.18 5.05 Favored Pre-proline 0 N--CA 1.428 -1.536 0 CA-C-N 113.835 -1.529 . . . . 1.3300000000000001 110.418 -177.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 73.7 Cg_endo -67.18 109.01 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 125.236 3.957 . . . . 0.20000000000000001 113.492 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -122.82 151.73 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-N 114.559 -1.201 . . . . 0.29999999999999999 111.405 -173.433 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.469 ' ND2' ' CD2' ' A' ' 409' ' ' TYR . 11.5 p-10 -93.61 -28.83 15.79 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.457 -1.247 . . . . 1.8400000000000001 110.065 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.472 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 67.5 m-85 -142.77 119.66 11.27 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.296 . . . . 0.44 110.601 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.737 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.1 t-105 -125.56 135.15 51.92 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.606 -1.179 . . . . 0.13 111.112 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.563 ' HE3' ' CG2' ' A' ' 457' ' ' VAL . 1.0 OUTLIER -134.9 86.38 32.79 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.804 -1.089 . . . . 0.40999999999999998 111.279 174.433 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.65 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 94.7 Cg_endo -72.23 138.61 30.76 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 122.833 2.355 . . . . 0.16 111.558 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.2 pt -124.66 -14.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.973 -1.467 . . . . 0.17000000000000001 110.916 -173.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -133.7 162.81 30.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.449 -0.796 . . . . 1.5900000000000001 109.7 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -94.11 14.29 20.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.022 0.378 . . . . 0.31 112.022 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.1 p -93.27 -25.6 17.7 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.565 -1.272 . . . . 0.44 107.565 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 121.59 26.31 1.99 Allowed Glycine 0 N--CA 1.426 -2.031 0 CA-C-N 112.773 -2.012 . . . . 0.23999999999999999 111.63 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 441' ' ' GLY . 55.9 t -98.07 146.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.165 0.507 . . . . 0.17000000000000001 111.0 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.75 -165.0 36.06 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.923 -1.035 . . . . 0.10000000000000001 111.464 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.438 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -105.53 137.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.693 -0.854 . . . . 0.12 108.693 176.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.904 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.7 p80 -154.16 170.58 20.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 122.011 0.91 . . . . 0.14999999999999999 111.582 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 153.52 20.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.523 -1.671 . . . . 0.41999999999999998 108.766 174.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.554 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 3.4 p -141.24 99.65 3.62 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 122.827 1.298 . . . . 1.48 109.833 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.35 -31.13 13.57 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 112.457 -2.156 . . . . 0.34999999999999998 109.992 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.564 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 9.2 p90 -68.23 -26.88 65.92 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 114.354 -1.294 . . . . 0.17999999999999999 108.923 173.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.595 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -119.38 82.42 24.26 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.613 -1.63 . . . . 1.3300000000000001 110.135 -175.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.76 5.02 6.2 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 C-N-CA 124.802 3.668 . . . . 0.23000000000000001 114.211 -161.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.33 153.25 30.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.406 0.441 . . . . 1.1000000000000001 110.07 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.732 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.5 OUTLIER -163.15 127.98 3.04 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.99 1.316 . . . . 0.38 107.86 -173.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.28 -167.72 29.02 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 119.689 -1.243 . . . . 0.13 111.05 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.606 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.15 156.64 0.0 OUTLIER Glycine 0 C--N 1.341 0.857 0 O-C-N 124.935 1.021 . . . . 0.20000000000000001 113.225 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.461 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -54.92 100.62 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 123.692 1.711 . . . . 0.33000000000000002 111.579 -148.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 32.8 mt -97.21 -31.16 12.58 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 110.611 -2.995 . . . . 0.17999999999999999 109.453 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.478 ' HA ' HG23 ' A' ' 369' ' ' VAL . 14.8 p-90 -49.06 -32.32 9.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 112.881 -1.963 . . . . 0.22 111.729 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.814 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 53.4 mttt -64.06 -19.67 65.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.297 0.851 . . . . 0.64000000000000001 113.297 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 72.5 p -120.72 -36.64 3.13 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.644 -0.707 . . . . 0.25 110.628 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.595 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.2 mtp85 -82.05 -15.04 54.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.65 -1.159 . . . . 0.35999999999999999 112.773 -169.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.532 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.82 41.42 33.89 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 116.554 1.381 . . . . 0.20999999999999999 116.554 159.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 18.4 m -85.81 131.97 34.21 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 118.225 1.013 . . . . 0.46999999999999997 109.563 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -97.68 68.74 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.683 -0.635 . . . . 0.40999999999999998 110.85 -170.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.582 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 85.4 -9.81 66.15 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.819 -0.913 . . . . 0.17999999999999999 110.819 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 20.8 p -89.52 137.58 32.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.946 -0.627 . . . . 0.82999999999999996 110.079 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -96.77 113.12 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.618 -0.719 . . . . 0.14999999999999999 110.483 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.566 ' HB2' HG13 ' A' ' 369' ' ' VAL . 2.2 m-20 -80.76 92.12 6.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.006 . . . . 1.77 111.678 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.698 HG23 HG21 ' A' ' 366' ' ' THR . 98.0 m -89.44 140.85 28.48 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.542 -0.754 . . . . 0.17999999999999999 109.572 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 53.3 Cg_exo -55.08 136.81 74.7 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.803 2.335 . . . . 0.12 111.202 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.742 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 58.4 Cg_exo -55.96 -32.94 87.65 Favored 'Trans proline' 0 CA--C 1.5 -1.199 0 C-N-CA 124.195 3.263 . . . . 0.16 112.634 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.7 p -79.64 -38.35 33.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.522 -1.217 . . . . 1.1699999999999999 109.719 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.628 HG11 ' HB ' ' A' ' 366' ' ' THR . 84.3 t -78.54 -30.44 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.17000000000000001 111.439 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.677 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -64.47 -23.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.893 0.854 . . . . 0.46000000000000002 110.426 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -75.42 -27.02 58.82 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.408 -1.269 . . . . 0.81000000000000005 111.916 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.669 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.9 mm-40 -77.6 -46.19 22.92 Favored 'General case' 0 CA--C 1.472 -2.045 0 CA-C-N 113.489 -1.687 . . . . 0.38 106.991 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 457' ' ' VAL . 24.6 tp -65.4 -67.78 0.41 Allowed 'General case' 0 N--CA 1.401 -2.903 0 CA-C-N 111.472 -2.604 . . . . 0.059999999999999998 112.601 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.535 ' CD2' ' SD ' ' A' ' 411' ' ' MET . 31.4 t80 -51.31 -27.16 8.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.183 1.468 . . . . 0.31 107.988 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.425 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.06 -31.02 74.33 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 112.116 -2.311 . . . . 0.13 112.064 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.669 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.26 -48.39 7.4 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.834 0.826 . . . . 0.13 111.189 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.667 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 1.1 p -107.19 134.36 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-O 123.344 1.545 . . . . 0.23000000000000001 114.461 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.588 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 12.6 pt-20 -139.81 -176.55 4.61 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 110.948 -2.842 . . . . 0.82999999999999996 107.032 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.9 mtmt -46.21 154.42 0.27 Allowed 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 123.032 1.396 . . . . 0.23999999999999999 113.578 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 95.22 -24.75 27.47 Favored Glycine 0 C--N 1.292 -1.913 0 CA-C-N 112.275 -2.239 . . . . 0.37 112.821 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.504 ' HB ' HG23 ' A' ' 457' ' ' VAL . 6.6 m -89.3 142.23 29.67 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 109.685 -0.487 . . . . 0.14999999999999999 109.685 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.636 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.9 Cg_exo -74.64 168.3 25.13 Favored 'Trans proline' 0 N--CA 1.43 -2.209 0 C-N-CA 122.067 1.844 . . . . 0.12 111.571 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.477 HG21 HG21 ' A' ' 413' ' ' ILE . 69.8 t -135.46 134.77 52.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 113.869 -1.514 . . . . 1.0900000000000001 108.265 173.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.7 tp -112.93 143.43 44.23 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.157 0.503 . . . . 0.13 110.408 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.13 146.64 21.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.74 -1.578 . . . . 0.089999999999999997 106.74 164.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.729 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 21.0 p90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.523 -0.751 . . . . 1.1599999999999999 111.217 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.638 HG23 ' HA ' ' A' ' 358' ' ' LYS . 6.9 m . . . . . 0 N--CA 1.423 -1.823 0 N-CA-C 108.518 -0.919 . . . . 0.45000000000000001 108.518 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.645 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 14.0 p90 -164.66 -169.81 1.84 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.136 -0.938 . . . . 0.32000000000000001 110.443 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -103.57 158.07 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.178 -0.919 . . . . 0.080000000000000002 108.6 166.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.501 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.6 tt0 -140.07 155.91 46.82 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 118.89 0.768 . . . . 0.17000000000000001 111.131 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.672 HG22 ' HG3' ' A' ' 354' ' ' MET . 56.3 t -151.07 138.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.721 -1.127 . . . . 0.080000000000000002 109.432 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.45 115.35 23.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.723 -1.126 . . . . 0.37 108.076 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.521 ' H ' HD22 ' A' ' 349' ' ' LEU . 2.0 mm? -66.51 -47.83 71.71 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.789 1.281 . . . . 0.32000000000000001 110.319 -175.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -55.38 -53.87 50.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.49 -2.141 . . . . 1.51 112.384 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -98.03 10.34 40.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 114.093 -1.412 . . . . 0.91000000000000003 108.51 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.906 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.0 mm-40 38.01 69.48 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 125.316 1.635 . . . . 2.2200000000000002 111.841 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.479 ' CD2' ' CE2' ' A' ' 355' ' ' TRP . 7.7 t60 -148.16 125.96 11.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.273 -0.876 . . . . 0.13 109.729 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.672 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -113.0 127.96 56.37 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.57 0.7 . . . . 0.059999999999999998 110.428 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.729 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.0 m-90 -112.78 173.16 6.51 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 114.386 -1.279 . . . . 0.10000000000000001 111.76 -176.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.643 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -125.25 113.65 17.91 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.97 -1.863 . . . . 0.22 105.97 163.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 344' ' ' TYR . 22.1 m-85 -95.35 126.0 40.36 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.17999999999999999 112.028 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.638 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.0 ttpt -148.19 139.02 23.07 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 113.293 -1.776 . . . . 0.46999999999999997 108.305 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.447 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.63 14.89 6.1 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.677 -1.601 . . . . 0.59999999999999998 109.0 178.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.59 16.45 77.67 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.555 -2.111 . . . . 0.23000000000000001 111.653 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.666 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.5 OUTLIER -138.37 178.44 7.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.238 -2.134 . . . . 0.68000000000000005 105.238 -170.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.729 HG11 ' CD1' ' A' ' 355' ' ' TRP . 3.0 m -107.0 135.67 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-O 124.093 1.901 . . . . 0.53000000000000003 112.517 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.542 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -86.29 -26.0 25.19 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 109.412 -3.54 . . . . 0.12 108.009 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.671 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.25 154.68 36.23 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 113.953 -1.476 . . . . 0.080000000000000002 109.785 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.5 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 2.0 pt-20 -162.41 121.99 2.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 110.533 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.645 ' HB ' HG11 ' A' ' 449' ' ' VAL . 6.0 t -149.35 167.28 26.55 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 122.352 1.072 . . . . 0.089999999999999997 112.662 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.0 p-10 -86.11 141.5 29.36 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 112.925 -1.943 . . . . 1.8799999999999999 107.64 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.653 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -141.79 -176.31 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.546 -0.752 . . . . 0.11 112.356 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.906 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -151.71 116.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.051 -0.977 . . . . 0.12 110.322 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.459 ' OG ' HD12 ' A' ' 349' ' ' LEU . 56.5 p -140.53 141.09 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.475 0.916 . . . . 0.69999999999999996 113.475 -163.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.767 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.54 46.86 45.34 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 116.961 1.545 . . . . 0.13 116.961 162.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.534 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 6.1 pttt -46.05 145.71 2.4 Favored Pre-proline 0 C--O 1.216 -0.678 0 CA-C-N 119.318 1.559 . . . . 0.47999999999999998 111.041 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.802 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.3 OUTLIER -37.95 -31.19 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 125.244 3.962 . . . . 0.23000000000000001 115.276 -175.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.3 p -81.88 -33.33 30.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 0.29999999999999999 111.096 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -140.47 71.61 31.8 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 122.134 0.969 . . . . 0.29999999999999999 110.066 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.767 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.1 Cg_exo -69.93 163.0 40.04 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 125.552 4.168 . . . . 0.16 115.451 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.65 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.64 154.5 87.44 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 113.285 -1.779 . . . . 0.12 111.127 172.352 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.506 ' CD ' HG22 ' A' ' 377' ' ' THR . 3.4 Cg_endo -83.81 -52.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 1 C-N-CA 125.378 4.052 . . . . 0.089999999999999997 114.334 -172.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.71 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 70.64 122.79 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.932 1.086 . . . . 0.089999999999999997 113.932 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.66 -129.59 1.96 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 114.135 -1.393 . . . . 0.11 111.363 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.78 98.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.363 -0.977 . . . . 0.89000000000000001 108.363 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.821 ' HB2' HG22 ' A' ' 463' ' ' VAL . 97.0 m-85 -102.69 166.76 10.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.392 -0.822 . . . . 0.16 110.484 -169.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.699 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -150.09 139.23 21.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 119.753 -0.165 . . . . 0.68999999999999995 110.62 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -75.5 119.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 119.723 -0.791 . . . . 0.14000000000000001 110.432 176.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -107.26 4.5 26.66 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.796 -0.638 . . . . 0.19 112.616 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.646 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 12.5 t-20 -162.98 146.3 10.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.766 -1.198 . . . . 0.40999999999999998 107.766 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 387' ' ' LYS . 0.2 OUTLIER -119.45 112.11 18.98 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.102 -1.073 . . . . 1.0900000000000001 108.102 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.569 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -118.33 128.21 54.44 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.399 -1.273 . . . . 0.38 111.052 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 42.6 mt-10 -128.2 134.21 49.0 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.849 -1.523 . . . . 1.96 109.827 -177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.5 t70 52.53 39.39 27.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 123.367 1.556 . . . . 0.40000000000000002 107.675 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -94.06 169.84 9.97 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 112.439 -2.164 . . . . 0.16 111.546 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 19.9 m -127.12 105.25 8.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.094 -1.412 . . . . 0.27000000000000002 110.033 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.5 mp -71.74 154.66 41.18 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.375 -1.739 . . . . 0.23999999999999999 109.692 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.487 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 9.7 mtpt . . . . . 0 N--CA 1.402 -2.85 0 CA-C-N 114.583 -1.19 . . . . 0.67000000000000004 108.26 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.4 mt-10 . . . . . 0 CA--C 1.503 -0.83 0 CA-C-O 122.337 1.065 . . . . 0.62 111.287 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.705 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.6 m -143.89 97.76 5.32 Favored Pre-proline 0 N--CA 1.419 -2.019 0 CA-C-N 113.067 -1.878 . . . . 1.3300000000000001 109.06 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 72.9 Cg_endo -67.5 106.46 1.25 Allowed 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 124.269 3.313 . . . . 0.20000000000000001 112.726 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -116.79 163.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.695 -1.138 . . . . 0.29999999999999999 111.206 -174.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 11.2 m120 -113.91 -31.51 6.38 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.083 -1.871 . . . . 1.8400000000000001 107.39 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.485 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 70.9 m-85 -136.98 116.16 12.53 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.063 -1.881 . . . . 0.44 110.905 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.766 ' HB2' HG11 ' A' ' 407' ' ' VAL . 5.7 t-105 -124.02 134.15 53.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.44 -1.255 . . . . 0.13 110.974 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.847 ' SD ' HG22 ' A' ' 457' ' ' VAL . 5.8 mtm -134.32 88.05 31.38 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 114.728 -1.124 . . . . 0.40999999999999998 112.28 171.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.03 137.87 29.94 Favored 'Trans proline' 0 CA--C 1.506 -0.897 0 C-N-CA 123.113 2.542 . . . . 0.16 111.744 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.9 pt -123.51 -16.37 5.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 113.763 -1.562 . . . . 0.17000000000000001 110.696 -173.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -135.15 158.51 44.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.748 -0.66 . . . . 1.5900000000000001 109.895 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -87.92 13.55 10.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.337 0.495 . . . . 0.31 112.337 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 5.8 p -92.15 -25.85 18.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.444 -1.317 . . . . 0.44 107.444 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 120.06 30.79 1.4 Allowed Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 112.933 -1.939 . . . . 0.23999999999999999 111.78 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 441' ' ' GLY . 53.4 t -100.94 147.5 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.384 -0.408 . . . . 0.17000000000000001 110.73 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.27 -168.5 41.27 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.191 -0.913 . . . . 0.10000000000000001 112.058 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.41 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -104.06 139.55 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.56 -0.904 . . . . 0.12 108.56 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.805 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.7 p80 -151.84 164.88 36.13 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.641 0.734 . . . . 0.14999999999999999 112.079 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.73 141.4 28.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 113.931 -1.486 . . . . 0.41999999999999998 107.549 172.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 3.6 t -138.57 104.28 5.09 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 123.194 1.473 . . . . 1.48 110.731 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.37 -30.77 14.94 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.798 -2.456 . . . . 0.34999999999999998 110.852 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.429 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 14.6 p90 -68.27 -27.32 66.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.541 -1.209 . . . . 0.17999999999999999 109.475 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.489 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.1 81.59 28.53 Favored Pre-proline 0 CA--C 1.495 -1.144 0 CA-C-N 113.747 -1.57 . . . . 1.3300000000000001 109.798 -175.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -82.55 6.52 5.71 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 124.833 3.689 . . . . 0.23000000000000001 114.522 -161.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -114.72 151.09 34.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.508 -0.553 . . . . 1.1000000000000001 109.508 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.586 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -160.73 128.25 4.35 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.578 1.151 . . . . 0.38 108.115 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.62 -166.53 28.72 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.31 -1.424 . . . . 0.13 111.254 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.32 152.47 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 O-C-N 125.159 1.152 . . . . 0.20000000000000001 113.006 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.435 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 4.1 m-20 -55.04 101.5 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 123.506 1.622 . . . . 0.33000000000000002 112.136 -146.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.9 mt -96.73 -31.31 12.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 110.856 -2.883 . . . . 0.17999999999999999 109.364 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.55 ' HA ' HG23 ' A' ' 369' ' ' VAL . 12.8 p-90 -50.0 -31.99 14.13 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 112.84 -1.982 . . . . 0.22 111.871 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.802 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 38.5 mttt -65.27 -20.56 66.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.356 -0.838 . . . . 0.64000000000000001 112.685 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.0 p -118.65 -37.92 3.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.29 -0.868 . . . . 0.25 110.297 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.488 ' HB2' HG21 ' A' ' 369' ' ' VAL . 7.4 mtp85 -83.35 -16.24 46.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.868 -1.06 . . . . 0.35999999999999999 113.056 -169.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 77.72 40.74 21.31 Favored Glycine 0 C--N 1.31 -0.861 0 N-CA-C 116.895 1.518 . . . . 0.20999999999999999 116.895 159.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 19.8 m -80.72 136.52 36.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 118.26 1.03 . . . . 0.46999999999999997 109.763 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -98.03 65.77 1.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.943 -0.473 . . . . 0.40999999999999998 110.932 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.569 ' H ' ' HA2' ' A' ' 371' ' ' GLY . . . 87.29 -14.1 58.44 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.618 -0.993 . . . . 0.17999999999999999 110.618 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.4 p -85.36 148.58 25.95 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.464 -0.368 . . . . 0.82999999999999996 110.142 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.65 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -99.37 123.2 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 122.212 1.005 . . . . 0.14999999999999999 110.934 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.753 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.7 OUTLIER -81.44 83.35 6.98 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.51 -1.677 . . . . 1.77 111.395 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 24.5 m -88.04 138.02 31.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-O 121.558 0.694 . . . . 0.17999999999999999 109.581 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.413 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.7 Cg_exo -57.48 136.15 74.17 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.716 2.277 . . . . 0.12 111.827 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.5 Cg_exo -53.93 -32.77 69.26 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 124.547 3.498 . . . . 0.16 112.915 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.2 m -79.52 -41.94 26.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.383 -1.281 . . . . 1.1699999999999999 109.881 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 366' ' ' THR . 65.4 t -78.58 -30.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.558 0.694 . . . . 0.17000000000000001 111.7 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.738 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.24 -19.44 65.52 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.851 0.834 . . . . 0.46000000000000002 110.294 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -79.31 -23.23 43.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 114.494 -1.23 . . . . 0.81000000000000005 111.01 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.708 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.04 -46.98 15.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 113.075 -1.875 . . . . 0.38 107.193 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.0 tp -64.24 -66.7 0.51 Allowed 'General case' 0 N--CA 1.402 -2.844 0 CA-C-N 111.826 -2.443 . . . . 0.059999999999999998 112.289 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 454' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -52.99 -24.7 10.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.97 1.367 . . . . 0.31 108.387 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.52 -26.01 74.07 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 112.533 -2.121 . . . . 0.13 112.025 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.708 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.4 ptp -94.97 -49.92 5.34 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.876 0.846 . . . . 0.13 111.161 169.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.847 HG22 ' SD ' ' A' ' 411' ' ' MET . 2.1 p -108.61 132.08 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 CA-C-O 123.585 1.66 . . . . 0.23000000000000001 114.447 -167.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.457 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 7.3 pt-20 -140.82 -176.85 4.81 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.335 -3.12 . . . . 0.82999999999999996 106.127 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.619 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.3 mtmt -45.32 154.24 0.18 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.971 1.367 . . . . 0.23999999999999999 114.095 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 98.43 -32.75 6.62 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 112.013 -2.358 . . . . 0.37 112.54 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.583 ' HB ' HG23 ' A' ' 457' ' ' VAL . 6.2 m -83.6 143.12 43.56 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.304 -0.628 . . . . 0.14999999999999999 109.304 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 4.8 Cg_exo -75.36 169.8 21.67 Favored 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 121.789 1.659 . . . . 0.12 111.503 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.29 158.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.891 -1.152 . . . . 1.0900000000000001 107.891 167.221 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.501 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.4 tp -130.56 146.2 52.03 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.514 -0.766 . . . . 0.13 110.331 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.7 147.61 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.501 -1.296 . . . . 0.089999999999999997 107.501 165.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.468 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 16.9 p90 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.499 -0.762 . . . . 1.1599999999999999 111.402 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 358' ' ' LYS . 3.9 m . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 106.94 -1.504 . . . . 0.45000000000000001 106.94 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.632 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.8 p90 -160.16 -170.11 2.72 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.617 0.723 . . . . 0.32000000000000001 111.009 -173.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.581 HD11 ' CB ' ' A' ' 457' ' ' VAL . 11.7 mm -103.91 160.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.781 -1.099 . . . . 0.080000000000000002 108.216 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.488 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.0 tt0 -140.94 156.1 46.13 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 119.0 0.818 . . . . 0.17000000000000001 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.676 HG22 ' HG3' ' A' ' 354' ' ' MET . 68.3 t -150.62 137.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.663 -1.153 . . . . 0.080000000000000002 109.625 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.07 106.36 9.54 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 122.153 0.978 . . . . 0.37 108.826 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.484 HD21 HG23 ' A' ' 465' ' ' VAL . 1.9 mm? -63.4 -38.97 93.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 112.89 -1.959 . . . . 0.32000000000000001 111.298 -168.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.88 -57.06 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 111.673 -2.512 . . . . 1.51 112.552 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -95.64 2.74 54.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 114.685 -1.143 . . . . 0.91000000000000003 110.066 -172.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.871 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.4 mm-40 49.54 66.01 1.24 Allowed 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 112.654 -2.066 . . . . 2.2200000000000002 111.406 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.523 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -145.5 127.4 15.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.344 0.592 . . . . 0.13 109.725 -176.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.676 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.6 ttp -114.15 128.41 56.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.433 -0.803 . . . . 0.059999999999999998 110.613 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.649 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.54 173.29 6.48 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 114.608 -1.178 . . . . 0.10000000000000001 112.084 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.661 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 1.1 t80 -124.79 113.43 17.92 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.666 -1.605 . . . . 0.22 106.666 165.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.496 ' CE1' HG12 ' A' ' 362' ' ' VAL . 19.2 m-85 -96.94 125.41 41.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.303 1.049 . . . . 0.17999999999999999 112.43 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.681 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.8 ttpt -149.34 139.46 22.14 Favored 'General case' 0 N--CA 1.398 -3.075 0 CA-C-N 112.827 -1.988 . . . . 0.46999999999999997 108.091 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.449 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.1 17.62 7.24 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 113.61 -1.632 . . . . 0.59999999999999998 109.011 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.47 18.36 79.19 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 112.466 -2.152 . . . . 0.23000000000000001 111.824 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -138.82 177.61 7.76 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.798 -1.927 . . . . 0.68000000000000005 105.798 -169.309 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.753 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -106.96 138.09 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 CA-C-O 124.008 1.861 . . . . 0.53000000000000003 112.15 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.648 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.03 -23.76 18.56 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 109.587 -3.46 . . . . 0.12 108.479 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.601 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.7 tp -154.4 154.69 33.69 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.712 -1.585 . . . . 0.080000000000000002 108.977 -172.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.753 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.11 122.43 1.55 Allowed 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.576 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.657 ' HB ' HG11 ' A' ' 449' ' ' VAL . 3.6 t -146.88 166.24 27.31 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.688 0.756 . . . . 0.089999999999999997 111.215 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.49 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 42.1 m-20 -84.84 148.87 26.07 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.463 -1.681 . . . . 1.8799999999999999 106.463 174.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.657 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -144.02 -171.15 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.412 -0.813 . . . . 0.11 110.945 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.871 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -152.99 120.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.995 -1.002 . . . . 0.12 108.604 173.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.497 ' HB2' HG13 ' A' ' 443' ' ' ILE . 5.7 t -143.51 142.91 31.33 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.684 0.994 . . . . 0.69999999999999996 113.684 -167.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.76 44.78 37.34 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 117.046 1.578 . . . . 0.13 117.046 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.591 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.66 145.02 3.21 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 119.255 1.528 . . . . 0.47999999999999998 110.509 -174.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.784 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -35.11 -31.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.803 4.336 . . . . 0.23000000000000001 115.972 -173.283 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.591 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -81.17 -35.87 30.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.29999999999999999 111.033 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.467 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -140.39 72.64 31.43 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 122.227 1.013 . . . . 0.29999999999999999 110.461 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 24.5 Cg_exo -71.02 163.21 40.05 Favored 'Trans proline' 0 C--N 1.322 -0.817 1 C-N-CA 125.526 4.151 . . . . 0.16 114.153 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.7 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.04 153.61 88.68 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.418 -1.719 . . . . 0.12 110.946 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.71 -49.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.038 3.825 . . . . 0.089999999999999997 113.673 -171.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.722 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.66 122.87 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.568 0.951 . . . . 0.089999999999999997 113.568 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.41 -123.55 1.18 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.16 -1.382 . . . . 0.11 111.396 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -127.88 112.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 122.035 0.922 . . . . 0.89000000000000001 108.915 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.768 ' HB2' HG22 ' A' ' 463' ' ' VAL . 94.3 m-85 -115.74 160.87 19.53 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.027 -0.988 . . . . 0.16 109.706 -169.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.752 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 78.5 m-85 -147.63 137.19 22.61 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 119.703 -0.189 . . . . 0.68999999999999995 110.535 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.44 118.2 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 119.258 -0.977 . . . . 0.14000000000000001 110.172 176.428 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -106.36 2.15 26.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.385 -0.825 . . . . 0.19 112.451 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.681 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 17.0 t-20 -160.24 148.75 16.91 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.815 -1.18 . . . . 0.40999999999999998 107.815 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.5 OUTLIER -119.73 117.88 29.4 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.915 -1.143 . . . . 1.0900000000000001 107.915 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.5 mt-10 -123.54 128.11 49.27 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.523 -1.217 . . . . 0.38 111.265 -173.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -125.75 135.52 52.14 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 113.559 -1.655 . . . . 1.96 109.393 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.89 38.67 29.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 123.338 1.542 . . . . 0.40000000000000002 107.731 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -93.1 170.14 9.87 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.213 -2.267 . . . . 0.16 111.841 -175.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 11.6 m -128.39 104.91 7.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.998 -1.455 . . . . 0.27000000000000002 110.413 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.753 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -76.57 158.43 31.17 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 112.74 -2.027 . . . . 0.23999999999999999 110.628 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 8.6 mtpt . . . . . 0 N--CA 1.4 -2.934 0 CA-C-N 115.218 -0.901 . . . . 0.67000000000000004 109.117 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.6 mt-10 . . . . . 0 CA--C 1.506 -0.738 0 CA-C-O 122.135 0.969 . . . . 0.62 111.52 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.753 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.15 99.25 12.31 Favored Pre-proline 0 N--CA 1.418 -2.072 0 CA-C-N 113.429 -1.714 . . . . 1.3300000000000001 107.726 175.222 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.2 Cg_endo -67.42 102.3 0.69 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.348 2.032 . . . . 0.20000000000000001 110.042 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.723 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.2 160.46 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 114.547 -1.206 . . . . 0.29999999999999999 110.362 -173.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -113.59 -32.06 6.3 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.288 -1.778 . . . . 1.8400000000000001 107.377 -174.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.559 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 62.2 m-85 -137.77 115.92 11.73 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.894 -1.957 . . . . 0.44 110.46 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.723 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.1 t-105 -123.56 134.1 53.88 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.932 -1.031 . . . . 0.13 110.823 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.519 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.6 mtp -134.06 86.18 37.89 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.705 -1.134 . . . . 0.40999999999999998 111.297 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 97.7 Cg_endo -72.5 139.52 31.58 Favored 'Trans proline' 0 CA--C 1.507 -0.862 0 C-N-CA 123.063 2.509 . . . . 0.16 111.828 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.752 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.97 -14.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 0.17000000000000001 111.054 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -134.11 164.69 26.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.339 -0.846 . . . . 1.5900000000000001 109.4 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -96.78 14.41 25.25 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.135 0.42 . . . . 0.31 112.135 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.2 p -94.41 -27.05 16.24 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.674 -1.232 . . . . 0.44 107.674 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.27 31.64 0.83 Allowed Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 112.898 -1.955 . . . . 0.23999999999999999 112.166 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 441' ' ' GLY . 73.3 t -102.3 147.47 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.296 0.569 . . . . 0.17000000000000001 110.914 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.94 -166.18 37.73 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 114.637 -1.165 . . . . 0.10000000000000001 111.325 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -104.35 140.3 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.504 -0.925 . . . . 0.12 108.504 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 407' ' ' VAL . 29.4 p80 -151.42 164.26 37.14 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.55 0.69 . . . . 0.14999999999999999 111.428 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.781 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -87.15 146.6 25.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.143 -1.389 . . . . 0.41999999999999998 108.066 172.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.5 m -139.35 102.5 4.5 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.021 1.391 . . . . 1.48 111.003 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.76 -26.96 16.75 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 109.904 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.521 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 12.2 p90 -72.65 -26.6 61.71 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.148 -1.387 . . . . 0.17999999999999999 109.817 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 80.56 25.17 Favored Pre-proline 0 CA--C 1.491 -1.296 0 CA-C-N 114.005 -1.452 . . . . 1.3300000000000001 108.953 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 24.0 Cg_endo -81.94 5.54 6.26 Favored 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 125.083 3.855 . . . . 0.23000000000000001 114.121 -162.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -115.07 150.18 36.34 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.986 -0.552 . . . . 1.1000000000000001 109.516 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.49 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.43 125.02 4.23 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.626 1.203 . . . . 0.38 108.08 -172.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.55 -166.77 29.18 Favored Glycine 0 C--N 1.294 -1.778 0 C-N-CA 119.199 -1.476 . . . . 0.13 111.083 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.64 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.26 153.16 0.0 OUTLIER Glycine 0 C--N 1.338 0.691 0 O-C-N 125.115 1.127 . . . . 0.20000000000000001 113.432 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.405 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.3 m-20 -55.56 100.73 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 123.832 1.777 . . . . 0.33000000000000002 112.063 -147.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.2 mt -96.82 -30.48 13.14 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 110.51 -3.041 . . . . 0.17999999999999999 108.098 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.54 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.0 p-90 -47.34 -38.61 13.21 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.791 0.682 . . . . 0.22 111.496 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.784 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 23.8 mttt -60.92 -23.05 64.95 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.306 -0.861 . . . . 0.64000000000000001 112.855 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 67.5 p -114.4 -37.06 4.44 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.799 0.809 . . . . 0.25 110.248 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.0 mtp85 -85.44 -15.61 42.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.691 -1.14 . . . . 0.35999999999999999 112.761 -169.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.89 41.17 28.74 Favored Glycine 0 C--N 1.313 -0.695 0 N-CA-C 116.128 1.211 . . . . 0.20999999999999999 116.128 159.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 439' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 369' ' ' VAL . 1.2 m -79.56 141.76 36.32 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 117.823 0.811 . . . . 0.46999999999999997 109.138 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 440' ' ' HIS . . . . . 0.403 ' NE2' ' HE3' ' A' ' 372' ' ' LYS . 63.2 m80 -110.79 71.93 0.76 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.362 -0.836 . . . . 0.40999999999999998 110.554 -171.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.603 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 83.97 -12.61 52.93 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.377 -1.089 . . . . 0.17999999999999999 110.377 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.482 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.0 p -90.26 145.05 25.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.213 -0.494 . . . . 0.82999999999999996 110.595 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.7 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -104.26 115.45 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.717 -0.674 . . . . 0.14999999999999999 110.416 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.557 ' HB2' HG13 ' A' ' 369' ' ' VAL . 18.7 m120 -79.69 91.96 5.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 1.77 111.217 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 38.3 m -88.45 137.82 30.45 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.29 -0.633 . . . . 0.17999999999999999 109.29 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.6 Cg_exo -55.67 135.94 71.82 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.892 2.395 . . . . 0.12 111.528 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.781 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 40.2 Cg_exo -54.96 -33.99 84.88 Favored 'Trans proline' 0 CA--C 1.502 -1.08 0 C-N-CA 124.372 3.382 . . . . 0.16 112.864 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.8 m -79.32 -40.11 31.15 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.76 -1.109 . . . . 1.1699999999999999 109.857 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.657 HG11 ' HB ' ' A' ' 366' ' ' THR . 72.4 t -78.76 -29.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.763 -0.653 . . . . 0.17000000000000001 111.518 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.691 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.2 tpt -68.08 -18.94 64.8 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.916 0.865 . . . . 0.46000000000000002 110.089 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -79.97 -24.13 41.14 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.432 -1.258 . . . . 0.81000000000000005 110.887 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.701 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.1 mm-40 -79.77 -46.95 16.05 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 112.955 -1.929 . . . . 0.38 107.094 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.562 HD23 ' SD ' ' A' ' 450' ' ' MET . 22.3 tp -64.88 -67.72 0.41 Allowed 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 111.857 -2.429 . . . . 0.059999999999999998 112.576 175.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.519 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 30.0 t80 -50.68 -26.37 5.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.054 1.407 . . . . 0.31 108.201 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.48 -30.72 68.71 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-N 112.316 -2.22 . . . . 0.13 112.052 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -88.57 -49.61 6.79 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.729 0.776 . . . . 0.13 110.714 170.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.661 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 1.3 p -106.91 132.84 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 123.575 1.655 . . . . 0.23000000000000001 114.39 -167.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.515 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 9.3 pt-20 -139.65 -176.68 4.64 Favored 'General case' 0 N--CA 1.404 -2.738 0 CA-C-N 110.646 -2.979 . . . . 0.82999999999999996 106.469 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.1 mtmt -45.4 154.14 0.2 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.971 1.367 . . . . 0.23999999999999999 113.789 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.51 -36.89 3.68 Favored Glycine 0 C--N 1.293 -1.823 0 CA-C-N 112.105 -2.316 . . . . 0.37 112.501 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.53 ' HB ' HG23 ' A' ' 457' ' ' VAL . 4.3 m -79.54 142.76 58.16 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 109.676 -0.491 . . . . 0.14999999999999999 109.676 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.689 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 6.0 Cg_exo -75.9 169.9 21.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 121.931 1.754 . . . . 0.12 111.677 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.91 157.59 38.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.718 -1.216 . . . . 1.0900000000000001 107.718 165.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.0 tp -128.39 145.34 51.11 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.343 -0.844 . . . . 0.13 110.004 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.722 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.33 147.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.158 -1.423 . . . . 0.089999999999999997 107.158 165.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.59 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 18.4 p90 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.4 -0.81 . . . . 1.1599999999999999 111.026 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.666 HG23 ' HA ' ' A' ' 358' ' ' LYS . 2.3 m . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 107.741 -1.207 . . . . 0.45000000000000001 107.741 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.665 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.1 p90 -160.11 -171.21 3.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.407 -0.815 . . . . 0.32000000000000001 110.533 -175.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.563 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.5 mm -106.05 161.11 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.25 -1.018 . . . . 0.080000000000000002 108.25 167.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.511 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.7 tt0 -141.57 155.45 45.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.877 0.762 . . . . 0.17000000000000001 111.12 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 354' ' ' MET . 60.0 t -151.05 137.07 12.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.519 -1.218 . . . . 0.080000000000000002 109.763 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -116.61 117.7 30.57 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.04 -1.096 . . . . 0.37 108.04 171.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.556 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -72.5 -46.05 56.51 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.705 0.764 . . . . 0.32000000000000001 109.716 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -59.86 -46.46 89.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.542 -1.663 . . . . 1.51 112.601 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -107.62 19.49 20.1 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.91000000000000003 109.161 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 20.8 mp0 33.6 69.08 0.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 125.743 1.902 . . . . 2.2200000000000002 112.568 171.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.599 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 8.4 t60 -152.06 124.12 8.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.2 0.524 . . . . 0.13 110.054 -176.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.6 ttp -109.82 127.76 54.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.521 0.677 . . . . 0.059999999999999998 110.616 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.655 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.5 m-90 -112.57 173.01 6.58 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.447 -1.251 . . . . 0.10000000000000001 111.925 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.726 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.7 t80 -126.35 118.96 26.14 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.495 -1.668 . . . . 0.22 106.495 165.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 22.4 m-85 -101.12 127.21 47.77 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-O 122.335 1.064 . . . . 0.17999999999999999 112.467 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.666 ' HA ' HG23 ' A' ' 343' ' ' THR . 2.6 ttpt -149.38 139.82 22.42 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-N 112.73 -2.032 . . . . 0.46999999999999997 107.326 174.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 72.74 15.9 4.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.08 -1.418 . . . . 0.59999999999999998 109.069 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.65 79.0 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 112.523 -2.126 . . . . 0.23000000000000001 111.533 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.668 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 2.2 tppt? -140.17 178.23 7.43 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.446 -1.877 . . . . 0.68000000000000005 105.961 -167.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.733 HG21 ' HG2' ' A' ' 365' ' ' GLU . 2.9 m -106.36 138.61 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-O 124.053 1.882 . . . . 0.53000000000000003 112.328 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -94.71 -24.59 17.07 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 109.419 -3.537 . . . . 0.12 108.589 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.617 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.4 tp -153.05 154.91 35.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.701 -1.591 . . . . 0.080000000000000002 108.808 -171.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.733 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.7 122.94 1.21 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.817 -0.629 . . . . 0.60999999999999999 109.475 -174.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.664 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.6 t -147.56 166.84 26.12 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.564 0.697 . . . . 0.089999999999999997 111.406 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 50.6 m-20 -83.92 147.56 27.42 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.08 -1.452 . . . . 1.8799999999999999 107.08 174.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.66 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.281 -0.872 . . . . 0.11 111.425 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.597 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.03 118.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.997 -1.002 . . . . 0.12 108.727 175.355 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.509 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.3 t -142.26 147.85 37.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.327 -0.851 . . . . 0.69999999999999996 112.306 -168.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.44 45.31 55.01 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 116.736 1.454 . . . . 0.13 116.736 162.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.633 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.28 144.24 3.29 Favored Pre-proline 0 C--O 1.217 -0.611 0 CA-C-N 118.706 1.253 . . . . 0.47999999999999998 110.309 -175.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.82 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.69 -29.15 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.593 1 C-N-CA 125.75 4.3 . . . . 0.23000000000000001 116.001 -171.977 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.633 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -84.14 -33.92 24.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.4 0.619 . . . . 0.29999999999999999 111.04 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -140.35 72.08 32.16 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 122.201 1.001 . . . . 0.29999999999999999 110.245 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.9 Cg_exo -70.78 165.55 31.77 Favored 'Trans proline' 0 C--N 1.324 -0.727 1 C-N-CA 125.368 4.046 . . . . 0.16 114.21 -176.568 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.713 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -78.69 152.82 78.08 Favored Pre-proline 0 N--CA 1.435 -1.202 0 CA-C-N 113.799 -1.546 . . . . 0.12 110.427 174.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.527 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.34 -49.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.983 3.788 . . . . 0.089999999999999997 113.311 -172.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.705 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.52 122.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.666 0.987 . . . . 0.089999999999999997 113.666 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.95 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.282 -1.326 . . . . 0.11 111.577 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.3 p -129.09 106.0 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.307 1.051 . . . . 0.89000000000000001 109.323 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.802 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.5 m-85 -109.54 163.88 13.04 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.799 -1.091 . . . . 0.16 110.071 -169.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.687 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 69.6 m-85 -147.93 137.88 22.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 121.261 -0.176 . . . . 0.68999999999999995 110.749 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.622 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.5 124.6 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.863 -0.735 . . . . 0.14000000000000001 110.538 177.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -109.52 4.49 22.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.533 -0.758 . . . . 0.19 112.163 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.717 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 15.2 t-20 -166.52 150.97 7.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.40999999999999998 110.684 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 12.1 mtpt -109.53 118.68 37.23 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.583 0.706 . . . . 1.0900000000000001 109.86 169.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.6 mt-10 -119.4 112.96 20.07 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 123.034 1.397 . . . . 0.38 112.803 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -108.93 136.58 48.23 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 113.785 -1.552 . . . . 1.96 110.994 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 390' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 38.7 t70 51.36 34.74 12.38 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 123.466 1.603 . . . . 0.40000000000000002 107.9 -175.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.15 170.82 10.72 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.21 -2.268 . . . . 0.16 111.991 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.0 m -129.32 104.41 7.49 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.742 -1.572 . . . . 0.27000000000000002 109.64 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.728 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.12 155.06 40.69 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 112.889 -1.959 . . . . 0.23999999999999999 109.972 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.46 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 9.6 mtpt . . . . . 0 N--CA 1.404 -2.767 0 O-C-N 124.529 1.143 . . . . 0.67000000000000004 108.543 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.7 mt-10 . . . . . 0 CA--C 1.507 -0.71 0 CA-C-O 122.764 1.269 . . . . 0.62 112.111 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.728 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -140.1 98.15 7.65 Favored Pre-proline 0 N--CA 1.421 -1.916 0 CA-C-N 112.356 -2.202 . . . . 1.3300000000000001 107.768 172.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 62.9 Cg_endo -68.17 102.66 0.82 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.325 2.017 . . . . 0.20000000000000001 110.658 175.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.786 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.06 163.84 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.684 -1.144 . . . . 0.29999999999999999 110.393 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 390' ' ' ASP . 11.9 m120 -115.94 -31.38 5.77 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 113.517 -1.674 . . . . 1.8400000000000001 107.602 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.462 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 55.8 m-85 -138.61 115.65 10.92 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.142 -1.845 . . . . 0.44 110.107 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.786 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.09 135.65 54.48 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.075 -0.966 . . . . 0.13 109.95 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.525 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -135.89 85.1 30.12 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.98 -1.009 . . . . 0.40999999999999998 111.019 174.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.712 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.6 Cg_endo -71.41 140.67 37.15 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.98 2.453 . . . . 0.16 112.236 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -124.25 -15.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.841 -1.527 . . . . 0.17000000000000001 111.105 -173.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -134.36 166.01 23.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 1.5900000000000001 109.328 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.44 13.86 31.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.405 0.52 . . . . 0.31 112.405 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.2 p -92.88 -27.1 17.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.342 -1.355 . . . . 0.44 107.342 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 126.65 32.25 0.72 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 113.062 -1.881 . . . . 0.23999999999999999 112.36 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 441' ' ' GLY . 72.4 t -102.59 147.62 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 121.24 0.543 . . . . 0.17000000000000001 111.164 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.57 -166.0 38.16 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.979 -1.009 . . . . 0.10000000000000001 111.621 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.33 140.35 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.846 -0.798 . . . . 0.12 108.846 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 33.4 p80 -150.83 165.42 33.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.763 0.792 . . . . 0.14999999999999999 111.556 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.53 139.64 30.33 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.936 -1.484 . . . . 0.41999999999999998 107.611 172.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.8 p -128.49 99.79 5.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.897 1.332 . . . . 1.48 109.957 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.0 -34.41 11.78 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 112.497 -2.138 . . . . 0.34999999999999998 110.778 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.553 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 11.2 p90 -67.14 -26.91 66.9 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.566 -1.197 . . . . 0.17999999999999999 109.213 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.588 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.98 81.91 20.41 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.586 -1.643 . . . . 1.3300000000000001 109.253 -174.223 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 427' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 28.7 Cg_endo -79.91 5.9 5.63 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 C-N-CA 124.844 3.696 . . . . 0.23000000000000001 113.824 -161.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.76 153.53 30.16 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.945 -0.57 . . . . 1.1000000000000001 111.14 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -164.0 123.72 2.05 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 114.347 -1.297 . . . . 0.38 108.341 -172.176 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.61 -166.66 28.71 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 119.394 -1.384 . . . . 0.13 110.535 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.63 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.94 151.7 0.0 OUTLIER Glycine 0 C--N 1.34 0.767 0 O-C-N 125.296 1.233 . . . . 0.20000000000000001 113.416 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 124.089 1.9 . . . . 0.33000000000000002 111.913 -152.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 46.5 mt -97.17 -33.47 11.48 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 109.964 -3.289 . . . . 0.17999999999999999 107.752 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.597 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.82 -37.48 6.17 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.961 0.788 . . . . 0.22 111.61 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.82 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 35.3 mttt -60.51 -24.4 65.29 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.984 -1.007 . . . . 0.64000000000000001 112.737 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -114.8 -36.43 4.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.753 0.787 . . . . 0.25 110.044 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.588 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.4 mtp85 -83.72 -15.02 50.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.553 -1.203 . . . . 0.35999999999999999 112.724 -169.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.49 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.41 40.9 38.72 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.331 1.292 . . . . 0.20999999999999999 116.331 159.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.4 m -81.88 134.5 35.41 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 118.038 0.919 . . . . 0.46999999999999997 109.612 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -99.28 70.45 1.75 Allowed 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.771 -0.58 . . . . 0.40999999999999998 110.466 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.644 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 80.72 -7.13 59.56 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.754 -0.938 . . . . 0.17999999999999999 110.754 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 19.1 p -93.05 131.09 38.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.692 0.758 . . . . 0.82999999999999996 110.548 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -91.61 113.74 27.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.978 -1.01 . . . . 0.14999999999999999 110.494 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.576 ' HB2' HG13 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -76.89 89.73 3.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.992 -1.003 . . . . 1.77 110.982 -177.167 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.623 HG23 HG21 ' A' ' 366' ' ' THR . 31.5 m -89.05 136.09 30.88 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 109.214 -0.661 . . . . 0.17999999999999999 109.214 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.451 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.2 Cg_exo -57.46 131.93 47.6 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.39 . . . . 0.12 113.107 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.763 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.9 Cg_exo -50.79 -39.1 58.06 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 123.463 2.775 . . . . 0.16 112.398 -168.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 451' ' ' LYS . 17.0 p -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.529 -1.214 . . . . 1.1699999999999999 109.974 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.664 HG11 ' HB ' ' A' ' 366' ' ' THR . 68.7 t -78.37 -29.64 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.211 0.529 . . . . 0.17000000000000001 111.252 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.674 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.48 -20.28 65.45 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 122.009 0.909 . . . . 0.46000000000000002 110.013 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 448' ' ' SER . 0.1 OUTLIER -75.67 -29.71 59.15 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 114.059 -1.428 . . . . 0.81000000000000005 111.266 176.195 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -76.05 -47.28 25.29 Favored 'General case' 0 CA--C 1.473 -2.0 0 CA-C-N 112.645 -2.07 . . . . 0.38 107.297 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.584 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.9 tp -64.57 -66.49 0.54 Allowed 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 111.771 -2.468 . . . . 0.059999999999999998 112.546 175.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.444 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.6 t80 -50.32 -24.93 3.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.041 1.4 . . . . 0.31 108.342 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.8 -28.14 63.49 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 112.432 -2.167 . . . . 0.13 111.967 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -89.84 -48.4 7.26 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 121.769 0.795 . . . . 0.13 111.461 170.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.563 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.7 OUTLIER -103.21 137.45 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 CA-C-O 123.503 1.62 . . . . 0.23000000000000001 114.297 -167.167 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.83 -178.6 5.26 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 110.592 -3.004 . . . . 0.82999999999999996 106.607 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.717 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.5 mtmt -52.1 162.19 0.51 Allowed 'General case' 0 N--CA 1.413 -2.324 0 CA-C-O 123.092 1.425 . . . . 0.23999999999999999 113.009 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.92 4.55 Favored Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 112.576 -2.102 . . . . 0.37 112.535 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.3 m -77.04 141.13 67.13 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.231 -0.655 . . . . 0.14999999999999999 109.231 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.665 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.8 Cg_exo -73.62 167.42 27.3 Favored 'Trans proline' 0 N--CA 1.427 -2.438 0 C-N-CA 121.677 1.585 . . . . 0.12 111.106 174.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.802 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.7 156.78 38.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.398 -1.334 . . . . 1.0900000000000001 107.398 166.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.491 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.1 tp -128.06 145.33 51.03 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 115.552 -0.749 . . . . 0.13 110.17 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.32 147.72 20.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.962 -1.496 . . . . 0.089999999999999997 106.962 165.04 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.692 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.8 p90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.079 -0.962 . . . . 1.1599999999999999 111.573 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.629 HG23 ' HA ' ' A' ' 358' ' ' LYS . 96.2 m . . . . . 0 N--CA 1.426 -1.663 0 N-CA-C 107.754 -1.202 . . . . 0.45000000000000001 107.754 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.658 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 10.7 p90 -160.58 -170.73 2.87 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.031 -0.986 . . . . 0.32000000000000001 110.987 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.576 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -102.53 157.2 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 107.693 -1.225 . . . . 0.080000000000000002 107.693 165.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.2 tt0 -137.91 154.08 49.46 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 118.59 0.632 . . . . 0.17000000000000001 110.659 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 354' ' ' MET . 58.0 t -150.81 135.17 9.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.911 -1.04 . . . . 0.080000000000000002 109.913 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -114.78 117.88 32.0 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.607 -1.179 . . . . 0.37 108.097 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.531 HD21 HG23 ' A' ' 465' ' ' VAL . 2.0 mm? -72.07 -48.77 41.75 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.335 1.064 . . . . 0.32000000000000001 110.122 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -54.58 -51.68 64.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.026 -1.897 . . . . 1.51 112.374 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -104.4 16.62 25.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.38 -1.282 . . . . 0.91000000000000003 108.914 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.789 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.7 mm-40 34.09 69.27 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 112.94 -1.936 . . . . 2.2200000000000002 112.55 172.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.473 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.8 t60 -150.05 125.38 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.702 -0.681 . . . . 0.13 109.561 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.666 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -111.78 128.44 56.1 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.495 0.664 . . . . 0.059999999999999998 110.356 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.618 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 30.9 m-90 -113.07 171.71 7.38 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.438 -1.255 . . . . 0.10000000000000001 111.636 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.685 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.6 t80 -122.3 116.07 23.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.823 -1.918 . . . . 0.22 105.823 164.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.468 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 21.0 m-85 -100.82 131.35 46.75 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.739 0.78 . . . . 0.17999999999999999 110.962 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.662 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 4.6 ttpt -147.7 137.66 22.82 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 114.266 -1.334 . . . . 0.46999999999999997 108.656 174.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.8 OUTLIER 69.72 18.31 7.54 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 113.104 -1.862 . . . . 0.59999999999999998 108.34 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.01 71.89 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 112.28 -2.236 . . . . 0.23000000000000001 111.834 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.622 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.84 165.39 27.42 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.91 -1.645 . . . . 0.68000000000000005 106.729 -168.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.622 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 54.5 t -94.66 132.42 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 123.54 1.638 . . . . 0.53000000000000003 111.632 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.685 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -98.87 -28.14 13.59 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 110.944 -2.844 . . . . 0.12 109.856 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.631 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.2 tp -152.64 148.61 27.52 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.408 -1.269 . . . . 0.080000000000000002 109.625 -170.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.618 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -158.71 123.02 4.05 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.257 -0.428 . . . . 0.60999999999999999 110.099 -171.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.652 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.9 t -148.93 166.74 27.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 122.402 1.096 . . . . 0.089999999999999997 112.262 172.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.616 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.9 p-10 -86.01 141.27 29.6 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 112.827 -1.988 . . . . 1.8799999999999999 107.418 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.642 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.83 -171.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.477 -0.783 . . . . 0.11 112.155 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.789 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.26 119.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.998 -1.001 . . . . 0.12 109.529 175.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.8 t -142.35 144.56 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 0.69999999999999996 112.642 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.02 45.37 26.56 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 116.784 1.474 . . . . 0.13 116.784 163.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.551 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.6 143.08 5.99 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-N 118.921 1.361 . . . . 0.47999999999999998 110.007 -174.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.768 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -32.94 -31.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.7 1 C-N-CA 126.056 4.504 . . . . 0.23000000000000001 116.471 -170.041 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.9 p -81.94 -33.75 30.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.208 0.528 . . . . 0.29999999999999999 111.126 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.462 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.8 m -140.16 73.82 31.33 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-O 122.212 1.006 . . . . 0.29999999999999999 109.955 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.9 Cg_exo -71.21 161.73 44.86 Favored 'Trans proline' 0 C--N 1.319 -0.998 1 C-N-CA 125.308 4.006 . . . . 0.16 113.741 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.682 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.95 152.18 90.84 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-N 113.657 -1.611 . . . . 0.12 110.67 175.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.523 ' HG2' ' CE1' ' A' ' 382' ' ' PHE . 1.4 Cg_endo -80.18 -49.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 125.044 3.829 . . . . 0.089999999999999997 113.497 -171.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.711 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.23 123.04 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.143 0.973 . . . . 0.089999999999999997 113.545 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.82 -126.31 1.48 Allowed Glycine 0 N--CA 1.436 -1.325 0 CA-C-N 113.895 -1.502 . . . . 0.11 110.671 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.9 p -129.18 104.46 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.286 1.041 . . . . 0.89000000000000001 109.346 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.628 ' CE2' HG22 ' A' ' 465' ' ' VAL . 51.1 m-85 -107.78 169.25 8.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.005 -0.998 . . . . 0.16 109.173 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.702 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 74.1 m-85 -148.92 138.04 21.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 121.225 -0.19 . . . . 0.68999999999999995 110.579 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.17 123.66 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 119.833 -0.747 . . . . 0.14000000000000001 110.123 176.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -111.63 6.48 20.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.412 -0.813 . . . . 0.19 111.846 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.719 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 14.0 t-20 -166.7 150.66 7.15 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.401 -0.818 . . . . 0.40999999999999998 110.93 175.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.7 mtpt -109.99 120.32 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.529 -0.76 . . . . 1.0900000000000001 109.466 169.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.574 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.9 mt-10 -122.58 112.88 18.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 123.29 1.519 . . . . 0.38 113.243 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 24.0 mp0 -108.93 135.38 50.22 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.509 -1.678 . . . . 1.96 111.022 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 24.6 t70 52.23 35.69 17.5 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.582 1.658 . . . . 0.40000000000000002 107.545 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.03 170.81 10.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.196 -2.275 . . . . 0.16 112.225 -175.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 30.5 m -128.12 102.53 6.76 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.341 -1.754 . . . . 0.27000000000000002 109.937 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.727 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.42 156.49 36.95 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.878 -1.965 . . . . 0.23999999999999999 110.262 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 10.3 mtpt . . . . . 0 N--CA 1.401 -2.918 0 O-C-N 124.235 0.959 . . . . 0.67000000000000004 108.701 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 5.4 mt-10 . . . . . 0 CA--C 1.507 -0.707 0 CA-C-O 122.448 1.118 . . . . 0.62 112.302 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.727 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.21 98.77 9.14 Favored Pre-proline 0 N--CA 1.422 -1.843 0 CA-C-N 113.012 -1.904 . . . . 1.3300000000000001 108.193 174.733 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.1 Cg_endo -67.42 102.7 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.454 2.102 . . . . 0.20000000000000001 110.336 174.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.64 160.88 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.397 -1.274 . . . . 0.29999999999999999 110.134 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 10.4 m120 -111.82 -32.85 6.49 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.656 -1.611 . . . . 1.8400000000000001 107.19 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.443 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 49.8 m-85 -137.67 115.98 11.87 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.064 -1.88 . . . . 0.44 110.225 175.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.778 ' HB2' HG11 ' A' ' 407' ' ' VAL . 9.8 t-105 -122.87 135.57 54.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.957 -1.02 . . . . 0.13 109.794 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.54 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.5 OUTLIER -136.34 86.07 25.19 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.882 -1.054 . . . . 0.40999999999999998 110.851 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.6 Cg_endo -72.34 141.5 35.51 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.975 2.45 . . . . 0.16 111.691 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.52 -15.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.393 -1.276 . . . . 0.17000000000000001 111.809 -171.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.818 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 3.9 p30 -135.98 171.03 15.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.778 -0.646 . . . . 1.5900000000000001 110.074 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -98.23 16.43 21.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 0.31 111.681 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.9 p -99.65 -27.91 13.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.583 -0.895 . . . . 0.44 108.583 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 132.31 26.24 0.68 Allowed Glycine 0 N--CA 1.432 -1.622 0 CA-C-N 114.337 -1.302 . . . . 0.23999999999999999 113.902 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.818 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.1 t -105.12 152.4 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.523 0.678 . . . . 0.17000000000000001 112.083 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.76 -168.07 40.55 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 114.82 -1.082 . . . . 0.10000000000000001 111.209 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.5 141.6 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 109.119 -0.697 . . . . 0.12 109.119 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.615 ' O ' ' HB ' ' A' ' 445' ' ' THR . 33.7 p80 -150.54 165.04 34.47 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.75 0.786 . . . . 0.14999999999999999 111.768 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.776 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -93.25 142.85 26.85 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.004 -1.453 . . . . 0.41999999999999998 107.16 171.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.93 104.94 5.89 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.925 1.345 . . . . 1.48 110.203 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.97 -27.62 15.56 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 112.34 -2.209 . . . . 0.34999999999999998 111.288 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.533 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 9.0 p90 -69.3 -24.61 63.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.481 -1.236 . . . . 0.17999999999999999 108.877 174.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.436 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.1 OUTLIER -119.17 100.2 50.36 Favored Pre-proline 0 CA--C 1.488 -1.404 0 CA-C-N 112.985 -1.916 . . . . 1.3300000000000001 108.465 -176.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -88.52 2.2 6.21 Favored 'Trans proline' 0 C--N 1.283 -2.914 0 C-N-CA 123.04 2.493 . . . . 0.23000000000000001 114.863 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.41 ' HB3' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -112.97 151.86 30.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.986 -1.086 . . . . 1.1000000000000001 111.567 -177.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.616 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.64 125.77 2.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.762 -1.563 . . . . 0.38 108.472 -171.423 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.71 -169.01 28.6 Favored Glycine 0 C--N 1.299 -1.527 0 C-N-CA 119.416 -1.373 . . . . 0.13 111.203 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.669 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.06 0.01 OUTLIER Glycine 0 C--N 1.34 0.778 0 O-C-N 125.163 1.155 . . . . 0.20000000000000001 112.97 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.403 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.4 m-20 -54.55 100.96 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 123.988 1.852 . . . . 0.33000000000000002 111.799 -146.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.8 mt -97.14 -31.71 12.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 110.09 -3.232 . . . . 0.17999999999999999 108.614 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.606 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.6 p-90 -45.95 -37.68 6.74 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.804 0.69 . . . . 0.22 111.515 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.768 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 56.4 mttt -61.34 -24.18 66.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.113 -0.949 . . . . 0.64000000000000001 113.211 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.5 p -114.85 -37.38 4.21 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.684 0.754 . . . . 0.25 110.162 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.508 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.5 mtp85 -82.36 -15.72 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.78 -1.1 . . . . 0.35999999999999999 112.137 -170.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.551 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 71.87 41.43 55.62 Favored Glycine 0 C--N 1.314 -0.66 0 N-CA-C 116.13 1.212 . . . . 0.20999999999999999 116.13 160.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 38.5 m -90.28 130.1 36.44 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.565 1.182 . . . . 0.46999999999999997 108.522 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -95.4 65.35 2.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.06 -0.4 . . . . 0.40999999999999998 111.187 -166.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.593 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 93.76 -13.77 66.75 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.548 -1.021 . . . . 0.17999999999999999 110.548 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 21.0 p -87.52 138.45 31.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.971 0.415 . . . . 0.82999999999999996 110.455 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -91.72 116.15 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.78 0.8 . . . . 0.14999999999999999 110.768 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.525 ' CB ' HG13 ' A' ' 369' ' ' VAL . 1.8 t-20 -76.73 84.3 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.236 -1.347 . . . . 1.77 111.405 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 51.3 m -89.64 137.96 28.41 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-O 121.659 0.743 . . . . 0.17999999999999999 109.773 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.429 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.8 Cg_exo -57.55 135.84 72.13 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.909 2.406 . . . . 0.12 111.735 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.776 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.8 Cg_exo -55.27 -34.04 86.95 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.256 3.304 . . . . 0.16 112.96 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.7 p -78.54 -39.48 37.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.651 -1.159 . . . . 1.1699999999999999 109.928 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.652 HG11 ' HB ' ' A' ' 366' ' ' THR . 86.2 t -79.58 -31.25 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.866 -0.606 . . . . 0.17000000000000001 111.384 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.696 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.6 tpt -66.76 -18.73 65.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.521 0.677 . . . . 0.46000000000000002 110.448 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -81.04 -23.05 38.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.395 1.093 . . . . 0.81000000000000005 110.989 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 456' ' ' MET . 7.7 mm-40 -79.69 -46.95 16.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 112.841 -1.981 . . . . 0.38 107.106 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.619 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.2 tp -64.39 -66.99 0.47 Allowed 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 111.835 -2.439 . . . . 0.059999999999999998 112.243 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.437 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 33.0 t80 -49.67 -27.04 4.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.018 1.39 . . . . 0.31 108.328 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.57 -30.76 66.12 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 112.465 -2.152 . . . . 0.13 112.409 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -88.38 -48.34 7.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.929 0.871 . . . . 0.13 111.369 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.612 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.6 OUTLIER -102.45 138.03 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 123.587 1.66 . . . . 0.23000000000000001 113.992 -168.045 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.96 -178.44 5.2 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 110.52 -3.037 . . . . 0.82999999999999996 106.419 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.719 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.6 mtmt -50.87 162.96 0.22 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 123.06 1.41 . . . . 0.23999999999999999 113.318 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.02 -35.29 3.95 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 112.577 -2.102 . . . . 0.37 112.47 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 462' ' ' PRO . 17.8 m -72.57 141.69 82.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 CA-C-N 115.252 -0.474 . . . . 0.14999999999999999 109.837 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.658 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.4 164.97 33.73 Favored 'Trans proline' 0 N--CA 1.43 -2.241 0 C-N-CA 122.043 1.829 . . . . 0.12 111.084 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.0 t -135.16 133.45 53.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 CA-C-N 113.702 -1.59 . . . . 1.0900000000000001 107.872 173.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.46 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.9 tp -112.55 142.96 44.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.032 -0.531 . . . . 0.13 110.371 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.711 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.19 147.46 20.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.06 -1.459 . . . . 0.089999999999999997 107.06 165.291 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.654 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.9 p90 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.657 -0.687 . . . . 1.1599999999999999 111.342 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 358' ' ' LYS . 4.1 m . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 106.95 -1.5 . . . . 0.45000000000000001 106.95 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.646 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.2 p90 -158.65 -171.03 3.27 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.597 0.713 . . . . 0.32000000000000001 111.081 -174.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.608 HD11 ' HB ' ' A' ' 457' ' ' VAL . 8.9 mm -105.58 161.09 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.719 -1.128 . . . . 0.080000000000000002 108.022 167.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.479 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.2 tt0 -142.42 155.39 45.1 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 118.843 0.747 . . . . 0.17000000000000001 111.046 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.711 HG22 ' HG3' ' A' ' 354' ' ' MET . 63.2 t -150.3 136.57 12.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.795 -1.093 . . . . 0.080000000000000002 109.851 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -117.84 111.28 18.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.721 -1.127 . . . . 0.37 108.053 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.543 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -64.63 -49.41 71.16 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 122.704 1.24 . . . . 0.32000000000000001 110.197 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -53.31 -54.82 30.86 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 112.507 -2.133 . . . . 1.51 112.224 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -94.9 3.86 54.48 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.788 -1.097 . . . . 0.91000000000000003 109.994 -173.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.764 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.2 mm-40 47.01 64.96 1.36 Allowed 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 112.584 -2.098 . . . . 2.2200000000000002 112.27 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.598 ' HE1' ' HB2' ' A' ' 365' ' ' GLU . 15.1 t-80 -145.86 124.62 12.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.107 0.48 . . . . 0.13 110.021 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.711 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.4 ttp -110.83 127.61 55.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.438 0.637 . . . . 0.059999999999999998 110.515 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.638 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.3 m-90 -111.55 173.26 6.43 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.538 -1.21 . . . . 0.10000000000000001 111.889 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.724 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -127.14 117.48 22.46 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 106.251 -1.759 . . . . 0.22 106.251 164.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 25.2 m-85 -100.48 128.6 46.49 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.188 0.994 . . . . 0.17999999999999999 111.898 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.675 ' HA ' HG23 ' A' ' 343' ' ' THR . 5.1 ttpt -148.35 137.37 21.81 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.218 -1.81 . . . . 0.46999999999999997 108.225 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.7 OUTLIER 70.56 14.46 7.27 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 113.409 -1.723 . . . . 0.59999999999999998 108.92 178.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.62 15.65 75.3 Favored Glycine 0 N--CA 1.423 -2.203 0 CA-C-N 112.588 -2.096 . . . . 0.23000000000000001 111.847 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.63 171.75 13.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.954 -1.869 . . . . 0.68000000000000005 105.954 -170.646 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.689 HG21 ' HG2' ' A' ' 365' ' ' GLU . 2.9 m -102.99 137.84 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.834 0 CA-C-O 124.421 2.058 . . . . 0.53000000000000003 112.186 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.724 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.01 -24.76 18.24 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 109.291 -3.595 . . . . 0.12 108.574 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.687 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.4 154.81 36.33 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.854 -1.521 . . . . 0.080000000000000002 109.018 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.689 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.56 122.05 1.41 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.763 -0.653 . . . . 0.60999999999999999 109.442 -175.226 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.697 HG21 HG23 ' A' ' 445' ' ' THR . 5.2 t -148.34 167.55 24.91 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 122.34 1.066 . . . . 0.089999999999999997 112.133 174.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.673 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.0 OUTLIER -86.45 139.97 30.41 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 112.941 -1.936 . . . . 1.8799999999999999 107.41 176.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.643 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.28 -171.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.349 -0.841 . . . . 0.11 112.014 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.764 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.17 117.14 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.862 -1.063 . . . . 0.12 109.203 177.161 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.498 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.0 t -142.85 146.62 34.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.78 -1.1 . . . . 0.69999999999999996 112.531 -168.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.6 45.93 50.36 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 116.824 1.489 . . . . 0.13 116.824 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.498 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.55 144.45 3.44 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 118.994 1.397 . . . . 0.47999999999999998 110.616 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.814 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.74 -29.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 1 C-N-CA 125.848 4.365 . . . . 0.23000000000000001 116.45 -172.412 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.2 p -86.97 -31.99 20.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.465 0.65 . . . . 0.29999999999999999 110.809 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.512 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.7 m -138.47 70.55 45.91 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 122.187 0.994 . . . . 0.29999999999999999 109.892 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.7 Cg_exo -72.64 163.47 38.41 Favored 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.325 4.017 . . . . 0.16 114.36 -175.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.718 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.41 152.65 85.74 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 113.23 -1.804 . . . . 0.12 110.271 173.678 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.53 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.28 -49.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.326 -0.634 0 C-N-CA 124.909 3.74 . . . . 0.089999999999999997 113.634 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.72 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.71 123.03 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.586 0.958 . . . . 0.089999999999999997 113.586 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.05 -122.76 1.1 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.225 -1.352 . . . . 0.11 111.575 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 381' ' ' VAL . 11.7 p -129.12 107.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.117 0.96 . . . . 0.89000000000000001 109.301 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.789 ' HB2' HG22 ' A' ' 463' ' ' VAL . 98.9 m-85 -110.59 161.95 15.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.154 -0.93 . . . . 0.16 109.945 -170.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.0 m-85 -148.21 135.68 20.59 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 121.234 -0.186 . . . . 0.68999999999999995 111.13 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.607 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.08 125.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.585 0.707 . . . . 0.14000000000000001 110.891 177.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -109.68 2.4 20.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.21 -0.905 . . . . 0.19 111.745 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.752 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 15.8 t-20 -165.17 146.71 7.62 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.355 -0.839 . . . . 0.40999999999999998 110.805 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -107.24 109.8 21.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.179 -0.919 . . . . 1.0900000000000001 109.224 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.575 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -107.74 119.66 40.06 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 122.589 1.185 . . . . 0.38 111.447 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 19.2 mt-10 -115.96 142.15 47.17 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.966 -1.47 . . . . 1.96 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 35.2 t70 55.86 26.87 10.18 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 111.21 -2.723 . . . . 0.40000000000000002 107.656 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 169.64 15.37 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 112.753 -2.021 . . . . 0.16 112.404 -166.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 60.8 m -125.07 102.96 7.75 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 112.866 -1.97 . . . . 0.27000000000000002 109.532 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 9.0 mp -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-N 113.176 -1.829 . . . . 0.23999999999999999 109.76 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.432 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 9.9 mtpt . . . . . 0 N--CA 1.4 -2.928 0 N-CA-C 107.814 -1.18 . . . . 0.67000000000000004 107.814 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.9 mt-10 . . . . . 0 CA--C 1.506 -0.735 0 CA-C-O 122.205 1.002 . . . . 0.62 111.388 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.695 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.3 m -142.72 98.05 5.86 Favored Pre-proline 0 N--CA 1.42 -1.959 0 CA-C-N 113.36 -1.745 . . . . 1.3300000000000001 109.478 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.2 Cg_endo -66.89 108.28 1.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 124.648 3.565 . . . . 0.20000000000000001 113.22 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -118.62 161.11 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.495 -1.23 . . . . 0.29999999999999999 110.003 -175.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.5 OUTLIER -100.23 -40.3 7.62 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.394 -1.336 . . . . 1.8400000000000001 107.394 169.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.534 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 10.2 m-30 -125.94 113.47 17.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.395 -1.275 . . . . 0.44 110.439 -175.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.724 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.4 t-105 -123.28 135.92 54.46 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.747 -1.57 . . . . 0.13 110.1 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.508 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.5 OUTLIER -135.96 85.02 29.85 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-N 114.859 -1.064 . . . . 0.40999999999999998 111.092 174.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.69 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.8 Cg_endo -70.68 140.47 39.28 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.025 2.484 . . . . 0.16 111.63 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.6 pt -123.53 -16.33 5.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.085 -1.416 . . . . 0.17000000000000001 111.154 -172.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.58 169.75 16.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.093 -0.958 . . . . 1.5900000000000001 108.945 177.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.2 14.19 32.76 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.489 0.922 . . . . 0.31 113.489 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' THR . . . . . 0.479 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 23.3 p -98.16 -28.36 13.76 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.906 -1.146 . . . . 0.44 107.906 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.6 31.17 0.31 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 114.037 -1.438 . . . . 0.23999999999999999 113.148 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 441' ' ' GLY . 72.9 t -102.75 149.4 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.383 0.611 . . . . 0.17000000000000001 111.515 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.77 -166.04 37.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.911 -1.041 . . . . 0.10000000000000001 111.57 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.7 138.45 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.936 -0.764 . . . . 0.12 108.936 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.746 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.4 p80 -151.86 171.46 17.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.093 0.949 . . . . 0.14999999999999999 111.712 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.739 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -92.44 149.56 21.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.122 -1.854 . . . . 0.41999999999999998 108.322 174.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 4.8 p -133.8 101.75 5.2 Favored 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 123.137 1.446 . . . . 1.48 110.376 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -95.8 -32.0 12.91 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 112.139 -2.3 . . . . 0.34999999999999998 110.846 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.628 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 15.5 p90 -71.67 -26.76 62.66 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 114.73 -1.123 . . . . 0.17999999999999999 108.972 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.536 ' HG2' ' HB3' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -111.05 95.5 25.11 Favored Pre-proline 0 CA--C 1.489 -1.365 0 CA-C-N 113.469 -1.696 . . . . 1.3300000000000001 108.923 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 427' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 426' ' ' GLN . 17.7 Cg_endo -85.12 2.4 7.92 Favored 'Trans proline' 0 N--CA 1.415 -3.122 0 C-N-CA 122.808 2.338 . . . . 0.23000000000000001 113.418 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.1 148.69 36.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.041 -1.064 . . . . 1.1000000000000001 110.162 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.673 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.0 OUTLIER -162.93 124.78 2.56 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.733 1.271 . . . . 0.38 108.225 -173.537 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.02 -166.04 28.47 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 119.389 -1.386 . . . . 0.13 111.241 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.62 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.52 149.58 0.01 OUTLIER Glycine 0 C--N 1.342 0.883 0 O-C-N 125.17 1.159 . . . . 0.20000000000000001 112.907 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.403 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 1.8 m-20 -54.97 101.6 0.05 Allowed 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 112.112 -145.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.4 mt -97.35 -32.14 12.03 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 110.498 -3.046 . . . . 0.17999999999999999 108.302 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.57 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.32 -37.79 5.17 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.745 0.653 . . . . 0.22 111.465 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.814 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.9 mttt -60.47 -26.57 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 114.822 -1.081 . . . . 0.64000000000000001 112.758 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.9 p -112.73 -37.89 4.74 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.717 0.77 . . . . 0.25 110.083 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.46 ' HD3' HE22 ' A' ' 426' ' ' GLN . 7.3 mtp85 -82.74 -14.76 53.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.6 -1.182 . . . . 0.35999999999999999 112.616 -168.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.63 40.7 37.48 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 116.069 1.187 . . . . 0.20999999999999999 116.069 159.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.2 m -79.86 140.87 36.61 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 117.809 0.804 . . . . 0.46999999999999997 109.52 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -106.29 68.54 0.76 Allowed 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.881 -0.512 . . . . 0.40999999999999998 110.392 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.643 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 84.63 -8.13 70.31 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.069 -0.813 . . . . 0.17999999999999999 111.069 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.487 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 26.3 p -94.92 135.09 36.86 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.393 0.616 . . . . 0.82999999999999996 110.715 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.718 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -96.42 113.74 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.254 -0.885 . . . . 0.14999999999999999 110.343 -174.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.536 ' HB3' ' HG2' ' A' ' 426' ' ' GLN . 18.9 m-80 -83.45 93.04 7.71 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.835 -1.075 . . . . 1.77 111.881 -175.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.697 HG23 HG21 ' A' ' 366' ' ' THR . 53.4 m -91.36 136.68 26.68 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.35 -0.841 . . . . 0.17999999999999999 109.604 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.2 Cg_exo -52.99 135.55 58.91 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.524 2.15 . . . . 0.12 111.214 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.739 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 49.0 Cg_exo -55.28 -31.38 76.37 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.055 3.17 . . . . 0.16 112.547 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.3 m -79.75 -38.3 33.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.286 -1.324 . . . . 1.1699999999999999 109.943 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.597 HG11 ' HB ' ' A' ' 366' ' ' THR . 86.5 t -78.55 -29.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.643 -0.708 . . . . 0.17000000000000001 111.539 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.617 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.3 tpt -66.34 -20.9 66.21 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.598 0.713 . . . . 0.46000000000000002 110.179 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -76.27 -25.27 54.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.827 -1.079 . . . . 0.81000000000000005 111.628 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -79.21 -46.66 17.43 Favored 'General case' 0 CA--C 1.473 -2.003 0 CA-C-N 113.129 -1.85 . . . . 0.38 107.092 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.546 HD23 ' SD ' ' A' ' 450' ' ' MET . 24.3 tp -66.06 -67.42 0.45 Allowed 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 111.72 -2.491 . . . . 0.059999999999999998 112.43 175.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 409' ' ' TYR . 28.7 t80 -48.94 -26.88 2.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.806 1.289 . . . . 0.31 108.344 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.54 -30.35 64.46 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.601 -2.09 . . . . 0.13 112.555 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.687 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -88.75 -48.5 7.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.65 0.738 . . . . 0.13 111.513 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.653 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.4 OUTLIER -101.03 138.3 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 123.105 1.431 . . . . 0.23000000000000001 113.902 -168.202 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -136.5 -178.94 5.39 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 111.284 -2.689 . . . . 0.82999999999999996 107.397 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.752 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.1 mtmt -52.79 157.73 1.56 Allowed 'General case' 0 N--CA 1.413 -2.286 0 CA-C-O 122.82 1.295 . . . . 0.23999999999999999 114.009 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.1 18.01 70.53 Favored Glycine 0 C--N 1.281 -2.492 0 CA-C-N 112.659 -2.064 . . . . 0.37 113.699 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 462' ' ' PRO . 9.5 m -103.85 141.68 23.02 Favored Pre-proline 0 N--CA 1.427 -1.585 0 N-CA-C 107.664 -1.235 . . . . 0.14999999999999999 107.664 165.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.646 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.3 Cg_exo -74.74 164.62 33.27 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.648 1.565 . . . . 0.12 110.73 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -134.73 154.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 107.271 -1.381 . . . . 1.0900000000000001 107.271 166.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.3 tp -126.59 145.15 50.65 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 0.13 110.195 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.04 147.44 20.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.291 -1.374 . . . . 0.089999999999999997 107.291 165.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.593 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 17.3 p90 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.535 -0.745 . . . . 1.1599999999999999 110.846 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.62 HG23 ' HA ' ' A' ' 358' ' ' LYS . 98.9 m . . . . . 0 N--CA 1.428 -1.565 0 N-CA-C 106.841 -1.54 . . . . 0.45000000000000001 106.841 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.666 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.9 p90 -158.4 -171.05 3.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.388 -0.824 . . . . 0.32000000000000001 111.322 -170.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.1 mm -103.24 156.47 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.935 -1.135 . . . . 0.080000000000000002 107.935 165.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.484 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.5 tt0 -137.22 155.02 50.02 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.596 0.634 . . . . 0.17000000000000001 110.633 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.649 HG22 ' HG3' ' A' ' 354' ' ' MET . 55.7 t -150.41 136.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.775 -1.102 . . . . 0.080000000000000002 110.0 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.04 118.94 34.3 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.553 -1.203 . . . . 0.37 108.074 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.479 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -71.17 -49.3 45.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.419 1.104 . . . . 0.32000000000000001 110.511 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -54.85 -53.56 53.77 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 112.996 -1.911 . . . . 1.51 112.308 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -98.09 10.65 39.94 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.543 -1.208 . . . . 0.91000000000000003 108.738 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.867 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.2 mm-40 38.14 71.76 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 125.088 1.493 . . . . 2.2200000000000002 111.856 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -151.63 124.11 8.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.685 -0.689 . . . . 0.13 109.872 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.649 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -110.87 128.01 55.64 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.379 0.609 . . . . 0.059999999999999998 110.484 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.671 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.9 m-90 -111.37 173.39 6.36 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.612 -1.176 . . . . 0.10000000000000001 111.895 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.723 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -126.84 116.34 20.72 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.194 -1.78 . . . . 0.22 106.194 165.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 362' ' ' VAL . 21.5 m-85 -100.07 129.63 46.13 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.927 0.87 . . . . 0.17999999999999999 111.534 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.634 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 5.1 ttpt -149.12 139.2 22.14 Favored 'General case' 0 N--CA 1.398 -3.053 0 CA-C-N 113.633 -1.621 . . . . 0.46999999999999997 107.66 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 72.64 11.68 5.5 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.064 -1.425 . . . . 0.59999999999999998 108.908 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.84 13.99 73.78 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 112.747 -2.024 . . . . 0.23000000000000001 111.753 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.631 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.75 172.75 12.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.705 -1.961 . . . . 0.68000000000000005 105.705 -171.079 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.0 m -102.68 139.27 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.864 0 CA-C-O 124.364 2.031 . . . . 0.53000000000000003 112.358 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.723 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.38 -25.32 17.74 Favored 'General case' 0 N--CA 1.396 -3.166 0 CA-C-N 109.206 -3.634 . . . . 0.12 108.498 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.698 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.32 155.18 37.16 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.695 -1.593 . . . . 0.080000000000000002 109.102 -172.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.802 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.19 122.54 1.3 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.718 -0.673 . . . . 0.60999999999999999 109.543 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.678 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.6 t -147.35 166.81 26.01 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.866 0.841 . . . . 0.089999999999999997 111.744 173.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.495 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 1.6 m-20 -82.68 146.0 29.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.592 -1.633 . . . . 1.8799999999999999 106.592 174.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.17 -172.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.506 -0.77 . . . . 0.11 111.245 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.867 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -154.01 118.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.931 -1.031 . . . . 0.12 108.973 174.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.445 ' HB2' HG13 ' A' ' 443' ' ' ILE . 6.9 t -143.02 142.84 31.68 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.164 -0.925 . . . . 0.69999999999999996 113.395 -166.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.86 47.56 24.98 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.941 1.536 . . . . 0.13 116.941 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 17.5 ptmt -44.56 148.1 0.95 Allowed Pre-proline 0 C--O 1.222 -0.39 0 CA-C-N 118.521 1.16 . . . . 0.47999999999999998 111.372 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.807 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -37.2 -31.18 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.053 1 C-N-CA 125.522 4.148 . . . . 0.23000000000000001 115.268 -177.664 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.497 HG23 ' HE2' ' A' ' 372' ' ' LYS . 4.0 p -82.68 -36.28 26.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.327 0.584 . . . . 0.29999999999999999 110.776 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.442 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 8.9 m -140.74 73.94 27.72 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 122.067 0.937 . . . . 0.29999999999999999 110.238 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.713 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 36.9 Cg_exo -69.3 161.62 45.14 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 125.061 3.841 . . . . 0.16 114.073 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.675 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -71.35 151.62 94.22 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 113.35 -1.75 . . . . 0.12 110.91 175.65 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.535 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.01 -49.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.997 3.798 . . . . 0.089999999999999997 113.443 -171.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.706 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.59 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.155 0.979 . . . . 0.089999999999999997 113.552 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.02 -128.67 1.8 Allowed Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 113.997 -1.456 . . . . 0.11 111.13 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 97.7 t -128.19 99.89 5.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.424 -0.954 . . . . 0.89000000000000001 108.424 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 413' ' ' ILE . 50.4 m-85 -104.58 169.87 8.21 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.39 -0.823 . . . . 0.16 109.124 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.736 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.6 m-85 -149.23 139.54 22.32 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 110.413 -0.217 . . . . 0.68999999999999995 110.413 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.594 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -74.55 120.69 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 119.903 -0.719 . . . . 0.14000000000000001 110.397 176.115 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 385' ' ' TRP . . . . . 0.404 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 40.8 p-90 -109.21 4.41 22.81 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.391 -0.822 . . . . 0.19 112.159 -176.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.735 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 17.3 t-20 -165.11 148.16 8.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.227 -0.897 . . . . 0.40999999999999998 110.009 175.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.445 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 14.8 mtpt -109.62 110.69 21.82 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.423 -0.808 . . . . 1.0900000000000001 109.866 170.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -109.08 120.82 43.69 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.561 1.172 . . . . 0.38 110.763 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.04 142.97 46.28 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.225 -1.352 . . . . 1.96 109.784 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 36.3 t70 54.19 26.34 6.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 111.782 -2.463 . . . . 0.40000000000000002 108.63 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.29 170.74 14.3 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.079 -1.873 . . . . 0.16 112.247 -167.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 22.4 m -128.5 102.88 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.568 -1.651 . . . . 0.27000000000000002 109.733 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.749 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.76 157.84 36.73 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 112.865 -1.971 . . . . 0.23999999999999999 110.459 176.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.494 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.8 mtpt . . . . . 0 N--CA 1.392 -3.369 0 CA-C-N 114.5 -1.227 . . . . 0.67000000000000004 108.082 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 9.4 mt-10 . . . . . 0 CA--C 1.512 -0.516 0 CA-C-O 122.302 1.048 . . . . 0.62 111.706 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.749 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.47 98.66 12.25 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 113.199 -1.819 . . . . 1.3300000000000001 108.273 178.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 59.5 Cg_endo -66.97 101.76 0.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.442 2.095 . . . . 0.20000000000000001 110.28 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.43 163.55 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.852 0 CA-C-N 114.239 -1.346 . . . . 0.29999999999999999 109.83 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -114.99 -33.82 5.28 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.474 -1.694 . . . . 1.8400000000000001 106.808 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.407 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.8 m-85 -136.09 116.25 13.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.796 -2.002 . . . . 0.44 110.681 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.746 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.33 134.72 54.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.665 -1.152 . . . . 0.13 110.102 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.594 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.6 OUTLIER -136.28 86.24 25.17 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.905 -1.043 . . . . 0.40999999999999998 110.937 174.359 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 79.9 Cg_endo -72.11 141.61 36.57 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.892 2.395 . . . . 0.16 111.655 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.09 -16.2 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.537 -1.21 . . . . 0.17000000000000001 111.936 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.761 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.7 p30 -136.1 171.12 14.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 1.5900000000000001 110.222 170.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -99.18 15.9 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.76 -0.655 . . . . 0.31 111.467 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 1.8 p -97.03 -26.88 14.85 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.089 -1.078 . . . . 0.44 108.089 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 130.15 27.62 0.76 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.904 -1.498 . . . . 0.23999999999999999 113.677 169.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.761 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 49.2 t -104.43 149.78 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.43 0.633 . . . . 0.17000000000000001 112.463 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . -178.96 -164.32 31.5 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.966 -1.016 . . . . 0.10000000000000001 111.942 174.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.47 139.55 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.54 -0.911 . . . . 0.12 108.54 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.553 ' HB2' HG21 ' A' ' 407' ' ' VAL . 11.5 p-80 -150.02 164.16 36.25 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.637 0.732 . . . . 0.14999999999999999 111.457 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.774 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.07 138.79 31.33 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.203 -1.362 . . . . 0.41999999999999998 107.474 172.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.631 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 4.8 t -133.13 104.67 6.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.326 1.536 . . . . 1.48 110.667 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.32 -28.83 15.97 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 111.43 -2.623 . . . . 0.34999999999999998 110.83 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.568 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.7 p90 -72.01 -27.23 62.59 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.471 -1.24 . . . . 0.17999999999999999 109.728 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.631 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -118.01 81.18 15.71 Favored Pre-proline 0 CA--C 1.496 -1.106 0 CA-C-N 114.276 -1.329 . . . . 1.3300000000000001 110.015 -176.067 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 427' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 14.9 Cg_endo -84.34 8.59 4.54 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 C-N-CA 125.122 3.881 . . . . 0.23000000000000001 114.313 -163.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -114.89 150.52 35.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.177 -0.675 . . . . 1.1000000000000001 109.177 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.495 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -159.61 125.52 4.28 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.629 1.172 . . . . 0.38 108.285 -171.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 148.3 -166.97 29.05 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.353 -1.403 . . . . 0.13 111.305 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.85 154.44 0.0 OUTLIER Glycine 0 C--N 1.341 0.818 0 O-C-N 125.151 1.148 . . . . 0.20000000000000001 113.2 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 2.9 m-20 -55.28 101.42 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.806 1.765 . . . . 0.33000000000000002 112.17 -146.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.0 mt -97.03 -31.35 12.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 110.53 -3.032 . . . . 0.17999999999999999 109.39 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.499 ' HA ' HG23 ' A' ' 369' ' ' VAL . 14.2 p-90 -50.13 -30.87 12.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.96 -1.927 . . . . 0.22 111.844 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.807 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 44.9 mttt -66.65 -22.12 66.1 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.919 -1.037 . . . . 0.64000000000000001 112.872 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.8 p -117.43 -38.72 3.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.855 0.836 . . . . 0.25 110.049 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.515 ' HB3' ' NE2' ' A' ' 426' ' ' GLN . 10.0 mtp85 -80.3 -15.32 57.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.48 -1.236 . . . . 0.35999999999999999 111.952 -171.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 71.84 40.58 57.61 Favored Glycine 0 C--N 1.311 -0.821 0 N-CA-C 115.697 1.039 . . . . 0.20999999999999999 115.697 159.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 1.4 m -80.01 130.84 35.58 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 108.85 -0.796 . . . . 0.46999999999999997 108.85 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -99.97 65.64 1.3 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.314 -0.866 . . . . 0.40999999999999998 111.562 -169.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 377' ' ' THR . . . 94.92 -18.77 56.65 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 111.09 -0.804 . . . . 0.17999999999999999 111.09 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.514 ' C ' HD12 ' A' ' 443' ' ' ILE . 37.1 m -90.36 159.17 16.75 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.951 -0.7 . . . . 0.82999999999999996 111.214 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.675 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -107.64 120.29 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.522 -0.763 . . . . 0.14999999999999999 110.578 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.51 ' HB2' HG13 ' A' ' 369' ' ' VAL . 25.2 m-80 -83.74 91.93 7.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.686 -0.688 . . . . 1.77 111.588 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.6 HG23 HG21 ' A' ' 366' ' ' THR . 37.3 m -90.0 136.86 28.51 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-O 121.393 0.615 . . . . 0.17999999999999999 109.489 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -57.15 132.12 49.36 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.842 2.361 . . . . 0.12 112.862 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.774 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.5 Cg_exo -50.51 -40.47 54.36 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 123.489 2.793 . . . . 0.16 112.39 -169.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.1 p -73.44 -40.44 64.21 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.806 -1.088 . . . . 1.1699999999999999 110.113 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.678 HG11 ' HB ' ' A' ' 366' ' ' THR . 67.3 t -77.05 -29.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.382 0.61 . . . . 0.17000000000000001 111.303 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.674 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.0 tpt -67.85 -19.67 65.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.748 0.785 . . . . 0.46000000000000002 109.958 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -79.4 -22.66 44.0 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.63 -1.168 . . . . 0.81000000000000005 110.918 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.54 -47.73 13.8 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 112.922 -1.945 . . . . 0.38 107.329 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.61 HD23 ' SD ' ' A' ' 450' ' ' MET . 27.1 tp -63.66 -66.91 0.48 Allowed 'General case' 0 N--CA 1.403 -2.799 0 CA-C-N 111.83 -2.441 . . . . 0.059999999999999998 112.241 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.458 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 35.5 t80 -50.15 -26.55 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.962 1.363 . . . . 0.31 108.167 176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.01 -28.19 69.0 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 112.592 -2.095 . . . . 0.13 112.347 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.698 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -91.71 -47.96 7.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.666 0.746 . . . . 0.13 111.768 171.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.644 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.5 OUTLIER -101.5 138.36 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 123.457 1.599 . . . . 0.23000000000000001 113.892 -168.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.445 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.7 pt-20 -136.83 -178.69 5.3 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 110.813 -2.903 . . . . 0.82999999999999996 106.503 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.735 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.7 mtmt -51.69 162.48 0.4 Allowed 'General case' 0 N--CA 1.413 -2.321 0 CA-C-O 123.12 1.438 . . . . 0.23999999999999999 113.179 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.38 -33.64 4.66 Favored Glycine 0 N--CA 1.424 -2.141 0 CA-C-N 112.441 -2.163 . . . . 0.37 112.284 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 462' ' ' PRO . 10.6 m -73.96 140.78 77.62 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-O 121.119 0.485 . . . . 0.14999999999999999 109.822 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.666 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.44 162.96 38.9 Favored 'Trans proline' 0 N--CA 1.432 -2.132 0 C-N-CA 122.265 1.977 . . . . 0.12 111.142 174.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.5 t -132.95 131.96 59.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 CA-C-N 113.757 -1.565 . . . . 1.0900000000000001 108.169 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 2.9 tp -112.03 143.04 43.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.989 -0.551 . . . . 0.13 110.331 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.16 148.08 19.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.126 -1.435 . . . . 0.089999999999999997 107.126 165.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.595 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.7 p90 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.301 -0.857 . . . . 1.1599999999999999 111.27 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.563 HG23 ' HA ' ' A' ' 358' ' ' LYS . 88.9 m . . . . . 0 N--CA 1.428 -1.571 0 CA-C-O 121.595 0.712 . . . . 0.45000000000000001 109.801 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.633 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 5.0 p90 -160.94 -169.31 2.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.119 -1.4 . . . . 0.32000000000000001 110.584 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 453' ' ' LEU . 10.7 mm -101.39 162.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.204 -1.036 . . . . 0.080000000000000002 108.204 165.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.5 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -143.67 156.31 44.5 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 119.063 0.847 . . . . 0.17000000000000001 111.729 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.673 HG22 ' HG3' ' A' ' 354' ' ' MET . 77.8 t -150.71 137.44 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.741 -1.118 . . . . 0.080000000000000002 110.115 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.401 ' HB2' ' HZ3' ' A' ' 355' ' ' TRP . 7.4 t0 -124.61 106.51 10.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.175 0.988 . . . . 0.37 108.52 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.443 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -64.73 -42.13 95.45 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 112.772 -2.013 . . . . 0.32000000000000001 111.602 -168.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.46 -57.58 11.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.412 -2.176 . . . . 1.51 112.892 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -92.79 1.44 57.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 114.838 -1.074 . . . . 0.91000000000000003 109.924 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.856 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.0 mm-40 48.73 63.75 1.98 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 112.624 -2.08 . . . . 2.2200000000000002 111.565 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.457 ' CD2' ' CE2' ' A' ' 355' ' ' TRP . 6.8 t60 -143.41 128.63 18.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.803 -0.635 . . . . 0.13 109.716 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.673 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.7 ttp -115.28 128.6 56.23 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.438 0.695 . . . . 0.059999999999999998 110.444 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.676 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.5 m-90 -112.82 173.43 6.38 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.755 -1.111 . . . . 0.10000000000000001 111.598 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.588 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -125.08 112.9 17.05 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 105.577 -2.008 . . . . 0.22 105.577 163.319 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 18.1 m-85 -92.98 124.85 37.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.457 -0.897 . . . . 0.17999999999999999 111.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.563 ' HA ' HG23 ' A' ' 343' ' ' THR . 37.4 ttmt -140.17 142.52 35.93 Favored 'General case' 0 N--CA 1.386 -3.634 0 CA-C-N 114.031 -1.441 . . . . 0.46999999999999997 108.771 173.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.423 ' N ' ' HG2' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 66.0 16.35 10.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.742 -1.572 . . . . 0.59999999999999998 108.849 175.202 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.02 72.49 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 112.167 -2.288 . . . . 0.23000000000000001 111.968 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.606 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 4.9 tppt? -138.83 179.21 6.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.435 -2.061 . . . . 0.68000000000000005 105.435 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.676 HG11 ' CD1' ' A' ' 355' ' ' TRP . 2.8 m -106.65 135.6 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.72 0 CA-C-O 124.197 1.951 . . . . 0.53000000000000003 112.394 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -87.84 -26.06 23.0 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 109.351 -3.568 . . . . 0.12 107.985 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.72 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 4.0 tp -153.15 156.0 37.79 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.181 -1.372 . . . . 0.080000000000000002 109.777 -173.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 2.2 pt-20 -162.6 121.99 2.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.84 -0.618 . . . . 0.60999999999999999 110.706 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.688 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.3 t -149.13 166.78 27.75 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 122.501 1.143 . . . . 0.089999999999999997 113.196 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.685 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.6 p-10 -84.36 140.02 31.87 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.712 -2.04 . . . . 1.8799999999999999 108.182 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.96 -171.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.161 -0.927 . . . . 0.11 111.843 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.856 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -153.74 121.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.794 -1.094 . . . . 0.12 108.849 174.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 443' ' ' ILE . 7.0 t -144.57 143.01 30.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.917 1.08 . . . . 0.69999999999999996 113.917 -167.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.47 45.93 35.02 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 116.845 1.498 . . . . 0.13 116.845 162.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.584 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.46 144.1 4.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 118.636 1.218 . . . . 0.47999999999999998 110.917 -174.212 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.803 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.34 -32.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -0.979 1 C-N-CA 125.709 4.273 . . . . 0.23000000000000001 116.183 -170.8 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.584 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.8 p -79.92 -35.42 37.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.095 0.474 . . . . 0.29999999999999999 111.161 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.456 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 m -140.31 74.63 29.21 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 122.431 1.11 . . . . 0.29999999999999999 110.003 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.5 Cg_exo -69.79 160.42 49.75 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.044 3.83 . . . . 0.16 113.365 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.692 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -69.79 150.36 96.56 Favored Pre-proline 0 N--CA 1.434 -1.255 0 CA-C-N 113.55 -1.659 . . . . 0.12 110.92 177.259 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.507 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.0 OUTLIER -77.14 -48.78 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.893 3.729 . . . . 0.089999999999999997 112.98 -170.632 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.871 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 67.13 122.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.626 0.973 . . . . 0.089999999999999997 113.626 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.7 -126.62 1.5 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.457 -1.247 . . . . 0.11 111.382 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -126.01 104.12 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 122.516 1.15 . . . . 0.89000000000000001 109.328 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.796 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.2 m-85 -107.33 162.16 14.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.904 -1.044 . . . . 0.16 110.014 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.8 m-85 -147.91 137.51 22.45 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 121.252 -0.179 . . . . 0.68999999999999995 110.789 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.63 124.97 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 119.993 -0.683 . . . . 0.14000000000000001 110.296 177.055 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -109.55 3.99 21.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.491 -0.777 . . . . 0.19 111.929 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.721 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 14.8 t-20 -165.13 149.34 8.78 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.485 -0.779 . . . . 0.40999999999999998 111.083 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.482 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.8 mtpt -107.46 110.74 22.77 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.411 -0.813 . . . . 1.0900000000000001 109.685 169.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -112.08 123.17 49.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.654 1.216 . . . . 0.38 111.067 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.76 143.48 47.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.139 -1.391 . . . . 1.96 110.035 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 35.4 t70 54.24 25.99 6.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 111.894 -2.412 . . . . 0.40000000000000002 108.667 -174.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.482 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 167.13 17.8 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.205 -1.816 . . . . 0.16 112.163 -167.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 107.84 12.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.774 -1.557 . . . . 0.27000000000000002 110.131 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.9 mp -75.85 156.7 34.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 112.834 -1.985 . . . . 0.23999999999999999 110.448 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.506 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 11.8 mtpt . . . . . 0 N--CA 1.401 -2.916 0 CA-C-N 114.651 -1.159 . . . . 0.67000000000000004 108.016 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 15.0 mt-10 . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 122.052 0.929 . . . . 0.62 111.058 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.696 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.0 m -142.28 98.3 6.08 Favored Pre-proline 0 N--CA 1.421 -1.879 0 CA-C-N 113.678 -1.601 . . . . 1.3300000000000001 109.222 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.9 Cg_endo -67.97 106.19 1.29 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 124.342 3.362 . . . . 0.20000000000000001 112.644 -177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.808 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -114.61 163.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 114.534 -1.212 . . . . 0.29999999999999999 110.56 -175.611 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -111.76 -34.04 6.15 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.403 -1.726 . . . . 1.8400000000000001 106.943 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.4 m-85 -133.86 115.99 15.12 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.726 -2.034 . . . . 0.44 110.639 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.777 ' HB2' HG11 ' A' ' 407' ' ' VAL . 5.1 t-105 -123.86 135.29 53.65 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.4 -1.273 . . . . 0.13 110.355 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.563 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.53 84.81 26.99 Favored Pre-proline 0 N--CA 1.427 -1.579 0 CA-C-N 115.007 -0.997 . . . . 0.40999999999999998 110.943 172.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 72.2 Cg_endo -70.84 141.07 39.97 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.06 2.507 . . . . 0.16 112.258 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -123.8 -16.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.009 -1.45 . . . . 0.17000000000000001 111.063 -173.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -135.46 162.7 31.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.277 -0.874 . . . . 1.5900000000000001 109.312 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -93.78 13.32 22.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.236 0.458 . . . . 0.31 112.236 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -91.36 -26.57 18.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.396 -1.335 . . . . 0.44 107.396 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.93 29.55 1.13 Allowed Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 112.976 -1.92 . . . . 0.23999999999999999 112.326 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 441' ' ' GLY . 89.5 t -102.55 147.9 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.297 0.57 . . . . 0.17000000000000001 110.93 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.37 -166.11 37.91 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.734 -1.121 . . . . 0.10000000000000001 111.306 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.402 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.54 138.42 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.698 -0.853 . . . . 0.12 108.698 175.637 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.808 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.1 p80 -151.24 164.9 35.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.725 0.774 . . . . 0.14999999999999999 112.076 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.779 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 146.05 24.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.074 -1.421 . . . . 0.41999999999999998 107.858 173.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.415 ' CB ' HD22 ' A' ' 444' ' ' ASN . 0.4 OUTLIER -140.07 102.85 4.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 123.06 1.409 . . . . 1.48 110.998 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -93.16 -26.97 17.17 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 111.752 -2.476 . . . . 0.34999999999999998 109.742 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 5.7 p90 -70.27 -26.14 63.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.312 -1.313 . . . . 0.17999999999999999 109.714 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.403 ' HG3' ' NE1' ' A' ' 425' ' ' TRP . 0.0 OUTLIER -119.8 80.7 25.09 Favored Pre-proline 0 CA--C 1.492 -1.286 0 CA-C-N 113.829 -1.532 . . . . 1.3300000000000001 109.315 -176.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 427' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 27.7 Cg_endo -81.08 5.53 6.17 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 125.089 3.86 . . . . 0.23000000000000001 114.015 -162.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -115.67 149.73 37.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.739 -0.664 . . . . 1.1000000000000001 109.411 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.685 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -160.99 125.57 3.57 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 124.587 1.18 . . . . 0.38 108.179 -173.253 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.88 -166.92 28.83 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 119.484 -1.341 . . . . 0.13 110.899 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.595 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 154.1 0.0 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.931 1.018 . . . . 0.20000000000000001 113.159 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.404 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -55.72 101.33 0.05 Allowed 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 123.924 1.821 . . . . 0.33000000000000002 112.289 -146.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.7 mt -97.33 -32.03 12.1 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 110.228 -3.169 . . . . 0.17999999999999999 108.222 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.558 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.4 p-90 -45.82 -38.84 7.67 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 124.067 0.854 . . . . 0.22 111.49 -174.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.803 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.5 mttt -60.05 -26.12 65.9 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.006 -0.997 . . . . 0.64000000000000001 112.821 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.9 p -111.93 -36.11 5.49 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.701 0.762 . . . . 0.25 110.033 -176.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.481 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 6.8 mtp85 -84.54 -15.94 44.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.689 -1.141 . . . . 0.35999999999999999 112.642 -169.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.05 40.39 30.03 Favored Glycine 0 C--N 1.313 -0.714 0 N-CA-C 116.089 1.196 . . . . 0.20999999999999999 116.089 159.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 439' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 372' ' ' LYS . 1.0 OUTLIER -79.63 131.6 36.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 117.782 0.791 . . . . 0.46999999999999997 109.545 176.006 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -100.7 68.3 1.31 Allowed 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.643 -0.661 . . . . 0.40999999999999998 110.306 -172.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 88.7 -11.8 67.49 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.924 -0.87 . . . . 0.17999999999999999 110.924 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.461 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 27.2 p -90.79 142.82 27.36 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.361 -0.42 . . . . 0.82999999999999996 110.8 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.692 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -101.43 114.55 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.752 -0.658 . . . . 0.14999999999999999 110.362 -176.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.597 ' HB2' HG13 ' A' ' 369' ' ' VAL . 18.7 m120 -78.81 90.38 4.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.842 -0.617 . . . . 1.77 111.098 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.9 m -86.63 137.34 34.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 109.132 -0.692 . . . . 0.17999999999999999 109.132 174.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.5 Cg_exo -54.86 135.79 69.44 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.747 2.298 . . . . 0.12 111.337 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.779 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.4 Cg_exo -55.34 -32.16 80.17 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 C-N-CA 124.225 3.283 . . . . 0.16 112.825 -173.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.23 -38.79 26.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.441 -1.254 . . . . 1.1699999999999999 110.09 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.688 HG11 ' HB ' ' A' ' 366' ' ' THR . 60.2 t -80.77 -29.41 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.17000000000000001 111.376 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.681 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.4 tpt -65.93 -19.91 66.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.781 0.8 . . . . 0.46000000000000002 109.985 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -79.36 -24.97 42.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.522 -1.217 . . . . 0.81000000000000005 111.239 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.694 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -79.15 -46.3 18.24 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 113.127 -1.851 . . . . 0.38 107.111 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.576 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.7 tp -64.43 -67.17 0.45 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.663 -2.517 . . . . 0.059999999999999998 112.169 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.424 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.2 t80 -49.62 -27.73 4.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 123.127 1.442 . . . . 0.31 108.304 177.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.2 -31.3 69.08 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 112.37 -2.195 . . . . 0.13 112.237 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.72 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.5 ptp -88.17 -48.43 7.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.729 0.776 . . . . 0.13 111.501 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.588 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.7 OUTLIER -102.09 138.16 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 123.582 1.658 . . . . 0.23000000000000001 114.005 -167.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.482 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.2 pt-20 -136.37 -178.28 5.09 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 110.705 -2.952 . . . . 0.82999999999999996 106.552 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.4 mtmt -52.71 162.56 0.57 Allowed 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.949 1.357 . . . . 0.23999999999999999 112.405 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.23 -30.56 6.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 112.685 -2.052 . . . . 0.37 112.383 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 462' ' ' PRO . 15.0 m -80.89 141.96 51.7 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.134 -0.691 . . . . 0.14999999999999999 109.134 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 4.5 Cg_exo -75.78 168.54 24.06 Favored 'Trans proline' 0 N--CA 1.425 -2.502 0 C-N-CA 121.681 1.587 . . . . 0.12 111.098 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.81 154.49 34.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.299 -1.371 . . . . 1.0900000000000001 107.299 166.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.0 tp -125.86 144.25 50.74 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.45 -0.796 . . . . 0.13 110.657 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.66 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.14 146.04 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 105.937 -1.875 . . . . 0.089999999999999997 105.937 163.487 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.871 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 8.6 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.089 -0.958 . . . . 1.1599999999999999 111.824 -175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 358' ' ' LYS . 9.1 m . . . . . 0 N--CA 1.425 -1.693 0 N-CA-C 106.688 -1.597 . . . . 0.45000000000000001 106.688 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.651 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.2 p90 -156.15 -171.59 3.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.485 0.659 . . . . 0.32000000000000001 110.852 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.584 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.8 mm -102.52 161.5 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.97 -1.122 . . . . 0.080000000000000002 107.97 167.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.4 tt0 -140.61 155.18 46.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 118.818 0.736 . . . . 0.17000000000000001 111.1 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.716 HG22 ' HG3' ' A' ' 354' ' ' MET . 64.4 t -150.81 135.8 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.539 -1.21 . . . . 0.080000000000000002 110.027 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -116.89 117.78 30.64 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.797 -1.092 . . . . 0.37 108.176 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.503 HD21 HG23 ' A' ' 465' ' ' VAL . 1.8 mm? -70.26 -48.2 57.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.51 1.148 . . . . 0.32000000000000001 110.487 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -54.89 -54.13 46.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 112.851 -1.977 . . . . 1.51 112.454 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -98.27 11.31 38.36 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.572 -1.195 . . . . 0.91000000000000003 108.637 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.861 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.1 mm-40 37.6 70.38 0.19 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 125.269 1.606 . . . . 2.2200000000000002 111.829 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -150.22 125.12 9.86 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.773 -0.649 . . . . 0.13 109.827 -175.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.716 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.9 ttp -111.93 127.61 55.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.471 0.653 . . . . 0.059999999999999998 110.451 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.681 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.84 173.72 6.24 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.528 -1.214 . . . . 0.10000000000000001 111.841 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.701 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.4 t80 -126.79 117.07 21.9 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 106.795 -1.557 . . . . 0.22 106.795 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.543 ' CE1' HG12 ' A' ' 362' ' ' VAL . 18.8 m-85 -100.77 124.84 46.98 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.128 0.966 . . . . 0.17999999999999999 112.33 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.672 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.0 ttpt -149.46 139.34 21.92 Favored 'General case' 0 N--CA 1.4 -2.939 0 CA-C-N 113.105 -1.861 . . . . 0.46999999999999997 107.992 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.475 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 70.95 16.46 6.5 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 113.768 -1.56 . . . . 0.59999999999999998 108.608 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.56 17.47 78.99 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.377 -2.192 . . . . 0.23000000000000001 111.715 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.597 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.2 OUTLIER -136.9 170.86 15.39 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.91 -1.885 . . . . 0.68000000000000005 105.91 -168.737 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.745 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.7 m -101.35 137.56 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.853 0 CA-C-O 124.157 1.932 . . . . 0.53000000000000003 111.72 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.701 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -23.84 19.0 Favored 'General case' 0 N--CA 1.399 -2.984 0 CA-C-N 109.392 -3.549 . . . . 0.12 108.529 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.681 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -154.07 154.82 34.33 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 113.511 -1.677 . . . . 0.080000000000000002 108.856 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.745 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.98 121.78 1.29 Allowed 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.766 -0.652 . . . . 0.60999999999999999 109.395 -175.413 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.654 HG21 HG23 ' A' ' 445' ' ' THR . 5.1 t -148.08 166.5 27.62 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.245 1.021 . . . . 0.089999999999999997 111.967 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.631 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.1 p-10 -85.37 140.36 30.83 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 113.025 -1.898 . . . . 1.8799999999999999 107.193 176.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.634 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -141.47 -171.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.154 -0.93 . . . . 0.11 111.888 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.861 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -157.73 119.38 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.136 -0.938 . . . . 0.12 109.792 175.656 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.6 t -143.15 145.98 33.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.977 -1.011 . . . . 0.69999999999999996 112.839 -166.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.04 46.09 37.95 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 117.178 1.631 . . . . 0.13 117.178 161.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.446 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.2 pttt -46.75 145.83 2.9 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.6 1.7 . . . . 0.47999999999999998 111.129 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.83 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -33.41 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.041 1 C-N-CA 125.543 4.162 . . . . 0.23000000000000001 115.609 -175.884 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.4 p -77.19 -39.27 49.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.267 0.555 . . . . 0.29999999999999999 110.917 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.47 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.9 m -140.56 72.92 30.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.245 1.021 . . . . 0.29999999999999999 110.434 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.7 Cg_exo -68.9 163.3 38.03 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 125.256 3.97 . . . . 0.16 114.118 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -74.76 151.23 86.73 Favored Pre-proline 0 N--CA 1.437 -1.092 0 CA-C-N 113.512 -1.676 . . . . 0.12 110.714 175.702 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.533 ' CD ' HG22 ' A' ' 377' ' ' THR . 0.9 OUTLIER -78.28 -50.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.83 3.686 . . . . 0.089999999999999997 113.724 -171.248 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.757 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.0 121.91 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.443 0.905 . . . . 0.089999999999999997 113.443 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.89 -124.48 1.26 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.268 -1.333 . . . . 0.11 111.46 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.7 p -126.28 108.88 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 122.137 0.97 . . . . 0.89000000000000001 109.372 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.784 ' HB2' HG22 ' A' ' 463' ' ' VAL . 94.0 m-85 -114.24 159.89 19.64 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.881 -1.054 . . . . 0.16 109.661 -170.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.719 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 70.0 m-85 -146.01 135.63 23.22 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 117.661 0.209 . . . . 0.68999999999999995 111.113 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.617 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.57 122.26 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.872 -0.731 . . . . 0.14000000000000001 110.46 176.493 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -108.93 3.16 21.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.43 -0.804 . . . . 0.19 112.026 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.765 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 16.9 t-20 -164.08 149.57 10.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.181 -0.918 . . . . 0.40999999999999998 110.704 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -109.24 114.65 28.54 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.377 -0.829 . . . . 1.0900000000000001 109.386 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -113.12 120.39 41.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.724 1.25 . . . . 0.38 111.478 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.8 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 25.9 mt-10 -116.11 143.71 45.12 Favored 'General case' 0 N--CA 1.409 -2.475 0 CA-C-N 113.802 -1.544 . . . . 1.96 110.562 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 37.8 t70 55.98 27.3 11.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 111.196 -2.729 . . . . 0.40000000000000002 107.758 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.14 169.58 15.69 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 112.692 -2.049 . . . . 0.16 112.16 -167.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 16.1 m -128.72 102.45 6.58 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 113.12 -1.855 . . . . 0.27000000000000002 109.382 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.752 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.0 mp -71.97 156.3 39.39 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 112.789 -2.005 . . . . 0.23999999999999999 109.767 174.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.5 mtpt . . . . . 0 N--CA 1.395 -3.183 0 CA-C-N 114.647 -1.161 . . . . 0.67000000000000004 108.089 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.4 mt-10 . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 122.387 1.089 . . . . 0.62 112.208 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.752 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.69 99.43 8.49 Favored Pre-proline 0 N--CA 1.426 -1.664 0 CA-C-N 112.857 -1.974 . . . . 1.3300000000000001 108.543 175.427 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 62.3 Cg_endo -67.44 103.43 0.8 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.868 2.378 . . . . 0.20000000000000001 110.912 174.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.708 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -118.12 158.78 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.27 -1.332 . . . . 0.29999999999999999 109.391 -174.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.6 OUTLIER -101.46 -38.93 7.78 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 107.762 -1.199 . . . . 1.8400000000000001 107.762 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.539 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 10.3 m-30 -125.53 113.46 17.47 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.726 -1.124 . . . . 0.44 110.51 -176.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.708 ' HB2' HG11 ' A' ' 407' ' ' VAL . 8.3 t-105 -123.59 136.39 54.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.692 -1.594 . . . . 0.13 110.379 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.57 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.3 85.93 25.76 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 114.792 -1.094 . . . . 0.40999999999999998 111.041 173.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.7 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 82.6 Cg_endo -71.64 141.75 38.54 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 123.163 2.575 . . . . 0.16 112.091 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -122.94 -17.74 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.207 -1.36 . . . . 0.17000000000000001 111.239 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.772 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 6.9 p30 -134.76 170.47 15.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.715 -0.675 . . . . 1.5900000000000001 109.695 171.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -96.88 16.08 20.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 0.31 111.993 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 20.3 p -100.16 -28.31 13.08 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.258 -1.015 . . . . 0.44 108.258 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 131.74 26.41 0.71 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.24 -1.346 . . . . 0.23999999999999999 113.546 173.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.772 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 68.8 t -102.46 148.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.492 0.663 . . . . 0.17000000000000001 111.165 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 175.59 -164.1 34.22 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.712 -1.131 . . . . 0.10000000000000001 111.13 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.401 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -102.59 138.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.988 -0.745 . . . . 0.12 108.988 175.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.4 p80 -149.35 167.28 26.56 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.065 0.936 . . . . 0.14999999999999999 111.178 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.744 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -89.43 149.28 23.03 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 113.501 -1.682 . . . . 0.41999999999999998 107.806 172.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -136.42 100.0 4.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.675 1.226 . . . . 1.48 110.035 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -95.17 -33.37 12.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.606 -2.088 . . . . 0.34999999999999998 110.416 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.492 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 13.9 p90 -68.08 -27.08 66.18 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.589 -1.187 . . . . 0.17999999999999999 109.255 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.58 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.95 82.0 20.45 Favored Pre-proline 0 CA--C 1.494 -1.208 0 CA-C-N 113.816 -1.538 . . . . 1.3300000000000001 110.201 -173.701 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 427' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 32.1 Cg_endo -80.33 4.96 6.39 Favored 'Trans proline' 0 N--CA 1.432 -2.103 0 C-N-CA 124.821 3.681 . . . . 0.23000000000000001 114.464 -162.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.32 154.03 28.73 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 123.385 0.428 . . . . 1.1000000000000001 110.293 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.631 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -163.64 126.34 2.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.25 -1.341 . . . . 0.38 108.364 -172.194 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.81 -167.85 28.74 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.051 -1.547 . . . . 0.13 111.556 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.634 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.52 153.36 0.0 OUTLIER Glycine 0 C--N 1.342 0.916 0 O-C-N 125.043 1.084 . . . . 0.20000000000000001 113.207 174.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.439 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.8 m-20 -54.9 100.99 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 123.999 1.857 . . . . 0.33000000000000002 112.156 -146.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.4 mt -97.16 -33.44 11.49 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 110.273 -3.149 . . . . 0.17999999999999999 109.357 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.558 ' HA ' HG23 ' A' ' 369' ' ' VAL . 11.2 p-90 -47.36 -33.59 6.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 112.8 -2.0 . . . . 0.22 111.9 -174.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.83 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 43.4 mttt -63.5 -22.99 67.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 124.08 0.863 . . . . 0.64000000000000001 113.055 -176.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.2 p -117.43 -38.41 3.33 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.525 -0.761 . . . . 0.25 110.215 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.58 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 4.5 mtp85 -79.14 -15.22 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.609 -1.178 . . . . 0.35999999999999999 112.375 -169.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 75.72 40.48 31.46 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 116.216 1.246 . . . . 0.20999999999999999 116.216 159.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 439' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 442' ' ' CYS . 7.4 m -82.15 134.35 35.31 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 117.768 0.784 . . . . 0.46999999999999997 109.188 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -101.75 70.09 1.24 Allowed 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.477 -0.764 . . . . 0.40999999999999998 110.447 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.625 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 83.63 -8.2 66.34 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.815 -0.914 . . . . 0.17999999999999999 110.815 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.532 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 22.4 p -94.17 128.77 40.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.689 0.757 . . . . 0.82999999999999996 110.561 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.715 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -89.74 113.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.813 -1.085 . . . . 0.14999999999999999 110.527 -172.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.596 ' HB2' HG13 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -77.27 91.39 3.79 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.042 -0.981 . . . . 1.77 111.068 -177.467 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.654 HG23 HG21 ' A' ' 366' ' ' THR . 79.3 m -89.88 137.54 28.26 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 109.2 -0.667 . . . . 0.17999999999999999 109.2 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.1 Cg_exo -55.41 135.88 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.66 2.24 . . . . 0.12 111.248 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.744 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.8 Cg_exo -55.34 -32.87 83.22 Favored 'Trans proline' 0 CA--C 1.501 -1.148 0 C-N-CA 124.125 3.217 . . . . 0.16 112.849 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.2 m -79.75 -38.01 34.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.774 -1.103 . . . . 1.1699999999999999 110.016 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.62 HG11 ' HB ' ' A' ' 366' ' ' THR . 88.7 t -78.8 -29.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 0.17000000000000001 111.454 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.638 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -66.23 -20.48 66.13 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.698 0.761 . . . . 0.46000000000000002 109.925 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -76.3 -25.63 55.02 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.569 -1.196 . . . . 0.81000000000000005 111.69 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.7 mm-40 -80.33 -45.87 17.08 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-N 113.13 -1.85 . . . . 0.38 107.056 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.545 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 23.7 tp -66.22 -66.59 0.53 Allowed 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 111.756 -2.474 . . . . 0.059999999999999998 112.229 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.48 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 26.7 t80 -50.03 -25.77 3.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.89 1.329 . . . . 0.31 108.28 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.41 -27.65 65.26 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 112.867 -1.969 . . . . 0.13 112.583 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -91.02 -49.02 6.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.776 0.798 . . . . 0.13 111.384 171.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.584 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.84 137.39 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 CA-C-O 123.478 1.608 . . . . 0.23000000000000001 113.87 -167.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.64 -178.45 5.18 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 110.671 -2.968 . . . . 0.82999999999999996 106.567 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.765 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.0 mtmt -52.56 161.29 0.72 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-O 123.063 1.411 . . . . 0.23999999999999999 113.361 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.51 -32.88 5.26 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 112.498 -2.137 . . . . 0.37 112.31 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 384' ' ' VAL . 3.4 m -78.25 141.07 61.56 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.412 -0.588 . . . . 0.14999999999999999 109.412 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.651 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 5.8 Cg_exo -75.63 167.74 25.83 Favored 'Trans proline' 0 N--CA 1.425 -2.542 0 C-N-CA 122.084 1.856 . . . . 0.12 111.244 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.784 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -133.55 150.51 32.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.602 -1.259 . . . . 1.0900000000000001 107.602 165.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.8 tp -119.41 144.34 46.98 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.954 -1.021 . . . . 0.13 109.634 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.757 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -142.89 146.54 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.757 -1.571 . . . . 0.089999999999999997 106.757 165.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.643 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 17.5 p90 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.258 -0.877 . . . . 1.1599999999999999 110.993 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.641 HG23 ' HA ' ' A' ' 358' ' ' LYS . 2.7 m . . . . . 0 N--CA 1.422 -1.86 0 N-CA-C 108.096 -1.075 . . . . 0.45000000000000001 108.096 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.668 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.9 p90 -161.12 -171.04 2.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.322 -0.854 . . . . 0.32000000000000001 110.533 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.578 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.2 mm -105.06 160.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.977 -1.119 . . . . 0.080000000000000002 107.977 167.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.519 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -140.93 155.92 46.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.972 0.806 . . . . 0.17000000000000001 111.327 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.724 HG22 ' HG3' ' A' ' 354' ' ' MET . 65.5 t -151.16 136.65 11.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.747 -1.115 . . . . 0.080000000000000002 109.923 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -116.97 119.11 34.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.615 -1.175 . . . . 0.37 108.078 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 352' ' ' GLN . 1.9 mm? -70.81 -47.83 57.36 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.202 1.001 . . . . 0.32000000000000001 110.492 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -57.97 -55.07 39.61 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.752 -2.022 . . . . 1.51 112.0 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -94.77 10.69 34.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.21 -1.359 . . . . 0.91000000000000003 108.657 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.675 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 3.6 mm-40 35.01 74.14 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.349 1.656 . . . . 2.2200000000000002 112.964 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.542 ' HE1' ' HB2' ' A' ' 365' ' ' GLU . 18.6 t-80 -152.27 124.3 8.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.32 -0.855 . . . . 0.13 109.744 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.724 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.3 ttp -111.88 126.94 55.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.586 -0.734 . . . . 0.059999999999999998 110.366 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.662 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -111.95 172.9 6.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 114.528 -1.214 . . . . 0.10000000000000001 111.911 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.681 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.3 t80 -125.93 115.73 20.39 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.577 -1.638 . . . . 0.22 106.577 165.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.501 ' CE1' HG12 ' A' ' 362' ' ' VAL . 23.8 m-85 -98.98 126.4 44.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.259 1.028 . . . . 0.17999999999999999 112.519 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.641 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.2 ttpt -148.94 139.29 22.42 Favored 'General case' 0 N--CA 1.396 -3.135 0 CA-C-N 112.95 -1.932 . . . . 0.46999999999999997 107.759 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 72.4 15.22 5.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 113.929 -1.487 . . . . 0.59999999999999998 108.871 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.79 78.58 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.603 -2.09 . . . . 0.23000000000000001 111.699 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.634 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -139.58 174.69 10.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 112.416 -1.892 . . . . 0.68000000000000005 106.108 -168.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.704 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.0 m -104.89 138.86 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 CA-C-O 124.227 1.965 . . . . 0.53000000000000003 112.397 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.681 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.36 -24.83 17.96 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 109.37 -3.559 . . . . 0.12 108.707 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.668 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -152.65 154.31 35.08 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.578 -1.646 . . . . 0.080000000000000002 108.67 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.704 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.11 120.49 1.16 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.708 -0.678 . . . . 0.60999999999999999 109.675 -174.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.696 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.0 t -147.79 167.33 25.0 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 122.199 0.999 . . . . 0.089999999999999997 111.981 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.66 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.3 p-10 -86.0 140.2 30.51 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 113.225 -1.807 . . . . 1.8799999999999999 107.867 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.675 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -140.88 -171.89 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.238 -0.892 . . . . 0.11 111.989 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.639 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.65 119.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.05 -0.977 . . . . 0.12 108.816 174.41 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.671 ' H ' HE22 ' A' ' 352' ' ' GLN . 7.6 t -142.23 144.2 33.24 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.415 -0.811 . . . . 0.69999999999999996 112.397 -166.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.02 44.48 45.46 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 116.569 1.388 . . . . 0.13 116.569 163.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.604 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.58 143.64 5.53 Favored Pre-proline 0 CA--C 1.509 -0.598 0 CA-C-N 118.472 1.136 . . . . 0.47999999999999998 110.49 -174.211 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.816 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.46 -33.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.966 1 C-N-CA 125.745 4.296 . . . . 0.23000000000000001 116.034 -170.925 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.604 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -79.74 -34.02 40.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.082 0.467 . . . . 0.29999999999999999 110.723 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.457 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.0 m -140.65 73.38 29.05 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 122.144 0.973 . . . . 0.29999999999999999 110.461 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.3 Cg_exo -70.62 161.51 45.78 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.201 3.934 . . . . 0.16 114.41 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.685 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.77 154.02 87.17 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 113.551 -1.659 . . . . 0.12 110.936 176.092 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.526 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.3 Cg_endo -80.84 -49.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 125.062 3.841 . . . . 0.089999999999999997 113.752 -172.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.692 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.05 122.55 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.123 0.964 . . . . 0.089999999999999997 113.449 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.35 -125.32 1.32 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.23 -1.35 . . . . 0.11 111.7 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.28 103.84 9.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.262 -1.014 . . . . 0.89000000000000001 108.262 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.767 ' HB2' HG22 ' A' ' 463' ' ' VAL . 95.6 m-85 -110.23 158.5 18.32 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.478 -0.783 . . . . 0.16 109.656 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.807 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 9.3 m-85 -146.59 139.63 25.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 118.194 0.452 . . . . 0.68999999999999995 110.699 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -75.63 125.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 119.92 -0.712 . . . . 0.14000000000000001 110.626 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -111.03 4.03 19.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.181 -0.918 . . . . 0.19 112.04 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.737 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 19.2 t-20 -164.56 150.11 10.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.326 -0.852 . . . . 0.40999999999999998 110.51 175.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.447 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.3 mtpt -109.98 113.65 26.53 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.609 -0.723 . . . . 1.0900000000000001 110.025 170.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 1.9 mt-10 -112.79 125.1 53.97 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.647 -1.16 . . . . 0.38 110.931 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 42.5 mt-10 -123.5 135.05 53.85 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.14 -1.391 . . . . 1.96 110.196 -176.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.8 t70 52.56 39.44 28.05 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 123.387 1.565 . . . . 0.40000000000000002 107.661 -172.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.9 167.47 12.41 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 112.474 -2.148 . . . . 0.16 111.256 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 37.5 m -128.11 102.5 6.74 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.964 -1.471 . . . . 0.27000000000000002 109.682 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.753 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -74.28 157.34 35.97 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 112.984 -1.916 . . . . 0.23999999999999999 110.406 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.439 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 8.5 mtpt . . . . . 0 N--CA 1.399 -3.024 0 CA-C-N 114.945 -1.025 . . . . 0.67000000000000004 108.759 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 8.7 mt-10 . . . . . 0 CA--C 1.508 -0.645 0 CA-C-O 122.34 1.067 . . . . 0.62 111.831 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.753 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.56 98.62 12.17 Favored Pre-proline 0 N--CA 1.419 -1.982 0 CA-C-N 113.07 -1.877 . . . . 1.3300000000000001 107.747 175.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.8 Cg_endo -68.04 101.59 0.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.308 2.006 . . . . 0.20000000000000001 110.326 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -114.48 157.53 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.866 0 CA-C-N 114.242 -1.344 . . . . 0.29999999999999999 109.95 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 12.7 m120 -108.22 -33.8 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.39 -1.732 . . . . 1.8400000000000001 107.098 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.421 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 61.3 m-85 -134.55 116.18 14.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.86 -1.973 . . . . 0.44 111.134 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.75 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.71 134.24 53.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.223 -1.353 . . . . 0.13 110.258 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.517 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.1 OUTLIER -134.91 86.54 32.31 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.124 -0.943 . . . . 0.40999999999999998 111.054 174.049 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.06 140.22 34.17 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.81 2.34 . . . . 0.16 112.154 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.79 -15.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.479 . . . . 0.17000000000000001 111.214 -172.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -134.63 162.5 32.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.392 -0.822 . . . . 1.5900000000000001 109.447 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -93.47 13.8 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.358 0.503 . . . . 0.31 112.358 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.1 p -94.24 -27.42 16.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.674 -1.232 . . . . 0.44 107.674 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.48 34.36 0.76 Allowed Glycine 0 N--CA 1.427 -1.95 0 CA-C-N 113.112 -1.858 . . . . 0.23999999999999999 112.414 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 441' ' ' GLY . 76.8 t -103.79 151.49 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 120.987 0.422 . . . . 0.17000000000000001 110.762 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 170.92 -168.1 41.24 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.214 -0.903 . . . . 0.10000000000000001 111.664 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.46 141.16 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.933 -0.766 . . . . 0.12 108.933 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.564 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.0 p80 -150.6 163.72 37.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.803 0.811 . . . . 0.14999999999999999 111.776 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.14 142.6 27.56 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.916 -1.493 . . . . 0.41999999999999998 107.323 172.024 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.462 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 3.5 t -136.92 103.51 5.19 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.877 1.323 . . . . 1.48 110.395 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.55 -28.7 15.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.125 -2.307 . . . . 0.34999999999999998 111.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.533 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.4 p90 -70.27 -26.56 63.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 114.432 -1.258 . . . . 0.17999999999999999 109.342 175.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.575 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -120.58 82.18 33.0 Favored Pre-proline 0 CA--C 1.491 -1.31 0 CA-C-N 113.5 -1.682 . . . . 1.3300000000000001 109.465 -175.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -81.34 6.68 5.45 Favored 'Trans proline' 0 N--CA 1.43 -2.254 0 C-N-CA 124.693 3.596 . . . . 0.23000000000000001 113.907 -162.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 3.2 tp10 -114.47 154.54 28.01 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 1.1000000000000001 111.013 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.66 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -164.11 127.84 2.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.715 -1.584 . . . . 0.38 108.076 -169.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.31 -167.24 28.51 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 119.232 -1.461 . . . . 0.13 111.124 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.643 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.43 153.95 0.01 OUTLIER Glycine 0 C--N 1.336 0.583 0 O-C-N 124.927 1.016 . . . . 0.20000000000000001 112.897 174.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.65 100.81 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 123.862 1.791 . . . . 0.33000000000000002 112.0 -146.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 54.1 mt -97.02 -30.32 13.13 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 110.562 -3.017 . . . . 0.17999999999999999 108.205 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.639 ' HA ' HG23 ' A' ' 369' ' ' VAL . 7.6 p-90 -46.85 -38.01 9.66 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.876 0.735 . . . . 0.22 111.583 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.816 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.7 mttt -62.22 -23.01 66.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.274 -0.876 . . . . 0.64000000000000001 112.9 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -114.95 -37.03 4.26 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.578 -0.737 . . . . 0.25 110.361 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.575 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.8 mtp85 -85.18 -15.86 42.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.811 -1.086 . . . . 0.35999999999999999 112.691 -168.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.09 42.05 25.38 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 116.804 1.482 . . . . 0.20999999999999999 116.804 159.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.6 m -85.82 131.11 34.37 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 118.682 1.241 . . . . 0.46999999999999997 108.946 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -100.04 71.38 1.62 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.678 -0.639 . . . . 0.40999999999999998 111.227 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.74 -14.12 59.15 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.422 -1.071 . . . . 0.17999999999999999 110.422 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.523 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -88.29 148.53 24.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.36 -0.42 . . . . 0.82999999999999996 110.192 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.685 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -100.01 119.54 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.776 0.798 . . . . 0.14999999999999999 110.759 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.58 ' HB3' HG13 ' A' ' 369' ' ' VAL . 2.6 t30 -79.93 82.97 5.92 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.557 -1.201 . . . . 1.77 111.42 -175.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.2 m -87.42 140.25 31.99 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-O 121.605 0.716 . . . . 0.17999999999999999 109.846 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.9 Cg_exo -58.85 136.14 71.64 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.814 2.342 . . . . 0.12 111.744 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.3 Cg_exo -55.01 -34.07 85.59 Favored 'Trans proline' 0 CA--C 1.504 -1.009 0 C-N-CA 124.415 3.41 . . . . 0.16 113.005 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.5 t -79.47 -38.33 34.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.893 -1.049 . . . . 1.1699999999999999 109.418 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.696 HG11 ' HB ' ' A' ' 366' ' ' THR . 46.9 t -82.51 -28.42 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 0.17000000000000001 111.269 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.725 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.5 tpt -67.68 -18.74 65.03 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.882 0.849 . . . . 0.46000000000000002 110.008 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -80.43 -23.24 40.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.442 -1.253 . . . . 0.81000000000000005 111.007 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.686 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.0 mm-40 -80.35 -46.99 15.15 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.957 -1.929 . . . . 0.38 107.215 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.584 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -64.68 -67.18 0.46 Allowed 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 111.798 -2.455 . . . . 0.059999999999999998 112.321 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -50.47 -26.36 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.18 1.467 . . . . 0.31 108.21 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.44 -32.77 67.96 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 112.182 -2.281 . . . . 0.13 112.22 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.686 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.8 ptp -87.5 -49.43 7.2 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 121.745 0.783 . . . . 0.13 111.509 172.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.635 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.7 OUTLIER -102.08 137.6 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 CA-C-O 123.518 1.627 . . . . 0.23000000000000001 113.835 -167.136 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.447 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.58 -178.23 5.08 Favored 'General case' 0 N--CA 1.401 -2.881 0 CA-C-N 110.585 -3.007 . . . . 0.82999999999999996 106.89 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.737 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 48.2 mtmt -51.59 161.78 0.46 Allowed 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 122.888 1.328 . . . . 0.23999999999999999 112.593 175.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.67 -31.52 5.8 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 112.623 -2.08 . . . . 0.37 112.368 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.5 m -82.92 140.77 43.39 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.683 -0.858 . . . . 0.14999999999999999 108.683 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.807 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.57 173.46 14.15 Favored 'Trans proline' 0 N--CA 1.415 -3.146 0 C-N-CA 121.093 1.196 . . . . 0.12 111.71 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -137.09 160.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.768 -1.197 . . . . 1.0900000000000001 107.768 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.442 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.8 tp -129.83 146.22 51.57 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.443 -0.799 . . . . 0.13 110.334 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.1 147.26 20.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.073 -1.454 . . . . 0.089999999999999997 107.073 165.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.648 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.1 p90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.855 -0.593 . . . . 1.1599999999999999 111.646 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.603 HG23 ' HA ' ' A' ' 358' ' ' LYS . 94.0 m . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 108.813 -0.81 . . . . 0.45000000000000001 108.813 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.647 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.0 p90 -160.93 -170.31 2.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.217 -1.356 . . . . 0.32000000000000001 110.668 -173.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.3 mm -101.7 161.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.183 -1.043 . . . . 0.080000000000000002 108.183 166.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.492 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -142.24 155.6 45.25 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.407 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.671 HG22 ' HG3' ' A' ' 354' ' ' MET . 68.0 t -151.0 142.35 16.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.437 -1.256 . . . . 0.080000000000000002 109.146 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.499 ' HA ' ' OXT' ' A' ' 466' ' ' PHE . 7.2 t70 -130.67 107.49 9.21 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.37 109.129 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.547 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -69.27 -30.08 68.11 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.814 -1.539 . . . . 0.32000000000000001 110.575 -170.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -57.09 -63.61 1.16 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.89 0.852 . . . . 1.51 111.096 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -89.42 -3.53 58.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.047 -1.433 . . . . 0.91000000000000003 110.774 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.703 ' OE1' HD12 ' A' ' 368' ' ' ILE . 85.1 mm-40 49.64 68.64 0.7 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 112.084 -2.325 . . . . 2.2200000000000002 111.368 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.462 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.5 t60 -143.82 128.43 18.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.991 -1.004 . . . . 0.13 109.293 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.9 ttp -114.33 129.01 56.63 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 123.573 0.749 . . . . 0.059999999999999998 110.558 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.66 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.32 173.1 6.57 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.724 -1.126 . . . . 0.10000000000000001 111.802 -176.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.71 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -125.88 113.96 17.91 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.008 -1.849 . . . . 0.22 106.008 164.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.469 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.1 m-85 -98.53 129.21 45.09 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.811 0.815 . . . . 0.17999999999999999 111.218 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.603 ' HA ' HG23 ' A' ' 343' ' ' THR . 5.7 ttpt -147.6 137.65 22.94 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 113.912 -1.494 . . . . 0.46999999999999997 108.161 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.464 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.79 11.94 7.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 113.489 -1.687 . . . . 0.59999999999999998 108.629 178.345 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.06 12.25 71.38 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 112.785 -2.007 . . . . 0.23000000000000001 111.806 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.621 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -131.43 168.68 17.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.107 -1.812 . . . . 0.68000000000000005 106.107 -172.202 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.65 HG11 ' CD1' ' A' ' 355' ' ' TRP . 3.2 m -100.96 136.9 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 124.442 2.067 . . . . 0.53000000000000003 111.958 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.71 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -90.62 -25.92 19.9 Favored 'General case' 0 N--CA 1.397 -3.081 0 CA-C-N 109.085 -3.688 . . . . 0.12 108.57 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.64 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.6 tp -152.51 154.25 35.1 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.577 -1.647 . . . . 0.080000000000000002 108.744 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.66 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -164.92 121.53 1.5 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.67 -0.696 . . . . 0.60999999999999999 109.489 -175.358 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.704 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.5 t -148.51 167.03 26.44 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.25 1.024 . . . . 0.089999999999999997 112.099 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.688 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.8 p-10 -85.9 139.79 30.93 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 113.173 -1.831 . . . . 1.8799999999999999 107.827 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.703 HD12 ' OE1' ' A' ' 352' ' ' GLN . 1.7 pp -140.63 -172.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.207 -0.906 . . . . 0.11 111.554 -175.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.596 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.8 119.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.399 -0.819 . . . . 0.12 109.05 174.585 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.2 t -141.27 145.11 35.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.747 -1.115 . . . . 0.69999999999999996 112.562 -167.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.08 46.1 37.51 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 117.333 1.693 . . . . 0.13 117.333 162.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.453 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.1 pttt -45.86 145.55 2.31 Favored Pre-proline 0 C--N 1.347 0.462 0 CA-C-N 119.842 1.821 . . . . 0.47999999999999998 110.779 -174.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.798 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.99 -36.46 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 1 C-N-CA 125.422 4.081 . . . . 0.23000000000000001 115.529 -173.58 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -35.89 57.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.076 0.465 . . . . 0.29999999999999999 110.903 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.464 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -139.88 72.56 34.67 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 122.111 0.958 . . . . 0.29999999999999999 110.522 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.4 Cg_exo -71.75 162.76 41.06 Favored 'Trans proline' 0 C--N 1.324 -0.741 1 C-N-CA 125.35 4.033 . . . . 0.16 113.978 -177.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.725 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.33 152.43 90.09 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 113.651 -1.613 . . . . 0.12 111.062 175.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.514 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.42 -49.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 125.116 3.877 . . . . 0.089999999999999997 113.712 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.74 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.89 120.95 0.03 OUTLIER 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.767 1.025 . . . . 0.089999999999999997 113.767 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.77 -123.25 1.15 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.343 -1.299 . . . . 0.11 111.563 -176.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.1 p -126.13 112.17 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.079 0.942 . . . . 0.89000000000000001 108.933 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.779 ' HB2' HG22 ' A' ' 463' ' ' VAL . 90.4 m-85 -115.66 160.09 20.49 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.219 -0.9 . . . . 0.16 109.83 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.713 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 77.2 m-85 -147.8 135.29 20.74 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 120.97 -0.292 . . . . 0.68999999999999995 111.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.49 121.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.63 -0.828 . . . . 0.14000000000000001 110.234 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -108.44 2.21 22.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.247 -0.888 . . . . 0.19 111.784 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.755 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 16.6 t-20 -164.65 150.81 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.838 -1.074 . . . . 0.40999999999999998 110.217 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -112.8 126.98 56.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.616 -0.72 . . . . 1.0900000000000001 109.123 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.576 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -127.14 112.76 15.53 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 123.195 1.474 . . . . 0.38 113.249 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 3.1 mp0 -108.17 134.15 51.43 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.286 -1.779 . . . . 1.96 110.862 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 36.9 t70 52.17 37.11 20.94 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.394 1.568 . . . . 0.40000000000000002 107.744 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.576 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.79 170.31 10.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.225 -2.261 . . . . 0.16 112.028 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 16.5 m -125.98 105.81 9.17 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.679 -1.601 . . . . 0.27000000000000002 109.823 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.7 mp -72.05 156.11 39.56 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.243 -1.799 . . . . 0.23999999999999999 109.79 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.478 ' HG2' ' HG3' ' A' ' 404' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.389 -3.482 0 CA-C-N 114.863 -1.062 . . . . 0.67000000000000004 109.136 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.7 mt-10 . . . . . 0 CA--C 1.504 -0.827 0 CA-C-O 122.383 1.087 . . . . 0.62 112.027 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.708 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.8 m -143.64 97.86 5.42 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.254 -1.794 . . . . 1.3300000000000001 109.464 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.7 Cg_endo -68.93 105.97 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.534 0 C-N-CA 124.359 3.373 . . . . 0.20000000000000001 112.999 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.832 HG11 ' HB2' ' A' ' 410' ' ' TRP . 0.6 OUTLIER -115.89 162.6 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 114.58 -1.191 . . . . 0.29999999999999999 110.87 -174.053 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 14.4 m120 -111.25 -33.59 6.39 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.152 -1.84 . . . . 1.8400000000000001 107.008 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.36 115.53 13.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.189 -1.823 . . . . 0.44 110.835 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.832 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.8 t-105 -122.59 136.26 54.84 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.558 -1.201 . . . . 0.13 109.897 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.534 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.54 86.17 23.81 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.006 -0.997 . . . . 0.40999999999999998 111.222 173.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.1 Cg_endo -70.85 140.11 37.88 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.889 2.393 . . . . 0.16 112.053 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.713 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.46 -15.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.804 -1.544 . . . . 0.17000000000000001 111.068 -173.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -135.37 163.76 29.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 1.5900000000000001 110.032 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -94.38 14.53 20.24 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.304 0.483 . . . . 0.31 112.304 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.4 p -94.11 -26.98 16.49 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.613 -1.254 . . . . 0.44 107.613 173.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.06 30.44 1.02 Allowed Glycine 0 N--CA 1.427 -1.93 0 CA-C-N 113.053 -1.885 . . . . 0.23999999999999999 112.274 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 441' ' ' GLY . 73.1 t -102.46 149.81 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 120.587 -0.445 . . . . 0.17000000000000001 111.112 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.18 -166.69 39.25 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.153 -0.93 . . . . 0.10000000000000001 111.789 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.407 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.8 OUTLIER -103.88 141.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.036 -0.727 . . . . 0.12 109.036 176.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.795 ' HB2' HG21 ' A' ' 407' ' ' VAL . 35.5 p80 -151.48 165.1 35.23 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.669 0.747 . . . . 0.14999999999999999 112.26 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.775 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.8 139.68 30.43 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.027 -1.442 . . . . 0.41999999999999998 107.449 171.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.813 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 1.6 t -135.6 104.25 5.73 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 123.212 1.482 . . . . 1.48 110.144 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -93.17 -25.85 17.66 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 111.855 -2.43 . . . . 0.34999999999999998 110.17 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.494 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 6.9 p90 -70.8 -26.41 63.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.385 -1.279 . . . . 0.17999999999999999 109.316 173.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.578 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.1 OUTLIER -118.93 83.08 22.27 Favored Pre-proline 0 CA--C 1.496 -1.121 0 CA-C-N 114.036 -1.438 . . . . 1.3300000000000001 110.6 -174.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -82.94 6.58 5.72 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 C-N-CA 124.515 3.477 . . . . 0.23000000000000001 114.554 -162.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.64 153.46 30.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 123.372 0.42 . . . . 1.1000000000000001 110.226 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.688 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -162.74 125.62 2.8 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.327 1.051 . . . . 0.38 109.203 -170.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.8 28.83 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.026 -1.559 . . . . 0.13 111.792 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.5 154.96 0.01 OUTLIER Glycine 0 C--N 1.339 0.748 0 O-C-N 124.985 1.05 . . . . 0.20000000000000001 112.762 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.41 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.039 1.876 . . . . 0.33000000000000002 112.284 -147.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 43.6 mt -96.68 -33.54 11.7 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 110.223 -3.171 . . . . 0.17999999999999999 108.094 175.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.508 ' HA ' HG23 ' A' ' 369' ' ' VAL . 2.9 p-90 -45.37 -37.96 5.46 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.936 0.772 . . . . 0.22 111.327 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.798 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.4 mttt -58.27 -23.7 57.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.059 -0.973 . . . . 0.64000000000000001 113.007 -176.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 49.0 p -116.63 -35.55 4.19 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.458 -0.792 . . . . 0.25 110.0 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.577 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.6 mtp85 -84.65 -14.92 47.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.634 -1.167 . . . . 0.35999999999999999 112.714 -169.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 73.47 41.54 44.25 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 116.459 1.344 . . . . 0.20999999999999999 116.459 159.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.7 m -87.53 131.49 34.36 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 118.267 1.033 . . . . 0.46999999999999997 109.113 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -97.58 68.32 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.817 -0.552 . . . . 0.40999999999999998 111.097 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.587 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.64 -12.28 63.8 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.582 -1.007 . . . . 0.17999999999999999 110.582 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 26.3 p -87.34 143.66 27.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.271 -0.464 . . . . 0.82999999999999996 109.923 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -99.26 115.97 41.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.23 0.538 . . . . 0.14999999999999999 110.734 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.813 ' ND2' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -78.39 93.74 4.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.132 -0.94 . . . . 1.77 111.356 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 25.0 m -91.49 136.07 27.22 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.621 -0.718 . . . . 0.17999999999999999 109.284 173.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 50.1 Cg_exo -56.79 132.65 53.01 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.073 2.515 . . . . 0.12 112.696 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.775 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 16.2 Cg_exo -50.21 -39.24 52.24 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.625 2.883 . . . . 0.16 112.713 -168.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 61.6 m -74.99 -42.22 57.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.709 -1.132 . . . . 1.1699999999999999 109.867 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.704 HG11 ' HB ' ' A' ' 366' ' ' THR . 62.0 t -75.88 -28.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.353 0.597 . . . . 0.17000000000000001 111.294 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.693 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.7 tpt -68.33 -20.13 64.71 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.583 0.706 . . . . 0.46000000000000002 110.17 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -79.61 -22.27 43.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 122.496 1.141 . . . . 0.81000000000000005 110.974 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.679 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.25 -47.4 14.67 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 112.894 -1.957 . . . . 0.38 107.399 177.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.578 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.8 tp -63.93 -67.27 0.44 Allowed 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 111.81 -2.45 . . . . 0.059999999999999998 112.302 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.441 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 39.7 t80 -49.82 -27.23 4.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 123.026 1.393 . . . . 0.31 108.335 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.06 -31.16 66.89 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 112.388 -2.187 . . . . 0.13 112.266 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.679 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -87.97 -49.35 7.12 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 121.772 0.796 . . . . 0.13 111.383 172.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.07 138.02 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-O 123.455 1.598 . . . . 0.23000000000000001 113.796 -167.27 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.25 -178.87 5.35 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 110.821 -2.9 . . . . 0.82999999999999996 106.662 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.755 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.3 mtmt -51.61 161.5 0.5 Allowed 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.966 1.365 . . . . 0.23999999999999999 112.869 175.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.77 -33.69 4.89 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.688 -2.051 . . . . 0.37 112.535 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 462' ' ' PRO . 6.9 m -78.78 142.34 60.85 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.362 -0.607 . . . . 0.14999999999999999 109.362 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 5.1 Cg_exo -76.09 169.2 22.55 Favored 'Trans proline' 0 N--CA 1.425 -2.527 0 C-N-CA 121.89 1.727 . . . . 0.12 111.335 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.779 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.12 157.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 107.422 -1.325 . . . . 1.0900000000000001 107.422 166.023 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.473 HD22 ' CE1' ' A' ' 344' ' ' TYR . 2.8 tp -127.25 146.05 50.56 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.197 -0.911 . . . . 0.13 109.935 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 147.08 20.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.276 -1.379 . . . . 0.089999999999999997 107.276 165.705 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.52 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 20.4 p90 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.742 -0.647 . . . . 1.1599999999999999 111.103 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.0 m . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 107.129 -1.434 . . . . 0.45000000000000001 107.129 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.641 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.2 p90 -157.15 -171.38 3.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.451 0.643 . . . . 0.32000000000000001 111.636 -174.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.559 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.2 mm -104.31 160.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 107.839 -1.171 . . . . 0.080000000000000002 107.839 166.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.499 ' CD ' ' HE2' ' A' ' 466' ' ' PHE . 2.1 tt0 -140.41 155.49 46.71 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 118.82 0.737 . . . . 0.17000000000000001 111.336 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.627 HG22 ' HG3' ' A' ' 354' ' ' MET . 63.8 t -150.38 134.48 8.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.589 -1.187 . . . . 0.080000000000000002 110.251 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.412 ' HB2' ' HZ3' ' A' ' 355' ' ' TRP . 18.2 t0 -115.48 114.66 25.33 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.832 -1.076 . . . . 0.37 108.139 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.466 HD21 HG23 ' A' ' 465' ' ' VAL . 1.8 mm? -68.21 -51.93 39.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.803 1.287 . . . . 0.32000000000000001 110.586 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.57 -52.97 15.9 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.179 -1.828 . . . . 1.51 113.298 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -102.54 9.14 39.66 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.73 -1.123 . . . . 0.91000000000000003 109.06 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.75 ' OE1' HD12 ' A' ' 368' ' ' ILE . 85.0 mm-40 36.93 73.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.058 1.474 . . . . 2.2200000000000002 111.871 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.8 t60 -150.3 125.95 10.31 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.54 -1.209 . . . . 0.13 109.434 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.627 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -112.46 128.43 56.32 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.234 0.614 . . . . 0.059999999999999998 110.743 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.67 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.0 m-90 -111.87 173.11 6.51 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.634 -1.167 . . . . 0.10000000000000001 111.817 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.702 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.9 t80 -126.06 116.12 20.91 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 106.775 -1.565 . . . . 0.22 106.775 165.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.493 ' CE1' HG12 ' A' ' 362' ' ' VAL . 17.8 m-85 -98.86 126.33 44.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.142 0.973 . . . . 0.17999999999999999 112.165 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.678 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.5 ttpt -149.64 139.76 22.11 Favored 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 113.196 -1.82 . . . . 0.46999999999999997 107.846 174.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.43 15.44 6.21 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 114.008 -1.451 . . . . 0.59999999999999998 108.799 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.59 18.62 77.34 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 112.378 -2.192 . . . . 0.23000000000000001 111.783 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.63 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.07 173.65 11.34 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.86 -1.904 . . . . 0.68000000000000005 105.86 -170.151 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.724 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.5 m -104.23 137.67 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 124.338 2.018 . . . . 0.53000000000000003 112.246 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.702 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.37 -23.73 19.13 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-N 109.218 -3.628 . . . . 0.12 108.624 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.689 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -153.84 154.72 34.46 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 113.567 -1.651 . . . . 0.080000000000000002 108.405 -172.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.724 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.26 122.39 1.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.73 -0.668 . . . . 0.60999999999999999 109.299 -174.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.663 HG21 HG23 ' A' ' 445' ' ' THR . 6.3 t -149.05 166.87 27.42 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 122.105 0.955 . . . . 0.089999999999999997 111.84 173.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.646 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.7 p-10 -86.48 141.55 29.01 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 113.228 -1.805 . . . . 1.8799999999999999 107.444 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.75 HD12 ' OE1' ' A' ' 352' ' ' GLN . 1.6 pp -142.0 -171.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.21 -0.904 . . . . 0.11 111.525 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.59 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -155.66 119.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.466 -0.788 . . . . 0.12 108.92 175.428 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.416 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.8 143.89 33.66 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.792 -1.095 . . . . 0.69999999999999996 112.748 -165.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.623 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.08 44.82 34.39 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 116.924 1.529 . . . . 0.13 116.924 162.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.489 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.69 142.36 6.71 Favored Pre-proline 0 CA--C 1.507 -0.676 0 CA-C-N 118.593 1.196 . . . . 0.47999999999999998 110.081 -175.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.791 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.59 -31.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.967 1 C-N-CA 125.885 4.39 . . . . 0.23000000000000001 116.365 -170.07 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -82.89 -32.58 27.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.297 0.57 . . . . 0.29999999999999999 110.672 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.445 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 12.1 m -140.77 74.55 26.71 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 122.151 0.976 . . . . 0.29999999999999999 110.239 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.623 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.76 162.41 42.13 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 125.068 3.845 . . . . 0.16 113.419 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.05 152.47 90.7 Favored Pre-proline 0 N--CA 1.436 -1.15 0 CA-C-N 113.665 -1.607 . . . . 0.12 110.806 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.47 -48.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.885 3.723 . . . . 0.089999999999999997 113.548 -172.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.803 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 66.31 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.918 1.081 . . . . 0.089999999999999997 113.918 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.79 -123.47 1.18 Allowed Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 114.301 -1.318 . . . . 0.11 111.414 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.6 p -129.8 104.93 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 122.371 1.081 . . . . 0.89000000000000001 109.538 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.616 ' CE2' HG22 ' A' ' 465' ' ' VAL . 55.3 m-85 -110.4 166.33 11.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.994 -1.003 . . . . 0.16 108.862 -172.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.705 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -148.77 136.28 20.4 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 117.63 0.195 . . . . 0.68999999999999995 110.714 177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.583 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -72.29 124.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.555 0.693 . . . . 0.14000000000000001 110.573 176.731 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -113.04 4.49 16.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.275 -0.875 . . . . 0.19 112.005 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.743 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 16.9 t-20 -163.96 148.97 10.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.493 -0.776 . . . . 0.40999999999999998 110.583 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.7 mtpt -110.81 109.74 20.07 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.811 0.815 . . . . 1.0900000000000001 110.412 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -107.95 131.87 54.09 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.304 -1.316 . . . . 0.38 109.382 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.548 -1.205 . . . . 1.96 110.092 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 25.8 t70 50.43 40.42 22.99 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.597 1.665 . . . . 0.40000000000000002 107.516 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.32 170.2 9.98 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 111.927 -2.397 . . . . 0.16 110.809 -173.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 23.9 m -129.91 102.92 6.5 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.1 -1.409 . . . . 0.27000000000000002 110.136 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.784 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -75.17 158.16 33.46 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 112.717 -2.038 . . . . 0.23999999999999999 110.298 174.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.501 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 6.8 mtpt . . . . . 0 N--CA 1.398 -3.048 0 CA-C-N 115.224 -0.898 . . . . 0.67000000000000004 108.919 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.4 mt-10 . . . . . 0 CA--C 1.511 -0.541 0 CA-C-O 122.329 1.061 . . . . 0.62 112.182 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.784 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -134.16 99.21 13.62 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-N 113.236 -1.802 . . . . 1.3300000000000001 108.595 176.49 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.91 101.05 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.793 2.329 . . . . 0.20000000000000001 110.182 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -120.28 133.91 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-N 114.004 -1.453 . . . . 0.29999999999999999 111.234 -171.555 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.455 ' ND2' ' CD2' ' A' ' 409' ' ' TYR . 14.0 p-10 -78.08 -30.32 49.56 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.822 -1.081 . . . . 1.8400000000000001 110.599 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.568 ' HB3' ' CD1' ' A' ' 454' ' ' PHE . 64.1 m-85 -142.15 117.83 10.41 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.728 -1.124 . . . . 0.44 110.758 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.697 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.9 t-105 -122.94 135.65 54.57 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.24 -1.346 . . . . 0.13 110.296 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.583 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -136.33 87.18 22.89 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 115.25 -0.886 . . . . 0.40999999999999998 110.962 174.499 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 90.8 Cg_endo -72.68 140.95 33.34 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.834 2.356 . . . . 0.16 111.554 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -122.55 -15.81 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.38 -1.282 . . . . 0.17000000000000001 111.656 -171.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.779 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.9 p30 -135.78 170.16 16.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.486 -0.779 . . . . 1.5900000000000001 109.58 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -96.08 15.31 21.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.206 -0.452 . . . . 0.31 111.989 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 18.3 p -96.85 -27.52 14.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.072 -1.085 . . . . 0.44 108.072 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.82 27.3 0.87 Allowed Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.958 -1.473 . . . . 0.23999999999999999 113.314 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.779 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 61.5 t -103.44 151.77 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.266 0.555 . . . . 0.17000000000000001 111.428 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 173.34 -163.99 35.62 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.149 -0.932 . . . . 0.10000000000000001 111.41 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.98 137.81 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 109.251 -0.648 . . . . 0.12 109.251 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.735 ' HB2' HG21 ' A' ' 407' ' ' VAL . 33.3 p80 -152.65 169.84 21.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.725 0.774 . . . . 0.14999999999999999 111.422 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.731 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.87 154.5 19.44 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 113.827 -1.533 . . . . 0.41999999999999998 108.699 174.403 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 18.5 p -140.11 99.95 3.8 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.583 1.182 . . . . 1.48 109.936 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.93 -31.17 13.78 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.621 -2.081 . . . . 0.34999999999999998 110.411 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.554 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.2 p90 -70.25 -26.99 64.09 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.369 -1.287 . . . . 0.17999999999999999 108.765 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.489 ' HB3' HD22 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.27 82.83 24.02 Favored Pre-proline 0 CA--C 1.489 -1.375 0 CA-C-N 113.437 -1.711 . . . . 1.3300000000000001 109.037 -174.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 427' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 35.9 Cg_endo -80.07 3.61 7.47 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 124.483 3.455 . . . . 0.23000000000000001 114.619 -159.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 428' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 2.9 tp10 -113.96 157.17 22.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.892 0.377 . . . . 1.1000000000000001 110.738 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.646 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.66 125.89 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.293 -1.321 . . . . 0.38 108.68 -171.277 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -168.34 28.72 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.419 -1.372 . . . . 0.13 112.158 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.596 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.36 0.01 OUTLIER Glycine 0 C--N 1.341 0.843 0 O-C-N 124.983 1.049 . . . . 0.20000000000000001 112.783 173.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.22 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.281 0 CA-C-O 124.025 1.869 . . . . 0.33000000000000002 112.249 -146.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 36.3 mt -97.84 -33.53 11.21 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 110.06 -3.246 . . . . 0.17999999999999999 109.298 175.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.56 ' HA ' HG23 ' A' ' 369' ' ' VAL . 8.0 p-90 -46.88 -34.45 5.43 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.214 -1.812 . . . . 0.22 112.16 -174.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.791 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 47.9 mttt -61.93 -23.79 66.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.334 -0.848 . . . . 0.64000000000000001 113.188 -177.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -115.8 -36.66 4.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.686 0.755 . . . . 0.25 110.085 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.585 ' HD2' HD22 ' A' ' 433' ' ' LEU . 4.5 mtp85 -81.65 -15.48 54.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.489 -1.232 . . . . 0.35999999999999999 112.973 -169.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.48 42.85 26.23 Favored Glycine 0 C--N 1.314 -0.646 0 N-CA-C 116.344 1.298 . . . . 0.20999999999999999 116.344 158.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 13.7 m -85.73 131.37 34.34 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 118.282 1.041 . . . . 0.46999999999999997 109.117 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -101.8 71.73 1.32 Allowed 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.405 -0.809 . . . . 0.40999999999999998 110.919 -169.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.517 ' H ' ' HA2' ' A' ' 371' ' ' GLY . . . 85.8 -13.57 55.79 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.223 -1.151 . . . . 0.17999999999999999 110.223 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.569 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.1 p -88.59 148.18 24.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.063 -0.568 . . . . 0.82999999999999996 110.218 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.716 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -103.64 118.78 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.107 -0.497 . . . . 0.14999999999999999 110.348 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.632 ' HB3' ' OG ' ' A' ' 423' ' ' SER . 2.1 m-20 -85.49 90.01 7.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.589 -0.732 . . . . 1.77 111.641 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 99.5 m -87.02 138.76 32.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 121.473 0.654 . . . . 0.17999999999999999 109.726 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.0 Cg_exo -54.36 136.58 69.61 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.685 2.257 . . . . 0.12 111.043 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.731 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 44.5 Cg_exo -55.65 -31.98 81.71 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 C-N-CA 123.984 3.122 . . . . 0.16 112.638 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.7 p -80.63 -39.04 28.11 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.279 -1.328 . . . . 1.1699999999999999 109.623 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.588 HG11 ' HB ' ' A' ' 366' ' ' THR . 92.3 t -77.32 -31.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.552 -0.749 . . . . 0.17000000000000001 111.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.643 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 3.6 tpt -63.03 -24.4 67.9 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.584 0.707 . . . . 0.46000000000000002 110.523 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -72.28 -30.49 64.87 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.539 -1.209 . . . . 0.81000000000000005 112.628 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.67 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.7 mm-40 -75.68 -46.6 30.35 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-N 113.005 -1.907 . . . . 0.38 107.362 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.521 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 26.1 tp -64.97 -67.35 0.44 Allowed 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 111.491 -2.595 . . . . 0.059999999999999998 112.379 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 409' ' ' TYR . 26.8 t80 -50.37 -25.91 4.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 123.146 1.45 . . . . 0.31 108.309 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.34 -30.89 64.13 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 112.475 -2.148 . . . . 0.13 112.156 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.689 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -87.63 -48.38 7.94 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-O 121.661 0.743 . . . . 0.13 111.324 172.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.647 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.5 OUTLIER -102.19 137.89 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.351 1.548 . . . . 0.23000000000000001 113.989 -168.33 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.3 pt-20 -136.25 -178.56 5.21 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 110.965 -2.834 . . . . 0.82999999999999996 106.739 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.743 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.8 mtmt -50.95 160.54 0.46 Allowed 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 123.102 1.43 . . . . 0.23999999999999999 113.363 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.76 -36.21 3.78 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 112.433 -2.167 . . . . 0.37 112.475 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 462' ' ' PRO . 19.3 m -70.35 141.17 88.15 Favored Pre-proline 0 N--CA 1.438 -1.048 0 CA-C-O 121.196 0.522 . . . . 0.14999999999999999 110.282 -175.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.641 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.58 161.56 41.86 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.215 1.943 . . . . 0.12 110.884 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 71.8 t -132.26 131.42 60.84 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 113.466 -1.697 . . . . 1.0900000000000001 107.833 173.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.1 tp -109.83 142.03 41.69 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.232 0.539 . . . . 0.13 110.308 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.01 145.49 22.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.088 -1.819 . . . . 0.089999999999999997 106.088 164.316 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.803 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.135 -0.936 . . . . 1.1599999999999999 111.591 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.614 HG23 ' HA ' ' A' ' 358' ' ' LYS . 22.6 m . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 108.627 -0.879 . . . . 0.45000000000000001 108.627 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.642 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 6.1 p90 -156.88 -171.01 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.52 0.676 . . . . 0.32000000000000001 111.41 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.4 mm -102.26 162.14 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 108.221 -1.029 . . . . 0.080000000000000002 108.221 167.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.4 tt0 -142.14 156.54 45.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 118.835 0.743 . . . . 0.17000000000000001 111.545 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.691 HG22 ' HG3' ' A' ' 354' ' ' MET . 62.7 t -151.3 136.91 11.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.491 -1.231 . . . . 0.080000000000000002 110.077 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -117.67 115.34 24.87 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.68 -1.145 . . . . 0.37 108.104 172.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.509 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -67.83 -49.5 61.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.355 1.074 . . . . 0.32000000000000001 110.564 -176.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -52.89 -55.2 24.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.774 -2.012 . . . . 1.51 112.185 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -95.82 4.0 53.24 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.738 -1.119 . . . . 0.91000000000000003 109.964 -171.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.715 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.5 mm-40 47.08 66.14 1.07 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.448 -2.16 . . . . 2.2200000000000002 112.129 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.5 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -148.48 125.35 11.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.286 0.565 . . . . 0.13 109.916 -175.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.691 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -112.35 127.42 56.0 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 123.606 0.763 . . . . 0.059999999999999998 110.359 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.684 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -113.62 173.7 6.28 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.609 -1.178 . . . . 0.10000000000000001 112.062 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.717 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -126.49 115.83 20.17 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 106.529 -1.656 . . . . 0.22 106.529 165.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.508 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.9 m-85 -100.44 127.91 46.65 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.993 0.901 . . . . 0.17999999999999999 112.118 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.614 ' HA ' HG23 ' A' ' 343' ' ' THR . 6.0 ttpt -147.79 137.68 22.71 Favored 'General case' 0 N--CA 1.398 -3.034 0 CA-C-N 113.667 -1.606 . . . . 0.46999999999999997 108.548 174.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 70.48 14.2 7.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.402 -1.726 . . . . 0.59999999999999998 108.601 178.439 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.49 71.01 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 112.701 -2.045 . . . . 0.23000000000000001 112.186 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.583 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.69 169.9 16.97 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.158 -1.793 . . . . 0.68000000000000005 106.158 -170.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -101.41 138.23 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 CA-C-O 124.207 1.956 . . . . 0.53000000000000003 111.976 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.717 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.63 -25.01 18.48 Favored 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 109.361 -3.563 . . . . 0.12 108.688 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.714 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.87 155.18 36.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 113.74 -1.573 . . . . 0.080000000000000002 109.301 -173.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.8 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.14 123.0 1.6 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.469 -0.787 . . . . 0.60999999999999999 109.339 -175.418 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.815 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.9 t -148.32 165.68 30.31 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 122.415 1.102 . . . . 0.089999999999999997 112.017 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.734 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.7 p-10 -83.46 140.85 32.09 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 112.881 -1.963 . . . . 1.8799999999999999 107.821 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.26 -171.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.264 -0.88 . . . . 0.11 112.064 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.715 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -157.94 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.936 -1.029 . . . . 0.12 109.352 176.531 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.5 t -140.94 145.54 36.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.28 -0.873 . . . . 0.69999999999999996 112.892 -165.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 68.54 46.68 61.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 116.199 1.24 . . . . 0.13 116.199 162.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.562 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.38 145.42 2.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 118.267 1.033 . . . . 0.47999999999999998 110.184 -175.252 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.771 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.47 -33.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 125.242 3.961 . . . . 0.23000000000000001 115.911 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.562 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -80.41 -34.4 36.24 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.738 -0.601 . . . . 0.29999999999999999 110.752 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.456 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.3 m -139.98 73.06 33.53 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 122.209 1.004 . . . . 0.29999999999999999 109.994 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 29.5 Cg_exo -69.71 161.62 45.24 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 C-N-CA 125.301 4.001 . . . . 0.16 113.967 -177.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.696 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -72.99 154.03 90.85 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.562 -1.654 . . . . 0.12 110.358 175.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.543 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -80.24 -50.32 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 125.029 3.82 . . . . 0.089999999999999997 113.564 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.714 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.8 123.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.996 0.903 . . . . 0.089999999999999997 113.322 -176.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.29 -124.07 1.22 Allowed Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.271 -1.331 . . . . 0.11 111.491 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 381' ' ' VAL . 9.2 p -128.63 104.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.454 1.121 . . . . 0.89000000000000001 109.831 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.785 ' HB2' HG22 ' A' ' 463' ' ' VAL . 93.8 m-85 -107.92 161.35 15.01 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.516 -1.22 . . . . 0.16 110.03 -170.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.5 m-85 -147.3 136.99 22.92 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 122.974 0.171 . . . . 0.68999999999999995 110.694 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.625 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.2 120.36 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.937 -0.705 . . . . 0.14000000000000001 110.16 176.235 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 385' ' ' TRP . . . . . 0.467 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 40.6 p-90 -106.31 3.62 27.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.404 -0.816 . . . . 0.19 111.789 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.721 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 16.4 t-20 -164.54 148.86 9.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.224 -0.898 . . . . 0.40999999999999998 110.813 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.483 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.3 mtpt -107.4 111.16 23.36 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.478 -0.783 . . . . 1.0900000000000001 109.863 169.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.1 mt-10 -111.87 122.92 49.11 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.657 1.218 . . . . 0.38 110.912 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -118.1 145.0 45.18 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.079 -1.419 . . . . 1.96 109.253 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 34.6 t70 54.34 25.88 6.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 112.026 -2.352 . . . . 0.40000000000000002 108.582 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.09 170.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.09 -1.868 . . . . 0.16 112.063 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 31.5 m -127.49 102.26 6.79 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.526 -1.67 . . . . 0.27000000000000002 110.099 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.746 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.9 mp -72.9 158.46 35.46 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 113.03 -1.896 . . . . 0.23999999999999999 110.502 175.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 6.4 mtpt . . . . . 0 N--CA 1.396 -3.148 0 N-CA-C 108.636 -0.876 . . . . 0.67000000000000004 108.636 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.1 mt-10 . . . . . 0 CA--C 1.509 -0.603 0 CA-C-O 122.342 1.067 . . . . 0.62 111.692 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.746 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.2 98.95 12.39 Favored Pre-proline 0 N--CA 1.42 -1.951 0 CA-C-N 113.12 -1.855 . . . . 1.3300000000000001 107.568 176.139 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.4 Cg_endo -67.29 102.02 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 122.318 2.012 . . . . 0.20000000000000001 110.165 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.725 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.39 163.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.853 0 CA-C-N 114.192 -1.367 . . . . 0.29999999999999999 109.914 -173.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -114.92 -33.8 5.32 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 113.417 -1.72 . . . . 1.8400000000000001 107.081 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.423 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 59.8 m-85 -134.87 115.68 13.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.629 -2.078 . . . . 0.44 110.485 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.725 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.5 t-105 -123.81 134.27 53.66 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.13 110.254 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.584 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -135.56 85.04 32.22 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.936 -1.029 . . . . 0.40999999999999998 110.93 173.514 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 73.2 Cg_endo -70.52 140.65 40.3 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.929 2.42 . . . . 0.16 112.102 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.728 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -124.39 -16.19 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.076 -1.42 . . . . 0.17000000000000001 111.162 -173.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -134.88 161.0 36.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.536 -0.756 . . . . 1.5900000000000001 109.532 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -92.13 13.84 17.81 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.147 0.425 . . . . 0.31 112.147 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -93.02 -25.66 17.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.745 -1.206 . . . . 0.44 107.745 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.22 29.16 1.38 Allowed Glycine 0 N--CA 1.425 -2.054 0 CA-C-N 113.073 -1.876 . . . . 0.23999999999999999 112.179 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 441' ' ' GLY . 84.8 t -102.27 148.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.281 0.562 . . . . 0.17000000000000001 110.626 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 173.97 -166.04 38.01 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.731 -1.122 . . . . 0.10000000000000001 111.186 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.411 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.67 138.99 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 108.795 -0.817 . . . . 0.12 108.795 176.074 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.717 ' CE1' ' HB2' ' A' ' 442' ' ' CYS . 9.9 p-80 -149.98 163.63 37.59 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.652 0.739 . . . . 0.14999999999999999 111.969 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.789 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.33 137.35 32.43 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.293 -1.321 . . . . 0.41999999999999998 107.951 173.066 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.5 OUTLIER -130.73 101.46 5.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.421 1.105 . . . . 1.48 109.606 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -95.18 -30.54 13.96 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.082 -1.872 . . . . 0.34999999999999998 111.021 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.445 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 19.0 p90 -66.66 -26.54 67.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.414 -1.266 . . . . 0.17999999999999999 109.151 174.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.504 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.95 82.65 28.84 Favored Pre-proline 0 CA--C 1.49 -1.347 0 CA-C-N 113.614 -1.63 . . . . 1.3300000000000001 109.451 -173.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -80.86 5.94 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 124.784 3.656 . . . . 0.23000000000000001 114.21 -160.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.67 153.7 29.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.336 -0.393 . . . . 1.1000000000000001 110.614 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.734 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.95 124.73 2.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.214 -1.357 . . . . 0.38 108.097 -172.189 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.86 -168.12 28.75 Favored Glycine 0 C--N 1.297 -1.629 0 C-N-CA 119.283 -1.437 . . . . 0.13 111.123 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.673 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.6 152.33 0.0 OUTLIER Glycine 0 C--N 1.342 0.891 0 O-C-N 125.141 1.142 . . . . 0.20000000000000001 113.176 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.6 m-20 -54.59 101.06 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 123.86 1.79 . . . . 0.33000000000000002 111.797 -145.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 55.6 mt -96.53 -30.79 13.11 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 110.474 -3.057 . . . . 0.17999999999999999 108.111 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.593 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.0 p-90 -46.46 -38.01 8.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.867 0.73 . . . . 0.22 111.398 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.771 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 36.4 mttt -62.3 -24.34 67.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.921 -1.036 . . . . 0.64000000000000001 112.845 -175.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 31.1 p -113.23 -36.18 5.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.568 0.699 . . . . 0.25 110.16 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.519 ' HB2' HG21 ' A' ' 369' ' ' VAL . 5.7 mtp85 -86.96 -16.83 34.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.783 -1.099 . . . . 0.35999999999999999 112.664 -168.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.497 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.47 43.79 29.34 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 116.506 1.362 . . . . 0.20999999999999999 116.506 162.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -86.21 130.74 34.42 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 118.701 1.251 . . . . 0.46999999999999997 108.179 172.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -99.72 64.34 1.27 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.47 -0.769 . . . . 0.40999999999999998 110.96 -168.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.566 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 94.9 -12.75 68.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.577 -1.009 . . . . 0.17999999999999999 110.577 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.717 ' HB2' ' CE1' ' A' ' 421' ' ' HIS . 10.7 p -90.49 142.77 27.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.238 -0.481 . . . . 0.82999999999999996 110.66 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -95.91 120.74 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 122.579 1.18 . . . . 0.14999999999999999 111.19 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.5 OUTLIER -78.92 82.48 5.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.784 -2.007 . . . . 1.77 111.936 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.567 HG23 HG21 ' A' ' 366' ' ' THR . 16.5 m -87.05 137.75 32.99 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-O 121.383 0.611 . . . . 0.17999999999999999 109.509 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.499 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 50.9 Cg_exo -57.42 136.14 74.21 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.723 2.282 . . . . 0.12 111.595 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.789 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.8 Cg_exo -55.14 -33.0 82.44 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 124.245 3.297 . . . . 0.16 113.138 -172.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.418 ' O ' ' HG2' ' A' ' 452' ' ' GLU . 4.6 t -81.42 -38.51 26.38 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.883 -1.053 . . . . 1.1699999999999999 109.304 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.815 HG11 ' HB ' ' A' ' 366' ' ' THR . 26.1 t -82.9 -26.85 8.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.652 . . . . 0.17000000000000001 111.11 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.699 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.7 tpt -68.58 -19.92 64.49 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.878 0.847 . . . . 0.46000000000000002 110.073 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.48 -23.22 46.53 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.609 -1.178 . . . . 0.81000000000000005 111.075 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.84 -45.97 16.05 Favored 'General case' 0 CA--C 1.477 -1.838 0 CA-C-N 112.905 -1.952 . . . . 0.38 107.473 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.597 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -65.01 -66.85 0.49 Allowed 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 111.89 -2.414 . . . . 0.059999999999999998 112.311 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.434 ' HB2' ' HE3' ' A' ' 450' ' ' MET . 24.1 t80 -50.16 -27.86 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.94 1.352 . . . . 0.31 107.965 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.58 -30.13 71.09 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 112.491 -2.14 . . . . 0.13 112.469 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.714 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.88 -48.26 7.35 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.597 0.713 . . . . 0.13 111.611 172.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.24 138.69 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 123.365 1.555 . . . . 0.23000000000000001 114.182 -167.073 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.483 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.4 -178.74 5.3 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 110.834 -2.894 . . . . 0.82999999999999996 106.845 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.9 mtmt -52.22 162.77 0.45 Allowed 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 123.114 1.435 . . . . 0.23999999999999999 113.058 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.64 -34.63 4.27 Favored Glycine 0 N--CA 1.424 -2.149 0 CA-C-N 112.48 -2.145 . . . . 0.37 112.283 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 462' ' ' PRO . 7.6 m -76.04 141.33 71.01 Favored Pre-proline 0 N--CA 1.434 -1.261 0 N-CA-C 109.484 -0.562 . . . . 0.14999999999999999 109.484 -176.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.642 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.6 166.47 28.4 Favored 'Trans proline' 0 N--CA 1.425 -2.53 0 C-N-CA 122.024 1.816 . . . . 0.12 111.157 173.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.63 153.2 34.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 107.634 -1.247 . . . . 1.0900000000000001 107.634 166.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.3 tp -123.4 145.25 48.93 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.096 -0.956 . . . . 0.13 110.155 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.28 146.05 21.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.413 -1.699 . . . . 0.089999999999999997 106.413 164.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.654 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 18.0 p90 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.62 -0.705 . . . . 1.1599999999999999 111.364 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.602 HG23 ' HA ' ' A' ' 358' ' ' LYS . 27.1 m . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.959 -1.126 . . . . 0.45000000000000001 107.959 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.656 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.4 p90 -161.0 -170.75 2.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.153 -0.931 . . . . 0.32000000000000001 110.768 -175.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.45 161.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.097 -1.075 . . . . 0.080000000000000002 108.097 167.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.518 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.7 tt0 -140.35 155.85 46.63 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.956 0.798 . . . . 0.17000000000000001 111.253 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.727 HG22 ' HG3' ' A' ' 354' ' ' MET . 67.0 t -150.84 133.4 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.413 -1.267 . . . . 0.080000000000000002 109.721 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 50.9 t0 -115.05 111.78 21.61 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.336 -1.357 . . . . 0.37 107.336 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.645 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.6 mm? -60.61 -58.67 7.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.783 1.277 . . . . 0.32000000000000001 107.618 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.496 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 11.9 mm-40 -48.94 -46.85 43.92 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 111.353 -2.658 . . . . 1.51 112.943 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -111.13 20.73 17.13 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 125.206 1.567 . . . . 0.91000000000000003 109.203 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 20.2 mp0 36.24 68.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.27 -1.787 . . . . 2.2200000000000002 112.622 170.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.499 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -153.17 124.5 7.58 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.194 0.521 . . . . 0.13 109.914 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.727 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -110.91 127.54 55.5 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.454 0.702 . . . . 0.059999999999999998 110.605 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.654 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.1 m-90 -112.25 173.76 6.21 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 114.459 -1.246 . . . . 0.10000000000000001 112.05 -175.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.718 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.3 t80 -127.41 119.15 25.51 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 106.261 -1.755 . . . . 0.22 106.261 165.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.522 ' CE1' HG12 ' A' ' 362' ' ' VAL . 18.5 m-85 -102.49 129.52 49.03 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.941 0.877 . . . . 0.17999999999999999 111.524 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.5 ttpt -148.46 137.43 21.7 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 113.722 -1.581 . . . . 0.46999999999999997 108.116 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.38 15.1 6.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.456 -1.702 . . . . 0.59999999999999998 108.752 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 80.51 17.79 72.57 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 112.667 -2.06 . . . . 0.23000000000000001 111.899 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.546 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -137.12 168.07 20.31 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.098 -1.816 . . . . 0.68000000000000005 106.098 -171.67 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.687 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -100.11 138.21 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.802 0 CA-C-O 124.25 1.976 . . . . 0.53000000000000003 111.874 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.718 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.24 -25.18 17.9 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 109.305 -3.589 . . . . 0.12 108.564 177.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.679 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -152.46 155.36 37.36 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.868 -1.515 . . . . 0.080000000000000002 109.227 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.687 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.93 122.51 1.36 Allowed 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 109.614 -174.74 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.74 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.6 t -148.3 167.16 25.9 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.177 0.989 . . . . 0.089999999999999997 112.136 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.5 p-10 -86.77 140.93 29.25 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.222 -1.808 . . . . 1.8799999999999999 107.916 177.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -143.15 -172.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.309 -0.859 . . . . 0.11 112.484 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.63 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -154.36 119.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.705 -1.134 . . . . 0.12 108.696 175.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 6.6 t -141.27 143.41 34.09 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.759 -0.655 . . . . 0.69999999999999996 112.742 -168.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.53 45.1 24.59 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 117.716 -1.602 . . . . 0.13 117.001 163.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.435 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.3 OUTLIER -46.71 143.85 3.94 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-N 119.722 1.761 . . . . 0.47999999999999998 110.363 -173.146 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.824 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.68 -33.67 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.948 4.432 . . . . 0.23000000000000001 115.912 -170.811 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 3.1 p -75.06 -37.97 61.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.3 0.571 . . . . 0.29999999999999999 111.076 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.1 m -140.55 74.31 28.32 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.106 0.955 . . . . 0.29999999999999999 110.606 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.4 Cg_exo -70.94 160.44 49.37 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 125.175 3.917 . . . . 0.16 113.853 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.69 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -71.1 153.09 94.65 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.269 -1.787 . . . . 0.12 111.357 177.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.526 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.5 Cg_endo -80.17 -49.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 125.09 3.86 . . . . 0.089999999999999997 113.734 -171.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.701 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.3 122.86 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.737 1.014 . . . . 0.089999999999999997 113.737 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.08 -124.74 1.28 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.242 -1.345 . . . . 0.11 111.423 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.6 p -128.72 105.65 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 122.296 1.046 . . . . 0.89000000000000001 109.267 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.814 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.8 m-85 -108.97 164.16 12.65 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.138 -0.937 . . . . 0.16 110.058 -169.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.694 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 68.9 m-85 -147.34 137.23 23.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 121.196 -0.202 . . . . 0.68999999999999995 110.954 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.589 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.63 121.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.491 0.662 . . . . 0.14000000000000001 110.364 176.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 385' ' ' TRP . . . . . 0.405 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 42.7 p-90 -108.62 5.86 25.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.421 -0.809 . . . . 0.19 111.88 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.729 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 13.8 t-20 -164.6 146.82 8.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.874 . . . . 0.40999999999999998 110.251 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -108.89 115.63 30.45 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.958 -0.756 . . . . 1.0900000000000001 108.958 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.572 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -118.65 111.98 19.23 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.472 1.606 . . . . 0.38 113.065 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 2.6 mp0 -103.84 143.74 32.42 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 113.289 -1.778 . . . . 1.96 109.708 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.7 t70 57.08 22.23 7.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.259 -2.246 . . . . 0.40000000000000002 108.604 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.572 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -82.33 171.15 14.53 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.403 -1.726 . . . . 0.16 112.56 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 15.7 m -127.5 104.23 7.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.051 -1.886 . . . . 0.27000000000000002 110.004 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.735 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.0 mp -73.26 156.99 37.93 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 112.642 -2.072 . . . . 0.23999999999999999 109.98 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.491 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.3 mtpt . . . . . 0 N--CA 1.398 -3.058 0 O-C-N 124.352 1.032 . . . . 0.67000000000000004 108.789 -176.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.2 mt-10 . . . . . 0 CA--C 1.512 -0.487 0 CA-C-O 122.392 1.091 . . . . 0.62 112.112 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.735 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.91 99.22 10.24 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-N 112.948 -1.933 . . . . 1.3300000000000001 108.239 176.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 64.0 Cg_endo -67.62 102.24 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.549 2.166 . . . . 0.20000000000000001 110.669 175.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -113.64 165.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 114.238 -1.346 . . . . 0.29999999999999999 109.84 -173.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 11.3 m120 -116.3 -33.5 4.95 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.551 -1.659 . . . . 1.8400000000000001 107.083 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.412 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 46.3 m-85 -136.2 115.47 12.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.062 -1.881 . . . . 0.44 110.474 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.757 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.7 t-105 -122.95 135.77 54.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.712 -1.131 . . . . 0.13 110.065 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.57 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.8 OUTLIER -136.51 83.49 30.88 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.892 -1.049 . . . . 0.40999999999999998 110.923 173.496 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 13.9 Cg_endo -70.31 139.5 38.44 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.141 2.561 . . . . 0.16 112.659 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.93 -15.15 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 113.792 -1.549 . . . . 0.17000000000000001 111.453 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -134.39 163.64 29.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 1.5900000000000001 109.483 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -96.96 13.55 28.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.801 0.334 . . . . 0.31 111.735 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.4 p -92.45 -27.06 17.7 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.538 -1.282 . . . . 0.44 107.538 173.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.68 29.36 1.07 Allowed Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 112.862 -1.972 . . . . 0.23999999999999999 112.353 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 441' ' ' GLY . 74.3 t -102.47 148.76 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.232 0.539 . . . . 0.17000000000000001 111.142 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.49 -167.46 39.78 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.831 -1.077 . . . . 0.10000000000000001 111.336 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.61 141.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.858 -0.793 . . . . 0.12 108.858 175.528 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.593 ' O ' ' HB ' ' A' ' 445' ' ' THR . 32.9 p80 -149.46 165.16 32.95 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.747 0.784 . . . . 0.14999999999999999 111.616 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -93.28 139.39 30.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.019 -1.475 . . . . 0.41999999999999998 107.019 171.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.42 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 1.8 t -134.06 103.2 5.69 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.97 1.367 . . . . 1.48 110.066 -176.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.49 -32.36 13.53 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 112.234 -2.257 . . . . 0.34999999999999998 111.162 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -65.67 -27.19 68.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.55 -1.205 . . . . 0.17999999999999999 109.055 175.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.592 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -121.36 82.62 39.21 Favored Pre-proline 0 CA--C 1.493 -1.221 0 CA-C-N 113.406 -1.724 . . . . 1.3300000000000001 109.485 -174.239 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -81.24 7.33 5.03 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 C-N-CA 124.818 3.678 . . . . 0.23000000000000001 114.471 -160.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.68 154.46 27.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.009 0.433 . . . . 1.1000000000000001 111.303 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.606 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.97 126.0 2.39 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.178 -1.374 . . . . 0.38 108.86 -171.165 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 430' ' ' GLY . . . . . 0.565 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 146.95 -166.63 28.38 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.68 -1.248 . . . . 0.13 110.65 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.66 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.14 151.89 0.0 OUTLIER Glycine 0 C--N 1.341 0.822 0 O-C-N 125.187 1.169 . . . . 0.20000000000000001 113.258 173.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.01 100.5 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 111.944 -152.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.3 mt -97.69 -32.12 11.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 110.403 -3.089 . . . . 0.17999999999999999 107.941 174.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.63 ' HA ' HG23 ' A' ' 369' ' ' VAL . 3.8 p-90 -46.0 -38.54 7.89 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.987 0.804 . . . . 0.22 111.414 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.824 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 34.9 mttt -59.11 -26.63 64.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 114.781 -1.1 . . . . 0.64000000000000001 113.021 -176.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.6 p -111.53 -35.35 5.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.898 0.856 . . . . 0.25 109.859 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.592 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.0 mtp85 -86.77 -15.55 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.439 -1.255 . . . . 0.35999999999999999 112.647 -168.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.435 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.65 41.89 33.95 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 116.608 1.403 . . . . 0.20999999999999999 116.608 159.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.7 p -91.07 131.76 36.45 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 118.318 1.059 . . . . 0.46999999999999997 109.124 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -98.6 69.08 1.86 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.673 -0.642 . . . . 0.40999999999999998 111.209 -167.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 88.41 -11.77 66.96 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 110.39 -1.084 . . . . 0.17999999999999999 110.39 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 18.4 p -86.88 141.34 28.84 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.181 -0.51 . . . . 0.82999999999999996 109.924 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.69 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -95.52 117.71 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.668 0.747 . . . . 0.14999999999999999 110.781 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.603 ' HB3' HG13 ' A' ' 369' ' ' VAL . 2.1 t30 -76.86 82.59 3.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.498 -1.228 . . . . 1.77 111.354 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.4 m -86.94 138.85 32.75 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-O 121.549 0.69 . . . . 0.17999999999999999 109.628 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.6 Cg_exo -58.13 135.26 67.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.654 2.236 . . . . 0.12 111.416 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 30.3 Cg_exo -54.44 -34.08 79.97 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 124.299 3.333 . . . . 0.16 112.783 -174.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 44.7 m -78.98 -41.37 29.29 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.458 -1.247 . . . . 1.1699999999999999 110.07 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.74 HG11 ' HB ' ' A' ' 366' ' ' THR . 54.0 t -79.21 -28.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.252 0.549 . . . . 0.17000000000000001 111.487 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.692 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.8 tpt -68.29 -18.58 64.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.775 0.797 . . . . 0.46000000000000002 110.096 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.09 -22.23 42.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.7 -1.136 . . . . 0.81000000000000005 110.875 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.687 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.3 mm-40 -81.0 -47.3 13.81 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 112.767 -2.015 . . . . 0.38 107.38 177.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.629 HD23 ' SD ' ' A' ' 450' ' ' MET . 25.5 tp -64.28 -67.01 0.47 Allowed 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 111.878 -2.419 . . . . 0.059999999999999998 112.318 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.442 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.0 t80 -49.76 -26.8 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 123.181 1.467 . . . . 0.31 108.285 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.7 -30.95 65.54 Favored Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 112.251 -2.25 . . . . 0.13 112.331 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.687 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -89.19 -48.88 7.08 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 121.688 0.756 . . . . 0.13 111.572 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -100.26 139.23 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 123.328 1.537 . . . . 0.23000000000000001 113.764 -168.719 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -136.19 -178.78 5.31 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 110.816 -2.902 . . . . 0.82999999999999996 106.883 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.729 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.6 mtmt -52.98 162.73 0.59 Allowed 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 123.025 1.393 . . . . 0.23999999999999999 112.694 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.4 -36.51 3.61 Favored Glycine 0 N--CA 1.423 -2.207 0 CA-C-N 112.577 -2.101 . . . . 0.37 112.514 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.1 m -74.27 141.72 77.66 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.471 -0.566 . . . . 0.14999999999999999 109.471 -175.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 3.7 Cg_exo -74.39 167.74 26.44 Favored 'Trans proline' 0 N--CA 1.424 -2.559 0 C-N-CA 121.765 1.644 . . . . 0.12 111.041 173.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.814 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.57 156.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 107.504 -1.295 . . . . 1.0900000000000001 107.504 166.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 346' ' ' GLU . 2.8 tp -126.98 145.15 50.8 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.462 -0.79 . . . . 0.13 110.233 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.701 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.27 146.7 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 106.869 -1.53 . . . . 0.089999999999999997 106.869 164.429 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.685 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.7 p90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.372 -0.823 . . . . 1.1599999999999999 111.477 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 358' ' ' LYS . 33.1 m . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 108.524 -0.917 . . . . 0.45000000000000001 108.524 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.64 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 7.9 p90 -162.33 -170.32 2.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.913 -1.039 . . . . 0.32000000000000001 110.585 -174.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.562 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.1 mm -101.71 160.98 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.078 -1.082 . . . . 0.080000000000000002 108.078 166.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.479 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 3.6 tt0 -140.95 154.62 46.16 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 118.805 0.73 . . . . 0.17000000000000001 110.898 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.712 HG22 ' HG3' ' A' ' 354' ' ' MET . 61.4 t -150.24 134.69 9.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.31 -1.314 . . . . 0.080000000000000002 109.296 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -117.51 110.42 17.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.202 -1.407 . . . . 0.37 107.202 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.63 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -58.52 -56.98 15.13 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.835 -1.172 . . . . 0.32000000000000001 107.835 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -46.27 -51.21 14.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 111.956 -2.384 . . . . 1.51 112.993 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -100.73 4.42 43.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.394 -1.73 . . . . 0.91000000000000003 110.082 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.677 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 1.7 mp0 47.42 67.01 0.88 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 112.428 -2.169 . . . . 2.2200000000000002 112.363 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.3 t60 -146.79 125.69 12.74 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.377 0.608 . . . . 0.13 110.107 -177.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.712 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -112.6 128.38 56.35 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.54 0.736 . . . . 0.059999999999999998 110.658 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.675 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.76 173.27 6.46 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.44 -1.254 . . . . 0.10000000000000001 111.869 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.688 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.0 t80 -126.93 116.67 21.16 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.33 -1.729 . . . . 0.22 106.33 165.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 24.4 m-85 -100.53 128.93 46.44 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.899 0.857 . . . . 0.17999999999999999 111.609 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.606 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.5 ttpt -148.18 137.37 22.02 Favored 'General case' 0 N--CA 1.399 -3.013 0 CA-C-N 113.761 -1.563 . . . . 0.46999999999999997 108.473 173.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.73 16.69 6.71 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 113.332 -1.758 . . . . 0.59999999999999998 108.803 178.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.9 72.06 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 112.652 -2.067 . . . . 0.23000000000000001 111.819 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.574 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.96 169.56 17.57 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.349 -1.723 . . . . 0.68000000000000005 106.349 -170.615 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.692 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -102.36 138.36 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.865 0 CA-C-O 124.252 1.977 . . . . 0.53000000000000003 111.839 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.18 -25.37 17.87 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 109.24 -3.618 . . . . 0.12 108.647 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.639 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -153.23 154.87 35.53 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.762 -1.563 . . . . 0.080000000000000002 108.654 -171.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.692 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.59 122.07 1.17 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.738 -0.665 . . . . 0.60999999999999999 109.651 -174.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.678 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.8 t -148.74 167.09 26.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.089999999999999997 112.01 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.666 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.2 p-10 -85.13 142.01 29.81 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 113.061 -1.881 . . . . 1.8799999999999999 107.69 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.677 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -142.02 -174.34 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.257 -0.883 . . . . 0.11 112.122 -175.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.709 ' O ' ' HB2' ' A' ' 444' ' ' ASN . 0.2 OUTLIER -152.46 117.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.931 . . . . 0.12 109.318 175.21 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 30.2 t -141.54 148.25 39.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.963 0.727 . . . . 0.69999999999999996 112.963 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.61 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.7 44.96 47.02 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 116.197 1.239 . . . . 0.13 116.197 162.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.573 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.9 143.76 4.2 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 118.317 1.058 . . . . 0.47999999999999998 109.977 -174.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.796 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.19 -32.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.826 1 C-N-CA 125.705 4.27 . . . . 0.23000000000000001 116.08 -170.681 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 374' ' ' THR . . . . . 0.573 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.35 -34.56 31.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.359 0.599 . . . . 0.29999999999999999 110.755 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.465 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 m -140.04 73.04 33.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 122.125 0.964 . . . . 0.29999999999999999 110.302 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.61 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.81 161.47 44.97 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 125.22 3.947 . . . . 0.16 113.869 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.723 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.52 151.97 91.71 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 113.333 -1.758 . . . . 0.12 111.05 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.521 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.9 Cg_endo -80.0 -48.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 125.277 3.984 . . . . 0.089999999999999997 113.913 -170.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.697 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.32 122.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.992 1.108 . . . . 0.089999999999999997 113.992 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.36 -125.88 1.43 Allowed Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.121 -1.4 . . . . 0.11 110.778 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.7 p -125.77 112.57 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.921 0.867 . . . . 0.89000000000000001 108.761 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.803 ' HB2' HG22 ' A' ' 463' ' ' VAL . 98.1 m-85 -114.17 163.35 15.34 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.296 -0.866 . . . . 0.16 109.994 -169.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 71.8 m-85 -146.68 136.68 23.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 121.188 -0.205 . . . . 0.68999999999999995 110.974 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.89 123.13 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 C-N-CA 119.938 -0.705 . . . . 0.14000000000000001 110.552 177.655 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -107.08 3.41 25.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.602 -0.727 . . . . 0.19 112.035 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.737 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 18.9 t-20 -165.4 148.44 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.461 -0.79 . . . . 0.40999999999999998 110.764 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 387' ' ' LYS . . . . . 0.423 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 13.5 mtpt -107.59 109.05 20.6 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.444 -0.798 . . . . 1.0900000000000001 109.714 168.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.3 mt-10 -106.41 121.21 43.8 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.44 1.114 . . . . 0.38 110.634 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -120.62 134.84 55.24 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.535 -1.211 . . . . 1.96 110.511 -174.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.58 38.72 23.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 123.636 1.684 . . . . 0.40000000000000002 107.141 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.29 169.4 11.14 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 112.1 -2.318 . . . . 0.16 111.671 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 7.6 m -127.24 105.12 8.34 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 113.417 -1.719 . . . . 0.27000000000000002 109.626 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.734 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.27 157.67 35.42 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 112.963 -1.926 . . . . 0.23999999999999999 110.302 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.1 mtpt . . . . . 0 N--CA 1.397 -3.094 0 CA-C-N 114.793 -1.094 . . . . 0.67000000000000004 108.454 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.4 mt-10 . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 122.034 0.921 . . . . 0.62 111.914 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.734 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.68 99.75 10.31 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-N 113.355 -1.748 . . . . 1.3300000000000001 108.046 176.239 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.0 Cg_endo -67.41 102.83 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.577 2.185 . . . . 0.20000000000000001 110.653 174.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.781 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.31 156.68 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.588 0 CA-C-N 114.146 -1.388 . . . . 0.29999999999999999 109.776 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -105.17 -34.67 7.85 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.529 -1.669 . . . . 1.8400000000000001 107.359 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.775 ' HB2' ' SD ' ' A' ' 450' ' ' MET . 52.4 m-85 -137.85 119.43 14.97 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.306 -1.77 . . . . 0.44 111.217 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.781 ' HB2' HG11 ' A' ' 407' ' ' VAL . 8.1 t-105 -125.2 135.58 52.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 113.841 -1.527 . . . . 0.13 110.185 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.542 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -134.94 85.18 35.59 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 114.992 -1.004 . . . . 0.40999999999999998 111.152 174.794 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 87.5 Cg_endo -72.29 141.23 35.18 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.161 2.574 . . . . 0.16 112.469 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -124.97 -15.93 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 113.828 -1.533 . . . . 0.17000000000000001 111.031 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.93 162.32 32.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.303 -0.862 . . . . 1.5900000000000001 109.393 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -95.03 13.78 23.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.355 0.502 . . . . 0.31 112.355 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 13.1 p -94.0 -26.66 16.71 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.531 -1.285 . . . . 0.44 107.531 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.67 33.25 0.77 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.108 -1.86 . . . . 0.23999999999999999 112.32 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 441' ' ' GLY . 79.8 t -103.16 148.48 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.184 0.516 . . . . 0.17000000000000001 110.963 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 169.97 -167.43 40.52 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.948 -1.024 . . . . 0.10000000000000001 111.446 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' ILE . . . . . 0.491 HG21 HD23 ' A' ' 453' ' ' LEU . 0.9 OUTLIER -101.97 140.08 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 109.141 -0.688 . . . . 0.12 109.141 174.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.542 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 32.2 p80 -146.52 160.54 41.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.956 0.884 . . . . 0.14999999999999999 111.712 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -85.72 136.9 33.16 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 113.817 -1.538 . . . . 0.41999999999999998 107.399 170.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.95 102.01 5.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 123.015 1.388 . . . . 1.48 110.999 -175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -94.82 -33.48 12.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 112.168 -2.287 . . . . 0.34999999999999998 111.484 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.462 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 21.5 p90 -66.48 -27.24 67.64 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.687 -1.142 . . . . 0.17999999999999999 109.505 175.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.525 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -121.27 81.27 37.3 Favored Pre-proline 0 CA--C 1.494 -1.202 0 CA-C-N 113.664 -1.607 . . . . 1.3300000000000001 110.351 -174.616 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -82.2 7.84 4.86 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 125.062 3.841 . . . . 0.23000000000000001 114.162 -163.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -114.58 153.35 30.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 123.462 0.476 . . . . 1.1000000000000001 110.267 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.666 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.47 126.87 2.72 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.756 1.285 . . . . 0.38 108.202 -169.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 146.55 -164.54 28.43 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 118.849 -1.643 . . . . 0.13 111.193 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -27.84 151.04 0.0 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 125.208 1.181 . . . . 0.20000000000000001 113.075 171.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 112.031 -149.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 40.4 mt -97.44 -33.87 11.23 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 110.583 -3.008 . . . . 0.17999999999999999 107.95 174.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.567 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.1 p-90 -46.2 -37.45 7.12 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.638 0.586 . . . . 0.22 111.61 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.796 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 32.3 mttt -61.5 -23.74 66.11 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.223 -0.899 . . . . 0.64000000000000001 112.923 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.5 p -113.58 -35.02 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.886 0.851 . . . . 0.25 109.879 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.525 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 3.7 mtp180 -87.2 -16.49 35.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.612 -1.176 . . . . 0.35999999999999999 112.785 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.01 41.75 39.28 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.264 1.266 . . . . 0.20999999999999999 116.264 159.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.0 m -84.21 133.83 34.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 118.233 1.016 . . . . 0.46999999999999997 108.541 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -103.96 68.14 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.45 -0.781 . . . . 0.40999999999999998 110.884 -166.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.679 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 89.46 -11.11 70.97 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.518 -1.033 . . . . 0.17999999999999999 110.518 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.6 p -90.68 137.24 32.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.211 -0.494 . . . . 0.82999999999999996 110.667 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 377' ' ' THR . 1.4 mp -92.01 120.6 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 CA-C-O 122.734 1.254 . . . . 0.14999999999999999 111.164 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.709 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.5 OUTLIER -79.42 82.44 5.56 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.317 -2.22 . . . . 1.77 112.14 -177.025 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 366' ' ' THR . 19.6 m -86.75 137.72 33.63 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-O 121.499 0.666 . . . . 0.17999999999999999 109.599 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 49.4 Cg_exo -58.67 134.12 58.68 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.562 2.174 . . . . 0.12 110.679 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.9 Cg_exo -56.43 -34.89 95.69 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 C-N-CA 123.881 3.054 . . . . 0.16 112.938 -171.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.8 m -77.21 -37.59 53.12 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.698 -1.137 . . . . 1.1699999999999999 109.778 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.678 HG11 ' HB ' ' A' ' 366' ' ' THR . 59.2 t -80.77 -27.39 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.835 -0.62 . . . . 0.17000000000000001 111.063 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.775 ' SD ' ' HB2' ' A' ' 409' ' ' TYR . 0.0 OUTLIER -63.62 -35.48 80.66 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-O 121.859 0.838 . . . . 0.46000000000000002 109.281 177.302 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -64.54 -25.03 67.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.48 -1.236 . . . . 0.81000000000000005 111.985 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 456' ' ' MET . 16.1 mm-40 -79.1 -46.96 17.0 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 113.692 -1.595 . . . . 0.38 107.64 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.531 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 28.8 tp -64.48 -67.16 0.46 Allowed 'General case' 0 N--CA 1.404 -2.772 0 CA-C-N 111.644 -2.525 . . . . 0.059999999999999998 112.55 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.673 ' HB2' ' SD ' ' A' ' 450' ' ' MET . 39.8 t80 -49.31 -28.62 5.03 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.216 1.484 . . . . 0.31 107.919 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.65 -32.43 74.57 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 112.143 -2.298 . . . . 0.13 112.058 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.647 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -87.83 -48.09 8.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.66 0.743 . . . . 0.13 111.677 172.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.562 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.3 138.39 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 123.604 1.669 . . . . 0.23000000000000001 114.239 -167.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 458' ' ' GLU . . . . . 0.423 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.6 pt-20 -136.88 -178.27 5.12 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 110.634 -2.985 . . . . 0.82999999999999996 106.504 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.737 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.0 mtmt -53.17 163.39 0.55 Allowed 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 123.129 1.442 . . . . 0.23999999999999999 112.661 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.49 4.74 Favored Glycine 0 N--CA 1.423 -2.179 0 CA-C-N 112.496 -2.138 . . . . 0.37 112.26 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 462' ' ' PRO . 8.7 m -76.65 141.61 69.21 Favored Pre-proline 0 N--CA 1.433 -1.321 0 N-CA-C 109.335 -0.617 . . . . 0.14999999999999999 109.335 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.64 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -75.26 166.34 29.08 Favored 'Trans proline' 0 N--CA 1.425 -2.525 0 C-N-CA 121.833 1.689 . . . . 0.12 110.865 173.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.71 155.79 39.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 107.449 -1.315 . . . . 1.0900000000000001 107.449 167.036 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -126.39 145.06 50.61 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.327 -0.851 . . . . 0.13 110.051 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.697 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.22 147.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 N-CA-C 107.189 -1.411 . . . . 0.089999999999999997 107.189 164.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.645 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.274 -0.869 . . . . 1.1599999999999999 111.496 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.5 m . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 107.761 -1.2 . . . . 0.45000000000000001 107.761 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' TYR . . . . . 0.631 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.0 p90 -157.11 -171.08 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.596 0.712 . . . . 0.32000000000000001 111.178 -174.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 453' ' ' LEU . 10.3 mm -103.05 161.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.055 -1.091 . . . . 0.080000000000000002 108.055 167.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.1 tt0 -141.53 155.36 45.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.493 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 354' ' ' MET . 76.2 t -150.98 137.4 12.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.701 -1.136 . . . . 0.080000000000000002 110.355 -177.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -123.48 107.34 11.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.852 -1.166 . . . . 0.37 107.852 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' LEU . . . . . 0.499 ' H ' HD22 ' A' ' 349' ' ' LEU . 2.3 mm? -68.26 -39.43 82.2 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 113.228 -1.805 . . . . 0.32000000000000001 111.24 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.4 -55.78 16.16 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.022 -2.354 . . . . 1.51 111.432 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -93.51 11.83 27.25 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.62 -1.173 . . . . 0.91000000000000003 108.654 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' GLN . . . . . 0.689 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 2.4 mm-40 35.36 73.28 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 125.537 1.773 . . . . 2.2200000000000002 113.079 177.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.0 t60 -151.15 125.59 9.48 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.333 -0.849 . . . . 0.13 109.625 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' MET . . . . . 0.73 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -113.34 127.48 56.15 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.478 0.711 . . . . 0.059999999999999998 110.358 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' TRP . . . . . 0.682 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.5 m-90 -113.14 173.68 6.27 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.659 -1.155 . . . . 0.10000000000000001 111.886 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' TYR . . . . . 0.703 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -127.12 117.44 22.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.625 -1.62 . . . . 0.22 106.625 165.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 362' ' ' VAL . 26.5 m-85 -101.37 126.33 48.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.146 0.974 . . . . 0.17999999999999999 112.362 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.8 ttpt -148.96 137.5 21.11 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 113.099 -1.864 . . . . 0.46999999999999997 108.458 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 70.52 15.98 7.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 113.334 -1.757 . . . . 0.59999999999999998 108.822 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.03 78.87 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 112.561 -2.109 . . . . 0.23000000000000001 111.551 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' LYS . . . . . 0.582 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -133.86 169.75 16.62 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.344 -1.928 . . . . 0.68000000000000005 106.255 -169.793 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 362' ' ' VAL . . . . . 0.752 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -101.03 137.5 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 CA-C-O 124.325 2.012 . . . . 0.53000000000000003 111.824 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -24.31 18.85 Favored 'General case' 0 N--CA 1.398 -3.047 0 CA-C-N 109.211 -3.632 . . . . 0.12 108.573 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 364' ' ' LEU . . . . . 0.672 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.71 154.93 35.0 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.729 -1.578 . . . . 0.080000000000000002 108.919 -172.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLU . . . . . 0.752 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.08 122.06 1.29 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.562 -175.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.668 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.7 t -148.7 167.58 25.16 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-O 122.22 1.009 . . . . 0.089999999999999997 112.3 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 6.3 p-10 -86.09 139.9 30.71 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.163 -1.835 . . . . 1.8799999999999999 107.913 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.689 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -140.8 -172.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.138 -0.937 . . . . 0.11 112.22 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.82 115.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.133 -0.939 . . . . 0.12 109.704 174.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 370' ' ' SER . . . . . 0.574 ' H ' HE22 ' A' ' 352' ' ' GLN . 30.2 t -140.54 149.67 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 0.69999999999999996 112.535 -169.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.35 44.17 52.57 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 116.854 1.502 . . . . 0.13 116.854 162.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 372' ' ' LYS . . . . . 0.508 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 1.6 pttt -47.61 146.1 3.86 Favored Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 119.153 1.477 . . . . 0.47999999999999998 110.683 -174.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' PRO . . . . . 0.794 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -34.19 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 1 C-N-CA 125.985 4.457 . . . . 0.23000000000000001 115.71 -174.127 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.1 p -77.43 -39.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.171 0.51 . . . . 0.29999999999999999 110.975 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 4.1 m -140.21 72.83 32.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 122.263 1.03 . . . . 0.29999999999999999 110.197 -177.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 376' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 31.9 Cg_exo -69.13 164.46 33.84 Favored 'Trans proline' 0 C--N 1.322 -0.84 1 C-N-CA 125.64 4.227 . . . . 0.16 114.463 -176.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 377' ' ' THR . . . . . 0.701 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -76.4 152.01 83.45 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 113.565 -1.652 . . . . 0.12 110.45 174.506 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.55 -49.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.328 -0.516 0 C-N-CA 125.093 3.862 . . . . 0.089999999999999997 113.813 -170.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 68.34 122.8 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.921 1.082 . . . . 0.089999999999999997 113.921 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.21 -122.26 1.07 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.257 -1.338 . . . . 0.11 111.426 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 381' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -128.01 112.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.86 0.838 . . . . 0.89000000000000001 108.812 177.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' PHE . . . . . 0.78 ' HB2' HG22 ' A' ' 463' ' ' VAL . 95.9 m-85 -115.79 161.21 19.07 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.42 -0.809 . . . . 0.16 109.697 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -147.78 136.31 21.68 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 121.132 -0.227 . . . . 0.68999999999999995 110.681 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' VAL . . . . . 0.639 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.6 125.31 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.855 -0.738 . . . . 0.14000000000000001 110.653 177.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -110.71 0.7 17.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.436 -0.802 . . . . 0.19 112.176 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' ASN . . . . . 0.729 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 20.1 t-20 -162.56 149.25 13.08 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.155 -0.93 . . . . 0.40999999999999998 109.639 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -113.0 119.76 39.01 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.807 0.813 . . . . 1.0900000000000001 109.934 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' GLU . . . . . 0.568 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -119.35 121.28 39.2 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.226 -1.352 . . . . 0.38 111.229 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.78 143.58 46.83 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.032 -1.44 . . . . 1.96 109.774 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.0 t70 54.1 26.12 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.835 -2.439 . . . . 0.40000000000000002 108.637 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.26 171.16 13.88 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 112.769 -2.014 . . . . 0.16 111.879 -167.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 8.9 m -129.89 102.95 6.52 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.628 -1.624 . . . . 0.27000000000000002 110.159 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' LEU . . . . . 0.735 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.42 156.89 38.58 Favored 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 112.254 -2.248 . . . . 0.23999999999999999 110.242 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 9.7 mtpt . . . . . 0 N--CA 1.396 -3.136 0 CA-C-N 114.436 -1.256 . . . . 0.67000000000000004 108.419 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 404' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.8 mt-10 . . . . . 0 CA--C 1.51 -0.576 0 CA-C-O 122.535 1.16 . . . . 0.62 111.446 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' SER . . . . . 0.735 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.44 99.23 9.71 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 112.822 -1.99 . . . . 1.3300000000000001 107.791 174.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 406' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.7 Cg_endo -68.17 102.1 0.77 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.269 1.979 . . . . 0.20000000000000001 110.362 174.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 407' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.69 162.56 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.631 0 CA-C-N 114.446 -1.252 . . . . 0.29999999999999999 109.95 -173.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -112.14 -34.99 5.77 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 113.597 -1.638 . . . . 1.8400000000000001 107.018 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' TYR . . . . . 0.49 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.5 m-85 -134.56 115.89 14.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.966 -1.925 . . . . 0.44 110.879 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' TRP . . . . . 0.748 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.9 t-105 -123.41 134.78 53.93 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.237 -1.347 . . . . 0.13 110.263 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 411' ' ' MET . . . . . 0.577 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.1 OUTLIER -135.83 86.18 27.92 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 114.808 -1.087 . . . . 0.40999999999999998 111.293 174.314 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PRO . . . . . 0.708 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 98.1 Cg_endo -71.84 140.03 34.52 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.961 2.441 . . . . 0.16 112.175 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 413' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.2 pt -123.05 -15.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 113.883 -1.508 . . . . 0.17000000000000001 110.869 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -134.86 163.55 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 1.5900000000000001 109.552 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -95.03 13.83 23.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.529 0.566 . . . . 0.31 112.529 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.6 p -93.1 -27.22 17.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.412 -1.329 . . . . 0.44 107.412 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.61 30.89 0.86 Allowed Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 112.919 -1.946 . . . . 0.23999999999999999 112.086 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 441' ' ' GLY . 70.7 t -102.08 148.88 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 120.564 -0.455 . . . . 0.17000000000000001 110.976 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 171.49 -166.47 39.51 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.118 -0.946 . . . . 0.10000000000000001 111.812 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.95 141.04 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.815 -0.809 . . . . 0.12 108.815 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' HIS . . . . . 0.554 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 33.5 p80 -150.22 165.55 32.6 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.721 0.772 . . . . 0.14999999999999999 111.215 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.72 147.98 22.59 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 113.9 -1.5 . . . . 0.41999999999999998 107.11 171.685 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 423' ' ' SER . . . . . 0.516 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 3.7 t -141.87 103.97 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.988 1.375 . . . . 1.48 110.589 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.63 -30.23 15.05 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 111.915 -2.402 . . . . 0.34999999999999998 111.13 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' TRP . . . . . 0.445 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 17.1 p90 -68.95 -27.02 65.36 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 114.52 -1.218 . . . . 0.17999999999999999 109.352 176.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 426' ' ' GLN . . . . . 0.516 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -119.44 81.18 22.76 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 113.581 -1.645 . . . . 1.3300000000000001 109.311 -176.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -82.32 8.13 4.7 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 124.95 3.767 . . . . 0.23000000000000001 113.694 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -114.08 147.64 38.41 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.925 0.765 . . . . 1.1000000000000001 109.572 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' TYR . . . . . 0.546 ' HA ' HG12 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -158.84 128.43 5.65 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.993 1.317 . . . . 0.38 107.67 -172.16 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.33 -165.16 28.67 Favored Glycine 0 N--CA 1.431 -1.68 0 C-N-CA 118.884 -1.627 . . . . 0.13 111.196 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 431' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.36 154.02 0.0 OUTLIER Glycine 0 C--N 1.336 0.58 0 O-C-N 124.879 0.988 . . . . 0.20000000000000001 113.013 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 432' ' ' ASP . . . . . 0.404 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.0 m-20 -56.47 101.32 0.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 123.612 1.673 . . . . 0.33000000000000002 112.143 -147.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.8 mt -97.8 -31.94 11.97 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 110.654 -2.975 . . . . 0.17999999999999999 108.178 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 434' ' ' TRP . . . . . 0.573 ' HA ' HG23 ' A' ' 369' ' ' VAL . 9.0 p-90 -44.78 -40.23 5.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.674 0.609 . . . . 0.22 111.737 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 435' ' ' LYS . . . . . 0.794 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 37.0 mttt -61.14 -23.68 65.71 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 113.009 0.744 . . . . 0.64000000000000001 113.009 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.2 p -113.57 -35.92 5.08 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.455 -0.793 . . . . 0.25 110.208 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 437' ' ' ARG . . . . . 0.492 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.4 mtp85 -88.91 -15.69 33.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.858 -1.064 . . . . 0.35999999999999999 113.204 -168.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 438' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 76.46 41.45 25.17 Favored Glycine 0 C--N 1.31 -0.914 0 N-CA-C 116.59 1.396 . . . . 0.20999999999999999 116.59 158.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 21.6 m -83.51 141.8 31.37 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 118.136 0.968 . . . . 0.46999999999999997 108.752 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -109.31 73.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.726 -0.609 . . . . 0.40999999999999998 110.836 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' GLY . . . . . 0.664 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 82.8 -8.54 62.35 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.914 -0.874 . . . . 0.17999999999999999 110.914 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' CYS . . . . . 0.554 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -96.06 131.96 41.92 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.322 0.582 . . . . 0.82999999999999996 110.526 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 443' ' ' ILE . . . . . 0.701 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -88.77 117.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.283 -0.871 . . . . 0.14999999999999999 111.109 -174.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 2.8 t30 -78.44 82.54 4.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.492 -1.685 . . . . 1.77 111.572 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' THR . . . . . 0.593 HG23 HG21 ' A' ' 366' ' ' THR . 27.7 m -87.78 140.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.508 0.67 . . . . 0.17999999999999999 110.048 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.4 Cg_exo -57.37 136.48 76.37 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.815 2.343 . . . . 0.12 111.714 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 447' ' ' PRO . . . . . 0.812 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 52.3 Cg_exo -56.03 -32.53 86.58 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.296 3.331 . . . . 0.16 112.888 -173.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.1 p -81.72 -38.22 26.09 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.717 -1.129 . . . . 1.1699999999999999 110.115 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' VAL . . . . . 0.668 HG11 ' HB ' ' A' ' 366' ' ' THR . 88.2 t -80.29 -29.88 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.326 0.584 . . . . 0.17000000000000001 111.407 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' MET . . . . . 0.683 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.0 tpt -66.65 -19.62 65.81 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.842 0.83 . . . . 0.46000000000000002 110.115 177.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.94 -23.6 41.59 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.511 -1.222 . . . . 0.81000000000000005 111.124 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 456' ' ' MET . 6.8 mm-40 -78.31 -47.36 17.94 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 113.192 -1.822 . . . . 0.38 107.103 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 453' ' ' LEU . . . . . 0.59 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.5 tp -63.92 -67.36 0.44 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.642 -2.526 . . . . 0.059999999999999998 112.292 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 454' ' ' PHE . . . . . 0.434 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 38.1 t80 -49.95 -26.93 4.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 123.193 1.473 . . . . 0.31 108.303 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 455' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.86 -31.81 66.95 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 112.426 -2.17 . . . . 0.13 112.291 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 456' ' ' MET . . . . . 0.678 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -87.5 -48.0 8.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.637 0.732 . . . . 0.13 111.586 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 457' ' ' VAL . . . . . 0.546 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -102.84 139.05 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 123.407 1.575 . . . . 0.23000000000000001 114.06 -168.108 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.46 -178.62 5.25 Favored 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 110.961 -2.836 . . . . 0.82999999999999996 107.108 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' LYS . . . . . 0.729 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -50.44 160.8 0.36 Allowed 'General case' 0 N--CA 1.411 -2.385 0 CA-C-O 123.043 1.401 . . . . 0.23999999999999999 113.109 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.26 -35.93 3.78 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 112.565 -2.107 . . . . 0.37 112.354 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 462' ' ' PRO . 3.9 m -74.44 141.12 76.31 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 109.452 -0.573 . . . . 0.14999999999999999 109.452 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 5.1 Cg_exo -75.18 166.26 29.36 Favored 'Trans proline' 0 N--CA 1.422 -2.682 0 C-N-CA 121.98 1.787 . . . . 0.12 111.07 174.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' VAL . . . . . 0.78 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -133.65 154.76 39.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 107.455 -1.313 . . . . 1.0900000000000001 107.455 166.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.0 tp -124.36 144.82 49.81 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.317 -0.856 . . . . 0.13 110.087 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' VAL . . . . . 0.686 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.17 146.67 21.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.843 -1.54 . . . . 0.089999999999999997 106.843 165.1 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 466' ' ' PHE . . . . . 0.704 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.4 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.79 -0.624 . . . . 1.1599999999999999 111.486 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLY . . . . . 0.726 ' N ' ' HH ' ' A' ' 357' ' ' TYR . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.094 -0.802 . . . . 3.9399999999999999 111.094 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.652 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.6 t-160 -174.61 94.4 0.08 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.913 -0.773 . . . . 1.8500000000000001 108.913 -172.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.652 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 33.7 mtm 77.53 179.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.776 1.298 . . . . 1.03 110.696 -171.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -118.33 -7.74 10.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.153 -0.93 . . . . 1.1000000000000001 111.231 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.66 166.16 1.0 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 123.04 1.4 . . . . 0.97999999999999998 113.629 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.647 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.4 m -94.15 123.16 37.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.749 -2.023 . . . . 0.45000000000000001 107.396 168.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.672 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 17.8 p90 -163.33 -170.84 2.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.76 0.791 . . . . 0.32000000000000001 111.04 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.553 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -103.85 156.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.603 -1.18 . . . . 0.080000000000000002 107.938 166.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.538 ' HG3' HD23 ' A' ' 464' ' ' LEU . 4.7 tt0 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.171 0.896 . . . . 0.17000000000000001 110.595 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.678 HG22 ' HG3' ' A' ' 354' ' ' MET . 66.8 t -149.27 137.27 14.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.614 -1.176 . . . . 0.080000000000000002 109.098 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 466' ' ' PHE . 7.8 t70 -120.42 115.02 22.68 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.077 -1.083 . . . . 0.37 108.077 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.523 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -66.2 -48.37 70.85 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 123.099 1.428 . . . . 0.32000000000000001 110.195 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.32 -52.01 49.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 112.623 -2.081 . . . . 1.51 112.901 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -102.71 9.74 38.99 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.191 -1.368 . . . . 0.91000000000000003 108.664 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.728 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 83.7 mm-40 36.09 72.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 125.154 1.534 . . . . 2.2200000000000002 111.8 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.6 t60 -150.11 126.41 10.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.641 -1.163 . . . . 0.13 109.469 -176.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.678 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -112.99 128.34 56.47 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.659 0.783 . . . . 0.059999999999999998 110.618 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.68 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.75 173.61 6.34 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.513 -1.221 . . . . 0.10000000000000001 111.889 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.615 ' CE2' ' HB2' ' A' ' 456' ' ' MET . 1.2 t80 -125.1 115.92 21.26 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.336 -1.727 . . . . 0.22 106.336 165.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.726 ' HH ' ' N ' ' A' ' 338' ' ' GLY . 27.9 m-85 -101.24 127.29 47.89 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.153 0.978 . . . . 0.17999999999999999 112.021 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.647 ' HA ' HG23 ' A' ' 343' ' ' THR . 2.8 ttpt -148.26 137.19 21.81 Favored 'General case' 0 N--CA 1.399 -3.023 0 CA-C-N 113.376 -1.738 . . . . 0.46999999999999997 108.628 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.9 OUTLIER 71.29 13.84 6.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 113.159 -1.837 . . . . 0.59999999999999998 108.992 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.89 74.97 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 112.783 -2.008 . . . . 0.23000000000000001 111.771 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.573 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.09 168.11 19.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 105.991 -1.855 . . . . 0.68000000000000005 105.991 -171.037 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.851 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.6 m -101.05 139.02 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-O 124.164 1.935 . . . . 0.53000000000000003 111.868 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.614 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.67 -25.01 18.45 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 109.675 -3.421 . . . . 0.12 108.586 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.659 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.42 155.2 35.9 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 113.711 -1.586 . . . . 0.080000000000000002 109.222 -171.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.851 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.79 122.63 1.41 Allowed 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.736 -0.665 . . . . 0.60999999999999999 109.498 -176.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.69 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.7 t -147.11 166.9 25.5 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.631 0.729 . . . . 0.089999999999999997 110.823 173.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.474 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 48.1 m-20 -84.23 148.76 26.54 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.984 -1.488 . . . . 1.8799999999999999 106.984 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.728 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.4 pp -144.37 -178.32 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.841 0.713 . . . . 0.11 111.535 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.572 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -149.85 118.5 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.449 -0.796 . . . . 0.12 109.56 173.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 443' ' ' ILE . 34.3 p -141.32 142.55 33.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.835 -1.075 . . . . 0.69999999999999996 111.699 -165.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.04 44.62 29.25 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 116.678 1.431 . . . . 0.13 116.678 162.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.641 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.65 144.56 3.47 Favored Pre-proline 0 C--O 1.221 -0.439 0 CA-C-N 118.639 1.219 . . . . 0.47999999999999998 110.187 -174.725 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.808 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.12 -28.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.553 1 C-N-CA 126.056 4.504 . . . . 0.23000000000000001 116.215 -172.518 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.641 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -85.45 -32.13 22.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.265 0.555 . . . . 0.29999999999999999 110.813 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.448 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 11.8 m -140.91 72.9 28.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 122.14 0.971 . . . . 0.29999999999999999 110.155 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.739 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.3 Cg_exo -70.85 161.28 46.63 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 125.269 3.979 . . . . 0.16 114.39 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.691 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.64 151.73 89.27 Favored Pre-proline 0 N--CA 1.435 -1.219 0 CA-C-N 113.375 -1.738 . . . . 0.12 110.835 175.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.502 ' CD ' HG22 ' A' ' 377' ' ' THR . 2.0 Cg_endo -81.04 -51.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 125.144 3.896 . . . . 0.089999999999999997 113.886 -171.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.741 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.35 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.301 0.852 . . . . 0.089999999999999997 113.301 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.89 -124.97 1.29 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 114.302 -1.317 . . . . 0.11 111.417 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 381' ' ' VAL . 13.0 p -126.04 108.17 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 122.093 0.949 . . . . 0.89000000000000001 109.222 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.744 ' HB2' HG22 ' A' ' 463' ' ' VAL . 91.8 m-85 -113.68 155.87 24.76 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.128 -0.942 . . . . 0.16 109.633 -170.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.798 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 10.6 m-85 -147.06 139.83 25.01 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 117.872 0.306 . . . . 0.68999999999999995 110.447 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.648 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -74.66 124.3 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 119.88 -0.728 . . . . 0.14000000000000001 110.895 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -107.5 1.96 23.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.314 -0.857 . . . . 0.19 111.925 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.759 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 16.9 t-20 -164.63 150.26 10.19 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.189 -0.914 . . . . 0.40999999999999998 110.276 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 458' ' ' GLU . 15.0 mtpt -111.28 119.41 38.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.783 0.802 . . . . 1.0900000000000001 110.138 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.573 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -118.54 122.1 41.84 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.589 -1.187 . . . . 0.38 111.076 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -120.43 136.96 54.57 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.416 -1.265 . . . . 1.96 109.95 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.6 t70 52.21 38.82 25.58 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 123.584 1.659 . . . . 0.40000000000000002 107.292 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.573 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -91.74 170.44 9.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 112.329 -2.214 . . . . 0.16 111.907 -175.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 15.5 m -129.86 104.54 7.44 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.691 -1.595 . . . . 0.27000000000000002 109.545 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.72 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.02 155.0 40.8 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.147 -1.842 . . . . 0.23999999999999999 109.713 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 10.3 mtpt -155.68 174.27 15.53 Favored 'General case' 0 N--CA 1.4 -2.931 0 CA-C-N 114.704 -1.134 . . . . 0.67000000000000004 108.415 -175.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 170.0 164.89 26.49 Favored Glycine 0 CA--C 1.475 -2.46 0 C-N-CA 117.875 -2.107 . . . . 0.81000000000000005 113.285 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.86 118.4 32.43 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 122.493 1.139 . . . . 0.79000000000000004 108.509 173.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.518 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.5 m-80 -51.85 179.05 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 111.868 -2.423 . . . . 1.1200000000000001 111.967 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -54.61 -24.35 20.95 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.436 0.636 . . . . 1.6499999999999999 110.397 167.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 401' ' ' THR . 1.0 OUTLIER -88.0 -25.65 23.02 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.486 -0.779 . . . . 2.0 109.975 -174.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.85 32.95 6.27 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.343 -1.103 . . . . 0.66000000000000003 110.343 -170.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.518 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 57.8 p -114.79 126.81 27.45 Favored Pre-proline 0 N--CA 1.413 -2.278 0 N-CA-C 107.588 -1.264 . . . . 0.68000000000000005 107.588 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.922 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 13.1 Cg_exo -72.21 141.35 35.68 Favored 'Trans proline' 0 N--CA 1.421 -2.755 0 C-N-CA 122.498 2.132 . . . . 0.81000000000000005 111.386 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 17.5 p90 -134.94 -177.95 4.87 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.491 -2.141 . . . . 0.38 107.958 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.7 mt-10 -141.92 163.1 33.81 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.604 1.192 . . . . 0.62 112.224 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.72 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -141.59 98.85 6.4 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.443 -2.162 . . . . 1.3300000000000001 107.562 172.16 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.2 Cg_endo -67.72 103.38 0.84 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.496 2.131 . . . . 0.20000000000000001 110.613 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.55 161.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-N 114.332 -1.304 . . . . 0.29999999999999999 110.242 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -113.4 -32.23 6.31 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.5 -1.682 . . . . 1.8400000000000001 107.501 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.47 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 67.1 m-85 -136.56 116.02 12.78 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.828 -1.987 . . . . 0.44 110.713 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.757 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -125.01 135.21 52.56 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.656 -1.156 . . . . 0.13 110.379 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.483 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -136.07 86.3 26.26 Favored Pre-proline 0 C--N 1.3 -1.583 0 CA-C-N 114.941 -1.027 . . . . 0.40999999999999998 111.205 174.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.697 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.9 Cg_endo -71.44 139.93 35.58 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 122.993 2.462 . . . . 0.16 112.427 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -124.03 -15.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.751 -1.568 . . . . 0.17000000000000001 110.941 -174.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -133.72 165.28 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.171 -0.922 . . . . 1.5900000000000001 109.582 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -98.47 15.22 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.215 0.45 . . . . 0.31 112.215 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.8 p -95.04 -26.81 15.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.601 -1.259 . . . . 0.44 107.601 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.75 31.72 1.01 Allowed Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 112.927 -1.942 . . . . 0.23999999999999999 111.971 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 441' ' ' GLY . 81.6 t -101.6 148.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.204 0.525 . . . . 0.17000000000000001 110.775 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 171.57 -167.49 40.56 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.735 -1.12 . . . . 0.10000000000000001 111.191 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.74 139.53 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.875 -0.787 . . . . 0.12 108.875 175.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.626 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 30.9 p80 -149.2 163.31 37.99 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.823 0.821 . . . . 0.14999999999999999 111.792 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.782 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.92 138.27 31.72 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.091 -1.413 . . . . 0.41999999999999998 107.453 172.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.8 OUTLIER -131.36 101.07 5.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.48 1.133 . . . . 1.48 109.057 -174.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -95.18 -35.26 11.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.953 -1.931 . . . . 0.34999999999999998 111.562 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.438 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 21.1 p90 -63.53 -26.96 68.94 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.398 -1.274 . . . . 0.17999999999999999 109.055 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.809 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.81 83.42 36.39 Favored Pre-proline 0 CA--C 1.498 -1.035 0 CA-C-N 113.404 -1.726 . . . . 1.3300000000000001 109.966 -172.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -80.93 5.53 6.15 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 124.901 3.734 . . . . 0.23000000000000001 114.649 -160.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.2 156.35 23.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.975 0.417 . . . . 1.1000000000000001 111.021 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.474 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.83 125.15 2.31 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.653 -1.158 . . . . 0.38 109.312 -171.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.94 -166.3 28.87 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 119.659 -1.258 . . . . 0.13 111.769 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.641 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.02 155.67 0.0 OUTLIER Glycine 0 C--N 1.339 0.745 0 O-C-N 125.21 1.182 . . . . 0.20000000000000001 112.989 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.415 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.7 m-20 -56.36 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 123.97 1.843 . . . . 0.33000000000000002 112.134 -147.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 51.3 mt -96.49 -32.62 12.2 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 110.342 -3.117 . . . . 0.17999999999999999 108.055 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.572 ' HA ' HG23 ' A' ' 369' ' ' VAL . 4.4 p-90 -46.24 -37.27 7.0 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 124.002 0.814 . . . . 0.22 111.15 -174.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.808 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 40.2 mttt -59.28 -27.19 65.61 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.695 -1.138 . . . . 0.64000000000000001 112.762 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -112.3 -36.41 5.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.604 -0.726 . . . . 0.25 109.908 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.567 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.7 mtp85 -84.53 -15.46 45.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.542 -1.208 . . . . 0.35999999999999999 113.038 -167.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.03 41.58 31.92 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 116.769 1.468 . . . . 0.20999999999999999 116.769 159.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.6 m -85.74 131.73 34.27 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 118.272 1.036 . . . . 0.46999999999999997 109.228 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.458 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 80.5 m80 -97.05 67.43 2.21 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.67 -0.643 . . . . 0.40999999999999998 111.358 -169.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.46 -13.6 59.93 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.213 -1.155 . . . . 0.17999999999999999 110.213 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.626 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.0 p -86.15 140.92 29.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.708 -0.746 . . . . 0.82999999999999996 110.164 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.691 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -94.98 115.33 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.549 0.69 . . . . 0.14999999999999999 111.087 -176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.809 ' OD1' ' HB3' ' A' ' 426' ' ' GLN . 0.1 OUTLIER -76.66 89.41 3.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.606 -1.179 . . . . 1.77 111.021 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.564 HG23 HG21 ' A' ' 366' ' ' THR . 32.0 m -91.22 140.62 25.79 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.47 0.652 . . . . 0.17999999999999999 109.335 174.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 49.7 Cg_exo -57.84 136.27 74.26 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.801 2.334 . . . . 0.12 111.836 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.782 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.6 Cg_exo -55.72 -32.49 84.22 Favored 'Trans proline' 0 CA--C 1.501 -1.133 0 C-N-CA 124.244 3.296 . . . . 0.16 113.069 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.5 p -82.02 -38.7 24.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.63 -1.168 . . . . 1.1699999999999999 110.348 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.69 HG11 ' HB ' ' A' ' 366' ' ' THR . 59.0 t -80.64 -29.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.374 0.607 . . . . 0.17000000000000001 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.689 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.3 tpt -67.92 -19.18 64.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.945 0.878 . . . . 0.46000000000000002 109.969 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.04 -22.54 42.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.442 -1.254 . . . . 0.81000000000000005 110.777 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.98 -46.85 14.47 Favored 'General case' 0 CA--C 1.476 -1.89 0 CA-C-N 112.991 -1.913 . . . . 0.38 107.438 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.607 HD23 ' SD ' ' A' ' 450' ' ' MET . 27.2 tp -64.76 -67.19 0.46 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 111.872 -2.422 . . . . 0.059999999999999998 112.486 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.43 ' HB2' ' HE3' ' A' ' 450' ' ' MET . 19.3 t80 -50.47 -26.18 4.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.0 1.381 . . . . 0.31 108.066 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.31 -30.24 67.37 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 112.517 -2.129 . . . . 0.13 112.296 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.659 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.05 -48.42 7.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.775 0.797 . . . . 0.13 111.444 171.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.553 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.8 OUTLIER -103.38 138.01 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 123.415 1.578 . . . . 0.23000000000000001 114.103 -167.043 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 387' ' ' LYS . 6.8 pt-20 -137.22 -178.18 5.09 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 110.754 -2.93 . . . . 0.82999999999999996 106.778 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.759 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.0 mtmt -51.48 161.28 0.49 Allowed 'General case' 0 N--CA 1.412 -2.354 0 CA-C-O 122.894 1.331 . . . . 0.23999999999999999 112.534 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.55 -28.95 8.29 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-N 112.646 -2.07 . . . . 0.37 112.185 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 462' ' ' PRO . 10.0 m -84.96 140.9 37.39 Favored Pre-proline 0 N--CA 1.433 -1.292 0 N-CA-C 108.534 -0.913 . . . . 0.14999999999999999 108.534 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.93 173.69 13.65 Favored 'Trans proline' 0 N--CA 1.416 -3.084 0 C-N-CA 121.097 1.198 . . . . 0.12 111.738 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.31 159.54 35.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.642 -1.244 . . . . 1.0900000000000001 107.642 167.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.538 HD23 ' HG3' ' A' ' 346' ' ' GLU . 2.8 tp -130.27 146.11 51.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 115.159 -0.928 . . . . 0.13 110.046 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.741 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 146.82 20.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.292 -1.373 . . . . 0.089999999999999997 107.292 165.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.481 ' CE2' ' HG2' ' A' ' 346' ' ' GLU . 19.9 p90 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.533 -0.746 . . . . 1.1599999999999999 111.464 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 111.983 -0.447 . . . . 3.9399999999999999 111.983 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.7 t-80 -82.75 96.14 8.09 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.646 -0.501 . . . . 1.8500000000000001 109.646 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 11.9 mtp 71.71 -178.29 0.21 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.877 1.361 . . . . 1.03 111.051 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.63 -6.81 1.31 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.168 0.433 . . . . 1.1000000000000001 112.168 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.94 169.08 0.55 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.859 1.314 . . . . 0.97999999999999998 113.062 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 358' ' ' LYS . 97.2 m -91.99 123.7 35.55 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 113.274 -1.785 . . . . 0.45000000000000001 108.539 167.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.633 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.5 p90 -162.44 -170.32 2.4 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.461 -1.245 . . . . 0.32000000000000001 110.489 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.9 mm -102.19 157.32 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.071 -1.085 . . . . 0.080000000000000002 108.071 165.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.523 ' HG3' HD23 ' A' ' 464' ' ' LEU . 4.6 tt0 -139.06 154.39 48.19 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 118.617 0.644 . . . . 0.17000000000000001 110.543 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.655 HG22 ' HG3' ' A' ' 354' ' ' MET . 53.5 t -149.98 136.38 12.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.035 -0.984 . . . . 0.080000000000000002 109.988 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -117.19 116.31 27.03 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.703 -1.135 . . . . 0.37 108.24 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -69.02 -49.03 61.29 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.53 1.157 . . . . 0.32000000000000001 110.452 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.69 -54.82 36.78 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.835 -1.984 . . . . 1.51 112.213 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -96.62 10.08 39.61 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.559 -1.201 . . . . 0.91000000000000003 108.601 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.79 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.1 mm-40 38.16 71.85 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 125.315 1.634 . . . . 2.2200000000000002 111.98 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.442 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -152.68 124.91 8.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.548 -0.751 . . . . 0.13 109.634 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.655 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.7 ttp -111.87 128.61 56.18 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.667 -0.697 . . . . 0.059999999999999998 110.3 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.682 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.25 173.05 6.55 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 114.595 -1.184 . . . . 0.10000000000000001 111.899 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.559 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.3 OUTLIER -125.38 112.78 16.71 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.621 -1.992 . . . . 0.22 105.621 163.449 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 25.6 m-85 -94.97 125.09 39.4 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.499 -0.88 . . . . 0.17999999999999999 110.963 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.565 ' HA ' HG23 ' A' ' 343' ' ' THR . 37.3 ttmt -134.42 137.38 43.98 Favored 'General case' 0 N--CA 1.387 -3.583 0 CA-C-N 114.332 -1.304 . . . . 0.46999999999999997 109.68 173.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.32 12.22 7.05 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 112.941 -1.936 . . . . 0.59999999999999998 109.092 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 88.61 14.28 61.73 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 112.79 -2.005 . . . . 0.23000000000000001 112.301 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -128.36 172.65 10.89 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.383 -2.081 . . . . 0.68000000000000005 105.383 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.805 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.5 m -104.86 136.01 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 CA-C-O 124.318 2.009 . . . . 0.53000000000000003 112.316 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.5 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -89.49 -25.13 21.6 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.408 -3.542 . . . . 0.12 108.355 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.614 HD13 ' CE ' ' A' ' 456' ' ' MET . 2.7 tp -154.71 154.18 32.48 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.051 -1.431 . . . . 0.080000000000000002 108.927 -172.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.805 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.22 121.51 1.42 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 123.514 0.509 . . . . 0.60999999999999999 109.913 -175.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.636 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.3 t -148.62 167.41 25.52 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 122.225 1.012 . . . . 0.089999999999999997 112.12 175.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.2 p-10 -84.73 141.71 30.35 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 113.238 -1.801 . . . . 1.8799999999999999 107.893 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -142.32 -171.91 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 0.11 112.091 -176.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.79 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -158.31 114.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.035 -0.984 . . . . 0.12 109.283 177.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 15.0 t -141.93 145.46 34.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.908 -1.042 . . . . 0.69999999999999996 112.802 -167.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.696 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.11 44.95 33.67 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 116.747 1.459 . . . . 0.13 116.747 162.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.618 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.75 143.42 6.04 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 118.601 1.2 . . . . 0.47999999999999998 110.456 -174.689 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.822 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.13 -32.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.749 4.299 . . . . 0.23000000000000001 116.089 -171.29 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.618 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 2.0 p -80.23 -35.36 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.36 0.6 . . . . 0.29999999999999999 110.816 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.481 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.1 m -139.77 72.2 35.68 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 122.291 1.043 . . . . 0.29999999999999999 109.688 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.5 Cg_exo -70.21 162.92 40.52 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 125.253 3.969 . . . . 0.16 114.007 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.737 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.82 149.5 83.14 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 113.625 -1.625 . . . . 0.12 110.001 174.637 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.516 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.5 Cg_endo -76.89 -49.0 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 125.108 3.872 . . . . 0.089999999999999997 113.283 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.695 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.69 121.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.965 1.098 . . . . 0.089999999999999997 113.965 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.45 -126.31 1.51 Allowed Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 113.995 -1.457 . . . . 0.11 110.613 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.5 p -126.18 108.98 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.935 0.874 . . . . 0.89000000000000001 108.96 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.632 ' HB3' ' HB ' ' A' ' 413' ' ' ILE . 53.0 m-85 -113.14 170.1 8.46 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.381 -0.827 . . . . 0.16 109.16 -173.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.706 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 79.0 m-85 -150.8 139.81 21.02 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.239 -0.282 . . . . 0.68999999999999995 110.239 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.68 121.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.691 -0.804 . . . . 0.14000000000000001 110.328 176.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 385' ' ' TRP . . . . . 0.44 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 46.6 p-90 -109.66 3.0 20.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.492 -0.777 . . . . 0.19 112.422 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.709 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 12.5 t-20 -161.13 144.72 13.07 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.579 -1.267 . . . . 0.40999999999999998 107.579 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 387' ' ' LYS . 0.3 OUTLIER -118.56 109.85 16.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.324 1.059 . . . . 1.0900000000000001 108.506 -177.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -116.73 130.6 56.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.41 -1.268 . . . . 0.38 110.829 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.79 135.12 48.06 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 113.738 -1.574 . . . . 1.96 109.601 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 23.2 t70 52.95 40.53 31.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 123.298 1.523 . . . . 0.40000000000000002 107.357 -173.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.548 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.19 170.42 9.41 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 112.223 -2.262 . . . . 0.16 111.807 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 5.2 m -127.84 105.53 8.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.942 -1.481 . . . . 0.27000000000000002 110.157 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.74 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.9 mp -74.41 158.35 34.04 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.061 -1.881 . . . . 0.23999999999999999 110.767 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.4 mtpt -148.5 -175.44 4.92 Favored 'General case' 0 N--CA 1.396 -3.17 0 CA-C-N 114.72 -1.127 . . . . 0.67000000000000004 108.818 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.72 -147.4 7.51 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 117.331 -2.366 . . . . 0.81000000000000005 114.67 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.47 117.94 10.87 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 113.541 -1.329 . . . . 0.79000000000000004 108.658 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.6 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.7 m-80 -54.31 -179.45 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 112.271 -2.241 . . . . 1.1200000000000001 113.221 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 374' ' ' THR . 0.2 OUTLIER -53.23 -22.51 6.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.169 0.509 . . . . 1.6499999999999999 110.853 167.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.61 -24.34 18.72 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 116.026 -0.534 . . . . 2.0 111.545 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.07 33.86 6.14 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 119.751 -1.214 . . . . 0.66000000000000003 110.066 -168.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 55.0 p -116.19 126.99 27.11 Favored Pre-proline 0 N--CA 1.413 -2.275 0 N-CA-C 106.997 -1.482 . . . . 0.68000000000000005 106.997 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 20.2 Cg_exo -67.69 151.41 79.09 Favored 'Trans proline' 0 C--N 1.284 -2.866 0 C-N-CA 122.102 1.868 . . . . 0.81000000000000005 111.366 -175.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 19.1 p90 -140.11 -174.33 3.9 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 112.786 -2.006 . . . . 0.38 107.103 -175.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.0 mt-10 -142.02 160.74 39.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.167 0.984 . . . . 0.62 112.028 176.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.74 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.95 99.97 9.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 113.268 -1.787 . . . . 1.3300000000000001 107.75 176.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 68.3 Cg_endo -68.02 102.31 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.741 2.294 . . . . 0.20000000000000001 110.493 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.739 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.36 160.77 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-N 114.483 -1.235 . . . . 0.29999999999999999 110.563 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -113.3 -31.48 6.58 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.33 -1.759 . . . . 1.8400000000000001 107.564 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 68.2 m-85 -137.18 116.85 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.143 -1.844 . . . . 0.44 110.898 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.739 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.7 t-105 -125.27 134.04 52.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.813 -1.085 . . . . 0.13 111.084 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.501 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.5 mtp -134.57 86.68 33.82 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 114.628 -1.169 . . . . 0.40999999999999998 111.334 173.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 89.7 Cg_endo -72.96 139.08 29.51 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.846 2.364 . . . . 0.16 111.445 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -125.7 -12.85 4.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 0.17000000000000001 111.055 -172.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -133.95 168.85 18.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.845 . . . . 1.5900000000000001 109.448 173.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.5 14.78 28.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.45 0.907 . . . . 0.31 113.45 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.445 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 37.9 p -99.73 -27.69 13.53 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.916 -1.142 . . . . 0.44 107.916 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 134.73 29.72 0.41 Allowed Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 113.814 -1.539 . . . . 0.23999999999999999 112.711 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 441' ' ' GLY . 60.3 t -102.45 146.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.513 0.673 . . . . 0.17000000000000001 111.583 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.19 37.86 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.743 -1.117 . . . . 0.10000000000000001 111.546 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.458 HG12 ' SD ' ' A' ' 354' ' ' MET . 0.9 OUTLIER -104.82 140.93 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.613 -0.884 . . . . 0.12 108.613 176.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.548 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 31.8 p80 -150.78 166.41 30.54 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.672 0.749 . . . . 0.14999999999999999 111.288 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.786 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.44 136.19 33.29 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.193 -1.367 . . . . 0.41999999999999998 107.482 171.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 6.2 t -130.86 102.72 6.19 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 122.879 1.324 . . . . 1.48 109.435 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.14 -30.57 14.56 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.387 -2.188 . . . . 0.34999999999999998 110.964 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.455 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 20.6 p90 -68.66 -27.36 65.92 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.436 -1.256 . . . . 0.17999999999999999 109.35 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.604 ' HB3' HD21 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.69 80.16 31.59 Favored Pre-proline 0 CA--C 1.496 -1.114 0 CA-C-N 113.788 -1.551 . . . . 1.3300000000000001 109.615 -176.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -83.71 8.65 4.5 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 C-N-CA 125.248 3.965 . . . . 0.23000000000000001 113.991 -163.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -114.22 148.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.207 -0.664 . . . . 1.1000000000000001 109.207 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.575 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -159.47 131.38 6.37 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.841 1.338 . . . . 0.38 107.497 -171.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 146.56 -166.76 28.18 Favored Glycine 0 C--N 1.296 -1.684 0 C-N-CA 119.19 -1.481 . . . . 0.13 111.036 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.581 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 152.11 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 O-C-N 125.201 1.177 . . . . 0.20000000000000001 112.834 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.77 101.13 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 123.864 1.792 . . . . 0.33000000000000002 111.766 -145.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.8 mt -96.62 -31.57 12.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 110.524 -3.034 . . . . 0.17999999999999999 108.213 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.59 ' HA ' HG23 ' A' ' 369' ' ' VAL . 7.3 p-90 -46.34 -38.48 8.83 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.894 0.746 . . . . 0.22 111.425 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.822 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.5 mttt -62.01 -24.85 67.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.115 -0.948 . . . . 0.64000000000000001 112.819 -175.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.4 p -112.53 -37.45 4.93 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.497 -0.774 . . . . 0.25 110.074 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.506 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.6 mtp85 -82.44 -18.85 40.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.35999999999999999 112.016 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.546 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.02 42.45 24.65 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.709 -1.234 . . . . 0.20999999999999999 115.746 164.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.7 m -85.26 131.54 34.4 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 118.404 1.102 . . . . 0.46999999999999997 108.905 174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.443 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 63.1 m80 -98.83 68.64 1.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.501 -0.749 . . . . 0.40999999999999998 110.609 -169.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.683 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 86.32 -7.76 77.21 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.833 -0.907 . . . . 0.17999999999999999 110.833 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 13.8 p -94.16 128.56 40.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.657 0.742 . . . . 0.82999999999999996 110.789 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.737 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -88.47 112.94 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.821 -1.081 . . . . 0.14999999999999999 110.556 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.604 HD21 ' HB3' ' A' ' 426' ' ' GLN . 2.8 m-20 -78.83 88.84 4.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.851 -1.068 . . . . 1.77 111.263 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.61 HG23 HG21 ' A' ' 366' ' ' THR . 28.5 m -86.69 136.58 34.55 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 108.988 -0.745 . . . . 0.17999999999999999 108.988 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -54.21 135.41 64.65 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.583 2.188 . . . . 0.12 111.083 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.786 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 29.1 Cg_exo -54.6 -31.66 71.27 Favored 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 124.063 3.175 . . . . 0.16 112.816 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.7 -39.2 24.64 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.4 -1.273 . . . . 1.1699999999999999 110.338 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.636 HG11 ' HB ' ' A' ' 366' ' ' THR . 64.2 t -79.26 -30.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.464 0.65 . . . . 0.17000000000000001 111.355 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.7 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 8.1 tpt -67.31 -19.62 65.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.939 0.876 . . . . 0.46000000000000002 110.103 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.34 -22.98 43.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.413 -1.267 . . . . 0.81000000000000005 110.572 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.693 ' O ' ' HG2' ' A' ' 456' ' ' MET . 10.8 mm-40 -80.28 -47.86 13.91 Favored 'General case' 0 CA--C 1.474 -1.965 0 CA-C-N 112.803 -1.999 . . . . 0.38 107.293 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.565 HD23 ' SD ' ' A' ' 450' ' ' MET . 23.6 tp -64.68 -67.45 0.43 Allowed 'General case' 0 N--CA 1.401 -2.885 0 CA-C-N 111.85 -2.432 . . . . 0.059999999999999998 112.631 176.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.501 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 27.8 t80 -51.11 -26.57 6.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.36 1.552 . . . . 0.31 107.989 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.429 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.88 -31.37 72.72 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.04 -2.346 . . . . 0.13 111.948 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.693 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.42 -49.21 6.83 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 121.748 0.785 . . . . 0.13 111.116 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.572 ' CB ' HD11 ' A' ' 345' ' ' ILE . 1.2 p -106.71 133.37 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 CA-C-O 123.635 1.683 . . . . 0.23000000000000001 114.151 -167.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.482 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 9.9 pt-20 -139.93 -177.01 4.79 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 110.379 -3.1 . . . . 0.82999999999999996 106.302 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.2 mtmt -47.09 155.08 0.31 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 122.854 1.311 . . . . 0.23999999999999999 113.679 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.37 -34.23 5.27 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 112.169 -2.287 . . . . 0.37 112.71 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.533 ' HB ' HG23 ' A' ' 457' ' ' VAL . 10.5 m -79.88 142.26 56.15 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-O 120.968 0.414 . . . . 0.14999999999999999 110.035 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.633 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.71 165.01 33.36 Favored 'Trans proline' 0 N--CA 1.433 -2.057 0 C-N-CA 122.353 2.035 . . . . 0.12 111.254 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 81.6 t -135.2 134.8 52.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 113.816 -1.538 . . . . 1.0900000000000001 108.474 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.523 HD23 ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -113.94 143.44 44.7 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.126 -0.488 . . . . 0.13 110.369 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.45 149.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.383 -1.34 . . . . 0.089999999999999997 107.383 165.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.683 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.565 -0.731 . . . . 1.1599999999999999 111.254 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 111.508 -0.637 . . . . 3.9399999999999999 111.508 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 340' ' ' MET . 2.7 t-80 59.21 84.56 0.11 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.296 0.569 . . . . 1.8500000000000001 110.474 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 33.2 mtm 76.47 -175.43 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.806 -1.543 . . . . 1.03 110.847 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -138.35 -4.87 1.64 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.308 -0.86 . . . . 1.1000000000000001 110.907 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -55.64 167.37 0.54 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 123.041 1.401 . . . . 0.97999999999999998 112.949 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 358' ' ' LYS . 85.4 m -92.73 122.03 34.72 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.119 -1.855 . . . . 0.45000000000000001 107.255 166.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.679 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 9.7 p90 -156.66 -170.67 3.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.265 -0.88 . . . . 0.32000000000000001 110.625 -174.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.585 HD11 ' CB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.97 161.06 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.271 -1.011 . . . . 0.080000000000000002 108.271 167.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.485 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.1 tt0 -142.24 155.67 45.26 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.691 0.678 . . . . 0.17000000000000001 111.229 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 354' ' ' MET . 60.7 t -150.93 138.35 13.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.648 -1.16 . . . . 0.080000000000000002 109.64 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -117.89 117.74 30.11 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.729 -1.123 . . . . 0.37 107.989 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.529 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -72.69 -45.12 60.45 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.589 0.709 . . . . 0.32000000000000001 110.045 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.12 -45.42 93.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.862 -1.517 . . . . 1.51 112.826 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.26 18.26 21.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.687 -1.142 . . . . 0.91000000000000003 108.928 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.641 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.7 mp0 34.3 68.96 0.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.994 -1.912 . . . . 2.2200000000000002 112.773 171.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.489 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.9 t60 -152.47 125.02 8.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.216 0.531 . . . . 0.13 109.649 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.708 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.8 ttp -111.25 127.48 55.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.649 -0.705 . . . . 0.059999999999999998 110.28 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.658 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.06 173.37 6.39 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.536 -1.211 . . . . 0.10000000000000001 111.746 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.573 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -126.35 116.39 21.13 Favored 'General case' 0 C--O 1.201 -1.468 0 N-CA-C 105.622 -1.992 . . . . 0.22 105.622 163.466 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 20.7 m-85 -97.0 125.09 41.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.43 -0.908 . . . . 0.17999999999999999 111.613 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 343' ' ' THR . 35.6 ttmt -138.23 140.31 39.65 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 113.818 -1.537 . . . . 0.46999999999999997 109.0 173.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.9 t70 65.41 14.56 9.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.473 -1.694 . . . . 0.59999999999999998 109.036 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.29 16.09 72.52 Favored Glycine 0 N--CA 1.419 -2.44 0 CA-C-N 112.281 -2.236 . . . . 0.23000000000000001 111.968 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.649 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -130.84 172.91 11.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.177 -2.157 . . . . 0.68000000000000005 105.177 -173.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.76 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.8 m -102.73 138.49 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 124.136 1.922 . . . . 0.53000000000000003 111.604 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.99 -23.81 18.57 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.529 -3.487 . . . . 0.12 108.243 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.676 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -155.3 154.66 32.44 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.942 -1.481 . . . . 0.080000000000000002 108.72 -172.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.76 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.12 121.87 1.48 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.103 -0.499 . . . . 0.60999999999999999 109.706 -175.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.6 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.7 t -148.1 167.09 25.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 122.473 1.13 . . . . 0.089999999999999997 112.429 174.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.774 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.3 p-10 -83.85 139.92 32.34 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.675 -2.057 . . . . 1.8799999999999999 107.791 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.641 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -143.06 -172.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.501 -0.772 . . . . 0.11 111.886 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.616 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.59 120.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.006 -0.997 . . . . 0.12 108.856 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.467 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.6 t -142.68 145.08 33.05 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.505 -0.77 . . . . 0.69999999999999996 113.038 -167.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.16 46.6 49.75 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 116.959 1.544 . . . . 0.13 116.959 162.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.562 ' HE2' ' CA ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.71 143.21 4.31 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 118.982 1.391 . . . . 0.47999999999999998 110.495 -174.283 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.795 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.17 -32.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 1 C-N-CA 125.866 4.377 . . . . 0.23000000000000001 116.22 -170.466 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.43 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -82.71 -32.81 27.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.181 0.515 . . . . 0.29999999999999999 111.081 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.5 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -139.06 72.51 39.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 122.237 1.018 . . . . 0.29999999999999999 110.059 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.66 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.8 Cg_exo -73.35 163.06 38.8 Favored 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.528 4.152 . . . . 0.16 114.18 -177.552 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.724 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.48 154.17 87.75 Favored Pre-proline 0 N--CA 1.435 -1.211 0 CA-C-N 113.347 -1.751 . . . . 0.12 110.992 175.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.523 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.0 OUTLIER -79.93 -51.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.995 3.797 . . . . 0.089999999999999997 113.641 -172.006 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.705 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.48 122.58 0.03 OUTLIER 'General case' 0 C--O 1.232 0.153 0 N-CA-C 113.474 0.916 . . . . 0.089999999999999997 113.474 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.67 -124.64 1.25 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.243 -1.344 . . . . 0.11 111.384 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.7 p -128.23 107.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.547 1.165 . . . . 0.89000000000000001 109.296 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.763 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.4 m-85 -109.79 160.25 16.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.755 -1.111 . . . . 0.16 109.831 -170.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.681 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 80.8 m-85 -148.23 135.73 20.6 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 119.592 -0.242 . . . . 0.68999999999999995 110.609 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.36 123.6 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.337 -0.945 . . . . 0.14000000000000001 110.656 178.186 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -109.12 2.75 21.29 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.709 -0.678 . . . . 0.19 112.284 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.653 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 20.9 t-20 -161.52 148.07 14.31 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.198 -1.038 . . . . 0.40999999999999998 108.198 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.546 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -117.41 116.67 27.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.948 -1.13 . . . . 1.0900000000000001 107.948 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.569 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -121.49 129.79 53.15 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.689 -1.141 . . . . 0.38 111.045 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.6 mt-10 -128.29 136.1 50.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 113.781 -1.554 . . . . 1.96 109.887 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 38.7 t70 51.67 40.06 26.54 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 123.611 1.672 . . . . 0.40000000000000002 107.213 -172.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.569 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.82 168.19 11.35 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 112.131 -2.304 . . . . 0.16 111.581 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 49.6 m -127.26 101.06 6.32 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.657 -1.61 . . . . 0.27000000000000002 109.959 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.76 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -73.28 157.3 37.31 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 112.765 -2.016 . . . . 0.23999999999999999 110.16 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.4 mtpt -152.13 168.0 26.7 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 114.615 -1.175 . . . . 0.67000000000000004 108.255 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.921 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.3 163.38 30.82 Favored Glycine 0 CA--C 1.481 -2.077 0 C-N-CA 118.512 -1.804 . . . . 0.81000000000000005 113.339 -170.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.21 117.75 31.4 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-O 122.99 1.376 . . . . 0.79000000000000004 110.48 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.576 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 4.0 m-80 -50.85 -179.65 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.263 -2.699 . . . . 1.1200000000000001 113.44 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.14 -22.36 16.62 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.607 -0.724 . . . . 1.6499999999999999 110.256 170.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -96.15 -25.91 15.67 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.435 0.636 . . . . 2.0 110.1 -174.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.14 33.89 4.75 Favored Glycine 0 N--CA 1.433 -1.536 0 N-CA-C 110.37 -1.092 . . . . 0.66000000000000003 110.37 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 42.0 p -115.77 128.22 26.14 Favored Pre-proline 0 N--CA 1.414 -2.226 0 N-CA-C 107.376 -1.342 . . . . 0.68000000000000005 107.376 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.921 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.4 Cg_exo -70.06 144.45 52.46 Favored 'Trans proline' 0 N--CA 1.417 -2.987 0 C-N-CA 121.934 1.756 . . . . 0.81000000000000005 111.844 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 6.2 p90 -131.64 -177.16 4.3 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 112.196 -2.274 . . . . 0.38 106.646 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 18.1 mt-10 -137.74 162.45 33.86 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.459 1.123 . . . . 0.62 112.678 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.76 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.47 99.05 9.74 Favored Pre-proline 0 N--CA 1.422 -1.859 0 CA-C-N 112.965 -1.925 . . . . 1.3300000000000001 108.525 174.413 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 63.3 Cg_endo -67.9 103.67 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.787 2.324 . . . . 0.20000000000000001 110.604 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 421' ' ' HIS . 1.2 t -118.42 154.37 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 CA-C-N 114.555 -1.202 . . . . 0.29999999999999999 110.578 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.1 OUTLIER -95.91 -34.47 11.81 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.437 -0.801 . . . . 1.8400000000000001 108.881 174.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.478 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 60.2 m-85 -136.91 115.94 12.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.172 -1.376 . . . . 0.44 111.218 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.663 ' HB2' HG11 ' A' ' 407' ' ' VAL . 9.7 t-105 -123.63 134.54 53.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.002 -1.454 . . . . 0.13 111.089 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.542 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.0 OUTLIER -133.97 87.23 35.48 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 114.639 -1.164 . . . . 0.40999999999999998 111.372 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.2 Cg_endo -73.68 140.0 28.8 Favored 'Trans proline' 0 CA--C 1.505 -0.937 0 C-N-CA 123.164 2.576 . . . . 0.16 111.545 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.4 pt -123.35 -17.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.329 -1.305 . . . . 0.17000000000000001 111.425 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.814 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.0 p30 -136.31 173.75 11.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.5900000000000001 110.124 172.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -100.26 15.84 26.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.829 -0.623 . . . . 0.31 111.832 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 16.8 p -97.57 -27.88 14.2 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.051 -1.092 . . . . 0.44 108.051 174.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.6 26.98 0.91 Allowed Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 113.874 -1.512 . . . . 0.23999999999999999 113.355 173.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.814 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.8 t -103.64 151.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.704 0.764 . . . . 0.17000000000000001 111.394 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.39 -166.06 36.82 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.562 -1.199 . . . . 0.10000000000000001 110.841 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.439 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -102.73 136.83 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 108.672 -0.862 . . . . 0.12 108.672 175.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.2 p80 -151.1 168.12 25.61 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.142 0.972 . . . . 0.14999999999999999 110.937 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.762 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.09 150.65 22.64 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.359 -1.746 . . . . 0.41999999999999998 108.363 174.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.514 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -138.0 100.34 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.688 1.232 . . . . 1.48 109.989 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -94.61 -31.59 13.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 112.667 -2.061 . . . . 0.34999999999999998 110.189 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.53 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 19.9 p90 -70.17 -27.64 64.69 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 114.52 -1.218 . . . . 0.17999999999999999 109.296 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.542 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.1 OUTLIER -114.73 81.88 7.61 Favored Pre-proline 0 CA--C 1.492 -1.281 0 CA-C-N 113.821 -1.536 . . . . 1.3300000000000001 109.427 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 27.8 Cg_endo -80.18 5.2 6.19 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 124.788 3.659 . . . . 0.23000000000000001 113.944 -161.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 152.82 32.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 123.702 0.626 . . . . 1.1000000000000001 110.69 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.774 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -164.2 125.4 2.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 114.293 -1.321 . . . . 0.38 108.084 -172.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.32 -165.88 28.61 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.633 -1.27 . . . . 0.13 110.206 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.49 152.53 0.01 OUTLIER Glycine 0 C--N 1.34 0.752 0 O-C-N 125.093 1.114 . . . . 0.20000000000000001 113.178 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.08 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 124.244 1.973 . . . . 0.33000000000000002 112.42 -152.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.5 mt -97.71 -32.5 11.72 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.013 -3.267 . . . . 0.17999999999999999 107.906 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.616 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.9 p-90 -47.8 -39.36 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.873 -0.603 . . . . 0.22 111.568 -173.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.795 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 22.7 mttt -60.33 -25.23 65.64 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.919 -1.037 . . . . 0.64000000000000001 112.595 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 55.5 p -112.09 -36.27 5.41 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.494 -0.775 . . . . 0.25 110.306 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.542 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.7 mtp85 -85.49 -16.18 40.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.905 -1.043 . . . . 0.35999999999999999 112.326 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.562 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.84 43.13 28.93 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 119.425 -1.369 . . . . 0.20999999999999999 116.198 162.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 439' ' ' SER . . . . . 0.541 ' HG ' HG22 ' A' ' 369' ' ' VAL . 2.4 m -82.31 130.92 35.21 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 118.185 0.992 . . . . 0.46999999999999997 108.996 174.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -98.28 67.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.838 -0.539 . . . . 0.40999999999999998 110.539 -169.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 377' ' ' THR . . . 89.13 -14.7 60.03 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.392 -1.083 . . . . 0.17999999999999999 110.392 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.523 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.9 p -86.75 148.19 25.52 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.344 -0.428 . . . . 0.82999999999999996 110.55 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.724 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -102.47 119.46 50.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.093 -0.503 . . . . 0.14999999999999999 110.191 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.583 ' HB2' HG13 ' A' ' 369' ' ' VAL . 49.6 m-20 -81.55 89.88 6.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.864 -0.607 . . . . 1.77 111.135 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.6 m -88.06 137.93 31.09 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.285 -0.635 . . . . 0.17999999999999999 109.285 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 52.9 Cg_exo -58.6 132.3 47.41 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.905 2.403 . . . . 0.12 113.04 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.762 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.7 Cg_exo -51.07 -40.46 59.42 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.52 2.813 . . . . 0.16 112.052 -169.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.3 m -71.66 -40.83 69.4 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.496 -1.229 . . . . 1.1699999999999999 109.724 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.6 HG11 ' HB ' ' A' ' 366' ' ' THR . 84.5 t -76.51 -31.09 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.626 -0.715 . . . . 0.17000000000000001 111.684 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.702 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.4 tpt -66.49 -21.43 66.18 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.966 0.888 . . . . 0.46000000000000002 110.203 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -76.9 -25.52 53.1 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.18 -1.373 . . . . 0.81000000000000005 111.124 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.727 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -79.07 -47.01 16.93 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 113.41 -1.723 . . . . 0.38 107.392 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.534 HD23 ' SD ' ' A' ' 450' ' ' MET . 24.5 tp -63.75 -67.71 0.41 Allowed 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 111.444 -2.617 . . . . 0.059999999999999998 112.395 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.542 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 33.8 t80 -51.77 -26.85 10.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 123.108 1.432 . . . . 0.31 107.878 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.02 -29.04 72.46 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 112.404 -2.18 . . . . 0.13 112.079 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.727 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.9 ptp -90.78 -48.75 6.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.617 0.722 . . . . 0.13 111.056 170.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.585 ' CB ' HD11 ' A' ' 345' ' ' ILE . 1.1 p -106.87 134.18 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 123.403 1.573 . . . . 0.23000000000000001 114.614 -167.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.546 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 7.8 pt-20 -140.15 -176.19 4.51 Favored 'General case' 0 N--CA 1.405 -2.679 0 CA-C-N 110.889 -2.869 . . . . 0.82999999999999996 107.018 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.652 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 49.0 mtmt -45.26 153.43 0.22 Allowed 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 122.88 1.324 . . . . 0.23999999999999999 113.66 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.6 -30.91 8.44 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 112.191 -2.277 . . . . 0.37 112.312 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 462' ' ' PRO . 5.0 m -86.76 142.42 34.5 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 109.578 -0.527 . . . . 0.14999999999999999 109.578 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.681 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 3.8 Cg_exo -75.62 170.29 20.53 Favored 'Trans proline' 0 N--CA 1.428 -2.349 0 C-N-CA 122.083 1.856 . . . . 0.12 111.631 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.3 158.5 38.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.797 -1.186 . . . . 1.0900000000000001 107.797 165.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.485 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.3 tp -129.95 145.56 51.63 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.335 -0.848 . . . . 0.13 110.179 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.2 148.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.304 -1.369 . . . . 0.089999999999999997 107.304 165.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.534 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 13.2 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.772 -0.632 . . . . 1.1599999999999999 111.785 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 111.364 -0.694 . . . . 3.9399999999999999 111.364 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.629 ' O ' ' HB2' ' A' ' 340' ' ' MET . 2.9 t-160 -79.19 93.33 5.2 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.402 -0.962 . . . . 1.8500000000000001 108.402 171.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.629 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 32.7 mtm 79.48 172.98 0.15 Allowed 'General case' 0 C--N 1.328 -0.367 0 O-C-N 125.214 1.571 . . . . 1.03 110.12 -166.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -106.56 -9.45 16.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.178 -0.919 . . . . 1.1000000000000001 111.555 -172.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.5 166.93 1.13 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 123.195 1.474 . . . . 0.97999999999999998 113.931 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.689 HG23 ' HA ' ' A' ' 358' ' ' LYS . 3.6 m -93.08 122.63 35.64 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 112.649 -2.068 . . . . 0.45000000000000001 106.956 165.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.671 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 16.4 p90 -160.7 -172.04 3.35 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.643 0.735 . . . . 0.32000000000000001 110.951 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.586 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.8 mm -104.58 159.25 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.002 -1.11 . . . . 0.080000000000000002 108.002 166.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.542 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -139.95 155.09 47.31 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 118.881 0.764 . . . . 0.17000000000000001 111.036 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.689 HG22 ' HG3' ' A' ' 354' ' ' MET . 65.4 t -150.79 137.09 12.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 114.425 -1.261 . . . . 0.080000000000000002 109.476 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 30.2 t0 -118.03 116.32 26.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.737 -1.12 . . . . 0.37 108.219 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.571 HD21 HG23 ' A' ' 465' ' ' VAL . 1.9 mm? -71.96 -44.3 63.78 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.078 0.942 . . . . 0.32000000000000001 109.391 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.484 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 7.1 mm-40 -57.38 -49.48 76.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.876 -1.965 . . . . 1.51 112.515 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -106.29 14.07 27.93 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.352 -1.295 . . . . 0.91000000000000003 109.296 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.616 ' OE1' ' HA2' ' A' ' 431' ' ' GLY . 20.5 mp0 38.87 73.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 125.151 1.532 . . . . 2.2200000000000002 112.096 174.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.5 t60 -155.91 125.26 6.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.243 0.544 . . . . 0.13 110.164 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.689 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.5 ttp -110.83 128.33 55.73 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.766 -0.652 . . . . 0.059999999999999998 110.563 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.684 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -114.31 173.95 6.19 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.635 -1.166 . . . . 0.10000000000000001 112.027 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.716 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.7 t80 -126.29 119.79 28.28 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.963 -1.866 . . . . 0.22 105.963 164.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.504 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.6 m-85 -103.9 130.79 51.53 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.159 0.981 . . . . 0.17999999999999999 111.811 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.689 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.4 ttpt -147.73 136.13 21.58 Favored 'General case' 0 N--CA 1.398 -3.028 0 CA-C-N 113.206 -1.815 . . . . 0.46999999999999997 108.338 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.1 t70 71.63 13.15 6.34 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.375 -1.739 . . . . 0.59999999999999998 108.573 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.01 83.51 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 112.788 -2.005 . . . . 0.23000000000000001 112.02 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.636 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -124.9 169.58 11.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.668 -1.975 . . . . 0.68000000000000005 105.668 -172.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.757 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -102.18 138.76 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.819 0 CA-C-O 124.258 1.98 . . . . 0.53000000000000003 112.092 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.716 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.56 -24.67 18.66 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 109.322 -3.581 . . . . 0.12 108.656 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.68 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -152.93 154.72 35.61 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.927 -1.488 . . . . 0.080000000000000002 109.168 -172.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.757 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.37 121.96 1.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.002 -0.545 . . . . 0.60999999999999999 110.196 -174.656 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.61 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.5 t -147.22 166.83 25.84 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.517 0.675 . . . . 0.089999999999999997 111.352 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 1.3 m-20 -85.73 149.52 25.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.646 -1.613 . . . . 1.8799999999999999 106.646 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -146.32 -171.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 124.052 0.845 . . . . 0.11 111.305 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.588 HG23 ' CA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.16 118.91 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.761 -1.109 . . . . 0.12 108.775 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.467 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.86 146.12 35.43 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.081 -0.963 . . . . 0.69999999999999996 112.561 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.635 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.28 44.82 41.89 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 116.548 1.379 . . . . 0.13 116.548 163.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.551 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.93 144.21 3.94 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-N 118.335 1.068 . . . . 0.47999999999999998 110.24 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.785 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.49 -31.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.787 1 C-N-CA 125.82 4.346 . . . . 0.23000000000000001 116.278 -170.749 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.551 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.87 -34.82 29.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.014 0.435 . . . . 0.29999999999999999 110.791 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.459 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.9 m -140.53 73.62 29.44 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-O 122.112 0.958 . . . . 0.29999999999999999 110.423 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.635 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -72.29 161.06 45.5 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 125.187 3.925 . . . . 0.16 113.898 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.696 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.3 152.42 88.0 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.518 -1.674 . . . . 0.12 111.395 178.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.508 ' CD ' HG22 ' A' ' 377' ' ' THR . 2.0 Cg_endo -80.93 -49.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 125.234 3.956 . . . . 0.089999999999999997 113.986 -171.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.727 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.36 123.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.616 0.969 . . . . 0.089999999999999997 113.616 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.91 -126.57 1.46 Allowed Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.42 -1.264 . . . . 0.11 111.441 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.1 p -127.19 98.9 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 122.475 1.131 . . . . 0.89000000000000001 109.884 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.754 ' HB2' HG22 ' A' ' 463' ' ' VAL . 99.1 m-85 -101.71 162.02 13.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.67 -1.15 . . . . 0.16 110.22 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -147.58 135.57 21.27 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 121.337 -0.145 . . . . 0.68999999999999995 110.878 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.632 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.82 124.2 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.741 -0.784 . . . . 0.14000000000000001 110.612 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.89 2.76 20.03 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.399 -0.818 . . . . 0.19 112.183 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.751 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 17.6 t-20 -165.14 151.85 10.44 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.544 -0.753 . . . . 0.40999999999999998 110.3 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -112.25 128.37 56.24 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.802 0.811 . . . . 1.0900000000000001 109.725 170.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.582 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.3 mt-10 -129.43 118.56 22.36 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.361 -1.29 . . . . 0.38 112.019 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 1.5 mp0 -115.27 136.73 52.79 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.315 -1.311 . . . . 1.96 110.592 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.5 t70 49.83 37.74 14.14 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.585 1.66 . . . . 0.40000000000000002 107.565 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -89.76 169.7 11.05 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.161 -2.29 . . . . 0.16 111.844 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 104.56 8.02 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.812 -1.54 . . . . 0.27000000000000002 109.991 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.749 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -74.66 158.09 34.22 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.733 -2.031 . . . . 0.23999999999999999 110.47 173.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.8 mtpt -145.27 -176.37 5.08 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 114.962 -1.017 . . . . 0.67000000000000004 108.685 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.748 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.92 -146.48 6.94 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 116.956 -2.545 . . . . 0.81000000000000005 115.322 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 401' ' ' THR . 0.6 OUTLIER -141.46 121.06 13.33 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 112.873 -1.663 . . . . 0.79000000000000004 109.774 175.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.575 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 6.8 m-20 -52.77 -178.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 111.831 -2.441 . . . . 1.1200000000000001 112.162 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -51.03 -27.31 7.63 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.737 -0.665 . . . . 1.6499999999999999 111.346 171.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.575 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.6 OUTLIER -98.16 -29.97 12.91 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.137 0.494 . . . . 2.0 111.292 -174.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.68 37.52 1.16 Allowed Glycine 0 C--N 1.295 -1.696 0 C-N-CA 119.548 -1.31 . . . . 0.66000000000000003 111.797 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 396' ' ' THR . 77.7 p -119.17 151.61 51.07 Favored Pre-proline 0 N--CA 1.422 -1.857 0 N-CA-C 107.911 -1.144 . . . . 0.68000000000000005 107.911 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.748 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 72.5 Cg_endo -65.39 163.15 30.66 Favored 'Trans proline' 0 C--N 1.279 -3.117 0 C-N-CA 122.842 2.361 . . . . 0.81000000000000005 113.449 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.584 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 13.1 p90 -152.86 -173.92 4.74 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 112.44 -2.164 . . . . 0.38 107.252 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.9 mt-10 -143.08 159.25 42.62 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.162 0.982 . . . . 0.62 111.561 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.749 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.54 98.3 12.4 Favored Pre-proline 0 N--CA 1.419 -1.99 0 CA-C-N 113.168 -1.833 . . . . 1.3300000000000001 107.793 175.431 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.6 Cg_endo -67.46 102.68 0.73 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.328 2.019 . . . . 0.20000000000000001 110.091 174.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.796 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -113.98 159.74 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 CA-C-N 114.4 -1.273 . . . . 0.29999999999999999 109.757 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 13.1 m120 -108.92 -34.23 6.7 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.585 -1.643 . . . . 1.8400000000000001 107.167 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.497 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 46.9 m-85 -136.43 116.17 13.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.923 -1.944 . . . . 0.44 110.684 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.796 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.3 t-105 -123.02 135.01 54.28 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.931 -1.031 . . . . 0.13 110.025 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.521 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.36 86.33 24.49 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 114.875 -1.057 . . . . 0.40999999999999998 110.82 173.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 78.0 Cg_endo -71.34 140.42 36.89 Favored 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 123.024 2.483 . . . . 0.16 112.046 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 6.0 pt -123.65 -16.61 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.972 -1.467 . . . . 0.17000000000000001 111.111 -172.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.83 169.37 17.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 1.5900000000000001 109.33 176.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -101.75 14.62 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.242 0.831 . . . . 0.31 113.242 -176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.513 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 23.9 p -98.25 -28.08 13.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.968 -1.123 . . . . 0.44 107.968 172.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.86 28.96 0.37 Allowed Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 113.967 -1.469 . . . . 0.23999999999999999 113.259 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 441' ' ' GLY . 97.7 t -102.76 148.23 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.548 0.69 . . . . 0.17000000000000001 111.717 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.75 -166.47 37.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.664 -1.153 . . . . 0.10000000000000001 111.204 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.63 138.44 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.541 -0.911 . . . . 0.12 108.541 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.779 ' CE1' ' HB2' ' A' ' 442' ' ' CYS . 10.4 p-80 -151.24 166.13 31.84 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.869 0.843 . . . . 0.14999999999999999 111.451 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.778 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.68 145.05 24.9 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 113.77 -1.559 . . . . 0.41999999999999998 107.742 173.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.56 102.22 5.23 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 123.32 1.533 . . . . 1.48 110.208 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.93 -30.63 15.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 110.09 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.471 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 10.8 p90 -71.46 -27.28 63.15 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.023 -1.444 . . . . 0.17999999999999999 109.146 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.426 HE22 ' HD3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.3 82.9 19.32 Favored Pre-proline 0 CA--C 1.49 -1.328 0 CA-C-N 113.762 -1.563 . . . . 1.3300000000000001 108.724 -172.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 35.8 Cg_endo -79.32 3.64 7.3 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 124.571 3.514 . . . . 0.23000000000000001 114.452 -159.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -114.78 156.56 24.63 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.169 0.509 . . . . 1.1000000000000001 111.916 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.515 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -164.08 124.01 2.06 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.115 -1.402 . . . . 0.38 108.675 -172.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.42 -167.49 28.55 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.861 -1.161 . . . . 0.13 111.149 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.655 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.9 154.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 O-C-N 125.389 1.287 . . . . 0.20000000000000001 113.151 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.76 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 111.985 -152.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 53.1 mt -97.32 -32.05 12.08 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 109.962 -3.29 . . . . 0.17999999999999999 108.086 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.588 ' CA ' HG23 ' A' ' 369' ' ' VAL . 5.5 p-90 -46.44 -37.47 7.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.65 -0.704 . . . . 0.22 111.584 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.785 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 24.4 mttt -60.86 -24.44 65.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.18 -0.918 . . . . 0.64000000000000001 113.192 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 p -113.95 -35.19 5.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.691 0.758 . . . . 0.25 110.256 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.541 ' HD2' HD22 ' A' ' 433' ' ' LEU . 5.8 mtp85 -85.62 -15.34 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.605 -1.18 . . . . 0.35999999999999999 112.481 -169.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.506 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.06 42.0 38.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.256 1.263 . . . . 0.20999999999999999 116.256 159.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.5 m -85.62 130.38 34.58 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 118.485 1.143 . . . . 0.46999999999999997 109.226 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.495 ' NE2' ' HE3' ' A' ' 372' ' ' LYS . 62.2 m80 -101.21 68.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.547 -0.721 . . . . 0.40999999999999998 110.75 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.541 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 90.92 -14.17 64.08 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.353 -1.099 . . . . 0.17999999999999999 110.353 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.779 ' HB2' ' CE1' ' A' ' 421' ' ' HIS . 23.4 p -89.95 148.14 23.29 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.326 -0.437 . . . . 0.82999999999999996 110.62 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -104.15 119.0 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 116.204 -0.453 . . . . 0.14999999999999999 110.621 -176.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.48 ' HB2' HG13 ' A' ' 369' ' ' VAL . 6.9 m120 -79.28 88.99 4.92 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.609 -0.436 . . . . 1.77 111.186 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 41.3 m -86.97 135.65 35.01 Favored Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 109.17 -0.678 . . . . 0.17999999999999999 109.17 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.418 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 53.0 Cg_exo -55.75 135.37 69.17 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.725 2.283 . . . . 0.12 111.398 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.778 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.0 Cg_exo -54.8 -33.89 82.84 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 C-N-CA 124.225 3.284 . . . . 0.16 112.99 -173.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 67.8 m -79.24 -39.02 34.19 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.783 -1.098 . . . . 1.1699999999999999 110.06 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.61 HG11 ' HB ' ' A' ' 366' ' ' THR . 97.8 t -78.8 -30.48 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 0.17000000000000001 111.408 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.685 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.9 tpt -67.56 -19.0 65.21 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.788 0.804 . . . . 0.46000000000000002 110.32 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -80.03 -22.88 41.88 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 114.528 -1.215 . . . . 0.81000000000000005 110.839 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.68 -46.78 15.01 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 112.921 -1.945 . . . . 0.38 107.329 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.635 HD23 ' SD ' ' A' ' 450' ' ' MET . 25.8 tp -64.64 -66.58 0.52 Allowed 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 111.906 -2.406 . . . . 0.059999999999999998 112.423 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.429 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 32.6 t80 -50.34 -25.16 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 123.059 1.409 . . . . 0.31 108.247 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.63 -28.66 66.94 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 112.486 -2.143 . . . . 0.13 112.507 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.68 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -92.2 -48.18 6.83 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.783 0.802 . . . . 0.13 111.614 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.632 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.8 OUTLIER -103.94 136.75 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 123.344 1.545 . . . . 0.23000000000000001 113.953 -167.027 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -136.56 -178.49 5.2 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 110.916 -2.856 . . . . 0.82999999999999996 106.583 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.751 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.4 mtmt -51.71 160.85 0.6 Allowed 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 123.114 1.435 . . . . 0.23999999999999999 112.958 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.75 7.91 Favored Glycine 0 N--CA 1.426 -2.033 0 CA-C-N 112.527 -2.124 . . . . 0.37 112.528 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 462' ' ' PRO . 6.1 m -82.01 142.95 48.69 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 109.308 -0.627 . . . . 0.14999999999999999 109.308 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.36 168.75 23.92 Favored 'Trans proline' 0 N--CA 1.426 -2.48 0 C-N-CA 121.855 1.703 . . . . 0.12 111.262 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.2 m -136.32 155.13 34.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.125 -1.435 . . . . 1.0900000000000001 107.125 165.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.436 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 3.4 tp -126.06 145.68 50.22 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.254 -0.885 . . . . 0.13 110.158 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.0 146.3 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 N-CA-C 106.896 -1.52 . . . . 0.089999999999999997 106.896 164.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.678 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 16.4 p90 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.229 -0.891 . . . . 1.1599999999999999 111.431 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 112.06 -0.416 . . . . 3.9399999999999999 112.06 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.67 -176.01 6.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.573 0.701 . . . . 1.8500000000000001 110.257 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 40.8 mtm -54.46 176.53 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.705 -1.589 . . . . 1.03 115.127 -169.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -134.02 -5.13 2.75 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.667 -1.606 . . . . 1.1000000000000001 110.181 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.24 169.2 0.19 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 123.038 1.399 . . . . 0.97999999999999998 112.404 172.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 358' ' ' LYS . 98.5 m -91.16 124.01 35.05 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 113.077 -1.874 . . . . 0.45000000000000001 109.189 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.636 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 4.7 p90 -159.12 -170.61 3.06 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.012 -1.449 . . . . 0.32000000000000001 110.637 -174.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.606 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -99.87 159.64 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 108.073 -1.084 . . . . 0.080000000000000002 108.073 166.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.2 tt0 -138.68 154.1 48.58 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.074 -0.65 . . . . 0.17000000000000001 111.146 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.682 HG22 ' HG3' ' A' ' 354' ' ' MET . 64.1 t -149.98 134.33 9.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 114.263 -1.335 . . . . 0.080000000000000002 109.436 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 15.4 t0 -115.57 124.5 51.15 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.714 -1.13 . . . . 0.37 108.377 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 465' ' ' VAL . 2.1 mm? -75.22 -43.81 49.73 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.811 1.291 . . . . 0.32000000000000001 110.525 -177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 5.4 mm-40 -57.38 -54.96 40.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.623 -2.08 . . . . 1.51 112.816 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 20.58 18.61 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.843 0.83 . . . . 0.91000000000000003 109.752 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.873 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.3 mm-40 35.94 71.25 0.13 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 112.104 -2.316 . . . . 2.2200000000000002 112.16 169.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -149.19 125.89 11.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.186 -0.916 . . . . 0.13 109.174 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.682 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.8 ttp -111.81 127.5 55.83 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.488 0.661 . . . . 0.059999999999999998 110.481 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.68 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -111.55 173.39 6.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.552 -1.204 . . . . 0.10000000000000001 111.753 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.697 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.5 t80 -125.3 111.79 15.61 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.242 -1.762 . . . . 0.22 106.242 165.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 362' ' ' VAL . 21.9 m-85 -97.47 127.44 43.43 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.766 0.793 . . . . 0.17999999999999999 111.174 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.621 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 4.3 ttpt -142.86 135.35 27.62 Favored 'General case' 0 N--CA 1.398 -3.049 0 CA-C-N 113.964 -1.471 . . . . 0.46999999999999997 108.297 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.8 t70 71.26 11.37 6.78 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 113.209 -1.814 . . . . 0.59999999999999998 108.806 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.84 68.81 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 112.763 -2.017 . . . . 0.23000000000000001 111.757 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -129.66 167.0 18.66 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.15 -1.796 . . . . 0.68000000000000005 106.15 -172.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.747 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -101.91 138.68 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 CA-C-O 124.429 2.062 . . . . 0.53000000000000003 112.21 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.61 -25.45 17.52 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 109.341 -3.572 . . . . 0.12 108.671 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.64 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.71 155.26 36.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 113.627 -1.624 . . . . 0.080000000000000002 108.891 -172.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.747 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.38 122.12 1.45 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.691 -0.686 . . . . 0.60999999999999999 109.473 -175.087 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.698 HG21 HG23 ' A' ' 445' ' ' THR . 5.3 t -148.95 166.68 27.89 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.326 1.06 . . . . 0.089999999999999997 112.224 173.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.732 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.6 p-10 -84.54 139.62 32.01 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.936 -1.938 . . . . 1.8799999999999999 107.737 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -141.46 -172.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.163 -0.926 . . . . 0.11 111.724 -175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.873 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.22 120.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.127 -0.942 . . . . 0.12 109.26 175.2 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.5 t -141.84 144.58 33.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.56 0.948 . . . . 0.69999999999999996 113.56 -165.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.63 45.96 50.01 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 116.771 1.468 . . . . 0.13 116.771 161.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.571 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -48.09 144.04 6.2 Favored Pre-proline 0 CA--C 1.511 -0.535 0 CA-C-N 118.263 1.031 . . . . 0.47999999999999998 111.342 -176.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.814 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.02 -31.91 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.564 1 C-N-CA 125.88 4.387 . . . . 0.23000000000000001 115.671 -172.88 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.628 ' HB ' ' OD1' ' A' ' 398' ' ' ASP . 0.9 OUTLIER -78.94 -36.89 41.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.263 -0.426 . . . . 0.29999999999999999 110.838 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.455 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -141.44 72.74 25.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-O 122.174 0.988 . . . . 0.29999999999999999 110.15 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.4 Cg_exo -69.33 162.38 42.07 Favored 'Trans proline' 0 C--N 1.322 -0.837 1 C-N-CA 125.357 4.038 . . . . 0.16 114.245 -176.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.67 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.0 152.46 88.66 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 113.581 -1.645 . . . . 0.12 110.647 176.362 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.536 ' CD ' HG22 ' A' ' 377' ' ' THR . 0.9 OUTLIER -79.68 -49.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 125.076 3.851 . . . . 0.089999999999999997 113.461 -172.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.729 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 67.05 124.25 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.974 0.892 . . . . 0.089999999999999997 113.267 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 162.63 -122.48 1.11 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.445 -1.252 . . . . 0.11 111.405 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.2 p -130.77 106.62 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-O 121.979 0.895 . . . . 0.89000000000000001 109.283 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 465' ' ' VAL . 52.2 m-85 -111.48 167.53 10.25 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.223 -0.899 . . . . 0.16 109.282 -172.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.688 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 82.2 m-85 -149.02 138.46 21.7 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 110.618 -0.141 . . . . 0.68999999999999995 110.618 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.626 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -72.82 122.77 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 119.67 -0.812 . . . . 0.14000000000000001 110.476 175.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -109.79 3.87 21.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.46 -0.791 . . . . 0.19 112.286 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.658 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 18.9 t-20 -163.88 148.03 10.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.279 -1.008 . . . . 0.40999999999999998 108.279 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.588 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -118.98 114.9 23.27 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.196 0.998 . . . . 1.0900000000000001 108.43 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -118.84 132.54 56.12 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.28 -1.327 . . . . 0.38 110.298 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -131.68 134.51 46.03 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.026 -1.443 . . . . 1.96 109.622 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 52.69 40.45 30.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 123.435 1.588 . . . . 0.40000000000000002 107.479 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.564 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.76 169.53 9.95 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 112.35 -2.204 . . . . 0.16 111.683 -172.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 7.7 m -126.57 106.49 9.47 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 113.956 -1.474 . . . . 0.27000000000000002 109.926 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.741 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.3 mp -71.02 158.9 35.72 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.986 . . . . 0.23999999999999999 110.626 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.3 mtpt -147.96 -175.44 4.88 Favored 'General case' 0 N--CA 1.393 -3.3 0 O-C-N 124.39 1.056 . . . . 0.67000000000000004 108.529 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -176.88 -145.15 5.57 Favored Glycine 0 C--N 1.296 -1.654 0 C-N-CA 117.493 -2.289 . . . . 0.81000000000000005 114.863 177.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.87 123.05 13.73 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.393 -1.404 . . . . 0.79000000000000004 108.85 171.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.43 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 5.5 m-20 -55.4 -178.18 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 112.055 -2.339 . . . . 1.1200000000000001 111.824 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.628 ' OD1' ' HB ' ' A' ' 374' ' ' THR . 26.0 t70 -53.47 -21.01 5.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.502 -0.317 . . . . 1.6499999999999999 111.569 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.43 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.5 OUTLIER -106.14 -28.83 10.24 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 120.962 0.41 . . . . 2.0 111.394 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.95 37.54 1.13 Allowed Glycine 0 C--N 1.293 -1.807 0 C-N-CA 119.502 -1.332 . . . . 0.66000000000000003 111.549 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 61.4 p -117.48 127.74 26.47 Favored Pre-proline 0 N--CA 1.418 -2.044 0 N-CA-C 106.158 -1.793 . . . . 0.68000000000000005 106.158 174.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 28.1 Cg_exo -64.57 164.07 25.01 Favored 'Trans proline' 0 C--N 1.284 -2.846 0 C-N-CA 121.901 1.734 . . . . 0.81000000000000005 112.746 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.591 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 17.4 p90 -142.46 -169.93 3.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.716 -1.587 . . . . 0.38 106.716 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 12.6 mt-10 -148.26 154.8 40.54 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.037 0.922 . . . . 0.62 112.038 175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.741 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.5 m -144.12 99.18 5.05 Favored Pre-proline 0 N--CA 1.428 -1.536 0 CA-C-N 113.835 -1.529 . . . . 1.3300000000000001 110.418 -177.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 73.7 Cg_endo -67.18 109.01 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 125.236 3.957 . . . . 0.20000000000000001 113.492 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -122.82 151.73 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-N 114.559 -1.201 . . . . 0.29999999999999999 111.405 -173.433 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.469 ' ND2' ' CD2' ' A' ' 409' ' ' TYR . 11.5 p-10 -93.61 -28.83 15.79 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.457 -1.247 . . . . 1.8400000000000001 110.065 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.472 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 67.5 m-85 -142.77 119.66 11.27 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.296 . . . . 0.44 110.601 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.737 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.1 t-105 -125.56 135.15 51.92 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.606 -1.179 . . . . 0.13 111.112 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.563 ' HE3' ' CG2' ' A' ' 457' ' ' VAL . 1.0 OUTLIER -134.9 86.38 32.79 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.804 -1.089 . . . . 0.40999999999999998 111.279 174.433 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.65 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 94.7 Cg_endo -72.23 138.61 30.76 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 122.833 2.355 . . . . 0.16 111.558 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.2 pt -124.66 -14.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.973 -1.467 . . . . 0.17000000000000001 110.916 -173.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -133.7 162.81 30.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.449 -0.796 . . . . 1.5900000000000001 109.7 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -94.11 14.29 20.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.022 0.378 . . . . 0.31 112.022 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.1 p -93.27 -25.6 17.7 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.565 -1.272 . . . . 0.44 107.565 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 121.59 26.31 1.99 Allowed Glycine 0 N--CA 1.426 -2.031 0 CA-C-N 112.773 -2.012 . . . . 0.23999999999999999 111.63 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 441' ' ' GLY . 55.9 t -98.07 146.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.165 0.507 . . . . 0.17000000000000001 111.0 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.75 -165.0 36.06 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.923 -1.035 . . . . 0.10000000000000001 111.464 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.438 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -105.53 137.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.693 -0.854 . . . . 0.12 108.693 176.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.904 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.7 p80 -154.16 170.58 20.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 122.011 0.91 . . . . 0.14999999999999999 111.582 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 153.52 20.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.523 -1.671 . . . . 0.41999999999999998 108.766 174.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.554 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 3.4 p -141.24 99.65 3.62 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 122.827 1.298 . . . . 1.48 109.833 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.35 -31.13 13.57 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 112.457 -2.156 . . . . 0.34999999999999998 109.992 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.564 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 9.2 p90 -68.23 -26.88 65.92 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 114.354 -1.294 . . . . 0.17999999999999999 108.923 173.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.595 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -119.38 82.42 24.26 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.613 -1.63 . . . . 1.3300000000000001 110.135 -175.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.76 5.02 6.2 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 C-N-CA 124.802 3.668 . . . . 0.23000000000000001 114.211 -161.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.33 153.25 30.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.406 0.441 . . . . 1.1000000000000001 110.07 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.732 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.5 OUTLIER -163.15 127.98 3.04 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.99 1.316 . . . . 0.38 107.86 -173.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.28 -167.72 29.02 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 119.689 -1.243 . . . . 0.13 111.05 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.606 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.15 156.64 0.0 OUTLIER Glycine 0 C--N 1.341 0.857 0 O-C-N 124.935 1.021 . . . . 0.20000000000000001 113.225 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.461 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -54.92 100.62 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 123.692 1.711 . . . . 0.33000000000000002 111.579 -148.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 32.8 mt -97.21 -31.16 12.58 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 110.611 -2.995 . . . . 0.17999999999999999 109.453 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.478 ' HA ' HG23 ' A' ' 369' ' ' VAL . 14.8 p-90 -49.06 -32.32 9.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 112.881 -1.963 . . . . 0.22 111.729 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.814 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 53.4 mttt -64.06 -19.67 65.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.297 0.851 . . . . 0.64000000000000001 113.297 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 72.5 p -120.72 -36.64 3.13 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.644 -0.707 . . . . 0.25 110.628 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.595 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.2 mtp85 -82.05 -15.04 54.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.65 -1.159 . . . . 0.35999999999999999 112.773 -169.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.532 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.82 41.42 33.89 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 116.554 1.381 . . . . 0.20999999999999999 116.554 159.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 18.4 m -85.81 131.97 34.21 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 118.225 1.013 . . . . 0.46999999999999997 109.563 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.446 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 67.9 m80 -97.68 68.74 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.683 -0.635 . . . . 0.40999999999999998 110.85 -170.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.582 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 85.4 -9.81 66.15 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.819 -0.913 . . . . 0.17999999999999999 110.819 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 20.8 p -89.52 137.58 32.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.946 -0.627 . . . . 0.82999999999999996 110.079 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -96.77 113.12 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.618 -0.719 . . . . 0.14999999999999999 110.483 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.566 ' HB2' HG13 ' A' ' 369' ' ' VAL . 2.2 m-20 -80.76 92.12 6.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.006 . . . . 1.77 111.678 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.698 HG23 HG21 ' A' ' 366' ' ' THR . 98.0 m -89.44 140.85 28.48 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.542 -0.754 . . . . 0.17999999999999999 109.572 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 53.3 Cg_exo -55.08 136.81 74.7 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.803 2.335 . . . . 0.12 111.202 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.742 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 58.4 Cg_exo -55.96 -32.94 87.65 Favored 'Trans proline' 0 CA--C 1.5 -1.199 0 C-N-CA 124.195 3.263 . . . . 0.16 112.634 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.7 p -79.64 -38.35 33.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.522 -1.217 . . . . 1.1699999999999999 109.719 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.628 HG11 ' HB ' ' A' ' 366' ' ' THR . 84.3 t -78.54 -30.44 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.17000000000000001 111.439 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.677 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -64.47 -23.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.893 0.854 . . . . 0.46000000000000002 110.426 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -75.42 -27.02 58.82 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.408 -1.269 . . . . 0.81000000000000005 111.916 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.669 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.9 mm-40 -77.6 -46.19 22.92 Favored 'General case' 0 CA--C 1.472 -2.045 0 CA-C-N 113.489 -1.687 . . . . 0.38 106.991 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 457' ' ' VAL . 24.6 tp -65.4 -67.78 0.41 Allowed 'General case' 0 N--CA 1.401 -2.903 0 CA-C-N 111.472 -2.604 . . . . 0.059999999999999998 112.601 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.535 ' CD2' ' SD ' ' A' ' 411' ' ' MET . 31.4 t80 -51.31 -27.16 8.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.183 1.468 . . . . 0.31 107.988 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.425 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.06 -31.02 74.33 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 112.116 -2.311 . . . . 0.13 112.064 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.669 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.26 -48.39 7.4 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.834 0.826 . . . . 0.13 111.189 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.667 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 1.1 p -107.19 134.36 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-O 123.344 1.545 . . . . 0.23000000000000001 114.461 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.588 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 12.6 pt-20 -139.81 -176.55 4.61 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 110.948 -2.842 . . . . 0.82999999999999996 107.032 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.9 mtmt -46.21 154.42 0.27 Allowed 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 123.032 1.396 . . . . 0.23999999999999999 113.578 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 95.22 -24.75 27.47 Favored Glycine 0 C--N 1.292 -1.913 0 CA-C-N 112.275 -2.239 . . . . 0.37 112.821 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.504 ' HB ' HG23 ' A' ' 457' ' ' VAL . 6.6 m -89.3 142.23 29.67 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 109.685 -0.487 . . . . 0.14999999999999999 109.685 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.636 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.9 Cg_exo -74.64 168.3 25.13 Favored 'Trans proline' 0 N--CA 1.43 -2.209 0 C-N-CA 122.067 1.844 . . . . 0.12 111.571 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.477 HG21 HG21 ' A' ' 413' ' ' ILE . 69.8 t -135.46 134.77 52.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 113.869 -1.514 . . . . 1.0900000000000001 108.265 173.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.7 tp -112.93 143.43 44.23 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.157 0.503 . . . . 0.13 110.408 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.13 146.64 21.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.74 -1.578 . . . . 0.089999999999999997 106.74 164.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.729 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 21.0 p90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.523 -0.751 . . . . 1.1599999999999999 111.217 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.821 -0.511 . . . . 3.9399999999999999 111.821 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -84.66 96.3 9.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.047 0.451 . . . . 1.8500000000000001 109.85 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 36.9 mtm 63.78 -173.58 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.545 -1.207 . . . . 1.03 111.427 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -144.37 -5.69 0.75 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.641 -0.709 . . . . 1.1000000000000001 111.329 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.95 167.08 0.64 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.77 1.272 . . . . 0.97999999999999998 113.018 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.638 HG23 ' HA ' ' A' ' 358' ' ' LYS . 6.9 m -92.78 123.14 35.84 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.417 -1.72 . . . . 0.45000000000000001 108.518 172.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.645 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 14.0 p90 -164.66 -169.81 1.84 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.136 -0.938 . . . . 0.32000000000000001 110.443 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -103.57 158.07 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.178 -0.919 . . . . 0.080000000000000002 108.6 166.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.501 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.6 tt0 -140.07 155.91 46.82 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 118.89 0.768 . . . . 0.17000000000000001 111.131 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.672 HG22 ' HG3' ' A' ' 354' ' ' MET . 56.3 t -151.07 138.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.721 -1.127 . . . . 0.080000000000000002 109.432 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.45 115.35 23.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.723 -1.126 . . . . 0.37 108.076 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.521 ' H ' HD22 ' A' ' 349' ' ' LEU . 2.0 mm? -66.51 -47.83 71.71 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.789 1.281 . . . . 0.32000000000000001 110.319 -175.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -55.38 -53.87 50.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.49 -2.141 . . . . 1.51 112.384 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -98.03 10.34 40.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 114.093 -1.412 . . . . 0.91000000000000003 108.51 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.906 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.0 mm-40 38.01 69.48 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 125.316 1.635 . . . . 2.2200000000000002 111.841 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.479 ' CD2' ' CE2' ' A' ' 355' ' ' TRP . 7.7 t60 -148.16 125.96 11.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.273 -0.876 . . . . 0.13 109.729 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.672 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -113.0 127.96 56.37 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.57 0.7 . . . . 0.059999999999999998 110.428 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.729 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.0 m-90 -112.78 173.16 6.51 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 114.386 -1.279 . . . . 0.10000000000000001 111.76 -176.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.643 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -125.25 113.65 17.91 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.97 -1.863 . . . . 0.22 105.97 163.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 344' ' ' TYR . 22.1 m-85 -95.35 126.0 40.36 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.17999999999999999 112.028 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.638 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.0 ttpt -148.19 139.02 23.07 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 113.293 -1.776 . . . . 0.46999999999999997 108.305 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.447 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.63 14.89 6.1 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.677 -1.601 . . . . 0.59999999999999998 109.0 178.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.59 16.45 77.67 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.555 -2.111 . . . . 0.23000000000000001 111.653 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.666 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.5 OUTLIER -138.37 178.44 7.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.238 -2.134 . . . . 0.68000000000000005 105.238 -170.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.729 HG11 ' CD1' ' A' ' 355' ' ' TRP . 3.0 m -107.0 135.67 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-O 124.093 1.901 . . . . 0.53000000000000003 112.517 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.542 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -86.29 -26.0 25.19 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 109.412 -3.54 . . . . 0.12 108.009 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.671 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.25 154.68 36.23 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 113.953 -1.476 . . . . 0.080000000000000002 109.785 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.5 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 2.0 pt-20 -162.41 121.99 2.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 110.533 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.645 ' HB ' HG11 ' A' ' 449' ' ' VAL . 6.0 t -149.35 167.28 26.55 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 122.352 1.072 . . . . 0.089999999999999997 112.662 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.0 p-10 -86.11 141.5 29.36 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 112.925 -1.943 . . . . 1.8799999999999999 107.64 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.653 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -141.79 -176.31 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.546 -0.752 . . . . 0.11 112.356 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.906 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -151.71 116.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.051 -0.977 . . . . 0.12 110.322 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.459 ' OG ' HD12 ' A' ' 349' ' ' LEU . 56.5 p -140.53 141.09 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.475 0.916 . . . . 0.69999999999999996 113.475 -163.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.767 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.54 46.86 45.34 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 116.961 1.545 . . . . 0.13 116.961 162.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.534 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 6.1 pttt -46.05 145.71 2.4 Favored Pre-proline 0 C--O 1.216 -0.678 0 CA-C-N 119.318 1.559 . . . . 0.47999999999999998 111.041 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.802 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.3 OUTLIER -37.95 -31.19 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 125.244 3.962 . . . . 0.23000000000000001 115.276 -175.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.3 p -81.88 -33.33 30.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 0.29999999999999999 111.096 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -140.47 71.61 31.8 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 122.134 0.969 . . . . 0.29999999999999999 110.066 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.767 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.1 Cg_exo -69.93 163.0 40.04 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 125.552 4.168 . . . . 0.16 115.451 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.65 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.64 154.5 87.44 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 113.285 -1.779 . . . . 0.12 111.127 172.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.506 ' CD ' HG22 ' A' ' 377' ' ' THR . 3.4 Cg_endo -83.81 -52.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 1 C-N-CA 125.378 4.052 . . . . 0.089999999999999997 114.334 -172.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.71 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 70.64 122.79 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.932 1.086 . . . . 0.089999999999999997 113.932 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.66 -129.59 1.96 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 114.135 -1.393 . . . . 0.11 111.363 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.78 98.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.363 -0.977 . . . . 0.89000000000000001 108.363 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.821 ' HB2' HG22 ' A' ' 463' ' ' VAL . 97.0 m-85 -102.69 166.76 10.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.392 -0.822 . . . . 0.16 110.484 -169.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.699 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -150.09 139.23 21.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 119.753 -0.165 . . . . 0.68999999999999995 110.62 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -75.5 119.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 119.723 -0.791 . . . . 0.14000000000000001 110.432 176.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -107.26 4.5 26.66 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.796 -0.638 . . . . 0.19 112.616 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.646 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 12.5 t-20 -162.98 146.3 10.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.766 -1.198 . . . . 0.40999999999999998 107.766 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 387' ' ' LYS . 0.2 OUTLIER -119.45 112.11 18.98 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.102 -1.073 . . . . 1.0900000000000001 108.102 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.569 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -118.33 128.21 54.44 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.399 -1.273 . . . . 0.38 111.052 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 42.6 mt-10 -128.2 134.21 49.0 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.849 -1.523 . . . . 1.96 109.827 -177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.5 t70 52.53 39.39 27.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 123.367 1.556 . . . . 0.40000000000000002 107.675 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -94.06 169.84 9.97 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 112.439 -2.164 . . . . 0.16 111.546 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 19.9 m -127.12 105.25 8.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.094 -1.412 . . . . 0.27000000000000002 110.033 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.5 mp -71.74 154.66 41.18 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.375 -1.739 . . . . 0.23999999999999999 109.692 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.7 mtpt -154.49 175.59 13.41 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 114.583 -1.19 . . . . 0.67000000000000004 108.26 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 167.22 166.09 25.72 Favored Glycine 0 CA--C 1.476 -2.354 0 C-N-CA 117.565 -2.255 . . . . 0.81000000000000005 113.866 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.55 121.11 34.62 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-O 122.771 1.272 . . . . 0.79000000000000004 109.179 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.45 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 3.0 m120 -51.62 179.29 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 111.649 -2.523 . . . . 1.1200000000000001 111.017 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.56 -21.9 29.69 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.511 0.672 . . . . 1.6499999999999999 110.612 168.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.34 -25.51 21.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.372 -0.831 . . . . 2.0 111.775 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.04 33.41 5.77 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 119.902 -1.142 . . . . 0.66000000000000003 110.473 -169.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.532 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 73.0 p -116.4 127.4 26.78 Favored Pre-proline 0 N--CA 1.418 -2.066 0 N-CA-C 107.644 -1.243 . . . . 0.68000000000000005 107.644 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.922 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.4 Cg_exo -70.26 149.28 63.46 Favored 'Trans proline' 0 C--N 1.29 -2.53 0 C-N-CA 122.414 2.076 . . . . 0.81000000000000005 111.678 -175.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 20.4 p90 -138.79 -175.95 4.32 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 112.984 -1.916 . . . . 0.38 108.249 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.4 mt-10 -146.17 156.81 43.68 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.337 1.065 . . . . 0.62 111.287 175.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.705 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.6 m -143.89 97.76 5.32 Favored Pre-proline 0 N--CA 1.419 -2.019 0 CA-C-N 113.067 -1.878 . . . . 1.3300000000000001 109.06 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 72.9 Cg_endo -67.5 106.46 1.25 Allowed 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 124.269 3.313 . . . . 0.20000000000000001 112.726 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -116.79 163.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.695 -1.138 . . . . 0.29999999999999999 111.206 -174.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 11.2 m120 -113.91 -31.51 6.38 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.083 -1.871 . . . . 1.8400000000000001 107.39 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.485 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 70.9 m-85 -136.98 116.16 12.53 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.063 -1.881 . . . . 0.44 110.905 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.766 ' HB2' HG11 ' A' ' 407' ' ' VAL . 5.7 t-105 -124.02 134.15 53.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.44 -1.255 . . . . 0.13 110.974 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.847 ' SD ' HG22 ' A' ' 457' ' ' VAL . 5.8 mtm -134.32 88.05 31.38 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 114.728 -1.124 . . . . 0.40999999999999998 112.28 171.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.03 137.87 29.94 Favored 'Trans proline' 0 CA--C 1.506 -0.897 0 C-N-CA 123.113 2.542 . . . . 0.16 111.744 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.9 pt -123.51 -16.37 5.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 113.763 -1.562 . . . . 0.17000000000000001 110.696 -173.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -135.15 158.51 44.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.748 -0.66 . . . . 1.5900000000000001 109.895 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -87.92 13.55 10.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.337 0.495 . . . . 0.31 112.337 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 5.8 p -92.15 -25.85 18.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.444 -1.317 . . . . 0.44 107.444 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 120.06 30.79 1.4 Allowed Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 112.933 -1.939 . . . . 0.23999999999999999 111.78 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 441' ' ' GLY . 53.4 t -100.94 147.5 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.384 -0.408 . . . . 0.17000000000000001 110.73 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.27 -168.5 41.27 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.191 -0.913 . . . . 0.10000000000000001 112.058 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.41 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -104.06 139.55 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.56 -0.904 . . . . 0.12 108.56 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.805 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.7 p80 -151.84 164.88 36.13 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.641 0.734 . . . . 0.14999999999999999 112.079 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.73 141.4 28.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 113.931 -1.486 . . . . 0.41999999999999998 107.549 172.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 3.6 t -138.57 104.28 5.09 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 123.194 1.473 . . . . 1.48 110.731 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.37 -30.77 14.94 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.798 -2.456 . . . . 0.34999999999999998 110.852 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.429 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 14.6 p90 -68.27 -27.32 66.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.541 -1.209 . . . . 0.17999999999999999 109.475 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.489 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.1 81.59 28.53 Favored Pre-proline 0 CA--C 1.495 -1.144 0 CA-C-N 113.747 -1.57 . . . . 1.3300000000000001 109.798 -175.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -82.55 6.52 5.71 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 124.833 3.689 . . . . 0.23000000000000001 114.522 -161.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -114.72 151.09 34.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.508 -0.553 . . . . 1.1000000000000001 109.508 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.586 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -160.73 128.25 4.35 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.578 1.151 . . . . 0.38 108.115 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.62 -166.53 28.72 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.31 -1.424 . . . . 0.13 111.254 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.32 152.47 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 O-C-N 125.159 1.152 . . . . 0.20000000000000001 113.006 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.435 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 4.1 m-20 -55.04 101.5 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 123.506 1.622 . . . . 0.33000000000000002 112.136 -146.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.9 mt -96.73 -31.31 12.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 110.856 -2.883 . . . . 0.17999999999999999 109.364 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.55 ' HA ' HG23 ' A' ' 369' ' ' VAL . 12.8 p-90 -50.0 -31.99 14.13 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 112.84 -1.982 . . . . 0.22 111.871 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.802 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 38.5 mttt -65.27 -20.56 66.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.356 -0.838 . . . . 0.64000000000000001 112.685 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.0 p -118.65 -37.92 3.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.29 -0.868 . . . . 0.25 110.297 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.488 ' HB2' HG21 ' A' ' 369' ' ' VAL . 7.4 mtp85 -83.35 -16.24 46.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.868 -1.06 . . . . 0.35999999999999999 113.056 -169.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 77.72 40.74 21.31 Favored Glycine 0 C--N 1.31 -0.861 0 N-CA-C 116.895 1.518 . . . . 0.20999999999999999 116.895 159.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 19.8 m -80.72 136.52 36.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 118.26 1.03 . . . . 0.46999999999999997 109.763 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -98.03 65.77 1.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.943 -0.473 . . . . 0.40999999999999998 110.932 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.569 ' H ' ' HA2' ' A' ' 371' ' ' GLY . . . 87.29 -14.1 58.44 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.618 -0.993 . . . . 0.17999999999999999 110.618 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.4 p -85.36 148.58 25.95 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.464 -0.368 . . . . 0.82999999999999996 110.142 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.65 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -99.37 123.2 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 122.212 1.005 . . . . 0.14999999999999999 110.934 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.753 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.7 OUTLIER -81.44 83.35 6.98 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.51 -1.677 . . . . 1.77 111.395 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 24.5 m -88.04 138.02 31.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-O 121.558 0.694 . . . . 0.17999999999999999 109.581 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.413 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.7 Cg_exo -57.48 136.15 74.17 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.716 2.277 . . . . 0.12 111.827 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.5 Cg_exo -53.93 -32.77 69.26 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 124.547 3.498 . . . . 0.16 112.915 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.2 m -79.52 -41.94 26.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.383 -1.281 . . . . 1.1699999999999999 109.881 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 366' ' ' THR . 65.4 t -78.58 -30.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.558 0.694 . . . . 0.17000000000000001 111.7 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.738 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.24 -19.44 65.52 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.851 0.834 . . . . 0.46000000000000002 110.294 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -79.31 -23.23 43.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 114.494 -1.23 . . . . 0.81000000000000005 111.01 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.708 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.04 -46.98 15.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 113.075 -1.875 . . . . 0.38 107.193 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.0 tp -64.24 -66.7 0.51 Allowed 'General case' 0 N--CA 1.402 -2.844 0 CA-C-N 111.826 -2.443 . . . . 0.059999999999999998 112.289 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 454' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -52.99 -24.7 10.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.97 1.367 . . . . 0.31 108.387 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.52 -26.01 74.07 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 112.533 -2.121 . . . . 0.13 112.025 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.708 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.4 ptp -94.97 -49.92 5.34 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.876 0.846 . . . . 0.13 111.161 169.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.847 HG22 ' SD ' ' A' ' 411' ' ' MET . 2.1 p -108.61 132.08 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 CA-C-O 123.585 1.66 . . . . 0.23000000000000001 114.447 -167.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.457 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 7.3 pt-20 -140.82 -176.85 4.81 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.335 -3.12 . . . . 0.82999999999999996 106.127 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.619 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.3 mtmt -45.32 154.24 0.18 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.971 1.367 . . . . 0.23999999999999999 114.095 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 98.43 -32.75 6.62 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 112.013 -2.358 . . . . 0.37 112.54 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.583 ' HB ' HG23 ' A' ' 457' ' ' VAL . 6.2 m -83.6 143.12 43.56 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.304 -0.628 . . . . 0.14999999999999999 109.304 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 4.8 Cg_exo -75.36 169.8 21.67 Favored 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 121.789 1.659 . . . . 0.12 111.503 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.29 158.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.891 -1.152 . . . . 1.0900000000000001 107.891 167.221 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.501 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.4 tp -130.56 146.2 52.03 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.514 -0.766 . . . . 0.13 110.331 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.7 147.61 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.501 -1.296 . . . . 0.089999999999999997 107.501 165.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.468 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 16.9 p90 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.499 -0.762 . . . . 1.1599999999999999 111.402 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.691 0 N-CA-C 112.21 -0.356 . . . . 3.9399999999999999 112.21 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 340' ' ' MET . 2.7 t-80 -94.8 94.01 7.82 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.513 0.673 . . . . 1.8500000000000001 110.003 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 12.8 mtp 69.09 178.95 0.25 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.732 -1.576 . . . . 1.03 111.301 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -131.35 -7.01 3.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.135 -0.484 . . . . 1.1000000000000001 110.675 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.21 167.17 0.69 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.983 1.373 . . . . 0.97999999999999998 113.607 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 358' ' ' LYS . 3.9 m -93.28 122.63 35.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.039 -1.891 . . . . 0.45000000000000001 106.94 165.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.632 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.8 p90 -160.16 -170.11 2.72 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.617 0.723 . . . . 0.32000000000000001 111.009 -173.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.581 HD11 ' CB ' ' A' ' 457' ' ' VAL . 11.7 mm -103.91 160.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.781 -1.099 . . . . 0.080000000000000002 108.216 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.488 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.0 tt0 -140.94 156.1 46.13 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 119.0 0.818 . . . . 0.17000000000000001 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.676 HG22 ' HG3' ' A' ' 354' ' ' MET . 68.3 t -150.62 137.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.663 -1.153 . . . . 0.080000000000000002 109.625 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.07 106.36 9.54 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 122.153 0.978 . . . . 0.37 108.826 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.484 HD21 HG23 ' A' ' 465' ' ' VAL . 1.9 mm? -63.4 -38.97 93.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 112.89 -1.959 . . . . 0.32000000000000001 111.298 -168.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.88 -57.06 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 111.673 -2.512 . . . . 1.51 112.552 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -95.64 2.74 54.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 114.685 -1.143 . . . . 0.91000000000000003 110.066 -172.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.871 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.4 mm-40 49.54 66.01 1.24 Allowed 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 112.654 -2.066 . . . . 2.2200000000000002 111.406 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.523 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -145.5 127.4 15.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.344 0.592 . . . . 0.13 109.725 -176.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.676 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.6 ttp -114.15 128.41 56.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.433 -0.803 . . . . 0.059999999999999998 110.613 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.649 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.54 173.29 6.48 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 114.608 -1.178 . . . . 0.10000000000000001 112.084 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.661 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 1.1 t80 -124.79 113.43 17.92 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.666 -1.605 . . . . 0.22 106.666 165.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.496 ' CE1' HG12 ' A' ' 362' ' ' VAL . 19.2 m-85 -96.94 125.41 41.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.303 1.049 . . . . 0.17999999999999999 112.43 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.681 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.8 ttpt -149.34 139.46 22.14 Favored 'General case' 0 N--CA 1.398 -3.075 0 CA-C-N 112.827 -1.988 . . . . 0.46999999999999997 108.091 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.449 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.1 17.62 7.24 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 113.61 -1.632 . . . . 0.59999999999999998 109.011 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.47 18.36 79.19 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 112.466 -2.152 . . . . 0.23000000000000001 111.824 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -138.82 177.61 7.76 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.798 -1.927 . . . . 0.68000000000000005 105.798 -169.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.753 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -106.96 138.09 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 CA-C-O 124.008 1.861 . . . . 0.53000000000000003 112.15 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.648 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.03 -23.76 18.56 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 109.587 -3.46 . . . . 0.12 108.479 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.601 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.7 tp -154.4 154.69 33.69 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.712 -1.585 . . . . 0.080000000000000002 108.977 -172.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.753 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.11 122.43 1.55 Allowed 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.576 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.657 ' HB ' HG11 ' A' ' 449' ' ' VAL . 3.6 t -146.88 166.24 27.31 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.688 0.756 . . . . 0.089999999999999997 111.215 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.49 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 42.1 m-20 -84.84 148.87 26.07 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.463 -1.681 . . . . 1.8799999999999999 106.463 174.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.657 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -144.02 -171.15 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.412 -0.813 . . . . 0.11 110.945 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.871 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -152.99 120.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.995 -1.002 . . . . 0.12 108.604 173.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.497 ' HB2' HG13 ' A' ' 443' ' ' ILE . 5.7 t -143.51 142.91 31.33 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.684 0.994 . . . . 0.69999999999999996 113.684 -167.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.76 44.78 37.34 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 117.046 1.578 . . . . 0.13 117.046 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.591 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.66 145.02 3.21 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 119.255 1.528 . . . . 0.47999999999999998 110.509 -174.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.784 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -35.11 -31.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.803 4.336 . . . . 0.23000000000000001 115.972 -173.283 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.591 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -81.17 -35.87 30.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.29999999999999999 111.033 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.467 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -140.39 72.64 31.43 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 122.227 1.013 . . . . 0.29999999999999999 110.461 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 24.5 Cg_exo -71.02 163.21 40.05 Favored 'Trans proline' 0 C--N 1.322 -0.817 1 C-N-CA 125.526 4.151 . . . . 0.16 114.153 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.7 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.04 153.61 88.68 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.418 -1.719 . . . . 0.12 110.946 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.71 -49.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.038 3.825 . . . . 0.089999999999999997 113.673 -171.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.722 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.66 122.87 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.568 0.951 . . . . 0.089999999999999997 113.568 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.41 -123.55 1.18 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.16 -1.382 . . . . 0.11 111.396 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -127.88 112.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 122.035 0.922 . . . . 0.89000000000000001 108.915 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.768 ' HB2' HG22 ' A' ' 463' ' ' VAL . 94.3 m-85 -115.74 160.87 19.53 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.027 -0.988 . . . . 0.16 109.706 -169.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.752 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 78.5 m-85 -147.63 137.19 22.61 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 119.703 -0.189 . . . . 0.68999999999999995 110.535 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.44 118.2 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 119.258 -0.977 . . . . 0.14000000000000001 110.172 176.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -106.36 2.15 26.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.385 -0.825 . . . . 0.19 112.451 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.681 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 17.0 t-20 -160.24 148.75 16.91 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.815 -1.18 . . . . 0.40999999999999998 107.815 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.5 OUTLIER -119.73 117.88 29.4 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.915 -1.143 . . . . 1.0900000000000001 107.915 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.5 mt-10 -123.54 128.11 49.27 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.523 -1.217 . . . . 0.38 111.265 -173.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -125.75 135.52 52.14 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 113.559 -1.655 . . . . 1.96 109.393 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.89 38.67 29.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 123.338 1.542 . . . . 0.40000000000000002 107.731 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -93.1 170.14 9.87 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.213 -2.267 . . . . 0.16 111.841 -175.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 11.6 m -128.39 104.91 7.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.998 -1.455 . . . . 0.27000000000000002 110.413 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.753 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -76.57 158.43 31.17 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 112.74 -2.027 . . . . 0.23999999999999999 110.628 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 8.6 mtpt -148.6 -176.07 5.18 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 115.218 -0.901 . . . . 0.67000000000000004 109.117 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.34 -142.89 5.17 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 117.196 -2.431 . . . . 0.81000000000000005 115.09 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.65 122.95 13.86 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 112.697 -1.752 . . . . 0.79000000000000004 108.291 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.47 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 4.7 m-20 -54.29 179.97 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 112.587 -2.097 . . . . 1.1200000000000001 111.334 177.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.24 -24.25 26.83 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.21 0.529 . . . . 1.6499999999999999 110.586 168.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.23 -25.33 21.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.68 -0.691 . . . . 2.0 111.724 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.71 34.45 5.23 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.126 -1.035 . . . . 0.66000000000000003 110.694 -170.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 52.0 p -119.18 127.18 26.63 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 106.773 -1.565 . . . . 0.68000000000000005 106.773 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 27.0 Cg_exo -64.16 159.24 44.02 Favored 'Trans proline' 0 C--N 1.285 -2.795 0 C-N-CA 122.037 1.824 . . . . 0.81000000000000005 112.468 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.531 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 24.2 p90 -143.47 -171.69 3.56 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.162 -1.835 . . . . 0.38 106.953 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.6 mt-10 -143.83 160.46 40.73 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.135 0.969 . . . . 0.62 111.52 174.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.753 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.15 99.25 12.31 Favored Pre-proline 0 N--CA 1.418 -2.072 0 CA-C-N 113.429 -1.714 . . . . 1.3300000000000001 107.726 175.222 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.2 Cg_endo -67.42 102.3 0.69 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.348 2.032 . . . . 0.20000000000000001 110.042 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.723 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.2 160.46 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 114.547 -1.206 . . . . 0.29999999999999999 110.362 -173.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -113.59 -32.06 6.3 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.288 -1.778 . . . . 1.8400000000000001 107.377 -174.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.559 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 62.2 m-85 -137.77 115.92 11.73 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.894 -1.957 . . . . 0.44 110.46 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.723 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.1 t-105 -123.56 134.1 53.88 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.932 -1.031 . . . . 0.13 110.823 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.519 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.6 mtp -134.06 86.18 37.89 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.705 -1.134 . . . . 0.40999999999999998 111.297 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 97.7 Cg_endo -72.5 139.52 31.58 Favored 'Trans proline' 0 CA--C 1.507 -0.862 0 C-N-CA 123.063 2.509 . . . . 0.16 111.828 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.752 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.97 -14.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 0.17000000000000001 111.054 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -134.11 164.69 26.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.339 -0.846 . . . . 1.5900000000000001 109.4 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -96.78 14.41 25.25 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.135 0.42 . . . . 0.31 112.135 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.2 p -94.41 -27.05 16.24 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.674 -1.232 . . . . 0.44 107.674 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.27 31.64 0.83 Allowed Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 112.898 -1.955 . . . . 0.23999999999999999 112.166 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 441' ' ' GLY . 73.3 t -102.3 147.47 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.296 0.569 . . . . 0.17000000000000001 110.914 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.94 -166.18 37.73 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 114.637 -1.165 . . . . 0.10000000000000001 111.325 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -104.35 140.3 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.504 -0.925 . . . . 0.12 108.504 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 407' ' ' VAL . 29.4 p80 -151.42 164.26 37.14 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.55 0.69 . . . . 0.14999999999999999 111.428 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.781 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -87.15 146.6 25.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.143 -1.389 . . . . 0.41999999999999998 108.066 172.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.5 m -139.35 102.5 4.5 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.021 1.391 . . . . 1.48 111.003 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.76 -26.96 16.75 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 109.904 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.521 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 12.2 p90 -72.65 -26.6 61.71 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.148 -1.387 . . . . 0.17999999999999999 109.817 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 80.56 25.17 Favored Pre-proline 0 CA--C 1.491 -1.296 0 CA-C-N 114.005 -1.452 . . . . 1.3300000000000001 108.953 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 24.0 Cg_endo -81.94 5.54 6.26 Favored 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 125.083 3.855 . . . . 0.23000000000000001 114.121 -162.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -115.07 150.18 36.34 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.986 -0.552 . . . . 1.1000000000000001 109.516 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.49 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.43 125.02 4.23 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.626 1.203 . . . . 0.38 108.08 -172.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.55 -166.77 29.18 Favored Glycine 0 C--N 1.294 -1.778 0 C-N-CA 119.199 -1.476 . . . . 0.13 111.083 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.64 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.26 153.16 0.0 OUTLIER Glycine 0 C--N 1.338 0.691 0 O-C-N 125.115 1.127 . . . . 0.20000000000000001 113.432 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.405 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.3 m-20 -55.56 100.73 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 123.832 1.777 . . . . 0.33000000000000002 112.063 -147.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.2 mt -96.82 -30.48 13.14 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 110.51 -3.041 . . . . 0.17999999999999999 108.098 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.54 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.0 p-90 -47.34 -38.61 13.21 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.791 0.682 . . . . 0.22 111.496 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.784 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 23.8 mttt -60.92 -23.05 64.95 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.306 -0.861 . . . . 0.64000000000000001 112.855 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 67.5 p -114.4 -37.06 4.44 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.799 0.809 . . . . 0.25 110.248 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.0 mtp85 -85.44 -15.61 42.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.691 -1.14 . . . . 0.35999999999999999 112.761 -169.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.89 41.17 28.74 Favored Glycine 0 C--N 1.313 -0.695 0 N-CA-C 116.128 1.211 . . . . 0.20999999999999999 116.128 159.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 369' ' ' VAL . 1.2 m -79.56 141.76 36.32 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 117.823 0.811 . . . . 0.46999999999999997 109.138 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.422 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 63.2 m80 -110.79 71.93 0.76 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.362 -0.836 . . . . 0.40999999999999998 110.554 -171.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.603 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 83.97 -12.61 52.93 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.377 -1.089 . . . . 0.17999999999999999 110.377 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.482 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.0 p -90.26 145.05 25.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.213 -0.494 . . . . 0.82999999999999996 110.595 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.7 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -104.26 115.45 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.717 -0.674 . . . . 0.14999999999999999 110.416 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.557 ' HB2' HG13 ' A' ' 369' ' ' VAL . 18.7 m120 -79.69 91.96 5.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 1.77 111.217 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 38.3 m -88.45 137.82 30.45 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.29 -0.633 . . . . 0.17999999999999999 109.29 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.6 Cg_exo -55.67 135.94 71.82 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.892 2.395 . . . . 0.12 111.528 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.781 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 40.2 Cg_exo -54.96 -33.99 84.88 Favored 'Trans proline' 0 CA--C 1.502 -1.08 0 C-N-CA 124.372 3.382 . . . . 0.16 112.864 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.8 m -79.32 -40.11 31.15 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.76 -1.109 . . . . 1.1699999999999999 109.857 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.657 HG11 ' HB ' ' A' ' 366' ' ' THR . 72.4 t -78.76 -29.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.763 -0.653 . . . . 0.17000000000000001 111.518 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.691 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.2 tpt -68.08 -18.94 64.8 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.916 0.865 . . . . 0.46000000000000002 110.089 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -79.97 -24.13 41.14 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.432 -1.258 . . . . 0.81000000000000005 110.887 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.701 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.1 mm-40 -79.77 -46.95 16.05 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 112.955 -1.929 . . . . 0.38 107.094 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.562 HD23 ' SD ' ' A' ' 450' ' ' MET . 22.3 tp -64.88 -67.72 0.41 Allowed 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 111.857 -2.429 . . . . 0.059999999999999998 112.576 175.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.519 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 30.0 t80 -50.68 -26.37 5.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.054 1.407 . . . . 0.31 108.201 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.48 -30.72 68.71 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-N 112.316 -2.22 . . . . 0.13 112.052 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -88.57 -49.61 6.79 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.729 0.776 . . . . 0.13 110.714 170.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.661 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 1.3 p -106.91 132.84 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 123.575 1.655 . . . . 0.23000000000000001 114.39 -167.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.515 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 9.3 pt-20 -139.65 -176.68 4.64 Favored 'General case' 0 N--CA 1.404 -2.738 0 CA-C-N 110.646 -2.979 . . . . 0.82999999999999996 106.469 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.1 mtmt -45.4 154.14 0.2 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.971 1.367 . . . . 0.23999999999999999 113.789 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.51 -36.89 3.68 Favored Glycine 0 C--N 1.293 -1.823 0 CA-C-N 112.105 -2.316 . . . . 0.37 112.501 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.53 ' HB ' HG23 ' A' ' 457' ' ' VAL . 4.3 m -79.54 142.76 58.16 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 109.676 -0.491 . . . . 0.14999999999999999 109.676 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.689 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 6.0 Cg_exo -75.9 169.9 21.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 121.931 1.754 . . . . 0.12 111.677 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.91 157.59 38.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.718 -1.216 . . . . 1.0900000000000001 107.718 165.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.0 tp -128.39 145.34 51.11 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.343 -0.844 . . . . 0.13 110.004 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.722 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.33 147.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.158 -1.423 . . . . 0.089999999999999997 107.158 165.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.59 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 18.4 p90 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.4 -0.81 . . . . 1.1599999999999999 111.026 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 112.299 -0.32 . . . . 3.9399999999999999 112.299 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.489 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.5 t-80 -88.72 91.99 9.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.691 -0.485 . . . . 1.8500000000000001 109.691 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 34.7 mtm 73.6 -175.42 0.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.218 -1.356 . . . . 1.03 111.774 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -145.09 -4.97 0.7 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.489 -0.778 . . . . 1.1000000000000001 112.102 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.14 169.41 0.25 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.763 1.268 . . . . 0.97999999999999998 112.411 171.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.666 HG23 ' HA ' ' A' ' 358' ' ' LYS . 2.3 m -91.52 121.52 33.29 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 113.61 -1.632 . . . . 0.45000000000000001 107.741 169.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.665 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.1 p90 -160.11 -171.21 3.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.407 -0.815 . . . . 0.32000000000000001 110.533 -175.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.563 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.5 mm -106.05 161.11 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.25 -1.018 . . . . 0.080000000000000002 108.25 167.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.511 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.7 tt0 -141.57 155.45 45.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.877 0.762 . . . . 0.17000000000000001 111.12 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 354' ' ' MET . 60.0 t -151.05 137.07 12.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.519 -1.218 . . . . 0.080000000000000002 109.763 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -116.61 117.7 30.57 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.04 -1.096 . . . . 0.37 108.04 171.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.556 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -72.5 -46.05 56.51 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.705 0.764 . . . . 0.32000000000000001 109.716 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -59.86 -46.46 89.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.542 -1.663 . . . . 1.51 112.601 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -107.62 19.49 20.1 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.91000000000000003 109.161 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 20.8 mp0 33.6 69.08 0.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 125.743 1.902 . . . . 2.2200000000000002 112.568 171.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.599 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 8.4 t60 -152.06 124.12 8.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.2 0.524 . . . . 0.13 110.054 -176.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.6 ttp -109.82 127.76 54.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.521 0.677 . . . . 0.059999999999999998 110.616 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.655 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.5 m-90 -112.57 173.01 6.58 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.447 -1.251 . . . . 0.10000000000000001 111.925 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.726 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.7 t80 -126.35 118.96 26.14 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.495 -1.668 . . . . 0.22 106.495 165.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 22.4 m-85 -101.12 127.21 47.77 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-O 122.335 1.064 . . . . 0.17999999999999999 112.467 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.666 ' HA ' HG23 ' A' ' 343' ' ' THR . 2.6 ttpt -149.38 139.82 22.42 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-N 112.73 -2.032 . . . . 0.46999999999999997 107.326 174.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 72.74 15.9 4.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.08 -1.418 . . . . 0.59999999999999998 109.069 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.65 79.0 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 112.523 -2.126 . . . . 0.23000000000000001 111.533 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.668 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 2.2 tppt? -140.17 178.23 7.43 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.446 -1.877 . . . . 0.68000000000000005 105.961 -167.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.733 HG21 ' HG2' ' A' ' 365' ' ' GLU . 2.9 m -106.36 138.61 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-O 124.053 1.882 . . . . 0.53000000000000003 112.328 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -94.71 -24.59 17.07 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 109.419 -3.537 . . . . 0.12 108.589 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.617 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.4 tp -153.05 154.91 35.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.701 -1.591 . . . . 0.080000000000000002 108.808 -171.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.733 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.7 122.94 1.21 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.817 -0.629 . . . . 0.60999999999999999 109.475 -174.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.664 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.6 t -147.56 166.84 26.12 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.564 0.697 . . . . 0.089999999999999997 111.406 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 50.6 m-20 -83.92 147.56 27.42 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.08 -1.452 . . . . 1.8799999999999999 107.08 174.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.66 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.281 -0.872 . . . . 0.11 111.425 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.597 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.03 118.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.997 -1.002 . . . . 0.12 108.727 175.355 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.509 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.3 t -142.26 147.85 37.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.327 -0.851 . . . . 0.69999999999999996 112.306 -168.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.44 45.31 55.01 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 116.736 1.454 . . . . 0.13 116.736 162.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.633 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.28 144.24 3.29 Favored Pre-proline 0 C--O 1.217 -0.611 0 CA-C-N 118.706 1.253 . . . . 0.47999999999999998 110.309 -175.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.82 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.69 -29.15 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.593 1 C-N-CA 125.75 4.3 . . . . 0.23000000000000001 116.001 -171.977 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.633 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -84.14 -33.92 24.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.4 0.619 . . . . 0.29999999999999999 111.04 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -140.35 72.08 32.16 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 122.201 1.001 . . . . 0.29999999999999999 110.245 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.9 Cg_exo -70.78 165.55 31.77 Favored 'Trans proline' 0 C--N 1.324 -0.727 1 C-N-CA 125.368 4.046 . . . . 0.16 114.21 -176.568 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.713 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -78.69 152.82 78.08 Favored Pre-proline 0 N--CA 1.435 -1.202 0 CA-C-N 113.799 -1.546 . . . . 0.12 110.427 174.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.527 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.34 -49.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.983 3.788 . . . . 0.089999999999999997 113.311 -172.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.705 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.52 122.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.666 0.987 . . . . 0.089999999999999997 113.666 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.95 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.282 -1.326 . . . . 0.11 111.577 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.3 p -129.09 106.0 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.307 1.051 . . . . 0.89000000000000001 109.323 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.802 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.5 m-85 -109.54 163.88 13.04 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.799 -1.091 . . . . 0.16 110.071 -169.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.687 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 69.6 m-85 -147.93 137.88 22.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 121.261 -0.176 . . . . 0.68999999999999995 110.749 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.622 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.5 124.6 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.863 -0.735 . . . . 0.14000000000000001 110.538 177.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -109.52 4.49 22.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.533 -0.758 . . . . 0.19 112.163 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.717 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 15.2 t-20 -166.52 150.97 7.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.40999999999999998 110.684 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 12.1 mtpt -109.53 118.68 37.23 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.583 0.706 . . . . 1.0900000000000001 109.86 169.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.6 mt-10 -119.4 112.96 20.07 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 123.034 1.397 . . . . 0.38 112.803 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -108.93 136.58 48.23 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 113.785 -1.552 . . . . 1.96 110.994 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 38.7 t70 51.36 34.74 12.38 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 123.466 1.603 . . . . 0.40000000000000002 107.9 -175.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.15 170.82 10.72 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.21 -2.268 . . . . 0.16 111.991 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.0 m -129.32 104.41 7.49 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.742 -1.572 . . . . 0.27000000000000002 109.64 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.728 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.12 155.06 40.69 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 112.889 -1.959 . . . . 0.23999999999999999 109.972 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.6 mtpt -155.86 172.48 18.29 Favored 'General case' 0 N--CA 1.404 -2.767 0 O-C-N 124.529 1.143 . . . . 0.67000000000000004 108.543 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.93 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 171.48 166.45 30.26 Favored Glycine 0 CA--C 1.48 -2.135 0 C-N-CA 117.518 -2.277 . . . . 0.81000000000000005 113.938 -175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 115.91 28.91 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 122.745 1.26 . . . . 0.79000000000000004 109.448 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.572 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.2 m-80 -50.96 179.49 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 111.543 -2.571 . . . . 1.1200000000000001 113.261 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.38 -24.92 8.53 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.065 0.459 . . . . 1.6499999999999999 110.83 166.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.538 ' HB3' HG23 ' A' ' 401' ' ' THR . 0.2 OUTLIER -90.53 -24.7 20.55 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.304 0.573 . . . . 2.0 110.741 -175.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.49 34.24 5.88 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 110.126 -1.19 . . . . 0.66000000000000003 110.126 -169.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.572 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 42.2 p -117.01 128.9 25.71 Favored Pre-proline 0 N--CA 1.416 -2.148 0 N-CA-C 107.772 -1.196 . . . . 0.68000000000000005 107.772 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.93 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.1 Cg_exo -70.55 146.99 56.8 Favored 'Trans proline' 0 N--CA 1.422 -2.714 0 C-N-CA 122.447 2.098 . . . . 0.81000000000000005 111.423 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.634 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 19.3 p90 -140.56 -177.77 5.2 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 112.692 -2.049 . . . . 0.38 107.995 -175.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.7 mt-10 -141.47 162.8 34.61 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.764 1.269 . . . . 0.62 112.111 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.728 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -140.1 98.15 7.65 Favored Pre-proline 0 N--CA 1.421 -1.916 0 CA-C-N 112.356 -2.202 . . . . 1.3300000000000001 107.768 172.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 62.9 Cg_endo -68.17 102.66 0.82 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.325 2.017 . . . . 0.20000000000000001 110.658 175.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.786 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.06 163.84 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.684 -1.144 . . . . 0.29999999999999999 110.393 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 390' ' ' ASP . 11.9 m120 -115.94 -31.38 5.77 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 113.517 -1.674 . . . . 1.8400000000000001 107.602 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.462 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 55.8 m-85 -138.61 115.65 10.92 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.142 -1.845 . . . . 0.44 110.107 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.786 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.09 135.65 54.48 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.075 -0.966 . . . . 0.13 109.95 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.525 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -135.89 85.1 30.12 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.98 -1.009 . . . . 0.40999999999999998 111.019 174.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.712 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.6 Cg_endo -71.41 140.67 37.15 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.98 2.453 . . . . 0.16 112.236 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -124.25 -15.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.841 -1.527 . . . . 0.17000000000000001 111.105 -173.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -134.36 166.01 23.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 1.5900000000000001 109.328 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.44 13.86 31.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.405 0.52 . . . . 0.31 112.405 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.2 p -92.88 -27.1 17.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.342 -1.355 . . . . 0.44 107.342 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 126.65 32.25 0.72 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 113.062 -1.881 . . . . 0.23999999999999999 112.36 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 441' ' ' GLY . 72.4 t -102.59 147.62 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 121.24 0.543 . . . . 0.17000000000000001 111.164 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.57 -166.0 38.16 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.979 -1.009 . . . . 0.10000000000000001 111.621 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.33 140.35 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.846 -0.798 . . . . 0.12 108.846 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 33.4 p80 -150.83 165.42 33.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.763 0.792 . . . . 0.14999999999999999 111.556 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.53 139.64 30.33 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.936 -1.484 . . . . 0.41999999999999998 107.611 172.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.8 p -128.49 99.79 5.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.897 1.332 . . . . 1.48 109.957 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.0 -34.41 11.78 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 112.497 -2.138 . . . . 0.34999999999999998 110.778 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.553 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 11.2 p90 -67.14 -26.91 66.9 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.566 -1.197 . . . . 0.17999999999999999 109.213 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.588 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.98 81.91 20.41 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.586 -1.643 . . . . 1.3300000000000001 109.253 -174.223 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 28.7 Cg_endo -79.91 5.9 5.63 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 C-N-CA 124.844 3.696 . . . . 0.23000000000000001 113.824 -161.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.76 153.53 30.16 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.945 -0.57 . . . . 1.1000000000000001 111.14 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -164.0 123.72 2.05 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 114.347 -1.297 . . . . 0.38 108.341 -172.176 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.61 -166.66 28.71 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 119.394 -1.384 . . . . 0.13 110.535 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.63 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.94 151.7 0.0 OUTLIER Glycine 0 C--N 1.34 0.767 0 O-C-N 125.296 1.233 . . . . 0.20000000000000001 113.416 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 124.089 1.9 . . . . 0.33000000000000002 111.913 -152.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 46.5 mt -97.17 -33.47 11.48 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 109.964 -3.289 . . . . 0.17999999999999999 107.752 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.597 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.82 -37.48 6.17 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.961 0.788 . . . . 0.22 111.61 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.82 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 35.3 mttt -60.51 -24.4 65.29 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.984 -1.007 . . . . 0.64000000000000001 112.737 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -114.8 -36.43 4.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.753 0.787 . . . . 0.25 110.044 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.588 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.4 mtp85 -83.72 -15.02 50.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.553 -1.203 . . . . 0.35999999999999999 112.724 -169.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.49 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.41 40.9 38.72 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.331 1.292 . . . . 0.20999999999999999 116.331 159.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.4 m -81.88 134.5 35.41 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 118.038 0.919 . . . . 0.46999999999999997 109.612 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -99.28 70.45 1.75 Allowed 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.771 -0.58 . . . . 0.40999999999999998 110.466 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.644 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 80.72 -7.13 59.56 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.754 -0.938 . . . . 0.17999999999999999 110.754 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 19.1 p -93.05 131.09 38.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.692 0.758 . . . . 0.82999999999999996 110.548 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -91.61 113.74 27.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.978 -1.01 . . . . 0.14999999999999999 110.494 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.576 ' HB2' HG13 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -76.89 89.73 3.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.992 -1.003 . . . . 1.77 110.982 -177.167 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.623 HG23 HG21 ' A' ' 366' ' ' THR . 31.5 m -89.05 136.09 30.88 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 109.214 -0.661 . . . . 0.17999999999999999 109.214 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.451 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.2 Cg_exo -57.46 131.93 47.6 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.39 . . . . 0.12 113.107 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.763 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.9 Cg_exo -50.79 -39.1 58.06 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 123.463 2.775 . . . . 0.16 112.398 -168.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 451' ' ' LYS . 17.0 p -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.529 -1.214 . . . . 1.1699999999999999 109.974 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.664 HG11 ' HB ' ' A' ' 366' ' ' THR . 68.7 t -78.37 -29.64 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.211 0.529 . . . . 0.17000000000000001 111.252 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.674 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.48 -20.28 65.45 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 122.009 0.909 . . . . 0.46000000000000002 110.013 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 448' ' ' SER . 0.1 OUTLIER -75.67 -29.71 59.15 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 114.059 -1.428 . . . . 0.81000000000000005 111.266 176.195 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -76.05 -47.28 25.29 Favored 'General case' 0 CA--C 1.473 -2.0 0 CA-C-N 112.645 -2.07 . . . . 0.38 107.297 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.584 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.9 tp -64.57 -66.49 0.54 Allowed 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 111.771 -2.468 . . . . 0.059999999999999998 112.546 175.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.444 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.6 t80 -50.32 -24.93 3.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.041 1.4 . . . . 0.31 108.342 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.8 -28.14 63.49 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 112.432 -2.167 . . . . 0.13 111.967 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -89.84 -48.4 7.26 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 121.769 0.795 . . . . 0.13 111.461 170.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.563 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.7 OUTLIER -103.21 137.45 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 CA-C-O 123.503 1.62 . . . . 0.23000000000000001 114.297 -167.167 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.83 -178.6 5.26 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 110.592 -3.004 . . . . 0.82999999999999996 106.607 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.717 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.5 mtmt -52.1 162.19 0.51 Allowed 'General case' 0 N--CA 1.413 -2.324 0 CA-C-O 123.092 1.425 . . . . 0.23999999999999999 113.009 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.92 4.55 Favored Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 112.576 -2.102 . . . . 0.37 112.535 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.3 m -77.04 141.13 67.13 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.231 -0.655 . . . . 0.14999999999999999 109.231 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.665 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.8 Cg_exo -73.62 167.42 27.3 Favored 'Trans proline' 0 N--CA 1.427 -2.438 0 C-N-CA 121.677 1.585 . . . . 0.12 111.106 174.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.802 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.7 156.78 38.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.398 -1.334 . . . . 1.0900000000000001 107.398 166.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.491 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.1 tp -128.06 145.33 51.03 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 115.552 -0.749 . . . . 0.13 110.17 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.32 147.72 20.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.962 -1.496 . . . . 0.089999999999999997 106.962 165.04 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.692 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.8 p90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.079 -0.962 . . . . 1.1599999999999999 111.573 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.63 -0.588 . . . . 3.9399999999999999 111.63 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -75.36 100.55 4.46 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.028 0.442 . . . . 1.8500000000000001 110.278 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 17.8 mtp 63.87 -176.49 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.459 -1.246 . . . . 1.03 111.512 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -141.36 -6.6 1.04 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.126 -0.488 . . . . 1.1000000000000001 111.63 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -56.43 167.45 0.69 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 123.281 1.515 . . . . 0.97999999999999998 113.246 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.629 HG23 ' HA ' ' A' ' 358' ' ' LYS . 96.2 m -94.12 123.14 37.31 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 112.834 -1.985 . . . . 0.45000000000000001 107.754 167.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.658 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 10.7 p90 -160.58 -170.73 2.87 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.031 -0.986 . . . . 0.32000000000000001 110.987 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.576 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -102.53 157.2 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 107.693 -1.225 . . . . 0.080000000000000002 107.693 165.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.2 tt0 -137.91 154.08 49.46 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 118.59 0.632 . . . . 0.17000000000000001 110.659 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 354' ' ' MET . 58.0 t -150.81 135.17 9.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.911 -1.04 . . . . 0.080000000000000002 109.913 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -114.78 117.88 32.0 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.607 -1.179 . . . . 0.37 108.097 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.531 HD21 HG23 ' A' ' 465' ' ' VAL . 2.0 mm? -72.07 -48.77 41.75 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.335 1.064 . . . . 0.32000000000000001 110.122 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -54.58 -51.68 64.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.026 -1.897 . . . . 1.51 112.374 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -104.4 16.62 25.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.38 -1.282 . . . . 0.91000000000000003 108.914 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.789 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.7 mm-40 34.09 69.27 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 112.94 -1.936 . . . . 2.2200000000000002 112.55 172.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.473 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.8 t60 -150.05 125.38 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.702 -0.681 . . . . 0.13 109.561 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.666 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -111.78 128.44 56.1 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.495 0.664 . . . . 0.059999999999999998 110.356 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.618 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 30.9 m-90 -113.07 171.71 7.38 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.438 -1.255 . . . . 0.10000000000000001 111.636 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.685 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.6 t80 -122.3 116.07 23.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.823 -1.918 . . . . 0.22 105.823 164.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.468 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 21.0 m-85 -100.82 131.35 46.75 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.739 0.78 . . . . 0.17999999999999999 110.962 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.662 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 4.6 ttpt -147.7 137.66 22.82 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 114.266 -1.334 . . . . 0.46999999999999997 108.656 174.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.8 OUTLIER 69.72 18.31 7.54 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 113.104 -1.862 . . . . 0.59999999999999998 108.34 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.01 71.89 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 112.28 -2.236 . . . . 0.23000000000000001 111.834 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.622 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.84 165.39 27.42 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.91 -1.645 . . . . 0.68000000000000005 106.729 -168.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.622 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 54.5 t -94.66 132.42 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 123.54 1.638 . . . . 0.53000000000000003 111.632 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.685 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -98.87 -28.14 13.59 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 110.944 -2.844 . . . . 0.12 109.856 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.631 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.2 tp -152.64 148.61 27.52 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.408 -1.269 . . . . 0.080000000000000002 109.625 -170.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.618 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -158.71 123.02 4.05 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.257 -0.428 . . . . 0.60999999999999999 110.099 -171.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.652 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.9 t -148.93 166.74 27.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 122.402 1.096 . . . . 0.089999999999999997 112.262 172.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.616 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.9 p-10 -86.01 141.27 29.6 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 112.827 -1.988 . . . . 1.8799999999999999 107.418 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.642 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.83 -171.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.477 -0.783 . . . . 0.11 112.155 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.789 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.26 119.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.998 -1.001 . . . . 0.12 109.529 175.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.8 t -142.35 144.56 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 0.69999999999999996 112.642 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.02 45.37 26.56 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 116.784 1.474 . . . . 0.13 116.784 163.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.551 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.6 143.08 5.99 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-N 118.921 1.361 . . . . 0.47999999999999998 110.007 -174.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.768 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -32.94 -31.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.7 1 C-N-CA 126.056 4.504 . . . . 0.23000000000000001 116.471 -170.041 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 398' ' ' ASP . 1.9 p -81.94 -33.75 30.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.208 0.528 . . . . 0.29999999999999999 111.126 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.462 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.8 m -140.16 73.82 31.33 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-O 122.212 1.006 . . . . 0.29999999999999999 109.955 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.9 Cg_exo -71.21 161.73 44.86 Favored 'Trans proline' 0 C--N 1.319 -0.998 1 C-N-CA 125.308 4.006 . . . . 0.16 113.741 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.682 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.95 152.18 90.84 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-N 113.657 -1.611 . . . . 0.12 110.67 175.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.523 ' HG2' ' CE1' ' A' ' 382' ' ' PHE . 1.4 Cg_endo -80.18 -49.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 125.044 3.829 . . . . 0.089999999999999997 113.497 -171.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.711 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.23 123.04 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.143 0.973 . . . . 0.089999999999999997 113.545 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.82 -126.31 1.48 Allowed Glycine 0 N--CA 1.436 -1.325 0 CA-C-N 113.895 -1.502 . . . . 0.11 110.671 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.9 p -129.18 104.46 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.286 1.041 . . . . 0.89000000000000001 109.346 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.628 ' CE2' HG22 ' A' ' 465' ' ' VAL . 51.1 m-85 -107.78 169.25 8.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.005 -0.998 . . . . 0.16 109.173 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.702 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 74.1 m-85 -148.92 138.04 21.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 121.225 -0.19 . . . . 0.68999999999999995 110.579 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.17 123.66 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 119.833 -0.747 . . . . 0.14000000000000001 110.123 176.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -111.63 6.48 20.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.412 -0.813 . . . . 0.19 111.846 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.719 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 14.0 t-20 -166.7 150.66 7.15 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.401 -0.818 . . . . 0.40999999999999998 110.93 175.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.7 mtpt -109.99 120.32 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.529 -0.76 . . . . 1.0900000000000001 109.466 169.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.574 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.9 mt-10 -122.58 112.88 18.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 123.29 1.519 . . . . 0.38 113.243 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 24.0 mp0 -108.93 135.38 50.22 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.509 -1.678 . . . . 1.96 111.022 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 24.6 t70 52.23 35.69 17.5 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.582 1.658 . . . . 0.40000000000000002 107.545 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.03 170.81 10.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.196 -2.275 . . . . 0.16 112.225 -175.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 30.5 m -128.12 102.53 6.76 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.341 -1.754 . . . . 0.27000000000000002 109.937 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.727 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.42 156.49 36.95 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.878 -1.965 . . . . 0.23999999999999999 110.262 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 10.3 mtpt -154.08 169.34 23.76 Favored 'General case' 0 N--CA 1.401 -2.918 0 O-C-N 124.235 0.959 . . . . 0.67000000000000004 108.701 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.911 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 177.73 164.58 31.36 Favored Glycine 0 CA--C 1.479 -2.177 0 C-N-CA 118.085 -2.007 . . . . 0.81000000000000005 113.302 -172.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.02 115.82 29.84 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 122.863 1.316 . . . . 0.79000000000000004 110.082 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.6 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 2.4 m120 -50.95 -179.72 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 111.376 -2.647 . . . . 1.1200000000000001 114.046 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' A' ' 374' ' ' THR . 0.0 OUTLIER -51.15 -23.68 3.47 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.451 -0.795 . . . . 1.6499999999999999 110.697 168.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.481 ' HB3' HG23 ' A' ' 401' ' ' THR . 3.9 t70 -96.88 -25.83 15.3 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.586 0.707 . . . . 2.0 110.525 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.76 34.04 5.08 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 109.897 -1.281 . . . . 0.66000000000000003 109.897 -167.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 36.9 p -115.41 127.36 26.87 Favored Pre-proline 0 N--CA 1.413 -2.275 0 N-CA-C 107.154 -1.425 . . . . 0.68000000000000005 107.154 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.911 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.5 Cg_exo -69.73 147.35 62.84 Favored 'Trans proline' 0 N--CA 1.42 -2.847 0 C-N-CA 122.299 1.999 . . . . 0.81000000000000005 111.462 -175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 11.5 p90 -135.43 -174.69 3.7 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 112.694 -2.048 . . . . 0.38 107.13 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 5.4 mt-10 -143.53 163.09 34.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.448 1.118 . . . . 0.62 112.302 175.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.727 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.21 98.77 9.14 Favored Pre-proline 0 N--CA 1.422 -1.843 0 CA-C-N 113.012 -1.904 . . . . 1.3300000000000001 108.193 174.733 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.1 Cg_endo -67.42 102.7 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.454 2.102 . . . . 0.20000000000000001 110.336 174.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.64 160.88 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.397 -1.274 . . . . 0.29999999999999999 110.134 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 10.4 m120 -111.82 -32.85 6.49 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.656 -1.611 . . . . 1.8400000000000001 107.19 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.443 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 49.8 m-85 -137.67 115.98 11.87 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.064 -1.88 . . . . 0.44 110.225 175.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.778 ' HB2' HG11 ' A' ' 407' ' ' VAL . 9.8 t-105 -122.87 135.57 54.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.957 -1.02 . . . . 0.13 109.794 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.54 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.5 OUTLIER -136.34 86.07 25.19 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.882 -1.054 . . . . 0.40999999999999998 110.851 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.6 Cg_endo -72.34 141.5 35.51 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.975 2.45 . . . . 0.16 111.691 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.52 -15.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.393 -1.276 . . . . 0.17000000000000001 111.809 -171.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.818 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 3.9 p30 -135.98 171.03 15.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.778 -0.646 . . . . 1.5900000000000001 110.074 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -98.23 16.43 21.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 0.31 111.681 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.9 p -99.65 -27.91 13.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.583 -0.895 . . . . 0.44 108.583 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 132.31 26.24 0.68 Allowed Glycine 0 N--CA 1.432 -1.622 0 CA-C-N 114.337 -1.302 . . . . 0.23999999999999999 113.902 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.818 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.1 t -105.12 152.4 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.523 0.678 . . . . 0.17000000000000001 112.083 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.76 -168.07 40.55 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 114.82 -1.082 . . . . 0.10000000000000001 111.209 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.5 141.6 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 109.119 -0.697 . . . . 0.12 109.119 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.615 ' O ' ' HB ' ' A' ' 445' ' ' THR . 33.7 p80 -150.54 165.04 34.47 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.75 0.786 . . . . 0.14999999999999999 111.768 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.776 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -93.25 142.85 26.85 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.004 -1.453 . . . . 0.41999999999999998 107.16 171.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.93 104.94 5.89 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.925 1.345 . . . . 1.48 110.203 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.97 -27.62 15.56 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 112.34 -2.209 . . . . 0.34999999999999998 111.288 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.533 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 9.0 p90 -69.3 -24.61 63.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.481 -1.236 . . . . 0.17999999999999999 108.877 174.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.436 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.1 OUTLIER -119.17 100.2 50.36 Favored Pre-proline 0 CA--C 1.488 -1.404 0 CA-C-N 112.985 -1.916 . . . . 1.3300000000000001 108.465 -176.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -88.52 2.2 6.21 Favored 'Trans proline' 0 C--N 1.283 -2.914 0 C-N-CA 123.04 2.493 . . . . 0.23000000000000001 114.863 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.41 ' HB3' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -112.97 151.86 30.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.986 -1.086 . . . . 1.1000000000000001 111.567 -177.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.616 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.64 125.77 2.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.762 -1.563 . . . . 0.38 108.472 -171.423 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.71 -169.01 28.6 Favored Glycine 0 C--N 1.299 -1.527 0 C-N-CA 119.416 -1.373 . . . . 0.13 111.203 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.669 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.06 0.01 OUTLIER Glycine 0 C--N 1.34 0.778 0 O-C-N 125.163 1.155 . . . . 0.20000000000000001 112.97 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.403 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.4 m-20 -54.55 100.96 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 123.988 1.852 . . . . 0.33000000000000002 111.799 -146.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.8 mt -97.14 -31.71 12.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 110.09 -3.232 . . . . 0.17999999999999999 108.614 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.606 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.6 p-90 -45.95 -37.68 6.74 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.804 0.69 . . . . 0.22 111.515 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.768 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 56.4 mttt -61.34 -24.18 66.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.113 -0.949 . . . . 0.64000000000000001 113.211 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.5 p -114.85 -37.38 4.21 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.684 0.754 . . . . 0.25 110.162 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.508 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.5 mtp85 -82.36 -15.72 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.78 -1.1 . . . . 0.35999999999999999 112.137 -170.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.551 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 71.87 41.43 55.62 Favored Glycine 0 C--N 1.314 -0.66 0 N-CA-C 116.13 1.212 . . . . 0.20999999999999999 116.13 160.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 38.5 m -90.28 130.1 36.44 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.565 1.182 . . . . 0.46999999999999997 108.522 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.519 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 73.2 m80 -95.4 65.35 2.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.06 -0.4 . . . . 0.40999999999999998 111.187 -166.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.593 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 93.76 -13.77 66.75 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.548 -1.021 . . . . 0.17999999999999999 110.548 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 21.0 p -87.52 138.45 31.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.971 0.415 . . . . 0.82999999999999996 110.455 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -91.72 116.15 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.78 0.8 . . . . 0.14999999999999999 110.768 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.525 ' CB ' HG13 ' A' ' 369' ' ' VAL . 1.8 t-20 -76.73 84.3 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.236 -1.347 . . . . 1.77 111.405 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 51.3 m -89.64 137.96 28.41 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-O 121.659 0.743 . . . . 0.17999999999999999 109.773 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.429 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.8 Cg_exo -57.55 135.84 72.13 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.909 2.406 . . . . 0.12 111.735 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.776 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.8 Cg_exo -55.27 -34.04 86.95 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.256 3.304 . . . . 0.16 112.96 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.7 p -78.54 -39.48 37.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.651 -1.159 . . . . 1.1699999999999999 109.928 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.652 HG11 ' HB ' ' A' ' 366' ' ' THR . 86.2 t -79.58 -31.25 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.866 -0.606 . . . . 0.17000000000000001 111.384 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.696 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.6 tpt -66.76 -18.73 65.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.521 0.677 . . . . 0.46000000000000002 110.448 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -81.04 -23.05 38.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.395 1.093 . . . . 0.81000000000000005 110.989 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 456' ' ' MET . 7.7 mm-40 -79.69 -46.95 16.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 112.841 -1.981 . . . . 0.38 107.106 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.619 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.2 tp -64.39 -66.99 0.47 Allowed 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 111.835 -2.439 . . . . 0.059999999999999998 112.243 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.437 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 33.0 t80 -49.67 -27.04 4.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.018 1.39 . . . . 0.31 108.328 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.57 -30.76 66.12 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 112.465 -2.152 . . . . 0.13 112.409 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -88.38 -48.34 7.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.929 0.871 . . . . 0.13 111.369 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.612 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.6 OUTLIER -102.45 138.03 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 123.587 1.66 . . . . 0.23000000000000001 113.992 -168.045 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.96 -178.44 5.2 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 110.52 -3.037 . . . . 0.82999999999999996 106.419 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.719 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.6 mtmt -50.87 162.96 0.22 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 123.06 1.41 . . . . 0.23999999999999999 113.318 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.02 -35.29 3.95 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 112.577 -2.102 . . . . 0.37 112.47 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 462' ' ' PRO . 17.8 m -72.57 141.69 82.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 CA-C-N 115.252 -0.474 . . . . 0.14999999999999999 109.837 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.658 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.4 164.97 33.73 Favored 'Trans proline' 0 N--CA 1.43 -2.241 0 C-N-CA 122.043 1.829 . . . . 0.12 111.084 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.0 t -135.16 133.45 53.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 CA-C-N 113.702 -1.59 . . . . 1.0900000000000001 107.872 173.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.46 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.9 tp -112.55 142.96 44.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.032 -0.531 . . . . 0.13 110.371 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.711 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.19 147.46 20.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.06 -1.459 . . . . 0.089999999999999997 107.06 165.291 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.654 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.9 p90 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.657 -0.687 . . . . 1.1599999999999999 111.342 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.834 -0.507 . . . . 3.9399999999999999 111.834 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -72.97 98.96 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.21 0.528 . . . . 1.8500000000000001 110.525 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 35.0 mtm 62.74 -176.15 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.466 -1.243 . . . . 1.03 111.921 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.4 -5.15 1.82 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.304 -0.862 . . . . 1.1000000000000001 110.602 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -55.22 167.06 0.48 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 123.026 1.393 . . . . 0.97999999999999998 113.508 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 358' ' ' LYS . 4.1 m -92.74 121.87 34.57 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 112.857 -1.974 . . . . 0.45000000000000001 106.95 165.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.646 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.2 p90 -158.65 -171.03 3.27 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.597 0.713 . . . . 0.32000000000000001 111.081 -174.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.608 HD11 ' HB ' ' A' ' 457' ' ' VAL . 8.9 mm -105.58 161.09 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.719 -1.128 . . . . 0.080000000000000002 108.022 167.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.479 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.2 tt0 -142.42 155.39 45.1 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 118.843 0.747 . . . . 0.17000000000000001 111.046 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.711 HG22 ' HG3' ' A' ' 354' ' ' MET . 63.2 t -150.3 136.57 12.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.795 -1.093 . . . . 0.080000000000000002 109.851 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -117.84 111.28 18.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.721 -1.127 . . . . 0.37 108.053 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.543 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -64.63 -49.41 71.16 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 122.704 1.24 . . . . 0.32000000000000001 110.197 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -53.31 -54.82 30.86 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 112.507 -2.133 . . . . 1.51 112.224 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -94.9 3.86 54.48 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.788 -1.097 . . . . 0.91000000000000003 109.994 -173.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.764 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.2 mm-40 47.01 64.96 1.36 Allowed 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 112.584 -2.098 . . . . 2.2200000000000002 112.27 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.598 ' HE1' ' HB2' ' A' ' 365' ' ' GLU . 15.1 t-80 -145.86 124.62 12.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.107 0.48 . . . . 0.13 110.021 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.711 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.4 ttp -110.83 127.61 55.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.438 0.637 . . . . 0.059999999999999998 110.515 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.638 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.3 m-90 -111.55 173.26 6.43 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.538 -1.21 . . . . 0.10000000000000001 111.889 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.724 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -127.14 117.48 22.46 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 106.251 -1.759 . . . . 0.22 106.251 164.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 25.2 m-85 -100.48 128.6 46.49 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.188 0.994 . . . . 0.17999999999999999 111.898 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.675 ' HA ' HG23 ' A' ' 343' ' ' THR . 5.1 ttpt -148.35 137.37 21.81 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.218 -1.81 . . . . 0.46999999999999997 108.225 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.7 OUTLIER 70.56 14.46 7.27 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 113.409 -1.723 . . . . 0.59999999999999998 108.92 178.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.62 15.65 75.3 Favored Glycine 0 N--CA 1.423 -2.203 0 CA-C-N 112.588 -2.096 . . . . 0.23000000000000001 111.847 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.63 171.75 13.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.954 -1.869 . . . . 0.68000000000000005 105.954 -170.646 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.689 HG21 ' HG2' ' A' ' 365' ' ' GLU . 2.9 m -102.99 137.84 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.834 0 CA-C-O 124.421 2.058 . . . . 0.53000000000000003 112.186 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.724 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.01 -24.76 18.24 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 109.291 -3.595 . . . . 0.12 108.574 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.687 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.4 154.81 36.33 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.854 -1.521 . . . . 0.080000000000000002 109.018 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.689 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.56 122.05 1.41 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.763 -0.653 . . . . 0.60999999999999999 109.442 -175.226 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.697 HG21 HG23 ' A' ' 445' ' ' THR . 5.2 t -148.34 167.55 24.91 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 122.34 1.066 . . . . 0.089999999999999997 112.133 174.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.673 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.0 OUTLIER -86.45 139.97 30.41 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 112.941 -1.936 . . . . 1.8799999999999999 107.41 176.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.643 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.28 -171.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.349 -0.841 . . . . 0.11 112.014 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.764 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.17 117.14 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.862 -1.063 . . . . 0.12 109.203 177.161 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.498 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.0 t -142.85 146.62 34.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.78 -1.1 . . . . 0.69999999999999996 112.531 -168.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.6 45.93 50.36 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 116.824 1.489 . . . . 0.13 116.824 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.498 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.55 144.45 3.44 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 118.994 1.397 . . . . 0.47999999999999998 110.616 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.814 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.74 -29.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 1 C-N-CA 125.848 4.365 . . . . 0.23000000000000001 116.45 -172.412 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.2 p -86.97 -31.99 20.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.465 0.65 . . . . 0.29999999999999999 110.809 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.512 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.7 m -138.47 70.55 45.91 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 122.187 0.994 . . . . 0.29999999999999999 109.892 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.7 Cg_exo -72.64 163.47 38.41 Favored 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.325 4.017 . . . . 0.16 114.36 -175.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.718 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.41 152.65 85.74 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 113.23 -1.804 . . . . 0.12 110.271 173.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.53 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.28 -49.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.326 -0.634 0 C-N-CA 124.909 3.74 . . . . 0.089999999999999997 113.634 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.72 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.71 123.03 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.586 0.958 . . . . 0.089999999999999997 113.586 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.05 -122.76 1.1 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.225 -1.352 . . . . 0.11 111.575 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 381' ' ' VAL . 11.7 p -129.12 107.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.117 0.96 . . . . 0.89000000000000001 109.301 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.789 ' HB2' HG22 ' A' ' 463' ' ' VAL . 98.9 m-85 -110.59 161.95 15.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.154 -0.93 . . . . 0.16 109.945 -170.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.0 m-85 -148.21 135.68 20.59 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 121.234 -0.186 . . . . 0.68999999999999995 111.13 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.607 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.08 125.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.585 0.707 . . . . 0.14000000000000001 110.891 177.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -109.68 2.4 20.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.21 -0.905 . . . . 0.19 111.745 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.752 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 15.8 t-20 -165.17 146.71 7.62 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.355 -0.839 . . . . 0.40999999999999998 110.805 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -107.24 109.8 21.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.179 -0.919 . . . . 1.0900000000000001 109.224 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.575 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -107.74 119.66 40.06 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 122.589 1.185 . . . . 0.38 111.447 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 19.2 mt-10 -115.96 142.15 47.17 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.966 -1.47 . . . . 1.96 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 35.2 t70 55.86 26.87 10.18 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 111.21 -2.723 . . . . 0.40000000000000002 107.656 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 169.64 15.37 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 112.753 -2.021 . . . . 0.16 112.404 -166.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 60.8 m -125.07 102.96 7.75 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 112.866 -1.97 . . . . 0.27000000000000002 109.532 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 9.0 mp -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-N 113.176 -1.829 . . . . 0.23999999999999999 109.76 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.432 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 9.9 mtpt -154.09 172.38 17.62 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 107.814 -1.18 . . . . 0.67000000000000004 107.814 -174.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.914 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 171.95 167.23 31.79 Favored Glycine 0 CA--C 1.481 -2.058 0 C-N-CA 118.052 -2.023 . . . . 0.81000000000000005 113.449 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.4 121.05 32.77 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 123.111 1.434 . . . . 0.79000000000000004 110.842 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 4.0 m-20 -50.21 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 110.935 -2.848 . . . . 1.1200000000000001 112.368 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.31 -24.02 10.71 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.88 -0.6 . . . . 1.6499999999999999 110.513 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.7 -28.83 13.72 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.372 0.606 . . . . 2.0 111.33 -172.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 106.73 32.52 3.57 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.064 -1.065 . . . . 0.66000000000000003 110.706 -167.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 40.0 p -118.4 130.53 24.71 Favored Pre-proline 0 N--CA 1.417 -2.095 0 N-CA-C 106.603 -1.629 . . . . 0.68000000000000005 106.603 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.914 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 24.1 Cg_exo -66.19 156.15 66.28 Favored 'Trans proline' 0 N--CA 1.42 -2.809 0 C-N-CA 121.789 1.659 . . . . 0.81000000000000005 112.898 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.512 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 19.4 p90 -134.46 -169.69 2.39 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.396 -1.729 . . . . 0.38 107.417 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.9 mt-10 -148.41 155.27 41.01 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 122.205 1.002 . . . . 0.62 111.388 172.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.695 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.3 m -142.72 98.05 5.86 Favored Pre-proline 0 N--CA 1.42 -1.959 0 CA-C-N 113.36 -1.745 . . . . 1.3300000000000001 109.478 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.2 Cg_endo -66.89 108.28 1.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 124.648 3.565 . . . . 0.20000000000000001 113.22 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -118.62 161.11 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.495 -1.23 . . . . 0.29999999999999999 110.003 -175.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.5 OUTLIER -100.23 -40.3 7.62 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.394 -1.336 . . . . 1.8400000000000001 107.394 169.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.534 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 10.2 m-30 -125.94 113.47 17.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.395 -1.275 . . . . 0.44 110.439 -175.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.724 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.4 t-105 -123.28 135.92 54.46 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.747 -1.57 . . . . 0.13 110.1 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.508 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.5 OUTLIER -135.96 85.02 29.85 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-N 114.859 -1.064 . . . . 0.40999999999999998 111.092 174.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.69 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.8 Cg_endo -70.68 140.47 39.28 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.025 2.484 . . . . 0.16 111.63 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.6 pt -123.53 -16.33 5.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.085 -1.416 . . . . 0.17000000000000001 111.154 -172.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.58 169.75 16.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.093 -0.958 . . . . 1.5900000000000001 108.945 177.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.2 14.19 32.76 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.489 0.922 . . . . 0.31 113.489 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' THR . . . . . 0.479 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 23.3 p -98.16 -28.36 13.76 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.906 -1.146 . . . . 0.44 107.906 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.6 31.17 0.31 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 114.037 -1.438 . . . . 0.23999999999999999 113.148 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 441' ' ' GLY . 72.9 t -102.75 149.4 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.383 0.611 . . . . 0.17000000000000001 111.515 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.77 -166.04 37.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.911 -1.041 . . . . 0.10000000000000001 111.57 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.7 138.45 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.936 -0.764 . . . . 0.12 108.936 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.746 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.4 p80 -151.86 171.46 17.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.093 0.949 . . . . 0.14999999999999999 111.712 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.739 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -92.44 149.56 21.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.122 -1.854 . . . . 0.41999999999999998 108.322 174.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 4.8 p -133.8 101.75 5.2 Favored 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 123.137 1.446 . . . . 1.48 110.376 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -95.8 -32.0 12.91 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 112.139 -2.3 . . . . 0.34999999999999998 110.846 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.628 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 15.5 p90 -71.67 -26.76 62.66 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 114.73 -1.123 . . . . 0.17999999999999999 108.972 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.536 ' HG2' ' HB3' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -111.05 95.5 25.11 Favored Pre-proline 0 CA--C 1.489 -1.365 0 CA-C-N 113.469 -1.696 . . . . 1.3300000000000001 108.923 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 426' ' ' GLN . 17.7 Cg_endo -85.12 2.4 7.92 Favored 'Trans proline' 0 N--CA 1.415 -3.122 0 C-N-CA 122.808 2.338 . . . . 0.23000000000000001 113.418 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.1 148.69 36.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.041 -1.064 . . . . 1.1000000000000001 110.162 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.673 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.0 OUTLIER -162.93 124.78 2.56 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.733 1.271 . . . . 0.38 108.225 -173.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.02 -166.04 28.47 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 119.389 -1.386 . . . . 0.13 111.241 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.62 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.52 149.58 0.01 OUTLIER Glycine 0 C--N 1.342 0.883 0 O-C-N 125.17 1.159 . . . . 0.20000000000000001 112.907 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.403 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 1.8 m-20 -54.97 101.6 0.05 Allowed 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 112.112 -145.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.4 mt -97.35 -32.14 12.03 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 110.498 -3.046 . . . . 0.17999999999999999 108.302 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.57 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.32 -37.79 5.17 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.745 0.653 . . . . 0.22 111.465 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.814 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.9 mttt -60.47 -26.57 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 114.822 -1.081 . . . . 0.64000000000000001 112.758 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.9 p -112.73 -37.89 4.74 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.717 0.77 . . . . 0.25 110.083 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.46 ' HD3' HE22 ' A' ' 426' ' ' GLN . 7.3 mtp85 -82.74 -14.76 53.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.6 -1.182 . . . . 0.35999999999999999 112.616 -168.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.63 40.7 37.48 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 116.069 1.187 . . . . 0.20999999999999999 116.069 159.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.2 m -79.86 140.87 36.61 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 117.809 0.804 . . . . 0.46999999999999997 109.52 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -106.29 68.54 0.76 Allowed 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.881 -0.512 . . . . 0.40999999999999998 110.392 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.643 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 84.63 -8.13 70.31 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.069 -0.813 . . . . 0.17999999999999999 111.069 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.487 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 26.3 p -94.92 135.09 36.86 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.393 0.616 . . . . 0.82999999999999996 110.715 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.718 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -96.42 113.74 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.254 -0.885 . . . . 0.14999999999999999 110.343 -174.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.536 ' HB3' ' HG2' ' A' ' 426' ' ' GLN . 18.9 m-80 -83.45 93.04 7.71 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.835 -1.075 . . . . 1.77 111.881 -175.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.697 HG23 HG21 ' A' ' 366' ' ' THR . 53.4 m -91.36 136.68 26.68 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.35 -0.841 . . . . 0.17999999999999999 109.604 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.2 Cg_exo -52.99 135.55 58.91 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.524 2.15 . . . . 0.12 111.214 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.739 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 49.0 Cg_exo -55.28 -31.38 76.37 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.055 3.17 . . . . 0.16 112.547 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.3 m -79.75 -38.3 33.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.286 -1.324 . . . . 1.1699999999999999 109.943 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.597 HG11 ' HB ' ' A' ' 366' ' ' THR . 86.5 t -78.55 -29.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.643 -0.708 . . . . 0.17000000000000001 111.539 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.617 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.3 tpt -66.34 -20.9 66.21 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.598 0.713 . . . . 0.46000000000000002 110.179 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -76.27 -25.27 54.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.827 -1.079 . . . . 0.81000000000000005 111.628 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -79.21 -46.66 17.43 Favored 'General case' 0 CA--C 1.473 -2.003 0 CA-C-N 113.129 -1.85 . . . . 0.38 107.092 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.546 HD23 ' SD ' ' A' ' 450' ' ' MET . 24.3 tp -66.06 -67.42 0.45 Allowed 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 111.72 -2.491 . . . . 0.059999999999999998 112.43 175.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 409' ' ' TYR . 28.7 t80 -48.94 -26.88 2.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.806 1.289 . . . . 0.31 108.344 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.54 -30.35 64.46 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.601 -2.09 . . . . 0.13 112.555 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.687 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -88.75 -48.5 7.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.65 0.738 . . . . 0.13 111.513 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.653 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.4 OUTLIER -101.03 138.3 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 123.105 1.431 . . . . 0.23000000000000001 113.902 -168.202 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -136.5 -178.94 5.39 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 111.284 -2.689 . . . . 0.82999999999999996 107.397 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.752 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.1 mtmt -52.79 157.73 1.56 Allowed 'General case' 0 N--CA 1.413 -2.286 0 CA-C-O 122.82 1.295 . . . . 0.23999999999999999 114.009 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.1 18.01 70.53 Favored Glycine 0 C--N 1.281 -2.492 0 CA-C-N 112.659 -2.064 . . . . 0.37 113.699 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 462' ' ' PRO . 9.5 m -103.85 141.68 23.02 Favored Pre-proline 0 N--CA 1.427 -1.585 0 N-CA-C 107.664 -1.235 . . . . 0.14999999999999999 107.664 165.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.646 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.3 Cg_exo -74.74 164.62 33.27 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.648 1.565 . . . . 0.12 110.73 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -134.73 154.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 107.271 -1.381 . . . . 1.0900000000000001 107.271 166.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.3 tp -126.59 145.15 50.65 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 0.13 110.195 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.04 147.44 20.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.291 -1.374 . . . . 0.089999999999999997 107.291 165.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.593 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 17.3 p90 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.535 -0.745 . . . . 1.1599999999999999 110.846 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.384 -0.686 . . . . 3.9399999999999999 111.384 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.564 ' O ' ' HB2' ' A' ' 340' ' ' MET . 5.9 t-80 -82.71 88.31 6.73 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.002 -0.74 . . . . 1.8500000000000001 109.002 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 36.9 mtm 73.85 -179.99 0.2 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.636 -1.62 . . . . 1.03 110.523 -170.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -116.64 -6.4 11.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.868 -1.06 . . . . 1.1000000000000001 111.133 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.03 166.14 3.73 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 123.248 1.499 . . . . 0.97999999999999998 114.253 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.62 HG23 ' HA ' ' A' ' 358' ' ' LYS . 98.9 m -99.12 122.7 42.68 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.375 -2.193 . . . . 0.45000000000000001 106.841 165.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.666 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.9 p90 -158.4 -171.05 3.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.388 -0.824 . . . . 0.32000000000000001 111.322 -170.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.1 mm -103.24 156.47 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.935 -1.135 . . . . 0.080000000000000002 107.935 165.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.484 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.5 tt0 -137.22 155.02 50.02 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.596 0.634 . . . . 0.17000000000000001 110.633 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.649 HG22 ' HG3' ' A' ' 354' ' ' MET . 55.7 t -150.41 136.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.775 -1.102 . . . . 0.080000000000000002 110.0 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.04 118.94 34.3 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.553 -1.203 . . . . 0.37 108.074 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.479 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -71.17 -49.3 45.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.419 1.104 . . . . 0.32000000000000001 110.511 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -54.85 -53.56 53.77 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 112.996 -1.911 . . . . 1.51 112.308 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -98.09 10.65 39.94 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.543 -1.208 . . . . 0.91000000000000003 108.738 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.867 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.2 mm-40 38.14 71.76 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 125.088 1.493 . . . . 2.2200000000000002 111.856 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -151.63 124.11 8.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.685 -0.689 . . . . 0.13 109.872 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.649 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -110.87 128.01 55.64 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.379 0.609 . . . . 0.059999999999999998 110.484 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.671 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.9 m-90 -111.37 173.39 6.36 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.612 -1.176 . . . . 0.10000000000000001 111.895 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.723 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -126.84 116.34 20.72 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.194 -1.78 . . . . 0.22 106.194 165.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 362' ' ' VAL . 21.5 m-85 -100.07 129.63 46.13 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.927 0.87 . . . . 0.17999999999999999 111.534 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.634 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 5.1 ttpt -149.12 139.2 22.14 Favored 'General case' 0 N--CA 1.398 -3.053 0 CA-C-N 113.633 -1.621 . . . . 0.46999999999999997 107.66 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 72.64 11.68 5.5 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.064 -1.425 . . . . 0.59999999999999998 108.908 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.84 13.99 73.78 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 112.747 -2.024 . . . . 0.23000000000000001 111.753 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.631 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.75 172.75 12.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.705 -1.961 . . . . 0.68000000000000005 105.705 -171.079 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.0 m -102.68 139.27 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.864 0 CA-C-O 124.364 2.031 . . . . 0.53000000000000003 112.358 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.723 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.38 -25.32 17.74 Favored 'General case' 0 N--CA 1.396 -3.166 0 CA-C-N 109.206 -3.634 . . . . 0.12 108.498 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.698 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.32 155.18 37.16 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.695 -1.593 . . . . 0.080000000000000002 109.102 -172.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.802 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.19 122.54 1.3 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.718 -0.673 . . . . 0.60999999999999999 109.543 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.678 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.6 t -147.35 166.81 26.01 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.866 0.841 . . . . 0.089999999999999997 111.744 173.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.495 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 1.6 m-20 -82.68 146.0 29.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.592 -1.633 . . . . 1.8799999999999999 106.592 174.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.17 -172.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.506 -0.77 . . . . 0.11 111.245 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.867 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -154.01 118.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.931 -1.031 . . . . 0.12 108.973 174.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.445 ' HB2' HG13 ' A' ' 443' ' ' ILE . 6.9 t -143.02 142.84 31.68 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.164 -0.925 . . . . 0.69999999999999996 113.395 -166.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.86 47.56 24.98 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.941 1.536 . . . . 0.13 116.941 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 17.5 ptmt -44.56 148.1 0.95 Allowed Pre-proline 0 C--O 1.222 -0.39 0 CA-C-N 118.521 1.16 . . . . 0.47999999999999998 111.372 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.807 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -37.2 -31.18 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.053 1 C-N-CA 125.522 4.148 . . . . 0.23000000000000001 115.268 -177.664 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.497 HG23 ' HE2' ' A' ' 372' ' ' LYS . 4.0 p -82.68 -36.28 26.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.327 0.584 . . . . 0.29999999999999999 110.776 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.442 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 8.9 m -140.74 73.94 27.72 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 122.067 0.937 . . . . 0.29999999999999999 110.238 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.713 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 36.9 Cg_exo -69.3 161.62 45.14 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 125.061 3.841 . . . . 0.16 114.073 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.675 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -71.35 151.62 94.22 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 113.35 -1.75 . . . . 0.12 110.91 175.65 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.535 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.01 -49.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.997 3.798 . . . . 0.089999999999999997 113.443 -171.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.706 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.59 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.155 0.979 . . . . 0.089999999999999997 113.552 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.02 -128.67 1.8 Allowed Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 113.997 -1.456 . . . . 0.11 111.13 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 97.7 t -128.19 99.89 5.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.424 -0.954 . . . . 0.89000000000000001 108.424 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 413' ' ' ILE . 50.4 m-85 -104.58 169.87 8.21 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.39 -0.823 . . . . 0.16 109.124 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.736 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.6 m-85 -149.23 139.54 22.32 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 110.413 -0.217 . . . . 0.68999999999999995 110.413 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.594 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -74.55 120.69 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 119.903 -0.719 . . . . 0.14000000000000001 110.397 176.115 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 385' ' ' TRP . . . . . 0.404 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 40.8 p-90 -109.21 4.41 22.81 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.391 -0.822 . . . . 0.19 112.159 -176.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.735 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 17.3 t-20 -165.11 148.16 8.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.227 -0.897 . . . . 0.40999999999999998 110.009 175.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.445 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 14.8 mtpt -109.62 110.69 21.82 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.423 -0.808 . . . . 1.0900000000000001 109.866 170.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -109.08 120.82 43.69 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.561 1.172 . . . . 0.38 110.763 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.04 142.97 46.28 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.225 -1.352 . . . . 1.96 109.784 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 36.3 t70 54.19 26.34 6.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 111.782 -2.463 . . . . 0.40000000000000002 108.63 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.29 170.74 14.3 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.079 -1.873 . . . . 0.16 112.247 -167.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 22.4 m -128.5 102.88 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.568 -1.651 . . . . 0.27000000000000002 109.733 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.749 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.76 157.84 36.73 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 112.865 -1.971 . . . . 0.23999999999999999 110.459 176.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.8 mtpt -145.46 -177.46 5.58 Favored 'General case' 0 N--CA 1.392 -3.369 0 CA-C-N 114.5 -1.227 . . . . 0.67000000000000004 108.082 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -172.42 -150.4 7.27 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 117.153 -2.451 . . . . 0.81000000000000005 114.92 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.54 121.24 12.61 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.312 -1.444 . . . . 0.79000000000000004 108.449 170.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.507 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.1 m-20 -55.62 -179.14 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 112.485 -2.143 . . . . 1.1200000000000001 111.133 177.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -56.26 -24.31 41.94 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.641 0.734 . . . . 1.6499999999999999 110.161 170.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.67 -26.45 21.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.006 -0.997 . . . . 2.0 111.828 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.46 31.57 5.78 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.804 -1.189 . . . . 0.66000000000000003 110.497 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 44.1 p -115.21 126.94 27.26 Favored Pre-proline 0 N--CA 1.417 -2.082 0 N-CA-C 106.825 -1.546 . . . . 0.68000000000000005 106.825 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 24.1 Cg_exo -65.24 160.82 40.33 Favored 'Trans proline' 0 C--N 1.283 -2.874 0 C-N-CA 121.831 1.687 . . . . 0.81000000000000005 112.493 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 3.7 p90 -140.86 -169.55 2.84 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.429 -1.714 . . . . 0.38 106.95 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 9.4 mt-10 -148.0 155.25 41.31 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.302 1.048 . . . . 0.62 111.706 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.749 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.47 98.66 12.25 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 113.199 -1.819 . . . . 1.3300000000000001 108.273 178.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 59.5 Cg_endo -66.97 101.76 0.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.442 2.095 . . . . 0.20000000000000001 110.28 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.43 163.55 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.852 0 CA-C-N 114.239 -1.346 . . . . 0.29999999999999999 109.83 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -114.99 -33.82 5.28 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.474 -1.694 . . . . 1.8400000000000001 106.808 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.407 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.8 m-85 -136.09 116.25 13.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.796 -2.002 . . . . 0.44 110.681 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.746 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.33 134.72 54.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.665 -1.152 . . . . 0.13 110.102 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.594 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.6 OUTLIER -136.28 86.24 25.17 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.905 -1.043 . . . . 0.40999999999999998 110.937 174.359 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 79.9 Cg_endo -72.11 141.61 36.57 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.892 2.395 . . . . 0.16 111.655 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.09 -16.2 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.537 -1.21 . . . . 0.17000000000000001 111.936 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.761 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.7 p30 -136.1 171.12 14.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 1.5900000000000001 110.222 170.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -99.18 15.9 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.76 -0.655 . . . . 0.31 111.467 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 1.8 p -97.03 -26.88 14.85 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.089 -1.078 . . . . 0.44 108.089 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 130.15 27.62 0.76 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.904 -1.498 . . . . 0.23999999999999999 113.677 169.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.761 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 49.2 t -104.43 149.78 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.43 0.633 . . . . 0.17000000000000001 112.463 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . -178.96 -164.32 31.5 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.966 -1.016 . . . . 0.10000000000000001 111.942 174.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.47 139.55 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.54 -0.911 . . . . 0.12 108.54 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.553 ' HB2' HG21 ' A' ' 407' ' ' VAL . 11.5 p-80 -150.02 164.16 36.25 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.637 0.732 . . . . 0.14999999999999999 111.457 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.774 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.07 138.79 31.33 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.203 -1.362 . . . . 0.41999999999999998 107.474 172.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.631 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 4.8 t -133.13 104.67 6.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.326 1.536 . . . . 1.48 110.667 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.32 -28.83 15.97 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 111.43 -2.623 . . . . 0.34999999999999998 110.83 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.568 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.7 p90 -72.01 -27.23 62.59 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.471 -1.24 . . . . 0.17999999999999999 109.728 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.631 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -118.01 81.18 15.71 Favored Pre-proline 0 CA--C 1.496 -1.106 0 CA-C-N 114.276 -1.329 . . . . 1.3300000000000001 110.015 -176.067 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 14.9 Cg_endo -84.34 8.59 4.54 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 C-N-CA 125.122 3.881 . . . . 0.23000000000000001 114.313 -163.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -114.89 150.52 35.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.177 -0.675 . . . . 1.1000000000000001 109.177 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.495 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -159.61 125.52 4.28 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.629 1.172 . . . . 0.38 108.285 -171.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 148.3 -166.97 29.05 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.353 -1.403 . . . . 0.13 111.305 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.85 154.44 0.0 OUTLIER Glycine 0 C--N 1.341 0.818 0 O-C-N 125.151 1.148 . . . . 0.20000000000000001 113.2 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 2.9 m-20 -55.28 101.42 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.806 1.765 . . . . 0.33000000000000002 112.17 -146.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.0 mt -97.03 -31.35 12.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 110.53 -3.032 . . . . 0.17999999999999999 109.39 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.499 ' HA ' HG23 ' A' ' 369' ' ' VAL . 14.2 p-90 -50.13 -30.87 12.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.96 -1.927 . . . . 0.22 111.844 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.807 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 44.9 mttt -66.65 -22.12 66.1 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.919 -1.037 . . . . 0.64000000000000001 112.872 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.8 p -117.43 -38.72 3.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.855 0.836 . . . . 0.25 110.049 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.515 ' HB3' ' NE2' ' A' ' 426' ' ' GLN . 10.0 mtp85 -80.3 -15.32 57.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.48 -1.236 . . . . 0.35999999999999999 111.952 -171.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 71.84 40.58 57.61 Favored Glycine 0 C--N 1.311 -0.821 0 N-CA-C 115.697 1.039 . . . . 0.20999999999999999 115.697 159.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 1.4 m -80.01 130.84 35.58 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 108.85 -0.796 . . . . 0.46999999999999997 108.85 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.408 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 67.3 m80 -99.97 65.64 1.3 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.314 -0.866 . . . . 0.40999999999999998 111.562 -169.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 377' ' ' THR . . . 94.92 -18.77 56.65 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 111.09 -0.804 . . . . 0.17999999999999999 111.09 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.514 ' C ' HD12 ' A' ' 443' ' ' ILE . 37.1 m -90.36 159.17 16.75 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.951 -0.7 . . . . 0.82999999999999996 111.214 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.675 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -107.64 120.29 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.522 -0.763 . . . . 0.14999999999999999 110.578 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.51 ' HB2' HG13 ' A' ' 369' ' ' VAL . 25.2 m-80 -83.74 91.93 7.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.686 -0.688 . . . . 1.77 111.588 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.6 HG23 HG21 ' A' ' 366' ' ' THR . 37.3 m -90.0 136.86 28.51 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-O 121.393 0.615 . . . . 0.17999999999999999 109.489 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -57.15 132.12 49.36 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.842 2.361 . . . . 0.12 112.862 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.774 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.5 Cg_exo -50.51 -40.47 54.36 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 123.489 2.793 . . . . 0.16 112.39 -169.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.1 p -73.44 -40.44 64.21 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.806 -1.088 . . . . 1.1699999999999999 110.113 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.678 HG11 ' HB ' ' A' ' 366' ' ' THR . 67.3 t -77.05 -29.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.382 0.61 . . . . 0.17000000000000001 111.303 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.674 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.0 tpt -67.85 -19.67 65.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.748 0.785 . . . . 0.46000000000000002 109.958 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -79.4 -22.66 44.0 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.63 -1.168 . . . . 0.81000000000000005 110.918 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.54 -47.73 13.8 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 112.922 -1.945 . . . . 0.38 107.329 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.61 HD23 ' SD ' ' A' ' 450' ' ' MET . 27.1 tp -63.66 -66.91 0.48 Allowed 'General case' 0 N--CA 1.403 -2.799 0 CA-C-N 111.83 -2.441 . . . . 0.059999999999999998 112.241 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.458 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 35.5 t80 -50.15 -26.55 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.962 1.363 . . . . 0.31 108.167 176.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.01 -28.19 69.0 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 112.592 -2.095 . . . . 0.13 112.347 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.698 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -91.71 -47.96 7.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.666 0.746 . . . . 0.13 111.768 171.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.644 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.5 OUTLIER -101.5 138.36 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 123.457 1.599 . . . . 0.23000000000000001 113.892 -168.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.445 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.7 pt-20 -136.83 -178.69 5.3 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 110.813 -2.903 . . . . 0.82999999999999996 106.503 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.735 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.7 mtmt -51.69 162.48 0.4 Allowed 'General case' 0 N--CA 1.413 -2.321 0 CA-C-O 123.12 1.438 . . . . 0.23999999999999999 113.179 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.38 -33.64 4.66 Favored Glycine 0 N--CA 1.424 -2.141 0 CA-C-N 112.441 -2.163 . . . . 0.37 112.284 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 462' ' ' PRO . 10.6 m -73.96 140.78 77.62 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-O 121.119 0.485 . . . . 0.14999999999999999 109.822 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.666 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.44 162.96 38.9 Favored 'Trans proline' 0 N--CA 1.432 -2.132 0 C-N-CA 122.265 1.977 . . . . 0.12 111.142 174.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.5 t -132.95 131.96 59.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 CA-C-N 113.757 -1.565 . . . . 1.0900000000000001 108.169 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 2.9 tp -112.03 143.04 43.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.989 -0.551 . . . . 0.13 110.331 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.16 148.08 19.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.126 -1.435 . . . . 0.089999999999999997 107.126 165.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.595 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.7 p90 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.301 -0.857 . . . . 1.1599999999999999 111.27 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.954 0 N-CA-C 111.829 -0.509 . . . . 3.9399999999999999 111.829 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -162.55 97.74 0.98 Allowed 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.615 -0.513 . . . . 1.8500000000000001 109.615 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.457 ' HB3' ' OD1' ' A' ' 342' ' ' ASP . 34.4 mtm 67.99 -174.52 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 O-C-N 124.526 1.141 . . . . 1.03 111.148 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.41 -12.22 0.81 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.792 0.664 . . . . 1.1000000000000001 112.792 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 340' ' ' MET . 0.2 OUTLIER -59.8 167.87 1.98 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.427 1.108 . . . . 0.97999999999999998 113.702 175.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.563 HG23 ' HA ' ' A' ' 358' ' ' LYS . 88.9 m -90.14 124.22 34.64 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.13 -1.396 . . . . 0.45000000000000001 109.801 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.633 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 5.0 p90 -160.94 -169.31 2.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.119 -1.4 . . . . 0.32000000000000001 110.584 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 453' ' ' LEU . 10.7 mm -101.39 162.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.204 -1.036 . . . . 0.080000000000000002 108.204 165.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.5 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -143.67 156.31 44.5 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 119.063 0.847 . . . . 0.17000000000000001 111.729 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.673 HG22 ' HG3' ' A' ' 354' ' ' MET . 77.8 t -150.71 137.44 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.741 -1.118 . . . . 0.080000000000000002 110.115 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.401 ' HB2' ' HZ3' ' A' ' 355' ' ' TRP . 7.4 t0 -124.61 106.51 10.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.175 0.988 . . . . 0.37 108.52 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.443 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -64.73 -42.13 95.45 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 112.772 -2.013 . . . . 0.32000000000000001 111.602 -168.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.46 -57.58 11.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.412 -2.176 . . . . 1.51 112.892 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -92.79 1.44 57.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 114.838 -1.074 . . . . 0.91000000000000003 109.924 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.856 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.0 mm-40 48.73 63.75 1.98 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 112.624 -2.08 . . . . 2.2200000000000002 111.565 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.457 ' CD2' ' CE2' ' A' ' 355' ' ' TRP . 6.8 t60 -143.41 128.63 18.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.803 -0.635 . . . . 0.13 109.716 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.673 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.7 ttp -115.28 128.6 56.23 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.438 0.695 . . . . 0.059999999999999998 110.444 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.676 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.5 m-90 -112.82 173.43 6.38 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.755 -1.111 . . . . 0.10000000000000001 111.598 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.588 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -125.08 112.9 17.05 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 105.577 -2.008 . . . . 0.22 105.577 163.319 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 18.1 m-85 -92.98 124.85 37.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.457 -0.897 . . . . 0.17999999999999999 111.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.563 ' HA ' HG23 ' A' ' 343' ' ' THR . 37.4 ttmt -140.17 142.52 35.93 Favored 'General case' 0 N--CA 1.386 -3.634 0 CA-C-N 114.031 -1.441 . . . . 0.46999999999999997 108.771 173.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.423 ' N ' ' HG2' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 66.0 16.35 10.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.742 -1.572 . . . . 0.59999999999999998 108.849 175.202 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.02 72.49 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 112.167 -2.288 . . . . 0.23000000000000001 111.968 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.606 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 4.9 tppt? -138.83 179.21 6.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.435 -2.061 . . . . 0.68000000000000005 105.435 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.676 HG11 ' CD1' ' A' ' 355' ' ' TRP . 2.8 m -106.65 135.6 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.72 0 CA-C-O 124.197 1.951 . . . . 0.53000000000000003 112.394 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -87.84 -26.06 23.0 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 109.351 -3.568 . . . . 0.12 107.985 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.72 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 4.0 tp -153.15 156.0 37.79 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.181 -1.372 . . . . 0.080000000000000002 109.777 -173.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 2.2 pt-20 -162.6 121.99 2.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.84 -0.618 . . . . 0.60999999999999999 110.706 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.688 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.3 t -149.13 166.78 27.75 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 122.501 1.143 . . . . 0.089999999999999997 113.196 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.685 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.6 p-10 -84.36 140.02 31.87 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.712 -2.04 . . . . 1.8799999999999999 108.182 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.96 -171.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.161 -0.927 . . . . 0.11 111.843 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.856 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -153.74 121.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.794 -1.094 . . . . 0.12 108.849 174.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 443' ' ' ILE . 7.0 t -144.57 143.01 30.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.917 1.08 . . . . 0.69999999999999996 113.917 -167.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.47 45.93 35.02 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 116.845 1.498 . . . . 0.13 116.845 162.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.584 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.46 144.1 4.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 118.636 1.218 . . . . 0.47999999999999998 110.917 -174.212 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.803 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.34 -32.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -0.979 1 C-N-CA 125.709 4.273 . . . . 0.23000000000000001 116.183 -170.8 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.584 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.8 p -79.92 -35.42 37.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.095 0.474 . . . . 0.29999999999999999 111.161 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.456 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 m -140.31 74.63 29.21 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 122.431 1.11 . . . . 0.29999999999999999 110.003 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.5 Cg_exo -69.79 160.42 49.75 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.044 3.83 . . . . 0.16 113.365 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.692 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -69.79 150.36 96.56 Favored Pre-proline 0 N--CA 1.434 -1.255 0 CA-C-N 113.55 -1.659 . . . . 0.12 110.92 177.259 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.507 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.0 OUTLIER -77.14 -48.78 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.893 3.729 . . . . 0.089999999999999997 112.98 -170.632 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.871 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 67.13 122.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.626 0.973 . . . . 0.089999999999999997 113.626 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.7 -126.62 1.5 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.457 -1.247 . . . . 0.11 111.382 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -126.01 104.12 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 122.516 1.15 . . . . 0.89000000000000001 109.328 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.796 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.2 m-85 -107.33 162.16 14.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.904 -1.044 . . . . 0.16 110.014 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.8 m-85 -147.91 137.51 22.45 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 121.252 -0.179 . . . . 0.68999999999999995 110.789 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.63 124.97 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 119.993 -0.683 . . . . 0.14000000000000001 110.296 177.055 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -109.55 3.99 21.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.491 -0.777 . . . . 0.19 111.929 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.721 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 14.8 t-20 -165.13 149.34 8.78 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.485 -0.779 . . . . 0.40999999999999998 111.083 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.482 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.8 mtpt -107.46 110.74 22.77 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.411 -0.813 . . . . 1.0900000000000001 109.685 169.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -112.08 123.17 49.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.654 1.216 . . . . 0.38 111.067 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.76 143.48 47.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.139 -1.391 . . . . 1.96 110.035 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 35.4 t70 54.24 25.99 6.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 111.894 -2.412 . . . . 0.40000000000000002 108.667 -174.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.482 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 167.13 17.8 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.205 -1.816 . . . . 0.16 112.163 -167.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 107.84 12.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.774 -1.557 . . . . 0.27000000000000002 110.131 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.9 mp -75.85 156.7 34.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 112.834 -1.985 . . . . 0.23999999999999999 110.448 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.506 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 11.8 mtpt -151.7 167.76 27.15 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.651 -1.159 . . . . 0.67000000000000004 108.016 -176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.926 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 178.94 165.47 33.37 Favored Glycine 0 CA--C 1.482 -1.993 0 C-N-CA 118.181 -1.961 . . . . 0.81000000000000005 113.33 -171.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.94 122.19 37.33 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 123.036 1.398 . . . . 0.79000000000000004 110.679 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.426 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 5.1 m-20 -50.93 -178.71 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 110.939 -2.846 . . . . 1.1200000000000001 112.278 175.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -51.92 -21.87 3.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.365 -0.379 . . . . 1.6499999999999999 111.448 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.6 OUTLIER -108.88 -29.98 8.35 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.226 0.536 . . . . 2.0 111.729 -172.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 116.73 37.52 0.97 Allowed Glycine 0 C--N 1.295 -1.75 0 C-N-CA 119.529 -1.32 . . . . 0.66000000000000003 111.413 -171.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 62.4 p -116.93 128.47 26.0 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 106.652 -1.61 . . . . 0.68000000000000005 106.652 173.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.926 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.9 Cg_exo -70.33 148.91 62.4 Favored 'Trans proline' 0 N--CA 1.419 -2.888 0 C-N-CA 122.024 1.816 . . . . 0.81000000000000005 112.588 -175.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 10.4 p90 -128.99 -171.56 2.51 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 112.648 -2.069 . . . . 0.38 107.051 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 15.0 mt-10 -144.81 157.3 44.22 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.052 0.929 . . . . 0.62 111.058 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.696 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.0 m -142.28 98.3 6.08 Favored Pre-proline 0 N--CA 1.421 -1.879 0 CA-C-N 113.678 -1.601 . . . . 1.3300000000000001 109.222 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.9 Cg_endo -67.97 106.19 1.29 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 124.342 3.362 . . . . 0.20000000000000001 112.644 -177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.808 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -114.61 163.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 114.534 -1.212 . . . . 0.29999999999999999 110.56 -175.611 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -111.76 -34.04 6.15 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.403 -1.726 . . . . 1.8400000000000001 106.943 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.4 m-85 -133.86 115.99 15.12 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.726 -2.034 . . . . 0.44 110.639 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.777 ' HB2' HG11 ' A' ' 407' ' ' VAL . 5.1 t-105 -123.86 135.29 53.65 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.4 -1.273 . . . . 0.13 110.355 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.563 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.53 84.81 26.99 Favored Pre-proline 0 N--CA 1.427 -1.579 0 CA-C-N 115.007 -0.997 . . . . 0.40999999999999998 110.943 172.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 72.2 Cg_endo -70.84 141.07 39.97 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.06 2.507 . . . . 0.16 112.258 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -123.8 -16.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.009 -1.45 . . . . 0.17000000000000001 111.063 -173.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -135.46 162.7 31.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.277 -0.874 . . . . 1.5900000000000001 109.312 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -93.78 13.32 22.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.236 0.458 . . . . 0.31 112.236 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -91.36 -26.57 18.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.396 -1.335 . . . . 0.44 107.396 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.93 29.55 1.13 Allowed Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 112.976 -1.92 . . . . 0.23999999999999999 112.326 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 441' ' ' GLY . 89.5 t -102.55 147.9 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.297 0.57 . . . . 0.17000000000000001 110.93 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.37 -166.11 37.91 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.734 -1.121 . . . . 0.10000000000000001 111.306 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.402 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.54 138.42 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.698 -0.853 . . . . 0.12 108.698 175.637 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.808 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.1 p80 -151.24 164.9 35.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.725 0.774 . . . . 0.14999999999999999 112.076 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.779 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 146.05 24.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.074 -1.421 . . . . 0.41999999999999998 107.858 173.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.415 ' CB ' HD22 ' A' ' 444' ' ' ASN . 0.4 OUTLIER -140.07 102.85 4.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 123.06 1.409 . . . . 1.48 110.998 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -93.16 -26.97 17.17 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 111.752 -2.476 . . . . 0.34999999999999998 109.742 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 5.7 p90 -70.27 -26.14 63.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.312 -1.313 . . . . 0.17999999999999999 109.714 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.403 ' HG3' ' NE1' ' A' ' 425' ' ' TRP . 0.0 OUTLIER -119.8 80.7 25.09 Favored Pre-proline 0 CA--C 1.492 -1.286 0 CA-C-N 113.829 -1.532 . . . . 1.3300000000000001 109.315 -176.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 27.7 Cg_endo -81.08 5.53 6.17 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 125.089 3.86 . . . . 0.23000000000000001 114.015 -162.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -115.67 149.73 37.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.739 -0.664 . . . . 1.1000000000000001 109.411 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.685 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -160.99 125.57 3.57 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 124.587 1.18 . . . . 0.38 108.179 -173.253 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.88 -166.92 28.83 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 119.484 -1.341 . . . . 0.13 110.899 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.595 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 154.1 0.0 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.931 1.018 . . . . 0.20000000000000001 113.159 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.404 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -55.72 101.33 0.05 Allowed 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 123.924 1.821 . . . . 0.33000000000000002 112.289 -146.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.7 mt -97.33 -32.03 12.1 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 110.228 -3.169 . . . . 0.17999999999999999 108.222 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.558 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.4 p-90 -45.82 -38.84 7.67 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 124.067 0.854 . . . . 0.22 111.49 -174.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.803 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.5 mttt -60.05 -26.12 65.9 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.006 -0.997 . . . . 0.64000000000000001 112.821 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.9 p -111.93 -36.11 5.49 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.701 0.762 . . . . 0.25 110.033 -176.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.481 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 6.8 mtp85 -84.54 -15.94 44.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.689 -1.141 . . . . 0.35999999999999999 112.642 -169.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.05 40.39 30.03 Favored Glycine 0 C--N 1.313 -0.714 0 N-CA-C 116.089 1.196 . . . . 0.20999999999999999 116.089 159.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 372' ' ' LYS . 1.0 OUTLIER -79.63 131.6 36.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 117.782 0.791 . . . . 0.46999999999999997 109.545 176.006 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.431 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 63.3 m80 -100.7 68.3 1.31 Allowed 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.643 -0.661 . . . . 0.40999999999999998 110.306 -172.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 88.7 -11.8 67.49 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.924 -0.87 . . . . 0.17999999999999999 110.924 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.461 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 27.2 p -90.79 142.82 27.36 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.361 -0.42 . . . . 0.82999999999999996 110.8 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.692 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -101.43 114.55 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.752 -0.658 . . . . 0.14999999999999999 110.362 -176.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.597 ' HB2' HG13 ' A' ' 369' ' ' VAL . 18.7 m120 -78.81 90.38 4.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.842 -0.617 . . . . 1.77 111.098 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.9 m -86.63 137.34 34.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 109.132 -0.692 . . . . 0.17999999999999999 109.132 174.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.5 Cg_exo -54.86 135.79 69.44 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.747 2.298 . . . . 0.12 111.337 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.779 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.4 Cg_exo -55.34 -32.16 80.17 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 C-N-CA 124.225 3.283 . . . . 0.16 112.825 -173.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.23 -38.79 26.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.441 -1.254 . . . . 1.1699999999999999 110.09 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.688 HG11 ' HB ' ' A' ' 366' ' ' THR . 60.2 t -80.77 -29.41 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.17000000000000001 111.376 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.681 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.4 tpt -65.93 -19.91 66.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.781 0.8 . . . . 0.46000000000000002 109.985 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -79.36 -24.97 42.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.522 -1.217 . . . . 0.81000000000000005 111.239 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.694 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -79.15 -46.3 18.24 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 113.127 -1.851 . . . . 0.38 107.111 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.576 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.7 tp -64.43 -67.17 0.45 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.663 -2.517 . . . . 0.059999999999999998 112.169 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.424 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.2 t80 -49.62 -27.73 4.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 123.127 1.442 . . . . 0.31 108.304 177.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.2 -31.3 69.08 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 112.37 -2.195 . . . . 0.13 112.237 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.72 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.5 ptp -88.17 -48.43 7.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.729 0.776 . . . . 0.13 111.501 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.588 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.7 OUTLIER -102.09 138.16 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 123.582 1.658 . . . . 0.23000000000000001 114.005 -167.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.482 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.2 pt-20 -136.37 -178.28 5.09 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 110.705 -2.952 . . . . 0.82999999999999996 106.552 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.4 mtmt -52.71 162.56 0.57 Allowed 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.949 1.357 . . . . 0.23999999999999999 112.405 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.23 -30.56 6.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 112.685 -2.052 . . . . 0.37 112.383 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 462' ' ' PRO . 15.0 m -80.89 141.96 51.7 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.134 -0.691 . . . . 0.14999999999999999 109.134 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 4.5 Cg_exo -75.78 168.54 24.06 Favored 'Trans proline' 0 N--CA 1.425 -2.502 0 C-N-CA 121.681 1.587 . . . . 0.12 111.098 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.81 154.49 34.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.299 -1.371 . . . . 1.0900000000000001 107.299 166.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.0 tp -125.86 144.25 50.74 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.45 -0.796 . . . . 0.13 110.657 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.66 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.14 146.04 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 105.937 -1.875 . . . . 0.089999999999999997 105.937 163.487 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.871 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 8.6 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.089 -0.958 . . . . 1.1599999999999999 111.824 -175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 112.078 -0.409 . . . . 3.9399999999999999 112.078 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.511 ' CD2' ' H ' ' A' ' 340' ' ' MET . 1.8 t60 -76.45 -178.64 4.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.257 -0.645 . . . . 1.8500000000000001 109.257 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.511 ' H ' ' CD2' ' A' ' 339' ' ' HIS . 46.7 mtm -142.46 176.76 8.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.899 0.857 . . . . 1.03 112.553 -173.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.48 -4.45 8.28 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.733 -1.576 . . . . 1.1000000000000001 108.825 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.49 169.79 0.28 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.63 -1.623 . . . . 0.97999999999999998 113.262 172.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 358' ' ' LYS . 9.1 m -90.79 121.68 32.87 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 112.473 -2.149 . . . . 0.45000000000000001 106.688 167.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.651 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.2 p90 -156.15 -171.59 3.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.485 0.659 . . . . 0.32000000000000001 110.852 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.584 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.8 mm -102.52 161.5 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.97 -1.122 . . . . 0.080000000000000002 107.97 167.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.4 tt0 -140.61 155.18 46.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 118.818 0.736 . . . . 0.17000000000000001 111.1 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.716 HG22 ' HG3' ' A' ' 354' ' ' MET . 64.4 t -150.81 135.8 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.539 -1.21 . . . . 0.080000000000000002 110.027 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -116.89 117.78 30.64 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.797 -1.092 . . . . 0.37 108.176 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.503 HD21 HG23 ' A' ' 465' ' ' VAL . 1.8 mm? -70.26 -48.2 57.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.51 1.148 . . . . 0.32000000000000001 110.487 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -54.89 -54.13 46.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 112.851 -1.977 . . . . 1.51 112.454 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -98.27 11.31 38.36 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.572 -1.195 . . . . 0.91000000000000003 108.637 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.861 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.1 mm-40 37.6 70.38 0.19 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 125.269 1.606 . . . . 2.2200000000000002 111.829 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -150.22 125.12 9.86 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.773 -0.649 . . . . 0.13 109.827 -175.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.716 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.9 ttp -111.93 127.61 55.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.471 0.653 . . . . 0.059999999999999998 110.451 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.681 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.84 173.72 6.24 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.528 -1.214 . . . . 0.10000000000000001 111.841 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.701 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.4 t80 -126.79 117.07 21.9 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 106.795 -1.557 . . . . 0.22 106.795 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.543 ' CE1' HG12 ' A' ' 362' ' ' VAL . 18.8 m-85 -100.77 124.84 46.98 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.128 0.966 . . . . 0.17999999999999999 112.33 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.672 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.0 ttpt -149.46 139.34 21.92 Favored 'General case' 0 N--CA 1.4 -2.939 0 CA-C-N 113.105 -1.861 . . . . 0.46999999999999997 107.992 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.475 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 70.95 16.46 6.5 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 113.768 -1.56 . . . . 0.59999999999999998 108.608 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.56 17.47 78.99 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.377 -2.192 . . . . 0.23000000000000001 111.715 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.597 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.2 OUTLIER -136.9 170.86 15.39 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.91 -1.885 . . . . 0.68000000000000005 105.91 -168.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.745 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.7 m -101.35 137.56 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.853 0 CA-C-O 124.157 1.932 . . . . 0.53000000000000003 111.72 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.701 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -23.84 19.0 Favored 'General case' 0 N--CA 1.399 -2.984 0 CA-C-N 109.392 -3.549 . . . . 0.12 108.529 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.681 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -154.07 154.82 34.33 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 113.511 -1.677 . . . . 0.080000000000000002 108.856 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.745 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.98 121.78 1.29 Allowed 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.766 -0.652 . . . . 0.60999999999999999 109.395 -175.413 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.654 HG21 HG23 ' A' ' 445' ' ' THR . 5.1 t -148.08 166.5 27.62 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.245 1.021 . . . . 0.089999999999999997 111.967 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.631 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.1 p-10 -85.37 140.36 30.83 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 113.025 -1.898 . . . . 1.8799999999999999 107.193 176.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.634 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -141.47 -171.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.154 -0.93 . . . . 0.11 111.888 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.861 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -157.73 119.38 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.136 -0.938 . . . . 0.12 109.792 175.656 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.6 t -143.15 145.98 33.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.977 -1.011 . . . . 0.69999999999999996 112.839 -166.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.04 46.09 37.95 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 117.178 1.631 . . . . 0.13 117.178 161.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.446 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.2 pttt -46.75 145.83 2.9 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.6 1.7 . . . . 0.47999999999999998 111.129 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.83 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -33.41 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.041 1 C-N-CA 125.543 4.162 . . . . 0.23000000000000001 115.609 -175.884 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.4 p -77.19 -39.27 49.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.267 0.555 . . . . 0.29999999999999999 110.917 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.47 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.9 m -140.56 72.92 30.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.245 1.021 . . . . 0.29999999999999999 110.434 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.7 Cg_exo -68.9 163.3 38.03 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 125.256 3.97 . . . . 0.16 114.118 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -74.76 151.23 86.73 Favored Pre-proline 0 N--CA 1.437 -1.092 0 CA-C-N 113.512 -1.676 . . . . 0.12 110.714 175.702 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.533 ' CD ' HG22 ' A' ' 377' ' ' THR . 0.9 OUTLIER -78.28 -50.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.83 3.686 . . . . 0.089999999999999997 113.724 -171.248 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.757 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.0 121.91 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.443 0.905 . . . . 0.089999999999999997 113.443 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.89 -124.48 1.26 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.268 -1.333 . . . . 0.11 111.46 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.7 p -126.28 108.88 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 122.137 0.97 . . . . 0.89000000000000001 109.372 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.784 ' HB2' HG22 ' A' ' 463' ' ' VAL . 94.0 m-85 -114.24 159.89 19.64 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.881 -1.054 . . . . 0.16 109.661 -170.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.719 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 70.0 m-85 -146.01 135.63 23.22 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 117.661 0.209 . . . . 0.68999999999999995 111.113 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.617 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.57 122.26 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.872 -0.731 . . . . 0.14000000000000001 110.46 176.493 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -108.93 3.16 21.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.43 -0.804 . . . . 0.19 112.026 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.765 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 16.9 t-20 -164.08 149.57 10.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.181 -0.918 . . . . 0.40999999999999998 110.704 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -109.24 114.65 28.54 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.377 -0.829 . . . . 1.0900000000000001 109.386 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -113.12 120.39 41.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.724 1.25 . . . . 0.38 111.478 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.8 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 25.9 mt-10 -116.11 143.71 45.12 Favored 'General case' 0 N--CA 1.409 -2.475 0 CA-C-N 113.802 -1.544 . . . . 1.96 110.562 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 37.8 t70 55.98 27.3 11.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 111.196 -2.729 . . . . 0.40000000000000002 107.758 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.14 169.58 15.69 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 112.692 -2.049 . . . . 0.16 112.16 -167.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 16.1 m -128.72 102.45 6.58 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 113.12 -1.855 . . . . 0.27000000000000002 109.382 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.752 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.0 mp -71.97 156.3 39.39 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 112.789 -2.005 . . . . 0.23999999999999999 109.767 174.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.5 mtpt -149.95 -176.58 5.49 Favored 'General case' 0 N--CA 1.395 -3.183 0 CA-C-N 114.647 -1.161 . . . . 0.67000000000000004 108.089 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -178.8 -142.31 4.78 Favored Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 116.965 -2.541 . . . . 0.81000000000000005 115.062 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.79 124.24 14.79 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.791 -1.704 . . . . 0.79000000000000004 108.449 171.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.53 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 5.7 m-20 -54.7 -178.73 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 112.3 -2.227 . . . . 1.1200000000000001 111.856 177.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -51.79 -24.26 5.76 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.883 -0.598 . . . . 1.6499999999999999 111.665 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.53 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 1.1 p30 -102.72 -29.44 11.5 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.05 0.453 . . . . 2.0 111.957 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.9 37.52 1.14 Allowed Glycine 0 C--N 1.295 -1.724 0 C-N-CA 119.504 -1.331 . . . . 0.66000000000000003 111.545 -172.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 65.1 p -119.03 127.81 26.3 Favored Pre-proline 0 N--CA 1.422 -1.844 0 N-CA-C 106.722 -1.584 . . . . 0.68000000000000005 106.722 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 26.1 Cg_exo -65.03 161.54 36.53 Favored 'Trans proline' 0 C--N 1.287 -2.694 0 C-N-CA 121.999 1.8 . . . . 0.81000000000000005 112.827 -173.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.56 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 17.8 p90 -141.7 -168.77 2.75 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 113.548 -1.66 . . . . 0.38 107.066 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.4 mt-10 -147.56 159.93 43.19 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 122.387 1.089 . . . . 0.62 112.208 174.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.752 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.69 99.43 8.49 Favored Pre-proline 0 N--CA 1.426 -1.664 0 CA-C-N 112.857 -1.974 . . . . 1.3300000000000001 108.543 175.427 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 62.3 Cg_endo -67.44 103.43 0.8 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.868 2.378 . . . . 0.20000000000000001 110.912 174.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.708 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -118.12 158.78 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.27 -1.332 . . . . 0.29999999999999999 109.391 -174.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.6 OUTLIER -101.46 -38.93 7.78 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 107.762 -1.199 . . . . 1.8400000000000001 107.762 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.539 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 10.3 m-30 -125.53 113.46 17.47 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.726 -1.124 . . . . 0.44 110.51 -176.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.708 ' HB2' HG11 ' A' ' 407' ' ' VAL . 8.3 t-105 -123.59 136.39 54.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.692 -1.594 . . . . 0.13 110.379 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.57 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.3 85.93 25.76 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 114.792 -1.094 . . . . 0.40999999999999998 111.041 173.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.7 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 82.6 Cg_endo -71.64 141.75 38.54 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 123.163 2.575 . . . . 0.16 112.091 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -122.94 -17.74 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.207 -1.36 . . . . 0.17000000000000001 111.239 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.772 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 6.9 p30 -134.76 170.47 15.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.715 -0.675 . . . . 1.5900000000000001 109.695 171.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -96.88 16.08 20.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 0.31 111.993 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 20.3 p -100.16 -28.31 13.08 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.258 -1.015 . . . . 0.44 108.258 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 131.74 26.41 0.71 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.24 -1.346 . . . . 0.23999999999999999 113.546 173.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.772 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 68.8 t -102.46 148.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.492 0.663 . . . . 0.17000000000000001 111.165 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 175.59 -164.1 34.22 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.712 -1.131 . . . . 0.10000000000000001 111.13 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.401 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -102.59 138.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.988 -0.745 . . . . 0.12 108.988 175.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.4 p80 -149.35 167.28 26.56 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.065 0.936 . . . . 0.14999999999999999 111.178 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.744 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -89.43 149.28 23.03 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 113.501 -1.682 . . . . 0.41999999999999998 107.806 172.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -136.42 100.0 4.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.675 1.226 . . . . 1.48 110.035 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -95.17 -33.37 12.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.606 -2.088 . . . . 0.34999999999999998 110.416 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.492 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 13.9 p90 -68.08 -27.08 66.18 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.589 -1.187 . . . . 0.17999999999999999 109.255 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.58 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.95 82.0 20.45 Favored Pre-proline 0 CA--C 1.494 -1.208 0 CA-C-N 113.816 -1.538 . . . . 1.3300000000000001 110.201 -173.701 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 32.1 Cg_endo -80.33 4.96 6.39 Favored 'Trans proline' 0 N--CA 1.432 -2.103 0 C-N-CA 124.821 3.681 . . . . 0.23000000000000001 114.464 -162.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.32 154.03 28.73 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 123.385 0.428 . . . . 1.1000000000000001 110.293 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.631 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -163.64 126.34 2.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.25 -1.341 . . . . 0.38 108.364 -172.194 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.81 -167.85 28.74 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.051 -1.547 . . . . 0.13 111.556 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.634 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.52 153.36 0.0 OUTLIER Glycine 0 C--N 1.342 0.916 0 O-C-N 125.043 1.084 . . . . 0.20000000000000001 113.207 174.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.439 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.8 m-20 -54.9 100.99 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 123.999 1.857 . . . . 0.33000000000000002 112.156 -146.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.4 mt -97.16 -33.44 11.49 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 110.273 -3.149 . . . . 0.17999999999999999 109.357 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.558 ' HA ' HG23 ' A' ' 369' ' ' VAL . 11.2 p-90 -47.36 -33.59 6.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 112.8 -2.0 . . . . 0.22 111.9 -174.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.83 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 43.4 mttt -63.5 -22.99 67.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 124.08 0.863 . . . . 0.64000000000000001 113.055 -176.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.2 p -117.43 -38.41 3.33 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.525 -0.761 . . . . 0.25 110.215 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.58 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 4.5 mtp85 -79.14 -15.22 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.609 -1.178 . . . . 0.35999999999999999 112.375 -169.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 75.72 40.48 31.46 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 116.216 1.246 . . . . 0.20999999999999999 116.216 159.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 439' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 442' ' ' CYS . 7.4 m -82.15 134.35 35.31 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 117.768 0.784 . . . . 0.46999999999999997 109.188 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.505 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 78.1 m80 -101.75 70.09 1.24 Allowed 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.477 -0.764 . . . . 0.40999999999999998 110.447 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.625 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 83.63 -8.2 66.34 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.815 -0.914 . . . . 0.17999999999999999 110.815 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.532 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 22.4 p -94.17 128.77 40.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.689 0.757 . . . . 0.82999999999999996 110.561 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.715 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -89.74 113.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.813 -1.085 . . . . 0.14999999999999999 110.527 -172.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.596 ' HB2' HG13 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -77.27 91.39 3.79 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.042 -0.981 . . . . 1.77 111.068 -177.467 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.654 HG23 HG21 ' A' ' 366' ' ' THR . 79.3 m -89.88 137.54 28.26 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 109.2 -0.667 . . . . 0.17999999999999999 109.2 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.1 Cg_exo -55.41 135.88 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.66 2.24 . . . . 0.12 111.248 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.744 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.8 Cg_exo -55.34 -32.87 83.22 Favored 'Trans proline' 0 CA--C 1.501 -1.148 0 C-N-CA 124.125 3.217 . . . . 0.16 112.849 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.2 m -79.75 -38.01 34.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.774 -1.103 . . . . 1.1699999999999999 110.016 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.62 HG11 ' HB ' ' A' ' 366' ' ' THR . 88.7 t -78.8 -29.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 0.17000000000000001 111.454 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.638 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -66.23 -20.48 66.13 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.698 0.761 . . . . 0.46000000000000002 109.925 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -76.3 -25.63 55.02 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.569 -1.196 . . . . 0.81000000000000005 111.69 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.7 mm-40 -80.33 -45.87 17.08 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-N 113.13 -1.85 . . . . 0.38 107.056 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.545 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 23.7 tp -66.22 -66.59 0.53 Allowed 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 111.756 -2.474 . . . . 0.059999999999999998 112.229 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.48 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 26.7 t80 -50.03 -25.77 3.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.89 1.329 . . . . 0.31 108.28 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.41 -27.65 65.26 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 112.867 -1.969 . . . . 0.13 112.583 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -91.02 -49.02 6.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.776 0.798 . . . . 0.13 111.384 171.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.584 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.84 137.39 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 CA-C-O 123.478 1.608 . . . . 0.23000000000000001 113.87 -167.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.64 -178.45 5.18 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 110.671 -2.968 . . . . 0.82999999999999996 106.567 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.765 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.0 mtmt -52.56 161.29 0.72 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-O 123.063 1.411 . . . . 0.23999999999999999 113.361 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.51 -32.88 5.26 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 112.498 -2.137 . . . . 0.37 112.31 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 384' ' ' VAL . 3.4 m -78.25 141.07 61.56 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.412 -0.588 . . . . 0.14999999999999999 109.412 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.651 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 5.8 Cg_exo -75.63 167.74 25.83 Favored 'Trans proline' 0 N--CA 1.425 -2.542 0 C-N-CA 122.084 1.856 . . . . 0.12 111.244 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.784 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -133.55 150.51 32.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.602 -1.259 . . . . 1.0900000000000001 107.602 165.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.8 tp -119.41 144.34 46.98 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.954 -1.021 . . . . 0.13 109.634 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.757 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -142.89 146.54 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.757 -1.571 . . . . 0.089999999999999997 106.757 165.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.643 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 17.5 p90 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.258 -0.877 . . . . 1.1599999999999999 110.993 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.898 0 N-CA-C 112.104 -0.398 . . . . 3.9399999999999999 112.104 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.8 t-80 -92.03 93.52 8.79 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.368 -0.604 . . . . 1.8500000000000001 109.368 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 35.1 mtm 69.12 -175.69 0.2 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.379 -1.282 . . . . 1.03 110.654 -170.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.11 -4.38 0.91 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 111.166 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -55.21 167.84 0.4 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.669 1.223 . . . . 0.97999999999999998 112.403 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.641 HG23 ' HA ' ' A' ' 358' ' ' LYS . 2.7 m -91.64 122.34 34.12 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 113.7 -1.591 . . . . 0.45000000000000001 108.096 169.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.668 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.9 p90 -161.12 -171.04 2.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.322 -0.854 . . . . 0.32000000000000001 110.533 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.578 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.2 mm -105.06 160.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.977 -1.119 . . . . 0.080000000000000002 107.977 167.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.519 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -140.93 155.92 46.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.972 0.806 . . . . 0.17000000000000001 111.327 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.724 HG22 ' HG3' ' A' ' 354' ' ' MET . 65.5 t -151.16 136.65 11.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.747 -1.115 . . . . 0.080000000000000002 109.923 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -116.97 119.11 34.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.615 -1.175 . . . . 0.37 108.078 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 352' ' ' GLN . 1.9 mm? -70.81 -47.83 57.36 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.202 1.001 . . . . 0.32000000000000001 110.492 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -57.97 -55.07 39.61 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.752 -2.022 . . . . 1.51 112.0 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -94.77 10.69 34.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.21 -1.359 . . . . 0.91000000000000003 108.657 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.675 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 3.6 mm-40 35.01 74.14 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.349 1.656 . . . . 2.2200000000000002 112.964 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.542 ' HE1' ' HB2' ' A' ' 365' ' ' GLU . 18.6 t-80 -152.27 124.3 8.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.32 -0.855 . . . . 0.13 109.744 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.724 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.3 ttp -111.88 126.94 55.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.586 -0.734 . . . . 0.059999999999999998 110.366 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.662 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -111.95 172.9 6.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 114.528 -1.214 . . . . 0.10000000000000001 111.911 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.681 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.3 t80 -125.93 115.73 20.39 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.577 -1.638 . . . . 0.22 106.577 165.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.501 ' CE1' HG12 ' A' ' 362' ' ' VAL . 23.8 m-85 -98.98 126.4 44.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.259 1.028 . . . . 0.17999999999999999 112.519 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.641 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.2 ttpt -148.94 139.29 22.42 Favored 'General case' 0 N--CA 1.396 -3.135 0 CA-C-N 112.95 -1.932 . . . . 0.46999999999999997 107.759 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 72.4 15.22 5.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 113.929 -1.487 . . . . 0.59999999999999998 108.871 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.79 78.58 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.603 -2.09 . . . . 0.23000000000000001 111.699 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.634 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -139.58 174.69 10.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 112.416 -1.892 . . . . 0.68000000000000005 106.108 -168.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.704 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.0 m -104.89 138.86 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 CA-C-O 124.227 1.965 . . . . 0.53000000000000003 112.397 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.681 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.36 -24.83 17.96 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 109.37 -3.559 . . . . 0.12 108.707 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.668 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -152.65 154.31 35.08 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.578 -1.646 . . . . 0.080000000000000002 108.67 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.704 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.11 120.49 1.16 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.708 -0.678 . . . . 0.60999999999999999 109.675 -174.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.696 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.0 t -147.79 167.33 25.0 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 122.199 0.999 . . . . 0.089999999999999997 111.981 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.66 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.3 p-10 -86.0 140.2 30.51 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 113.225 -1.807 . . . . 1.8799999999999999 107.867 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.675 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -140.88 -171.89 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.238 -0.892 . . . . 0.11 111.989 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.639 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.65 119.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.05 -0.977 . . . . 0.12 108.816 174.41 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.671 ' H ' HE22 ' A' ' 352' ' ' GLN . 7.6 t -142.23 144.2 33.24 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.415 -0.811 . . . . 0.69999999999999996 112.397 -166.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.02 44.48 45.46 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 116.569 1.388 . . . . 0.13 116.569 163.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.604 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.58 143.64 5.53 Favored Pre-proline 0 CA--C 1.509 -0.598 0 CA-C-N 118.472 1.136 . . . . 0.47999999999999998 110.49 -174.211 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.816 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.46 -33.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.966 1 C-N-CA 125.745 4.296 . . . . 0.23000000000000001 116.034 -170.925 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.604 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -79.74 -34.02 40.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.082 0.467 . . . . 0.29999999999999999 110.723 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.457 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.0 m -140.65 73.38 29.05 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 122.144 0.973 . . . . 0.29999999999999999 110.461 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.3 Cg_exo -70.62 161.51 45.78 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.201 3.934 . . . . 0.16 114.41 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.685 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.77 154.02 87.17 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 113.551 -1.659 . . . . 0.12 110.936 176.092 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.526 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.3 Cg_endo -80.84 -49.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 125.062 3.841 . . . . 0.089999999999999997 113.752 -172.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.692 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.05 122.55 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.123 0.964 . . . . 0.089999999999999997 113.449 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.35 -125.32 1.32 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.23 -1.35 . . . . 0.11 111.7 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.28 103.84 9.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.262 -1.014 . . . . 0.89000000000000001 108.262 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.767 ' HB2' HG22 ' A' ' 463' ' ' VAL . 95.6 m-85 -110.23 158.5 18.32 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.478 -0.783 . . . . 0.16 109.656 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.807 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 9.3 m-85 -146.59 139.63 25.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 118.194 0.452 . . . . 0.68999999999999995 110.699 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -75.63 125.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 119.92 -0.712 . . . . 0.14000000000000001 110.626 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -111.03 4.03 19.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.181 -0.918 . . . . 0.19 112.04 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.737 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 19.2 t-20 -164.56 150.11 10.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.326 -0.852 . . . . 0.40999999999999998 110.51 175.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.447 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.3 mtpt -109.98 113.65 26.53 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.609 -0.723 . . . . 1.0900000000000001 110.025 170.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 1.9 mt-10 -112.79 125.1 53.97 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.647 -1.16 . . . . 0.38 110.931 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 42.5 mt-10 -123.5 135.05 53.85 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.14 -1.391 . . . . 1.96 110.196 -176.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.8 t70 52.56 39.44 28.05 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 123.387 1.565 . . . . 0.40000000000000002 107.661 -172.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.9 167.47 12.41 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 112.474 -2.148 . . . . 0.16 111.256 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 37.5 m -128.11 102.5 6.74 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.964 -1.471 . . . . 0.27000000000000002 109.682 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.753 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -74.28 157.34 35.97 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 112.984 -1.916 . . . . 0.23999999999999999 110.406 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 8.5 mtpt -149.07 -176.6 5.42 Favored 'General case' 0 N--CA 1.399 -3.024 0 CA-C-N 114.945 -1.025 . . . . 0.67000000000000004 108.759 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.96 -142.08 4.93 Favored Glycine 0 CA--C 1.489 -1.579 0 C-N-CA 117.269 -2.396 . . . . 0.81000000000000005 114.918 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.65 120.82 12.2 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.309 -1.445 . . . . 0.79000000000000004 109.035 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.452 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 4.4 m-20 -53.1 -179.14 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.183 -2.28 . . . . 1.1200000000000001 112.313 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -52.16 -26.67 11.99 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.624 -0.716 . . . . 1.6499999999999999 110.855 167.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -91.81 -27.2 18.13 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.871 -0.604 . . . . 2.0 111.19 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.91 30.06 5.29 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.201 -0.999 . . . . 0.66000000000000003 110.801 -169.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 43.4 p -115.78 128.56 25.87 Favored Pre-proline 0 N--CA 1.42 -1.961 0 N-CA-C 106.637 -1.616 . . . . 0.68000000000000005 106.637 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 30.8 Cg_exo -63.79 160.75 35.46 Favored 'Trans proline' 0 C--N 1.284 -2.843 0 C-N-CA 121.898 1.732 . . . . 0.81000000000000005 112.647 -173.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.538 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 29.1 p90 -142.69 -171.36 3.41 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.352 -1.749 . . . . 0.38 107.074 -177.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 8.7 mt-10 -145.21 158.76 43.74 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.34 1.067 . . . . 0.62 111.831 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.753 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.56 98.62 12.17 Favored Pre-proline 0 N--CA 1.419 -1.982 0 CA-C-N 113.07 -1.877 . . . . 1.3300000000000001 107.747 175.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.8 Cg_endo -68.04 101.59 0.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.308 2.006 . . . . 0.20000000000000001 110.326 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -114.48 157.53 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.866 0 CA-C-N 114.242 -1.344 . . . . 0.29999999999999999 109.95 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 12.7 m120 -108.22 -33.8 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.39 -1.732 . . . . 1.8400000000000001 107.098 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.421 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 61.3 m-85 -134.55 116.18 14.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.86 -1.973 . . . . 0.44 111.134 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.75 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.71 134.24 53.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.223 -1.353 . . . . 0.13 110.258 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.517 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.1 OUTLIER -134.91 86.54 32.31 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.124 -0.943 . . . . 0.40999999999999998 111.054 174.049 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.06 140.22 34.17 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.81 2.34 . . . . 0.16 112.154 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.79 -15.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.479 . . . . 0.17000000000000001 111.214 -172.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -134.63 162.5 32.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.392 -0.822 . . . . 1.5900000000000001 109.447 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -93.47 13.8 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.358 0.503 . . . . 0.31 112.358 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.1 p -94.24 -27.42 16.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.674 -1.232 . . . . 0.44 107.674 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.48 34.36 0.76 Allowed Glycine 0 N--CA 1.427 -1.95 0 CA-C-N 113.112 -1.858 . . . . 0.23999999999999999 112.414 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 441' ' ' GLY . 76.8 t -103.79 151.49 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 120.987 0.422 . . . . 0.17000000000000001 110.762 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 170.92 -168.1 41.24 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.214 -0.903 . . . . 0.10000000000000001 111.664 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.46 141.16 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.933 -0.766 . . . . 0.12 108.933 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.564 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.0 p80 -150.6 163.72 37.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.803 0.811 . . . . 0.14999999999999999 111.776 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.14 142.6 27.56 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.916 -1.493 . . . . 0.41999999999999998 107.323 172.024 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.462 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 3.5 t -136.92 103.51 5.19 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.877 1.323 . . . . 1.48 110.395 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.55 -28.7 15.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.125 -2.307 . . . . 0.34999999999999998 111.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.533 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.4 p90 -70.27 -26.56 63.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 114.432 -1.258 . . . . 0.17999999999999999 109.342 175.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.575 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -120.58 82.18 33.0 Favored Pre-proline 0 CA--C 1.491 -1.31 0 CA-C-N 113.5 -1.682 . . . . 1.3300000000000001 109.465 -175.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -81.34 6.68 5.45 Favored 'Trans proline' 0 N--CA 1.43 -2.254 0 C-N-CA 124.693 3.596 . . . . 0.23000000000000001 113.907 -162.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 3.2 tp10 -114.47 154.54 28.01 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 1.1000000000000001 111.013 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.66 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -164.11 127.84 2.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.715 -1.584 . . . . 0.38 108.076 -169.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.31 -167.24 28.51 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 119.232 -1.461 . . . . 0.13 111.124 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.643 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.43 153.95 0.01 OUTLIER Glycine 0 C--N 1.336 0.583 0 O-C-N 124.927 1.016 . . . . 0.20000000000000001 112.897 174.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.65 100.81 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 123.862 1.791 . . . . 0.33000000000000002 112.0 -146.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 54.1 mt -97.02 -30.32 13.13 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 110.562 -3.017 . . . . 0.17999999999999999 108.205 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.639 ' HA ' HG23 ' A' ' 369' ' ' VAL . 7.6 p-90 -46.85 -38.01 9.66 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.876 0.735 . . . . 0.22 111.583 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.816 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.7 mttt -62.22 -23.01 66.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.274 -0.876 . . . . 0.64000000000000001 112.9 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -114.95 -37.03 4.26 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.578 -0.737 . . . . 0.25 110.361 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.575 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.8 mtp85 -85.18 -15.86 42.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.811 -1.086 . . . . 0.35999999999999999 112.691 -168.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.09 42.05 25.38 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 116.804 1.482 . . . . 0.20999999999999999 116.804 159.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.6 m -85.82 131.11 34.37 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 118.682 1.241 . . . . 0.46999999999999997 108.946 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.492 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 68.3 m80 -100.04 71.38 1.62 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.678 -0.639 . . . . 0.40999999999999998 111.227 -167.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.74 -14.12 59.15 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.422 -1.071 . . . . 0.17999999999999999 110.422 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.523 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -88.29 148.53 24.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.36 -0.42 . . . . 0.82999999999999996 110.192 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.685 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -100.01 119.54 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.776 0.798 . . . . 0.14999999999999999 110.759 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.58 ' HB3' HG13 ' A' ' 369' ' ' VAL . 2.6 t30 -79.93 82.97 5.92 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.557 -1.201 . . . . 1.77 111.42 -175.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.2 m -87.42 140.25 31.99 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-O 121.605 0.716 . . . . 0.17999999999999999 109.846 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.9 Cg_exo -58.85 136.14 71.64 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.814 2.342 . . . . 0.12 111.744 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.3 Cg_exo -55.01 -34.07 85.59 Favored 'Trans proline' 0 CA--C 1.504 -1.009 0 C-N-CA 124.415 3.41 . . . . 0.16 113.005 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.5 t -79.47 -38.33 34.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.893 -1.049 . . . . 1.1699999999999999 109.418 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.696 HG11 ' HB ' ' A' ' 366' ' ' THR . 46.9 t -82.51 -28.42 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 0.17000000000000001 111.269 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.725 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.5 tpt -67.68 -18.74 65.03 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.882 0.849 . . . . 0.46000000000000002 110.008 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -80.43 -23.24 40.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.442 -1.253 . . . . 0.81000000000000005 111.007 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.686 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.0 mm-40 -80.35 -46.99 15.15 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.957 -1.929 . . . . 0.38 107.215 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.584 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -64.68 -67.18 0.46 Allowed 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 111.798 -2.455 . . . . 0.059999999999999998 112.321 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -50.47 -26.36 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.18 1.467 . . . . 0.31 108.21 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.44 -32.77 67.96 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 112.182 -2.281 . . . . 0.13 112.22 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.686 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.8 ptp -87.5 -49.43 7.2 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 121.745 0.783 . . . . 0.13 111.509 172.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.635 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.7 OUTLIER -102.08 137.6 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 CA-C-O 123.518 1.627 . . . . 0.23000000000000001 113.835 -167.136 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.447 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.58 -178.23 5.08 Favored 'General case' 0 N--CA 1.401 -2.881 0 CA-C-N 110.585 -3.007 . . . . 0.82999999999999996 106.89 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.737 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 48.2 mtmt -51.59 161.78 0.46 Allowed 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 122.888 1.328 . . . . 0.23999999999999999 112.593 175.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.67 -31.52 5.8 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 112.623 -2.08 . . . . 0.37 112.368 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.5 m -82.92 140.77 43.39 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.683 -0.858 . . . . 0.14999999999999999 108.683 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.807 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.57 173.46 14.15 Favored 'Trans proline' 0 N--CA 1.415 -3.146 0 C-N-CA 121.093 1.196 . . . . 0.12 111.71 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -137.09 160.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.768 -1.197 . . . . 1.0900000000000001 107.768 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.442 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.8 tp -129.83 146.22 51.57 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.443 -0.799 . . . . 0.13 110.334 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.1 147.26 20.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.073 -1.454 . . . . 0.089999999999999997 107.073 165.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.648 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.1 p90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.855 -0.593 . . . . 1.1599999999999999 111.646 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 111.758 -0.537 . . . . 3.9399999999999999 111.758 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -168.51 -172.92 1.79 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.309 0.576 . . . . 1.8500000000000001 111.349 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 33.3 mtm -69.75 -175.69 0.93 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.681 -1.145 . . . . 1.03 111.961 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.63 -3.95 2.06 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.813 -1.085 . . . . 1.1000000000000001 110.09 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -54.48 166.99 0.37 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.829 1.3 . . . . 0.97999999999999998 112.732 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.603 HG23 ' HA ' ' A' ' 358' ' ' LYS . 94.0 m -93.33 123.6 36.73 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 113.41 -1.723 . . . . 0.45000000000000001 108.813 171.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.647 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.0 p90 -160.93 -170.31 2.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.217 -1.356 . . . . 0.32000000000000001 110.668 -173.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.3 mm -101.7 161.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.183 -1.043 . . . . 0.080000000000000002 108.183 166.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.492 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -142.24 155.6 45.25 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.407 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.671 HG22 ' HG3' ' A' ' 354' ' ' MET . 68.0 t -151.0 142.35 16.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.437 -1.256 . . . . 0.080000000000000002 109.146 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.499 ' HA ' ' OXT' ' A' ' 466' ' ' PHE . 7.2 t70 -130.67 107.49 9.21 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.37 109.129 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.547 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -69.27 -30.08 68.11 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.814 -1.539 . . . . 0.32000000000000001 110.575 -170.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -57.09 -63.61 1.16 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.89 0.852 . . . . 1.51 111.096 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -89.42 -3.53 58.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.047 -1.433 . . . . 0.91000000000000003 110.774 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.703 ' OE1' HD12 ' A' ' 368' ' ' ILE . 85.1 mm-40 49.64 68.64 0.7 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 112.084 -2.325 . . . . 2.2200000000000002 111.368 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.462 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.5 t60 -143.82 128.43 18.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.991 -1.004 . . . . 0.13 109.293 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.9 ttp -114.33 129.01 56.63 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 123.573 0.749 . . . . 0.059999999999999998 110.558 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.66 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.32 173.1 6.57 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.724 -1.126 . . . . 0.10000000000000001 111.802 -176.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.71 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -125.88 113.96 17.91 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.008 -1.849 . . . . 0.22 106.008 164.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.469 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.1 m-85 -98.53 129.21 45.09 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.811 0.815 . . . . 0.17999999999999999 111.218 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.603 ' HA ' HG23 ' A' ' 343' ' ' THR . 5.7 ttpt -147.6 137.65 22.94 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 113.912 -1.494 . . . . 0.46999999999999997 108.161 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.464 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.79 11.94 7.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 113.489 -1.687 . . . . 0.59999999999999998 108.629 178.345 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.06 12.25 71.38 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 112.785 -2.007 . . . . 0.23000000000000001 111.806 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.621 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -131.43 168.68 17.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.107 -1.812 . . . . 0.68000000000000005 106.107 -172.202 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.65 HG11 ' CD1' ' A' ' 355' ' ' TRP . 3.2 m -100.96 136.9 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 124.442 2.067 . . . . 0.53000000000000003 111.958 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.71 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -90.62 -25.92 19.9 Favored 'General case' 0 N--CA 1.397 -3.081 0 CA-C-N 109.085 -3.688 . . . . 0.12 108.57 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.64 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.6 tp -152.51 154.25 35.1 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.577 -1.647 . . . . 0.080000000000000002 108.744 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.66 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -164.92 121.53 1.5 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.67 -0.696 . . . . 0.60999999999999999 109.489 -175.358 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.704 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.5 t -148.51 167.03 26.44 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.25 1.024 . . . . 0.089999999999999997 112.099 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.688 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.8 p-10 -85.9 139.79 30.93 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 113.173 -1.831 . . . . 1.8799999999999999 107.827 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.703 HD12 ' OE1' ' A' ' 352' ' ' GLN . 1.7 pp -140.63 -172.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.207 -0.906 . . . . 0.11 111.554 -175.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.596 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.8 119.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.399 -0.819 . . . . 0.12 109.05 174.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.2 t -141.27 145.11 35.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.747 -1.115 . . . . 0.69999999999999996 112.562 -167.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.08 46.1 37.51 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 117.333 1.693 . . . . 0.13 117.333 162.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.453 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.1 pttt -45.86 145.55 2.31 Favored Pre-proline 0 C--N 1.347 0.462 0 CA-C-N 119.842 1.821 . . . . 0.47999999999999998 110.779 -174.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.798 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.99 -36.46 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 1 C-N-CA 125.422 4.081 . . . . 0.23000000000000001 115.529 -173.58 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -35.89 57.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.076 0.465 . . . . 0.29999999999999999 110.903 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.464 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -139.88 72.56 34.67 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 122.111 0.958 . . . . 0.29999999999999999 110.522 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.4 Cg_exo -71.75 162.76 41.06 Favored 'Trans proline' 0 C--N 1.324 -0.741 1 C-N-CA 125.35 4.033 . . . . 0.16 113.978 -177.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.725 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.33 152.43 90.09 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 113.651 -1.613 . . . . 0.12 111.062 175.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.514 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.42 -49.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 125.116 3.877 . . . . 0.089999999999999997 113.712 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.74 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.89 120.95 0.03 OUTLIER 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.767 1.025 . . . . 0.089999999999999997 113.767 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.77 -123.25 1.15 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.343 -1.299 . . . . 0.11 111.563 -176.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.1 p -126.13 112.17 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.079 0.942 . . . . 0.89000000000000001 108.933 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.779 ' HB2' HG22 ' A' ' 463' ' ' VAL . 90.4 m-85 -115.66 160.09 20.49 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.219 -0.9 . . . . 0.16 109.83 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.713 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 77.2 m-85 -147.8 135.29 20.74 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 120.97 -0.292 . . . . 0.68999999999999995 111.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.49 121.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.63 -0.828 . . . . 0.14000000000000001 110.234 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -108.44 2.21 22.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.247 -0.888 . . . . 0.19 111.784 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.755 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 16.6 t-20 -164.65 150.81 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.838 -1.074 . . . . 0.40999999999999998 110.217 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -112.8 126.98 56.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.616 -0.72 . . . . 1.0900000000000001 109.123 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.576 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -127.14 112.76 15.53 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 123.195 1.474 . . . . 0.38 113.249 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 3.1 mp0 -108.17 134.15 51.43 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.286 -1.779 . . . . 1.96 110.862 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 36.9 t70 52.17 37.11 20.94 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.394 1.568 . . . . 0.40000000000000002 107.744 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.576 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.79 170.31 10.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.225 -2.261 . . . . 0.16 112.028 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 16.5 m -125.98 105.81 9.17 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.679 -1.601 . . . . 0.27000000000000002 109.823 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.7 mp -72.05 156.11 39.56 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.243 -1.799 . . . . 0.23999999999999999 109.79 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 0.0 OUTLIER -149.86 -177.04 5.67 Favored 'General case' 0 N--CA 1.389 -3.482 0 CA-C-N 114.863 -1.062 . . . . 0.67000000000000004 109.136 -176.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 178.32 -143.47 5.98 Favored Glycine 0 CA--C 1.485 -1.811 0 C-N-CA 117.041 -2.504 . . . . 0.81000000000000005 115.104 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.26 122.12 13.56 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 112.814 -1.693 . . . . 0.79000000000000004 108.353 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.439 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 4.7 m-20 -52.21 -179.56 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 112.379 -2.191 . . . . 1.1200000000000001 112.079 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -22.36 7.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.282 -0.417 . . . . 1.6499999999999999 110.448 171.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.67 -27.02 13.6 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 116.383 -0.371 . . . . 2.0 111.504 -174.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.32 34.53 2.48 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.582 -1.294 . . . . 0.66000000000000003 111.444 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 64.9 p -117.56 127.05 26.91 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 106.582 -1.636 . . . . 0.68000000000000005 106.582 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 24.2 Cg_exo -65.5 154.62 72.87 Favored 'Trans proline' 0 C--N 1.284 -2.827 0 C-N-CA 122.211 1.941 . . . . 0.81000000000000005 111.934 -173.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.648 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 29.1 p90 -141.95 -177.61 5.3 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.097 -1.865 . . . . 0.38 107.203 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.7 mt-10 -142.09 159.13 42.84 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.383 1.087 . . . . 0.62 112.027 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.708 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.8 m -143.64 97.86 5.42 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.254 -1.794 . . . . 1.3300000000000001 109.464 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.7 Cg_endo -68.93 105.97 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.534 0 C-N-CA 124.359 3.373 . . . . 0.20000000000000001 112.999 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.832 HG11 ' HB2' ' A' ' 410' ' ' TRP . 0.6 OUTLIER -115.89 162.6 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 114.58 -1.191 . . . . 0.29999999999999999 110.87 -174.053 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 14.4 m120 -111.25 -33.59 6.39 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.152 -1.84 . . . . 1.8400000000000001 107.008 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.36 115.53 13.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.189 -1.823 . . . . 0.44 110.835 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.832 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.8 t-105 -122.59 136.26 54.84 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.558 -1.201 . . . . 0.13 109.897 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.534 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.54 86.17 23.81 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.006 -0.997 . . . . 0.40999999999999998 111.222 173.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.1 Cg_endo -70.85 140.11 37.88 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.889 2.393 . . . . 0.16 112.053 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.713 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.46 -15.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.804 -1.544 . . . . 0.17000000000000001 111.068 -173.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -135.37 163.76 29.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 1.5900000000000001 110.032 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -94.38 14.53 20.24 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.304 0.483 . . . . 0.31 112.304 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.4 p -94.11 -26.98 16.49 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.613 -1.254 . . . . 0.44 107.613 173.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.06 30.44 1.02 Allowed Glycine 0 N--CA 1.427 -1.93 0 CA-C-N 113.053 -1.885 . . . . 0.23999999999999999 112.274 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 441' ' ' GLY . 73.1 t -102.46 149.81 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 120.587 -0.445 . . . . 0.17000000000000001 111.112 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.18 -166.69 39.25 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.153 -0.93 . . . . 0.10000000000000001 111.789 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.407 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.8 OUTLIER -103.88 141.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.036 -0.727 . . . . 0.12 109.036 176.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.795 ' HB2' HG21 ' A' ' 407' ' ' VAL . 35.5 p80 -151.48 165.1 35.23 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.669 0.747 . . . . 0.14999999999999999 112.26 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.775 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.8 139.68 30.43 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.027 -1.442 . . . . 0.41999999999999998 107.449 171.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.813 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 1.6 t -135.6 104.25 5.73 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 123.212 1.482 . . . . 1.48 110.144 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -93.17 -25.85 17.66 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 111.855 -2.43 . . . . 0.34999999999999998 110.17 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.494 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 6.9 p90 -70.8 -26.41 63.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.385 -1.279 . . . . 0.17999999999999999 109.316 173.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.578 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.1 OUTLIER -118.93 83.08 22.27 Favored Pre-proline 0 CA--C 1.496 -1.121 0 CA-C-N 114.036 -1.438 . . . . 1.3300000000000001 110.6 -174.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -82.94 6.58 5.72 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 C-N-CA 124.515 3.477 . . . . 0.23000000000000001 114.554 -162.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.64 153.46 30.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 123.372 0.42 . . . . 1.1000000000000001 110.226 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.688 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -162.74 125.62 2.8 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.327 1.051 . . . . 0.38 109.203 -170.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.8 28.83 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.026 -1.559 . . . . 0.13 111.792 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.5 154.96 0.01 OUTLIER Glycine 0 C--N 1.339 0.748 0 O-C-N 124.985 1.05 . . . . 0.20000000000000001 112.762 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.41 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.039 1.876 . . . . 0.33000000000000002 112.284 -147.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 43.6 mt -96.68 -33.54 11.7 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 110.223 -3.171 . . . . 0.17999999999999999 108.094 175.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.508 ' HA ' HG23 ' A' ' 369' ' ' VAL . 2.9 p-90 -45.37 -37.96 5.46 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.936 0.772 . . . . 0.22 111.327 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.798 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.4 mttt -58.27 -23.7 57.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.059 -0.973 . . . . 0.64000000000000001 113.007 -176.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 49.0 p -116.63 -35.55 4.19 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.458 -0.792 . . . . 0.25 110.0 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.577 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.6 mtp85 -84.65 -14.92 47.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.634 -1.167 . . . . 0.35999999999999999 112.714 -169.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 73.47 41.54 44.25 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 116.459 1.344 . . . . 0.20999999999999999 116.459 159.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.7 m -87.53 131.49 34.36 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 118.267 1.033 . . . . 0.46999999999999997 109.113 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.479 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 72.1 m80 -97.58 68.32 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.817 -0.552 . . . . 0.40999999999999998 111.097 -169.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.587 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.64 -12.28 63.8 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.582 -1.007 . . . . 0.17999999999999999 110.582 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 26.3 p -87.34 143.66 27.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.271 -0.464 . . . . 0.82999999999999996 109.923 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -99.26 115.97 41.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.23 0.538 . . . . 0.14999999999999999 110.734 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.813 ' ND2' ' HB3' ' A' ' 423' ' ' SER . 0.8 OUTLIER -78.39 93.74 4.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.132 -0.94 . . . . 1.77 111.356 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 25.0 m -91.49 136.07 27.22 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.621 -0.718 . . . . 0.17999999999999999 109.284 173.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 50.1 Cg_exo -56.79 132.65 53.01 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.073 2.515 . . . . 0.12 112.696 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.775 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 16.2 Cg_exo -50.21 -39.24 52.24 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.625 2.883 . . . . 0.16 112.713 -168.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 61.6 m -74.99 -42.22 57.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.709 -1.132 . . . . 1.1699999999999999 109.867 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.704 HG11 ' HB ' ' A' ' 366' ' ' THR . 62.0 t -75.88 -28.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.353 0.597 . . . . 0.17000000000000001 111.294 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.693 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.7 tpt -68.33 -20.13 64.71 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.583 0.706 . . . . 0.46000000000000002 110.17 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -79.61 -22.27 43.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 122.496 1.141 . . . . 0.81000000000000005 110.974 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.679 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.25 -47.4 14.67 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 112.894 -1.957 . . . . 0.38 107.399 177.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.578 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.8 tp -63.93 -67.27 0.44 Allowed 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 111.81 -2.45 . . . . 0.059999999999999998 112.302 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.441 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 39.7 t80 -49.82 -27.23 4.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 123.026 1.393 . . . . 0.31 108.335 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.06 -31.16 66.89 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 112.388 -2.187 . . . . 0.13 112.266 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.679 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -87.97 -49.35 7.12 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 121.772 0.796 . . . . 0.13 111.383 172.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.07 138.02 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-O 123.455 1.598 . . . . 0.23000000000000001 113.796 -167.27 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.25 -178.87 5.35 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 110.821 -2.9 . . . . 0.82999999999999996 106.662 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.755 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.3 mtmt -51.61 161.5 0.5 Allowed 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.966 1.365 . . . . 0.23999999999999999 112.869 175.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.77 -33.69 4.89 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.688 -2.051 . . . . 0.37 112.535 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 462' ' ' PRO . 6.9 m -78.78 142.34 60.85 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.362 -0.607 . . . . 0.14999999999999999 109.362 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 5.1 Cg_exo -76.09 169.2 22.55 Favored 'Trans proline' 0 N--CA 1.425 -2.527 0 C-N-CA 121.89 1.727 . . . . 0.12 111.335 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.779 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.12 157.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 107.422 -1.325 . . . . 1.0900000000000001 107.422 166.023 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.473 HD22 ' CE1' ' A' ' 344' ' ' TYR . 2.8 tp -127.25 146.05 50.56 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.197 -0.911 . . . . 0.13 109.935 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 147.08 20.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.276 -1.379 . . . . 0.089999999999999997 107.276 165.705 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.52 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 20.4 p90 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.742 -0.647 . . . . 1.1599999999999999 111.103 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 CA-C-O 120.112 -0.271 . . . . 3.9399999999999999 112.596 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.619 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.5 p-80 -104.11 140.04 38.35 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 117.89 0.845 . . . . 1.8500000000000001 111.814 -176.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.619 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 35.6 mtm 83.69 172.2 0.08 Allowed 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 125.342 1.651 . . . . 1.03 110.959 -169.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -114.08 -9.15 12.98 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.667 -1.151 . . . . 1.1000000000000001 110.441 -175.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.23 167.07 1.41 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 123.024 1.392 . . . . 0.97999999999999998 113.756 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.0 m -93.15 122.65 35.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 112.909 -1.951 . . . . 0.45000000000000001 107.129 164.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.641 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.2 p90 -157.15 -171.38 3.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.451 0.643 . . . . 0.32000000000000001 111.636 -174.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.559 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.2 mm -104.31 160.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 107.839 -1.171 . . . . 0.080000000000000002 107.839 166.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.499 ' CD ' ' HE2' ' A' ' 466' ' ' PHE . 2.1 tt0 -140.41 155.49 46.71 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 118.82 0.737 . . . . 0.17000000000000001 111.336 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.627 HG22 ' HG3' ' A' ' 354' ' ' MET . 63.8 t -150.38 134.48 8.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.589 -1.187 . . . . 0.080000000000000002 110.251 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.412 ' HB2' ' HZ3' ' A' ' 355' ' ' TRP . 18.2 t0 -115.48 114.66 25.33 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.832 -1.076 . . . . 0.37 108.139 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.466 HD21 HG23 ' A' ' 465' ' ' VAL . 1.8 mm? -68.21 -51.93 39.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.803 1.287 . . . . 0.32000000000000001 110.586 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.57 -52.97 15.9 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.179 -1.828 . . . . 1.51 113.298 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -102.54 9.14 39.66 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.73 -1.123 . . . . 0.91000000000000003 109.06 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.75 ' OE1' HD12 ' A' ' 368' ' ' ILE . 85.0 mm-40 36.93 73.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.058 1.474 . . . . 2.2200000000000002 111.871 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.8 t60 -150.3 125.95 10.31 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.54 -1.209 . . . . 0.13 109.434 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.627 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -112.46 128.43 56.32 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.234 0.614 . . . . 0.059999999999999998 110.743 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.67 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.0 m-90 -111.87 173.11 6.51 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.634 -1.167 . . . . 0.10000000000000001 111.817 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.702 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.9 t80 -126.06 116.12 20.91 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 106.775 -1.565 . . . . 0.22 106.775 165.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.493 ' CE1' HG12 ' A' ' 362' ' ' VAL . 17.8 m-85 -98.86 126.33 44.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.142 0.973 . . . . 0.17999999999999999 112.165 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.678 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.5 ttpt -149.64 139.76 22.11 Favored 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 113.196 -1.82 . . . . 0.46999999999999997 107.846 174.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.43 15.44 6.21 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 114.008 -1.451 . . . . 0.59999999999999998 108.799 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.59 18.62 77.34 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 112.378 -2.192 . . . . 0.23000000000000001 111.783 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.63 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.07 173.65 11.34 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.86 -1.904 . . . . 0.68000000000000005 105.86 -170.151 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.724 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.5 m -104.23 137.67 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 124.338 2.018 . . . . 0.53000000000000003 112.246 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.702 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.37 -23.73 19.13 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-N 109.218 -3.628 . . . . 0.12 108.624 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.689 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -153.84 154.72 34.46 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 113.567 -1.651 . . . . 0.080000000000000002 108.405 -172.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.724 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.26 122.39 1.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.73 -0.668 . . . . 0.60999999999999999 109.299 -174.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.663 HG21 HG23 ' A' ' 445' ' ' THR . 6.3 t -149.05 166.87 27.42 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 122.105 0.955 . . . . 0.089999999999999997 111.84 173.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.646 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.7 p-10 -86.48 141.55 29.01 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 113.228 -1.805 . . . . 1.8799999999999999 107.444 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.75 HD12 ' OE1' ' A' ' 352' ' ' GLN . 1.6 pp -142.0 -171.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.21 -0.904 . . . . 0.11 111.525 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.59 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -155.66 119.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.466 -0.788 . . . . 0.12 108.92 175.428 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.416 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.8 143.89 33.66 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.792 -1.095 . . . . 0.69999999999999996 112.748 -165.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.623 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.08 44.82 34.39 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 116.924 1.529 . . . . 0.13 116.924 162.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.489 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.69 142.36 6.71 Favored Pre-proline 0 CA--C 1.507 -0.676 0 CA-C-N 118.593 1.196 . . . . 0.47999999999999998 110.081 -175.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.791 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.59 -31.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.967 1 C-N-CA 125.885 4.39 . . . . 0.23000000000000001 116.365 -170.07 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -82.89 -32.58 27.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.297 0.57 . . . . 0.29999999999999999 110.672 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.445 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 12.1 m -140.77 74.55 26.71 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 122.151 0.976 . . . . 0.29999999999999999 110.239 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.623 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.76 162.41 42.13 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 125.068 3.845 . . . . 0.16 113.419 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.05 152.47 90.7 Favored Pre-proline 0 N--CA 1.436 -1.15 0 CA-C-N 113.665 -1.607 . . . . 0.12 110.806 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.47 -48.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.885 3.723 . . . . 0.089999999999999997 113.548 -172.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.803 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 66.31 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.918 1.081 . . . . 0.089999999999999997 113.918 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.79 -123.47 1.18 Allowed Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 114.301 -1.318 . . . . 0.11 111.414 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.6 p -129.8 104.93 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 122.371 1.081 . . . . 0.89000000000000001 109.538 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.616 ' CE2' HG22 ' A' ' 465' ' ' VAL . 55.3 m-85 -110.4 166.33 11.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.994 -1.003 . . . . 0.16 108.862 -172.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.705 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -148.77 136.28 20.4 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 117.63 0.195 . . . . 0.68999999999999995 110.714 177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.583 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -72.29 124.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.555 0.693 . . . . 0.14000000000000001 110.573 176.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -113.04 4.49 16.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.275 -0.875 . . . . 0.19 112.005 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.743 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 16.9 t-20 -163.96 148.97 10.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.493 -0.776 . . . . 0.40999999999999998 110.583 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.7 mtpt -110.81 109.74 20.07 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.811 0.815 . . . . 1.0900000000000001 110.412 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -107.95 131.87 54.09 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.304 -1.316 . . . . 0.38 109.382 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.548 -1.205 . . . . 1.96 110.092 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 25.8 t70 50.43 40.42 22.99 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.597 1.665 . . . . 0.40000000000000002 107.516 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.32 170.2 9.98 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 111.927 -2.397 . . . . 0.16 110.809 -173.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 23.9 m -129.91 102.92 6.5 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.1 -1.409 . . . . 0.27000000000000002 110.136 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.784 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -75.17 158.16 33.46 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 112.717 -2.038 . . . . 0.23999999999999999 110.298 174.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 6.8 mtpt -148.55 -175.85 5.09 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 115.224 -0.898 . . . . 0.67000000000000004 108.919 -177.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.33 -144.23 6.06 Favored Glycine 0 CA--C 1.489 -1.553 0 C-N-CA 117.338 -2.363 . . . . 0.81000000000000005 114.975 176.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.05 121.44 13.18 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 113.488 -1.356 . . . . 0.79000000000000004 108.827 172.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.456 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.0 m-20 -54.13 -179.38 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 112.113 -2.312 . . . . 1.1200000000000001 111.771 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -52.27 -27.23 14.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.889 -0.596 . . . . 1.6499999999999999 110.774 168.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.95 -26.99 18.16 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.312 0.577 . . . . 2.0 111.008 -174.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.61 35.54 3.77 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 110.469 -1.052 . . . . 0.66000000000000003 110.469 -170.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 41.6 p -118.83 127.88 26.28 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 106.504 -1.665 . . . . 0.68000000000000005 106.504 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 26.7 Cg_exo -64.35 161.87 32.73 Favored 'Trans proline' 0 C--N 1.286 -2.745 0 C-N-CA 121.949 1.766 . . . . 0.81000000000000005 112.461 -173.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.552 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 25.0 p90 -143.23 -170.94 3.38 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.502 -1.681 . . . . 0.38 107.119 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.4 mt-10 -147.76 157.35 43.5 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.329 1.061 . . . . 0.62 112.182 175.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.784 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -134.16 99.21 13.62 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-N 113.236 -1.802 . . . . 1.3300000000000001 108.595 176.49 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.91 101.05 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.793 2.329 . . . . 0.20000000000000001 110.182 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -120.28 133.91 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-N 114.004 -1.453 . . . . 0.29999999999999999 111.234 -171.555 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.455 ' ND2' ' CD2' ' A' ' 409' ' ' TYR . 14.0 p-10 -78.08 -30.32 49.56 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.822 -1.081 . . . . 1.8400000000000001 110.599 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.568 ' HB3' ' CD1' ' A' ' 454' ' ' PHE . 64.1 m-85 -142.15 117.83 10.41 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.728 -1.124 . . . . 0.44 110.758 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.697 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.9 t-105 -122.94 135.65 54.57 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.24 -1.346 . . . . 0.13 110.296 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.583 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -136.33 87.18 22.89 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 115.25 -0.886 . . . . 0.40999999999999998 110.962 174.499 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 90.8 Cg_endo -72.68 140.95 33.34 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.834 2.356 . . . . 0.16 111.554 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -122.55 -15.81 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.38 -1.282 . . . . 0.17000000000000001 111.656 -171.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.779 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.9 p30 -135.78 170.16 16.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.486 -0.779 . . . . 1.5900000000000001 109.58 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -96.08 15.31 21.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.206 -0.452 . . . . 0.31 111.989 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 18.3 p -96.85 -27.52 14.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.072 -1.085 . . . . 0.44 108.072 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.82 27.3 0.87 Allowed Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.958 -1.473 . . . . 0.23999999999999999 113.314 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.779 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 61.5 t -103.44 151.77 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.266 0.555 . . . . 0.17000000000000001 111.428 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 173.34 -163.99 35.62 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.149 -0.932 . . . . 0.10000000000000001 111.41 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.98 137.81 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 109.251 -0.648 . . . . 0.12 109.251 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.735 ' HB2' HG21 ' A' ' 407' ' ' VAL . 33.3 p80 -152.65 169.84 21.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.725 0.774 . . . . 0.14999999999999999 111.422 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.731 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.87 154.5 19.44 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 113.827 -1.533 . . . . 0.41999999999999998 108.699 174.403 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 18.5 p -140.11 99.95 3.8 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.583 1.182 . . . . 1.48 109.936 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.93 -31.17 13.78 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.621 -2.081 . . . . 0.34999999999999998 110.411 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.554 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.2 p90 -70.25 -26.99 64.09 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.369 -1.287 . . . . 0.17999999999999999 108.765 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.489 ' HB3' HD22 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.27 82.83 24.02 Favored Pre-proline 0 CA--C 1.489 -1.375 0 CA-C-N 113.437 -1.711 . . . . 1.3300000000000001 109.037 -174.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 427' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 35.9 Cg_endo -80.07 3.61 7.47 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 124.483 3.455 . . . . 0.23000000000000001 114.619 -159.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 428' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 2.9 tp10 -113.96 157.17 22.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.892 0.377 . . . . 1.1000000000000001 110.738 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.646 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.66 125.89 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.293 -1.321 . . . . 0.38 108.68 -171.277 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -168.34 28.72 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.419 -1.372 . . . . 0.13 112.158 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.596 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.36 0.01 OUTLIER Glycine 0 C--N 1.341 0.843 0 O-C-N 124.983 1.049 . . . . 0.20000000000000001 112.783 173.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.22 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.281 0 CA-C-O 124.025 1.869 . . . . 0.33000000000000002 112.249 -146.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 36.3 mt -97.84 -33.53 11.21 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 110.06 -3.246 . . . . 0.17999999999999999 109.298 175.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.56 ' HA ' HG23 ' A' ' 369' ' ' VAL . 8.0 p-90 -46.88 -34.45 5.43 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.214 -1.812 . . . . 0.22 112.16 -174.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.791 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 47.9 mttt -61.93 -23.79 66.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.334 -0.848 . . . . 0.64000000000000001 113.188 -177.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -115.8 -36.66 4.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.686 0.755 . . . . 0.25 110.085 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.585 ' HD2' HD22 ' A' ' 433' ' ' LEU . 4.5 mtp85 -81.65 -15.48 54.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.489 -1.232 . . . . 0.35999999999999999 112.973 -169.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.48 42.85 26.23 Favored Glycine 0 C--N 1.314 -0.646 0 N-CA-C 116.344 1.298 . . . . 0.20999999999999999 116.344 158.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 13.7 m -85.73 131.37 34.34 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 118.282 1.041 . . . . 0.46999999999999997 109.117 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.442 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 60.2 m80 -101.8 71.73 1.32 Allowed 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.405 -0.809 . . . . 0.40999999999999998 110.919 -169.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.517 ' H ' ' HA2' ' A' ' 371' ' ' GLY . . . 85.8 -13.57 55.79 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.223 -1.151 . . . . 0.17999999999999999 110.223 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.569 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.1 p -88.59 148.18 24.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.063 -0.568 . . . . 0.82999999999999996 110.218 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.716 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -103.64 118.78 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.107 -0.497 . . . . 0.14999999999999999 110.348 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.632 ' HB3' ' OG ' ' A' ' 423' ' ' SER . 2.1 m-20 -85.49 90.01 7.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.589 -0.732 . . . . 1.77 111.641 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 99.5 m -87.02 138.76 32.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 121.473 0.654 . . . . 0.17999999999999999 109.726 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.0 Cg_exo -54.36 136.58 69.61 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.685 2.257 . . . . 0.12 111.043 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.731 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 44.5 Cg_exo -55.65 -31.98 81.71 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 C-N-CA 123.984 3.122 . . . . 0.16 112.638 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.7 p -80.63 -39.04 28.11 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.279 -1.328 . . . . 1.1699999999999999 109.623 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.588 HG11 ' HB ' ' A' ' 366' ' ' THR . 92.3 t -77.32 -31.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.552 -0.749 . . . . 0.17000000000000001 111.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.643 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 3.6 tpt -63.03 -24.4 67.9 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.584 0.707 . . . . 0.46000000000000002 110.523 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -72.28 -30.49 64.87 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.539 -1.209 . . . . 0.81000000000000005 112.628 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.67 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.7 mm-40 -75.68 -46.6 30.35 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-N 113.005 -1.907 . . . . 0.38 107.362 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.521 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 26.1 tp -64.97 -67.35 0.44 Allowed 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 111.491 -2.595 . . . . 0.059999999999999998 112.379 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 409' ' ' TYR . 26.8 t80 -50.37 -25.91 4.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 123.146 1.45 . . . . 0.31 108.309 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.34 -30.89 64.13 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 112.475 -2.148 . . . . 0.13 112.156 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.689 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -87.63 -48.38 7.94 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-O 121.661 0.743 . . . . 0.13 111.324 172.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.647 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.5 OUTLIER -102.19 137.89 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.351 1.548 . . . . 0.23000000000000001 113.989 -168.33 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.3 pt-20 -136.25 -178.56 5.21 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 110.965 -2.834 . . . . 0.82999999999999996 106.739 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.743 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.8 mtmt -50.95 160.54 0.46 Allowed 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 123.102 1.43 . . . . 0.23999999999999999 113.363 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.76 -36.21 3.78 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 112.433 -2.167 . . . . 0.37 112.475 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 462' ' ' PRO . 19.3 m -70.35 141.17 88.15 Favored Pre-proline 0 N--CA 1.438 -1.048 0 CA-C-O 121.196 0.522 . . . . 0.14999999999999999 110.282 -175.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.641 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.58 161.56 41.86 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.215 1.943 . . . . 0.12 110.884 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 71.8 t -132.26 131.42 60.84 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 113.466 -1.697 . . . . 1.0900000000000001 107.833 173.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' A' ' 339' ' ' HIS . 3.1 tp -109.83 142.03 41.69 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.232 0.539 . . . . 0.13 110.308 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.01 145.49 22.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.088 -1.819 . . . . 0.089999999999999997 106.088 164.316 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.803 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.135 -0.936 . . . . 1.1599999999999999 111.591 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.238 -0.745 . . . . 3.9399999999999999 111.238 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.476 ' HD2' ' O ' ' A' ' 339' ' ' HIS . 1.0 OUTLIER -150.66 125.33 9.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.847 0.323 . . . . 1.8500000000000001 111.473 176.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 37.7 mtm 52.83 106.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.695 1.368 . . . . 1.03 114.695 164.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.58 -2.76 18.17 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.034 -1.894 . . . . 1.1000000000000001 110.45 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -57.24 166.5 1.12 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 123.175 1.464 . . . . 0.97999999999999998 114.266 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.614 HG23 ' HA ' ' A' ' 358' ' ' LYS . 22.6 m -94.99 124.64 39.15 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 112.339 -2.21 . . . . 0.45000000000000001 108.627 168.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.642 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 6.1 p90 -156.88 -171.01 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.52 0.676 . . . . 0.32000000000000001 111.41 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.4 mm -102.26 162.14 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 108.221 -1.029 . . . . 0.080000000000000002 108.221 167.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.4 tt0 -142.14 156.54 45.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 118.835 0.743 . . . . 0.17000000000000001 111.545 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.691 HG22 ' HG3' ' A' ' 354' ' ' MET . 62.7 t -151.3 136.91 11.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.491 -1.231 . . . . 0.080000000000000002 110.077 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -117.67 115.34 24.87 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.68 -1.145 . . . . 0.37 108.104 172.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.509 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -67.83 -49.5 61.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.355 1.074 . . . . 0.32000000000000001 110.564 -176.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -52.89 -55.2 24.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.774 -2.012 . . . . 1.51 112.185 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -95.82 4.0 53.24 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.738 -1.119 . . . . 0.91000000000000003 109.964 -171.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.715 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.5 mm-40 47.08 66.14 1.07 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.448 -2.16 . . . . 2.2200000000000002 112.129 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.5 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -148.48 125.35 11.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.286 0.565 . . . . 0.13 109.916 -175.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.691 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -112.35 127.42 56.0 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 123.606 0.763 . . . . 0.059999999999999998 110.359 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.684 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -113.62 173.7 6.28 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.609 -1.178 . . . . 0.10000000000000001 112.062 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.717 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -126.49 115.83 20.17 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 106.529 -1.656 . . . . 0.22 106.529 165.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.508 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.9 m-85 -100.44 127.91 46.65 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.993 0.901 . . . . 0.17999999999999999 112.118 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.614 ' HA ' HG23 ' A' ' 343' ' ' THR . 6.0 ttpt -147.79 137.68 22.71 Favored 'General case' 0 N--CA 1.398 -3.034 0 CA-C-N 113.667 -1.606 . . . . 0.46999999999999997 108.548 174.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 70.48 14.2 7.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.402 -1.726 . . . . 0.59999999999999998 108.601 178.439 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.49 71.01 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 112.701 -2.045 . . . . 0.23000000000000001 112.186 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.583 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.69 169.9 16.97 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.158 -1.793 . . . . 0.68000000000000005 106.158 -170.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -101.41 138.23 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 CA-C-O 124.207 1.956 . . . . 0.53000000000000003 111.976 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.717 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.63 -25.01 18.48 Favored 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 109.361 -3.563 . . . . 0.12 108.688 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.714 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.87 155.18 36.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 113.74 -1.573 . . . . 0.080000000000000002 109.301 -173.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.8 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.14 123.0 1.6 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.469 -0.787 . . . . 0.60999999999999999 109.339 -175.418 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.815 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.9 t -148.32 165.68 30.31 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 122.415 1.102 . . . . 0.089999999999999997 112.017 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.734 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.7 p-10 -83.46 140.85 32.09 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 112.881 -1.963 . . . . 1.8799999999999999 107.821 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.26 -171.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.264 -0.88 . . . . 0.11 112.064 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.715 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -157.94 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.936 -1.029 . . . . 0.12 109.352 176.531 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.5 t -140.94 145.54 36.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.28 -0.873 . . . . 0.69999999999999996 112.892 -165.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 68.54 46.68 61.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 116.199 1.24 . . . . 0.13 116.199 162.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.562 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.38 145.42 2.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 118.267 1.033 . . . . 0.47999999999999998 110.184 -175.252 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.771 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.47 -33.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 125.242 3.961 . . . . 0.23000000000000001 115.911 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.562 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -80.41 -34.4 36.24 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.738 -0.601 . . . . 0.29999999999999999 110.752 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.456 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.3 m -139.98 73.06 33.53 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 122.209 1.004 . . . . 0.29999999999999999 109.994 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 29.5 Cg_exo -69.71 161.62 45.24 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 C-N-CA 125.301 4.001 . . . . 0.16 113.967 -177.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.696 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -72.99 154.03 90.85 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.562 -1.654 . . . . 0.12 110.358 175.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.543 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -80.24 -50.32 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 125.029 3.82 . . . . 0.089999999999999997 113.564 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.714 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.8 123.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.996 0.903 . . . . 0.089999999999999997 113.322 -176.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.29 -124.07 1.22 Allowed Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.271 -1.331 . . . . 0.11 111.491 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 381' ' ' VAL . 9.2 p -128.63 104.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.454 1.121 . . . . 0.89000000000000001 109.831 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.785 ' HB2' HG22 ' A' ' 463' ' ' VAL . 93.8 m-85 -107.92 161.35 15.01 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.516 -1.22 . . . . 0.16 110.03 -170.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.5 m-85 -147.3 136.99 22.92 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 122.974 0.171 . . . . 0.68999999999999995 110.694 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.625 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.2 120.36 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.937 -0.705 . . . . 0.14000000000000001 110.16 176.235 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 385' ' ' TRP . . . . . 0.467 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 40.6 p-90 -106.31 3.62 27.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.404 -0.816 . . . . 0.19 111.789 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.721 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 16.4 t-20 -164.54 148.86 9.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.224 -0.898 . . . . 0.40999999999999998 110.813 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.483 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.3 mtpt -107.4 111.16 23.36 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.478 -0.783 . . . . 1.0900000000000001 109.863 169.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.1 mt-10 -111.87 122.92 49.11 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.657 1.218 . . . . 0.38 110.912 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -118.1 145.0 45.18 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.079 -1.419 . . . . 1.96 109.253 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 34.6 t70 54.34 25.88 6.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 112.026 -2.352 . . . . 0.40000000000000002 108.582 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.09 170.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.09 -1.868 . . . . 0.16 112.063 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 31.5 m -127.49 102.26 6.79 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.526 -1.67 . . . . 0.27000000000000002 110.099 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.746 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.9 mp -72.9 158.46 35.46 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 113.03 -1.896 . . . . 0.23999999999999999 110.502 175.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 6.4 mtpt -146.09 -176.98 5.37 Favored 'General case' 0 N--CA 1.396 -3.148 0 N-CA-C 108.636 -0.876 . . . . 0.67000000000000004 108.636 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -178.27 -149.8 8.29 Favored Glycine 0 C--N 1.296 -1.665 0 C-N-CA 117.1 -2.476 . . . . 0.81000000000000005 115.239 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' A' ' 401' ' ' THR . 0.7 OUTLIER -139.44 119.8 13.87 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.522 -1.339 . . . . 0.79000000000000004 110.077 174.222 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.426 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.8 m-20 -52.72 -179.39 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 111.733 -2.485 . . . . 1.1200000000000001 112.192 175.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -52.42 -24.05 7.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.087 0.47 . . . . 1.6499999999999999 111.046 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -95.19 -27.78 15.37 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.317 -0.402 . . . . 2.0 111.909 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.45 31.68 4.21 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 119.314 -1.422 . . . . 0.66000000000000003 111.087 -170.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' A' ' 396' ' ' THR . 44.9 p -113.84 153.32 46.06 Favored Pre-proline 0 N--CA 1.416 -2.166 0 N-CA-C 106.328 -1.73 . . . . 0.68000000000000005 106.328 177.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.773 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 97.9 Cg_endo -69.6 172.31 12.72 Favored 'Trans proline' 0 C--N 1.274 -3.351 0 C-N-CA 121.777 1.652 . . . . 0.81000000000000005 112.88 -174.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.594 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 8.5 p90 -155.01 -170.45 3.5 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 112.518 -2.128 . . . . 0.38 106.905 171.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.1 mt-10 -147.7 158.16 43.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.342 1.067 . . . . 0.62 111.692 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.746 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.2 98.95 12.39 Favored Pre-proline 0 N--CA 1.42 -1.951 0 CA-C-N 113.12 -1.855 . . . . 1.3300000000000001 107.568 176.139 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.4 Cg_endo -67.29 102.02 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 122.318 2.012 . . . . 0.20000000000000001 110.165 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.725 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.39 163.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.853 0 CA-C-N 114.192 -1.367 . . . . 0.29999999999999999 109.914 -173.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -114.92 -33.8 5.32 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 113.417 -1.72 . . . . 1.8400000000000001 107.081 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.423 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 59.8 m-85 -134.87 115.68 13.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.629 -2.078 . . . . 0.44 110.485 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.725 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.5 t-105 -123.81 134.27 53.66 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.13 110.254 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.584 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -135.56 85.04 32.22 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.936 -1.029 . . . . 0.40999999999999998 110.93 173.514 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 73.2 Cg_endo -70.52 140.65 40.3 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.929 2.42 . . . . 0.16 112.102 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.728 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -124.39 -16.19 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.076 -1.42 . . . . 0.17000000000000001 111.162 -173.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -134.88 161.0 36.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.536 -0.756 . . . . 1.5900000000000001 109.532 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -92.13 13.84 17.81 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.147 0.425 . . . . 0.31 112.147 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -93.02 -25.66 17.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.745 -1.206 . . . . 0.44 107.745 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.22 29.16 1.38 Allowed Glycine 0 N--CA 1.425 -2.054 0 CA-C-N 113.073 -1.876 . . . . 0.23999999999999999 112.179 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 441' ' ' GLY . 84.8 t -102.27 148.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.281 0.562 . . . . 0.17000000000000001 110.626 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 173.97 -166.04 38.01 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.731 -1.122 . . . . 0.10000000000000001 111.186 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.411 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.67 138.99 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 108.795 -0.817 . . . . 0.12 108.795 176.074 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.717 ' CE1' ' HB2' ' A' ' 442' ' ' CYS . 9.9 p-80 -149.98 163.63 37.59 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.652 0.739 . . . . 0.14999999999999999 111.969 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.789 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.33 137.35 32.43 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.293 -1.321 . . . . 0.41999999999999998 107.951 173.066 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.5 OUTLIER -130.73 101.46 5.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.421 1.105 . . . . 1.48 109.606 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -95.18 -30.54 13.96 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.082 -1.872 . . . . 0.34999999999999998 111.021 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.445 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 19.0 p90 -66.66 -26.54 67.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.414 -1.266 . . . . 0.17999999999999999 109.151 174.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.504 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.95 82.65 28.84 Favored Pre-proline 0 CA--C 1.49 -1.347 0 CA-C-N 113.614 -1.63 . . . . 1.3300000000000001 109.451 -173.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -80.86 5.94 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 124.784 3.656 . . . . 0.23000000000000001 114.21 -160.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.67 153.7 29.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.336 -0.393 . . . . 1.1000000000000001 110.614 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.734 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.95 124.73 2.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.214 -1.357 . . . . 0.38 108.097 -172.189 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.86 -168.12 28.75 Favored Glycine 0 C--N 1.297 -1.629 0 C-N-CA 119.283 -1.437 . . . . 0.13 111.123 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.673 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.6 152.33 0.0 OUTLIER Glycine 0 C--N 1.342 0.891 0 O-C-N 125.141 1.142 . . . . 0.20000000000000001 113.176 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.6 m-20 -54.59 101.06 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 123.86 1.79 . . . . 0.33000000000000002 111.797 -145.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 55.6 mt -96.53 -30.79 13.11 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 110.474 -3.057 . . . . 0.17999999999999999 108.111 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.593 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.0 p-90 -46.46 -38.01 8.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.867 0.73 . . . . 0.22 111.398 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.771 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 36.4 mttt -62.3 -24.34 67.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.921 -1.036 . . . . 0.64000000000000001 112.845 -175.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 31.1 p -113.23 -36.18 5.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.568 0.699 . . . . 0.25 110.16 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.519 ' HB2' HG21 ' A' ' 369' ' ' VAL . 5.7 mtp85 -86.96 -16.83 34.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.783 -1.099 . . . . 0.35999999999999999 112.664 -168.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.497 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.47 43.79 29.34 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 116.506 1.362 . . . . 0.20999999999999999 116.506 162.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -86.21 130.74 34.42 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 118.701 1.251 . . . . 0.46999999999999997 108.179 172.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.479 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 61.7 m80 -99.72 64.34 1.27 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.47 -0.769 . . . . 0.40999999999999998 110.96 -168.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.566 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 94.9 -12.75 68.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.577 -1.009 . . . . 0.17999999999999999 110.577 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.717 ' HB2' ' CE1' ' A' ' 421' ' ' HIS . 10.7 p -90.49 142.77 27.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.238 -0.481 . . . . 0.82999999999999996 110.66 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -95.91 120.74 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 122.579 1.18 . . . . 0.14999999999999999 111.19 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.5 OUTLIER -78.92 82.48 5.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.784 -2.007 . . . . 1.77 111.936 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.567 HG23 HG21 ' A' ' 366' ' ' THR . 16.5 m -87.05 137.75 32.99 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-O 121.383 0.611 . . . . 0.17999999999999999 109.509 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.499 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 50.9 Cg_exo -57.42 136.14 74.21 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.723 2.282 . . . . 0.12 111.595 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.789 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.8 Cg_exo -55.14 -33.0 82.44 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 124.245 3.297 . . . . 0.16 113.138 -172.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.418 ' O ' ' HG2' ' A' ' 452' ' ' GLU . 4.6 t -81.42 -38.51 26.38 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.883 -1.053 . . . . 1.1699999999999999 109.304 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.815 HG11 ' HB ' ' A' ' 366' ' ' THR . 26.1 t -82.9 -26.85 8.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.652 . . . . 0.17000000000000001 111.11 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.699 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.7 tpt -68.58 -19.92 64.49 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.878 0.847 . . . . 0.46000000000000002 110.073 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.48 -23.22 46.53 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.609 -1.178 . . . . 0.81000000000000005 111.075 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.84 -45.97 16.05 Favored 'General case' 0 CA--C 1.477 -1.838 0 CA-C-N 112.905 -1.952 . . . . 0.38 107.473 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.597 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -65.01 -66.85 0.49 Allowed 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 111.89 -2.414 . . . . 0.059999999999999998 112.311 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.434 ' HB2' ' HE3' ' A' ' 450' ' ' MET . 24.1 t80 -50.16 -27.86 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.94 1.352 . . . . 0.31 107.965 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.58 -30.13 71.09 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 112.491 -2.14 . . . . 0.13 112.469 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.714 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.88 -48.26 7.35 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.597 0.713 . . . . 0.13 111.611 172.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.24 138.69 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 123.365 1.555 . . . . 0.23000000000000001 114.182 -167.073 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.483 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.4 -178.74 5.3 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 110.834 -2.894 . . . . 0.82999999999999996 106.845 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.9 mtmt -52.22 162.77 0.45 Allowed 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 123.114 1.435 . . . . 0.23999999999999999 113.058 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.64 -34.63 4.27 Favored Glycine 0 N--CA 1.424 -2.149 0 CA-C-N 112.48 -2.145 . . . . 0.37 112.283 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 462' ' ' PRO . 7.6 m -76.04 141.33 71.01 Favored Pre-proline 0 N--CA 1.434 -1.261 0 N-CA-C 109.484 -0.562 . . . . 0.14999999999999999 109.484 -176.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.642 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.6 166.47 28.4 Favored 'Trans proline' 0 N--CA 1.425 -2.53 0 C-N-CA 122.024 1.816 . . . . 0.12 111.157 173.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.63 153.2 34.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 107.634 -1.247 . . . . 1.0900000000000001 107.634 166.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.3 tp -123.4 145.25 48.93 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.096 -0.956 . . . . 0.13 110.155 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.28 146.05 21.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.413 -1.699 . . . . 0.089999999999999997 106.413 164.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.654 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 18.0 p90 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.62 -0.705 . . . . 1.1599999999999999 111.364 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.961 -0.456 . . . . 3.9399999999999999 111.961 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -111.05 96.66 6.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.187 0.517 . . . . 1.8500000000000001 109.9 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 36.0 mtm 62.21 -173.53 0.15 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.411 -1.268 . . . . 1.03 111.597 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.83 -4.83 0.73 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.434 -0.803 . . . . 1.1000000000000001 111.029 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -54.88 168.04 0.33 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 123.193 1.473 . . . . 0.97999999999999998 113.008 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.602 HG23 ' HA ' ' A' ' 358' ' ' LYS . 27.1 m -91.82 123.28 35.08 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 112.803 -1.999 . . . . 0.45000000000000001 107.959 169.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.656 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.4 p90 -161.0 -170.75 2.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.153 -0.931 . . . . 0.32000000000000001 110.768 -175.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.45 161.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.097 -1.075 . . . . 0.080000000000000002 108.097 167.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.518 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.7 tt0 -140.35 155.85 46.63 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.956 0.798 . . . . 0.17000000000000001 111.253 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.727 HG22 ' HG3' ' A' ' 354' ' ' MET . 67.0 t -150.84 133.4 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.413 -1.267 . . . . 0.080000000000000002 109.721 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 50.9 t0 -115.05 111.78 21.61 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.336 -1.357 . . . . 0.37 107.336 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.645 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.6 mm? -60.61 -58.67 7.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.783 1.277 . . . . 0.32000000000000001 107.618 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.496 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 11.9 mm-40 -48.94 -46.85 43.92 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 111.353 -2.658 . . . . 1.51 112.943 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -111.13 20.73 17.13 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 125.206 1.567 . . . . 0.91000000000000003 109.203 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.61 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 20.2 mp0 36.24 68.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.27 -1.787 . . . . 2.2200000000000002 112.622 170.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.499 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -153.17 124.5 7.58 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.194 0.521 . . . . 0.13 109.914 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.727 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -110.91 127.54 55.5 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.454 0.702 . . . . 0.059999999999999998 110.605 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.654 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.1 m-90 -112.25 173.76 6.21 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 114.459 -1.246 . . . . 0.10000000000000001 112.05 -175.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.718 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.3 t80 -127.41 119.15 25.51 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 106.261 -1.755 . . . . 0.22 106.261 165.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.522 ' CE1' HG12 ' A' ' 362' ' ' VAL . 18.5 m-85 -102.49 129.52 49.03 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.941 0.877 . . . . 0.17999999999999999 111.524 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.5 ttpt -148.46 137.43 21.7 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 113.722 -1.581 . . . . 0.46999999999999997 108.116 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.38 15.1 6.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.456 -1.702 . . . . 0.59999999999999998 108.752 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 80.51 17.79 72.57 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 112.667 -2.06 . . . . 0.23000000000000001 111.899 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.546 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -137.12 168.07 20.31 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.098 -1.816 . . . . 0.68000000000000005 106.098 -171.67 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.687 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -100.11 138.21 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.802 0 CA-C-O 124.25 1.976 . . . . 0.53000000000000003 111.874 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.718 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.24 -25.18 17.9 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 109.305 -3.589 . . . . 0.12 108.564 177.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.679 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -152.46 155.36 37.36 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.868 -1.515 . . . . 0.080000000000000002 109.227 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.687 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.93 122.51 1.36 Allowed 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 109.614 -174.74 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.74 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.6 t -148.3 167.16 25.9 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.177 0.989 . . . . 0.089999999999999997 112.136 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.5 p-10 -86.77 140.93 29.25 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.222 -1.808 . . . . 1.8799999999999999 107.916 177.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -143.15 -172.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.309 -0.859 . . . . 0.11 112.484 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.63 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -154.36 119.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.705 -1.134 . . . . 0.12 108.696 175.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 6.6 t -141.27 143.41 34.09 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.759 -0.655 . . . . 0.69999999999999996 112.742 -168.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.53 45.1 24.59 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 117.716 -1.602 . . . . 0.13 117.001 163.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.435 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.3 OUTLIER -46.71 143.85 3.94 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-N 119.722 1.761 . . . . 0.47999999999999998 110.363 -173.146 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.824 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.68 -33.67 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.948 4.432 . . . . 0.23000000000000001 115.912 -170.811 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 3.1 p -75.06 -37.97 61.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.3 0.571 . . . . 0.29999999999999999 111.076 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.1 m -140.55 74.31 28.32 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.106 0.955 . . . . 0.29999999999999999 110.606 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.4 Cg_exo -70.94 160.44 49.37 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 125.175 3.917 . . . . 0.16 113.853 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.69 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -71.1 153.09 94.65 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.269 -1.787 . . . . 0.12 111.357 177.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.526 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.5 Cg_endo -80.17 -49.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 125.09 3.86 . . . . 0.089999999999999997 113.734 -171.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.701 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.3 122.86 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.737 1.014 . . . . 0.089999999999999997 113.737 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.08 -124.74 1.28 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.242 -1.345 . . . . 0.11 111.423 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.6 p -128.72 105.65 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 122.296 1.046 . . . . 0.89000000000000001 109.267 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.814 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.8 m-85 -108.97 164.16 12.65 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.138 -0.937 . . . . 0.16 110.058 -169.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.694 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 68.9 m-85 -147.34 137.23 23.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 121.196 -0.202 . . . . 0.68999999999999995 110.954 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.589 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.63 121.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.491 0.662 . . . . 0.14000000000000001 110.364 176.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 385' ' ' TRP . . . . . 0.405 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 42.7 p-90 -108.62 5.86 25.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.421 -0.809 . . . . 0.19 111.88 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.729 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 13.8 t-20 -164.6 146.82 8.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.874 . . . . 0.40999999999999998 110.251 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -108.89 115.63 30.45 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.958 -0.756 . . . . 1.0900000000000001 108.958 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.572 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -118.65 111.98 19.23 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.472 1.606 . . . . 0.38 113.065 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 2.6 mp0 -103.84 143.74 32.42 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 113.289 -1.778 . . . . 1.96 109.708 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.7 t70 57.08 22.23 7.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.259 -2.246 . . . . 0.40000000000000002 108.604 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.572 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -82.33 171.15 14.53 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.403 -1.726 . . . . 0.16 112.56 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 15.7 m -127.5 104.23 7.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.051 -1.886 . . . . 0.27000000000000002 110.004 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.735 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.0 mp -73.26 156.99 37.93 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 112.642 -2.072 . . . . 0.23999999999999999 109.98 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.491 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.3 mtpt -150.83 -175.71 5.23 Favored 'General case' 0 N--CA 1.398 -3.058 0 O-C-N 124.352 1.032 . . . . 0.67000000000000004 108.789 -176.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.44 -142.04 5.05 Favored Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 117.411 -2.328 . . . . 0.81000000000000005 114.922 176.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.25 124.06 15.17 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 113.117 -1.542 . . . . 0.79000000000000004 108.46 170.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.518 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 4.9 m-20 -54.2 -178.75 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 112.222 -2.263 . . . . 1.1200000000000001 111.643 177.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -51.7 -25.34 7.1 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.838 -0.619 . . . . 1.6499999999999999 111.549 171.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.518 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.6 OUTLIER -101.43 -30.08 11.65 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.048 0.451 . . . . 2.0 111.554 -174.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 115.86 36.24 1.17 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.59 -1.291 . . . . 0.66000000000000003 111.736 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 67.6 p -117.56 128.53 25.94 Favored Pre-proline 0 N--CA 1.421 -1.913 0 N-CA-C 106.035 -1.839 . . . . 0.68000000000000005 106.035 174.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 27.4 Cg_exo -64.65 161.43 35.66 Favored 'Trans proline' 0 C--N 1.284 -2.858 0 C-N-CA 121.703 1.602 . . . . 0.81000000000000005 112.213 -174.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.574 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 26.9 p90 -140.88 -170.09 2.96 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 113.792 -1.549 . . . . 0.38 106.998 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.2 mt-10 -148.79 158.01 43.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.392 1.091 . . . . 0.62 112.112 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.735 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.91 99.22 10.24 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-N 112.948 -1.933 . . . . 1.3300000000000001 108.239 176.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 64.0 Cg_endo -67.62 102.24 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.549 2.166 . . . . 0.20000000000000001 110.669 175.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -113.64 165.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 114.238 -1.346 . . . . 0.29999999999999999 109.84 -173.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 11.3 m120 -116.3 -33.5 4.95 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.551 -1.659 . . . . 1.8400000000000001 107.083 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.412 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 46.3 m-85 -136.2 115.47 12.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.062 -1.881 . . . . 0.44 110.474 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.757 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.7 t-105 -122.95 135.77 54.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.712 -1.131 . . . . 0.13 110.065 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.57 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.8 OUTLIER -136.51 83.49 30.88 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.892 -1.049 . . . . 0.40999999999999998 110.923 173.496 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 13.9 Cg_endo -70.31 139.5 38.44 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.141 2.561 . . . . 0.16 112.659 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.93 -15.15 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 113.792 -1.549 . . . . 0.17000000000000001 111.453 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -134.39 163.64 29.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 1.5900000000000001 109.483 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -96.96 13.55 28.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.801 0.334 . . . . 0.31 111.735 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.4 p -92.45 -27.06 17.7 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.538 -1.282 . . . . 0.44 107.538 173.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.68 29.36 1.07 Allowed Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 112.862 -1.972 . . . . 0.23999999999999999 112.353 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 441' ' ' GLY . 74.3 t -102.47 148.76 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.232 0.539 . . . . 0.17000000000000001 111.142 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.49 -167.46 39.78 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.831 -1.077 . . . . 0.10000000000000001 111.336 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.61 141.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.858 -0.793 . . . . 0.12 108.858 175.528 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.593 ' O ' ' HB ' ' A' ' 445' ' ' THR . 32.9 p80 -149.46 165.16 32.95 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.747 0.784 . . . . 0.14999999999999999 111.616 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -93.28 139.39 30.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.019 -1.475 . . . . 0.41999999999999998 107.019 171.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.42 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 1.8 t -134.06 103.2 5.69 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.97 1.367 . . . . 1.48 110.066 -176.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.49 -32.36 13.53 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 112.234 -2.257 . . . . 0.34999999999999998 111.162 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -65.67 -27.19 68.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.55 -1.205 . . . . 0.17999999999999999 109.055 175.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.592 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -121.36 82.62 39.21 Favored Pre-proline 0 CA--C 1.493 -1.221 0 CA-C-N 113.406 -1.724 . . . . 1.3300000000000001 109.485 -174.239 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -81.24 7.33 5.03 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 C-N-CA 124.818 3.678 . . . . 0.23000000000000001 114.471 -160.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.68 154.46 27.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.009 0.433 . . . . 1.1000000000000001 111.303 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.606 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.97 126.0 2.39 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.178 -1.374 . . . . 0.38 108.86 -171.165 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.565 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 146.95 -166.63 28.38 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.68 -1.248 . . . . 0.13 110.65 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.66 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.14 151.89 0.0 OUTLIER Glycine 0 C--N 1.341 0.822 0 O-C-N 125.187 1.169 . . . . 0.20000000000000001 113.258 173.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.01 100.5 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 111.944 -152.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.3 mt -97.69 -32.12 11.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 110.403 -3.089 . . . . 0.17999999999999999 107.941 174.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.63 ' HA ' HG23 ' A' ' 369' ' ' VAL . 3.8 p-90 -46.0 -38.54 7.89 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.987 0.804 . . . . 0.22 111.414 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.824 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 34.9 mttt -59.11 -26.63 64.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 114.781 -1.1 . . . . 0.64000000000000001 113.021 -176.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.6 p -111.53 -35.35 5.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.898 0.856 . . . . 0.25 109.859 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.592 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.0 mtp85 -86.77 -15.55 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.439 -1.255 . . . . 0.35999999999999999 112.647 -168.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.435 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.65 41.89 33.95 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 116.608 1.403 . . . . 0.20999999999999999 116.608 159.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.7 p -91.07 131.76 36.45 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 118.318 1.059 . . . . 0.46999999999999997 109.124 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.52 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 71.3 m80 -98.6 69.08 1.86 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.673 -0.642 . . . . 0.40999999999999998 111.209 -167.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 88.41 -11.77 66.96 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 110.39 -1.084 . . . . 0.17999999999999999 110.39 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 18.4 p -86.88 141.34 28.84 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.181 -0.51 . . . . 0.82999999999999996 109.924 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.69 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -95.52 117.71 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.668 0.747 . . . . 0.14999999999999999 110.781 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.603 ' HB3' HG13 ' A' ' 369' ' ' VAL . 2.1 t30 -76.86 82.59 3.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.498 -1.228 . . . . 1.77 111.354 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.4 m -86.94 138.85 32.75 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-O 121.549 0.69 . . . . 0.17999999999999999 109.628 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.6 Cg_exo -58.13 135.26 67.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.654 2.236 . . . . 0.12 111.416 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 30.3 Cg_exo -54.44 -34.08 79.97 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 124.299 3.333 . . . . 0.16 112.783 -174.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 44.7 m -78.98 -41.37 29.29 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.458 -1.247 . . . . 1.1699999999999999 110.07 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.74 HG11 ' HB ' ' A' ' 366' ' ' THR . 54.0 t -79.21 -28.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.252 0.549 . . . . 0.17000000000000001 111.487 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.692 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.8 tpt -68.29 -18.58 64.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.775 0.797 . . . . 0.46000000000000002 110.096 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.09 -22.23 42.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.7 -1.136 . . . . 0.81000000000000005 110.875 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.687 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.3 mm-40 -81.0 -47.3 13.81 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 112.767 -2.015 . . . . 0.38 107.38 177.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.629 HD23 ' SD ' ' A' ' 450' ' ' MET . 25.5 tp -64.28 -67.01 0.47 Allowed 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 111.878 -2.419 . . . . 0.059999999999999998 112.318 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.442 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.0 t80 -49.76 -26.8 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 123.181 1.467 . . . . 0.31 108.285 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.7 -30.95 65.54 Favored Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 112.251 -2.25 . . . . 0.13 112.331 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.687 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -89.19 -48.88 7.08 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 121.688 0.756 . . . . 0.13 111.572 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -100.26 139.23 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 123.328 1.537 . . . . 0.23000000000000001 113.764 -168.719 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -136.19 -178.78 5.31 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 110.816 -2.902 . . . . 0.82999999999999996 106.883 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.729 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.6 mtmt -52.98 162.73 0.59 Allowed 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 123.025 1.393 . . . . 0.23999999999999999 112.694 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.4 -36.51 3.61 Favored Glycine 0 N--CA 1.423 -2.207 0 CA-C-N 112.577 -2.101 . . . . 0.37 112.514 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.1 m -74.27 141.72 77.66 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.471 -0.566 . . . . 0.14999999999999999 109.471 -175.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 3.7 Cg_exo -74.39 167.74 26.44 Favored 'Trans proline' 0 N--CA 1.424 -2.559 0 C-N-CA 121.765 1.644 . . . . 0.12 111.041 173.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.814 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.57 156.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 107.504 -1.295 . . . . 1.0900000000000001 107.504 166.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 346' ' ' GLU . 2.8 tp -126.98 145.15 50.8 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.462 -0.79 . . . . 0.13 110.233 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.701 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.27 146.7 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 106.869 -1.53 . . . . 0.089999999999999997 106.869 164.429 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.685 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.7 p90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.372 -0.823 . . . . 1.1599999999999999 111.477 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.067 -0.413 . . . . 3.9399999999999999 112.067 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 339' ' ' HIS . . . . . 0.511 ' O ' ' HB2' ' A' ' 340' ' ' MET . 5.9 t-80 -116.51 87.41 2.68 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.13 0.491 . . . . 1.8500000000000001 109.934 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 32.7 mtm 76.27 -175.97 0.12 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.82 -1.536 . . . . 1.03 111.53 -175.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.27 -8.91 1.3 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.408 -0.815 . . . . 1.1000000000000001 112.332 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.06 169.34 0.55 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 123.048 1.404 . . . . 0.97999999999999998 112.934 173.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 358' ' ' LYS . 33.1 m -92.28 122.86 35.16 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 113.122 -1.854 . . . . 0.45000000000000001 108.524 171.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.64 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 7.9 p90 -162.33 -170.32 2.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.913 -1.039 . . . . 0.32000000000000001 110.585 -174.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.562 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.1 mm -101.71 160.98 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.078 -1.082 . . . . 0.080000000000000002 108.078 166.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.479 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 3.6 tt0 -140.95 154.62 46.16 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 118.805 0.73 . . . . 0.17000000000000001 110.898 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.712 HG22 ' HG3' ' A' ' 354' ' ' MET . 61.4 t -150.24 134.69 9.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.31 -1.314 . . . . 0.080000000000000002 109.296 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -117.51 110.42 17.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.202 -1.407 . . . . 0.37 107.202 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.63 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -58.52 -56.98 15.13 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.835 -1.172 . . . . 0.32000000000000001 107.835 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -46.27 -51.21 14.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 111.956 -2.384 . . . . 1.51 112.993 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -100.73 4.42 43.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.394 -1.73 . . . . 0.91000000000000003 110.082 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.677 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 1.7 mp0 47.42 67.01 0.88 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 112.428 -2.169 . . . . 2.2200000000000002 112.363 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.3 t60 -146.79 125.69 12.74 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.377 0.608 . . . . 0.13 110.107 -177.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.712 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -112.6 128.38 56.35 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.54 0.736 . . . . 0.059999999999999998 110.658 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.675 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.76 173.27 6.46 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.44 -1.254 . . . . 0.10000000000000001 111.869 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.688 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.0 t80 -126.93 116.67 21.16 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.33 -1.729 . . . . 0.22 106.33 165.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 24.4 m-85 -100.53 128.93 46.44 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.899 0.857 . . . . 0.17999999999999999 111.609 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.606 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.5 ttpt -148.18 137.37 22.02 Favored 'General case' 0 N--CA 1.399 -3.013 0 CA-C-N 113.761 -1.563 . . . . 0.46999999999999997 108.473 173.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.73 16.69 6.71 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 113.332 -1.758 . . . . 0.59999999999999998 108.803 178.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.9 72.06 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 112.652 -2.067 . . . . 0.23000000000000001 111.819 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.574 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.96 169.56 17.57 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.349 -1.723 . . . . 0.68000000000000005 106.349 -170.615 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.692 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -102.36 138.36 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.865 0 CA-C-O 124.252 1.977 . . . . 0.53000000000000003 111.839 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.18 -25.37 17.87 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 109.24 -3.618 . . . . 0.12 108.647 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.639 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -153.23 154.87 35.53 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.762 -1.563 . . . . 0.080000000000000002 108.654 -171.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.692 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.59 122.07 1.17 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.738 -0.665 . . . . 0.60999999999999999 109.651 -174.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.678 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.8 t -148.74 167.09 26.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.089999999999999997 112.01 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.666 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.2 p-10 -85.13 142.01 29.81 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 113.061 -1.881 . . . . 1.8799999999999999 107.69 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.677 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -142.02 -174.34 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.257 -0.883 . . . . 0.11 112.122 -175.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.709 ' O ' ' HB2' ' A' ' 444' ' ' ASN . 0.2 OUTLIER -152.46 117.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.931 . . . . 0.12 109.318 175.21 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 30.2 t -141.54 148.25 39.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.963 0.727 . . . . 0.69999999999999996 112.963 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.61 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.7 44.96 47.02 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 116.197 1.239 . . . . 0.13 116.197 162.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.573 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.9 143.76 4.2 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 118.317 1.058 . . . . 0.47999999999999998 109.977 -174.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.796 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.19 -32.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.826 1 C-N-CA 125.705 4.27 . . . . 0.23000000000000001 116.08 -170.681 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 374' ' ' THR . . . . . 0.573 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.35 -34.56 31.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.359 0.599 . . . . 0.29999999999999999 110.755 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.465 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 m -140.04 73.04 33.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 122.125 0.964 . . . . 0.29999999999999999 110.302 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.61 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.81 161.47 44.97 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 125.22 3.947 . . . . 0.16 113.869 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.723 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.52 151.97 91.71 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 113.333 -1.758 . . . . 0.12 111.05 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.521 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.9 Cg_endo -80.0 -48.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 125.277 3.984 . . . . 0.089999999999999997 113.913 -170.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.697 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.32 122.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.992 1.108 . . . . 0.089999999999999997 113.992 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.36 -125.88 1.43 Allowed Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.121 -1.4 . . . . 0.11 110.778 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.7 p -125.77 112.57 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.921 0.867 . . . . 0.89000000000000001 108.761 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.803 ' HB2' HG22 ' A' ' 463' ' ' VAL . 98.1 m-85 -114.17 163.35 15.34 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.296 -0.866 . . . . 0.16 109.994 -169.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 71.8 m-85 -146.68 136.68 23.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 121.188 -0.205 . . . . 0.68999999999999995 110.974 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.89 123.13 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 C-N-CA 119.938 -0.705 . . . . 0.14000000000000001 110.552 177.655 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -107.08 3.41 25.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.602 -0.727 . . . . 0.19 112.035 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.737 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 18.9 t-20 -165.4 148.44 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.461 -0.79 . . . . 0.40999999999999998 110.764 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 387' ' ' LYS . . . . . 0.423 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 13.5 mtpt -107.59 109.05 20.6 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.444 -0.798 . . . . 1.0900000000000001 109.714 168.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.3 mt-10 -106.41 121.21 43.8 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.44 1.114 . . . . 0.38 110.634 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -120.62 134.84 55.24 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.535 -1.211 . . . . 1.96 110.511 -174.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.58 38.72 23.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 123.636 1.684 . . . . 0.40000000000000002 107.141 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.29 169.4 11.14 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 112.1 -2.318 . . . . 0.16 111.671 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 7.6 m -127.24 105.12 8.34 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 113.417 -1.719 . . . . 0.27000000000000002 109.626 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.734 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.27 157.67 35.42 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 112.963 -1.926 . . . . 0.23999999999999999 110.302 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.1 mtpt -148.03 -175.69 4.99 Favored 'General case' 0 N--CA 1.397 -3.094 0 CA-C-N 114.793 -1.094 . . . . 0.67000000000000004 108.454 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.45 -141.69 4.89 Favored Glycine 0 CA--C 1.485 -1.816 0 C-N-CA 116.984 -2.531 . . . . 0.81000000000000005 115.13 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' THR . . . . . 0.402 ' HB ' ' HA2' ' A' ' 400' ' ' GLY . 0.6 OUTLIER -142.45 124.12 15.02 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 112.996 -1.602 . . . . 0.79000000000000004 108.755 172.266 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.558 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 5.5 m-20 -54.36 -178.35 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 112.093 -2.321 . . . . 1.1200000000000001 111.991 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -51.02 -25.18 4.45 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.834 -0.621 . . . . 1.6499999999999999 111.6 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ASP . . . . . 0.558 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 1.1 p30 -102.39 -29.53 11.58 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.193 0.52 . . . . 2.0 111.915 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 396' ' ' THR . . . 114.67 36.85 1.23 Allowed Glycine 0 C--N 1.296 -1.678 0 C-N-CA 119.53 -1.319 . . . . 0.66000000000000003 111.491 -172.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 70.9 p -118.22 128.46 25.97 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 106.31 -1.737 . . . . 0.68000000000000005 106.31 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 32.3 Cg_exo -64.16 162.27 30.47 Favored 'Trans proline' 0 C--N 1.286 -2.759 0 C-N-CA 121.817 1.678 . . . . 0.81000000000000005 112.801 -174.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.549 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 26.6 p90 -143.88 -169.72 3.16 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.559 -1.655 . . . . 0.38 106.959 -176.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.4 mt-10 -144.67 159.54 42.66 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.034 0.921 . . . . 0.62 111.914 173.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.734 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.68 99.75 10.31 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-N 113.355 -1.748 . . . . 1.3300000000000001 108.046 176.239 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.0 Cg_endo -67.41 102.83 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.577 2.185 . . . . 0.20000000000000001 110.653 174.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.781 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.31 156.68 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.588 0 CA-C-N 114.146 -1.388 . . . . 0.29999999999999999 109.776 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -105.17 -34.67 7.85 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.529 -1.669 . . . . 1.8400000000000001 107.359 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.775 ' HB2' ' SD ' ' A' ' 450' ' ' MET . 52.4 m-85 -137.85 119.43 14.97 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.306 -1.77 . . . . 0.44 111.217 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.781 ' HB2' HG11 ' A' ' 407' ' ' VAL . 8.1 t-105 -125.2 135.58 52.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 113.841 -1.527 . . . . 0.13 110.185 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.542 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -134.94 85.18 35.59 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 114.992 -1.004 . . . . 0.40999999999999998 111.152 174.794 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 87.5 Cg_endo -72.29 141.23 35.18 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.161 2.574 . . . . 0.16 112.469 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -124.97 -15.93 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 113.828 -1.533 . . . . 0.17000000000000001 111.031 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.93 162.32 32.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.303 -0.862 . . . . 1.5900000000000001 109.393 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -95.03 13.78 23.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.355 0.502 . . . . 0.31 112.355 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 13.1 p -94.0 -26.66 16.71 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.531 -1.285 . . . . 0.44 107.531 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.67 33.25 0.77 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.108 -1.86 . . . . 0.23999999999999999 112.32 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 441' ' ' GLY . 79.8 t -103.16 148.48 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.184 0.516 . . . . 0.17000000000000001 110.963 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 169.97 -167.43 40.52 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.948 -1.024 . . . . 0.10000000000000001 111.446 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' ILE . . . . . 0.491 HG21 HD23 ' A' ' 453' ' ' LEU . 0.9 OUTLIER -101.97 140.08 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 109.141 -0.688 . . . . 0.12 109.141 174.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.542 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 32.2 p80 -146.52 160.54 41.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.956 0.884 . . . . 0.14999999999999999 111.712 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -85.72 136.9 33.16 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 113.817 -1.538 . . . . 0.41999999999999998 107.399 170.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.95 102.01 5.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 123.015 1.388 . . . . 1.48 110.999 -175.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -94.82 -33.48 12.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 112.168 -2.287 . . . . 0.34999999999999998 111.484 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.462 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 21.5 p90 -66.48 -27.24 67.64 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.687 -1.142 . . . . 0.17999999999999999 109.505 175.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.525 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -121.27 81.27 37.3 Favored Pre-proline 0 CA--C 1.494 -1.202 0 CA-C-N 113.664 -1.607 . . . . 1.3300000000000001 110.351 -174.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -82.2 7.84 4.86 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 125.062 3.841 . . . . 0.23000000000000001 114.162 -163.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -114.58 153.35 30.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 123.462 0.476 . . . . 1.1000000000000001 110.267 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.666 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.47 126.87 2.72 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.756 1.285 . . . . 0.38 108.202 -169.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 146.55 -164.54 28.43 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 118.849 -1.643 . . . . 0.13 111.193 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -27.84 151.04 0.0 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 125.208 1.181 . . . . 0.20000000000000001 113.075 171.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 112.031 -149.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 40.4 mt -97.44 -33.87 11.23 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 110.583 -3.008 . . . . 0.17999999999999999 107.95 174.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.567 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.1 p-90 -46.2 -37.45 7.12 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.638 0.586 . . . . 0.22 111.61 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.796 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 32.3 mttt -61.5 -23.74 66.11 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.223 -0.899 . . . . 0.64000000000000001 112.923 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.5 p -113.58 -35.02 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.886 0.851 . . . . 0.25 109.879 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.525 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 3.7 mtp180 -87.2 -16.49 35.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.612 -1.176 . . . . 0.35999999999999999 112.785 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.01 41.75 39.28 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.264 1.266 . . . . 0.20999999999999999 116.264 159.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.0 m -84.21 133.83 34.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 118.233 1.016 . . . . 0.46999999999999997 108.541 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.431 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 55.4 m80 -103.96 68.14 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.45 -0.781 . . . . 0.40999999999999998 110.884 -166.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.679 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 89.46 -11.11 70.97 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.518 -1.033 . . . . 0.17999999999999999 110.518 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.6 p -90.68 137.24 32.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.211 -0.494 . . . . 0.82999999999999996 110.667 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 377' ' ' THR . 1.4 mp -92.01 120.6 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 CA-C-O 122.734 1.254 . . . . 0.14999999999999999 111.164 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.709 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.5 OUTLIER -79.42 82.44 5.56 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.317 -2.22 . . . . 1.77 112.14 -177.025 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 366' ' ' THR . 19.6 m -86.75 137.72 33.63 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-O 121.499 0.666 . . . . 0.17999999999999999 109.599 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 49.4 Cg_exo -58.67 134.12 58.68 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.562 2.174 . . . . 0.12 110.679 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.9 Cg_exo -56.43 -34.89 95.69 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 C-N-CA 123.881 3.054 . . . . 0.16 112.938 -171.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.8 m -77.21 -37.59 53.12 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.698 -1.137 . . . . 1.1699999999999999 109.778 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.678 HG11 ' HB ' ' A' ' 366' ' ' THR . 59.2 t -80.77 -27.39 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.835 -0.62 . . . . 0.17000000000000001 111.063 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.775 ' SD ' ' HB2' ' A' ' 409' ' ' TYR . 0.0 OUTLIER -63.62 -35.48 80.66 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-O 121.859 0.838 . . . . 0.46000000000000002 109.281 177.302 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -64.54 -25.03 67.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.48 -1.236 . . . . 0.81000000000000005 111.985 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 456' ' ' MET . 16.1 mm-40 -79.1 -46.96 17.0 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 113.692 -1.595 . . . . 0.38 107.64 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.531 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 28.8 tp -64.48 -67.16 0.46 Allowed 'General case' 0 N--CA 1.404 -2.772 0 CA-C-N 111.644 -2.525 . . . . 0.059999999999999998 112.55 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.673 ' HB2' ' SD ' ' A' ' 450' ' ' MET . 39.8 t80 -49.31 -28.62 5.03 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.216 1.484 . . . . 0.31 107.919 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.65 -32.43 74.57 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 112.143 -2.298 . . . . 0.13 112.058 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.647 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -87.83 -48.09 8.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.66 0.743 . . . . 0.13 111.677 172.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.562 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.3 138.39 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 123.604 1.669 . . . . 0.23000000000000001 114.239 -167.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 458' ' ' GLU . . . . . 0.423 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.6 pt-20 -136.88 -178.27 5.12 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 110.634 -2.985 . . . . 0.82999999999999996 106.504 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.737 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.0 mtmt -53.17 163.39 0.55 Allowed 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 123.129 1.442 . . . . 0.23999999999999999 112.661 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.49 4.74 Favored Glycine 0 N--CA 1.423 -2.179 0 CA-C-N 112.496 -2.138 . . . . 0.37 112.26 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 462' ' ' PRO . 8.7 m -76.65 141.61 69.21 Favored Pre-proline 0 N--CA 1.433 -1.321 0 N-CA-C 109.335 -0.617 . . . . 0.14999999999999999 109.335 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.64 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -75.26 166.34 29.08 Favored 'Trans proline' 0 N--CA 1.425 -2.525 0 C-N-CA 121.833 1.689 . . . . 0.12 110.865 173.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.71 155.79 39.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 107.449 -1.315 . . . . 1.0900000000000001 107.449 167.036 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -126.39 145.06 50.61 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.327 -0.851 . . . . 0.13 110.051 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.697 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.22 147.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 N-CA-C 107.189 -1.411 . . . . 0.089999999999999997 107.189 164.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.645 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.274 -0.869 . . . . 1.1599999999999999 111.496 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.35 -0.7 . . . . 3.9399999999999999 111.35 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 62.24 90.79 0.07 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.737 0.779 . . . . 1.8500000000000001 110.861 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 37.2 mtm 63.76 -171.81 0.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.699 -1.592 . . . . 1.03 111.744 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.83 -3.17 0.4 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.253 -0.885 . . . . 1.1000000000000001 111.392 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -55.67 167.71 0.51 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.954 1.359 . . . . 0.97999999999999998 113.117 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.5 m -92.26 121.92 34.24 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 113.376 -1.738 . . . . 0.45000000000000001 107.761 168.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' TYR . . . . . 0.631 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.0 p90 -157.11 -171.08 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.596 0.712 . . . . 0.32000000000000001 111.178 -174.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 453' ' ' LEU . 10.3 mm -103.05 161.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.055 -1.091 . . . . 0.080000000000000002 108.055 167.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.1 tt0 -141.53 155.36 45.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.493 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 354' ' ' MET . 76.2 t -150.98 137.4 12.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.701 -1.136 . . . . 0.080000000000000002 110.355 -177.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -123.48 107.34 11.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.852 -1.166 . . . . 0.37 107.852 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.499 ' H ' HD22 ' A' ' 349' ' ' LEU . 2.3 mm? -68.26 -39.43 82.2 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 113.228 -1.805 . . . . 0.32000000000000001 111.24 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.4 -55.78 16.16 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.022 -2.354 . . . . 1.51 111.432 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -93.51 11.83 27.25 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.62 -1.173 . . . . 0.91000000000000003 108.654 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' GLN . . . . . 0.689 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 2.4 mm-40 35.36 73.28 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 125.537 1.773 . . . . 2.2200000000000002 113.079 177.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 353' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.0 t60 -151.15 125.59 9.48 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.333 -0.849 . . . . 0.13 109.625 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' MET . . . . . 0.73 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -113.34 127.48 56.15 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.478 0.711 . . . . 0.059999999999999998 110.358 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' TRP . . . . . 0.682 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.5 m-90 -113.14 173.68 6.27 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.659 -1.155 . . . . 0.10000000000000001 111.886 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' TYR . . . . . 0.703 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -127.12 117.44 22.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.625 -1.62 . . . . 0.22 106.625 165.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 362' ' ' VAL . 26.5 m-85 -101.37 126.33 48.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.146 0.974 . . . . 0.17999999999999999 112.362 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.8 ttpt -148.96 137.5 21.11 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 113.099 -1.864 . . . . 0.46999999999999997 108.458 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 70.52 15.98 7.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 113.334 -1.757 . . . . 0.59999999999999998 108.822 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.03 78.87 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 112.561 -2.109 . . . . 0.23000000000000001 111.551 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LYS . . . . . 0.582 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -133.86 169.75 16.62 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.344 -1.928 . . . . 0.68000000000000005 106.255 -169.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 362' ' ' VAL . . . . . 0.752 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -101.03 137.5 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 CA-C-O 124.325 2.012 . . . . 0.53000000000000003 111.824 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -24.31 18.85 Favored 'General case' 0 N--CA 1.398 -3.047 0 CA-C-N 109.211 -3.632 . . . . 0.12 108.573 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 364' ' ' LEU . . . . . 0.672 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.71 154.93 35.0 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.729 -1.578 . . . . 0.080000000000000002 108.919 -172.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.752 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.08 122.06 1.29 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.562 -175.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.668 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.7 t -148.7 167.58 25.16 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-O 122.22 1.009 . . . . 0.089999999999999997 112.3 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 6.3 p-10 -86.09 139.9 30.71 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.163 -1.835 . . . . 1.8799999999999999 107.913 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.689 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -140.8 -172.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.138 -0.937 . . . . 0.11 112.22 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.82 115.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.133 -0.939 . . . . 0.12 109.704 174.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 370' ' ' SER . . . . . 0.574 ' H ' HE22 ' A' ' 352' ' ' GLN . 30.2 t -140.54 149.67 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 0.69999999999999996 112.535 -169.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.35 44.17 52.57 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 116.854 1.502 . . . . 0.13 116.854 162.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 372' ' ' LYS . . . . . 0.508 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 1.6 pttt -47.61 146.1 3.86 Favored Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 119.153 1.477 . . . . 0.47999999999999998 110.683 -174.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' PRO . . . . . 0.794 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -34.19 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 1 C-N-CA 125.985 4.457 . . . . 0.23000000000000001 115.71 -174.127 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.1 p -77.43 -39.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.171 0.51 . . . . 0.29999999999999999 110.975 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 4.1 m -140.21 72.83 32.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 122.263 1.03 . . . . 0.29999999999999999 110.197 -177.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 376' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 31.9 Cg_exo -69.13 164.46 33.84 Favored 'Trans proline' 0 C--N 1.322 -0.84 1 C-N-CA 125.64 4.227 . . . . 0.16 114.463 -176.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 377' ' ' THR . . . . . 0.701 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -76.4 152.01 83.45 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 113.565 -1.652 . . . . 0.12 110.45 174.506 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.55 -49.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.328 -0.516 0 C-N-CA 125.093 3.862 . . . . 0.089999999999999997 113.813 -170.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 68.34 122.8 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.921 1.082 . . . . 0.089999999999999997 113.921 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.21 -122.26 1.07 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.257 -1.338 . . . . 0.11 111.426 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -128.01 112.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.86 0.838 . . . . 0.89000000000000001 108.812 177.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' PHE . . . . . 0.78 ' HB2' HG22 ' A' ' 463' ' ' VAL . 95.9 m-85 -115.79 161.21 19.07 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.42 -0.809 . . . . 0.16 109.697 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -147.78 136.31 21.68 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 121.132 -0.227 . . . . 0.68999999999999995 110.681 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' VAL . . . . . 0.639 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.6 125.31 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.855 -0.738 . . . . 0.14000000000000001 110.653 177.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -110.71 0.7 17.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.436 -0.802 . . . . 0.19 112.176 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' ASN . . . . . 0.729 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 20.1 t-20 -162.56 149.25 13.08 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.155 -0.93 . . . . 0.40999999999999998 109.639 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -113.0 119.76 39.01 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.807 0.813 . . . . 1.0900000000000001 109.934 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.568 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -119.35 121.28 39.2 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.226 -1.352 . . . . 0.38 111.229 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.78 143.58 46.83 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.032 -1.44 . . . . 1.96 109.774 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.0 t70 54.1 26.12 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.835 -2.439 . . . . 0.40000000000000002 108.637 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.26 171.16 13.88 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 112.769 -2.014 . . . . 0.16 111.879 -167.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 8.9 m -129.89 102.95 6.52 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.628 -1.624 . . . . 0.27000000000000002 110.159 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' LEU . . . . . 0.735 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.42 156.89 38.58 Favored 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 112.254 -2.248 . . . . 0.23999999999999999 110.242 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.7 mtpt -149.14 -175.85 5.13 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 114.436 -1.256 . . . . 0.67000000000000004 108.419 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' GLY . . . . . 0.534 ' HA3' ' CE2' ' A' ' 403' ' ' TYR . . . -179.08 -138.99 3.41 Favored Glycine 0 CA--C 1.482 -2.023 0 C-N-CA 117.12 -2.467 . . . . 0.81000000000000005 114.515 175.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.11 122.36 13.89 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 113.113 -1.543 . . . . 0.79000000000000004 108.311 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ASN . . . . . 0.512 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.2 m-20 -52.7 -179.69 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 112.652 -2.067 . . . . 1.1200000000000001 111.304 175.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -56.03 -23.95 36.36 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.482 0.658 . . . . 1.6499999999999999 109.954 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.72 -27.18 21.37 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.088 -0.96 . . . . 2.0 111.061 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.75 31.84 5.59 Favored Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 110.328 -1.109 . . . . 0.66000000000000003 110.328 -169.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 41.3 p -119.2 127.79 26.29 Favored Pre-proline 0 N--CA 1.42 -1.949 0 N-CA-C 106.746 -1.576 . . . . 0.68000000000000005 106.746 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 401' ' ' THR . 1.0 OUTLIER -71.13 156.0 60.32 Favored 'Trans proline' 0 N--CA 1.407 -3.585 0 C-N-CA 121.124 1.216 . . . . 0.81000000000000005 112.836 -168.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 403' ' ' TYR . . . . . 0.534 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 38.9 p90 -131.88 -169.73 2.26 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.516 -1.674 . . . . 0.38 107.491 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.8 mt-10 -144.59 159.6 42.53 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.535 1.16 . . . . 0.62 111.446 173.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' SER . . . . . 0.735 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.44 99.23 9.71 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 112.822 -1.99 . . . . 1.3300000000000001 107.791 174.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 406' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.7 Cg_endo -68.17 102.1 0.77 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.269 1.979 . . . . 0.20000000000000001 110.362 174.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 407' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.69 162.56 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.631 0 CA-C-N 114.446 -1.252 . . . . 0.29999999999999999 109.95 -173.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -112.14 -34.99 5.77 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 113.597 -1.638 . . . . 1.8400000000000001 107.018 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' TYR . . . . . 0.49 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.5 m-85 -134.56 115.89 14.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.966 -1.925 . . . . 0.44 110.879 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' TRP . . . . . 0.748 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.9 t-105 -123.41 134.78 53.93 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.237 -1.347 . . . . 0.13 110.263 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 411' ' ' MET . . . . . 0.577 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.1 OUTLIER -135.83 86.18 27.92 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 114.808 -1.087 . . . . 0.40999999999999998 111.293 174.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PRO . . . . . 0.708 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 98.1 Cg_endo -71.84 140.03 34.52 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.961 2.441 . . . . 0.16 112.175 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 413' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.2 pt -123.05 -15.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 113.883 -1.508 . . . . 0.17000000000000001 110.869 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -134.86 163.55 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 1.5900000000000001 109.552 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -95.03 13.83 23.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.529 0.566 . . . . 0.31 112.529 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.6 p -93.1 -27.22 17.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.412 -1.329 . . . . 0.44 107.412 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.61 30.89 0.86 Allowed Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 112.919 -1.946 . . . . 0.23999999999999999 112.086 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 441' ' ' GLY . 70.7 t -102.08 148.88 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 120.564 -0.455 . . . . 0.17000000000000001 110.976 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 171.49 -166.47 39.51 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.118 -0.946 . . . . 0.10000000000000001 111.812 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.95 141.04 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.815 -0.809 . . . . 0.12 108.815 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' HIS . . . . . 0.554 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 33.5 p80 -150.22 165.55 32.6 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.721 0.772 . . . . 0.14999999999999999 111.215 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.72 147.98 22.59 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 113.9 -1.5 . . . . 0.41999999999999998 107.11 171.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 423' ' ' SER . . . . . 0.516 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 3.7 t -141.87 103.97 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.988 1.375 . . . . 1.48 110.589 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.63 -30.23 15.05 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 111.915 -2.402 . . . . 0.34999999999999998 111.13 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' TRP . . . . . 0.445 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 17.1 p90 -68.95 -27.02 65.36 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 114.52 -1.218 . . . . 0.17999999999999999 109.352 176.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLN . . . . . 0.516 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -119.44 81.18 22.76 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 113.581 -1.645 . . . . 1.3300000000000001 109.311 -176.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -82.32 8.13 4.7 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 124.95 3.767 . . . . 0.23000000000000001 113.694 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -114.08 147.64 38.41 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.925 0.765 . . . . 1.1000000000000001 109.572 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' TYR . . . . . 0.546 ' HA ' HG12 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -158.84 128.43 5.65 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.993 1.317 . . . . 0.38 107.67 -172.16 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.33 -165.16 28.67 Favored Glycine 0 N--CA 1.431 -1.68 0 C-N-CA 118.884 -1.627 . . . . 0.13 111.196 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.36 154.02 0.0 OUTLIER Glycine 0 C--N 1.336 0.58 0 O-C-N 124.879 0.988 . . . . 0.20000000000000001 113.013 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.404 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.0 m-20 -56.47 101.32 0.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 123.612 1.673 . . . . 0.33000000000000002 112.143 -147.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.8 mt -97.8 -31.94 11.97 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 110.654 -2.975 . . . . 0.17999999999999999 108.178 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' TRP . . . . . 0.573 ' HA ' HG23 ' A' ' 369' ' ' VAL . 9.0 p-90 -44.78 -40.23 5.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.674 0.609 . . . . 0.22 111.737 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' LYS . . . . . 0.794 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 37.0 mttt -61.14 -23.68 65.71 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 113.009 0.744 . . . . 0.64000000000000001 113.009 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.2 p -113.57 -35.92 5.08 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.455 -0.793 . . . . 0.25 110.208 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.492 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.4 mtp85 -88.91 -15.69 33.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.858 -1.064 . . . . 0.35999999999999999 113.204 -168.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 76.46 41.45 25.17 Favored Glycine 0 C--N 1.31 -0.914 0 N-CA-C 116.59 1.396 . . . . 0.20999999999999999 116.59 158.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 21.6 m -83.51 141.8 31.37 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 118.136 0.968 . . . . 0.46999999999999997 108.752 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' HIS . . . . . 0.511 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 57.8 m80 -109.31 73.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.726 -0.609 . . . . 0.40999999999999998 110.836 -170.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 441' ' ' GLY . . . . . 0.664 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 82.8 -8.54 62.35 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.914 -0.874 . . . . 0.17999999999999999 110.914 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' CYS . . . . . 0.554 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -96.06 131.96 41.92 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.322 0.582 . . . . 0.82999999999999996 110.526 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' ILE . . . . . 0.701 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -88.77 117.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.283 -0.871 . . . . 0.14999999999999999 111.109 -174.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 2.8 t30 -78.44 82.54 4.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.492 -1.685 . . . . 1.77 111.572 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' THR . . . . . 0.593 HG23 HG21 ' A' ' 366' ' ' THR . 27.7 m -87.78 140.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.508 0.67 . . . . 0.17999999999999999 110.048 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.4 Cg_exo -57.37 136.48 76.37 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.815 2.343 . . . . 0.12 111.714 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' PRO . . . . . 0.812 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 52.3 Cg_exo -56.03 -32.53 86.58 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.296 3.331 . . . . 0.16 112.888 -173.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.1 p -81.72 -38.22 26.09 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.717 -1.129 . . . . 1.1699999999999999 110.115 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' VAL . . . . . 0.668 HG11 ' HB ' ' A' ' 366' ' ' THR . 88.2 t -80.29 -29.88 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.326 0.584 . . . . 0.17000000000000001 111.407 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' MET . . . . . 0.683 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.0 tpt -66.65 -19.62 65.81 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.842 0.83 . . . . 0.46000000000000002 110.115 177.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.94 -23.6 41.59 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.511 -1.222 . . . . 0.81000000000000005 111.124 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 456' ' ' MET . 6.8 mm-40 -78.31 -47.36 17.94 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 113.192 -1.822 . . . . 0.38 107.103 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 453' ' ' LEU . . . . . 0.59 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.5 tp -63.92 -67.36 0.44 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.642 -2.526 . . . . 0.059999999999999998 112.292 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 454' ' ' PHE . . . . . 0.434 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 38.1 t80 -49.95 -26.93 4.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 123.193 1.473 . . . . 0.31 108.303 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 455' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.86 -31.81 66.95 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 112.426 -2.17 . . . . 0.13 112.291 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 456' ' ' MET . . . . . 0.678 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -87.5 -48.0 8.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.637 0.732 . . . . 0.13 111.586 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 457' ' ' VAL . . . . . 0.546 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -102.84 139.05 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 123.407 1.575 . . . . 0.23000000000000001 114.06 -168.108 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.46 -178.62 5.25 Favored 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 110.961 -2.836 . . . . 0.82999999999999996 107.108 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' LYS . . . . . 0.729 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -50.44 160.8 0.36 Allowed 'General case' 0 N--CA 1.411 -2.385 0 CA-C-O 123.043 1.401 . . . . 0.23999999999999999 113.109 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.26 -35.93 3.78 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 112.565 -2.107 . . . . 0.37 112.354 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 462' ' ' PRO . 3.9 m -74.44 141.12 76.31 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 109.452 -0.573 . . . . 0.14999999999999999 109.452 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 5.1 Cg_exo -75.18 166.26 29.36 Favored 'Trans proline' 0 N--CA 1.422 -2.682 0 C-N-CA 121.98 1.787 . . . . 0.12 111.07 174.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' VAL . . . . . 0.78 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -133.65 154.76 39.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 107.455 -1.313 . . . . 1.0900000000000001 107.455 166.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.0 tp -124.36 144.82 49.81 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.317 -0.856 . . . . 0.13 110.087 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' VAL . . . . . 0.686 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.17 146.67 21.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.843 -1.54 . . . . 0.089999999999999997 106.843 165.1 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 466' ' ' PHE . . . . . 0.704 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.4 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.79 -0.624 . . . . 1.1599999999999999 111.486 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.647 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.4 m . . . . . 0 N--CA 1.429 -1.493 0 N-CA-C 107.396 -1.335 . . . . 0.45000000000000001 107.396 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.672 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 17.8 p90 -163.33 -170.84 2.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.76 0.791 . . . . 0.32000000000000001 111.04 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.553 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -103.85 156.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.603 -1.18 . . . . 0.080000000000000002 107.938 166.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.538 ' HG3' HD23 ' A' ' 464' ' ' LEU . 4.7 tt0 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.171 0.896 . . . . 0.17000000000000001 110.595 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.678 HG22 ' HG3' ' A' ' 354' ' ' MET . 66.8 t -149.27 137.27 14.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.614 -1.176 . . . . 0.080000000000000002 109.098 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 466' ' ' PHE . 7.8 t70 -120.42 115.02 22.68 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.077 -1.083 . . . . 0.37 108.077 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.523 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -66.2 -48.37 70.85 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 123.099 1.428 . . . . 0.32000000000000001 110.195 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.32 -52.01 49.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 112.623 -2.081 . . . . 1.51 112.901 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -102.71 9.74 38.99 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.191 -1.368 . . . . 0.91000000000000003 108.664 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.814 ' NE2' HD12 ' A' ' 368' ' ' ILE . 15.1 mm100 36.09 72.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 125.154 1.534 . . . . 2.2200000000000002 111.8 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.6 t60 -150.11 126.41 10.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.641 -1.163 . . . . 0.13 109.469 -176.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.678 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -112.99 128.34 56.47 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.659 0.783 . . . . 0.059999999999999998 110.618 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.68 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.75 173.61 6.34 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.513 -1.221 . . . . 0.10000000000000001 111.889 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.615 ' CE2' ' HB2' ' A' ' 456' ' ' MET . 1.2 t80 -125.1 115.92 21.26 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.336 -1.727 . . . . 0.22 106.336 165.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.515 ' HB2' ' CE1' ' A' ' 344' ' ' TYR . 27.9 m-85 -101.24 127.29 47.89 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.153 0.978 . . . . 0.17999999999999999 112.021 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.647 ' HA ' HG23 ' A' ' 343' ' ' THR . 2.8 ttpt -148.26 137.19 21.81 Favored 'General case' 0 N--CA 1.399 -3.023 0 CA-C-N 113.376 -1.738 . . . . 0.46999999999999997 108.628 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.9 OUTLIER 71.29 13.84 6.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 113.159 -1.837 . . . . 0.59999999999999998 108.992 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.89 74.97 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 112.783 -2.008 . . . . 0.23000000000000001 111.771 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.573 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.09 168.11 19.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 105.991 -1.855 . . . . 0.68000000000000005 105.991 -171.037 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.851 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.6 m -101.05 139.02 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-O 124.164 1.935 . . . . 0.53000000000000003 111.868 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.614 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.67 -25.01 18.45 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 109.675 -3.421 . . . . 0.12 108.586 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.659 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.42 155.2 35.9 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 113.711 -1.586 . . . . 0.080000000000000002 109.222 -171.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.851 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.79 122.63 1.41 Allowed 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.736 -0.665 . . . . 0.60999999999999999 109.498 -176.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.69 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.7 t -147.11 166.9 25.5 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.631 0.729 . . . . 0.089999999999999997 110.823 173.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.474 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 48.1 m-20 -84.23 148.76 26.54 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.984 -1.488 . . . . 1.8799999999999999 106.984 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.814 HD12 ' NE2' ' A' ' 352' ' ' GLN . 1.4 pp -144.37 -178.32 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.841 0.713 . . . . 0.11 111.535 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.654 ' HA ' ' NE2' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -149.85 118.5 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.449 -0.796 . . . . 0.12 109.56 173.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 443' ' ' ILE . 34.3 p -141.32 142.55 33.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.835 -1.075 . . . . 0.69999999999999996 111.699 -165.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.04 44.62 29.25 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 116.678 1.431 . . . . 0.13 116.678 162.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.641 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.65 144.56 3.47 Favored Pre-proline 0 C--O 1.221 -0.439 0 CA-C-N 118.639 1.219 . . . . 0.47999999999999998 110.187 -174.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.808 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.12 -28.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.553 1 C-N-CA 126.056 4.504 . . . . 0.23000000000000001 116.215 -172.518 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.641 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -85.45 -32.13 22.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.265 0.555 . . . . 0.29999999999999999 110.813 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.448 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 11.8 m -140.91 72.9 28.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 122.14 0.971 . . . . 0.29999999999999999 110.155 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.739 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.3 Cg_exo -70.85 161.28 46.63 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 125.269 3.979 . . . . 0.16 114.39 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.691 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.64 151.73 89.27 Favored Pre-proline 0 N--CA 1.435 -1.219 0 CA-C-N 113.375 -1.738 . . . . 0.12 110.835 175.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.502 ' CD ' HG22 ' A' ' 377' ' ' THR . 2.0 Cg_endo -81.04 -51.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 125.144 3.896 . . . . 0.089999999999999997 113.886 -171.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.741 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.35 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.301 0.852 . . . . 0.089999999999999997 113.301 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.89 -124.97 1.29 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 114.302 -1.317 . . . . 0.11 111.417 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 381' ' ' VAL . 13.0 p -126.04 108.17 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 122.093 0.949 . . . . 0.89000000000000001 109.222 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.744 ' HB2' HG22 ' A' ' 463' ' ' VAL . 91.8 m-85 -113.68 155.87 24.76 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.128 -0.942 . . . . 0.16 109.633 -170.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.798 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 10.6 m-85 -147.06 139.83 25.01 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 117.872 0.306 . . . . 0.68999999999999995 110.447 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.648 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -74.66 124.3 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 119.88 -0.728 . . . . 0.14000000000000001 110.895 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -107.5 1.96 23.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.314 -0.857 . . . . 0.19 111.925 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.759 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.2 t30 -164.63 150.26 10.19 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.189 -0.914 . . . . 0.40999999999999998 110.276 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 458' ' ' GLU . 15.0 mtpt -111.28 119.41 38.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.783 0.802 . . . . 1.0900000000000001 110.138 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.573 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -118.54 122.1 41.84 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.589 -1.187 . . . . 0.38 111.076 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -120.43 136.96 54.57 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.416 -1.265 . . . . 1.96 109.95 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.6 t70 52.21 38.82 25.58 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 123.584 1.659 . . . . 0.40000000000000002 107.292 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.573 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -91.74 170.44 9.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 112.329 -2.214 . . . . 0.16 111.907 -175.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 15.5 m -129.86 104.54 7.44 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.691 -1.595 . . . . 0.27000000000000002 109.545 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.72 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.02 155.0 40.8 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.147 -1.842 . . . . 0.23999999999999999 109.713 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.425 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 10.3 mtpt . . . . . 0 N--CA 1.4 -2.931 0 CA-C-N 114.704 -1.134 . . . . 0.67000000000000004 108.415 -175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.7 mt-10 . . . . . 0 CA--C 1.508 -0.667 0 CA-C-O 122.604 1.192 . . . . 0.62 112.224 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.72 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -141.59 98.85 6.4 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.443 -2.162 . . . . 1.3300000000000001 107.562 172.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.2 Cg_endo -67.72 103.38 0.84 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.496 2.131 . . . . 0.20000000000000001 110.613 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.55 161.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-N 114.332 -1.304 . . . . 0.29999999999999999 110.242 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.4 -32.23 6.31 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.5 -1.682 . . . . 1.8400000000000001 107.501 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.47 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 67.1 m-85 -136.56 116.02 12.78 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.828 -1.987 . . . . 0.44 110.713 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.757 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -125.01 135.21 52.56 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.656 -1.156 . . . . 0.13 110.379 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.483 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -136.07 86.3 26.26 Favored Pre-proline 0 C--N 1.3 -1.583 0 CA-C-N 114.941 -1.027 . . . . 0.40999999999999998 111.205 174.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.697 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.9 Cg_endo -71.44 139.93 35.58 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 122.993 2.462 . . . . 0.16 112.427 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -124.03 -15.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.751 -1.568 . . . . 0.17000000000000001 110.941 -174.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -133.72 165.28 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.171 -0.922 . . . . 1.5900000000000001 109.582 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -98.47 15.22 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.215 0.45 . . . . 0.31 112.215 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.8 p -95.04 -26.81 15.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.601 -1.259 . . . . 0.44 107.601 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.75 31.72 1.01 Allowed Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 112.927 -1.942 . . . . 0.23999999999999999 111.971 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 441' ' ' GLY . 81.6 t -101.6 148.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.204 0.525 . . . . 0.17000000000000001 110.775 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 171.57 -167.49 40.56 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.735 -1.12 . . . . 0.10000000000000001 111.191 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.74 139.53 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.875 -0.787 . . . . 0.12 108.875 175.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.626 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 30.9 p80 -149.2 163.31 37.99 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.823 0.821 . . . . 0.14999999999999999 111.792 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.782 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.92 138.27 31.72 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.091 -1.413 . . . . 0.41999999999999998 107.453 172.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.8 OUTLIER -131.36 101.07 5.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.48 1.133 . . . . 1.48 109.057 -174.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -95.18 -35.26 11.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.953 -1.931 . . . . 0.34999999999999998 111.562 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.438 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 21.1 p90 -63.53 -26.96 68.94 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.398 -1.274 . . . . 0.17999999999999999 109.055 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.809 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.81 83.42 36.39 Favored Pre-proline 0 CA--C 1.498 -1.035 0 CA-C-N 113.404 -1.726 . . . . 1.3300000000000001 109.966 -172.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -80.93 5.53 6.15 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 124.901 3.734 . . . . 0.23000000000000001 114.649 -160.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.2 156.35 23.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.975 0.417 . . . . 1.1000000000000001 111.021 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.474 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.83 125.15 2.31 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.653 -1.158 . . . . 0.38 109.312 -171.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.94 -166.3 28.87 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 119.659 -1.258 . . . . 0.13 111.769 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.641 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.02 155.67 0.0 OUTLIER Glycine 0 C--N 1.339 0.745 0 O-C-N 125.21 1.182 . . . . 0.20000000000000001 112.989 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.415 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.7 m-20 -56.36 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 123.97 1.843 . . . . 0.33000000000000002 112.134 -147.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 51.3 mt -96.49 -32.62 12.2 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 110.342 -3.117 . . . . 0.17999999999999999 108.055 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.572 ' HA ' HG23 ' A' ' 369' ' ' VAL . 4.4 p-90 -46.24 -37.27 7.0 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 124.002 0.814 . . . . 0.22 111.15 -174.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.808 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 40.2 mttt -59.28 -27.19 65.61 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.695 -1.138 . . . . 0.64000000000000001 112.762 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -112.3 -36.41 5.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.604 -0.726 . . . . 0.25 109.908 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.567 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.7 mtp85 -84.53 -15.46 45.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.542 -1.208 . . . . 0.35999999999999999 113.038 -167.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.03 41.58 31.92 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 116.769 1.468 . . . . 0.20999999999999999 116.769 159.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.6 m -85.74 131.73 34.27 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 118.272 1.036 . . . . 0.46999999999999997 109.228 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -97.05 67.43 2.21 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.67 -0.643 . . . . 0.40999999999999998 111.358 -169.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.46 -13.6 59.93 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.213 -1.155 . . . . 0.17999999999999999 110.213 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.626 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.0 p -86.15 140.92 29.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.708 -0.746 . . . . 0.82999999999999996 110.164 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.691 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -94.98 115.33 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.549 0.69 . . . . 0.14999999999999999 111.087 -176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.809 ' OD1' ' HB3' ' A' ' 426' ' ' GLN . 0.1 OUTLIER -76.66 89.41 3.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.606 -1.179 . . . . 1.77 111.021 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.564 HG23 HG21 ' A' ' 366' ' ' THR . 32.0 m -91.22 140.62 25.79 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.47 0.652 . . . . 0.17999999999999999 109.335 174.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 49.7 Cg_exo -57.84 136.27 74.26 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.801 2.334 . . . . 0.12 111.836 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.782 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.6 Cg_exo -55.72 -32.49 84.22 Favored 'Trans proline' 0 CA--C 1.501 -1.133 0 C-N-CA 124.244 3.296 . . . . 0.16 113.069 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.5 p -82.02 -38.7 24.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.63 -1.168 . . . . 1.1699999999999999 110.348 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.69 HG11 ' HB ' ' A' ' 366' ' ' THR . 59.0 t -80.64 -29.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.374 0.607 . . . . 0.17000000000000001 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.689 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.3 tpt -67.92 -19.18 64.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.945 0.878 . . . . 0.46000000000000002 109.969 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.04 -22.54 42.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.442 -1.254 . . . . 0.81000000000000005 110.777 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.98 -46.85 14.47 Favored 'General case' 0 CA--C 1.476 -1.89 0 CA-C-N 112.991 -1.913 . . . . 0.38 107.438 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.607 HD23 ' SD ' ' A' ' 450' ' ' MET . 27.2 tp -64.76 -67.19 0.46 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 111.872 -2.422 . . . . 0.059999999999999998 112.486 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.43 ' HB2' ' HE3' ' A' ' 450' ' ' MET . 19.3 t80 -50.47 -26.18 4.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.0 1.381 . . . . 0.31 108.066 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.31 -30.24 67.37 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 112.517 -2.129 . . . . 0.13 112.296 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.659 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.05 -48.42 7.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.775 0.797 . . . . 0.13 111.444 171.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.553 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.8 OUTLIER -103.38 138.01 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 123.415 1.578 . . . . 0.23000000000000001 114.103 -167.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 387' ' ' LYS . 6.8 pt-20 -137.22 -178.18 5.09 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 110.754 -2.93 . . . . 0.82999999999999996 106.778 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.759 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.0 mtmt -51.48 161.28 0.49 Allowed 'General case' 0 N--CA 1.412 -2.354 0 CA-C-O 122.894 1.331 . . . . 0.23999999999999999 112.534 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.55 -28.95 8.29 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-N 112.646 -2.07 . . . . 0.37 112.185 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 462' ' ' PRO . 10.0 m -84.96 140.9 37.39 Favored Pre-proline 0 N--CA 1.433 -1.292 0 N-CA-C 108.534 -0.913 . . . . 0.14999999999999999 108.534 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.93 173.69 13.65 Favored 'Trans proline' 0 N--CA 1.416 -3.084 0 C-N-CA 121.097 1.198 . . . . 0.12 111.738 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.31 159.54 35.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.642 -1.244 . . . . 1.0900000000000001 107.642 167.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.538 HD23 ' HG3' ' A' ' 346' ' ' GLU . 2.8 tp -130.27 146.11 51.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 115.159 -0.928 . . . . 0.13 110.046 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.741 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 146.82 20.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.292 -1.373 . . . . 0.089999999999999997 107.292 165.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.481 ' CE2' ' HG2' ' A' ' 346' ' ' GLU . 19.9 p90 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.533 -0.746 . . . . 1.1599999999999999 111.464 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 358' ' ' LYS . 97.2 m . . . . . 0 N--CA 1.426 -1.669 0 N-CA-C 108.539 -0.911 . . . . 0.45000000000000001 108.539 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.633 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.5 p90 -162.44 -170.32 2.4 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.461 -1.245 . . . . 0.32000000000000001 110.489 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.9 mm -102.19 157.32 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.071 -1.085 . . . . 0.080000000000000002 108.071 165.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.523 ' HG3' HD23 ' A' ' 464' ' ' LEU . 4.6 tt0 -139.06 154.39 48.19 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 118.617 0.644 . . . . 0.17000000000000001 110.543 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.655 HG22 ' HG3' ' A' ' 354' ' ' MET . 53.5 t -149.98 136.38 12.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.035 -0.984 . . . . 0.080000000000000002 109.988 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -117.19 116.31 27.03 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.703 -1.135 . . . . 0.37 108.24 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -69.02 -49.03 61.29 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.53 1.157 . . . . 0.32000000000000001 110.452 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.69 -54.82 36.78 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.835 -1.984 . . . . 1.51 112.213 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -96.62 10.08 39.61 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.559 -1.201 . . . . 0.91000000000000003 108.601 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.79 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.1 mm-40 38.16 71.85 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 125.315 1.634 . . . . 2.2200000000000002 111.98 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.442 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -152.68 124.91 8.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.548 -0.751 . . . . 0.13 109.634 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.655 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.7 ttp -111.87 128.61 56.18 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.667 -0.697 . . . . 0.059999999999999998 110.3 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.682 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.25 173.05 6.55 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 114.595 -1.184 . . . . 0.10000000000000001 111.899 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.559 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.3 OUTLIER -125.38 112.78 16.71 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.621 -1.992 . . . . 0.22 105.621 163.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 25.6 m-85 -94.97 125.09 39.4 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.499 -0.88 . . . . 0.17999999999999999 110.963 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.565 ' HA ' HG23 ' A' ' 343' ' ' THR . 37.3 ttmt -134.42 137.38 43.98 Favored 'General case' 0 N--CA 1.387 -3.583 0 CA-C-N 114.332 -1.304 . . . . 0.46999999999999997 109.68 173.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.32 12.22 7.05 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 112.941 -1.936 . . . . 0.59999999999999998 109.092 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 88.61 14.28 61.73 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 112.79 -2.005 . . . . 0.23000000000000001 112.301 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -128.36 172.65 10.89 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.383 -2.081 . . . . 0.68000000000000005 105.383 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.805 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.5 m -104.86 136.01 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 CA-C-O 124.318 2.009 . . . . 0.53000000000000003 112.316 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.5 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -89.49 -25.13 21.6 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.408 -3.542 . . . . 0.12 108.355 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.614 HD13 ' CE ' ' A' ' 456' ' ' MET . 2.7 tp -154.71 154.18 32.48 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.051 -1.431 . . . . 0.080000000000000002 108.927 -172.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.805 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.22 121.51 1.42 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 123.514 0.509 . . . . 0.60999999999999999 109.913 -175.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.636 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.3 t -148.62 167.41 25.52 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 122.225 1.012 . . . . 0.089999999999999997 112.12 175.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.2 p-10 -84.73 141.71 30.35 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 113.238 -1.801 . . . . 1.8799999999999999 107.893 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -142.32 -171.91 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 0.11 112.091 -176.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.79 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -158.31 114.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.035 -0.984 . . . . 0.12 109.283 177.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 15.0 t -141.93 145.46 34.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.908 -1.042 . . . . 0.69999999999999996 112.802 -167.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.696 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.11 44.95 33.67 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 116.747 1.459 . . . . 0.13 116.747 162.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.618 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.75 143.42 6.04 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 118.601 1.2 . . . . 0.47999999999999998 110.456 -174.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.822 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.13 -32.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.749 4.299 . . . . 0.23000000000000001 116.089 -171.29 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.618 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 2.0 p -80.23 -35.36 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.36 0.6 . . . . 0.29999999999999999 110.816 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.481 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.1 m -139.77 72.2 35.68 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 122.291 1.043 . . . . 0.29999999999999999 109.688 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.5 Cg_exo -70.21 162.92 40.52 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 125.253 3.969 . . . . 0.16 114.007 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.737 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.82 149.5 83.14 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 113.625 -1.625 . . . . 0.12 110.001 174.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.516 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.5 Cg_endo -76.89 -49.0 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 125.108 3.872 . . . . 0.089999999999999997 113.283 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.695 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.69 121.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.965 1.098 . . . . 0.089999999999999997 113.965 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.45 -126.31 1.51 Allowed Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 113.995 -1.457 . . . . 0.11 110.613 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.5 p -126.18 108.98 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.935 0.874 . . . . 0.89000000000000001 108.96 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.632 ' HB3' ' HB ' ' A' ' 413' ' ' ILE . 53.0 m-85 -113.14 170.1 8.46 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.381 -0.827 . . . . 0.16 109.16 -173.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.706 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 79.0 m-85 -150.8 139.81 21.02 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.239 -0.282 . . . . 0.68999999999999995 110.239 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.68 121.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.691 -0.804 . . . . 0.14000000000000001 110.328 176.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . 0.44 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 46.6 p-90 -109.66 3.0 20.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.492 -0.777 . . . . 0.19 112.422 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.709 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.0 t30 -161.13 144.72 13.07 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.579 -1.267 . . . . 0.40999999999999998 107.579 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.511 ' HG2' ' O ' ' A' ' 387' ' ' LYS . 0.3 OUTLIER -118.56 109.85 16.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.324 1.059 . . . . 1.0900000000000001 108.506 -177.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -116.73 130.6 56.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.41 -1.268 . . . . 0.38 110.829 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.79 135.12 48.06 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 113.738 -1.574 . . . . 1.96 109.601 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 23.2 t70 52.95 40.53 31.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 123.298 1.523 . . . . 0.40000000000000002 107.357 -173.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.548 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.19 170.42 9.41 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 112.223 -2.262 . . . . 0.16 111.807 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 5.2 m -127.84 105.53 8.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.942 -1.481 . . . . 0.27000000000000002 110.157 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.74 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.9 mp -74.41 158.35 34.04 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.061 -1.881 . . . . 0.23999999999999999 110.767 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.474 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.4 mtpt . . . . . 0 N--CA 1.396 -3.17 0 CA-C-N 114.72 -1.127 . . . . 0.67000000000000004 108.818 -178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.0 mt-10 . . . . . 0 CA--C 1.512 -0.489 0 CA-C-O 122.167 0.984 . . . . 0.62 112.028 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.74 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.95 99.97 9.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 113.268 -1.787 . . . . 1.3300000000000001 107.75 176.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 68.3 Cg_endo -68.02 102.31 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.741 2.294 . . . . 0.20000000000000001 110.493 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.739 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.36 160.77 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-N 114.483 -1.235 . . . . 0.29999999999999999 110.563 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.3 -31.48 6.58 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.33 -1.759 . . . . 1.8400000000000001 107.564 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 68.2 m-85 -137.18 116.85 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.143 -1.844 . . . . 0.44 110.898 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.739 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.7 t-105 -125.27 134.04 52.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.813 -1.085 . . . . 0.13 111.084 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.501 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.5 mtp -134.57 86.68 33.82 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 114.628 -1.169 . . . . 0.40999999999999998 111.334 173.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 89.7 Cg_endo -72.96 139.08 29.51 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.846 2.364 . . . . 0.16 111.445 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -125.7 -12.85 4.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 0.17000000000000001 111.055 -172.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -133.95 168.85 18.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.845 . . . . 1.5900000000000001 109.448 173.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.5 14.78 28.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.45 0.907 . . . . 0.31 113.45 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.445 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 37.9 p -99.73 -27.69 13.53 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.916 -1.142 . . . . 0.44 107.916 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 134.73 29.72 0.41 Allowed Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 113.814 -1.539 . . . . 0.23999999999999999 112.711 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 441' ' ' GLY . 60.3 t -102.45 146.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.513 0.673 . . . . 0.17000000000000001 111.583 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.19 37.86 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.743 -1.117 . . . . 0.10000000000000001 111.546 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.458 HG12 ' SD ' ' A' ' 354' ' ' MET . 0.9 OUTLIER -104.82 140.93 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.613 -0.884 . . . . 0.12 108.613 176.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.548 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 31.8 p80 -150.78 166.41 30.54 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.672 0.749 . . . . 0.14999999999999999 111.288 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.786 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.44 136.19 33.29 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.193 -1.367 . . . . 0.41999999999999998 107.482 171.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 6.2 t -130.86 102.72 6.19 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 122.879 1.324 . . . . 1.48 109.435 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.14 -30.57 14.56 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.387 -2.188 . . . . 0.34999999999999998 110.964 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.455 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 20.6 p90 -68.66 -27.36 65.92 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.436 -1.256 . . . . 0.17999999999999999 109.35 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.505 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -120.69 80.16 31.59 Favored Pre-proline 0 CA--C 1.496 -1.114 0 CA-C-N 113.788 -1.551 . . . . 1.3300000000000001 109.615 -176.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -83.71 8.65 4.5 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 C-N-CA 125.248 3.965 . . . . 0.23000000000000001 113.991 -163.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -114.22 148.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.207 -0.664 . . . . 1.1000000000000001 109.207 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.575 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -159.47 131.38 6.37 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.841 1.338 . . . . 0.38 107.497 -171.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 146.56 -166.76 28.18 Favored Glycine 0 C--N 1.296 -1.684 0 C-N-CA 119.19 -1.481 . . . . 0.13 111.036 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.581 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 152.11 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 O-C-N 125.201 1.177 . . . . 0.20000000000000001 112.834 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.77 101.13 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 123.864 1.792 . . . . 0.33000000000000002 111.766 -145.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.8 mt -96.62 -31.57 12.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 110.524 -3.034 . . . . 0.17999999999999999 108.213 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.59 ' HA ' HG23 ' A' ' 369' ' ' VAL . 7.3 p-90 -46.34 -38.48 8.83 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.894 0.746 . . . . 0.22 111.425 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.822 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.5 mttt -62.01 -24.85 67.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.115 -0.948 . . . . 0.64000000000000001 112.819 -175.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.4 p -112.53 -37.45 4.93 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.497 -0.774 . . . . 0.25 110.074 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.506 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.6 mtp85 -82.44 -18.85 40.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.35999999999999999 112.016 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.546 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.02 42.45 24.65 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.709 -1.234 . . . . 0.20999999999999999 115.746 164.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.7 m -85.26 131.54 34.4 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 118.404 1.102 . . . . 0.46999999999999997 108.905 174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -98.83 68.64 1.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.501 -0.749 . . . . 0.40999999999999998 110.609 -169.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.683 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 86.32 -7.76 77.21 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.833 -0.907 . . . . 0.17999999999999999 110.833 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 13.8 p -94.16 128.56 40.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.657 0.742 . . . . 0.82999999999999996 110.789 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.737 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -88.47 112.94 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.821 -1.081 . . . . 0.14999999999999999 110.556 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.597 ' HB2' HG13 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -78.83 88.84 4.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.851 -1.068 . . . . 1.77 111.263 -177.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.61 HG23 HG21 ' A' ' 366' ' ' THR . 28.5 m -86.69 136.58 34.55 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 108.988 -0.745 . . . . 0.17999999999999999 108.988 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -54.21 135.41 64.65 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.583 2.188 . . . . 0.12 111.083 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.786 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 29.1 Cg_exo -54.6 -31.66 71.27 Favored 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 124.063 3.175 . . . . 0.16 112.816 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.7 -39.2 24.64 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.4 -1.273 . . . . 1.1699999999999999 110.338 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.636 HG11 ' HB ' ' A' ' 366' ' ' THR . 64.2 t -79.26 -30.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.464 0.65 . . . . 0.17000000000000001 111.355 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.7 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 8.1 tpt -67.31 -19.62 65.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.939 0.876 . . . . 0.46000000000000002 110.103 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.34 -22.98 43.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.413 -1.267 . . . . 0.81000000000000005 110.572 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.693 ' O ' ' HG2' ' A' ' 456' ' ' MET . 10.8 mm-40 -80.28 -47.86 13.91 Favored 'General case' 0 CA--C 1.474 -1.965 0 CA-C-N 112.803 -1.999 . . . . 0.38 107.293 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.565 HD23 ' SD ' ' A' ' 450' ' ' MET . 23.6 tp -64.68 -67.45 0.43 Allowed 'General case' 0 N--CA 1.401 -2.885 0 CA-C-N 111.85 -2.432 . . . . 0.059999999999999998 112.631 176.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.501 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 27.8 t80 -51.11 -26.57 6.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.36 1.552 . . . . 0.31 107.989 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.429 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.88 -31.37 72.72 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.04 -2.346 . . . . 0.13 111.948 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.693 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.42 -49.21 6.83 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 121.748 0.785 . . . . 0.13 111.116 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.572 ' CB ' HD11 ' A' ' 345' ' ' ILE . 1.2 p -106.71 133.37 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 CA-C-O 123.635 1.683 . . . . 0.23000000000000001 114.151 -167.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.482 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 9.9 pt-20 -139.93 -177.01 4.79 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 110.379 -3.1 . . . . 0.82999999999999996 106.302 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.2 mtmt -47.09 155.08 0.31 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 122.854 1.311 . . . . 0.23999999999999999 113.679 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.37 -34.23 5.27 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 112.169 -2.287 . . . . 0.37 112.71 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.533 ' HB ' HG23 ' A' ' 457' ' ' VAL . 10.5 m -79.88 142.26 56.15 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-O 120.968 0.414 . . . . 0.14999999999999999 110.035 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.633 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.71 165.01 33.36 Favored 'Trans proline' 0 N--CA 1.433 -2.057 0 C-N-CA 122.353 2.035 . . . . 0.12 111.254 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 81.6 t -135.2 134.8 52.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 113.816 -1.538 . . . . 1.0900000000000001 108.474 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.523 HD23 ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -113.94 143.44 44.7 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.126 -0.488 . . . . 0.13 110.369 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.45 149.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.383 -1.34 . . . . 0.089999999999999997 107.383 165.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.683 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.565 -0.731 . . . . 1.1599999999999999 111.254 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 358' ' ' LYS . 85.4 m . . . . . 0 N--CA 1.426 -1.665 0 N-CA-C 107.255 -1.387 . . . . 0.45000000000000001 107.255 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.679 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 9.7 p90 -156.66 -170.67 3.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.265 -0.88 . . . . 0.32000000000000001 110.625 -174.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.585 HD11 ' CB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.97 161.06 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.271 -1.011 . . . . 0.080000000000000002 108.271 167.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.485 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.1 tt0 -142.24 155.67 45.26 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.691 0.678 . . . . 0.17000000000000001 111.229 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 354' ' ' MET . 60.7 t -150.93 138.35 13.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.648 -1.16 . . . . 0.080000000000000002 109.64 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -117.89 117.74 30.11 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.729 -1.123 . . . . 0.37 107.989 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.529 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -72.69 -45.12 60.45 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.589 0.709 . . . . 0.32000000000000001 110.045 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.12 -45.42 93.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.862 -1.517 . . . . 1.51 112.826 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.26 18.26 21.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.687 -1.142 . . . . 0.91000000000000003 108.928 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.641 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.7 mp0 34.3 68.96 0.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.994 -1.912 . . . . 2.2200000000000002 112.773 171.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.489 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.9 t60 -152.47 125.02 8.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.216 0.531 . . . . 0.13 109.649 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.708 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.8 ttp -111.25 127.48 55.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.649 -0.705 . . . . 0.059999999999999998 110.28 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.658 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.06 173.37 6.39 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.536 -1.211 . . . . 0.10000000000000001 111.746 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.573 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -126.35 116.39 21.13 Favored 'General case' 0 C--O 1.201 -1.468 0 N-CA-C 105.622 -1.992 . . . . 0.22 105.622 163.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 20.7 m-85 -97.0 125.09 41.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.43 -0.908 . . . . 0.17999999999999999 111.613 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 343' ' ' THR . 35.6 ttmt -138.23 140.31 39.65 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 113.818 -1.537 . . . . 0.46999999999999997 109.0 173.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.9 t70 65.41 14.56 9.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.473 -1.694 . . . . 0.59999999999999998 109.036 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.29 16.09 72.52 Favored Glycine 0 N--CA 1.419 -2.44 0 CA-C-N 112.281 -2.236 . . . . 0.23000000000000001 111.968 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.649 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -130.84 172.91 11.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.177 -2.157 . . . . 0.68000000000000005 105.177 -173.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.76 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.8 m -102.73 138.49 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 124.136 1.922 . . . . 0.53000000000000003 111.604 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.99 -23.81 18.57 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.529 -3.487 . . . . 0.12 108.243 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.676 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -155.3 154.66 32.44 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.942 -1.481 . . . . 0.080000000000000002 108.72 -172.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.76 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.12 121.87 1.48 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.103 -0.499 . . . . 0.60999999999999999 109.706 -175.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.6 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.7 t -148.1 167.09 25.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 122.473 1.13 . . . . 0.089999999999999997 112.429 174.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.774 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.3 p-10 -83.85 139.92 32.34 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.675 -2.057 . . . . 1.8799999999999999 107.791 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.641 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -143.06 -172.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.501 -0.772 . . . . 0.11 111.886 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.616 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.59 120.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.006 -0.997 . . . . 0.12 108.856 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.467 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.6 t -142.68 145.08 33.05 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.505 -0.77 . . . . 0.69999999999999996 113.038 -167.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.16 46.6 49.75 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 116.959 1.544 . . . . 0.13 116.959 162.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.562 ' HE2' ' CA ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.71 143.21 4.31 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 118.982 1.391 . . . . 0.47999999999999998 110.495 -174.283 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.795 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.17 -32.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 1 C-N-CA 125.866 4.377 . . . . 0.23000000000000001 116.22 -170.466 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.43 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -82.71 -32.81 27.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.181 0.515 . . . . 0.29999999999999999 111.081 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.5 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -139.06 72.51 39.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 122.237 1.018 . . . . 0.29999999999999999 110.059 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.66 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.8 Cg_exo -73.35 163.06 38.8 Favored 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.528 4.152 . . . . 0.16 114.18 -177.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.724 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.48 154.17 87.75 Favored Pre-proline 0 N--CA 1.435 -1.211 0 CA-C-N 113.347 -1.751 . . . . 0.12 110.992 175.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.523 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.0 OUTLIER -79.93 -51.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.995 3.797 . . . . 0.089999999999999997 113.641 -172.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.705 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.48 122.58 0.03 OUTLIER 'General case' 0 C--O 1.232 0.153 0 N-CA-C 113.474 0.916 . . . . 0.089999999999999997 113.474 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.67 -124.64 1.25 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.243 -1.344 . . . . 0.11 111.384 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.7 p -128.23 107.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.547 1.165 . . . . 0.89000000000000001 109.296 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.763 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.4 m-85 -109.79 160.25 16.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.755 -1.111 . . . . 0.16 109.831 -170.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.681 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 80.8 m-85 -148.23 135.73 20.6 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 119.592 -0.242 . . . . 0.68999999999999995 110.609 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.36 123.6 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.337 -0.945 . . . . 0.14000000000000001 110.656 178.186 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -109.12 2.75 21.29 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.709 -0.678 . . . . 0.19 112.284 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.653 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.6 t30 -161.52 148.07 14.31 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.198 -1.038 . . . . 0.40999999999999998 108.198 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.546 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -117.41 116.67 27.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.948 -1.13 . . . . 1.0900000000000001 107.948 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.569 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -121.49 129.79 53.15 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.689 -1.141 . . . . 0.38 111.045 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.6 mt-10 -128.29 136.1 50.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 113.781 -1.554 . . . . 1.96 109.887 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 38.7 t70 51.67 40.06 26.54 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 123.611 1.672 . . . . 0.40000000000000002 107.213 -172.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.569 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.82 168.19 11.35 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 112.131 -2.304 . . . . 0.16 111.581 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 49.6 m -127.26 101.06 6.32 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.657 -1.61 . . . . 0.27000000000000002 109.959 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.76 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -73.28 157.3 37.31 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 112.765 -2.016 . . . . 0.23999999999999999 110.16 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 9.4 mtpt . . . . . 0 N--CA 1.394 -3.269 0 CA-C-N 114.615 -1.175 . . . . 0.67000000000000004 108.255 -176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 18.1 mt-10 . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 122.459 1.123 . . . . 0.62 112.678 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.76 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.47 99.05 9.74 Favored Pre-proline 0 N--CA 1.422 -1.859 0 CA-C-N 112.965 -1.925 . . . . 1.3300000000000001 108.525 174.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 63.3 Cg_endo -67.9 103.67 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.787 2.324 . . . . 0.20000000000000001 110.604 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 421' ' ' HIS . 1.2 t -118.42 154.37 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 CA-C-N 114.555 -1.202 . . . . 0.29999999999999999 110.578 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.1 OUTLIER -95.91 -34.47 11.81 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.437 -0.801 . . . . 1.8400000000000001 108.881 174.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.478 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 60.2 m-85 -136.91 115.94 12.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.172 -1.376 . . . . 0.44 111.218 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.663 ' HB2' HG11 ' A' ' 407' ' ' VAL . 9.7 t-105 -123.63 134.54 53.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.002 -1.454 . . . . 0.13 111.089 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.542 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.0 OUTLIER -133.97 87.23 35.48 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 114.639 -1.164 . . . . 0.40999999999999998 111.372 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.2 Cg_endo -73.68 140.0 28.8 Favored 'Trans proline' 0 CA--C 1.505 -0.937 0 C-N-CA 123.164 2.576 . . . . 0.16 111.545 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.4 pt -123.35 -17.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.329 -1.305 . . . . 0.17000000000000001 111.425 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.814 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.0 p30 -136.31 173.75 11.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.5900000000000001 110.124 172.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -100.26 15.84 26.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.829 -0.623 . . . . 0.31 111.832 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 16.8 p -97.57 -27.88 14.2 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.051 -1.092 . . . . 0.44 108.051 174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.6 26.98 0.91 Allowed Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 113.874 -1.512 . . . . 0.23999999999999999 113.355 173.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.814 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.8 t -103.64 151.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.704 0.764 . . . . 0.17000000000000001 111.394 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.39 -166.06 36.82 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.562 -1.199 . . . . 0.10000000000000001 110.841 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.439 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -102.73 136.83 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 108.672 -0.862 . . . . 0.12 108.672 175.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.2 p80 -151.1 168.12 25.61 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.142 0.972 . . . . 0.14999999999999999 110.937 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.762 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.09 150.65 22.64 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.359 -1.746 . . . . 0.41999999999999998 108.363 174.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.514 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -138.0 100.34 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.688 1.232 . . . . 1.48 109.989 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -94.61 -31.59 13.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 112.667 -2.061 . . . . 0.34999999999999998 110.189 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.53 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 19.9 p90 -70.17 -27.64 64.69 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 114.52 -1.218 . . . . 0.17999999999999999 109.296 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.542 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.1 OUTLIER -114.73 81.88 7.61 Favored Pre-proline 0 CA--C 1.492 -1.281 0 CA-C-N 113.821 -1.536 . . . . 1.3300000000000001 109.427 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 27.8 Cg_endo -80.18 5.2 6.19 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 124.788 3.659 . . . . 0.23000000000000001 113.944 -161.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 152.82 32.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 123.702 0.626 . . . . 1.1000000000000001 110.69 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.774 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -164.2 125.4 2.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 114.293 -1.321 . . . . 0.38 108.084 -172.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.32 -165.88 28.61 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.633 -1.27 . . . . 0.13 110.206 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.49 152.53 0.01 OUTLIER Glycine 0 C--N 1.34 0.752 0 O-C-N 125.093 1.114 . . . . 0.20000000000000001 113.178 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.08 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 124.244 1.973 . . . . 0.33000000000000002 112.42 -152.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.5 mt -97.71 -32.5 11.72 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.013 -3.267 . . . . 0.17999999999999999 107.906 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.616 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.9 p-90 -47.8 -39.36 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.873 -0.603 . . . . 0.22 111.568 -173.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.795 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 22.7 mttt -60.33 -25.23 65.64 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.919 -1.037 . . . . 0.64000000000000001 112.595 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 55.5 p -112.09 -36.27 5.41 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.494 -0.775 . . . . 0.25 110.306 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.542 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.7 mtp85 -85.49 -16.18 40.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.905 -1.043 . . . . 0.35999999999999999 112.326 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.562 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.84 43.13 28.93 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 119.425 -1.369 . . . . 0.20999999999999999 116.198 162.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.4 m -82.31 130.92 35.21 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 118.185 0.992 . . . . 0.46999999999999997 108.996 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -98.28 67.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.838 -0.539 . . . . 0.40999999999999998 110.539 -169.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 377' ' ' THR . . . 89.13 -14.7 60.03 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.392 -1.083 . . . . 0.17999999999999999 110.392 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.523 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.9 p -86.75 148.19 25.52 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.344 -0.428 . . . . 0.82999999999999996 110.55 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.724 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -102.47 119.46 50.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.093 -0.503 . . . . 0.14999999999999999 110.191 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.583 ' HB2' HG13 ' A' ' 369' ' ' VAL . 8.6 m120 -81.55 89.88 6.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.864 -0.607 . . . . 1.77 111.135 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.6 m -88.06 137.93 31.09 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.285 -0.635 . . . . 0.17999999999999999 109.285 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 52.9 Cg_exo -58.6 132.3 47.41 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.905 2.403 . . . . 0.12 113.04 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.762 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.7 Cg_exo -51.07 -40.46 59.42 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.52 2.813 . . . . 0.16 112.052 -169.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.3 m -71.66 -40.83 69.4 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.496 -1.229 . . . . 1.1699999999999999 109.724 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.6 HG11 ' HB ' ' A' ' 366' ' ' THR . 84.5 t -76.51 -31.09 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.626 -0.715 . . . . 0.17000000000000001 111.684 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.702 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.4 tpt -66.49 -21.43 66.18 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.966 0.888 . . . . 0.46000000000000002 110.203 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -76.9 -25.52 53.1 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.18 -1.373 . . . . 0.81000000000000005 111.124 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.727 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -79.07 -47.01 16.93 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 113.41 -1.723 . . . . 0.38 107.392 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.534 HD23 ' SD ' ' A' ' 450' ' ' MET . 24.5 tp -63.75 -67.71 0.41 Allowed 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 111.444 -2.617 . . . . 0.059999999999999998 112.395 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.542 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 33.8 t80 -51.77 -26.85 10.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 123.108 1.432 . . . . 0.31 107.878 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.02 -29.04 72.46 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 112.404 -2.18 . . . . 0.13 112.079 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.727 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.9 ptp -90.78 -48.75 6.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.617 0.722 . . . . 0.13 111.056 170.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.585 ' CB ' HD11 ' A' ' 345' ' ' ILE . 1.1 p -106.87 134.18 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 123.403 1.573 . . . . 0.23000000000000001 114.614 -167.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.546 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 7.8 pt-20 -140.15 -176.19 4.51 Favored 'General case' 0 N--CA 1.405 -2.679 0 CA-C-N 110.889 -2.869 . . . . 0.82999999999999996 107.018 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.652 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 49.0 mtmt -45.26 153.43 0.22 Allowed 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 122.88 1.324 . . . . 0.23999999999999999 113.66 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.6 -30.91 8.44 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 112.191 -2.277 . . . . 0.37 112.312 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 462' ' ' PRO . 5.0 m -86.76 142.42 34.5 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 109.578 -0.527 . . . . 0.14999999999999999 109.578 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.681 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 3.8 Cg_exo -75.62 170.29 20.53 Favored 'Trans proline' 0 N--CA 1.428 -2.349 0 C-N-CA 122.083 1.856 . . . . 0.12 111.631 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.3 158.5 38.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.797 -1.186 . . . . 1.0900000000000001 107.797 165.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.485 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.3 tp -129.95 145.56 51.63 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.335 -0.848 . . . . 0.13 110.179 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.2 148.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.304 -1.369 . . . . 0.089999999999999997 107.304 165.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.534 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 13.2 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.772 -0.632 . . . . 1.1599999999999999 111.785 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.689 HG23 ' HA ' ' A' ' 358' ' ' LYS . 3.6 m . . . . . 0 N--CA 1.428 -1.54 0 N-CA-C 106.956 -1.498 . . . . 0.45000000000000001 106.956 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.671 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 16.4 p90 -160.7 -172.04 3.35 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.643 0.735 . . . . 0.32000000000000001 110.951 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.586 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.8 mm -104.58 159.25 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.002 -1.11 . . . . 0.080000000000000002 108.002 166.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.542 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -139.95 155.09 47.31 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 118.881 0.764 . . . . 0.17000000000000001 111.036 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.689 HG22 ' HG3' ' A' ' 354' ' ' MET . 65.4 t -150.79 137.09 12.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 114.425 -1.261 . . . . 0.080000000000000002 109.476 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 30.2 t0 -118.03 116.32 26.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.737 -1.12 . . . . 0.37 108.219 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.571 HD21 HG23 ' A' ' 465' ' ' VAL . 1.9 mm? -71.96 -44.3 63.78 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.078 0.942 . . . . 0.32000000000000001 109.391 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.484 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 7.1 mm-40 -57.38 -49.48 76.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.876 -1.965 . . . . 1.51 112.515 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -106.29 14.07 27.93 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.352 -1.295 . . . . 0.91000000000000003 109.296 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.616 ' OE1' ' HA2' ' A' ' 431' ' ' GLY . 20.5 mp0 38.87 73.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 125.151 1.532 . . . . 2.2200000000000002 112.096 174.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.5 t60 -155.91 125.26 6.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.243 0.544 . . . . 0.13 110.164 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.689 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.5 ttp -110.83 128.33 55.73 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.766 -0.652 . . . . 0.059999999999999998 110.563 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.684 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -114.31 173.95 6.19 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.635 -1.166 . . . . 0.10000000000000001 112.027 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.716 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.7 t80 -126.29 119.79 28.28 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.963 -1.866 . . . . 0.22 105.963 164.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.504 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.6 m-85 -103.9 130.79 51.53 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.159 0.981 . . . . 0.17999999999999999 111.811 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.689 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.4 ttpt -147.73 136.13 21.58 Favored 'General case' 0 N--CA 1.398 -3.028 0 CA-C-N 113.206 -1.815 . . . . 0.46999999999999997 108.338 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.1 t70 71.63 13.15 6.34 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.375 -1.739 . . . . 0.59999999999999998 108.573 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.01 83.51 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 112.788 -2.005 . . . . 0.23000000000000001 112.02 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.636 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -124.9 169.58 11.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.668 -1.975 . . . . 0.68000000000000005 105.668 -172.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.757 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -102.18 138.76 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.819 0 CA-C-O 124.258 1.98 . . . . 0.53000000000000003 112.092 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.716 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.56 -24.67 18.66 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 109.322 -3.581 . . . . 0.12 108.656 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.68 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -152.93 154.72 35.61 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.927 -1.488 . . . . 0.080000000000000002 109.168 -172.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.757 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.37 121.96 1.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.002 -0.545 . . . . 0.60999999999999999 110.196 -174.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.61 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.5 t -147.22 166.83 25.84 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.517 0.675 . . . . 0.089999999999999997 111.352 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 1.3 m-20 -85.73 149.52 25.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.646 -1.613 . . . . 1.8799999999999999 106.646 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -146.32 -171.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 124.052 0.845 . . . . 0.11 111.305 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.588 HG23 ' CA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.16 118.91 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.761 -1.109 . . . . 0.12 108.775 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.467 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.86 146.12 35.43 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.081 -0.963 . . . . 0.69999999999999996 112.561 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.635 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.28 44.82 41.89 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 116.548 1.379 . . . . 0.13 116.548 163.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.551 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.93 144.21 3.94 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-N 118.335 1.068 . . . . 0.47999999999999998 110.24 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.785 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.49 -31.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.787 1 C-N-CA 125.82 4.346 . . . . 0.23000000000000001 116.278 -170.749 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.551 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.87 -34.82 29.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.014 0.435 . . . . 0.29999999999999999 110.791 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.459 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.9 m -140.53 73.62 29.44 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-O 122.112 0.958 . . . . 0.29999999999999999 110.423 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.635 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -72.29 161.06 45.5 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 125.187 3.925 . . . . 0.16 113.898 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.696 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.3 152.42 88.0 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.518 -1.674 . . . . 0.12 111.395 178.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.508 ' CD ' HG22 ' A' ' 377' ' ' THR . 2.0 Cg_endo -80.93 -49.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 125.234 3.956 . . . . 0.089999999999999997 113.986 -171.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.727 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.36 123.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.616 0.969 . . . . 0.089999999999999997 113.616 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.91 -126.57 1.46 Allowed Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.42 -1.264 . . . . 0.11 111.441 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.1 p -127.19 98.9 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 122.475 1.131 . . . . 0.89000000000000001 109.884 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.754 ' HB2' HG22 ' A' ' 463' ' ' VAL . 99.1 m-85 -101.71 162.02 13.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.67 -1.15 . . . . 0.16 110.22 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -147.58 135.57 21.27 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 121.337 -0.145 . . . . 0.68999999999999995 110.878 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.632 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.82 124.2 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.741 -0.784 . . . . 0.14000000000000001 110.612 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.89 2.76 20.03 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.399 -0.818 . . . . 0.19 112.183 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.751 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.2 t30 -165.14 151.85 10.44 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.544 -0.753 . . . . 0.40999999999999998 110.3 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -112.25 128.37 56.24 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.802 0.811 . . . . 1.0900000000000001 109.725 170.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.582 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.3 mt-10 -129.43 118.56 22.36 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.361 -1.29 . . . . 0.38 112.019 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 1.5 mp0 -115.27 136.73 52.79 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.315 -1.311 . . . . 1.96 110.592 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.5 t70 49.83 37.74 14.14 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.585 1.66 . . . . 0.40000000000000002 107.565 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -89.76 169.7 11.05 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.161 -2.29 . . . . 0.16 111.844 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 104.56 8.02 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.812 -1.54 . . . . 0.27000000000000002 109.991 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.749 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -74.66 158.09 34.22 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.733 -2.031 . . . . 0.23999999999999999 110.47 173.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.8 mtpt . . . . . 0 N--CA 1.395 -3.209 0 CA-C-N 114.962 -1.017 . . . . 0.67000000000000004 108.685 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.9 mt-10 . . . . . 0 CA--C 1.506 -0.712 0 CA-C-O 122.162 0.982 . . . . 0.62 111.561 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.749 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.54 98.3 12.4 Favored Pre-proline 0 N--CA 1.419 -1.99 0 CA-C-N 113.168 -1.833 . . . . 1.3300000000000001 107.793 175.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.6 Cg_endo -67.46 102.68 0.73 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.328 2.019 . . . . 0.20000000000000001 110.091 174.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.796 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -113.98 159.74 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 CA-C-N 114.4 -1.273 . . . . 0.29999999999999999 109.757 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.417 HD22 ' CG ' ' A' ' 422' ' ' ASP . 21.2 m-80 -108.92 -34.23 6.7 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.585 -1.643 . . . . 1.8400000000000001 107.167 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.497 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 46.9 m-85 -136.43 116.17 13.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.923 -1.944 . . . . 0.44 110.684 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.796 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.3 t-105 -123.02 135.01 54.28 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.931 -1.031 . . . . 0.13 110.025 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.521 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.36 86.33 24.49 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 114.875 -1.057 . . . . 0.40999999999999998 110.82 173.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 78.0 Cg_endo -71.34 140.42 36.89 Favored 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 123.024 2.483 . . . . 0.16 112.046 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 6.0 pt -123.65 -16.61 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.972 -1.467 . . . . 0.17000000000000001 111.111 -172.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.83 169.37 17.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 1.5900000000000001 109.33 176.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -101.75 14.62 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.242 0.831 . . . . 0.31 113.242 -176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.513 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 23.9 p -98.25 -28.08 13.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.968 -1.123 . . . . 0.44 107.968 172.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.86 28.96 0.37 Allowed Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 113.967 -1.469 . . . . 0.23999999999999999 113.259 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 441' ' ' GLY . 97.7 t -102.76 148.23 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.548 0.69 . . . . 0.17000000000000001 111.717 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.75 -166.47 37.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.664 -1.153 . . . . 0.10000000000000001 111.204 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.63 138.44 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.541 -0.911 . . . . 0.12 108.541 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.581 ' NE2' ' HB2' ' A' ' 442' ' ' CYS . 32.0 p80 -151.24 166.13 31.84 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.869 0.843 . . . . 0.14999999999999999 111.451 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.778 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.68 145.05 24.9 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 113.77 -1.559 . . . . 0.41999999999999998 107.742 173.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.56 102.22 5.23 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 123.32 1.533 . . . . 1.48 110.208 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.93 -30.63 15.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 110.09 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.471 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 10.8 p90 -71.46 -27.28 63.15 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.023 -1.444 . . . . 0.17999999999999999 109.146 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.426 HE22 ' HD3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.3 82.9 19.32 Favored Pre-proline 0 CA--C 1.49 -1.328 0 CA-C-N 113.762 -1.563 . . . . 1.3300000000000001 108.724 -172.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 35.8 Cg_endo -79.32 3.64 7.3 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 124.571 3.514 . . . . 0.23000000000000001 114.452 -159.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -114.78 156.56 24.63 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.169 0.509 . . . . 1.1000000000000001 111.916 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.515 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -164.08 124.01 2.06 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.115 -1.402 . . . . 0.38 108.675 -172.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.42 -167.49 28.55 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.861 -1.161 . . . . 0.13 111.149 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.655 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.9 154.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 O-C-N 125.389 1.287 . . . . 0.20000000000000001 113.151 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.76 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 111.985 -152.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 53.1 mt -97.32 -32.05 12.08 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 109.962 -3.29 . . . . 0.17999999999999999 108.086 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.588 ' CA ' HG23 ' A' ' 369' ' ' VAL . 5.5 p-90 -46.44 -37.47 7.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.65 -0.704 . . . . 0.22 111.584 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.785 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 24.4 mttt -60.86 -24.44 65.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.18 -0.918 . . . . 0.64000000000000001 113.192 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 p -113.95 -35.19 5.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.691 0.758 . . . . 0.25 110.256 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.541 ' HD2' HD22 ' A' ' 433' ' ' LEU . 5.8 mtp85 -85.62 -15.34 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.605 -1.18 . . . . 0.35999999999999999 112.481 -169.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.506 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.06 42.0 38.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.256 1.263 . . . . 0.20999999999999999 116.256 159.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.5 m -85.62 130.38 34.58 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 118.485 1.143 . . . . 0.46999999999999997 109.226 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.495 ' NE2' ' HE3' ' A' ' 372' ' ' LYS . 62.2 m80 -101.21 68.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.547 -0.721 . . . . 0.40999999999999998 110.75 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.541 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 90.92 -14.17 64.08 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.353 -1.099 . . . . 0.17999999999999999 110.353 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.581 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 23.4 p -89.95 148.14 23.29 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.326 -0.437 . . . . 0.82999999999999996 110.62 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -104.15 119.0 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 116.204 -0.453 . . . . 0.14999999999999999 110.621 -176.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.541 HD22 ' CE1' ' A' ' 421' ' ' HIS . 6.9 m120 -79.28 88.99 4.92 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.609 -0.436 . . . . 1.77 111.186 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 41.3 m -86.97 135.65 35.01 Favored Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 109.17 -0.678 . . . . 0.17999999999999999 109.17 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.418 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 53.0 Cg_exo -55.75 135.37 69.17 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.725 2.283 . . . . 0.12 111.398 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.778 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.0 Cg_exo -54.8 -33.89 82.84 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 C-N-CA 124.225 3.284 . . . . 0.16 112.99 -173.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 67.8 m -79.24 -39.02 34.19 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.783 -1.098 . . . . 1.1699999999999999 110.06 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.61 HG11 ' HB ' ' A' ' 366' ' ' THR . 97.8 t -78.8 -30.48 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 0.17000000000000001 111.408 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.685 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.9 tpt -67.56 -19.0 65.21 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.788 0.804 . . . . 0.46000000000000002 110.32 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -80.03 -22.88 41.88 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 114.528 -1.215 . . . . 0.81000000000000005 110.839 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.68 -46.78 15.01 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 112.921 -1.945 . . . . 0.38 107.329 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.635 HD23 ' SD ' ' A' ' 450' ' ' MET . 25.8 tp -64.64 -66.58 0.52 Allowed 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 111.906 -2.406 . . . . 0.059999999999999998 112.423 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.429 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 32.6 t80 -50.34 -25.16 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 123.059 1.409 . . . . 0.31 108.247 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.63 -28.66 66.94 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 112.486 -2.143 . . . . 0.13 112.507 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.68 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -92.2 -48.18 6.83 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.783 0.802 . . . . 0.13 111.614 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.632 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.8 OUTLIER -103.94 136.75 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 123.344 1.545 . . . . 0.23000000000000001 113.953 -167.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -136.56 -178.49 5.2 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 110.916 -2.856 . . . . 0.82999999999999996 106.583 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.751 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.4 mtmt -51.71 160.85 0.6 Allowed 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 123.114 1.435 . . . . 0.23999999999999999 112.958 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.75 7.91 Favored Glycine 0 N--CA 1.426 -2.033 0 CA-C-N 112.527 -2.124 . . . . 0.37 112.528 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 462' ' ' PRO . 6.1 m -82.01 142.95 48.69 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 109.308 -0.627 . . . . 0.14999999999999999 109.308 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.36 168.75 23.92 Favored 'Trans proline' 0 N--CA 1.426 -2.48 0 C-N-CA 121.855 1.703 . . . . 0.12 111.262 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.2 m -136.32 155.13 34.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.125 -1.435 . . . . 1.0900000000000001 107.125 165.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.436 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 3.4 tp -126.06 145.68 50.22 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.254 -0.885 . . . . 0.13 110.158 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.0 146.3 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 N-CA-C 106.896 -1.52 . . . . 0.089999999999999997 106.896 164.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.678 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 16.4 p90 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.229 -0.891 . . . . 1.1599999999999999 111.431 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 358' ' ' LYS . 98.5 m . . . . . 0 N--CA 1.417 -2.089 0 CA-C-O 121.566 0.698 . . . . 0.45000000000000001 109.189 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.636 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 4.7 p90 -159.12 -170.61 3.06 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.012 -1.449 . . . . 0.32000000000000001 110.637 -174.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.606 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -99.87 159.64 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 108.073 -1.084 . . . . 0.080000000000000002 108.073 166.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.2 tt0 -138.68 154.1 48.58 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.074 -0.65 . . . . 0.17000000000000001 111.146 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.682 HG22 ' HG3' ' A' ' 354' ' ' MET . 64.1 t -149.98 134.33 9.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 114.263 -1.335 . . . . 0.080000000000000002 109.436 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 15.4 t0 -115.57 124.5 51.15 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.714 -1.13 . . . . 0.37 108.377 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 465' ' ' VAL . 2.1 mm? -75.22 -43.81 49.73 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.811 1.291 . . . . 0.32000000000000001 110.525 -177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 5.4 mm-40 -57.38 -54.96 40.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.623 -2.08 . . . . 1.51 112.816 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 20.58 18.61 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.843 0.83 . . . . 0.91000000000000003 109.752 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.873 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.3 mm-40 35.94 71.25 0.13 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 112.104 -2.316 . . . . 2.2200000000000002 112.16 169.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -149.19 125.89 11.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.186 -0.916 . . . . 0.13 109.174 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.682 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.8 ttp -111.81 127.5 55.83 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.488 0.661 . . . . 0.059999999999999998 110.481 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.68 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -111.55 173.39 6.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.552 -1.204 . . . . 0.10000000000000001 111.753 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.697 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.5 t80 -125.3 111.79 15.61 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.242 -1.762 . . . . 0.22 106.242 165.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 362' ' ' VAL . 21.9 m-85 -97.47 127.44 43.43 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.766 0.793 . . . . 0.17999999999999999 111.174 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.621 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 4.3 ttpt -142.86 135.35 27.62 Favored 'General case' 0 N--CA 1.398 -3.049 0 CA-C-N 113.964 -1.471 . . . . 0.46999999999999997 108.297 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.8 t70 71.26 11.37 6.78 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 113.209 -1.814 . . . . 0.59999999999999998 108.806 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.84 68.81 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 112.763 -2.017 . . . . 0.23000000000000001 111.757 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -129.66 167.0 18.66 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.15 -1.796 . . . . 0.68000000000000005 106.15 -172.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.747 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -101.91 138.68 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 CA-C-O 124.429 2.062 . . . . 0.53000000000000003 112.21 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.61 -25.45 17.52 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 109.341 -3.572 . . . . 0.12 108.671 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.64 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.71 155.26 36.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 113.627 -1.624 . . . . 0.080000000000000002 108.891 -172.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.747 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.38 122.12 1.45 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.691 -0.686 . . . . 0.60999999999999999 109.473 -175.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.698 HG21 HG23 ' A' ' 445' ' ' THR . 5.3 t -148.95 166.68 27.89 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.326 1.06 . . . . 0.089999999999999997 112.224 173.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.732 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.6 p-10 -84.54 139.62 32.01 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.936 -1.938 . . . . 1.8799999999999999 107.737 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -141.46 -172.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.163 -0.926 . . . . 0.11 111.724 -175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.873 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.22 120.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.127 -0.942 . . . . 0.12 109.26 175.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.5 t -141.84 144.58 33.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.56 0.948 . . . . 0.69999999999999996 113.56 -165.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.63 45.96 50.01 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 116.771 1.468 . . . . 0.13 116.771 161.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.571 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -48.09 144.04 6.2 Favored Pre-proline 0 CA--C 1.511 -0.535 0 CA-C-N 118.263 1.031 . . . . 0.47999999999999998 111.342 -176.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.814 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.02 -31.91 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.564 1 C-N-CA 125.88 4.387 . . . . 0.23000000000000001 115.671 -172.88 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.571 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 0.9 OUTLIER -78.94 -36.89 41.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.263 -0.426 . . . . 0.29999999999999999 110.838 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.455 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -141.44 72.74 25.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-O 122.174 0.988 . . . . 0.29999999999999999 110.15 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.4 Cg_exo -69.33 162.38 42.07 Favored 'Trans proline' 0 C--N 1.322 -0.837 1 C-N-CA 125.357 4.038 . . . . 0.16 114.245 -176.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.67 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.0 152.46 88.66 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 113.581 -1.645 . . . . 0.12 110.647 176.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.536 ' CD ' HG22 ' A' ' 377' ' ' THR . 0.9 OUTLIER -79.68 -49.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 125.076 3.851 . . . . 0.089999999999999997 113.461 -172.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.729 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 67.05 124.25 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.974 0.892 . . . . 0.089999999999999997 113.267 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 162.63 -122.48 1.11 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.445 -1.252 . . . . 0.11 111.405 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.2 p -130.77 106.62 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-O 121.979 0.895 . . . . 0.89000000000000001 109.283 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 465' ' ' VAL . 52.2 m-85 -111.48 167.53 10.25 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.223 -0.899 . . . . 0.16 109.282 -172.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.688 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 82.2 m-85 -149.02 138.46 21.7 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 110.618 -0.141 . . . . 0.68999999999999995 110.618 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.626 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -72.82 122.77 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 119.67 -0.812 . . . . 0.14000000000000001 110.476 175.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -109.79 3.87 21.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.46 -0.791 . . . . 0.19 112.286 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.658 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 8.0 t30 -163.88 148.03 10.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.279 -1.008 . . . . 0.40999999999999998 108.279 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.588 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -118.98 114.9 23.27 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.196 0.998 . . . . 1.0900000000000001 108.43 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -118.84 132.54 56.12 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.28 -1.327 . . . . 0.38 110.298 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -131.68 134.51 46.03 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.026 -1.443 . . . . 1.96 109.622 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 52.69 40.45 30.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 123.435 1.588 . . . . 0.40000000000000002 107.479 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.564 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.76 169.53 9.95 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 112.35 -2.204 . . . . 0.16 111.683 -172.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 7.7 m -126.57 106.49 9.47 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 113.956 -1.474 . . . . 0.27000000000000002 109.926 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.741 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.3 mp -71.02 158.9 35.72 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.986 . . . . 0.23999999999999999 110.626 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.498 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.3 mtpt . . . . . 0 N--CA 1.393 -3.3 0 O-C-N 124.39 1.056 . . . . 0.67000000000000004 108.529 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 12.6 mt-10 . . . . . 0 CA--C 1.511 -0.53 0 CA-C-O 122.037 0.922 . . . . 0.62 112.038 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.741 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.5 m -144.12 99.18 5.05 Favored Pre-proline 0 N--CA 1.428 -1.536 0 CA-C-N 113.835 -1.529 . . . . 1.3300000000000001 110.418 -177.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 73.7 Cg_endo -67.18 109.01 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 125.236 3.957 . . . . 0.20000000000000001 113.492 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -122.82 151.73 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-N 114.559 -1.201 . . . . 0.29999999999999999 111.405 -173.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.709 HD22 ' H ' ' A' ' 408' ' ' ASN . 0.1 OUTLIER -93.61 -28.83 15.79 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.457 -1.247 . . . . 1.8400000000000001 110.065 177.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.472 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 67.5 m-85 -142.77 119.66 11.27 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.296 . . . . 0.44 110.601 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.737 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.1 t-105 -125.56 135.15 51.92 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.606 -1.179 . . . . 0.13 111.112 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.563 ' HE3' ' CG2' ' A' ' 457' ' ' VAL . 1.0 OUTLIER -134.9 86.38 32.79 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.804 -1.089 . . . . 0.40999999999999998 111.279 174.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.65 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 94.7 Cg_endo -72.23 138.61 30.76 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 122.833 2.355 . . . . 0.16 111.558 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.2 pt -124.66 -14.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.973 -1.467 . . . . 0.17000000000000001 110.916 -173.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -133.7 162.81 30.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.449 -0.796 . . . . 1.5900000000000001 109.7 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -94.11 14.29 20.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.022 0.378 . . . . 0.31 112.022 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.1 p -93.27 -25.6 17.7 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.565 -1.272 . . . . 0.44 107.565 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 121.59 26.31 1.99 Allowed Glycine 0 N--CA 1.426 -2.031 0 CA-C-N 112.773 -2.012 . . . . 0.23999999999999999 111.63 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 441' ' ' GLY . 55.9 t -98.07 146.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.165 0.507 . . . . 0.17000000000000001 111.0 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.75 -165.0 36.06 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.923 -1.035 . . . . 0.10000000000000001 111.464 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.438 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -105.53 137.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.693 -0.854 . . . . 0.12 108.693 176.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.904 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.7 p80 -154.16 170.58 20.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 122.011 0.91 . . . . 0.14999999999999999 111.582 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 153.52 20.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.523 -1.671 . . . . 0.41999999999999998 108.766 174.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.554 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 3.4 p -141.24 99.65 3.62 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 122.827 1.298 . . . . 1.48 109.833 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.35 -31.13 13.57 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 112.457 -2.156 . . . . 0.34999999999999998 109.992 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.564 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 9.2 p90 -68.23 -26.88 65.92 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 114.354 -1.294 . . . . 0.17999999999999999 108.923 173.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.595 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -119.38 82.42 24.26 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.613 -1.63 . . . . 1.3300000000000001 110.135 -175.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.76 5.02 6.2 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 C-N-CA 124.802 3.668 . . . . 0.23000000000000001 114.211 -161.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.33 153.25 30.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.406 0.441 . . . . 1.1000000000000001 110.07 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.732 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.5 OUTLIER -163.15 127.98 3.04 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.99 1.316 . . . . 0.38 107.86 -173.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.28 -167.72 29.02 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 119.689 -1.243 . . . . 0.13 111.05 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.606 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.15 156.64 0.0 OUTLIER Glycine 0 C--N 1.341 0.857 0 O-C-N 124.935 1.021 . . . . 0.20000000000000001 113.225 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.461 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -54.92 100.62 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 123.692 1.711 . . . . 0.33000000000000002 111.579 -148.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 32.8 mt -97.21 -31.16 12.58 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 110.611 -2.995 . . . . 0.17999999999999999 109.453 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.478 ' HA ' HG23 ' A' ' 369' ' ' VAL . 14.8 p-90 -49.06 -32.32 9.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 112.881 -1.963 . . . . 0.22 111.729 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.814 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 53.4 mttt -64.06 -19.67 65.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.297 0.851 . . . . 0.64000000000000001 113.297 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 72.5 p -120.72 -36.64 3.13 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.644 -0.707 . . . . 0.25 110.628 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.595 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.2 mtp85 -82.05 -15.04 54.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.65 -1.159 . . . . 0.35999999999999999 112.773 -169.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.532 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.82 41.42 33.89 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 116.554 1.381 . . . . 0.20999999999999999 116.554 159.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 18.4 m -85.81 131.97 34.21 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 118.225 1.013 . . . . 0.46999999999999997 109.563 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -97.68 68.74 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.683 -0.635 . . . . 0.40999999999999998 110.85 -170.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.582 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 85.4 -9.81 66.15 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.819 -0.913 . . . . 0.17999999999999999 110.819 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 20.8 p -89.52 137.58 32.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.946 -0.627 . . . . 0.82999999999999996 110.079 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -96.77 113.12 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.618 -0.719 . . . . 0.14999999999999999 110.483 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.566 ' HB2' HG13 ' A' ' 369' ' ' VAL . 2.2 m-20 -80.76 92.12 6.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.006 . . . . 1.77 111.678 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.698 HG23 HG21 ' A' ' 366' ' ' THR . 98.0 m -89.44 140.85 28.48 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.542 -0.754 . . . . 0.17999999999999999 109.572 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 53.3 Cg_exo -55.08 136.81 74.7 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.803 2.335 . . . . 0.12 111.202 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.742 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 58.4 Cg_exo -55.96 -32.94 87.65 Favored 'Trans proline' 0 CA--C 1.5 -1.199 0 C-N-CA 124.195 3.263 . . . . 0.16 112.634 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.7 p -79.64 -38.35 33.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.522 -1.217 . . . . 1.1699999999999999 109.719 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.628 HG11 ' HB ' ' A' ' 366' ' ' THR . 84.3 t -78.54 -30.44 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.17000000000000001 111.439 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.677 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -64.47 -23.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.893 0.854 . . . . 0.46000000000000002 110.426 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -75.42 -27.02 58.82 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.408 -1.269 . . . . 0.81000000000000005 111.916 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.669 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.9 mm-40 -77.6 -46.19 22.92 Favored 'General case' 0 CA--C 1.472 -2.045 0 CA-C-N 113.489 -1.687 . . . . 0.38 106.991 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 457' ' ' VAL . 24.6 tp -65.4 -67.78 0.41 Allowed 'General case' 0 N--CA 1.401 -2.903 0 CA-C-N 111.472 -2.604 . . . . 0.059999999999999998 112.601 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.535 ' CD2' ' SD ' ' A' ' 411' ' ' MET . 31.4 t80 -51.31 -27.16 8.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.183 1.468 . . . . 0.31 107.988 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.425 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.06 -31.02 74.33 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 112.116 -2.311 . . . . 0.13 112.064 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.669 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.26 -48.39 7.4 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.834 0.826 . . . . 0.13 111.189 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.667 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 1.1 p -107.19 134.36 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-O 123.344 1.545 . . . . 0.23000000000000001 114.461 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.588 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 12.6 pt-20 -139.81 -176.55 4.61 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 110.948 -2.842 . . . . 0.82999999999999996 107.032 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.9 mtmt -46.21 154.42 0.27 Allowed 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 123.032 1.396 . . . . 0.23999999999999999 113.578 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 95.22 -24.75 27.47 Favored Glycine 0 C--N 1.292 -1.913 0 CA-C-N 112.275 -2.239 . . . . 0.37 112.821 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.504 ' HB ' HG23 ' A' ' 457' ' ' VAL . 6.6 m -89.3 142.23 29.67 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 109.685 -0.487 . . . . 0.14999999999999999 109.685 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.636 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.9 Cg_exo -74.64 168.3 25.13 Favored 'Trans proline' 0 N--CA 1.43 -2.209 0 C-N-CA 122.067 1.844 . . . . 0.12 111.571 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.477 HG21 HG21 ' A' ' 413' ' ' ILE . 69.8 t -135.46 134.77 52.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 113.869 -1.514 . . . . 1.0900000000000001 108.265 173.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.7 tp -112.93 143.43 44.23 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.157 0.503 . . . . 0.13 110.408 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.13 146.64 21.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.74 -1.578 . . . . 0.089999999999999997 106.74 164.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.729 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 21.0 p90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.523 -0.751 . . . . 1.1599999999999999 111.217 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.638 HG23 ' HA ' ' A' ' 358' ' ' LYS . 6.9 m . . . . . 0 N--CA 1.423 -1.823 0 N-CA-C 108.518 -0.919 . . . . 0.45000000000000001 108.518 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.645 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 14.0 p90 -164.66 -169.81 1.84 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.136 -0.938 . . . . 0.32000000000000001 110.443 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -103.57 158.07 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.178 -0.919 . . . . 0.080000000000000002 108.6 166.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.501 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.6 tt0 -140.07 155.91 46.82 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 118.89 0.768 . . . . 0.17000000000000001 111.131 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.672 HG22 ' HG3' ' A' ' 354' ' ' MET . 56.3 t -151.07 138.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.721 -1.127 . . . . 0.080000000000000002 109.432 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.45 115.35 23.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.723 -1.126 . . . . 0.37 108.076 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.521 ' H ' HD22 ' A' ' 349' ' ' LEU . 2.0 mm? -66.51 -47.83 71.71 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.789 1.281 . . . . 0.32000000000000001 110.319 -175.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -55.38 -53.87 50.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.49 -2.141 . . . . 1.51 112.384 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -98.03 10.34 40.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 114.093 -1.412 . . . . 0.91000000000000003 108.51 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.906 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.0 mm-40 38.01 69.48 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 125.316 1.635 . . . . 2.2200000000000002 111.841 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.479 ' CD2' ' CE2' ' A' ' 355' ' ' TRP . 7.7 t60 -148.16 125.96 11.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.273 -0.876 . . . . 0.13 109.729 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.672 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -113.0 127.96 56.37 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.57 0.7 . . . . 0.059999999999999998 110.428 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.729 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.0 m-90 -112.78 173.16 6.51 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 114.386 -1.279 . . . . 0.10000000000000001 111.76 -176.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.643 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -125.25 113.65 17.91 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.97 -1.863 . . . . 0.22 105.97 163.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 344' ' ' TYR . 22.1 m-85 -95.35 126.0 40.36 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.17999999999999999 112.028 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.638 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.0 ttpt -148.19 139.02 23.07 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 113.293 -1.776 . . . . 0.46999999999999997 108.305 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.447 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.63 14.89 6.1 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.677 -1.601 . . . . 0.59999999999999998 109.0 178.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.59 16.45 77.67 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.555 -2.111 . . . . 0.23000000000000001 111.653 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.666 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.5 OUTLIER -138.37 178.44 7.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.238 -2.134 . . . . 0.68000000000000005 105.238 -170.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.729 HG11 ' CD1' ' A' ' 355' ' ' TRP . 3.0 m -107.0 135.67 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-O 124.093 1.901 . . . . 0.53000000000000003 112.517 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.542 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -86.29 -26.0 25.19 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 109.412 -3.54 . . . . 0.12 108.009 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.671 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.25 154.68 36.23 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 113.953 -1.476 . . . . 0.080000000000000002 109.785 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.5 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 2.0 pt-20 -162.41 121.99 2.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 110.533 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.645 ' HB ' HG11 ' A' ' 449' ' ' VAL . 6.0 t -149.35 167.28 26.55 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 122.352 1.072 . . . . 0.089999999999999997 112.662 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.0 p-10 -86.11 141.5 29.36 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 112.925 -1.943 . . . . 1.8799999999999999 107.64 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.653 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -141.79 -176.31 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.546 -0.752 . . . . 0.11 112.356 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.906 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -151.71 116.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.051 -0.977 . . . . 0.12 110.322 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.459 ' OG ' HD12 ' A' ' 349' ' ' LEU . 56.5 p -140.53 141.09 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.475 0.916 . . . . 0.69999999999999996 113.475 -163.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.767 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.54 46.86 45.34 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 116.961 1.545 . . . . 0.13 116.961 162.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.534 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 6.1 pttt -46.05 145.71 2.4 Favored Pre-proline 0 C--O 1.216 -0.678 0 CA-C-N 119.318 1.559 . . . . 0.47999999999999998 111.041 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.802 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.3 OUTLIER -37.95 -31.19 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 125.244 3.962 . . . . 0.23000000000000001 115.276 -175.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.3 p -81.88 -33.33 30.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 0.29999999999999999 111.096 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -140.47 71.61 31.8 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 122.134 0.969 . . . . 0.29999999999999999 110.066 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.767 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.1 Cg_exo -69.93 163.0 40.04 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 125.552 4.168 . . . . 0.16 115.451 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.65 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.64 154.5 87.44 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 113.285 -1.779 . . . . 0.12 111.127 172.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.506 ' CD ' HG22 ' A' ' 377' ' ' THR . 3.4 Cg_endo -83.81 -52.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 1 C-N-CA 125.378 4.052 . . . . 0.089999999999999997 114.334 -172.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.71 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 70.64 122.79 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.932 1.086 . . . . 0.089999999999999997 113.932 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.66 -129.59 1.96 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 114.135 -1.393 . . . . 0.11 111.363 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.78 98.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.363 -0.977 . . . . 0.89000000000000001 108.363 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.821 ' HB2' HG22 ' A' ' 463' ' ' VAL . 97.0 m-85 -102.69 166.76 10.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.392 -0.822 . . . . 0.16 110.484 -169.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.699 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -150.09 139.23 21.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 119.753 -0.165 . . . . 0.68999999999999995 110.62 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -75.5 119.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 119.723 -0.791 . . . . 0.14000000000000001 110.432 176.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -107.26 4.5 26.66 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.796 -0.638 . . . . 0.19 112.616 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.646 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.6 t30 -162.98 146.3 10.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.766 -1.198 . . . . 0.40999999999999998 107.766 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 387' ' ' LYS . 0.2 OUTLIER -119.45 112.11 18.98 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.102 -1.073 . . . . 1.0900000000000001 108.102 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.569 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -118.33 128.21 54.44 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.399 -1.273 . . . . 0.38 111.052 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 42.6 mt-10 -128.2 134.21 49.0 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.849 -1.523 . . . . 1.96 109.827 -177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.5 t70 52.53 39.39 27.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 123.367 1.556 . . . . 0.40000000000000002 107.675 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -94.06 169.84 9.97 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 112.439 -2.164 . . . . 0.16 111.546 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 19.9 m -127.12 105.25 8.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.094 -1.412 . . . . 0.27000000000000002 110.033 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.5 mp -71.74 154.66 41.18 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.375 -1.739 . . . . 0.23999999999999999 109.692 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.487 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 9.7 mtpt . . . . . 0 N--CA 1.402 -2.85 0 CA-C-N 114.583 -1.19 . . . . 0.67000000000000004 108.26 -175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.4 mt-10 . . . . . 0 CA--C 1.503 -0.83 0 CA-C-O 122.337 1.065 . . . . 0.62 111.287 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.705 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.6 m -143.89 97.76 5.32 Favored Pre-proline 0 N--CA 1.419 -2.019 0 CA-C-N 113.067 -1.878 . . . . 1.3300000000000001 109.06 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 72.9 Cg_endo -67.5 106.46 1.25 Allowed 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 124.269 3.313 . . . . 0.20000000000000001 112.726 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -116.79 163.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.695 -1.138 . . . . 0.29999999999999999 111.206 -174.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.9 m-80 -113.91 -31.51 6.38 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.083 -1.871 . . . . 1.8400000000000001 107.39 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.485 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 70.9 m-85 -136.98 116.16 12.53 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.063 -1.881 . . . . 0.44 110.905 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.766 ' HB2' HG11 ' A' ' 407' ' ' VAL . 5.7 t-105 -124.02 134.15 53.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.44 -1.255 . . . . 0.13 110.974 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.847 ' SD ' HG22 ' A' ' 457' ' ' VAL . 5.8 mtm -134.32 88.05 31.38 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 114.728 -1.124 . . . . 0.40999999999999998 112.28 171.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.03 137.87 29.94 Favored 'Trans proline' 0 CA--C 1.506 -0.897 0 C-N-CA 123.113 2.542 . . . . 0.16 111.744 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.9 pt -123.51 -16.37 5.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 113.763 -1.562 . . . . 0.17000000000000001 110.696 -173.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -135.15 158.51 44.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.748 -0.66 . . . . 1.5900000000000001 109.895 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -87.92 13.55 10.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.337 0.495 . . . . 0.31 112.337 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 5.8 p -92.15 -25.85 18.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.444 -1.317 . . . . 0.44 107.444 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 120.06 30.79 1.4 Allowed Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 112.933 -1.939 . . . . 0.23999999999999999 111.78 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 441' ' ' GLY . 53.4 t -100.94 147.5 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.384 -0.408 . . . . 0.17000000000000001 110.73 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.27 -168.5 41.27 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.191 -0.913 . . . . 0.10000000000000001 112.058 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.41 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -104.06 139.55 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.56 -0.904 . . . . 0.12 108.56 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.805 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.7 p80 -151.84 164.88 36.13 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.641 0.734 . . . . 0.14999999999999999 112.079 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.73 141.4 28.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 113.931 -1.486 . . . . 0.41999999999999998 107.549 172.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 3.6 t -138.57 104.28 5.09 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 123.194 1.473 . . . . 1.48 110.731 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.37 -30.77 14.94 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.798 -2.456 . . . . 0.34999999999999998 110.852 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.429 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 14.6 p90 -68.27 -27.32 66.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.541 -1.209 . . . . 0.17999999999999999 109.475 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.489 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.1 81.59 28.53 Favored Pre-proline 0 CA--C 1.495 -1.144 0 CA-C-N 113.747 -1.57 . . . . 1.3300000000000001 109.798 -175.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -82.55 6.52 5.71 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 124.833 3.689 . . . . 0.23000000000000001 114.522 -161.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -114.72 151.09 34.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.508 -0.553 . . . . 1.1000000000000001 109.508 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.586 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -160.73 128.25 4.35 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.578 1.151 . . . . 0.38 108.115 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.62 -166.53 28.72 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.31 -1.424 . . . . 0.13 111.254 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.32 152.47 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 O-C-N 125.159 1.152 . . . . 0.20000000000000001 113.006 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.435 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 4.1 m-20 -55.04 101.5 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 123.506 1.622 . . . . 0.33000000000000002 112.136 -146.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.9 mt -96.73 -31.31 12.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 110.856 -2.883 . . . . 0.17999999999999999 109.364 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.55 ' HA ' HG23 ' A' ' 369' ' ' VAL . 12.8 p-90 -50.0 -31.99 14.13 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 112.84 -1.982 . . . . 0.22 111.871 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.802 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 38.5 mttt -65.27 -20.56 66.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.356 -0.838 . . . . 0.64000000000000001 112.685 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.0 p -118.65 -37.92 3.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.29 -0.868 . . . . 0.25 110.297 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.488 ' HB2' HG21 ' A' ' 369' ' ' VAL . 7.4 mtp85 -83.35 -16.24 46.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.868 -1.06 . . . . 0.35999999999999999 113.056 -169.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 77.72 40.74 21.31 Favored Glycine 0 C--N 1.31 -0.861 0 N-CA-C 116.895 1.518 . . . . 0.20999999999999999 116.895 159.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 19.8 m -80.72 136.52 36.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 118.26 1.03 . . . . 0.46999999999999997 109.763 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -98.03 65.77 1.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.943 -0.473 . . . . 0.40999999999999998 110.932 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.569 ' H ' ' HA2' ' A' ' 371' ' ' GLY . . . 87.29 -14.1 58.44 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.618 -0.993 . . . . 0.17999999999999999 110.618 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.4 p -85.36 148.58 25.95 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.464 -0.368 . . . . 0.82999999999999996 110.142 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.65 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -99.37 123.2 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 122.212 1.005 . . . . 0.14999999999999999 110.934 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.753 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.7 OUTLIER -81.44 83.35 6.98 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.51 -1.677 . . . . 1.77 111.395 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 24.5 m -88.04 138.02 31.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-O 121.558 0.694 . . . . 0.17999999999999999 109.581 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.413 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.7 Cg_exo -57.48 136.15 74.17 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.716 2.277 . . . . 0.12 111.827 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.5 Cg_exo -53.93 -32.77 69.26 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 124.547 3.498 . . . . 0.16 112.915 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.2 m -79.52 -41.94 26.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.383 -1.281 . . . . 1.1699999999999999 109.881 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 366' ' ' THR . 65.4 t -78.58 -30.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.558 0.694 . . . . 0.17000000000000001 111.7 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.738 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.24 -19.44 65.52 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.851 0.834 . . . . 0.46000000000000002 110.294 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -79.31 -23.23 43.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 114.494 -1.23 . . . . 0.81000000000000005 111.01 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.708 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.04 -46.98 15.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 113.075 -1.875 . . . . 0.38 107.193 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.0 tp -64.24 -66.7 0.51 Allowed 'General case' 0 N--CA 1.402 -2.844 0 CA-C-N 111.826 -2.443 . . . . 0.059999999999999998 112.289 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -52.99 -24.7 10.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.97 1.367 . . . . 0.31 108.387 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.52 -26.01 74.07 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 112.533 -2.121 . . . . 0.13 112.025 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.708 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.4 ptp -94.97 -49.92 5.34 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.876 0.846 . . . . 0.13 111.161 169.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.847 HG22 ' SD ' ' A' ' 411' ' ' MET . 2.1 p -108.61 132.08 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 CA-C-O 123.585 1.66 . . . . 0.23000000000000001 114.447 -167.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.457 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 7.3 pt-20 -140.82 -176.85 4.81 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.335 -3.12 . . . . 0.82999999999999996 106.127 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.619 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.3 mtmt -45.32 154.24 0.18 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.971 1.367 . . . . 0.23999999999999999 114.095 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 98.43 -32.75 6.62 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 112.013 -2.358 . . . . 0.37 112.54 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.583 ' HB ' HG23 ' A' ' 457' ' ' VAL . 6.2 m -83.6 143.12 43.56 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.304 -0.628 . . . . 0.14999999999999999 109.304 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 4.8 Cg_exo -75.36 169.8 21.67 Favored 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 121.789 1.659 . . . . 0.12 111.503 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.29 158.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.891 -1.152 . . . . 1.0900000000000001 107.891 167.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.501 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.4 tp -130.56 146.2 52.03 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.514 -0.766 . . . . 0.13 110.331 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.7 147.61 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.501 -1.296 . . . . 0.089999999999999997 107.501 165.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.468 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 16.9 p90 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.499 -0.762 . . . . 1.1599999999999999 111.402 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 358' ' ' LYS . 3.9 m . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 106.94 -1.504 . . . . 0.45000000000000001 106.94 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.632 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.8 p90 -160.16 -170.11 2.72 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.617 0.723 . . . . 0.32000000000000001 111.009 -173.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.581 HD11 ' CB ' ' A' ' 457' ' ' VAL . 11.7 mm -103.91 160.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.781 -1.099 . . . . 0.080000000000000002 108.216 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.488 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.0 tt0 -140.94 156.1 46.13 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 119.0 0.818 . . . . 0.17000000000000001 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.676 HG22 ' HG3' ' A' ' 354' ' ' MET . 68.3 t -150.62 137.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.663 -1.153 . . . . 0.080000000000000002 109.625 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.07 106.36 9.54 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 122.153 0.978 . . . . 0.37 108.826 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.484 HD21 HG23 ' A' ' 465' ' ' VAL . 1.9 mm? -63.4 -38.97 93.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 112.89 -1.959 . . . . 0.32000000000000001 111.298 -168.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.88 -57.06 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 111.673 -2.512 . . . . 1.51 112.552 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -95.64 2.74 54.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 114.685 -1.143 . . . . 0.91000000000000003 110.066 -172.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.871 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.4 mm-40 49.54 66.01 1.24 Allowed 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 112.654 -2.066 . . . . 2.2200000000000002 111.406 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.523 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -145.5 127.4 15.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.344 0.592 . . . . 0.13 109.725 -176.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.676 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.6 ttp -114.15 128.41 56.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.433 -0.803 . . . . 0.059999999999999998 110.613 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.649 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.54 173.29 6.48 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 114.608 -1.178 . . . . 0.10000000000000001 112.084 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.661 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 1.1 t80 -124.79 113.43 17.92 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.666 -1.605 . . . . 0.22 106.666 165.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.496 ' CE1' HG12 ' A' ' 362' ' ' VAL . 19.2 m-85 -96.94 125.41 41.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.303 1.049 . . . . 0.17999999999999999 112.43 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.681 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.8 ttpt -149.34 139.46 22.14 Favored 'General case' 0 N--CA 1.398 -3.075 0 CA-C-N 112.827 -1.988 . . . . 0.46999999999999997 108.091 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.449 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.1 17.62 7.24 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 113.61 -1.632 . . . . 0.59999999999999998 109.011 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.47 18.36 79.19 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 112.466 -2.152 . . . . 0.23000000000000001 111.824 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -138.82 177.61 7.76 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.798 -1.927 . . . . 0.68000000000000005 105.798 -169.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.753 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -106.96 138.09 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 CA-C-O 124.008 1.861 . . . . 0.53000000000000003 112.15 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.648 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.03 -23.76 18.56 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 109.587 -3.46 . . . . 0.12 108.479 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.601 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.7 tp -154.4 154.69 33.69 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.712 -1.585 . . . . 0.080000000000000002 108.977 -172.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.753 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.11 122.43 1.55 Allowed 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.576 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.657 ' HB ' HG11 ' A' ' 449' ' ' VAL . 3.6 t -146.88 166.24 27.31 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.688 0.756 . . . . 0.089999999999999997 111.215 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.49 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 42.1 m-20 -84.84 148.87 26.07 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.463 -1.681 . . . . 1.8799999999999999 106.463 174.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.657 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -144.02 -171.15 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.412 -0.813 . . . . 0.11 110.945 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.871 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -152.99 120.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.995 -1.002 . . . . 0.12 108.604 173.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.497 ' HB2' HG13 ' A' ' 443' ' ' ILE . 5.7 t -143.51 142.91 31.33 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.684 0.994 . . . . 0.69999999999999996 113.684 -167.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.76 44.78 37.34 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 117.046 1.578 . . . . 0.13 117.046 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.591 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.66 145.02 3.21 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 119.255 1.528 . . . . 0.47999999999999998 110.509 -174.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.784 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -35.11 -31.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.803 4.336 . . . . 0.23000000000000001 115.972 -173.283 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.591 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -81.17 -35.87 30.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.29999999999999999 111.033 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.467 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -140.39 72.64 31.43 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 122.227 1.013 . . . . 0.29999999999999999 110.461 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 24.5 Cg_exo -71.02 163.21 40.05 Favored 'Trans proline' 0 C--N 1.322 -0.817 1 C-N-CA 125.526 4.151 . . . . 0.16 114.153 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.7 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.04 153.61 88.68 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.418 -1.719 . . . . 0.12 110.946 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.71 -49.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.038 3.825 . . . . 0.089999999999999997 113.673 -171.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.722 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.66 122.87 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.568 0.951 . . . . 0.089999999999999997 113.568 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.41 -123.55 1.18 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.16 -1.382 . . . . 0.11 111.396 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -127.88 112.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 122.035 0.922 . . . . 0.89000000000000001 108.915 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.768 ' HB2' HG22 ' A' ' 463' ' ' VAL . 94.3 m-85 -115.74 160.87 19.53 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.027 -0.988 . . . . 0.16 109.706 -169.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.752 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 78.5 m-85 -147.63 137.19 22.61 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 119.703 -0.189 . . . . 0.68999999999999995 110.535 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.44 118.2 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 119.258 -0.977 . . . . 0.14000000000000001 110.172 176.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -106.36 2.15 26.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.385 -0.825 . . . . 0.19 112.451 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.681 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -160.24 148.75 16.91 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.815 -1.18 . . . . 0.40999999999999998 107.815 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.5 OUTLIER -119.73 117.88 29.4 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.915 -1.143 . . . . 1.0900000000000001 107.915 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.5 mt-10 -123.54 128.11 49.27 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.523 -1.217 . . . . 0.38 111.265 -173.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -125.75 135.52 52.14 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 113.559 -1.655 . . . . 1.96 109.393 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.89 38.67 29.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 123.338 1.542 . . . . 0.40000000000000002 107.731 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -93.1 170.14 9.87 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.213 -2.267 . . . . 0.16 111.841 -175.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 11.6 m -128.39 104.91 7.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.998 -1.455 . . . . 0.27000000000000002 110.413 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.753 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -76.57 158.43 31.17 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 112.74 -2.027 . . . . 0.23999999999999999 110.628 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 8.6 mtpt . . . . . 0 N--CA 1.4 -2.934 0 CA-C-N 115.218 -0.901 . . . . 0.67000000000000004 109.117 -177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.6 mt-10 . . . . . 0 CA--C 1.506 -0.738 0 CA-C-O 122.135 0.969 . . . . 0.62 111.52 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.753 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.15 99.25 12.31 Favored Pre-proline 0 N--CA 1.418 -2.072 0 CA-C-N 113.429 -1.714 . . . . 1.3300000000000001 107.726 175.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.2 Cg_endo -67.42 102.3 0.69 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.348 2.032 . . . . 0.20000000000000001 110.042 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.723 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.2 160.46 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 114.547 -1.206 . . . . 0.29999999999999999 110.362 -173.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 408' ' ' ASN . 11.3 m-80 -113.59 -32.06 6.3 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.288 -1.778 . . . . 1.8400000000000001 107.377 -174.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.559 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 62.2 m-85 -137.77 115.92 11.73 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.894 -1.957 . . . . 0.44 110.46 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.723 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.1 t-105 -123.56 134.1 53.88 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.932 -1.031 . . . . 0.13 110.823 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.519 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.6 mtp -134.06 86.18 37.89 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.705 -1.134 . . . . 0.40999999999999998 111.297 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 97.7 Cg_endo -72.5 139.52 31.58 Favored 'Trans proline' 0 CA--C 1.507 -0.862 0 C-N-CA 123.063 2.509 . . . . 0.16 111.828 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.752 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.97 -14.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 0.17000000000000001 111.054 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -134.11 164.69 26.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.339 -0.846 . . . . 1.5900000000000001 109.4 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -96.78 14.41 25.25 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.135 0.42 . . . . 0.31 112.135 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.2 p -94.41 -27.05 16.24 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.674 -1.232 . . . . 0.44 107.674 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.27 31.64 0.83 Allowed Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 112.898 -1.955 . . . . 0.23999999999999999 112.166 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 441' ' ' GLY . 73.3 t -102.3 147.47 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.296 0.569 . . . . 0.17000000000000001 110.914 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.94 -166.18 37.73 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 114.637 -1.165 . . . . 0.10000000000000001 111.325 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -104.35 140.3 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.504 -0.925 . . . . 0.12 108.504 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 407' ' ' VAL . 29.4 p80 -151.42 164.26 37.14 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.55 0.69 . . . . 0.14999999999999999 111.428 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.781 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -87.15 146.6 25.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.143 -1.389 . . . . 0.41999999999999998 108.066 172.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.5 m -139.35 102.5 4.5 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.021 1.391 . . . . 1.48 111.003 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.76 -26.96 16.75 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 109.904 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.521 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 12.2 p90 -72.65 -26.6 61.71 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.148 -1.387 . . . . 0.17999999999999999 109.817 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 80.56 25.17 Favored Pre-proline 0 CA--C 1.491 -1.296 0 CA-C-N 114.005 -1.452 . . . . 1.3300000000000001 108.953 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 24.0 Cg_endo -81.94 5.54 6.26 Favored 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 125.083 3.855 . . . . 0.23000000000000001 114.121 -162.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -115.07 150.18 36.34 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.986 -0.552 . . . . 1.1000000000000001 109.516 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.49 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.43 125.02 4.23 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.626 1.203 . . . . 0.38 108.08 -172.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.55 -166.77 29.18 Favored Glycine 0 C--N 1.294 -1.778 0 C-N-CA 119.199 -1.476 . . . . 0.13 111.083 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.64 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.26 153.16 0.0 OUTLIER Glycine 0 C--N 1.338 0.691 0 O-C-N 125.115 1.127 . . . . 0.20000000000000001 113.432 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.405 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.3 m-20 -55.56 100.73 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 123.832 1.777 . . . . 0.33000000000000002 112.063 -147.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.2 mt -96.82 -30.48 13.14 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 110.51 -3.041 . . . . 0.17999999999999999 108.098 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.54 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.0 p-90 -47.34 -38.61 13.21 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.791 0.682 . . . . 0.22 111.496 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.784 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 23.8 mttt -60.92 -23.05 64.95 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.306 -0.861 . . . . 0.64000000000000001 112.855 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 67.5 p -114.4 -37.06 4.44 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.799 0.809 . . . . 0.25 110.248 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.0 mtp85 -85.44 -15.61 42.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.691 -1.14 . . . . 0.35999999999999999 112.761 -169.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.89 41.17 28.74 Favored Glycine 0 C--N 1.313 -0.695 0 N-CA-C 116.128 1.211 . . . . 0.20999999999999999 116.128 159.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 369' ' ' VAL . 1.2 m -79.56 141.76 36.32 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 117.823 0.811 . . . . 0.46999999999999997 109.138 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . 0.403 ' NE2' ' HE3' ' A' ' 372' ' ' LYS . 63.2 m80 -110.79 71.93 0.76 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.362 -0.836 . . . . 0.40999999999999998 110.554 -171.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.603 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 83.97 -12.61 52.93 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.377 -1.089 . . . . 0.17999999999999999 110.377 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.482 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.0 p -90.26 145.05 25.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.213 -0.494 . . . . 0.82999999999999996 110.595 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.7 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -104.26 115.45 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.717 -0.674 . . . . 0.14999999999999999 110.416 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.557 ' HB2' HG13 ' A' ' 369' ' ' VAL . 18.7 m120 -79.69 91.96 5.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 1.77 111.217 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 38.3 m -88.45 137.82 30.45 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.29 -0.633 . . . . 0.17999999999999999 109.29 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.6 Cg_exo -55.67 135.94 71.82 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.892 2.395 . . . . 0.12 111.528 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.781 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 40.2 Cg_exo -54.96 -33.99 84.88 Favored 'Trans proline' 0 CA--C 1.502 -1.08 0 C-N-CA 124.372 3.382 . . . . 0.16 112.864 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.8 m -79.32 -40.11 31.15 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.76 -1.109 . . . . 1.1699999999999999 109.857 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.657 HG11 ' HB ' ' A' ' 366' ' ' THR . 72.4 t -78.76 -29.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.763 -0.653 . . . . 0.17000000000000001 111.518 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.691 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.2 tpt -68.08 -18.94 64.8 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.916 0.865 . . . . 0.46000000000000002 110.089 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -79.97 -24.13 41.14 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.432 -1.258 . . . . 0.81000000000000005 110.887 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.701 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.1 mm-40 -79.77 -46.95 16.05 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 112.955 -1.929 . . . . 0.38 107.094 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.562 HD23 ' SD ' ' A' ' 450' ' ' MET . 22.3 tp -64.88 -67.72 0.41 Allowed 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 111.857 -2.429 . . . . 0.059999999999999998 112.576 175.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.519 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 30.0 t80 -50.68 -26.37 5.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.054 1.407 . . . . 0.31 108.201 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.48 -30.72 68.71 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-N 112.316 -2.22 . . . . 0.13 112.052 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -88.57 -49.61 6.79 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.729 0.776 . . . . 0.13 110.714 170.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.661 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 1.3 p -106.91 132.84 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 123.575 1.655 . . . . 0.23000000000000001 114.39 -167.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.515 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 9.3 pt-20 -139.65 -176.68 4.64 Favored 'General case' 0 N--CA 1.404 -2.738 0 CA-C-N 110.646 -2.979 . . . . 0.82999999999999996 106.469 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.1 mtmt -45.4 154.14 0.2 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.971 1.367 . . . . 0.23999999999999999 113.789 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.51 -36.89 3.68 Favored Glycine 0 C--N 1.293 -1.823 0 CA-C-N 112.105 -2.316 . . . . 0.37 112.501 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.53 ' HB ' HG23 ' A' ' 457' ' ' VAL . 4.3 m -79.54 142.76 58.16 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 109.676 -0.491 . . . . 0.14999999999999999 109.676 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.689 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 6.0 Cg_exo -75.9 169.9 21.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 121.931 1.754 . . . . 0.12 111.677 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.91 157.59 38.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.718 -1.216 . . . . 1.0900000000000001 107.718 165.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.0 tp -128.39 145.34 51.11 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.343 -0.844 . . . . 0.13 110.004 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.722 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.33 147.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.158 -1.423 . . . . 0.089999999999999997 107.158 165.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.59 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 18.4 p90 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.4 -0.81 . . . . 1.1599999999999999 111.026 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.666 HG23 ' HA ' ' A' ' 358' ' ' LYS . 2.3 m . . . . . 0 N--CA 1.425 -1.71 0 N-CA-C 107.741 -1.207 . . . . 0.45000000000000001 107.741 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.665 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.1 p90 -160.11 -171.21 3.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.407 -0.815 . . . . 0.32000000000000001 110.533 -175.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.563 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.5 mm -106.05 161.11 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.25 -1.018 . . . . 0.080000000000000002 108.25 167.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.511 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.7 tt0 -141.57 155.45 45.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.877 0.762 . . . . 0.17000000000000001 111.12 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 354' ' ' MET . 60.0 t -151.05 137.07 12.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.519 -1.218 . . . . 0.080000000000000002 109.763 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -116.61 117.7 30.57 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.04 -1.096 . . . . 0.37 108.04 171.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.556 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -72.5 -46.05 56.51 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.705 0.764 . . . . 0.32000000000000001 109.716 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -59.86 -46.46 89.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.542 -1.663 . . . . 1.51 112.601 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -107.62 19.49 20.1 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.91000000000000003 109.161 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 20.8 mp0 33.6 69.08 0.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 125.743 1.902 . . . . 2.2200000000000002 112.568 171.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.599 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 8.4 t60 -152.06 124.12 8.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.2 0.524 . . . . 0.13 110.054 -176.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.6 ttp -109.82 127.76 54.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.521 0.677 . . . . 0.059999999999999998 110.616 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.655 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.5 m-90 -112.57 173.01 6.58 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.447 -1.251 . . . . 0.10000000000000001 111.925 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.726 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.7 t80 -126.35 118.96 26.14 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.495 -1.668 . . . . 0.22 106.495 165.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 22.4 m-85 -101.12 127.21 47.77 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-O 122.335 1.064 . . . . 0.17999999999999999 112.467 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.666 ' HA ' HG23 ' A' ' 343' ' ' THR . 2.6 ttpt -149.38 139.82 22.42 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-N 112.73 -2.032 . . . . 0.46999999999999997 107.326 174.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 72.74 15.9 4.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.08 -1.418 . . . . 0.59999999999999998 109.069 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.65 79.0 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 112.523 -2.126 . . . . 0.23000000000000001 111.533 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.668 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 2.2 tppt? -140.17 178.23 7.43 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.446 -1.877 . . . . 0.68000000000000005 105.961 -167.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.733 HG21 ' HG2' ' A' ' 365' ' ' GLU . 2.9 m -106.36 138.61 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-O 124.053 1.882 . . . . 0.53000000000000003 112.328 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -94.71 -24.59 17.07 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 109.419 -3.537 . . . . 0.12 108.589 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.617 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.4 tp -153.05 154.91 35.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.701 -1.591 . . . . 0.080000000000000002 108.808 -171.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.733 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.7 122.94 1.21 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.817 -0.629 . . . . 0.60999999999999999 109.475 -174.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.664 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.6 t -147.56 166.84 26.12 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.564 0.697 . . . . 0.089999999999999997 111.406 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 50.6 m-20 -83.92 147.56 27.42 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.08 -1.452 . . . . 1.8799999999999999 107.08 174.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.66 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.281 -0.872 . . . . 0.11 111.425 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.597 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.03 118.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.997 -1.002 . . . . 0.12 108.727 175.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.509 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.3 t -142.26 147.85 37.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.327 -0.851 . . . . 0.69999999999999996 112.306 -168.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.44 45.31 55.01 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 116.736 1.454 . . . . 0.13 116.736 162.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.633 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.28 144.24 3.29 Favored Pre-proline 0 C--O 1.217 -0.611 0 CA-C-N 118.706 1.253 . . . . 0.47999999999999998 110.309 -175.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.82 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.69 -29.15 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.593 1 C-N-CA 125.75 4.3 . . . . 0.23000000000000001 116.001 -171.977 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.633 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -84.14 -33.92 24.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.4 0.619 . . . . 0.29999999999999999 111.04 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -140.35 72.08 32.16 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 122.201 1.001 . . . . 0.29999999999999999 110.245 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.9 Cg_exo -70.78 165.55 31.77 Favored 'Trans proline' 0 C--N 1.324 -0.727 1 C-N-CA 125.368 4.046 . . . . 0.16 114.21 -176.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.713 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -78.69 152.82 78.08 Favored Pre-proline 0 N--CA 1.435 -1.202 0 CA-C-N 113.799 -1.546 . . . . 0.12 110.427 174.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.527 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.34 -49.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.983 3.788 . . . . 0.089999999999999997 113.311 -172.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.705 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.52 122.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.666 0.987 . . . . 0.089999999999999997 113.666 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.95 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.282 -1.326 . . . . 0.11 111.577 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.3 p -129.09 106.0 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.307 1.051 . . . . 0.89000000000000001 109.323 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.802 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.5 m-85 -109.54 163.88 13.04 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.799 -1.091 . . . . 0.16 110.071 -169.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.687 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 69.6 m-85 -147.93 137.88 22.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 121.261 -0.176 . . . . 0.68999999999999995 110.749 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.622 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.5 124.6 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.863 -0.735 . . . . 0.14000000000000001 110.538 177.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -109.52 4.49 22.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.533 -0.758 . . . . 0.19 112.163 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.717 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.2 t30 -166.52 150.97 7.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.40999999999999998 110.684 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 12.1 mtpt -109.53 118.68 37.23 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.583 0.706 . . . . 1.0900000000000001 109.86 169.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.6 mt-10 -119.4 112.96 20.07 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 123.034 1.397 . . . . 0.38 112.803 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -108.93 136.58 48.23 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 113.785 -1.552 . . . . 1.96 110.994 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 38.7 t70 51.36 34.74 12.38 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 123.466 1.603 . . . . 0.40000000000000002 107.9 -175.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.15 170.82 10.72 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.21 -2.268 . . . . 0.16 111.991 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.0 m -129.32 104.41 7.49 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.742 -1.572 . . . . 0.27000000000000002 109.64 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.728 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.12 155.06 40.69 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 112.889 -1.959 . . . . 0.23999999999999999 109.972 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.46 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 9.6 mtpt . . . . . 0 N--CA 1.404 -2.767 0 O-C-N 124.529 1.143 . . . . 0.67000000000000004 108.543 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.7 mt-10 . . . . . 0 CA--C 1.507 -0.71 0 CA-C-O 122.764 1.269 . . . . 0.62 112.111 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.728 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -140.1 98.15 7.65 Favored Pre-proline 0 N--CA 1.421 -1.916 0 CA-C-N 112.356 -2.202 . . . . 1.3300000000000001 107.768 172.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 62.9 Cg_endo -68.17 102.66 0.82 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.325 2.017 . . . . 0.20000000000000001 110.658 175.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.786 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.06 163.84 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.684 -1.144 . . . . 0.29999999999999999 110.393 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 390' ' ' ASP . 19.5 m-80 -115.94 -31.38 5.77 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 113.517 -1.674 . . . . 1.8400000000000001 107.602 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.462 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 55.8 m-85 -138.61 115.65 10.92 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.142 -1.845 . . . . 0.44 110.107 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.786 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.09 135.65 54.48 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.075 -0.966 . . . . 0.13 109.95 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.525 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -135.89 85.1 30.12 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.98 -1.009 . . . . 0.40999999999999998 111.019 174.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.712 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.6 Cg_endo -71.41 140.67 37.15 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.98 2.453 . . . . 0.16 112.236 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -124.25 -15.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.841 -1.527 . . . . 0.17000000000000001 111.105 -173.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -134.36 166.01 23.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 1.5900000000000001 109.328 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.44 13.86 31.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.405 0.52 . . . . 0.31 112.405 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.2 p -92.88 -27.1 17.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.342 -1.355 . . . . 0.44 107.342 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 126.65 32.25 0.72 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 113.062 -1.881 . . . . 0.23999999999999999 112.36 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 441' ' ' GLY . 72.4 t -102.59 147.62 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 121.24 0.543 . . . . 0.17000000000000001 111.164 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.57 -166.0 38.16 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.979 -1.009 . . . . 0.10000000000000001 111.621 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.33 140.35 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.846 -0.798 . . . . 0.12 108.846 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 33.4 p80 -150.83 165.42 33.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.763 0.792 . . . . 0.14999999999999999 111.556 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.53 139.64 30.33 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.936 -1.484 . . . . 0.41999999999999998 107.611 172.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.8 p -128.49 99.79 5.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.897 1.332 . . . . 1.48 109.957 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.0 -34.41 11.78 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 112.497 -2.138 . . . . 0.34999999999999998 110.778 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.553 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 11.2 p90 -67.14 -26.91 66.9 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.566 -1.197 . . . . 0.17999999999999999 109.213 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.588 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.98 81.91 20.41 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.586 -1.643 . . . . 1.3300000000000001 109.253 -174.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 28.7 Cg_endo -79.91 5.9 5.63 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 C-N-CA 124.844 3.696 . . . . 0.23000000000000001 113.824 -161.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.76 153.53 30.16 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.945 -0.57 . . . . 1.1000000000000001 111.14 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -164.0 123.72 2.05 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 114.347 -1.297 . . . . 0.38 108.341 -172.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.61 -166.66 28.71 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 119.394 -1.384 . . . . 0.13 110.535 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.63 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.94 151.7 0.0 OUTLIER Glycine 0 C--N 1.34 0.767 0 O-C-N 125.296 1.233 . . . . 0.20000000000000001 113.416 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 124.089 1.9 . . . . 0.33000000000000002 111.913 -152.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 46.5 mt -97.17 -33.47 11.48 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 109.964 -3.289 . . . . 0.17999999999999999 107.752 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.597 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.82 -37.48 6.17 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.961 0.788 . . . . 0.22 111.61 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.82 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 35.3 mttt -60.51 -24.4 65.29 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.984 -1.007 . . . . 0.64000000000000001 112.737 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -114.8 -36.43 4.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.753 0.787 . . . . 0.25 110.044 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.588 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.4 mtp85 -83.72 -15.02 50.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.553 -1.203 . . . . 0.35999999999999999 112.724 -169.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.49 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.41 40.9 38.72 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.331 1.292 . . . . 0.20999999999999999 116.331 159.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.4 m -81.88 134.5 35.41 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 118.038 0.919 . . . . 0.46999999999999997 109.612 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -99.28 70.45 1.75 Allowed 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.771 -0.58 . . . . 0.40999999999999998 110.466 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.644 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 80.72 -7.13 59.56 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.754 -0.938 . . . . 0.17999999999999999 110.754 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 19.1 p -93.05 131.09 38.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.692 0.758 . . . . 0.82999999999999996 110.548 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -91.61 113.74 27.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.978 -1.01 . . . . 0.14999999999999999 110.494 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.576 ' HB2' HG13 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -76.89 89.73 3.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.992 -1.003 . . . . 1.77 110.982 -177.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.623 HG23 HG21 ' A' ' 366' ' ' THR . 31.5 m -89.05 136.09 30.88 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 109.214 -0.661 . . . . 0.17999999999999999 109.214 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.451 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.2 Cg_exo -57.46 131.93 47.6 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.39 . . . . 0.12 113.107 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.763 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.9 Cg_exo -50.79 -39.1 58.06 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 123.463 2.775 . . . . 0.16 112.398 -168.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 451' ' ' LYS . 17.0 p -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.529 -1.214 . . . . 1.1699999999999999 109.974 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.664 HG11 ' HB ' ' A' ' 366' ' ' THR . 68.7 t -78.37 -29.64 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.211 0.529 . . . . 0.17000000000000001 111.252 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.674 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.48 -20.28 65.45 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 122.009 0.909 . . . . 0.46000000000000002 110.013 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 448' ' ' SER . 0.1 OUTLIER -75.67 -29.71 59.15 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 114.059 -1.428 . . . . 0.81000000000000005 111.266 176.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -76.05 -47.28 25.29 Favored 'General case' 0 CA--C 1.473 -2.0 0 CA-C-N 112.645 -2.07 . . . . 0.38 107.297 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.584 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.9 tp -64.57 -66.49 0.54 Allowed 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 111.771 -2.468 . . . . 0.059999999999999998 112.546 175.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.444 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.6 t80 -50.32 -24.93 3.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.041 1.4 . . . . 0.31 108.342 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.8 -28.14 63.49 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 112.432 -2.167 . . . . 0.13 111.967 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -89.84 -48.4 7.26 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 121.769 0.795 . . . . 0.13 111.461 170.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.563 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.7 OUTLIER -103.21 137.45 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 CA-C-O 123.503 1.62 . . . . 0.23000000000000001 114.297 -167.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.83 -178.6 5.26 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 110.592 -3.004 . . . . 0.82999999999999996 106.607 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.717 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.5 mtmt -52.1 162.19 0.51 Allowed 'General case' 0 N--CA 1.413 -2.324 0 CA-C-O 123.092 1.425 . . . . 0.23999999999999999 113.009 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.92 4.55 Favored Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 112.576 -2.102 . . . . 0.37 112.535 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.3 m -77.04 141.13 67.13 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.231 -0.655 . . . . 0.14999999999999999 109.231 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.665 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.8 Cg_exo -73.62 167.42 27.3 Favored 'Trans proline' 0 N--CA 1.427 -2.438 0 C-N-CA 121.677 1.585 . . . . 0.12 111.106 174.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.802 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.7 156.78 38.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.398 -1.334 . . . . 1.0900000000000001 107.398 166.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.491 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.1 tp -128.06 145.33 51.03 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 115.552 -0.749 . . . . 0.13 110.17 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.32 147.72 20.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.962 -1.496 . . . . 0.089999999999999997 106.962 165.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.692 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.8 p90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.079 -0.962 . . . . 1.1599999999999999 111.573 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.629 HG23 ' HA ' ' A' ' 358' ' ' LYS . 96.2 m . . . . . 0 N--CA 1.426 -1.663 0 N-CA-C 107.754 -1.202 . . . . 0.45000000000000001 107.754 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.658 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 10.7 p90 -160.58 -170.73 2.87 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.031 -0.986 . . . . 0.32000000000000001 110.987 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.576 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -102.53 157.2 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 107.693 -1.225 . . . . 0.080000000000000002 107.693 165.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.2 tt0 -137.91 154.08 49.46 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 118.59 0.632 . . . . 0.17000000000000001 110.659 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 354' ' ' MET . 58.0 t -150.81 135.17 9.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.911 -1.04 . . . . 0.080000000000000002 109.913 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -114.78 117.88 32.0 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.607 -1.179 . . . . 0.37 108.097 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.531 HD21 HG23 ' A' ' 465' ' ' VAL . 2.0 mm? -72.07 -48.77 41.75 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.335 1.064 . . . . 0.32000000000000001 110.122 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -54.58 -51.68 64.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.026 -1.897 . . . . 1.51 112.374 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -104.4 16.62 25.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.38 -1.282 . . . . 0.91000000000000003 108.914 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.789 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.7 mm-40 34.09 69.27 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 112.94 -1.936 . . . . 2.2200000000000002 112.55 172.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.473 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.8 t60 -150.05 125.38 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.702 -0.681 . . . . 0.13 109.561 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.666 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -111.78 128.44 56.1 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.495 0.664 . . . . 0.059999999999999998 110.356 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.618 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 30.9 m-90 -113.07 171.71 7.38 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.438 -1.255 . . . . 0.10000000000000001 111.636 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.685 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.6 t80 -122.3 116.07 23.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.823 -1.918 . . . . 0.22 105.823 164.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.468 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 21.0 m-85 -100.82 131.35 46.75 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.739 0.78 . . . . 0.17999999999999999 110.962 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.662 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 4.6 ttpt -147.7 137.66 22.82 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 114.266 -1.334 . . . . 0.46999999999999997 108.656 174.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.8 OUTLIER 69.72 18.31 7.54 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 113.104 -1.862 . . . . 0.59999999999999998 108.34 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.01 71.89 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 112.28 -2.236 . . . . 0.23000000000000001 111.834 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.622 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.84 165.39 27.42 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.91 -1.645 . . . . 0.68000000000000005 106.729 -168.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.622 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 54.5 t -94.66 132.42 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 123.54 1.638 . . . . 0.53000000000000003 111.632 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.685 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -98.87 -28.14 13.59 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 110.944 -2.844 . . . . 0.12 109.856 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.631 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.2 tp -152.64 148.61 27.52 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.408 -1.269 . . . . 0.080000000000000002 109.625 -170.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.618 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -158.71 123.02 4.05 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.257 -0.428 . . . . 0.60999999999999999 110.099 -171.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.652 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.9 t -148.93 166.74 27.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 122.402 1.096 . . . . 0.089999999999999997 112.262 172.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.616 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.9 p-10 -86.01 141.27 29.6 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 112.827 -1.988 . . . . 1.8799999999999999 107.418 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.642 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.83 -171.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.477 -0.783 . . . . 0.11 112.155 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.789 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.26 119.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.998 -1.001 . . . . 0.12 109.529 175.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.8 t -142.35 144.56 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 0.69999999999999996 112.642 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.02 45.37 26.56 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 116.784 1.474 . . . . 0.13 116.784 163.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.551 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.6 143.08 5.99 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-N 118.921 1.361 . . . . 0.47999999999999998 110.007 -174.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.768 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -32.94 -31.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.7 1 C-N-CA 126.056 4.504 . . . . 0.23000000000000001 116.471 -170.041 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.9 p -81.94 -33.75 30.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.208 0.528 . . . . 0.29999999999999999 111.126 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.462 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.8 m -140.16 73.82 31.33 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-O 122.212 1.006 . . . . 0.29999999999999999 109.955 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.9 Cg_exo -71.21 161.73 44.86 Favored 'Trans proline' 0 C--N 1.319 -0.998 1 C-N-CA 125.308 4.006 . . . . 0.16 113.741 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.682 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.95 152.18 90.84 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-N 113.657 -1.611 . . . . 0.12 110.67 175.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.523 ' HG2' ' CE1' ' A' ' 382' ' ' PHE . 1.4 Cg_endo -80.18 -49.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 125.044 3.829 . . . . 0.089999999999999997 113.497 -171.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.711 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.23 123.04 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.143 0.973 . . . . 0.089999999999999997 113.545 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.82 -126.31 1.48 Allowed Glycine 0 N--CA 1.436 -1.325 0 CA-C-N 113.895 -1.502 . . . . 0.11 110.671 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.9 p -129.18 104.46 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.286 1.041 . . . . 0.89000000000000001 109.346 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.628 ' CE2' HG22 ' A' ' 465' ' ' VAL . 51.1 m-85 -107.78 169.25 8.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.005 -0.998 . . . . 0.16 109.173 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.702 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 74.1 m-85 -148.92 138.04 21.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 121.225 -0.19 . . . . 0.68999999999999995 110.579 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.17 123.66 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 119.833 -0.747 . . . . 0.14000000000000001 110.123 176.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -111.63 6.48 20.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.412 -0.813 . . . . 0.19 111.846 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.719 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.5 t30 -166.7 150.66 7.15 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.401 -0.818 . . . . 0.40999999999999998 110.93 175.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.7 mtpt -109.99 120.32 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.529 -0.76 . . . . 1.0900000000000001 109.466 169.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.574 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.9 mt-10 -122.58 112.88 18.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 123.29 1.519 . . . . 0.38 113.243 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 24.0 mp0 -108.93 135.38 50.22 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.509 -1.678 . . . . 1.96 111.022 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 24.6 t70 52.23 35.69 17.5 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.582 1.658 . . . . 0.40000000000000002 107.545 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.03 170.81 10.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.196 -2.275 . . . . 0.16 112.225 -175.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 30.5 m -128.12 102.53 6.76 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.341 -1.754 . . . . 0.27000000000000002 109.937 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.727 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.42 156.49 36.95 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.878 -1.965 . . . . 0.23999999999999999 110.262 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 10.3 mtpt . . . . . 0 N--CA 1.401 -2.918 0 O-C-N 124.235 0.959 . . . . 0.67000000000000004 108.701 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 5.4 mt-10 . . . . . 0 CA--C 1.507 -0.707 0 CA-C-O 122.448 1.118 . . . . 0.62 112.302 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.727 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.21 98.77 9.14 Favored Pre-proline 0 N--CA 1.422 -1.843 0 CA-C-N 113.012 -1.904 . . . . 1.3300000000000001 108.193 174.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.1 Cg_endo -67.42 102.7 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.454 2.102 . . . . 0.20000000000000001 110.336 174.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.64 160.88 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.397 -1.274 . . . . 0.29999999999999999 110.134 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 13.7 m-80 -111.82 -32.85 6.49 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.656 -1.611 . . . . 1.8400000000000001 107.19 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.443 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 49.8 m-85 -137.67 115.98 11.87 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.064 -1.88 . . . . 0.44 110.225 175.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.778 ' HB2' HG11 ' A' ' 407' ' ' VAL . 9.8 t-105 -122.87 135.57 54.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.957 -1.02 . . . . 0.13 109.794 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.54 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.5 OUTLIER -136.34 86.07 25.19 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.882 -1.054 . . . . 0.40999999999999998 110.851 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.6 Cg_endo -72.34 141.5 35.51 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.975 2.45 . . . . 0.16 111.691 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.52 -15.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.393 -1.276 . . . . 0.17000000000000001 111.809 -171.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.818 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 3.9 p30 -135.98 171.03 15.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.778 -0.646 . . . . 1.5900000000000001 110.074 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -98.23 16.43 21.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 0.31 111.681 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.9 p -99.65 -27.91 13.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.583 -0.895 . . . . 0.44 108.583 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 132.31 26.24 0.68 Allowed Glycine 0 N--CA 1.432 -1.622 0 CA-C-N 114.337 -1.302 . . . . 0.23999999999999999 113.902 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.818 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.1 t -105.12 152.4 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.523 0.678 . . . . 0.17000000000000001 112.083 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.76 -168.07 40.55 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 114.82 -1.082 . . . . 0.10000000000000001 111.209 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.5 141.6 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 109.119 -0.697 . . . . 0.12 109.119 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.615 ' O ' ' HB ' ' A' ' 445' ' ' THR . 33.7 p80 -150.54 165.04 34.47 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.75 0.786 . . . . 0.14999999999999999 111.768 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.776 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -93.25 142.85 26.85 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.004 -1.453 . . . . 0.41999999999999998 107.16 171.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.93 104.94 5.89 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.925 1.345 . . . . 1.48 110.203 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.97 -27.62 15.56 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 112.34 -2.209 . . . . 0.34999999999999998 111.288 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.533 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 9.0 p90 -69.3 -24.61 63.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.481 -1.236 . . . . 0.17999999999999999 108.877 174.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.436 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.1 OUTLIER -119.17 100.2 50.36 Favored Pre-proline 0 CA--C 1.488 -1.404 0 CA-C-N 112.985 -1.916 . . . . 1.3300000000000001 108.465 -176.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -88.52 2.2 6.21 Favored 'Trans proline' 0 C--N 1.283 -2.914 0 C-N-CA 123.04 2.493 . . . . 0.23000000000000001 114.863 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.41 ' HB3' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -112.97 151.86 30.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.986 -1.086 . . . . 1.1000000000000001 111.567 -177.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.616 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.64 125.77 2.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.762 -1.563 . . . . 0.38 108.472 -171.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.71 -169.01 28.6 Favored Glycine 0 C--N 1.299 -1.527 0 C-N-CA 119.416 -1.373 . . . . 0.13 111.203 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.669 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.06 0.01 OUTLIER Glycine 0 C--N 1.34 0.778 0 O-C-N 125.163 1.155 . . . . 0.20000000000000001 112.97 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.403 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.4 m-20 -54.55 100.96 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 123.988 1.852 . . . . 0.33000000000000002 111.799 -146.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.8 mt -97.14 -31.71 12.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 110.09 -3.232 . . . . 0.17999999999999999 108.614 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.606 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.6 p-90 -45.95 -37.68 6.74 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.804 0.69 . . . . 0.22 111.515 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.768 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 56.4 mttt -61.34 -24.18 66.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.113 -0.949 . . . . 0.64000000000000001 113.211 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.5 p -114.85 -37.38 4.21 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.684 0.754 . . . . 0.25 110.162 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.508 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.5 mtp85 -82.36 -15.72 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.78 -1.1 . . . . 0.35999999999999999 112.137 -170.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.551 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 71.87 41.43 55.62 Favored Glycine 0 C--N 1.314 -0.66 0 N-CA-C 116.13 1.212 . . . . 0.20999999999999999 116.13 160.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 38.5 m -90.28 130.1 36.44 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.565 1.182 . . . . 0.46999999999999997 108.522 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -95.4 65.35 2.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.06 -0.4 . . . . 0.40999999999999998 111.187 -166.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.593 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 93.76 -13.77 66.75 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.548 -1.021 . . . . 0.17999999999999999 110.548 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 21.0 p -87.52 138.45 31.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.971 0.415 . . . . 0.82999999999999996 110.455 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -91.72 116.15 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.78 0.8 . . . . 0.14999999999999999 110.768 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.525 ' CB ' HG13 ' A' ' 369' ' ' VAL . 1.8 t-20 -76.73 84.3 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.236 -1.347 . . . . 1.77 111.405 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 51.3 m -89.64 137.96 28.41 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-O 121.659 0.743 . . . . 0.17999999999999999 109.773 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.429 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.8 Cg_exo -57.55 135.84 72.13 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.909 2.406 . . . . 0.12 111.735 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.776 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.8 Cg_exo -55.27 -34.04 86.95 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.256 3.304 . . . . 0.16 112.96 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.7 p -78.54 -39.48 37.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.651 -1.159 . . . . 1.1699999999999999 109.928 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.652 HG11 ' HB ' ' A' ' 366' ' ' THR . 86.2 t -79.58 -31.25 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.866 -0.606 . . . . 0.17000000000000001 111.384 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.696 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.6 tpt -66.76 -18.73 65.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.521 0.677 . . . . 0.46000000000000002 110.448 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -81.04 -23.05 38.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.395 1.093 . . . . 0.81000000000000005 110.989 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 456' ' ' MET . 7.7 mm-40 -79.69 -46.95 16.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 112.841 -1.981 . . . . 0.38 107.106 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.619 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.2 tp -64.39 -66.99 0.47 Allowed 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 111.835 -2.439 . . . . 0.059999999999999998 112.243 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.437 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 33.0 t80 -49.67 -27.04 4.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.018 1.39 . . . . 0.31 108.328 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.57 -30.76 66.12 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 112.465 -2.152 . . . . 0.13 112.409 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -88.38 -48.34 7.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.929 0.871 . . . . 0.13 111.369 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.612 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.6 OUTLIER -102.45 138.03 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 123.587 1.66 . . . . 0.23000000000000001 113.992 -168.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.96 -178.44 5.2 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 110.52 -3.037 . . . . 0.82999999999999996 106.419 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.719 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.6 mtmt -50.87 162.96 0.22 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 123.06 1.41 . . . . 0.23999999999999999 113.318 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.02 -35.29 3.95 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 112.577 -2.102 . . . . 0.37 112.47 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 462' ' ' PRO . 17.8 m -72.57 141.69 82.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 CA-C-N 115.252 -0.474 . . . . 0.14999999999999999 109.837 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.658 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.4 164.97 33.73 Favored 'Trans proline' 0 N--CA 1.43 -2.241 0 C-N-CA 122.043 1.829 . . . . 0.12 111.084 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.0 t -135.16 133.45 53.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 CA-C-N 113.702 -1.59 . . . . 1.0900000000000001 107.872 173.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.46 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.9 tp -112.55 142.96 44.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.032 -0.531 . . . . 0.13 110.371 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.711 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.19 147.46 20.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.06 -1.459 . . . . 0.089999999999999997 107.06 165.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.654 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.9 p90 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.657 -0.687 . . . . 1.1599999999999999 111.342 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 358' ' ' LYS . 4.1 m . . . . . 0 N--CA 1.427 -1.605 0 N-CA-C 106.95 -1.5 . . . . 0.45000000000000001 106.95 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.646 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.2 p90 -158.65 -171.03 3.27 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.597 0.713 . . . . 0.32000000000000001 111.081 -174.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.608 HD11 ' HB ' ' A' ' 457' ' ' VAL . 8.9 mm -105.58 161.09 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.719 -1.128 . . . . 0.080000000000000002 108.022 167.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.479 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.2 tt0 -142.42 155.39 45.1 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 118.843 0.747 . . . . 0.17000000000000001 111.046 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.711 HG22 ' HG3' ' A' ' 354' ' ' MET . 63.2 t -150.3 136.57 12.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.795 -1.093 . . . . 0.080000000000000002 109.851 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -117.84 111.28 18.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.721 -1.127 . . . . 0.37 108.053 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.543 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -64.63 -49.41 71.16 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 122.704 1.24 . . . . 0.32000000000000001 110.197 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -53.31 -54.82 30.86 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 112.507 -2.133 . . . . 1.51 112.224 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -94.9 3.86 54.48 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.788 -1.097 . . . . 0.91000000000000003 109.994 -173.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.764 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.2 mm-40 47.01 64.96 1.36 Allowed 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 112.584 -2.098 . . . . 2.2200000000000002 112.27 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.545 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.5 t60 -145.86 124.62 12.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.107 0.48 . . . . 0.13 110.021 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.711 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.4 ttp -110.83 127.61 55.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.438 0.637 . . . . 0.059999999999999998 110.515 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.638 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.3 m-90 -111.55 173.26 6.43 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.538 -1.21 . . . . 0.10000000000000001 111.889 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.724 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -127.14 117.48 22.46 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 106.251 -1.759 . . . . 0.22 106.251 164.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 25.2 m-85 -100.48 128.6 46.49 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.188 0.994 . . . . 0.17999999999999999 111.898 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.675 ' HA ' HG23 ' A' ' 343' ' ' THR . 5.1 ttpt -148.35 137.37 21.81 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.218 -1.81 . . . . 0.46999999999999997 108.225 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.7 OUTLIER 70.56 14.46 7.27 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 113.409 -1.723 . . . . 0.59999999999999998 108.92 178.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.62 15.65 75.3 Favored Glycine 0 N--CA 1.423 -2.203 0 CA-C-N 112.588 -2.096 . . . . 0.23000000000000001 111.847 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.63 171.75 13.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.954 -1.869 . . . . 0.68000000000000005 105.954 -170.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.689 HG21 ' HG2' ' A' ' 365' ' ' GLU . 2.9 m -102.99 137.84 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.834 0 CA-C-O 124.421 2.058 . . . . 0.53000000000000003 112.186 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.724 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.01 -24.76 18.24 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 109.291 -3.595 . . . . 0.12 108.574 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.687 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.4 154.81 36.33 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.854 -1.521 . . . . 0.080000000000000002 109.018 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.689 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.56 122.05 1.41 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.763 -0.653 . . . . 0.60999999999999999 109.442 -175.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.697 HG21 HG23 ' A' ' 445' ' ' THR . 5.2 t -148.34 167.55 24.91 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 122.34 1.066 . . . . 0.089999999999999997 112.133 174.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.673 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.0 OUTLIER -86.45 139.97 30.41 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 112.941 -1.936 . . . . 1.8799999999999999 107.41 176.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.643 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.28 -171.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.349 -0.841 . . . . 0.11 112.014 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.764 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.17 117.14 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.862 -1.063 . . . . 0.12 109.203 177.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.498 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.0 t -142.85 146.62 34.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.78 -1.1 . . . . 0.69999999999999996 112.531 -168.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.6 45.93 50.36 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 116.824 1.489 . . . . 0.13 116.824 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.498 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.55 144.45 3.44 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 118.994 1.397 . . . . 0.47999999999999998 110.616 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.814 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.74 -29.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 1 C-N-CA 125.848 4.365 . . . . 0.23000000000000001 116.45 -172.412 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.2 p -86.97 -31.99 20.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.465 0.65 . . . . 0.29999999999999999 110.809 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.512 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.7 m -138.47 70.55 45.91 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 122.187 0.994 . . . . 0.29999999999999999 109.892 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.7 Cg_exo -72.64 163.47 38.41 Favored 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.325 4.017 . . . . 0.16 114.36 -175.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.718 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.41 152.65 85.74 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 113.23 -1.804 . . . . 0.12 110.271 173.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.53 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.28 -49.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.326 -0.634 0 C-N-CA 124.909 3.74 . . . . 0.089999999999999997 113.634 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.72 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.71 123.03 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.586 0.958 . . . . 0.089999999999999997 113.586 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.05 -122.76 1.1 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.225 -1.352 . . . . 0.11 111.575 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 381' ' ' VAL . 11.7 p -129.12 107.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.117 0.96 . . . . 0.89000000000000001 109.301 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.789 ' HB2' HG22 ' A' ' 463' ' ' VAL . 98.9 m-85 -110.59 161.95 15.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.154 -0.93 . . . . 0.16 109.945 -170.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.0 m-85 -148.21 135.68 20.59 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 121.234 -0.186 . . . . 0.68999999999999995 111.13 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.607 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.08 125.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.585 0.707 . . . . 0.14000000000000001 110.891 177.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -109.68 2.4 20.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.21 -0.905 . . . . 0.19 111.745 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.752 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.2 t30 -165.17 146.71 7.62 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.355 -0.839 . . . . 0.40999999999999998 110.805 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -107.24 109.8 21.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.179 -0.919 . . . . 1.0900000000000001 109.224 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.575 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -107.74 119.66 40.06 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 122.589 1.185 . . . . 0.38 111.447 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 19.2 mt-10 -115.96 142.15 47.17 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.966 -1.47 . . . . 1.96 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 35.2 t70 55.86 26.87 10.18 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 111.21 -2.723 . . . . 0.40000000000000002 107.656 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 169.64 15.37 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 112.753 -2.021 . . . . 0.16 112.404 -166.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 60.8 m -125.07 102.96 7.75 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 112.866 -1.97 . . . . 0.27000000000000002 109.532 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 9.0 mp -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-N 113.176 -1.829 . . . . 0.23999999999999999 109.76 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.432 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 9.9 mtpt . . . . . 0 N--CA 1.4 -2.928 0 N-CA-C 107.814 -1.18 . . . . 0.67000000000000004 107.814 -174.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.9 mt-10 . . . . . 0 CA--C 1.506 -0.735 0 CA-C-O 122.205 1.002 . . . . 0.62 111.388 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.695 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.3 m -142.72 98.05 5.86 Favored Pre-proline 0 N--CA 1.42 -1.959 0 CA-C-N 113.36 -1.745 . . . . 1.3300000000000001 109.478 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.2 Cg_endo -66.89 108.28 1.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 124.648 3.565 . . . . 0.20000000000000001 113.22 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -118.62 161.11 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.495 -1.23 . . . . 0.29999999999999999 110.003 -175.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.2 OUTLIER -100.23 -40.3 7.62 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.394 -1.336 . . . . 1.8400000000000001 107.394 169.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.534 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 10.2 m-30 -125.94 113.47 17.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.395 -1.275 . . . . 0.44 110.439 -175.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.724 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.4 t-105 -123.28 135.92 54.46 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.747 -1.57 . . . . 0.13 110.1 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.508 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.5 OUTLIER -135.96 85.02 29.85 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-N 114.859 -1.064 . . . . 0.40999999999999998 111.092 174.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.69 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.8 Cg_endo -70.68 140.47 39.28 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.025 2.484 . . . . 0.16 111.63 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.6 pt -123.53 -16.33 5.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.085 -1.416 . . . . 0.17000000000000001 111.154 -172.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.58 169.75 16.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.093 -0.958 . . . . 1.5900000000000001 108.945 177.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.2 14.19 32.76 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.489 0.922 . . . . 0.31 113.489 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . 0.479 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 23.3 p -98.16 -28.36 13.76 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.906 -1.146 . . . . 0.44 107.906 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.6 31.17 0.31 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 114.037 -1.438 . . . . 0.23999999999999999 113.148 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 441' ' ' GLY . 72.9 t -102.75 149.4 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.383 0.611 . . . . 0.17000000000000001 111.515 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.77 -166.04 37.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.911 -1.041 . . . . 0.10000000000000001 111.57 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.7 138.45 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.936 -0.764 . . . . 0.12 108.936 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.746 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.4 p80 -151.86 171.46 17.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.093 0.949 . . . . 0.14999999999999999 111.712 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.739 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -92.44 149.56 21.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.122 -1.854 . . . . 0.41999999999999998 108.322 174.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 4.8 p -133.8 101.75 5.2 Favored 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 123.137 1.446 . . . . 1.48 110.376 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -95.8 -32.0 12.91 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 112.139 -2.3 . . . . 0.34999999999999998 110.846 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.628 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 15.5 p90 -71.67 -26.76 62.66 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 114.73 -1.123 . . . . 0.17999999999999999 108.972 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.536 ' HG2' ' HB3' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -111.05 95.5 25.11 Favored Pre-proline 0 CA--C 1.489 -1.365 0 CA-C-N 113.469 -1.696 . . . . 1.3300000000000001 108.923 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 426' ' ' GLN . 17.7 Cg_endo -85.12 2.4 7.92 Favored 'Trans proline' 0 N--CA 1.415 -3.122 0 C-N-CA 122.808 2.338 . . . . 0.23000000000000001 113.418 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.1 148.69 36.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.041 -1.064 . . . . 1.1000000000000001 110.162 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.673 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.0 OUTLIER -162.93 124.78 2.56 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.733 1.271 . . . . 0.38 108.225 -173.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.02 -166.04 28.47 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 119.389 -1.386 . . . . 0.13 111.241 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.62 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.52 149.58 0.01 OUTLIER Glycine 0 C--N 1.342 0.883 0 O-C-N 125.17 1.159 . . . . 0.20000000000000001 112.907 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.403 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 1.8 m-20 -54.97 101.6 0.05 Allowed 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 112.112 -145.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.4 mt -97.35 -32.14 12.03 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 110.498 -3.046 . . . . 0.17999999999999999 108.302 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.57 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.32 -37.79 5.17 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.745 0.653 . . . . 0.22 111.465 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.814 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.9 mttt -60.47 -26.57 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 114.822 -1.081 . . . . 0.64000000000000001 112.758 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.9 p -112.73 -37.89 4.74 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.717 0.77 . . . . 0.25 110.083 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.46 ' HD3' HE22 ' A' ' 426' ' ' GLN . 7.3 mtp85 -82.74 -14.76 53.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.6 -1.182 . . . . 0.35999999999999999 112.616 -168.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.63 40.7 37.48 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 116.069 1.187 . . . . 0.20999999999999999 116.069 159.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.2 m -79.86 140.87 36.61 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 117.809 0.804 . . . . 0.46999999999999997 109.52 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -106.29 68.54 0.76 Allowed 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.881 -0.512 . . . . 0.40999999999999998 110.392 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.643 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 84.63 -8.13 70.31 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.069 -0.813 . . . . 0.17999999999999999 111.069 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.487 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 26.3 p -94.92 135.09 36.86 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.393 0.616 . . . . 0.82999999999999996 110.715 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.718 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -96.42 113.74 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.254 -0.885 . . . . 0.14999999999999999 110.343 -174.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.536 ' HB3' ' HG2' ' A' ' 426' ' ' GLN . 18.9 m-80 -83.45 93.04 7.71 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.835 -1.075 . . . . 1.77 111.881 -175.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.697 HG23 HG21 ' A' ' 366' ' ' THR . 53.4 m -91.36 136.68 26.68 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.35 -0.841 . . . . 0.17999999999999999 109.604 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.2 Cg_exo -52.99 135.55 58.91 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.524 2.15 . . . . 0.12 111.214 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.739 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 49.0 Cg_exo -55.28 -31.38 76.37 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.055 3.17 . . . . 0.16 112.547 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.3 m -79.75 -38.3 33.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.286 -1.324 . . . . 1.1699999999999999 109.943 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.597 HG11 ' HB ' ' A' ' 366' ' ' THR . 86.5 t -78.55 -29.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.643 -0.708 . . . . 0.17000000000000001 111.539 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.617 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.3 tpt -66.34 -20.9 66.21 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.598 0.713 . . . . 0.46000000000000002 110.179 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -76.27 -25.27 54.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.827 -1.079 . . . . 0.81000000000000005 111.628 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -79.21 -46.66 17.43 Favored 'General case' 0 CA--C 1.473 -2.003 0 CA-C-N 113.129 -1.85 . . . . 0.38 107.092 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.546 HD23 ' SD ' ' A' ' 450' ' ' MET . 24.3 tp -66.06 -67.42 0.45 Allowed 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 111.72 -2.491 . . . . 0.059999999999999998 112.43 175.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 409' ' ' TYR . 28.7 t80 -48.94 -26.88 2.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.806 1.289 . . . . 0.31 108.344 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.54 -30.35 64.46 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.601 -2.09 . . . . 0.13 112.555 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.687 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -88.75 -48.5 7.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.65 0.738 . . . . 0.13 111.513 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.653 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.4 OUTLIER -101.03 138.3 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 123.105 1.431 . . . . 0.23000000000000001 113.902 -168.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -136.5 -178.94 5.39 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 111.284 -2.689 . . . . 0.82999999999999996 107.397 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.752 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.1 mtmt -52.79 157.73 1.56 Allowed 'General case' 0 N--CA 1.413 -2.286 0 CA-C-O 122.82 1.295 . . . . 0.23999999999999999 114.009 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.1 18.01 70.53 Favored Glycine 0 C--N 1.281 -2.492 0 CA-C-N 112.659 -2.064 . . . . 0.37 113.699 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 462' ' ' PRO . 9.5 m -103.85 141.68 23.02 Favored Pre-proline 0 N--CA 1.427 -1.585 0 N-CA-C 107.664 -1.235 . . . . 0.14999999999999999 107.664 165.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.646 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.3 Cg_exo -74.74 164.62 33.27 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.648 1.565 . . . . 0.12 110.73 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -134.73 154.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 107.271 -1.381 . . . . 1.0900000000000001 107.271 166.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.3 tp -126.59 145.15 50.65 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 0.13 110.195 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.04 147.44 20.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.291 -1.374 . . . . 0.089999999999999997 107.291 165.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.593 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 17.3 p90 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.535 -0.745 . . . . 1.1599999999999999 110.846 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.62 HG23 ' HA ' ' A' ' 358' ' ' LYS . 98.9 m . . . . . 0 N--CA 1.428 -1.565 0 N-CA-C 106.841 -1.54 . . . . 0.45000000000000001 106.841 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.666 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.9 p90 -158.4 -171.05 3.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.388 -0.824 . . . . 0.32000000000000001 111.322 -170.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.1 mm -103.24 156.47 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.935 -1.135 . . . . 0.080000000000000002 107.935 165.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.484 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.5 tt0 -137.22 155.02 50.02 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.596 0.634 . . . . 0.17000000000000001 110.633 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.649 HG22 ' HG3' ' A' ' 354' ' ' MET . 55.7 t -150.41 136.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.775 -1.102 . . . . 0.080000000000000002 110.0 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.04 118.94 34.3 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.553 -1.203 . . . . 0.37 108.074 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.479 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -71.17 -49.3 45.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.419 1.104 . . . . 0.32000000000000001 110.511 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -54.85 -53.56 53.77 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 112.996 -1.911 . . . . 1.51 112.308 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -98.09 10.65 39.94 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.543 -1.208 . . . . 0.91000000000000003 108.738 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.867 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.2 mm-40 38.14 71.76 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 125.088 1.493 . . . . 2.2200000000000002 111.856 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -151.63 124.11 8.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.685 -0.689 . . . . 0.13 109.872 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.649 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -110.87 128.01 55.64 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.379 0.609 . . . . 0.059999999999999998 110.484 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.671 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.9 m-90 -111.37 173.39 6.36 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.612 -1.176 . . . . 0.10000000000000001 111.895 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.723 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -126.84 116.34 20.72 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.194 -1.78 . . . . 0.22 106.194 165.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 362' ' ' VAL . 21.5 m-85 -100.07 129.63 46.13 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.927 0.87 . . . . 0.17999999999999999 111.534 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.634 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 5.1 ttpt -149.12 139.2 22.14 Favored 'General case' 0 N--CA 1.398 -3.053 0 CA-C-N 113.633 -1.621 . . . . 0.46999999999999997 107.66 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 72.64 11.68 5.5 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.064 -1.425 . . . . 0.59999999999999998 108.908 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.84 13.99 73.78 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 112.747 -2.024 . . . . 0.23000000000000001 111.753 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.631 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.75 172.75 12.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.705 -1.961 . . . . 0.68000000000000005 105.705 -171.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.0 m -102.68 139.27 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.864 0 CA-C-O 124.364 2.031 . . . . 0.53000000000000003 112.358 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.723 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.38 -25.32 17.74 Favored 'General case' 0 N--CA 1.396 -3.166 0 CA-C-N 109.206 -3.634 . . . . 0.12 108.498 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.698 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.32 155.18 37.16 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.695 -1.593 . . . . 0.080000000000000002 109.102 -172.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.802 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.19 122.54 1.3 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.718 -0.673 . . . . 0.60999999999999999 109.543 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.678 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.6 t -147.35 166.81 26.01 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.866 0.841 . . . . 0.089999999999999997 111.744 173.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.495 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 1.6 m-20 -82.68 146.0 29.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.592 -1.633 . . . . 1.8799999999999999 106.592 174.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.17 -172.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.506 -0.77 . . . . 0.11 111.245 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.867 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -154.01 118.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.931 -1.031 . . . . 0.12 108.973 174.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.445 ' HB2' HG13 ' A' ' 443' ' ' ILE . 6.9 t -143.02 142.84 31.68 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.164 -0.925 . . . . 0.69999999999999996 113.395 -166.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.86 47.56 24.98 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.941 1.536 . . . . 0.13 116.941 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 17.5 ptmt -44.56 148.1 0.95 Allowed Pre-proline 0 C--O 1.222 -0.39 0 CA-C-N 118.521 1.16 . . . . 0.47999999999999998 111.372 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.807 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -37.2 -31.18 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.053 1 C-N-CA 125.522 4.148 . . . . 0.23000000000000001 115.268 -177.664 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.497 HG23 ' HE2' ' A' ' 372' ' ' LYS . 4.0 p -82.68 -36.28 26.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.327 0.584 . . . . 0.29999999999999999 110.776 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.442 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 8.9 m -140.74 73.94 27.72 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 122.067 0.937 . . . . 0.29999999999999999 110.238 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.713 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 36.9 Cg_exo -69.3 161.62 45.14 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 125.061 3.841 . . . . 0.16 114.073 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.675 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -71.35 151.62 94.22 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 113.35 -1.75 . . . . 0.12 110.91 175.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.535 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.01 -49.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.997 3.798 . . . . 0.089999999999999997 113.443 -171.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.706 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.59 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.155 0.979 . . . . 0.089999999999999997 113.552 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.02 -128.67 1.8 Allowed Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 113.997 -1.456 . . . . 0.11 111.13 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 97.7 t -128.19 99.89 5.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.424 -0.954 . . . . 0.89000000000000001 108.424 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 413' ' ' ILE . 50.4 m-85 -104.58 169.87 8.21 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.39 -0.823 . . . . 0.16 109.124 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.736 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.6 m-85 -149.23 139.54 22.32 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 110.413 -0.217 . . . . 0.68999999999999995 110.413 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.594 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -74.55 120.69 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 119.903 -0.719 . . . . 0.14000000000000001 110.397 176.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . 0.404 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 40.8 p-90 -109.21 4.41 22.81 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.391 -0.822 . . . . 0.19 112.159 -176.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.735 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 5.1 t30 -165.11 148.16 8.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.227 -0.897 . . . . 0.40999999999999998 110.009 175.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.445 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 14.8 mtpt -109.62 110.69 21.82 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.423 -0.808 . . . . 1.0900000000000001 109.866 170.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -109.08 120.82 43.69 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.561 1.172 . . . . 0.38 110.763 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.04 142.97 46.28 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.225 -1.352 . . . . 1.96 109.784 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 36.3 t70 54.19 26.34 6.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 111.782 -2.463 . . . . 0.40000000000000002 108.63 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.29 170.74 14.3 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.079 -1.873 . . . . 0.16 112.247 -167.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 22.4 m -128.5 102.88 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.568 -1.651 . . . . 0.27000000000000002 109.733 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.749 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.76 157.84 36.73 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 112.865 -1.971 . . . . 0.23999999999999999 110.459 176.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.494 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.8 mtpt . . . . . 0 N--CA 1.392 -3.369 0 CA-C-N 114.5 -1.227 . . . . 0.67000000000000004 108.082 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 9.4 mt-10 . . . . . 0 CA--C 1.512 -0.516 0 CA-C-O 122.302 1.048 . . . . 0.62 111.706 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.749 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.47 98.66 12.25 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 113.199 -1.819 . . . . 1.3300000000000001 108.273 178.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 59.5 Cg_endo -66.97 101.76 0.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.442 2.095 . . . . 0.20000000000000001 110.28 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.43 163.55 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.852 0 CA-C-N 114.239 -1.346 . . . . 0.29999999999999999 109.83 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -114.99 -33.82 5.28 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.474 -1.694 . . . . 1.8400000000000001 106.808 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.407 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.8 m-85 -136.09 116.25 13.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.796 -2.002 . . . . 0.44 110.681 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.746 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.33 134.72 54.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.665 -1.152 . . . . 0.13 110.102 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.594 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.6 OUTLIER -136.28 86.24 25.17 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.905 -1.043 . . . . 0.40999999999999998 110.937 174.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 79.9 Cg_endo -72.11 141.61 36.57 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.892 2.395 . . . . 0.16 111.655 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.09 -16.2 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.537 -1.21 . . . . 0.17000000000000001 111.936 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.761 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.7 p30 -136.1 171.12 14.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 1.5900000000000001 110.222 170.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -99.18 15.9 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.76 -0.655 . . . . 0.31 111.467 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 1.8 p -97.03 -26.88 14.85 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.089 -1.078 . . . . 0.44 108.089 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 130.15 27.62 0.76 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.904 -1.498 . . . . 0.23999999999999999 113.677 169.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.761 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 49.2 t -104.43 149.78 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.43 0.633 . . . . 0.17000000000000001 112.463 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . -178.96 -164.32 31.5 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.966 -1.016 . . . . 0.10000000000000001 111.942 174.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.47 139.55 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.54 -0.911 . . . . 0.12 108.54 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.553 ' HB2' HG21 ' A' ' 407' ' ' VAL . 31.7 p80 -150.02 164.16 36.25 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.637 0.732 . . . . 0.14999999999999999 111.457 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.774 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.07 138.79 31.33 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.203 -1.362 . . . . 0.41999999999999998 107.474 172.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.631 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 4.8 t -133.13 104.67 6.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.326 1.536 . . . . 1.48 110.667 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.32 -28.83 15.97 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 111.43 -2.623 . . . . 0.34999999999999998 110.83 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.568 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.7 p90 -72.01 -27.23 62.59 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.471 -1.24 . . . . 0.17999999999999999 109.728 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.631 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -118.01 81.18 15.71 Favored Pre-proline 0 CA--C 1.496 -1.106 0 CA-C-N 114.276 -1.329 . . . . 1.3300000000000001 110.015 -176.067 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 14.9 Cg_endo -84.34 8.59 4.54 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 C-N-CA 125.122 3.881 . . . . 0.23000000000000001 114.313 -163.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -114.89 150.52 35.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.177 -0.675 . . . . 1.1000000000000001 109.177 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.495 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -159.61 125.52 4.28 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.629 1.172 . . . . 0.38 108.285 -171.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 148.3 -166.97 29.05 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.353 -1.403 . . . . 0.13 111.305 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.85 154.44 0.0 OUTLIER Glycine 0 C--N 1.341 0.818 0 O-C-N 125.151 1.148 . . . . 0.20000000000000001 113.2 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 2.9 m-20 -55.28 101.42 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.806 1.765 . . . . 0.33000000000000002 112.17 -146.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.0 mt -97.03 -31.35 12.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 110.53 -3.032 . . . . 0.17999999999999999 109.39 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.499 ' HA ' HG23 ' A' ' 369' ' ' VAL . 14.2 p-90 -50.13 -30.87 12.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.96 -1.927 . . . . 0.22 111.844 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.807 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 44.9 mttt -66.65 -22.12 66.1 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.919 -1.037 . . . . 0.64000000000000001 112.872 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.8 p -117.43 -38.72 3.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.855 0.836 . . . . 0.25 110.049 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.474 ' HD2' HD22 ' A' ' 433' ' ' LEU . 10.0 mtp85 -80.3 -15.32 57.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.48 -1.236 . . . . 0.35999999999999999 111.952 -171.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 71.84 40.58 57.61 Favored Glycine 0 C--N 1.311 -0.821 0 N-CA-C 115.697 1.039 . . . . 0.20999999999999999 115.697 159.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 1.4 m -80.01 130.84 35.58 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 108.85 -0.796 . . . . 0.46999999999999997 108.85 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -99.97 65.64 1.3 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.314 -0.866 . . . . 0.40999999999999998 111.562 -169.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 377' ' ' THR . . . 94.92 -18.77 56.65 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 111.09 -0.804 . . . . 0.17999999999999999 111.09 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.514 ' C ' HD12 ' A' ' 443' ' ' ILE . 37.1 m -90.36 159.17 16.75 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.951 -0.7 . . . . 0.82999999999999996 111.214 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.675 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -107.64 120.29 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.522 -0.763 . . . . 0.14999999999999999 110.578 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.51 ' HB2' HG13 ' A' ' 369' ' ' VAL . 25.2 m-80 -83.74 91.93 7.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.686 -0.688 . . . . 1.77 111.588 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.6 HG23 HG21 ' A' ' 366' ' ' THR . 37.3 m -90.0 136.86 28.51 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-O 121.393 0.615 . . . . 0.17999999999999999 109.489 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -57.15 132.12 49.36 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.842 2.361 . . . . 0.12 112.862 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.774 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.5 Cg_exo -50.51 -40.47 54.36 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 123.489 2.793 . . . . 0.16 112.39 -169.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.1 p -73.44 -40.44 64.21 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.806 -1.088 . . . . 1.1699999999999999 110.113 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.678 HG11 ' HB ' ' A' ' 366' ' ' THR . 67.3 t -77.05 -29.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.382 0.61 . . . . 0.17000000000000001 111.303 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.674 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.0 tpt -67.85 -19.67 65.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.748 0.785 . . . . 0.46000000000000002 109.958 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -79.4 -22.66 44.0 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.63 -1.168 . . . . 0.81000000000000005 110.918 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.54 -47.73 13.8 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 112.922 -1.945 . . . . 0.38 107.329 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.61 HD23 ' SD ' ' A' ' 450' ' ' MET . 27.1 tp -63.66 -66.91 0.48 Allowed 'General case' 0 N--CA 1.403 -2.799 0 CA-C-N 111.83 -2.441 . . . . 0.059999999999999998 112.241 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.458 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 35.5 t80 -50.15 -26.55 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.962 1.363 . . . . 0.31 108.167 176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.01 -28.19 69.0 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 112.592 -2.095 . . . . 0.13 112.347 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.698 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -91.71 -47.96 7.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.666 0.746 . . . . 0.13 111.768 171.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.644 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.5 OUTLIER -101.5 138.36 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 123.457 1.599 . . . . 0.23000000000000001 113.892 -168.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.445 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.7 pt-20 -136.83 -178.69 5.3 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 110.813 -2.903 . . . . 0.82999999999999996 106.503 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.735 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.7 mtmt -51.69 162.48 0.4 Allowed 'General case' 0 N--CA 1.413 -2.321 0 CA-C-O 123.12 1.438 . . . . 0.23999999999999999 113.179 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.38 -33.64 4.66 Favored Glycine 0 N--CA 1.424 -2.141 0 CA-C-N 112.441 -2.163 . . . . 0.37 112.284 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 462' ' ' PRO . 10.6 m -73.96 140.78 77.62 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-O 121.119 0.485 . . . . 0.14999999999999999 109.822 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.666 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.44 162.96 38.9 Favored 'Trans proline' 0 N--CA 1.432 -2.132 0 C-N-CA 122.265 1.977 . . . . 0.12 111.142 174.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.5 t -132.95 131.96 59.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 CA-C-N 113.757 -1.565 . . . . 1.0900000000000001 108.169 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 2.9 tp -112.03 143.04 43.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.989 -0.551 . . . . 0.13 110.331 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.16 148.08 19.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.126 -1.435 . . . . 0.089999999999999997 107.126 165.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.595 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.7 p90 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.301 -0.857 . . . . 1.1599999999999999 111.27 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.563 HG23 ' HA ' ' A' ' 358' ' ' LYS . 88.9 m . . . . . 0 N--CA 1.428 -1.571 0 CA-C-O 121.595 0.712 . . . . 0.45000000000000001 109.801 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.633 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 5.0 p90 -160.94 -169.31 2.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.119 -1.4 . . . . 0.32000000000000001 110.584 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 453' ' ' LEU . 10.7 mm -101.39 162.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.204 -1.036 . . . . 0.080000000000000002 108.204 165.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.5 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -143.67 156.31 44.5 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 119.063 0.847 . . . . 0.17000000000000001 111.729 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.673 HG22 ' HG3' ' A' ' 354' ' ' MET . 77.8 t -150.71 137.44 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.741 -1.118 . . . . 0.080000000000000002 110.115 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.401 ' HB2' ' HZ3' ' A' ' 355' ' ' TRP . 7.4 t0 -124.61 106.51 10.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.175 0.988 . . . . 0.37 108.52 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.443 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -64.73 -42.13 95.45 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 112.772 -2.013 . . . . 0.32000000000000001 111.602 -168.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.46 -57.58 11.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.412 -2.176 . . . . 1.51 112.892 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -92.79 1.44 57.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 114.838 -1.074 . . . . 0.91000000000000003 109.924 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.856 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.0 mm-40 48.73 63.75 1.98 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 112.624 -2.08 . . . . 2.2200000000000002 111.565 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.457 ' CD2' ' CE2' ' A' ' 355' ' ' TRP . 6.8 t60 -143.41 128.63 18.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.803 -0.635 . . . . 0.13 109.716 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.673 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.7 ttp -115.28 128.6 56.23 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.438 0.695 . . . . 0.059999999999999998 110.444 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.676 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.5 m-90 -112.82 173.43 6.38 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.755 -1.111 . . . . 0.10000000000000001 111.598 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.588 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -125.08 112.9 17.05 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 105.577 -2.008 . . . . 0.22 105.577 163.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 18.1 m-85 -92.98 124.85 37.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.457 -0.897 . . . . 0.17999999999999999 111.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.563 ' HA ' HG23 ' A' ' 343' ' ' THR . 37.4 ttmt -140.17 142.52 35.93 Favored 'General case' 0 N--CA 1.386 -3.634 0 CA-C-N 114.031 -1.441 . . . . 0.46999999999999997 108.771 173.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.423 ' N ' ' HG2' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 66.0 16.35 10.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.742 -1.572 . . . . 0.59999999999999998 108.849 175.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.02 72.49 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 112.167 -2.288 . . . . 0.23000000000000001 111.968 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.606 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 4.9 tppt? -138.83 179.21 6.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.435 -2.061 . . . . 0.68000000000000005 105.435 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.676 HG11 ' CD1' ' A' ' 355' ' ' TRP . 2.8 m -106.65 135.6 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.72 0 CA-C-O 124.197 1.951 . . . . 0.53000000000000003 112.394 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -87.84 -26.06 23.0 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 109.351 -3.568 . . . . 0.12 107.985 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.72 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 4.0 tp -153.15 156.0 37.79 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.181 -1.372 . . . . 0.080000000000000002 109.777 -173.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 2.2 pt-20 -162.6 121.99 2.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.84 -0.618 . . . . 0.60999999999999999 110.706 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.688 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.3 t -149.13 166.78 27.75 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 122.501 1.143 . . . . 0.089999999999999997 113.196 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.685 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.6 p-10 -84.36 140.02 31.87 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.712 -2.04 . . . . 1.8799999999999999 108.182 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.96 -171.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.161 -0.927 . . . . 0.11 111.843 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.856 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -153.74 121.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.794 -1.094 . . . . 0.12 108.849 174.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 443' ' ' ILE . 7.0 t -144.57 143.01 30.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.917 1.08 . . . . 0.69999999999999996 113.917 -167.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.47 45.93 35.02 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 116.845 1.498 . . . . 0.13 116.845 162.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.584 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.46 144.1 4.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 118.636 1.218 . . . . 0.47999999999999998 110.917 -174.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.803 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.34 -32.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -0.979 1 C-N-CA 125.709 4.273 . . . . 0.23000000000000001 116.183 -170.8 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.584 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.8 p -79.92 -35.42 37.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.095 0.474 . . . . 0.29999999999999999 111.161 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.456 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 m -140.31 74.63 29.21 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 122.431 1.11 . . . . 0.29999999999999999 110.003 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.5 Cg_exo -69.79 160.42 49.75 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.044 3.83 . . . . 0.16 113.365 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.692 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -69.79 150.36 96.56 Favored Pre-proline 0 N--CA 1.434 -1.255 0 CA-C-N 113.55 -1.659 . . . . 0.12 110.92 177.259 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.507 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.0 OUTLIER -77.14 -48.78 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.893 3.729 . . . . 0.089999999999999997 112.98 -170.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.871 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 67.13 122.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.626 0.973 . . . . 0.089999999999999997 113.626 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.7 -126.62 1.5 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.457 -1.247 . . . . 0.11 111.382 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -126.01 104.12 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 122.516 1.15 . . . . 0.89000000000000001 109.328 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.796 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.2 m-85 -107.33 162.16 14.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.904 -1.044 . . . . 0.16 110.014 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.8 m-85 -147.91 137.51 22.45 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 121.252 -0.179 . . . . 0.68999999999999995 110.789 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.63 124.97 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 119.993 -0.683 . . . . 0.14000000000000001 110.296 177.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -109.55 3.99 21.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.491 -0.777 . . . . 0.19 111.929 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.721 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.6 t30 -165.13 149.34 8.78 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.485 -0.779 . . . . 0.40999999999999998 111.083 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.482 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.8 mtpt -107.46 110.74 22.77 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.411 -0.813 . . . . 1.0900000000000001 109.685 169.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -112.08 123.17 49.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.654 1.216 . . . . 0.38 111.067 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.76 143.48 47.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.139 -1.391 . . . . 1.96 110.035 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 35.4 t70 54.24 25.99 6.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 111.894 -2.412 . . . . 0.40000000000000002 108.667 -174.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.482 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 167.13 17.8 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.205 -1.816 . . . . 0.16 112.163 -167.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 107.84 12.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.774 -1.557 . . . . 0.27000000000000002 110.131 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.9 mp -75.85 156.7 34.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 112.834 -1.985 . . . . 0.23999999999999999 110.448 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.506 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 11.8 mtpt . . . . . 0 N--CA 1.401 -2.916 0 CA-C-N 114.651 -1.159 . . . . 0.67000000000000004 108.016 -176.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 15.0 mt-10 . . . . . 0 CA--C 1.509 -0.625 0 CA-C-O 122.052 0.929 . . . . 0.62 111.058 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.696 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.0 m -142.28 98.3 6.08 Favored Pre-proline 0 N--CA 1.421 -1.879 0 CA-C-N 113.678 -1.601 . . . . 1.3300000000000001 109.222 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.9 Cg_endo -67.97 106.19 1.29 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 124.342 3.362 . . . . 0.20000000000000001 112.644 -177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.808 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -114.61 163.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 114.534 -1.212 . . . . 0.29999999999999999 110.56 -175.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -111.76 -34.04 6.15 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.403 -1.726 . . . . 1.8400000000000001 106.943 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.4 m-85 -133.86 115.99 15.12 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.726 -2.034 . . . . 0.44 110.639 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.777 ' HB2' HG11 ' A' ' 407' ' ' VAL . 5.1 t-105 -123.86 135.29 53.65 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.4 -1.273 . . . . 0.13 110.355 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.563 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.53 84.81 26.99 Favored Pre-proline 0 N--CA 1.427 -1.579 0 CA-C-N 115.007 -0.997 . . . . 0.40999999999999998 110.943 172.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 72.2 Cg_endo -70.84 141.07 39.97 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.06 2.507 . . . . 0.16 112.258 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -123.8 -16.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.009 -1.45 . . . . 0.17000000000000001 111.063 -173.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -135.46 162.7 31.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.277 -0.874 . . . . 1.5900000000000001 109.312 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -93.78 13.32 22.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.236 0.458 . . . . 0.31 112.236 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -91.36 -26.57 18.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.396 -1.335 . . . . 0.44 107.396 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.93 29.55 1.13 Allowed Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 112.976 -1.92 . . . . 0.23999999999999999 112.326 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 441' ' ' GLY . 89.5 t -102.55 147.9 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.297 0.57 . . . . 0.17000000000000001 110.93 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.37 -166.11 37.91 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.734 -1.121 . . . . 0.10000000000000001 111.306 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.402 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.54 138.42 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.698 -0.853 . . . . 0.12 108.698 175.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.808 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.1 p80 -151.24 164.9 35.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.725 0.774 . . . . 0.14999999999999999 112.076 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.779 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 146.05 24.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.074 -1.421 . . . . 0.41999999999999998 107.858 173.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.415 ' CB ' HD22 ' A' ' 444' ' ' ASN . 0.4 OUTLIER -140.07 102.85 4.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 123.06 1.409 . . . . 1.48 110.998 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -93.16 -26.97 17.17 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 111.752 -2.476 . . . . 0.34999999999999998 109.742 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 5.7 p90 -70.27 -26.14 63.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.312 -1.313 . . . . 0.17999999999999999 109.714 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.403 ' HG3' ' NE1' ' A' ' 425' ' ' TRP . 0.0 OUTLIER -119.8 80.7 25.09 Favored Pre-proline 0 CA--C 1.492 -1.286 0 CA-C-N 113.829 -1.532 . . . . 1.3300000000000001 109.315 -176.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 27.7 Cg_endo -81.08 5.53 6.17 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 125.089 3.86 . . . . 0.23000000000000001 114.015 -162.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -115.67 149.73 37.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.739 -0.664 . . . . 1.1000000000000001 109.411 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.685 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -160.99 125.57 3.57 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 124.587 1.18 . . . . 0.38 108.179 -173.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.88 -166.92 28.83 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 119.484 -1.341 . . . . 0.13 110.899 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.595 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 154.1 0.0 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.931 1.018 . . . . 0.20000000000000001 113.159 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.404 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -55.72 101.33 0.05 Allowed 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 123.924 1.821 . . . . 0.33000000000000002 112.289 -146.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.7 mt -97.33 -32.03 12.1 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 110.228 -3.169 . . . . 0.17999999999999999 108.222 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.558 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.4 p-90 -45.82 -38.84 7.67 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 124.067 0.854 . . . . 0.22 111.49 -174.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.803 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.5 mttt -60.05 -26.12 65.9 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.006 -0.997 . . . . 0.64000000000000001 112.821 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.9 p -111.93 -36.11 5.49 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.701 0.762 . . . . 0.25 110.033 -176.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.481 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 6.8 mtp85 -84.54 -15.94 44.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.689 -1.141 . . . . 0.35999999999999999 112.642 -169.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.05 40.39 30.03 Favored Glycine 0 C--N 1.313 -0.714 0 N-CA-C 116.089 1.196 . . . . 0.20999999999999999 116.089 159.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 372' ' ' LYS . 1.0 OUTLIER -79.63 131.6 36.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 117.782 0.791 . . . . 0.46999999999999997 109.545 176.006 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 63.3 m80 -100.7 68.3 1.31 Allowed 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.643 -0.661 . . . . 0.40999999999999998 110.306 -172.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 88.7 -11.8 67.49 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.924 -0.87 . . . . 0.17999999999999999 110.924 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.461 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 27.2 p -90.79 142.82 27.36 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.361 -0.42 . . . . 0.82999999999999996 110.8 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.692 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -101.43 114.55 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.752 -0.658 . . . . 0.14999999999999999 110.362 -176.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.597 ' HB2' HG13 ' A' ' 369' ' ' VAL . 18.7 m120 -78.81 90.38 4.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.842 -0.617 . . . . 1.77 111.098 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.9 m -86.63 137.34 34.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 109.132 -0.692 . . . . 0.17999999999999999 109.132 174.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.5 Cg_exo -54.86 135.79 69.44 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.747 2.298 . . . . 0.12 111.337 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.779 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.4 Cg_exo -55.34 -32.16 80.17 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 C-N-CA 124.225 3.283 . . . . 0.16 112.825 -173.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.23 -38.79 26.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.441 -1.254 . . . . 1.1699999999999999 110.09 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.688 HG11 ' HB ' ' A' ' 366' ' ' THR . 60.2 t -80.77 -29.41 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.17000000000000001 111.376 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.681 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.4 tpt -65.93 -19.91 66.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.781 0.8 . . . . 0.46000000000000002 109.985 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -79.36 -24.97 42.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.522 -1.217 . . . . 0.81000000000000005 111.239 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.694 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -79.15 -46.3 18.24 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 113.127 -1.851 . . . . 0.38 107.111 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.576 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.7 tp -64.43 -67.17 0.45 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.663 -2.517 . . . . 0.059999999999999998 112.169 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.424 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.2 t80 -49.62 -27.73 4.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 123.127 1.442 . . . . 0.31 108.304 177.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.2 -31.3 69.08 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 112.37 -2.195 . . . . 0.13 112.237 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.72 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.5 ptp -88.17 -48.43 7.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.729 0.776 . . . . 0.13 111.501 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.588 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.7 OUTLIER -102.09 138.16 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 123.582 1.658 . . . . 0.23000000000000001 114.005 -167.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.482 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.2 pt-20 -136.37 -178.28 5.09 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 110.705 -2.952 . . . . 0.82999999999999996 106.552 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.4 mtmt -52.71 162.56 0.57 Allowed 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.949 1.357 . . . . 0.23999999999999999 112.405 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.23 -30.56 6.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 112.685 -2.052 . . . . 0.37 112.383 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 462' ' ' PRO . 15.0 m -80.89 141.96 51.7 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.134 -0.691 . . . . 0.14999999999999999 109.134 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 4.5 Cg_exo -75.78 168.54 24.06 Favored 'Trans proline' 0 N--CA 1.425 -2.502 0 C-N-CA 121.681 1.587 . . . . 0.12 111.098 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.81 154.49 34.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.299 -1.371 . . . . 1.0900000000000001 107.299 166.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.0 tp -125.86 144.25 50.74 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.45 -0.796 . . . . 0.13 110.657 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.66 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.14 146.04 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 105.937 -1.875 . . . . 0.089999999999999997 105.937 163.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.871 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 8.6 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.089 -0.958 . . . . 1.1599999999999999 111.824 -175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 358' ' ' LYS . 9.1 m . . . . . 0 N--CA 1.425 -1.693 0 N-CA-C 106.688 -1.597 . . . . 0.45000000000000001 106.688 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.651 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.2 p90 -156.15 -171.59 3.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.485 0.659 . . . . 0.32000000000000001 110.852 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.584 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.8 mm -102.52 161.5 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.97 -1.122 . . . . 0.080000000000000002 107.97 167.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.4 tt0 -140.61 155.18 46.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 118.818 0.736 . . . . 0.17000000000000001 111.1 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.716 HG22 ' HG3' ' A' ' 354' ' ' MET . 64.4 t -150.81 135.8 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.539 -1.21 . . . . 0.080000000000000002 110.027 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -116.89 117.78 30.64 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.797 -1.092 . . . . 0.37 108.176 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.503 HD21 HG23 ' A' ' 465' ' ' VAL . 1.8 mm? -70.26 -48.2 57.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.51 1.148 . . . . 0.32000000000000001 110.487 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -54.89 -54.13 46.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 112.851 -1.977 . . . . 1.51 112.454 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -98.27 11.31 38.36 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.572 -1.195 . . . . 0.91000000000000003 108.637 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.861 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.1 mm-40 37.6 70.38 0.19 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 125.269 1.606 . . . . 2.2200000000000002 111.829 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -150.22 125.12 9.86 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.773 -0.649 . . . . 0.13 109.827 -175.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.716 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.9 ttp -111.93 127.61 55.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.471 0.653 . . . . 0.059999999999999998 110.451 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.681 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.84 173.72 6.24 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.528 -1.214 . . . . 0.10000000000000001 111.841 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.701 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.4 t80 -126.79 117.07 21.9 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 106.795 -1.557 . . . . 0.22 106.795 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.543 ' CE1' HG12 ' A' ' 362' ' ' VAL . 18.8 m-85 -100.77 124.84 46.98 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.128 0.966 . . . . 0.17999999999999999 112.33 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.672 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.0 ttpt -149.46 139.34 21.92 Favored 'General case' 0 N--CA 1.4 -2.939 0 CA-C-N 113.105 -1.861 . . . . 0.46999999999999997 107.992 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.475 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 70.95 16.46 6.5 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 113.768 -1.56 . . . . 0.59999999999999998 108.608 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.56 17.47 78.99 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.377 -2.192 . . . . 0.23000000000000001 111.715 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.597 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.2 OUTLIER -136.9 170.86 15.39 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.91 -1.885 . . . . 0.68000000000000005 105.91 -168.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.745 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.7 m -101.35 137.56 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.853 0 CA-C-O 124.157 1.932 . . . . 0.53000000000000003 111.72 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.701 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -23.84 19.0 Favored 'General case' 0 N--CA 1.399 -2.984 0 CA-C-N 109.392 -3.549 . . . . 0.12 108.529 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.681 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -154.07 154.82 34.33 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 113.511 -1.677 . . . . 0.080000000000000002 108.856 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.745 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.98 121.78 1.29 Allowed 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.766 -0.652 . . . . 0.60999999999999999 109.395 -175.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.654 HG21 HG23 ' A' ' 445' ' ' THR . 5.1 t -148.08 166.5 27.62 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.245 1.021 . . . . 0.089999999999999997 111.967 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.631 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.1 p-10 -85.37 140.36 30.83 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 113.025 -1.898 . . . . 1.8799999999999999 107.193 176.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.634 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -141.47 -171.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.154 -0.93 . . . . 0.11 111.888 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.861 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -157.73 119.38 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.136 -0.938 . . . . 0.12 109.792 175.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.6 t -143.15 145.98 33.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.977 -1.011 . . . . 0.69999999999999996 112.839 -166.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.04 46.09 37.95 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 117.178 1.631 . . . . 0.13 117.178 161.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.446 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.2 pttt -46.75 145.83 2.9 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.6 1.7 . . . . 0.47999999999999998 111.129 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.83 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -33.41 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.041 1 C-N-CA 125.543 4.162 . . . . 0.23000000000000001 115.609 -175.884 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.4 p -77.19 -39.27 49.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.267 0.555 . . . . 0.29999999999999999 110.917 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.47 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.9 m -140.56 72.92 30.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.245 1.021 . . . . 0.29999999999999999 110.434 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.7 Cg_exo -68.9 163.3 38.03 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 125.256 3.97 . . . . 0.16 114.118 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -74.76 151.23 86.73 Favored Pre-proline 0 N--CA 1.437 -1.092 0 CA-C-N 113.512 -1.676 . . . . 0.12 110.714 175.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.533 ' CD ' HG22 ' A' ' 377' ' ' THR . 0.9 OUTLIER -78.28 -50.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.83 3.686 . . . . 0.089999999999999997 113.724 -171.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.757 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.0 121.91 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.443 0.905 . . . . 0.089999999999999997 113.443 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.89 -124.48 1.26 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.268 -1.333 . . . . 0.11 111.46 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.7 p -126.28 108.88 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 122.137 0.97 . . . . 0.89000000000000001 109.372 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.784 ' HB2' HG22 ' A' ' 463' ' ' VAL . 94.0 m-85 -114.24 159.89 19.64 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.881 -1.054 . . . . 0.16 109.661 -170.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.719 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 70.0 m-85 -146.01 135.63 23.22 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 117.661 0.209 . . . . 0.68999999999999995 111.113 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.617 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.57 122.26 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.872 -0.731 . . . . 0.14000000000000001 110.46 176.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -108.93 3.16 21.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.43 -0.804 . . . . 0.19 112.026 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.765 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.6 t30 -164.08 149.57 10.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.181 -0.918 . . . . 0.40999999999999998 110.704 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -109.24 114.65 28.54 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.377 -0.829 . . . . 1.0900000000000001 109.386 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -113.12 120.39 41.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.724 1.25 . . . . 0.38 111.478 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.8 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 25.9 mt-10 -116.11 143.71 45.12 Favored 'General case' 0 N--CA 1.409 -2.475 0 CA-C-N 113.802 -1.544 . . . . 1.96 110.562 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 37.8 t70 55.98 27.3 11.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 111.196 -2.729 . . . . 0.40000000000000002 107.758 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.14 169.58 15.69 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 112.692 -2.049 . . . . 0.16 112.16 -167.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 16.1 m -128.72 102.45 6.58 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 113.12 -1.855 . . . . 0.27000000000000002 109.382 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.752 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.0 mp -71.97 156.3 39.39 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 112.789 -2.005 . . . . 0.23999999999999999 109.767 174.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.5 mtpt . . . . . 0 N--CA 1.395 -3.183 0 CA-C-N 114.647 -1.161 . . . . 0.67000000000000004 108.089 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.4 mt-10 . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 122.387 1.089 . . . . 0.62 112.208 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.752 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.69 99.43 8.49 Favored Pre-proline 0 N--CA 1.426 -1.664 0 CA-C-N 112.857 -1.974 . . . . 1.3300000000000001 108.543 175.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 62.3 Cg_endo -67.44 103.43 0.8 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.868 2.378 . . . . 0.20000000000000001 110.912 174.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.708 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -118.12 158.78 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.27 -1.332 . . . . 0.29999999999999999 109.391 -174.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.2 OUTLIER -101.46 -38.93 7.78 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 107.762 -1.199 . . . . 1.8400000000000001 107.762 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.539 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 10.3 m-30 -125.53 113.46 17.47 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.726 -1.124 . . . . 0.44 110.51 -176.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.708 ' HB2' HG11 ' A' ' 407' ' ' VAL . 8.3 t-105 -123.59 136.39 54.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.692 -1.594 . . . . 0.13 110.379 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.57 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.3 85.93 25.76 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 114.792 -1.094 . . . . 0.40999999999999998 111.041 173.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.7 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 82.6 Cg_endo -71.64 141.75 38.54 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 123.163 2.575 . . . . 0.16 112.091 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -122.94 -17.74 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.207 -1.36 . . . . 0.17000000000000001 111.239 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.772 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 6.9 p30 -134.76 170.47 15.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.715 -0.675 . . . . 1.5900000000000001 109.695 171.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -96.88 16.08 20.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 0.31 111.993 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 20.3 p -100.16 -28.31 13.08 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.258 -1.015 . . . . 0.44 108.258 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 131.74 26.41 0.71 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.24 -1.346 . . . . 0.23999999999999999 113.546 173.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.772 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 68.8 t -102.46 148.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.492 0.663 . . . . 0.17000000000000001 111.165 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 175.59 -164.1 34.22 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.712 -1.131 . . . . 0.10000000000000001 111.13 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.401 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -102.59 138.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.988 -0.745 . . . . 0.12 108.988 175.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.4 p80 -149.35 167.28 26.56 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.065 0.936 . . . . 0.14999999999999999 111.178 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.744 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -89.43 149.28 23.03 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 113.501 -1.682 . . . . 0.41999999999999998 107.806 172.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -136.42 100.0 4.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.675 1.226 . . . . 1.48 110.035 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -95.17 -33.37 12.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.606 -2.088 . . . . 0.34999999999999998 110.416 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.492 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 13.9 p90 -68.08 -27.08 66.18 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.589 -1.187 . . . . 0.17999999999999999 109.255 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.58 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.95 82.0 20.45 Favored Pre-proline 0 CA--C 1.494 -1.208 0 CA-C-N 113.816 -1.538 . . . . 1.3300000000000001 110.201 -173.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 32.1 Cg_endo -80.33 4.96 6.39 Favored 'Trans proline' 0 N--CA 1.432 -2.103 0 C-N-CA 124.821 3.681 . . . . 0.23000000000000001 114.464 -162.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.32 154.03 28.73 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 123.385 0.428 . . . . 1.1000000000000001 110.293 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.631 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -163.64 126.34 2.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.25 -1.341 . . . . 0.38 108.364 -172.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.81 -167.85 28.74 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.051 -1.547 . . . . 0.13 111.556 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.634 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.52 153.36 0.0 OUTLIER Glycine 0 C--N 1.342 0.916 0 O-C-N 125.043 1.084 . . . . 0.20000000000000001 113.207 174.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.439 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.8 m-20 -54.9 100.99 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 123.999 1.857 . . . . 0.33000000000000002 112.156 -146.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.4 mt -97.16 -33.44 11.49 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 110.273 -3.149 . . . . 0.17999999999999999 109.357 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.558 ' HA ' HG23 ' A' ' 369' ' ' VAL . 11.2 p-90 -47.36 -33.59 6.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 112.8 -2.0 . . . . 0.22 111.9 -174.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.83 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 43.4 mttt -63.5 -22.99 67.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 124.08 0.863 . . . . 0.64000000000000001 113.055 -176.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.2 p -117.43 -38.41 3.33 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.525 -0.761 . . . . 0.25 110.215 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.58 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 4.5 mtp85 -79.14 -15.22 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.609 -1.178 . . . . 0.35999999999999999 112.375 -169.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 75.72 40.48 31.46 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 116.216 1.246 . . . . 0.20999999999999999 116.216 159.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 442' ' ' CYS . 7.4 m -82.15 134.35 35.31 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 117.768 0.784 . . . . 0.46999999999999997 109.188 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -101.75 70.09 1.24 Allowed 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.477 -0.764 . . . . 0.40999999999999998 110.447 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.625 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 83.63 -8.2 66.34 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.815 -0.914 . . . . 0.17999999999999999 110.815 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.532 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 22.4 p -94.17 128.77 40.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.689 0.757 . . . . 0.82999999999999996 110.561 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.715 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -89.74 113.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.813 -1.085 . . . . 0.14999999999999999 110.527 -172.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.596 ' HB2' HG13 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -77.27 91.39 3.79 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.042 -0.981 . . . . 1.77 111.068 -177.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.654 HG23 HG21 ' A' ' 366' ' ' THR . 79.3 m -89.88 137.54 28.26 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 109.2 -0.667 . . . . 0.17999999999999999 109.2 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.1 Cg_exo -55.41 135.88 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.66 2.24 . . . . 0.12 111.248 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.744 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.8 Cg_exo -55.34 -32.87 83.22 Favored 'Trans proline' 0 CA--C 1.501 -1.148 0 C-N-CA 124.125 3.217 . . . . 0.16 112.849 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.2 m -79.75 -38.01 34.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.774 -1.103 . . . . 1.1699999999999999 110.016 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.62 HG11 ' HB ' ' A' ' 366' ' ' THR . 88.7 t -78.8 -29.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 0.17000000000000001 111.454 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.638 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -66.23 -20.48 66.13 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.698 0.761 . . . . 0.46000000000000002 109.925 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -76.3 -25.63 55.02 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.569 -1.196 . . . . 0.81000000000000005 111.69 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.7 mm-40 -80.33 -45.87 17.08 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-N 113.13 -1.85 . . . . 0.38 107.056 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.545 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 23.7 tp -66.22 -66.59 0.53 Allowed 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 111.756 -2.474 . . . . 0.059999999999999998 112.229 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.48 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 26.7 t80 -50.03 -25.77 3.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.89 1.329 . . . . 0.31 108.28 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.41 -27.65 65.26 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 112.867 -1.969 . . . . 0.13 112.583 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -91.02 -49.02 6.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.776 0.798 . . . . 0.13 111.384 171.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.584 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.84 137.39 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 CA-C-O 123.478 1.608 . . . . 0.23000000000000001 113.87 -167.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.64 -178.45 5.18 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 110.671 -2.968 . . . . 0.82999999999999996 106.567 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.765 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.0 mtmt -52.56 161.29 0.72 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-O 123.063 1.411 . . . . 0.23999999999999999 113.361 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.51 -32.88 5.26 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 112.498 -2.137 . . . . 0.37 112.31 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 384' ' ' VAL . 3.4 m -78.25 141.07 61.56 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.412 -0.588 . . . . 0.14999999999999999 109.412 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.651 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 5.8 Cg_exo -75.63 167.74 25.83 Favored 'Trans proline' 0 N--CA 1.425 -2.542 0 C-N-CA 122.084 1.856 . . . . 0.12 111.244 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.784 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -133.55 150.51 32.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.602 -1.259 . . . . 1.0900000000000001 107.602 165.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.8 tp -119.41 144.34 46.98 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.954 -1.021 . . . . 0.13 109.634 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.757 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -142.89 146.54 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.757 -1.571 . . . . 0.089999999999999997 106.757 165.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.643 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 17.5 p90 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.258 -0.877 . . . . 1.1599999999999999 110.993 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.641 HG23 ' HA ' ' A' ' 358' ' ' LYS . 2.7 m . . . . . 0 N--CA 1.422 -1.86 0 N-CA-C 108.096 -1.075 . . . . 0.45000000000000001 108.096 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.668 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.9 p90 -161.12 -171.04 2.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.322 -0.854 . . . . 0.32000000000000001 110.533 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.578 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.2 mm -105.06 160.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.977 -1.119 . . . . 0.080000000000000002 107.977 167.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.519 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -140.93 155.92 46.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.972 0.806 . . . . 0.17000000000000001 111.327 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.724 HG22 ' HG3' ' A' ' 354' ' ' MET . 65.5 t -151.16 136.65 11.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.747 -1.115 . . . . 0.080000000000000002 109.923 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -116.97 119.11 34.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.615 -1.175 . . . . 0.37 108.078 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 352' ' ' GLN . 1.9 mm? -70.81 -47.83 57.36 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.202 1.001 . . . . 0.32000000000000001 110.492 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -57.97 -55.07 39.61 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.752 -2.022 . . . . 1.51 112.0 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -94.77 10.69 34.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.21 -1.359 . . . . 0.91000000000000003 108.657 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.675 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 3.6 mm-40 35.01 74.14 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.349 1.656 . . . . 2.2200000000000002 112.964 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.52 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.5 t60 -152.27 124.3 8.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.32 -0.855 . . . . 0.13 109.744 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.724 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.3 ttp -111.88 126.94 55.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.586 -0.734 . . . . 0.059999999999999998 110.366 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.662 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -111.95 172.9 6.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 114.528 -1.214 . . . . 0.10000000000000001 111.911 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.681 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.3 t80 -125.93 115.73 20.39 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.577 -1.638 . . . . 0.22 106.577 165.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.501 ' CE1' HG12 ' A' ' 362' ' ' VAL . 23.8 m-85 -98.98 126.4 44.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.259 1.028 . . . . 0.17999999999999999 112.519 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.641 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.2 ttpt -148.94 139.29 22.42 Favored 'General case' 0 N--CA 1.396 -3.135 0 CA-C-N 112.95 -1.932 . . . . 0.46999999999999997 107.759 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 72.4 15.22 5.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 113.929 -1.487 . . . . 0.59999999999999998 108.871 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.79 78.58 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.603 -2.09 . . . . 0.23000000000000001 111.699 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.634 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -139.58 174.69 10.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 112.416 -1.892 . . . . 0.68000000000000005 106.108 -168.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.704 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.0 m -104.89 138.86 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 CA-C-O 124.227 1.965 . . . . 0.53000000000000003 112.397 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.681 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.36 -24.83 17.96 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 109.37 -3.559 . . . . 0.12 108.707 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.668 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -152.65 154.31 35.08 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.578 -1.646 . . . . 0.080000000000000002 108.67 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.704 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.11 120.49 1.16 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.708 -0.678 . . . . 0.60999999999999999 109.675 -174.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.696 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.0 t -147.79 167.33 25.0 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 122.199 0.999 . . . . 0.089999999999999997 111.981 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.66 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.3 p-10 -86.0 140.2 30.51 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 113.225 -1.807 . . . . 1.8799999999999999 107.867 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.675 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -140.88 -171.89 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.238 -0.892 . . . . 0.11 111.989 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.639 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.65 119.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.05 -0.977 . . . . 0.12 108.816 174.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.671 ' H ' HE22 ' A' ' 352' ' ' GLN . 7.6 t -142.23 144.2 33.24 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.415 -0.811 . . . . 0.69999999999999996 112.397 -166.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.02 44.48 45.46 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 116.569 1.388 . . . . 0.13 116.569 163.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.604 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.58 143.64 5.53 Favored Pre-proline 0 CA--C 1.509 -0.598 0 CA-C-N 118.472 1.136 . . . . 0.47999999999999998 110.49 -174.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.816 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.46 -33.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.966 1 C-N-CA 125.745 4.296 . . . . 0.23000000000000001 116.034 -170.925 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.604 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -79.74 -34.02 40.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.082 0.467 . . . . 0.29999999999999999 110.723 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.457 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.0 m -140.65 73.38 29.05 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 122.144 0.973 . . . . 0.29999999999999999 110.461 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.3 Cg_exo -70.62 161.51 45.78 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.201 3.934 . . . . 0.16 114.41 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.685 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.77 154.02 87.17 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 113.551 -1.659 . . . . 0.12 110.936 176.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.526 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.3 Cg_endo -80.84 -49.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 125.062 3.841 . . . . 0.089999999999999997 113.752 -172.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.692 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.05 122.55 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.123 0.964 . . . . 0.089999999999999997 113.449 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.35 -125.32 1.32 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.23 -1.35 . . . . 0.11 111.7 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.28 103.84 9.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.262 -1.014 . . . . 0.89000000000000001 108.262 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.767 ' HB2' HG22 ' A' ' 463' ' ' VAL . 95.6 m-85 -110.23 158.5 18.32 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.478 -0.783 . . . . 0.16 109.656 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.807 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 9.3 m-85 -146.59 139.63 25.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 118.194 0.452 . . . . 0.68999999999999995 110.699 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -75.63 125.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 119.92 -0.712 . . . . 0.14000000000000001 110.626 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -111.03 4.03 19.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.181 -0.918 . . . . 0.19 112.04 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.737 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.7 t30 -164.56 150.11 10.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.326 -0.852 . . . . 0.40999999999999998 110.51 175.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.447 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.3 mtpt -109.98 113.65 26.53 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.609 -0.723 . . . . 1.0900000000000001 110.025 170.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 1.9 mt-10 -112.79 125.1 53.97 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.647 -1.16 . . . . 0.38 110.931 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 42.5 mt-10 -123.5 135.05 53.85 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.14 -1.391 . . . . 1.96 110.196 -176.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.8 t70 52.56 39.44 28.05 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 123.387 1.565 . . . . 0.40000000000000002 107.661 -172.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.9 167.47 12.41 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 112.474 -2.148 . . . . 0.16 111.256 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 37.5 m -128.11 102.5 6.74 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.964 -1.471 . . . . 0.27000000000000002 109.682 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.753 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -74.28 157.34 35.97 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 112.984 -1.916 . . . . 0.23999999999999999 110.406 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.439 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 8.5 mtpt . . . . . 0 N--CA 1.399 -3.024 0 CA-C-N 114.945 -1.025 . . . . 0.67000000000000004 108.759 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 8.7 mt-10 . . . . . 0 CA--C 1.508 -0.645 0 CA-C-O 122.34 1.067 . . . . 0.62 111.831 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.753 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.56 98.62 12.17 Favored Pre-proline 0 N--CA 1.419 -1.982 0 CA-C-N 113.07 -1.877 . . . . 1.3300000000000001 107.747 175.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.8 Cg_endo -68.04 101.59 0.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.308 2.006 . . . . 0.20000000000000001 110.326 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -114.48 157.53 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.866 0 CA-C-N 114.242 -1.344 . . . . 0.29999999999999999 109.95 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.408 HD22 ' CG ' ' A' ' 422' ' ' ASP . 22.5 m-80 -108.22 -33.8 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.39 -1.732 . . . . 1.8400000000000001 107.098 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.421 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 61.3 m-85 -134.55 116.18 14.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.86 -1.973 . . . . 0.44 111.134 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.75 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.71 134.24 53.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.223 -1.353 . . . . 0.13 110.258 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.517 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.1 OUTLIER -134.91 86.54 32.31 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.124 -0.943 . . . . 0.40999999999999998 111.054 174.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.06 140.22 34.17 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.81 2.34 . . . . 0.16 112.154 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.79 -15.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.479 . . . . 0.17000000000000001 111.214 -172.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -134.63 162.5 32.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.392 -0.822 . . . . 1.5900000000000001 109.447 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -93.47 13.8 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.358 0.503 . . . . 0.31 112.358 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.1 p -94.24 -27.42 16.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.674 -1.232 . . . . 0.44 107.674 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.48 34.36 0.76 Allowed Glycine 0 N--CA 1.427 -1.95 0 CA-C-N 113.112 -1.858 . . . . 0.23999999999999999 112.414 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 441' ' ' GLY . 76.8 t -103.79 151.49 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 120.987 0.422 . . . . 0.17000000000000001 110.762 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 170.92 -168.1 41.24 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.214 -0.903 . . . . 0.10000000000000001 111.664 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.46 141.16 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.933 -0.766 . . . . 0.12 108.933 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.564 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.0 p80 -150.6 163.72 37.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.803 0.811 . . . . 0.14999999999999999 111.776 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.14 142.6 27.56 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.916 -1.493 . . . . 0.41999999999999998 107.323 172.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.462 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 3.5 t -136.92 103.51 5.19 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.877 1.323 . . . . 1.48 110.395 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.55 -28.7 15.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.125 -2.307 . . . . 0.34999999999999998 111.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.533 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.4 p90 -70.27 -26.56 63.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 114.432 -1.258 . . . . 0.17999999999999999 109.342 175.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.575 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -120.58 82.18 33.0 Favored Pre-proline 0 CA--C 1.491 -1.31 0 CA-C-N 113.5 -1.682 . . . . 1.3300000000000001 109.465 -175.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -81.34 6.68 5.45 Favored 'Trans proline' 0 N--CA 1.43 -2.254 0 C-N-CA 124.693 3.596 . . . . 0.23000000000000001 113.907 -162.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 3.2 tp10 -114.47 154.54 28.01 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 1.1000000000000001 111.013 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.66 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -164.11 127.84 2.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.715 -1.584 . . . . 0.38 108.076 -169.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.31 -167.24 28.51 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 119.232 -1.461 . . . . 0.13 111.124 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.643 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.43 153.95 0.01 OUTLIER Glycine 0 C--N 1.336 0.583 0 O-C-N 124.927 1.016 . . . . 0.20000000000000001 112.897 174.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.65 100.81 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 123.862 1.791 . . . . 0.33000000000000002 112.0 -146.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 54.1 mt -97.02 -30.32 13.13 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 110.562 -3.017 . . . . 0.17999999999999999 108.205 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.639 ' HA ' HG23 ' A' ' 369' ' ' VAL . 7.6 p-90 -46.85 -38.01 9.66 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.876 0.735 . . . . 0.22 111.583 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.816 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.7 mttt -62.22 -23.01 66.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.274 -0.876 . . . . 0.64000000000000001 112.9 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -114.95 -37.03 4.26 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.578 -0.737 . . . . 0.25 110.361 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.575 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.8 mtp85 -85.18 -15.86 42.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.811 -1.086 . . . . 0.35999999999999999 112.691 -168.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.09 42.05 25.38 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 116.804 1.482 . . . . 0.20999999999999999 116.804 159.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.6 m -85.82 131.11 34.37 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 118.682 1.241 . . . . 0.46999999999999997 108.946 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -100.04 71.38 1.62 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.678 -0.639 . . . . 0.40999999999999998 111.227 -167.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.74 -14.12 59.15 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.422 -1.071 . . . . 0.17999999999999999 110.422 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.523 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -88.29 148.53 24.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.36 -0.42 . . . . 0.82999999999999996 110.192 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.685 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -100.01 119.54 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.776 0.798 . . . . 0.14999999999999999 110.759 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.58 ' HB3' HG13 ' A' ' 369' ' ' VAL . 2.6 t30 -79.93 82.97 5.92 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.557 -1.201 . . . . 1.77 111.42 -175.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.2 m -87.42 140.25 31.99 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-O 121.605 0.716 . . . . 0.17999999999999999 109.846 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.9 Cg_exo -58.85 136.14 71.64 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.814 2.342 . . . . 0.12 111.744 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.3 Cg_exo -55.01 -34.07 85.59 Favored 'Trans proline' 0 CA--C 1.504 -1.009 0 C-N-CA 124.415 3.41 . . . . 0.16 113.005 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.5 t -79.47 -38.33 34.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.893 -1.049 . . . . 1.1699999999999999 109.418 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.696 HG11 ' HB ' ' A' ' 366' ' ' THR . 46.9 t -82.51 -28.42 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 0.17000000000000001 111.269 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.725 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.5 tpt -67.68 -18.74 65.03 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.882 0.849 . . . . 0.46000000000000002 110.008 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -80.43 -23.24 40.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.442 -1.253 . . . . 0.81000000000000005 111.007 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.686 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.0 mm-40 -80.35 -46.99 15.15 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.957 -1.929 . . . . 0.38 107.215 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.584 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -64.68 -67.18 0.46 Allowed 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 111.798 -2.455 . . . . 0.059999999999999998 112.321 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -50.47 -26.36 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.18 1.467 . . . . 0.31 108.21 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.44 -32.77 67.96 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 112.182 -2.281 . . . . 0.13 112.22 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.686 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.8 ptp -87.5 -49.43 7.2 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 121.745 0.783 . . . . 0.13 111.509 172.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.635 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.7 OUTLIER -102.08 137.6 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 CA-C-O 123.518 1.627 . . . . 0.23000000000000001 113.835 -167.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.447 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.58 -178.23 5.08 Favored 'General case' 0 N--CA 1.401 -2.881 0 CA-C-N 110.585 -3.007 . . . . 0.82999999999999996 106.89 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.737 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 48.2 mtmt -51.59 161.78 0.46 Allowed 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 122.888 1.328 . . . . 0.23999999999999999 112.593 175.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.67 -31.52 5.8 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 112.623 -2.08 . . . . 0.37 112.368 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.5 m -82.92 140.77 43.39 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.683 -0.858 . . . . 0.14999999999999999 108.683 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.807 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.57 173.46 14.15 Favored 'Trans proline' 0 N--CA 1.415 -3.146 0 C-N-CA 121.093 1.196 . . . . 0.12 111.71 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -137.09 160.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.768 -1.197 . . . . 1.0900000000000001 107.768 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.442 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.8 tp -129.83 146.22 51.57 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.443 -0.799 . . . . 0.13 110.334 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.1 147.26 20.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.073 -1.454 . . . . 0.089999999999999997 107.073 165.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.648 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.1 p90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.855 -0.593 . . . . 1.1599999999999999 111.646 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.603 HG23 ' HA ' ' A' ' 358' ' ' LYS . 94.0 m . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 108.813 -0.81 . . . . 0.45000000000000001 108.813 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.647 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.0 p90 -160.93 -170.31 2.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.217 -1.356 . . . . 0.32000000000000001 110.668 -173.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.3 mm -101.7 161.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.183 -1.043 . . . . 0.080000000000000002 108.183 166.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.492 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -142.24 155.6 45.25 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.407 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.671 HG22 ' HG3' ' A' ' 354' ' ' MET . 68.0 t -151.0 142.35 16.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.437 -1.256 . . . . 0.080000000000000002 109.146 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.499 ' HA ' ' OXT' ' A' ' 466' ' ' PHE . 7.2 t70 -130.67 107.49 9.21 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.37 109.129 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.547 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -69.27 -30.08 68.11 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.814 -1.539 . . . . 0.32000000000000001 110.575 -170.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -57.09 -63.61 1.16 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.89 0.852 . . . . 1.51 111.096 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -89.42 -3.53 58.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.047 -1.433 . . . . 0.91000000000000003 110.774 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.703 ' OE1' HD12 ' A' ' 368' ' ' ILE . 85.1 mm-40 49.64 68.64 0.7 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 112.084 -2.325 . . . . 2.2200000000000002 111.368 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.462 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.5 t60 -143.82 128.43 18.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.991 -1.004 . . . . 0.13 109.293 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.9 ttp -114.33 129.01 56.63 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 123.573 0.749 . . . . 0.059999999999999998 110.558 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.66 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.32 173.1 6.57 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.724 -1.126 . . . . 0.10000000000000001 111.802 -176.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.71 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -125.88 113.96 17.91 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.008 -1.849 . . . . 0.22 106.008 164.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.469 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.1 m-85 -98.53 129.21 45.09 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.811 0.815 . . . . 0.17999999999999999 111.218 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.603 ' HA ' HG23 ' A' ' 343' ' ' THR . 5.7 ttpt -147.6 137.65 22.94 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 113.912 -1.494 . . . . 0.46999999999999997 108.161 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.464 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.79 11.94 7.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 113.489 -1.687 . . . . 0.59999999999999998 108.629 178.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.06 12.25 71.38 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 112.785 -2.007 . . . . 0.23000000000000001 111.806 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.621 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -131.43 168.68 17.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.107 -1.812 . . . . 0.68000000000000005 106.107 -172.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.65 HG11 ' CD1' ' A' ' 355' ' ' TRP . 3.2 m -100.96 136.9 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 124.442 2.067 . . . . 0.53000000000000003 111.958 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.71 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -90.62 -25.92 19.9 Favored 'General case' 0 N--CA 1.397 -3.081 0 CA-C-N 109.085 -3.688 . . . . 0.12 108.57 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.64 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.6 tp -152.51 154.25 35.1 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.577 -1.647 . . . . 0.080000000000000002 108.744 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.66 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -164.92 121.53 1.5 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.67 -0.696 . . . . 0.60999999999999999 109.489 -175.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.704 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.5 t -148.51 167.03 26.44 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.25 1.024 . . . . 0.089999999999999997 112.099 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.688 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.8 p-10 -85.9 139.79 30.93 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 113.173 -1.831 . . . . 1.8799999999999999 107.827 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.703 HD12 ' OE1' ' A' ' 352' ' ' GLN . 1.7 pp -140.63 -172.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.207 -0.906 . . . . 0.11 111.554 -175.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.596 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.8 119.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.399 -0.819 . . . . 0.12 109.05 174.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.2 t -141.27 145.11 35.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.747 -1.115 . . . . 0.69999999999999996 112.562 -167.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.08 46.1 37.51 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 117.333 1.693 . . . . 0.13 117.333 162.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.453 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.1 pttt -45.86 145.55 2.31 Favored Pre-proline 0 C--N 1.347 0.462 0 CA-C-N 119.842 1.821 . . . . 0.47999999999999998 110.779 -174.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.798 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.99 -36.46 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 1 C-N-CA 125.422 4.081 . . . . 0.23000000000000001 115.529 -173.58 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -35.89 57.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.076 0.465 . . . . 0.29999999999999999 110.903 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.464 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -139.88 72.56 34.67 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 122.111 0.958 . . . . 0.29999999999999999 110.522 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.4 Cg_exo -71.75 162.76 41.06 Favored 'Trans proline' 0 C--N 1.324 -0.741 1 C-N-CA 125.35 4.033 . . . . 0.16 113.978 -177.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.725 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.33 152.43 90.09 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 113.651 -1.613 . . . . 0.12 111.062 175.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.514 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.42 -49.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 125.116 3.877 . . . . 0.089999999999999997 113.712 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.74 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.89 120.95 0.03 OUTLIER 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.767 1.025 . . . . 0.089999999999999997 113.767 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.77 -123.25 1.15 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.343 -1.299 . . . . 0.11 111.563 -176.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.1 p -126.13 112.17 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.079 0.942 . . . . 0.89000000000000001 108.933 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.779 ' HB2' HG22 ' A' ' 463' ' ' VAL . 90.4 m-85 -115.66 160.09 20.49 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.219 -0.9 . . . . 0.16 109.83 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.713 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 77.2 m-85 -147.8 135.29 20.74 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 120.97 -0.292 . . . . 0.68999999999999995 111.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.49 121.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.63 -0.828 . . . . 0.14000000000000001 110.234 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -108.44 2.21 22.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.247 -0.888 . . . . 0.19 111.784 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.755 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.4 t30 -164.65 150.81 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.838 -1.074 . . . . 0.40999999999999998 110.217 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -112.8 126.98 56.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.616 -0.72 . . . . 1.0900000000000001 109.123 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.576 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -127.14 112.76 15.53 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 123.195 1.474 . . . . 0.38 113.249 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 3.1 mp0 -108.17 134.15 51.43 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.286 -1.779 . . . . 1.96 110.862 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 36.9 t70 52.17 37.11 20.94 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.394 1.568 . . . . 0.40000000000000002 107.744 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.576 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.79 170.31 10.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.225 -2.261 . . . . 0.16 112.028 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 16.5 m -125.98 105.81 9.17 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.679 -1.601 . . . . 0.27000000000000002 109.823 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.7 mp -72.05 156.11 39.56 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.243 -1.799 . . . . 0.23999999999999999 109.79 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.478 ' HG2' ' HG3' ' A' ' 404' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.389 -3.482 0 CA-C-N 114.863 -1.062 . . . . 0.67000000000000004 109.136 -176.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.7 mt-10 . . . . . 0 CA--C 1.504 -0.827 0 CA-C-O 122.383 1.087 . . . . 0.62 112.027 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.708 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.8 m -143.64 97.86 5.42 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.254 -1.794 . . . . 1.3300000000000001 109.464 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.7 Cg_endo -68.93 105.97 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.534 0 C-N-CA 124.359 3.373 . . . . 0.20000000000000001 112.999 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.832 HG11 ' HB2' ' A' ' 410' ' ' TRP . 0.6 OUTLIER -115.89 162.6 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 114.58 -1.191 . . . . 0.29999999999999999 110.87 -174.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 27.0 m-80 -111.25 -33.59 6.39 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.152 -1.84 . . . . 1.8400000000000001 107.008 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.36 115.53 13.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.189 -1.823 . . . . 0.44 110.835 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.832 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.8 t-105 -122.59 136.26 54.84 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.558 -1.201 . . . . 0.13 109.897 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.534 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.54 86.17 23.81 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.006 -0.997 . . . . 0.40999999999999998 111.222 173.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.1 Cg_endo -70.85 140.11 37.88 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.889 2.393 . . . . 0.16 112.053 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.713 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.46 -15.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.804 -1.544 . . . . 0.17000000000000001 111.068 -173.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -135.37 163.76 29.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 1.5900000000000001 110.032 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -94.38 14.53 20.24 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.304 0.483 . . . . 0.31 112.304 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.4 p -94.11 -26.98 16.49 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.613 -1.254 . . . . 0.44 107.613 173.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.06 30.44 1.02 Allowed Glycine 0 N--CA 1.427 -1.93 0 CA-C-N 113.053 -1.885 . . . . 0.23999999999999999 112.274 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 441' ' ' GLY . 73.1 t -102.46 149.81 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 120.587 -0.445 . . . . 0.17000000000000001 111.112 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.18 -166.69 39.25 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.153 -0.93 . . . . 0.10000000000000001 111.789 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.407 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.8 OUTLIER -103.88 141.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.036 -0.727 . . . . 0.12 109.036 176.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.795 ' HB2' HG21 ' A' ' 407' ' ' VAL . 35.5 p80 -151.48 165.1 35.23 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.669 0.747 . . . . 0.14999999999999999 112.26 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.775 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.8 139.68 30.43 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.027 -1.442 . . . . 0.41999999999999998 107.449 171.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.663 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 1.6 t -135.6 104.25 5.73 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 123.212 1.482 . . . . 1.48 110.144 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -93.17 -25.85 17.66 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 111.855 -2.43 . . . . 0.34999999999999998 110.17 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.494 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 6.9 p90 -70.8 -26.41 63.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.385 -1.279 . . . . 0.17999999999999999 109.316 173.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.578 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.1 OUTLIER -118.93 83.08 22.27 Favored Pre-proline 0 CA--C 1.496 -1.121 0 CA-C-N 114.036 -1.438 . . . . 1.3300000000000001 110.6 -174.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -82.94 6.58 5.72 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 C-N-CA 124.515 3.477 . . . . 0.23000000000000001 114.554 -162.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.64 153.46 30.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 123.372 0.42 . . . . 1.1000000000000001 110.226 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.688 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -162.74 125.62 2.8 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.327 1.051 . . . . 0.38 109.203 -170.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.8 28.83 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.026 -1.559 . . . . 0.13 111.792 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.5 154.96 0.01 OUTLIER Glycine 0 C--N 1.339 0.748 0 O-C-N 124.985 1.05 . . . . 0.20000000000000001 112.762 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.41 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.039 1.876 . . . . 0.33000000000000002 112.284 -147.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 43.6 mt -96.68 -33.54 11.7 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 110.223 -3.171 . . . . 0.17999999999999999 108.094 175.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.508 ' HA ' HG23 ' A' ' 369' ' ' VAL . 2.9 p-90 -45.37 -37.96 5.46 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.936 0.772 . . . . 0.22 111.327 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.798 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.4 mttt -58.27 -23.7 57.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.059 -0.973 . . . . 0.64000000000000001 113.007 -176.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 49.0 p -116.63 -35.55 4.19 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.458 -0.792 . . . . 0.25 110.0 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.577 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.6 mtp85 -84.65 -14.92 47.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.634 -1.167 . . . . 0.35999999999999999 112.714 -169.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 73.47 41.54 44.25 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 116.459 1.344 . . . . 0.20999999999999999 116.459 159.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.7 m -87.53 131.49 34.36 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 118.267 1.033 . . . . 0.46999999999999997 109.113 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -97.58 68.32 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.817 -0.552 . . . . 0.40999999999999998 111.097 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.587 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.64 -12.28 63.8 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.582 -1.007 . . . . 0.17999999999999999 110.582 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 26.3 p -87.34 143.66 27.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.271 -0.464 . . . . 0.82999999999999996 109.923 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -99.26 115.97 41.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.23 0.538 . . . . 0.14999999999999999 110.734 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.663 ' OD1' ' HB3' ' A' ' 423' ' ' SER . 8.2 t30 -78.39 93.74 4.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.132 -0.94 . . . . 1.77 111.356 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 25.0 m -91.49 136.07 27.22 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.621 -0.718 . . . . 0.17999999999999999 109.284 173.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 50.1 Cg_exo -56.79 132.65 53.01 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.073 2.515 . . . . 0.12 112.696 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.775 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 16.2 Cg_exo -50.21 -39.24 52.24 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.625 2.883 . . . . 0.16 112.713 -168.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 61.6 m -74.99 -42.22 57.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.709 -1.132 . . . . 1.1699999999999999 109.867 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.704 HG11 ' HB ' ' A' ' 366' ' ' THR . 62.0 t -75.88 -28.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.353 0.597 . . . . 0.17000000000000001 111.294 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.693 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.7 tpt -68.33 -20.13 64.71 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.583 0.706 . . . . 0.46000000000000002 110.17 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -79.61 -22.27 43.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 122.496 1.141 . . . . 0.81000000000000005 110.974 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.679 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.25 -47.4 14.67 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 112.894 -1.957 . . . . 0.38 107.399 177.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.578 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.8 tp -63.93 -67.27 0.44 Allowed 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 111.81 -2.45 . . . . 0.059999999999999998 112.302 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.441 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 39.7 t80 -49.82 -27.23 4.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 123.026 1.393 . . . . 0.31 108.335 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.06 -31.16 66.89 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 112.388 -2.187 . . . . 0.13 112.266 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.679 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -87.97 -49.35 7.12 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 121.772 0.796 . . . . 0.13 111.383 172.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.07 138.02 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-O 123.455 1.598 . . . . 0.23000000000000001 113.796 -167.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.25 -178.87 5.35 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 110.821 -2.9 . . . . 0.82999999999999996 106.662 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.755 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.3 mtmt -51.61 161.5 0.5 Allowed 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.966 1.365 . . . . 0.23999999999999999 112.869 175.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.77 -33.69 4.89 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.688 -2.051 . . . . 0.37 112.535 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 462' ' ' PRO . 6.9 m -78.78 142.34 60.85 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.362 -0.607 . . . . 0.14999999999999999 109.362 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 5.1 Cg_exo -76.09 169.2 22.55 Favored 'Trans proline' 0 N--CA 1.425 -2.527 0 C-N-CA 121.89 1.727 . . . . 0.12 111.335 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.779 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.12 157.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 107.422 -1.325 . . . . 1.0900000000000001 107.422 166.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.473 HD22 ' CE1' ' A' ' 344' ' ' TYR . 2.8 tp -127.25 146.05 50.56 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.197 -0.911 . . . . 0.13 109.935 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 147.08 20.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.276 -1.379 . . . . 0.089999999999999997 107.276 165.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.52 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 20.4 p90 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.742 -0.647 . . . . 1.1599999999999999 111.103 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.0 m . . . . . 0 N--CA 1.428 -1.551 0 N-CA-C 107.129 -1.434 . . . . 0.45000000000000001 107.129 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.641 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.2 p90 -157.15 -171.38 3.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.451 0.643 . . . . 0.32000000000000001 111.636 -174.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.559 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.2 mm -104.31 160.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 107.839 -1.171 . . . . 0.080000000000000002 107.839 166.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.499 ' CD ' ' HE2' ' A' ' 466' ' ' PHE . 2.1 tt0 -140.41 155.49 46.71 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 118.82 0.737 . . . . 0.17000000000000001 111.336 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.627 HG22 ' HG3' ' A' ' 354' ' ' MET . 63.8 t -150.38 134.48 8.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.589 -1.187 . . . . 0.080000000000000002 110.251 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.412 ' HB2' ' HZ3' ' A' ' 355' ' ' TRP . 18.2 t0 -115.48 114.66 25.33 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.832 -1.076 . . . . 0.37 108.139 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.466 HD21 HG23 ' A' ' 465' ' ' VAL . 1.8 mm? -68.21 -51.93 39.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.803 1.287 . . . . 0.32000000000000001 110.586 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.57 -52.97 15.9 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.179 -1.828 . . . . 1.51 113.298 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -102.54 9.14 39.66 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.73 -1.123 . . . . 0.91000000000000003 109.06 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.75 ' OE1' HD12 ' A' ' 368' ' ' ILE . 85.0 mm-40 36.93 73.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.058 1.474 . . . . 2.2200000000000002 111.871 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.8 t60 -150.3 125.95 10.31 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.54 -1.209 . . . . 0.13 109.434 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.627 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -112.46 128.43 56.32 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.234 0.614 . . . . 0.059999999999999998 110.743 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.67 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.0 m-90 -111.87 173.11 6.51 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.634 -1.167 . . . . 0.10000000000000001 111.817 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.702 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.9 t80 -126.06 116.12 20.91 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 106.775 -1.565 . . . . 0.22 106.775 165.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.493 ' CE1' HG12 ' A' ' 362' ' ' VAL . 17.8 m-85 -98.86 126.33 44.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.142 0.973 . . . . 0.17999999999999999 112.165 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.678 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.5 ttpt -149.64 139.76 22.11 Favored 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 113.196 -1.82 . . . . 0.46999999999999997 107.846 174.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.43 15.44 6.21 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 114.008 -1.451 . . . . 0.59999999999999998 108.799 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.59 18.62 77.34 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 112.378 -2.192 . . . . 0.23000000000000001 111.783 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.63 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.07 173.65 11.34 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.86 -1.904 . . . . 0.68000000000000005 105.86 -170.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.724 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.5 m -104.23 137.67 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 124.338 2.018 . . . . 0.53000000000000003 112.246 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.702 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.37 -23.73 19.13 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-N 109.218 -3.628 . . . . 0.12 108.624 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.689 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -153.84 154.72 34.46 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 113.567 -1.651 . . . . 0.080000000000000002 108.405 -172.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.724 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.26 122.39 1.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.73 -0.668 . . . . 0.60999999999999999 109.299 -174.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.663 HG21 HG23 ' A' ' 445' ' ' THR . 6.3 t -149.05 166.87 27.42 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 122.105 0.955 . . . . 0.089999999999999997 111.84 173.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.646 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.7 p-10 -86.48 141.55 29.01 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 113.228 -1.805 . . . . 1.8799999999999999 107.444 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.75 HD12 ' OE1' ' A' ' 352' ' ' GLN . 1.6 pp -142.0 -171.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.21 -0.904 . . . . 0.11 111.525 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.59 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -155.66 119.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.466 -0.788 . . . . 0.12 108.92 175.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.416 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.8 143.89 33.66 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.792 -1.095 . . . . 0.69999999999999996 112.748 -165.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.623 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.08 44.82 34.39 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 116.924 1.529 . . . . 0.13 116.924 162.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.489 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.69 142.36 6.71 Favored Pre-proline 0 CA--C 1.507 -0.676 0 CA-C-N 118.593 1.196 . . . . 0.47999999999999998 110.081 -175.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.791 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.59 -31.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.967 1 C-N-CA 125.885 4.39 . . . . 0.23000000000000001 116.365 -170.07 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -82.89 -32.58 27.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.297 0.57 . . . . 0.29999999999999999 110.672 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.445 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 12.1 m -140.77 74.55 26.71 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 122.151 0.976 . . . . 0.29999999999999999 110.239 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.623 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.76 162.41 42.13 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 125.068 3.845 . . . . 0.16 113.419 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.05 152.47 90.7 Favored Pre-proline 0 N--CA 1.436 -1.15 0 CA-C-N 113.665 -1.607 . . . . 0.12 110.806 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.47 -48.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.885 3.723 . . . . 0.089999999999999997 113.548 -172.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.803 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 66.31 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.918 1.081 . . . . 0.089999999999999997 113.918 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.79 -123.47 1.18 Allowed Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 114.301 -1.318 . . . . 0.11 111.414 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.6 p -129.8 104.93 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 122.371 1.081 . . . . 0.89000000000000001 109.538 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.616 ' CE2' HG22 ' A' ' 465' ' ' VAL . 55.3 m-85 -110.4 166.33 11.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.994 -1.003 . . . . 0.16 108.862 -172.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.705 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -148.77 136.28 20.4 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 117.63 0.195 . . . . 0.68999999999999995 110.714 177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.583 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -72.29 124.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.555 0.693 . . . . 0.14000000000000001 110.573 176.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -113.04 4.49 16.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.275 -0.875 . . . . 0.19 112.005 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.743 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 5.8 t30 -163.96 148.97 10.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.493 -0.776 . . . . 0.40999999999999998 110.583 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.7 mtpt -110.81 109.74 20.07 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.811 0.815 . . . . 1.0900000000000001 110.412 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -107.95 131.87 54.09 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.304 -1.316 . . . . 0.38 109.382 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.548 -1.205 . . . . 1.96 110.092 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 25.8 t70 50.43 40.42 22.99 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.597 1.665 . . . . 0.40000000000000002 107.516 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.32 170.2 9.98 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 111.927 -2.397 . . . . 0.16 110.809 -173.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 23.9 m -129.91 102.92 6.5 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.1 -1.409 . . . . 0.27000000000000002 110.136 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.784 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -75.17 158.16 33.46 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 112.717 -2.038 . . . . 0.23999999999999999 110.298 174.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.501 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 6.8 mtpt . . . . . 0 N--CA 1.398 -3.048 0 CA-C-N 115.224 -0.898 . . . . 0.67000000000000004 108.919 -177.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.4 mt-10 . . . . . 0 CA--C 1.511 -0.541 0 CA-C-O 122.329 1.061 . . . . 0.62 112.182 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.784 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -134.16 99.21 13.62 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-N 113.236 -1.802 . . . . 1.3300000000000001 108.595 176.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.91 101.05 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.793 2.329 . . . . 0.20000000000000001 110.182 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -120.28 133.91 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-N 114.004 -1.453 . . . . 0.29999999999999999 111.234 -171.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.572 HD22 ' H ' ' A' ' 408' ' ' ASN . 0.1 OUTLIER -78.08 -30.32 49.56 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.822 -1.081 . . . . 1.8400000000000001 110.599 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.568 ' HB3' ' CD1' ' A' ' 454' ' ' PHE . 64.1 m-85 -142.15 117.83 10.41 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.728 -1.124 . . . . 0.44 110.758 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.697 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.9 t-105 -122.94 135.65 54.57 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.24 -1.346 . . . . 0.13 110.296 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.583 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -136.33 87.18 22.89 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 115.25 -0.886 . . . . 0.40999999999999998 110.962 174.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 90.8 Cg_endo -72.68 140.95 33.34 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.834 2.356 . . . . 0.16 111.554 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -122.55 -15.81 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.38 -1.282 . . . . 0.17000000000000001 111.656 -171.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.779 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.9 p30 -135.78 170.16 16.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.486 -0.779 . . . . 1.5900000000000001 109.58 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -96.08 15.31 21.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.206 -0.452 . . . . 0.31 111.989 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 18.3 p -96.85 -27.52 14.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.072 -1.085 . . . . 0.44 108.072 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.82 27.3 0.87 Allowed Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.958 -1.473 . . . . 0.23999999999999999 113.314 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.779 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 61.5 t -103.44 151.77 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.266 0.555 . . . . 0.17000000000000001 111.428 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 173.34 -163.99 35.62 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.149 -0.932 . . . . 0.10000000000000001 111.41 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.98 137.81 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 109.251 -0.648 . . . . 0.12 109.251 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.735 ' HB2' HG21 ' A' ' 407' ' ' VAL . 33.3 p80 -152.65 169.84 21.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.725 0.774 . . . . 0.14999999999999999 111.422 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.731 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.87 154.5 19.44 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 113.827 -1.533 . . . . 0.41999999999999998 108.699 174.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 18.5 p -140.11 99.95 3.8 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.583 1.182 . . . . 1.48 109.936 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.93 -31.17 13.78 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.621 -2.081 . . . . 0.34999999999999998 110.411 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.554 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.2 p90 -70.25 -26.99 64.09 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.369 -1.287 . . . . 0.17999999999999999 108.765 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.489 ' HB3' HD22 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.27 82.83 24.02 Favored Pre-proline 0 CA--C 1.489 -1.375 0 CA-C-N 113.437 -1.711 . . . . 1.3300000000000001 109.037 -174.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 35.9 Cg_endo -80.07 3.61 7.47 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 124.483 3.455 . . . . 0.23000000000000001 114.619 -159.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 2.9 tp10 -113.96 157.17 22.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.892 0.377 . . . . 1.1000000000000001 110.738 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.646 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.66 125.89 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.293 -1.321 . . . . 0.38 108.68 -171.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -168.34 28.72 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.419 -1.372 . . . . 0.13 112.158 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.596 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.36 0.01 OUTLIER Glycine 0 C--N 1.341 0.843 0 O-C-N 124.983 1.049 . . . . 0.20000000000000001 112.783 173.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.22 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.281 0 CA-C-O 124.025 1.869 . . . . 0.33000000000000002 112.249 -146.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 36.3 mt -97.84 -33.53 11.21 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 110.06 -3.246 . . . . 0.17999999999999999 109.298 175.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.56 ' HA ' HG23 ' A' ' 369' ' ' VAL . 8.0 p-90 -46.88 -34.45 5.43 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.214 -1.812 . . . . 0.22 112.16 -174.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.791 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 47.9 mttt -61.93 -23.79 66.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.334 -0.848 . . . . 0.64000000000000001 113.188 -177.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -115.8 -36.66 4.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.686 0.755 . . . . 0.25 110.085 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.585 ' HD2' HD22 ' A' ' 433' ' ' LEU . 4.5 mtp85 -81.65 -15.48 54.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.489 -1.232 . . . . 0.35999999999999999 112.973 -169.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.48 42.85 26.23 Favored Glycine 0 C--N 1.314 -0.646 0 N-CA-C 116.344 1.298 . . . . 0.20999999999999999 116.344 158.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 13.7 m -85.73 131.37 34.34 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 118.282 1.041 . . . . 0.46999999999999997 109.117 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -101.8 71.73 1.32 Allowed 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.405 -0.809 . . . . 0.40999999999999998 110.919 -169.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.517 ' H ' ' HA2' ' A' ' 371' ' ' GLY . . . 85.8 -13.57 55.79 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.223 -1.151 . . . . 0.17999999999999999 110.223 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.569 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.1 p -88.59 148.18 24.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.063 -0.568 . . . . 0.82999999999999996 110.218 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.716 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -103.64 118.78 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.107 -0.497 . . . . 0.14999999999999999 110.348 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.632 ' HB3' ' OG ' ' A' ' 423' ' ' SER . 2.1 m-20 -85.49 90.01 7.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.589 -0.732 . . . . 1.77 111.641 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 99.5 m -87.02 138.76 32.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 121.473 0.654 . . . . 0.17999999999999999 109.726 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.0 Cg_exo -54.36 136.58 69.61 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.685 2.257 . . . . 0.12 111.043 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.731 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 44.5 Cg_exo -55.65 -31.98 81.71 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 C-N-CA 123.984 3.122 . . . . 0.16 112.638 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.7 p -80.63 -39.04 28.11 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.279 -1.328 . . . . 1.1699999999999999 109.623 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.588 HG11 ' HB ' ' A' ' 366' ' ' THR . 92.3 t -77.32 -31.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.552 -0.749 . . . . 0.17000000000000001 111.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.643 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 3.6 tpt -63.03 -24.4 67.9 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.584 0.707 . . . . 0.46000000000000002 110.523 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -72.28 -30.49 64.87 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.539 -1.209 . . . . 0.81000000000000005 112.628 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.67 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.7 mm-40 -75.68 -46.6 30.35 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-N 113.005 -1.907 . . . . 0.38 107.362 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.521 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 26.1 tp -64.97 -67.35 0.44 Allowed 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 111.491 -2.595 . . . . 0.059999999999999998 112.379 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 409' ' ' TYR . 26.8 t80 -50.37 -25.91 4.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 123.146 1.45 . . . . 0.31 108.309 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.34 -30.89 64.13 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 112.475 -2.148 . . . . 0.13 112.156 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.689 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -87.63 -48.38 7.94 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-O 121.661 0.743 . . . . 0.13 111.324 172.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.647 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.5 OUTLIER -102.19 137.89 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.351 1.548 . . . . 0.23000000000000001 113.989 -168.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.3 pt-20 -136.25 -178.56 5.21 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 110.965 -2.834 . . . . 0.82999999999999996 106.739 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.743 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.8 mtmt -50.95 160.54 0.46 Allowed 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 123.102 1.43 . . . . 0.23999999999999999 113.363 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.76 -36.21 3.78 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 112.433 -2.167 . . . . 0.37 112.475 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 462' ' ' PRO . 19.3 m -70.35 141.17 88.15 Favored Pre-proline 0 N--CA 1.438 -1.048 0 CA-C-O 121.196 0.522 . . . . 0.14999999999999999 110.282 -175.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.641 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.58 161.56 41.86 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.215 1.943 . . . . 0.12 110.884 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 71.8 t -132.26 131.42 60.84 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 113.466 -1.697 . . . . 1.0900000000000001 107.833 173.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.432 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.1 tp -109.83 142.03 41.69 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.232 0.539 . . . . 0.13 110.308 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.01 145.49 22.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.088 -1.819 . . . . 0.089999999999999997 106.088 164.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.803 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.135 -0.936 . . . . 1.1599999999999999 111.591 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.614 HG23 ' HA ' ' A' ' 358' ' ' LYS . 22.6 m . . . . . 0 N--CA 1.428 -1.572 0 N-CA-C 108.627 -0.879 . . . . 0.45000000000000001 108.627 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.642 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 6.1 p90 -156.88 -171.01 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.52 0.676 . . . . 0.32000000000000001 111.41 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.4 mm -102.26 162.14 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 108.221 -1.029 . . . . 0.080000000000000002 108.221 167.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.4 tt0 -142.14 156.54 45.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 118.835 0.743 . . . . 0.17000000000000001 111.545 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.691 HG22 ' HG3' ' A' ' 354' ' ' MET . 62.7 t -151.3 136.91 11.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.491 -1.231 . . . . 0.080000000000000002 110.077 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -117.67 115.34 24.87 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.68 -1.145 . . . . 0.37 108.104 172.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.509 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -67.83 -49.5 61.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.355 1.074 . . . . 0.32000000000000001 110.564 -176.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -52.89 -55.2 24.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.774 -2.012 . . . . 1.51 112.185 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -95.82 4.0 53.24 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.738 -1.119 . . . . 0.91000000000000003 109.964 -171.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.715 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.5 mm-40 47.08 66.14 1.07 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.448 -2.16 . . . . 2.2200000000000002 112.129 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.5 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -148.48 125.35 11.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.286 0.565 . . . . 0.13 109.916 -175.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.691 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -112.35 127.42 56.0 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 123.606 0.763 . . . . 0.059999999999999998 110.359 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.684 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -113.62 173.7 6.28 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.609 -1.178 . . . . 0.10000000000000001 112.062 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.717 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -126.49 115.83 20.17 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 106.529 -1.656 . . . . 0.22 106.529 165.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.508 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.9 m-85 -100.44 127.91 46.65 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.993 0.901 . . . . 0.17999999999999999 112.118 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.614 ' HA ' HG23 ' A' ' 343' ' ' THR . 6.0 ttpt -147.79 137.68 22.71 Favored 'General case' 0 N--CA 1.398 -3.034 0 CA-C-N 113.667 -1.606 . . . . 0.46999999999999997 108.548 174.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 70.48 14.2 7.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.402 -1.726 . . . . 0.59999999999999998 108.601 178.439 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.49 71.01 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 112.701 -2.045 . . . . 0.23000000000000001 112.186 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.583 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.69 169.9 16.97 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.158 -1.793 . . . . 0.68000000000000005 106.158 -170.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -101.41 138.23 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 CA-C-O 124.207 1.956 . . . . 0.53000000000000003 111.976 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.717 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.63 -25.01 18.48 Favored 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 109.361 -3.563 . . . . 0.12 108.688 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.714 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.87 155.18 36.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 113.74 -1.573 . . . . 0.080000000000000002 109.301 -173.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.8 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.14 123.0 1.6 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.469 -0.787 . . . . 0.60999999999999999 109.339 -175.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.815 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.9 t -148.32 165.68 30.31 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 122.415 1.102 . . . . 0.089999999999999997 112.017 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.734 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.7 p-10 -83.46 140.85 32.09 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 112.881 -1.963 . . . . 1.8799999999999999 107.821 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.26 -171.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.264 -0.88 . . . . 0.11 112.064 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.715 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -157.94 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.936 -1.029 . . . . 0.12 109.352 176.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.5 t -140.94 145.54 36.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.28 -0.873 . . . . 0.69999999999999996 112.892 -165.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 68.54 46.68 61.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 116.199 1.24 . . . . 0.13 116.199 162.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.562 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.38 145.42 2.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 118.267 1.033 . . . . 0.47999999999999998 110.184 -175.252 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.771 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.47 -33.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 125.242 3.961 . . . . 0.23000000000000001 115.911 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.562 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -80.41 -34.4 36.24 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.738 -0.601 . . . . 0.29999999999999999 110.752 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.456 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.3 m -139.98 73.06 33.53 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 122.209 1.004 . . . . 0.29999999999999999 109.994 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 29.5 Cg_exo -69.71 161.62 45.24 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 C-N-CA 125.301 4.001 . . . . 0.16 113.967 -177.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.696 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -72.99 154.03 90.85 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.562 -1.654 . . . . 0.12 110.358 175.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.543 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -80.24 -50.32 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 125.029 3.82 . . . . 0.089999999999999997 113.564 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.714 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.8 123.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.996 0.903 . . . . 0.089999999999999997 113.322 -176.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.29 -124.07 1.22 Allowed Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.271 -1.331 . . . . 0.11 111.491 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 381' ' ' VAL . 9.2 p -128.63 104.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.454 1.121 . . . . 0.89000000000000001 109.831 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.785 ' HB2' HG22 ' A' ' 463' ' ' VAL . 93.8 m-85 -107.92 161.35 15.01 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.516 -1.22 . . . . 0.16 110.03 -170.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.5 m-85 -147.3 136.99 22.92 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 122.974 0.171 . . . . 0.68999999999999995 110.694 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.625 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.2 120.36 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.937 -0.705 . . . . 0.14000000000000001 110.16 176.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . 0.467 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 40.6 p-90 -106.31 3.62 27.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.404 -0.816 . . . . 0.19 111.789 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.721 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.7 t30 -164.54 148.86 9.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.224 -0.898 . . . . 0.40999999999999998 110.813 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.483 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.3 mtpt -107.4 111.16 23.36 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.478 -0.783 . . . . 1.0900000000000001 109.863 169.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.1 mt-10 -111.87 122.92 49.11 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.657 1.218 . . . . 0.38 110.912 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -118.1 145.0 45.18 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.079 -1.419 . . . . 1.96 109.253 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 34.6 t70 54.34 25.88 6.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 112.026 -2.352 . . . . 0.40000000000000002 108.582 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.09 170.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.09 -1.868 . . . . 0.16 112.063 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 31.5 m -127.49 102.26 6.79 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.526 -1.67 . . . . 0.27000000000000002 110.099 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.746 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.9 mp -72.9 158.46 35.46 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 113.03 -1.896 . . . . 0.23999999999999999 110.502 175.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 6.4 mtpt . . . . . 0 N--CA 1.396 -3.148 0 N-CA-C 108.636 -0.876 . . . . 0.67000000000000004 108.636 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.1 mt-10 . . . . . 0 CA--C 1.509 -0.603 0 CA-C-O 122.342 1.067 . . . . 0.62 111.692 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.746 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.2 98.95 12.39 Favored Pre-proline 0 N--CA 1.42 -1.951 0 CA-C-N 113.12 -1.855 . . . . 1.3300000000000001 107.568 176.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.4 Cg_endo -67.29 102.02 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 122.318 2.012 . . . . 0.20000000000000001 110.165 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.725 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.39 163.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.853 0 CA-C-N 114.192 -1.367 . . . . 0.29999999999999999 109.914 -173.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -114.92 -33.8 5.32 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 113.417 -1.72 . . . . 1.8400000000000001 107.081 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.423 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 59.8 m-85 -134.87 115.68 13.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.629 -2.078 . . . . 0.44 110.485 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.725 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.5 t-105 -123.81 134.27 53.66 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.13 110.254 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.584 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -135.56 85.04 32.22 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.936 -1.029 . . . . 0.40999999999999998 110.93 173.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 73.2 Cg_endo -70.52 140.65 40.3 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.929 2.42 . . . . 0.16 112.102 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.728 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -124.39 -16.19 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.076 -1.42 . . . . 0.17000000000000001 111.162 -173.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -134.88 161.0 36.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.536 -0.756 . . . . 1.5900000000000001 109.532 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -92.13 13.84 17.81 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.147 0.425 . . . . 0.31 112.147 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -93.02 -25.66 17.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.745 -1.206 . . . . 0.44 107.745 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.22 29.16 1.38 Allowed Glycine 0 N--CA 1.425 -2.054 0 CA-C-N 113.073 -1.876 . . . . 0.23999999999999999 112.179 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 441' ' ' GLY . 84.8 t -102.27 148.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.281 0.562 . . . . 0.17000000000000001 110.626 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 173.97 -166.04 38.01 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.731 -1.122 . . . . 0.10000000000000001 111.186 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.411 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.67 138.99 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 108.795 -0.817 . . . . 0.12 108.795 176.074 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.543 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.3 p80 -149.98 163.63 37.59 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.652 0.739 . . . . 0.14999999999999999 111.969 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.789 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.33 137.35 32.43 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.293 -1.321 . . . . 0.41999999999999998 107.951 173.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.5 OUTLIER -130.73 101.46 5.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.421 1.105 . . . . 1.48 109.606 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -95.18 -30.54 13.96 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.082 -1.872 . . . . 0.34999999999999998 111.021 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.445 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 19.0 p90 -66.66 -26.54 67.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.414 -1.266 . . . . 0.17999999999999999 109.151 174.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.504 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.95 82.65 28.84 Favored Pre-proline 0 CA--C 1.49 -1.347 0 CA-C-N 113.614 -1.63 . . . . 1.3300000000000001 109.451 -173.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -80.86 5.94 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 124.784 3.656 . . . . 0.23000000000000001 114.21 -160.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.67 153.7 29.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.336 -0.393 . . . . 1.1000000000000001 110.614 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.734 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.95 124.73 2.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.214 -1.357 . . . . 0.38 108.097 -172.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.86 -168.12 28.75 Favored Glycine 0 C--N 1.297 -1.629 0 C-N-CA 119.283 -1.437 . . . . 0.13 111.123 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.673 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.6 152.33 0.0 OUTLIER Glycine 0 C--N 1.342 0.891 0 O-C-N 125.141 1.142 . . . . 0.20000000000000001 113.176 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.6 m-20 -54.59 101.06 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 123.86 1.79 . . . . 0.33000000000000002 111.797 -145.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 55.6 mt -96.53 -30.79 13.11 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 110.474 -3.057 . . . . 0.17999999999999999 108.111 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.593 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.0 p-90 -46.46 -38.01 8.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.867 0.73 . . . . 0.22 111.398 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.771 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 36.4 mttt -62.3 -24.34 67.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.921 -1.036 . . . . 0.64000000000000001 112.845 -175.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 31.1 p -113.23 -36.18 5.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.568 0.699 . . . . 0.25 110.16 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.519 ' HB2' HG21 ' A' ' 369' ' ' VAL . 5.7 mtp85 -86.96 -16.83 34.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.783 -1.099 . . . . 0.35999999999999999 112.664 -168.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.497 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.47 43.79 29.34 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 116.506 1.362 . . . . 0.20999999999999999 116.506 162.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -86.21 130.74 34.42 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 118.701 1.251 . . . . 0.46999999999999997 108.179 172.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -99.72 64.34 1.27 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.47 -0.769 . . . . 0.40999999999999998 110.96 -168.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.566 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 94.9 -12.75 68.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.577 -1.009 . . . . 0.17999999999999999 110.577 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.517 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 10.7 p -90.49 142.77 27.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.238 -0.481 . . . . 0.82999999999999996 110.66 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -95.91 120.74 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 122.579 1.18 . . . . 0.14999999999999999 111.19 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.5 OUTLIER -78.92 82.48 5.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.784 -2.007 . . . . 1.77 111.936 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.567 HG23 HG21 ' A' ' 366' ' ' THR . 16.5 m -87.05 137.75 32.99 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-O 121.383 0.611 . . . . 0.17999999999999999 109.509 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.499 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 50.9 Cg_exo -57.42 136.14 74.21 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.723 2.282 . . . . 0.12 111.595 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.789 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.8 Cg_exo -55.14 -33.0 82.44 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 124.245 3.297 . . . . 0.16 113.138 -172.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.418 ' O ' ' HG2' ' A' ' 452' ' ' GLU . 4.6 t -81.42 -38.51 26.38 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.883 -1.053 . . . . 1.1699999999999999 109.304 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.815 HG11 ' HB ' ' A' ' 366' ' ' THR . 26.1 t -82.9 -26.85 8.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.652 . . . . 0.17000000000000001 111.11 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.699 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.7 tpt -68.58 -19.92 64.49 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.878 0.847 . . . . 0.46000000000000002 110.073 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.48 -23.22 46.53 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.609 -1.178 . . . . 0.81000000000000005 111.075 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.84 -45.97 16.05 Favored 'General case' 0 CA--C 1.477 -1.838 0 CA-C-N 112.905 -1.952 . . . . 0.38 107.473 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.597 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -65.01 -66.85 0.49 Allowed 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 111.89 -2.414 . . . . 0.059999999999999998 112.311 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.434 ' HB2' ' HE3' ' A' ' 450' ' ' MET . 24.1 t80 -50.16 -27.86 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.94 1.352 . . . . 0.31 107.965 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.58 -30.13 71.09 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 112.491 -2.14 . . . . 0.13 112.469 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.714 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.88 -48.26 7.35 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.597 0.713 . . . . 0.13 111.611 172.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.24 138.69 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 123.365 1.555 . . . . 0.23000000000000001 114.182 -167.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.483 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.4 -178.74 5.3 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 110.834 -2.894 . . . . 0.82999999999999996 106.845 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.9 mtmt -52.22 162.77 0.45 Allowed 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 123.114 1.435 . . . . 0.23999999999999999 113.058 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.64 -34.63 4.27 Favored Glycine 0 N--CA 1.424 -2.149 0 CA-C-N 112.48 -2.145 . . . . 0.37 112.283 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 462' ' ' PRO . 7.6 m -76.04 141.33 71.01 Favored Pre-proline 0 N--CA 1.434 -1.261 0 N-CA-C 109.484 -0.562 . . . . 0.14999999999999999 109.484 -176.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.642 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.6 166.47 28.4 Favored 'Trans proline' 0 N--CA 1.425 -2.53 0 C-N-CA 122.024 1.816 . . . . 0.12 111.157 173.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.63 153.2 34.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 107.634 -1.247 . . . . 1.0900000000000001 107.634 166.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.3 tp -123.4 145.25 48.93 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.096 -0.956 . . . . 0.13 110.155 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.28 146.05 21.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.413 -1.699 . . . . 0.089999999999999997 106.413 164.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.654 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 18.0 p90 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.62 -0.705 . . . . 1.1599999999999999 111.364 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.602 HG23 ' HA ' ' A' ' 358' ' ' LYS . 27.1 m . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.959 -1.126 . . . . 0.45000000000000001 107.959 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.656 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.4 p90 -161.0 -170.75 2.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.153 -0.931 . . . . 0.32000000000000001 110.768 -175.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.45 161.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.097 -1.075 . . . . 0.080000000000000002 108.097 167.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.518 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.7 tt0 -140.35 155.85 46.63 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.956 0.798 . . . . 0.17000000000000001 111.253 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.727 HG22 ' HG3' ' A' ' 354' ' ' MET . 67.0 t -150.84 133.4 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.413 -1.267 . . . . 0.080000000000000002 109.721 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 50.9 t0 -115.05 111.78 21.61 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.336 -1.357 . . . . 0.37 107.336 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.645 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.6 mm? -60.61 -58.67 7.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.783 1.277 . . . . 0.32000000000000001 107.618 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.496 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 11.9 mm-40 -48.94 -46.85 43.92 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 111.353 -2.658 . . . . 1.51 112.943 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -111.13 20.73 17.13 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 125.206 1.567 . . . . 0.91000000000000003 109.203 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.713 ' NE2' ' HA2' ' A' ' 431' ' ' GLY . 1.2 mp0 36.24 68.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.27 -1.787 . . . . 2.2200000000000002 112.622 170.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.499 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -153.17 124.5 7.58 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.194 0.521 . . . . 0.13 109.914 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.727 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -110.91 127.54 55.5 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.454 0.702 . . . . 0.059999999999999998 110.605 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.654 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.1 m-90 -112.25 173.76 6.21 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 114.459 -1.246 . . . . 0.10000000000000001 112.05 -175.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.718 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.3 t80 -127.41 119.15 25.51 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 106.261 -1.755 . . . . 0.22 106.261 165.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.522 ' CE1' HG12 ' A' ' 362' ' ' VAL . 18.5 m-85 -102.49 129.52 49.03 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.941 0.877 . . . . 0.17999999999999999 111.524 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.5 ttpt -148.46 137.43 21.7 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 113.722 -1.581 . . . . 0.46999999999999997 108.116 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.38 15.1 6.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.456 -1.702 . . . . 0.59999999999999998 108.752 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 80.51 17.79 72.57 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 112.667 -2.06 . . . . 0.23000000000000001 111.899 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.546 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -137.12 168.07 20.31 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.098 -1.816 . . . . 0.68000000000000005 106.098 -171.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.687 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -100.11 138.21 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.802 0 CA-C-O 124.25 1.976 . . . . 0.53000000000000003 111.874 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.718 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.24 -25.18 17.9 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 109.305 -3.589 . . . . 0.12 108.564 177.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.679 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -152.46 155.36 37.36 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.868 -1.515 . . . . 0.080000000000000002 109.227 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.687 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.93 122.51 1.36 Allowed 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 109.614 -174.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.74 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.6 t -148.3 167.16 25.9 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.177 0.989 . . . . 0.089999999999999997 112.136 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.5 p-10 -86.77 140.93 29.25 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.222 -1.808 . . . . 1.8799999999999999 107.916 177.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -143.15 -172.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.309 -0.859 . . . . 0.11 112.484 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.63 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -154.36 119.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.705 -1.134 . . . . 0.12 108.696 175.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 6.6 t -141.27 143.41 34.09 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.759 -0.655 . . . . 0.69999999999999996 112.742 -168.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.53 45.1 24.59 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 117.716 -1.602 . . . . 0.13 117.001 163.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.435 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.3 OUTLIER -46.71 143.85 3.94 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-N 119.722 1.761 . . . . 0.47999999999999998 110.363 -173.146 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.824 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.68 -33.67 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.948 4.432 . . . . 0.23000000000000001 115.912 -170.811 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 3.1 p -75.06 -37.97 61.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.3 0.571 . . . . 0.29999999999999999 111.076 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.1 m -140.55 74.31 28.32 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.106 0.955 . . . . 0.29999999999999999 110.606 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.4 Cg_exo -70.94 160.44 49.37 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 125.175 3.917 . . . . 0.16 113.853 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.69 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -71.1 153.09 94.65 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.269 -1.787 . . . . 0.12 111.357 177.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.526 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.5 Cg_endo -80.17 -49.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 125.09 3.86 . . . . 0.089999999999999997 113.734 -171.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.701 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.3 122.86 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.737 1.014 . . . . 0.089999999999999997 113.737 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.08 -124.74 1.28 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.242 -1.345 . . . . 0.11 111.423 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.6 p -128.72 105.65 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 122.296 1.046 . . . . 0.89000000000000001 109.267 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.814 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.8 m-85 -108.97 164.16 12.65 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.138 -0.937 . . . . 0.16 110.058 -169.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.694 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 68.9 m-85 -147.34 137.23 23.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 121.196 -0.202 . . . . 0.68999999999999995 110.954 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.589 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.63 121.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.491 0.662 . . . . 0.14000000000000001 110.364 176.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . 0.405 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 42.7 p-90 -108.62 5.86 25.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.421 -0.809 . . . . 0.19 111.88 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.729 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 4.2 t30 -164.6 146.82 8.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.874 . . . . 0.40999999999999998 110.251 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -108.89 115.63 30.45 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.958 -0.756 . . . . 1.0900000000000001 108.958 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.572 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -118.65 111.98 19.23 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.472 1.606 . . . . 0.38 113.065 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 2.6 mp0 -103.84 143.74 32.42 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 113.289 -1.778 . . . . 1.96 109.708 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.7 t70 57.08 22.23 7.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.259 -2.246 . . . . 0.40000000000000002 108.604 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.572 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -82.33 171.15 14.53 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.403 -1.726 . . . . 0.16 112.56 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 15.7 m -127.5 104.23 7.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.051 -1.886 . . . . 0.27000000000000002 110.004 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.735 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.0 mp -73.26 156.99 37.93 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 112.642 -2.072 . . . . 0.23999999999999999 109.98 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.491 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.3 mtpt . . . . . 0 N--CA 1.398 -3.058 0 O-C-N 124.352 1.032 . . . . 0.67000000000000004 108.789 -176.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.2 mt-10 . . . . . 0 CA--C 1.512 -0.487 0 CA-C-O 122.392 1.091 . . . . 0.62 112.112 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.735 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.91 99.22 10.24 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-N 112.948 -1.933 . . . . 1.3300000000000001 108.239 176.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 64.0 Cg_endo -67.62 102.24 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.549 2.166 . . . . 0.20000000000000001 110.669 175.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -113.64 165.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 114.238 -1.346 . . . . 0.29999999999999999 109.84 -173.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.0 m-80 -116.3 -33.5 4.95 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.551 -1.659 . . . . 1.8400000000000001 107.083 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.412 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 46.3 m-85 -136.2 115.47 12.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.062 -1.881 . . . . 0.44 110.474 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.757 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.7 t-105 -122.95 135.77 54.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.712 -1.131 . . . . 0.13 110.065 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.57 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.8 OUTLIER -136.51 83.49 30.88 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.892 -1.049 . . . . 0.40999999999999998 110.923 173.496 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 13.9 Cg_endo -70.31 139.5 38.44 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.141 2.561 . . . . 0.16 112.659 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.93 -15.15 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 113.792 -1.549 . . . . 0.17000000000000001 111.453 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -134.39 163.64 29.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 1.5900000000000001 109.483 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -96.96 13.55 28.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.801 0.334 . . . . 0.31 111.735 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.4 p -92.45 -27.06 17.7 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.538 -1.282 . . . . 0.44 107.538 173.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.68 29.36 1.07 Allowed Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 112.862 -1.972 . . . . 0.23999999999999999 112.353 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 441' ' ' GLY . 74.3 t -102.47 148.76 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.232 0.539 . . . . 0.17000000000000001 111.142 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.49 -167.46 39.78 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.831 -1.077 . . . . 0.10000000000000001 111.336 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.61 141.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.858 -0.793 . . . . 0.12 108.858 175.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.593 ' O ' ' HB ' ' A' ' 445' ' ' THR . 32.9 p80 -149.46 165.16 32.95 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.747 0.784 . . . . 0.14999999999999999 111.616 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -93.28 139.39 30.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.019 -1.475 . . . . 0.41999999999999998 107.019 171.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.42 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 1.8 t -134.06 103.2 5.69 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.97 1.367 . . . . 1.48 110.066 -176.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.49 -32.36 13.53 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 112.234 -2.257 . . . . 0.34999999999999998 111.162 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -65.67 -27.19 68.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.55 -1.205 . . . . 0.17999999999999999 109.055 175.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.592 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -121.36 82.62 39.21 Favored Pre-proline 0 CA--C 1.493 -1.221 0 CA-C-N 113.406 -1.724 . . . . 1.3300000000000001 109.485 -174.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -81.24 7.33 5.03 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 C-N-CA 124.818 3.678 . . . . 0.23000000000000001 114.471 -160.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.68 154.46 27.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.009 0.433 . . . . 1.1000000000000001 111.303 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.606 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.97 126.0 2.39 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.178 -1.374 . . . . 0.38 108.86 -171.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . 0.565 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 146.95 -166.63 28.38 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.68 -1.248 . . . . 0.13 110.65 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.713 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -29.14 151.89 0.0 OUTLIER Glycine 0 C--N 1.341 0.822 0 O-C-N 125.187 1.169 . . . . 0.20000000000000001 113.258 173.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.01 100.5 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 111.944 -152.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.3 mt -97.69 -32.12 11.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 110.403 -3.089 . . . . 0.17999999999999999 107.941 174.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.63 ' HA ' HG23 ' A' ' 369' ' ' VAL . 3.8 p-90 -46.0 -38.54 7.89 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.987 0.804 . . . . 0.22 111.414 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.824 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 34.9 mttt -59.11 -26.63 64.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 114.781 -1.1 . . . . 0.64000000000000001 113.021 -176.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.6 p -111.53 -35.35 5.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.898 0.856 . . . . 0.25 109.859 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.592 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.0 mtp85 -86.77 -15.55 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.439 -1.255 . . . . 0.35999999999999999 112.647 -168.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.435 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.65 41.89 33.95 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 116.608 1.403 . . . . 0.20999999999999999 116.608 159.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.7 p -91.07 131.76 36.45 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 118.318 1.059 . . . . 0.46999999999999997 109.124 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 71.3 m80 -98.6 69.08 1.86 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.673 -0.642 . . . . 0.40999999999999998 111.209 -167.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 88.41 -11.77 66.96 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 110.39 -1.084 . . . . 0.17999999999999999 110.39 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 18.4 p -86.88 141.34 28.84 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.181 -0.51 . . . . 0.82999999999999996 109.924 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.69 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -95.52 117.71 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.668 0.747 . . . . 0.14999999999999999 110.781 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.603 ' HB3' HG13 ' A' ' 369' ' ' VAL . 2.1 t30 -76.86 82.59 3.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.498 -1.228 . . . . 1.77 111.354 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.4 m -86.94 138.85 32.75 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-O 121.549 0.69 . . . . 0.17999999999999999 109.628 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.6 Cg_exo -58.13 135.26 67.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.654 2.236 . . . . 0.12 111.416 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 30.3 Cg_exo -54.44 -34.08 79.97 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 124.299 3.333 . . . . 0.16 112.783 -174.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 44.7 m -78.98 -41.37 29.29 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.458 -1.247 . . . . 1.1699999999999999 110.07 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.74 HG11 ' HB ' ' A' ' 366' ' ' THR . 54.0 t -79.21 -28.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.252 0.549 . . . . 0.17000000000000001 111.487 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.692 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.8 tpt -68.29 -18.58 64.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.775 0.797 . . . . 0.46000000000000002 110.096 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.09 -22.23 42.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.7 -1.136 . . . . 0.81000000000000005 110.875 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.687 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.3 mm-40 -81.0 -47.3 13.81 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 112.767 -2.015 . . . . 0.38 107.38 177.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.629 HD23 ' SD ' ' A' ' 450' ' ' MET . 25.5 tp -64.28 -67.01 0.47 Allowed 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 111.878 -2.419 . . . . 0.059999999999999998 112.318 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.442 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.0 t80 -49.76 -26.8 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 123.181 1.467 . . . . 0.31 108.285 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.7 -30.95 65.54 Favored Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 112.251 -2.25 . . . . 0.13 112.331 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.687 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -89.19 -48.88 7.08 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 121.688 0.756 . . . . 0.13 111.572 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -100.26 139.23 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 123.328 1.537 . . . . 0.23000000000000001 113.764 -168.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -136.19 -178.78 5.31 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 110.816 -2.902 . . . . 0.82999999999999996 106.883 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.729 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.6 mtmt -52.98 162.73 0.59 Allowed 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 123.025 1.393 . . . . 0.23999999999999999 112.694 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.4 -36.51 3.61 Favored Glycine 0 N--CA 1.423 -2.207 0 CA-C-N 112.577 -2.101 . . . . 0.37 112.514 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.1 m -74.27 141.72 77.66 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.471 -0.566 . . . . 0.14999999999999999 109.471 -175.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 3.7 Cg_exo -74.39 167.74 26.44 Favored 'Trans proline' 0 N--CA 1.424 -2.559 0 C-N-CA 121.765 1.644 . . . . 0.12 111.041 173.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.814 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.57 156.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 107.504 -1.295 . . . . 1.0900000000000001 107.504 166.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 346' ' ' GLU . 2.8 tp -126.98 145.15 50.8 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.462 -0.79 . . . . 0.13 110.233 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.701 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.27 146.7 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 106.869 -1.53 . . . . 0.089999999999999997 106.869 164.429 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.685 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.7 p90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.372 -0.823 . . . . 1.1599999999999999 111.477 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 358' ' ' LYS . 33.1 m . . . . . 0 N--CA 1.424 -1.726 0 N-CA-C 108.524 -0.917 . . . . 0.45000000000000001 108.524 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.64 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 7.9 p90 -162.33 -170.32 2.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.913 -1.039 . . . . 0.32000000000000001 110.585 -174.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.562 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.1 mm -101.71 160.98 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.078 -1.082 . . . . 0.080000000000000002 108.078 166.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.479 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 3.6 tt0 -140.95 154.62 46.16 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 118.805 0.73 . . . . 0.17000000000000001 110.898 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.712 HG22 ' HG3' ' A' ' 354' ' ' MET . 61.4 t -150.24 134.69 9.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.31 -1.314 . . . . 0.080000000000000002 109.296 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -117.51 110.42 17.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.202 -1.407 . . . . 0.37 107.202 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.63 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -58.52 -56.98 15.13 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.835 -1.172 . . . . 0.32000000000000001 107.835 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -46.27 -51.21 14.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 111.956 -2.384 . . . . 1.51 112.993 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -100.73 4.42 43.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.394 -1.73 . . . . 0.91000000000000003 110.082 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.677 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 1.7 mp0 47.42 67.01 0.88 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 112.428 -2.169 . . . . 2.2200000000000002 112.363 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.3 t60 -146.79 125.69 12.74 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.377 0.608 . . . . 0.13 110.107 -177.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.712 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -112.6 128.38 56.35 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.54 0.736 . . . . 0.059999999999999998 110.658 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.675 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.76 173.27 6.46 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.44 -1.254 . . . . 0.10000000000000001 111.869 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.688 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.0 t80 -126.93 116.67 21.16 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.33 -1.729 . . . . 0.22 106.33 165.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 24.4 m-85 -100.53 128.93 46.44 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.899 0.857 . . . . 0.17999999999999999 111.609 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.606 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.5 ttpt -148.18 137.37 22.02 Favored 'General case' 0 N--CA 1.399 -3.013 0 CA-C-N 113.761 -1.563 . . . . 0.46999999999999997 108.473 173.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.73 16.69 6.71 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 113.332 -1.758 . . . . 0.59999999999999998 108.803 178.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.9 72.06 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 112.652 -2.067 . . . . 0.23000000000000001 111.819 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.574 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.96 169.56 17.57 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.349 -1.723 . . . . 0.68000000000000005 106.349 -170.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.692 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -102.36 138.36 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.865 0 CA-C-O 124.252 1.977 . . . . 0.53000000000000003 111.839 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.18 -25.37 17.87 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 109.24 -3.618 . . . . 0.12 108.647 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.639 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -153.23 154.87 35.53 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.762 -1.563 . . . . 0.080000000000000002 108.654 -171.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.692 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.59 122.07 1.17 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.738 -0.665 . . . . 0.60999999999999999 109.651 -174.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.678 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.8 t -148.74 167.09 26.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.089999999999999997 112.01 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.666 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.2 p-10 -85.13 142.01 29.81 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 113.061 -1.881 . . . . 1.8799999999999999 107.69 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.677 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -142.02 -174.34 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.257 -0.883 . . . . 0.11 112.122 -175.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.709 ' O ' ' HB2' ' A' ' 444' ' ' ASN . 0.2 OUTLIER -152.46 117.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.931 . . . . 0.12 109.318 175.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 30.2 t -141.54 148.25 39.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.963 0.727 . . . . 0.69999999999999996 112.963 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.61 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.7 44.96 47.02 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 116.197 1.239 . . . . 0.13 116.197 162.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.573 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.9 143.76 4.2 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 118.317 1.058 . . . . 0.47999999999999998 109.977 -174.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.796 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.19 -32.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.826 1 C-N-CA 125.705 4.27 . . . . 0.23000000000000001 116.08 -170.681 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . 0.573 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.35 -34.56 31.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.359 0.599 . . . . 0.29999999999999999 110.755 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.465 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 m -140.04 73.04 33.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 122.125 0.964 . . . . 0.29999999999999999 110.302 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.61 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.81 161.47 44.97 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 125.22 3.947 . . . . 0.16 113.869 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.723 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.52 151.97 91.71 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 113.333 -1.758 . . . . 0.12 111.05 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.521 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.9 Cg_endo -80.0 -48.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 125.277 3.984 . . . . 0.089999999999999997 113.913 -170.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.697 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.32 122.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.992 1.108 . . . . 0.089999999999999997 113.992 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.36 -125.88 1.43 Allowed Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.121 -1.4 . . . . 0.11 110.778 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.7 p -125.77 112.57 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.921 0.867 . . . . 0.89000000000000001 108.761 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.803 ' HB2' HG22 ' A' ' 463' ' ' VAL . 98.1 m-85 -114.17 163.35 15.34 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.296 -0.866 . . . . 0.16 109.994 -169.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 71.8 m-85 -146.68 136.68 23.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 121.188 -0.205 . . . . 0.68999999999999995 110.974 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.89 123.13 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 C-N-CA 119.938 -0.705 . . . . 0.14000000000000001 110.552 177.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -107.08 3.41 25.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.602 -0.727 . . . . 0.19 112.035 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.737 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.4 t30 -165.4 148.44 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.461 -0.79 . . . . 0.40999999999999998 110.764 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . 0.423 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 13.5 mtpt -107.59 109.05 20.6 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.444 -0.798 . . . . 1.0900000000000001 109.714 168.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.3 mt-10 -106.41 121.21 43.8 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.44 1.114 . . . . 0.38 110.634 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -120.62 134.84 55.24 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.535 -1.211 . . . . 1.96 110.511 -174.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.58 38.72 23.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 123.636 1.684 . . . . 0.40000000000000002 107.141 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.29 169.4 11.14 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 112.1 -2.318 . . . . 0.16 111.671 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 7.6 m -127.24 105.12 8.34 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 113.417 -1.719 . . . . 0.27000000000000002 109.626 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.734 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.27 157.67 35.42 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 112.963 -1.926 . . . . 0.23999999999999999 110.302 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.1 mtpt . . . . . 0 N--CA 1.397 -3.094 0 CA-C-N 114.793 -1.094 . . . . 0.67000000000000004 108.454 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.4 mt-10 . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 122.034 0.921 . . . . 0.62 111.914 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.734 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.68 99.75 10.31 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-N 113.355 -1.748 . . . . 1.3300000000000001 108.046 176.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.0 Cg_endo -67.41 102.83 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.577 2.185 . . . . 0.20000000000000001 110.653 174.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.781 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.31 156.68 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.588 0 CA-C-N 114.146 -1.388 . . . . 0.29999999999999999 109.776 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -105.17 -34.67 7.85 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.529 -1.669 . . . . 1.8400000000000001 107.359 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.775 ' HB2' ' SD ' ' A' ' 450' ' ' MET . 52.4 m-85 -137.85 119.43 14.97 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.306 -1.77 . . . . 0.44 111.217 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.781 ' HB2' HG11 ' A' ' 407' ' ' VAL . 8.1 t-105 -125.2 135.58 52.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 113.841 -1.527 . . . . 0.13 110.185 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.542 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -134.94 85.18 35.59 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 114.992 -1.004 . . . . 0.40999999999999998 111.152 174.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 87.5 Cg_endo -72.29 141.23 35.18 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.161 2.574 . . . . 0.16 112.469 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -124.97 -15.93 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 113.828 -1.533 . . . . 0.17000000000000001 111.031 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.93 162.32 32.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.303 -0.862 . . . . 1.5900000000000001 109.393 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -95.03 13.78 23.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.355 0.502 . . . . 0.31 112.355 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 13.1 p -94.0 -26.66 16.71 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.531 -1.285 . . . . 0.44 107.531 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.67 33.25 0.77 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.108 -1.86 . . . . 0.23999999999999999 112.32 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 441' ' ' GLY . 79.8 t -103.16 148.48 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.184 0.516 . . . . 0.17000000000000001 110.963 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 169.97 -167.43 40.52 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.948 -1.024 . . . . 0.10000000000000001 111.446 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . 0.491 HG21 HD23 ' A' ' 453' ' ' LEU . 0.9 OUTLIER -101.97 140.08 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 109.141 -0.688 . . . . 0.12 109.141 174.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.542 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 32.2 p80 -146.52 160.54 41.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.956 0.884 . . . . 0.14999999999999999 111.712 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -85.72 136.9 33.16 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 113.817 -1.538 . . . . 0.41999999999999998 107.399 170.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.95 102.01 5.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 123.015 1.388 . . . . 1.48 110.999 -175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -94.82 -33.48 12.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 112.168 -2.287 . . . . 0.34999999999999998 111.484 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.462 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 21.5 p90 -66.48 -27.24 67.64 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.687 -1.142 . . . . 0.17999999999999999 109.505 175.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.695 ' HB3' HD21 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -121.27 81.27 37.3 Favored Pre-proline 0 CA--C 1.494 -1.202 0 CA-C-N 113.664 -1.607 . . . . 1.3300000000000001 110.351 -174.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -82.2 7.84 4.86 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 125.062 3.841 . . . . 0.23000000000000001 114.162 -163.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -114.58 153.35 30.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 123.462 0.476 . . . . 1.1000000000000001 110.267 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.666 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.47 126.87 2.72 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.756 1.285 . . . . 0.38 108.202 -169.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 146.55 -164.54 28.43 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 118.849 -1.643 . . . . 0.13 111.193 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -27.84 151.04 0.0 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 125.208 1.181 . . . . 0.20000000000000001 113.075 171.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 112.031 -149.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 40.4 mt -97.44 -33.87 11.23 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 110.583 -3.008 . . . . 0.17999999999999999 107.95 174.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.567 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.1 p-90 -46.2 -37.45 7.12 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.638 0.586 . . . . 0.22 111.61 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.796 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 32.3 mttt -61.5 -23.74 66.11 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.223 -0.899 . . . . 0.64000000000000001 112.923 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.5 p -113.58 -35.02 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.886 0.851 . . . . 0.25 109.879 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.525 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 3.7 mtp180 -87.2 -16.49 35.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.612 -1.176 . . . . 0.35999999999999999 112.785 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.01 41.75 39.28 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.264 1.266 . . . . 0.20999999999999999 116.264 159.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.0 m -84.21 133.83 34.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 118.233 1.016 . . . . 0.46999999999999997 108.541 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -103.96 68.14 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.45 -0.781 . . . . 0.40999999999999998 110.884 -166.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.679 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 89.46 -11.11 70.97 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.518 -1.033 . . . . 0.17999999999999999 110.518 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.6 p -90.68 137.24 32.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.211 -0.494 . . . . 0.82999999999999996 110.667 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 377' ' ' THR . 1.4 mp -92.01 120.6 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 CA-C-O 122.734 1.254 . . . . 0.14999999999999999 111.164 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.709 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.8 OUTLIER -79.42 82.44 5.56 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.317 -2.22 . . . . 1.77 112.14 -177.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 366' ' ' THR . 19.6 m -86.75 137.72 33.63 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-O 121.499 0.666 . . . . 0.17999999999999999 109.599 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 49.4 Cg_exo -58.67 134.12 58.68 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.562 2.174 . . . . 0.12 110.679 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.9 Cg_exo -56.43 -34.89 95.69 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 C-N-CA 123.881 3.054 . . . . 0.16 112.938 -171.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.8 m -77.21 -37.59 53.12 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.698 -1.137 . . . . 1.1699999999999999 109.778 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.678 HG11 ' HB ' ' A' ' 366' ' ' THR . 59.2 t -80.77 -27.39 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.835 -0.62 . . . . 0.17000000000000001 111.063 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.775 ' SD ' ' HB2' ' A' ' 409' ' ' TYR . 0.0 OUTLIER -63.62 -35.48 80.66 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-O 121.859 0.838 . . . . 0.46000000000000002 109.281 177.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -64.54 -25.03 67.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.48 -1.236 . . . . 0.81000000000000005 111.985 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 456' ' ' MET . 16.1 mm-40 -79.1 -46.96 17.0 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 113.692 -1.595 . . . . 0.38 107.64 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.531 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 28.8 tp -64.48 -67.16 0.46 Allowed 'General case' 0 N--CA 1.404 -2.772 0 CA-C-N 111.644 -2.525 . . . . 0.059999999999999998 112.55 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.673 ' HB2' ' SD ' ' A' ' 450' ' ' MET . 39.8 t80 -49.31 -28.62 5.03 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.216 1.484 . . . . 0.31 107.919 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.65 -32.43 74.57 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 112.143 -2.298 . . . . 0.13 112.058 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.647 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -87.83 -48.09 8.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.66 0.743 . . . . 0.13 111.677 172.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.562 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.3 138.39 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 123.604 1.669 . . . . 0.23000000000000001 114.239 -167.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . 0.423 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.6 pt-20 -136.88 -178.27 5.12 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 110.634 -2.985 . . . . 0.82999999999999996 106.504 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.737 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.0 mtmt -53.17 163.39 0.55 Allowed 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 123.129 1.442 . . . . 0.23999999999999999 112.661 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.49 4.74 Favored Glycine 0 N--CA 1.423 -2.179 0 CA-C-N 112.496 -2.138 . . . . 0.37 112.26 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 462' ' ' PRO . 8.7 m -76.65 141.61 69.21 Favored Pre-proline 0 N--CA 1.433 -1.321 0 N-CA-C 109.335 -0.617 . . . . 0.14999999999999999 109.335 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.64 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -75.26 166.34 29.08 Favored 'Trans proline' 0 N--CA 1.425 -2.525 0 C-N-CA 121.833 1.689 . . . . 0.12 110.865 173.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.71 155.79 39.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 107.449 -1.315 . . . . 1.0900000000000001 107.449 167.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -126.39 145.06 50.61 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.327 -0.851 . . . . 0.13 110.051 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.697 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.22 147.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 N-CA-C 107.189 -1.411 . . . . 0.089999999999999997 107.189 164.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.645 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.274 -0.869 . . . . 1.1599999999999999 111.496 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.5 m . . . . . 0 N--CA 1.429 -1.488 0 N-CA-C 107.761 -1.2 . . . . 0.45000000000000001 107.761 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' TYR . . . . . 0.631 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.0 p90 -157.11 -171.08 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.596 0.712 . . . . 0.32000000000000001 111.178 -174.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 453' ' ' LEU . 10.3 mm -103.05 161.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.055 -1.091 . . . . 0.080000000000000002 108.055 167.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.1 tt0 -141.53 155.36 45.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.493 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 354' ' ' MET . 76.2 t -150.98 137.4 12.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.701 -1.136 . . . . 0.080000000000000002 110.355 -177.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -123.48 107.34 11.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.852 -1.166 . . . . 0.37 107.852 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' LEU . . . . . 0.499 ' H ' HD22 ' A' ' 349' ' ' LEU . 2.3 mm? -68.26 -39.43 82.2 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 113.228 -1.805 . . . . 0.32000000000000001 111.24 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.4 -55.78 16.16 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.022 -2.354 . . . . 1.51 111.432 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -93.51 11.83 27.25 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.62 -1.173 . . . . 0.91000000000000003 108.654 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' GLN . . . . . 0.689 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 2.4 mm-40 35.36 73.28 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 125.537 1.773 . . . . 2.2200000000000002 113.079 177.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.0 t60 -151.15 125.59 9.48 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.333 -0.849 . . . . 0.13 109.625 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' MET . . . . . 0.73 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -113.34 127.48 56.15 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.478 0.711 . . . . 0.059999999999999998 110.358 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' TRP . . . . . 0.682 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.5 m-90 -113.14 173.68 6.27 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.659 -1.155 . . . . 0.10000000000000001 111.886 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' TYR . . . . . 0.703 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -127.12 117.44 22.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.625 -1.62 . . . . 0.22 106.625 165.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 362' ' ' VAL . 26.5 m-85 -101.37 126.33 48.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.146 0.974 . . . . 0.17999999999999999 112.362 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.8 ttpt -148.96 137.5 21.11 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 113.099 -1.864 . . . . 0.46999999999999997 108.458 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 70.52 15.98 7.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 113.334 -1.757 . . . . 0.59999999999999998 108.822 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.03 78.87 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 112.561 -2.109 . . . . 0.23000000000000001 111.551 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' LYS . . . . . 0.582 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -133.86 169.75 16.62 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.344 -1.928 . . . . 0.68000000000000005 106.255 -169.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' VAL . . . . . 0.752 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -101.03 137.5 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 CA-C-O 124.325 2.012 . . . . 0.53000000000000003 111.824 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -24.31 18.85 Favored 'General case' 0 N--CA 1.398 -3.047 0 CA-C-N 109.211 -3.632 . . . . 0.12 108.573 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' LEU . . . . . 0.672 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.71 154.93 35.0 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.729 -1.578 . . . . 0.080000000000000002 108.919 -172.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLU . . . . . 0.752 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.08 122.06 1.29 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.562 -175.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.668 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.7 t -148.7 167.58 25.16 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-O 122.22 1.009 . . . . 0.089999999999999997 112.3 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 6.3 p-10 -86.09 139.9 30.71 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.163 -1.835 . . . . 1.8799999999999999 107.913 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.689 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -140.8 -172.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.138 -0.937 . . . . 0.11 112.22 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.82 115.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.133 -0.939 . . . . 0.12 109.704 174.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' SER . . . . . 0.574 ' H ' HE22 ' A' ' 352' ' ' GLN . 30.2 t -140.54 149.67 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 0.69999999999999996 112.535 -169.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.35 44.17 52.57 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 116.854 1.502 . . . . 0.13 116.854 162.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' LYS . . . . . 0.508 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 1.6 pttt -47.61 146.1 3.86 Favored Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 119.153 1.477 . . . . 0.47999999999999998 110.683 -174.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' PRO . . . . . 0.794 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -34.19 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 1 C-N-CA 125.985 4.457 . . . . 0.23000000000000001 115.71 -174.127 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.1 p -77.43 -39.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.171 0.51 . . . . 0.29999999999999999 110.975 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 4.1 m -140.21 72.83 32.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 122.263 1.03 . . . . 0.29999999999999999 110.197 -177.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 31.9 Cg_exo -69.13 164.46 33.84 Favored 'Trans proline' 0 C--N 1.322 -0.84 1 C-N-CA 125.64 4.227 . . . . 0.16 114.463 -176.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' THR . . . . . 0.701 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -76.4 152.01 83.45 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 113.565 -1.652 . . . . 0.12 110.45 174.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.55 -49.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.328 -0.516 0 C-N-CA 125.093 3.862 . . . . 0.089999999999999997 113.813 -170.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 68.34 122.8 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.921 1.082 . . . . 0.089999999999999997 113.921 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.21 -122.26 1.07 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.257 -1.338 . . . . 0.11 111.426 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -128.01 112.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.86 0.838 . . . . 0.89000000000000001 108.812 177.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' PHE . . . . . 0.78 ' HB2' HG22 ' A' ' 463' ' ' VAL . 95.9 m-85 -115.79 161.21 19.07 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.42 -0.809 . . . . 0.16 109.697 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -147.78 136.31 21.68 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 121.132 -0.227 . . . . 0.68999999999999995 110.681 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' VAL . . . . . 0.639 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.6 125.31 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.855 -0.738 . . . . 0.14000000000000001 110.653 177.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -110.71 0.7 17.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.436 -0.802 . . . . 0.19 112.176 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' ASN . . . . . 0.729 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 5.2 t30 -162.56 149.25 13.08 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.155 -0.93 . . . . 0.40999999999999998 109.639 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -113.0 119.76 39.01 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.807 0.813 . . . . 1.0900000000000001 109.934 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' GLU . . . . . 0.568 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -119.35 121.28 39.2 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.226 -1.352 . . . . 0.38 111.229 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.78 143.58 46.83 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.032 -1.44 . . . . 1.96 109.774 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.0 t70 54.1 26.12 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.835 -2.439 . . . . 0.40000000000000002 108.637 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.26 171.16 13.88 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 112.769 -2.014 . . . . 0.16 111.879 -167.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 8.9 m -129.89 102.95 6.52 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.628 -1.624 . . . . 0.27000000000000002 110.159 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' LEU . . . . . 0.735 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.42 156.89 38.58 Favored 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 112.254 -2.248 . . . . 0.23999999999999999 110.242 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' LYS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 9.7 mtpt . . . . . 0 N--CA 1.396 -3.136 0 CA-C-N 114.436 -1.256 . . . . 0.67000000000000004 108.419 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.8 mt-10 . . . . . 0 CA--C 1.51 -0.576 0 CA-C-O 122.535 1.16 . . . . 0.62 111.446 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' SER . . . . . 0.735 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.44 99.23 9.71 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 112.822 -1.99 . . . . 1.3300000000000001 107.791 174.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.7 Cg_endo -68.17 102.1 0.77 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.269 1.979 . . . . 0.20000000000000001 110.362 174.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.69 162.56 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.631 0 CA-C-N 114.446 -1.252 . . . . 0.29999999999999999 109.95 -173.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' ASN . . . . . 0.415 HD22 ' CG ' ' A' ' 422' ' ' ASP . 23.4 m-80 -112.14 -34.99 5.77 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 113.597 -1.638 . . . . 1.8400000000000001 107.018 -177.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' TYR . . . . . 0.49 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.5 m-85 -134.56 115.89 14.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.966 -1.925 . . . . 0.44 110.879 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' TRP . . . . . 0.748 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.9 t-105 -123.41 134.78 53.93 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.237 -1.347 . . . . 0.13 110.263 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' MET . . . . . 0.577 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.1 OUTLIER -135.83 86.18 27.92 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 114.808 -1.087 . . . . 0.40999999999999998 111.293 174.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . 0.708 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 98.1 Cg_endo -71.84 140.03 34.52 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.961 2.441 . . . . 0.16 112.175 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.2 pt -123.05 -15.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 113.883 -1.508 . . . . 0.17000000000000001 110.869 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -134.86 163.55 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 1.5900000000000001 109.552 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -95.03 13.83 23.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.529 0.566 . . . . 0.31 112.529 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.6 p -93.1 -27.22 17.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.412 -1.329 . . . . 0.44 107.412 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.61 30.89 0.86 Allowed Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 112.919 -1.946 . . . . 0.23999999999999999 112.086 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 441' ' ' GLY . 70.7 t -102.08 148.88 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 120.564 -0.455 . . . . 0.17000000000000001 110.976 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 171.49 -166.47 39.51 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.118 -0.946 . . . . 0.10000000000000001 111.812 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.95 141.04 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.815 -0.809 . . . . 0.12 108.815 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' HIS . . . . . 0.554 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 33.5 p80 -150.22 165.55 32.6 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.721 0.772 . . . . 0.14999999999999999 111.215 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.72 147.98 22.59 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 113.9 -1.5 . . . . 0.41999999999999998 107.11 171.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' SER . . . . . 0.516 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 3.7 t -141.87 103.97 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.988 1.375 . . . . 1.48 110.589 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.63 -30.23 15.05 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 111.915 -2.402 . . . . 0.34999999999999998 111.13 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' TRP . . . . . 0.445 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 17.1 p90 -68.95 -27.02 65.36 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 114.52 -1.218 . . . . 0.17999999999999999 109.352 176.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' GLN . . . . . 0.516 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -119.44 81.18 22.76 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 113.581 -1.645 . . . . 1.3300000000000001 109.311 -176.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -82.32 8.13 4.7 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 124.95 3.767 . . . . 0.23000000000000001 113.694 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -114.08 147.64 38.41 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.925 0.765 . . . . 1.1000000000000001 109.572 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' TYR . . . . . 0.546 ' HA ' HG12 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -158.84 128.43 5.65 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.993 1.317 . . . . 0.38 107.67 -172.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.33 -165.16 28.67 Favored Glycine 0 N--CA 1.431 -1.68 0 C-N-CA 118.884 -1.627 . . . . 0.13 111.196 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.36 154.02 0.0 OUTLIER Glycine 0 C--N 1.336 0.58 0 O-C-N 124.879 0.988 . . . . 0.20000000000000001 113.013 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' ASP . . . . . 0.404 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.0 m-20 -56.47 101.32 0.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 123.612 1.673 . . . . 0.33000000000000002 112.143 -147.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.8 mt -97.8 -31.94 11.97 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 110.654 -2.975 . . . . 0.17999999999999999 108.178 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 434' ' ' TRP . . . . . 0.573 ' HA ' HG23 ' A' ' 369' ' ' VAL . 9.0 p-90 -44.78 -40.23 5.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.674 0.609 . . . . 0.22 111.737 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 435' ' ' LYS . . . . . 0.794 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 37.0 mttt -61.14 -23.68 65.71 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 113.009 0.744 . . . . 0.64000000000000001 113.009 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.2 p -113.57 -35.92 5.08 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.455 -0.793 . . . . 0.25 110.208 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' ARG . . . . . 0.492 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.4 mtp85 -88.91 -15.69 33.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.858 -1.064 . . . . 0.35999999999999999 113.204 -168.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 76.46 41.45 25.17 Favored Glycine 0 C--N 1.31 -0.914 0 N-CA-C 116.59 1.396 . . . . 0.20999999999999999 116.59 158.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 21.6 m -83.51 141.8 31.37 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 118.136 0.968 . . . . 0.46999999999999997 108.752 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -109.31 73.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.726 -0.609 . . . . 0.40999999999999998 110.836 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' GLY . . . . . 0.664 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 82.8 -8.54 62.35 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.914 -0.874 . . . . 0.17999999999999999 110.914 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' CYS . . . . . 0.554 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -96.06 131.96 41.92 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.322 0.582 . . . . 0.82999999999999996 110.526 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' ILE . . . . . 0.701 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -88.77 117.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.283 -0.871 . . . . 0.14999999999999999 111.109 -174.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 2.8 t30 -78.44 82.54 4.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.492 -1.685 . . . . 1.77 111.572 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' THR . . . . . 0.593 HG23 HG21 ' A' ' 366' ' ' THR . 27.7 m -87.78 140.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.508 0.67 . . . . 0.17999999999999999 110.048 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.4 Cg_exo -57.37 136.48 76.37 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.815 2.343 . . . . 0.12 111.714 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' PRO . . . . . 0.812 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 52.3 Cg_exo -56.03 -32.53 86.58 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.296 3.331 . . . . 0.16 112.888 -173.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.1 p -81.72 -38.22 26.09 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.717 -1.129 . . . . 1.1699999999999999 110.115 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' VAL . . . . . 0.668 HG11 ' HB ' ' A' ' 366' ' ' THR . 88.2 t -80.29 -29.88 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.326 0.584 . . . . 0.17000000000000001 111.407 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' MET . . . . . 0.683 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.0 tpt -66.65 -19.62 65.81 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.842 0.83 . . . . 0.46000000000000002 110.115 177.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.94 -23.6 41.59 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.511 -1.222 . . . . 0.81000000000000005 111.124 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 456' ' ' MET . 6.8 mm-40 -78.31 -47.36 17.94 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 113.192 -1.822 . . . . 0.38 107.103 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' LEU . . . . . 0.59 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.5 tp -63.92 -67.36 0.44 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.642 -2.526 . . . . 0.059999999999999998 112.292 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' PHE . . . . . 0.434 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 38.1 t80 -49.95 -26.93 4.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 123.193 1.473 . . . . 0.31 108.303 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.86 -31.81 66.95 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 112.426 -2.17 . . . . 0.13 112.291 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' MET . . . . . 0.678 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -87.5 -48.0 8.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.637 0.732 . . . . 0.13 111.586 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' VAL . . . . . 0.546 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -102.84 139.05 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 123.407 1.575 . . . . 0.23000000000000001 114.06 -168.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.46 -178.62 5.25 Favored 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 110.961 -2.836 . . . . 0.82999999999999996 107.108 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' LYS . . . . . 0.729 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -50.44 160.8 0.36 Allowed 'General case' 0 N--CA 1.411 -2.385 0 CA-C-O 123.043 1.401 . . . . 0.23999999999999999 113.109 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.26 -35.93 3.78 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 112.565 -2.107 . . . . 0.37 112.354 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 462' ' ' PRO . 3.9 m -74.44 141.12 76.31 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 109.452 -0.573 . . . . 0.14999999999999999 109.452 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 5.1 Cg_exo -75.18 166.26 29.36 Favored 'Trans proline' 0 N--CA 1.422 -2.682 0 C-N-CA 121.98 1.787 . . . . 0.12 111.07 174.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' VAL . . . . . 0.78 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -133.65 154.76 39.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 107.455 -1.313 . . . . 1.0900000000000001 107.455 166.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.0 tp -124.36 144.82 49.81 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.317 -0.856 . . . . 0.13 110.087 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' VAL . . . . . 0.686 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.17 146.67 21.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.843 -1.54 . . . . 0.089999999999999997 106.843 165.1 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' PHE . . . . . 0.704 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.4 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.79 -0.624 . . . . 1.1599999999999999 111.486 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . 0.726 ' N ' ' HH ' ' A' ' 357' ' ' TYR . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 111.094 -0.802 . . . . 3.9399999999999999 111.094 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.652 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.6 t-160 -174.61 94.4 0.08 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.913 -0.773 . . . . 1.8500000000000001 108.913 -172.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.652 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 33.7 mtm 77.53 179.68 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.776 1.298 . . . . 1.03 110.696 -171.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -118.33 -7.74 10.67 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.153 -0.93 . . . . 1.1000000000000001 111.231 -174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.66 166.16 1.0 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 123.04 1.4 . . . . 0.97999999999999998 113.629 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.647 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.4 m -94.15 123.16 37.35 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.749 -2.023 . . . . 0.45000000000000001 107.396 168.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.672 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 17.8 p90 -163.33 -170.84 2.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.76 0.791 . . . . 0.32000000000000001 111.04 -173.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.553 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -103.85 156.83 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-N 114.603 -1.18 . . . . 0.080000000000000002 107.938 166.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.538 ' HG3' HD23 ' A' ' 464' ' ' LEU . 4.7 tt0 -137.18 154.57 50.18 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.171 0.896 . . . . 0.17000000000000001 110.595 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.678 HG22 ' HG3' ' A' ' 354' ' ' MET . 66.8 t -149.27 137.27 14.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 114.614 -1.176 . . . . 0.080000000000000002 109.098 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 466' ' ' PHE . 7.8 t70 -120.42 115.02 22.68 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.077 -1.083 . . . . 0.37 108.077 174.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.523 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -66.2 -48.37 70.85 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 123.099 1.428 . . . . 0.32000000000000001 110.195 -177.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -51.32 -52.01 49.22 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 112.623 -2.081 . . . . 1.51 112.901 -176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 35.4 m-80 -102.71 9.74 38.99 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-N 114.191 -1.368 . . . . 0.91000000000000003 108.664 -175.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.814 ' NE2' HD12 ' A' ' 368' ' ' ILE . 15.1 mm100 36.09 72.67 0.1 Allowed 'General case' 0 N--CA 1.468 0.429 0 O-C-N 125.154 1.534 . . . . 2.2200000000000002 111.8 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.502 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.6 t60 -150.11 126.41 10.73 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.641 -1.163 . . . . 0.13 109.469 -176.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.678 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -112.99 128.34 56.47 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 123.659 0.783 . . . . 0.059999999999999998 110.618 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.68 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.75 173.61 6.34 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 114.513 -1.221 . . . . 0.10000000000000001 111.889 -176.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.615 ' CE2' ' HB2' ' A' ' 456' ' ' MET . 1.2 t80 -125.1 115.92 21.26 Favored 'General case' 0 CA--C 1.492 -1.27 0 N-CA-C 106.336 -1.727 . . . . 0.22 106.336 165.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.726 ' HH ' ' N ' ' A' ' 338' ' ' GLY . 27.9 m-85 -101.24 127.29 47.89 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-O 122.153 0.978 . . . . 0.17999999999999999 112.021 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.647 ' HA ' HG23 ' A' ' 343' ' ' THR . 2.8 ttpt -148.26 137.19 21.81 Favored 'General case' 0 N--CA 1.399 -3.023 0 CA-C-N 113.376 -1.738 . . . . 0.46999999999999997 108.628 174.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.9 OUTLIER 71.29 13.84 6.6 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-N 113.159 -1.837 . . . . 0.59999999999999998 108.992 -179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.55 14.89 74.97 Favored Glycine 0 N--CA 1.425 -2.086 0 CA-C-N 112.783 -2.008 . . . . 0.23000000000000001 111.771 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.573 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.09 168.11 19.42 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 105.991 -1.855 . . . . 0.68000000000000005 105.991 -171.037 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.851 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.6 m -101.05 139.02 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.767 0 CA-C-O 124.164 1.935 . . . . 0.53000000000000003 111.868 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.614 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.67 -25.01 18.45 Favored 'General case' 0 N--CA 1.402 -2.873 0 CA-C-N 109.675 -3.421 . . . . 0.12 108.586 176.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.659 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.42 155.2 35.9 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 113.711 -1.586 . . . . 0.080000000000000002 109.222 -171.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.851 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.79 122.63 1.41 Allowed 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.736 -0.665 . . . . 0.60999999999999999 109.498 -176.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.69 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.7 t -147.11 166.9 25.5 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.631 0.729 . . . . 0.089999999999999997 110.823 173.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.474 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 48.1 m-20 -84.23 148.76 26.54 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.984 -1.488 . . . . 1.8799999999999999 106.984 175.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.814 HD12 ' NE2' ' A' ' 352' ' ' GLN . 1.4 pp -144.37 -178.32 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 123.841 0.713 . . . . 0.11 111.535 -177.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.654 ' HA ' ' NE2' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -149.85 118.5 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.449 -0.796 . . . . 0.12 109.56 173.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 443' ' ' ILE . 34.3 p -141.32 142.55 33.82 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 114.835 -1.075 . . . . 0.69999999999999996 111.699 -165.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.739 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.04 44.62 29.25 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 116.678 1.431 . . . . 0.13 116.678 162.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.641 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.65 144.56 3.47 Favored Pre-proline 0 C--O 1.221 -0.439 0 CA-C-N 118.639 1.219 . . . . 0.47999999999999998 110.187 -174.725 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.808 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.12 -28.82 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.553 1 C-N-CA 126.056 4.504 . . . . 0.23000000000000001 116.215 -172.518 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.641 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -85.45 -32.13 22.46 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.265 0.555 . . . . 0.29999999999999999 110.813 -177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.448 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 11.8 m -140.91 72.9 28.06 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 122.14 0.971 . . . . 0.29999999999999999 110.155 178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.739 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.3 Cg_exo -70.85 161.28 46.63 Favored 'Trans proline' 0 C--N 1.319 -0.976 0 C-N-CA 125.269 3.979 . . . . 0.16 114.39 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.691 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.64 151.73 89.27 Favored Pre-proline 0 N--CA 1.435 -1.219 0 CA-C-N 113.375 -1.738 . . . . 0.12 110.835 175.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.502 ' CD ' HG22 ' A' ' 377' ' ' THR . 2.0 Cg_endo -81.04 -51.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.327 -0.559 0 C-N-CA 125.144 3.896 . . . . 0.089999999999999997 113.886 -171.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.741 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.35 121.93 0.03 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 113.301 0.852 . . . . 0.089999999999999997 113.301 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.89 -124.97 1.29 Allowed Glycine 0 N--CA 1.441 -0.975 0 CA-C-N 114.302 -1.317 . . . . 0.11 111.417 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 381' ' ' VAL . 13.0 p -126.04 108.17 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-O 122.093 0.949 . . . . 0.89000000000000001 109.222 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.744 ' HB2' HG22 ' A' ' 463' ' ' VAL . 91.8 m-85 -113.68 155.87 24.76 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.128 -0.942 . . . . 0.16 109.633 -170.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.798 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 10.6 m-85 -147.06 139.83 25.01 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 117.872 0.306 . . . . 0.68999999999999995 110.447 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.648 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -74.66 124.3 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 C-N-CA 119.88 -0.728 . . . . 0.14000000000000001 110.895 179.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.5 p-90 -107.5 1.96 23.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.314 -0.857 . . . . 0.19 111.925 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.759 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.2 t30 -164.63 150.26 10.19 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.189 -0.914 . . . . 0.40999999999999998 110.276 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 458' ' ' GLU . 15.0 mtpt -111.28 119.41 38.79 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 121.783 0.802 . . . . 1.0900000000000001 110.138 171.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.573 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -118.54 122.1 41.84 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.589 -1.187 . . . . 0.38 111.076 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -120.43 136.96 54.57 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.416 -1.265 . . . . 1.96 109.95 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 29.6 t70 52.21 38.82 25.58 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 123.584 1.659 . . . . 0.40000000000000002 107.292 -173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.573 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -91.74 170.44 9.9 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 112.329 -2.214 . . . . 0.16 111.907 -175.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 15.5 m -129.86 104.54 7.44 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.691 -1.595 . . . . 0.27000000000000002 109.545 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.72 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.02 155.0 40.8 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 113.147 -1.842 . . . . 0.23999999999999999 109.713 174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 10.3 mtpt -155.68 174.27 15.53 Favored 'General case' 0 N--CA 1.4 -2.931 0 CA-C-N 114.704 -1.134 . . . . 0.67000000000000004 108.415 -175.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 170.0 164.89 26.49 Favored Glycine 0 CA--C 1.475 -2.46 0 C-N-CA 117.875 -2.107 . . . . 0.81000000000000005 113.285 -177.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.86 118.4 32.43 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-O 122.493 1.139 . . . . 0.79000000000000004 108.509 173.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.518 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.5 m-80 -51.85 179.05 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 111.868 -2.423 . . . . 1.1200000000000001 111.967 178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -54.61 -24.35 20.95 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.436 0.636 . . . . 1.6499999999999999 110.397 167.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 401' ' ' THR . 1.0 OUTLIER -88.0 -25.65 23.02 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.486 -0.779 . . . . 2.0 109.975 -174.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.85 32.95 6.27 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 110.343 -1.103 . . . . 0.66000000000000003 110.343 -170.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.518 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 57.8 p -114.79 126.81 27.45 Favored Pre-proline 0 N--CA 1.413 -2.278 0 N-CA-C 107.588 -1.264 . . . . 0.68000000000000005 107.588 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.922 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 13.1 Cg_exo -72.21 141.35 35.68 Favored 'Trans proline' 0 N--CA 1.421 -2.755 0 C-N-CA 122.498 2.132 . . . . 0.81000000000000005 111.386 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 17.5 p90 -134.94 -177.95 4.87 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.491 -2.141 . . . . 0.38 107.958 -173.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.7 mt-10 -141.92 163.1 33.81 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 122.604 1.192 . . . . 0.62 112.224 177.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.72 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -141.59 98.85 6.4 Favored Pre-proline 0 N--CA 1.423 -1.815 0 CA-C-N 112.443 -2.162 . . . . 1.3300000000000001 107.562 172.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.2 Cg_endo -67.72 103.38 0.84 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.496 2.131 . . . . 0.20000000000000001 110.613 175.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.55 161.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.713 0 CA-C-N 114.332 -1.304 . . . . 0.29999999999999999 110.242 -173.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.4 -32.23 6.31 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.5 -1.682 . . . . 1.8400000000000001 107.501 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.47 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 67.1 m-85 -136.56 116.02 12.78 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 112.828 -1.987 . . . . 0.44 110.713 175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.757 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -125.01 135.21 52.56 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.656 -1.156 . . . . 0.13 110.379 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.483 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -136.07 86.3 26.26 Favored Pre-proline 0 C--N 1.3 -1.583 0 CA-C-N 114.941 -1.027 . . . . 0.40999999999999998 111.205 174.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.697 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.9 Cg_endo -71.44 139.93 35.58 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 C-N-CA 122.993 2.462 . . . . 0.16 112.427 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.635 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -124.03 -15.56 5.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 113.751 -1.568 . . . . 0.17000000000000001 110.941 -174.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -133.72 165.28 25.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.171 -0.922 . . . . 1.5900000000000001 109.582 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -98.47 15.22 25.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.215 0.45 . . . . 0.31 112.215 -177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.8 p -95.04 -26.81 15.91 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 107.601 -1.259 . . . . 0.44 107.601 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.75 31.72 1.01 Allowed Glycine 0 N--CA 1.425 -2.04 0 CA-C-N 112.927 -1.942 . . . . 0.23999999999999999 111.971 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 441' ' ' GLY . 81.6 t -101.6 148.81 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.086 0 CA-C-O 121.204 0.525 . . . . 0.17000000000000001 110.775 176.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 171.57 -167.49 40.56 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 114.735 -1.12 . . . . 0.10000000000000001 111.191 -178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.74 139.53 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 108.875 -0.787 . . . . 0.12 108.875 175.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.626 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 30.9 p80 -149.2 163.31 37.99 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-O 121.823 0.821 . . . . 0.14999999999999999 111.792 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.782 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.92 138.27 31.72 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.091 -1.413 . . . . 0.41999999999999998 107.453 172.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.8 OUTLIER -131.36 101.07 5.39 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 122.48 1.133 . . . . 1.48 109.057 -174.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -95.18 -35.26 11.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 112.953 -1.931 . . . . 0.34999999999999998 111.562 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.438 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 21.1 p90 -63.53 -26.96 68.94 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-N 114.398 -1.274 . . . . 0.17999999999999999 109.055 174.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.809 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.81 83.42 36.39 Favored Pre-proline 0 CA--C 1.498 -1.035 0 CA-C-N 113.404 -1.726 . . . . 1.3300000000000001 109.966 -172.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -80.93 5.53 6.15 Favored 'Trans proline' 0 C--N 1.295 -2.258 0 C-N-CA 124.901 3.734 . . . . 0.23000000000000001 114.649 -160.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -113.2 156.35 23.41 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-O 120.975 0.417 . . . . 1.1000000000000001 111.021 -175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.474 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.83 125.15 2.31 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.653 -1.158 . . . . 0.38 109.312 -171.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.94 -166.3 28.87 Favored Glycine 0 C--N 1.304 -1.196 0 C-N-CA 119.659 -1.258 . . . . 0.13 111.769 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.641 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.02 155.67 0.0 OUTLIER Glycine 0 C--N 1.339 0.745 0 O-C-N 125.21 1.182 . . . . 0.20000000000000001 112.989 173.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.415 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.7 m-20 -56.36 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 CA-C-O 123.97 1.843 . . . . 0.33000000000000002 112.134 -147.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 51.3 mt -96.49 -32.62 12.2 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 110.342 -3.117 . . . . 0.17999999999999999 108.055 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.572 ' HA ' HG23 ' A' ' 369' ' ' VAL . 4.4 p-90 -46.24 -37.27 7.0 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 124.002 0.814 . . . . 0.22 111.15 -174.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.808 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 40.2 mttt -59.28 -27.19 65.61 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 114.695 -1.138 . . . . 0.64000000000000001 112.762 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -112.3 -36.41 5.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.604 -0.726 . . . . 0.25 109.908 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.567 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.7 mtp85 -84.53 -15.46 45.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.542 -1.208 . . . . 0.35999999999999999 113.038 -167.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.488 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.03 41.58 31.92 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 116.769 1.468 . . . . 0.20999999999999999 116.769 159.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.6 m -85.74 131.73 34.27 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 118.272 1.036 . . . . 0.46999999999999997 109.228 174.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.458 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 80.5 m80 -97.05 67.43 2.21 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.67 -0.643 . . . . 0.40999999999999998 111.358 -169.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.46 -13.6 59.93 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.213 -1.155 . . . . 0.17999999999999999 110.213 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.626 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.0 p -86.15 140.92 29.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 114.708 -0.746 . . . . 0.82999999999999996 110.164 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.691 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -94.98 115.33 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 CA-C-O 121.549 0.69 . . . . 0.14999999999999999 111.087 -176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.809 ' OD1' ' HB3' ' A' ' 426' ' ' GLN . 0.1 OUTLIER -76.66 89.41 3.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.606 -1.179 . . . . 1.77 111.021 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.564 HG23 HG21 ' A' ' 366' ' ' THR . 32.0 m -91.22 140.62 25.79 Favored Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-O 121.47 0.652 . . . . 0.17999999999999999 109.335 174.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.445 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 49.7 Cg_exo -57.84 136.27 74.26 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.801 2.334 . . . . 0.12 111.836 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.782 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.6 Cg_exo -55.72 -32.49 84.22 Favored 'Trans proline' 0 CA--C 1.501 -1.133 0 C-N-CA 124.244 3.296 . . . . 0.16 113.069 -174.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.5 p -82.02 -38.7 24.61 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 114.63 -1.168 . . . . 1.1699999999999999 110.348 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.69 HG11 ' HB ' ' A' ' 366' ' ' THR . 59.0 t -80.64 -29.11 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.374 0.607 . . . . 0.17000000000000001 111.193 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.689 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.3 tpt -67.92 -19.18 64.96 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-O 121.945 0.878 . . . . 0.46000000000000002 109.969 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.04 -22.54 42.25 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 114.442 -1.254 . . . . 0.81000000000000005 110.777 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.98 -46.85 14.47 Favored 'General case' 0 CA--C 1.476 -1.89 0 CA-C-N 112.991 -1.913 . . . . 0.38 107.438 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.607 HD23 ' SD ' ' A' ' 450' ' ' MET . 27.2 tp -64.76 -67.19 0.46 Allowed 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 111.872 -2.422 . . . . 0.059999999999999998 112.486 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.43 ' HB2' ' HE3' ' A' ' 450' ' ' MET . 19.3 t80 -50.47 -26.18 4.83 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 123.0 1.381 . . . . 0.31 108.066 177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.414 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.31 -30.24 67.37 Favored Glycine 0 N--CA 1.43 -1.731 0 CA-C-N 112.517 -2.129 . . . . 0.13 112.296 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.659 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.05 -48.42 7.43 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.775 0.797 . . . . 0.13 111.444 171.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.553 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.8 OUTLIER -103.38 138.01 29.46 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 CA-C-O 123.415 1.578 . . . . 0.23000000000000001 114.103 -167.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.448 ' HB2' ' HD2' ' A' ' 387' ' ' LYS . 6.8 pt-20 -137.22 -178.18 5.09 Favored 'General case' 0 N--CA 1.403 -2.798 0 CA-C-N 110.754 -2.93 . . . . 0.82999999999999996 106.778 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.759 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.0 mtmt -51.48 161.28 0.49 Allowed 'General case' 0 N--CA 1.412 -2.354 0 CA-C-O 122.894 1.331 . . . . 0.23999999999999999 112.534 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.55 -28.95 8.29 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-N 112.646 -2.07 . . . . 0.37 112.185 -178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.563 HG22 ' O ' ' A' ' 462' ' ' PRO . 10.0 m -84.96 140.9 37.39 Favored Pre-proline 0 N--CA 1.433 -1.292 0 N-CA-C 108.534 -0.913 . . . . 0.14999999999999999 108.534 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.798 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.93 173.69 13.65 Favored 'Trans proline' 0 N--CA 1.416 -3.084 0 C-N-CA 121.097 1.198 . . . . 0.12 111.738 173.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.31 159.54 35.65 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.224 0 N-CA-C 107.642 -1.244 . . . . 1.0900000000000001 107.642 167.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.538 HD23 ' HG3' ' A' ' 346' ' ' GLU . 2.8 tp -130.27 146.11 51.83 Favored 'General case' 0 C--N 1.285 -2.228 0 CA-C-N 115.159 -0.928 . . . . 0.13 110.046 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.741 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 146.82 20.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.292 -1.373 . . . . 0.089999999999999997 107.292 165.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.481 ' CE2' ' HG2' ' A' ' 346' ' ' GLU . 19.9 p90 . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.533 -0.746 . . . . 1.1599999999999999 111.464 -177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.832 0 N-CA-C 111.983 -0.447 . . . . 3.9399999999999999 111.983 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.4 t-160 -82.75 96.14 8.09 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.646 -0.501 . . . . 1.8500000000000001 109.646 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 11.9 mtp 71.71 -178.29 0.21 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.877 1.361 . . . . 1.03 111.051 -174.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -139.63 -6.81 1.31 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.168 0.433 . . . . 1.1000000000000001 112.168 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.94 169.08 0.55 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 122.859 1.314 . . . . 0.97999999999999998 113.062 172.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.565 HG23 ' HA ' ' A' ' 358' ' ' LYS . 97.2 m -91.99 123.7 35.55 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 113.274 -1.785 . . . . 0.45000000000000001 108.539 167.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.633 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.5 p90 -162.44 -170.32 2.4 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.461 -1.245 . . . . 0.32000000000000001 110.489 -174.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.9 mm -102.19 157.32 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 108.071 -1.085 . . . . 0.080000000000000002 108.071 165.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.523 ' HG3' HD23 ' A' ' 464' ' ' LEU . 4.6 tt0 -139.06 154.39 48.19 Favored 'General case' 0 CA--C 1.498 -1.027 0 CA-C-N 118.617 0.644 . . . . 0.17000000000000001 110.543 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.655 HG22 ' HG3' ' A' ' 354' ' ' MET . 53.5 t -149.98 136.38 12.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.035 -0.984 . . . . 0.080000000000000002 109.988 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -117.19 116.31 27.03 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.703 -1.135 . . . . 0.37 108.24 173.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.474 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -69.02 -49.03 61.29 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.53 1.157 . . . . 0.32000000000000001 110.452 -177.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -54.69 -54.82 36.78 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 112.835 -1.984 . . . . 1.51 112.213 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 50.1 m-80 -96.62 10.08 39.61 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.559 -1.201 . . . . 0.91000000000000003 108.601 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.79 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.1 mm-40 38.16 71.85 0.14 Allowed 'General case' 0 C--O 1.234 0.256 0 O-C-N 125.315 1.634 . . . . 2.2200000000000002 111.98 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.442 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -152.68 124.91 8.09 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.548 -0.751 . . . . 0.13 109.634 -176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.655 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.7 ttp -111.87 128.61 56.18 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.667 -0.697 . . . . 0.059999999999999998 110.3 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.682 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.25 173.05 6.55 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 114.595 -1.184 . . . . 0.10000000000000001 111.899 -177.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.559 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.3 OUTLIER -125.38 112.78 16.71 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 105.621 -1.992 . . . . 0.22 105.621 163.449 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.489 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 25.6 m-85 -94.97 125.09 39.4 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.499 -0.88 . . . . 0.17999999999999999 110.963 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.565 ' HA ' HG23 ' A' ' 343' ' ' THR . 37.3 ttmt -134.42 137.38 43.98 Favored 'General case' 0 N--CA 1.387 -3.583 0 CA-C-N 114.332 -1.304 . . . . 0.46999999999999997 109.68 173.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 64.32 12.22 7.05 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 112.941 -1.936 . . . . 0.59999999999999998 109.092 176.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 88.61 14.28 61.73 Favored Glycine 0 N--CA 1.418 -2.545 0 CA-C-N 112.79 -2.005 . . . . 0.23000000000000001 112.301 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -128.36 172.65 10.89 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.383 -2.081 . . . . 0.68000000000000005 105.383 -175.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.805 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.5 m -104.86 136.01 40.39 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.619 0 CA-C-O 124.318 2.009 . . . . 0.53000000000000003 112.316 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.5 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -89.49 -25.13 21.6 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 109.408 -3.542 . . . . 0.12 108.355 177.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.614 HD13 ' CE ' ' A' ' 456' ' ' MET . 2.7 tp -154.71 154.18 32.48 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.051 -1.431 . . . . 0.080000000000000002 108.927 -172.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.805 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.22 121.51 1.42 Allowed 'General case' 0 CA--C 1.497 -1.081 0 O-C-N 123.514 0.509 . . . . 0.60999999999999999 109.913 -175.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.636 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.3 t -148.62 167.41 25.52 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-O 122.225 1.012 . . . . 0.089999999999999997 112.12 175.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.575 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.2 p-10 -84.73 141.71 30.35 Favored 'General case' 0 N--CA 1.419 -1.996 0 CA-C-N 113.238 -1.801 . . . . 1.8799999999999999 107.893 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.626 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -142.32 -171.91 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.347 -0.842 . . . . 0.11 112.091 -176.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.79 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -158.31 114.32 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.035 -0.984 . . . . 0.12 109.283 177.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 15.0 t -141.93 145.46 34.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.908 -1.042 . . . . 0.69999999999999996 112.802 -167.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.696 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.11 44.95 33.67 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 116.747 1.459 . . . . 0.13 116.747 162.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.618 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.75 143.42 6.04 Favored Pre-proline 0 N--CA 1.447 -0.618 0 CA-C-N 118.601 1.2 . . . . 0.47999999999999998 110.456 -174.689 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.822 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.13 -32.89 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.749 4.299 . . . . 0.23000000000000001 116.089 -171.29 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.618 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 2.0 p -80.23 -35.36 36.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.36 0.6 . . . . 0.29999999999999999 110.816 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.481 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.1 m -139.77 72.2 35.68 Favored Pre-proline 0 N--CA 1.447 -0.608 0 CA-C-O 122.291 1.043 . . . . 0.29999999999999999 109.688 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.696 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.5 Cg_exo -70.21 162.92 40.52 Favored 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 125.253 3.969 . . . . 0.16 114.007 -176.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.737 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.82 149.5 83.14 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 113.625 -1.625 . . . . 0.12 110.001 174.637 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.516 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.5 Cg_endo -76.89 -49.0 0.11 Allowed 'Trans proline' 0 C--N 1.324 -0.743 0 C-N-CA 125.108 3.872 . . . . 0.089999999999999997 113.283 -170.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.695 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.69 121.56 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 113.965 1.098 . . . . 0.089999999999999997 113.965 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.45 -126.31 1.51 Allowed Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 113.995 -1.457 . . . . 0.11 110.613 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.5 p -126.18 108.98 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 CA-C-O 121.935 0.874 . . . . 0.89000000000000001 108.96 178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.632 ' HB3' ' HB ' ' A' ' 413' ' ' ILE . 53.0 m-85 -113.14 170.1 8.46 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.381 -0.827 . . . . 0.16 109.16 -173.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.706 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 79.0 m-85 -150.8 139.81 21.02 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 110.239 -0.282 . . . . 0.68999999999999995 110.239 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.68 121.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.691 -0.804 . . . . 0.14000000000000001 110.328 176.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . 0.44 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 46.6 p-90 -109.66 3.0 20.56 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-N 115.492 -0.777 . . . . 0.19 112.422 -175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.709 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.0 t30 -161.13 144.72 13.07 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 107.579 -1.267 . . . . 0.40999999999999998 107.579 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.511 ' O ' ' HG2' ' A' ' 387' ' ' LYS . 0.3 OUTLIER -118.56 109.85 16.67 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-O 122.324 1.059 . . . . 1.0900000000000001 108.506 -177.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.563 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -116.73 130.6 56.82 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.41 -1.268 . . . . 0.38 110.829 -172.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.79 135.12 48.06 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 113.738 -1.574 . . . . 1.96 109.601 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 23.2 t70 52.95 40.53 31.17 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 123.298 1.523 . . . . 0.40000000000000002 107.357 -173.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.548 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.19 170.42 9.41 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 112.223 -2.262 . . . . 0.16 111.807 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 5.2 m -127.84 105.53 8.5 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 113.942 -1.481 . . . . 0.27000000000000002 110.157 -178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.74 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.9 mp -74.41 158.35 34.04 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 113.061 -1.881 . . . . 0.23999999999999999 110.767 175.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.4 mtpt -148.5 -175.44 4.92 Favored 'General case' 0 N--CA 1.396 -3.17 0 CA-C-N 114.72 -1.127 . . . . 0.67000000000000004 108.818 -178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.646 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.72 -147.4 7.51 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 117.331 -2.366 . . . . 0.81000000000000005 114.67 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.47 117.94 10.87 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-N 113.541 -1.329 . . . . 0.79000000000000004 108.658 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.6 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.7 m-80 -54.31 -179.45 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 112.271 -2.241 . . . . 1.1200000000000001 113.221 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 374' ' ' THR . 0.2 OUTLIER -53.23 -22.51 6.91 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.169 0.509 . . . . 1.6499999999999999 110.853 167.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.61 -24.34 18.72 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 116.026 -0.534 . . . . 2.0 111.545 -177.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.07 33.86 6.14 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 119.751 -1.214 . . . . 0.66000000000000003 110.066 -168.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 55.0 p -116.19 126.99 27.11 Favored Pre-proline 0 N--CA 1.413 -2.275 0 N-CA-C 106.997 -1.482 . . . . 0.68000000000000005 106.997 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.646 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 20.2 Cg_exo -67.69 151.41 79.09 Favored 'Trans proline' 0 C--N 1.284 -2.866 0 C-N-CA 122.102 1.868 . . . . 0.81000000000000005 111.366 -175.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 19.1 p90 -140.11 -174.33 3.9 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 112.786 -2.006 . . . . 0.38 107.103 -175.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.0 mt-10 -142.02 160.74 39.61 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 122.167 0.984 . . . . 0.62 112.028 176.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.74 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.95 99.97 9.01 Favored Pre-proline 0 N--CA 1.424 -1.761 0 CA-C-N 113.268 -1.787 . . . . 1.3300000000000001 107.75 176.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.469 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 68.3 Cg_endo -68.02 102.31 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.741 2.294 . . . . 0.20000000000000001 110.493 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.739 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.36 160.77 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.714 0 CA-C-N 114.483 -1.235 . . . . 0.29999999999999999 110.563 -172.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -113.3 -31.48 6.58 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 113.33 -1.759 . . . . 1.8400000000000001 107.564 -176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 68.2 m-85 -137.18 116.85 12.98 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 113.143 -1.844 . . . . 0.44 110.898 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.739 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.7 t-105 -125.27 134.04 52.44 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.813 -1.085 . . . . 0.13 111.084 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.501 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.5 mtp -134.57 86.68 33.82 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 114.628 -1.169 . . . . 0.40999999999999998 111.334 173.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 89.7 Cg_endo -72.96 139.08 29.51 Favored 'Trans proline' 0 CA--C 1.502 -1.11 0 C-N-CA 122.846 2.364 . . . . 0.16 111.445 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -125.7 -12.85 4.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 114.118 -1.401 . . . . 0.17000000000000001 111.055 -172.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -133.95 168.85 18.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.342 -0.845 . . . . 1.5900000000000001 109.448 173.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -99.5 14.78 28.68 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.45 0.907 . . . . 0.31 113.45 -175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.445 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 37.9 p -99.73 -27.69 13.53 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 107.916 -1.142 . . . . 0.44 107.916 174.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 134.73 29.72 0.41 Allowed Glycine 0 N--CA 1.426 -2.004 0 CA-C-N 113.814 -1.539 . . . . 0.23999999999999999 112.711 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 441' ' ' GLY . 60.3 t -102.45 146.36 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 121.513 0.673 . . . . 0.17000000000000001 111.583 177.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.73 -166.19 37.86 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 114.743 -1.117 . . . . 0.10000000000000001 111.546 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.458 HG12 ' SD ' ' A' ' 354' ' ' MET . 0.9 OUTLIER -104.82 140.93 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 N-CA-C 108.613 -0.884 . . . . 0.12 108.613 176.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.548 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 31.8 p80 -150.78 166.41 30.54 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.672 0.749 . . . . 0.14999999999999999 111.288 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.786 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.44 136.19 33.29 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 114.193 -1.367 . . . . 0.41999999999999998 107.482 171.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.505 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 6.2 t -130.86 102.72 6.19 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 122.879 1.324 . . . . 1.48 109.435 -176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -94.14 -30.57 14.56 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 112.387 -2.188 . . . . 0.34999999999999998 110.964 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.455 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 20.6 p90 -68.66 -27.36 65.92 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.436 -1.256 . . . . 0.17999999999999999 109.35 175.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.505 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -120.69 80.16 31.59 Favored Pre-proline 0 CA--C 1.496 -1.114 0 CA-C-N 113.788 -1.551 . . . . 1.3300000000000001 109.615 -176.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -83.71 8.65 4.5 Favored 'Trans proline' 0 N--CA 1.435 -1.923 0 C-N-CA 125.248 3.965 . . . . 0.23000000000000001 113.991 -163.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -114.22 148.37 37.47 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 109.207 -0.664 . . . . 1.1000000000000001 109.207 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.575 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -159.47 131.38 6.37 Favored 'General case' 0 C--N 1.311 -1.082 0 O-C-N 124.841 1.338 . . . . 0.38 107.497 -171.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 146.56 -166.76 28.18 Favored Glycine 0 C--N 1.296 -1.684 0 C-N-CA 119.19 -1.481 . . . . 0.13 111.036 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.581 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 152.11 0.01 OUTLIER Glycine 0 C--N 1.339 0.73 0 O-C-N 125.201 1.177 . . . . 0.20000000000000001 112.834 175.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.77 101.13 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.144 0 CA-C-O 123.864 1.792 . . . . 0.33000000000000002 111.766 -145.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.8 mt -96.62 -31.57 12.66 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 110.524 -3.034 . . . . 0.17999999999999999 108.213 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.59 ' HA ' HG23 ' A' ' 369' ' ' VAL . 7.3 p-90 -46.34 -38.48 8.83 Favored 'General case' 0 C--N 1.316 -0.871 0 O-C-N 123.894 0.746 . . . . 0.22 111.425 -175.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.822 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.5 mttt -62.01 -24.85 67.3 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 115.115 -0.948 . . . . 0.64000000000000001 112.819 -175.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.4 p -112.53 -37.45 4.93 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.497 -0.774 . . . . 0.25 110.074 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.506 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.6 mtp85 -82.44 -18.85 40.34 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.86 -1.064 . . . . 0.35999999999999999 112.016 -170.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.546 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.02 42.45 24.65 Favored Glycine 0 C--N 1.309 -0.962 0 C-N-CA 119.709 -1.234 . . . . 0.20999999999999999 115.746 164.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.7 m -85.26 131.54 34.4 Favored 'General case' 0 C--O 1.209 -1.055 0 CA-C-N 118.404 1.102 . . . . 0.46999999999999997 108.905 174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.443 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 63.1 m80 -98.83 68.64 1.76 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 121.501 -0.749 . . . . 0.40999999999999998 110.609 -169.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.683 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 86.32 -7.76 77.21 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.833 -0.907 . . . . 0.17999999999999999 110.833 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.548 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 13.8 p -94.16 128.56 40.66 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.657 0.742 . . . . 0.82999999999999996 110.789 -176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.737 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -88.47 112.94 24.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.821 -1.081 . . . . 0.14999999999999999 110.556 -173.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.597 ' HB2' HG13 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -78.83 88.84 4.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.851 -1.068 . . . . 1.77 111.263 -177.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.61 HG23 HG21 ' A' ' 366' ' ' THR . 28.5 m -86.69 136.58 34.55 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 108.988 -0.745 . . . . 0.17999999999999999 108.988 174.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -54.21 135.41 64.65 Favored 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 122.583 2.188 . . . . 0.12 111.083 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.786 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 29.1 Cg_exo -54.6 -31.66 71.27 Favored 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 124.063 3.175 . . . . 0.16 112.816 -172.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.7 -39.2 24.64 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-N 114.4 -1.273 . . . . 1.1699999999999999 110.338 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.636 HG11 ' HB ' ' A' ' 366' ' ' THR . 64.2 t -79.26 -30.05 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 CA-C-O 121.464 0.65 . . . . 0.17000000000000001 111.355 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.7 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 8.1 tpt -67.31 -19.62 65.49 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.939 0.876 . . . . 0.46000000000000002 110.103 178.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.34 -22.98 43.73 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.413 -1.267 . . . . 0.81000000000000005 110.572 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.693 ' O ' ' HG2' ' A' ' 456' ' ' MET . 10.8 mm-40 -80.28 -47.86 13.91 Favored 'General case' 0 CA--C 1.474 -1.965 0 CA-C-N 112.803 -1.999 . . . . 0.38 107.293 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.565 HD23 ' SD ' ' A' ' 450' ' ' MET . 23.6 tp -64.68 -67.45 0.43 Allowed 'General case' 0 N--CA 1.401 -2.885 0 CA-C-N 111.85 -2.432 . . . . 0.059999999999999998 112.631 176.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.501 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 27.8 t80 -51.11 -26.57 6.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.36 1.552 . . . . 0.31 107.989 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.429 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.88 -31.37 72.72 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.04 -2.346 . . . . 0.13 111.948 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.693 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.42 -49.21 6.83 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 121.748 0.785 . . . . 0.13 111.116 170.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.572 ' CB ' HD11 ' A' ' 345' ' ' ILE . 1.2 p -106.71 133.37 51.45 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.257 0 CA-C-O 123.635 1.683 . . . . 0.23000000000000001 114.151 -167.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.482 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 9.9 pt-20 -139.93 -177.01 4.79 Favored 'General case' 0 N--CA 1.403 -2.788 0 CA-C-N 110.379 -3.1 . . . . 0.82999999999999996 106.302 177.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.628 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.2 mtmt -47.09 155.08 0.31 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-O 122.854 1.311 . . . . 0.23999999999999999 113.679 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.37 -34.23 5.27 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 112.169 -2.287 . . . . 0.37 112.71 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.533 ' HB ' HG23 ' A' ' 457' ' ' VAL . 10.5 m -79.88 142.26 56.15 Favored Pre-proline 0 N--CA 1.438 -1.031 0 CA-C-O 120.968 0.414 . . . . 0.14999999999999999 110.035 -177.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.633 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.71 165.01 33.36 Favored 'Trans proline' 0 N--CA 1.433 -2.057 0 C-N-CA 122.353 2.035 . . . . 0.12 111.254 174.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 81.6 t -135.2 134.8 52.73 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.332 0 CA-C-N 113.816 -1.538 . . . . 1.0900000000000001 108.474 173.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.523 HD23 ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -113.94 143.44 44.7 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 116.126 -0.488 . . . . 0.13 110.369 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.45 149.91 17.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.383 -1.34 . . . . 0.089999999999999997 107.383 165.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.683 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.565 -0.731 . . . . 1.1599999999999999 111.254 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.807 0 N-CA-C 111.508 -0.637 . . . . 3.9399999999999999 111.508 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.587 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.6 t-160 59.21 84.56 0.11 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.296 0.569 . . . . 1.8500000000000001 110.474 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.587 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 33.2 mtm 76.47 -175.43 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.806 -1.543 . . . . 1.03 110.847 -173.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -138.35 -4.87 1.64 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.308 -0.86 . . . . 1.1000000000000001 110.907 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -55.64 167.37 0.54 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 123.041 1.401 . . . . 0.97999999999999998 112.949 173.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 358' ' ' LYS . 85.4 m -92.73 122.03 34.72 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.119 -1.855 . . . . 0.45000000000000001 107.255 166.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.679 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 9.7 p90 -156.66 -170.67 3.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.265 -0.88 . . . . 0.32000000000000001 110.625 -174.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.585 HD11 ' CB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.97 161.06 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 N-CA-C 108.271 -1.011 . . . . 0.080000000000000002 108.271 167.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.485 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.1 tt0 -142.24 155.67 45.26 Favored 'General case' 0 CA--C 1.498 -1.048 0 CA-C-N 118.691 0.678 . . . . 0.17000000000000001 111.229 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.708 HG22 ' HG3' ' A' ' 354' ' ' MET . 60.7 t -150.93 138.35 13.63 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 114.648 -1.16 . . . . 0.080000000000000002 109.64 -178.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -117.89 117.74 30.11 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.729 -1.123 . . . . 0.37 107.989 171.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.529 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -72.69 -45.12 60.45 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.589 0.709 . . . . 0.32000000000000001 110.045 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -62.12 -45.42 93.54 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.862 -1.517 . . . . 1.51 112.826 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -107.26 18.26 21.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.687 -1.142 . . . . 0.91000000000000003 108.928 -175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.641 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 21.7 mp0 34.3 68.96 0.16 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 112.994 -1.912 . . . . 2.2200000000000002 112.773 171.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.489 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.9 t60 -152.47 125.02 8.29 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.216 0.531 . . . . 0.13 109.649 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.708 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.8 ttp -111.25 127.48 55.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.649 -0.705 . . . . 0.059999999999999998 110.28 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.658 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.06 173.37 6.39 Favored 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 114.536 -1.211 . . . . 0.10000000000000001 111.746 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.573 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -126.35 116.39 21.13 Favored 'General case' 0 C--O 1.201 -1.468 0 N-CA-C 105.622 -1.992 . . . . 0.22 105.622 163.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 20.7 m-85 -97.0 125.09 41.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.43 -0.908 . . . . 0.17999999999999999 111.613 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 343' ' ' THR . 35.6 ttmt -138.23 140.31 39.65 Favored 'General case' 0 N--CA 1.389 -3.525 0 CA-C-N 113.818 -1.537 . . . . 0.46999999999999997 109.0 173.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . . . . . . . . . 3.9 t70 65.41 14.56 9.53 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 113.473 -1.694 . . . . 0.59999999999999998 109.036 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 82.29 16.09 72.52 Favored Glycine 0 N--CA 1.419 -2.44 0 CA-C-N 112.281 -2.236 . . . . 0.23000000000000001 111.968 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.649 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -130.84 172.91 11.49 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 105.177 -2.157 . . . . 0.68000000000000005 105.177 -173.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.76 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.8 m -102.73 138.49 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.613 0 CA-C-O 124.136 1.922 . . . . 0.53000000000000003 111.604 176.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.519 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.99 -23.81 18.57 Favored 'General case' 0 N--CA 1.405 -2.706 0 CA-C-N 109.529 -3.487 . . . . 0.12 108.243 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.676 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -155.3 154.66 32.44 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.942 -1.481 . . . . 0.080000000000000002 108.72 -172.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.76 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.12 121.87 1.48 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-N 116.103 -0.499 . . . . 0.60999999999999999 109.706 -175.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.6 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.7 t -148.1 167.09 25.9 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-O 122.473 1.13 . . . . 0.089999999999999997 112.429 174.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.774 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.3 p-10 -83.85 139.92 32.34 Favored 'General case' 0 N--CA 1.417 -2.106 0 CA-C-N 112.675 -2.057 . . . . 1.8799999999999999 107.791 176.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.641 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -143.06 -172.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.501 -0.772 . . . . 0.11 111.886 -176.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.616 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.59 120.75 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.006 -0.997 . . . . 0.12 108.856 175.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.467 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.6 t -142.68 145.08 33.05 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.505 -0.77 . . . . 0.69999999999999996 113.038 -167.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.16 46.6 49.75 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 116.959 1.544 . . . . 0.13 116.959 162.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.562 ' HE2' ' CA ' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.71 143.21 4.31 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 118.982 1.391 . . . . 0.47999999999999998 110.495 -174.283 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.795 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.17 -32.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.819 1 C-N-CA 125.866 4.377 . . . . 0.23000000000000001 116.22 -170.466 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.43 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -82.71 -32.81 27.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.181 0.515 . . . . 0.29999999999999999 111.081 -177.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.5 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -139.06 72.51 39.76 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 122.237 1.018 . . . . 0.29999999999999999 110.059 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.66 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.8 Cg_exo -73.35 163.06 38.8 Favored 'Trans proline' 0 C--N 1.322 -0.864 1 C-N-CA 125.528 4.152 . . . . 0.16 114.18 -177.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.724 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.48 154.17 87.75 Favored Pre-proline 0 N--CA 1.435 -1.211 0 CA-C-N 113.347 -1.751 . . . . 0.12 110.992 175.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.523 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.0 OUTLIER -79.93 -51.57 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.995 3.797 . . . . 0.089999999999999997 113.641 -172.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.705 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.48 122.58 0.03 OUTLIER 'General case' 0 C--O 1.232 0.153 0 N-CA-C 113.474 0.916 . . . . 0.089999999999999997 113.474 -177.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.67 -124.64 1.25 Allowed Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.243 -1.344 . . . . 0.11 111.384 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.7 p -128.23 107.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.547 1.165 . . . . 0.89000000000000001 109.296 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.763 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.4 m-85 -109.79 160.25 16.5 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.755 -1.111 . . . . 0.16 109.831 -170.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.681 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 80.8 m-85 -148.23 135.73 20.6 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-O 119.592 -0.242 . . . . 0.68999999999999995 110.609 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.36 123.6 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 C-N-CA 119.337 -0.945 . . . . 0.14000000000000001 110.656 178.186 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.7 p-90 -109.12 2.75 21.29 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 115.709 -0.678 . . . . 0.19 112.284 -175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.653 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 5.6 t30 -161.52 148.07 14.31 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.198 -1.038 . . . . 0.40999999999999998 108.198 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.546 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -117.41 116.67 27.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.948 -1.13 . . . . 1.0900000000000001 107.948 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.569 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -121.49 129.79 53.15 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.689 -1.141 . . . . 0.38 111.045 -173.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 41.6 mt-10 -128.29 136.1 50.54 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 113.781 -1.554 . . . . 1.96 109.887 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 38.7 t70 51.67 40.06 26.54 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 123.611 1.672 . . . . 0.40000000000000002 107.213 -172.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.569 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.82 168.19 11.35 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 112.131 -2.304 . . . . 0.16 111.581 -174.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 49.6 m -127.26 101.06 6.32 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.657 -1.61 . . . . 0.27000000000000002 109.959 -175.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.76 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -73.28 157.3 37.31 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 112.765 -2.016 . . . . 0.23999999999999999 110.16 175.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.4 mtpt -152.13 168.0 26.7 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 114.615 -1.175 . . . . 0.67000000000000004 108.255 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.921 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.3 163.38 30.82 Favored Glycine 0 CA--C 1.481 -2.077 0 C-N-CA 118.512 -1.804 . . . . 0.81000000000000005 113.339 -170.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.21 117.75 31.4 Favored 'General case' 0 N--CA 1.418 -2.027 0 CA-C-O 122.99 1.376 . . . . 0.79000000000000004 110.48 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.576 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 4.0 m-80 -50.85 -179.65 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 111.263 -2.699 . . . . 1.1200000000000001 113.44 176.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.14 -22.36 16.62 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.607 -0.724 . . . . 1.6499999999999999 110.256 170.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -96.15 -25.91 15.67 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.435 0.636 . . . . 2.0 110.1 -174.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.14 33.89 4.75 Favored Glycine 0 N--CA 1.433 -1.536 0 N-CA-C 110.37 -1.092 . . . . 0.66000000000000003 110.37 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 42.0 p -115.77 128.22 26.14 Favored Pre-proline 0 N--CA 1.414 -2.226 0 N-CA-C 107.376 -1.342 . . . . 0.68000000000000005 107.376 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.921 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.4 Cg_exo -70.06 144.45 52.46 Favored 'Trans proline' 0 N--CA 1.417 -2.987 0 C-N-CA 121.934 1.756 . . . . 0.81000000000000005 111.844 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.661 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 6.2 p90 -131.64 -177.16 4.3 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 112.196 -2.274 . . . . 0.38 106.646 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 18.1 mt-10 -137.74 162.45 33.86 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 122.459 1.123 . . . . 0.62 112.678 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.76 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.47 99.05 9.74 Favored Pre-proline 0 N--CA 1.422 -1.859 0 CA-C-N 112.965 -1.925 . . . . 1.3300000000000001 108.525 174.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 63.3 Cg_endo -67.9 103.67 0.9 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.787 2.324 . . . . 0.20000000000000001 110.604 174.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.675 HG21 ' HB2' ' A' ' 421' ' ' HIS . 1.2 t -118.42 154.37 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.431 0 CA-C-N 114.555 -1.202 . . . . 0.29999999999999999 110.578 -173.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.1 OUTLIER -95.91 -34.47 11.81 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 115.437 -0.801 . . . . 1.8400000000000001 108.881 174.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.478 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 60.2 m-85 -136.91 115.94 12.39 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.172 -1.376 . . . . 0.44 111.218 -177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.663 ' HB2' HG11 ' A' ' 407' ' ' VAL . 9.7 t-105 -123.63 134.54 53.76 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.002 -1.454 . . . . 0.13 111.089 -175.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.542 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.0 OUTLIER -133.97 87.23 35.48 Favored Pre-proline 0 C--N 1.302 -1.476 0 CA-C-N 114.639 -1.164 . . . . 0.40999999999999998 111.372 174.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.2 Cg_endo -73.68 140.0 28.8 Favored 'Trans proline' 0 CA--C 1.505 -0.937 0 C-N-CA 123.164 2.576 . . . . 0.16 111.545 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.663 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.4 pt -123.35 -17.8 4.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 114.329 -1.305 . . . . 0.17000000000000001 111.425 -171.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.814 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.0 p30 -136.31 173.75 11.37 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.805 -0.634 . . . . 1.5900000000000001 110.124 172.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -100.26 15.84 26.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.829 -0.623 . . . . 0.31 111.832 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 16.8 p -97.57 -27.88 14.2 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 108.051 -1.092 . . . . 0.44 108.051 174.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.6 26.98 0.91 Allowed Glycine 0 N--CA 1.428 -1.867 0 CA-C-N 113.874 -1.512 . . . . 0.23999999999999999 113.355 173.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.814 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.8 t -103.64 151.74 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-O 121.704 0.764 . . . . 0.17000000000000001 111.394 176.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.39 -166.06 36.82 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.562 -1.199 . . . . 0.10000000000000001 110.841 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.439 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -102.73 136.83 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.39 0 N-CA-C 108.672 -0.862 . . . . 0.12 108.672 175.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.675 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.2 p80 -151.1 168.12 25.61 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.142 0.972 . . . . 0.14999999999999999 110.937 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.762 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.09 150.65 22.64 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.359 -1.746 . . . . 0.41999999999999998 108.363 174.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.514 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -138.0 100.34 4.13 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.688 1.232 . . . . 1.48 109.989 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -94.61 -31.59 13.8 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 112.667 -2.061 . . . . 0.34999999999999998 110.189 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.53 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 19.9 p90 -70.17 -27.64 64.69 Favored 'General case' 0 CA--C 1.506 -0.724 0 CA-C-N 114.52 -1.218 . . . . 0.17999999999999999 109.296 173.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.542 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.1 OUTLIER -114.73 81.88 7.61 Favored Pre-proline 0 CA--C 1.492 -1.281 0 CA-C-N 113.821 -1.536 . . . . 1.3300000000000001 109.427 -176.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 27.8 Cg_endo -80.18 5.2 6.19 Favored 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 124.788 3.659 . . . . 0.23000000000000001 113.944 -161.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 152.82 32.44 Favored 'General case' 0 N--CA 1.44 -0.97 0 O-C-N 123.702 0.626 . . . . 1.1000000000000001 110.69 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.774 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -164.2 125.4 2.22 Favored 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 114.293 -1.321 . . . . 0.38 108.084 -172.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.505 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.32 -165.88 28.61 Favored Glycine 0 N--CA 1.429 -1.819 0 C-N-CA 119.633 -1.27 . . . . 0.13 110.206 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.49 152.53 0.01 OUTLIER Glycine 0 C--N 1.34 0.752 0 O-C-N 125.093 1.114 . . . . 0.20000000000000001 113.178 174.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.08 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 124.244 1.973 . . . . 0.33000000000000002 112.42 -152.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.5 mt -97.71 -32.5 11.72 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 110.013 -3.267 . . . . 0.17999999999999999 107.906 171.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.616 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.9 p-90 -47.8 -39.36 18.02 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.873 -0.603 . . . . 0.22 111.568 -173.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.795 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 22.7 mttt -60.33 -25.23 65.64 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.919 -1.037 . . . . 0.64000000000000001 112.595 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 55.5 p -112.09 -36.27 5.41 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.494 -0.775 . . . . 0.25 110.306 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.542 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.7 mtp85 -85.49 -16.18 40.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.905 -1.043 . . . . 0.35999999999999999 112.326 -170.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.562 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.84 43.13 28.93 Favored Glycine 0 C--N 1.304 -1.215 0 C-N-CA 119.425 -1.369 . . . . 0.20999999999999999 116.198 162.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.4 m -82.31 130.92 35.21 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-N 118.185 0.992 . . . . 0.46999999999999997 108.996 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 76.0 m80 -98.28 67.9 1.87 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.838 -0.539 . . . . 0.40999999999999998 110.539 -169.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.529 ' O ' HG23 ' A' ' 377' ' ' THR . . . 89.13 -14.7 60.03 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.392 -1.083 . . . . 0.17999999999999999 110.392 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.523 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.9 p -86.75 148.19 25.52 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.344 -0.428 . . . . 0.82999999999999996 110.55 -177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.724 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -102.47 119.46 50.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.093 -0.503 . . . . 0.14999999999999999 110.191 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.583 ' HB2' HG13 ' A' ' 369' ' ' VAL . 8.6 m120 -81.55 89.88 6.22 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.864 -0.607 . . . . 1.77 111.135 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.601 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.6 m -88.06 137.93 31.09 Favored Pre-proline 0 N--CA 1.448 -0.57 0 N-CA-C 109.285 -0.635 . . . . 0.17999999999999999 109.285 174.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.529 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 52.9 Cg_exo -58.6 132.3 47.41 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.905 2.403 . . . . 0.12 113.04 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.762 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.7 Cg_exo -51.07 -40.46 59.42 Favored 'Trans proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.52 2.813 . . . . 0.16 112.052 -169.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.3 m -71.66 -40.83 69.4 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.496 -1.229 . . . . 1.1699999999999999 109.724 -177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.6 HG11 ' HB ' ' A' ' 366' ' ' THR . 84.5 t -76.51 -31.09 19.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.626 -0.715 . . . . 0.17000000000000001 111.684 -179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.702 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.4 tpt -66.49 -21.43 66.18 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 121.966 0.888 . . . . 0.46000000000000002 110.203 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -76.9 -25.52 53.1 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 114.18 -1.373 . . . . 0.81000000000000005 111.124 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.727 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -79.07 -47.01 16.93 Favored 'General case' 0 CA--C 1.468 -2.182 0 CA-C-N 113.41 -1.723 . . . . 0.38 107.392 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.534 HD23 ' SD ' ' A' ' 450' ' ' MET . 24.5 tp -63.75 -67.71 0.41 Allowed 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 111.444 -2.617 . . . . 0.059999999999999998 112.395 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.542 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 33.8 t80 -51.77 -26.85 10.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 123.108 1.432 . . . . 0.31 107.878 178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.02 -29.04 72.46 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 112.404 -2.18 . . . . 0.13 112.079 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.727 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.9 ptp -90.78 -48.75 6.85 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.617 0.722 . . . . 0.13 111.056 170.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.585 ' CB ' HD11 ' A' ' 345' ' ' ILE . 1.1 p -106.87 134.18 49.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 CA-C-O 123.403 1.573 . . . . 0.23000000000000001 114.614 -167.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.546 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 7.8 pt-20 -140.15 -176.19 4.51 Favored 'General case' 0 N--CA 1.405 -2.679 0 CA-C-N 110.889 -2.869 . . . . 0.82999999999999996 107.018 174.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.652 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 49.0 mtmt -45.26 153.43 0.22 Allowed 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 122.88 1.324 . . . . 0.23999999999999999 113.66 177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.6 -30.91 8.44 Favored Glycine 0 C--N 1.292 -1.864 0 CA-C-N 112.191 -2.277 . . . . 0.37 112.312 -176.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 462' ' ' PRO . 5.0 m -86.76 142.42 34.5 Favored Pre-proline 0 N--CA 1.437 -1.12 0 N-CA-C 109.578 -0.527 . . . . 0.14999999999999999 109.578 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.681 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 3.8 Cg_exo -75.62 170.29 20.53 Favored 'Trans proline' 0 N--CA 1.428 -2.349 0 C-N-CA 122.083 1.856 . . . . 0.12 111.631 173.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.763 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.3 158.5 38.19 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 N-CA-C 107.797 -1.186 . . . . 1.0900000000000001 107.797 165.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.485 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.3 tp -129.95 145.56 51.63 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.335 -0.848 . . . . 0.13 110.179 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.2 148.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.304 -1.369 . . . . 0.089999999999999997 107.304 165.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.534 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 13.2 p90 . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.772 -0.632 . . . . 1.1599999999999999 111.785 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.859 0 N-CA-C 111.364 -0.694 . . . . 3.9399999999999999 111.364 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.629 ' O ' ' HB2' ' A' ' 340' ' ' MET . 2.9 t-160 -79.19 93.33 5.2 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.402 -0.962 . . . . 1.8500000000000001 108.402 171.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.629 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 32.7 mtm 79.48 172.98 0.15 Allowed 'General case' 0 C--N 1.328 -0.367 0 O-C-N 125.214 1.571 . . . . 1.03 110.12 -166.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -106.56 -9.45 16.59 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.178 -0.919 . . . . 1.1000000000000001 111.555 -172.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.5 166.93 1.13 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 123.195 1.474 . . . . 0.97999999999999998 113.931 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.689 HG23 ' HA ' ' A' ' 358' ' ' LYS . 3.6 m -93.08 122.63 35.64 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-N 112.649 -2.068 . . . . 0.45000000000000001 106.956 165.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.671 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 16.4 p90 -160.7 -172.04 3.35 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.643 0.735 . . . . 0.32000000000000001 110.951 -174.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.586 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.8 mm -104.58 159.25 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 108.002 -1.11 . . . . 0.080000000000000002 108.002 166.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.542 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -139.95 155.09 47.31 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 118.881 0.764 . . . . 0.17000000000000001 111.036 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.689 HG22 ' HG3' ' A' ' 354' ' ' MET . 65.4 t -150.79 137.09 12.46 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 114.425 -1.261 . . . . 0.080000000000000002 109.476 -178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.484 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 30.2 t0 -118.03 116.32 26.65 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.737 -1.12 . . . . 0.37 108.219 173.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.571 HD21 HG23 ' A' ' 465' ' ' VAL . 1.9 mm? -71.96 -44.3 63.78 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.078 0.942 . . . . 0.32000000000000001 109.391 -178.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.484 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 7.1 mm-40 -57.38 -49.48 76.04 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 112.876 -1.965 . . . . 1.51 112.515 -177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 -106.29 14.07 27.93 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.352 -1.295 . . . . 0.91000000000000003 109.296 -174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.616 ' OE1' ' HA2' ' A' ' 431' ' ' GLY . 20.5 mp0 38.87 73.14 0.11 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 125.151 1.532 . . . . 2.2200000000000002 112.096 174.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.458 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.5 t60 -155.91 125.26 6.24 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.243 0.544 . . . . 0.13 110.164 -177.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.689 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.5 ttp -110.83 128.33 55.73 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.766 -0.652 . . . . 0.059999999999999998 110.563 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.684 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -114.31 173.95 6.19 Favored 'General case' 0 C--O 1.211 -0.952 0 CA-C-N 114.635 -1.166 . . . . 0.10000000000000001 112.027 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.716 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.7 t80 -126.29 119.79 28.28 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 105.963 -1.866 . . . . 0.22 105.963 164.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.504 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.6 m-85 -103.9 130.79 51.53 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-O 122.159 0.981 . . . . 0.17999999999999999 111.811 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.689 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.4 ttpt -147.73 136.13 21.58 Favored 'General case' 0 N--CA 1.398 -3.028 0 CA-C-N 113.206 -1.815 . . . . 0.46999999999999997 108.338 172.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.1 t70 71.63 13.15 6.34 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 113.375 -1.739 . . . . 0.59999999999999998 108.573 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 84.66 8.01 83.51 Favored Glycine 0 N--CA 1.424 -2.121 0 CA-C-N 112.788 -2.005 . . . . 0.23000000000000001 112.02 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.636 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -124.9 169.58 11.93 Favored 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 105.668 -1.975 . . . . 0.68000000000000005 105.668 -172.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.757 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -102.18 138.76 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.819 0 CA-C-O 124.258 1.98 . . . . 0.53000000000000003 112.092 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.716 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.56 -24.67 18.66 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 109.322 -3.581 . . . . 0.12 108.656 176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.68 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -152.93 154.72 35.61 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-N 113.927 -1.488 . . . . 0.080000000000000002 109.168 -172.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.757 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.37 121.96 1.21 Allowed 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 116.002 -0.545 . . . . 0.60999999999999999 110.196 -174.656 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.61 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.5 t -147.22 166.83 25.84 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.517 0.675 . . . . 0.089999999999999997 111.352 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.515 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 1.3 m-20 -85.73 149.52 25.23 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.646 -1.613 . . . . 1.8799999999999999 106.646 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.59 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -146.32 -171.6 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 124.052 0.845 . . . . 0.11 111.305 -176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.588 HG23 ' CA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.16 118.91 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.761 -1.109 . . . . 0.12 108.775 176.658 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.467 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.86 146.12 35.43 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.081 -0.963 . . . . 0.69999999999999996 112.561 -167.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.635 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.28 44.82 41.89 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 116.548 1.379 . . . . 0.13 116.548 163.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.551 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.93 144.21 3.94 Favored Pre-proline 0 CA--C 1.509 -0.627 0 CA-C-N 118.335 1.068 . . . . 0.47999999999999998 110.24 -174.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.785 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.49 -31.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.787 1 C-N-CA 125.82 4.346 . . . . 0.23000000000000001 116.278 -170.749 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.551 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.87 -34.82 29.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.014 0.435 . . . . 0.29999999999999999 110.791 -177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.459 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.9 m -140.53 73.62 29.44 Favored Pre-proline 0 N--CA 1.448 -0.553 0 CA-C-O 122.112 0.958 . . . . 0.29999999999999999 110.423 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.635 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -72.29 161.06 45.5 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 125.187 3.925 . . . . 0.16 113.898 -178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.696 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.3 152.42 88.0 Favored Pre-proline 0 N--CA 1.438 -1.073 0 CA-C-N 113.518 -1.674 . . . . 0.12 111.395 178.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.508 ' CD ' HG22 ' A' ' 377' ' ' THR . 2.0 Cg_endo -80.93 -49.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 125.234 3.956 . . . . 0.089999999999999997 113.986 -171.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.727 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.36 123.22 0.03 OUTLIER 'General case' 0 C--O 1.232 0.145 0 N-CA-C 113.616 0.969 . . . . 0.089999999999999997 113.616 -178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.91 -126.57 1.46 Allowed Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 114.42 -1.264 . . . . 0.11 111.441 -177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.1 p -127.19 98.9 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 CA-C-O 122.475 1.131 . . . . 0.89000000000000001 109.884 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.754 ' HB2' HG22 ' A' ' 463' ' ' VAL . 99.1 m-85 -101.71 162.02 13.22 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.67 -1.15 . . . . 0.16 110.22 -170.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.673 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -147.58 135.57 21.27 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 121.337 -0.145 . . . . 0.68999999999999995 110.878 177.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.632 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.82 124.2 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 C-N-CA 119.741 -0.784 . . . . 0.14000000000000001 110.612 177.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -109.89 2.76 20.03 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.399 -0.818 . . . . 0.19 112.183 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.751 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.2 t30 -165.14 151.85 10.44 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.544 -0.753 . . . . 0.40999999999999998 110.3 177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -112.25 128.37 56.24 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 121.802 0.811 . . . . 1.0900000000000001 109.725 170.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.582 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.3 mt-10 -129.43 118.56 22.36 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 114.361 -1.29 . . . . 0.38 112.019 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 1.5 mp0 -115.27 136.73 52.79 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 114.315 -1.311 . . . . 1.96 110.592 -176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.5 t70 49.83 37.74 14.14 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 123.585 1.66 . . . . 0.40000000000000002 107.565 -173.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.567 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -89.76 169.7 11.05 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-N 112.161 -2.29 . . . . 0.16 111.844 -175.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.1 m -127.2 104.56 8.02 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.812 -1.54 . . . . 0.27000000000000002 109.991 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.749 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -74.66 158.09 34.22 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.733 -2.031 . . . . 0.23999999999999999 110.47 173.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.8 mtpt -145.27 -176.37 5.08 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 114.962 -1.017 . . . . 0.67000000000000004 108.685 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.748 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.92 -146.48 6.94 Favored Glycine 0 N--CA 1.426 -1.988 0 C-N-CA 116.956 -2.545 . . . . 0.81000000000000005 115.322 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 401' ' ' THR . 0.6 OUTLIER -141.46 121.06 13.33 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 112.873 -1.663 . . . . 0.79000000000000004 109.774 175.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.575 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -52.77 -178.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 111.831 -2.441 . . . . 1.1200000000000001 112.162 178.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -51.03 -27.31 7.63 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 115.737 -0.665 . . . . 1.6499999999999999 111.346 171.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.575 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.6 OUTLIER -98.16 -29.97 12.91 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.137 0.494 . . . . 2.0 111.292 -174.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.68 37.52 1.16 Allowed Glycine 0 C--N 1.295 -1.696 0 C-N-CA 119.548 -1.31 . . . . 0.66000000000000003 111.797 -173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 396' ' ' THR . 77.7 p -119.17 151.61 51.07 Favored Pre-proline 0 N--CA 1.422 -1.857 0 N-CA-C 107.911 -1.144 . . . . 0.68000000000000005 107.911 174.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.748 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 72.5 Cg_endo -65.39 163.15 30.66 Favored 'Trans proline' 0 C--N 1.279 -3.117 0 C-N-CA 122.842 2.361 . . . . 0.81000000000000005 113.449 -173.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.584 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 13.1 p90 -152.86 -173.92 4.74 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 112.44 -2.164 . . . . 0.38 107.252 173.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.624 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.9 mt-10 -143.08 159.25 42.62 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.162 0.982 . . . . 0.62 111.561 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.749 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.54 98.3 12.4 Favored Pre-proline 0 N--CA 1.419 -1.99 0 CA-C-N 113.168 -1.833 . . . . 1.3300000000000001 107.793 175.431 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.6 Cg_endo -67.46 102.68 0.73 Allowed 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 122.328 2.019 . . . . 0.20000000000000001 110.091 174.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.796 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -113.98 159.74 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.722 0 CA-C-N 114.4 -1.273 . . . . 0.29999999999999999 109.757 -174.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.417 HD22 ' CG ' ' A' ' 422' ' ' ASP . 21.2 m-80 -108.92 -34.23 6.7 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 113.585 -1.643 . . . . 1.8400000000000001 107.167 -178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.497 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 46.9 m-85 -136.43 116.17 13.04 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.923 -1.944 . . . . 0.44 110.684 177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.796 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.3 t-105 -123.02 135.01 54.28 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.931 -1.031 . . . . 0.13 110.025 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.521 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.36 86.33 24.49 Favored Pre-proline 0 C--N 1.3 -1.559 0 CA-C-N 114.875 -1.057 . . . . 0.40999999999999998 110.82 173.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.709 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 78.0 Cg_endo -71.34 140.42 36.89 Favored 'Trans proline' 0 CA--C 1.509 -0.755 0 C-N-CA 123.024 2.483 . . . . 0.16 112.046 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 6.0 pt -123.65 -16.61 4.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 113.972 -1.467 . . . . 0.17000000000000001 111.111 -172.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.513 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.83 169.37 17.47 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.121 -0.945 . . . . 1.5900000000000001 109.33 176.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -101.75 14.62 31.44 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.242 0.831 . . . . 0.31 113.242 -176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.513 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 23.9 p -98.25 -28.08 13.85 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.968 -1.123 . . . . 0.44 107.968 172.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.86 28.96 0.37 Allowed Glycine 0 N--CA 1.428 -1.843 0 CA-C-N 113.967 -1.469 . . . . 0.23999999999999999 113.259 172.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 441' ' ' GLY . 97.7 t -102.76 148.23 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-O 121.548 0.69 . . . . 0.17000000000000001 111.717 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 176.75 -166.47 37.3 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 114.664 -1.153 . . . . 0.10000000000000001 111.204 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.63 138.44 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.541 -0.911 . . . . 0.12 108.541 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.581 ' NE2' ' HB2' ' A' ' 442' ' ' CYS . 32.0 p80 -151.24 166.13 31.84 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 121.869 0.843 . . . . 0.14999999999999999 111.451 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.778 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -91.68 145.05 24.9 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 113.77 -1.559 . . . . 0.41999999999999998 107.742 173.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.56 102.22 5.23 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 123.32 1.533 . . . . 1.48 110.208 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -92.93 -30.63 15.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 110.09 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.471 ' O ' ' HD3' ' A' ' 427' ' ' PRO . 10.8 p90 -71.46 -27.28 63.15 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 114.023 -1.444 . . . . 0.17999999999999999 109.146 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.426 HE22 ' HD3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.3 82.9 19.32 Favored Pre-proline 0 CA--C 1.49 -1.328 0 CA-C-N 113.762 -1.563 . . . . 1.3300000000000001 108.724 -172.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 35.8 Cg_endo -79.32 3.64 7.3 Favored 'Trans proline' 0 C--N 1.294 -2.321 0 C-N-CA 124.571 3.514 . . . . 0.23000000000000001 114.452 -159.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -114.78 156.56 24.63 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.169 0.509 . . . . 1.1000000000000001 111.916 -176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.515 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -164.08 124.01 2.06 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.115 -1.402 . . . . 0.38 108.675 -172.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.53 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.42 -167.49 28.55 Favored Glycine 0 N--CA 1.433 -1.531 0 C-N-CA 119.861 -1.161 . . . . 0.13 111.149 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.655 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.9 154.2 0.01 OUTLIER Glycine 0 C--N 1.34 0.764 0 O-C-N 125.389 1.287 . . . . 0.20000000000000001 113.151 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -51.76 100.33 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 111.985 -152.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 53.1 mt -97.32 -32.05 12.08 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 109.962 -3.29 . . . . 0.17999999999999999 108.086 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.588 ' CA ' HG23 ' A' ' 369' ' ' VAL . 5.5 p-90 -46.44 -37.47 7.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.65 -0.704 . . . . 0.22 111.584 -172.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.785 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 24.4 mttt -60.86 -24.44 65.92 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.18 -0.918 . . . . 0.64000000000000001 113.192 -176.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.4 p -113.95 -35.19 5.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.691 0.758 . . . . 0.25 110.256 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.541 ' HD2' HD22 ' A' ' 433' ' ' LEU . 5.8 mtp85 -85.62 -15.34 42.84 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.605 -1.18 . . . . 0.35999999999999999 112.481 -169.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.506 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.06 42.0 38.07 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 116.256 1.263 . . . . 0.20999999999999999 116.256 159.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 5.5 m -85.62 130.38 34.58 Favored 'General case' 0 C--O 1.209 -1.052 0 CA-C-N 118.485 1.143 . . . . 0.46999999999999997 109.226 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.495 ' NE2' ' HE3' ' A' ' 372' ' ' LYS . 62.2 m80 -101.21 68.38 1.23 Allowed 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.547 -0.721 . . . . 0.40999999999999998 110.75 -167.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.541 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 90.92 -14.17 64.08 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 110.353 -1.099 . . . . 0.17999999999999999 110.353 -177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.581 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 23.4 p -89.95 148.14 23.29 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.326 -0.437 . . . . 0.82999999999999996 110.62 -177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -104.15 119.0 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 116.204 -0.453 . . . . 0.14999999999999999 110.621 -176.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.541 HD22 ' CE1' ' A' ' 421' ' ' HIS . 6.9 m120 -79.28 88.99 4.92 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.609 -0.436 . . . . 1.77 111.186 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.619 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 41.3 m -86.97 135.65 35.01 Favored Pre-proline 0 N--CA 1.44 -0.958 0 N-CA-C 109.17 -0.678 . . . . 0.17999999999999999 109.17 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.418 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 53.0 Cg_exo -55.75 135.37 69.17 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.725 2.283 . . . . 0.12 111.398 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.778 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 31.0 Cg_exo -54.8 -33.89 82.84 Favored 'Trans proline' 0 CA--C 1.503 -1.07 0 C-N-CA 124.225 3.284 . . . . 0.16 112.99 -173.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 67.8 m -79.24 -39.02 34.19 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.783 -1.098 . . . . 1.1699999999999999 110.06 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.61 HG11 ' HB ' ' A' ' 366' ' ' THR . 97.8 t -78.8 -30.48 14.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.674 -0.694 . . . . 0.17000000000000001 111.408 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.685 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.9 tpt -67.56 -19.0 65.21 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.788 0.804 . . . . 0.46000000000000002 110.32 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.6 ttpt -80.03 -22.88 41.88 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 114.528 -1.215 . . . . 0.81000000000000005 110.839 176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.68 -46.78 15.01 Favored 'General case' 0 CA--C 1.477 -1.842 0 CA-C-N 112.921 -1.945 . . . . 0.38 107.329 177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.635 HD23 ' SD ' ' A' ' 450' ' ' MET . 25.8 tp -64.64 -66.58 0.52 Allowed 'General case' 0 N--CA 1.405 -2.714 0 CA-C-N 111.906 -2.406 . . . . 0.059999999999999998 112.423 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.429 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 32.6 t80 -50.34 -25.16 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 123.059 1.409 . . . . 0.31 108.247 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.63 -28.66 66.94 Favored Glycine 0 N--CA 1.429 -1.799 0 CA-C-N 112.486 -2.143 . . . . 0.13 112.507 179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.68 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -92.2 -48.18 6.83 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.783 0.802 . . . . 0.13 111.614 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.632 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.8 OUTLIER -103.94 136.75 35.65 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.22 0 CA-C-O 123.344 1.545 . . . . 0.23000000000000001 113.953 -167.027 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -136.56 -178.49 5.2 Favored 'General case' 0 N--CA 1.404 -2.741 0 CA-C-N 110.916 -2.856 . . . . 0.82999999999999996 106.583 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.751 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.4 mtmt -51.71 160.85 0.6 Allowed 'General case' 0 N--CA 1.413 -2.314 0 CA-C-O 123.114 1.435 . . . . 0.23999999999999999 112.958 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 93.28 -29.75 7.91 Favored Glycine 0 N--CA 1.426 -2.033 0 CA-C-N 112.527 -2.124 . . . . 0.37 112.528 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 462' ' ' PRO . 6.1 m -82.01 142.95 48.69 Favored Pre-proline 0 N--CA 1.434 -1.244 0 N-CA-C 109.308 -0.627 . . . . 0.14999999999999999 109.308 -177.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.671 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.36 168.75 23.92 Favored 'Trans proline' 0 N--CA 1.426 -2.48 0 C-N-CA 121.855 1.703 . . . . 0.12 111.262 172.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.754 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.2 m -136.32 155.13 34.12 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 107.125 -1.435 . . . . 1.0900000000000001 107.125 165.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.436 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 3.4 tp -126.06 145.68 50.22 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.254 -0.885 . . . . 0.13 110.158 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.727 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.0 146.3 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.873 0 N-CA-C 106.896 -1.52 . . . . 0.089999999999999997 106.896 164.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.678 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 16.4 p90 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.229 -0.891 . . . . 1.1599999999999999 111.431 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.743 0 N-CA-C 112.06 -0.416 . . . . 3.9399999999999999 112.06 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -83.67 -176.01 6.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.573 0.701 . . . . 1.8500000000000001 110.257 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 40.8 mtm -54.46 176.53 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.705 -1.589 . . . . 1.03 115.127 -169.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -134.02 -5.13 2.75 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.667 -1.606 . . . . 1.1000000000000001 110.181 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.24 169.2 0.19 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 123.038 1.399 . . . . 0.97999999999999998 112.404 172.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.576 HG23 ' HA ' ' A' ' 358' ' ' LYS . 98.5 m -91.16 124.01 35.05 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 113.077 -1.874 . . . . 0.45000000000000001 109.189 174.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.636 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 4.7 p90 -159.12 -170.61 3.06 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.012 -1.449 . . . . 0.32000000000000001 110.637 -174.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.606 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -99.87 159.64 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 N-CA-C 108.073 -1.084 . . . . 0.080000000000000002 108.073 166.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.2 tt0 -138.68 154.1 48.58 Favored 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 120.074 -0.65 . . . . 0.17000000000000001 111.146 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.682 HG22 ' HG3' ' A' ' 354' ' ' MET . 64.1 t -149.98 134.33 9.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 114.263 -1.335 . . . . 0.080000000000000002 109.436 -178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 15.4 t0 -115.57 124.5 51.15 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 114.714 -1.13 . . . . 0.37 108.377 172.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.437 HD21 HG23 ' A' ' 465' ' ' VAL . 2.1 mm? -75.22 -43.81 49.73 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.811 1.291 . . . . 0.32000000000000001 110.525 -177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 5.4 mm-40 -57.38 -54.96 40.88 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.623 -2.08 . . . . 1.51 112.816 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -105.16 20.58 18.61 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-O 121.843 0.83 . . . . 0.91000000000000003 109.752 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.873 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.3 mm-40 35.94 71.25 0.13 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 112.104 -2.316 . . . . 2.2200000000000002 112.16 169.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -149.19 125.89 11.08 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.186 -0.916 . . . . 0.13 109.174 -174.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.682 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.8 ttp -111.81 127.5 55.83 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.488 0.661 . . . . 0.059999999999999998 110.481 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.68 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -111.55 173.39 6.37 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.552 -1.204 . . . . 0.10000000000000001 111.753 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.697 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.5 t80 -125.3 111.79 15.61 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.242 -1.762 . . . . 0.22 106.242 165.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 362' ' ' VAL . 21.9 m-85 -97.47 127.44 43.43 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.766 0.793 . . . . 0.17999999999999999 111.174 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.621 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 4.3 ttpt -142.86 135.35 27.62 Favored 'General case' 0 N--CA 1.398 -3.049 0 CA-C-N 113.964 -1.471 . . . . 0.46999999999999997 108.297 172.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.8 t70 71.26 11.37 6.78 Favored 'General case' 0 CA--C 1.496 -1.105 0 CA-C-N 113.209 -1.814 . . . . 0.59999999999999998 108.806 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.55 12.84 68.81 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 112.763 -2.017 . . . . 0.23000000000000001 111.757 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.535 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.0 OUTLIER -129.66 167.0 18.66 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 106.15 -1.796 . . . . 0.68000000000000005 106.15 -172.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.747 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -101.91 138.68 25.29 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.768 0 CA-C-O 124.429 2.062 . . . . 0.53000000000000003 112.21 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.697 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.61 -25.45 17.52 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 109.341 -3.572 . . . . 0.12 108.671 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.64 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.71 155.26 36.9 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 113.627 -1.624 . . . . 0.080000000000000002 108.891 -172.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.747 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.38 122.12 1.45 Allowed 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 115.691 -0.686 . . . . 0.60999999999999999 109.473 -175.087 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.698 HG21 HG23 ' A' ' 445' ' ' THR . 5.3 t -148.95 166.68 27.89 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 122.326 1.06 . . . . 0.089999999999999997 112.224 173.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.732 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.6 p-10 -84.54 139.62 32.01 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 112.936 -1.938 . . . . 1.8799999999999999 107.737 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -141.46 -172.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.163 -0.926 . . . . 0.11 111.724 -175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.873 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.22 120.01 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.127 -0.942 . . . . 0.12 109.26 175.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.448 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 8.5 t -141.84 144.58 33.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 113.56 0.948 . . . . 0.69999999999999996 113.56 -165.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.693 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.63 45.96 50.01 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 116.771 1.468 . . . . 0.13 116.771 161.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.571 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -48.09 144.04 6.2 Favored Pre-proline 0 CA--C 1.511 -0.535 0 CA-C-N 118.263 1.031 . . . . 0.47999999999999998 111.342 -176.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.814 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.02 -31.91 0.1 OUTLIER 'Trans proline' 0 CA--C 1.535 0.564 1 C-N-CA 125.88 4.387 . . . . 0.23000000000000001 115.671 -172.88 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.628 ' HB ' ' OD1' ' A' ' 398' ' ' ASP . 0.9 OUTLIER -78.94 -36.89 41.02 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.263 -0.426 . . . . 0.29999999999999999 110.838 -179.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.455 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -141.44 72.74 25.6 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-O 122.174 0.988 . . . . 0.29999999999999999 110.15 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.693 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.4 Cg_exo -69.33 162.38 42.07 Favored 'Trans proline' 0 C--N 1.322 -0.837 1 C-N-CA 125.357 4.038 . . . . 0.16 114.245 -176.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.67 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.0 152.46 88.66 Favored Pre-proline 0 N--CA 1.434 -1.231 0 CA-C-N 113.581 -1.645 . . . . 0.12 110.647 176.362 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.536 ' CD ' HG22 ' A' ' 377' ' ' THR . 0.9 OUTLIER -79.68 -49.8 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 125.076 3.851 . . . . 0.089999999999999997 113.461 -172.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.729 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 67.05 124.25 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.974 0.892 . . . . 0.089999999999999997 113.267 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 162.63 -122.48 1.11 Allowed Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.445 -1.252 . . . . 0.11 111.405 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.453 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.2 p -130.77 106.62 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-O 121.979 0.895 . . . . 0.89000000000000001 109.283 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 465' ' ' VAL . 52.2 m-85 -111.48 167.53 10.25 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.223 -0.899 . . . . 0.16 109.282 -172.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.688 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 82.2 m-85 -149.02 138.46 21.7 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 110.618 -0.141 . . . . 0.68999999999999995 110.618 176.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.626 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -72.82 122.77 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 C-N-CA 119.67 -0.812 . . . . 0.14000000000000001 110.476 175.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 39.2 p-90 -109.79 3.87 21.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 115.46 -0.791 . . . . 0.19 112.286 -175.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.658 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 8.0 t30 -163.88 148.03 10.19 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.279 -1.008 . . . . 0.40999999999999998 108.279 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.588 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.4 OUTLIER -118.98 114.9 23.27 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 122.196 0.998 . . . . 1.0900000000000001 108.43 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.574 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -118.84 132.54 56.12 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.28 -1.327 . . . . 0.38 110.298 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -131.68 134.51 46.03 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.026 -1.443 . . . . 1.96 109.622 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 38.4 t70 52.69 40.45 30.3 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 123.435 1.588 . . . . 0.40000000000000002 107.479 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.564 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -95.76 169.53 9.95 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 112.35 -2.204 . . . . 0.16 111.683 -172.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 7.7 m -126.57 106.49 9.47 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 113.956 -1.474 . . . . 0.27000000000000002 109.926 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.741 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.3 mp -71.02 158.9 35.72 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.986 . . . . 0.23999999999999999 110.626 177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.3 mtpt -147.96 -175.44 4.88 Favored 'General case' 0 N--CA 1.393 -3.3 0 O-C-N 124.39 1.056 . . . . 0.67000000000000004 108.529 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.608 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -176.88 -145.15 5.57 Favored Glycine 0 C--N 1.296 -1.654 0 C-N-CA 117.493 -2.289 . . . . 0.81000000000000005 114.863 177.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.87 123.05 13.73 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-N 113.393 -1.404 . . . . 0.79000000000000004 108.85 171.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.43 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -55.4 -178.18 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 112.055 -2.339 . . . . 1.1200000000000001 111.824 177.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.628 ' OD1' ' HB ' ' A' ' 374' ' ' THR . 26.0 t70 -53.47 -21.01 5.44 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.502 -0.317 . . . . 1.6499999999999999 111.569 173.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.43 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.5 OUTLIER -106.14 -28.83 10.24 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 120.962 0.41 . . . . 2.0 111.394 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.95 37.54 1.13 Allowed Glycine 0 C--N 1.293 -1.807 0 C-N-CA 119.502 -1.332 . . . . 0.66000000000000003 111.549 -173.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 61.4 p -117.48 127.74 26.47 Favored Pre-proline 0 N--CA 1.418 -2.044 0 N-CA-C 106.158 -1.793 . . . . 0.68000000000000005 106.158 174.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.608 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 28.1 Cg_exo -64.57 164.07 25.01 Favored 'Trans proline' 0 C--N 1.284 -2.846 0 C-N-CA 121.901 1.734 . . . . 0.81000000000000005 112.746 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.591 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 17.4 p90 -142.46 -169.93 3.08 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.716 -1.587 . . . . 0.38 106.716 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 12.6 mt-10 -148.26 154.8 40.54 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 122.037 0.922 . . . . 0.62 112.038 175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.741 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.5 m -144.12 99.18 5.05 Favored Pre-proline 0 N--CA 1.428 -1.536 0 CA-C-N 113.835 -1.529 . . . . 1.3300000000000001 110.418 -177.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 73.7 Cg_endo -67.18 109.01 1.65 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 125.236 3.957 . . . . 0.20000000000000001 113.492 -177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -122.82 151.73 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.806 0 CA-C-N 114.559 -1.201 . . . . 0.29999999999999999 111.405 -173.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.709 HD22 ' H ' ' A' ' 408' ' ' ASN . 0.1 OUTLIER -93.61 -28.83 15.79 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.457 -1.247 . . . . 1.8400000000000001 110.065 177.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.472 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 67.5 m-85 -142.77 119.66 11.27 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.348 -1.296 . . . . 0.44 110.601 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.737 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.1 t-105 -125.56 135.15 51.92 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.606 -1.179 . . . . 0.13 111.112 -175.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.563 ' HE3' ' CG2' ' A' ' 457' ' ' VAL . 1.0 OUTLIER -134.9 86.38 32.79 Favored Pre-proline 0 N--CA 1.429 -1.504 0 CA-C-N 114.804 -1.089 . . . . 0.40999999999999998 111.279 174.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.65 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 94.7 Cg_endo -72.23 138.61 30.76 Favored 'Trans proline' 0 CA--C 1.503 -1.055 0 C-N-CA 122.833 2.355 . . . . 0.16 111.558 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.2 pt -124.66 -14.55 4.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 CA-C-N 113.973 -1.467 . . . . 0.17000000000000001 110.916 -173.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -133.7 162.81 30.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.449 -0.796 . . . . 1.5900000000000001 109.7 176.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.5 m-90 -94.11 14.29 20.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.022 0.378 . . . . 0.31 112.022 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.1 p -93.27 -25.6 17.7 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.565 -1.272 . . . . 0.44 107.565 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 121.59 26.31 1.99 Allowed Glycine 0 N--CA 1.426 -2.031 0 CA-C-N 112.773 -2.012 . . . . 0.23999999999999999 111.63 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 441' ' ' GLY . 55.9 t -98.07 146.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 121.165 0.507 . . . . 0.17000000000000001 111.0 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.75 -165.0 36.06 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 114.923 -1.035 . . . . 0.10000000000000001 111.464 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.438 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -105.53 137.64 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.254 0 N-CA-C 108.693 -0.854 . . . . 0.12 108.693 176.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.904 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.7 p80 -154.16 170.58 20.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 122.011 0.91 . . . . 0.14999999999999999 111.582 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.742 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 153.52 20.42 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 113.523 -1.671 . . . . 0.41999999999999998 108.766 174.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.554 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 3.4 p -141.24 99.65 3.62 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 122.827 1.298 . . . . 1.48 109.833 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -95.35 -31.13 13.57 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 112.457 -2.156 . . . . 0.34999999999999998 109.992 176.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.564 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 9.2 p90 -68.23 -26.88 65.92 Favored 'General case' 0 CA--C 1.507 -0.702 0 CA-C-N 114.354 -1.294 . . . . 0.17999999999999999 108.923 173.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.595 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -119.38 82.42 24.26 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.613 -1.63 . . . . 1.3300000000000001 110.135 -175.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -79.76 5.02 6.2 Favored 'Trans proline' 0 N--CA 1.431 -2.15 0 C-N-CA 124.802 3.668 . . . . 0.23000000000000001 114.211 -161.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -114.33 153.25 30.1 Favored 'General case' 0 N--CA 1.442 -0.855 0 O-C-N 123.406 0.441 . . . . 1.1000000000000001 110.07 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.732 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.5 OUTLIER -163.15 127.98 3.04 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 124.99 1.316 . . . . 0.38 107.86 -173.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.28 -167.72 29.02 Favored Glycine 0 C--N 1.299 -1.475 0 C-N-CA 119.689 -1.243 . . . . 0.13 111.05 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.606 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.15 156.64 0.0 OUTLIER Glycine 0 C--N 1.341 0.857 0 O-C-N 124.935 1.021 . . . . 0.20000000000000001 113.225 175.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.461 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -54.92 100.62 0.04 OUTLIER 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 123.692 1.711 . . . . 0.33000000000000002 111.579 -148.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 32.8 mt -97.21 -31.16 12.58 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 110.611 -2.995 . . . . 0.17999999999999999 109.453 177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.478 ' HA ' HG23 ' A' ' 369' ' ' VAL . 14.8 p-90 -49.06 -32.32 9.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 112.881 -1.963 . . . . 0.22 111.729 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.814 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 53.4 mttt -64.06 -19.67 65.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 113.297 0.851 . . . . 0.64000000000000001 113.297 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 72.5 p -120.72 -36.64 3.13 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.644 -0.707 . . . . 0.25 110.628 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.595 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.2 mtp85 -82.05 -15.04 54.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.65 -1.159 . . . . 0.35999999999999999 112.773 -169.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.532 ' CA ' ' HE2' ' A' ' 372' ' ' LYS . . . 74.82 41.42 33.89 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 116.554 1.381 . . . . 0.20999999999999999 116.554 159.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 18.4 m -85.81 131.97 34.21 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-N 118.225 1.013 . . . . 0.46999999999999997 109.563 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.446 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 67.9 m80 -97.68 68.74 2.11 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.683 -0.635 . . . . 0.40999999999999998 110.85 -170.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.582 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 85.4 -9.81 66.15 Favored Glycine 0 N--CA 1.444 -0.787 0 N-CA-C 110.819 -0.913 . . . . 0.17999999999999999 110.819 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 20.8 p -89.52 137.58 32.21 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.946 -0.627 . . . . 0.82999999999999996 110.079 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.67 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -96.77 113.12 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 CA-C-N 115.618 -0.719 . . . . 0.14999999999999999 110.483 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.566 ' HB2' HG13 ' A' ' 369' ' ' VAL . 2.2 m-20 -80.76 92.12 6.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.988 -1.006 . . . . 1.77 111.678 -176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.698 HG23 HG21 ' A' ' 366' ' ' THR . 98.0 m -89.44 140.85 28.48 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 115.542 -0.754 . . . . 0.17999999999999999 109.572 175.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 53.3 Cg_exo -55.08 136.81 74.7 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 122.803 2.335 . . . . 0.12 111.202 177.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.742 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 58.4 Cg_exo -55.96 -32.94 87.65 Favored 'Trans proline' 0 CA--C 1.5 -1.199 0 C-N-CA 124.195 3.263 . . . . 0.16 112.634 -173.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 19.7 p -79.64 -38.35 33.97 Favored 'General case' 0 N--CA 1.427 -1.618 0 CA-C-N 114.522 -1.217 . . . . 1.1699999999999999 109.719 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.628 HG11 ' HB ' ' A' ' 366' ' ' THR . 84.3 t -78.54 -30.44 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.522 -0.763 . . . . 0.17000000000000001 111.439 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.677 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -64.47 -23.11 67.17 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 121.893 0.854 . . . . 0.46000000000000002 110.426 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.2 ttpt -75.42 -27.02 58.82 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.408 -1.269 . . . . 0.81000000000000005 111.916 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.669 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.9 mm-40 -77.6 -46.19 22.92 Favored 'General case' 0 CA--C 1.472 -2.045 0 CA-C-N 113.489 -1.687 . . . . 0.38 106.991 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 457' ' ' VAL . 24.6 tp -65.4 -67.78 0.41 Allowed 'General case' 0 N--CA 1.401 -2.903 0 CA-C-N 111.472 -2.604 . . . . 0.059999999999999998 112.601 176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.535 ' CD2' ' SD ' ' A' ' 411' ' ' MET . 31.4 t80 -51.31 -27.16 8.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.183 1.468 . . . . 0.31 107.988 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.425 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.06 -31.02 74.33 Favored Glycine 0 N--CA 1.428 -1.865 0 CA-C-N 112.116 -2.311 . . . . 0.13 112.064 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.669 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -89.26 -48.39 7.4 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.834 0.826 . . . . 0.13 111.189 170.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.667 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 1.1 p -107.19 134.36 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.093 0 CA-C-O 123.344 1.545 . . . . 0.23000000000000001 114.461 -167.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.588 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 12.6 pt-20 -139.81 -176.55 4.61 Favored 'General case' 0 N--CA 1.404 -2.726 0 CA-C-N 110.948 -2.842 . . . . 0.82999999999999996 107.032 175.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.658 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.9 mtmt -46.21 154.42 0.27 Allowed 'General case' 0 N--CA 1.42 -1.948 0 CA-C-O 123.032 1.396 . . . . 0.23999999999999999 113.578 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 95.22 -24.75 27.47 Favored Glycine 0 C--N 1.292 -1.913 0 CA-C-N 112.275 -2.239 . . . . 0.37 112.821 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.504 ' HB ' HG23 ' A' ' 457' ' ' VAL . 6.6 m -89.3 142.23 29.67 Favored Pre-proline 0 N--CA 1.438 -1.069 0 N-CA-C 109.685 -0.487 . . . . 0.14999999999999999 109.685 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.636 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.9 Cg_exo -74.64 168.3 25.13 Favored 'Trans proline' 0 N--CA 1.43 -2.209 0 C-N-CA 122.067 1.844 . . . . 0.12 111.571 174.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.477 HG21 HG21 ' A' ' 413' ' ' ILE . 69.8 t -135.46 134.77 52.06 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 113.869 -1.514 . . . . 1.0900000000000001 108.265 173.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.7 tp -112.93 143.43 44.23 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.157 0.503 . . . . 0.13 110.408 177.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.699 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.13 146.64 21.35 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 N-CA-C 106.74 -1.578 . . . . 0.089999999999999997 106.74 164.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.729 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 21.0 p90 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.523 -0.751 . . . . 1.1599999999999999 111.217 -175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.773 0 N-CA-C 111.821 -0.511 . . . . 3.9399999999999999 111.821 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -84.66 96.3 9.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.047 0.451 . . . . 1.8500000000000001 109.85 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 36.9 mtm 63.78 -173.58 0.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.545 -1.207 . . . . 1.03 111.427 -175.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -144.37 -5.69 0.75 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.641 -0.709 . . . . 1.1000000000000001 111.329 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.95 167.08 0.64 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 122.77 1.272 . . . . 0.97999999999999998 113.018 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.638 HG23 ' HA ' ' A' ' 358' ' ' LYS . 6.9 m -92.78 123.14 35.84 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 113.417 -1.72 . . . . 0.45000000000000001 108.518 172.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.645 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 14.0 p90 -164.66 -169.81 1.84 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.136 -0.938 . . . . 0.32000000000000001 110.443 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.6 mm -103.57 158.07 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 115.178 -0.919 . . . . 0.080000000000000002 108.6 166.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.501 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.6 tt0 -140.07 155.91 46.82 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-N 118.89 0.768 . . . . 0.17000000000000001 111.131 -179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.672 HG22 ' HG3' ' A' ' 354' ' ' MET . 56.3 t -151.07 138.68 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.721 -1.127 . . . . 0.080000000000000002 109.432 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -120.45 115.35 23.32 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.723 -1.126 . . . . 0.37 108.076 173.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.521 ' H ' HD22 ' A' ' 349' ' ' LEU . 2.0 mm? -66.51 -47.83 71.71 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 122.789 1.281 . . . . 0.32000000000000001 110.319 -175.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -55.38 -53.87 50.8 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 112.49 -2.141 . . . . 1.51 112.384 -176.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -98.03 10.34 40.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 114.093 -1.412 . . . . 0.91000000000000003 108.51 -174.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.906 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.0 mm-40 38.01 69.48 0.24 Allowed 'General case' 0 CA--C 1.517 -0.322 0 O-C-N 125.316 1.635 . . . . 2.2200000000000002 111.841 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.479 ' CD2' ' CE2' ' A' ' 355' ' ' TRP . 7.7 t60 -148.16 125.96 11.91 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.273 -0.876 . . . . 0.13 109.729 -176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.672 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -113.0 127.96 56.37 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.57 0.7 . . . . 0.059999999999999998 110.428 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.729 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.0 m-90 -112.78 173.16 6.51 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-N 114.386 -1.279 . . . . 0.10000000000000001 111.76 -176.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.643 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -125.25 113.65 17.91 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 105.97 -1.863 . . . . 0.22 105.97 163.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.475 ' HB2' ' CE1' ' A' ' 344' ' ' TYR . 22.1 m-85 -95.35 126.0 40.36 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.318 -0.953 . . . . 0.17999999999999999 112.028 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.638 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.0 ttpt -148.19 139.02 23.07 Favored 'General case' 0 N--CA 1.395 -3.193 0 CA-C-N 113.293 -1.776 . . . . 0.46999999999999997 108.305 174.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.447 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.63 14.89 6.1 Favored 'General case' 0 CA--C 1.494 -1.198 0 CA-C-N 113.677 -1.601 . . . . 0.59999999999999998 109.0 178.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.59 16.45 77.67 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.555 -2.111 . . . . 0.23000000000000001 111.653 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.666 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.5 OUTLIER -138.37 178.44 7.14 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.238 -2.134 . . . . 0.68000000000000005 105.238 -170.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.729 HG11 ' CD1' ' A' ' 355' ' ' TRP . 3.0 m -107.0 135.67 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-O 124.093 1.901 . . . . 0.53000000000000003 112.517 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.542 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -86.29 -26.0 25.19 Favored 'General case' 0 N--CA 1.403 -2.787 0 CA-C-N 109.412 -3.54 . . . . 0.12 108.009 174.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.671 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.25 154.68 36.23 Favored 'General case' 0 N--CA 1.419 -1.979 0 CA-C-N 113.953 -1.476 . . . . 0.080000000000000002 109.785 -174.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.5 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 2.0 pt-20 -162.41 121.99 2.34 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 110.533 -175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.645 ' HB ' HG11 ' A' ' 449' ' ' VAL . 6.0 t -149.35 167.28 26.55 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 122.352 1.072 . . . . 0.089999999999999997 112.662 173.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.0 p-10 -86.11 141.5 29.36 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 112.925 -1.943 . . . . 1.8799999999999999 107.64 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.653 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -141.79 -176.31 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.546 -0.752 . . . . 0.11 112.356 -175.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.906 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -151.71 116.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.051 -0.977 . . . . 0.12 110.322 174.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.459 ' OG ' HD12 ' A' ' 349' ' ' LEU . 56.5 p -140.53 141.09 35.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.475 0.916 . . . . 0.69999999999999996 113.475 -163.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.767 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.54 46.86 45.34 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 116.961 1.545 . . . . 0.13 116.961 162.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.534 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 6.1 pttt -46.05 145.71 2.4 Favored Pre-proline 0 C--O 1.216 -0.678 0 CA-C-N 119.318 1.559 . . . . 0.47999999999999998 111.041 -175.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.802 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.3 OUTLIER -37.95 -31.19 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 125.244 3.962 . . . . 0.23000000000000001 115.276 -175.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.3 p -81.88 -33.33 30.61 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.212 0.53 . . . . 0.29999999999999999 111.096 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.0 m -140.47 71.61 31.8 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-O 122.134 0.969 . . . . 0.29999999999999999 110.066 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.767 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.1 Cg_exo -69.93 163.0 40.04 Favored 'Trans proline' 0 C--N 1.322 -0.853 1 C-N-CA 125.552 4.168 . . . . 0.16 115.451 -174.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.65 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.64 154.5 87.44 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 113.285 -1.779 . . . . 0.12 111.127 172.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.506 ' CD ' HG22 ' A' ' 377' ' ' THR . 3.4 Cg_endo -83.81 -52.51 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.336 1 C-N-CA 125.378 4.052 . . . . 0.089999999999999997 114.334 -172.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.71 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 70.64 122.79 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 113.932 1.086 . . . . 0.089999999999999997 113.932 -176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.66 -129.59 1.96 Allowed Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 114.135 -1.393 . . . . 0.11 111.363 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.78 98.89 4.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.363 -0.977 . . . . 0.89000000000000001 108.363 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.821 ' HB2' HG22 ' A' ' 463' ' ' VAL . 97.0 m-85 -102.69 166.76 10.31 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.392 -0.822 . . . . 0.16 110.484 -169.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.699 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.9 m-85 -150.09 139.23 21.17 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-O 119.753 -0.165 . . . . 0.68999999999999995 110.62 175.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -75.5 119.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 C-N-CA 119.723 -0.791 . . . . 0.14000000000000001 110.432 176.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -107.26 4.5 26.66 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.796 -0.638 . . . . 0.19 112.616 -175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.646 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.6 t30 -162.98 146.3 10.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.766 -1.198 . . . . 0.40999999999999998 107.766 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 387' ' ' LYS . 0.2 OUTLIER -119.45 112.11 18.98 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.102 -1.073 . . . . 1.0900000000000001 108.102 -178.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.569 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -118.33 128.21 54.44 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 114.399 -1.273 . . . . 0.38 111.052 -173.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 42.6 mt-10 -128.2 134.21 49.0 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.849 -1.523 . . . . 1.96 109.827 -177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 32.5 t70 52.53 39.39 27.88 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 123.367 1.556 . . . . 0.40000000000000002 107.675 -172.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -94.06 169.84 9.97 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 112.439 -2.164 . . . . 0.16 111.546 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 19.9 m -127.12 105.25 8.45 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 114.094 -1.412 . . . . 0.27000000000000002 110.033 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.705 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.5 mp -71.74 154.66 41.18 Favored 'General case' 0 N--CA 1.422 -1.857 0 CA-C-N 113.375 -1.739 . . . . 0.23999999999999999 109.692 176.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.7 mtpt -154.49 175.59 13.41 Favored 'General case' 0 N--CA 1.402 -2.85 0 CA-C-N 114.583 -1.19 . . . . 0.67000000000000004 108.26 -175.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.922 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 167.22 166.09 25.72 Favored Glycine 0 CA--C 1.476 -2.354 0 C-N-CA 117.565 -2.255 . . . . 0.81000000000000005 113.866 -178.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.55 121.11 34.62 Favored 'General case' 0 N--CA 1.41 -2.457 0 CA-C-O 122.771 1.272 . . . . 0.79000000000000004 109.179 173.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.45 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 1.1 m-80 -51.62 179.29 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 111.649 -2.523 . . . . 1.1200000000000001 111.017 176.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.56 -21.9 29.69 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.511 0.672 . . . . 1.6499999999999999 110.612 168.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.34 -25.51 21.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.372 -0.831 . . . . 2.0 111.775 -176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.04 33.41 5.77 Favored Glycine 0 N--CA 1.433 -1.5 0 C-N-CA 119.902 -1.142 . . . . 0.66000000000000003 110.473 -169.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.532 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 73.0 p -116.4 127.4 26.78 Favored Pre-proline 0 N--CA 1.418 -2.066 0 N-CA-C 107.644 -1.243 . . . . 0.68000000000000005 107.644 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.922 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.4 Cg_exo -70.26 149.28 63.46 Favored 'Trans proline' 0 C--N 1.29 -2.53 0 C-N-CA 122.414 2.076 . . . . 0.81000000000000005 111.678 -175.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.596 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 20.4 p90 -138.79 -175.95 4.32 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 112.984 -1.916 . . . . 0.38 108.249 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.4 mt-10 -146.17 156.81 43.68 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 122.337 1.065 . . . . 0.62 111.287 175.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.705 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.6 m -143.89 97.76 5.32 Favored Pre-proline 0 N--CA 1.419 -2.019 0 CA-C-N 113.067 -1.878 . . . . 1.3300000000000001 109.06 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 72.9 Cg_endo -67.5 106.46 1.25 Allowed 'Trans proline' 0 CA--C 1.513 -0.566 0 C-N-CA 124.269 3.313 . . . . 0.20000000000000001 112.726 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.805 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -116.79 163.61 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.339 0 CA-C-N 114.695 -1.138 . . . . 0.29999999999999999 111.206 -174.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 17.9 m-80 -113.91 -31.51 6.38 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.083 -1.871 . . . . 1.8400000000000001 107.39 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.485 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 70.9 m-85 -136.98 116.16 12.53 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.063 -1.881 . . . . 0.44 110.905 175.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.766 ' HB2' HG11 ' A' ' 407' ' ' VAL . 5.7 t-105 -124.02 134.15 53.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.44 -1.255 . . . . 0.13 110.974 -177.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.847 ' SD ' HG22 ' A' ' 457' ' ' VAL . 5.8 mtm -134.32 88.05 31.38 Favored Pre-proline 0 N--CA 1.423 -1.776 0 CA-C-N 114.728 -1.124 . . . . 0.40999999999999998 112.28 171.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.646 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.03 137.87 29.94 Favored 'Trans proline' 0 CA--C 1.506 -0.897 0 C-N-CA 123.113 2.542 . . . . 0.16 111.744 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.9 pt -123.51 -16.37 5.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 113.763 -1.562 . . . . 0.17000000000000001 110.696 -173.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -135.15 158.51 44.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.748 -0.66 . . . . 1.5900000000000001 109.895 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -87.92 13.55 10.65 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.337 0.495 . . . . 0.31 112.337 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 5.8 p -92.15 -25.85 18.52 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 107.444 -1.317 . . . . 0.44 107.444 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 120.06 30.79 1.4 Allowed Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 112.933 -1.939 . . . . 0.23999999999999999 111.78 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 441' ' ' GLY . 53.4 t -100.94 147.5 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 CA-C-N 115.384 -0.408 . . . . 0.17000000000000001 110.73 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.27 -168.5 41.27 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.191 -0.913 . . . . 0.10000000000000001 112.058 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.41 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -104.06 139.55 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 108.56 -0.904 . . . . 0.12 108.56 175.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.805 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.7 p80 -151.84 164.88 36.13 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 121.641 0.734 . . . . 0.14999999999999999 112.079 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.73 141.4 28.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 113.931 -1.486 . . . . 0.41999999999999998 107.549 172.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 3.6 t -138.57 104.28 5.09 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 123.194 1.473 . . . . 1.48 110.731 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.37 -30.77 14.94 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 111.798 -2.456 . . . . 0.34999999999999998 110.852 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.429 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 14.6 p90 -68.27 -27.32 66.22 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.541 -1.209 . . . . 0.17999999999999999 109.475 176.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.489 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -120.1 81.59 28.53 Favored Pre-proline 0 CA--C 1.495 -1.144 0 CA-C-N 113.747 -1.57 . . . . 1.3300000000000001 109.798 -175.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -82.55 6.52 5.71 Favored 'Trans proline' 0 C--N 1.297 -2.169 0 C-N-CA 124.833 3.689 . . . . 0.23000000000000001 114.522 -161.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -114.72 151.09 34.26 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 109.508 -0.553 . . . . 1.1000000000000001 109.508 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.586 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -160.73 128.25 4.35 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 124.578 1.151 . . . . 0.38 108.115 -172.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.62 -166.53 28.72 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 119.31 -1.424 . . . . 0.13 111.254 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.32 152.47 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 O-C-N 125.159 1.152 . . . . 0.20000000000000001 113.006 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.435 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 4.1 m-20 -55.04 101.5 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 123.506 1.622 . . . . 0.33000000000000002 112.136 -146.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.9 mt -96.73 -31.31 12.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 110.856 -2.883 . . . . 0.17999999999999999 109.364 177.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.55 ' HA ' HG23 ' A' ' 369' ' ' VAL . 12.8 p-90 -50.0 -31.99 14.13 Favored 'General case' 0 CA--C 1.505 -0.759 0 CA-C-N 112.84 -1.982 . . . . 0.22 111.871 -175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.802 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 38.5 mttt -65.27 -20.56 66.47 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.356 -0.838 . . . . 0.64000000000000001 112.685 -178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 52.0 p -118.65 -37.92 3.2 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.29 -0.868 . . . . 0.25 110.297 -176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.488 ' HB2' HG21 ' A' ' 369' ' ' VAL . 7.4 mtp85 -83.35 -16.24 46.83 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.868 -1.06 . . . . 0.35999999999999999 113.056 -169.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 77.72 40.74 21.31 Favored Glycine 0 C--N 1.31 -0.861 0 N-CA-C 116.895 1.518 . . . . 0.20999999999999999 116.895 159.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 19.8 m -80.72 136.52 36.18 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 118.26 1.03 . . . . 0.46999999999999997 109.763 174.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -98.03 65.77 1.79 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 121.943 -0.473 . . . . 0.40999999999999998 110.932 -172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.569 ' H ' ' HA2' ' A' ' 371' ' ' GLY . . . 87.29 -14.1 58.44 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.618 -0.993 . . . . 0.17999999999999999 110.618 177.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.439 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.4 p -85.36 148.58 25.95 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.464 -0.368 . . . . 0.82999999999999996 110.142 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.65 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -99.37 123.2 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 CA-C-O 122.212 1.005 . . . . 0.14999999999999999 110.934 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.753 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.7 OUTLIER -81.44 83.35 6.98 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.51 -1.677 . . . . 1.77 111.395 -175.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 24.5 m -88.04 138.02 31.09 Favored Pre-proline 0 N--CA 1.446 -0.662 0 CA-C-O 121.558 0.694 . . . . 0.17999999999999999 109.581 178.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.413 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.7 Cg_exo -57.48 136.15 74.17 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.716 2.277 . . . . 0.12 111.827 178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 28.5 Cg_exo -53.93 -32.77 69.26 Favored 'Trans proline' 0 CA--C 1.502 -1.091 0 C-N-CA 124.547 3.498 . . . . 0.16 112.915 -175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.2 m -79.52 -41.94 26.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.383 -1.281 . . . . 1.1699999999999999 109.881 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.645 HG11 ' HB ' ' A' ' 366' ' ' THR . 65.4 t -78.58 -30.54 15.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.558 0.694 . . . . 0.17000000000000001 111.7 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.738 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.24 -19.44 65.52 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.851 0.834 . . . . 0.46000000000000002 110.294 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -79.31 -23.23 43.65 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 114.494 -1.23 . . . . 0.81000000000000005 111.01 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.708 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.4 mm-40 -80.04 -46.98 15.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 113.075 -1.875 . . . . 0.38 107.193 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.0 tp -64.24 -66.7 0.51 Allowed 'General case' 0 N--CA 1.402 -2.844 0 CA-C-N 111.826 -2.443 . . . . 0.059999999999999998 112.289 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -52.99 -24.7 10.02 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 122.97 1.367 . . . . 0.31 108.387 177.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.52 -26.01 74.07 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 112.533 -2.121 . . . . 0.13 112.025 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.708 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.4 ptp -94.97 -49.92 5.34 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-O 121.876 0.846 . . . . 0.13 111.161 169.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.847 HG22 ' SD ' ' A' ' 411' ' ' MET . 2.1 p -108.61 132.08 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 CA-C-O 123.585 1.66 . . . . 0.23000000000000001 114.447 -167.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.457 ' HB2' ' CE ' ' A' ' 387' ' ' LYS . 7.3 pt-20 -140.82 -176.85 4.81 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 110.335 -3.12 . . . . 0.82999999999999996 106.127 175.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.619 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.3 mtmt -45.32 154.24 0.18 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-O 122.971 1.367 . . . . 0.23999999999999999 114.095 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 98.43 -32.75 6.62 Favored Glycine 0 C--N 1.297 -1.633 0 CA-C-N 112.013 -2.358 . . . . 0.37 112.54 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.583 ' HB ' HG23 ' A' ' 457' ' ' VAL . 6.2 m -83.6 143.12 43.56 Favored Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.304 -0.628 . . . . 0.14999999999999999 109.304 -177.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 4.8 Cg_exo -75.36 169.8 21.67 Favored 'Trans proline' 0 N--CA 1.428 -2.37 0 C-N-CA 121.789 1.659 . . . . 0.12 111.503 174.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.821 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -137.29 158.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.891 -1.152 . . . . 1.0900000000000001 107.891 167.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.501 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.4 tp -130.56 146.2 52.03 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.514 -0.766 . . . . 0.13 110.331 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.71 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.7 147.61 19.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.501 -1.296 . . . . 0.089999999999999997 107.501 165.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.468 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 16.9 p90 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.499 -0.762 . . . . 1.1599999999999999 111.402 -176.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.691 0 N-CA-C 112.21 -0.356 . . . . 3.9399999999999999 112.21 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.5 t-160 -94.8 94.01 7.82 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.513 0.673 . . . . 1.8500000000000001 110.003 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.41 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 12.8 mtp 69.09 178.95 0.25 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 113.732 -1.576 . . . . 1.03 111.301 -176.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -131.35 -7.01 3.77 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.135 -0.484 . . . . 1.1000000000000001 110.675 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.21 167.17 0.69 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.983 1.373 . . . . 0.97999999999999998 113.607 177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 358' ' ' LYS . 3.9 m -93.28 122.63 35.88 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.039 -1.891 . . . . 0.45000000000000001 106.94 165.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.632 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.8 p90 -160.16 -170.11 2.72 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 121.617 0.723 . . . . 0.32000000000000001 111.009 -173.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.581 HD11 ' CB ' ' A' ' 457' ' ' VAL . 11.7 mm -103.91 160.3 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 CA-C-N 114.781 -1.099 . . . . 0.080000000000000002 108.216 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.488 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.0 tt0 -140.94 156.1 46.13 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-N 119.0 0.818 . . . . 0.17000000000000001 111.058 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.676 HG22 ' HG3' ' A' ' 354' ' ' MET . 68.3 t -150.62 137.99 13.58 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.663 -1.153 . . . . 0.080000000000000002 109.625 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -126.07 106.36 9.54 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 122.153 0.978 . . . . 0.37 108.826 176.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.484 HD21 HG23 ' A' ' 465' ' ' VAL . 1.9 mm? -63.4 -38.97 93.22 Favored 'General case' 0 CA--C 1.494 -1.179 0 CA-C-N 112.89 -1.959 . . . . 0.32000000000000001 111.298 -168.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -57.88 -57.06 14.44 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 111.673 -2.512 . . . . 1.51 112.552 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -95.64 2.74 54.26 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-N 114.685 -1.143 . . . . 0.91000000000000003 110.066 -172.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.871 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.4 mm-40 49.54 66.01 1.24 Allowed 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 112.654 -2.066 . . . . 2.2200000000000002 111.406 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.523 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -145.5 127.4 15.44 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.344 0.592 . . . . 0.13 109.725 -176.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.676 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.6 ttp -114.15 128.41 56.36 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.433 -0.803 . . . . 0.059999999999999998 110.613 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.649 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.54 173.29 6.48 Favored 'General case' 0 CA--C 1.499 -1.014 0 CA-C-N 114.608 -1.178 . . . . 0.10000000000000001 112.084 -175.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.661 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 1.1 t80 -124.79 113.43 17.92 Favored 'General case' 0 C--O 1.207 -1.152 0 N-CA-C 106.666 -1.605 . . . . 0.22 106.666 165.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.496 ' CE1' HG12 ' A' ' 362' ' ' VAL . 19.2 m-85 -96.94 125.41 41.35 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 122.303 1.049 . . . . 0.17999999999999999 112.43 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.681 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.8 ttpt -149.34 139.46 22.14 Favored 'General case' 0 N--CA 1.398 -3.075 0 CA-C-N 112.827 -1.988 . . . . 0.46999999999999997 108.091 175.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.449 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.1 17.62 7.24 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-N 113.61 -1.632 . . . . 0.59999999999999998 109.011 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 76.47 18.36 79.19 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 112.466 -2.152 . . . . 0.23000000000000001 111.824 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.681 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -138.82 177.61 7.76 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.798 -1.927 . . . . 0.68000000000000005 105.798 -169.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.753 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -106.96 138.09 34.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.737 0 CA-C-O 124.008 1.861 . . . . 0.53000000000000003 112.15 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.648 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.03 -23.76 18.56 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 109.587 -3.46 . . . . 0.12 108.479 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.601 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.7 tp -154.4 154.69 33.69 Favored 'General case' 0 N--CA 1.418 -2.047 0 CA-C-N 113.712 -1.585 . . . . 0.080000000000000002 108.977 -172.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.753 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.11 122.43 1.55 Allowed 'General case' 0 CA--C 1.497 -1.063 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.576 -175.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.657 ' HB ' HG11 ' A' ' 449' ' ' VAL . 3.6 t -146.88 166.24 27.31 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 121.688 0.756 . . . . 0.089999999999999997 111.215 172.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.49 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 42.1 m-20 -84.84 148.87 26.07 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 106.463 -1.681 . . . . 1.8799999999999999 106.463 174.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.657 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -144.02 -171.15 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.412 -0.813 . . . . 0.11 110.945 -177.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.871 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -152.99 120.44 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 114.995 -1.002 . . . . 0.12 108.604 173.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.497 ' HB2' HG13 ' A' ' 443' ' ' ILE . 5.7 t -143.51 142.91 31.33 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.684 0.994 . . . . 0.69999999999999996 113.684 -167.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.76 44.78 37.34 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 117.046 1.578 . . . . 0.13 117.046 162.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.591 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.66 145.02 3.21 Favored Pre-proline 0 N--CA 1.45 -0.453 0 CA-C-N 119.255 1.528 . . . . 0.47999999999999998 110.509 -174.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.784 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -35.11 -31.81 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 125.803 4.336 . . . . 0.23000000000000001 115.972 -173.283 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.591 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.4 p -81.17 -35.87 30.89 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.043 0.449 . . . . 0.29999999999999999 111.033 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.467 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -140.39 72.64 31.43 Favored Pre-proline 0 N--CA 1.45 -0.464 0 CA-C-O 122.227 1.013 . . . . 0.29999999999999999 110.461 -178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 24.5 Cg_exo -71.02 163.21 40.05 Favored 'Trans proline' 0 C--N 1.322 -0.817 1 C-N-CA 125.526 4.151 . . . . 0.16 114.153 -177.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.7 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.04 153.61 88.68 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.418 -1.719 . . . . 0.12 110.946 176.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.71 -49.82 0.07 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 125.038 3.825 . . . . 0.089999999999999997 113.673 -171.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.722 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.66 122.87 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.568 0.951 . . . . 0.089999999999999997 113.568 -177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.41 -123.55 1.18 Allowed Glycine 0 N--CA 1.441 -0.993 0 CA-C-N 114.16 -1.382 . . . . 0.11 111.396 -177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -127.88 112.37 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 CA-C-O 122.035 0.922 . . . . 0.89000000000000001 108.915 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.768 ' HB2' HG22 ' A' ' 463' ' ' VAL . 94.3 m-85 -115.74 160.87 19.53 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.027 -0.988 . . . . 0.16 109.706 -169.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.752 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 78.5 m-85 -147.63 137.19 22.61 Favored 'General case' 0 CA--C 1.497 -1.07 0 CA-C-O 119.703 -0.189 . . . . 0.68999999999999995 110.535 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 412' ' ' PRO . 0.2 OUTLIER -74.44 118.2 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 C-N-CA 119.258 -0.977 . . . . 0.14000000000000001 110.172 176.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 47.9 p-90 -106.36 2.15 26.32 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.385 -0.825 . . . . 0.19 112.451 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.681 ' O ' ' HD2' ' A' ' 412' ' ' PRO . 6.4 t30 -160.24 148.75 16.91 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.815 -1.18 . . . . 0.40999999999999998 107.815 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 458' ' ' GLU . 0.5 OUTLIER -119.73 117.88 29.4 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.915 -1.143 . . . . 1.0900000000000001 107.915 179.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.556 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.5 mt-10 -123.54 128.11 49.27 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 114.523 -1.217 . . . . 0.38 111.265 -173.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -125.75 135.52 52.14 Favored 'General case' 0 N--CA 1.416 -2.158 0 CA-C-N 113.559 -1.655 . . . . 1.96 109.393 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.0 t0 53.89 38.67 29.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 123.338 1.542 . . . . 0.40000000000000002 107.731 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.533 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -93.1 170.14 9.87 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 112.213 -2.267 . . . . 0.16 111.841 -175.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 11.6 m -128.39 104.91 7.97 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 113.998 -1.455 . . . . 0.27000000000000002 110.413 -177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.753 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.5 mp -76.57 158.43 31.17 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 112.74 -2.027 . . . . 0.23999999999999999 110.628 174.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 8.6 mtpt -148.6 -176.07 5.18 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 115.218 -0.901 . . . . 0.67000000000000004 109.117 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.34 -142.89 5.17 Favored Glycine 0 N--CA 1.428 -1.895 0 C-N-CA 117.196 -2.431 . . . . 0.81000000000000005 115.09 176.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.65 122.95 13.86 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-N 112.697 -1.752 . . . . 0.79000000000000004 108.291 172.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.47 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -54.29 179.97 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 112.587 -2.097 . . . . 1.1200000000000001 111.334 177.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.24 -24.25 26.83 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.21 0.529 . . . . 1.6499999999999999 110.586 168.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.23 -25.33 21.8 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-N 115.68 -0.691 . . . . 2.0 111.724 -176.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 98.71 34.45 5.23 Favored Glycine 0 N--CA 1.436 -1.321 0 C-N-CA 120.126 -1.035 . . . . 0.66000000000000003 110.694 -170.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.47 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 52.0 p -119.18 127.18 26.63 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 106.773 -1.565 . . . . 0.68000000000000005 106.773 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 27.0 Cg_exo -64.16 159.24 44.02 Favored 'Trans proline' 0 C--N 1.285 -2.795 0 C-N-CA 122.037 1.824 . . . . 0.81000000000000005 112.468 -173.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.531 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 24.2 p90 -143.47 -171.69 3.56 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 113.162 -1.835 . . . . 0.38 106.953 -177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.6 mt-10 -143.83 160.46 40.73 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 122.135 0.969 . . . . 0.62 111.52 174.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.753 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.15 99.25 12.31 Favored Pre-proline 0 N--CA 1.418 -2.072 0 CA-C-N 113.429 -1.714 . . . . 1.3300000000000001 107.726 175.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.465 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.2 Cg_endo -67.42 102.3 0.69 Allowed 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.348 2.032 . . . . 0.20000000000000001 110.042 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.723 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.2 160.46 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-N 114.547 -1.206 . . . . 0.29999999999999999 110.362 -173.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.405 ' ND2' ' N ' ' A' ' 408' ' ' ASN . 11.3 m-80 -113.59 -32.06 6.3 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 113.288 -1.778 . . . . 1.8400000000000001 107.377 -174.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.559 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 62.2 m-85 -137.77 115.92 11.73 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 112.894 -1.957 . . . . 0.44 110.46 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.723 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.1 t-105 -123.56 134.1 53.88 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.932 -1.031 . . . . 0.13 110.823 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.519 ' SD ' ' CD1' ' A' ' 454' ' ' PHE . 1.6 mtp -134.06 86.18 37.89 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 114.705 -1.134 . . . . 0.40999999999999998 111.297 173.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.681 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 97.7 Cg_endo -72.5 139.52 31.58 Favored 'Trans proline' 0 CA--C 1.507 -0.862 0 C-N-CA 123.063 2.509 . . . . 0.16 111.828 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.752 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.97 -14.59 4.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 0.17000000000000001 111.054 -173.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -134.11 164.69 26.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.339 -0.846 . . . . 1.5900000000000001 109.4 175.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -96.78 14.41 25.25 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.135 0.42 . . . . 0.31 112.135 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.2 p -94.41 -27.05 16.24 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 107.674 -1.232 . . . . 0.44 107.674 173.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.27 31.64 0.83 Allowed Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 112.898 -1.955 . . . . 0.23999999999999999 112.166 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 441' ' ' GLY . 73.3 t -102.3 147.47 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 CA-C-O 121.296 0.569 . . . . 0.17000000000000001 110.914 176.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.94 -166.18 37.73 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-N 114.637 -1.165 . . . . 0.10000000000000001 111.325 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -104.35 140.3 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 N-CA-C 108.504 -0.925 . . . . 0.12 108.504 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 407' ' ' VAL . 29.4 p80 -151.42 164.26 37.14 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.55 0.69 . . . . 0.14999999999999999 111.428 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.781 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -87.15 146.6 25.97 Favored 'General case' 0 N--CA 1.423 -1.823 0 CA-C-N 114.143 -1.389 . . . . 0.41999999999999998 108.066 172.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 1.5 m -139.35 102.5 4.5 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 123.021 1.391 . . . . 1.48 111.003 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -93.76 -26.96 16.75 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 111.458 -2.61 . . . . 0.34999999999999998 109.904 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.521 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 12.2 p90 -72.65 -26.6 61.71 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 114.148 -1.387 . . . . 0.17999999999999999 109.817 174.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.83 80.56 25.17 Favored Pre-proline 0 CA--C 1.491 -1.296 0 CA-C-N 114.005 -1.452 . . . . 1.3300000000000001 108.953 -176.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 24.0 Cg_endo -81.94 5.54 6.26 Favored 'Trans proline' 0 N--CA 1.432 -2.101 0 C-N-CA 125.083 3.855 . . . . 0.23000000000000001 114.121 -162.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -115.07 150.18 36.34 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.986 -0.552 . . . . 1.1000000000000001 109.516 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.49 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.9 OUTLIER -159.43 125.02 4.23 Favored 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.626 1.203 . . . . 0.38 108.08 -172.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.55 -166.77 29.18 Favored Glycine 0 C--N 1.294 -1.778 0 C-N-CA 119.199 -1.476 . . . . 0.13 111.083 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.64 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.26 153.16 0.0 OUTLIER Glycine 0 C--N 1.338 0.691 0 O-C-N 125.115 1.127 . . . . 0.20000000000000001 113.432 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.405 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.3 m-20 -55.56 100.73 0.04 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 123.832 1.777 . . . . 0.33000000000000002 112.063 -147.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.2 mt -96.82 -30.48 13.14 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 110.51 -3.041 . . . . 0.17999999999999999 108.098 176.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.54 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.0 p-90 -47.34 -38.61 13.21 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.791 0.682 . . . . 0.22 111.496 -174.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.784 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 23.8 mttt -60.92 -23.05 64.95 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.306 -0.861 . . . . 0.64000000000000001 112.855 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 67.5 p -114.4 -37.06 4.44 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.799 0.809 . . . . 0.25 110.248 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.503 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 7.0 mtp85 -85.44 -15.61 42.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.691 -1.14 . . . . 0.35999999999999999 112.761 -169.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.89 41.17 28.74 Favored Glycine 0 C--N 1.313 -0.695 0 N-CA-C 116.128 1.211 . . . . 0.20999999999999999 116.128 159.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . 0.411 ' OG ' HG22 ' A' ' 369' ' ' VAL . 1.2 m -79.56 141.76 36.32 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 117.823 0.811 . . . . 0.46999999999999997 109.138 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.422 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 63.2 m80 -110.79 71.93 0.76 Allowed 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.362 -0.836 . . . . 0.40999999999999998 110.554 -171.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.603 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 83.97 -12.61 52.93 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 110.377 -1.089 . . . . 0.17999999999999999 110.377 -177.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.482 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 27.0 p -90.26 145.05 25.29 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.213 -0.494 . . . . 0.82999999999999996 110.595 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.7 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -104.26 115.45 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-N 115.717 -0.674 . . . . 0.14999999999999999 110.416 -177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.557 ' HB2' HG13 ' A' ' 369' ' ' VAL . 18.7 m120 -79.69 91.96 5.33 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.94 -0.573 . . . . 1.77 111.217 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.639 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 38.3 m -88.45 137.82 30.45 Favored Pre-proline 0 C--N 1.319 -0.744 0 N-CA-C 109.29 -0.633 . . . . 0.17999999999999999 109.29 174.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.6 Cg_exo -55.67 135.94 71.82 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.892 2.395 . . . . 0.12 111.528 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.781 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 40.2 Cg_exo -54.96 -33.99 84.88 Favored 'Trans proline' 0 CA--C 1.502 -1.08 0 C-N-CA 124.372 3.382 . . . . 0.16 112.864 -173.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 49.8 m -79.32 -40.11 31.15 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.76 -1.109 . . . . 1.1699999999999999 109.857 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.657 HG11 ' HB ' ' A' ' 366' ' ' THR . 72.4 t -78.76 -29.42 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.763 -0.653 . . . . 0.17000000000000001 111.518 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.691 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.2 tpt -68.08 -18.94 64.8 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.916 0.865 . . . . 0.46000000000000002 110.089 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -79.97 -24.13 41.14 Favored 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 114.432 -1.258 . . . . 0.81000000000000005 110.887 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.701 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.1 mm-40 -79.77 -46.95 16.05 Favored 'General case' 0 CA--C 1.473 -1.983 0 CA-C-N 112.955 -1.929 . . . . 0.38 107.094 178.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.562 HD23 ' SD ' ' A' ' 450' ' ' MET . 22.3 tp -64.88 -67.72 0.41 Allowed 'General case' 0 N--CA 1.402 -2.874 0 CA-C-N 111.857 -2.429 . . . . 0.059999999999999998 112.576 175.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.519 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 30.0 t80 -50.68 -26.37 5.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.054 1.407 . . . . 0.31 108.201 178.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.48 -30.72 68.71 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-N 112.316 -2.22 . . . . 0.13 112.052 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 2.0 ptp -88.57 -49.61 6.79 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.729 0.776 . . . . 0.13 110.714 170.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.661 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 1.3 p -106.91 132.84 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.179 0 CA-C-O 123.575 1.655 . . . . 0.23000000000000001 114.39 -167.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.515 ' HB2' ' HE3' ' A' ' 387' ' ' LYS . 9.3 pt-20 -139.65 -176.68 4.64 Favored 'General case' 0 N--CA 1.404 -2.738 0 CA-C-N 110.646 -2.979 . . . . 0.82999999999999996 106.469 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.651 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.1 mtmt -45.4 154.14 0.2 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 122.971 1.367 . . . . 0.23999999999999999 113.789 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 97.51 -36.89 3.68 Favored Glycine 0 C--N 1.293 -1.823 0 CA-C-N 112.105 -2.316 . . . . 0.37 112.501 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.53 ' HB ' HG23 ' A' ' 457' ' ' VAL . 4.3 m -79.54 142.76 58.16 Favored Pre-proline 0 N--CA 1.439 -0.99 0 N-CA-C 109.676 -0.491 . . . . 0.14999999999999999 109.676 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.689 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 6.0 Cg_exo -75.9 169.9 21.24 Favored 'Trans proline' 0 N--CA 1.427 -2.435 0 C-N-CA 121.931 1.754 . . . . 0.12 111.677 173.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.768 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.91 157.59 38.56 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.219 0 N-CA-C 107.718 -1.216 . . . . 1.0900000000000001 107.718 165.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.444 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.0 tp -128.39 145.34 51.11 Favored 'General case' 0 C--N 1.286 -2.177 0 CA-C-N 115.343 -0.844 . . . . 0.13 110.004 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.722 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.33 147.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 107.158 -1.423 . . . . 0.089999999999999997 107.158 165.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.59 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 18.4 p90 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.4 -0.81 . . . . 1.1599999999999999 111.026 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.977 0 N-CA-C 112.299 -0.32 . . . . 3.9399999999999999 112.299 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.489 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.1 t-160 -88.72 91.99 9.03 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.691 -0.485 . . . . 1.8500000000000001 109.691 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 34.7 mtm 73.6 -175.42 0.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.218 -1.356 . . . . 1.03 111.774 -175.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -145.09 -4.97 0.7 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.489 -0.778 . . . . 1.1000000000000001 112.102 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.14 169.41 0.25 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.763 1.268 . . . . 0.97999999999999998 112.411 171.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.666 HG23 ' HA ' ' A' ' 358' ' ' LYS . 2.3 m -91.52 121.52 33.29 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-N 113.61 -1.632 . . . . 0.45000000000000001 107.741 169.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.665 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.1 p90 -160.11 -171.21 3.12 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.407 -0.815 . . . . 0.32000000000000001 110.533 -175.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.563 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.5 mm -106.05 161.11 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 108.25 -1.018 . . . . 0.080000000000000002 108.25 167.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.511 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.7 tt0 -141.57 155.45 45.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 118.877 0.762 . . . . 0.17000000000000001 111.12 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.7 HG22 ' HG3' ' A' ' 354' ' ' MET . 60.0 t -151.05 137.07 12.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 114.519 -1.218 . . . . 0.080000000000000002 109.763 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -116.61 117.7 30.57 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 108.04 -1.096 . . . . 0.37 108.04 171.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.556 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -72.5 -46.05 56.51 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.705 0.764 . . . . 0.32000000000000001 109.716 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -59.86 -46.46 89.21 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.542 -1.663 . . . . 1.51 112.601 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -107.62 19.49 20.1 Favored 'General case' 0 CA--C 1.503 -0.864 0 CA-C-N 114.844 -1.071 . . . . 0.91000000000000003 109.161 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.585 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 20.8 mp0 33.6 69.08 0.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 125.743 1.902 . . . . 2.2200000000000002 112.568 171.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.599 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 8.4 t60 -152.06 124.12 8.1 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.2 0.524 . . . . 0.13 110.054 -176.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.7 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.6 ttp -109.82 127.76 54.88 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.521 0.677 . . . . 0.059999999999999998 110.616 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.655 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.5 m-90 -112.57 173.01 6.58 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.447 -1.251 . . . . 0.10000000000000001 111.925 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.726 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.7 t80 -126.35 118.96 26.14 Favored 'General case' 0 CA--C 1.488 -1.409 0 N-CA-C 106.495 -1.668 . . . . 0.22 106.495 165.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 22.4 m-85 -101.12 127.21 47.77 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-O 122.335 1.064 . . . . 0.17999999999999999 112.467 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.666 ' HA ' HG23 ' A' ' 343' ' ' THR . 2.6 ttpt -149.38 139.82 22.42 Favored 'General case' 0 N--CA 1.395 -3.216 0 CA-C-N 112.73 -2.032 . . . . 0.46999999999999997 107.326 174.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 72.74 15.9 4.74 Favored 'General case' 0 CA--C 1.495 -1.142 0 CA-C-N 114.08 -1.418 . . . . 0.59999999999999998 109.069 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.38 17.65 79.0 Favored Glycine 0 N--CA 1.427 -1.966 0 CA-C-N 112.523 -2.126 . . . . 0.23000000000000001 111.533 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.668 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 2.2 tppt? -140.17 178.23 7.43 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 112.446 -1.877 . . . . 0.68000000000000005 105.961 -167.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.733 HG21 ' HG2' ' A' ' 365' ' ' GLU . 2.9 m -106.36 138.61 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-O 124.053 1.882 . . . . 0.53000000000000003 112.328 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.726 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -94.71 -24.59 17.07 Favored 'General case' 0 N--CA 1.401 -2.896 0 CA-C-N 109.419 -3.537 . . . . 0.12 108.589 176.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.617 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.4 tp -153.05 154.91 35.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 113.701 -1.591 . . . . 0.080000000000000002 108.808 -171.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.733 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.7 122.94 1.21 Allowed 'General case' 0 CA--C 1.496 -1.118 0 CA-C-N 115.817 -0.629 . . . . 0.60999999999999999 109.475 -174.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.664 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.6 t -147.56 166.84 26.12 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 121.564 0.697 . . . . 0.089999999999999997 111.406 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.51 ' O ' ' HB3' ' A' ' 429' ' ' TYR . 50.6 m-20 -83.92 147.56 27.42 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.08 -1.452 . . . . 1.8799999999999999 107.08 174.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.585 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.66 -172.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.281 -0.872 . . . . 0.11 111.425 -176.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.597 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.03 118.53 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 114.997 -1.002 . . . . 0.12 108.727 175.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.509 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.3 t -142.26 147.85 37.13 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.327 -0.851 . . . . 0.69999999999999996 112.306 -168.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.694 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.44 45.31 55.01 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 116.736 1.454 . . . . 0.13 116.736 162.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.633 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.28 144.24 3.29 Favored Pre-proline 0 C--O 1.217 -0.611 0 CA-C-N 118.706 1.253 . . . . 0.47999999999999998 110.309 -175.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.82 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.69 -29.15 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.593 1 C-N-CA 125.75 4.3 . . . . 0.23000000000000001 116.001 -171.977 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.633 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -84.14 -33.92 24.16 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.4 0.619 . . . . 0.29999999999999999 111.04 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.0 m -140.35 72.08 32.16 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 122.201 1.001 . . . . 0.29999999999999999 110.245 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.9 Cg_exo -70.78 165.55 31.77 Favored 'Trans proline' 0 C--N 1.324 -0.727 1 C-N-CA 125.368 4.046 . . . . 0.16 114.21 -176.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.713 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -78.69 152.82 78.08 Favored Pre-proline 0 N--CA 1.435 -1.202 0 CA-C-N 113.799 -1.546 . . . . 0.12 110.427 174.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.527 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.34 -49.88 0.07 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.983 3.788 . . . . 0.089999999999999997 113.311 -172.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.705 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 69.52 122.45 0.03 OUTLIER 'General case' 0 C--O 1.234 0.247 0 N-CA-C 113.666 0.987 . . . . 0.089999999999999997 113.666 -177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.79 -123.95 1.2 Allowed Glycine 0 N--CA 1.44 -1.069 0 CA-C-N 114.282 -1.326 . . . . 0.11 111.577 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.3 p -129.09 106.0 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.307 1.051 . . . . 0.89000000000000001 109.323 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.802 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.5 m-85 -109.54 163.88 13.04 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.799 -1.091 . . . . 0.16 110.071 -169.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.687 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 69.6 m-85 -147.93 137.88 22.65 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 121.261 -0.176 . . . . 0.68999999999999995 110.749 176.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.622 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.5 124.6 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.863 -0.735 . . . . 0.14000000000000001 110.538 177.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.1 p-90 -109.52 4.49 22.32 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 115.533 -0.758 . . . . 0.19 112.163 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.717 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.2 t30 -166.52 150.97 7.57 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.431 -0.804 . . . . 0.40999999999999998 110.684 175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 12.1 mtpt -109.53 118.68 37.23 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.583 0.706 . . . . 1.0900000000000001 109.86 169.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.6 mt-10 -119.4 112.96 20.07 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 123.034 1.397 . . . . 0.38 112.803 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -108.93 136.58 48.23 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 113.785 -1.552 . . . . 1.96 110.994 -175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 38.7 t70 51.36 34.74 12.38 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 123.466 1.603 . . . . 0.40000000000000002 107.9 -175.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.535 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.15 170.82 10.72 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 112.21 -2.268 . . . . 0.16 111.991 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 6.0 m -129.32 104.41 7.49 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 113.742 -1.572 . . . . 0.27000000000000002 109.64 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.728 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.12 155.06 40.69 Favored 'General case' 0 N--CA 1.422 -1.825 0 CA-C-N 112.889 -1.959 . . . . 0.23999999999999999 109.972 174.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.6 mtpt -155.86 172.48 18.29 Favored 'General case' 0 N--CA 1.404 -2.767 0 O-C-N 124.529 1.143 . . . . 0.67000000000000004 108.543 -175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.93 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 171.48 166.45 30.26 Favored Glycine 0 CA--C 1.48 -2.135 0 C-N-CA 117.518 -2.277 . . . . 0.81000000000000005 113.938 -175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.73 115.91 28.91 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-O 122.745 1.26 . . . . 0.79000000000000004 109.448 174.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.572 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 5.2 m-80 -50.96 179.49 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 111.543 -2.571 . . . . 1.1200000000000001 113.261 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.38 -24.92 8.53 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.065 0.459 . . . . 1.6499999999999999 110.83 166.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.538 ' HB3' HG23 ' A' ' 401' ' ' THR . 0.2 OUTLIER -90.53 -24.7 20.55 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-O 121.304 0.573 . . . . 2.0 110.741 -175.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.49 34.24 5.88 Favored Glycine 0 N--CA 1.436 -1.322 0 N-CA-C 110.126 -1.19 . . . . 0.66000000000000003 110.126 -169.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.572 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 42.2 p -117.01 128.9 25.71 Favored Pre-proline 0 N--CA 1.416 -2.148 0 N-CA-C 107.772 -1.196 . . . . 0.68000000000000005 107.772 -178.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.93 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.1 Cg_exo -70.55 146.99 56.8 Favored 'Trans proline' 0 N--CA 1.422 -2.714 0 C-N-CA 122.447 2.098 . . . . 0.81000000000000005 111.423 -176.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.634 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 19.3 p90 -140.56 -177.77 5.2 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 112.692 -2.049 . . . . 0.38 107.995 -175.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.7 mt-10 -141.47 162.8 34.61 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.764 1.269 . . . . 0.62 112.111 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.728 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -140.1 98.15 7.65 Favored Pre-proline 0 N--CA 1.421 -1.916 0 CA-C-N 112.356 -2.202 . . . . 1.3300000000000001 107.768 172.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 62.9 Cg_endo -68.17 102.66 0.82 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 122.325 2.017 . . . . 0.20000000000000001 110.658 175.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.786 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.06 163.84 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.684 -1.144 . . . . 0.29999999999999999 110.393 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 390' ' ' ASP . 19.5 m-80 -115.94 -31.38 5.77 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 113.517 -1.674 . . . . 1.8400000000000001 107.602 -175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.462 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 55.8 m-85 -138.61 115.65 10.92 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.142 -1.845 . . . . 0.44 110.107 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.786 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.09 135.65 54.48 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.075 -0.966 . . . . 0.13 109.95 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.525 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -135.89 85.1 30.12 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 114.98 -1.009 . . . . 0.40999999999999998 111.019 174.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.712 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.6 Cg_endo -71.41 140.67 37.15 Favored 'Trans proline' 0 CA--C 1.512 -0.585 0 C-N-CA 122.98 2.453 . . . . 0.16 112.236 -178.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.687 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -124.25 -15.91 4.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 113.841 -1.527 . . . . 0.17000000000000001 111.105 -173.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -134.36 166.01 23.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 1.5900000000000001 109.328 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.8 m-90 -99.44 13.86 31.81 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.405 0.52 . . . . 0.31 112.405 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.2 p -92.88 -27.1 17.32 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.342 -1.355 . . . . 0.44 107.342 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 126.65 32.25 0.72 Allowed Glycine 0 N--CA 1.426 -1.989 0 CA-C-N 113.062 -1.881 . . . . 0.23999999999999999 112.36 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.644 HG13 ' O ' ' A' ' 441' ' ' GLY . 72.4 t -102.59 147.62 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-O 121.24 0.543 . . . . 0.17000000000000001 111.164 177.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.57 -166.0 38.16 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.979 -1.009 . . . . 0.10000000000000001 111.621 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.33 140.35 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.846 -0.798 . . . . 0.12 108.846 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 33.4 p80 -150.83 165.42 33.62 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-O 121.763 0.792 . . . . 0.14999999999999999 111.556 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.763 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -89.53 139.64 30.33 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-N 113.936 -1.484 . . . . 0.41999999999999998 107.611 172.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 2.8 p -128.49 99.79 5.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.897 1.332 . . . . 1.48 109.957 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -96.0 -34.41 11.78 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 112.497 -2.138 . . . . 0.34999999999999998 110.778 179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.553 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 11.2 p90 -67.14 -26.91 66.9 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.566 -1.197 . . . . 0.17999999999999999 109.213 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.588 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.98 81.91 20.41 Favored Pre-proline 0 CA--C 1.492 -1.266 0 CA-C-N 113.586 -1.643 . . . . 1.3300000000000001 109.253 -174.223 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 28.7 Cg_endo -79.91 5.9 5.63 Favored 'Trans proline' 0 N--CA 1.431 -2.184 0 C-N-CA 124.844 3.696 . . . . 0.23000000000000001 113.824 -161.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.76 153.53 30.16 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.945 -0.57 . . . . 1.1000000000000001 111.14 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -164.0 123.72 2.05 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 114.347 -1.297 . . . . 0.38 108.341 -172.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.575 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 147.61 -166.66 28.71 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 119.394 -1.384 . . . . 0.13 110.535 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.63 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.94 151.7 0.0 OUTLIER Glycine 0 C--N 1.34 0.767 0 O-C-N 125.296 1.233 . . . . 0.20000000000000001 113.416 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -51.94 100.6 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 124.089 1.9 . . . . 0.33000000000000002 111.913 -152.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 46.5 mt -97.17 -33.47 11.48 Favored 'General case' 0 N--CA 1.414 -2.23 0 CA-C-N 109.964 -3.289 . . . . 0.17999999999999999 107.752 173.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.597 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.82 -37.48 6.17 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 123.961 0.788 . . . . 0.22 111.61 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.82 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 35.3 mttt -60.51 -24.4 65.29 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 114.984 -1.007 . . . . 0.64000000000000001 112.737 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 63.6 p -114.8 -36.43 4.5 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.753 0.787 . . . . 0.25 110.044 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.588 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.4 mtp85 -83.72 -15.02 50.25 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.553 -1.203 . . . . 0.35999999999999999 112.724 -169.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.49 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.41 40.9 38.72 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 116.331 1.292 . . . . 0.20999999999999999 116.331 159.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.4 m -81.88 134.5 35.41 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 118.038 0.919 . . . . 0.46999999999999997 109.612 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -99.28 70.45 1.75 Allowed 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.771 -0.58 . . . . 0.40999999999999998 110.466 -173.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.644 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 80.72 -7.13 59.56 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.754 -0.938 . . . . 0.17999999999999999 110.754 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 19.1 p -93.05 131.09 38.38 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.692 0.758 . . . . 0.82999999999999996 110.548 -176.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.713 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -91.61 113.74 27.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.978 -1.01 . . . . 0.14999999999999999 110.494 -172.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.576 ' HB2' HG13 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -76.89 89.73 3.5 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.992 -1.003 . . . . 1.77 110.982 -177.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.623 HG23 HG21 ' A' ' 366' ' ' THR . 31.5 m -89.05 136.09 30.88 Favored Pre-proline 0 N--CA 1.442 -0.845 0 N-CA-C 109.214 -0.661 . . . . 0.17999999999999999 109.214 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.451 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.2 Cg_exo -57.46 131.93 47.6 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.886 2.39 . . . . 0.12 113.107 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.763 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.9 Cg_exo -50.79 -39.1 58.06 Favored 'Trans proline' 0 C--N 1.315 -1.185 0 C-N-CA 123.463 2.775 . . . . 0.16 112.398 -168.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 451' ' ' LYS . 17.0 p -74.3 -39.56 62.83 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.529 -1.214 . . . . 1.1699999999999999 109.974 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.664 HG11 ' HB ' ' A' ' 366' ' ' THR . 68.7 t -78.37 -29.64 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 121.211 0.529 . . . . 0.17000000000000001 111.252 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.674 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.5 tpt -67.48 -20.28 65.45 Favored 'General case' 0 C--O 1.21 -1.025 0 CA-C-O 122.009 0.909 . . . . 0.46000000000000002 110.013 178.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 448' ' ' SER . 0.1 OUTLIER -75.67 -29.71 59.15 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-N 114.059 -1.428 . . . . 0.81000000000000005 111.266 176.195 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -76.05 -47.28 25.29 Favored 'General case' 0 CA--C 1.473 -2.0 0 CA-C-N 112.645 -2.07 . . . . 0.38 107.297 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.584 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.9 tp -64.57 -66.49 0.54 Allowed 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 111.771 -2.468 . . . . 0.059999999999999998 112.546 175.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.444 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.6 t80 -50.32 -24.93 3.28 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 123.041 1.4 . . . . 0.31 108.342 177.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.43 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.8 -28.14 63.49 Favored Glycine 0 N--CA 1.426 -1.998 0 CA-C-N 112.432 -2.167 . . . . 0.13 111.967 -179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -89.84 -48.4 7.26 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 121.769 0.795 . . . . 0.13 111.461 170.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.563 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.7 OUTLIER -103.21 137.45 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.088 0 CA-C-O 123.503 1.62 . . . . 0.23000000000000001 114.297 -167.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.83 -178.6 5.26 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 110.592 -3.004 . . . . 0.82999999999999996 106.607 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.717 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 46.5 mtmt -52.1 162.19 0.51 Allowed 'General case' 0 N--CA 1.413 -2.324 0 CA-C-O 123.092 1.425 . . . . 0.23999999999999999 113.009 177.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.92 4.55 Favored Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 112.576 -2.102 . . . . 0.37 112.535 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.3 m -77.04 141.13 67.13 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.231 -0.655 . . . . 0.14999999999999999 109.231 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.665 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 2.8 Cg_exo -73.62 167.42 27.3 Favored 'Trans proline' 0 N--CA 1.427 -2.438 0 C-N-CA 121.677 1.585 . . . . 0.12 111.106 174.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.802 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.7 156.78 38.37 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.381 0 N-CA-C 107.398 -1.334 . . . . 1.0900000000000001 107.398 166.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.491 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.1 tp -128.06 145.33 51.03 Favored 'General case' 0 C--N 1.282 -2.334 0 CA-C-N 115.552 -0.749 . . . . 0.13 110.17 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.705 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.32 147.72 20.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 106.962 -1.496 . . . . 0.089999999999999997 106.962 165.04 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.692 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.8 p90 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.079 -0.962 . . . . 1.1599999999999999 111.573 -176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.63 -0.588 . . . . 3.9399999999999999 111.63 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -75.36 100.55 4.46 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.028 0.442 . . . . 1.8500000000000001 110.278 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 17.8 mtp 63.87 -176.49 0.16 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.459 -1.246 . . . . 1.03 111.512 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -141.36 -6.6 1.04 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.126 -0.488 . . . . 1.1000000000000001 111.63 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -56.43 167.45 0.69 Allowed 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 123.281 1.515 . . . . 0.97999999999999998 113.246 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.629 HG23 ' HA ' ' A' ' 358' ' ' LYS . 96.2 m -94.12 123.14 37.31 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 112.834 -1.985 . . . . 0.45000000000000001 107.754 167.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.658 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 10.7 p90 -160.58 -170.73 2.87 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.031 -0.986 . . . . 0.32000000000000001 110.987 -172.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.576 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.6 mm -102.53 157.2 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 107.693 -1.225 . . . . 0.080000000000000002 107.693 165.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 4.2 tt0 -137.91 154.08 49.46 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 118.59 0.632 . . . . 0.17000000000000001 110.659 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.666 HG22 ' HG3' ' A' ' 354' ' ' MET . 58.0 t -150.81 135.17 9.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 114.911 -1.04 . . . . 0.080000000000000002 109.913 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -114.78 117.88 32.0 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 114.607 -1.179 . . . . 0.37 108.097 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.531 HD21 HG23 ' A' ' 465' ' ' VAL . 2.0 mm? -72.07 -48.77 41.75 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.335 1.064 . . . . 0.32000000000000001 110.122 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -54.58 -51.68 64.53 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 113.026 -1.897 . . . . 1.51 112.374 -178.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -104.4 16.62 25.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.38 -1.282 . . . . 0.91000000000000003 108.914 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.789 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.7 mm-40 34.09 69.27 0.15 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 112.94 -1.936 . . . . 2.2200000000000002 112.55 172.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.473 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.8 t60 -150.05 125.38 10.14 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.702 -0.681 . . . . 0.13 109.561 -176.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.666 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -111.78 128.44 56.1 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.495 0.664 . . . . 0.059999999999999998 110.356 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.618 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 30.9 m-90 -113.07 171.71 7.38 Favored 'General case' 0 C--O 1.209 -1.027 0 CA-C-N 114.438 -1.255 . . . . 0.10000000000000001 111.636 -178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.685 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.6 t80 -122.3 116.07 23.44 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.823 -1.918 . . . . 0.22 105.823 164.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.468 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 21.0 m-85 -100.82 131.35 46.75 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.739 0.78 . . . . 0.17999999999999999 110.962 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.662 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 4.6 ttpt -147.7 137.66 22.82 Favored 'General case' 0 N--CA 1.406 -2.635 0 CA-C-N 114.266 -1.334 . . . . 0.46999999999999997 108.656 174.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.8 OUTLIER 69.72 18.31 7.54 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-N 113.104 -1.862 . . . . 0.59999999999999998 108.34 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.23 22.01 71.89 Favored Glycine 0 N--CA 1.426 -2.016 0 CA-C-N 112.28 -2.236 . . . . 0.23000000000000001 111.834 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.622 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.84 165.39 27.42 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.91 -1.645 . . . . 0.68000000000000005 106.729 -168.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.622 ' H ' ' HE2' ' A' ' 361' ' ' LYS . 54.5 t -94.66 132.42 38.72 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.764 0 CA-C-O 123.54 1.638 . . . . 0.53000000000000003 111.632 -177.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.685 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -98.87 -28.14 13.59 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 110.944 -2.844 . . . . 0.12 109.856 175.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.631 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.2 tp -152.64 148.61 27.52 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.408 -1.269 . . . . 0.080000000000000002 109.625 -170.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.618 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -158.71 123.02 4.05 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.257 -0.428 . . . . 0.60999999999999999 110.099 -171.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.652 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.9 t -148.93 166.74 27.68 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 122.402 1.096 . . . . 0.089999999999999997 112.262 172.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.616 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.9 p-10 -86.01 141.27 29.6 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 112.827 -1.988 . . . . 1.8799999999999999 107.418 176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.642 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.83 -171.89 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.477 -0.783 . . . . 0.11 112.155 -175.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.789 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.26 119.65 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 114.998 -1.001 . . . . 0.12 109.529 175.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.8 t -142.35 144.56 33.25 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.968 -1.015 . . . . 0.69999999999999996 112.642 -167.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.02 45.37 26.56 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 116.784 1.474 . . . . 0.13 116.784 163.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.551 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -47.6 143.08 5.99 Favored Pre-proline 0 CA--C 1.51 -0.573 0 CA-C-N 118.921 1.361 . . . . 0.47999999999999998 110.007 -174.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.768 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -32.94 -31.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.7 1 C-N-CA 126.056 4.504 . . . . 0.23000000000000001 116.471 -170.041 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 398' ' ' ASP . 1.9 p -81.94 -33.75 30.15 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.208 0.528 . . . . 0.29999999999999999 111.126 -177.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.462 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.8 m -140.16 73.82 31.33 Favored Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-O 122.212 1.006 . . . . 0.29999999999999999 109.955 178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.671 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.9 Cg_exo -71.21 161.73 44.86 Favored 'Trans proline' 0 C--N 1.319 -0.998 1 C-N-CA 125.308 4.006 . . . . 0.16 113.741 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.682 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.95 152.18 90.84 Favored Pre-proline 0 N--CA 1.433 -1.294 0 CA-C-N 113.657 -1.611 . . . . 0.12 110.67 175.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.523 ' HG2' ' CE1' ' A' ' 382' ' ' PHE . 1.4 Cg_endo -80.18 -49.68 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 125.044 3.829 . . . . 0.089999999999999997 113.497 -171.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.711 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.23 123.04 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 122.143 0.973 . . . . 0.089999999999999997 113.545 -177.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.82 -126.31 1.48 Allowed Glycine 0 N--CA 1.436 -1.325 0 CA-C-N 113.895 -1.502 . . . . 0.11 110.671 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.9 p -129.18 104.46 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 CA-C-O 122.286 1.041 . . . . 0.89000000000000001 109.346 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.628 ' CE2' HG22 ' A' ' 465' ' ' VAL . 51.1 m-85 -107.78 169.25 8.71 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.005 -0.998 . . . . 0.16 109.173 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.702 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 74.1 m-85 -148.92 138.04 21.53 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 121.225 -0.19 . . . . 0.68999999999999995 110.579 175.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.17 123.66 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 119.833 -0.747 . . . . 0.14000000000000001 110.123 176.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -111.63 6.48 20.0 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.412 -0.813 . . . . 0.19 111.846 -178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.719 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.5 t30 -166.7 150.66 7.15 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.401 -0.818 . . . . 0.40999999999999998 110.93 175.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.7 mtpt -109.99 120.32 42.09 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.529 -0.76 . . . . 1.0900000000000001 109.466 169.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.574 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.9 mt-10 -122.58 112.88 18.53 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-O 123.29 1.519 . . . . 0.38 113.243 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 24.0 mp0 -108.93 135.38 50.22 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.509 -1.678 . . . . 1.96 111.022 -175.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 24.6 t70 52.23 35.69 17.5 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 123.582 1.658 . . . . 0.40000000000000002 107.545 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.574 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -88.03 170.81 10.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 112.196 -2.275 . . . . 0.16 112.225 -175.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 30.5 m -128.12 102.53 6.76 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.341 -1.754 . . . . 0.27000000000000002 109.937 -176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.727 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.42 156.49 36.95 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 112.878 -1.965 . . . . 0.23999999999999999 110.262 174.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 10.3 mtpt -154.08 169.34 23.76 Favored 'General case' 0 N--CA 1.401 -2.918 0 O-C-N 124.235 0.959 . . . . 0.67000000000000004 108.701 -175.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.911 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 177.73 164.58 31.36 Favored Glycine 0 CA--C 1.479 -2.177 0 C-N-CA 118.085 -2.007 . . . . 0.81000000000000005 113.302 -172.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.02 115.82 29.84 Favored 'General case' 0 N--CA 1.42 -1.953 0 CA-C-O 122.863 1.316 . . . . 0.79000000000000004 110.082 177.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.6 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 4.8 m-80 -50.95 -179.72 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-N 111.376 -2.647 . . . . 1.1200000000000001 114.046 179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . 0.503 ' HB3' ' HB ' ' A' ' 374' ' ' THR . 0.0 OUTLIER -51.15 -23.68 3.47 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.451 -0.795 . . . . 1.6499999999999999 110.697 168.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.481 ' HB3' HG23 ' A' ' 401' ' ' THR . 3.9 t70 -96.88 -25.83 15.3 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-O 121.586 0.707 . . . . 2.0 110.525 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.76 34.04 5.08 Favored Glycine 0 N--CA 1.433 -1.538 0 N-CA-C 109.897 -1.281 . . . . 0.66000000000000003 109.897 -167.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.6 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 36.9 p -115.41 127.36 26.87 Favored Pre-proline 0 N--CA 1.413 -2.275 0 N-CA-C 107.154 -1.425 . . . . 0.68000000000000005 107.154 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.911 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.5 Cg_exo -69.73 147.35 62.84 Favored 'Trans proline' 0 N--CA 1.42 -2.847 0 C-N-CA 122.299 1.999 . . . . 0.81000000000000005 111.462 -175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.543 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 11.5 p90 -135.43 -174.69 3.7 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 112.694 -2.048 . . . . 0.38 107.13 -177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.631 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 5.4 mt-10 -143.53 163.09 34.14 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.448 1.118 . . . . 0.62 112.302 175.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.727 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.21 98.77 9.14 Favored Pre-proline 0 N--CA 1.422 -1.843 0 CA-C-N 113.012 -1.904 . . . . 1.3300000000000001 108.193 174.733 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.1 Cg_endo -67.42 102.7 0.72 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.454 2.102 . . . . 0.20000000000000001 110.336 174.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -115.64 160.88 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.637 0 CA-C-N 114.397 -1.274 . . . . 0.29999999999999999 110.134 -173.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 13.7 m-80 -111.82 -32.85 6.49 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 113.656 -1.611 . . . . 1.8400000000000001 107.19 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.443 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 49.8 m-85 -137.67 115.98 11.87 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.064 -1.88 . . . . 0.44 110.225 175.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.778 ' HB2' HG11 ' A' ' 407' ' ' VAL . 9.8 t-105 -122.87 135.57 54.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.957 -1.02 . . . . 0.13 109.794 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.54 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.5 OUTLIER -136.34 86.07 25.19 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-N 114.882 -1.054 . . . . 0.40999999999999998 110.851 174.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.68 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 83.6 Cg_endo -72.34 141.5 35.51 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.975 2.45 . . . . 0.16 111.691 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.52 -15.78 5.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 114.393 -1.276 . . . . 0.17000000000000001 111.809 -171.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.818 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 3.9 p30 -135.98 171.03 15.05 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.778 -0.646 . . . . 1.5900000000000001 110.074 169.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -98.23 16.43 21.42 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.825 -0.625 . . . . 0.31 111.681 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 7.9 p -99.65 -27.91 13.45 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.583 -0.895 . . . . 0.44 108.583 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 132.31 26.24 0.68 Allowed Glycine 0 N--CA 1.432 -1.622 0 CA-C-N 114.337 -1.302 . . . . 0.23999999999999999 113.902 171.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.818 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 76.1 t -105.12 152.4 7.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.523 0.678 . . . . 0.17000000000000001 112.083 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.76 -168.07 40.55 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 114.82 -1.082 . . . . 0.10000000000000001 111.209 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.5 141.6 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 N-CA-C 109.119 -0.697 . . . . 0.12 109.119 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.615 ' O ' ' HB ' ' A' ' 445' ' ' THR . 33.7 p80 -150.54 165.04 34.47 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-O 121.75 0.786 . . . . 0.14999999999999999 111.768 177.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.776 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -93.25 142.85 26.85 Favored 'General case' 0 N--CA 1.423 -1.782 0 CA-C-N 114.004 -1.453 . . . . 0.41999999999999998 107.16 171.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.93 104.94 5.89 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.925 1.345 . . . . 1.48 110.203 -176.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.97 -27.62 15.56 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 112.34 -2.209 . . . . 0.34999999999999998 111.288 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.533 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 9.0 p90 -69.3 -24.61 63.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 114.481 -1.236 . . . . 0.17999999999999999 108.877 174.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.436 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.1 OUTLIER -119.17 100.2 50.36 Favored Pre-proline 0 CA--C 1.488 -1.404 0 CA-C-N 112.985 -1.916 . . . . 1.3300000000000001 108.465 -176.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -88.52 2.2 6.21 Favored 'Trans proline' 0 C--N 1.283 -2.914 0 C-N-CA 123.04 2.493 . . . . 0.23000000000000001 114.863 -173.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.41 ' HB3' ' CD ' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -112.97 151.86 30.08 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.986 -1.086 . . . . 1.1000000000000001 111.567 -177.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.616 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.64 125.77 2.48 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 113.762 -1.563 . . . . 0.38 108.472 -171.423 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.71 -169.01 28.6 Favored Glycine 0 C--N 1.299 -1.527 0 C-N-CA 119.416 -1.373 . . . . 0.13 111.203 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.669 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.06 0.01 OUTLIER Glycine 0 C--N 1.34 0.778 0 O-C-N 125.163 1.155 . . . . 0.20000000000000001 112.97 175.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.403 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.4 m-20 -54.55 100.96 0.04 OUTLIER 'General case' 0 CA--C 1.491 -1.322 0 CA-C-O 123.988 1.852 . . . . 0.33000000000000002 111.799 -146.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.669 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.8 mt -97.14 -31.71 12.33 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 110.09 -3.232 . . . . 0.17999999999999999 108.614 175.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.606 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.6 p-90 -45.95 -37.68 6.74 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.804 0.69 . . . . 0.22 111.515 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.768 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 56.4 mttt -61.34 -24.18 66.28 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 115.113 -0.949 . . . . 0.64000000000000001 113.211 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 50.5 p -114.85 -37.38 4.21 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.684 0.754 . . . . 0.25 110.162 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.508 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.5 mtp85 -82.36 -15.72 51.77 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.78 -1.1 . . . . 0.35999999999999999 112.137 -170.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.551 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 71.87 41.43 55.62 Favored Glycine 0 C--N 1.314 -0.66 0 N-CA-C 116.13 1.212 . . . . 0.20999999999999999 116.13 160.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 38.5 m -90.28 130.1 36.44 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 118.565 1.182 . . . . 0.46999999999999997 108.522 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.519 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 73.2 m80 -95.4 65.35 2.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 122.06 -0.4 . . . . 0.40999999999999998 111.187 -166.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.593 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 93.76 -13.77 66.75 Favored Glycine 0 N--CA 1.44 -1.092 0 N-CA-C 110.548 -1.021 . . . . 0.17999999999999999 110.548 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.567 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 21.0 p -87.52 138.45 31.47 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 120.971 0.415 . . . . 0.82999999999999996 110.455 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -91.72 116.15 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-O 121.78 0.8 . . . . 0.14999999999999999 110.768 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.525 ' CB ' HG13 ' A' ' 369' ' ' VAL . 1.8 t-20 -76.73 84.3 3.35 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.236 -1.347 . . . . 1.77 111.405 -176.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.615 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 51.3 m -89.64 137.96 28.41 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-O 121.659 0.743 . . . . 0.17999999999999999 109.773 177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.429 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 52.8 Cg_exo -57.55 135.84 72.13 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 122.909 2.406 . . . . 0.12 111.735 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.776 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.8 Cg_exo -55.27 -34.04 86.95 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.256 3.304 . . . . 0.16 112.96 -174.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 34.7 p -78.54 -39.48 37.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.651 -1.159 . . . . 1.1699999999999999 109.928 -177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.652 HG11 ' HB ' ' A' ' 366' ' ' THR . 86.2 t -79.58 -31.25 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.866 -0.606 . . . . 0.17000000000000001 111.384 -179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.696 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.6 tpt -66.76 -18.73 65.52 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.521 0.677 . . . . 0.46000000000000002 110.448 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -81.04 -23.05 38.86 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-O 122.395 1.093 . . . . 0.81000000000000005 110.989 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.657 ' O ' ' HG2' ' A' ' 456' ' ' MET . 7.7 mm-40 -79.69 -46.95 16.15 Favored 'General case' 0 CA--C 1.474 -1.953 0 CA-C-N 112.841 -1.981 . . . . 0.38 107.106 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.619 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.2 tp -64.39 -66.99 0.47 Allowed 'General case' 0 N--CA 1.403 -2.805 0 CA-C-N 111.835 -2.439 . . . . 0.059999999999999998 112.243 174.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.437 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 33.0 t80 -49.67 -27.04 4.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 123.018 1.39 . . . . 0.31 108.328 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.57 -30.76 66.12 Favored Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 112.465 -2.152 . . . . 0.13 112.409 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.657 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -88.38 -48.34 7.71 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.929 0.871 . . . . 0.13 111.369 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.612 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.6 OUTLIER -102.45 138.03 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 CA-C-O 123.587 1.66 . . . . 0.23000000000000001 113.992 -168.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.96 -178.44 5.2 Favored 'General case' 0 N--CA 1.402 -2.843 0 CA-C-N 110.52 -3.037 . . . . 0.82999999999999996 106.419 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.719 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.6 mtmt -50.87 162.96 0.22 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-O 123.06 1.41 . . . . 0.23999999999999999 113.318 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.02 -35.29 3.95 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 112.577 -2.102 . . . . 0.37 112.47 -179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 462' ' ' PRO . 17.8 m -72.57 141.69 82.99 Favored Pre-proline 0 N--CA 1.435 -1.224 0 CA-C-N 115.252 -0.474 . . . . 0.14999999999999999 109.837 -176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.658 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.4 164.97 33.73 Favored 'Trans proline' 0 N--CA 1.43 -2.241 0 C-N-CA 122.043 1.829 . . . . 0.12 111.084 173.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.0 t -135.16 133.45 53.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 CA-C-N 113.702 -1.59 . . . . 1.0900000000000001 107.872 173.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.46 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.9 tp -112.55 142.96 44.5 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.032 -0.531 . . . . 0.13 110.371 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.711 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.19 147.46 20.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 107.06 -1.459 . . . . 0.089999999999999997 107.06 165.291 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.654 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.9 p90 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.657 -0.687 . . . . 1.1599999999999999 111.342 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.834 -0.507 . . . . 3.9399999999999999 111.834 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -72.97 98.96 2.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.21 0.528 . . . . 1.8500000000000001 110.525 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 35.0 mtm 62.74 -176.15 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.466 -1.243 . . . . 1.03 111.921 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.4 -5.15 1.82 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.304 -0.862 . . . . 1.1000000000000001 110.602 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -55.22 167.06 0.48 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 123.026 1.393 . . . . 0.97999999999999998 113.508 176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 358' ' ' LYS . 4.1 m -92.74 121.87 34.57 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 112.857 -1.974 . . . . 0.45000000000000001 106.95 165.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.646 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.2 p90 -158.65 -171.03 3.27 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.597 0.713 . . . . 0.32000000000000001 111.081 -174.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.608 HD11 ' HB ' ' A' ' 457' ' ' VAL . 8.9 mm -105.58 161.09 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 114.719 -1.128 . . . . 0.080000000000000002 108.022 167.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.479 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 4.2 tt0 -142.42 155.39 45.1 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 118.843 0.747 . . . . 0.17000000000000001 111.046 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.711 HG22 ' HG3' ' A' ' 354' ' ' MET . 63.2 t -150.3 136.57 12.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.795 -1.093 . . . . 0.080000000000000002 109.851 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -117.84 111.28 18.83 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.721 -1.127 . . . . 0.37 108.053 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.543 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -64.63 -49.41 71.16 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 122.704 1.24 . . . . 0.32000000000000001 110.197 -176.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -53.31 -54.82 30.86 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 112.507 -2.133 . . . . 1.51 112.224 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -94.9 3.86 54.48 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 114.788 -1.097 . . . . 0.91000000000000003 109.994 -173.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.764 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.2 mm-40 47.01 64.96 1.36 Allowed 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 112.584 -2.098 . . . . 2.2200000000000002 112.27 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.545 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.5 t60 -145.86 124.62 12.6 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.107 0.48 . . . . 0.13 110.021 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.711 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.4 ttp -110.83 127.61 55.47 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.438 0.637 . . . . 0.059999999999999998 110.515 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.638 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.3 m-90 -111.55 173.26 6.43 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.538 -1.21 . . . . 0.10000000000000001 111.889 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.724 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -127.14 117.48 22.46 Favored 'General case' 0 CA--C 1.49 -1.355 0 N-CA-C 106.251 -1.759 . . . . 0.22 106.251 164.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.447 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 25.2 m-85 -100.48 128.6 46.49 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 122.188 0.994 . . . . 0.17999999999999999 111.898 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.675 ' HA ' HG23 ' A' ' 343' ' ' THR . 5.1 ttpt -148.35 137.37 21.81 Favored 'General case' 0 N--CA 1.399 -2.995 0 CA-C-N 113.218 -1.81 . . . . 0.46999999999999997 108.225 174.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.431 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.7 OUTLIER 70.56 14.46 7.27 Favored 'General case' 0 CA--C 1.497 -1.069 0 CA-C-N 113.409 -1.723 . . . . 0.59999999999999998 108.92 178.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 81.62 15.65 75.3 Favored Glycine 0 N--CA 1.423 -2.203 0 CA-C-N 112.588 -2.096 . . . . 0.23000000000000001 111.847 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -134.63 171.75 13.9 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 105.954 -1.869 . . . . 0.68000000000000005 105.954 -170.646 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.689 HG21 ' HG2' ' A' ' 365' ' ' GLU . 2.9 m -102.99 137.84 29.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.834 0 CA-C-O 124.421 2.058 . . . . 0.53000000000000003 112.186 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.724 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.01 -24.76 18.24 Favored 'General case' 0 N--CA 1.399 -3.019 0 CA-C-N 109.291 -3.595 . . . . 0.12 108.574 177.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.687 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.4 154.81 36.33 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.854 -1.521 . . . . 0.080000000000000002 109.018 -173.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.689 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.56 122.05 1.41 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.763 -0.653 . . . . 0.60999999999999999 109.442 -175.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.697 HG21 HG23 ' A' ' 445' ' ' THR . 5.2 t -148.34 167.55 24.91 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-O 122.34 1.066 . . . . 0.089999999999999997 112.133 174.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.673 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.0 OUTLIER -86.45 139.97 30.41 Favored 'General case' 0 N--CA 1.417 -2.116 0 CA-C-N 112.941 -1.936 . . . . 1.8799999999999999 107.41 176.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.643 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.28 -171.36 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.349 -0.841 . . . . 0.11 112.014 -175.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.764 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -158.17 117.14 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.862 -1.063 . . . . 0.12 109.203 177.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.498 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.0 t -142.85 146.62 34.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.78 -1.1 . . . . 0.69999999999999996 112.531 -168.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.678 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 70.6 45.93 50.36 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 116.824 1.489 . . . . 0.13 116.824 161.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.498 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.0 OUTLIER -46.55 144.45 3.44 Favored Pre-proline 0 C--O 1.219 -0.549 0 CA-C-N 118.994 1.397 . . . . 0.47999999999999998 110.616 -174.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.814 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -36.74 -29.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 1 C-N-CA 125.848 4.365 . . . . 0.23000000000000001 116.45 -172.412 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.487 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.2 p -86.97 -31.99 20.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.465 0.65 . . . . 0.29999999999999999 110.809 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.512 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.7 m -138.47 70.55 45.91 Favored Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 122.187 0.994 . . . . 0.29999999999999999 109.892 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.678 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 21.7 Cg_exo -72.64 163.47 38.41 Favored 'Trans proline' 0 C--N 1.322 -0.842 1 C-N-CA 125.325 4.017 . . . . 0.16 114.36 -175.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.718 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -75.41 152.65 85.74 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 113.23 -1.804 . . . . 0.12 110.271 173.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.53 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.28 -49.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.326 -0.634 0 C-N-CA 124.909 3.74 . . . . 0.089999999999999997 113.634 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.72 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.71 123.03 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 113.586 0.958 . . . . 0.089999999999999997 113.586 -178.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.05 -122.76 1.1 Allowed Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 114.225 -1.352 . . . . 0.11 111.575 -178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 381' ' ' VAL . 11.7 p -129.12 107.19 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 CA-C-O 122.117 0.96 . . . . 0.89000000000000001 109.301 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.789 ' HB2' HG22 ' A' ' 463' ' ' VAL . 98.9 m-85 -110.59 161.95 15.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.154 -0.93 . . . . 0.16 109.945 -170.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.0 m-85 -148.21 135.68 20.59 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 121.234 -0.186 . . . . 0.68999999999999995 111.13 176.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.607 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.08 125.98 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 CA-C-O 121.585 0.707 . . . . 0.14000000000000001 110.891 177.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 28.7 p-90 -109.68 2.4 20.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.21 -0.905 . . . . 0.19 111.745 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.752 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.2 t30 -165.17 146.71 7.62 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.355 -0.839 . . . . 0.40999999999999998 110.805 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -107.24 109.8 21.69 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.179 -0.919 . . . . 1.0900000000000001 109.224 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.575 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -107.74 119.66 40.06 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 122.589 1.185 . . . . 0.38 111.447 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.774 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 19.2 mt-10 -115.96 142.15 47.17 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-N 113.966 -1.47 . . . . 1.96 110.901 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 35.2 t70 55.86 26.87 10.18 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 111.21 -2.723 . . . . 0.40000000000000002 107.656 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 169.64 15.37 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 112.753 -2.021 . . . . 0.16 112.404 -166.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 60.8 m -125.07 102.96 7.75 Favored 'General case' 0 N--CA 1.419 -2.001 0 CA-C-N 112.866 -1.97 . . . . 0.27000000000000002 109.532 -176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 9.0 mp -71.87 155.87 39.91 Favored 'General case' 0 N--CA 1.42 -1.947 0 CA-C-N 113.176 -1.829 . . . . 0.23999999999999999 109.76 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.432 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 9.9 mtpt -154.09 172.38 17.62 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 107.814 -1.18 . . . . 0.67000000000000004 107.814 -174.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.914 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 171.95 167.23 31.79 Favored Glycine 0 CA--C 1.481 -2.058 0 C-N-CA 118.052 -2.023 . . . . 0.81000000000000005 113.449 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.4 121.05 32.77 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-O 123.111 1.434 . . . . 0.79000000000000004 110.842 177.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.476 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -50.21 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 110.935 -2.848 . . . . 1.1200000000000001 112.368 174.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.31 -24.02 10.71 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.88 -0.6 . . . . 1.6499999999999999 110.513 169.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -97.7 -28.83 13.72 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.372 0.606 . . . . 2.0 111.33 -172.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 106.73 32.52 3.57 Favored Glycine 0 N--CA 1.435 -1.422 0 C-N-CA 120.064 -1.065 . . . . 0.66000000000000003 110.706 -167.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 40.0 p -118.4 130.53 24.71 Favored Pre-proline 0 N--CA 1.417 -2.095 0 N-CA-C 106.603 -1.629 . . . . 0.68000000000000005 106.603 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.914 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 24.1 Cg_exo -66.19 156.15 66.28 Favored 'Trans proline' 0 N--CA 1.42 -2.809 0 C-N-CA 121.789 1.659 . . . . 0.81000000000000005 112.898 -174.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.512 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 19.4 p90 -134.46 -169.69 2.39 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.396 -1.729 . . . . 0.38 107.417 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 11.9 mt-10 -148.41 155.27 41.01 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 122.205 1.002 . . . . 0.62 111.388 172.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.695 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.3 m -142.72 98.05 5.86 Favored Pre-proline 0 N--CA 1.42 -1.959 0 CA-C-N 113.36 -1.745 . . . . 1.3300000000000001 109.478 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.2 Cg_endo -66.89 108.28 1.45 Allowed 'Trans proline' 0 CA--C 1.513 -0.554 0 C-N-CA 124.648 3.565 . . . . 0.20000000000000001 113.22 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -118.62 161.11 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.495 -1.23 . . . . 0.29999999999999999 110.003 -175.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.774 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.2 OUTLIER -100.23 -40.3 7.62 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.394 -1.336 . . . . 1.8400000000000001 107.394 169.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.534 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 10.2 m-30 -125.94 113.47 17.23 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 114.395 -1.275 . . . . 0.44 110.439 -175.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.724 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.4 t-105 -123.28 135.92 54.46 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 113.747 -1.57 . . . . 0.13 110.1 -178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.508 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.5 OUTLIER -135.96 85.02 29.85 Favored Pre-proline 0 C--N 1.297 -1.716 0 CA-C-N 114.859 -1.064 . . . . 0.40999999999999998 111.092 174.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.69 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 71.8 Cg_endo -70.68 140.47 39.28 Favored 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 123.025 2.484 . . . . 0.16 111.63 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.6 pt -123.53 -16.33 5.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 114.085 -1.416 . . . . 0.17000000000000001 111.154 -172.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 416' ' ' THR . 0.0 OUTLIER -134.58 169.75 16.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.093 -0.958 . . . . 1.5900000000000001 108.945 177.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -101.2 14.19 32.76 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.489 0.922 . . . . 0.31 113.489 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . 0.479 ' H ' ' CG ' ' A' ' 414' ' ' ASP . 23.3 p -98.16 -28.36 13.76 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.906 -1.146 . . . . 0.44 107.906 173.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 135.6 31.17 0.31 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 114.037 -1.438 . . . . 0.23999999999999999 113.148 172.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.643 HG13 ' O ' ' A' ' 441' ' ' GLY . 72.9 t -102.75 149.4 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-O 121.383 0.611 . . . . 0.17000000000000001 111.515 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 174.77 -166.04 37.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.911 -1.041 . . . . 0.10000000000000001 111.57 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.7 138.45 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.936 -0.764 . . . . 0.12 108.936 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.746 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.4 p80 -151.86 171.46 17.71 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.093 0.949 . . . . 0.14999999999999999 111.712 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.739 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -92.44 149.56 21.32 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.122 -1.854 . . . . 0.41999999999999998 108.322 174.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.428 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 4.8 p -133.8 101.75 5.2 Favored 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 123.137 1.446 . . . . 1.48 110.376 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -95.8 -32.0 12.91 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-N 112.139 -2.3 . . . . 0.34999999999999998 110.846 176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.628 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 15.5 p90 -71.67 -26.76 62.66 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 114.73 -1.123 . . . . 0.17999999999999999 108.972 174.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.536 ' HG2' ' HB3' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -111.05 95.5 25.11 Favored Pre-proline 0 CA--C 1.489 -1.365 0 CA-C-N 113.469 -1.696 . . . . 1.3300000000000001 108.923 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 426' ' ' GLN . 17.7 Cg_endo -85.12 2.4 7.92 Favored 'Trans proline' 0 N--CA 1.415 -3.122 0 C-N-CA 122.808 2.338 . . . . 0.23000000000000001 113.418 -176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.1 148.69 36.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 119.041 -1.064 . . . . 1.1000000000000001 110.162 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.673 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.0 OUTLIER -162.93 124.78 2.56 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 124.733 1.271 . . . . 0.38 108.225 -173.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.02 -166.04 28.47 Favored Glycine 0 C--N 1.297 -1.584 0 C-N-CA 119.389 -1.386 . . . . 0.13 111.241 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.62 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -28.52 149.58 0.01 OUTLIER Glycine 0 C--N 1.342 0.883 0 O-C-N 125.17 1.159 . . . . 0.20000000000000001 112.907 175.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.403 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 1.8 m-20 -54.97 101.6 0.05 Allowed 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 123.905 1.812 . . . . 0.33000000000000002 112.112 -145.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 57.4 mt -97.35 -32.14 12.03 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-N 110.498 -3.046 . . . . 0.17999999999999999 108.302 176.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.57 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.8 p-90 -45.32 -37.79 5.17 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 123.745 0.653 . . . . 0.22 111.465 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.814 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.9 mttt -60.47 -26.57 66.88 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 114.822 -1.081 . . . . 0.64000000000000001 112.758 -175.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 45.9 p -112.73 -37.89 4.74 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.717 0.77 . . . . 0.25 110.083 -176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.46 ' HD3' HE22 ' A' ' 426' ' ' GLN . 7.3 mtp85 -82.74 -14.76 53.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.6 -1.182 . . . . 0.35999999999999999 112.616 -168.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.63 40.7 37.48 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 116.069 1.187 . . . . 0.20999999999999999 116.069 159.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 2.2 m -79.86 140.87 36.61 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 117.809 0.804 . . . . 0.46999999999999997 109.52 176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -106.29 68.54 0.76 Allowed 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.881 -0.512 . . . . 0.40999999999999998 110.392 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.643 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 84.63 -8.13 70.31 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.069 -0.813 . . . . 0.17999999999999999 111.069 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.487 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 26.3 p -94.92 135.09 36.86 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.393 0.616 . . . . 0.82999999999999996 110.715 -175.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.718 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -96.42 113.74 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.254 -0.885 . . . . 0.14999999999999999 110.343 -174.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.536 ' HB3' ' HG2' ' A' ' 426' ' ' GLN . 18.9 m-80 -83.45 93.04 7.71 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.835 -1.075 . . . . 1.77 111.881 -175.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.697 HG23 HG21 ' A' ' 366' ' ' THR . 53.4 m -91.36 136.68 26.68 Favored Pre-proline 0 N--CA 1.444 -0.731 0 CA-C-N 115.35 -0.841 . . . . 0.17999999999999999 109.604 176.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.2 Cg_exo -52.99 135.55 58.91 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.524 2.15 . . . . 0.12 111.214 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.739 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 49.0 Cg_exo -55.28 -31.38 76.37 Favored 'Trans proline' 0 CA--C 1.5 -1.211 0 C-N-CA 124.055 3.17 . . . . 0.16 112.547 -172.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 72.3 m -79.75 -38.3 33.55 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 114.286 -1.324 . . . . 1.1699999999999999 109.943 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.597 HG11 ' HB ' ' A' ' 366' ' ' THR . 86.5 t -78.55 -29.0 14.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.643 -0.708 . . . . 0.17000000000000001 111.539 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.617 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.3 tpt -66.34 -20.9 66.21 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.598 0.713 . . . . 0.46000000000000002 110.179 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -76.27 -25.27 54.77 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.827 -1.079 . . . . 0.81000000000000005 111.628 175.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.668 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.5 mm-40 -79.21 -46.66 17.43 Favored 'General case' 0 CA--C 1.473 -2.003 0 CA-C-N 113.129 -1.85 . . . . 0.38 107.092 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.546 HD23 ' SD ' ' A' ' 450' ' ' MET . 24.3 tp -66.06 -67.42 0.45 Allowed 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 111.72 -2.491 . . . . 0.059999999999999998 112.43 175.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 409' ' ' TYR . 28.7 t80 -48.94 -26.88 2.74 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.806 1.289 . . . . 0.31 108.344 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.54 -30.35 64.46 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.601 -2.09 . . . . 0.13 112.555 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.687 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -88.75 -48.5 7.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.65 0.738 . . . . 0.13 111.513 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.653 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.4 OUTLIER -101.03 138.3 25.71 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.142 0 CA-C-O 123.105 1.431 . . . . 0.23000000000000001 113.902 -168.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -136.5 -178.94 5.39 Favored 'General case' 0 N--CA 1.401 -2.912 0 CA-C-N 111.284 -2.689 . . . . 0.82999999999999996 107.397 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.752 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.1 mtmt -52.79 157.73 1.56 Allowed 'General case' 0 N--CA 1.413 -2.286 0 CA-C-O 122.82 1.295 . . . . 0.23999999999999999 114.009 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 68.1 18.01 70.53 Favored Glycine 0 C--N 1.281 -2.492 0 CA-C-N 112.659 -2.064 . . . . 0.37 113.699 -175.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 462' ' ' PRO . 9.5 m -103.85 141.68 23.02 Favored Pre-proline 0 N--CA 1.427 -1.585 0 N-CA-C 107.664 -1.235 . . . . 0.14999999999999999 107.664 165.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.646 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.3 Cg_exo -74.74 164.62 33.27 Favored 'Trans proline' 0 N--CA 1.426 -2.464 0 C-N-CA 121.648 1.565 . . . . 0.12 110.73 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.789 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -134.73 154.97 37.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.563 0 N-CA-C 107.271 -1.381 . . . . 1.0900000000000001 107.271 166.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.3 tp -126.59 145.15 50.65 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-N 115.317 -0.856 . . . . 0.13 110.195 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.72 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.04 147.44 20.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.291 -1.374 . . . . 0.089999999999999997 107.291 165.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.593 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 17.3 p90 . . . . . 0 C--O 1.245 0.843 0 CA-C-O 118.535 -0.745 . . . . 1.1599999999999999 110.846 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.732 0 N-CA-C 111.384 -0.686 . . . . 3.9399999999999999 111.384 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.564 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.5 t-160 -82.71 88.31 6.73 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.002 -0.74 . . . . 1.8500000000000001 109.002 174.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 36.9 mtm 73.85 -179.99 0.2 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.636 -1.62 . . . . 1.03 110.523 -170.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -116.64 -6.4 11.62 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.868 -1.06 . . . . 1.1000000000000001 111.133 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.03 166.14 3.73 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 123.248 1.499 . . . . 0.97999999999999998 114.253 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.62 HG23 ' HA ' ' A' ' 358' ' ' LYS . 98.9 m -99.12 122.7 42.68 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 112.375 -2.193 . . . . 0.45000000000000001 106.841 165.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.666 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 12.9 p90 -158.4 -171.05 3.31 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.388 -0.824 . . . . 0.32000000000000001 111.322 -170.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.577 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.1 mm -103.24 156.47 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 N-CA-C 107.935 -1.135 . . . . 0.080000000000000002 107.935 165.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.484 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.5 tt0 -137.22 155.02 50.02 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.596 0.634 . . . . 0.17000000000000001 110.633 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.649 HG22 ' HG3' ' A' ' 354' ' ' MET . 55.7 t -150.41 136.36 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.775 -1.102 . . . . 0.080000000000000002 110.0 -178.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -116.04 118.94 34.3 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.553 -1.203 . . . . 0.37 108.074 172.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.479 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.7 mm? -71.17 -49.3 45.3 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 122.419 1.104 . . . . 0.32000000000000001 110.511 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -54.85 -53.56 53.77 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 112.996 -1.911 . . . . 1.51 112.308 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -98.09 10.65 39.94 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.543 -1.208 . . . . 0.91000000000000003 108.738 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.867 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.2 mm-40 38.14 71.76 0.15 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 125.088 1.493 . . . . 2.2200000000000002 111.856 175.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.476 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.1 t60 -151.63 124.11 8.36 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.685 -0.689 . . . . 0.13 109.872 -175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.649 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -110.87 128.01 55.64 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.379 0.609 . . . . 0.059999999999999998 110.484 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.671 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 31.9 m-90 -111.37 173.39 6.36 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.612 -1.176 . . . . 0.10000000000000001 111.895 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.723 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -126.84 116.34 20.72 Favored 'General case' 0 CA--C 1.489 -1.402 0 N-CA-C 106.194 -1.78 . . . . 0.22 106.194 165.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 362' ' ' VAL . 21.5 m-85 -100.07 129.63 46.13 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.927 0.87 . . . . 0.17999999999999999 111.534 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.634 ' HB2' ' HE1' ' A' ' 356' ' ' TYR . 5.1 ttpt -149.12 139.2 22.14 Favored 'General case' 0 N--CA 1.398 -3.053 0 CA-C-N 113.633 -1.621 . . . . 0.46999999999999997 107.66 173.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.458 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 72.64 11.68 5.5 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-N 114.064 -1.425 . . . . 0.59999999999999998 108.908 179.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.84 13.99 73.78 Favored Glycine 0 N--CA 1.428 -1.893 0 CA-C-N 112.747 -2.024 . . . . 0.23000000000000001 111.753 178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.631 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.75 172.75 12.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.705 -1.961 . . . . 0.68000000000000005 105.705 -171.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.802 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.0 m -102.68 139.27 24.12 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.864 0 CA-C-O 124.364 2.031 . . . . 0.53000000000000003 112.358 -178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.723 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.38 -25.32 17.74 Favored 'General case' 0 N--CA 1.396 -3.166 0 CA-C-N 109.206 -3.634 . . . . 0.12 108.498 176.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.698 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -152.32 155.18 37.16 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 113.695 -1.593 . . . . 0.080000000000000002 109.102 -172.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.802 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.19 122.54 1.3 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.718 -0.673 . . . . 0.60999999999999999 109.543 -175.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.678 ' HB ' HG11 ' A' ' 449' ' ' VAL . 4.6 t -147.35 166.81 26.01 Favored 'General case' 0 N--CA 1.426 -1.655 0 CA-C-O 121.866 0.841 . . . . 0.089999999999999997 111.744 173.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.495 ' C ' ' HB3' ' A' ' 429' ' ' TYR . 1.6 m-20 -82.68 146.0 29.31 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.592 -1.633 . . . . 1.8799999999999999 106.592 174.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.616 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -144.17 -172.47 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.506 -0.77 . . . . 0.11 111.245 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.867 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -154.01 118.99 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.931 -1.031 . . . . 0.12 108.973 174.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.445 ' HB2' HG13 ' A' ' 443' ' ' ILE . 6.9 t -143.02 142.84 31.68 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 115.164 -0.925 . . . . 0.69999999999999996 113.395 -166.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.86 47.56 24.98 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 116.941 1.536 . . . . 0.13 116.941 160.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.516 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 17.5 ptmt -44.56 148.1 0.95 Allowed Pre-proline 0 C--O 1.222 -0.39 0 CA-C-N 118.521 1.16 . . . . 0.47999999999999998 111.372 -175.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.807 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -37.2 -31.18 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.053 1 C-N-CA 125.522 4.148 . . . . 0.23000000000000001 115.268 -177.664 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.497 HG23 ' HE2' ' A' ' 372' ' ' LYS . 4.0 p -82.68 -36.28 26.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.327 0.584 . . . . 0.29999999999999999 110.776 -178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.442 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 8.9 m -140.74 73.94 27.72 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-O 122.067 0.937 . . . . 0.29999999999999999 110.238 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.713 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 36.9 Cg_exo -69.3 161.62 45.14 Favored 'Trans proline' 0 C--N 1.322 -0.83 0 C-N-CA 125.061 3.841 . . . . 0.16 114.073 -178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.675 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -71.35 151.62 94.22 Favored Pre-proline 0 N--CA 1.434 -1.252 0 CA-C-N 113.35 -1.75 . . . . 0.12 110.91 175.65 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.535 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -79.01 -49.78 0.07 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 124.997 3.798 . . . . 0.089999999999999997 113.443 -171.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.706 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.59 122.34 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 122.155 0.979 . . . . 0.089999999999999997 113.552 -177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.02 -128.67 1.8 Allowed Glycine 0 N--CA 1.437 -1.272 0 CA-C-N 113.997 -1.456 . . . . 0.11 111.13 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 97.7 t -128.19 99.89 5.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 108.424 -0.954 . . . . 0.89000000000000001 108.424 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.599 ' HB3' ' HB ' ' A' ' 413' ' ' ILE . 50.4 m-85 -104.58 169.87 8.21 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.39 -0.823 . . . . 0.16 109.124 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.736 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.6 m-85 -149.23 139.54 22.32 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 110.413 -0.217 . . . . 0.68999999999999995 110.413 176.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.594 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -74.55 120.69 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 119.903 -0.719 . . . . 0.14000000000000001 110.397 176.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . 0.404 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 40.8 p-90 -109.21 4.41 22.81 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 115.391 -0.822 . . . . 0.19 112.159 -176.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.735 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 5.1 t30 -165.11 148.16 8.28 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.227 -0.897 . . . . 0.40999999999999998 110.009 175.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.445 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 14.8 mtpt -109.62 110.69 21.82 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.423 -0.808 . . . . 1.0900000000000001 109.866 170.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -109.08 120.82 43.69 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.561 1.172 . . . . 0.38 110.763 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -117.04 142.97 46.28 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 114.225 -1.352 . . . . 1.96 109.784 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 36.3 t70 54.19 26.34 6.6 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 111.782 -2.463 . . . . 0.40000000000000002 108.63 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.29 170.74 14.3 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.079 -1.873 . . . . 0.16 112.247 -167.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 22.4 m -128.5 102.88 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 113.568 -1.651 . . . . 0.27000000000000002 109.733 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.749 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.76 157.84 36.73 Favored 'General case' 0 N--CA 1.419 -2.008 0 CA-C-N 112.865 -1.971 . . . . 0.23999999999999999 110.459 176.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.8 mtpt -145.46 -177.46 5.58 Favored 'General case' 0 N--CA 1.392 -3.369 0 CA-C-N 114.5 -1.227 . . . . 0.67000000000000004 108.082 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -172.42 -150.4 7.27 Favored Glycine 0 N--CA 1.428 -1.874 0 C-N-CA 117.153 -2.451 . . . . 0.81000000000000005 114.92 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.54 121.24 12.61 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 113.312 -1.444 . . . . 0.79000000000000004 108.449 170.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.507 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -55.62 -179.14 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 112.485 -2.143 . . . . 1.1200000000000001 111.133 177.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -56.26 -24.31 41.94 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.641 0.734 . . . . 1.6499999999999999 110.161 170.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -88.67 -26.45 21.85 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.006 -0.997 . . . . 2.0 111.828 -177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.46 31.57 5.78 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 119.804 -1.189 . . . . 0.66000000000000003 110.497 -169.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 44.1 p -115.21 126.94 27.26 Favored Pre-proline 0 N--CA 1.417 -2.082 0 N-CA-C 106.825 -1.546 . . . . 0.68000000000000005 106.825 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 24.1 Cg_exo -65.24 160.82 40.33 Favored 'Trans proline' 0 C--N 1.283 -2.874 0 C-N-CA 121.831 1.687 . . . . 0.81000000000000005 112.493 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 3.7 p90 -140.86 -169.55 2.84 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 113.429 -1.714 . . . . 0.38 106.95 -178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 9.4 mt-10 -148.0 155.25 41.31 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.302 1.048 . . . . 0.62 111.706 175.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.749 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.47 98.66 12.25 Favored Pre-proline 0 N--CA 1.423 -1.782 0 CA-C-N 113.199 -1.819 . . . . 1.3300000000000001 108.273 178.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 59.5 Cg_endo -66.97 101.76 0.6 Allowed 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.442 2.095 . . . . 0.20000000000000001 110.28 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.43 163.55 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.852 0 CA-C-N 114.239 -1.346 . . . . 0.29999999999999999 109.83 -173.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -114.99 -33.82 5.28 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 113.474 -1.694 . . . . 1.8400000000000001 106.808 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.407 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.8 m-85 -136.09 116.25 13.43 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 112.796 -2.002 . . . . 0.44 110.681 176.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.746 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.33 134.72 54.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 114.665 -1.152 . . . . 0.13 110.102 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.594 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.6 OUTLIER -136.28 86.24 25.17 Favored Pre-proline 0 C--N 1.298 -1.64 0 CA-C-N 114.905 -1.043 . . . . 0.40999999999999998 110.937 174.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 79.9 Cg_endo -72.11 141.61 36.57 Favored 'Trans proline' 0 CA--C 1.507 -0.848 0 C-N-CA 122.892 2.395 . . . . 0.16 111.655 -179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.736 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.1 pt -124.09 -16.2 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.537 -1.21 . . . . 0.17000000000000001 111.936 -171.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.761 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.7 p30 -136.1 171.12 14.93 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.107 -0.497 . . . . 1.5900000000000001 110.222 170.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 14.2 m-90 -99.18 15.9 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.76 -0.655 . . . . 0.31 111.467 -177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 1.8 p -97.03 -26.88 14.85 Favored 'General case' 0 CA--C 1.505 -0.75 0 N-CA-C 108.089 -1.078 . . . . 0.44 108.089 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 130.15 27.62 0.76 Allowed Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.904 -1.498 . . . . 0.23999999999999999 113.677 169.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.761 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 49.2 t -104.43 149.78 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.43 0.633 . . . . 0.17000000000000001 112.463 176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . -178.96 -164.32 31.5 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 114.966 -1.016 . . . . 0.10000000000000001 111.942 174.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.47 139.55 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 108.54 -0.911 . . . . 0.12 108.54 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.553 ' HB2' HG21 ' A' ' 407' ' ' VAL . 31.7 p80 -150.02 164.16 36.25 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.637 0.732 . . . . 0.14999999999999999 111.457 178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.774 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.07 138.79 31.33 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 114.203 -1.362 . . . . 0.41999999999999998 107.474 172.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.631 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 4.8 t -133.13 104.67 6.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.326 1.536 . . . . 1.48 110.667 -176.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.32 -28.83 15.97 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 111.43 -2.623 . . . . 0.34999999999999998 110.83 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.568 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.7 p90 -72.01 -27.23 62.59 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 114.471 -1.24 . . . . 0.17999999999999999 109.728 175.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.631 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -118.01 81.18 15.71 Favored Pre-proline 0 CA--C 1.496 -1.106 0 CA-C-N 114.276 -1.329 . . . . 1.3300000000000001 110.015 -176.067 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 14.9 Cg_endo -84.34 8.59 4.54 Favored 'Trans proline' 0 N--CA 1.435 -1.943 0 C-N-CA 125.122 3.881 . . . . 0.23000000000000001 114.313 -163.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -114.89 150.52 35.49 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.177 -0.675 . . . . 1.1000000000000001 109.177 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.495 ' HB3' ' C ' ' A' ' 367' ' ' ASP . 0.3 OUTLIER -159.61 125.52 4.28 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 124.629 1.172 . . . . 0.38 108.285 -171.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 148.3 -166.97 29.05 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.353 -1.403 . . . . 0.13 111.305 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.85 154.44 0.0 OUTLIER Glycine 0 C--N 1.341 0.818 0 O-C-N 125.151 1.148 . . . . 0.20000000000000001 113.2 175.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 2.9 m-20 -55.28 101.42 0.05 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 CA-C-O 123.806 1.765 . . . . 0.33000000000000002 112.17 -146.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.0 mt -97.03 -31.35 12.55 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 110.53 -3.032 . . . . 0.17999999999999999 109.39 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.499 ' HA ' HG23 ' A' ' 369' ' ' VAL . 14.2 p-90 -50.13 -30.87 12.1 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 112.96 -1.927 . . . . 0.22 111.844 -174.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.807 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 44.9 mttt -66.65 -22.12 66.1 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.919 -1.037 . . . . 0.64000000000000001 112.872 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.8 p -117.43 -38.72 3.27 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.855 0.836 . . . . 0.25 110.049 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.474 ' HD2' HD22 ' A' ' 433' ' ' LEU . 10.0 mtp85 -80.3 -15.32 57.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.48 -1.236 . . . . 0.35999999999999999 111.952 -171.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 71.84 40.58 57.61 Favored Glycine 0 C--N 1.311 -0.821 0 N-CA-C 115.697 1.039 . . . . 0.20999999999999999 115.697 159.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 1.4 m -80.01 130.84 35.58 Favored 'General case' 0 C--O 1.209 -1.066 0 N-CA-C 108.85 -0.796 . . . . 0.46999999999999997 108.85 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.408 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 67.3 m80 -99.97 65.64 1.3 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.314 -0.866 . . . . 0.40999999999999998 111.562 -169.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.593 ' O ' HG23 ' A' ' 377' ' ' THR . . . 94.92 -18.77 56.65 Favored Glycine 0 N--CA 1.435 -1.417 0 N-CA-C 111.09 -0.804 . . . . 0.17999999999999999 111.09 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.514 ' C ' HD12 ' A' ' 443' ' ' ILE . 37.1 m -90.36 159.17 16.75 Favored 'General case' 0 C--N 1.313 -0.988 0 C-N-CA 119.951 -0.7 . . . . 0.82999999999999996 111.214 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.675 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -107.64 120.29 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 CA-C-N 115.522 -0.763 . . . . 0.14999999999999999 110.578 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.51 ' HB2' HG13 ' A' ' 369' ' ' VAL . 25.2 m-80 -83.74 91.93 7.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.686 -0.688 . . . . 1.77 111.588 -178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.6 HG23 HG21 ' A' ' 366' ' ' THR . 37.3 m -90.0 136.86 28.51 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-O 121.393 0.615 . . . . 0.17999999999999999 109.489 177.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.4 Cg_exo -57.15 132.12 49.36 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.842 2.361 . . . . 0.12 112.862 -178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.774 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 20.5 Cg_exo -50.51 -40.47 54.36 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 C-N-CA 123.489 2.793 . . . . 0.16 112.39 -169.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 20.1 p -73.44 -40.44 64.21 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 114.806 -1.088 . . . . 1.1699999999999999 110.113 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.678 HG11 ' HB ' ' A' ' 366' ' ' THR . 67.3 t -77.05 -29.94 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 121.382 0.61 . . . . 0.17000000000000001 111.303 -178.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.674 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.0 tpt -67.85 -19.67 65.07 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.748 0.785 . . . . 0.46000000000000002 109.958 177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -79.4 -22.66 44.0 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.63 -1.168 . . . . 0.81000000000000005 110.918 177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.659 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.54 -47.73 13.8 Favored 'General case' 0 CA--C 1.475 -1.905 0 CA-C-N 112.922 -1.945 . . . . 0.38 107.329 177.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.61 HD23 ' SD ' ' A' ' 450' ' ' MET . 27.1 tp -63.66 -66.91 0.48 Allowed 'General case' 0 N--CA 1.403 -2.799 0 CA-C-N 111.83 -2.441 . . . . 0.059999999999999998 112.241 175.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.458 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 35.5 t80 -50.15 -26.55 4.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.962 1.363 . . . . 0.31 108.167 176.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.01 -28.19 69.0 Favored Glycine 0 N--CA 1.427 -1.942 0 CA-C-N 112.592 -2.095 . . . . 0.13 112.347 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.698 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -91.71 -47.96 7.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.666 0.746 . . . . 0.13 111.768 171.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.644 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.5 OUTLIER -101.5 138.36 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.162 0 CA-C-O 123.457 1.599 . . . . 0.23000000000000001 113.892 -168.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.445 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.7 pt-20 -136.83 -178.69 5.3 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-N 110.813 -2.903 . . . . 0.82999999999999996 106.503 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.735 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.7 mtmt -51.69 162.48 0.4 Allowed 'General case' 0 N--CA 1.413 -2.321 0 CA-C-O 123.12 1.438 . . . . 0.23999999999999999 113.179 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.38 -33.64 4.66 Favored Glycine 0 N--CA 1.424 -2.141 0 CA-C-N 112.441 -2.163 . . . . 0.37 112.284 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 462' ' ' PRO . 10.6 m -73.96 140.78 77.62 Favored Pre-proline 0 N--CA 1.435 -1.188 0 CA-C-O 121.119 0.485 . . . . 0.14999999999999999 109.822 -177.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.666 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.0 Cg_exo -73.44 162.96 38.9 Favored 'Trans proline' 0 N--CA 1.432 -2.132 0 C-N-CA 122.265 1.977 . . . . 0.12 111.142 174.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 75.5 t -132.95 131.96 59.07 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 CA-C-N 113.757 -1.565 . . . . 1.0900000000000001 108.169 173.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 2.9 tp -112.03 143.04 43.7 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.989 -0.551 . . . . 0.13 110.331 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.706 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.1 m -143.16 148.08 19.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 107.126 -1.435 . . . . 0.089999999999999997 107.126 165.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.595 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.7 p90 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.301 -0.857 . . . . 1.1599999999999999 111.27 -175.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.954 0 N-CA-C 111.829 -0.509 . . . . 3.9399999999999999 111.829 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -162.55 97.74 0.98 Allowed 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.615 -0.513 . . . . 1.8500000000000001 109.615 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.457 ' HB3' ' OD1' ' A' ' 342' ' ' ASP . 34.4 mtm 67.99 -174.52 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 O-C-N 124.526 1.141 . . . . 1.03 111.148 -175.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.41 -12.22 0.81 Allowed 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 112.792 0.664 . . . . 1.1000000000000001 112.792 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . 0.457 ' OD1' ' HB3' ' A' ' 340' ' ' MET . 0.2 OUTLIER -59.8 167.87 1.98 Allowed 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 122.427 1.108 . . . . 0.97999999999999998 113.702 175.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.563 HG23 ' HA ' ' A' ' 358' ' ' LYS . 88.9 m -90.14 124.22 34.64 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 114.13 -1.396 . . . . 0.45000000000000001 109.801 171.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.633 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 5.0 p90 -160.94 -169.31 2.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.119 -1.4 . . . . 0.32000000000000001 110.584 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.542 HD12 HD11 ' A' ' 453' ' ' LEU . 10.7 mm -101.39 162.05 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 N-CA-C 108.204 -1.036 . . . . 0.080000000000000002 108.204 165.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.5 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -143.67 156.31 44.5 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 119.063 0.847 . . . . 0.17000000000000001 111.729 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.673 HG22 ' HG3' ' A' ' 354' ' ' MET . 77.8 t -150.71 137.44 12.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.741 -1.118 . . . . 0.080000000000000002 110.115 -178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.401 ' HB2' ' HZ3' ' A' ' 355' ' ' TRP . 7.4 t0 -124.61 106.51 10.18 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 122.175 0.988 . . . . 0.37 108.52 177.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.443 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -64.73 -42.13 95.45 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-N 112.772 -2.013 . . . . 0.32000000000000001 111.602 -168.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.46 -57.58 11.3 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 112.412 -2.176 . . . . 1.51 112.892 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -92.79 1.44 57.28 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-N 114.838 -1.074 . . . . 0.91000000000000003 109.924 -171.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.856 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 13.0 mm-40 48.73 63.75 1.98 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 112.624 -2.08 . . . . 2.2200000000000002 111.565 179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.457 ' CD2' ' CE2' ' A' ' 355' ' ' TRP . 6.8 t60 -143.41 128.63 18.76 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.803 -0.635 . . . . 0.13 109.716 -175.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.673 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.7 ttp -115.28 128.6 56.23 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.438 0.695 . . . . 0.059999999999999998 110.444 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.676 ' CD1' HG11 ' A' ' 362' ' ' VAL . 32.5 m-90 -112.82 173.43 6.38 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 114.755 -1.111 . . . . 0.10000000000000001 111.598 -176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.588 ' HE2' ' HB ' ' A' ' 457' ' ' VAL . 0.2 OUTLIER -125.08 112.9 17.05 Favored 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 105.577 -2.008 . . . . 0.22 105.577 163.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 361' ' ' LYS . 18.1 m-85 -92.98 124.85 37.25 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 119.457 -0.897 . . . . 0.17999999999999999 111.516 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.563 ' HA ' HG23 ' A' ' 343' ' ' THR . 37.4 ttmt -140.17 142.52 35.93 Favored 'General case' 0 N--CA 1.386 -3.634 0 CA-C-N 114.031 -1.441 . . . . 0.46999999999999997 108.771 173.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.423 ' N ' ' HG2' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 66.0 16.35 10.43 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.742 -1.572 . . . . 0.59999999999999998 108.849 175.202 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.41 19.02 72.49 Favored Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 112.167 -2.288 . . . . 0.23000000000000001 111.968 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.606 ' HD3' ' H ' ' A' ' 362' ' ' VAL . 4.9 tppt? -138.83 179.21 6.62 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.435 -2.061 . . . . 0.68000000000000005 105.435 -171.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.676 HG11 ' CD1' ' A' ' 355' ' ' TRP . 2.8 m -106.65 135.6 44.47 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.72 0 CA-C-O 124.197 1.951 . . . . 0.53000000000000003 112.394 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.516 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -87.84 -26.06 23.0 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 109.351 -3.568 . . . . 0.12 107.985 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.72 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 4.0 tp -153.15 156.0 37.79 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 114.181 -1.372 . . . . 0.080000000000000002 109.777 -173.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 2.2 pt-20 -162.6 121.99 2.27 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.84 -0.618 . . . . 0.60999999999999999 110.706 -176.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.688 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.3 t -149.13 166.78 27.75 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 122.501 1.143 . . . . 0.089999999999999997 113.196 173.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.685 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.6 p-10 -84.36 140.02 31.87 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-N 112.712 -2.04 . . . . 1.8799999999999999 108.182 175.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.655 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.96 -171.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-N 115.161 -0.927 . . . . 0.11 111.843 -176.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.856 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -153.74 121.95 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 114.794 -1.094 . . . . 0.12 108.849 174.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 443' ' ' ILE . 7.0 t -144.57 143.01 30.6 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.917 1.08 . . . . 0.69999999999999996 113.917 -167.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.47 45.93 35.02 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 116.845 1.498 . . . . 0.13 116.845 162.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.584 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.46 144.1 4.95 Favored Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-N 118.636 1.218 . . . . 0.47999999999999998 110.917 -174.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.803 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.34 -32.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.319 -0.979 1 C-N-CA 125.709 4.273 . . . . 0.23000000000000001 116.183 -170.8 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.584 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.8 p -79.92 -35.42 37.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.095 0.474 . . . . 0.29999999999999999 111.161 -177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.456 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 24.4 m -140.31 74.63 29.21 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-O 122.431 1.11 . . . . 0.29999999999999999 110.003 178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.684 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.5 Cg_exo -69.79 160.42 49.75 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.044 3.83 . . . . 0.16 113.365 -179.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.692 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -69.79 150.36 96.56 Favored Pre-proline 0 N--CA 1.434 -1.255 0 CA-C-N 113.55 -1.659 . . . . 0.12 110.92 177.259 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.507 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.0 OUTLIER -77.14 -48.78 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 124.893 3.729 . . . . 0.089999999999999997 112.98 -170.632 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.871 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 67.13 122.61 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 113.626 0.973 . . . . 0.089999999999999997 113.626 -177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.7 -126.62 1.5 Allowed Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 114.457 -1.247 . . . . 0.11 111.382 -178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -126.01 104.12 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 CA-C-O 122.516 1.15 . . . . 0.89000000000000001 109.328 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.796 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.2 m-85 -107.33 162.16 14.16 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 114.904 -1.044 . . . . 0.16 110.014 -170.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.8 m-85 -147.91 137.51 22.45 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 121.252 -0.179 . . . . 0.68999999999999995 110.789 176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.64 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.63 124.97 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.025 0 C-N-CA 119.993 -0.683 . . . . 0.14000000000000001 110.296 177.055 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 42.8 p-90 -109.55 3.99 21.75 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.491 -0.777 . . . . 0.19 111.929 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.721 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.6 t30 -165.13 149.34 8.78 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.485 -0.779 . . . . 0.40999999999999998 111.083 175.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.482 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.8 mtpt -107.46 110.74 22.77 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.411 -0.813 . . . . 1.0900000000000001 109.685 169.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.7 mt-10 -112.08 123.17 49.68 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.654 1.216 . . . . 0.38 111.067 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.76 143.48 47.79 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-N 114.139 -1.391 . . . . 1.96 110.035 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 35.4 t70 54.24 25.99 6.35 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 111.894 -2.412 . . . . 0.40000000000000002 108.667 -174.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.482 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.4 167.13 17.8 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 113.205 -1.816 . . . . 0.16 112.163 -167.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 4.1 m -122.34 107.84 12.55 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.774 -1.557 . . . . 0.27000000000000002 110.131 -176.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.9 mp -75.85 156.7 34.14 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 112.834 -1.985 . . . . 0.23999999999999999 110.448 175.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.506 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 11.8 mtpt -151.7 167.76 27.15 Favored 'General case' 0 N--CA 1.401 -2.916 0 CA-C-N 114.651 -1.159 . . . . 0.67000000000000004 108.016 -176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.926 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 178.94 165.47 33.37 Favored Glycine 0 CA--C 1.482 -1.993 0 C-N-CA 118.181 -1.961 . . . . 0.81000000000000005 113.33 -171.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -94.94 122.19 37.33 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-O 123.036 1.398 . . . . 0.79000000000000004 110.679 177.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.426 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -50.93 -178.71 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 110.939 -2.846 . . . . 1.1200000000000001 112.278 175.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -51.92 -21.87 3.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.365 -0.379 . . . . 1.6499999999999999 111.448 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.6 OUTLIER -108.88 -29.98 8.35 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.226 0.536 . . . . 2.0 111.729 -172.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 116.73 37.52 0.97 Allowed Glycine 0 C--N 1.295 -1.75 0 C-N-CA 119.529 -1.32 . . . . 0.66000000000000003 111.413 -171.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 62.4 p -116.93 128.47 26.0 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 106.652 -1.61 . . . . 0.68000000000000005 106.652 173.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.926 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 16.9 Cg_exo -70.33 148.91 62.4 Favored 'Trans proline' 0 N--CA 1.419 -2.888 0 C-N-CA 122.024 1.816 . . . . 0.81000000000000005 112.588 -175.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.481 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 10.4 p90 -128.99 -171.56 2.51 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 112.648 -2.069 . . . . 0.38 107.051 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 15.0 mt-10 -144.81 157.3 44.22 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 122.052 0.929 . . . . 0.62 111.058 173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.696 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 3.0 m -142.28 98.3 6.08 Favored Pre-proline 0 N--CA 1.421 -1.879 0 CA-C-N 113.678 -1.601 . . . . 1.3300000000000001 109.222 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.9 Cg_endo -67.97 106.19 1.29 Allowed 'Trans proline' 0 CA--C 1.512 -0.602 0 C-N-CA 124.342 3.362 . . . . 0.20000000000000001 112.644 -177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.808 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.5 OUTLIER -114.61 163.21 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.38 0 CA-C-N 114.534 -1.212 . . . . 0.29999999999999999 110.56 -175.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -111.76 -34.04 6.15 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 113.403 -1.726 . . . . 1.8400000000000001 106.943 -178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.5 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.4 m-85 -133.86 115.99 15.12 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.726 -2.034 . . . . 0.44 110.639 177.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.777 ' HB2' HG11 ' A' ' 407' ' ' VAL . 5.1 t-105 -123.86 135.29 53.65 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.4 -1.273 . . . . 0.13 110.355 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.563 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.53 84.81 26.99 Favored Pre-proline 0 N--CA 1.427 -1.579 0 CA-C-N 115.007 -0.997 . . . . 0.40999999999999998 110.943 172.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.649 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 72.2 Cg_endo -70.84 141.07 39.97 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 C-N-CA 123.06 2.507 . . . . 0.16 112.258 -178.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.68 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -123.8 -16.29 4.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.009 -1.45 . . . . 0.17000000000000001 111.063 -173.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -135.46 162.7 31.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.277 -0.874 . . . . 1.5900000000000001 109.312 175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.2 m-90 -93.78 13.32 22.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.236 0.458 . . . . 0.31 112.236 -178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -91.36 -26.57 18.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.396 -1.335 . . . . 0.44 107.396 173.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.93 29.55 1.13 Allowed Glycine 0 N--CA 1.424 -2.117 0 CA-C-N 112.976 -1.92 . . . . 0.23999999999999999 112.326 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.596 HG13 ' O ' ' A' ' 441' ' ' GLY . 89.5 t -102.55 147.9 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.132 0 CA-C-O 121.297 0.57 . . . . 0.17000000000000001 110.93 177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.37 -166.11 37.91 Favored Glycine 0 N--CA 1.442 -0.948 0 CA-C-N 114.734 -1.121 . . . . 0.10000000000000001 111.306 -179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.402 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.54 138.42 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.267 0 N-CA-C 108.698 -0.853 . . . . 0.12 108.698 175.637 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.808 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.1 p80 -151.24 164.9 35.54 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.725 0.774 . . . . 0.14999999999999999 112.076 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.779 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.24 146.05 24.53 Favored 'General case' 0 N--CA 1.424 -1.763 0 CA-C-N 114.074 -1.421 . . . . 0.41999999999999998 107.858 173.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.415 ' CB ' HD22 ' A' ' 444' ' ' ASN . 0.4 OUTLIER -140.07 102.85 4.48 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 123.06 1.409 . . . . 1.48 110.998 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -93.16 -26.97 17.17 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 111.752 -2.476 . . . . 0.34999999999999998 109.742 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.575 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 5.7 p90 -70.27 -26.14 63.68 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.312 -1.313 . . . . 0.17999999999999999 109.714 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.403 ' HG3' ' NE1' ' A' ' 425' ' ' TRP . 0.0 OUTLIER -119.8 80.7 25.09 Favored Pre-proline 0 CA--C 1.492 -1.286 0 CA-C-N 113.829 -1.532 . . . . 1.3300000000000001 109.315 -176.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 27.7 Cg_endo -81.08 5.53 6.17 Favored 'Trans proline' 0 N--CA 1.436 -1.909 0 C-N-CA 125.089 3.86 . . . . 0.23000000000000001 114.015 -162.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -115.67 149.73 37.91 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.739 -0.664 . . . . 1.1000000000000001 109.411 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.685 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -160.99 125.57 3.57 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 124.587 1.18 . . . . 0.38 108.179 -173.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.88 -166.92 28.83 Favored Glycine 0 C--N 1.297 -1.615 0 C-N-CA 119.484 -1.341 . . . . 0.13 110.899 -178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.595 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.41 154.1 0.0 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.931 1.018 . . . . 0.20000000000000001 113.159 175.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.404 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.1 m-20 -55.72 101.33 0.05 Allowed 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 123.924 1.821 . . . . 0.33000000000000002 112.289 -146.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 45.7 mt -97.33 -32.03 12.1 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-N 110.228 -3.169 . . . . 0.17999999999999999 108.222 175.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.558 ' HA ' HG23 ' A' ' 369' ' ' VAL . 6.4 p-90 -45.82 -38.84 7.67 Favored 'General case' 0 C--N 1.318 -0.784 0 O-C-N 124.067 0.854 . . . . 0.22 111.49 -174.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.803 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.5 mttt -60.05 -26.12 65.9 Favored 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 115.006 -0.997 . . . . 0.64000000000000001 112.821 -175.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 43.9 p -111.93 -36.11 5.49 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.701 0.762 . . . . 0.25 110.033 -176.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.481 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 6.8 mtp85 -84.54 -15.94 44.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.689 -1.141 . . . . 0.35999999999999999 112.642 -169.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.524 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.05 40.39 30.03 Favored Glycine 0 C--N 1.313 -0.714 0 N-CA-C 116.089 1.196 . . . . 0.20999999999999999 116.089 159.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 372' ' ' LYS . 1.0 OUTLIER -79.63 131.6 36.03 Favored 'General case' 0 C--O 1.212 -0.919 0 CA-C-N 117.782 0.791 . . . . 0.46999999999999997 109.545 176.006 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.431 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 63.3 m80 -100.7 68.3 1.31 Allowed 'General case' 0 C--N 1.317 -0.814 0 O-C-N 121.643 -0.661 . . . . 0.40999999999999998 110.306 -172.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.596 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 88.7 -11.8 67.49 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 110.924 -0.87 . . . . 0.17999999999999999 110.924 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.461 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 27.2 p -90.79 142.82 27.36 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.361 -0.42 . . . . 0.82999999999999996 110.8 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.692 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -101.43 114.55 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 115.752 -0.658 . . . . 0.14999999999999999 110.362 -176.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.597 ' HB2' HG13 ' A' ' 369' ' ' VAL . 18.7 m120 -78.81 90.38 4.67 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.842 -0.617 . . . . 1.77 111.098 -178.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 35.9 m -86.63 137.34 34.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 N-CA-C 109.132 -0.692 . . . . 0.17999999999999999 109.132 174.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.5 Cg_exo -54.86 135.79 69.44 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 122.747 2.298 . . . . 0.12 111.337 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.779 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 37.4 Cg_exo -55.34 -32.16 80.17 Favored 'Trans proline' 0 CA--C 1.5 -1.19 0 C-N-CA 124.225 3.283 . . . . 0.16 112.825 -173.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 12.8 p -81.23 -38.79 26.39 Favored 'General case' 0 N--CA 1.426 -1.634 0 CA-C-N 114.441 -1.254 . . . . 1.1699999999999999 110.09 -178.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.688 HG11 ' HB ' ' A' ' 366' ' ' THR . 60.2 t -80.77 -29.41 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.096 -0.502 . . . . 0.17000000000000001 111.376 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.681 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.4 tpt -65.93 -19.91 66.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.781 0.8 . . . . 0.46000000000000002 109.985 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -79.36 -24.97 42.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-N 114.522 -1.217 . . . . 0.81000000000000005 111.239 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.694 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -79.15 -46.3 18.24 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 113.127 -1.851 . . . . 0.38 107.111 178.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.576 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.7 tp -64.43 -67.17 0.45 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.663 -2.517 . . . . 0.059999999999999998 112.169 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.424 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.2 t80 -49.62 -27.73 4.95 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 123.127 1.442 . . . . 0.31 108.304 177.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.405 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.2 -31.3 69.08 Favored Glycine 0 N--CA 1.428 -1.856 0 CA-C-N 112.37 -2.195 . . . . 0.13 112.237 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.72 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.5 ptp -88.17 -48.43 7.71 Favored 'General case' 0 C--N 1.344 0.328 0 CA-C-O 121.729 0.776 . . . . 0.13 111.501 172.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.588 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.7 OUTLIER -102.09 138.16 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.087 0 CA-C-O 123.582 1.658 . . . . 0.23000000000000001 114.005 -167.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.482 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.2 pt-20 -136.37 -178.28 5.09 Favored 'General case' 0 N--CA 1.404 -2.75 0 CA-C-N 110.705 -2.952 . . . . 0.82999999999999996 106.552 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.4 mtmt -52.71 162.56 0.57 Allowed 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.949 1.357 . . . . 0.23999999999999999 112.405 175.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.23 -30.56 6.65 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 112.685 -2.052 . . . . 0.37 112.383 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 462' ' ' PRO . 15.0 m -80.89 141.96 51.7 Favored Pre-proline 0 N--CA 1.433 -1.28 0 N-CA-C 109.134 -0.691 . . . . 0.14999999999999999 109.134 -177.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 4.5 Cg_exo -75.78 168.54 24.06 Favored 'Trans proline' 0 N--CA 1.425 -2.502 0 C-N-CA 121.681 1.587 . . . . 0.12 111.098 172.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.796 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.81 154.49 34.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.299 -1.371 . . . . 1.0900000000000001 107.299 166.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.0 tp -125.86 144.25 50.74 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 115.45 -0.796 . . . . 0.13 110.657 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.66 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.14 146.04 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 105.937 -1.875 . . . . 0.089999999999999997 105.937 163.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.871 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 8.6 p90 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.089 -0.958 . . . . 1.1599999999999999 111.824 -175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.821 0 N-CA-C 112.078 -0.409 . . . . 3.9399999999999999 112.078 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.511 ' CD2' ' H ' ' A' ' 340' ' ' MET . 1.8 t60 -76.45 -178.64 4.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.257 -0.645 . . . . 1.8500000000000001 109.257 177.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.511 ' H ' ' CD2' ' A' ' 339' ' ' HIS . 46.7 mtm -142.46 176.76 8.77 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 121.899 0.857 . . . . 1.03 112.553 -173.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.48 -4.45 8.28 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 113.733 -1.576 . . . . 1.1000000000000001 108.825 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.49 169.79 0.28 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.63 -1.623 . . . . 0.97999999999999998 113.262 172.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 358' ' ' LYS . 9.1 m -90.79 121.68 32.87 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 112.473 -2.149 . . . . 0.45000000000000001 106.688 167.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.651 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.2 p90 -156.15 -171.59 3.78 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.485 0.659 . . . . 0.32000000000000001 110.852 -174.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.584 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.8 mm -102.52 161.5 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 107.97 -1.122 . . . . 0.080000000000000002 107.97 167.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.543 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.4 tt0 -140.61 155.18 46.63 Favored 'General case' 0 CA--C 1.497 -1.061 0 CA-C-N 118.818 0.736 . . . . 0.17000000000000001 111.1 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.716 HG22 ' HG3' ' A' ' 354' ' ' MET . 64.4 t -150.81 135.8 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.539 -1.21 . . . . 0.080000000000000002 110.027 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -116.89 117.78 30.64 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 114.797 -1.092 . . . . 0.37 108.176 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.503 HD21 HG23 ' A' ' 465' ' ' VAL . 1.8 mm? -70.26 -48.2 57.9 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.51 1.148 . . . . 0.32000000000000001 110.487 -178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -54.89 -54.13 46.5 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 112.851 -1.977 . . . . 1.51 112.454 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -98.27 11.31 38.36 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-N 114.572 -1.195 . . . . 0.91000000000000003 108.637 -174.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.861 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 12.1 mm-40 37.6 70.38 0.19 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 125.269 1.606 . . . . 2.2200000000000002 111.829 176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.491 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -150.22 125.12 9.86 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.773 -0.649 . . . . 0.13 109.827 -175.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.716 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.9 ttp -111.93 127.61 55.91 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.471 0.653 . . . . 0.059999999999999998 110.451 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.681 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -112.84 173.72 6.24 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 114.528 -1.214 . . . . 0.10000000000000001 111.841 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.701 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.4 t80 -126.79 117.07 21.9 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 106.795 -1.557 . . . . 0.22 106.795 165.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.543 ' CE1' HG12 ' A' ' 362' ' ' VAL . 18.8 m-85 -100.77 124.84 46.98 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-O 122.128 0.966 . . . . 0.17999999999999999 112.33 -178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.672 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.0 ttpt -149.46 139.34 21.92 Favored 'General case' 0 N--CA 1.4 -2.939 0 CA-C-N 113.105 -1.861 . . . . 0.46999999999999997 107.992 175.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.475 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.6 OUTLIER 70.95 16.46 6.5 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-N 113.768 -1.56 . . . . 0.59999999999999998 108.608 179.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.56 17.47 78.99 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 112.377 -2.192 . . . . 0.23000000000000001 111.715 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.597 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.2 OUTLIER -136.9 170.86 15.39 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 105.91 -1.885 . . . . 0.68000000000000005 105.91 -168.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.745 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.7 m -101.35 137.56 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.853 0 CA-C-O 124.157 1.932 . . . . 0.53000000000000003 111.72 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.701 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -23.84 19.0 Favored 'General case' 0 N--CA 1.399 -2.984 0 CA-C-N 109.392 -3.549 . . . . 0.12 108.529 177.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.681 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.9 tp -154.07 154.82 34.33 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 113.511 -1.677 . . . . 0.080000000000000002 108.856 -172.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.745 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.98 121.78 1.29 Allowed 'General case' 0 CA--C 1.496 -1.122 0 CA-C-N 115.766 -0.652 . . . . 0.60999999999999999 109.395 -175.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.654 HG21 HG23 ' A' ' 445' ' ' THR . 5.1 t -148.08 166.5 27.62 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-O 122.245 1.021 . . . . 0.089999999999999997 111.967 174.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.631 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.1 p-10 -85.37 140.36 30.83 Favored 'General case' 0 N--CA 1.415 -2.224 0 CA-C-N 113.025 -1.898 . . . . 1.8799999999999999 107.193 176.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.634 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -141.47 -171.82 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.154 -0.93 . . . . 0.11 111.888 -175.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.861 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -157.73 119.38 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.136 -0.938 . . . . 0.12 109.792 175.656 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.483 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 12.6 t -143.15 145.98 33.31 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.977 -1.011 . . . . 0.69999999999999996 112.839 -166.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.04 46.09 37.95 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 117.178 1.631 . . . . 0.13 117.178 161.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.446 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.2 pttt -46.75 145.83 2.9 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-N 119.6 1.7 . . . . 0.47999999999999998 111.129 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.83 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -33.41 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.041 1 C-N-CA 125.543 4.162 . . . . 0.23000000000000001 115.609 -175.884 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.4 p -77.19 -39.27 49.41 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.267 0.555 . . . . 0.29999999999999999 110.917 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.47 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 6.9 m -140.56 72.92 30.2 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 122.245 1.021 . . . . 0.29999999999999999 110.434 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.664 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 33.7 Cg_exo -68.9 163.3 38.03 Favored 'Trans proline' 0 C--N 1.32 -0.944 0 C-N-CA 125.256 3.97 . . . . 0.16 114.118 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.715 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -74.76 151.23 86.73 Favored Pre-proline 0 N--CA 1.437 -1.092 0 CA-C-N 113.512 -1.676 . . . . 0.12 110.714 175.702 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.533 ' CD ' HG22 ' A' ' 377' ' ' THR . 0.9 OUTLIER -78.28 -50.23 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.83 3.686 . . . . 0.089999999999999997 113.724 -171.248 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.757 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.0 121.91 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.443 0.905 . . . . 0.089999999999999997 113.443 -176.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.89 -124.48 1.26 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.268 -1.333 . . . . 0.11 111.46 -177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.7 p -126.28 108.88 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.103 0 CA-C-O 122.137 0.97 . . . . 0.89000000000000001 109.372 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.784 ' HB2' HG22 ' A' ' 463' ' ' VAL . 94.0 m-85 -114.24 159.89 19.64 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 114.881 -1.054 . . . . 0.16 109.661 -170.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.719 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 70.0 m-85 -146.01 135.63 23.22 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-N 117.661 0.209 . . . . 0.68999999999999995 111.113 177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.617 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.57 122.26 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.872 -0.731 . . . . 0.14000000000000001 110.46 176.493 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -108.93 3.16 21.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.43 -0.804 . . . . 0.19 112.026 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.765 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.6 t30 -164.08 149.57 10.69 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.181 -0.918 . . . . 0.40999999999999998 110.704 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -109.24 114.65 28.54 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.377 -0.829 . . . . 1.0900000000000001 109.386 169.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -113.12 120.39 41.13 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.724 1.25 . . . . 0.38 111.478 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.8 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 25.9 mt-10 -116.11 143.71 45.12 Favored 'General case' 0 N--CA 1.409 -2.475 0 CA-C-N 113.802 -1.544 . . . . 1.96 110.562 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 408' ' ' ASN . 37.8 t70 55.98 27.3 11.0 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 111.196 -2.729 . . . . 0.40000000000000002 107.758 -176.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.14 169.58 15.69 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 112.692 -2.049 . . . . 0.16 112.16 -167.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 16.1 m -128.72 102.45 6.58 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 113.12 -1.855 . . . . 0.27000000000000002 109.382 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.752 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.0 mp -71.97 156.3 39.39 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 112.789 -2.005 . . . . 0.23999999999999999 109.767 174.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 404' ' ' GLU . 7.5 mtpt -149.95 -176.58 5.49 Favored 'General case' 0 N--CA 1.395 -3.183 0 CA-C-N 114.647 -1.161 . . . . 0.67000000000000004 108.089 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -178.8 -142.31 4.78 Favored Glycine 0 CA--C 1.484 -1.845 0 C-N-CA 116.965 -2.541 . . . . 0.81000000000000005 115.062 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.79 124.24 14.79 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.791 -1.704 . . . . 0.79000000000000004 108.449 171.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.53 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -54.7 -178.73 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 112.3 -2.227 . . . . 1.1200000000000001 111.856 177.016 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -51.79 -24.26 5.76 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.883 -0.598 . . . . 1.6499999999999999 111.665 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.53 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 1.1 p30 -102.72 -29.44 11.5 Favored 'General case' 0 CA--C 1.504 -0.821 0 CA-C-O 121.05 0.453 . . . . 2.0 111.957 -175.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 114.9 37.52 1.14 Allowed Glycine 0 C--N 1.295 -1.724 0 C-N-CA 119.504 -1.331 . . . . 0.66000000000000003 111.545 -172.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 65.1 p -119.03 127.81 26.3 Favored Pre-proline 0 N--CA 1.422 -1.844 0 N-CA-C 106.722 -1.584 . . . . 0.68000000000000005 106.722 174.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.567 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 26.1 Cg_exo -65.03 161.54 36.53 Favored 'Trans proline' 0 C--N 1.287 -2.694 0 C-N-CA 121.999 1.8 . . . . 0.81000000000000005 112.827 -173.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.56 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 17.8 p90 -141.7 -168.77 2.75 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-N 113.548 -1.66 . . . . 0.38 107.066 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.4 mt-10 -147.56 159.93 43.19 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 122.387 1.089 . . . . 0.62 112.208 174.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.752 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -138.69 99.43 8.49 Favored Pre-proline 0 N--CA 1.426 -1.664 0 CA-C-N 112.857 -1.974 . . . . 1.3300000000000001 108.543 175.427 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 62.3 Cg_endo -67.44 103.43 0.8 Allowed 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.868 2.378 . . . . 0.20000000000000001 110.912 174.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.708 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -118.12 158.78 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.498 0 CA-C-N 114.27 -1.332 . . . . 0.29999999999999999 109.391 -174.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.8 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 0.2 OUTLIER -101.46 -38.93 7.78 Favored 'General case' 0 CA--C 1.485 -1.549 0 N-CA-C 107.762 -1.199 . . . . 1.8400000000000001 107.762 170.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.539 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 10.3 m-30 -125.53 113.46 17.47 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.726 -1.124 . . . . 0.44 110.51 -176.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.708 ' HB2' HG11 ' A' ' 407' ' ' VAL . 8.3 t-105 -123.59 136.39 54.49 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 113.692 -1.594 . . . . 0.13 110.379 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.57 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.3 85.93 25.76 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 114.792 -1.094 . . . . 0.40999999999999998 111.041 173.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.7 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 82.6 Cg_endo -71.64 141.75 38.54 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 123.163 2.575 . . . . 0.16 112.091 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.719 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.0 pt -122.94 -17.74 4.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.207 -1.36 . . . . 0.17000000000000001 111.239 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.772 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 6.9 p30 -134.76 170.47 15.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.715 -0.675 . . . . 1.5900000000000001 109.695 171.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -96.88 16.08 20.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 0.31 111.993 -175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 20.3 p -100.16 -28.31 13.08 Favored 'General case' 0 CA--C 1.507 -0.688 0 N-CA-C 108.258 -1.015 . . . . 0.44 108.258 174.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 131.74 26.41 0.71 Allowed Glycine 0 N--CA 1.428 -1.896 0 CA-C-N 114.24 -1.346 . . . . 0.23999999999999999 113.546 173.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.772 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 68.8 t -102.46 148.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-O 121.492 0.663 . . . . 0.17000000000000001 111.165 175.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 175.59 -164.1 34.22 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.712 -1.131 . . . . 0.10000000000000001 111.13 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.401 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -102.59 138.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.988 -0.745 . . . . 0.12 108.988 175.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.58 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.4 p80 -149.35 167.28 26.56 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-O 122.065 0.936 . . . . 0.14999999999999999 111.178 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.744 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -89.43 149.28 23.03 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-N 113.501 -1.682 . . . . 0.41999999999999998 107.806 172.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.439 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 2.4 p -136.42 100.0 4.25 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 122.675 1.226 . . . . 1.48 110.035 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -95.17 -33.37 12.65 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 112.606 -2.088 . . . . 0.34999999999999998 110.416 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.492 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 13.9 p90 -68.08 -27.08 66.18 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-N 114.589 -1.187 . . . . 0.17999999999999999 109.255 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.58 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -118.95 82.0 20.45 Favored Pre-proline 0 CA--C 1.494 -1.208 0 CA-C-N 113.816 -1.538 . . . . 1.3300000000000001 110.201 -173.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 32.1 Cg_endo -80.33 4.96 6.39 Favored 'Trans proline' 0 N--CA 1.432 -2.103 0 C-N-CA 124.821 3.681 . . . . 0.23000000000000001 114.464 -162.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.32 154.03 28.73 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 123.385 0.428 . . . . 1.1000000000000001 110.293 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.631 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -163.64 126.34 2.57 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.25 -1.341 . . . . 0.38 108.364 -172.194 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.452 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.81 -167.85 28.74 Favored Glycine 0 C--N 1.297 -1.596 0 C-N-CA 119.051 -1.547 . . . . 0.13 111.556 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.634 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.52 153.36 0.0 OUTLIER Glycine 0 C--N 1.342 0.916 0 O-C-N 125.043 1.084 . . . . 0.20000000000000001 113.207 174.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.439 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.8 m-20 -54.9 100.99 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.156 0 CA-C-O 123.999 1.857 . . . . 0.33000000000000002 112.156 -146.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 38.4 mt -97.16 -33.44 11.49 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 110.273 -3.149 . . . . 0.17999999999999999 109.357 177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.558 ' HA ' HG23 ' A' ' 369' ' ' VAL . 11.2 p-90 -47.36 -33.59 6.02 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 112.8 -2.0 . . . . 0.22 111.9 -174.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.83 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 43.4 mttt -63.5 -22.99 67.2 Favored 'General case' 0 N--CA 1.437 -1.082 0 O-C-N 124.08 0.863 . . . . 0.64000000000000001 113.055 -176.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 71.2 p -117.43 -38.41 3.33 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.525 -0.761 . . . . 0.25 110.215 -177.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.58 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 4.5 mtp85 -79.14 -15.22 58.43 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.609 -1.178 . . . . 0.35999999999999999 112.375 -169.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 75.72 40.48 31.46 Favored Glycine 0 C--N 1.313 -0.701 0 N-CA-C 116.216 1.246 . . . . 0.20999999999999999 116.216 159.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . 0.428 ' HB3' ' O ' ' A' ' 442' ' ' CYS . 7.4 m -82.15 134.35 35.31 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-N 117.768 0.784 . . . . 0.46999999999999997 109.188 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.505 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 78.1 m80 -101.75 70.09 1.24 Allowed 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.477 -0.764 . . . . 0.40999999999999998 110.447 -174.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.625 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 83.63 -8.2 66.34 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.815 -0.914 . . . . 0.17999999999999999 110.815 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.532 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 22.4 p -94.17 128.77 40.79 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.689 0.757 . . . . 0.82999999999999996 110.561 -176.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.715 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -89.74 113.02 25.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.813 -1.085 . . . . 0.14999999999999999 110.527 -172.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.596 ' HB2' HG13 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -77.27 91.39 3.79 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.042 -0.981 . . . . 1.77 111.068 -177.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.654 HG23 HG21 ' A' ' 366' ' ' THR . 79.3 m -89.88 137.54 28.26 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 109.2 -0.667 . . . . 0.17999999999999999 109.2 174.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.1 Cg_exo -55.41 135.88 71.18 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.66 2.24 . . . . 0.12 111.248 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.744 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.8 Cg_exo -55.34 -32.87 83.22 Favored 'Trans proline' 0 CA--C 1.501 -1.148 0 C-N-CA 124.125 3.217 . . . . 0.16 112.849 -172.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 75.2 m -79.75 -38.01 34.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.774 -1.103 . . . . 1.1699999999999999 110.016 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.62 HG11 ' HB ' ' A' ' 366' ' ' THR . 88.7 t -78.8 -29.34 14.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.619 -0.719 . . . . 0.17000000000000001 111.454 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.638 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 4.7 tpt -66.23 -20.48 66.13 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.698 0.761 . . . . 0.46000000000000002 109.925 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 5.3 ttpt -76.3 -25.63 55.02 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-N 114.569 -1.196 . . . . 0.81000000000000005 111.69 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.7 mm-40 -80.33 -45.87 17.08 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-N 113.13 -1.85 . . . . 0.38 107.056 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.545 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 23.7 tp -66.22 -66.59 0.53 Allowed 'General case' 0 N--CA 1.403 -2.807 0 CA-C-N 111.756 -2.474 . . . . 0.059999999999999998 112.229 174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.48 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 26.7 t80 -50.03 -25.77 3.71 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.89 1.329 . . . . 0.31 108.28 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -74.41 -27.65 65.26 Favored Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 112.867 -1.969 . . . . 0.13 112.583 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.8 ptp -91.02 -49.02 6.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.776 0.798 . . . . 0.13 111.384 171.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.584 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.84 137.39 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.291 0 CA-C-O 123.478 1.608 . . . . 0.23000000000000001 113.87 -167.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.64 -178.45 5.18 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 110.671 -2.968 . . . . 0.82999999999999996 106.567 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.765 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 44.0 mtmt -52.56 161.29 0.72 Allowed 'General case' 0 N--CA 1.413 -2.311 0 CA-C-O 123.063 1.411 . . . . 0.23999999999999999 113.361 177.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.51 -32.88 5.26 Favored Glycine 0 N--CA 1.426 -2.006 0 CA-C-N 112.498 -2.137 . . . . 0.37 112.31 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 384' ' ' VAL . 3.4 m -78.25 141.07 61.56 Favored Pre-proline 0 N--CA 1.435 -1.215 0 N-CA-C 109.412 -0.588 . . . . 0.14999999999999999 109.412 -176.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.651 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 5.8 Cg_exo -75.63 167.74 25.83 Favored 'Trans proline' 0 N--CA 1.425 -2.542 0 C-N-CA 122.084 1.856 . . . . 0.12 111.244 174.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.784 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -133.55 150.51 32.09 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.414 0 N-CA-C 107.602 -1.259 . . . . 1.0900000000000001 107.602 165.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.417 HD22 ' CE1' ' A' ' 344' ' ' TYR . 3.8 tp -119.41 144.34 46.98 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 114.954 -1.021 . . . . 0.13 109.634 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.757 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -142.89 146.54 21.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 106.757 -1.571 . . . . 0.089999999999999997 106.757 165.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.643 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 17.5 p90 . . . . . 0 C--O 1.246 0.9 0 CA-C-O 118.258 -0.877 . . . . 1.1599999999999999 110.993 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.898 0 N-CA-C 112.104 -0.398 . . . . 3.9399999999999999 112.104 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.0 t-160 -92.03 93.52 8.79 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 109.368 -0.604 . . . . 1.8500000000000001 109.368 177.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 35.1 mtm 69.12 -175.69 0.2 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.379 -1.282 . . . . 1.03 110.654 -170.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -143.11 -4.38 0.91 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.991 -0.55 . . . . 1.1000000000000001 111.166 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -55.21 167.84 0.4 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 122.669 1.223 . . . . 0.97999999999999998 112.403 174.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.641 HG23 ' HA ' ' A' ' 358' ' ' LYS . 2.7 m -91.64 122.34 34.12 Favored 'General case' 0 N--CA 1.422 -1.86 0 CA-C-N 113.7 -1.591 . . . . 0.45000000000000001 108.096 169.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.668 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.9 p90 -161.12 -171.04 2.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.322 -0.854 . . . . 0.32000000000000001 110.533 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.578 HD11 ' CB ' ' A' ' 457' ' ' VAL . 12.2 mm -105.06 160.89 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.977 -1.119 . . . . 0.080000000000000002 107.977 167.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.519 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -140.93 155.92 46.18 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 118.972 0.806 . . . . 0.17000000000000001 111.327 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.724 HG22 ' HG3' ' A' ' 354' ' ' MET . 65.5 t -151.16 136.65 11.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 CA-C-N 114.747 -1.115 . . . . 0.080000000000000002 109.923 -178.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -116.97 119.11 34.29 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.615 -1.175 . . . . 0.37 108.078 171.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.577 ' O ' ' HG2' ' A' ' 352' ' ' GLN . 1.9 mm? -70.81 -47.83 57.36 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 122.202 1.001 . . . . 0.32000000000000001 110.492 -176.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -57.97 -55.07 39.61 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 112.752 -2.022 . . . . 1.51 112.0 -177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -94.77 10.69 34.16 Favored 'General case' 0 CA--C 1.497 -1.095 0 CA-C-N 114.21 -1.359 . . . . 0.91000000000000003 108.657 -174.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.675 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 3.6 mm-40 35.01 74.14 0.07 Allowed 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 125.349 1.656 . . . . 2.2200000000000002 112.964 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.52 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.5 t60 -152.27 124.3 8.05 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.32 -0.855 . . . . 0.13 109.744 -176.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.724 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.3 ttp -111.88 126.94 55.64 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.586 -0.734 . . . . 0.059999999999999998 110.366 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.662 ' CD1' HG11 ' A' ' 362' ' ' VAL . 31.8 m-90 -111.95 172.9 6.63 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 114.528 -1.214 . . . . 0.10000000000000001 111.911 -175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.681 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.3 t80 -125.93 115.73 20.39 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 106.577 -1.638 . . . . 0.22 106.577 165.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.501 ' CE1' HG12 ' A' ' 362' ' ' VAL . 23.8 m-85 -98.98 126.4 44.66 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 122.259 1.028 . . . . 0.17999999999999999 112.519 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.641 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.2 ttpt -148.94 139.29 22.42 Favored 'General case' 0 N--CA 1.396 -3.135 0 CA-C-N 112.95 -1.932 . . . . 0.46999999999999997 107.759 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 72.4 15.22 5.23 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-N 113.929 -1.487 . . . . 0.59999999999999998 108.871 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 78.74 16.79 78.58 Favored Glycine 0 N--CA 1.428 -1.857 0 CA-C-N 112.603 -2.09 . . . . 0.23000000000000001 111.699 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.634 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.3 OUTLIER -139.58 174.69 10.25 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 112.416 -1.892 . . . . 0.68000000000000005 106.108 -168.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.704 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.0 m -104.89 138.86 27.82 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.688 0 CA-C-O 124.227 1.965 . . . . 0.53000000000000003 112.397 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.681 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.36 -24.83 17.96 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 109.37 -3.559 . . . . 0.12 108.707 176.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.668 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -152.65 154.31 35.08 Favored 'General case' 0 N--CA 1.417 -2.12 0 CA-C-N 113.578 -1.646 . . . . 0.080000000000000002 108.67 -172.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.704 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.11 120.49 1.16 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 115.708 -0.678 . . . . 0.60999999999999999 109.675 -174.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.696 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.0 t -147.79 167.33 25.0 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 122.199 0.999 . . . . 0.089999999999999997 111.981 175.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.66 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 3.3 p-10 -86.0 140.2 30.51 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 113.225 -1.807 . . . . 1.8799999999999999 107.867 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.675 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.8 pp -140.88 -171.89 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.238 -0.892 . . . . 0.11 111.989 -175.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.639 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.65 119.95 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.05 -0.977 . . . . 0.12 108.816 174.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.671 ' H ' HE22 ' A' ' 352' ' ' GLN . 7.6 t -142.23 144.2 33.24 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 115.415 -0.811 . . . . 0.69999999999999996 112.397 -166.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.687 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.02 44.48 45.46 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 116.569 1.388 . . . . 0.13 116.569 163.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.604 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.58 143.64 5.53 Favored Pre-proline 0 CA--C 1.509 -0.598 0 CA-C-N 118.472 1.136 . . . . 0.47999999999999998 110.49 -174.211 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.816 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.46 -33.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.32 -0.966 1 C-N-CA 125.745 4.296 . . . . 0.23000000000000001 116.034 -170.925 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.604 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.7 p -79.74 -34.02 40.3 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 121.082 0.467 . . . . 0.29999999999999999 110.723 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.457 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.0 m -140.65 73.38 29.05 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-O 122.144 0.973 . . . . 0.29999999999999999 110.461 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.687 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 27.3 Cg_exo -70.62 161.51 45.78 Favored 'Trans proline' 0 C--N 1.321 -0.886 0 C-N-CA 125.201 3.934 . . . . 0.16 114.41 -177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.685 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -74.77 154.02 87.17 Favored Pre-proline 0 N--CA 1.439 -0.991 0 CA-C-N 113.551 -1.659 . . . . 0.12 110.936 176.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.526 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.3 Cg_endo -80.84 -49.23 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 125.062 3.841 . . . . 0.089999999999999997 113.752 -172.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.692 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.05 122.55 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 122.123 0.964 . . . . 0.089999999999999997 113.449 -177.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 166.35 -125.32 1.32 Allowed Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.23 -1.35 . . . . 0.11 111.7 -176.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . . . . . . . . . 96.4 t -129.28 103.84 9.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.262 -1.014 . . . . 0.89000000000000001 108.262 -178.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.767 ' HB2' HG22 ' A' ' 463' ' ' VAL . 95.6 m-85 -110.23 158.5 18.32 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.478 -0.783 . . . . 0.16 109.656 -169.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.807 ' HA ' ' HA ' ' A' ' 462' ' ' PRO . 9.3 m-85 -146.59 139.63 25.48 Favored 'General case' 0 CA--C 1.499 -0.985 0 CA-C-N 118.194 0.452 . . . . 0.68999999999999995 110.699 175.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.1 OUTLIER -75.63 125.91 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 C-N-CA 119.92 -0.712 . . . . 0.14000000000000001 110.626 178.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -111.03 4.03 19.13 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.181 -0.918 . . . . 0.19 112.04 -177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.737 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.7 t30 -164.56 150.11 10.2 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.326 -0.852 . . . . 0.40999999999999998 110.51 175.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.447 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.3 mtpt -109.98 113.65 26.53 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.609 -0.723 . . . . 1.0900000000000001 110.025 170.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.541 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 1.9 mt-10 -112.79 125.1 53.97 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.647 -1.16 . . . . 0.38 110.931 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 42.5 mt-10 -123.5 135.05 53.85 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 114.14 -1.391 . . . . 1.96 110.196 -176.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 407' ' ' VAL . 37.8 t70 52.56 39.44 28.05 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 123.387 1.565 . . . . 0.40000000000000002 107.661 -172.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.9 167.47 12.41 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 112.474 -2.148 . . . . 0.16 111.256 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 37.5 m -128.11 102.5 6.74 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 113.964 -1.471 . . . . 0.27000000000000002 109.682 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.753 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -74.28 157.34 35.97 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 112.984 -1.916 . . . . 0.23999999999999999 110.406 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 8.5 mtpt -149.07 -176.6 5.42 Favored 'General case' 0 N--CA 1.399 -3.024 0 CA-C-N 114.945 -1.025 . . . . 0.67000000000000004 108.759 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -179.96 -142.08 4.93 Favored Glycine 0 CA--C 1.489 -1.579 0 C-N-CA 117.269 -2.396 . . . . 0.81000000000000005 114.918 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.65 120.82 12.2 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-N 113.309 -1.445 . . . . 0.79000000000000004 109.035 172.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.452 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -53.1 -179.14 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 112.183 -2.28 . . . . 1.1200000000000001 112.313 178.702 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -52.16 -26.67 11.99 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.624 -0.716 . . . . 1.6499999999999999 110.855 167.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -91.81 -27.2 18.13 Favored 'General case' 0 CA--C 1.511 -0.537 0 CA-C-N 115.871 -0.604 . . . . 2.0 111.19 -174.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.91 30.06 5.29 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.201 -0.999 . . . . 0.66000000000000003 110.801 -169.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 43.4 p -115.78 128.56 25.87 Favored Pre-proline 0 N--CA 1.42 -1.961 0 N-CA-C 106.637 -1.616 . . . . 0.68000000000000005 106.637 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 30.8 Cg_exo -63.79 160.75 35.46 Favored 'Trans proline' 0 C--N 1.284 -2.843 0 C-N-CA 121.898 1.732 . . . . 0.81000000000000005 112.647 -173.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.538 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 29.1 p90 -142.69 -171.36 3.41 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.352 -1.749 . . . . 0.38 107.074 -177.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.659 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 8.7 mt-10 -145.21 158.76 43.74 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.34 1.067 . . . . 0.62 111.831 174.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.753 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.56 98.62 12.17 Favored Pre-proline 0 N--CA 1.419 -1.982 0 CA-C-N 113.07 -1.877 . . . . 1.3300000000000001 107.747 175.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.8 Cg_endo -68.04 101.59 0.71 Allowed 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 122.308 2.006 . . . . 0.20000000000000001 110.326 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.1 t -114.48 157.53 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.866 0 CA-C-N 114.242 -1.344 . . . . 0.29999999999999999 109.95 -173.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.408 HD22 ' CG ' ' A' ' 422' ' ' ASP . 22.5 m-80 -108.22 -33.8 7.02 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 113.39 -1.732 . . . . 1.8400000000000001 107.098 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.421 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 61.3 m-85 -134.55 116.18 14.75 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 112.86 -1.973 . . . . 0.44 111.134 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.75 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.4 t-105 -123.71 134.24 53.74 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.223 -1.353 . . . . 0.13 110.258 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.517 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.1 OUTLIER -134.91 86.54 32.31 Favored Pre-proline 0 C--N 1.298 -1.635 0 CA-C-N 115.124 -0.943 . . . . 0.40999999999999998 111.054 174.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 95.1 Cg_endo -72.06 140.22 34.17 Favored 'Trans proline' 0 CA--C 1.511 -0.642 0 C-N-CA 122.81 2.34 . . . . 0.16 112.154 -178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.665 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.79 -15.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.479 . . . . 0.17000000000000001 111.214 -172.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -134.63 162.5 32.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.392 -0.822 . . . . 1.5900000000000001 109.447 176.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -93.47 13.8 20.62 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.358 0.503 . . . . 0.31 112.358 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.1 p -94.24 -27.42 16.17 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.674 -1.232 . . . . 0.44 107.674 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 123.48 34.36 0.76 Allowed Glycine 0 N--CA 1.427 -1.95 0 CA-C-N 113.112 -1.858 . . . . 0.23999999999999999 112.414 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 441' ' ' GLY . 76.8 t -103.79 151.49 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-O 120.987 0.422 . . . . 0.17000000000000001 110.762 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 170.92 -168.1 41.24 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-N 115.214 -0.903 . . . . 0.10000000000000001 111.664 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.46 141.16 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 108.933 -0.766 . . . . 0.12 108.933 177.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.564 ' HB2' HG21 ' A' ' 407' ' ' VAL . 34.0 p80 -150.6 163.72 37.8 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.803 0.811 . . . . 0.14999999999999999 111.776 178.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.14 142.6 27.56 Favored 'General case' 0 N--CA 1.423 -1.814 0 CA-C-N 113.916 -1.493 . . . . 0.41999999999999998 107.323 172.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.462 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 3.5 t -136.92 103.51 5.19 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 122.877 1.323 . . . . 1.48 110.395 -178.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -94.55 -28.7 15.28 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 112.125 -2.307 . . . . 0.34999999999999998 111.138 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.533 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.4 p90 -70.27 -26.56 63.87 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 114.432 -1.258 . . . . 0.17999999999999999 109.342 175.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.575 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -120.58 82.18 33.0 Favored Pre-proline 0 CA--C 1.491 -1.31 0 CA-C-N 113.5 -1.682 . . . . 1.3300000000000001 109.465 -175.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -81.34 6.68 5.45 Favored 'Trans proline' 0 N--CA 1.43 -2.254 0 C-N-CA 124.693 3.596 . . . . 0.23000000000000001 113.907 -162.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.403 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 3.2 tp10 -114.47 154.54 28.01 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.223 0.535 . . . . 1.1000000000000001 111.013 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.66 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.7 OUTLIER -164.11 127.84 2.62 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 113.715 -1.584 . . . . 0.38 108.076 -169.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.31 -167.24 28.51 Favored Glycine 0 N--CA 1.434 -1.495 0 C-N-CA 119.232 -1.461 . . . . 0.13 111.124 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.643 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.43 153.95 0.01 OUTLIER Glycine 0 C--N 1.336 0.583 0 O-C-N 124.927 1.016 . . . . 0.20000000000000001 112.897 174.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.65 100.81 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 CA-C-O 123.862 1.791 . . . . 0.33000000000000002 112.0 -146.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.643 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 54.1 mt -97.02 -30.32 13.13 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-N 110.562 -3.017 . . . . 0.17999999999999999 108.205 175.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.639 ' HA ' HG23 ' A' ' 369' ' ' VAL . 7.6 p-90 -46.85 -38.01 9.66 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 123.876 0.735 . . . . 0.22 111.583 -175.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.816 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 42.7 mttt -62.22 -23.01 66.4 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.274 -0.876 . . . . 0.64000000000000001 112.9 -175.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.0 p -114.95 -37.03 4.26 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.578 -0.737 . . . . 0.25 110.361 -177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.575 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.8 mtp85 -85.18 -15.86 42.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.811 -1.086 . . . . 0.35999999999999999 112.691 -168.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 76.09 42.05 25.38 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 116.804 1.482 . . . . 0.20999999999999999 116.804 159.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.6 m -85.82 131.11 34.37 Favored 'General case' 0 C--O 1.212 -0.901 0 CA-C-N 118.682 1.241 . . . . 0.46999999999999997 108.946 174.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.492 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 68.3 m80 -100.04 71.38 1.62 Allowed 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.678 -0.639 . . . . 0.40999999999999998 111.227 -167.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.6 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.74 -14.12 59.15 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.422 -1.071 . . . . 0.17999999999999999 110.422 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.523 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -88.29 148.53 24.26 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.36 -0.42 . . . . 0.82999999999999996 110.192 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.685 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -100.01 119.54 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.776 0.798 . . . . 0.14999999999999999 110.759 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.58 ' HB3' HG13 ' A' ' 369' ' ' VAL . 2.6 t30 -79.93 82.97 5.92 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.557 -1.201 . . . . 1.77 111.42 -175.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.558 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.2 m -87.42 140.25 31.99 Favored Pre-proline 0 N--CA 1.451 -0.412 0 CA-C-O 121.605 0.716 . . . . 0.17999999999999999 109.846 178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 50.9 Cg_exo -58.85 136.14 71.64 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.814 2.342 . . . . 0.12 111.744 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 34.3 Cg_exo -55.01 -34.07 85.59 Favored 'Trans proline' 0 CA--C 1.504 -1.009 0 C-N-CA 124.415 3.41 . . . . 0.16 113.005 -174.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.5 t -79.47 -38.33 34.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.893 -1.049 . . . . 1.1699999999999999 109.418 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.696 HG11 ' HB ' ' A' ' 366' ' ' THR . 46.9 t -82.51 -28.42 8.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 0.17000000000000001 111.269 -177.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.725 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.5 tpt -67.68 -18.74 65.03 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 121.882 0.849 . . . . 0.46000000000000002 110.008 177.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -80.43 -23.24 40.44 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.442 -1.253 . . . . 0.81000000000000005 111.007 177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.686 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.0 mm-40 -80.35 -46.99 15.15 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-N 112.957 -1.929 . . . . 0.38 107.215 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.584 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -64.68 -67.18 0.46 Allowed 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 111.798 -2.455 . . . . 0.059999999999999998 112.321 175.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -50.47 -26.36 5.01 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 123.18 1.467 . . . . 0.31 108.21 177.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.416 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.44 -32.77 67.96 Favored Glycine 0 N--CA 1.428 -1.86 0 CA-C-N 112.182 -2.281 . . . . 0.13 112.22 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.686 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.8 ptp -87.5 -49.43 7.2 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 121.745 0.783 . . . . 0.13 111.509 172.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.635 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.7 OUTLIER -102.08 137.6 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 CA-C-O 123.518 1.627 . . . . 0.23000000000000001 113.835 -167.136 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.447 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.1 pt-20 -136.58 -178.23 5.08 Favored 'General case' 0 N--CA 1.401 -2.881 0 CA-C-N 110.585 -3.007 . . . . 0.82999999999999996 106.89 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.737 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 48.2 mtmt -51.59 161.78 0.46 Allowed 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 122.888 1.328 . . . . 0.23999999999999999 112.593 175.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.67 -31.52 5.8 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-N 112.623 -2.08 . . . . 0.37 112.368 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.549 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.5 m -82.92 140.77 43.39 Favored Pre-proline 0 N--CA 1.435 -1.204 0 N-CA-C 108.683 -0.858 . . . . 0.14999999999999999 108.683 -178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.807 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 1.4 Cg_endo -77.57 173.46 14.15 Favored 'Trans proline' 0 N--CA 1.415 -3.146 0 C-N-CA 121.093 1.196 . . . . 0.12 111.71 174.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.767 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -137.09 160.17 36.28 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 107.768 -1.197 . . . . 1.0900000000000001 107.768 167.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.442 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.8 tp -129.83 146.22 51.57 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.443 -0.799 . . . . 0.13 110.334 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.692 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.1 147.26 20.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.073 -1.454 . . . . 0.089999999999999997 107.073 165.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.648 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.1 p90 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.855 -0.593 . . . . 1.1599999999999999 111.646 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.778 0 N-CA-C 111.758 -0.537 . . . . 3.9399999999999999 111.758 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.455 ' CD2' HD21 ' A' ' 464' ' ' LEU . 0.1 OUTLIER -168.51 -172.92 1.79 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.309 0.576 . . . . 1.8500000000000001 111.349 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 33.3 mtm -69.75 -175.69 0.93 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.681 -1.145 . . . . 1.03 111.961 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -136.63 -3.95 2.06 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.813 -1.085 . . . . 1.1000000000000001 110.09 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -54.48 166.99 0.37 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 122.829 1.3 . . . . 0.97999999999999998 112.732 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.603 HG23 ' HA ' ' A' ' 358' ' ' LYS . 94.0 m -93.33 123.6 36.73 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 113.41 -1.723 . . . . 0.45000000000000001 108.813 171.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.647 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.0 p90 -160.93 -170.31 2.67 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.217 -1.356 . . . . 0.32000000000000001 110.668 -173.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.566 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.3 mm -101.7 161.63 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 108.183 -1.043 . . . . 0.080000000000000002 108.183 166.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.492 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.8 tt0 -142.24 155.6 45.25 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.407 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.671 HG22 ' HG3' ' A' ' 354' ' ' MET . 68.0 t -151.0 142.35 16.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 114.437 -1.256 . . . . 0.080000000000000002 109.146 -178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.499 ' HA ' ' OXT' ' A' ' 466' ' ' PHE . 7.2 t70 -130.67 107.49 9.21 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.603 -0.726 . . . . 0.37 109.129 177.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.547 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.9 mm? -69.27 -30.08 68.11 Favored 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 113.814 -1.539 . . . . 0.32000000000000001 110.575 -170.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -57.09 -63.61 1.16 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.89 0.852 . . . . 1.51 111.096 174.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -89.42 -3.53 58.38 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.047 -1.433 . . . . 0.91000000000000003 110.774 -169.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.703 ' OE1' HD12 ' A' ' 368' ' ' ILE . 85.1 mm-40 49.64 68.64 0.7 Allowed 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 112.084 -2.325 . . . . 2.2200000000000002 111.368 -176.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.462 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.5 t60 -143.82 128.43 18.12 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.991 -1.004 . . . . 0.13 109.293 -176.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 347' ' ' VAL . 2.9 ttp -114.33 129.01 56.63 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 123.573 0.749 . . . . 0.059999999999999998 110.558 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.66 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.2 m-90 -113.32 173.1 6.57 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 114.724 -1.126 . . . . 0.10000000000000001 111.802 -176.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.71 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -125.88 113.96 17.91 Favored 'General case' 0 CA--C 1.489 -1.379 0 N-CA-C 106.008 -1.849 . . . . 0.22 106.008 164.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.469 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.1 m-85 -98.53 129.21 45.09 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-O 121.811 0.815 . . . . 0.17999999999999999 111.218 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.603 ' HA ' HG23 ' A' ' 343' ' ' THR . 5.7 ttpt -147.6 137.65 22.94 Favored 'General case' 0 N--CA 1.4 -2.949 0 CA-C-N 113.912 -1.494 . . . . 0.46999999999999997 108.161 173.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.464 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.79 11.94 7.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 CA-C-N 113.489 -1.687 . . . . 0.59999999999999998 108.629 178.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 86.06 12.25 71.38 Favored Glycine 0 N--CA 1.425 -2.044 0 CA-C-N 112.785 -2.007 . . . . 0.23000000000000001 111.806 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.621 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -131.43 168.68 17.19 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.107 -1.812 . . . . 0.68000000000000005 106.107 -172.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.65 HG11 ' CD1' ' A' ' 355' ' ' TRP . 3.2 m -100.96 136.9 30.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.82 0 CA-C-O 124.442 2.067 . . . . 0.53000000000000003 111.958 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.71 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -90.62 -25.92 19.9 Favored 'General case' 0 N--CA 1.397 -3.081 0 CA-C-N 109.085 -3.688 . . . . 0.12 108.57 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.64 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.6 tp -152.51 154.25 35.1 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 113.577 -1.647 . . . . 0.080000000000000002 108.744 -172.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.66 ' HB3' ' CD1' ' A' ' 355' ' ' TRP . 0.0 OUTLIER -164.92 121.53 1.5 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.67 -0.696 . . . . 0.60999999999999999 109.489 -175.358 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.704 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.5 t -148.51 167.03 26.44 Favored 'General case' 0 N--CA 1.422 -1.847 0 CA-C-O 122.25 1.024 . . . . 0.089999999999999997 112.099 174.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.688 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.8 p-10 -85.9 139.79 30.93 Favored 'General case' 0 N--CA 1.416 -2.143 0 CA-C-N 113.173 -1.831 . . . . 1.8799999999999999 107.827 176.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.703 HD12 ' OE1' ' A' ' 352' ' ' GLN . 1.7 pp -140.63 -172.22 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 CA-C-N 115.207 -0.906 . . . . 0.11 111.554 -175.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.596 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -156.8 119.66 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.399 -0.819 . . . . 0.12 109.05 174.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 7.2 t -141.27 145.11 35.11 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 114.747 -1.115 . . . . 0.69999999999999996 112.562 -167.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.663 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 72.08 46.1 37.51 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 117.333 1.693 . . . . 0.13 117.333 162.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.453 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 2.1 pttt -45.86 145.55 2.31 Favored Pre-proline 0 C--N 1.347 0.462 0 CA-C-N 119.842 1.821 . . . . 0.47999999999999998 110.779 -174.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.798 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.99 -36.46 0.1 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 1 C-N-CA 125.422 4.081 . . . . 0.23000000000000001 115.529 -173.58 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 1.6 p -76.56 -35.89 57.94 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.076 0.465 . . . . 0.29999999999999999 110.903 -177.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.464 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 3.8 m -139.88 72.56 34.67 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 122.111 0.958 . . . . 0.29999999999999999 110.522 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.663 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 23.4 Cg_exo -71.75 162.76 41.06 Favored 'Trans proline' 0 C--N 1.324 -0.741 1 C-N-CA 125.35 4.033 . . . . 0.16 113.978 -177.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.725 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.33 152.43 90.09 Favored Pre-proline 0 N--CA 1.438 -1.069 0 CA-C-N 113.651 -1.613 . . . . 0.12 111.062 175.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.514 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.42 -49.21 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 125.116 3.877 . . . . 0.089999999999999997 113.712 -171.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.74 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.89 120.95 0.03 OUTLIER 'General case' 0 C--O 1.232 0.173 0 N-CA-C 113.767 1.025 . . . . 0.089999999999999997 113.767 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.77 -123.25 1.15 Allowed Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 114.343 -1.299 . . . . 0.11 111.563 -176.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.417 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.1 p -126.13 112.17 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 CA-C-O 122.079 0.942 . . . . 0.89000000000000001 108.933 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.779 ' HB2' HG22 ' A' ' 463' ' ' VAL . 90.4 m-85 -115.66 160.09 20.49 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.219 -0.9 . . . . 0.16 109.83 -170.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.713 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 77.2 m-85 -147.8 135.29 20.74 Favored 'General case' 0 CA--C 1.498 -1.044 0 C-N-CA 120.97 -0.292 . . . . 0.68999999999999995 111.084 177.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.616 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.49 121.09 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 C-N-CA 119.63 -0.828 . . . . 0.14000000000000001 110.234 177.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 -108.44 2.21 22.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.247 -0.888 . . . . 0.19 111.784 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.755 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 7.4 t30 -164.65 150.81 10.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.838 -1.074 . . . . 0.40999999999999998 110.217 177.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 17.9 mtpt -112.8 126.98 56.02 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.616 -0.72 . . . . 1.0900000000000001 109.123 171.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.576 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.7 mt-10 -127.14 112.76 15.53 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 123.195 1.474 . . . . 0.38 113.249 -177.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 3.1 mp0 -108.17 134.15 51.43 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 113.286 -1.779 . . . . 1.96 110.862 -176.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 36.9 t70 52.17 37.11 20.94 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.394 1.568 . . . . 0.40000000000000002 107.744 -175.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.576 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.79 170.31 10.22 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.225 -2.261 . . . . 0.16 112.028 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 16.5 m -125.98 105.81 9.17 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 113.679 -1.601 . . . . 0.27000000000000002 109.823 -177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.708 ' HB2' ' HB2' ' A' ' 405' ' ' SER . 8.7 mp -72.05 156.11 39.56 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 113.243 -1.799 . . . . 0.23999999999999999 109.79 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.648 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 0.0 OUTLIER -149.86 -177.04 5.67 Favored 'General case' 0 N--CA 1.389 -3.482 0 CA-C-N 114.863 -1.062 . . . . 0.67000000000000004 109.136 -176.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 178.32 -143.47 5.98 Favored Glycine 0 CA--C 1.485 -1.811 0 C-N-CA 117.041 -2.504 . . . . 0.81000000000000005 115.104 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.26 122.12 13.56 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 112.814 -1.693 . . . . 0.79000000000000004 108.353 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.439 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -52.21 -179.56 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 112.379 -2.191 . . . . 1.1200000000000001 112.079 178.564 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -53.45 -22.36 7.74 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.282 -0.417 . . . . 1.6499999999999999 110.448 171.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.67 -27.02 13.6 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 116.383 -0.371 . . . . 2.0 111.504 -174.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.32 34.53 2.48 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.582 -1.294 . . . . 0.66000000000000003 111.444 -171.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.439 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 64.9 p -117.56 127.05 26.91 Favored Pre-proline 0 N--CA 1.419 -1.992 0 N-CA-C 106.582 -1.636 . . . . 0.68000000000000005 106.582 177.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.645 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 24.2 Cg_exo -65.5 154.62 72.87 Favored 'Trans proline' 0 C--N 1.284 -2.827 0 C-N-CA 122.211 1.941 . . . . 0.81000000000000005 111.934 -173.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.648 ' O ' ' HA ' ' A' ' 394' ' ' LYS . 29.1 p90 -141.95 -177.61 5.3 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.097 -1.865 . . . . 0.38 107.203 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.7 mt-10 -142.09 159.13 42.84 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.383 1.087 . . . . 0.62 112.027 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.708 ' HB2' ' HB2' ' A' ' 393' ' ' LEU . 2.8 m -143.64 97.86 5.42 Favored Pre-proline 0 N--CA 1.419 -2.008 0 CA-C-N 113.254 -1.794 . . . . 1.3300000000000001 109.464 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 71.7 Cg_endo -68.93 105.97 1.43 Allowed 'Trans proline' 0 CA--C 1.513 -0.534 0 C-N-CA 124.359 3.373 . . . . 0.20000000000000001 112.999 -177.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.832 HG11 ' HB2' ' A' ' 410' ' ' TRP . 0.6 OUTLIER -115.89 162.6 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.343 0 CA-C-N 114.58 -1.191 . . . . 0.29999999999999999 110.87 -174.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 27.0 m-80 -111.25 -33.59 6.39 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 113.152 -1.84 . . . . 1.8400000000000001 107.008 -178.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -135.36 115.53 13.32 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.189 -1.823 . . . . 0.44 110.835 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.832 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.8 t-105 -122.59 136.26 54.84 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.558 -1.201 . . . . 0.13 109.897 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.534 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -136.54 86.17 23.81 Favored Pre-proline 0 C--N 1.299 -1.589 0 CA-C-N 115.006 -0.997 . . . . 0.40999999999999998 111.222 173.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 84.1 Cg_endo -70.85 140.11 37.88 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 122.889 2.393 . . . . 0.16 112.053 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.713 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.8 pt -123.46 -15.16 5.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 113.804 -1.544 . . . . 0.17000000000000001 111.068 -173.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -135.37 163.76 29.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.495 -0.775 . . . . 1.5900000000000001 110.032 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -94.38 14.53 20.24 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.304 0.483 . . . . 0.31 112.304 -177.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 4.4 p -94.11 -26.98 16.49 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 107.613 -1.254 . . . . 0.44 107.613 173.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.06 30.44 1.02 Allowed Glycine 0 N--CA 1.427 -1.93 0 CA-C-N 113.053 -1.885 . . . . 0.23999999999999999 112.274 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 441' ' ' GLY . 73.1 t -102.46 149.81 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 120.587 -0.445 . . . . 0.17000000000000001 111.112 178.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 173.18 -166.69 39.25 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 115.153 -0.93 . . . . 0.10000000000000001 111.789 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.407 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.8 OUTLIER -103.88 141.54 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.037 0 N-CA-C 109.036 -0.727 . . . . 0.12 109.036 176.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.795 ' HB2' HG21 ' A' ' 407' ' ' VAL . 35.5 p80 -151.48 165.1 35.23 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 121.669 0.747 . . . . 0.14999999999999999 112.26 178.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.775 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.8 139.68 30.43 Favored 'General case' 0 N--CA 1.422 -1.845 0 CA-C-N 114.027 -1.442 . . . . 0.41999999999999998 107.449 171.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.663 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 1.6 t -135.6 104.25 5.73 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 123.212 1.482 . . . . 1.48 110.144 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -93.17 -25.85 17.66 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 111.855 -2.43 . . . . 0.34999999999999998 110.17 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.494 ' CH2' ' HB3' ' A' ' 405' ' ' SER . 6.9 p90 -70.8 -26.41 63.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 114.385 -1.279 . . . . 0.17999999999999999 109.316 173.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.578 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.1 OUTLIER -118.93 83.08 22.27 Favored Pre-proline 0 CA--C 1.496 -1.121 0 CA-C-N 114.036 -1.438 . . . . 1.3300000000000001 110.6 -174.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -82.94 6.58 5.72 Favored 'Trans proline' 0 C--N 1.294 -2.309 0 C-N-CA 124.515 3.477 . . . . 0.23000000000000001 114.554 -162.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.64 153.46 30.13 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 123.372 0.42 . . . . 1.1000000000000001 110.226 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.688 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.6 OUTLIER -162.74 125.62 2.8 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 124.327 1.051 . . . . 0.38 109.203 -170.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -165.8 28.83 Favored Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.026 -1.559 . . . . 0.13 111.792 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -31.5 154.96 0.01 OUTLIER Glycine 0 C--N 1.339 0.748 0 O-C-N 124.985 1.05 . . . . 0.20000000000000001 112.762 173.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -56.41 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 124.039 1.876 . . . . 0.33000000000000002 112.284 -147.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 43.6 mt -96.68 -33.54 11.7 Favored 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 110.223 -3.171 . . . . 0.17999999999999999 108.094 175.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.508 ' HA ' HG23 ' A' ' 369' ' ' VAL . 2.9 p-90 -45.37 -37.96 5.46 Favored 'General case' 0 C--N 1.316 -0.891 0 O-C-N 123.936 0.772 . . . . 0.22 111.327 -174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.798 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 54.4 mttt -58.27 -23.7 57.02 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 115.059 -0.973 . . . . 0.64000000000000001 113.007 -176.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 49.0 p -116.63 -35.55 4.19 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.458 -0.792 . . . . 0.25 110.0 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.577 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 5.6 mtp85 -84.65 -14.92 47.15 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.634 -1.167 . . . . 0.35999999999999999 112.714 -169.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 73.47 41.54 44.25 Favored Glycine 0 C--N 1.312 -0.758 0 N-CA-C 116.459 1.344 . . . . 0.20999999999999999 116.459 159.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 14.7 m -87.53 131.49 34.36 Favored 'General case' 0 C--O 1.214 -0.782 0 CA-C-N 118.267 1.033 . . . . 0.46999999999999997 109.113 175.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.479 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 72.1 m80 -97.58 68.32 2.11 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.817 -0.552 . . . . 0.40999999999999998 111.097 -169.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.587 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 87.64 -12.28 63.8 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.582 -1.007 . . . . 0.17999999999999999 110.582 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 26.3 p -87.34 143.66 27.15 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.271 -0.464 . . . . 0.82999999999999996 109.923 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -99.26 115.97 41.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.23 0.538 . . . . 0.14999999999999999 110.734 -177.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.663 ' OD1' ' HB3' ' A' ' 423' ' ' SER . 8.2 t30 -78.39 93.74 4.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.132 -0.94 . . . . 1.77 111.356 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 25.0 m -91.49 136.07 27.22 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.621 -0.718 . . . . 0.17999999999999999 109.284 173.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 447' ' ' PRO . 50.1 Cg_exo -56.79 132.65 53.01 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 123.073 2.515 . . . . 0.12 112.696 -178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.775 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 16.2 Cg_exo -50.21 -39.24 52.24 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 123.625 2.883 . . . . 0.16 112.713 -168.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 61.6 m -74.99 -42.22 57.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 114.709 -1.132 . . . . 1.1699999999999999 109.867 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.704 HG11 ' HB ' ' A' ' 366' ' ' THR . 62.0 t -75.88 -28.89 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-O 121.353 0.597 . . . . 0.17000000000000001 111.294 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.693 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 7.7 tpt -68.33 -20.13 64.71 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.583 0.706 . . . . 0.46000000000000002 110.17 177.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -79.61 -22.27 43.87 Favored 'General case' 0 CA--C 1.501 -0.916 0 CA-C-O 122.496 1.141 . . . . 0.81000000000000005 110.974 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.679 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.8 mm-40 -80.25 -47.4 14.67 Favored 'General case' 0 CA--C 1.474 -1.97 0 CA-C-N 112.894 -1.957 . . . . 0.38 107.399 177.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.578 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.8 tp -63.93 -67.27 0.44 Allowed 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 111.81 -2.45 . . . . 0.059999999999999998 112.302 175.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.441 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 39.7 t80 -49.82 -27.23 4.76 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 123.026 1.393 . . . . 0.31 108.335 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.409 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.06 -31.16 66.89 Favored Glycine 0 N--CA 1.429 -1.801 0 CA-C-N 112.388 -2.187 . . . . 0.13 112.266 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.679 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -87.97 -49.35 7.12 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 121.772 0.796 . . . . 0.13 111.383 172.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -101.07 138.02 26.7 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.124 0 CA-C-O 123.455 1.598 . . . . 0.23000000000000001 113.796 -167.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -136.25 -178.87 5.35 Favored 'General case' 0 N--CA 1.404 -2.769 0 CA-C-N 110.821 -2.9 . . . . 0.82999999999999996 106.662 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.755 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.3 mtmt -51.61 161.5 0.5 Allowed 'General case' 0 N--CA 1.412 -2.372 0 CA-C-O 122.966 1.365 . . . . 0.23999999999999999 112.869 175.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.77 -33.69 4.89 Favored Glycine 0 N--CA 1.424 -2.134 0 CA-C-N 112.688 -2.051 . . . . 0.37 112.535 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 462' ' ' PRO . 6.9 m -78.78 142.34 60.85 Favored Pre-proline 0 N--CA 1.437 -1.112 0 N-CA-C 109.362 -0.607 . . . . 0.14999999999999999 109.362 -176.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 5.1 Cg_exo -76.09 169.2 22.55 Favored 'Trans proline' 0 N--CA 1.425 -2.527 0 C-N-CA 121.89 1.727 . . . . 0.12 111.335 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.779 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -136.12 157.13 37.72 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 107.422 -1.325 . . . . 1.0900000000000001 107.422 166.023 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.473 HD22 ' CE1' ' A' ' 344' ' ' TYR . 2.8 tp -127.25 146.05 50.56 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.197 -0.911 . . . . 0.13 109.935 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.74 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.37 147.08 20.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 107.276 -1.379 . . . . 0.089999999999999997 107.276 165.705 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.52 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 20.4 p90 . . . . . 0 C--O 1.247 0.936 0 CA-C-O 118.742 -0.647 . . . . 1.1599999999999999 111.103 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.78 0 CA-C-O 120.112 -0.271 . . . . 3.9399999999999999 112.596 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.619 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.5 p-80 -104.11 140.04 38.35 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 117.89 0.845 . . . . 1.8500000000000001 111.814 -176.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.619 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 35.6 mtm 83.69 172.2 0.08 Allowed 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 125.342 1.651 . . . . 1.03 110.959 -169.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -114.08 -9.15 12.98 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.667 -1.151 . . . . 1.1000000000000001 110.441 -175.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.23 167.07 1.41 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 123.024 1.392 . . . . 0.97999999999999998 113.756 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.0 m -93.15 122.65 35.75 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 112.909 -1.951 . . . . 0.45000000000000001 107.129 164.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.641 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.2 p90 -157.15 -171.38 3.6 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.451 0.643 . . . . 0.32000000000000001 111.636 -174.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.559 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.2 mm -104.31 160.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 107.839 -1.171 . . . . 0.080000000000000002 107.839 166.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.499 ' CD ' ' HE2' ' A' ' 466' ' ' PHE . 2.1 tt0 -140.41 155.49 46.71 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 118.82 0.737 . . . . 0.17000000000000001 111.336 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.627 HG22 ' HG3' ' A' ' 354' ' ' MET . 63.8 t -150.38 134.48 8.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.589 -1.187 . . . . 0.080000000000000002 110.251 -178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.412 ' HB2' ' HZ3' ' A' ' 355' ' ' TRP . 18.2 t0 -115.48 114.66 25.33 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.832 -1.076 . . . . 0.37 108.139 174.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.466 HD21 HG23 ' A' ' 465' ' ' VAL . 1.8 mm? -68.21 -51.93 39.91 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.803 1.287 . . . . 0.32000000000000001 110.586 -177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -47.57 -52.97 15.9 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 113.179 -1.828 . . . . 1.51 113.298 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -102.54 9.14 39.66 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.73 -1.123 . . . . 0.91000000000000003 109.06 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.75 ' OE1' HD12 ' A' ' 368' ' ' ILE . 85.0 mm-40 36.93 73.35 0.09 Allowed 'General case' 0 N--CA 1.47 0.554 0 O-C-N 125.058 1.474 . . . . 2.2200000000000002 111.871 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.425 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.8 t60 -150.3 125.95 10.31 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.54 -1.209 . . . . 0.13 109.434 -176.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.627 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -112.46 128.43 56.32 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 123.234 0.614 . . . . 0.059999999999999998 110.743 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.67 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.0 m-90 -111.87 173.11 6.51 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 114.634 -1.167 . . . . 0.10000000000000001 111.817 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.702 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 1.9 t80 -126.06 116.12 20.91 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 106.775 -1.565 . . . . 0.22 106.775 165.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.493 ' CE1' HG12 ' A' ' 362' ' ' VAL . 17.8 m-85 -98.86 126.33 44.48 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.142 0.973 . . . . 0.17999999999999999 112.165 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.678 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.5 ttpt -149.64 139.76 22.11 Favored 'General case' 0 N--CA 1.398 -3.05 0 CA-C-N 113.196 -1.82 . . . . 0.46999999999999997 107.846 174.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.467 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.43 15.44 6.21 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 114.008 -1.451 . . . . 0.59999999999999998 108.799 178.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 77.59 18.62 77.34 Favored Glycine 0 N--CA 1.427 -1.943 0 CA-C-N 112.378 -2.192 . . . . 0.23000000000000001 111.783 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.63 ' HE2' ' H ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -139.07 173.65 11.34 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.86 -1.904 . . . . 0.68000000000000005 105.86 -170.151 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.724 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.5 m -104.23 137.67 32.12 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.674 0 CA-C-O 124.338 2.018 . . . . 0.53000000000000003 112.246 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.702 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.37 -23.73 19.13 Favored 'General case' 0 N--CA 1.4 -2.959 0 CA-C-N 109.218 -3.628 . . . . 0.12 108.624 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.689 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -153.84 154.72 34.46 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 113.567 -1.651 . . . . 0.080000000000000002 108.405 -172.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.724 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.26 122.39 1.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.73 -0.668 . . . . 0.60999999999999999 109.299 -174.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.663 HG21 HG23 ' A' ' 445' ' ' THR . 6.3 t -149.05 166.87 27.42 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-O 122.105 0.955 . . . . 0.089999999999999997 111.84 173.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.646 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 4.7 p-10 -86.48 141.55 29.01 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 113.228 -1.805 . . . . 1.8799999999999999 107.444 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.75 HD12 ' OE1' ' A' ' 352' ' ' GLN . 1.6 pp -142.0 -171.82 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 CA-C-N 115.21 -0.904 . . . . 0.11 111.525 -175.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.59 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.1 OUTLIER -155.66 119.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 115.466 -0.788 . . . . 0.12 108.92 175.428 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.416 ' HB2' HG13 ' A' ' 443' ' ' ILE . 8.1 t -141.8 143.89 33.66 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.792 -1.095 . . . . 0.69999999999999996 112.748 -165.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.623 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 73.08 44.82 34.39 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 116.924 1.529 . . . . 0.13 116.924 162.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.489 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -47.69 142.36 6.71 Favored Pre-proline 0 CA--C 1.507 -0.676 0 CA-C-N 118.593 1.196 . . . . 0.47999999999999998 110.081 -175.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.791 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.59 -31.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.32 -0.967 1 C-N-CA 125.885 4.39 . . . . 0.23000000000000001 116.365 -170.07 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -82.89 -32.58 27.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.297 0.57 . . . . 0.29999999999999999 110.672 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.445 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 12.1 m -140.77 74.55 26.71 Favored Pre-proline 0 N--CA 1.448 -0.564 0 CA-C-O 122.151 0.976 . . . . 0.29999999999999999 110.239 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.623 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.76 162.41 42.13 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 125.068 3.845 . . . . 0.16 113.419 -179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.716 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -73.05 152.47 90.7 Favored Pre-proline 0 N--CA 1.436 -1.15 0 CA-C-N 113.665 -1.607 . . . . 0.12 110.806 178.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.47 -48.1 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 124.885 3.723 . . . . 0.089999999999999997 113.548 -172.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.803 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 66.31 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.918 1.081 . . . . 0.089999999999999997 113.918 -178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 163.79 -123.47 1.18 Allowed Glycine 0 N--CA 1.439 -1.144 0 CA-C-N 114.301 -1.318 . . . . 0.11 111.414 -177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 381' ' ' VAL . 10.6 p -129.8 104.93 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.17 0 CA-C-O 122.371 1.081 . . . . 0.89000000000000001 109.538 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.616 ' CE2' HG22 ' A' ' 465' ' ' VAL . 55.3 m-85 -110.4 166.33 11.07 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.994 -1.003 . . . . 0.16 108.862 -172.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.705 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -148.77 136.28 20.4 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-N 117.63 0.195 . . . . 0.68999999999999995 110.714 177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.583 HG21 ' HG2' ' A' ' 411' ' ' MET . 0.2 OUTLIER -72.29 124.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 CA-C-O 121.555 0.693 . . . . 0.14000000000000001 110.573 176.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -113.04 4.49 16.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.275 -0.875 . . . . 0.19 112.005 -177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.743 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 5.8 t30 -163.96 148.97 10.46 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.493 -0.776 . . . . 0.40999999999999998 110.583 176.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.432 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 7.7 mtpt -110.81 109.74 20.07 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.811 0.815 . . . . 1.0900000000000001 110.412 170.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.8 mt-10 -107.95 131.87 54.09 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.304 -1.316 . . . . 0.38 109.382 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.548 -1.205 . . . . 1.96 110.092 -176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 25.8 t70 50.43 40.42 22.99 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 123.597 1.665 . . . . 0.40000000000000002 107.516 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -92.32 170.2 9.98 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 111.927 -2.397 . . . . 0.16 110.809 -173.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 23.9 m -129.91 102.92 6.5 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 114.1 -1.409 . . . . 0.27000000000000002 110.136 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.784 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -75.17 158.16 33.46 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 112.717 -2.038 . . . . 0.23999999999999999 110.298 174.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 6.8 mtpt -148.55 -175.85 5.09 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-N 115.224 -0.898 . . . . 0.67000000000000004 108.919 -177.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.647 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.33 -144.23 6.06 Favored Glycine 0 CA--C 1.489 -1.553 0 C-N-CA 117.338 -2.363 . . . . 0.81000000000000005 114.975 176.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.05 121.44 13.18 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 113.488 -1.356 . . . . 0.79000000000000004 108.827 172.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.456 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -54.13 -179.38 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 112.113 -2.312 . . . . 1.1200000000000001 111.771 178.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -52.27 -27.23 14.26 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.889 -0.596 . . . . 1.6499999999999999 110.774 168.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -91.95 -26.99 18.16 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 121.312 0.577 . . . . 2.0 111.008 -174.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.61 35.54 3.77 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 110.469 -1.052 . . . . 0.66000000000000003 110.469 -170.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 41.6 p -118.83 127.88 26.28 Favored Pre-proline 0 N--CA 1.417 -2.088 0 N-CA-C 106.504 -1.665 . . . . 0.68000000000000005 106.504 178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.647 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 26.7 Cg_exo -64.35 161.87 32.73 Favored 'Trans proline' 0 C--N 1.286 -2.745 0 C-N-CA 121.949 1.766 . . . . 0.81000000000000005 112.461 -173.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.552 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 25.0 p90 -143.23 -170.94 3.38 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 113.502 -1.681 . . . . 0.38 107.119 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.67 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 10.4 mt-10 -147.76 157.35 43.5 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.329 1.061 . . . . 0.62 112.182 175.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.784 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -134.16 99.21 13.62 Favored Pre-proline 0 N--CA 1.423 -1.811 0 CA-C-N 113.236 -1.802 . . . . 1.3300000000000001 108.595 176.49 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.91 101.05 0.75 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.793 2.329 . . . . 0.20000000000000001 110.182 172.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.735 HG21 ' HB2' ' A' ' 421' ' ' HIS . 0.8 OUTLIER -120.28 133.91 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 CA-C-N 114.004 -1.453 . . . . 0.29999999999999999 111.234 -171.555 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.572 ' H ' HD22 ' A' ' 408' ' ' ASN . 0.1 OUTLIER -78.08 -30.32 49.56 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.822 -1.081 . . . . 1.8400000000000001 110.599 179.859 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.568 ' HB3' ' CD1' ' A' ' 454' ' ' PHE . 64.1 m-85 -142.15 117.83 10.41 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.728 -1.124 . . . . 0.44 110.758 179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.697 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.9 t-105 -122.94 135.65 54.57 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 114.24 -1.346 . . . . 0.13 110.296 -177.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.583 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -136.33 87.18 22.89 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 115.25 -0.886 . . . . 0.40999999999999998 110.962 174.499 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 90.8 Cg_endo -72.68 140.95 33.34 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.834 2.356 . . . . 0.16 111.554 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -122.55 -15.81 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-N 114.38 -1.282 . . . . 0.17000000000000001 111.656 -171.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.779 ' OD2' ' HB ' ' A' ' 418' ' ' VAL . 4.9 p30 -135.78 170.16 16.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.486 -0.779 . . . . 1.5900000000000001 109.58 169.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -96.08 15.31 21.1 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.206 -0.452 . . . . 0.31 111.989 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 18.3 p -96.85 -27.52 14.65 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.072 -1.085 . . . . 0.44 108.072 174.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 128.82 27.3 0.87 Allowed Glycine 0 N--CA 1.428 -1.892 0 CA-C-N 113.958 -1.473 . . . . 0.23999999999999999 113.314 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.779 ' HB ' ' OD2' ' A' ' 414' ' ' ASP . 61.5 t -103.44 151.77 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-O 121.266 0.555 . . . . 0.17000000000000001 111.428 175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 173.34 -163.99 35.62 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 115.149 -0.932 . . . . 0.10000000000000001 111.41 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.98 137.81 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.122 0 N-CA-C 109.251 -0.648 . . . . 0.12 109.251 177.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.735 ' HB2' HG21 ' A' ' 407' ' ' VAL . 33.3 p80 -152.65 169.84 21.7 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.725 0.774 . . . . 0.14999999999999999 111.422 179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.731 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -90.87 154.5 19.44 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 113.827 -1.533 . . . . 0.41999999999999998 108.699 174.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.632 ' OG ' ' HB3' ' A' ' 444' ' ' ASN . 18.5 p -140.11 99.95 3.8 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 122.583 1.182 . . . . 1.48 109.936 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -94.93 -31.17 13.78 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 112.621 -2.081 . . . . 0.34999999999999998 110.411 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.554 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 18.2 p90 -70.25 -26.99 64.09 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 114.369 -1.287 . . . . 0.17999999999999999 108.765 174.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.489 ' HB3' HD22 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.27 82.83 24.02 Favored Pre-proline 0 CA--C 1.489 -1.375 0 CA-C-N 113.437 -1.711 . . . . 1.3300000000000001 109.037 -174.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 425' ' ' TRP . 35.9 Cg_endo -80.07 3.61 7.47 Favored 'Trans proline' 0 C--N 1.293 -2.346 0 C-N-CA 124.483 3.455 . . . . 0.23000000000000001 114.619 -159.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . 0.412 ' HG3' ' H ' ' A' ' 429' ' ' TYR . 2.9 tp10 -113.96 157.17 22.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 120.892 0.377 . . . . 1.1000000000000001 110.738 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.646 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.66 125.89 2.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.293 -1.321 . . . . 0.38 108.68 -171.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.83 -168.34 28.72 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 119.419 -1.372 . . . . 0.13 112.158 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.596 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -32.28 155.36 0.01 OUTLIER Glycine 0 C--N 1.341 0.843 0 O-C-N 124.983 1.049 . . . . 0.20000000000000001 112.783 173.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.22 100.53 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.281 0 CA-C-O 124.025 1.869 . . . . 0.33000000000000002 112.249 -146.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 36.3 mt -97.84 -33.53 11.21 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-N 110.06 -3.246 . . . . 0.17999999999999999 109.298 175.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.56 ' HA ' HG23 ' A' ' 369' ' ' VAL . 8.0 p-90 -46.88 -34.45 5.43 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 113.214 -1.812 . . . . 0.22 112.16 -174.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.791 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 47.9 mttt -61.93 -23.79 66.57 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.334 -0.848 . . . . 0.64000000000000001 113.188 -177.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 51.5 p -115.8 -36.66 4.12 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.686 0.755 . . . . 0.25 110.085 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.585 ' HD2' HD22 ' A' ' 433' ' ' LEU . 4.5 mtp85 -81.65 -15.48 54.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.489 -1.232 . . . . 0.35999999999999999 112.973 -169.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 75.48 42.85 26.23 Favored Glycine 0 C--N 1.314 -0.646 0 N-CA-C 116.344 1.298 . . . . 0.20999999999999999 116.344 158.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 13.7 m -85.73 131.37 34.34 Favored 'General case' 0 C--O 1.208 -1.106 0 CA-C-N 118.282 1.041 . . . . 0.46999999999999997 109.117 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.442 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 60.2 m80 -101.8 71.73 1.32 Allowed 'General case' 0 C--N 1.319 -0.721 0 O-C-N 121.405 -0.809 . . . . 0.40999999999999998 110.919 -169.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.517 ' H ' ' HA2' ' A' ' 371' ' ' GLY . . . 85.8 -13.57 55.79 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.223 -1.151 . . . . 0.17999999999999999 110.223 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.569 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 28.1 p -88.59 148.18 24.21 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.063 -0.568 . . . . 0.82999999999999996 110.218 -178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.716 HD11 HG21 ' A' ' 377' ' ' THR . 1.6 mp -103.64 118.78 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-N 116.107 -0.497 . . . . 0.14999999999999999 110.348 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.632 ' HB3' ' OG ' ' A' ' 423' ' ' SER . 2.1 m-20 -85.49 90.01 7.85 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.589 -0.732 . . . . 1.77 111.641 -176.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.684 ' O ' ' HA ' ' A' ' 422' ' ' ASP . 99.5 m -87.02 138.76 32.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-O 121.473 0.654 . . . . 0.17999999999999999 109.726 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.0 Cg_exo -54.36 136.58 69.61 Favored 'Trans proline' 0 N--CA 1.447 -1.23 0 C-N-CA 122.685 2.257 . . . . 0.12 111.043 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.731 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 44.5 Cg_exo -55.65 -31.98 81.71 Favored 'Trans proline' 0 CA--C 1.502 -1.112 0 C-N-CA 123.984 3.122 . . . . 0.16 112.638 -172.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 13.7 p -80.63 -39.04 28.11 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 114.279 -1.328 . . . . 1.1699999999999999 109.623 -177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.588 HG11 ' HB ' ' A' ' 366' ' ' THR . 92.3 t -77.32 -31.02 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 115.552 -0.749 . . . . 0.17000000000000001 111.361 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.643 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 3.6 tpt -63.03 -24.4 67.9 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.584 0.707 . . . . 0.46000000000000002 110.523 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -72.28 -30.49 64.87 Favored 'General case' 0 CA--C 1.498 -1.044 0 CA-C-N 114.539 -1.209 . . . . 0.81000000000000005 112.628 174.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.67 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.7 mm-40 -75.68 -46.6 30.35 Favored 'General case' 0 CA--C 1.469 -2.149 0 CA-C-N 113.005 -1.907 . . . . 0.38 107.362 -178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.521 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 26.1 tp -64.97 -67.35 0.44 Allowed 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 111.491 -2.595 . . . . 0.059999999999999998 112.379 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 409' ' ' TYR . 26.8 t80 -50.37 -25.91 4.37 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 123.146 1.45 . . . . 0.31 108.309 178.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.442 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -72.34 -30.89 64.13 Favored Glycine 0 N--CA 1.427 -1.908 0 CA-C-N 112.475 -2.148 . . . . 0.13 112.156 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.689 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.7 ptp -87.63 -48.38 7.94 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-O 121.661 0.743 . . . . 0.13 111.324 172.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.647 ' HB ' ' HE2' ' A' ' 356' ' ' TYR . 0.5 OUTLIER -102.19 137.89 28.42 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 CA-C-O 123.351 1.548 . . . . 0.23000000000000001 113.989 -168.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.432 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.3 pt-20 -136.25 -178.56 5.21 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 110.965 -2.834 . . . . 0.82999999999999996 106.739 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.743 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 45.8 mtmt -50.95 160.54 0.46 Allowed 'General case' 0 N--CA 1.412 -2.352 0 CA-C-O 123.102 1.43 . . . . 0.23999999999999999 113.363 177.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 92.76 -36.21 3.78 Favored Glycine 0 N--CA 1.425 -2.07 0 CA-C-N 112.433 -2.167 . . . . 0.37 112.475 -178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 462' ' ' PRO . 19.3 m -70.35 141.17 88.15 Favored Pre-proline 0 N--CA 1.438 -1.048 0 CA-C-O 121.196 0.522 . . . . 0.14999999999999999 110.282 -175.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.641 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -73.58 161.56 41.86 Favored 'Trans proline' 0 N--CA 1.43 -2.259 0 C-N-CA 122.215 1.943 . . . . 0.12 110.884 172.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.535 ' O ' ' HB2' ' A' ' 382' ' ' PHE . 71.8 t -132.26 131.42 60.84 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 CA-C-N 113.466 -1.697 . . . . 1.0900000000000001 107.833 173.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.441 HD21 ' CD2' ' A' ' 339' ' ' HIS . 3.1 tp -109.83 142.03 41.69 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.232 0.539 . . . . 0.13 110.308 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.7 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.01 145.49 22.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 106.088 -1.819 . . . . 0.089999999999999997 106.088 164.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.803 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.135 -0.936 . . . . 1.1599999999999999 111.591 -174.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.238 -0.745 . . . . 3.9399999999999999 111.238 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.476 ' HD2' ' O ' ' A' ' 339' ' ' HIS . 1.0 OUTLIER -150.66 125.33 9.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.847 0.323 . . . . 1.8500000000000001 111.473 176.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 37.7 mtm 52.83 106.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 114.695 1.368 . . . . 1.03 114.695 164.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -71.58 -2.76 18.17 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 113.034 -1.894 . . . . 1.1000000000000001 110.45 175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -57.24 166.5 1.12 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 123.175 1.464 . . . . 0.97999999999999998 114.266 175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.614 HG23 ' HA ' ' A' ' 358' ' ' LYS . 22.6 m -94.99 124.64 39.15 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 112.339 -2.21 . . . . 0.45000000000000001 108.627 168.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.642 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 6.1 p90 -156.88 -171.01 3.49 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.52 0.676 . . . . 0.32000000000000001 111.41 -177.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' A' ' 457' ' ' VAL . 10.4 mm -102.26 162.14 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 108.221 -1.029 . . . . 0.080000000000000002 108.221 167.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.4 tt0 -142.14 156.54 45.36 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 118.835 0.743 . . . . 0.17000000000000001 111.545 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.691 HG22 ' HG3' ' A' ' 354' ' ' MET . 62.7 t -151.3 136.91 11.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 114.491 -1.231 . . . . 0.080000000000000002 110.077 -178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -117.67 115.34 24.87 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.68 -1.145 . . . . 0.37 108.104 172.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.509 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -67.83 -49.5 61.84 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 122.355 1.074 . . . . 0.32000000000000001 110.564 -176.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -52.89 -55.2 24.98 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 112.774 -2.012 . . . . 1.51 112.185 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -95.82 4.0 53.24 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.738 -1.119 . . . . 0.91000000000000003 109.964 -171.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.715 ' OE1' ' HA ' ' A' ' 369' ' ' VAL . 11.5 mm-40 47.08 66.14 1.07 Allowed 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 112.448 -2.16 . . . . 2.2200000000000002 112.129 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.5 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.2 t60 -148.48 125.35 11.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.286 0.565 . . . . 0.13 109.916 -175.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.691 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -112.35 127.42 56.0 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 123.606 0.763 . . . . 0.059999999999999998 110.359 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.684 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.4 m-90 -113.62 173.7 6.28 Favored 'General case' 0 CA--C 1.499 -0.988 0 CA-C-N 114.609 -1.178 . . . . 0.10000000000000001 112.062 -175.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.717 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -126.49 115.83 20.17 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 106.529 -1.656 . . . . 0.22 106.529 165.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.508 ' CE1' HG12 ' A' ' 362' ' ' VAL . 22.9 m-85 -100.44 127.91 46.65 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.993 0.901 . . . . 0.17999999999999999 112.118 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.614 ' HA ' HG23 ' A' ' 343' ' ' THR . 6.0 ttpt -147.79 137.68 22.71 Favored 'General case' 0 N--CA 1.398 -3.034 0 CA-C-N 113.667 -1.606 . . . . 0.46999999999999997 108.548 174.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.46 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.2 OUTLIER 70.48 14.2 7.37 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.402 -1.726 . . . . 0.59999999999999998 108.601 178.439 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 83.52 15.49 71.01 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 112.701 -2.045 . . . . 0.23000000000000001 112.186 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.583 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.69 169.9 16.97 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.158 -1.793 . . . . 0.68000000000000005 106.158 -170.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -101.41 138.23 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.794 0 CA-C-O 124.207 1.956 . . . . 0.53000000000000003 111.976 -179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.717 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.63 -25.01 18.48 Favored 'General case' 0 N--CA 1.399 -3.014 0 CA-C-N 109.361 -3.563 . . . . 0.12 108.688 176.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.714 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.5 tp -152.87 155.18 36.58 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 113.74 -1.573 . . . . 0.080000000000000002 109.301 -173.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.8 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.14 123.0 1.6 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-N 115.469 -0.787 . . . . 0.60999999999999999 109.339 -175.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.815 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.9 t -148.32 165.68 30.31 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 122.415 1.102 . . . . 0.089999999999999997 112.017 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.734 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 1.7 p-10 -83.46 140.85 32.09 Favored 'General case' 0 N--CA 1.415 -2.196 0 CA-C-N 112.881 -1.963 . . . . 1.8799999999999999 107.821 176.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.637 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -142.26 -171.33 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 115.264 -0.88 . . . . 0.11 112.064 -176.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.715 ' HA ' ' OE1' ' A' ' 352' ' ' GLN . 0.2 OUTLIER -157.94 116.92 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 114.936 -1.029 . . . . 0.12 109.352 176.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 11.5 t -140.94 145.54 36.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.28 -0.873 . . . . 0.69999999999999996 112.892 -165.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.653 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 68.54 46.68 61.21 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 116.199 1.24 . . . . 0.13 116.199 162.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.562 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.38 145.42 2.79 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 118.267 1.033 . . . . 0.47999999999999998 110.184 -175.252 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.771 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.47 -33.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 125.242 3.961 . . . . 0.23000000000000001 115.911 -173.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.562 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.5 p -80.41 -34.4 36.24 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.738 -0.601 . . . . 0.29999999999999999 110.752 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.456 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 5.3 m -139.98 73.06 33.53 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-O 122.209 1.004 . . . . 0.29999999999999999 109.994 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.653 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 29.5 Cg_exo -69.71 161.62 45.24 Favored 'Trans proline' 0 C--N 1.321 -0.907 1 C-N-CA 125.301 4.001 . . . . 0.16 113.967 -177.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.696 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -72.99 154.03 90.85 Favored Pre-proline 0 N--CA 1.438 -1.068 0 CA-C-N 113.562 -1.654 . . . . 0.12 110.358 175.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.543 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.1 Cg_endo -80.24 -50.32 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 125.029 3.82 . . . . 0.089999999999999997 113.564 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.714 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 67.8 123.24 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.996 0.903 . . . . 0.089999999999999997 113.322 -176.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.29 -124.07 1.22 Allowed Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 114.271 -1.331 . . . . 0.11 111.491 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 381' ' ' VAL . 9.2 p -128.63 104.53 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.454 1.121 . . . . 0.89000000000000001 109.831 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.785 ' HB2' HG22 ' A' ' 463' ' ' VAL . 93.8 m-85 -107.92 161.35 15.01 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.516 -1.22 . . . . 0.16 110.03 -170.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.728 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 76.5 m-85 -147.3 136.99 22.92 Favored 'General case' 0 CA--C 1.5 -0.963 0 O-C-N 122.974 0.171 . . . . 0.68999999999999995 110.694 175.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.625 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -73.2 120.36 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.003 0 C-N-CA 119.937 -0.705 . . . . 0.14000000000000001 110.16 176.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . 0.467 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 40.6 p-90 -106.31 3.62 27.78 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.404 -0.816 . . . . 0.19 111.789 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.721 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.7 t30 -164.54 148.86 9.46 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.224 -0.898 . . . . 0.40999999999999998 110.813 175.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.483 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 10.3 mtpt -107.4 111.16 23.36 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.478 -0.783 . . . . 1.0900000000000001 109.863 169.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.538 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.1 mt-10 -111.87 122.92 49.11 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 122.657 1.218 . . . . 0.38 110.912 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -118.1 145.0 45.18 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 114.079 -1.419 . . . . 1.96 109.253 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 34.6 t70 54.34 25.88 6.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 112.026 -2.352 . . . . 0.40000000000000002 108.582 -176.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.09 170.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.09 -1.868 . . . . 0.16 112.063 -168.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 31.5 m -127.49 102.26 6.79 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.526 -1.67 . . . . 0.27000000000000002 110.099 -176.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.746 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 9.9 mp -72.9 158.46 35.46 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 113.03 -1.896 . . . . 0.23999999999999999 110.502 175.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.505 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 6.4 mtpt -146.09 -176.98 5.37 Favored 'General case' 0 N--CA 1.396 -3.148 0 N-CA-C 108.636 -0.876 . . . . 0.67000000000000004 108.636 -178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . -178.27 -149.8 8.29 Favored Glycine 0 C--N 1.296 -1.665 0 C-N-CA 117.1 -2.476 . . . . 0.81000000000000005 115.239 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.663 ' HA ' ' O ' ' A' ' 401' ' ' THR . 0.7 OUTLIER -139.44 119.8 13.87 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.522 -1.339 . . . . 0.79000000000000004 110.077 174.222 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.426 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -52.72 -179.39 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 111.733 -2.485 . . . . 1.1200000000000001 112.192 175.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -52.42 -24.05 7.13 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.087 0.47 . . . . 1.6499999999999999 111.046 170.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -95.19 -27.78 15.37 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 116.317 -0.402 . . . . 2.0 111.909 -173.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 105.45 31.68 4.21 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 119.314 -1.422 . . . . 0.66000000000000003 111.087 -170.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' A' ' 396' ' ' THR . 44.9 p -113.84 153.32 46.06 Favored Pre-proline 0 N--CA 1.416 -2.166 0 N-CA-C 106.328 -1.73 . . . . 0.68000000000000005 106.328 177.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.773 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 97.9 Cg_endo -69.6 172.31 12.72 Favored 'Trans proline' 0 C--N 1.274 -3.351 0 C-N-CA 121.777 1.652 . . . . 0.81000000000000005 112.88 -174.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.594 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 8.5 p90 -155.01 -170.45 3.5 Favored 'General case' 0 C--N 1.279 -2.457 0 CA-C-N 112.518 -2.128 . . . . 0.38 106.905 171.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.1 mt-10 -147.7 158.16 43.89 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.342 1.067 . . . . 0.62 111.692 175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.746 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -135.2 98.95 12.39 Favored Pre-proline 0 N--CA 1.42 -1.951 0 CA-C-N 113.12 -1.855 . . . . 1.3300000000000001 107.568 176.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.4 Cg_endo -67.29 102.02 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 122.318 2.012 . . . . 0.20000000000000001 110.165 174.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.725 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.39 163.54 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.853 0 CA-C-N 114.192 -1.367 . . . . 0.29999999999999999 109.914 -173.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -114.92 -33.8 5.32 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 113.417 -1.72 . . . . 1.8400000000000001 107.081 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.423 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 59.8 m-85 -134.87 115.68 13.9 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 112.629 -2.078 . . . . 0.44 110.485 176.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.725 ' HB2' HG11 ' A' ' 407' ' ' VAL . 6.5 t-105 -123.81 134.27 53.66 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.646 -1.161 . . . . 0.13 110.254 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.584 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.4 OUTLIER -135.56 85.04 32.22 Favored Pre-proline 0 C--N 1.297 -1.687 0 CA-C-N 114.936 -1.029 . . . . 0.40999999999999998 110.93 173.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.691 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 73.2 Cg_endo -70.52 140.65 40.3 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.929 2.42 . . . . 0.16 112.102 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.728 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.5 pt -124.39 -16.19 4.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.076 -1.42 . . . . 0.17000000000000001 111.162 -173.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -134.88 161.0 36.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.536 -0.756 . . . . 1.5900000000000001 109.532 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -92.13 13.84 17.81 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.147 0.425 . . . . 0.31 112.147 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.7 p -93.02 -25.66 17.86 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 107.745 -1.206 . . . . 0.44 107.745 174.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 122.22 29.16 1.38 Allowed Glycine 0 N--CA 1.425 -2.054 0 CA-C-N 113.073 -1.876 . . . . 0.23999999999999999 112.179 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 441' ' ' GLY . 84.8 t -102.27 148.26 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.281 0.562 . . . . 0.17000000000000001 110.626 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 173.97 -166.04 38.01 Favored Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 114.731 -1.122 . . . . 0.10000000000000001 111.186 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.411 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.67 138.99 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 N-CA-C 108.795 -0.817 . . . . 0.12 108.795 176.074 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.543 ' HB3' ' HE3' ' A' ' 410' ' ' TRP . 31.3 p80 -149.98 163.63 37.59 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 121.652 0.739 . . . . 0.14999999999999999 111.969 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.789 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.33 137.35 32.43 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-N 114.293 -1.321 . . . . 0.41999999999999998 107.951 173.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 444' ' ' ASN . 0.5 OUTLIER -130.73 101.46 5.68 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.421 1.105 . . . . 1.48 109.606 -175.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -95.18 -30.54 13.96 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 113.082 -1.872 . . . . 0.34999999999999998 111.021 -178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.445 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 19.0 p90 -66.66 -26.54 67.1 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 114.414 -1.266 . . . . 0.17999999999999999 109.151 174.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.504 ' HB3' ' OD1' ' A' ' 444' ' ' ASN . 0.0 OUTLIER -119.95 82.65 28.84 Favored Pre-proline 0 CA--C 1.49 -1.347 0 CA-C-N 113.614 -1.63 . . . . 1.3300000000000001 109.451 -173.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -80.86 5.94 5.86 Favored 'Trans proline' 0 C--N 1.297 -2.154 0 C-N-CA 124.784 3.656 . . . . 0.23000000000000001 114.21 -160.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.67 153.7 29.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 116.336 -0.393 . . . . 1.1000000000000001 110.614 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.734 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.95 124.73 2.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.214 -1.357 . . . . 0.38 108.097 -172.189 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 352' ' ' GLN . . . 147.86 -168.12 28.75 Favored Glycine 0 C--N 1.297 -1.629 0 C-N-CA 119.283 -1.437 . . . . 0.13 111.123 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.673 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -29.6 152.33 0.0 OUTLIER Glycine 0 C--N 1.342 0.891 0 O-C-N 125.141 1.142 . . . . 0.20000000000000001 113.176 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.453 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.6 m-20 -54.59 101.06 0.04 OUTLIER 'General case' 0 CA--C 1.492 -1.271 0 CA-C-O 123.86 1.79 . . . . 0.33000000000000002 111.797 -145.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 55.6 mt -96.53 -30.79 13.11 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 110.474 -3.057 . . . . 0.17999999999999999 108.111 177.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.593 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.0 p-90 -46.46 -38.01 8.57 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 123.867 0.73 . . . . 0.22 111.398 -175.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.771 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 36.4 mttt -62.3 -24.34 67.24 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.921 -1.036 . . . . 0.64000000000000001 112.845 -175.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 31.1 p -113.23 -36.18 5.11 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.568 0.699 . . . . 0.25 110.16 -176.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.519 ' HB2' HG21 ' A' ' 369' ' ' VAL . 5.7 mtp85 -86.96 -16.83 34.64 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.783 -1.099 . . . . 0.35999999999999999 112.664 -168.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.497 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.47 43.79 29.34 Favored Glycine 0 CA--C 1.531 1.087 0 N-CA-C 116.506 1.362 . . . . 0.20999999999999999 116.506 162.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 15.0 m -86.21 130.74 34.42 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 118.701 1.251 . . . . 0.46999999999999997 108.179 172.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.479 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 61.7 m80 -99.72 64.34 1.27 Allowed 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.47 -0.769 . . . . 0.40999999999999998 110.96 -168.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.566 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 94.9 -12.75 68.2 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.577 -1.009 . . . . 0.17999999999999999 110.577 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.517 ' HB2' ' NE2' ' A' ' 421' ' ' HIS . 10.7 p -90.49 142.77 27.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.238 -0.481 . . . . 0.82999999999999996 110.66 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -95.91 120.74 45.69 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-O 122.579 1.18 . . . . 0.14999999999999999 111.19 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.607 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.5 OUTLIER -78.92 82.48 5.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.784 -2.007 . . . . 1.77 111.936 -178.497 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.567 HG23 HG21 ' A' ' 366' ' ' THR . 16.5 m -87.05 137.75 32.99 Favored Pre-proline 0 N--CA 1.444 -0.763 0 CA-C-O 121.383 0.611 . . . . 0.17999999999999999 109.509 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.499 ' HG2' ' OG1' ' A' ' 366' ' ' THR . 50.9 Cg_exo -57.42 136.14 74.21 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.723 2.282 . . . . 0.12 111.595 177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.789 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 33.8 Cg_exo -55.14 -33.0 82.44 Favored 'Trans proline' 0 CA--C 1.503 -1.047 0 C-N-CA 124.245 3.297 . . . . 0.16 113.138 -172.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.418 ' O ' ' HG2' ' A' ' 452' ' ' GLU . 4.6 t -81.42 -38.51 26.38 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.883 -1.053 . . . . 1.1699999999999999 109.304 -177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.815 HG11 ' HB ' ' A' ' 366' ' ' THR . 26.1 t -82.9 -26.85 8.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.468 0.652 . . . . 0.17000000000000001 111.11 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.699 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.7 tpt -68.58 -19.92 64.49 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.878 0.847 . . . . 0.46000000000000002 110.073 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -78.48 -23.22 46.53 Favored 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 114.609 -1.178 . . . . 0.81000000000000005 111.075 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 456' ' ' MET . 4.8 mm-40 -80.84 -45.97 16.05 Favored 'General case' 0 CA--C 1.477 -1.838 0 CA-C-N 112.905 -1.952 . . . . 0.38 107.473 178.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.597 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.4 tp -65.01 -66.85 0.49 Allowed 'General case' 0 N--CA 1.405 -2.687 0 CA-C-N 111.89 -2.414 . . . . 0.059999999999999998 112.311 174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.434 ' HB2' ' HE3' ' A' ' 450' ' ' MET . 24.1 t80 -50.16 -27.86 6.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.94 1.352 . . . . 0.31 107.965 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -69.58 -30.13 71.09 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 112.491 -2.14 . . . . 0.13 112.469 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.714 ' SD ' ' HB2' ' A' ' 364' ' ' LEU . 1.6 ptp -89.88 -48.26 7.35 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-O 121.597 0.713 . . . . 0.13 111.611 172.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.537 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.24 138.69 25.56 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.046 0 CA-C-O 123.365 1.555 . . . . 0.23000000000000001 114.182 -167.073 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.483 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.0 pt-20 -136.4 -178.74 5.3 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 110.834 -2.894 . . . . 0.82999999999999996 106.845 -179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.721 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.9 mtmt -52.22 162.77 0.45 Allowed 'General case' 0 N--CA 1.413 -2.308 0 CA-C-O 123.114 1.435 . . . . 0.23999999999999999 113.058 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.64 -34.63 4.27 Favored Glycine 0 N--CA 1.424 -2.149 0 CA-C-N 112.48 -2.145 . . . . 0.37 112.283 -178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.52 HG22 ' O ' ' A' ' 462' ' ' PRO . 7.6 m -76.04 141.33 71.01 Favored Pre-proline 0 N--CA 1.434 -1.261 0 N-CA-C 109.484 -0.562 . . . . 0.14999999999999999 109.484 -176.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.642 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 4.8 Cg_exo -75.6 166.47 28.4 Favored 'Trans proline' 0 N--CA 1.425 -2.53 0 C-N-CA 122.024 1.816 . . . . 0.12 111.157 173.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.785 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.63 153.2 34.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 N-CA-C 107.634 -1.247 . . . . 1.0900000000000001 107.634 166.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.42 ' HB3' ' HA ' ' A' ' 346' ' ' GLU . 3.3 tp -123.4 145.25 48.93 Favored 'General case' 0 C--N 1.28 -2.45 0 CA-C-N 115.096 -0.956 . . . . 0.13 110.155 179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.28 146.05 21.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 106.413 -1.699 . . . . 0.089999999999999997 106.413 164.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.654 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 18.0 p90 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.62 -0.705 . . . . 1.1599999999999999 111.364 -175.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.721 0 N-CA-C 111.961 -0.456 . . . . 3.9399999999999999 111.961 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -111.05 96.66 6.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.187 0.517 . . . . 1.8500000000000001 109.9 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 36.0 mtm 62.21 -173.53 0.15 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.411 -1.268 . . . . 1.03 111.597 -175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.83 -4.83 0.73 Allowed 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.434 -0.803 . . . . 1.1000000000000001 111.029 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -54.88 168.04 0.33 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 123.193 1.473 . . . . 0.97999999999999998 113.008 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.602 HG23 ' HA ' ' A' ' 358' ' ' LYS . 27.1 m -91.82 123.28 35.08 Favored 'General case' 0 N--CA 1.424 -1.739 0 CA-C-N 112.803 -1.999 . . . . 0.45000000000000001 107.959 169.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.656 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 11.4 p90 -161.0 -170.75 2.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.153 -0.931 . . . . 0.32000000000000001 110.768 -175.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.593 HD11 ' HB ' ' A' ' 457' ' ' VAL . 11.9 mm -104.45 161.26 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.027 0 N-CA-C 108.097 -1.075 . . . . 0.080000000000000002 108.097 167.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.518 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 2.7 tt0 -140.35 155.85 46.63 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.956 0.798 . . . . 0.17000000000000001 111.253 179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.727 HG22 ' HG3' ' A' ' 354' ' ' MET . 67.0 t -150.84 133.4 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 114.413 -1.267 . . . . 0.080000000000000002 109.721 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . 0.496 ' OD1' ' HB2' ' A' ' 350' ' ' GLU . 50.9 t0 -115.05 111.78 21.61 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 107.336 -1.357 . . . . 0.37 107.336 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.645 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.6 mm? -60.61 -58.67 7.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 122.783 1.277 . . . . 0.32000000000000001 107.618 177.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.496 ' HB2' ' OD1' ' A' ' 348' ' ' ASP . 11.9 mm-40 -48.94 -46.85 43.92 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 111.353 -2.658 . . . . 1.51 112.943 -170.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -111.13 20.73 17.13 Favored 'General case' 0 CA--C 1.507 -0.703 0 O-C-N 125.206 1.567 . . . . 0.91000000000000003 109.203 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.713 ' NE2' ' HA2' ' A' ' 431' ' ' GLY . 1.2 mp0 36.24 68.84 0.22 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 113.27 -1.787 . . . . 2.2200000000000002 112.622 170.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.499 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 7.0 t60 -153.17 124.5 7.58 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.194 0.521 . . . . 0.13 109.914 -175.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.727 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.1 ttp -110.91 127.54 55.5 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 123.454 0.702 . . . . 0.059999999999999998 110.605 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.654 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.1 m-90 -112.25 173.76 6.21 Favored 'General case' 0 C--O 1.211 -0.969 0 CA-C-N 114.459 -1.246 . . . . 0.10000000000000001 112.05 -175.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.718 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.3 t80 -127.41 119.15 25.51 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 106.261 -1.755 . . . . 0.22 106.261 165.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.522 ' CE1' HG12 ' A' ' 362' ' ' VAL . 18.5 m-85 -102.49 129.52 49.03 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.941 0.877 . . . . 0.17999999999999999 111.524 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.602 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.5 ttpt -148.46 137.43 21.7 Favored 'General case' 0 N--CA 1.395 -3.188 0 CA-C-N 113.722 -1.581 . . . . 0.46999999999999997 108.116 173.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.5 OUTLIER 71.38 15.1 6.33 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.456 -1.702 . . . . 0.59999999999999998 108.752 178.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 80.51 17.79 72.57 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 112.667 -2.06 . . . . 0.23000000000000001 111.899 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.546 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -137.12 168.07 20.31 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.098 -1.816 . . . . 0.68000000000000005 106.098 -171.67 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.687 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -100.11 138.21 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.802 0 CA-C-O 124.25 1.976 . . . . 0.53000000000000003 111.874 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.718 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.24 -25.18 17.9 Favored 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 109.305 -3.589 . . . . 0.12 108.564 177.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.679 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.0 tp -152.46 155.36 37.36 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 113.868 -1.515 . . . . 0.080000000000000002 109.227 -171.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.687 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -165.93 122.51 1.36 Allowed 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 115.668 -0.696 . . . . 0.60999999999999999 109.614 -174.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.74 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.6 t -148.3 167.16 25.9 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 122.177 0.989 . . . . 0.089999999999999997 112.136 174.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.606 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 5.5 p-10 -86.77 140.93 29.25 Favored 'General case' 0 C--N 1.292 -1.925 0 CA-C-N 113.222 -1.808 . . . . 1.8799999999999999 107.916 177.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.61 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -143.15 -172.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 CA-C-N 115.309 -0.859 . . . . 0.11 112.484 -175.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.63 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -154.36 119.06 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.705 -1.134 . . . . 0.12 108.696 175.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 6.6 t -141.27 143.41 34.09 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.759 -0.655 . . . . 0.69999999999999996 112.742 -168.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 74.53 45.1 24.59 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 117.716 -1.602 . . . . 0.13 117.001 163.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.435 ' CB ' ' HA2' ' A' ' 438' ' ' GLY . 0.3 OUTLIER -46.71 143.85 3.94 Favored Pre-proline 0 C--O 1.219 -0.521 0 CA-C-N 119.722 1.761 . . . . 0.47999999999999998 110.363 -173.146 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.824 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.68 -33.67 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.948 4.432 . . . . 0.23000000000000001 115.912 -170.811 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 3.1 p -75.06 -37.97 61.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.3 0.571 . . . . 0.29999999999999999 111.076 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 7.1 m -140.55 74.31 28.32 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 122.106 0.955 . . . . 0.29999999999999999 110.606 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.642 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 25.4 Cg_exo -70.94 160.44 49.37 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 125.175 3.917 . . . . 0.16 113.853 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.69 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -71.1 153.09 94.65 Favored Pre-proline 0 N--CA 1.436 -1.125 0 CA-C-N 113.269 -1.787 . . . . 0.12 111.357 177.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.526 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.5 Cg_endo -80.17 -49.67 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 125.09 3.86 . . . . 0.089999999999999997 113.734 -171.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.701 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.3 122.86 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 113.737 1.014 . . . . 0.089999999999999997 113.737 -178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 165.08 -124.74 1.28 Allowed Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 114.242 -1.345 . . . . 0.11 111.423 -178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.6 p -128.72 105.65 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 CA-C-O 122.296 1.046 . . . . 0.89000000000000001 109.267 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.814 ' HB2' HG22 ' A' ' 463' ' ' VAL . 96.8 m-85 -108.97 164.16 12.65 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.138 -0.937 . . . . 0.16 110.058 -169.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.694 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 68.9 m-85 -147.34 137.23 23.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 121.196 -0.202 . . . . 0.68999999999999995 110.954 175.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.589 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.63 121.41 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 121.491 0.662 . . . . 0.14000000000000001 110.364 176.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . 0.405 ' C ' ' HD3' ' A' ' 459' ' ' LYS . 42.7 p-90 -108.62 5.86 25.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.421 -0.809 . . . . 0.19 111.88 -178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.729 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 4.2 t30 -164.6 146.82 8.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.874 . . . . 0.40999999999999998 110.251 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -108.89 115.63 30.45 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.958 -0.756 . . . . 1.0900000000000001 108.958 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.572 ' HB3' ' CB ' ' A' ' 391' ' ' ALA . 2.3 mt-10 -118.65 111.98 19.23 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 123.472 1.606 . . . . 0.38 113.065 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 408' ' ' ASN . 2.6 mp0 -103.84 143.74 32.42 Favored 'General case' 0 N--CA 1.409 -2.493 0 CA-C-N 113.289 -1.778 . . . . 1.96 109.708 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 30.7 t70 57.08 22.23 7.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 112.259 -2.246 . . . . 0.40000000000000002 108.604 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.572 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -82.33 171.15 14.53 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 113.403 -1.726 . . . . 0.16 112.56 -167.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 15.7 m -127.5 104.23 7.78 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 113.051 -1.886 . . . . 0.27000000000000002 110.004 -177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.735 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.0 mp -73.26 156.99 37.93 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 112.642 -2.072 . . . . 0.23999999999999999 109.98 174.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.491 ' HG3' ' CG ' ' A' ' 404' ' ' GLU . 7.3 mtpt -150.83 -175.71 5.23 Favored 'General case' 0 N--CA 1.398 -3.058 0 O-C-N 124.352 1.032 . . . . 0.67000000000000004 108.789 -176.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.612 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.44 -142.04 5.05 Favored Glycine 0 CA--C 1.487 -1.68 0 C-N-CA 117.411 -2.328 . . . . 0.81000000000000005 114.922 176.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.25 124.06 15.17 Favored 'General case' 0 N--CA 1.421 -1.883 0 CA-C-N 113.117 -1.542 . . . . 0.79000000000000004 108.46 170.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.518 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -54.2 -178.75 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 112.222 -2.263 . . . . 1.1200000000000001 111.643 177.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -51.7 -25.34 7.1 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.838 -0.619 . . . . 1.6499999999999999 111.549 171.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.518 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 0.6 OUTLIER -101.43 -30.08 11.65 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.048 0.451 . . . . 2.0 111.554 -174.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 115.86 36.24 1.17 Allowed Glycine 0 C--N 1.296 -1.673 0 C-N-CA 119.59 -1.291 . . . . 0.66000000000000003 111.736 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 67.6 p -117.56 128.53 25.94 Favored Pre-proline 0 N--CA 1.421 -1.913 0 N-CA-C 106.035 -1.839 . . . . 0.68000000000000005 106.035 174.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 27.4 Cg_exo -64.65 161.43 35.66 Favored 'Trans proline' 0 C--N 1.284 -2.858 0 C-N-CA 121.703 1.602 . . . . 0.81000000000000005 112.213 -174.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.574 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 26.9 p90 -140.88 -170.09 2.96 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 113.792 -1.549 . . . . 0.38 106.998 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.669 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 16.2 mt-10 -148.79 158.01 43.85 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 122.392 1.091 . . . . 0.62 112.112 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.735 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.91 99.22 10.24 Favored Pre-proline 0 N--CA 1.424 -1.766 0 CA-C-N 112.948 -1.933 . . . . 1.3300000000000001 108.239 176.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 64.0 Cg_endo -67.62 102.24 0.71 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 122.549 2.166 . . . . 0.20000000000000001 110.669 175.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.757 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -113.64 165.34 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.62 0 CA-C-N 114.238 -1.346 . . . . 0.29999999999999999 109.84 -173.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 389' ' ' GLU . 18.0 m-80 -116.3 -33.5 4.95 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 113.551 -1.659 . . . . 1.8400000000000001 107.083 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.412 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 46.3 m-85 -136.2 115.47 12.56 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.062 -1.881 . . . . 0.44 110.474 175.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.757 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.7 t-105 -122.95 135.77 54.61 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.712 -1.131 . . . . 0.13 110.065 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.57 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.8 OUTLIER -136.51 83.49 30.88 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 114.892 -1.049 . . . . 0.40999999999999998 110.923 173.496 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 13.9 Cg_endo -70.31 139.5 38.44 Favored 'Trans proline' 0 CA--C 1.515 -0.452 0 C-N-CA 123.141 2.561 . . . . 0.16 112.659 -179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.3 pt -123.93 -15.15 5.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 113.792 -1.549 . . . . 0.17000000000000001 111.453 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -134.39 163.64 29.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.323 -0.853 . . . . 1.5900000000000001 109.483 177.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -96.96 13.55 28.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.801 0.334 . . . . 0.31 111.735 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 3.4 p -92.45 -27.06 17.7 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.538 -1.282 . . . . 0.44 107.538 173.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.68 29.36 1.07 Allowed Glycine 0 N--CA 1.425 -2.066 0 CA-C-N 112.862 -1.972 . . . . 0.23999999999999999 112.353 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 441' ' ' GLY . 74.3 t -102.47 148.76 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 CA-C-O 121.232 0.539 . . . . 0.17000000000000001 111.142 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.459 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 174.49 -167.46 39.78 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 114.831 -1.077 . . . . 0.10000000000000001 111.336 -178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.419 HG21 ' CD2' ' A' ' 453' ' ' LEU . 0.9 OUTLIER -103.61 141.01 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 108.858 -0.793 . . . . 0.12 108.858 175.528 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.593 ' O ' ' HB ' ' A' ' 445' ' ' THR . 32.9 p80 -149.46 165.16 32.95 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 121.747 0.784 . . . . 0.14999999999999999 111.616 178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -93.28 139.39 30.69 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.019 -1.475 . . . . 0.41999999999999998 107.019 171.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.42 ' HB3' ' ND2' ' A' ' 444' ' ' ASN . 1.8 t -134.06 103.2 5.69 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 122.97 1.367 . . . . 1.48 110.066 -176.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -94.49 -32.36 13.53 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 112.234 -2.257 . . . . 0.34999999999999998 111.162 -178.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . . . . . . . . . 13.9 p90 -65.67 -27.19 68.18 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 114.55 -1.205 . . . . 0.17999999999999999 109.055 175.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.592 ' OE1' ' HB3' ' A' ' 437' ' ' ARG . 0.0 OUTLIER -121.36 82.62 39.21 Favored Pre-proline 0 CA--C 1.493 -1.221 0 CA-C-N 113.406 -1.724 . . . . 1.3300000000000001 109.485 -174.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -81.24 7.33 5.03 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 C-N-CA 124.818 3.678 . . . . 0.23000000000000001 114.471 -160.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.68 154.46 27.24 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.009 0.433 . . . . 1.1000000000000001 111.303 -177.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.606 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.1 OUTLIER -163.97 126.0 2.39 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 114.178 -1.374 . . . . 0.38 108.86 -171.165 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.565 ' O ' ' HG2' ' A' ' 352' ' ' GLN . . . 146.95 -166.63 28.38 Favored Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 119.68 -1.248 . . . . 0.13 110.65 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.713 ' HA2' ' NE2' ' A' ' 352' ' ' GLN . . . -29.14 151.89 0.0 OUTLIER Glycine 0 C--N 1.341 0.822 0 O-C-N 125.187 1.169 . . . . 0.20000000000000001 113.258 173.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.01 100.5 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.247 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 111.944 -152.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 42.3 mt -97.69 -32.12 11.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-N 110.403 -3.089 . . . . 0.17999999999999999 107.941 174.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.63 ' HA ' HG23 ' A' ' 369' ' ' VAL . 3.8 p-90 -46.0 -38.54 7.89 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.987 0.804 . . . . 0.22 111.414 -174.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.824 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 34.9 mttt -59.11 -26.63 64.85 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-N 114.781 -1.1 . . . . 0.64000000000000001 113.021 -176.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 42.6 p -111.53 -35.35 5.82 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.898 0.856 . . . . 0.25 109.859 -176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.592 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 7.0 mtp85 -86.77 -15.55 38.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 114.439 -1.255 . . . . 0.35999999999999999 112.647 -168.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.435 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.65 41.89 33.95 Favored Glycine 0 C--N 1.313 -0.702 0 N-CA-C 116.608 1.403 . . . . 0.20999999999999999 116.608 159.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 7.7 p -91.07 131.76 36.45 Favored 'General case' 0 C--O 1.213 -0.821 0 CA-C-N 118.318 1.059 . . . . 0.46999999999999997 109.124 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.52 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 71.3 m80 -98.6 69.08 1.86 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.673 -0.642 . . . . 0.40999999999999998 111.209 -167.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.571 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 88.41 -11.77 66.96 Favored Glycine 0 N--CA 1.441 -1.006 0 N-CA-C 110.39 -1.084 . . . . 0.17999999999999999 110.39 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.571 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 18.4 p -86.88 141.34 28.84 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.181 -0.51 . . . . 0.82999999999999996 109.924 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.69 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -95.52 117.71 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-O 121.668 0.747 . . . . 0.14999999999999999 110.781 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.603 ' HB3' HG13 ' A' ' 369' ' ' VAL . 2.1 t30 -76.86 82.59 3.43 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.498 -1.228 . . . . 1.77 111.354 -176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.593 ' HB ' ' O ' ' A' ' 421' ' ' HIS . 27.4 m -86.94 138.85 32.75 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-O 121.549 0.69 . . . . 0.17999999999999999 109.628 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 52.6 Cg_exo -58.13 135.26 67.3 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 122.654 2.236 . . . . 0.12 111.416 178.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.783 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 30.3 Cg_exo -54.44 -34.08 79.97 Favored 'Trans proline' 0 CA--C 1.501 -1.129 0 C-N-CA 124.299 3.333 . . . . 0.16 112.783 -174.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 44.7 m -78.98 -41.37 29.29 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 114.458 -1.247 . . . . 1.1699999999999999 110.07 -178.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.74 HG11 ' HB ' ' A' ' 366' ' ' THR . 54.0 t -79.21 -28.3 13.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.252 0.549 . . . . 0.17000000000000001 111.487 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.692 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 5.8 tpt -68.29 -18.58 64.56 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.775 0.797 . . . . 0.46000000000000002 110.096 177.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -80.09 -22.23 42.46 Favored 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.7 -1.136 . . . . 0.81000000000000005 110.875 177.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.687 ' O ' ' HG2' ' A' ' 456' ' ' MET . 5.3 mm-40 -81.0 -47.3 13.81 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 112.767 -2.015 . . . . 0.38 107.38 177.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.629 HD23 ' SD ' ' A' ' 450' ' ' MET . 25.5 tp -64.28 -67.01 0.47 Allowed 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 111.878 -2.419 . . . . 0.059999999999999998 112.318 175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.442 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 36.0 t80 -49.76 -26.8 4.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 123.181 1.467 . . . . 0.31 108.285 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -71.7 -30.95 65.54 Favored Glycine 0 N--CA 1.427 -1.954 0 CA-C-N 112.251 -2.25 . . . . 0.13 112.331 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.687 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.7 ptp -89.19 -48.88 7.08 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-O 121.688 0.756 . . . . 0.13 111.572 172.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.593 ' HB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -100.26 139.23 22.22 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.169 0 CA-C-O 123.328 1.537 . . . . 0.23000000000000001 113.764 -168.719 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -136.19 -178.78 5.31 Favored 'General case' 0 N--CA 1.402 -2.835 0 CA-C-N 110.816 -2.902 . . . . 0.82999999999999996 106.883 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.729 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 42.6 mtmt -52.98 162.73 0.59 Allowed 'General case' 0 N--CA 1.409 -2.504 0 CA-C-O 123.025 1.393 . . . . 0.23999999999999999 112.694 176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.4 -36.51 3.61 Favored Glycine 0 N--CA 1.423 -2.207 0 CA-C-N 112.577 -2.101 . . . . 0.37 112.514 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 462' ' ' PRO . 4.1 m -74.27 141.72 77.66 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 109.471 -0.566 . . . . 0.14999999999999999 109.471 -175.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 3.7 Cg_exo -74.39 167.74 26.44 Favored 'Trans proline' 0 N--CA 1.424 -2.559 0 C-N-CA 121.765 1.644 . . . . 0.12 111.041 173.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.814 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -135.57 156.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 107.504 -1.295 . . . . 1.0900000000000001 107.504 166.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 346' ' ' GLU . 2.8 tp -126.98 145.15 50.8 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.462 -0.79 . . . . 0.13 110.233 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.701 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.27 146.7 21.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 106.869 -1.53 . . . . 0.089999999999999997 106.869 164.429 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.685 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 14.7 p90 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.372 -0.823 . . . . 1.1599999999999999 111.477 -176.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.067 -0.413 . . . . 3.9399999999999999 112.067 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.511 ' O ' ' HB2' ' A' ' 340' ' ' MET . 3.5 t-160 -116.51 87.41 2.68 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 121.13 0.491 . . . . 1.8500000000000001 109.934 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 339' ' ' HIS . 32.7 mtm 76.27 -175.97 0.12 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.82 -1.536 . . . . 1.03 111.53 -175.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.27 -8.91 1.3 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.408 -0.815 . . . . 1.1000000000000001 112.332 -175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -57.06 169.34 0.55 Allowed 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 123.048 1.404 . . . . 0.97999999999999998 112.934 173.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.606 HG23 ' HA ' ' A' ' 358' ' ' LYS . 33.1 m -92.28 122.86 35.16 Favored 'General case' 0 N--CA 1.424 -1.726 0 CA-C-N 113.122 -1.854 . . . . 0.45000000000000001 108.524 171.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.64 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 7.9 p90 -162.33 -170.32 2.42 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.913 -1.039 . . . . 0.32000000000000001 110.585 -174.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.562 HD11 ' CB ' ' A' ' 457' ' ' VAL . 10.1 mm -101.71 160.98 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.078 -1.082 . . . . 0.080000000000000002 108.078 166.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.479 ' HG3' ' CD2' ' A' ' 464' ' ' LEU . 3.6 tt0 -140.95 154.62 46.16 Favored 'General case' 0 CA--C 1.493 -1.214 0 CA-C-N 118.805 0.73 . . . . 0.17000000000000001 110.898 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.712 HG22 ' HG3' ' A' ' 354' ' ' MET . 61.4 t -150.24 134.69 9.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.31 -1.314 . . . . 0.080000000000000002 109.296 -179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -117.51 110.42 17.94 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.202 -1.407 . . . . 0.37 107.202 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.63 ' H ' HD22 ' A' ' 349' ' ' LEU . 1.8 mm? -58.52 -56.98 15.13 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 107.835 -1.172 . . . . 0.32000000000000001 107.835 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -46.27 -51.21 14.95 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 111.956 -2.384 . . . . 1.51 112.993 -170.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -100.73 4.42 43.05 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 113.394 -1.73 . . . . 0.91000000000000003 110.082 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.677 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 1.7 mp0 47.42 67.01 0.88 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 112.428 -2.169 . . . . 2.2200000000000002 112.363 178.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.468 ' HD2' ' CE2' ' A' ' 355' ' ' TRP . 6.3 t60 -146.79 125.69 12.74 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.377 0.608 . . . . 0.13 110.107 -177.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.712 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -112.6 128.38 56.35 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 123.54 0.736 . . . . 0.059999999999999998 110.658 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.675 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.3 m-90 -112.76 173.27 6.46 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 114.44 -1.254 . . . . 0.10000000000000001 111.869 -176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.688 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 3.0 t80 -126.93 116.67 21.16 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.33 -1.729 . . . . 0.22 106.33 165.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.464 ' CD1' ' HB2' ' A' ' 346' ' ' GLU . 24.4 m-85 -100.53 128.93 46.44 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-O 121.899 0.857 . . . . 0.17999999999999999 111.609 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.606 ' HA ' HG23 ' A' ' 343' ' ' THR . 4.5 ttpt -148.18 137.37 22.02 Favored 'General case' 0 N--CA 1.399 -3.013 0 CA-C-N 113.761 -1.563 . . . . 0.46999999999999997 108.473 173.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.457 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 0.4 OUTLIER 70.73 16.69 6.71 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 113.332 -1.758 . . . . 0.59999999999999998 108.803 178.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.68 18.9 72.06 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 112.652 -2.067 . . . . 0.23000000000000001 111.819 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.574 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -136.96 169.56 17.57 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 106.349 -1.723 . . . . 0.68000000000000005 106.349 -170.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.692 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.1 m -102.36 138.36 26.91 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.865 0 CA-C-O 124.252 1.977 . . . . 0.53000000000000003 111.839 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.688 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -93.18 -25.37 17.87 Favored 'General case' 0 N--CA 1.4 -2.968 0 CA-C-N 109.24 -3.618 . . . . 0.12 108.647 177.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.639 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 2.8 tp -153.23 154.87 35.53 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 113.762 -1.563 . . . . 0.080000000000000002 108.654 -171.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.692 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.59 122.07 1.17 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.738 -0.665 . . . . 0.60999999999999999 109.651 -174.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.678 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.8 t -148.74 167.09 26.5 Favored 'General case' 0 N--CA 1.421 -1.917 0 CA-C-O 122.338 1.066 . . . . 0.089999999999999997 112.01 174.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.666 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 2.2 p-10 -85.13 142.01 29.81 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 113.061 -1.881 . . . . 1.8799999999999999 107.69 176.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.677 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.7 pp -142.02 -174.34 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.257 -0.883 . . . . 0.11 112.122 -175.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.709 ' O ' ' HB2' ' A' ' 444' ' ' ASN . 0.2 OUTLIER -152.46 117.12 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.151 -0.931 . . . . 0.12 109.318 175.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 443' ' ' ILE . 30.2 t -141.54 148.25 39.05 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.963 0.727 . . . . 0.69999999999999996 112.963 -168.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.61 ' CA ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.7 44.96 47.02 Favored Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 116.197 1.239 . . . . 0.13 116.197 162.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.573 ' HD2' ' OG1' ' A' ' 374' ' ' THR . 0.0 OUTLIER -46.9 143.76 4.2 Favored Pre-proline 0 CA--C 1.509 -0.634 0 CA-C-N 118.317 1.058 . . . . 0.47999999999999998 109.977 -174.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.796 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -34.19 -32.44 0.06 OUTLIER 'Trans proline' 0 C--N 1.322 -0.826 1 C-N-CA 125.705 4.27 . . . . 0.23000000000000001 116.08 -170.681 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . 0.573 ' OG1' ' HD2' ' A' ' 372' ' ' LYS . 1.6 p -81.35 -34.56 31.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.359 0.599 . . . . 0.29999999999999999 110.755 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.465 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 2.9 m -140.04 73.04 33.23 Favored Pre-proline 0 N--CA 1.446 -0.666 0 CA-C-O 122.125 0.964 . . . . 0.29999999999999999 110.302 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.61 ' HA ' ' CA ' ' A' ' 371' ' ' GLY . 23.0 Cg_exo -71.81 161.47 44.97 Favored 'Trans proline' 0 C--N 1.321 -0.87 0 C-N-CA 125.22 3.947 . . . . 0.16 113.869 -178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.723 HG21 HD11 ' A' ' 443' ' ' ILE . 0.0 OUTLIER -72.52 151.97 91.71 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 113.333 -1.758 . . . . 0.12 111.05 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.521 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.9 Cg_endo -80.0 -48.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 125.277 3.984 . . . . 0.089999999999999997 113.913 -170.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.697 ' HA ' HG22 ' A' ' 465' ' ' VAL . . . 68.32 122.33 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 113.992 1.108 . . . . 0.089999999999999997 113.992 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.36 -125.88 1.43 Allowed Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 114.121 -1.4 . . . . 0.11 110.778 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 381' ' ' VAL . 12.7 p -125.77 112.57 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.921 0.867 . . . . 0.89000000000000001 108.761 178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.803 ' HB2' HG22 ' A' ' 463' ' ' VAL . 98.1 m-85 -114.17 163.35 15.34 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.296 -0.866 . . . . 0.16 109.994 -169.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.668 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 71.8 m-85 -146.68 136.68 23.41 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 121.188 -0.205 . . . . 0.68999999999999995 110.974 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.605 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.89 123.13 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 C-N-CA 119.938 -0.705 . . . . 0.14000000000000001 110.552 177.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -107.08 3.41 25.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.602 -0.727 . . . . 0.19 112.035 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.737 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 6.4 t30 -165.4 148.44 8.0 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.461 -0.79 . . . . 0.40999999999999998 110.764 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . 0.423 ' HD2' ' CB ' ' A' ' 458' ' ' GLU . 13.5 mtpt -107.59 109.05 20.6 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.444 -0.798 . . . . 1.0900000000000001 109.714 168.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 2.3 mt-10 -106.41 121.21 43.8 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 122.44 1.114 . . . . 0.38 110.634 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -120.62 134.84 55.24 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.535 -1.211 . . . . 1.96 110.511 -174.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 28.1 t70 51.58 38.72 23.2 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 123.636 1.684 . . . . 0.40000000000000002 107.141 -172.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.532 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -90.29 169.4 11.14 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 112.1 -2.318 . . . . 0.16 111.671 -174.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 7.6 m -127.24 105.12 8.34 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 113.417 -1.719 . . . . 0.27000000000000002 109.626 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.734 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.2 mp -74.27 157.67 35.42 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 112.963 -1.926 . . . . 0.23999999999999999 110.302 174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 7.1 mtpt -148.03 -175.69 4.99 Favored 'General case' 0 N--CA 1.397 -3.094 0 CA-C-N 114.793 -1.094 . . . . 0.67000000000000004 108.454 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.618 ' O ' ' HA ' ' A' ' 402' ' ' PRO . . . 179.45 -141.69 4.89 Favored Glycine 0 CA--C 1.485 -1.816 0 C-N-CA 116.984 -2.531 . . . . 0.81000000000000005 115.13 177.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . 0.402 ' HB ' ' HA2' ' A' ' 400' ' ' GLY . 0.6 OUTLIER -142.45 124.12 15.02 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 112.996 -1.602 . . . . 0.79000000000000004 108.755 172.266 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.558 ' HB2' ' OD1' ' A' ' 399' ' ' ASP . 0.9 OUTLIER -54.36 -178.35 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 112.093 -2.321 . . . . 1.1200000000000001 111.991 177.305 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -51.02 -25.18 4.45 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.834 -0.621 . . . . 1.6499999999999999 111.6 170.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . 0.558 ' OD1' ' HB2' ' A' ' 397' ' ' ASN . 1.1 p30 -102.39 -29.53 11.58 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.193 0.52 . . . . 2.0 111.915 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 396' ' ' THR . . . 114.67 36.85 1.23 Allowed Glycine 0 C--N 1.296 -1.678 0 C-N-CA 119.53 -1.319 . . . . 0.66000000000000003 111.491 -172.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 402' ' ' PRO . 70.9 p -118.22 128.46 25.97 Favored Pre-proline 0 N--CA 1.421 -1.88 0 N-CA-C 106.31 -1.737 . . . . 0.68000000000000005 106.31 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.618 ' HA ' ' O ' ' A' ' 395' ' ' GLY . 32.3 Cg_exo -64.16 162.27 30.47 Favored 'Trans proline' 0 C--N 1.286 -2.759 0 C-N-CA 121.817 1.678 . . . . 0.81000000000000005 112.801 -174.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.549 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 26.6 p90 -143.88 -169.72 3.16 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 113.559 -1.655 . . . . 0.38 106.959 -176.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 13.4 mt-10 -144.67 159.54 42.66 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 122.034 0.921 . . . . 0.62 111.914 173.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.734 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -136.68 99.75 10.31 Favored Pre-proline 0 N--CA 1.425 -1.679 0 CA-C-N 113.355 -1.748 . . . . 1.3300000000000001 108.046 176.239 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 60.0 Cg_endo -67.41 102.83 0.73 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.577 2.185 . . . . 0.20000000000000001 110.653 174.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.781 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -116.31 156.68 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.588 0 CA-C-N 114.146 -1.388 . . . . 0.29999999999999999 109.776 -174.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -105.17 -34.67 7.85 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.529 -1.669 . . . . 1.8400000000000001 107.359 -178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.775 ' HB2' ' SD ' ' A' ' 450' ' ' MET . 52.4 m-85 -137.85 119.43 14.97 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.306 -1.77 . . . . 0.44 111.217 176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.781 ' HB2' HG11 ' A' ' 407' ' ' VAL . 8.1 t-105 -125.2 135.58 52.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 113.841 -1.527 . . . . 0.13 110.185 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.542 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.3 OUTLIER -134.94 85.18 35.59 Favored Pre-proline 0 C--N 1.299 -1.604 0 CA-C-N 114.992 -1.004 . . . . 0.40999999999999998 111.152 174.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 87.5 Cg_endo -72.29 141.23 35.18 Favored 'Trans proline' 0 CA--C 1.512 -0.59 0 C-N-CA 123.161 2.574 . . . . 0.16 112.469 -178.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 4.7 pt -124.97 -15.93 4.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 113.828 -1.533 . . . . 0.17000000000000001 111.031 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -133.93 162.32 32.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.303 -0.862 . . . . 1.5900000000000001 109.393 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 7.5 m-90 -95.03 13.78 23.99 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.355 0.502 . . . . 0.31 112.355 -177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 13.1 p -94.0 -26.66 16.71 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 107.531 -1.285 . . . . 0.44 107.531 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 124.67 33.25 0.77 Allowed Glycine 0 N--CA 1.426 -2.025 0 CA-C-N 113.108 -1.86 . . . . 0.23999999999999999 112.32 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.679 HG13 ' O ' ' A' ' 441' ' ' GLY . 79.8 t -103.16 148.48 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-O 121.184 0.516 . . . . 0.17000000000000001 110.963 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . . . . . . . . . . . 169.97 -167.43 40.52 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-N 114.948 -1.024 . . . . 0.10000000000000001 111.446 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . 0.491 HG21 HD23 ' A' ' 453' ' ' LEU . 0.9 OUTLIER -101.97 140.08 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 N-CA-C 109.141 -0.688 . . . . 0.12 109.141 174.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.542 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 32.2 p80 -146.52 160.54 41.99 Favored 'General case' 0 CA--C 1.501 -0.922 0 CA-C-O 121.956 0.884 . . . . 0.14999999999999999 111.712 176.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.0 OUTLIER -85.72 136.9 33.16 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 113.817 -1.538 . . . . 0.41999999999999998 107.399 170.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.95 102.01 5.87 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 123.015 1.388 . . . . 1.48 110.999 -175.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -94.82 -33.48 12.84 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 112.168 -2.287 . . . . 0.34999999999999998 111.484 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.462 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 21.5 p90 -66.48 -27.24 67.64 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 114.687 -1.142 . . . . 0.17999999999999999 109.505 175.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.695 ' HB3' HD21 ' A' ' 444' ' ' ASN . 0.0 OUTLIER -121.27 81.27 37.3 Favored Pre-proline 0 CA--C 1.494 -1.202 0 CA-C-N 113.664 -1.607 . . . . 1.3300000000000001 110.351 -174.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -82.2 7.84 4.86 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 125.062 3.841 . . . . 0.23000000000000001 114.162 -163.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -114.58 153.35 30.26 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 123.462 0.476 . . . . 1.1000000000000001 110.267 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.666 ' HB2' ' OD2' ' A' ' 367' ' ' ASP . 0.2 OUTLIER -163.47 126.87 2.72 Favored 'General case' 0 CA--C 1.504 -0.809 0 O-C-N 124.756 1.285 . . . . 0.38 108.202 -169.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 146.55 -164.54 28.43 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 118.849 -1.643 . . . . 0.13 111.193 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -27.84 151.04 0.0 OUTLIER Glycine 0 C--N 1.336 0.577 0 O-C-N 125.208 1.181 . . . . 0.20000000000000001 113.075 171.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.97 100.52 0.04 OUTLIER 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 123.863 1.792 . . . . 0.33000000000000002 112.031 -149.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 40.4 mt -97.44 -33.87 11.23 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 110.583 -3.008 . . . . 0.17999999999999999 107.95 174.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.567 ' HA ' HG23 ' A' ' 369' ' ' VAL . 5.1 p-90 -46.2 -37.45 7.12 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.638 0.586 . . . . 0.22 111.61 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.796 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 32.3 mttt -61.5 -23.74 66.11 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 115.223 -0.899 . . . . 0.64000000000000001 112.923 -176.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 44.5 p -113.58 -35.02 5.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.886 0.851 . . . . 0.25 109.879 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.525 ' HB3' ' OE1' ' A' ' 426' ' ' GLN . 3.7 mtp180 -87.2 -16.49 35.19 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.612 -1.176 . . . . 0.35999999999999999 112.785 -170.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.57 ' HA2' ' CB ' ' A' ' 372' ' ' LYS . . . 74.01 41.75 39.28 Favored Glycine 0 C--N 1.309 -0.947 0 N-CA-C 116.264 1.266 . . . . 0.20999999999999999 116.264 159.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 9.0 m -84.21 133.83 34.58 Favored 'General case' 0 C--O 1.211 -0.93 0 CA-C-N 118.233 1.016 . . . . 0.46999999999999997 108.541 174.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.431 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 55.4 m80 -103.96 68.14 0.9 Allowed 'General case' 0 C--N 1.322 -0.615 0 O-C-N 121.45 -0.781 . . . . 0.40999999999999998 110.884 -166.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.679 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 89.46 -11.11 70.97 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.518 -1.033 . . . . 0.17999999999999999 110.518 -178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.542 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 16.6 p -90.68 137.24 32.52 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.211 -0.494 . . . . 0.82999999999999996 110.667 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 377' ' ' THR . 1.4 mp -92.01 120.6 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.118 0 CA-C-O 122.734 1.254 . . . . 0.14999999999999999 111.164 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.709 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 0.8 OUTLIER -79.42 82.44 5.56 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.317 -2.22 . . . . 1.77 112.14 -177.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.497 HG23 HG21 ' A' ' 366' ' ' THR . 19.6 m -86.75 137.72 33.63 Favored Pre-proline 0 N--CA 1.443 -0.803 0 CA-C-O 121.499 0.666 . . . . 0.17999999999999999 109.599 177.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 49.4 Cg_exo -58.67 134.12 58.68 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.562 2.174 . . . . 0.12 110.679 177.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 47.9 Cg_exo -56.43 -34.89 95.69 Favored 'Trans proline' 0 CA--C 1.502 -1.116 0 C-N-CA 123.881 3.054 . . . . 0.16 112.938 -171.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 71.8 m -77.21 -37.59 53.12 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 114.698 -1.137 . . . . 1.1699999999999999 109.778 -178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.678 HG11 ' HB ' ' A' ' 366' ' ' THR . 59.2 t -80.77 -27.39 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.835 -0.62 . . . . 0.17000000000000001 111.063 178.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.775 ' SD ' ' HB2' ' A' ' 409' ' ' TYR . 0.0 OUTLIER -63.62 -35.48 80.66 Favored 'General case' 0 C--O 1.194 -1.844 0 CA-C-O 121.859 0.838 . . . . 0.46000000000000002 109.281 177.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -64.54 -25.03 67.81 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.48 -1.236 . . . . 0.81000000000000005 111.985 177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.647 ' O ' ' HG2' ' A' ' 456' ' ' MET . 16.1 mm-40 -79.1 -46.96 17.0 Favored 'General case' 0 CA--C 1.477 -1.844 0 CA-C-N 113.692 -1.595 . . . . 0.38 107.64 178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.531 ' HA ' ' CG ' ' A' ' 456' ' ' MET . 28.8 tp -64.48 -67.16 0.46 Allowed 'General case' 0 N--CA 1.404 -2.772 0 CA-C-N 111.644 -2.525 . . . . 0.059999999999999998 112.55 176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.673 ' HB2' ' SD ' ' A' ' 450' ' ' MET . 39.8 t80 -49.31 -28.62 5.03 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-O 123.216 1.484 . . . . 0.31 107.919 176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -68.65 -32.43 74.57 Favored Glycine 0 N--CA 1.427 -1.955 0 CA-C-N 112.143 -2.298 . . . . 0.13 112.058 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.647 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -87.83 -48.09 8.09 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.66 0.743 . . . . 0.13 111.677 172.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.562 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.5 OUTLIER -102.3 138.39 26.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 123.604 1.669 . . . . 0.23000000000000001 114.239 -167.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . 0.423 ' CB ' ' HD2' ' A' ' 387' ' ' LYS . 6.6 pt-20 -136.88 -178.27 5.12 Favored 'General case' 0 N--CA 1.406 -2.627 0 CA-C-N 110.634 -2.985 . . . . 0.82999999999999996 106.504 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.737 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 47.0 mtmt -53.17 163.39 0.55 Allowed 'General case' 0 N--CA 1.412 -2.368 0 CA-C-O 123.129 1.442 . . . . 0.23999999999999999 112.661 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.43 -33.49 4.74 Favored Glycine 0 N--CA 1.423 -2.179 0 CA-C-N 112.496 -2.138 . . . . 0.37 112.26 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 462' ' ' PRO . 8.7 m -76.65 141.61 69.21 Favored Pre-proline 0 N--CA 1.433 -1.321 0 N-CA-C 109.335 -0.617 . . . . 0.14999999999999999 109.335 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.64 ' HD2' ' HA ' ' A' ' 344' ' ' TYR . 3.8 Cg_exo -75.26 166.34 29.08 Favored 'Trans proline' 0 N--CA 1.425 -2.525 0 C-N-CA 121.833 1.689 . . . . 0.12 110.865 173.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.803 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.0 OUTLIER -134.71 155.79 39.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 107.449 -1.315 . . . . 1.0900000000000001 107.449 167.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.479 ' CD2' ' HG3' ' A' ' 346' ' ' GLU . 2.2 tp -126.39 145.06 50.61 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.327 -0.851 . . . . 0.13 110.051 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.697 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.22 147.47 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.785 0 N-CA-C 107.189 -1.411 . . . . 0.089999999999999997 107.189 164.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.645 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.0 p90 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.274 -0.869 . . . . 1.1599999999999999 111.496 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.722 0 N-CA-C 111.35 -0.7 . . . . 3.9399999999999999 111.35 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' HIS . . . . . 0.442 ' CD2' HD21 ' A' ' 464' ' ' LEU . 3.2 t-160 62.24 90.79 0.07 Allowed 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.737 0.779 . . . . 1.8500000000000001 110.861 179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' MET . . . . . . . . . . . . . 37.2 mtm 63.76 -171.81 0.17 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 113.699 -1.592 . . . . 1.03 111.744 -176.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.83 -3.17 0.4 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.253 -0.885 . . . . 1.1000000000000001 111.392 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -55.67 167.71 0.51 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 122.954 1.359 . . . . 0.97999999999999998 113.117 172.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' THR . . . . . 0.655 HG23 ' HA ' ' A' ' 358' ' ' LYS . 8.5 m -92.26 121.92 34.24 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 113.376 -1.738 . . . . 0.45000000000000001 107.761 168.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' TYR . . . . . 0.631 ' HA ' ' HD2' ' A' ' 462' ' ' PRO . 8.0 p90 -157.11 -171.08 3.49 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 121.596 0.712 . . . . 0.32000000000000001 111.178 -174.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ILE . . . . . 0.547 HD12 HD11 ' A' ' 453' ' ' LEU . 10.3 mm -103.05 161.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 N-CA-C 108.055 -1.091 . . . . 0.080000000000000002 108.055 167.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.52 ' HG2' ' HE2' ' A' ' 466' ' ' PHE . 3.1 tt0 -141.53 155.36 45.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 CA-C-N 118.96 0.8 . . . . 0.17000000000000001 111.493 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 354' ' ' MET . 76.2 t -150.98 137.4 12.58 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.701 -1.136 . . . . 0.080000000000000002 110.355 -177.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -123.48 107.34 11.47 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.852 -1.166 . . . . 0.37 107.852 175.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.499 ' H ' HD22 ' A' ' 349' ' ' LEU . 2.3 mm? -68.26 -39.43 82.2 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-N 113.228 -1.805 . . . . 0.32000000000000001 111.24 -168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -65.4 -55.78 16.16 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 112.022 -2.354 . . . . 1.51 111.432 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -93.51 11.83 27.25 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.62 -1.173 . . . . 0.91000000000000003 108.654 -175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' GLN . . . . . 0.689 ' HB3' ' O ' ' A' ' 368' ' ' ILE . 2.4 mm-40 35.36 73.28 0.09 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 125.537 1.773 . . . . 2.2200000000000002 113.079 177.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' HIS . . . . . 0.478 ' HA ' ' O ' ' A' ' 366' ' ' THR . 6.0 t60 -151.15 125.59 9.48 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.333 -0.849 . . . . 0.13 109.625 -177.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' MET . . . . . 0.73 ' HG3' HG22 ' A' ' 347' ' ' VAL . 3.0 ttp -113.34 127.48 56.15 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 123.478 0.711 . . . . 0.059999999999999998 110.358 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' TRP . . . . . 0.682 ' CD1' ' HB3' ' A' ' 365' ' ' GLU . 32.5 m-90 -113.14 173.68 6.27 Favored 'General case' 0 CA--C 1.499 -0.987 0 CA-C-N 114.659 -1.155 . . . . 0.10000000000000001 111.886 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' TYR . . . . . 0.703 ' CD1' ' HB3' ' A' ' 363' ' ' ALA . 2.5 t80 -127.12 117.44 22.4 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 106.625 -1.62 . . . . 0.22 106.625 165.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 362' ' ' VAL . 26.5 m-85 -101.37 126.33 48.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-O 122.146 0.974 . . . . 0.17999999999999999 112.362 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.655 ' HA ' HG23 ' A' ' 343' ' ' THR . 3.8 ttpt -148.96 137.5 21.11 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 113.099 -1.864 . . . . 0.46999999999999997 108.458 175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ASP . . . . . 0.433 ' N ' ' HG3' ' A' ' 358' ' ' LYS . 1.4 t70 70.52 15.98 7.08 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 113.334 -1.757 . . . . 0.59999999999999998 108.822 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' GLY . . . . . . . . . . . . . . . 79.39 16.03 78.87 Favored Glycine 0 N--CA 1.426 -1.97 0 CA-C-N 112.561 -2.109 . . . . 0.23000000000000001 111.551 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LYS . . . . . 0.582 ' HG3' ' N ' ' A' ' 362' ' ' VAL . 0.1 OUTLIER -133.86 169.75 16.62 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-N 112.344 -1.928 . . . . 0.68000000000000005 106.255 -169.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . 0.752 HG21 ' HG2' ' A' ' 365' ' ' GLU . 3.2 m -101.03 137.5 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.847 0 CA-C-O 124.325 2.012 . . . . 0.53000000000000003 111.824 178.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ALA . . . . . 0.703 ' HB3' ' CD1' ' A' ' 356' ' ' TYR . . . -92.47 -24.31 18.85 Favored 'General case' 0 N--CA 1.398 -3.047 0 CA-C-N 109.211 -3.632 . . . . 0.12 108.573 176.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . 0.672 ' HB2' ' SD ' ' A' ' 456' ' ' MET . 3.2 tp -153.71 154.93 35.0 Favored 'General case' 0 N--CA 1.416 -2.163 0 CA-C-N 113.729 -1.578 . . . . 0.080000000000000002 108.919 -172.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.752 ' HG2' HG21 ' A' ' 362' ' ' VAL . 0.0 OUTLIER -166.08 122.06 1.29 Allowed 'General case' 0 CA--C 1.495 -1.155 0 CA-C-N 115.683 -0.69 . . . . 0.60999999999999999 109.562 -175.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.668 ' HB ' HG11 ' A' ' 449' ' ' VAL . 5.7 t -148.7 167.58 25.16 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-O 122.22 1.009 . . . . 0.089999999999999997 112.3 174.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 429' ' ' TYR . 6.3 p-10 -86.09 139.9 30.71 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-N 113.163 -1.835 . . . . 1.8799999999999999 107.913 177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.689 ' O ' ' HB3' ' A' ' 352' ' ' GLN . 1.9 pp -140.8 -172.75 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.138 -0.937 . . . . 0.11 112.22 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 434' ' ' TRP . 0.2 OUTLIER -156.82 115.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.133 -0.939 . . . . 0.12 109.704 174.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' SER . . . . . 0.574 ' H ' HE22 ' A' ' 352' ' ' GLN . 30.2 t -140.54 149.67 42.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.775 -0.648 . . . . 0.69999999999999996 112.535 -169.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 376' ' ' PRO . . . 71.35 44.17 52.57 Favored Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 116.854 1.502 . . . . 0.13 116.854 162.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' LYS . . . . . 0.508 ' HB3' ' HA2' ' A' ' 438' ' ' GLY . 1.6 pttt -47.61 146.1 3.86 Favored Pre-proline 0 C--O 1.22 -0.495 0 CA-C-N 119.153 1.477 . . . . 0.47999999999999998 110.683 -174.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' PRO . . . . . 0.794 ' CD ' ' HA ' ' A' ' 435' ' ' LYS . 0.1 OUTLIER -33.61 -34.19 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.726 1 C-N-CA 125.985 4.457 . . . . 0.23000000000000001 115.71 -174.127 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' THR . . . . . . . . . . . . . 2.1 p -77.43 -39.35 47.15 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.171 0.51 . . . . 0.29999999999999999 110.975 -178.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 376' ' ' PRO . 4.1 m -140.21 72.83 32.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 122.263 1.03 . . . . 0.29999999999999999 110.197 -177.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' PRO . . . . . 0.677 ' HA ' ' O ' ' A' ' 371' ' ' GLY . 31.9 Cg_exo -69.13 164.46 33.84 Favored 'Trans proline' 0 C--N 1.322 -0.84 1 C-N-CA 125.64 4.227 . . . . 0.16 114.463 -176.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . 0.701 HG21 HD11 ' A' ' 443' ' ' ILE . 0.1 OUTLIER -76.4 152.01 83.45 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 113.565 -1.652 . . . . 0.12 110.45 174.506 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.519 ' CD ' HG22 ' A' ' 377' ' ' THR . 1.2 Cg_endo -79.55 -49.07 0.07 OUTLIER 'Trans proline' 0 C--N 1.328 -0.516 0 C-N-CA 125.093 3.862 . . . . 0.089999999999999997 113.813 -170.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' ALA . . . . . 0.704 ' HB1' ' HA ' ' A' ' 466' ' ' PHE . . . 68.34 122.8 0.03 OUTLIER 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.921 1.082 . . . . 0.089999999999999997 113.921 -178.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' GLY . . . . . . . . . . . . . . . 164.21 -122.26 1.07 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.257 -1.338 . . . . 0.11 111.426 -177.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 381' ' ' VAL . 14.1 p -128.01 112.94 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 CA-C-O 121.86 0.838 . . . . 0.89000000000000001 108.812 177.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' PHE . . . . . 0.78 ' HB2' HG22 ' A' ' 463' ' ' VAL . 95.9 m-85 -115.79 161.21 19.07 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.42 -0.809 . . . . 0.16 109.697 -170.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 413' ' ' ILE . 75.1 m-85 -147.78 136.31 21.68 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 121.132 -0.227 . . . . 0.68999999999999995 110.681 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' VAL . . . . . 0.639 HG22 ' HG2' ' A' ' 459' ' ' LYS . 0.2 OUTLIER -74.6 125.31 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 119.855 -0.738 . . . . 0.14000000000000001 110.653 177.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' TRP . . . . . . . . . . . . . 29.8 p-90 -110.71 0.7 17.52 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.436 -0.802 . . . . 0.19 112.176 -176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' ASN . . . . . 0.729 ' HA ' ' HD3' ' A' ' 459' ' ' LYS . 5.2 t30 -162.56 149.25 13.08 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.155 -0.93 . . . . 0.40999999999999998 109.639 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' LYS . . . . . . . . . . . . . 16.5 mtpt -113.0 119.76 39.01 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 121.807 0.813 . . . . 1.0900000000000001 109.934 172.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.568 ' CB ' ' HB3' ' A' ' 410' ' ' TRP . 3.1 mt-10 -119.35 121.28 39.2 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.226 -1.352 . . . . 0.38 111.229 -177.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -118.78 143.58 46.83 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 114.032 -1.44 . . . . 1.96 109.774 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ASP . . . . . . . . . . . . . 24.0 t70 54.1 26.12 6.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 111.835 -2.439 . . . . 0.40000000000000002 108.637 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 388' ' ' GLU . . . -83.26 171.16 13.88 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 112.769 -2.014 . . . . 0.16 111.879 -167.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' THR . . . . . . . . . . . . . 8.9 m -129.89 102.95 6.52 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 113.628 -1.624 . . . . 0.27000000000000002 110.159 -177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . 0.735 ' HB2' ' CB ' ' A' ' 405' ' ' SER . 10.1 mp -72.42 156.89 38.58 Favored 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 112.254 -2.248 . . . . 0.23999999999999999 110.242 175.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 403' ' ' TYR . 9.7 mtpt -149.14 -175.85 5.13 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 114.436 -1.256 . . . . 0.67000000000000004 108.419 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' GLY . . . . . 0.534 ' HA3' ' CE2' ' A' ' 403' ' ' TYR . . . -179.08 -138.99 3.41 Favored Glycine 0 CA--C 1.482 -2.023 0 C-N-CA 117.12 -2.467 . . . . 0.81000000000000005 114.515 175.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.11 122.36 13.89 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-N 113.113 -1.543 . . . . 0.79000000000000004 108.311 171.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ASN . . . . . 0.512 ' HB2' ' OG1' ' A' ' 401' ' ' THR . 0.9 OUTLIER -52.7 -179.69 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 112.652 -2.067 . . . . 1.1200000000000001 111.304 175.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -56.03 -23.95 36.36 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.482 0.658 . . . . 1.6499999999999999 109.954 169.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -88.72 -27.18 21.37 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-N 115.088 -0.96 . . . . 2.0 111.061 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.75 31.84 5.59 Favored Glycine 0 N--CA 1.436 -1.326 0 N-CA-C 110.328 -1.109 . . . . 0.66000000000000003 110.328 -169.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 397' ' ' ASN . 41.3 p -119.2 127.79 26.29 Favored Pre-proline 0 N--CA 1.42 -1.949 0 N-CA-C 106.746 -1.576 . . . . 0.68000000000000005 106.746 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 401' ' ' THR . 1.0 OUTLIER -71.13 156.0 60.32 Favored 'Trans proline' 0 N--CA 1.407 -3.585 0 C-N-CA 121.124 1.216 . . . . 0.81000000000000005 112.836 -168.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' TYR . . . . . 0.534 ' CE2' ' HA3' ' A' ' 395' ' ' GLY . 38.9 p90 -131.88 -169.73 2.26 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 113.516 -1.674 . . . . 0.38 107.491 -177.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' GLU . . . . . 0.643 ' HA ' ' O ' ' A' ' 393' ' ' LEU . 14.8 mt-10 -144.59 159.6 42.53 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 122.535 1.16 . . . . 0.62 111.446 173.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' SER . . . . . 0.735 ' CB ' ' HB2' ' A' ' 393' ' ' LEU . 0.1 OUTLIER -137.44 99.23 9.71 Favored Pre-proline 0 N--CA 1.421 -1.906 0 CA-C-N 112.822 -1.99 . . . . 1.3300000000000001 107.791 174.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 405' ' ' SER . 61.7 Cg_endo -68.17 102.1 0.77 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.269 1.979 . . . . 0.20000000000000001 110.362 174.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 410' ' ' TRP . 1.2 t -114.69 162.56 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.631 0 CA-C-N 114.446 -1.252 . . . . 0.29999999999999999 109.95 -173.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' ASN . . . . . 0.415 HD22 ' CG ' ' A' ' 422' ' ' ASP . 23.4 m-80 -112.14 -34.99 5.77 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 113.597 -1.638 . . . . 1.8400000000000001 107.018 -177.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' TYR . . . . . 0.49 ' HB2' ' HG3' ' A' ' 450' ' ' MET . 54.5 m-85 -134.56 115.89 14.41 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 112.966 -1.925 . . . . 0.44 110.879 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' TRP . . . . . 0.748 ' HB2' HG11 ' A' ' 407' ' ' VAL . 7.9 t-105 -123.41 134.78 53.93 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.237 -1.347 . . . . 0.13 110.263 -179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' MET . . . . . 0.577 ' HG2' HG21 ' A' ' 384' ' ' VAL . 0.1 OUTLIER -135.83 86.18 27.92 Favored Pre-proline 0 C--N 1.3 -1.582 0 CA-C-N 114.808 -1.087 . . . . 0.40999999999999998 111.293 174.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . 0.708 ' HD2' ' O ' ' A' ' 386' ' ' ASN . 98.1 Cg_endo -71.84 140.03 34.52 Favored 'Trans proline' 0 CA--C 1.51 -0.683 0 C-N-CA 122.961 2.441 . . . . 0.16 112.175 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' ILE . . . . . 0.666 ' HA ' ' O ' ' A' ' 383' ' ' TYR . 5.2 pt -123.05 -15.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 113.883 -1.508 . . . . 0.17000000000000001 110.869 -173.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -134.86 163.55 29.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.249 -0.887 . . . . 1.5900000000000001 109.552 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -95.03 13.83 23.85 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.529 0.566 . . . . 0.31 112.529 -176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' THR . . . . . . . . . . . . . 10.6 p -93.1 -27.22 17.08 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 107.412 -1.329 . . . . 0.44 107.412 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' GLY . . . . . . . . . . . . . . . 125.61 30.89 0.86 Allowed Glycine 0 N--CA 1.425 -2.063 0 CA-C-N 112.919 -1.946 . . . . 0.23999999999999999 112.086 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 441' ' ' GLY . 70.7 t -102.08 148.88 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 120.564 -0.455 . . . . 0.17000000000000001 110.976 177.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 412' ' ' PRO . . . 171.49 -166.47 39.51 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.118 -0.946 . . . . 0.10000000000000001 111.812 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -102.95 141.04 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.131 0 N-CA-C 108.815 -0.809 . . . . 0.12 108.815 176.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' HIS . . . . . 0.554 ' CD2' ' HB2' ' A' ' 442' ' ' CYS . 33.5 p80 -150.22 165.55 32.6 Favored 'General case' 0 CA--C 1.499 -1.012 0 CA-C-O 121.721 0.772 . . . . 0.14999999999999999 111.215 178.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' ASP . . . . . 0.812 ' HB2' ' HA ' ' A' ' 447' ' ' PRO . 0.1 OUTLIER -91.72 147.98 22.59 Favored 'General case' 0 N--CA 1.417 -2.118 0 CA-C-N 113.9 -1.5 . . . . 0.41999999999999998 107.11 171.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' SER . . . . . 0.516 ' OG ' ' HB2' ' A' ' 426' ' ' GLN . 3.7 t -141.87 103.97 4.43 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 122.988 1.375 . . . . 1.48 110.589 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -93.63 -30.23 15.05 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 111.915 -2.402 . . . . 0.34999999999999998 111.13 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' TRP . . . . . 0.445 ' HH2' ' HG ' ' A' ' 405' ' ' SER . 17.1 p90 -68.95 -27.02 65.36 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 114.52 -1.218 . . . . 0.17999999999999999 109.352 176.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLN . . . . . 0.516 ' HB2' ' OG ' ' A' ' 423' ' ' SER . 0.0 OUTLIER -119.44 81.18 22.76 Favored Pre-proline 0 CA--C 1.493 -1.231 0 CA-C-N 113.581 -1.645 . . . . 1.3300000000000001 109.311 -176.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -82.32 8.13 4.7 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 124.95 3.767 . . . . 0.23000000000000001 113.694 -163.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -114.08 147.64 38.41 Favored 'General case' 0 N--CA 1.442 -0.866 0 O-C-N 123.925 0.765 . . . . 1.1000000000000001 109.572 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' TYR . . . . . 0.546 ' HA ' HG12 ' A' ' 369' ' ' VAL . 0.8 OUTLIER -158.84 128.43 5.65 Favored 'General case' 0 C--N 1.315 -0.892 0 C-N-CA 124.993 1.317 . . . . 0.38 107.67 -172.16 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 147.33 -165.16 28.67 Favored Glycine 0 N--CA 1.431 -1.68 0 C-N-CA 118.884 -1.627 . . . . 0.13 111.196 179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 433' ' ' LEU . . . -30.36 154.02 0.0 OUTLIER Glycine 0 C--N 1.336 0.58 0 O-C-N 124.879 0.988 . . . . 0.20000000000000001 113.013 172.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.404 ' HB3' ' NE1' ' A' ' 434' ' ' TRP . 3.0 m-20 -56.47 101.32 0.06 Allowed 'General case' 0 CA--C 1.496 -1.121 0 CA-C-O 123.612 1.673 . . . . 0.33000000000000002 112.143 -147.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 431' ' ' GLY . 49.8 mt -97.8 -31.94 11.97 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 110.654 -2.975 . . . . 0.17999999999999999 108.178 175.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' TRP . . . . . 0.573 ' HA ' HG23 ' A' ' 369' ' ' VAL . 9.0 p-90 -44.78 -40.23 5.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 123.674 0.609 . . . . 0.22 111.737 -176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' LYS . . . . . 0.794 ' HA ' ' CD ' ' A' ' 373' ' ' PRO . 37.0 mttt -61.14 -23.68 65.71 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 113.009 0.744 . . . . 0.64000000000000001 113.009 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' THR . . . . . . . . . . . . . 37.2 p -113.57 -35.92 5.08 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.455 -0.793 . . . . 0.25 110.208 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.492 ' HG3' ' HB3' ' A' ' 433' ' ' LEU . 10.4 mtp85 -88.91 -15.69 33.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.858 -1.064 . . . . 0.35999999999999999 113.204 -168.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 372' ' ' LYS . . . 76.46 41.45 25.17 Favored Glycine 0 C--N 1.31 -0.914 0 N-CA-C 116.59 1.396 . . . . 0.20999999999999999 116.59 158.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' SER . . . . . . . . . . . . . 21.6 m -83.51 141.8 31.37 Favored 'General case' 0 C--O 1.214 -0.811 0 CA-C-N 118.136 0.968 . . . . 0.46999999999999997 108.752 174.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' HIS . . . . . 0.511 ' HB2' ' OH ' ' A' ' 403' ' ' TYR . 57.8 m80 -109.31 73.08 0.83 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.726 -0.609 . . . . 0.40999999999999998 110.836 -170.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' GLY . . . . . 0.664 ' O ' HG13 ' A' ' 418' ' ' VAL . . . 82.8 -8.54 62.35 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.914 -0.874 . . . . 0.17999999999999999 110.914 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' CYS . . . . . 0.554 ' HB2' ' CD2' ' A' ' 421' ' ' HIS . 25.9 p -96.06 131.96 41.92 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.322 0.582 . . . . 0.82999999999999996 110.526 -176.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' ILE . . . . . 0.701 HD11 HG21 ' A' ' 377' ' ' THR . 1.5 mp -88.77 117.14 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 115.283 -0.871 . . . . 0.14999999999999999 111.109 -174.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ASN . . . . . 0.551 ' HB2' ' O ' ' A' ' 369' ' ' VAL . 2.8 t30 -78.44 82.54 4.71 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.492 -1.685 . . . . 1.77 111.572 -175.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' THR . . . . . 0.593 HG23 HG21 ' A' ' 366' ' ' THR . 27.7 m -87.78 140.4 31.35 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-O 121.508 0.67 . . . . 0.17999999999999999 110.048 178.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 445' ' ' THR . 51.4 Cg_exo -57.37 136.48 76.37 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 122.815 2.343 . . . . 0.12 111.714 177.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' PRO . . . . . 0.812 ' HA ' ' HB2' ' A' ' 422' ' ' ASP . 52.3 Cg_exo -56.03 -32.53 86.58 Favored 'Trans proline' 0 CA--C 1.502 -1.084 0 C-N-CA 124.296 3.331 . . . . 0.16 112.888 -173.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 15.1 p -81.72 -38.22 26.09 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 114.717 -1.129 . . . . 1.1699999999999999 110.115 -177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' VAL . . . . . 0.668 HG11 ' HB ' ' A' ' 366' ' ' THR . 88.2 t -80.29 -29.88 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.326 0.584 . . . . 0.17000000000000001 111.407 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' MET . . . . . 0.683 ' HG2' ' N ' ' A' ' 422' ' ' ASP . 6.0 tpt -66.65 -19.62 65.81 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.842 0.83 . . . . 0.46000000000000002 110.115 177.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -79.94 -23.6 41.59 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 114.511 -1.222 . . . . 0.81000000000000005 111.124 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 456' ' ' MET . 6.8 mm-40 -78.31 -47.36 17.94 Favored 'General case' 0 CA--C 1.473 -2.015 0 CA-C-N 113.192 -1.822 . . . . 0.38 107.103 177.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' LEU . . . . . 0.59 HD23 ' SD ' ' A' ' 450' ' ' MET . 26.5 tp -63.92 -67.36 0.44 Allowed 'General case' 0 N--CA 1.402 -2.865 0 CA-C-N 111.642 -2.526 . . . . 0.059999999999999998 112.292 175.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' PHE . . . . . 0.434 ' CD1' ' SD ' ' A' ' 411' ' ' MET . 38.1 t80 -49.95 -26.93 4.64 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 123.193 1.473 . . . . 0.31 108.303 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' GLY . . . . . 0.408 ' N ' ' C ' ' A' ' 453' ' ' LEU . . . -70.86 -31.81 66.95 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 112.426 -2.17 . . . . 0.13 112.291 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' MET . . . . . 0.678 ' HG2' ' O ' ' A' ' 452' ' ' GLU . 1.6 ptp -87.5 -48.0 8.28 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.637 0.732 . . . . 0.13 111.586 172.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' VAL . . . . . 0.546 ' CB ' HD11 ' A' ' 345' ' ' ILE . 0.6 OUTLIER -102.84 139.05 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 123.407 1.575 . . . . 0.23000000000000001 114.06 -168.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -136.46 -178.62 5.25 Favored 'General case' 0 N--CA 1.404 -2.758 0 CA-C-N 110.961 -2.836 . . . . 0.82999999999999996 107.108 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' LYS . . . . . 0.729 ' HD3' ' HA ' ' A' ' 386' ' ' ASN . 43.8 mtmt -50.44 160.8 0.36 Allowed 'General case' 0 N--CA 1.411 -2.385 0 CA-C-O 123.043 1.401 . . . . 0.23999999999999999 113.109 176.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' GLY . . . . . . . . . . . . . . . 91.26 -35.93 3.78 Favored Glycine 0 N--CA 1.424 -2.128 0 CA-C-N 112.565 -2.107 . . . . 0.37 112.354 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 462' ' ' PRO . 3.9 m -74.44 141.12 76.31 Favored Pre-proline 0 N--CA 1.437 -1.11 0 N-CA-C 109.452 -0.573 . . . . 0.14999999999999999 109.452 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 383' ' ' TYR . 5.1 Cg_exo -75.18 166.26 29.36 Favored 'Trans proline' 0 N--CA 1.422 -2.682 0 C-N-CA 121.98 1.787 . . . . 0.12 111.07 174.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' VAL . . . . . 0.78 HG22 ' HB2' ' A' ' 382' ' ' PHE . 1.1 m -133.65 154.76 39.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 N-CA-C 107.455 -1.313 . . . . 1.0900000000000001 107.455 166.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.442 HD21 ' CD2' ' A' ' 339' ' ' HIS . 3.0 tp -124.36 144.82 49.81 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-N 115.317 -0.856 . . . . 0.13 110.087 178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' VAL . . . . . 0.686 HG22 ' HA ' ' A' ' 379' ' ' ALA . 1.0 OUTLIER -143.17 146.67 21.27 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 106.843 -1.54 . . . . 0.089999999999999997 106.843 165.1 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' PHE . . . . . 0.704 ' HA ' ' HB1' ' A' ' 379' ' ' ALA . 15.4 p90 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.79 -0.624 . . . . 1.1599999999999999 111.486 -176.617 . . . . . . . . 1 1 . 1 stop_ save_